Citrus Sinensis ID: 038860

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650--
Protein Sequence
MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFENGVSYPSLSTSPITLVYGRD
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHcccccccccEEccccccccccEEEEEcEEEccccEEEEcccccccEEEEEEcccccccccccccccEEEEEEEEEEEccccccccccEEEEEccccccccccccccccccccccccccccEEEEEEEcccccccccccccEEEEEEccEEEEEEEEccEEccccccccccccccccEEEEEEEEccccEEEEEEEEccccccccEEEEEEcccccccccEEEEEccccccccccEEEEcccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHEEEcccHHHHHHHcccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEEEcccccHHHHHHHHHHHHHHcccccccccccEEEccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccEEEEEccccccccEEEccccccccccccccEEccccccccccEEEcccccccccccccccccccccEEHHHHHHHHHHccccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHccccccccccccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHccccEEEEcccccccccEEEccEEEEccccEEEEEcccccccccEccccccEEEccccccEEEEEEEEEEEEEcccccccccEEEEEEEccccccccHHHHHEEEccccccccccEEEEEEEEcccccccccccccEEEEEEccccccccccccEEccccccEEEEEEccccEEEEEEcccccEEEEEEEccccccccccEEEEEccHHHccccEEEEEEEEEccccccccEEEEEEEccccccccccHHHcccccccccccccHEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHcccccccccccccccEEEEcEccccccEEEEEEEccccHccHHHHHHHHHHHHHcHHHHHHHHHHHHcccccEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHccEccccccHHHEEEcHHHcEEEccccccccccccccEEEccEEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccEEEHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHccccccccccHHHHHHHHccccccccccccccccHHHHHHHcccccccccccccccccccccc
Coil and Loop (DISEMBL)
MASFLRIFSALIFLsipvssqldelffpgfkdlsnnltlqgiakienngilrltndtsrkMGQAFYSSTLrfknslnsnvfsfSTSFAIVivpeyprlgghglaftispsndlnglpsqylgllnstdignfsnhlfavefdtvqdfefqdindnhigidinsmksnASVEAAvytdnstkqdlslkggKAILVWVDYdsaenilnvtvspnsskpkipilsfrvdlspifnefmyvgfsastgllasshnvlgwsfkingparaldlsslpslpgpkkkhhtgaIVGVSIASVVLAICILSLAIIYIIKKIKnaeviedwelevgpqrysYQELKQATNNFSakqllghggfgqvykgtlhnskTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMangsldsflfdepkavLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLldselngklgdfGLAKlyehgtnpattrvvgtlgylapetprtgkssassdVFAFGALLLEVAcgrrpietralpeeLVLVDWVwgkygegrvlevidpklnaeydqsqvlmgelelpdtlrgprssdgdkaAEGFDDLLNSLasssfdkttscsyfengvsypslstspitlvygrd
Flexible Loop (DISEMBL)
MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTdnstkqdlslKGGKAILVWVDYDSAENILNVtvspnsskpkiPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVkrisneskqgvrEFVSeiatigrlrhrnlvqlVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYehgtnpattrvVGTLGYLAPETprtgkssassDVFAFGALLLEVACGRRPietralpeelvlvdWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSyfengvsypslstspitlvygrd
Low Complexity Region (SEG)
MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQdindnhigidinSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDlsslpslpgpkkkHHTGAIVGVSIASVVlaicilslaiiyiikkiknaEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFENGVSYPSLSTSPITLVYGRD
Disordered region (IsUnstruct)
***FLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDN**KQDLSLKGGKAILVWVDYDSAENILNVTVSP***KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALD**************HTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI*****QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA*************DVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQ**VL*****************************************SCSYFENGVSY*******ITL*****
Disordered Region (DISOPRED)
*ASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKIN************************AIVGVSIASVVLAICILSLAIIYIIKKIKN*********EVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKR*************SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET***PEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLA**********************************
Disordered Region (DISEMBL)
MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE*********SSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFENGVSYPSLSTSPITLVYGRD
Disordered Region (DISPRO)
MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFEN*******************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFENGVSYPSLSTSPITLVYGRD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	652	2.2.26 [Sep-21-2011]
Q9M2S4	684	L-type lectin-domain cont	yes	no	0.871	0.830	0.611	0.0
Q9M345	677	L-type lectin-domain cont	no	no	0.868	0.836	0.521	1e-167
Q9SZD5	669	L-type lectin-domain cont	no	no	0.831	0.810	0.523	1e-163
O81291	669	L-type lectin-domain cont	no	no	0.891	0.868	0.494	1e-161
O80939	675	L-type lectin-domain cont	no	no	0.843	0.814	0.525	1e-161
O81292	674	L-type lectin-domain cont	no	no	0.868	0.839	0.496	1e-158
O04534	666	Putative L-type lectin-do	no	no	0.848	0.830	0.501	1e-157
O04533	656	Putative L-type lectin-do	no	no	0.823	0.818	0.466	1e-141
Q9M1G4	674	Probable L-type lectin-do	no	no	0.872	0.844	0.453	1e-139
Q9FIF1	674	Probable L-type lectin-do	no	no	0.826	0.799	0.476	1e-138

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  723 bits (1865), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/574 (61%), Positives = 449/574 (78%), Gaps = 6/574 (1%)

Query: 18  VSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLN 77
           VSS + +  F GFK  S NLTL G+A+I   G +RLT +T R +G AFYS  +RFK    
Sbjct: 19  VSSLIQDFSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIGV 78

Query: 78  SNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNG-LPSQYLGLLNSTDIGNFSNHL 136
           +   SFSTSFAI +VPE+  LGGHGLAF I+P+ DL G LPSQYLGLLNS+ + NFS+H 
Sbjct: 79  NRALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRV-NFSSHF 137

Query: 137 FAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWV 196
           FAVEFDTV+D EF+DINDNH+GIDINSM+S+ S  A  +  NSTK++L L GG+ I  W+
Sbjct: 138 FAVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWI 197

Query: 197 DYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWS 256
           DYDS +  L+V +SP S KPK+ +LS+ VDLS +  + MYVGFSASTGLLASSH +LGW+
Sbjct: 198 DYDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWN 257

Query: 257 FKINGPARALDLSSLPSLPGP---KKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIK 313
           F ++G A +L L SLP +P     +KK     I+GVS+   +L   +L  A +++++K+K
Sbjct: 258 FNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVRKVK 317

Query: 314 NAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
           + + +E+WEL+ GP R+SY+ELK+ATN F  K+LLG GGFG+VYKG L  S   VAVKRI
Sbjct: 318 DEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRI 377

Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-P 432
           S+ES+QGVREF+SE+++IG LRHRNLVQL+GWCRR+ DLLLVYDFM NGSLD +LFDE P
Sbjct: 378 SHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENP 437

Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + +L W+QRFKIIKGVASGLLYLHEG+EQ VIHRD+KA+NVLLDSE+NG++GDFGLAKLY
Sbjct: 438 EVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLY 497

Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL 552
           EHG++P  TRVVGT GYLAPE  ++GK + S+DV+AFGA+LLEVACGRRPIET ALPEEL
Sbjct: 498 EHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEEL 557

Query: 553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
           V+VDWVW ++  G + +V+D +LN E+D+ +V+M
Sbjct: 558 VMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVM 591

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  588 bits (1517), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 300/575 (52%), Positives = 410/575 (71%), Gaps = 9/575 (1%)

Query: 19  SSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNS 78
           SSQ     + GF     +++LQG+A +  NG+L+LTN + +K G AF +  +RFK+S N 
Sbjct: 21  SSQNLNFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFKDSQNG 80

Query: 79  NVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN-GLPSQYLGLLNSTDIGNFSNHLF 137
           NV SFST+F   I  + P L GHG+AF ++P+  L   LPSQY+GL N ++ GN +NH+F
Sbjct: 81  NVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGNDTNHIF 140

Query: 138 AVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTK-QDLSLKGGKAILVWV 196
           AVEFDT+Q  EF D NDNH+GID+N ++S A+   A Y D+  K Q+LSL   K I VW+
Sbjct: 141 AVEFDTIQSSEFGDPNDNHVGIDLNGLRS-ANYSTAGYRDDHDKFQNLSLISRKRIQVWI 199

Query: 197 DYDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGW 255
           DYD+  + ++VTV+P +S KP+ P++S+  DLS I  E MYVGFS++TG + S H ++GW
Sbjct: 200 DYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLSEHFLVGW 259

Query: 256 SFKINGPARALDLSSLPSLPG--PKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIK 313
           SF++NG A  L LS LP LP   P++      I G+ + S+ L   I+ LA   + +K K
Sbjct: 260 SFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKI-GMPLISLSLIFSIIFLAFYIVRRKKK 318

Query: 314 NAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
             E ++DWE E G  R+ ++EL  AT  F  K LLG GGFG+VY+G L  +K EVAVKR+
Sbjct: 319 YEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRV 378

Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
           S++SKQG++EFV+EI +IGR+ HRNLV L+G+CRR+G+LLLVYD+M NGSLD +L++ P+
Sbjct: 379 SHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPE 438

Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+W+QR  IIKGVASGL YLHE +EQVVIHRDVKASNVLLD++ NG+LGDFGLA+LY+
Sbjct: 439 TTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYD 498

Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE-L 552
           HG++P TT VVGTLGYLAPE  RTG+++ ++DV+AFGA LLEV  GRRPIE  +  ++  
Sbjct: 499 HGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTF 558

Query: 553 VLVDWVWGKYGEGRVLEVIDPKLNAE-YDQSQVLM 586
           +LV+WV+  +  G ++E  DPKL +  YD  +V M
Sbjct: 559 LLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEM 593

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  575 bits (1483), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 291/556 (52%), Positives = 390/556 (70%), Gaps = 14/556 (2%)

Query: 41  GIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGG 100
           GIA   + G+++LTN +    G  FY+S +RFKNS N  V SFST+F   IV     L G
Sbjct: 39  GIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGTVSSFSTTFVFAIVSNVNALDG 98

Query: 101 HGLAFTISPSNDLNGLP----SQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNH 156
           HGLAF ISP+    GLP    SQYLGL N T+ G+ SNH+ AVEFDT Q+ EF D+++NH
Sbjct: 99  HGLAFVISPTK---GLPYSSSSQYLGLFNLTNNGDPSNHIVAVEFDTFQNQEFDDMDNNH 155

Query: 157 IGIDINSMKSNASVEAAVYTDNS-TKQDLSLKGGKAILVWVDYDSAENILNVTVSP-NSS 214
           +GIDINS+ S  +  A  Y D+  T +++ L   K I  W++YDS+   LNVT+ P +  
Sbjct: 156 VGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLP 215

Query: 215 KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSL 274
           KPKIP+LS   DLSP   + MYVGF+++TG L SSH +LGW+FK+NG A  +D+S LP L
Sbjct: 216 KPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLPKL 275

Query: 275 PGPKKKHHTGAIVGVSIASVVLAICI-LSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQ 333
           P   +      I+ +S++   LAI + L+++ +  +K+ K  EV+EDWE++ GP R++Y+
Sbjct: 276 PRDSRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKKLMEVLEDWEVQFGPHRFAYK 335

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR 393
           +L  AT  F   +LLG GGFG+VYKGTL  S  ++AVK++S++S+QG+REFV+EIATIGR
Sbjct: 336 DLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGR 395

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           LRH NLV+L+G+CRRKG+L LVYD M  GSLD FL+ +P+  L+W QRFKIIK VASGL 
Sbjct: 396 LRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLC 455

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           YLH  + QV+IHRD+K +NVLLD  +NGKLGDFGLAKL EHG +P T+ V GT GY++PE
Sbjct: 456 YLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPE 515

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETRA-LPEELVLVDWVWGKYGEGRVLEVID 572
             RTGK+S SSDVFAFG L+LE+ CGRRP+  RA  P E+VL DWV   + E  +L+V+D
Sbjct: 516 LSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDWVLDCW-EDDILQVVD 574

Query: 573 PKLNAE--YDQSQVLM 586
            ++  +  Y + QV +
Sbjct: 575 ERVKQDDKYLEEQVAL 590

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  568 bits (1464), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 292/591 (49%), Positives = 404/591 (68%), Gaps = 10/591 (1%)

Query: 4   FLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQ 63
           F   F +  + S+  SSQ+ +  + GF+    ++++ GIA I  NG+L+LTN T +  G 
Sbjct: 7   FTIFFLSFFWQSLKSSSQIIDFTYNGFRPPPTDISILGIATITPNGLLKLTNTTMQSTGH 66

Query: 64  AFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN-GLPSQYLG 122
           AFY+  +RFK+S N  V SFST+F   I  + P    HG+AF I+P+  L  G P QYLG
Sbjct: 67  AFYTKPIRFKDSPNGTVSSFSTTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPLQYLG 124

Query: 123 LLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQ 182
           L N T+ GN  NH+FAVE DT+ + EF D N+NH+GIDINS+ S  S  A  + +N    
Sbjct: 125 LFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQFH 184

Query: 183 DLSLKGGKAILVWVDYDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFSA 241
           +L+L   K + VWVD+D   ++++VT++P    KP+ P++S   DLS +  + M+VGFS+
Sbjct: 185 NLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSS 244

Query: 242 STGLLASSHNVLGWSFKINGPARALDLSSLPSLP----GPKKKHHTGAIVGVSIASVVLA 297
           +TG + S   VLGWSF +NG A+ L LS LP LP     P + +         I+ +++ 
Sbjct: 245 ATGNIVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIP 304

Query: 298 ICILSLAIIYIIKKIKN-AEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQV 356
             ++   + +I+K+ +  AE +EDWE E G  R  +++L  AT  F  K +LG GGFG V
Sbjct: 305 FLLIIFLVRFIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSV 364

Query: 357 YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY 416
           YKG +  +K E+AVKR+SNES+QG++EFV+EI +IG++ HRNLV LVG+CRR+ +LLLVY
Sbjct: 365 YKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVY 424

Query: 417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD 476
           D+M NGSLD +L++ P+  L+W+QRFK+I GVAS L YLHE +EQVVIHRDVKASNVLLD
Sbjct: 425 DYMPNGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLD 484

Query: 477 SELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           +ELNG+LGDFGLA+L +HG++P TTRVVGT GYLAP+  RTG+++ ++DVFAFG LLLEV
Sbjct: 485 AELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEV 544

Query: 537 ACGRRPIETRALP-EELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
           ACGRRPIE      E +VLVDWV+  + E  +L+  DP L +EYDQ +V M
Sbjct: 545 ACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEM 595

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  567 bits (1462), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 292/556 (52%), Positives = 391/556 (70%), Gaps = 6/556 (1%)

Query: 36  NLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY 95
           +L++QGI  +  NG+L+LTN T +K G AFY+  +RFK+S N  V SFSTSF   I  + 
Sbjct: 38  DLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKDSPNGTVSSFSTSFVFAIHSQI 97

Query: 96  PRLGGHGLAFTISPSNDLN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDIND 154
             L GHG+AF ++P+  L  G PSQY+GL N  + GN +NH+FAVE DT+   EF D ND
Sbjct: 98  AILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDTND 157

Query: 155 NHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSP-NS 213
           NH+GIDINS+KS  S  A  + +    ++L+L   K + VWVDYD   N ++VT++P N 
Sbjct: 158 NHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNE 217

Query: 214 SKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPS 273
            KP  P+++   DLS +  + MYVGFS++TG + S H +LGWSF +N  A  L LS LP 
Sbjct: 218 DKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPK 277

Query: 274 LPG--PKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYS 331
           LP   PK+      I G+ + S+ L    + L    + ++ K AE +E+WE E G  R+ 
Sbjct: 278 LPRFEPKRISEFYKI-GMPLISLFLIFSFIFLVCYIVRRRRKFAEELEEWEKEFGKNRFR 336

Query: 332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATI 391
           +++L  AT  F  K LLG GGFG VYKG +  +K E+AVKR+S+ES+QG++EFV+EI +I
Sbjct: 337 FKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSI 396

Query: 392 GRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           GR+ HRNLV L+G+CRR+G+LLLVYD+M NGSLD +L++ P+  LNW+QR K+I GVASG
Sbjct: 397 GRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASG 456

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L YLHE +EQVVIHRDVKASNVLLD ELNG+LGDFGLA+LY+HG++P TT VVGTLGYLA
Sbjct: 457 LFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLA 516

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIE-TRALPEELVLVDWVWGKYGEGRVLEV 570
           PE  RTG+++ ++DVFAFGA LLEVACGRRPIE  +   E  +LVDWV+G + +G +L  
Sbjct: 517 PEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAA 576

Query: 571 IDPKLNAEYDQSQVLM 586
            DP + +E D+ +V M
Sbjct: 577 KDPNMGSECDEKEVEM 592

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  559 bits (1441), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 286/576 (49%), Positives = 394/576 (68%), Gaps = 10/576 (1%)

Query: 19  SSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNS 78
           SSQ     +  F     N+++QGIA + +NGIL+LT+ T    G AFY+  +RFK+S N 
Sbjct: 23  SSQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSPND 82

Query: 79  NVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN-GLPSQYLGLLNSTDIGNFSNHLF 137
            V SFST+F I I    P + GHG+AF I+P+  L+  + SQYLGL +ST+ GN +NH+ 
Sbjct: 83  TVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGNDTNHIL 142

Query: 138 AVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVD 197
           AVEFDT+ + EF D NDNH+GI+INS+ S  S     + + +   +L+L   K + VWVD
Sbjct: 143 AVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWVD 202

Query: 198 YDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWS 256
           YD   N ++VT++P    KP+  ++S   DLS +F + MY+GFSA+TG + S H V GWS
Sbjct: 203 YDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGWS 262

Query: 257 FKINGP-ARALDLSSLPSLP--GP----KKKHHTGAIVGVSIASVVLAICILSLAIIYII 309
           F + G  A  L LS +P  P  GP    +   +   +  + +  V+  + ++ L    + 
Sbjct: 263 FMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFIVR 322

Query: 310 KKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVA 369
           ++ K AE  EDWE E G  R  +++L  AT  F  K LLG GGFG+VY+G +  +K E+A
Sbjct: 323 RRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIA 382

Query: 370 VKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF 429
           VKR+SNES+QG++EFV+EI +IGR+ HRNLV L+G+CRR+ +LLLVYD+M NGSLD +L+
Sbjct: 383 VKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLY 442

Query: 430 DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA 489
           D P+  L+W+QRF +I GVASGL YLHE +EQVVIHRD+KASNVLLD+E NG+LGDFGLA
Sbjct: 443 DCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLA 502

Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP 549
           +L +HG++P TTRVVGT GYLAP+  RTG+++ ++DVFAFG LLLEVACGRRPIE     
Sbjct: 503 RLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIES 562

Query: 550 EE-LVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQV 584
           +E ++LVD V+G + EG +L+  DP L + YDQ +V
Sbjct: 563 DESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREV 598

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1

 Score =  556 bits (1434), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 280/558 (50%), Positives = 383/558 (68%), Gaps = 5/558 (0%)

Query: 34  SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVP 93
           S N+   G A I NNG++RLTN T +  GQ FY+  LRFKNS+N  V SFST+F   I  
Sbjct: 31  SGNMYTSGSAYINNNGLIRLTNSTPQTTGQVFYNDQLRFKNSVNGTVSSFSTTFVFSIEF 90

Query: 94  EYPRLGGHGLAFTISPSNDLN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDI 152
                GG+G+AF I P+ DL+   P+ YLGL N +++G+  NH+ AVE DT  D +F+D 
Sbjct: 91  HNGIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDPKNHIVAVELDTKVDQQFEDK 150

Query: 153 NDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSP- 211
           + NH+GIDIN++ S+    A  Y DN T + L L  G+ + +W++YDS +  +NVT+ P 
Sbjct: 151 DANHVGIDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHPL 210

Query: 212 NSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSL 271
              KPKIP+LS   DLSP   E MYVGF+++TG L +SH +LGW+FK+NG    +D S L
Sbjct: 211 YVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPDIDPSRL 270

Query: 272 PSLP---GPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQ 328
           P +P    P  +   G +      S V+ + ILSL++   +K+ K  EV+EDWE++ GP 
Sbjct: 271 PKIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLFLKRKKLLEVLEDWEVQFGPH 330

Query: 329 RYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEI 388
           R+++++L  AT  F   ++LG GGFG+VYKGTL  S  E+AVK +S++S+QG+REF++EI
Sbjct: 331 RFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIAEI 390

Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
           ATIGRLRH NLV+L G+CR KG+L LVYD MA GSLD FL+ +    L+W QRFKIIK V
Sbjct: 391 ATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLDWSQRFKIIKDV 450

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
           ASGL YLH+ + QV+IHRD+K +N+LLD+ +N KLGDFGLAKL +HGT+P T+ V GTLG
Sbjct: 451 ASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHVAGTLG 510

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL 568
           Y++PE  RTGK+S  SDVFAFG ++LE+ACGR+PI  RA   E+VL DWV   +    ++
Sbjct: 511 YISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWENEDIM 570

Query: 569 EVIDPKLNAEYDQSQVLM 586
           +V+D K+  EY + Q  +
Sbjct: 571 QVLDHKIGQEYVEEQAAL 588

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04533|LRK52_ARATH Putative L-type lectin-domain containing receptor kinase V.2 OS=Arabidopsis thaliana GN=LECRK52 PE=3 SV=1

 Score =  502 bits (1293), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 259/555 (46%), Positives = 361/555 (65%), Gaps = 18/555 (3%)

Query: 37  LTLQGIAKIENNGILRL-TNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY 95
           L   G+A +  +G+ +L T+ T    GQ  Y   L+FKNS N  V SFST+F   IV   
Sbjct: 37  LYTDGVADLNPDGLFKLITSKTQGGAGQVLYQFPLQFKNSPNGTVSSFSTTFVFAIVAVR 96

Query: 96  PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDN 155
             + G GL+F ISP+  LN +P+            + SNH  +V F T +  +    + N
Sbjct: 97  KTIAGCGLSFNISPTKGLNSVPNI-----------DHSNHSVSVGFHTAKSDKPDGEDVN 145

Query: 156 HIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTV-SPNSS 214
            +GI+I+S K + +  A  Y D+    +L +  GK I VW++Y+++   L+VT+ S   S
Sbjct: 146 LVGINIDSSKMDRNCSAGYYKDDGRLVNLDIASGKPIQVWIEYNNSTKQLDVTMHSIKIS 205

Query: 215 KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSL 274
           KPKIP+LS R DLSP  +E+MY+GF+ S G   SSH +LGWSF   G    ++LS LP +
Sbjct: 206 KPKIPLLSMRKDLSPYLHEYMYIGFT-SVGSPTSSHYILGWSFNNKGAVSDINLSRLPKV 264

Query: 275 PGPKKKHHTGA---IVGVSIASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYS 331
           P   ++    +    + +SI+ V L I +L L ++  +K+ K  EVIEDWE++ GP +++
Sbjct: 265 PDEDQERSLSSKILAISLSISGVTLVI-VLILGVMLFLKRKKFLEVIEDWEVQFGPHKFT 323

Query: 332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATI 391
           Y++L  AT  F   ++LG GGFG+V+KG L  S   +AVK+IS++S+QG+REF++EIATI
Sbjct: 324 YKDLFIATKGFKNSEVLGKGGFGKVFKGILPLSSIPIAVKKISHDSRQGMREFLAEIATI 383

Query: 392 GRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           GRLRH +LV+L+G+CRRKG+L LVYDFM  GSLD FL+++P  +L+W QRF IIK VASG
Sbjct: 384 GRLRHPDLVRLLGYCRRKGELYLVYDFMPKGSLDKFLYNQPNQILDWSQRFNIIKDVASG 443

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L YLH+ + QV+IHRD+K +N+LLD  +N KLGDFGLAKL +HG +  T+ V GT GY++
Sbjct: 444 LCYLHQQWVQVIIHRDIKPANILLDENMNAKLGDFGLAKLCDHGIDSQTSNVAGTFGYIS 503

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI 571
           PE  RTGKSS SSDVFAFG  +LE+ CGRRPI  R  P E+VL DWV   +  G +L+V+
Sbjct: 504 PELSRTGKSSTSSDVFAFGVFMLEITCGRRPIGPRGSPSEMVLTDWVLDCWDSGDILQVV 563

Query: 572 DPKLNAEYDQSQVLM 586
           D KL   Y   QV +
Sbjct: 564 DEKLGHRYLAEQVTL 578

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M1G4|LRK15_ARATH Probable L-type lectin-domain containing receptor kinase I.5 OS=Arabidopsis thaliana GN=LECRK15 PE=2 SV=2

 Score =  497 bits (1279), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 265/584 (45%), Positives = 382/584 (65%), Gaps = 15/584 (2%)

Query: 7   IFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFY 66
           + S+   +S   SS+     F GF    +NL L G A +  NG+L+L  D+  +MG AF 
Sbjct: 10  LISSFHLISFSTSSKDTSFVFNGFGQ--SNLALDGSATLLPNGLLQLAKDSQHQMGHAFI 67

Query: 67  SSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN-GLPSQYLGLLN 125
              + F +S      SFST F   +VP+    GGHG+ F ISP+ D     P++Y+G+ N
Sbjct: 68  KKPIDFSSS---KPLSFSTHFVCALVPKPGFEGGHGITFVISPTVDFTRAQPTRYMGIFN 124

Query: 126 STDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQ-DL 184
           ++  G+ S+HLFAVE DTV++ +F++ N+NHIGID+N+  S  S  A+ ++  + K   +
Sbjct: 125 ASTNGSPSSHLFAVELDTVRNPDFRETNNNHIGIDVNNPISVESAPASYFSKTAQKNVSI 184

Query: 185 SLKGGKAILVWVDYDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEF-MYVGFSAS 242
           +L  GK I VWVDY    N+LNV+V+P  + KP +P+LS  ++LS IF+   ++VGF+A+
Sbjct: 185 NLSSGKPIQVWVDYHG--NVLNVSVAPLEAEKPSLPLLSRSMNLSEIFSRRRLFVGFAAA 242

Query: 243 TGLLASSHNVLGWSFKINGP-ARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICIL 301
           TG   S H +LGWSF  N   ++ LD S LP +P P+ +H       +    V+LAI ++
Sbjct: 243 TGTSISYHYLLGWSFSTNRELSQLLDFSKLPQVPRPRAEHKKVQFALIIALPVILAIVVM 302

Query: 302 S-LAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGT 360
           + LA +Y  +K K AEV E WE + G  R+SY+ L  AT  F   + LG GGFG+VY+G 
Sbjct: 303 AVLAGVYYHRKKKYAEVSEPWEKKYGTHRFSYKSLYIATKGFHKDRFLGRGGFGEVYRGD 362

Query: 361 LHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA 420
           L  +KT VAVKR+S++ +QG+++FV+E+ ++  L+HRNLV L+G+CRRKG+LLLV ++M 
Sbjct: 363 LPLNKT-VAVKRVSHDGEQGMKQFVAEVVSMKSLKHRNLVPLLGYCRRKGELLLVSEYMP 421

Query: 421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN 480
           NGSLD  LFD+   VL+W QRF I+KG+AS L YLH   EQVV+HRD+KASNV+LD+ELN
Sbjct: 422 NGSLDQHLFDDQSPVLSWSQRFVILKGIASALFYLHTEAEQVVLHRDIKASNVMLDAELN 481

Query: 481 GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR 540
           G+LGDFG+A+ ++HG N ATT  VGT+GY+APE    G S+  +DV+AFG  LLEVACGR
Sbjct: 482 GRLGDFGMARFHDHGGNAATTAAVGTVGYMAPELITMGASTI-TDVYAFGVFLLEVACGR 540

Query: 541 RPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQV 584
           +P+E     E+  L+ WV   + +  +L+  DP+L  E+   +V
Sbjct: 541 KPVEFGVQVEKRFLIKWVCECWKKDSLLDAKDPRLGEEFVPEEV 584

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1

 Score =  493 bits (1269), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 269/564 (47%), Positives = 369/564 (65%), Gaps = 25/564 (4%)

Query: 30  FKDLSN-NLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFA 88
           + D  N +L L G+A   N+G L LTN+T+   G AFY+  ++F  S  S+    +    
Sbjct: 32  YYDFRNADLELDGMANT-NHGPLHLTNNTNTGTGHAFYNIPIKFTASSLSSFSFSTEF-V 89

Query: 89  IVIVPEYPRLGGHGLAFTISPSNDL--NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQD 146
             I P      GHG+AF +SP+ DL  NG  +  LG+ N  +    + H+FAVE DT Q+
Sbjct: 90  FAIFPLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFNRANDNKTATHIFAVELDTNQN 149

Query: 147 FEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQ-DLSLKGGKAILVWVDYDSAENIL 205
            E  D   N +GIDINS+ S  S +A+ +     K   L L  GK+ILVW+DYD  E +L
Sbjct: 150 SESFDKGGNDVGIDINSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGIEKVL 209

Query: 206 NVTVSPNSS------------KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVL 253
           NVT++P  +            KPK+P+LS  ++LS IF E MYVGFS STG + S+  +L
Sbjct: 210 NVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTGSIKSNQYIL 269

Query: 254 GWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLA-IIYIIKKI 312
           GWSFK  G A +LD+S L + P   K+     ++G +I++    I  L+L  I+Y+ KK 
Sbjct: 270 GWSFKQGGKAESLDISRLSNPPPSPKRFPLKEVLGATIST----IAFLTLGGIVYLYKKK 325

Query: 313 KNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKR 372
           K AEV+E WE E  PQRYS++ L +AT  F   QLLG GGFG+VYKG L  S T++AVKR
Sbjct: 326 KYAEVLEQWEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGIL-PSGTQIAVKR 384

Query: 373 ISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP 432
           + ++++QG++++V+EIA++GRLRH+NLV L+G+CRRKG+LLLVYD+M NGSLD +LF + 
Sbjct: 385 VYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHKN 444

Query: 433 KAV-LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
           K   L W QR  IIKGVAS LLYLHE +EQVV+HRD+KASN+LLD++LNGKLGDFGLA+ 
Sbjct: 445 KLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARF 504

Query: 492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE 551
           ++ G N   TRVVGT+GY+APE    G ++  +DV+AFGA +LEV CGRRP++  A  E+
Sbjct: 505 HDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPDAPREQ 564

Query: 552 LVLVDWVWGKYGEGRVLEVIDPKL 575
           ++LV WV        + + +D KL
Sbjct: 565 VILVKWVASCGKRDALTDTVDSKL 588

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	652
255584540	683	kinase, putative [Ricinus communis] gi|2	0.984	0.939	0.673	0.0
356567976	674	PREDICTED: L-type lectin-domain containi	0.978	0.946	0.666	0.0
449439978	683	PREDICTED: L-type lectin-domain containi	0.969	0.925	0.655	0.0
38112429	682	lectin-like receptor kinase 7;3 [Medicag	0.943	0.901	0.659	0.0
356523179	673	PREDICTED: L-type lectin-domain containi	0.953	0.924	0.649	0.0
224140289	645	predicted protein [Populus trichocarpa]	0.895	0.905	0.730	0.0
356506714	719	PREDICTED: L-type lectin-domain containi	0.986	0.894	0.629	0.0
356506718	684	PREDICTED: L-type lectin-domain containi	0.976	0.931	0.635	0.0
356496074	681	PREDICTED: L-type lectin-domain containi	0.967	0.926	0.645	0.0
359481749	1258	PREDICTED: L-type lectin-domain containi	0.901	0.467	0.711	0.0

>gi|255584540|ref|XP_002532997.1| kinase, putative [Ricinus communis] gi|223527226|gb|EEF29389.1| kinase, putative [Ricinus communis]

 Score =  927 bits (2396), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 461/684 (67%), Positives = 548/684 (80%), Gaps = 42/684 (6%)

Query: 1   MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSN-NLTLQGIAKIENNGILRLTNDTSR 59
           MA   R    L+F+SIPVS QL+EL++PGFK +   N++L G+A+I+ NGI+RLTN+TSR
Sbjct: 1   MAYVFRFVYVLLFISIPVSCQLNELYYPGFKHVDTVNISLTGVAEIQKNGIIRLTNETSR 60

Query: 60  KMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQ 119
            MGQAFY+S  +FKNS N   FSFSTSFA+ I PEY +LGGHGLAFTIS S DL GLPSQ
Sbjct: 61  LMGQAFYASPFQFKNSSNGKAFSFSTSFALAIFPEYKKLGGHGLAFTISASKDLKGLPSQ 120

Query: 120 YLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNS 179
           YLGLLN++D+GNF+NHL AVEFDTVQDFEF DINDNH+GIDIN++KSNAS  AA Y +++
Sbjct: 121 YLGLLNASDLGNFTNHLLAVEFDTVQDFEFGDINDNHVGIDINNLKSNASAAAAYYINDT 180

Query: 180 TKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGF 239
           +KQDL+LK GK I VW+DYDS +N+LNVT+SP S KP++PILSF +DLS IF E+MYVGF
Sbjct: 181 SKQDLNLKTGKPIQVWIDYDSIQNLLNVTISPTSEKPRLPILSFPIDLSQIFEEYMYVGF 240

Query: 240 SASTGLLASSHNVLGWSFKINGPARALDLSSLPSLP-GPKKKHHTGAIVGVSIASVVLAI 298
           SASTGLLASSH +LGWSFK++G ARALDLSSLPSLP GPK KH TG  + V + SV LAI
Sbjct: 241 SASTGLLASSHYILGWSFKMDGQARALDLSSLPSLPRGPKTKH-TGLTIAVIVPSVFLAI 299

Query: 299 CILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYK 358
             LSLAI Y+I+KI+NA+VIEDWELE+GP RYSYQELK+AT  FS K+LLG GGFGQVYK
Sbjct: 300 IALSLAIFYVIRKIRNADVIEDWELEIGPHRYSYQELKKATKGFSGKELLGQGGFGQVYK 359

Query: 359 GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF 418
           G L +SK +VAVKRISNES QG+REFVSEIA++GRLRHRNLVQL+GWCRR+ D LLVYD+
Sbjct: 360 GILPDSKVQVAVKRISNESNQGLREFVSEIASVGRLRHRNLVQLLGWCRRRDDFLLVYDY 419

Query: 419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE 478
           MANGSLD+FLFDEPK +LNWEQRFKIIK VASGLLYLHEGYEQVVIHRDVKASNVLLDSE
Sbjct: 420 MANGSLDNFLFDEPKIILNWEQRFKIIKDVASGLLYLHEGYEQVVIHRDVKASNVLLDSE 479

Query: 479 LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC 538
           L G+LGDFGLA+LYEHG+NP TTRVVGTLGYLAPE PRTGK++A SDV+AFGALLLEVAC
Sbjct: 480 LTGRLGDFGLARLYEHGSNPGTTRVVGTLGYLAPEMPRTGKATACSDVYAFGALLLEVAC 539

Query: 539 GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM------------ 586
           GRRPIE +A PEE+VLVDWVW  + +GRVL+V+D +LN EY++ +++M            
Sbjct: 540 GRRPIEPKASPEEMVLVDWVWEMFKQGRVLDVVDSRLNGEYNEGEMMMVLTLGLMCSNNA 599

Query: 587 ---------------GELELPDTLRGPR----SSDGDKA-AEGFDDLLNSLASSSFDK-T 625
                          GE+ +P+ L  P      S G K   EGFDDL+NS ASSSFD  +
Sbjct: 600 PMARPSMRQVVKYLDGEVGMPENLIAPHGHGIGSGGAKGIGEGFDDLVNSFASSSFDNIS 659

Query: 626 TSCSYFENGVSYPSLSTSPITLVY 649
           TS S+ ENG        SP++L++
Sbjct: 660 TSYSFMENG------ERSPLSLLH 677

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567976|ref|XP_003552190.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  910 bits (2353), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/683 (66%), Positives = 542/683 (79%), Gaps = 45/683 (6%)

Query: 1   MASFLRIFSALIFLSIPVSSQLDELFFPGFKDL-SNNLTLQGIAKIENNGILRLTNDTSR 59
           MA+ L+I S  + L IPVS Q+D+L + GFKD+ ++NLT+ G+AKIE+NGIL+LTND+SR
Sbjct: 1   MATLLKILSLTVLLLIPVSCQVDQLLYAGFKDVGASNLTMNGVAKIEHNGILKLTNDSSR 60

Query: 60  KMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQ 119
            MG AFY S  + KNS +  V SFS+SFA+ IVPEYP+LGGHGLAFTI+ S DL  LPSQ
Sbjct: 61  LMGHAFYPSPFQLKNSTSGKVLSFSSSFALAIVPEYPKLGGHGLAFTIATSKDLKALPSQ 120

Query: 120 YLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNS 179
           YLGLLNS+D GN SNH+FAVEFDTVQDFEF DINDNH+GIDINSM+SNAS        N 
Sbjct: 121 YLGLLNSSDNGNISNHIFAVEFDTVQDFEFGDINDNHVGIDINSMQSNASA-------NV 173

Query: 180 TKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGF 239
           +   L+LK GK IL WVDYDS  N+++V +SPNSSKPK P+L+F VDLSP+F++ MYVGF
Sbjct: 174 SLVGLTLKSGKPILAWVDYDSQLNLISVALSPNSSKPKTPLLTFNVDLSPVFHDIMYVGF 233

Query: 240 SASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAIC 299
           SASTGLLASSH +LGWSFKINGPA  LDLSSLP LP PKKK  T  I+GVS++  V+ + 
Sbjct: 234 SASTGLLASSHYILGWSFKINGPAPPLDLSSLPQLPQPKKKQ-TSLIIGVSVSVFVIVLL 292

Query: 300 ILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKG 359
            +S+ I Y  +KIKNA+VIE WELE+GP RYSYQELK+AT  F  K+LLG GGFG+VYKG
Sbjct: 293 AISIGI-YFYRKIKNADVIEAWELEIGPHRYSYQELKKATRGFKDKELLGQGGFGRVYKG 351

Query: 360 TLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM 419
           TL NSK +VAVKR+S+ESKQG+REFVSEIA+IGRLRHRNLVQL+GWCRR+GDLLLVYDFM
Sbjct: 352 TLPNSKIQVAVKRVSHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDFM 411

Query: 420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
           ANGSLD +LFDEPK +LNWE RFKIIKGVAS LLYLHEGYEQVVIHRDVKASNVLLD EL
Sbjct: 412 ANGSLDKYLFDEPKIILNWEHRFKIIKGVASALLYLHEGYEQVVIHRDVKASNVLLDFEL 471

Query: 480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
           NG+LGDFGLA+LYEHG NP+TTRVVGTLGYLAPE PRTGK++ SSDVFAFGALLLEVACG
Sbjct: 472 NGRLGDFGLARLYEHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVFAFGALLLEVACG 531

Query: 540 RRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM------------- 586
           RRPIE +ALPEELVLVDWVW KY +GR+L+++DPKLN  +D+ +V++             
Sbjct: 532 RRPIEPKALPEELVLVDWVWEKYKQGRILDLVDPKLNVYFDEKEVIVVLKLGLMCSNDVP 591

Query: 587 --------------GELELPDTLRGPRSSDGDKA-AEGFDDLLNSLASSSFDKTTSCSYF 631
                         GE+E+P+ L+ P    GD +  EGFD+ L+SLASSSFDK +S S F
Sbjct: 592 VTRPSMRQVVRYLDGEVEVPEDLKKP----GDISHHEGFDEFLHSLASSSFDKMSSGSNF 647

Query: 632 ENG---VSYPSLSTSPITLVYGR 651
            N     S+ S + SP +L++GR
Sbjct: 648 GNRDMESSFLSFANSPHSLLHGR 670

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439978|ref|XP_004137762.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus] gi|449524894|ref|XP_004169456.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus]

 Score =  891 bits (2303), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/670 (65%), Positives = 534/670 (79%), Gaps = 38/670 (5%)

Query: 17  PVSSQLDELFFPGFKD---LSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFK 73
           P +SQ  +L+F GF+D   ++ NLTL  IAKIE NGIL+LTNDTSR  G AFYSS +RFK
Sbjct: 18  PAASQ--QLYFSGFQDDAAVAANLTLTDIAKIEQNGILKLTNDTSRLQGHAFYSSPVRFK 75

Query: 74  NSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFS 133
           NS +  VFSFST+F I +VPEYP LGGHGLAFTI+PS +L GLPSQYLGLLN+ D+GNF+
Sbjct: 76  NSSDGKVFSFSTAFVIAVVPEYPTLGGHGLAFTIAPSKNLRGLPSQYLGLLNAKDVGNFT 135

Query: 134 NHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNS-TKQDLSLKGGKAI 192
           NHLFAVEFDTVQDFEF DINDNH+GI++N M SN S  A+ + D+  TKQ+L+LK G+ I
Sbjct: 136 NHLFAVEFDTVQDFEFADINDNHVGINLNHMISNVSTTASYFVDDGPTKQNLTLKSGRPI 195

Query: 193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNV 252
             WVDYDS+ N L V +SP+S+KPK PILSF VDLSPI +EFMYVGFSASTGLLASSH V
Sbjct: 196 QAWVDYDSSVNSLTVALSPSSTKPKKPILSFNVDLSPILDEFMYVGFSASTGLLASSHYV 255

Query: 253 LGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKI 312
           LGWSF +NG AR+LDLSSLPS+PGPKKKH T   +G+S+A+V++ I  + +A++ II KI
Sbjct: 256 LGWSFSMNGQARSLDLSSLPSVPGPKKKH-TAFTIGISVAAVLIVIIAICVAVL-IIWKI 313

Query: 313 KNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKR 372
           KNA++IE WE E+GP RYSY+ELK+AT  F  K+LLG GGFG+VYKGTL NSK +VAVKR
Sbjct: 314 KNADIIEAWEHEIGPHRYSYKELKKATKRFRDKELLGRGGFGKVYKGTLPNSKIQVAVKR 373

Query: 373 ISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP 432
           IS+ESKQG+REFVSEIA+IGRLRHRNLVQL+GWCRR+GDLLLVYDFMANGSLD+++FD+P
Sbjct: 374 ISHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDFMANGSLDNYIFDDP 433

Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
              L+W+QRF IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE+NGKLGDFGLA+LY
Sbjct: 434 DVNLSWQQRFGIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEMNGKLGDFGLARLY 493

Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL 552
           EHG NP+TTRVVGTLGYLAPE PRTGK++ SSDV+AFGALLLEVACGRRPI+ ++  EEL
Sbjct: 494 EHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVYAFGALLLEVACGRRPIDPKSSSEEL 553

Query: 553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM-------------------------- 586
           VLVDWVW  Y EG++L+V+DPKL  +++  + +M                          
Sbjct: 554 VLVDWVWENYREGKLLDVMDPKLKGDFNVVEAMMILKLGLFCSNDSAAARPSMRQVVRFL 613

Query: 587 -GELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFEN---GVSYPSLST 642
            GE+ +P+ +  P+  +G +  EGFDD +NS ASSSF+K +S S   N    +S+ S ST
Sbjct: 614 EGEMGVPEEISAPKVMEGGRNGEGFDDFVNSFASSSFNKFSSYSSTGNKDMDMSFASFST 673

Query: 643 SPITLVYGRD 652
           SP++L+ GRD
Sbjct: 674 SPLSLLNGRD 683

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38112429|gb|AAR11300.1| lectin-like receptor kinase 7;3 [Medicago truncatula]

 Score =  877 bits (2267), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/649 (65%), Positives = 514/649 (79%), Gaps = 34/649 (5%)

Query: 11  LIFLSIPVSSQLDELFFPGFKDLS-NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSST 69
           L+F  +PV SQ+D+L + GFKD+   NLTL GIA+IE NGI+RLTN+TSR +G AFY   
Sbjct: 9   LLFFFVPVLSQVDQLLYTGFKDVGPKNLTLNGIAEIEKNGIIRLTNETSRLLGHAFYPQP 68

Query: 70  LRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDI 129
            + KN     VFSFS+SFA+  VPEYP+LGGHG+AFTI PS DL  LPSQYLGLLNS+D+
Sbjct: 69  FQIKNKTTGKVFSFSSSFALACVPEYPKLGGHGMAFTIVPSKDLKALPSQYLGLLNSSDV 128

Query: 130 GNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGG 189
           GNFSNHLFAVEFDTVQDFEF DIN NH+GIDINSM+SNA++ A  Y+D+    ++S+KGG
Sbjct: 129 GNFSNHLFAVEFDTVQDFEFGDINYNHVGIDINSMRSNATITAGYYSDDDMVHNISIKGG 188

Query: 190 KAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASS 249
           K ILVWVDYDS+  +++VT+SP S+KPK PIL+F +DLSP+F + MYVGFSASTGLLASS
Sbjct: 189 KPILVWVDYDSSLELISVTLSPTSNKPKKPILTFHMDLSPLFLDTMYVGFSASTGLLASS 248

Query: 250 HNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYII 309
           H VLGWSFKINGPA  LDLS LP LP PKKKH T  I+G+S+ S ++ +C ++    YI 
Sbjct: 249 HYVLGWSFKINGPAPFLDLSKLPKLPHPKKKH-TSLILGLSLGSALIVLCSMAFGF-YIY 306

Query: 310 KKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVA 369
           +KIKNA+VIE WELEVGP RY+YQELK+AT  F  KQLLG GGFG+VY G L  SK +VA
Sbjct: 307 RKIKNADVIEAWELEVGPHRYTYQELKKATKGFKEKQLLGQGGFGKVYNGILPKSKIQVA 366

Query: 370 VKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF 429
           VKR+S+ESKQG+REFVSEIA+IGRLRHRNLV L+GWCRR+GDLLLVYD+MANGSLD +LF
Sbjct: 367 VKRVSHESKQGLREFVSEIASIGRLRHRNLVMLLGWCRRRGDLLLVYDYMANGSLDKYLF 426

Query: 430 DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA 489
           ++ + VL+WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD ELNG+LGDFGLA
Sbjct: 427 EDSEYVLSWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDFELNGRLGDFGLA 486

Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP 549
           +LYEHG NP TTRVVGTLGYLAPE PRTG+++ SSDVFAFGALLLEV CGRRPIE +A  
Sbjct: 487 RLYEHGANPGTTRVVGTLGYLAPELPRTGRATTSSDVFAFGALLLEVVCGRRPIEPKASQ 546

Query: 550 EELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM----------------------- 586
           +ELVLVDWVW ++ EGR  EV+DPKLN ++ +++V+M                       
Sbjct: 547 DELVLVDWVWERFKEGRAFEVVDPKLNGDFVETEVMMVLKLGLICSNDVPTIRPSMRQVV 606

Query: 587 ----GELELPDTLRGPRSSDGDKAAEGFDDLLNSLASS-SFDKTTSCSY 630
               GE+ELP+ +R P   D   + EGFD+ LNSL +S SFD+ +S SY
Sbjct: 607 RILDGEVELPNEMRKPGGID---SQEGFDEFLNSLGTSNSFDQMSSSSY 652

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523179|ref|XP_003530219.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  868 bits (2244), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 433/667 (64%), Positives = 524/667 (78%), Gaps = 45/667 (6%)

Query: 16  IPVSSQLDELFFPGFKDL-SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKN 74
           IPVS Q+D++ + GFKD+ ++NLT+ G+  IE NGIL+LTN++SR +G AFY S  + KN
Sbjct: 16  IPVSCQVDQVLYSGFKDVGASNLTMNGVTTIERNGILKLTNESSRSIGHAFYPSPFQLKN 75

Query: 75  SLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSN 134
           S +    SFS+SFA  IVPEYP+LGGHGLAFTI+ S DL  LP+QYLGLLNS+D GNFSN
Sbjct: 76  STSGKALSFSSSFAFAIVPEYPKLGGHGLAFTIATSKDLKALPNQYLGLLNSSDNGNFSN 135

Query: 135 HLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILV 194
           H+FAVEFDTVQDFEF DINDNH+GIDINSM+SN S   ++         L+LK GK IL 
Sbjct: 136 HIFAVEFDTVQDFEFGDINDNHVGIDINSMQSNTSANVSLV-------GLTLKSGKPILA 188

Query: 195 WVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLG 254
           WVDYDS  N+++V +SPNSSKPK P+L+F VDLSP+F++ MYVGFSASTGLLASSH +LG
Sbjct: 189 WVDYDSRLNLISVALSPNSSKPKTPLLTFNVDLSPVFHDTMYVGFSASTGLLASSHYILG 248

Query: 255 WSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAI-IYIIKKIK 313
           WSFKINGPA  LDLSSLP LP PKKK  +   + + ++  V+ I +L+++I IY  +KIK
Sbjct: 249 WSFKINGPAPPLDLSSLPQLPKPKKKQTS---LIIGVSVSVVVIVLLAISIGIYFYRKIK 305

Query: 314 NAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
           NA+VIE WELE+GP RYSYQELK+AT  F  K+LLG GGFG+VYKGTL NSK +VAVKR+
Sbjct: 306 NADVIEAWELEIGPHRYSYQELKKATRGFKDKELLGQGGFGRVYKGTLPNSKIQVAVKRV 365

Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
           S+ESKQG+REFVSEIA+IGRLRHRNLVQL+GWCRR+GDLLLVYDFMANGSLD +LFDEPK
Sbjct: 366 SHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRQGDLLLVYDFMANGSLDKYLFDEPK 425

Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
            +LNWE RFKIIKGVAS L+YLHEGYEQVVIHRDVKASNVLLD ELNG+LGDFGLA+LYE
Sbjct: 426 IILNWEHRFKIIKGVASALMYLHEGYEQVVIHRDVKASNVLLDFELNGRLGDFGLARLYE 485

Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
           HG NP+TTRVVGTLGYLAPE PRTGK++ SSDVFAFGALLLEV CGRRPIE +ALPEE+V
Sbjct: 486 HGANPSTTRVVGTLGYLAPELPRTGKATTSSDVFAFGALLLEVVCGRRPIEPKALPEEMV 545

Query: 554 LVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM--------------------------- 586
           LVDWVW KY +GR+L+V+DPKLN  +D+ +V++                           
Sbjct: 546 LVDWVWEKYKQGRILDVVDPKLNGHFDEKEVMVVLKLGLMCSNDVPAARPSMRQVVRYLD 605

Query: 587 GELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFEN---GVSYPSLSTS 643
           GE+E+P+ L+ P +       EGF++ L+SLASSSFDK +S S F N     S+ S S S
Sbjct: 606 GEVEVPEDLKKPGAVS---HHEGFEEFLHSLASSSFDKMSSGSNFGNRDMDSSFLSFSNS 662

Query: 644 PITLVYG 650
           P +L++G
Sbjct: 663 PHSLLHG 669

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224140289|ref|XP_002323515.1| predicted protein [Populus trichocarpa] gi|222868145|gb|EEF05276.1| predicted protein [Populus trichocarpa]

 Score =  866 bits (2238), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/589 (73%), Positives = 494/589 (83%), Gaps = 5/589 (0%)

Query: 1   MASFLRIFSALIFLSI-PVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR 59
           M   +  FSALIFLSI PVSSQL+E  + GFKD + N+TL G+++I+ NGILRLTN+TSR
Sbjct: 1   MGYLVESFSALIFLSIIPVSSQLNEFLYSGFKDAATNITLSGVSEIQKNGILRLTNETSR 60

Query: 60  KMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQ 119
            +G AFY S  +FKNS N    SFST F  +IVPEYP+LGGHGLAFTI+ + DL  LPSQ
Sbjct: 61  LLGHAFYPSPFKFKNSSNGTALSFSTCFVFIIVPEYPKLGGHGLAFTIATTKDLKALPSQ 120

Query: 120 YLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYT--D 177
           YLGLLNS+ + N +NHLFAVEFDTVQDFEF DINDNHIGID+ S+KSNAS  AA YT   
Sbjct: 121 YLGLLNSSVV-NLTNHLFAVEFDTVQDFEFGDINDNHIGIDLGSLKSNASASAAYYTGDS 179

Query: 178 NSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYV 237
           +S+KQDL+LKGGK I VW+DYDS +N++NVT+SP S KPKIPILS  VDLS +F E+MYV
Sbjct: 180 DSSKQDLNLKGGKPIQVWIDYDSVQNVVNVTISPTSKKPKIPILSSHVDLSSLFEEYMYV 239

Query: 238 GFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLA 297
           G SASTGLLASSH +LGWSFK+NG A ALDLSSLPSLPG  KK +TG ++GVS A VV  
Sbjct: 240 GLSASTGLLASSHYMLGWSFKLNGQAPALDLSSLPSLPGGHKKQYTGLVIGVSAAVVVFV 299

Query: 298 ICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVY 357
           I  +S AI Y+I+KIKNA+++EDWELE+GP RY YQELK+ATNNFS K LLG GGFGQVY
Sbjct: 300 IVSISTAI-YLIRKIKNADIVEDWELEMGPHRYCYQELKKATNNFSDKVLLGKGGFGQVY 358

Query: 358 KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD 417
           KG L +SK EVAVKRIS ES QG+REFVSEIA+IGRLRHRNLVQL+GW RR+ D LLVYD
Sbjct: 359 KGILPDSKIEVAVKRISKESTQGLREFVSEIASIGRLRHRNLVQLLGWYRRRDDFLLVYD 418

Query: 418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS 477
           +MANGSLD FLF+EPK +LNWEQRFKIIK VASGLLYLHEGYEQVVIHRDVKASNVLLD 
Sbjct: 419 YMANGSLDKFLFEEPKMILNWEQRFKIIKDVASGLLYLHEGYEQVVIHRDVKASNVLLDE 478

Query: 478 ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           ELNG+L DFGLA+LYEHG NP TTRVVGTLGYLAPE PRTGK++ SSDV+AFGALLLEV 
Sbjct: 479 ELNGRLSDFGLARLYEHGANPNTTRVVGTLGYLAPELPRTGKATESSDVYAFGALLLEVV 538

Query: 538 CGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
           CGRRPIE +ALPEELVLVD VW K+ EGR L+VIDPKLN EY++S+V+M
Sbjct: 539 CGRRPIEPKALPEELVLVDLVWEKFREGRALDVIDPKLNGEYNESEVMM 587

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356506714|ref|XP_003522121.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  858 bits (2217), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/683 (62%), Positives = 534/683 (78%), Gaps = 40/683 (5%)

Query: 4   FLRIFSALIFLSIPVSSQLDELFFPGFKDL-SNNLTLQGIAKIENNGILRLTNDTSRKMG 62
            L+  S L+FL IPVSSQ ++LF+ GFK L SNN+TL G+A+IE NG+L+LTND+S+ MG
Sbjct: 38  LLKFLSLLVFLLIPVSSQQNQLFYAGFKGLKSNNMTLDGVAEIEPNGVLKLTNDSSKVMG 97

Query: 63  QAFYSSTLRFKNSLN--SNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQY 120
            AFY +  RFKNS    +  FSFS+SFA+ IVPE+P+LGGHGLAF I+P+ +L   PSQY
Sbjct: 98  HAFYPTPFRFKNSSGGGNKAFSFSSSFALAIVPEFPKLGGHGLAFAIAPTKELKAHPSQY 157

Query: 121 LGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYT--DN 178
           LGLL+ST IGNFSNHLFAVEFDT +DFEF DI+DNH+GIDINS+ S AS  A  Y+  ++
Sbjct: 158 LGLLDSTGIGNFSNHLFAVEFDTAKDFEFGDIDDNHVGIDINSLSSIASASAGYYSGDED 217

Query: 179 STKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVG 238
           STKQ+++L+ G  IL WVDYD+A+++++VT+S +S+KPK P+LS+ VDLSPIF + MYVG
Sbjct: 218 STKQNVTLQSGVPILAWVDYDAAQSVVHVTISASSTKPKRPLLSYHVDLSPIFEDLMYVG 277

Query: 239 FSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAI 298
           FSASTG+LASSH +LGWSFKINGPA  LDLSSLP LPGPKKKH T  I+GVS + V L +
Sbjct: 278 FSASTGMLASSHYILGWSFKINGPALPLDLSSLPQLPGPKKKH-TSLIIGVSASVVFLVL 336

Query: 299 CILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYK 358
           C + L I Y+ ++ KNA+VIE WELE+GP RYSYQELK+AT  F  K LLG GGFG VYK
Sbjct: 337 CAVLLGI-YMYRRYKNADVIEAWELEIGPHRYSYQELKKATKGFKDKGLLGQGGFGSVYK 395

Query: 359 GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF 418
           GTL NS T+VAVKRIS++S QG+REFVSEIA+IGRLRHRNLVQL+GWCRR+GDLLLVYDF
Sbjct: 396 GTLPNSNTQVAVKRISHDSNQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLVYDF 455

Query: 419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE 478
           M NGSLD +LFDEP+ VL+WEQRFK+IK VAS LLYLHEGYEQVVIHRDVKASNVLLD E
Sbjct: 456 MENGSLDKYLFDEPEIVLSWEQRFKVIKDVASALLYLHEGYEQVVIHRDVKASNVLLDGE 515

Query: 479 LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC 538
           LNG+LGDFGLA+LYEHGTNP+TTRVVGTLGYLAPE PRTGK++ SSDVFAFGALLLEVAC
Sbjct: 516 LNGRLGDFGLARLYEHGTNPSTTRVVGTLGYLAPEVPRTGKATPSSDVFAFGALLLEVAC 575

Query: 539 GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM------------ 586
           G RP+E +A+PE++VLVD VW K+ +G +L+++DPKLN  +++ ++LM            
Sbjct: 576 GLRPLEPKAMPEDMVLVDCVWNKFKQGSILDLVDPKLNGVFNEREMLMVLKLGLLCSNSS 635

Query: 587 ---------------GELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY- 630
                          GE+ +PD L+ P         EGFD+ L+SL SSSFD+ ++ SY 
Sbjct: 636 PTARPSMRQVVRFLEGEVGVPDELKKPGEGG---YQEGFDEFLHSLESSSFDQMSTGSYG 692

Query: 631 --FENGVSYPSLSTSPITLVYGR 651
              +   S+PSL+ + +   +G+
Sbjct: 693 RTRDMDSSFPSLTDTSLFSPHGK 715

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356506718|ref|XP_003522123.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  850 bits (2195), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 432/680 (63%), Positives = 523/680 (76%), Gaps = 43/680 (6%)

Query: 1   MASFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRK 60
           +  FL +   L+FL IPVSSQ ++LF+ GF   SN ++L+G+A+IE+NGIL+LT+D+SR 
Sbjct: 8   LQQFLHV---LLFLLIPVSSQPNQLFYDGFLG-SNIMSLRGVAEIESNGILKLTDDSSRV 63

Query: 61  MGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQY 120
           +GQAFY + LRFKNS +   FSFS+SFA++I PEY +LGGHGLAFTI+ S +L  LPSQY
Sbjct: 64  VGQAFYPTGLRFKNSSDGKAFSFSSSFALIIFPEYEKLGGHGLAFTIASSKNLKALPSQY 123

Query: 121 LGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYT---D 177
           LGLLNST  GN SNHLFAVEFDT QDFEF DI+DNH+GIDINS+ S AS     YT   D
Sbjct: 124 LGLLNSTSTGNSSNHLFAVEFDTAQDFEFGDIDDNHVGIDINSLVSIASAPVGYYTGGDD 183

Query: 178 NSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYV 237
           NSTKQ+L+L  G+ I+ WVDYD++++I+NVT+S +S+KPK P+LS  VDLSPIF + M+V
Sbjct: 184 NSTKQNLTLTSGEPIIAWVDYDASQSIVNVTISESSTKPKRPLLSHHVDLSPIFEDLMFV 243

Query: 238 GFSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLA 297
           GFSASTGLLASSH +LGWSFKINGPA  L+LSSLP LPGPKKKH T  I GVSI S  LA
Sbjct: 244 GFSASTGLLASSHYILGWSFKINGPAPPLELSSLPQLPGPKKKH-TSLITGVSI-SGFLA 301

Query: 298 ICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVY 357
           +C   L  IY+ ++ KNA+VIE WELE+GP RYSYQELK+AT  F  K+LLG GGFG VY
Sbjct: 302 LCGF-LFGIYMYRRYKNADVIEAWELEIGPHRYSYQELKKATKGFKDKELLGQGGFGSVY 360

Query: 358 KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD 417
           KGTL NS T+VAVKRIS++SKQG+REFVSEIA+IGRLRHRNLV L+GWCRR+GDLLLVYD
Sbjct: 361 KGTLPNSNTQVAVKRISHDSKQGLREFVSEIASIGRLRHRNLVPLLGWCRRRGDLLLVYD 420

Query: 418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS 477
           FM NGSLD +LFD PK +L+WEQRFK+IK VAS LLYLHEGYEQVVIHRDVKASNVLLD 
Sbjct: 421 FMENGSLDKYLFDGPKTILSWEQRFKVIKDVASALLYLHEGYEQVVIHRDVKASNVLLDG 480

Query: 478 ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
            LNG+LGDFGLA+LYEHG NP+TTRVVGT GY+APE PRTGKS+ +SDVFAFGALLLEVA
Sbjct: 481 GLNGRLGDFGLARLYEHGANPSTTRVVGTFGYMAPEVPRTGKSTPNSDVFAFGALLLEVA 540

Query: 538 CGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM----------- 586
           CG RP+E +ALPE++VLVD VW KY +GR+L+++DPKLN  +++ +VLM           
Sbjct: 541 CGLRPLEPKALPEDVVLVDCVWNKYKQGRILDLVDPKLNGAFNEREVLMVLKLGILCSNA 600

Query: 587 ----------------GELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY 630
                           GE+ LPD LR P         EGFD+ +NSL  SSF + ++ SY
Sbjct: 601 APAARPSMRQVVRFLDGEVGLPDELRKPEEVG---YQEGFDEFMNSLEPSSFYQMSTSSY 657

Query: 631 ---FENGVSYPSLSTSPITL 647
               +    +P + TS  TL
Sbjct: 658 AIKTDMDARFPFIDTSLYTL 677

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496074|ref|XP_003516895.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  848 bits (2191), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 432/669 (64%), Positives = 529/669 (79%), Gaps = 38/669 (5%)

Query: 16  IPVSSQLDELFFPGFKDL-SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKN 74
           IPVSSQ ++LF+ GFK L SNN+TL G+A+IE NG+L+LTND+S+ MG AFY +  RFKN
Sbjct: 14  IPVSSQPNQLFYAGFKGLGSNNMTLDGVAEIEPNGVLKLTNDSSKVMGHAFYPTPFRFKN 73

Query: 75  SLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSN 134
           S     FSFS+SFA+ IVPE+P+LGGHGLAFTI+PS DL   PSQYLG+L+S++IGNFSN
Sbjct: 74  SSGGKAFSFSSSFALAIVPEFPKLGGHGLAFTIAPSKDLKAHPSQYLGILDSSNIGNFSN 133

Query: 135 HLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYT--DNSTKQDLSLKGGKAI 192
           HLFAVEFDT +DFEF DI+DNH+GIDINS+ SNAS  A  YT  D+S+KQ+L+L+    I
Sbjct: 134 HLFAVEFDTAKDFEFGDIDDNHVGIDINSLASNASASAGYYTGDDDSSKQNLTLQSRVPI 193

Query: 193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNV 252
           L WVDYD+A+++++VT+S +S+KPK P+LS+ VDLSPI  E MYVGFSASTGLLASSH +
Sbjct: 194 LAWVDYDAAKSVVHVTISASSTKPKRPLLSYHVDLSPILKESMYVGFSASTGLLASSHYI 253

Query: 253 LGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILSLAIIYIIKKI 312
           LGWSFKINGPA  LDLSSLP LPGPKKKH T  I+GVS++ VVLA+C + L  IY+ ++ 
Sbjct: 254 LGWSFKINGPAPPLDLSSLPQLPGPKKKH-TSLIIGVSVSVVVLALCAV-LFGIYMYRRY 311

Query: 313 KNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKR 372
           KNA+VIE WELE+GP RYSYQELK+AT  F  K+LLG GGFG VYKGTL NS T+VAVKR
Sbjct: 312 KNADVIEAWELEIGPHRYSYQELKKATKGFKDKELLGQGGFGSVYKGTLPNSNTQVAVKR 371

Query: 373 ISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP 432
           IS++S QG+REFVSEIA+IGRLRHRNLVQL+GWCRR GDLLLVYDFM NGSLD +LF+EP
Sbjct: 372 ISHDSNQGLREFVSEIASIGRLRHRNLVQLLGWCRRLGDLLLVYDFMENGSLDKYLFNEP 431

Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + +L+WEQRFK+IK VAS LLYLHEGYEQVVIHRDVKASNVLLD ELNG+LGDFGLA+LY
Sbjct: 432 ETILSWEQRFKVIKDVASALLYLHEGYEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 491

Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL 552
           EHGTNP+TTRVVGTLGYLAPE PRTGK++ SSDVFAFGALLLEVACG RP+E +A+PE++
Sbjct: 492 EHGTNPSTTRVVGTLGYLAPEVPRTGKATPSSDVFAFGALLLEVACGLRPLEPKAMPEDM 551

Query: 553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM-------------------------- 586
           VLVD VW K+ +GR+L ++DPKLN  +++ ++LM                          
Sbjct: 552 VLVDCVWNKFKQGRILNMVDPKLNGVFNEREMLMVLKLGLLCSNGSPTARPSMRQVVRFL 611

Query: 587 -GELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFEN---GVSYPSLST 642
            GE+ +PD LR P         EGFD+ L+SL SSSFD+  + SY  N     S+PSL+ 
Sbjct: 612 EGEVGVPDELRKPGEGG---YQEGFDEFLHSLESSSFDQMNTGSYGRNRDMDSSFPSLTG 668

Query: 643 SPITLVYGR 651
           + +   +G+
Sbjct: 669 TSLFSPHGK 677

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481749|ref|XP_003632669.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Vitis vinifera]

 Score =  845 bits (2183), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/597 (71%), Positives = 509/597 (85%), Gaps = 9/597 (1%)

Query: 1   MASFLRIFSALIFL-SIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR 59
           MA+ L I  A++FL S PV+SQ+DE+F+ GF D+  NLT  G+A+I+ +GILRLTN+TSR
Sbjct: 1   MATSLTILLAIVFLLSTPVTSQVDEIFYGGFSDVGANLTKTGVAEIDKDGILRLTNETSR 60

Query: 60  KMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNG-LPS 118
            MG AF+S  L+FKNS N   FSFSTSFA  IVPEYP+LGGHG AF ISPS +L G LPS
Sbjct: 61  LMGHAFHSFPLQFKNSTNGTAFSFSTSFAFAIVPEYPKLGGHGFAFAISPSKELRGALPS 120

Query: 119 QYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDN 178
           QYLGLLN++DIGNFSNHLFAVEFDTV+DFEF+DINDNH+GIDI+S++SNAS  AA YTD+
Sbjct: 121 QYLGLLNASDIGNFSNHLFAVEFDTVKDFEFEDINDNHVGIDIDSLESNASSPAAYYTDD 180

Query: 179 STKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVG 238
           ST+Q ++L+ G  I  W+DYDS  N+LNVT+SP+SSKPK+PILSF +DLSPI  EFMYVG
Sbjct: 181 STQQSINLQSGNTIQAWIDYDSVGNVLNVTLSPSSSKPKLPILSFPLDLSPILQEFMYVG 240

Query: 239 FSASTGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAI 298
           FSASTGLLASSH V GWSFK+NG AR+LDLSSLPSLP PK++H T   +G+S++SVVL I
Sbjct: 241 FSASTGLLASSHYVFGWSFKMNGVARSLDLSSLPSLPEPKERH-TALTIGLSVSSVVLVI 299

Query: 299 CILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYK 358
             +S+ IIY+I+KI+NA+VIE WEL++GP R+SYQELK+AT  F  K+LLGHGGFG+VY+
Sbjct: 300 SAVSI-IIYMIRKIRNADVIEAWELDIGPHRFSYQELKKATKGFRDKELLGHGGFGRVYR 358

Query: 359 GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF 418
           GTL NS+T++AVKRIS++SKQG+REFVSEIA+IGRLRHRNLVQL+GWCRR G+L+LVYDF
Sbjct: 359 GTLPNSQTQIAVKRISHDSKQGMREFVSEIASIGRLRHRNLVQLLGWCRRYGNLMLVYDF 418

Query: 419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE 478
           M NGSLD FLFDEPK +L+WEQRF IIKGVASGLLYLHEGYEQVVIHRD+KASNVLLD+E
Sbjct: 419 MENGSLDKFLFDEPKLILSWEQRFNIIKGVASGLLYLHEGYEQVVIHRDIKASNVLLDNE 478

Query: 479 LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC 538
           LNG++GDFGLA+LYEHG+NP TTRVVGTLGYLAPE  RTGK++ +SDVFAFGALLLEV C
Sbjct: 479 LNGRVGDFGLARLYEHGSNPGTTRVVGTLGYLAPELSRTGKATTNSDVFAFGALLLEVTC 538

Query: 539 GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTL 595
           GRRPIE +ALPEELVLVDWVW K+ EGR+LE +D  L  +YD+     GE   P TL
Sbjct: 539 GRRPIEAKALPEELVLVDWVWDKWTEGRILEAVDSTLTGQYDE-----GEFSFPFTL 590

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	652
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.894	0.852	0.567	2.1e-173
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.888	0.855	0.477	1e-139
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.415	0.405	0.613	2.4e-138
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.888	0.857	0.477	5.1e-138
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.412	0.399	0.611	1.1e-135
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.884	0.862	0.477	1.8e-135
TAIR|locus:2020608	666	AT1G70110 [Arabidopsis thalian	0.891	0.872	0.458	1.1e-133
TAIR|locus:2168509	674	AT5G59260 [Arabidopsis thalian	0.843	0.816	0.446	5.1e-123
TAIR|locus:2138381	686	AT4G04960 [Arabidopsis thalian	0.490	0.466	0.462	4.6e-120
TAIR|locus:2020593	656	AT1G70130 [Arabidopsis thalian	0.963	0.957	0.407	3.7e-119

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 1685 (598.2 bits), Expect = 2.1e-173, P = 2.1e-173
 Identities = 334/589 (56%), Positives = 423/589 (71%)

Query:     3 SFLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMG 62
             +F  I   LIFL+  VSS + +  F GFK  S NLTL G+A+I   G +RLT +T R +G
Sbjct:     4 TFAVILLLLIFLTHLVSSLIQDFSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIG 63

Query:    63 QAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNG-LPSQYL 121
              AFYS  +RFK    +   SFSTSFAI +VPE+  LGGHGLAF I+P+ DL G LPSQYL
Sbjct:    64 HAFYSLPIRFKPIGVNRALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYL 123

Query:   122 GLLNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTK 181
             GLLNS+ + NFS+H FAVEFDTV+D EF+            SM+S+ S  A  +  NSTK
Sbjct:   124 GLLNSSRV-NFSSHFFAVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTK 182

Query:   182 QDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSA 241
             ++L L GG+ I  W+DYDS +  L+V +SP S KPK+ +LS+ VDLS +  + MYVGFSA
Sbjct:   183 KELFLDGGRVIQAWIDYDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSA 242

Query:   242 STGLLASSHNVLGWSFKINGPARALDXXXXXXXXXXXXXH---HTGAIVGVSIASVVXXX 298
             STGLLASSH +LGW+F ++G A +L                      I+GVS+   +   
Sbjct:   243 STGLLASSHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIF 302

Query:   299 XXXXXXXXXXXXXXXXXEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYK 358
                              + +E+WEL+ GP R+SY+ELK+ATN F  K+LLG GGFG+VYK
Sbjct:   303 AVLVAASLFVVRKVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYK 362

Query:   359 GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF 418
             G L  S   VAVKRIS+ES+QGVREF+SE+++IG LRHRNLVQL+GWCRR+ DLLLVYDF
Sbjct:   363 GKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDF 422

Query:   419 MANGSLDSFLFDE-PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS 477
             M NGSLD +LFDE P+ +L W+QRFKIIKGVASGLLYLHEG+EQ VIHRD+KA+NVLLDS
Sbjct:   423 MPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDS 482

Query:   478 ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
             E+NG++GDFGLAKLYEHG++P  TRVVGT GYLAPE  ++GK + S+DV+AFGA+LLEVA
Sbjct:   483 EMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVA 542

Query:   538 CGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
             CGRRPIET ALPEELV+VDWVW ++  G + +V+D +LN E+D+ +V+M
Sbjct:   543 CGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVM 591

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 1367 (486.3 bits), Expect = 1.0e-139, P = 1.0e-139
 Identities = 280/587 (47%), Positives = 388/587 (66%)

Query:     7 IFSALIFLSIPVSSQLDELF-FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAF 65
             IF   +   I +SS  +  F + GF     +++LQG+A +  NG+L+LTN + +K G AF
Sbjct:     8 IFFFFLLCQIMISSSQNLNFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAF 67

Query:    66 YSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN-GLPSQYLGLL 124
              +  +RFK+S N NV SFST+F   I  + P L GHG+AF ++P+  L   LPSQY+GL 
Sbjct:    68 CTERIRFKDSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLF 127

Query:   125 NSTDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTK-QD 183
             N ++ GN +NH+FAVEFDT+Q  EF              ++S A+   A Y D+  K Q+
Sbjct:   128 NISNNGNDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRS-ANYSTAGYRDDHDKFQN 186

Query:   184 LSLKGGKAILVWVDYDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFSAS 242
             LSL   K I VW+DYD+  + ++VTV+P +S KP+ P++S+  DLS I  E MYVGFS++
Sbjct:   187 LSLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSA 246

Query:   243 TGLLASSHNVLGWSFKINGPARALDXXXXXXXXXXXXXHHTGAI-VGVSIASVVXXXXXX 301
             TG + S H ++GWSF++NG A  L                +    +G+ + S+       
Sbjct:   247 TGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSII 306

Query:   302 XXXXXXXXXXXXXXEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTL 361
                           E ++DWE E G  R+ ++EL  AT  F  K LLG GGFG+VY+G L
Sbjct:   307 FLAFYIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGIL 366

Query:   362 HNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN 421
               +K EVAVKR+S++SKQG++EFV+EI +IGR+ HRNLV L+G+CRR+G+LLLVYD+M N
Sbjct:   367 PTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPN 426

Query:   422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG 481
             GSLD +L++ P+  L+W+QR  IIKGVASGL YLHE +EQVVIHRDVKASNVLLD++ NG
Sbjct:   427 GSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNG 486

Query:   482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRR 541
             +LGDFGLA+LY+HG++P TT VVGTLGYLAPE  RTG+++ ++DV+AFGA LLEV  GRR
Sbjct:   487 RLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRR 546

Query:   542 PIETRALPEE-LVLVDWVWGKYGEGRVLEVIDPKLNAE-YDQSQVLM 586
             PIE  +  ++  +LV+WV+  +  G ++E  DPKL +  YD  +V M
Sbjct:   547 PIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEM 593

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 894 (319.8 bits), Expect = 2.4e-138, Sum P(2) = 2.4e-138
 Identities = 167/272 (61%), Positives = 214/272 (78%)

Query:   316 EVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN 375
             E +EDWE E G  R  +++L  AT  F  K +LG GGFG VYKG +  +K E+AVKR+SN
Sbjct:   324 EEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKRVSN 383

Query:   376 ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV 435
             ES+QG++EFV+EI +IG++ HRNLV LVG+CRR+ +LLLVYD+M NGSLD +L++ P+  
Sbjct:   384 ESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEVT 443

Query:   436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
             L+W+QRFK+I GVAS L YLHE +EQVVIHRDVKASNVLLD+ELNG+LGDFGLA+L +HG
Sbjct:   444 LDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHG 503

Query:   496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE-TRALPEELVL 554
             ++P TTRVVGT GYLAP+  RTG+++ ++DVFAFG LLLEVACGRRPIE      E +VL
Sbjct:   504 SDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVL 563

Query:   555 VDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
             VDWV+  + E  +L+  DP L +EYDQ +V M
Sbjct:   564 VDWVFRFWMEANILDAKDPNLGSEYDQKEVEM 595

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1351 (480.6 bits), Expect = 5.1e-138, P = 5.1e-138
 Identities = 281/588 (47%), Positives = 377/588 (64%)

Query:     4 FLRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQ 63
             F   F  LIF S   S  L+  +  GF     +L++QGI  +  NG+L+LTN T +K G 
Sbjct:     9 FFFFFFNLIFQSS--SQSLNFAYNNGFNP-PTDLSIQGITTVTPNGLLKLTNTTVQKTGH 65

Query:    64 AFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN-GLPSQYLG 122
             AFY+  +RFK+S N  V SFSTSF   I  +   L GHG+AF ++P+  L  G PSQY+G
Sbjct:    66 AFYTKPIRFKDSPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIG 125

Query:   123 LLNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQ 182
             L N  + GN +NH+FAVE DT+   EF             S+KS  S  A  + +    +
Sbjct:   126 LFNLANNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFK 185

Query:   183 DLSLKGGKAILVWVDYDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFSA 241
             +L+L   K + VWVDYD   N ++VT++P N  KP  P+++   DLS +  + MYVGFS+
Sbjct:   186 NLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSS 245

Query:   242 STGLLASSHNVLGWSFKIN--GPARALDXXXXXXXXXXXXXHHTGAIVGVSIASVVXXXX 299
             +TG + S H +LGWSF +N   P  AL                   I G+ + S+     
Sbjct:   246 ATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKI-GMPLISLFLIFS 304

Query:   300 XXXXXXXXXXXXXXXXEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKG 359
                             E +E+WE E G  R+ +++L  AT  F  K LLG GGFG VYKG
Sbjct:   305 FIFLVCYIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKG 364

Query:   360 TLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM 419
              +  +K E+AVKR+S+ES+QG++EFV+EI +IGR+ HRNLV L+G+CRR+G+LLLVYD+M
Sbjct:   365 VMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYM 424

Query:   420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
              NGSLD +L++ P+  LNW+QR K+I GVASGL YLHE +EQVVIHRDVKASNVLLD EL
Sbjct:   425 PNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGEL 484

Query:   480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
             NG+LGDFGLA+LY+HG++P TT VVGTLGYLAPE  RTG+++ ++DVFAFGA LLEVACG
Sbjct:   485 NGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACG 544

Query:   540 RRPIETRALPEE-LVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
             RRPIE +   +E  +LVDWV+G + +G +L   DP + +E D+ +V M
Sbjct:   545 RRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEM 592

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 877 (313.8 bits), Expect = 1.1e-135, Sum P(2) = 1.1e-135
 Identities = 165/270 (61%), Positives = 212/270 (78%)

Query:   316 EVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN 375
             E  EDWE E G  R  +++L  AT  F  K LLG GGFG+VY+G +  +K E+AVKR+SN
Sbjct:   329 EEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSN 388

Query:   376 ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV 435
             ES+QG++EFV+EI +IGR+ HRNLV L+G+CRR+ +LLLVYD+M NGSLD +L+D P+  
Sbjct:   389 ESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEVT 448

Query:   436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
             L+W+QRF +I GVASGL YLHE +EQVVIHRD+KASNVLLD+E NG+LGDFGLA+L +HG
Sbjct:   449 LDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHG 508

Query:   496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVL- 554
             ++P TTRVVGT GYLAP+  RTG+++ ++DVFAFG LLLEVACGRRPIE     +E VL 
Sbjct:   509 SDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLL 568

Query:   555 VDWVWGKYGEGRVLEVIDPKLNAEYDQSQV 584
             VD V+G + EG +L+  DP L + YDQ +V
Sbjct:   569 VDSVFGFWIEGNILDATDPNLGSVYDQREV 598

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 1327 (472.2 bits), Expect = 1.8e-135, P = 1.8e-135
 Identities = 282/590 (47%), Positives = 373/590 (63%)

Query:     5 LRIFSALIFLSIPVSSQLDELFFPGFKD-LSNNLTLQGIAKIENNGILRLTNDTSRKMGQ 63
             L +   L F S    SQ +E  F GF   L +N    GIA   + G+++LTN +    G 
Sbjct:     6 LVLLLVLQFFSNKALSQSEEGEF-GFNGYLYDN---SGIAITNSKGLMKLTNSSEFSYGH 61

Query:    64 AFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN-GLPSQYLG 122
              FY+S +RFKNS N  V SFST+F   IV     L GHGLAF ISP+  L     SQYLG
Sbjct:    62 VFYNSPVRFKNSPNGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLG 121

Query:   123 LLNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNS-TK 181
             L N T+ G+ SNH+ AVEFDT Q+ EF             S+ S  +  A  Y D+  T 
Sbjct:   122 LFNLTNNGDPSNHIVAVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTF 181

Query:   182 QDLSLKGGKAILVWVDYDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFS 240
             +++ L   K I  W++YDS+   LNVT+ P +  KPKIP+LS   DLSP   + MYVGF+
Sbjct:   182 KNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFT 241

Query:   241 ASTGLLASSHNVLGWSFKINGPARALDXXXXXXXXXXXXXHHTGAIVGVSIA-SVVXXXX 299
             ++TG L SSH +LGW+FK+NG A  +D                  I+ +S++ + +    
Sbjct:   242 SATGRLRSSHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILV 301

Query:   300 XXXXXXXXXXXXXXXXEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKG 359
                             EV+EDWE++ GP R++Y++L  AT  F   +LLG GGFG+VYKG
Sbjct:   302 FLTISYMLFLKRKKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKG 361

Query:   360 TLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM 419
             TL  S  ++AVK++S++S+QG+REFV+EIATIGRLRH NLV+L+G+CRRKG+L LVYD M
Sbjct:   362 TLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCM 421

Query:   420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
               GSLD FL+ +P+  L+W QRFKIIK VASGL YLH  + QV+IHRD+K +NVLLD  +
Sbjct:   422 PKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSM 481

Query:   480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
             NGKLGDFGLAKL EHG +P T+ V GT GY++PE  RTGK+S SSDVFAFG L+LE+ CG
Sbjct:   482 NGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCG 541

Query:   540 RRPIETRAL-PEELVLVDWVWGKYGEGRVLEVIDPKLNAE--YDQSQVLM 586
             RRP+  RA  P E+VL DWV   + E  +L+V+D ++  +  Y + QV +
Sbjct:   542 RRPVLPRASSPSEMVLTDWVLDCW-EDDILQVVDERVKQDDKYLEEQVAL 590

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1310 (466.2 bits), Expect = 1.1e-133, P = 1.1e-133
 Identities = 269/587 (45%), Positives = 367/587 (62%)

Query:     5 LRIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQA 64
             L +F  L F+   V  Q        F + S N+   G A I NNG++RLTN T +  GQ 
Sbjct:     3 LLLFLVLFFVPESVVCQRPNPNGVEF-NTSGNMYTSGSAYINNNGLIRLTNSTPQTTGQV 61

Query:    65 FYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNG-LPSQYLGL 123
             FY+  LRFKNS+N  V SFST+F   I       GG+G+AF I P+ DL+   P+ YLGL
Sbjct:    62 FYNDQLRFKNSVNGTVSSFSTTFVFSIEFHNGIYGGYGIAFVICPTRDLSPTFPTTYLGL 121

Query:   124 LNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQD 183
              N +++G+  NH+ AVE DT  D +F+            ++ S+    A  Y DN T + 
Sbjct:   122 FNRSNMGDPKNHIVAVELDTKVDQQFEDKDANHVGIDINTLVSDTVALAGYYMDNGTFRS 181

Query:   184 LSLKGGKAILVWVDYDSAENILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFSAS 242
             L L  G+ + +W++YDS +  +NVT+ P    KPKIP+LS   DLSP   E MYVGF+++
Sbjct:   182 LLLNSGQPMQIWIEYDSKQKQINVTLHPLYVPKPKIPLLSLEKDLSPYLLELMYVGFTST 241

Query:   243 TGLLASSHNVLGWSFKINGPARALDXXXXXXXXXXXX--XHHTGAIVGVSIA-SVVXXXX 299
             TG L +SH +LGW+FK+NG    +D                    I+ +S+  S V    
Sbjct:   242 TGDLTASHYILGWTFKMNGTTPDIDPSRLPKIPRYNQPWIQSPNGILTISLTVSGVIILI 301

Query:   300 XXXXXXXXXXXXXXXXEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKG 359
                             EV+EDWE++ GP R+++++L  AT  F   ++LG GGFG+VYKG
Sbjct:   302 ILSLSLWLFLKRKKLLEVLEDWEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKG 361

Query:   360 TLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM 419
             TL  S  E+AVK +S++S+QG+REF++EIATIGRLRH NLV+L G+CR KG+L LVYD M
Sbjct:   362 TLPVSNVEIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCM 421

Query:   420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
             A GSLD FL+ +    L+W QRFKIIK VASGL YLH+ + QV+IHRD+K +N+LLD+ +
Sbjct:   422 AKGSLDKFLYHQQTGNLDWSQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANM 481

Query:   480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
             N KLGDFGLAKL +HGT+P T+ V GTLGY++PE  RTGK+S  SDVFAFG ++LE+ACG
Sbjct:   482 NAKLGDFGLAKLCDHGTDPQTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACG 541

Query:   540 RRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
             R+PI  RA   E+VL DWV   +    +++V+D K+  EY + Q  +
Sbjct:   542 RKPILPRASQREMVLTDWVLECWENEDIMQVLDHKIGQEYVEEQAAL 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)]

 Score = 1193 (425.0 bits), Expect = 5.1e-123, Sum P(2) = 5.1e-123
 Identities = 257/576 (44%), Positives = 359/576 (62%)

Query:    30 FKDLSN-NLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFK-NSLNSNVFSFSTSF 87
             + D  N +L L G+A   N+G L LTN+T+   G AFY+  ++F  +SL+S  FSFST F
Sbjct:    32 YYDFRNADLELDGMANT-NHGPLHLTNNTNTGTGHAFYNIPIKFTASSLSS--FSFSTEF 88

Query:    88 AIVIVPEYPRLGGHGLAFTISPSNDL--NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQ 145
                I P      GHG+AF +SP+ DL  NG  +  LG+ N  +    + H+FAVE DT Q
Sbjct:    89 VFAIFPLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFNRANDNKTATHIFAVELDTNQ 148

Query:   146 DFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQ-DLSLKGGKAILVWVDYDSAENI 204
             + E              S+ S  S +A+ +     K   L L  GK+ILVW+DYD  E +
Sbjct:   149 NSESFDKGGNDVGIDINSIVSVESADASYFNARKGKNISLPLASGKSILVWIDYDGIEKV 208

Query:   205 LNVTVSPNSS------------KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNV 252
             LNVT++P  +            KPK+P+LS  ++LS IF E MYVGFS STG + S+  +
Sbjct:   209 LNVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEIFTETMYVGFSGSTGSIKSNQYI 268

Query:   253 LGWSFKINGPARALDXXXXXXXXXXXXXHHTGAIVGVSIASVVXXXXXXXXXXXXXXXXX 312
             LGWSFK  G A +LD                  ++G +I+++                  
Sbjct:   269 LGWSFKQGGKAESLDISRLSNPPPSPKRFPLKEVLGATISTIAFLTLGGIVYLYKKKKYA 328

Query:   313 XXXEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKR 372
                EV+E WE E  PQRYS++ L +AT  F   QLLG GGFG+VYKG L  S T++AVKR
Sbjct:   329 ---EVLEQWEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILP-SGTQIAVKR 384

Query:   373 ISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP 432
             + ++++QG++++V+EIA++GRLRH+NLV L+G+CRRKG+LLLVYD+M NGSLD +LF + 
Sbjct:   385 VYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHKN 444

Query:   433 KAV-LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
             K   L W QR  IIKGVAS LLYLHE +EQVV+HRD+KASN+LLD++LNGKLGDFGLA+ 
Sbjct:   445 KLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARF 504

Query:   492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE 551
             ++ G N   TRVVGT+GY+APE    G ++  +DV+AFGA +LEV CGRRP++  A  E+
Sbjct:   505 HDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPDAPREQ 564

Query:   552 LVLVDWVWGKYGEGRVLEVIDPKL-NAEYDQSQVLM 586
             ++LV WV        + + +D KL + + +++++L+
Sbjct:   565 VILVKWVASCGKRDALTDTVDSKLIDFKVEEAKLLL 600

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2138381 AT4G04960 [Arabidopsis thaliana (taxid:3702)]

 Score = 756 (271.2 bits), Expect = 4.6e-120, Sum P(2) = 4.6e-120
 Identities = 160/346 (46%), Positives = 224/346 (64%)

Query:   317 VIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE 376
             ++EDWE+E  P R  Y+E++  T  F  K ++G GG G+VYKG L     EVAVKRIS E
Sbjct:   322 LMEDWEMEYWPHRIPYEEIESGTKGFDEKNVIGIGGNGKVYKGLLQGGVVEVAVKRISQE 381

Query:   377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-GDLLLVYDFMANGSLDSFLF--DEPK 433
             S  G+REFV+EI+++GRL+HRNLV L GWC+++ G  +LVYD+M NGSLD ++F  DE  
Sbjct:   382 SSDGMREFVAEISSLGRLKHRNLVSLRGWCKKEVGSFMLVYDYMENGSLDRWIFENDEKI 441

Query:   434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
               L+ E+R +I+KGVASG+LYLHEG+E  V+HRD+KASNVLLD ++  +L DFGLA+++ 
Sbjct:   442 TTLSCEERIRILKGVASGILYLHEGWESKVLHRDIKASNVLLDRDMIPRLSDFGLARVHG 501

Query:   494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
             H     TTRVVGT GYLAPE  +TG++S  +DVFA+G L+LEV CGRRPIE    P    
Sbjct:   502 HEQPVRTTRVVGTAGYLAPEVVKTGRASTQTDVFAYGILVLEVMCGRRPIEEGKKP---- 557

Query:   554 LVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVL-MGE--LEL------PDTLRGPRSS--- 601
             L+DWVWG    G +L  +DP++      ++V+   E  L+L      PD  + P      
Sbjct:   558 LMDWVWGLMERGEILNGLDPQMMMTQGVTEVIDEAERVLQLGLLCAHPDPAKRPSMRQVV 617

Query:   602 ---DGDKA----AEGFDDLLNSLASSSFDKTTSCSYFENGVSYPSL 640
                +GDKA    AE  +D+ + +      + +S  ++    S+P++
Sbjct:   618 QVFEGDKAEIFEAESSEDVESWMLMKMGSRGSSREFWYGSSSHPTI 663

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020593 AT1G70130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1173 (418.0 bits), Expect = 3.7e-119, P = 3.7e-119
 Identities = 266/652 (40%), Positives = 374/652 (57%)

Query:     7 IFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRL-TNDTSRKMGQAF 65
             +FS   F    +S   D     G    +  L   G+A +  +G+ +L T+ T    GQ  
Sbjct:     9 LFSLFFFYMASISQCSDPT--GGQFSFNGYLYTDGVADLNPDGLFKLITSKTQGGAGQVL 66

Query:    66 YSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLN 125
             Y   L+FKNS N  V SFST+F   IV     + G GL+F ISP+  LN +P+       
Sbjct:    67 YQFPLQFKNSPNGTVSSFSTTFVFAIVAVRKTIAGCGLSFNISPTKGLNSVPNI------ 120

Query:   126 STDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLS 185
                  + SNH  +V F T +  +              S K + +  A  Y D+    +L 
Sbjct:   121 -----DHSNHSVSVGFHTAKSDKPDGEDVNLVGINIDSSKMDRNCSAGYYKDDGRLVNLD 175

Query:   186 LKGGKAILVWVDYDSAENILNVTV-SPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG 244
             +  GK I VW++Y+++   L+VT+ S   SKPKIP+LS R DLSP  +E+MY+GF+ S G
Sbjct:   176 IASGKPIQVWIEYNNSTKQLDVTMHSIKISKPKIPLLSMRKDLSPYLHEYMYIGFT-SVG 234

Query:   245 LLASSHNVLGWSFKINGPARALDXXXXXXXXXXXXXHHTGA-IVGVSIA-SVVXXXXXXX 302
                SSH +LGWSF   G    ++                 + I+ +S++ S V       
Sbjct:   235 SPTSSHYILGWSFNNKGAVSDINLSRLPKVPDEDQERSLSSKILAISLSISGVTLVIVLI 294

Query:   303 XXXXXXXXXXXXXEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH 362
                          EVIEDWE++ GP +++Y++L  AT  F   ++LG GGFG+V+KG L 
Sbjct:   295 LGVMLFLKRKKFLEVIEDWEVQFGPHKFTYKDLFIATKGFKNSEVLGKGGFGKVFKGILP 354

Query:   363 NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG 422
              S   +AVK+IS++S+QG+REF++EIATIGRLRH +LV+L+G+CRRKG+L LVYDFM  G
Sbjct:   355 LSSIPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYLVYDFMPKG 414

Query:   423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK 482
             SLD FL+++P  +L+W QRF IIK VASGL YLH+ + QV+IHRD+K +N+LLD  +N K
Sbjct:   415 SLDKFLYNQPNQILDWSQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPANILLDENMNAK 474

Query:   483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             LGDFGLAKL +HG +  T+ V GT GY++PE  RTGKSS SSDVFAFG  +LE+ CGRRP
Sbjct:   475 LGDFGLAKLCDHGIDSQTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVFMLEITCGRRP 534

Query:   543 IETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQV-LMGELEL----PDTLRG 597
             I  R  P E+VL DWV   +  G +L+V+D KL   Y   QV L+ +L L    P     
Sbjct:   535 IGPRGSPSEMVLTDWVLDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGLLCSHPVAATR 594

Query:   598 PRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFENGVSYPSL-STSPITLV 648
             P  S   +  +G   L ++L      +  +  +   GV+  S+ ++S ++LV
Sbjct:   595 PSMSSVIQFLDGVATLPHNLLDLVNSRIINEGFDTLGVTTESMEASSNVSLV 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9M2S4	LRKS4_ARATH	2, ., 7, ., 1, 1, ., 1	0.6114	0.8711	0.8304	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	652
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	1e-101
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	2e-94
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-40
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-31
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-31
cd01951	223	cd01951, lectin_L-type, legume lectins	3e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-27
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-25
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-24
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-24
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-24
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-22
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-16
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-04
cd07308	218	cd07308, lectin_leg-like, legume-like lectins: ERG	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  308 bits (790), Expect = e-101
 Identities = 119/239 (49%), Positives = 152/239 (63%), Gaps = 11/239 (4%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS--RKMGQAFYSSTLRFKNSLNSNVFSFS 84
           F GF    +NLTLQG A I +NG L+LTNDTS    +G+A YS  +R  +S    V SFS
Sbjct: 5   FNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVASFS 64

Query: 85  TSFAIVIVPEYPRLGGHGLAFTISPSNDL-NGLPSQYLGLLNSTDIGNFSNHLFAVEFDT 143
           TSF+  I P  P LGG GLAF ++P++ L       YLGL NS++ GN SNH+ AVEFDT
Sbjct: 65  TSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDT 124

Query: 144 VQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAEN 203
            Q+ EF D +DNH+GID+NS+ S      A Y D+       LK GK +  W+DYDS+  
Sbjct: 125 FQNPEFGDPDDNHVGIDVNSLVS----VKAGYWDDD---GGKLKSGKPMQAWIDYDSSSK 177

Query: 204 ILNVTVSP-NSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKING 261
            L+VT++    +KPK P+LS+ VDLS +  E +YVGFSASTGLL   H +L WSF  NG
Sbjct: 178 RLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSNG 236

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  290 bits (744), Expect = 2e-94
 Identities = 111/234 (47%), Positives = 142/234 (60%), Gaps = 11/234 (4%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTS 86
           + GF +  +NLTLQG A +  NG+L+LTN T+   G+A YS  +R  +S    V SFSTS
Sbjct: 7   YNGFSN-VSNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLWDSSTGKVASFSTS 65

Query: 87  FAIVIVPE-YPRLGGHGLAFTISPSNDL-NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTV 144
           F   I        GG GLAF ++PS          YLGL NS++ GN SNH+ AVEFDT 
Sbjct: 66  FVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSSNHIVAVEFDTF 125

Query: 145 QDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENI 204
            + EF DI+DNH+GID+NS+ S AS  A       +   L L  GK I VW+DYD +   
Sbjct: 126 LNPEFNDIDDNHVGIDVNSIISVASESA-------SFVPLDLNSGKPIQVWIDYDGSSKR 178

Query: 205 LNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFK 258
           L+VT++   +KPK P+LS  VDLS +  E++YVGFSASTG    SH VL WSF 
Sbjct: 179 LSVTLAY-PNKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWSFS 231

Length = 231

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  171 bits (436), Expect = 6e-49
 Identities = 69/201 (34%), Positives = 98/201 (48%), Gaps = 9/201 (4%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRNLVQL 402
            + LG G FG VYK     +   VAVK +   +E  +  +    EI  + RL H N+V+L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
           +     K  L LV ++   G L  +L       L+ ++  KI   +  GL YLH      
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHS---NG 118

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK-SS 521
           +IHRD+K  N+LLD     K+ DFGLAK     ++  TT  VGT  Y+APE    G    
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177

Query: 522 ASSDVFAFGALLLEVACGRRP 542
              DV++ G +L E+  G+ P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (428), Expect = 2e-48
 Identities = 69/191 (36%), Positives = 99/191 (51%), Gaps = 8/191 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQLVGWC 406
           LG GGFG VY      +  +VA+K I  E    + E  + EI  + +L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
             +  L LV ++   GSL   L +     L+ ++  +I+  +  GL YLH      +IHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 467 DVKASNVLLDSELNG-KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-PRTGKSSASS 524
           D+K  N+LLDS+    KL DFGL+KL     +   T  VGT  Y+APE     G  S  S
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKS 175

Query: 525 DVFAFGALLLE 535
           D+++ G +L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  168 bits (429), Expect = 5e-48
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 10/198 (5%)

Query: 345 KQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNL 399
            + LG G FG+VYKGTL       + EVAVK +  + S+Q + EF+ E   + +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           V+L+G C  +  L++V ++M  G L  +L       L+          +A G+ YL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPETPRTG 518
            +  IHRD+ A N L+   L  K+ DFGL++ LY+          +  + ++APE+ + G
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEG 179

Query: 519 KSSASSDVFAFGALLLEV 536
           K ++ SDV++FG LL E+
Sbjct: 180 KFTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (424), Expect = 2e-47
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLV 400
           +   + LG G FG+VY      +   VA+K I  +  +  RE  + EI  + +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYL 455
           +L      +  L LV ++   G L   L       E +A          ++ + S L YL
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H    + ++HRD+K  N+LLD + + KL DFGLA+  + G     T  VGT  Y+APE  
Sbjct: 114 HS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVL 168

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
                  + D+++ G +L E+  G+ P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  166 bits (424), Expect = 3e-47
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 23/205 (11%)

Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG G FG+VYKG L       TEVAVK +  + S++  ++F+ E   + +L H N+V+L+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFL-------FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           G C  +  L LV ++M  G L  +L           K+ L+ +        +A G+ YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG-----YLA 511
               +  +HRD+ A N L+  +L  K+ DFGL++               T G     ++A
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY----YRKKTGGKLPIRWMA 175

Query: 512 PETPRTGKSSASSDVFAFGALLLEV 536
           PE+ + G  ++ SDV++FG LL E+
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  165 bits (419), Expect = 1e-46
 Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 11/198 (5%)

Query: 345 KQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNL 399
            + LG G FG+VYKG L       K EVAVK +  + S+Q + EF+ E   + +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           V+L+G C  +  L +V ++M  G L S+L    +  L+          +A G+ YL    
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLE--- 119

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPETPRTG 518
            +  IHRD+ A N L+   L  K+ DFGL++ LY+          +  + ++APE+ + G
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEG 178

Query: 519 KSSASSDVFAFGALLLEV 536
           K ++ SDV++FG LL E+
Sbjct: 179 KFTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  157 bits (400), Expect = 7e-44
 Identities = 70/209 (33%), Positives = 111/209 (53%), Gaps = 21/209 (10%)

Query: 346 QLLGHGGFGQVYKGTLH----NSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLV 400
           + LG G FG+VYKGTL      ++T+VAVK +    S++   EF+ E + + +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +L+G C +   L +V ++M  G L  FL  +    L  +   ++   +A G+ YL     
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYL-----APET 514
           +  +HRD+ A N L+   L  K+ DFGL++ +YE              G L     APE+
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPES 175

Query: 515 PRTGKSSASSDVFAFGALLLEVAC-GRRP 542
            + GK ++ SDV++FG LL E+   G +P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  146 bits (372), Expect = 6e-40
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 22/208 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           +LLG G FG VY     ++   +AVK   +S +S++ +     EI  +  L+H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 404 GWCRR---KGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYL 455
           G   R   K  L +  ++++ GSL S L       EP       +++   + +  GL YL
Sbjct: 66  G-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKY--TRQILEGLAYL 117

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYLAPET 514
           H      ++HRD+K +N+L+DS+   KL DFG AK          T  V GT  ++APE 
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
            R  +   ++D+++ G  ++E+A G+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  142 bits (360), Expect = 2e-38
 Identities = 74/199 (37%), Positives = 104/199 (52%), Gaps = 11/199 (5%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
              +G G FG V  G     K  VAVK + ++S    + F++E + +  LRH NLVQL+G
Sbjct: 11  GATIGKGEFGDVMLGDYRGQK--VAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +   L +V ++MA GSL  +L    +AV+   Q+      V  G+ YL    E+  +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+ A NVL+  +L  K+ DFGLAK    G +     V  T    APE  R  K S  S
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180

Query: 525 DVFAFGALLLEV-ACGRRP 542
           DV++FG LL E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  134 bits (339), Expect = 1e-35
 Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 6/201 (2%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           F   + +G GGFG+VYK     +  EVA+K I  ESK+   + ++EI  + + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
             G   +K +L +V +F + GSL   L       L   Q   + K +  GL YLH     
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
            +IHRD+KA+N+LL S+   KL DFGL+         A   +VGT  ++APE        
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT--KARNTMVGTPYWMAPEVINGKPYD 175

Query: 522 ASSDVFAFGALLLEVACGRRP 542
             +D+++ G   +E+A G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 4e-33
 Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 10/205 (4%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+    L+G G FG VYKG    +   VA+K+IS E   ++ ++  + EI  +  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+ +G       L ++ ++  NGSL   +  +             +  V  GL YLHE 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHE- 117

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPETPRT 517
             Q VIHRD+KA+N+L   +   KL DFG+A KL +   + A+  VVGT  ++APE    
Sbjct: 118 --QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEM 173

Query: 518 GKSSASSDVFAFGALLLEVACGRRP 542
             +S +SD+++ G  ++E+  G  P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  124 bits (312), Expect = 7e-32
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 8/217 (3%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           F+ ++ LG G FG+V++G   N    VA+K + ++     ++F  E+  + RLRH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L   C     + ++ + M  GSL +FL      VL       +   VA G+ YL    EQ
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQ 123

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY-EHGTNPATTRVVGTLGYLAPETPRTGKS 520
             IHRD+ A N+L+  +L  K+ DFGLA+L  E     +  ++     + APE    G  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 521 SASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVD 556
           S  SDV++FG LL E+   G+ P       E    + 
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 1e-31
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 18/202 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V+ GT + + T+VAVK +    K G      F+ E   + +LRH  LVQL  
Sbjct: 14  LGAGQFGEVWMGTWNGT-TKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C  +  + +V ++M+ GSL  FL       L   Q   +   +A G+ YL     +  I
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSS 521
           HRD+ A N+L+   L  K+ DFGLA+L E   +  T R  G    + + APE    G+ +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAR-EGAKFPIKWTAPEAANYGRFT 182

Query: 522 ASSDVFAFGALLLE-VACGRRP 542
             SDV++FG LL E V  GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (310), Expect = 1e-31
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 22/221 (9%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRN 398
            +   + +G G FG+VY     +      +K I  SN S++   + ++E+  + +L H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------FDEPKAVLNWEQRFKIIKGVA 449
           +++       KG L +V ++   G L   +         F E + +L+W   F  +    
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ-ILDW---FVQL---C 113

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
             L YLH    + ++HRD+K  N+ L S    KLGDFG++K+     + A T VVGT  Y
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYY 169

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L+PE  +    +  SD+++ G +L E+   + P E   L E
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 2e-31
 Identities = 79/237 (33%), Positives = 114/237 (48%), Gaps = 20/237 (8%)

Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG 380
           WE++    R S Q L++          LG G FG+V++G L N+ T VAVK +   +   
Sbjct: 1   WEID----RTSIQLLRK----------LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMD- 44

Query: 381 VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
            ++F++E   + +LRH  L+QL   C  +  + +V + M  GSL  +L       L   Q
Sbjct: 45  PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQ 104

Query: 441 RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT 500
              +   VASG+ YL     Q  IHRD+ A NVL+      K+ DFGLA++ +     A 
Sbjct: 105 LIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161

Query: 501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLE-VACGRRPIETRALPEELVLVD 556
                 + + APE     + S  SDV++FG LL E V  GR P       E L  VD
Sbjct: 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 2e-31
 Identities = 70/206 (33%), Positives = 117/206 (56%), Gaps = 16/206 (7%)

Query: 346 QLLGHGGFGQVYKGTLH-NSKTE--VAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           +++G G FG+V +G L    K E  VA+K +   S    R +F++E + +G+  H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYE 460
           L G   +   ++++ ++M NGSLD FL  E        Q   +++G+ASG+ YL E  Y 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---TLGYLAPETPRT 517
              +HRD+ A N+L++S L  K+ DFGL++  E      TT+  G    + + APE    
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--GGKIPIRWTAPEAIAY 182

Query: 518 GKSSASSDVFAFGALLLEV-ACGRRP 542
            K +++SDV++FG ++ EV + G RP
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score =  121 bits (305), Expect = 3e-31
 Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 17/231 (7%)

Query: 28  PGFKDLSNNLTLQGIAKI-ENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTS 86
               +  +N  L G A +  ++G+LRLT DT  + G A+Y      K  ++ +   F+T+
Sbjct: 7   NFSNNNQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWY------KTPIDLS-KDFTTT 59

Query: 87  FAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQD 146
           F   +       G  G+AF +              G L    IGN      AVEFDT ++
Sbjct: 60  FKFYL-GTKGTNGADGIAFVLQNDPAGALGGGGGGGGLGYGGIGNS----VAVEFDTYKN 114

Query: 147 FEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILN 206
            +  D N NHI ID+N   +N ++  ++ + +          G    V + YD   N L 
Sbjct: 115 DDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGT---GLGNEHTVRITYDPTTNTLT 171

Query: 207 VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSF 257
           V +  N S      ++  VDL  +     Y GF+ASTG L + H++L WSF
Sbjct: 172 VYLD-NGSTLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSF 221

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (290), Expect = 1e-28
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLV 400
           + LG G FG+V          N+  +VAVK +++   +Q   +F  EI  +  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 401 QLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +  G C + G   L L+ +++ +GSL  +L    +  +N ++       +  G+ YL   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLGS- 127

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLAPETPR 516
             Q  IHRD+ A N+L++SE   K+ DFGLAK+     +    +  G     + APE  R
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 517 TGKSSASSDVFAFGALLLE 535
           T K S++SDV++FG  L E
Sbjct: 186 TSKFSSASDVWSFGVTLYE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (282), Expect = 1e-27
 Identities = 67/199 (33%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI---SNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG G  G V K     +   +AVK I    NE+ Q  ++ + E+  + +     +V   G
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPYIVGFYG 66

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
                GD+ +  ++M  GSLD  L  E +  +      KI   V  GL YLHE ++  +I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRDVK SN+L++S    KL DFG++       N      VGT  Y+APE  +    S  S
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 525 DVFAFGALLLEVACGRRPI 543
           D+++ G  L+E+A GR P 
Sbjct: 181 DIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  112 bits (281), Expect = 1e-27
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 4/195 (2%)

Query: 343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQL 402
           + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A +  ++H NLVQL
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL 67

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
           +G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S + YL +   + 
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KN 124

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
            IHRD+ A N L+      K+ DFGL++L    T  A       + + APE+    K S 
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 523 SSDVFAFGALLLEVA 537
            SDV+AFG LL E+A
Sbjct: 185 KSDVWAFGVLLWEIA 199

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  111 bits (280), Expect = 2e-27
 Identities = 71/209 (33%), Positives = 124/209 (59%), Gaps = 17/209 (8%)

Query: 345 KQLLGHGGFGQVYKGTL-HNSKTE--VAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++++G G FG+V +G L    K E  VA+K + S  +++  R+F+SE + +G+  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLF--DEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            L G   +   ++++ +FM NG+LDSFL   D    V+   Q   +++G+A+G+ YL   
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYLS-- 123

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT-NPATTRVVG---TLGYLAPET 514
            E   +HRD+ A N+L++S L  K+ DFGL++  E  T +P  T  +G    + + APE 
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 515 PRTGKSSASSDVFAFGALLLEV-ACGRRP 542
               K +++SDV+++G ++ EV + G RP
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  110 bits (278), Expect = 4e-27
 Identities = 60/198 (30%), Positives = 107/198 (54%), Gaps = 10/198 (5%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           LG G  G VYK     +    A+K+I  +  ++  ++ + E+ T+       +V+  G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF--KIIKGVASGLLYLHEGYEQVVI 464
            ++G++ +V ++M  GSL   L    K V    +     I + +  GL YLH   ++ +I
Sbjct: 69  YKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLH--TKRHII 122

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+L++S+   K+ DFG++K+ E+  +   T  VGT+ Y++PE  +    S ++
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQGESYSYAA 181

Query: 525 DVFAFGALLLEVACGRRP 542
           D+++ G  LLE A G+ P
Sbjct: 182 DIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  108 bits (271), Expect = 2e-26
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 14/219 (6%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHR 397
           +F   +++G G FG+V      ++K   A+K ++ +    K  VR  ++E   +  L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ-RFKIIKGVASGLLYLH 456
            LV L    + + ++ LV D +  G L   L    K   + EQ +F  I  +   L YLH
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKF-WICEIVLALEYLH 117

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
               + +IHRD+K  N+LLD + +  + DF +A      T   TT   GT GY+APE   
Sbjct: 118 S---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLC 172

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP--IETRALPEELV 553
               S + D ++ G    E   G+RP    +R + +++ 
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 3e-26
 Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 9/194 (4%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQLVG 404
           + +G G FG VYKG L    TEVAVK   +     ++  F+ E   + +  H N+V+L+G
Sbjct: 1   EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C +K  + +V + +  GSL +FL  + K  L  ++  ++    A+G+ YL     +  I
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHG--TNPATTRVVGTLGYLAPETPRTGKSSA 522
           HRD+ A N L+      K+ DFG+++  E G  T     + +  + + APE    G+ ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYTS 174

Query: 523 SSDVFAFGALLLEV 536
            SDV+++G LL E 
Sbjct: 175 ESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 3e-26
 Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 20/216 (9%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS---NESKQGVREFVSEIATIGRLRH- 396
           ++   + LG G FG+VY       +  VA+K ++       + V  F+ EI  +  L H 
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-FDEPKAVLNWEQRFKIIKGVASGLLYL 455
            N+V+L  + + +G L LV +++  GSL+  L     K  L+  +   I+  + S L YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 456 HEGYEQVVIHRDVKASNVLLDSELN-GKLGDFGLAKLYEHGTNPATTR-----VVGTLGY 509
           H    + +IHRD+K  N+LLD +    KL DFGLAKL     + ++        VGT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 510 LAPET---PRTGKSSASSDVFAFGALLLEVACGRRP 542
           +APE         +S+SSD+++ G  L E+  G  P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 4e-26
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V+ G     K +VA+K I  E      +F+ E   + +L H NLVQL G C 
Sbjct: 12  LGSGQFGVVHLGKWRG-KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + +V ++MANG L ++L  E K  L  E    +   V   + YL        IHRD
Sbjct: 70  KQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 468 VKASNVLLDSELNGKLGDFGLAK--LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           + A N L+  +   K+ DFGLA+  L +  T+   T+    + +  PE     + S+ SD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRFSSKSD 183

Query: 526 VFAFGALLLEV-ACGRRPIETR 546
           V++FG L+ EV + G+ P E  
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERF 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  107 bits (269), Expect = 4e-26
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 23/208 (11%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRIS-----NESKQGVREFVSEIATIGRLRHRNLV 400
           +LLG G FG VY+G   +     AVK +S        ++ V++   EIA + +L+H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYL 455
           Q +G  R + +L +  + +  GSL   L     F EP   L   Q       +  GL YL
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-------ILLGLEYL 118

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET- 514
           H+   +  +HRD+K +N+L+D+    KL DFG+AK              G+  ++APE  
Sbjct: 119 HD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVI 173

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
            + G    ++D+++ G  +LE+A G+ P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  107 bits (269), Expect = 5e-26
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 15/219 (6%)

Query: 329 RYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEI 388
            Y Y+      +    + +LG G +G VY     +++  +A+K I     + V+    EI
Sbjct: 2   EYEYE-----YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEI 56

Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII-KG 447
           A    L+HRN+VQ +G     G   +  + +  GSL + L  +   + + EQ      K 
Sbjct: 57  ALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVG 505
           +  GL YLH   +  ++HRD+K  NVL+++  +G  K+ DFG +K    G NP T    G
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA-GINPCTETFTG 171

Query: 506 TLGYLAPETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           TL Y+APE    G     A +D+++ G  ++E+A G+ P
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  107 bits (269), Expect = 5e-26
 Identities = 62/210 (29%), Positives = 120/210 (57%), Gaps = 11/210 (5%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNESKQGVR-EFVSEIATIGRLR 395
           ++ + ++++G G FG+V++G L      +  VA+K +     +  R +F+SE + +G+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H N+++L G   +    +++ ++M NG+LD +L D      ++ Q   +++G+A+G+ YL
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL 123

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLAPE 513
               +   +HRD+ A N+L++S L  K+ DFGL+++ E       T   G +   + APE
Sbjct: 124 S---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 514 TPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
                K +++SDV++FG ++ EV + G RP
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 6e-26
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G          +T VA+K ++ N S +   EF++E + +      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL--------FDEPKAVLNWEQRFKIIKGVASGLL 453
           L+G        L+V + MA G L S+L         +        ++  ++   +A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL     +  +HRD+ A N ++  +L  K+GDFG+ + +YE        + +  + ++AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 513 ETPRTGKSSASSDVFAFGALLLEVA 537
           E+ + G  +  SDV++FG +L E+A
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (265), Expect = 1e-25
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 6/206 (2%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRN 398
           +F     +G G FG V+K      K   A+K+I  S  +++   E + E   + +L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +++       KG L +V ++  NG L   L  +    L  +Q ++    +  GL +LH  
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS- 119

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
             + ++HRD+K+ N+ LD+  N K+GD G+AKL    TN A T +VGT  YL+PE     
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDK 176

Query: 519 KSSASSDVFAFGALLLEVACGRRPIE 544
             +  SDV+A G +L E   G+ P +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  106 bits (265), Expect = 1e-25
 Identities = 71/214 (33%), Positives = 120/214 (56%), Gaps = 19/214 (8%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
           +    ++++G G FG+V  G L    K E+ V     +     KQ  R+F+SE + +G+ 
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQF 62

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIKGVASGL 452
            H N++ L G   +   +++V ++M NGSLD+FL   D    V+   Q   +++G+ASG+
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGM 119

Query: 453 LYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--Y 509
            YL + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   +
Sbjct: 120 KYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
            APE     K +++SDV+++G ++ EV + G RP
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 13/207 (6%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG- 404
           Q +G G FG V  G    +K  VAVK I N++    + F++E + + +LRH NLVQL+G 
Sbjct: 12  QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
               KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL        +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+ A NVL+  +   K+ DFGL K  E  +   T ++   + + APE  R  K S  S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 180

Query: 525 DVFAFGALLLEV-ACGRRPIETRALPE 550
           DV++FG LL E+ + GR P     L +
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKD 207

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 37/225 (16%)

Query: 345 KQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRN 398
           K+ LG G FG+V+ G  +     N K  VAVK +   +    R+ F  E   +   +H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL------------FDEPKAVLNWEQRFKIIK 446
           +V+  G C      ++V+++M +G L+ FL             D P   L   Q  +I  
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATT---R 502
            +ASG++YL     Q  +HRD+   N L+  +L  K+GDFG+++ +Y       TT   R
Sbjct: 130 QIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-------TTDYYR 179

Query: 503 VVGT----LGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           V G     + ++ PE+    K +  SDV++FG +L E+   G++P
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 40/220 (18%)

Query: 346 QLLGHGGFGQVYKGT----LHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG VYKG         K  VA+K +  E+  +  +E + E   +  + H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-----PKAVLNW-EQRFKIIKGVASGLLY 454
           +L+G C     + L+   M  G L  ++ +       + +LNW  Q       +A G+ Y
Sbjct: 73  RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-------IAKGMSY 124

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL---------YEHGTNPATTRVVG 505
           L E   + ++HRD+ A NVL+ +  + K+ DFGLAKL          E G  P       
Sbjct: 125 LEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP------- 174

Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIE 544
            + ++A E+      +  SDV+++G  + E+   G +P E
Sbjct: 175 -IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 348 LGHGGFGQVYKGTL---HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLV 403
           LGHG FG V KG        + EVAVK +  E    G +EF+ E + + +L H  +V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 404 GWCRRKGD-LLLVYDFMANGSLDSFLFDEP----KAVLNWEQRFKIIKGVASGLLYLHEG 458
           G C  KG+ L+LV +    G L  +L          +     +      VA G+ YL   
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES- 113

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPR 516
             +  +HRD+ A NVLL +    K+ DFG+++    G++       G   L + APE   
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 517 TGKSSASSDVFAFGALLLEV-ACGRRP 542
            GK S+ SDV+++G  L E  + G +P
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (259), Expect = 7e-25
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 7/206 (3%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           Q +G G FG V+ G     K +VA+K I  E      +F+ E   + +L H  LVQL G 
Sbjct: 10  QEIGSGQFGLVWLGYWLE-KRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C  +  + LV++FM +G L  +L  + +   + E    +   V  G+ YL       VIH
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIH 123

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N L+      K+ DFG+ +        ++T     + + +PE     K S+ SD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 526 VFAFGALLLEV-ACGRRPIETRALPE 550
           V++FG L+ EV + G+ P E R+  E
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 9e-25
 Identities = 65/178 (36%), Positives = 95/178 (53%), Gaps = 25/178 (14%)

Query: 348 LGHGGFGQVYKGTLHNSKTE--VAVKRISNES-KQG-VREFVSEIATIGRLRHRNLVQLV 403
           +G G +GQVYK    N KT   VA+K+I  E+ K+G     + EI  + +LRH N+V+L 
Sbjct: 7   IGEGTYGQVYKA--RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 404 GWC--RRKGDLLLVYDFMA---NGSLDS--FLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
                + KG + +V+++M     G LDS    F E        Q    +K +  GL YLH
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-------QIKCYMKQLLEGLQYLH 117

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE-HGTNPATTRVVGTLGYLAPE 513
                 ++HRD+K SN+L++++   KL DFGLA+ Y    +   T RV+ TL Y  PE
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 70/206 (33%), Positives = 112/206 (54%), Gaps = 13/206 (6%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +++G G FG V +G     K  VAVK I  +     + F+ E A + +L H+NLV+L+G 
Sbjct: 12  EIIGEGEFGAVLQGEYTGQK--VAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
               G L +V + M+ G+L +FL    +A+++  Q  +    VA G+ YL     + ++H
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N+L+  +   K+ DFGLA++   G + +   V  T    APE  +  K S+ SD
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179

Query: 526 VFAFGALLLEV-ACGRRPIETRALPE 550
           V+++G LL EV + GR P    +L E
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKE 205

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (258), Expect = 1e-24
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 14  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 188 SFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (257), Expect = 1e-24
 Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 7/198 (3%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           + LG+G FG+V+ GT  N  T+VAVK +          F+ E   + +LRH  LVQL   
Sbjct: 12  KKLGNGQFGEVWMGTW-NGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              +  + +V ++M+ GSL  FL D     L       +   VA+G+ Y+        IH
Sbjct: 70  VSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIH 125

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD++++N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 526 VFAFGALLLE-VACGRRP 542
           V++FG LL E V  GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  102 bits (257), Expect = 2e-24
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 23/214 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G FG V K    +    +  K I   N +++  ++ VSE+  +  L+H N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 406 C--RRKGDLLLVYDFMANGSLDSFL---------FDEPKAVLNWEQRFKIIKGVASGLLY 454
              R    L +V ++   G L   +          +E      W    +I+  +   L  
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RILTQLLLALYE 120

Query: 455 LHEGY--EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            H        V+HRD+K +N+ LD+  N KLGDFGLAK+  H ++ A T  VGT  Y++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSP 179

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           E          SD+++ G L+ E+     P   R
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 3e-24
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 10/200 (5%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+VYK     +    A K I  ES++ + +F+ EI  +   +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  L ++ +F   G+LDS +  E +  L   Q   + + +   L +LH      VIHRD
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP-----ETPRTGKSSA 522
           +KA N+LL  + + KL DFG++   +       T  +GT  ++AP     ET +      
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDY 187

Query: 523 SSDVFAFGALLLEVACGRRP 542
            +D+++ G  L+E+A    P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (253), Expect = 5e-24
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 13/207 (6%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE---FVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V+ G  +N  T+VA+K +    KQG      F++E   + +L+H  LV+L  
Sbjct: 14  LGAGQFGEVWMG-YYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++     +  I
Sbjct: 69  VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYI 124

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G  +  S
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 525 DVFAFGALLLE-VACGRRPIETRALPE 550
           DV++FG LL E V  GR P      PE
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPE 211

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  101 bits (253), Expect = 6e-24
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 29/227 (12%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRIS------NESKQGVREFVSEIATIGRLRHRNL 399
           Q LG G F   Y+     + T +AVK+++      +E ++ V     EI  + RL H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLY 454
           ++++G         L  ++MA GS+   L     F E  AV+         + +  GL Y
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVII-----NYTEQLLRGLSY 118

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLA-KLYEHGTNPA--TTRVVGTLG 508
           LH   E  +IHRDVK +N+L+DS   G   ++ DFG A +L   GT       +++GT+ 
Sbjct: 119 LH---ENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
           ++APE  R  +   S DV++ G +++E+A  + P         L L+
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  101 bits (252), Expect = 6e-24
 Identities = 64/191 (33%), Positives = 105/191 (54%), Gaps = 6/191 (3%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVG 404
           +LLG G FG+V+KGTL + KT VAVK    +  Q ++ +F+SE   + +  H N+V+L+G
Sbjct: 1   ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C ++  + +V + +  G   SFL  + K  L  +Q  K     A+G+ YL     +  I
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+ A N L+      K+ DFG+++  + G   ++      + + APE    G+ S+ S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 525 DVFAFGALLLE 535
           DV+++G LL E
Sbjct: 176 DVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (252), Expect = 7e-24
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 7/201 (3%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           F   + LG G +G VYK     +   VA+K +  E    ++E + EI+ + +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
             G   +  DL +V ++   GS+ S +       L  E+   I+     GL YLH     
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---N 118

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             IHRD+KA N+LL+ E   KL DFG++           T V+GT  ++APE  +    +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177

Query: 522 ASSDVFAFGALLLEVACGRRP 542
             +D+++ G   +E+A G+ P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  101 bits (253), Expect = 9e-24
 Identities = 71/208 (34%), Positives = 100/208 (48%), Gaps = 31/208 (14%)

Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLV 400
           ++LG G FG+V    Y      +   VAVK +  E  Q     +  EI  +  L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 401 QLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +  G C  +G   L L+ +++  GSL  +L   PK  LN  Q     + +  G+ YLH  
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS- 125

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LY----EHGTNPATTRVVGTLG 508
             Q  IHRD+ A NVLLD++   K+GDFGLAK       Y    E G +P          
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-------- 175

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEV 536
           + A E  +  K S +SDV++FG  L E+
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  100 bits (251), Expect = 1e-23
 Identities = 69/205 (33%), Positives = 114/205 (55%), Gaps = 13/205 (6%)

Query: 345 KQLLGHGGFGQVYKGTLH-NSKTE--VAVK--RISNESKQGVREFVSEIATIGRLRHRNL 399
           +++LG G FG++ +G L   SK E  VA+   R     KQ  R F++E  T+G+  H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNI 68

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-G 458
           V+L G   R   +++V ++M+NG+LDSFL  + +  L   Q   ++ G+ASG+ YL E G
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           Y    +H+ + A  VL++S+L  K+  F   +  +      T      + + APE  +  
Sbjct: 128 Y----VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 519 KSSASSDVFAFGALLLEV-ACGRRP 542
             S++SDV++FG ++ EV + G RP
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  100 bits (252), Expect = 1e-23
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 38/231 (16%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVS-EIATIGRL-R 395
           ++F   +++G G F  V       +  E A+K +      K+   ++V  E   + RL  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
           H  +++L    + + +L  V ++  NG L  ++      DE         RF     +  
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT------RF-YAAEILL 113

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV------- 503
            L YLH    + +IHRD+K  N+LLD +++ K+ DFG AK+ +  ++P + +        
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 504 ------------VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
                       VGT  Y++PE      +  SSD++A G ++ ++  G+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  100 bits (252), Expect = 2e-23
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 14/225 (6%)

Query: 322 ELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQ 379
           E E+                +   + +G G  G+VYK T   +  EVA+K  R+  ++K+
Sbjct: 1   EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE 60

Query: 380 GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWE 439
            +   ++EI  +   +H N+V          +L +V ++M  GSL + +  +    +N  
Sbjct: 61  LI---INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEP 116

Query: 440 QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA 499
           Q   + + V  GL YLH    Q VIHRD+K+ N+LL  + + KL DFG A      T   
Sbjct: 117 QIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ---LTKEK 170

Query: 500 TTR--VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           + R  VVGT  ++APE  +        D+++ G + +E+A G  P
Sbjct: 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 2e-23
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 23/205 (11%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V      ++    A+K +  +    ++ V   ++E   + R+ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 405 WC--RRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
               + +  L LV ++   G L S L     F E +A      RF     +   L YLH 
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA------RF-YAAEIVLALEYLHS 111

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
                +I+RD+K  N+LLD++ + KL DFGLAK      +   T   GT  YLAPE    
Sbjct: 112 ---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLG 167

Query: 518 GKSSASSDVFAFGALLLEVACGRRP 542
                + D ++ G LL E+  G+ P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 29/213 (13%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
             +G G FG+VY     ++   +AVK  RI +   + ++E   E+  +  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFL---FDEPKAVLNWEQRF--KIIKGVASGLLYLHEG 458
           G    +  + +  ++ + G+L+  L       + V+   + +  ++++G+A    YLH  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RVYTLQLLEGLA----YLHS- 117

Query: 459 YEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRV---VGTLGYLAPE 513
               ++HRD+K +N+ LD   NG  KLGDFG A   ++ T      V    GT  Y+APE
Sbjct: 118 --HGIVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 514 ----TPRTGKSSASSDVFAFGALLLEVACGRRP 542
                   G   A +D+++ G ++LE+A G+RP
Sbjct: 174 VITGGKGKGHGRA-ADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 19/224 (8%)

Query: 348 LGHGGFGQVYKGTL-----HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
           LGHG FG+VY+G          + +VAVK +  + S+Q   +F+ E   + +  H+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDE-PKAV----LNWEQRFKIIKGVASGLLYLH 456
           L+G    +    ++ + MA G L SFL +  P+      L  +      + VA G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 457 EGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           E +    IHRD+ A N LL  +  G   K+ DFG+A+ +Y         R +  + ++ P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190

Query: 513 ETPRTGKSSASSDVFAFGALLLEV-ACGRRPIETRALPEELVLV 555
           E    G  ++ +DV++FG LL E+ + G  P   R   E +  V
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 348 LGHGGFGQVYKGTL-----HNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG+VYKG L       S T VA+K +   ++  V+ EF  E   +  L+H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKIIKG 447
           L+G C ++    ++++++A+G L  FL               +  K+ L+      I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL-YEHGTNPATTRVVGT 506
           +A+G+ YL   +    +HRD+ A N L+   L  K+ DFGL++  Y        ++ +  
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + ++ PE    GK +  SD+++FG +L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 98.7 bits (247), Expect = 6e-23
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 14/177 (7%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGV-REFVSEIATIGRLRHRNL 399
           +   + LG G +G VYK     +   VA+K+I  +  ++G+    + EI+ +  L+H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV-LNWEQR--FKIIKGVASGLLYLH 456
           V+L+     +  L LV+++     L  +L   P  +  N  +   +++++G+A    Y H
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCH 115

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
                 ++HRD+K  N+L++ +   KL DFGLA+ +       T  VV TL Y APE
Sbjct: 116 S---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 98.7 bits (246), Expect = 9e-23
 Identities = 73/224 (32%), Positives = 102/224 (45%), Gaps = 33/224 (14%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-----KQGVREFVSEIATIGR-LRHRNLVQ 401
           LG G  G V K  L N+    A+K I+ +      KQ +RE       I +  +   +V+
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILREL-----EINKSCKSPYIVK 63

Query: 402 LVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASGLL 453
             G    +    + +  ++   GSLDS      K V     R       KI + V  GL 
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           YLH    + +IHRD+K SN+LL  +   KL DFG++   E   + A T   GT  Y+APE
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGT-FTGTSFYMAPE 173

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPI----ETRALPEELV 553
             +    S +SDV++ G  LLEVA  R P     E    P EL+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 5/189 (2%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +NS T+VAVK +   +   V+ F+ E   +  L+H  LV+L     
Sbjct: 14  LGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MA GSL  FL  +    +   +       +A G+ Y+     +  IHRD
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 128

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+NVL+   L  K+ DFGLA++ E     A       + + APE    G  +  SDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 528 AFGALLLEV 536
           +FG LL E+
Sbjct: 189 SFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 28/215 (13%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK------RISNESKQGVREFV----SEIATIGRLR 395
           +L+G G +G+VY      +   +AVK       I+       ++ V    SEI T+  L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
           H N+VQ +G+   +  L +  +++  GS+ S L     F+E       EQ       V  
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ-------VLE 119

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG-TNPATTRVVGTLGY 509
           GL YLH    + ++HRD+KA N+L+D++   K+ DFG++K  +    N     + G++ +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 510 LAPETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           +APE   +     SA  D+++ G ++LE+  GRRP
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 58/180 (32%), Positives = 89/180 (49%), Gaps = 20/180 (11%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G FG+V+K     +K  VA+K++   NE +      + EI  +  L+H N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 406 CRR--------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           CR         KG   LV++F  +  L   L           +  K++K + +GL Y+H 
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNGLYYIHR 137

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA----TTRVVGTLGYLAPE 513
                ++HRD+KA+N+L+  +   KL DFGLA+ +    N      T RVV TL Y  PE
Sbjct: 138 NK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.4 bits (240), Expect = 5e-22
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 24/205 (11%)

Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + + + +R+F  EI  +  L+H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFL------FDEPKAVLNWEQRFKIIKGVASGLL 453
             G C   G  +L LV +++  GSL  +L       D  K +L   Q   I KG+     
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ---ICKGME---- 122

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLA 511
           YL     +  +HRD+   N+L++SE   K+GDFGL K+          R  G   + + A
Sbjct: 123 YLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 512 PETPRTGKSSASSDVFAFGALLLEV 536
           PE+    K S +SDV++FG +L E+
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 95.3 bits (237), Expect = 6e-22
 Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 13/201 (6%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   + +L H  LVQL G C 
Sbjct: 12  LGTGQFGVVKYGKWR-GQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + +V ++M+NG L ++L +  K      Q  ++ K V  G+ YL     +  IHRD
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L+D +   K+ DFGL++   +  +   T  VG+   + +  PE     K S+ S
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           DV+AFG L+ EV + G+ P E
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 25/209 (11%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G    VY      +  +VA+KRI  E  Q  V E   E+  + +  H N+V+     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 407 RRKGDLLLVYDFMANGSLDSFL--------FDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
               +L LV  +++ GSL   +         DE            ++K V  GL YLH  
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT-------VLKEVLKGLEYLHS- 120

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTR--VVGTLGYLAPE-- 513
                IHRD+KA N+LL  + + K+ DFG+ A L + G      R   VGT  ++APE  
Sbjct: 121 --NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRP 542
               G     +D+++FG   +E+A G  P
Sbjct: 179 EQVHG-YDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 94.9 bits (237), Expect = 2e-21
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 37/221 (16%)

Query: 332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS--EIA 389
           Y+ +KQ          LG G FG VY      +   VA+K++  +      E ++  E+ 
Sbjct: 1   YKVIKQ----------LGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVK 49

Query: 390 TIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNWEQR 441
           ++ +L  H N+V+L    R   +L  V+++M  G+L           F E          
Sbjct: 50  SLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVI------- 101

Query: 442 FKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT 500
             II  +  GL ++H+ G+     HRD+K  N+L+      K+ DFGLA+  E  + P  
Sbjct: 102 RSIIYQILQGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPY 155

Query: 501 TRVVGTLGYLAPET-PRTGKSSASSDVFAFGALLLEVACGR 540
           T  V T  Y APE   R+   S+  D++A G ++ E+   R
Sbjct: 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 67/196 (34%), Positives = 97/196 (49%), Gaps = 7/196 (3%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T+VA+K +          F+ E   + +LRH  LV L     
Sbjct: 14  LGQGCFGEVWMGTW-NGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V +FM  GSL  FL +     L   Q   +   +A G+ Y+        IHRD
Sbjct: 72  EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 528 AFGALLLE-VACGRRP 542
           +FG LL E V  GR P
Sbjct: 188 SFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 20/214 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGRL 394
            N+   +LLG G FG+VY     ++  E+AVK++     S E+K+ V     EI  +  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKA--VLNWEQRFKIIKGVASGL 452
           +H  +VQ  G  R    L +  ++M  GS+     D+ KA   L      K  + +  G+
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYTRQILEGV 117

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK----LYEHGTNPATTRVVGTLG 508
            YLH     +++HRD+K +N+L DS  N KLGDFG +K    +   GT   +  V GT  
Sbjct: 118 EYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPY 172

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +++PE          +DV++ G  ++E+   + P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 21/221 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRL 394
           +N   K+ LG G FG+V+    +N      K  VAVK + + S    ++F  E   +  L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-PKAVLNWE----------QRFK 443
           +H ++V+  G C     L++V+++M +G L+ FL    P AVL  E          Q   
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTR 502
           I + +A+G++YL     Q  +HRD+   N L+   L  K+GDFG+++ +Y          
Sbjct: 125 IAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
            +  + ++ PE+    K +  SDV++ G +L E+   G++P
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 19/208 (9%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREF-VSEIATIGRLR---HRNLVQ 401
            +G G +G VYK    N+   VA+K++    S++G+    + EIA + +L    H N+V+
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 402 LVGWC-----RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L+  C      R+  L LV++ + +  L ++L   PK  L  E    +++ +  G+ +LH
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
                 ++HRD+K  N+L+ S+   K+ DFGLA++Y      A T VV TL Y APE   
Sbjct: 125 S---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSVVVTLWYRAPEV-L 178

Query: 517 TGKSSASS-DVFAFGALLLEVACGRRPI 543
              S A+  D+++ G +  E+   RRP+
Sbjct: 179 LQSSYATPVDMWSVGCIFAELF-RRRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 22/209 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG GGFG+V    +  +    A K++  +    ++G +  ++E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 405 WCRRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
               K DL LV   M  G L           F E +A+    Q       +  GL +LH+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-------IICGLEHLHQ 113

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
              + +++RD+K  NVLLD   N ++ D GLA   + G         GT GY+APE  + 
Sbjct: 114 ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRAGTPGYMAPEVLQG 168

Query: 518 GKSSASSDVFAFGALLLEVACGRRPIETR 546
                S D FA G  L E+  GR P   R
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQR 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 93.3 bits (232), Expect = 7e-21
 Identities = 71/228 (31%), Positives = 115/228 (50%), Gaps = 33/228 (14%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGR 393
           K+  + F     +G G +GQVYK    ++   VA+K  R+ NE +      + EI  + +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 394 LRHRNLVQL----------VGWCRRKGDLLLVYDFMAN---GSLDSFLFDEPKAVLNWEQ 440
           L HRN+V L          + + + KG   LV+++M +   G L+S L        + + 
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-----FSEDH 117

Query: 441 RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-PA 499
               +K +  GL Y H+   +  +HRD+K SN+LL+++   KL DFGLA+LY    + P 
Sbjct: 118 IKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 500 TTRVVGTLGYLAPE----TPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           T +V+ TL Y  PE      R G    + DV++ G +L E+   ++PI
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYG---PAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 8/204 (3%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           +   Q +G G +G VYK     +   VA+K I  E          EI+ +   RH N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
             G   R+  L +V ++   GSL   ++   +  L+  Q   + +    GL YLH   E 
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH---ET 120

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET---PRTG 518
             IHRD+K +N+LL  + + KL DFG++           +  +GT  ++APE     R G
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAAVERKG 179

Query: 519 KSSASSDVFAFGALLLEVACGRRP 542
                 D++A G   +E+A  + P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)

Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG G FG+V+    HN      K  VAVK +   S+   ++F  E   +  L+H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLF-------------DEPKAVLNWEQRFKIIKGVA 449
            G C     LL+V+++M +G L+ FL              D     L   Q   I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLG 508
           SG++YL   +    +HRD+   N L+   L  K+GDFG+++ +Y         R +  + 
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           ++ PE+    K +  SD+++FG +L E+   G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 14/207 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLRHR 397
           N +    ++G G +G V K     +   VA+K  + S + +   +  + E+  + +LRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           N+V L    RRKG L LV++++    L+  L +     L  +     I  +   + Y H 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE---- 513
                +IHRD+K  N+L+      KL DFG A+          T  V T  Y APE    
Sbjct: 119 ---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGR 540
               GK     DV+A G ++ E+  G 
Sbjct: 176 DTNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+VYK     +   VA+K I   E++  + +   EI  + + R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFL----FDEPKAVLNWEQRFKIIKGVASGLLYL 455
           +  G    KG  L ++ ++   GS    L     DE            I++ V  GL YL
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYL 114

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           HE   +  IHRD+KA+N+LL  E + KL DFG++       +   T  VGT  ++APE  
Sbjct: 115 HE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVI 170

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
           +       +D+++ G   +E+A G  P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 6/190 (3%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           +G G FG+V+ G L    T VAVK         ++ +F+ E   + +  H N+V+L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
            +K  + +V + +  G   +FL  E    L  ++  ++++  A+G+ YL   +    IHR
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT-LGYLAPETPRTGKSSASSD 525
           D+ A N L+  +   K+ DFG+++  E G   +T  +    + + APE    G+ S+ SD
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 526 VFAFGALLLE 535
           V++FG LL E
Sbjct: 179 VWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 40/234 (17%)

Query: 347 LLGHGGFGQVYKGTL-----HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRNL 399
            LG G FGQV K         N  + VAVK +  + +++ + + VSE+  +  + +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFD------EPKAVLNWEQRFKIIK------- 446
           + L+G C ++G L +V ++ A+G+L  FL                     + +       
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 447 -GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNPA 499
             VA G+ +L     +  IHRD+ A NVL+  +   K+ DFGLA+       Y   TN  
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN-- 193

Query: 500 TTRVVGTLGY--LAPETPRTGKSSASSDVFAFGALLLE-VACGRRPIETRALPE 550
                G L    +APE       +  SDV++FG LL E    G  P     + E
Sbjct: 194 -----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 7/204 (3%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+  T +N  T+VAVK +   S   V  F++E   +  L+H  LV+L     
Sbjct: 14  LGAGQFGEVWMAT-YNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ +FMA GSL  FL  +  +     +       +A G+ ++ +   +  IHRD
Sbjct: 72  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 127

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+ + L  K+ DFGLA++ E     A       + + APE    G  +  SDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 528 AFGALLLE-VACGRRPIETRALPE 550
           +FG LL+E V  GR P    + PE
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE 211

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.5 bits (222), Expect = 5e-20
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 7/201 (3%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V+ G    ++ +VA+K I NE      +F+ E   + +L H  LVQL G C 
Sbjct: 12  LGSGQFGVVHLGKWR-AQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  L +V +FM NG L ++L  + +  L+ +    + + V  G+ YL        IHRD
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           + A N L+ S    K+ DFG+ +        +++     + +  PE     K S+ SDV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 528 AFGALLLEVAC-GRRPIETRA 547
           +FG L+ EV   G+ P E ++
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.4 bits (222), Expect = 7e-20
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTE---VAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           + LG G FG V +G    S  +   VAVK + ++     + +F+ E A +  L H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLN----WEQRFKIIKGVASGLLYLHE 457
           L G       L++V +    GSL   L  +           +   +I    A+G+ YL  
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES 115

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY----EHGTNPATTRVVGTLGYLAPE 513
              +  IHRD+ A N+LL S+   K+GDFGL +      +H       +V     + APE
Sbjct: 116 ---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPE 170

Query: 514 TPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           + RT   S +SDV+ FG  L E+   G  P
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.4 bits (222), Expect = 9e-20
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTE---VAVKRISNESKQGVRE-FVSEIATIGRLRHRNLV 400
            + +G G FG VY+G   + + E   VAVK   N +   VRE F+ E   + +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +L+G       + +V +    G L S+L    K  L+          +++ L YL     
Sbjct: 71  KLIGVITEN-PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES--- 125

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  +HRD+ A NVL+ S    KLGDFGL++  E  +    ++    + ++APE+    + 
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 521 SASSDVFAFGALLLEV 536
           +++SDV+ FG  + E+
Sbjct: 186 TSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 24/219 (10%)

Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           K+ LG G FG+V+    +N      K  VAVK + + +    ++F  E   +  L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFD--------------EPKAVLNWEQRFKII 445
           V+  G C     L++V+++M +G L+ FL                + K  L   Q   I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             +ASG++YL     Q  +HRD+   N L+ + L  K+GDFG+++ +Y           +
Sbjct: 130 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
             + ++ PE+    K +  SDV++FG +L E+   G++P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVR-EFVSEIATIGRLRHRN 398
            F     +G G +G VY+     S   VA+K++  +  + G+    + EI  +  LRH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 399 LVQL----VGWCRRKGDLLLVYDF----MANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +V+L    VG  +    + LV ++    +A+      L D      +  Q   ++  +  
Sbjct: 68  IVELKEVVVG--KHLDSIFLVMEYCEQDLAS------LLDNMPTPFSESQVKCLMLQLLR 119

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           GL YLHE +   +IHRD+K SN+LL  +   K+ DFGLA+ Y     P T +VV TL Y 
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175

Query: 511 APETPRTGKSSASS-DVFAFGALLLE 535
           APE      +  ++ D++A G +L E
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 22/207 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRH---RNLVQ 401
           +L+G G +G VY+G    +   VA+K I+ ++    V +   E+A + +LR     N+ +
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 402 LVGWCRRKG-DLLLVYDFMANGSLDSFL----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
             G    KG  L ++ ++   GS+ + +      E    +       II+ V   L Y+H
Sbjct: 67  YYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIH 118

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
           +     VIHRD+KA+N+L+ +  N KL DFG+A L    ++  +T  VGT  ++APE   
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVIT 174

Query: 517 TGKS-SASSDVFAFGALLLEVACGRRP 542
            GK     +D+++ G  + E+A G  P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTE--VAVKRISNESKQGV---REFVSEIATIGRLRHRNLVQL 402
           +GHG FG VY     + +T   VA+K++S   KQ     ++ + E+  + +LRH N ++ 
Sbjct: 23  IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            G   R+    LV ++    + D  + +  K  L   +   I  G   GL YLH  +E+ 
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAAICHGALQGLAYLHS-HER- 136

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE---TPRTGK 519
            IHRD+KA N+LL      KL DFG A L     +PA +  VGT  ++APE       G+
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS-FVGTPYWMAPEVILAMDEGQ 190

Query: 520 SSASSDVFAFGALLLEVACGRRP 542
                DV++ G   +E+A  R+P
Sbjct: 191 YDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 71/205 (34%), Positives = 102/205 (49%), Gaps = 15/205 (7%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRH-RNLVQLVG 404
            +G G FG V K     S T +AVKRI S   ++  +  + ++  + R      +V+  G
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 405 WCRRKGDLLLVYDFMANGSLDSF---LFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
              R+GD  +  + M + SLD F   +++  K+V+  E   KI       L YL E  E 
Sbjct: 71  ALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--EL 127

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPE---TPRT 517
            +IHRDVK SN+LLD   N KL DFG++ +L +   + A TR  G   Y+APE       
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSAR 184

Query: 518 GKSSASSDVFAFGALLLEVACGRRP 542
                 SDV++ G  L EVA G+ P
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-----EIATIGRLRHRNLVQ 401
            LG G +  VYK     +   VA+K+I    ++  ++ ++     EI  +  L+H N++ 
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66

Query: 402 LVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L+     K ++ LV++FM    L     D  +   P  + ++      ++G+     YLH
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYML--MTLRGLE----YLH 119

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
             +   ++HRD+K +N+L+ S+   KL DFGLA+ +       T +VV T  Y APE   
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175

Query: 517 TGKSSASS-DVFAFGALLLEVACGRRPI 543
             +      D+++ G +  E+   R P 
Sbjct: 176 GARHYGVGVDMWSVGCIFAEL-LLRVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKR-ISNESKQGVREF-VSEIATIGRLRHRNLVQLVG 404
           L+G G +G V K     +   VA+K+ + +E  + V++  + EI  + +LRH NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
             RRK  L LV++F+ +  LD  L   P   L+  +  K +  +  G+ + H      +I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDD-LEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNII 122

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE----TPRTGKS 520
           HRD+K  N+L+      KL DFG A+          T  V T  Y APE      + G+ 
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGR- 180

Query: 521 SASSDVFAFGALLLEVACG 539
             + D++A G L+ E+  G
Sbjct: 181 --AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 71/233 (30%), Positives = 115/233 (49%), Gaps = 17/233 (7%)

Query: 316 EVIEDWE-LEVGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTLHN-SKTE----V 368
           E I   E + + P +  Y    +   NN S  + LG G FG+V + T +  SK++    V
Sbjct: 9   ESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV 68

Query: 369 AVKRISNESKQGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDS 426
           AVK +   +    RE  +SE+  +  L  H N+V L+G C   G +L++ ++   G L +
Sbjct: 69  AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128

Query: 427 FLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF 486
           FL  + ++ L  E        VA G+ +L     +  IHRD+ A NVLL      K+ DF
Sbjct: 129 FLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDF 185

Query: 487 GLAKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           GLA+   + +N       R+   + ++APE+      +  SDV+++G LL E+
Sbjct: 186 GLARDIMNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.4 bits (217), Expect = 8e-19
 Identities = 71/212 (33%), Positives = 99/212 (46%), Gaps = 30/212 (14%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV---REFVSEIATIGRL-----RHRN 398
           +LG G FG+V    L  +    AVK +    K+ V    + V    T  R+     +H  
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVL----KKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L QL    + K  L  V +++  G L      S  FDEP+A      RF   + +  GL 
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA------RFYAAE-IVLGLQ 110

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAP 512
           +LHE   + +I+RD+K  NVLLDSE + K+ DFG+ K  E      TT    GT  Y+AP
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAP 165

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
           E         + D +A G LL E+  G+ P E
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 21/213 (9%)

Query: 342 FSAKQLLGHGGFGQVYKGTLH---NSKTEVAVK--RISNESKQGVREFVSEIATIGRLRH 396
               ++LG G FG V +G L     S+ +VAVK  ++   +   + EF+SE A +    H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 397 RNLVQLVGWCRRKGDL------LLVYDFMANGSLDSFLF-----DEPKAVLNWEQRFKII 445
            N+++L+G C     L      +++  FM +G L SFL        P+  L  +   K +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFM 119

Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG 505
             +A G+ YL     +  IHRD+ A N +L  ++   + DFGL+K    G      R+  
Sbjct: 120 VDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 506 T-LGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
             + ++A E+      ++ SDV+AFG  + E+A
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 35/238 (14%)

Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIG 392
           L   T  F   +++G G +G+VYK     +   VA+K +    + ++ ++E   E   + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILR 57

Query: 393 RL-RHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK-- 443
           +   H N+    G   +K        L LV +    GS+     D  K +    +R K  
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKGLRKKGKRLKEE 113

Query: 444 ----IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA 499
               I++    GL YLHE     VIHRD+K  N+LL      KL DFG++   +  T   
Sbjct: 114 WIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGR 169

Query: 500 TTRVVGTLGYLAPETPRTGKS-----SASSDVFAFGALLLEVACGRRPI----ETRAL 548
               +GT  ++APE     +       A SDV++ G   +E+A G+ P+      RAL
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL 227

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS------NESKQGVREFVSEIATIGRLRHRNLVQ 401
           +G G +G VYK     +   VA+K+I          K  +RE    I  +  L H N+++
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62

Query: 402 LVGWCRRKGDLLLVYDFMANGSLD-----SFLFDEP--KAVLNWEQRFKIIKGVASGLLY 454
           L+   R KGDL LV++FM                E   K+ L     +++++G+A    +
Sbjct: 63  LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-----YQLLQGLA----F 113

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET 514
            H      ++HRD+K  N+L+++E   KL DFGLA+ +     P T  VV T  Y APE 
Sbjct: 114 CHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPEL 169

Query: 515 P-RTGKSSASSDVFAFGALLLEVACGR 540
                  S   D+++ G +  E+   R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 27/217 (12%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNS--KTEVAVKRISN-ESKQGVREFVSEIATIGRL-R 395
           N+   + ++G G FGQV K  +     + + A+KR+    SK   R+F  E+  + +L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQR 441
           H N++ L+G C  +G L L  ++  +G+L  FL               +   + L+ +Q 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT 501
                 VA G+ YL +   +  IHRD+ A N+L+      K+ DFGL++    G      
Sbjct: 127 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179

Query: 502 RVVGTLG--YLAPETPRTGKSSASSDVFAFGALLLEV 536
           + +G L   ++A E+      + +SDV+++G LL E+
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 64/215 (29%), Positives = 113/215 (52%), Gaps = 11/215 (5%)

Query: 348 LGHGGFGQVYKGT--LHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVG 404
           LG G FG V KG   +   + +VA+K + NE+++ VR E + E   + +L +  +V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C  +  L+LV +  + G L+ FL  + K  +      +++  V+ G+ YL     +  +
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFV 117

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGKSSA 522
           HRD+ A NVLL ++   K+ DFGL+K      +    R  G   L + APE     K S+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 523 SSDVFAFGALLLEV-ACGRRPIETRALPEELVLVD 556
            SDV+++G  + E  + G++P +    PE +  ++
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 22/215 (10%)

Query: 347 LLGHGGFGQVYKGTLHN------SKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNL 399
            LG G FG+VY+GT  +          VAVK +   +  Q  +EF+ E   +    H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLY 454
           V+L+G C       ++ + M  G L S+L D         +L  ++   I   VA G +Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 455 LHEGYEQVVIHRDVKASNVLL-----DSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLG 508
           L + +    IHRD+ A N L+     D++   K+GDFGLA+ +Y+          +  + 
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           ++APE+   GK +  SDV++FG L+ E+   G++P
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 35/201 (17%)

Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQG-----VREFVSEIATI 391
              ++     LG G FG+VYK     +   VA+K+I   + K G     +RE    I  +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKIL 61

Query: 392 GRLRHRNLVQLV--------GWCRRKGDLLLVYDFMANGSLD-SFLFDEPKAVLNWEQRF 442
            +L+H N+V L+           R++G + +V  +M +   D S L + P   L   Q  
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH---DLSGLLENPSVKLTESQIK 118

Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE-------HG 495
             +  +  G+ YLHE     ++HRD+KA+N+L+D++   K+ DFGLA+ Y+        G
Sbjct: 119 CYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 496 TNPAT---TRVVGTLGYLAPE 513
               T   T +V T  Y  PE
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 12/210 (5%)

Query: 346 QLLGHGGFGQ--VYKGTLHNSKT---EVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG+  +Y+ T  +S     EV + R+S   ++  R+ ++EI  +  L+H N++
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNII 62

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
                      LL+  ++   G+L   +  +   +   E     +  + S + Y+H+   
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--- 119

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
             ++HRD+K  N+ L      KLGDFG++K+     + A T VVGT  Y++PE  +  K 
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKY 178

Query: 521 SASSDVFAFGALLLEVACGRRPIETRALPE 550
           +  SD++A G +L E+   +R  +      
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLN 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGRLR 395
           N+   +LLG G FG+VY     ++  E+AVK++     S E+ + V     EI  +  LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 396 HRNLVQLVGWCR--RKGDLLLVYDFMANGSLDSFLFDEPKA--VLNWEQRFKIIKGVASG 451
           H  +VQ  G  R   +  L +  ++M  GS+     D+ KA   L      +  + +  G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK----LYEHGTNPATTRVVGTL 507
           + YLH     +++HRD+K +N+L DS  N KLGDFG +K    +   GT      V GT 
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT--GIKSVTGTP 173

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            +++PE          +DV++    ++E+   + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 23/211 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG GGFG+V    +  +    A K+++ +    ++G    + E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 405 WCRRKGDLLLVYDFMANGSL---------DSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
             + K DL LV   M  G L         ++  F EP+A     Q       + SGL +L
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-------IISGLEHL 113

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H+   + +I+RD+K  NVLLD++ N ++ D GLA   + G +  T    GT G++APE  
Sbjct: 114 HQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELL 169

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           +  +   S D FA G  L E+   R P   R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 8/196 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           LG G  G V K     + T +A K +   +K  VR + + E+  +   R   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
             + ++ +  +FM  GSLD     +    +  E   KI   V  GL YL+      ++HR
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLY--NVHRIMHR 128

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           D+K SN+L++S    KL DFG++       N      VGT  Y++PE  + GK +  SDV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185

Query: 527 FAFGALLLEVACGRRP 542
           ++ G  ++E+A G+ P
Sbjct: 186 WSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 9/217 (4%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
            +   +++G G FG V+       +  V +K+I  E  +K       +E   +  L H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +++          L++V ++   G+L  ++     ++L+ +    I+      LL LH  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLALHHV 117

Query: 459 YEQVVIHRDVKASNVLLDSELN-GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
           + ++++HRD+K  N+LLD      K+GDFG++K     +      VVGT  Y++PE    
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175

Query: 518 GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVL 554
              +  SD++A G +L E+A  +R  E   LP  LVL
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLP-ALVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 23/212 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRI----SNE--SKQGVREFVSEIATIGRLRHRNL 399
           ++LG G +G VY G L N    +AVK++    SN   +++   +   E+  +  L+H N+
Sbjct: 6   EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDE-PKAVLNWEQRFKIIKGVASGLLYLH 456
           VQ +G C     + +  +F+  GS+ S L  F   P+ V     + +I+ GVA    YLH
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLH 119

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK----LYEHGTNPATTRVV-GTLGYLA 511
                 V+HRD+K +NV+L      KL DFG A+    +  HGT+    + + GT  ++A
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE          SD+++ G  + E+A G+ P+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGRLR 395
           N+   +LLG G FG+VY     ++  E+A K++     S E+ + V     EI  +  L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 396 HRNLVQLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKA--VLNWEQRFKIIKGVASG 451
           H  +VQ  G  R + +  L +  ++M  GS+     D+ KA   L      K  + +  G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGY 509
           + YLH     +++HRD+K +N+L DS  N KLGDFG +K  +      T    V GT  +
Sbjct: 119 MSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           ++PE          +DV++ G  ++E+   + P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 20/219 (9%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKR--ISNESKQGVREFVSEIATIGRLRHRN 398
           +F   + LG G +G VYK    +     A+K   + + S++   + V+EI  +  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 399 LVQ-----LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKA--VLNWEQRFKIIKGVASG 451
           ++      L G  +    L +V ++   G L   +    K   ++  ++ ++I   +  G
Sbjct: 61  IISYKEAFLDG-NK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L  LHE   Q ++HRD+K++N+LL +    K+GD G++K+            +GT  Y+A
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMA 169

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           PE  +    S  SD+++ G LL E+A    P E R++ +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 30/208 (14%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           +G G  G VYK     +    A+K I    +  VR +   EI  +  + H N+V+     
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 407 RRKGDLLLVYDFMANGSLDS-------FLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
              G++ ++ +FM  GSL+        FL D  + +L             SG+ YLH  +
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL-------------SGIAYLHRRH 188

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT-- 517
              ++HRD+K SN+L++S  N K+ DFG++++     +P  +  VGT+ Y++PE   T  
Sbjct: 189 ---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERINTDL 244

Query: 518 --GKSSA-SSDVFAFGALLLEVACGRRP 542
             G     + D+++ G  +LE   GR P
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 70/230 (30%), Positives = 101/230 (43%), Gaps = 49/230 (21%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG G +G V K     + T +AVKRI     S E K+ + +   +I+    +R  +    
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL--DIS----MRSVDCPYT 62

Query: 403 V---GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASGLL 453
           V   G   R+GD+ +  + M + SLD F     K V +           KI   +   L 
Sbjct: 63  VTFYGALFREGDVWICMEVM-DTSLDKFY----KKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG--------LAKLYEHGTNPATTRVVG 505
           YLH      VIHRDVK SNVL++     KL DFG        +AK  + G  P       
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP------- 168

Query: 506 TLGYLAPE--TPRTGKS--SASSDVFAFGALLLEVACGRRPIETRALPEE 551
              Y+APE   P   +      SDV++ G  ++E+A GR P ++   P +
Sbjct: 169 ---YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 30/224 (13%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGR 393
           NN    + +G G FG+V++        +   T VAVK +  E S     +F  E A +  
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------------FDEPK 433
             H N+V+L+G C     + L++++MA G L+ FL                         
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLY 492
             L+  ++  I K VA+G+ YL    E+  +HRD+   N L+   +  K+ DFGL+  +Y
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 A+      + ++ PE+    + +  SDV+A+G +L E+
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 84.6 bits (209), Expect = 5e-18
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 31/226 (13%)

Query: 345 KQLLGHGGFGQVY-------KGTLHNSKTE-------VAVKRISNESKQGVR-EFVSEIA 389
           K+ LG G FG+V+          L     E       VAVK +  +  +  R +F+ EI 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 390 TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------FDEPKAV--LNWE 439
            + RL++ N+++L+G C     L ++ ++M NG L+ FL        F     +  ++  
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 440 QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNP 498
               +   +ASG+ YL        +HRD+   N L+ +    K+ DFG+++ LY      
Sbjct: 130 NLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV--ACGRRP 542
              R V  + ++A E+   GK + +SDV+AFG  L E+   C  +P
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.2 bits (208), Expect = 6e-18
 Identities = 68/198 (34%), Positives = 100/198 (50%), Gaps = 13/198 (6%)

Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQL 402
           LG G FG+V    Y     N+  +VAVK +  ES    + +   EI  +  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 403 VGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            G C   G   + L+ +F+ +GSL  +L    K  +N +Q+ K    +  G+ YL  G  
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL--GSR 128

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR--VVGTLGYLAPETPRTG 518
           Q V HRD+ A NVL++SE   K+GDFGL K  E      T +  +   + + APE     
Sbjct: 129 QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 519 KSSASSDVFAFGALLLEV 536
           K   +SDV++FG  L E+
Sbjct: 188 KFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 20/200 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+VYK     +    A K I  +S++ + +++ EI  +    H N+V+L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII-KGVASGLLYLHEGYEQVVIHR 466
            + +L ++ +F A G++D+ + +  + +   E + +++ K     L YLHE     +IHR
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLT--EPQIRVVCKQTLEALNYLHENK---IIHR 127

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR----VVGTLGYLAP-----ETPRT 517
           D+KA N+L   + + KL DFG++       N  T +     +GT  ++AP     ET + 
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 518 GKSSASSDVFAFGALLLEVA 537
                 +DV++ G  L+E+A
Sbjct: 183 RPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 348 LGHGGFGQVYKGTLHNSKTE----VAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG   FG++YKG L+    +    VA+K + +  + Q   EF  E + +  L H N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLF------------DEP---KAVLNWEQRFKIIKG 447
           +G   ++  + ++++++  G L  FL             DE    K+ L+      I   
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT 506
           +A+G+ YL   +    +H+D+ A N+L+  +L+ K+ D GL++ +Y         + +  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + ++ PE    GK S+ SD+++FG +L E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 67/202 (33%), Positives = 99/202 (49%), Gaps = 18/202 (8%)

Query: 348 LGHGGFGQVYKGTLHN-SKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGW 405
           LG G  G V K  LH  S   +A K I  E K  +R + + E+  +       +V   G 
Sbjct: 9   LGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
               G++ +  + M  GSLD  L      P+ +L      KI   V  GL YL E  +  
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHK 120

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
           ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  Y++PE  +    +
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYT 176

Query: 522 ASSDVFAFGALLLEVACGRRPI 543
             SD+++ G  L+E+A GR PI
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 9/207 (4%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS---NESKQGVREFVSEIATIGRLRHR 397
           NF  ++ +G G F +VY+ T    +  VA+K++        +  ++ V EI  + +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIKGVASGLLYL 455
           N+++ +       +L +V +    G L   +  F + K ++     +K    + S + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H    + V+HRD+K +NV + +    KLGD GL + +   T  A + +VGT  Y++PE  
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 178

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
                +  SD+++ G LL E+A  + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 30/208 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL +S   K   AVK ++     + V +F+ E   +    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-------VASGLL 453
           L+G C   +G  L+V  +M +G L +F+  E             +K        VA G+ 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE--------THNPTVKDLIGFGLQVAKGME 112

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-----KLYEHGTNPATTRVVGTLG 508
           YL     +  +HRD+ A N +LD     K+ DFGLA     K Y    N    ++   + 
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVK 167

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEV 536
           ++A E+ +T K +  SDV++FG LL E+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 9/211 (4%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVRE-FVSEIATIGRLR 395
             NF  ++ +G G F  VYK         VA+K++          R+  + EI  + +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIKGVASGLL 453
           H N+++ +       +L +V +    G L   +  F + K ++     +K    + S L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           ++H    + ++HRD+K +NV + +    KLGD GL + +   T  A + +VGT  Y++PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
                  +  SD+++ G LL E+A  + P  
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)

Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLV 400
           +LLG G FG V+KG       + K  VA+K I + S +Q  +E    +  +G L H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNWEQRFKIIKGVASGLLYL 455
           +L+G C     L LV      GSL   +       +P+ +LNW  +      +A G+ YL
Sbjct: 73  RLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYL 125

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPET 514
            E     ++HR++ A N+LL S+   ++ DFG+A  LY        +     + ++A E+
Sbjct: 126 EE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 515 PRTGKSSASSDVFAFGALLLEV-ACGRRPIETRALPE 550
              G+ +  SDV+++G  + E+ + G  P       E
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 8/202 (3%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+VYKG  + +K  VA+K I   E++  + +   EI  + +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P   L       I++ +  GL YLH    
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHS--- 119

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL  + + KL DFG+A      T       VGT  ++APE  +    
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 521 SASSDVFAFGALLLEVACGRRP 542
              +D+++ G   +E+A G  P
Sbjct: 179 DFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)

Query: 346 QLLGHGGFGQVYKGTLHN--SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQL 402
             +G+G FG+V  G  H   SK  V VK + ++ +      F+ E+     L H N++Q 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIK---GVASGLLYLHEGY 459
           +G C      LLV +F   G L ++L      V    Q+  + +    VASGLL+LH+  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLA--KLYEHGTNPATTRVVGTLGYLAPETP-- 515
               IH D+   N  L ++L+ K+GD+GLA  +  E          V  L +LAPE    
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176

Query: 516 -----RTGKSSASSDVFAFGALLLEV 536
                     +  S++++ G  + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 16/208 (7%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRN 398
           FS  + +GHG FG VY      +   VA+K++S   KQ     ++ + E+  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            +Q  G   R+    LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 133

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE---TP 515
               +IHRDVKA N+LL      KLGDFG A +      PA    VGT  ++APE     
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX-FVGTPYWMAPEVILAM 186

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPI 543
             G+     DV++ G   +E+A  + P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 8/198 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG GGFG+V    + N+    A K++  +    K G +  + E   + ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
               K  L LV   M  G L   +++  +  L  E+       +  G+L+LH      ++
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           +RD+K  NVLLD + N +L D GLA   + G     T+  GT GY+APE  +    S   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 525 DVFAFGALLLEVACGRRP 542
           D FA G  + E+  GR P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 81.7 bits (201), Expect = 4e-17
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I   E++  + +   EI  + +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P   L+  Q   I++ +  GL YLH    
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS--- 119

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL      KL DFG+A      T       VGT  ++APE  +    
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 521 SASSDVFAFGALLLEVACGRRP 542
            + +D+++ G   +E+A G  P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 22/204 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS----NESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG GGFG+V    + +     A+K +      E+ Q      SE   +    H  +V+L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59

Query: 404 GWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
              + K  + ++ ++   G L     D  LFDE  A      RF  I  V     YLH  
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA------RF-YIACVVLAFEYLHN- 111

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
             + +I+RD+K  N+LLDS    KL DFG AK  + G    T    GT  Y+APE     
Sbjct: 112 --RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEIILNK 167

Query: 519 KSSASSDVFAFGALLLEVACGRRP 542
               S D ++ G LL E+  GR P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 82.4 bits (203), Expect = 6e-17
 Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 18/215 (8%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V K     S   +A K I  E K  +R + + E+  + 
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L +    P+ +L      K+   V 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVL 113

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 114 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 167

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           Y++PE  +    S  SD+++ G  L+E+A GR PI
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 18/213 (8%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGRLR 395
           N+   +LLG G FG+VY     ++  E+AVK++     S E+ + V     EI  +  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 396 HRNLVQLVGWCR--RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           H  +VQ  G  R   +  L +  + M  GS+   L        N  +++   + +  G+ 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--RQILEGVS 120

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE----HGTNPATTRVVGTLGY 509
           YLH     +++HRD+K +N+L DS  N KLGDFG +K  +     GT      V GT  +
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT--GMKSVTGTPYW 175

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           ++PE          +D+++ G  ++E+   + P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.1 bits (202), Expect = 6e-17
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 16/208 (7%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV---REFVSEIATIGRLRHRN 398
           F+  + +GHG FG VY      +   VA+K++S   KQ     ++ + E+  + R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            ++  G   R+    LV ++    + D  L +  K  L   +   I  G   GL YLH  
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS- 143

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE---TP 515
               +IHRD+KA N+LL      KL DFG A +     +PA +  VGT  ++APE     
Sbjct: 144 --HNMIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS-FVGTPYWMAPEVILAM 196

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPI 543
             G+     DV++ G   +E+A  + P+
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 81.4 bits (201), Expect = 7e-17
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 34/216 (15%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV-REFVSEIATIGRLRHRNL 399
           NF   + LG G +  VYKG    +   VA+K I  ++++G     + EI+ +  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 400 VQLVGWCRRKGDLLLVYDFMAN------------GSLDSFLFDEPKAVLNWEQRFKIIKG 447
           V+L      +  L+LV+++M              G+LD      P  V ++   ++++KG
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD------PNTVKSFT--YQLLKG 112

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +A    + HE     V+HRD+K  N+L++     KL DFGLA+ +    N  +  VV TL
Sbjct: 113 IA----FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TL 164

Query: 508 GYLAPET---PRTGKSSASSDVFAFGALLLEVACGR 540
            Y AP+     RT   S S D+++ G ++ E+  GR
Sbjct: 165 WYRAPDVLLGSRT--YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 7e-17
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 29/215 (13%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKR-----ISNESKQGVREFVS----EIATIGRLRHR 397
           L+G G FG VY G   +S   +AVK+     +S  SK   R  +     EIA +  L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGL 452
           N+VQ +G       L +  +++  GS+ + L     F+E   V N+      ++ +  GL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEET-LVRNF------VRQILKGL 119

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-----GTNPATTRVVGTL 507
            YLH    + +IHRD+K +N+L+D++   K+ DFG++K  E       TN A   + G++
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            ++APE  +    +  +D+++ G L++E+  G+ P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 17/173 (9%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG--VREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V+K     +   VA+K+++    +G    + + EI  +   +H  +V+L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK-----IIKGVASGLLYLHEGYE 460
                  +LV ++M    L   L DE + +   E + K     ++KGVA    Y+H    
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLP--EAQVKSYMRMLLKGVA----YMHA--- 117

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
             ++HRD+K +N+L+ ++   K+ DFGLA+L+        +  V T  Y APE
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 82.2 bits (203), Expect = 9e-17
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 14/199 (7%)

Query: 348 LGHGGFGQVYKGTLH--NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           L  G  G+V+  T H    + +V VK ++     G +    EI  +  + HR ++ L+  
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHA 154

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
            R K  + +V   M     D F + +    L  EQ   I + +   L YLH    + +IH
Sbjct: 155 YRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIH 208

Query: 466 RDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           RDVK  N+ LD   N  LGDFG A KL  H   P      GTL   +PE        A +
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKT 268

Query: 525 DVFAFGALLLEVACGRRPI 543
           D+++ G +L E++     +
Sbjct: 269 DIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 28/227 (12%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS---EIATIGRLRHR 397
            +   + +G G FG++Y     +      +K I    K  V+E  +   E+  + +++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLT-KMPVKEKEASKKEVILLAKMKHP 59

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           N+V      +  G L +V ++   G L          LF E + +L+W         ++ 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSW------FVQISL 112

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTL 507
           GL ++H+   + ++HRD+K+ N+ L    NG   KLGDFG+A+        A T  VGT 
Sbjct: 113 GLKHIHD---RKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELAYT-CVGTP 166

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVL 554
            YL+PE  +    +  +D+++ G +L E+   + P E   L  +LVL
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 24/216 (11%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRN 398
           F   ++LG GGFG+V    +  +    A K++  +    ++G    ++E   + ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-------FDEPKAVLNWEQRFKIIKGVASG 451
           +V L      K  L LV   M  G L   +       F+E +AV    +       +  G
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-------ICCG 114

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYL 510
           L  LH+   + +++RD+K  N+LLD   + ++ D GLA    H     T +  VGT+GY+
Sbjct: 115 LEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYM 168

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           APE  +  + + S D +A G LL E+  G+ P + R
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE----SKQGVREFVSEIATIGRLR 395
           ++F   + LG G FG+V       S    A+K +S       KQ V   ++E   +  +R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
           H  LV L G  +   +L LV +++  G L S L     F EP A      RF   + V  
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA------RFYAAQ-VVL 112

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            L YLH      +++RD+K  N+LLDS+   K+ DFG AK  +      T  + GT  YL
Sbjct: 113 ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYL 165

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE   +     + D +A G L+ E+  G  P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 32/225 (14%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRI-SNESKQGVREFVSEIATIGRL 394
           N    + LG G FG+V K T    K     T VAVK +  N S   +R+ +SE   + ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL----------------------FDEP 432
            H ++++L G C + G LLL+ ++   GSL SFL                       +  
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-L 491
           +  L           ++ G+ YL E     ++HRD+ A NVL+      K+ DFGL++ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           YE  +    ++    + ++A E+      +  SDV++FG LL E+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 345 KQLLGHGGFGQVYKGTLHNS--KTEVAVKRISN-ESKQGVREFVSEIATIGRL-RHRNLV 400
           + ++G G FGQV +  +     K   A+K +    S+   R+F  E+  + +L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFD------EPK--------AVLNWEQRFKIIK 446
            L+G C  +G L +  ++   G+L  FL        +P         + L  +Q  +   
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
            VA+G+ YL E   +  IHRD+ A NVL+   L  K+ DFGL++    G      + +G 
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGR 179

Query: 507 LG--YLAPETPRTGKSSASSDVFAFGALLLEV 536
           L   ++A E+      +  SDV++FG LL E+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 78/233 (33%), Positives = 109/233 (46%), Gaps = 34/233 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSE--IATIGRLRHRNLV 400
           ++LG G FG+V    L  S    AVK +  +       V   ++E  I ++ R  H  L 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 59

Query: 401 QLVGWCRRKGD-LLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           QL   C +  D L  V +F+  G L      S  FDE +A      RF   + + S L++
Sbjct: 60  QLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA------RFYAAE-ITSALMF 111

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAPE 513
           LH+   + +I+RD+K  NVLLD E + KL DFG+ K  E   N  TT    GT  Y+APE
Sbjct: 112 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE 166

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETRA--------LPEELVLVDWV 558
             +      S D +A G LL E+ CG  P E           L +E+V   W+
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 27/210 (12%)

Query: 347 LLGHGGFGQVYKGTLHNS--KTEVAVKRISN-ESKQGVREFVSEIATIGRL-RHRNLVQL 402
           ++G G FGQV K  +     + + A+KR+    SK   R+F  E+  + +L  H N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFD------EPK--------AVLNWEQRFKIIKGV 448
           +G C  +G L L  ++  +G+L  FL        +P         + L+ +Q       V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
           A G+ YL +   +  IHRD+ A N+L+      K+ DFGL++    G      + +G L 
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 174

Query: 509 --YLAPETPRTGKSSASSDVFAFGALLLEV 536
             ++A E+      + +SDV+++G LL E+
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ---GVREFVSEIATIGRLRHRNLVQLVG 404
           +GHG FG VY  T  ++   VAVK++S   KQ     ++ + E+  + +L+H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              ++    LV ++    + D  L +  K  L   +   I  G   GL YLH      +I
Sbjct: 89  CYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 143

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE---TPRTGKSS 521
           HRD+KA N+LL      KL DFG A      ++PA +  VGT  ++APE       G+  
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK----SSPANS-FVGTPYWMAPEVILAMDEGQYD 198

Query: 522 ASSDVFAFGALLLEVACGRRP 542
              DV++ G   +E+A  R+P
Sbjct: 199 GKVDVWSLGITCIELA-ERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I   E++  + +   EI  + +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFL----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           +  G   +   L ++ +++  GS    L    FDE        Q   ++K +  GL YLH
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE-------FQIATMLKEILKGLDYLH 118

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
               +  IHRD+KA+NVLL  + + KL DFG+A      T       VGT  ++APE  +
Sbjct: 119 S---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIQ 174

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
                + +D+++ G   +E+A G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 34/239 (14%)

Query: 345 KQLLGHGGFGQVY----------------KGTLHNSKTEVAVKRI-SNESKQGVREFVSE 387
            + LG G FG+V+                +    ++   VAVK +  + S     +F+ E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL----FDEPKAVLNWEQ--- 440
           +  + RL   N+ +L+G C     L ++ ++M NG L+ FL     +      N +    
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 441 --RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTN 497
                +   +ASG+ YL        +HRD+   N L+      K+ DFG+++ LY     
Sbjct: 130 STLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA--CGRRPIETRALPEELVL 554
               R    + ++A E+   GK +  SDV+AFG  L E+   C  +P E   L ++ V+
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH--LTDQQVI 243

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)

Query: 348 LGHGGFGQVYKGTLHNSKTE--VAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG     K+E  VAVK + N++       E + E   + +L +  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ FL  + K V   +   +++  V+ G+ YL E      
Sbjct: 63  GICEAE-SWMLVMELAELGPLNKFL-QKNKHVTE-KNITELVHQVSMGMKYLEE---TNF 116

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N    +  G   + + APE     K S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 17/199 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKR-ISNESKQGVREF-VSEIATIGRLRHRNLVQLVGW 405
           +G G +G V+K     +   VA+K+ + +E    +++  + EI  + +L+H NLV L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
            RRK  L LV+++  +  L+  L   P+ V       KII      + + H+      IH
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNE-LEKNPRGV-PEHLIKKIIWQTLQAVNFCHK---HNCIH 123

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE-----TPRTGKS 520
           RDVK  N+L+  +   KL DFG A++   G     T  V T  Y APE     T    + 
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGDT----QY 178

Query: 521 SASSDVFAFGALLLEVACG 539
               DV+A G +  E+  G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 13/206 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREF-VSEIATIGRLRHR 397
           N F    ++G G +G V K     +K  VA+K+  + E  + V+E  + E+  +  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---FKIIKGVASGLLY 454
           N+V+L    RR+G L LV++++    L+  L + P  V   + R   +++IK +      
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAI------ 113

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET 514
            H  ++  ++HRD+K  N+L+      KL DFG A+    G+N   T  V T  Y +PE 
Sbjct: 114 -HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172

Query: 515 PRTGKSSASSDVFAFGALLLEVACGR 540
                   + D+++ G +L E++ G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 20/200 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+VYK     +    A K I  +S++ + +++ EI  +    H  +V+L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII-KGVASGLLYLHEGYEQVVIHR 466
             G L ++ +F   G++D+ + +  + +   E + ++I + +   L YLH      +IHR
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLEALQYLH---SMKIIHR 134

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR----VVGTLGYLAP-----ETPRT 517
           D+KA NVLL  + + KL DFG++       N  T +     +GT  ++AP     ET + 
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 518 GKSSASSDVFAFGALLLEVA 537
                 +D+++ G  L+E+A
Sbjct: 190 TPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 29/224 (12%)

Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNL 399
           ++LG G FG VYKG         K  VA+K I NE+   +   EF+ E   +  + H +L
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLY 454
           V+L+G C     + LV   M +G L  ++ +       + +LNW  +      +A G++Y
Sbjct: 72  VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 124

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAP 512
           L E   + ++HRD+ A NVL+ S  + K+ DFGLA+L E G         G +   ++A 
Sbjct: 125 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWMAL 180

Query: 513 ETPRTGKSSASSDVFAFGALLLEVAC-GRRP---IETRALPEEL 552
           E     K +  SDV+++G  + E+   G +P   I TR +P+ L
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 69/215 (32%), Positives = 106/215 (49%), Gaps = 18/215 (8%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + E+  + 
Sbjct: 1   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L      P+ +L      K+   V 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 113

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 114 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 167

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           Y++PE  +    S  SD+++ G  L+E+A GR PI
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 15/203 (7%)

Query: 348 LGHGGFGQVYKGTLHN-------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           LG G F +++KG            KTEV +K +    +     F    + + +L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
              G C    + ++V +++  GSLD++L  + K ++N   + ++ K +A  L +L    +
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALHFLE---D 118

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR---VVGTLGYLAPETPRT 517
           + + H +V A NVLL  E + K G+    KL + G +        ++  + ++ PE    
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178

Query: 518 GKS-SASSDVFAFGALLLEVACG 539
            ++ S ++D ++FG  L E+  G
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 9/207 (4%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLRHR 397
           NF  ++ +G G F +VY+ T       VA+K++        +   + + EI  + +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIKGVASGLLYL 455
           N+++         +L +V +    G L   +  F + K ++  +  +K    + S L ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H    + V+HRD+K +NV + +    KLGD GL + +   T  A + +VGT  Y++PE  
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 178

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
                +  SD+++ G LL E+A  + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 33/234 (14%)

Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR 382
           L +  Q+Y         N+      +G G  GQVYK     +   +AVK++    + G +
Sbjct: 3   LTIDGQKY-----PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNK 54

Query: 383 EFVSEIAT---IGRLRHR--NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE----PK 433
           E    I     +    H    +V+  G+     D+ +  + M+   LD  L       P+
Sbjct: 55  EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPE 113

Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLY 492
            +L      K+   +   L YL E  +  VIHRDVK SN+LLD+  N KL DFG++ +L 
Sbjct: 114 DILG-----KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166

Query: 493 EHGTNPATTRVVGTLGYLAPE--TPRTGKSS--ASSDVFAFGALLLEVACGRRP 542
           +   + A TR  G   Y+APE   P          +DV++ G  L+E+A G+ P
Sbjct: 167 D---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 21/212 (9%)

Query: 348 LGHGGFGQVYKGTLH--NSKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG G FG V +G L+  +S  +VAVK  +I+  ++  + +F+SE   +    H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 404 GWCRRKGDL------LLVYDFMANGSLDSFLF-----DEPKAVLNWEQRFKIIKGVASGL 452
           G C +  +       +++  FM +G L SFL      D P+  L  +   K +  +ASG+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ-YLPTQMLVKFMTDIASGM 125

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT-LGYLA 511
            YL     +  IHRD+ A N +L+  +N  + DFGL+K   +G      R+    + ++A
Sbjct: 126 EYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 512 PETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
            E+      +  SDV++FG  + E+A  G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 13/199 (6%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLVQLV 403
           +++LGHG  G VYK     ++  +AVK I  + + +  ++ +SE+  + +     ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G    +  + +  +FM  GSLD +    P+ VL      +I   V  GL YL   +   +
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY-RKIPEHVLG-----RIAVAVVKGLTYL---WSLKI 116

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSAS 523
           +HRDVK SN+L+++    KL DFG++       N      VGT  Y+APE     +    
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 524 SDVFAFGALLLEVACGRRP 542
           SDV++ G   +E+A GR P
Sbjct: 174 SDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 40/235 (17%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTE----------------VAVKRISNESKQGVR-EFVSE 387
           K+ LG G FG+V+   + N +                  VAVK +  ++ +  R +F+ E
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69

Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------------FD 430
           +  + RL+  N+++L+G C  +  L ++ ++M NG L+ FL                   
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 431 EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
                +++     +   +ASG+ YL        +HRD+   N L+   L  K+ DFG+++
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 491 -LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV--ACGRRP 542
            LY         R V  + ++A E    GK + +SDV+AFG  L E+   C  +P
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.2 bits (196), Expect = 6e-16
 Identities = 67/190 (35%), Positives = 93/190 (48%), Gaps = 40/190 (21%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRI----SNESK-QGVREFVSEIATIGRLR-HRN 398
            Q LG G +G V+K     +K  VA+K+I     N +  Q  R F  EI  +  L  H N
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTF-REIMFLQELGDHPN 68

Query: 399 LVQLVGWCRRKG--DLLLVYDFM---------ANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           +V+L+   + +   D+ LV+++M         AN      L D  K  + + Q  K +K 
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN-----ILEDVHKRYIMY-QLLKALK- 121

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK----LYEHGTNPATTRV 503
                 Y+H G    VIHRD+K SN+LL+S+   KL DFGLA+    L E+  NP  T  
Sbjct: 122 ------YIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 504 VGTLGYLAPE 513
           V T  Y APE
Sbjct: 173 VATRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNS-KTEVAVKRIS----------NESKQGVREFVSEIA 389
            ++  + LG G FG VYK    N+ +  +A+K I+           E  + + + VSE+ 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 390 TIG-RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-DSFL-FDEPKAVLNWEQRFKIIK 446
            I  +LRH N+V+          L +V D +    L + F    E K     E+ + I  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
            +   L YLH+  E+ ++HRD+  +N++L  +    + DFGLAK  +       T VVGT
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGT 176

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           + Y  PE  +       +DV+AFG +L ++ 
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 24/210 (11%)

Query: 348 LGHGGFGQVYKGTLHNS-----KTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           LG   FG+VYKG L  +        VA+K + ++++  +RE F  E     RL+H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLF-----------DEPKAV---LNWEQRFKIIKG 447
           L+G   ++  L +++ + ++  L  FL            D+ K V   L       I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT 506
           +A+G+ +L   +   V+H+D+   NVL+  +LN K+ D GL + +Y           +  
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + +++PE    GK S  SD++++G +L EV
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 28/209 (13%)

Query: 347 LLGHGGFGQVYKGTLHNSKTE-----VAVKRISNESKQGVR-EFVSEIATIGRLRHRNLV 400
            LG G FG+V+       + E     V VK +     + ++ EF  E+    +L H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV-------LNWEQRFKIIKGVASGLL 453
           +L+G CR      ++ ++   G L  FL              L+ +Q+  +   +A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNPATTRVVGTL 507
           +L        +HRD+ A N L+ S+   K+    L+K       Y+        R     
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----- 183

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEV 536
            +LAPE  +    S  SDV++FG L+ EV
Sbjct: 184 -WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKT----EVAVKRISNESKQ-GVREFVSEIATIGRLRH 396
            +   LL  G FG+++ G L + K     EV VK + + + +  V   + E   +  L H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 397 RNLVQLVGWCRRKGDLLLV-YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV------A 449
           +N++ ++  C   G+   V Y +M  G+L  FL        N  Q     + V      A
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT-- 506
            G+ YLH+     VIH+D+ A N ++D EL  K+ D  L++ L+     P     +G   
Sbjct: 128 CGMSYLHK-RG--VIHKDIAARNCVIDEELQVKITDNALSRDLF-----PMDYHCLGDNE 179

Query: 507 ---LGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
              + ++A E+    + S++SDV++FG LL E+ 
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 58/205 (28%), Positives = 109/205 (53%), Gaps = 18/205 (8%)

Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G   +     ++T VAVK ++  +    R EF++E + +      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN-------WEQRFKIIKGVASGLL 453
           L+G   +    L+V + MA+G L S+L    P+A  N        ++  ++   +A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL+    +  +HRD+ A N ++  +   K+GDFG+ + +YE        + +  + ++AP
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 513 ETPRTGKSSASSDVFAFGALLLEVA 537
           E+ + G  + SSD+++FG +L E+ 
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 9/199 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYK     +   VA+K+I  E+  +GV    + EI+ +  L H N+V+L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              +  L LV++F+ +  L  ++   P   L+       +  +  G+ Y H      V+H
Sbjct: 67  VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLH 122

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASS 524
           RD+K  N+L+D E   KL DFGLA+ +       T  VV TL Y APE     +  S   
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPV 181

Query: 525 DVFAFGALLLEVACGRRPI 543
           D+++ G +  E+   RRP+
Sbjct: 182 DIWSIGCIFAEM-VNRRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 32/224 (14%)

Query: 342 FSAKQLLGHGGFGQVYKGTL---HNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRH 396
           F+  ++LG G FG V +  L     S  +VAVK +  +  S   + EF+ E A +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 397 RNLVQLVGWC---RRKGDL---LLVYDFMANGSLDSFLF-----DEPKAVLNWEQRFKII 445
            N+++L+G     R KG L   +++  FM +G L +FL      +EP   L  +   + +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP-FTLPLQTLVRFM 119

Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNPA 499
             +ASG+ YL     +  IHRD+ A N +L+  +   + DFGL+K       Y  G    
Sbjct: 120 IDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
                  + +LA E+      +  SDV+AFG  + E+   G+ P
Sbjct: 177 L-----PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--------------PKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+++     
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 18/205 (8%)

Query: 348 LGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G          +T VA+K ++  +    R EF++E + +      ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKG-------VASGLL 453
           L+G   +    L++ + M  G L S+L    P+   N  Q    +K        +A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL+       +HRD+ A N ++  +   K+GDFG+ + +YE        + +  + +++P
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 513 ETPRTGKSSASSDVFAFGALLLEVA 537
           E+ + G  +  SDV++FG +L E+A
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 27/213 (12%)

Query: 348 LGHGGFGQVYKGTLHNSKTE-------VAVKRIS-NESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV +   +            VAVK +  N + + + + +SE+  +  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FDEPKA---VLNWEQRFKI 444
           ++ L+G C ++G L ++ ++ A G+L  FL           FD  K     L+++     
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+ +++      T+  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG L+ E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 38/214 (17%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYKG    +   VA+K+I  ES+ +GV    + EI+ +  L+H N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 406 CRRKGDLLLVYDFM------------ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
             ++  L L+++F+                +D+ L    K+ L     ++I++G+    L
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELV---KSYL-----YQILQGI----L 115

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           + H    + V+HRD+K  N+L+D++   KL DFGLA+ +       T  VV TL Y APE
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPE 171

Query: 514 ----TPRTGKSSASSDVFAFGALLLEVACGRRPI 543
               +PR    S   D+++ G +  E+A  ++P+
Sbjct: 172 VLLGSPRY---STPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 27/208 (12%)

Query: 351 GGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRNLVQLVGWCR 407
           G +G+V+     ++    A+K I          V + ++E   + + +   +V+L    +
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 408 RKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYEQ 461
            K +L LV +++  G L S L      DE  A          I  +   L YLH  G   
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-------IYIAEIVLALEYLHSNG--- 113

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAK-------LYEHGTNPATTRVVGTLGYLAPET 514
            +IHRD+K  N+L+DS  + KL DFGL+K       +  +       R+VGT  Y+APE 
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
                 S + D ++ G +L E   G  P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 53/175 (30%), Positives = 91/175 (52%), Gaps = 26/175 (14%)

Query: 351 GGFGQVYKGTLHNSKTE--VAVKRISNESKQ------GVREFVSEIATIGRLRHRNLVQL 402
           G +G VY+    + KT   VA+K++  E ++       +RE    I  + +L+H N+V +
Sbjct: 16  GTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFPITSLRE----INILLKLQHPNIVTV 69

Query: 403 ----VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
               VG       + +V +++ +  L S +    +  L  E +  ++  + SG+ +LH+ 
Sbjct: 70  KEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSGVAHLHDN 125

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           +   ++HRD+K SN+LL++    K+ DFGLA+ Y     P T  VV TL Y APE
Sbjct: 126 W---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 75.7 bits (186), Expect = 5e-15
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)

Query: 345 KQLLGHGGFGQVY----KGTLH------------NSKTEVAVKRISNESKQGVR-EFVSE 387
           K+ LG G FG+V+    +G               N    VAVK +  ++ +  R +F+ E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------FDEPKAVLNW 438
           I  + RL+  N+++L+  C     L ++ ++M NG L+ FL                +++
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTN 497
                +   +ASG+ YL        +HRD+   N L+      K+ DFG+++ LY     
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA--CGRRP 542
               R V  + +++ E+   GK + +SDV+AFG  L E+   C  +P
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 8/199 (4%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRN 398
           NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L+     +  L LV++F+ +  L  F+   P + +        +  +  GL + H  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS- 118

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
               V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y APE     
Sbjct: 119 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 175

Query: 519 K-SSASSDVFAFGALLLEV 536
           K  S + D+++ G +  E+
Sbjct: 176 KYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.2 bits (187), Expect = 6e-15
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)

Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N    VAVK + ++ + + + + VSE+  +  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FDE---PKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           FD    P+  L ++     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRV 503
              VA G+ YL     Q  IHRD+ A NVL+  +   K+ DFGLA+ ++       TT  
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLR---HRNLVQL 402
           +G G +G VYK    +S   VA+K  R+           V E+A + RL    H N+V+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 403 VGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           +  C      R+  + LV++ + +  L ++L   P   L  E    +++    GL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
                ++HRD+K  N+L+ S    KL DFGLA++Y      A T VV TL Y APE    
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVLLQ 181

Query: 518 GKSSASSDVFAFGALLLEVACGRRPI 543
              +   D+++ G +  E+   R+P+
Sbjct: 182 STYATPVDMWSVGCIFAEMF-RRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.4 bits (193), Expect = 7e-15
 Identities = 75/306 (24%), Positives = 141/306 (46%), Gaps = 27/306 (8%)

Query: 291 IASVVLAICILSLA--IIYIIKKIKNAEVI----ED--WELEVGPQRYSYQ-ELKQATNN 341
           I   + A  +L+L       I+   N E+     ED  WEL+    + S    +    ++
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSS 691

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
              + ++  G  G  YKG    +  +  VK I++ +        SEIA +G+L+H N+V+
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVK 747

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G CR +    L+++++   +L   L +     L+WE+R KI  G+A  L +LH     
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
            V+  ++    +++D +    L      +L   G     T+   +  Y+APET  T   +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDIT 856

Query: 522 ASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP--KLNAEY 579
             SD++ FG +L+E+  G+ P +         +V+W    Y +  +   IDP  + +   
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSV 915

Query: 580 DQSQVL 585
           +Q++++
Sbjct: 916 NQNEIV 921

Length = 968

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.5 bits (183), Expect = 8e-15
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 32/206 (15%)

Query: 346 QLLGHGGFGQVYKGTLHNSKT--------EVAVKRISNESKQGVREFVSEIATIGRLRHR 397
           + +G G FG   K  L  SK         E+ + ++S + ++  R+   E+A +  ++H 
Sbjct: 6   KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHP 59

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           N+VQ        G+L +V D+   G L          LF E + +L+W   F  I     
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ-ILDW---FVQI----- 110

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
             L L   +++ ++HRD+K+ N+ L  +   KLGDFG+A++       A T  +GT  YL
Sbjct: 111 -CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYL 168

Query: 511 APETPRTGKSSASSDVFAFGALLLEV 536
           +PE       +  SD++A G +L E+
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 348 LGHGGFGQVYKG-TLHNSKTEVAVKRIS-NESKQGVR-EFVSEIATIGRLR---HRNLVQ 401
           +G G +G+V+K   L N    VA+KR+     ++G+    + E+A +  L    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 402 LVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L   C      R+  L LV++ + +  L ++L   P+  +  E    ++  +  GL +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
                 V+HRD+K  N+L+ S    KL DFGLA++Y      A T VV TL Y APE   
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLL 182

Query: 517 TGKSSASSDVFAFGALLLEVACGRRPI 543
               +   D+++ G +  E+   R+P+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMF-RRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSE--IATIGRLRHRNLV 400
           ++LG G FG+V    L  +    A+K +  +       V   ++E  I  +   +H  L 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLT 59

Query: 401 QLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
            L    + K  L  V +++  G L      S  FDEP++      RF   + V   L++L
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS------RFYAAE-VTLALMFL 112

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGYLAPE 513
           H      VI+RD+K  N+LLD+E + KL DFG+ K    G      TT   GT  Y+APE
Sbjct: 113 HR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPE 166

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
             +  +   S D +A G L+ E+  G+ P E
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.4 bits (182), Expect = 1e-14
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 17/221 (7%)

Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL 394
           L+     F   +L+G+G +GQVYKG  H    ++A  ++ + +     E   EI  + + 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKY 59

Query: 395 -RHRNLVQLVGWCRRKG------DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
             HRN+    G   +K        L LV +F   GS+   + +     L  E    I + 
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +  GL +LH+     VIHRD+K  NVLL      KL DFG++   +       T  +GT 
Sbjct: 120 ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTP 175

Query: 508 GYLAPETPRTGKSSAS-----SDVFAFGALLLEVACGRRPI 543
            ++APE     ++  +     SD+++ G   +E+A G  P+
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVG 404
           +G GG+GQV+     ++   VA+KR+          VR  ++E   +   +   LV+L+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ-RFKIIKGVASGLLYLHE-GYEQV 462
             +    L L  +++  G   + L +    VL+ +  RF + +   + +  LHE GY   
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEA-VDALHELGY--- 122

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
            IHRD+K  N L+D+  + KL DFGL+K    G       VVG+  Y+APE  R      
Sbjct: 123 -IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDF 177

Query: 523 SSDVFAFGALLLEVACGRRP 542
           + D ++ G +L E  CG  P
Sbjct: 178 TVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 35/214 (16%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS---NESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG G +G VYK     +   +A+K I    +ESK    + + E+  + +     +V   G
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKAVSPYIVDFYG 66

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAV--LNWEQRFKIIKGVASGLLYLHEGYEQV 462
               +G + +  ++M  GSLD  L+    A   +  +   +I   V  GL +L E  E  
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123

Query: 463 VIHRDVKASNVLLDSELNGKLGDFG--------LAKLYEHGTNPATTRVVGTLGYLAPET 514
           +IHRDVK +NVL++     KL DFG        LAK     TN      +G   Y+APE 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-----TN------IGCQSYMAPER 172

Query: 515 PRTGKSSA------SSDVFAFGALLLEVACGRRP 542
            ++G  +        SDV++ G  +LE+A GR P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 62/244 (25%), Positives = 106/244 (43%), Gaps = 19/244 (7%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G V   T  ++  +VAVK++    +Q      +E+  +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +F+  G+L   +       +N EQ   +   V   L YLH    Q VIHRD
Sbjct: 90  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHN---QGVIHRD 143

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           +K+ ++LL S+   KL DFG          P    +VGT  ++APE           D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 528 AFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMG 587
           + G +++E+  G  P       + +             R+ + + P++   +  S VL G
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAM------------RRIRDNLPPRVKDSHKVSSVLRG 250

Query: 588 ELEL 591
            L+L
Sbjct: 251 FLDL 254

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 7/195 (3%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGRLRHRNLVQLV 403
           +++G G +G+V          +  +K+++  N S++  +    E   + +L+H N+V   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 404 -GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
             W    G L +V  F   G L   L ++   +L   Q  +    +A  L YLHE +   
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--- 122

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           ++HRD+K  NV L      K+GD G+A++ E+  + A+T ++GT  Y++PE       + 
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNY 181

Query: 523 SSDVFAFGALLLEVA 537
            SDV+A G  + E+A
Sbjct: 182 KSDVWALGCCVYEMA 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 39/214 (18%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREF-VSEIATIGRLRHRNLVQLVGW 405
           +G G +G V+K     +   VA+KR+  ++  +GV    + EI  +  L+H+N+V+L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 406 CRRKGDLLLVYDFM----------ANGSLD-----SFLFDEPKAVLNWEQRFKIIKGVAS 450
                 L LV+++            NG +D     SF+F             +++KG+A 
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMF-------------QLLKGLA- 113

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L++     KL DFGLA+ +       +  VV TL Y 
Sbjct: 114 ---FCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYR 166

Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGRRPI 543
            P+     K  S S D+++ G +  E+A   RP+
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV-SEIATIGRLRHRNLVQLVGWC 406
           +G G  G V   T  ++  +VAVK++ +  KQ  RE + +E+  +   +H N+V++    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
               +L +V +F+  G+L   +       +N EQ   +   V   L +LH    Q VIHR
Sbjct: 86  LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHA---QGVIHR 139

Query: 467 DVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           D+K+ ++LL S+   KL DFG  A++ +    P    +VGT  ++APE           D
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 526 VFAFGALLLEVACGRRP 542
           +++ G +++E+  G  P
Sbjct: 198 IWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.3 bits (181), Expect = 6e-14
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 37/192 (19%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ESKQGVREFVSEIATIGRLR 395
           +   + +G G +G V       +  +VA+K+ISN      ++K+ +RE    I  +  LR
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHLR 57

Query: 396 HRNLVQLVGWCRRK-----GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ-------RFK 443
           H N++ L+   R        D+ +V + M     ++ L      V+   Q       ++ 
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDL----HKVIKSPQPLTDDHIQY- 107

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--T 501
            +  +  GL YLH      VIHRD+K SN+L++S  + K+ DFGLA+  +   +     T
Sbjct: 108 FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 502 RVVGTLGYLAPE 513
             V T  Y APE
Sbjct: 165 EYVVTRWYRAPE 176

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 44/117 (37%), Positives = 62/117 (52%), Gaps = 13/117 (11%)

Query: 429 FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL 488
           F EP AV    +       +A GL +LH    + +I+RD+K  NV+LD+E + K+ DFG+
Sbjct: 98  FKEPHAVFYAAE-------IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGM 147

Query: 489 AKLYEHGTNPATTRV-VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
            K  E+     TTR   GT  Y+APE         S D +AFG LL E+  G+ P +
Sbjct: 148 CK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 8/208 (3%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRN 398
           F   ++LG GGFG+V    +  +    A KR+  +    ++G    ++E   + ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V L      K  L LV   M  G L   +++        E+       +  GL  LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR- 120

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
             +  ++RD+K  N+LLD   + ++ D GLA     G   +    VGT+GY+APE     
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQ 176

Query: 519 KSSASSDVFAFGALLLEVACGRRPIETR 546
           + + S D +  G L+ E+  G+ P   R
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 22/215 (10%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRN 398
           F   ++LG GGFG+V    +  +    A K++  +    ++G    ++E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-------FDEPKAVLNWEQRFKIIKGVASG 451
           +V L      K  L LV   M  G L   +       FDE +AV    +       +  G
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-------ITCG 114

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L  LH    + +++RD+K  N+LLD   + ++ D GLA     G      RV GT+GY+A
Sbjct: 115 LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRV-GTVGYMA 169

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           PE  +  + + S D +  G L+ E+  G+ P   R
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 11/203 (5%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV-SEIATIGRLRHRNLV 400
           ++  + +G G  G V+      +  EVA+K+I N  KQ  +E + +EI  +  L++ N+V
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIV 79

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
             +       +L +V +++A GSL   +    +  ++  Q   + +     L +LH    
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHANQ- 135

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
             VIHRD+K+ NVLL  + + KL DFG  A++    +  +T  +VGT  ++APE      
Sbjct: 136 --VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 520 SSASSDVFAFGALLLEVACGRRP 542
                D+++ G + +E+  G  P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 9e-14
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 10/211 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           LG G +  V+KG    ++  VA+K I  E ++G     + E++ +  L+H N+V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
                L LV++++ +  L  ++ D+   +++       +  +  GL Y H    + V+HR
Sbjct: 74  HTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHR 128

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-- 524
           D+K  N+L++     KL DFGLA+     T   +  VV TL Y  P+    G S  S+  
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV-LLGSSEYSTQI 186

Query: 525 DVFAFGALLLEVACGRRPIETRALPEELVLV 555
           D++  G +  E+A GR       + +EL L+
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 17/221 (7%)

Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL 394
           L+     F   +++G+G +GQVYKG  H    ++A  ++ + ++    E   EI  + + 
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKY 69

Query: 395 -RHRNLVQLVGWCRRKG------DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
             HRN+    G   +K        L LV +F   GS+   + +     L  +    I + 
Sbjct: 70  SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +  GL +LH      VIHRD+K  NVLL      KL DFG++   +       T  +GT 
Sbjct: 130 ILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTP 185

Query: 508 GYLAPETPRTGKSSAS-----SDVFAFGALLLEVACGRRPI 543
            ++APE     ++  +     SD+++ G   +E+A G  P+
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           +++G G FG+       NS  + A+K I   +S   V +   E   + +++H N+V    
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 405 WCRRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
                G L +V ++   G L          LF E   +L W         +  G+ ++HE
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQW------FVQMCLGVQHIHE 118

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
              + V+HRD+K+ N+ L      KLGDFG A+L       A T  VGT  Y+ PE    
Sbjct: 119 ---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWEN 174

Query: 518 GKSSASSDVFAFGALLLEVACGRRPIE 544
              +  SD+++ G +L E+   + P +
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.5 bits (183), Expect = 1e-13
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 18/197 (9%)

Query: 367 EVAVKRISNESKQGVRE---FVSEIATIGRLRHRNLVQLVGWCRRKGDLLL-VYDFMANG 422
           EVA+K +  ++ +   +   F  E A   RL H N+V L+        LL  V++++   
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64

Query: 423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSEL 479
           +L   L  +    L   +  +++  V   L   H    Q ++HRD+K  N+++       
Sbjct: 65  TLREVLAAD--GALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119

Query: 480 NGKLGDFGLAKL------YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALL 533
           + K+ DFG+  L       +  T   TT V+GT  Y APE  R    + +SD++A+G + 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 534 LEVACGRRPIETRALPE 550
           LE   G+R ++  ++ E
Sbjct: 180 LECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 34/213 (15%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--------SKQGVREFVSEIATIGRLRHR 397
           ++LG G FG+V    L  +    A+K +  +            V   V  +A      H 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW----EHP 56

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRF---KIIKGVA 449
            L  L    + K  L  V +++  G L      S  FDE +A      RF   +II    
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA------RFYAAEII---- 106

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
            GL +LH+     +I+RD+K  NVLLD + + K+ DFG+ K   +G   A+T   GT  Y
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDY 162

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +APE  +  K + S D ++FG LL E+  G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 52/175 (29%), Positives = 89/175 (50%), Gaps = 10/175 (5%)

Query: 346 QLLGHGGFGQVYKGTLHN--SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQL 402
           + +G+G FG+V  G +++  +  +V VK +  + S Q   +F+ E      L+H NL+Q 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKA-VLNWEQRF--KIIKGVASGLLYLHEGY 459
           +G C      LLV +F   G L  +L    KA ++  +     ++   +A GLL+LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKL-YEHGTNPATTRVVGTLGYLAPE 513
           +   IH D+   N LL ++L  K+GD+GL+   Y+        ++   L ++APE
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 10/208 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           LG G +  VYKG    +   VA+K I  E ++G     + E++ +  L+H N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
             +  L LV++++ +  L  +L D+    +N       +  +  GL Y H    + V+HR
Sbjct: 74  HTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHR 128

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-- 524
           D+K  N+L++     KL DFGLA+     T   +  VV TL Y  P+    G +  S+  
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDI-LLGSTDYSTQI 186

Query: 525 DVFAFGALLLEVACGRRPIETRALPEEL 552
           D++  G +  E++ GR       + E+L
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 36/189 (19%)

Query: 349 GHGGFGQVYKGTLHNSKT--EVAVKRISNESKQGV---REFVSEIATIGRLRHRNLVQLV 403
           G G +G+VYK    N K   E A+K+   + +Q     +    EIA +  L+H N+V LV
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 404 GWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK-----------IIKGVAS 450
                  D  + L++D+  +             ++ + ++ K           ++  + +
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLW---------QIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPATT--RVV 504
           G+ YLH  +   V+HRD+K +N+L+  E       K+GD GLA+L+     P      VV
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 505 GTLGYLAPE 513
            T+ Y APE
Sbjct: 177 VTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYK     +   +A+K+I  E + +GV    + EI+ +  ++H N+V+L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLHEGYEQ 461
              +  L LV+++     LD  L     +  ++ +  ++IK     +  G+ Y H     
Sbjct: 70  VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---H 121

Query: 462 VVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
            V+HRD+K  N+L+D   N  KL DFGLA+ +       T  VV TL Y APE     + 
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRH 180

Query: 521 -SASSDVFAFGALLLEVACGRRPI 543
            S   D+++ G +  E+   ++P+
Sbjct: 181 YSTPVDIWSVGCIFAEMV-NQKPL 203

Length = 294

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 9/196 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV-SEIATIGRLRHRNLVQLVGWC 406
           +G G  G V      +S  +VAVK + +  KQ  RE + +E+  +   +H+N+V++    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
               +L ++ +F+  G+L   +    +  LN EQ   + + V   L YLH    Q VIHR
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHS---QGVIHR 141

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           D+K+ ++LL  +   KL DFG          P    +VGT  ++APE           D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 527 FAFGALLLEVACGRRP 542
           ++ G +++E+  G  P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 41/220 (18%)

Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRIS-NESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK +  + +++ + + VSE+  +  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P   + ++     
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              VA G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN- 198

Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 199 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 71.3 bits (174), Expect = 3e-13
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 13/202 (6%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQL 402
           +LLG G FG+V       S    A+K +  E   +K  V   ++E   +   RH  L  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASGLLYLHEGYEQ 461
               + K  L  V +++  G L    F   +  +  E R +     + S L YLH G   
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAPETPRTGKS 520
            +++RD+K  N++LD + + K+ DFGL K  E  T+ AT +   GT  YLAPE       
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 521 SASSDVFAFGALLLEVACGRRP 542
             + D +  G ++ E+ CGR P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 9/196 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV-SEIATIGRLRHRNLVQLVGWC 406
           +G G  G VY      +  EVA+K++ N  +Q  +E + +EI  +   +H N+V  +   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
               +L +V +++A GSL   +    +  ++  Q   + +     L +LH      VIHR
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 139

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           D+K+ N+LL  + + KL DFG         +  +T +VGT  ++APE           D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 527 FAFGALLLEVACGRRP 542
           ++ G + +E+  G  P
Sbjct: 199 WSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHR 397
           +F+   +LG G FG+V       +    A+K +  +       V   + E   +      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 398 NLVQLVGWCRRKGD-LLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             +  +  C +  D L  V +++  G L   +     F EP+AV    +       ++ G
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE-------ISVG 113

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYL 510
           L +LH    + +I+RD+K  NV+LDSE + K+ DFG+ K  EH  +  TTR   GT  Y+
Sbjct: 114 LFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYI 168

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
           APE         S D +A+G LL E+  G+ P +
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIAT-IGRLRHRNLVQ 401
           +++G G FG+V            AVK +  ++   K+  +  ++E    +  ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L    +    L  V D++  G L   L     F EP+A      RF   + +AS L YLH
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA------RFYAAE-IASALGYLH 113

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGYLAPET 514
                 +I+RD+K  N+LLDS+ +  L DFGL K    G   +  T+   GT  YLAPE 
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEV 167

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
            R      + D +  GA+L E+  G  P  +R   E
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 11/206 (5%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           +    +F   Q +G G +G VYK    N+    A+K I  E  +       EI  +   +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           H N+V   G   R+  L +  +F   GSL D +    P   L+  Q   + +    GL Y
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYY 121

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET 514
           LH   +   +HRD+K +N+LL    + KL DFG++      T       +GT  ++APE 
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEV 177

Query: 515 P---RTGKSSASSDVFAFGALLLEVA 537
               R G  +   D++A G   +E+A
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 10/211 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           LG G +  V+KG    ++  VA+K I  E ++G     + E++ +  L+H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
             +  L LV++++ +  L  +L D    +++       +  +  GL Y H+   + ++HR
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHR 127

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-- 524
           D+K  N+L++ +   KL DFGLA+     T   +  VV TL Y  P+    G +  S+  
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV-LLGSTEYSTPI 185

Query: 525 DVFAFGALLLEVACGRRPIETRALPEELVLV 555
           D++  G +L E+A GR       + EEL L+
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 66/218 (30%), Positives = 111/218 (50%), Gaps = 17/218 (7%)

Query: 346 QLLGHGGFGQVY---KGTLHNSKTEVAVKRISNESKQGVREFVS---EIATIGRLRHRNL 399
           ++LG G FG+V+   K T  ++    A+K +   + + VR+ V    E   +  + H  +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFI 60

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGVASGLLYLHE- 457
           V+L    + +G L L+ DF+  G L + L    K V+  E+  K  +  +A  L +LH  
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHSL 117

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
           G    +I+RD+K  N+LLD E + KL DFGL+K        A +   GT+ Y+APE    
Sbjct: 118 G----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNR 172

Query: 518 GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
              + S+D ++FG L+ E+  G  P + +   E + ++
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 21/205 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSE---IATIGRLRHRNLVQ 401
           LG G FG+V       +    A+K +      ++  V   + E     T    RH  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 402 LVGWCRRKGDLLLVYDFMANGSL----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           L    + +  +  V ++ A G L     + +F EP+AV            V  GL YLHE
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-------YAACVVLGLQYLHE 119

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
                +++RD+K  N+LLD+E   K+ DFGL K    G    T+   GT  +LAPE    
Sbjct: 120 ---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTE 175

Query: 518 GKSSASSDVFAFGALLLEVACGRRP 542
              + + D +  G L+ E+  G  P
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 11/201 (5%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQL 402
           +LLG G FG+V       +    A+K +  E   +K  V   V+E   +   RH  L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
               +    L  V ++ ANG    F     +       RF   + + S L YLH    + 
Sbjct: 61  KYAFQTHDRLCFVMEY-ANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS---RD 115

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAPETPRTGKSS 521
           V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YLAPE        
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 522 ASSDVFAFGALLLEVACGRRP 542
            + D +  G ++ E+ CGR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRN 398
           F   ++LG GGFG+V    +  +    A K++  +    ++G    ++E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-------FDEPKAVLNWEQRFKIIKGVASG 451
           +V L      K  L LV   M  G L   +       FDE +A+    +       +  G
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-------LCCG 114

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYL 510
           L  L     + +++RD+K  N+LLD   + ++ D GLA     G    T R  VGT+GY+
Sbjct: 115 LEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYM 168

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           APE     K + S D +  G L+ E+  G+ P   R
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 7/195 (3%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G V   T+ +S   VAVK++    +Q      +E+  +   +H N+V++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +F+  G+L   +       +N EQ   +   V   L  LH    Q VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRD 141

Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           +K+ ++LL  +   KL DFG          P    +VGT  ++APE           D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 528 AFGALLLEVACGRRP 542
           + G +++E+  G  P
Sbjct: 201 SLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LRHRNLVQ 401
           +++G G FG+V      +  +  AVK +  ++   K+     ++E   + + L+H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L    +    L  V D++  G L   L     F EP+A      RF   + VAS + YLH
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA------RFYAAE-VASAIGYLH 113

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP--ATTRVVGTLGYLAPET 514
                 +I+RD+K  N+LLDS+ +  L DFGL K    G  P   T+   GT  YLAPE 
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEV 167

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
            R      + D +  GA+L E+  G  P  +R
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 27/209 (12%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIA-TIGRLRHRNLVQ----- 401
           +G G FGQVY+    +++   A+K +S   K+ V +   E+A TIG    RN++      
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK--KEIVAK--KEVAHTIGE---RNILVRTLLD 53

Query: 402 ----LVGW---CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
               +VG     +   DL LV D+M+ G L   L  E +     E R K    +A  +L 
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFY--IAELVLA 108

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET 514
           L   ++  +++RD+K  N+LLD+  +  L DFGL+K      N  T    GT  YLAPE 
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEV 167

Query: 515 PRTGKS-SASSDVFAFGALLLEVACGRRP 542
               K  +   D ++ G L+ E+ CG  P
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 45/117 (38%), Positives = 63/117 (53%), Gaps = 13/117 (11%)

Query: 429 FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL 488
           F EP AV    +       +A GL +LH    + +I+RD+K  NV+LDSE + K+ DFG+
Sbjct: 98  FKEPHAVFYAAE-------IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 147

Query: 489 AKLYEHGTNPATTRV-VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
            K  E+  +  TT+   GT  Y+APE         S D +AFG LL E+  G+ P E
Sbjct: 148 CK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 33/226 (14%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES------KQGVR---EFVSEIATIGRLRHRN 398
           LG G F  +YKG L        V      S          R    F    + + +L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV-LNWEQRFKIIKGVASGLLYLHE 457
           LV+L G C R  + ++V +++  G LD FL  E   V L+W  +  + K +AS L YL  
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118

Query: 458 GYEQVVIHRDVKASNVLL-DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY------- 509
             ++ ++H +V   N+L+    LN     F   KL    ++P     V +          
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPF--IKL----SDPGIPITVLSREERVERIPW 170

Query: 510 LAPETPRTGKSSASS--DVFAFGALLLEVAC-GRRPIETRALPEEL 552
           +APE  R G++S +   D ++FG  LLE+   G  P+ T +  E+ 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 37/94 (39%), Positives = 55/94 (58%), Gaps = 1/94 (1%)

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYL 510
           LL +H  + + +IHRD+K++N+LL S    KLGDFG +K+Y    +    R   GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
           APE  R    S  +D+F+ G LL E+   +RP +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQL 402
           +LLG G FG+V       +    A+K +  E   +K  V   ++E   +   RH  L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRF---KIIKGVASGLLY 454
               +    L  V ++   G L   L     F E +A      RF   +I+    S L Y
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------RFYGAEIV----SALGY 110

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAPE 513
           LH      V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YLAPE
Sbjct: 111 LHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 165

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
                    + D +  G ++ E+ CGR P   +
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRH 396
           TN +   Q +G G FG V       +   VA+K+I       V  +    E+  +  LRH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 397 RNLVQLVG-WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF--KIIKGVASGLL 453
            N++ L   +     D+  V + +    L   L   P      E++F    +  +  GL 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP-----LEKQFIQYFLYQILRGLK 122

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           Y+H      V+HRD+K SN+L++   + K+ DFGLA++ +    P  T  V T  Y APE
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRYYRAPE 175

Query: 514 TPRT-GKSSASSDVFAFGALLLEVACGR 540
              T  K     D+++ G +  E+  G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 15/212 (7%)

Query: 341 NFSAKQLLGHGGFGQVY---KGTLHNSKTEVAVK---RISNESKQGVREFV-SEIATIGR 393
           NF   ++LG G +G+V+   K   H++    A+K   + +   K    E   +E   +  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 394 LRHRN-LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGL 452
           +R    LV L    +    L L+ D++  G L + L+       + E R  I + V + L
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLA-L 118

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            +LH+     +I+RD+K  N+LLDSE +  L DFGL+K +            GT+ Y+AP
Sbjct: 119 DHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 513 ETPRTGKSSASS--DVFAFGALLLEVACGRRP 542
           E  R G        D ++ G L  E+  G  P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 40/224 (17%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--------ESKQGVRE----FVS--EIATIGR 393
           LG G +G+V K     +   VA+K++          + +Q V      F +  E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           ++H N++ LV        + LV D MA   L   +  + K  L   Q   I+  + +GL 
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV--DRKIRLTESQVKCILLQILNGLN 133

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-------------- 499
            LH+ Y    +HRD+  +N+ ++S+   K+ DFGLA+ Y  G  P               
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY--GYPPYSDTLSKDETMQRRE 188

Query: 500 --TTRVVGTLGYLAPETPR-TGKSSASSDVFAFGALLLEVACGR 540
             T++VV TL Y APE      K   + D+++ G +  E+  G+
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 16/199 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           LG G +  VYKG    +   VA+K IS ++++GV    + E + +  L+H N+V L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---FKIIKGVASGLLYLHEGYEQVV 463
             K  L  V+++M +  L  ++   P  +  +  R   F++++G+A    Y+H    Q +
Sbjct: 73  HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA----YIHG---QHI 124

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSAS 523
           +HRD+K  N+L+      KL DFGLA+     +   ++ VV TL Y  P+    G +  S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV-LLGATDYS 182

Query: 524 S--DVFAFGALLLEVACGR 540
           S  D++  G + +E+  G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 22/207 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G V       +  +VA+K+I+N  +++   +  + EI  +  L H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 406 ----CRRK-GDLLLVYDFMANGSLDSFLFD---EPKAVLNWEQRFKIIKGVASGLLYLHE 457
                R    D+ +VY+ M     D+ L       + + +   ++ + + +  GL Y+H 
Sbjct: 73  MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLRGLKYIHS 126

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP-R 516
                V+HRD+K SN+LL++  + K+ DFGLA+          T  V T  Y APE    
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 517 TGKSSASSDVFAFGALLLEVACGRRPI 543
             + + + DV++ G +  E+  GR+P+
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 15/208 (7%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           +   +++   Q +G G +G VYK    ++    AVK I  E          EI  +   +
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64

Query: 396 HRNLVQLVG--WCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGL 452
           H N+V   G    R K  L +  ++   GSL D +    P + L   Q   + +    GL
Sbjct: 65  HCNIVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGL 119

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            YLH    +  +HRD+K +N+LL    + KL DFG+A      T       +GT  ++AP
Sbjct: 120 AYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAP 175

Query: 513 ETP---RTGKSSASSDVFAFGALLLEVA 537
           E     + G  +   D++A G   +E+A
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRN--LV 400
           ++LG G FG+V    L       AVK +  +       V   + E   +  L   N  L 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-LAWENPFLT 59

Query: 401 QLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
            L    + K  L  V +F+  G L     D   FD  +A     +       +  GL +L
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE-------IVCGLQFL 112

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H      +I+RD+K  NV+LD + + K+ DFG+ K    G N A+T   GT  Y+APE  
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEIL 168

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
           +  K + S D ++FG LL E+  G+ P
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 10/151 (6%)

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H  LV L    + +  L  V +++  G L  F     + +     RF   + ++  L YL
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAE-ISLALNYL 112

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGYLAPE 513
           HE   + +I+RD+K  NVLLDSE + KL D+G+ K    G  P   T+   GT  Y+APE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 166

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
             R      S D +A G L+ E+  GR P +
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 29/212 (13%)

Query: 348 LGHGGFGQVYKGTLHN-SKTEVAVKRIS--NESKQGVREFVSEIATIGRLRHRNLVQLVG 404
                   + K   H  + T VAVK+I+  + SK+ ++    EI T  +L+H N++  V 
Sbjct: 10  FEDLMIVHLAK---HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 405 WCRRKGDLLLVYDFMANGSLDSFL---FDE--PKAVLNWEQRFKIIKGVASGLLYLH-EG 458
                 +L +V   MA GS +  L   F E  P+  + +     I+K V + L Y+H +G
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIHSKG 121

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPA-----TTRVVGTLGYLAP 512
           +    IHR VKAS++LL  +    L     +  + +HG             V  L +L+P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 513 ETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           E  +      +  SD+++ G    E+A G  P
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 28/210 (13%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--------SKQGVREFVSEIATIGRLRHR 397
           ++LG G FG+V+   L  +    A+K +  +            V + V  +A      H 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHP 56

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGL 452
            L  L    + K +L  V +++  G L   +     FD P+A     +       +  GL
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE-------IICGL 109

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            +LH    + +++RD+K  N+LLD++ + K+ DFG+ K    G +  T    GT  Y+AP
Sbjct: 110 QFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAP 165

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E     K + S D ++FG LL E+  G+ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 16/199 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           LG G +  VYKG    +   VA+K I  E ++G     + E + +  L+H N+V L    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---FKIIKGVASGLLYLHEGYEQVV 463
             K  L LV++++ +  L  ++ D    +     R   F++++G+A    Y H+   + V
Sbjct: 73  HTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA----YCHQ---RRV 124

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS--S 521
           +HRD+K  N+L+      KL DFGLA+     +   +  VV TL Y  P+    G +  S
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDV-LLGSTEYS 182

Query: 522 ASSDVFAFGALLLEVACGR 540
            S D++  G +  E+A GR
Sbjct: 183 TSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 22/215 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LRHRNLVQ 401
           +++G G FG+V        +   AVK +  ++   K+  +  +SE   + + ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L    +    L  V D++  G L   L     F EP+A      RF   + +AS L YLH
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA------RFYAAE-IASALGYLH 113

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL-YEHGTNPATTRVVGTLGYLAPETP 515
                 +++RD+K  N+LLDS+ +  L DFGL K   EH  N  T+   GT  YLAPE  
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVL 168

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
                  + D +  GA+L E+  G  P  +R   E
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 29/224 (12%)

Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG VYKG       N K  VA+K +  N S +  +E + E   +  +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLYL 455
           +L+G C     + LV   M  G L  ++ +       + +LNW  +      +A G+ YL
Sbjct: 73  RLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYL 125

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY---EHGTNPATTRVVGTLGYLAP 512
            E     ++HRD+ A NVL+ S  + K+ DFGLA+L    E   +    +V   + ++A 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMAL 180

Query: 513 ETPRTGKSSASSDVFAFGALLLEVAC-GRRP---IETRALPEEL 552
           E+    + +  SDV+++G  + E+   G +P   I  R +P+ L
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 38/225 (16%)

Query: 341 NFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRL 394
            +   + LG G +G V       T  + +  VA+K+I+N    K   +  + E+  +   
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET--SEEETVAIKKITNVFSKKILAKRALRELKLLRHF 58

Query: 395 R-HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFK----- 443
           R H+N+  L        D+ +V+    N     +L++E        ++   Q        
Sbjct: 59  RGHKNITCLY-------DMDIVFPGNFNEL---YLYEELMEADLHQIIRSGQPLTDAHFQ 108

Query: 444 -IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE--HGTNPA- 499
             I  +  GL Y+H      V+HRD+K  N+L++++   K+ DFGLA+ +    G N   
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 500 TTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPI 543
            T  V T  Y APE   + +S + + DV++ G +L E+  GR+P+
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 25/217 (11%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRN 398
            +   + +G G +G V       S  +VA+K+I +        +  + E+  +   +H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 399 LVQLVGWCRRKG----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF--KIIKGVASGL 452
           ++ +    R  G    D+ +V D M +  L   +  +        + F  ++++G    L
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRG----L 120

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY-----EHGTNPATTRVVGTL 507
            Y+H      VIHRD+K SN+L++ +   ++GDFG+A+       EH      T  V T 
Sbjct: 121 KYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY--FMTEYVATR 175

Query: 508 GYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPI 543
            Y APE   +  + + + D+++ G +  E+  GRR +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.6 bits (154), Expect = 6e-11
 Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 9/196 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G VY      +  EVA+K+++ + +      ++EI  +   ++ N+V  +    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +++A GSL   +    +  ++  Q   + +     L +LH      VIHRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRD 140

Query: 468 VKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           +K+ N+LL  + + KL DFG  A++    +  +T  +VGT  ++APE           D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 527 FAFGALLLEVACGRRP 542
           ++ G + +E+  G  P
Sbjct: 199 WSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGY 509
           L +LHE     +I+RD+K  NVLLD+E + KL D+G+ K    G  P   T+   GT  Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNY 162

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
           +APE  R      S D +A G L+ E+  GR P +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 43/225 (19%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV-REFVSEIATIGRLRHRNL 399
            +     +G G +G V   T   +  +VA+K+IS    Q   +  + EI  + R +H N+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 400 VQLVGWCRRKG-----DLLLVYDFM-------------ANGSLDSFLFDEPKAVLNWEQR 441
           + ++   R        D+ +V + M             +N  +  FL+            
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY------------ 113

Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPA 499
            +I++G    L Y+H      V+HRD+K SN+LL++  + K+ DFGLA++   EH     
Sbjct: 114 -QILRG----LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 500 TTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPI 543
            T  V T  Y APE     K  + + D+++ G +L E+    RP+
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 24/216 (11%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT----IGRLRHRNLVQ 401
           +++G G FG+V            AVK +  +     +E    +A     +  ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L    +    L  V DF+  G L   L     F EP+A      RF   + +AS L YLH
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA------RFYAAE-IASALGYLH 113

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGYLAPET 514
                 +++RD+K  N+LLDS+ +  L DFGL K    G   +  TT   GT  YLAPE 
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEV 167

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
            R      + D +  GA+L E+  G  P   R + E
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 14/198 (7%)

Query: 351 GGFGQVYKGTLHNSKTEVAVKRI---SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           G FG VY     ++    A+K +      +K  V    +E A +        V  + +  
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 408 RKGD-LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
           +  D L LV +++  G   S +        +W +++  I  V  G+  LH+   + +IHR
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ---RGIIHR 121

Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           D+K  N+L+D   + KL DFGL++           + VGT  YLAPET         SD 
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYLAPETILGVGDDKMSDW 176

Query: 527 FAFGALLLEVACGRRPIE 544
           ++ G ++ E   G  P  
Sbjct: 177 WSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 64.3 bits (156), Expect = 8e-11
 Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 40/241 (16%)

Query: 326 GPQRYSYQELKQATNNFSAKQLLG---HGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR 382
           GP   +  +LK      +  +++     G FG+++   L  S  E   +R  N + QG  
Sbjct: 131 GPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKP 190

Query: 383 ------------------EFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV---YDFMAN 421
                             +  +EI  +GRL H N++++    R + +  ++   YDF   
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF--- 247

Query: 422 GSLDSFLFDEPKAVLNWE------QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL 475
             L SF++DE     +W+      Q   I+K +   + Y+H+   + +IHRD+K  N+ L
Sbjct: 248 -DLYSFMYDEA---FDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300

Query: 476 DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLE 535
           + +    LGDFG A  +E          VGT+   +PE          +D+++ G +LL+
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360

Query: 536 V 536
           +
Sbjct: 361 M 361

Length = 501

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 28/229 (12%)

Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIG 392
           + L   T+ +   + +G G +G+VYK T     +  AVK I +       E  +E   + 
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQ 73

Query: 393 RL-RHRNLVQLVGWCRRK-----GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK--- 443
            L  H N+V+  G   +      G L LV +    GS+   +    K +L   QR     
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAM 129

Query: 444 ---IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPA 499
              I+ G   GL +LH      +IHRDVK +N+LL +E   KL DFG+ A+L        
Sbjct: 130 ISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186

Query: 500 TTRVVGTLGYLAPETPRTGKSSASS-----DVFAFGALLLEVACGRRPI 543
           T+  VGT  ++APE     +    S     DV++ G   +E+  G  P+
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 14/203 (6%)

Query: 346 QLLGHGGFGQVY----KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           +LLG G FG+V     K T      ++  K +   +K  V   ++E   +   RH  L  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASGLLYLHEGYE 460
           L    +    L  V ++   G L    F   +  +  E R +     + S L YLH   E
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHS--E 114

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAPETPRTGK 519
           + V++RD+K  N++LD + + K+ DFGL K  E   + AT +   GT  YLAPE      
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 520 SSASSDVFAFGALLLEVACGRRP 542
              + D +  G ++ E+ CGR P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 19/212 (8%)

Query: 346 QLLGHGGFGQVYKGTLH--NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQL 402
           Q +G+G FG+V    ++       V VK + +N S +   EF+ +      L+H N++Q 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWE--QRFKIIKGVASGLLYLHEGYE 460
           +G C      LLV+++   G L S+L  E     N +     ++   +A+G+ ++H   +
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT--RVVGTLGYLAPE--TPR 516
              +H D+   N  L S+L  K+GD+G+     +  +   T       L +LAPE     
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 517 TGKSSAS-----SDVFAFGALLLEV-ACGRRP 542
            G    +     S+V+A G  L E+     +P
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 342 FSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRH 396
           F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV-----LNWEQRFKIIKGVASG 451
            ++ +L+G C     + L+   M  G L  ++ +    +     LNW  +      +A G
Sbjct: 69  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---TLG 508
           + YL E     ++HRD+ A NVL+ +  + K+ DFGLAKL   G +       G    + 
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPIK 176

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 45/135 (33%), Positives = 69/135 (51%), Gaps = 10/135 (7%)

Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           L LV +++  G L  F     + +     RF   + +   L +LHE   + +I+RD+K  
Sbjct: 71  LFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAE-ICIALNFLHE---RGIIYRDLKLD 125

Query: 472 NVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGYLAPETPRTGKSSASSDVFAF 529
           NVLLD++ + KL D+G+ K    G  P   T+   GT  Y+APE  R  +   S D +A 
Sbjct: 126 NVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182

Query: 530 GALLLEVACGRRPIE 544
           G L+ E+  GR P +
Sbjct: 183 GVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 61.3 bits (148), Expect = 3e-10
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 9/196 (4%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +++A GSL   +    +  ++  Q   + +     L +LH      VIHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141

Query: 468 VKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           +K+ N+LL  + + KL DFG  A++    +    + +VGT  ++APE           D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 527 FAFGALLLEVACGRRP 542
           ++ G + +E+  G  P
Sbjct: 200 WSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 64/224 (28%), Positives = 111/224 (49%), Gaps = 28/224 (12%)

Query: 348 LGHGGFGQVYKGTLH-----------NSKTEVAVKRISNESKQGVREFVSEIATIGR-LR 395
           LG G   Q+Y G L+             K    + ++ + S + +     E A++ R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H+++V L G C R  + ++V +F+  G LD F+  +   VL    +FK+ K +AS L YL
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYL 121

Query: 456 HEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEHGTNPATT----RVVGTLGYL 510
               ++ ++H +V   N+LL  E ++G+ G F   KL + G  P T       V  + ++
Sbjct: 122 E---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGI-PITVLSRQECVERIPWI 175

Query: 511 APETPRTGKS-SASSDVFAFGALLLEVAC--GRRPIETRALPEE 551
           APE     K+ S ++D ++FG  L E+ C  G  P++ + L E+
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEI-CYNGEIPLKDKTLAEK 218

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLV 403
           ++G GGFG+VY     ++    A+K +  +    KQG         T+  L  R ++ LV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNERIMLSLV 51

Query: 404 --GWC----------RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
             G C               L  + D M  G L   L  +       E RF   + +  G
Sbjct: 52  STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATE-IILG 109

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L ++H  +   V++RD+K +N+LLD   + ++ D GLA  +      A+   VGT GY+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163

Query: 512 PETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           PE  + G +  +S+D F+ G +L ++  G  P
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 345 KQLLGHGGFGQVY--KGTLHNSKTEVAV-KRIS------NESKQGVREFVSEIATIGRLR 395
           +Q LG G FG VY  K     ++  + V K I       NE+ Q  +E       + +L 
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLD 60

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H  +V+       +    ++ ++     LD    +E K         ++ +     LL +
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLD-CKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H  +++ ++HRD+KA N+ L + L  K+GDFG+++L     + ATT   GT  Y++PE  
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-FTGTPYYMSPEAL 177

Query: 516 RTGKSSASSDVFAFGALLLEVAC 538
           +     + SD+++ G +L E+ C
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 7e-10
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRN 398
           +++   + LG G +  VYKG    +   VA+K I  + ++G     + E + +  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V L      K  L LV++++ +  L  ++   P  +     +  + + +  GL Y+H+ 
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQR 122

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           Y   ++HRD+K  N+L+      KL DFGLA+     ++  +  VV TL Y  P+    G
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDV-LLG 177

Query: 519 KSSASS--DVFAFGALLLEVACG 539
            +  S+  D++  G + +E+  G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 33/224 (14%)

Query: 340 NNFSAKQLLGHGGFGQVY------KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR 393
            +F  K L+G G FG+V        G ++  K    +K+    +++ V  F  E   +  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV---MKKSVLLAQETVSFFEEERDILSI 57

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL------FDEPKAVLNWEQRFKIIKG 447
                + QL    + K +L LV ++   G L S L      FDE  A      +F +   
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA------QFYL--- 108

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGT 506
            A  +L +H  ++   +HRD+K  NVL+D   + KL DFG  A+L  +    +    VGT
Sbjct: 109 -AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP-VGT 166

Query: 507 LGYLAPE--TPRTGKSSASSDV----FAFGALLLEVACGRRPIE 544
             Y+APE  T   G    +  V    ++ G +  E+  GR P  
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (146), Expect = 9e-10
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 19/211 (9%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVG 404
           +G G FG+V +    +++   A+K I      S+  V   ++E   + ++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 405 WCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             +    L LV  F+  G L   L     FD  +A      RF      A  L  L   +
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYT----AELLCALENLH 110

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
           +  VI+RD+K  N+LLD + +  L DFGL KL     +   T   GT  YLAPE      
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHG 169

Query: 520 SSASSDVFAFGALLLEVACGRRPIETRALPE 550
            + + D +  G LL E+  G  P     + E
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 19/217 (8%)

Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSK-TEVAVKRISNES---KQGVREFVSEI 388
           ++ K    +F+  + LG G FG+V   T  N     VA+KR        ++ V    SE 
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
             +  + H   V L G  + +  L LV +F+  G   +FL           +RF    G 
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--------RRNKRFPNDVGC 134

Query: 449 --ASGLLYLHEGYEQV-VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG 505
             A+ ++ + E  + + +++RD+K  N+LLD +   K+ DFG AK+ +      T  + G
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCG 190

Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           T  Y+APE         ++D +  G  + E+  G  P
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 17/213 (7%)

Query: 341 NFSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISNES---KQGVREFV-SEIATIGR 393
           NF   ++LG G +G+V+   K + H+S    A+K +   +   K    E   +E   +  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 394 LRHRN-LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
           +R    LV L    +    L L+ D++  G L + L    +     EQ  +I  G +   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L +LH+     +I+RD+K  N+LLDS  +  L DFGL+K +            GT+ Y+A
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 512 PETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           P+  R G      + D ++ G L+ E+  G  P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 51/224 (22%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G  G V+     +    VAVK+I     Q V+  + EI  I RL H N+V+      
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66

Query: 408 RKGDLLLVYDFMAN---------GSLDSF--------LFDEPKAVLNWEQRFK------I 444
                  VY+ +           GSL             +   A +  +           
Sbjct: 67  -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKL----YEHGTNPA 499
           +  +  GL Y+H      V+HRD+K +NV +++E L  K+GDFGLA++    Y H    +
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 500 TTRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGR 540
              V  T  Y +P    +P     +   D++A G +  E+  G+
Sbjct: 177 EGLV--TKWYRSPRLLLSPNNYTKAI--DMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 18/149 (12%)

Query: 351 GGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           G FG+VY G   N+    AVK +      +K  V +  +E   +   +   +V L    +
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 408 RKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
              ++ LV +++  G + S L     FDE  AV       K I  VA  L YLH      
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV-------KYISEVALALDYLHR---HG 124

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKL 491
           +IHRD+K  N+L+ +E + KL DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 49/220 (22%)

Query: 347 LLGHGGFGQVY------KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           ++G GGFG+VY       G ++  K  +  KRI  + KQG         T+  L  R ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKC-LDKKRI--KMKQG--------ETLA-LNERIML 48

Query: 401 QLV--GWC----------RRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFK 443
            LV  G C               L  + D M  G L   L     F E       E RF 
Sbjct: 49  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------EMRFY 102

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
             + +  GL ++H  +   V++RD+K +N+LLD   + ++ D GLA  +      A+   
Sbjct: 103 AAE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--- 155

Query: 504 VGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           VGT GY+APE  + G +  +S+D F+ G +L ++  G  P
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV---------SEIATI 391
           +    + +G G FG+V+      S+   A+K ++      + E +         +E   +
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMA------IPEVIRLKQEQHVHNEKRVL 55

Query: 392 GRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
             + H  +++L      +  L ++ +++  G L S+L +  +   N    F   + +   
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASE-IVCA 113

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L YLH    + +++RD+K  N+LLD E + KL DFG AK         T  + GT  YLA
Sbjct: 114 LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLA 166

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           PE  ++   + + D +A G L+ E+  G  P
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 45/196 (22%), Positives = 83/196 (42%), Gaps = 13/196 (6%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
            ++  + L  G  G+V+  T       V +K     +       + E   +  + H +++
Sbjct: 67  GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVI 120

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           ++           +V     +  L ++L    +  L  +Q   I K +  GL YLH    
Sbjct: 121 RMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLHA--- 175

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           Q +IHRDVK  N+ ++      +GD G A+       PA   + GT+   APE     K 
Sbjct: 176 QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVETNAPEVLARDKY 233

Query: 521 SASSDVFAFGALLLEV 536
           ++ +D+++ G +L E+
Sbjct: 234 NSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 16/212 (7%)

Query: 341 NFSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISN----ESKQGVREFVSEIATIGR 393
           NF   ++LG G +G+V+   K T H++    A+K +      +  + V    +E   +  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 394 LRHRN-LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
           +R    LV L    + +  L L+ D+++ G + + L+         E   +   G +   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILA 117

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L +LH+     +++RD+K  N+LLDSE +  L DFGL+K +       T    GT+ Y+A
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 512 PETPRT-GKSSASSDVFAFGALLLEVACGRRP 542
           PE  R  G    + D ++ G L+ E+  G  P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 15/206 (7%)

Query: 345 KQLLGHGGFG---QVYKGTLHNSKTEVAVKRISN----ESKQGVREFVSEIATIGRLRHR 397
            ++LG GG+G   QV K T  ++    A+K +       +++      +E   +  ++H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
            +V L+   +  G L L+ ++++ G L  F+  E + +   +     +  ++  L +LH+
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-PR 516
              Q +I+RD+K  N+LLD++ + KL DFGL K   H     T    GT+ Y+APE   R
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTIEYMAPEILMR 174

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
           +G   A  D ++ GAL+ ++  G  P
Sbjct: 175 SGHGKA-VDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 40/204 (19%)

Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P RY  Q L            +G G +GQV       +  +VA+K++S   +S 
Sbjct: 11  WEV---PDRY--QNL----------SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA 55

Query: 379 QGVREFVSEIATIGRLRHRNLVQLVG-WCRRKG-----DLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  + H N++ L+  +          D+ LV   M    L++ +  + 
Sbjct: 56  IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQ- 113

Query: 433 KAVLNWEQ-RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL--DSELNGKLGDFGLA 489
              L+ +  +F ++  +  GL Y+H      +IHRD+K SN+ +  D EL  K+ DFGLA
Sbjct: 114 --KLSDDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL--KILDFGLA 165

Query: 490 KLYEHGTNPATTRVVGTLGYLAPE 513
           +  +       T  V T  Y APE
Sbjct: 166 RHTDD----EMTGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 38/218 (17%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES----KQGVREFVSEIATIGRLRH 396
           +F   + LG G FG+V       +    A+K +        KQ V+    E + +  L H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSH 77

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL------------FDEPKAVLNWEQRFKI 444
             +V ++   + +  +  + +F+  G L + L            F   + VL +E     
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----- 132

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
                    YLH    + +I+RD+K  N+LLD++ + K+ DFG AK         T  + 
Sbjct: 133 ---------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLC 176

Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           GT  YLAPE  ++     + D +  G LL E   G  P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 35/205 (17%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLR-HRNLVQL-- 402
           +G G F +V K     +    A+K +    +S + V     EI  + RL  H N+++L  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65

Query: 403 VGWCRRKGDLLLV--------YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           V + R+ G L LV        Y+ +           E + V ++   ++++K     L +
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKG---RKRPLPEKR-VKSY--MYQLLKS----LDH 115

Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           +H  G    + HRD+K  N+L+  ++  KL DFG  + +Y     P  T  + T  Y AP
Sbjct: 116 MHRNG----IFHRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYISTRWYRAP 167

Query: 513 ETPRT-GKSSASSDVFAFGALLLEV 536
           E   T G      D++A G +  E+
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 9e-09
 Identities = 58/240 (24%), Positives = 94/240 (39%), Gaps = 48/240 (20%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE----SKQGVREFVSEIATIGRLR 395
           ++F   +++G G FG+V+     ++    A+K +         Q +    +E   +    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              +V+L    + +  L LV ++M  G L + L     F E  A      RF I    A 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA------RFYI----AE 109

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------------------LY 492
            +L L   ++   IHRD+K  N+L+D++ + KL DFGL K                  L+
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 493 EHGTNPATTR----------VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
                                VGT  Y+APE  R        D ++ G +L E+  G  P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 25/228 (10%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATI 391
           +L+    +F   +++G G FG+V      +SK   A+K +S     K+    F  E   I
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 392 GRLRHRN---LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIK 446
             + H N   +VQL    +    L +V ++M  G L + +  +D P+    W  RF   +
Sbjct: 97  --MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KW-ARFYTAE 150

Query: 447 GVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVV 504
            V   L  +H  G+    IHRDVK  N+LLD   + KL DFG   K+  +G     T  V
Sbjct: 151 -VVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AV 204

Query: 505 GTLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRAL 548
           GT  Y++PE  ++    G      D ++ G  L E+  G  P    +L
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 16/184 (8%)

Query: 386 SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
           SE+  +    H  +V+     +    LLL+ ++ + G L+  +    K  L +++     
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY---- 169

Query: 446 KGVASGLLY------LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-P 498
                GLL+      L E + + ++HRD+K++N+ L      KLGDFG +K Y    +  
Sbjct: 170 ---EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWV 558
             +   GT  YLAPE     + S  +D+++ G +L E+    RP +  +  E  ++   +
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQVL 284

Query: 559 WGKY 562
           +GKY
Sbjct: 285 YGKY 288

Length = 478

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 31/213 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR-------LRHRN 398
           +++G G +G V      ++  +VA+K+I++     V E VS+   I R       LRH +
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKIND-----VFEHVSDATRILREIKLLRLLRHPD 60

Query: 399 LVQ----LVGWCRRK-GDLLLVYDFMANGSLDSFLFDEPKAV--LNWEQRFKIIKGVASG 451
           +V+    ++   RR+  D+ +V++ M     +S L    KA   L  E     +  +   
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRA 115

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGY 509
           L Y+H      V HRD+K  N+L +++   K+ DFGLA++  + T  A   T  V T  Y
Sbjct: 116 LKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 510 LAPETPRT--GKSSASSDVFAFGALLLEVACGR 540
            APE   +   K + + D+++ G +  EV  G+
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 28/227 (12%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           ++F   +++G G FG+V    + +++   A+K I N+ +   R      A     R    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMK-ILNKWEMLKR------AETACFREERN 53

Query: 400 VQLVGWCR----------RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA 449
           V + G C+           +  L LV D+   G L + L      +     RF I    A
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI----A 109

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGTLG 508
             +L +H  ++   +HRD+K  NVLLD   + +L DFG   K+ + GT  ++   VGT  
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-AVGTPD 168

Query: 509 YLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           Y++PE  +      GK     D ++ G  + E+  G  P    +L E
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 19/226 (8%)

Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIAT 390
           ++L+    ++   +++G G FG+V      +S+   A+K +S     K+    F  E   
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 391 IGRLRHRN-LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIKG 447
           I    +   +VQL    +    L +V ++M  G L + +  +D P+    W + +     
Sbjct: 96  IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KWAKFY----- 147

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGT 506
            A  +L L   +   +IHRDVK  N+LLD   + KL DFG   K+ E G     T  VGT
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGT 206

Query: 507 LGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRAL 548
             Y++PE  ++    G      D ++ G  L E+  G  P    +L
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.4 bits (131), Expect = 2e-07
 Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 58/229 (25%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLRHRNLVQLV 403
           L+G GG G+VY          VA+K+I     E+    + F+ E      L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---------------FKIIKGV 448
             C     +     ++   +L S L    K+V  W++                  I   +
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLL----KSV--WQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG-----DFGLAK------------- 490
            + + Y+H    + V+HRD+K  N+LL     G  G     D+G A              
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILL-----GLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 491 ------LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALL 533
                  Y   T P   ++VGT  Y+APE      +S S+D++A G +L
Sbjct: 175 VDERNICYSSMTIPG--KIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Length = 932

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.0 bits (129), Expect = 2e-07
 Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 37/243 (15%)

Query: 332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVS 386
           Y + +   N +   + +G+G FG+V+      ++     K IS    +G++E      V 
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS---YRGLKEREKSQLVI 61

Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQR--F 442
           E+  +  L+H+N+V+ +     K +  L ++ +F   G L   +    K     E+    
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 443 KIIKGVASGLLYLHEGYE----QVVIHRDVKASNVLLDS-------------ELNG---- 481
            I + +   L Y H   +    + V+HRD+K  N+ L +              LNG    
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE--TPRTGKSSASSDVFAFGALLLEVACG 539
           K+GDFGL+K    G        VGT  Y +PE     T      SD++A G ++ E+  G
Sbjct: 182 KIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 540 RRP 542
           + P
Sbjct: 240 KTP 242

Length = 1021

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 18/180 (10%)

Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVG-WCRRKG-----DLLLVYDFM 419
           VAVK++S   +++   +    E+  +  + H+N++ L+  +  +K      D+ LV + M
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
                D+ L       L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+ 
Sbjct: 109 -----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 160

Query: 480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
             K+ DFGLA+     TN   T  V T  Y APE         + D+++ G ++ E+  G
Sbjct: 161 TLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 16/220 (7%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE----FVSEIATIGRLRH 396
           +F   +++G G FG+V    L N+    A+K I N+ +   R     F  E   +    +
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           + +  L    + + +L LV D+   G L + L      +     RF +    A  ++ + 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL----AEMVIAID 116

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGTLGYLAPETP 515
             ++   +HRD+K  N+L+D   + +L DFG   KL E GT  ++   VGT  Y++PE  
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEIL 175

Query: 516 RT-----GKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           +      GK     D ++ G  + E+  G  P    +L E
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 32/230 (13%)

Query: 323 LEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--E 376
           +E+G   ++    YQ LK           +G G  G V        +  VA+K++S   +
Sbjct: 13  VEIGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62

Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVG-WCRRKG-----DLLLVYDFMANGSLDSFLFD 430
           ++   +    E+  +  + H+N++ L+  +  +K      D+ +V + M     D+ L  
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQ 117

Query: 431 EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Query: 491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR 540
               GT+   T  V T  Y APE         + D+++ G ++ E+  G 
Sbjct: 175 --TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 38/221 (17%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----RE-----FVSEI 388
           + +   + +G G +G+VYK    N+   VA+K+   E  ++G+     RE      +SE 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 389 ATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNW 438
             I RL    ++ +  G    K  L LV++++ +  L  F+             K + ++
Sbjct: 61  IYIVRLLDVEHVEEKNG----KPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTN 497
              ++++KGVA    + H+     V+HRD+K  N+L+D +    K+ D GL + +     
Sbjct: 116 --MYQLLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166

Query: 498 PATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVA 537
             T  +V TL Y APE        S   D+++ G +  E++
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 21/227 (9%)

Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE----FVSEI 388
           ++L+    ++   +++G G FG+V +   H S  +V   ++ ++ +   R     F  E 
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIK 446
             +       +VQL    +    L +V ++M  G L + +  +D P+    W + +    
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFY---- 147

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVG 505
             A  +L L   +    IHRDVK  N+LLD   + KL DFG   K+ + G     T  VG
Sbjct: 148 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVG 205

Query: 506 TLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRAL 548
           T  Y++PE  ++    G      D ++ G  L E+  G  P    +L
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 50/174 (28%), Positives = 88/174 (50%), Gaps = 12/174 (6%)

Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
           F    + + ++ H +L  + G C R  + ++V +F+ +G LD  L  E K  +    +  
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKIT 121

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-PATTR 502
           + + +AS L YL    ++ ++H +V A N+LL + L    G     KL + G +  A +R
Sbjct: 122 VAQQLASALSYLE---DKNLVHGNVCAKNILL-ARLGLAEGTSPFIKLSDPGVSFTALSR 177

Query: 503 V--VGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVAC--GRRPIETRALPEE 551
              V  + ++APE    G S S ++D ++FG  LLE+ C  G  P++ R   E+
Sbjct: 178 EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-CFDGEVPLKERTPSEK 230

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 32/218 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNSK--TEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQL 402
           + +G G +G+V+K  + N K  ++ AVK I +       E  +E   +  L  H N+V+ 
Sbjct: 24  ETIGKGTYGKVFK--VLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 403 VGWCRRK----GD-LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK------IIKGVASG 451
            G   +K    GD L LV +    GS+     D  K  L   +R +      I+     G
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYL 510
           L +LH       IHRDVK +N+LL +E   KL DFG+ A+L        T+  VGT  ++
Sbjct: 137 LQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWM 191

Query: 511 APETPRTGKSSASS-----DVFAFGALLLEVACGRRPI 543
           APE     +   S+     DV++ G   +E+  G  P+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 8e-07
 Identities = 59/233 (25%), Positives = 89/233 (38%), Gaps = 46/233 (19%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLV 403
           LLG G  G+V+   L  +    A+K +  +    +  V+  ++E   +  L H  L  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ-RFKIIKGVASGLLYLH-EGYEQ 461
              + +  L LV D+   G L   L  +P   L+ E  RF   + V   L YLH  G   
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-VLLALEYLHLLGI-- 124

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV------------------ 503
             ++RD+K  N+LL    +  L DF L+K     ++     V                  
Sbjct: 125 --VYRDLKPENILLHESGHIMLSDFDLSKQ----SDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 504 --------------VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
                         VGT  Y+APE        ++ D +  G LL E+  G  P
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 24/207 (11%)

Query: 348 LGHGGFGQVYKGTLHNSK--TEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLV 403
           +G G +G VYK    + K   + A+K+I     S    RE    IA +  L+H N++ L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64

Query: 404 GWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY-----LH 456
                  D  + L++D+  +       F   +A    ++  ++ +G+   LLY     +H
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFH--RASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 457 EGYEQVVIHRDVKASNVLLDSE----LNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGYL 510
             +   V+HRD+K +N+L+  E       K+ D G A+L+     P      VV T  Y 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 511 APETPRTGKS-SASSDVFAFGALLLEV 536
           APE     +  + + D++A G +  E+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 38/231 (16%)

Query: 321 WELEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQV---YKGTLHNSKTEVAVKRI 373
           + +EVG   ++    YQ LK           +G G  G V   Y   L  +   VA+K++
Sbjct: 4   YSVEVGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAVLDRN---VAIKKL 50

Query: 374 SN--ESKQGVREFVSEIATIGRLRHRNLVQLVG-WCRRKG-----DLLLVYDFMANGSLD 425
           S   +++   +    E+  +  + H+N++ L+  +  +K      D+ LV + M     D
Sbjct: 51  SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----D 105

Query: 426 SFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGD 485
           + L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ D
Sbjct: 106 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 162

Query: 486 FGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           FGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+
Sbjct: 163 FGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 37/230 (16%)

Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+        Y++LKQ          +G G +G V       +  +VA+K++    +S+
Sbjct: 11  WEV-----PDRYRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE 55

Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+          R  D  LV  FM    L   +  E 
Sbjct: 56  LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEK 114

Query: 433 KAVLNWEQRFK-IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
            +    E R + ++  +  GL Y+H      +IHRD+K  N+ ++ +   K+ DFGLA+ 
Sbjct: 115 LS----EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR- 166

Query: 492 YEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGR 540
               T+   T  V T  Y APE        + + D+++ G ++ E+  G+
Sbjct: 167 ---QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 26/63 (41%), Positives = 37/63 (58%), Gaps = 3/63 (4%)

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           GL YLH      ++HRD+K  N+L++S    K+ DFGLA++ E   +   T+ V T  Y 
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171

Query: 511 APE 513
           APE
Sbjct: 172 APE 174

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 348 LGHGGFGQVYKGTLHNSK--TEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQL- 402
           +G G +G VYK    + K   E A+K+I     S    RE    IA +  L+H N++ L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64

Query: 403 -VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY-----LH 456
            V        + L++D+  +       F   +A    ++  ++ + +   LLY     +H
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFH--RASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 457 EGYEQVVIHRDVKASNVLLDSE----LNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGYL 510
             +   V+HRD+K +N+L+  E       K+ D G A+L+     P      VV T  Y 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 511 APETPRTGKS-SASSDVFAFGALLLEV 536
           APE     +  + + D++A G +  E+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 9/99 (9%)

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN---PATTRVV 504
           VA G+ +L     +  IHRDV A NVLL      K+ DFGLA+   + +N       R+ 
Sbjct: 221 VAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276

Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
             + ++APE+      +  SDV+++G LL E+ + G+ P
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)

Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 13  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 57

Query: 379 QGVREFVSEIATIGRLRHRNLVQLVG------WCRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 58  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 114

Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 115 QKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-- 168

Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 169 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 19/192 (9%)

Query: 366 TEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGS 423
           T V V+   + N +++ ++   +E+      RH N++           L ++  FMA GS
Sbjct: 26  TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85

Query: 424 LDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGK 482
            +S L       ++      I+ G   GL YLH+ GY    IHR++KAS++L+  +  G 
Sbjct: 86  ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGD--GL 139

Query: 483 LGDFGLAKLYEHGTNPATTRVV--------GTLGYLAPETPRTGKS--SASSDVFAFGAL 532
           +   GL+ LY    N    +VV          L +L+PE  R      +  SD+++ G  
Sbjct: 140 VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGIT 199

Query: 533 LLEVACGRRPIE 544
             E+A GR P +
Sbjct: 200 ACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 35/229 (15%)

Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY  Q L            +G G +G V        + +VAVK++S   +S 
Sbjct: 11  WEV---PERY--QNLTP----------VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL 55

Query: 379 QGVREFVSEIATIGRLRHRNLVQLV------GWCRRKGDLLLVYDFMANGSLDSFLFDEP 432
              R    E+  +  ++H N++ L+             ++ LV + M    L++ +  + 
Sbjct: 56  IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG-ADLNNIV--KC 112

Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SNV ++ +   ++ DFGLA+  
Sbjct: 113 QKLSDEHVQF-LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-- 166

Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
               +   T  V T  Y APE        + + D+++ G ++ E+  G+
Sbjct: 167 --QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 42/117 (35%), Positives = 54/117 (46%), Gaps = 22/117 (18%)

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK---------LYEHGTNPAT-- 500
           L YLH  Y   ++HRD+K  N+L+ S  + KL DFGL+K         LYE      T  
Sbjct: 114 LEYLHN-YG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 501 ---TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI--ETRALPEEL 552
               +V GT  Y+APE           D +A G +L E   G  P   +T   PEEL
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEEL 224

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 19/149 (12%)

Query: 412 LLLVYDFMANGSLDSFL--FDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           L LV D+   G L + L  F++  P+ +     RF +    A  +L +   ++   +HRD
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDM----ARFYL----AEMVLAIDSVHQLGYVHRD 127

Query: 468 VKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGTLGYLAPETPR-----TGKSS 521
           +K  NVLLD   + +L DFG   +L   GT   +   VGT  Y++PE  +      G+  
Sbjct: 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYG 186

Query: 522 ASSDVFAFGALLLEVACGRRPIETRALPE 550
              D ++ G  + E+  G  P    +L E
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 39/203 (19%)

Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG 380
           WEL   P+RY+            + + +G G +G V       +  +VA+K++S      
Sbjct: 11  WEL---PERYT------------SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS------ 49

Query: 381 VREFVSEIAT------IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKA 434
            R F SEI        +  L+H     ++G        +   +F     +  ++  + + 
Sbjct: 50  -RPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQK 108

Query: 435 VLNW---EQRFK-IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
           ++     E + + ++  +  GL Y+H      +IHRD+K  N+ ++ +   K+ DFGLA+
Sbjct: 109 IMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Query: 491 LYEHGTNPATTRVVGTLGYLAPE 513
              H     T  VV T  Y APE
Sbjct: 166 ---HADAEMTGYVV-TRWYRAPE 184

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 65/272 (23%), Positives = 110/272 (40%), Gaps = 67/272 (24%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRN 398
           F   + LG G FG+V      ++K   A+K +  +    +  V    +E   +    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLL 453
           +V+L    + K +L  V D++  G + S L     F E  A      RF I +   +   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA------RFYIAELTCA--- 113

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL---------AKLYEHGT-------- 496
            +   ++   IHRD+K  N+L+D + + KL DFGL         +K Y+ G         
Sbjct: 114 -VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172

Query: 497 ------NPATTR-----------------------VVGTLGYLAPET-PRTGKSSASSDV 526
                 +PA  R                       +VGT  Y+APE   RTG +    D 
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDW 231

Query: 527 FAFGALLLEVACGRRP-IETRALPEELVLVDW 557
           ++ G +L E+  G+ P +    L  ++ +++W
Sbjct: 232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT 506
           VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+ +Y+   +P   R    
Sbjct: 182 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK---DPDYVRKGDA 235

Query: 507 ---LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              L ++APE+      +  SDV++FG LL E+
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 7/105 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           +N    + LG G FG+V + T       ++   VAVK +   +    RE  +SE+  +  
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLN 437
           L +H+N+V L+G C   G +L++ ++   G L +FL  + +  LN
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLN 142

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 11/110 (10%)

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT 506
           VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+ +Y+   +P   R    
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK---DPDYVRKGDA 241

Query: 507 ---LGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRPIETRALPEEL 552
              L ++APET      +  SDV++FG LL E+ + G  P     + EE 
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS------NESKQGVREFV 385
           YQ LK           +G G  G V       +   VA+K++S        +K+  RE V
Sbjct: 18  YQNLK----------PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV 67

Query: 386 SEIATIGRLRHRNLVQLVG-WCRRKG-----DLLLVYDFMANGSLDSFLFDEPKAVLNWE 439
                +  + H+N++ L+  +  +K      D+ LV + M     D+ L    +  L+ E
Sbjct: 68  ----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMDLDHE 118

Query: 440 QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA 499
           +   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+    GT+  
Sbjct: 119 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 173

Query: 500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR 540
            T  V T  Y APE         + D+++ G ++ E+  G 
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 49/183 (26%), Positives = 75/183 (40%), Gaps = 61/183 (33%)

Query: 409 KGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYEQV 462
           K +L  V D++  G + S L     F+E  A      RF I + +   +  +H+ G+   
Sbjct: 73  KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA------RFYIAE-LTCAIESVHKMGF--- 122

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGL---------AKLYEHGTNPAT------------- 500
            IHRD+K  N+L+D + + KL DFGL         +K Y+ G +                
Sbjct: 123 -IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 501 ---------------TRV-----VGTLGYLAPET-PRTGKSSASSDVFAFGALLLEVACG 539
                           R      VGT  Y+APE   RTG +    D ++ G +L E+  G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ-LCDWWSVGVILYEMLVG 240

Query: 540 RRP 542
           + P
Sbjct: 241 QPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 45/249 (18%)

Query: 341 NFSAKQLLGHGGFGQVY----KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH 396
           +F + +++G G FG+V     K T H    ++ +++     K+ V    +E   +     
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKI-LRKADMLEKEQVGHIRAERDILVEADS 60

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
             +V++    + K +L L+ +F+  G + + L  +   +   E +F I    A  +L + 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYI----AETVLAID 115

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGL---------------------------- 488
             ++   IHRD+K  N+LLDS+ + KL DFGL                            
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 489 ------AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
                 A+ ++          VGT  Y+APE       +   D ++ G ++ E+  G  P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 543 IETRALPEE 551
             +   P+E
Sbjct: 236 FCSET-PQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT 506
           VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+ +Y+   +P   R    
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK---DPDYVRKGSA 236

Query: 507 ---LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              L ++APE+      +  SDV++FG LL E+
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.3 bits (107), Expect = 7e-05
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)

Query: 445 IKGVASGLL----YLH-EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG--TN 497
           +  VA  LL    Y+H EG    +IHRD+K  NVL++   +  LGDFG A  +  G  + 
Sbjct: 262 VTAVARQLLSAIDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWST 316

Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           P    + GT+   APE       + S D+++ G ++ E A
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 61/258 (23%)

Query: 340 NNFSAKQLLGHGGFGQVY----KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           ++F + +++G G FG+V     K T H     +   +I  ++    +E V+ I    R  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGH-----IYAMKILRKADMLEKEQVAHI----RAE 51

Query: 396 HRNLVQLVG-WCRR-------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
              LV+  G W  +       K +L L+ +F+  G + + L  +   +     +F I   
Sbjct: 52  RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYI--- 107

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL---------AKLYEHGT-N 497
            A  +L +   ++   IHRD+K  N+LLD++ + KL DFGL          + Y + T N
Sbjct: 108 -AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 498 PATT------------------------RVVGTLGYLAPETPRTGKSSASSDVFAFGALL 533
           P +                           VGT  Y+APE       +   D ++ G ++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 534 LEVACGRRPIETRALPEE 551
            E+  G  P  +   P+E
Sbjct: 227 YEMLIGYPPFCSET-PQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 4/122 (3%)

Query: 416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL 475
           Y    +  + + L D+    L           VA G+ +L     +  +HRD+ A NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270

Query: 476 DSELNGKLGDFGLAKLYEHGTNPATT-RVVGTLGYLAPETPRTGKSSASSDVFAFGALLL 534
                 K+ DFGLA+   H +N  +       + ++APE+      +  SDV+++G LL 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 535 EV 536
           E+
Sbjct: 331 EI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 3/97 (3%)

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
           I + V   + YLHE     +IHRD+KA N+ ++   +  LGDFG A              
Sbjct: 187 IERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR 540
            GT+   APE         + D+++ G +L E+A   
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 7/88 (7%)

Query: 348 LGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGRL-RHRNLV 400
           LG G FG+V + T H      S  +VAVK + + ++   ++  +SE+  +  L  H N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFL 428
            L+G C + G + ++ ++   G L  +L
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT-RVVGT 506
           VA+G+ +L     +  +HRD+ A NVL+      K+ DFGLA+     +N  +       
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           L ++APE+      +  SDV++FG LL E+
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173892 cd07308, lectin_leg-like, legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 55/249 (22%), Positives = 83/249 (33%), Gaps = 53/249 (21%)

Query: 26  FFPGFKDLSNNL----TLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVF 81
             P F D ++      T+ G   I  N I RLT D   + G  +    +  K+      F
Sbjct: 7   LSPPFLDDNDGEIGNWTVGGSTVITKNYI-RLTPDVPSQSGSLWSRVPIPAKD------F 59

Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSN----DLNGLPSQYLGLLNSTDIGNFSNHLF 137
                F+I        LGG G AF  +        L G P ++ GL              
Sbjct: 60  EIEVEFSIH---GGSGLGGDGFAFWYTEEPGSDGPLFGGPDKFKGL-------------- 102

Query: 138 AVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQ------DLSLKGGKA 191
           A+ FDT         ND      I+   ++ +      TD    +               
Sbjct: 103 AIFFDTYD-------NDGKGFPSISVFLNDGTKSYDYETDGEKLELASCSLKFRNSNAPT 155

Query: 192 ILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHN 251
            L     +   N L V +    S+       F V+   + ++  Y GFSA TG L+ +H+
Sbjct: 156 TLRISYLN---NTLKVDI--TYSEGNNWKECFTVEDVILPSQG-YFGFSAQTGDLSDNHD 209

Query: 252 VLGWSFKIN 260
           +L  S    
Sbjct: 210 IL--SVHTY 216

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 218

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.0 bits (97), Expect = 0.001
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 39/164 (23%)

Query: 396 HRNLVQL---VGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKG 447
           + N ++L   V   +     +L+ D++ +G L   L       E +         KII+ 
Sbjct: 68  NPNFIKLYYSVTTLK---GHVLIMDYIKDGDLFDLLKKEGKLSEAEVK-------KIIRQ 117

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAK------LYEHGTNPAT 500
           +   L  LH+     +IH D+K  NVL D   +   L D+GL K       Y+       
Sbjct: 118 LVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------- 167

Query: 501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
               GTL Y +PE  +      S D +A G L  E+  G+ P +
Sbjct: 168 ----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 23/202 (11%)

Query: 368 VAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLD 425
           V V+RI+ E  + + V     E+       H N+V          +L +V  FMA GS  
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87

Query: 426 SFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLG 484
             +       ++      I++GV   L Y+H  GY    +HR VKAS++L+   ++GK+ 
Sbjct: 88  DLICTHFMDGMSELAIAYILQGVLKALDYIHHMGY----VHRSVKASHILI--SVDGKVY 141

Query: 485 DFGLAKLYEHGTNPATTRVV--------GTLGYLAPETPRTGKS--SASSDVFAFGALLL 534
             GL        +    RVV          L +L+PE  +       A SD+++ G    
Sbjct: 142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 201

Query: 535 EVACGRRPIE----TRALPEEL 552
           E+A G  P +    T+ L E+L
Sbjct: 202 ELANGHVPFKDMPATQMLLEKL 223

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 8/112 (7%)

Query: 428 LFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG 487
           + +E +  L+ E        VA G+ +L     +  IHRD+ A N+LL      K+ DFG
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFG 259

Query: 488 LAKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           LA+   + +N       R+   + ++APE+      +  SDV+++G LL E+
Sbjct: 260 LARDIRNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 7/96 (7%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +   +    RE  +SE+  +  
Sbjct: 35  NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94

Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL 428
           L  H N+V L+G C   G  L++ ++   G L +FL
Sbjct: 95  LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 65/271 (23%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRN 398
           F   + LG G FG+V      ++    A+K +  +   ++  V    +E   +    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLL 453
           +V+L    + K +L  V D++  G + S L     F E  A      RF I    A   L
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA------RFYI----AELTL 112

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL---------AKLYEHGTN------- 497
            +   ++   IHRD+K  N+L+D + + KL DFGL         +K Y+ G++       
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 498 PA------------------------------TTRVVGTLGYLAPETPRTGKSSASSDVF 527
           P+                                 +VGT  Y+APE       +   D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232

Query: 528 AFGALLLEVACGRRPIETRALPE-ELVLVDW 557
           + G +L E+  G+ P       E +L +++W
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 57/262 (21%), Positives = 118/262 (45%), Gaps = 47/262 (17%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           +    ++    ++G+G FG VY+    ++  +VA+K++  + +   RE +     +  L 
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117

Query: 396 HRNLVQLVGW----CRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK---- 443
           H N++ L  +    C +K +    L +V +F+            P+ V  + + +     
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFI------------PQTVHKYMKHYARNNH 165

Query: 444 -----IIK----GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAKLYE 493
                ++K     +   L Y+H  +   + HRD+K  N+L+D   +  KL DFG AK   
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222

Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASS--DVFAFGALLLEVACGRRPIETRALPEE 551
            G    +   + +  Y APE    G ++ ++  D+++ G ++ E+  G      ++  ++
Sbjct: 223 AGQR--SVSYICSRFYRAPEL-MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279

Query: 552 LVLVDWVWGKYGEGRVLEVIDP 573
           LV +  V G   E + L+ ++P
Sbjct: 280 LVRIIQVLGTPTEDQ-LKEMNP 300

Length = 440

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 34/152 (22%), Positives = 62/152 (40%), Gaps = 19/152 (12%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV--QL 402
            +LL  G   +VY   L     +  +K   +  K   RE   E+A +  L  + L   ++
Sbjct: 3   IKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKV 58

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
           +      G   L+ +++   +LD          ++ E++  I + +A  L  LH+    V
Sbjct: 59  LASGESDGWSYLLMEWIEGETLDE---------VSEEEKEDIAEQLAELLAKLHQLPLLV 109

Query: 463 VIHRDVKASNVLLDSELNGKLG--DFGLAKLY 492
           + H D+   N+L+D      LG  D+  A   
Sbjct: 110 LCHGDLHPGNILVDD--GKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 0.002
 Identities = 19/59 (32%), Positives = 27/59 (45%), Gaps = 1/59 (1%)

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
           IHRD+K  N+LLD++ + KL DFGL   L +         +   L     +      SS
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 41/183 (22%), Positives = 64/183 (34%), Gaps = 63/183 (34%)

Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWE------QRFKIIKGVASGLLYLHEGYEQVVIH 465
           L L+ +F+  G L + L       + ++       RF +    A  +L +   ++   IH
Sbjct: 76  LYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYM----AECVLAIEAVHKLGFIH 124

Query: 466 RDVKASNVLLDSELNGKLGDFGLA-------------KLYEH--GTNPATTR-------- 502
           RD+K  N+L+D   + KL DFGL+             KL +     N    R        
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 503 -----------------------VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
                                   VGT  Y+APE           D ++ GA++ E   G
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244

Query: 540 RRP 542
             P
Sbjct: 245 WPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 16/95 (16%)

Query: 346 QLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNESKQGV-----REFVSEIATIGRL- 394
           ++LGHG FG+V + +       +S   VAVK +    K+G      +  +SE+  +  + 
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML----KEGATASEHKALMSELKILIHIG 68

Query: 395 RHRNLVQLVGWCRR-KGDLLLVYDFMANGSLDSFL 428
            H N+V L+G C +  G L+++ +F   G+L +FL
Sbjct: 69  NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	652
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
PLN00181	793	protein SPA1-RELATED; Provisional	99.87
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
PRK10345	210	hypothetical protein; Provisional	99.76
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
smart00090	237	RIO RIO-like kinase.	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	99.71
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
KOG3839	351	consensus Lectin VIP36, involved in the transport	99.31
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.22
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.19
KOG1243	690	consensus Protein kinase [General function predict	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.09
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
KOG3087	229	consensus Serine/threonine protein kinase [General	99.03
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.96
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.83
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.82
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	98.76
PRK09902	216	hypothetical protein; Provisional	98.52
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.48
COG4248	637	Uncharacterized protein with protein kinase and he	98.45
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.43
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.35
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.18
PF01636	239	APH: Phosphotransferase enzyme family This family	98.14
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.1
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.08
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.01
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.01
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.98
PLN02876	822	acyl-CoA dehydrogenase	97.93
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.89
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.84
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.7
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.65
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.6
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.59
PRK10593	297	hypothetical protein; Provisional	97.56
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.54
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.37
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.29
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.24
PRK05231	319	homoserine kinase; Provisional	97.2
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.01
PLN02236	344	choline kinase	96.8
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.65
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.51
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.34
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.02
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.98
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.94
PLN02756	418	S-methyl-5-thioribose kinase	95.84
KOG2270	520	consensus Serine/threonine protein kinase involved	95.83
COG2334	331	Putative homoserine kinase type II (protein kinase	95.79
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.7
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	95.64
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.53

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=1.6e-53  Score=422.79  Aligned_cols=231  Identities=49%  Similarity=0.753  Sum_probs=210.2

Q ss_pred             eeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC--CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCc
Q 038860           23 DELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT--SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGG  100 (652)
Q Consensus        23 ~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~--~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g  100 (652)
                      .+|+|++|.....+|+|+|+|.+..+|.|+||++.  .+++|||+|++||+||+..+++++||+|+|+|.|.+.....+|
T Consensus         1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~g   80 (236)
T cd06899           1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLGG   80 (236)
T ss_pred             CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCCC
Confidence            36999999876679999999999768999999998  8999999999999999999999999999999999987767889


Q ss_pred             CcEEEEEccCCCCC-CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCC
Q 038860          101 HGLAFTISPSNDLN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNS  179 (652)
Q Consensus       101 dGlaF~l~p~~~~~-~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~  179 (652)
                      |||||||+|....+ +..|++|||++.++.+++.+++|||||||++|.+++||++||||||+|++.|..+..+...    
T Consensus        81 dGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~~----  156 (236)
T cd06899          81 DGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDD----  156 (236)
T ss_pred             CeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeeccccc----
Confidence            99999999987555 6899999999988777788999999999999998889999999999999988776654321    


Q ss_pred             CcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCC-CCCCCeeeEEecCCcccccceEEEEecccccccccceeeccccc
Q 038860          180 TKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSS-KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFK  258 (652)
Q Consensus       180 ~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~-~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~  258 (652)
                         ...+.+|+.++|||+||+.+++|+|+++..+. +|..|+++..+||+.+|+++|||||||+||...+.|.|++|+|+
T Consensus       157 ---~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF~  233 (236)
T cd06899         157 ---GGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFS  233 (236)
T ss_pred             ---cccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEEE
Confidence               34478999999999999999999999998876 88999999999999999999999999999999999999999998


Q ss_pred             cc
Q 038860          259 IN  260 (652)
Q Consensus       259 ~~  260 (652)
                      +.
T Consensus       234 s~  235 (236)
T cd06899         234 SN  235 (236)
T ss_pred             cC
Confidence            64

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=6.8e-52  Score=412.63  Aligned_cols=231  Identities=47%  Similarity=0.727  Sum_probs=204.7

Q ss_pred             eeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC-CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC--CCCCC
Q 038860           23 DELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS-RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE--YPRLG   99 (652)
Q Consensus        23 ~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~-~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~--~~~~~   99 (652)
                      .+|+|+.| .+..+++++|+|.+..+|.|+||++.. +++|||||++||+|||..+++++||+|+|+|.|...  ....+
T Consensus         2 ~~F~~~~F-~~~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~~~   80 (236)
T PF00139_consen    2 VSFSFPSF-SNSSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSNNG   80 (236)
T ss_dssp             EEEEESSB-TTGTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSSS-
T ss_pred             ceEEcCCC-CCCCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCccC
Confidence            68999999 445899999999996699999999887 999999999999999999999999999999999643  56778


Q ss_pred             cCcEEEEEccCCCCC-CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCC
Q 038860          100 GHGLAFTISPSNDLN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDN  178 (652)
Q Consensus       100 gdGlaF~l~p~~~~~-~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~  178 (652)
                      ||||||||+|....+ ++.|++||+++.++.+.+.++.|||||||++|.+++||++||||||+|++.|..+.+++++   
T Consensus        81 ~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~---  157 (236)
T PF00139_consen   81 GDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYY---  157 (236)
T ss_dssp             BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE-------
T ss_pred             CCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCccccccccccc---
Confidence            999999999998655 6799999999988777778999999999999999999999999999999999888766533   


Q ss_pred             CCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccccccceeeccccc
Q 038860          179 STKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFK  258 (652)
Q Consensus       179 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~  258 (652)
                       .....++.+|+.++|||+||+.+++|+|+++....+|..|+++..+||+.+++++||||||||||.+.+.|.|++|+|+
T Consensus       158 -~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~F~  236 (236)
T PF00139_consen  158 -SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNSSKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWSFS  236 (236)
T ss_dssp             -EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETTTTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred             -ccccccccCCcEEEEEEEEcCCccEEEEEEecccCCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEEeC
Confidence             2236678899999999999999999999999886688899999999999999999999999999999999999999985

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-51  Score=429.36  Aligned_cols=271  Identities=49%  Similarity=0.833  Sum_probs=233.0

Q ss_pred             CCcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEee
Q 038860          326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW  405 (652)
Q Consensus       326 ~~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  405 (652)
                      ..+.|+|.++..||++|...++||+|+||.||+|...+ +..||||++.....+..++|.+|+.++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            46789999999999999999999999999999999987 48999998877654325669999999999999999999999


Q ss_pred             eeccC-eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          406 CRRKG-DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       406 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      |.+.+ +.+||||||++|+|.++|+.....+++|.+|++|+.++|+||+|||+.+...|+|||||++|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99998 59999999999999999987554379999999999999999999999888899999999999999999999999


Q ss_pred             eeccceeccc-CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhc
Q 038860          485 DFGLAKLYEH-GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYG  563 (652)
Q Consensus       485 DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  563 (652)
                      |||+|+.... ........ .||.+|+|||+...+..+.|+|||||||+|+||+||++|.+......+..+++|++..+.
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976543 22211111 799999999999999999999999999999999999999887665566669999999999


Q ss_pred             CCccccccccccc-cCCCH-HHH-HHhhccCCCCCCCC
Q 038860          564 EGRVLEVIDPKLN-AEYDQ-SQV-LMGELELPDTLRGP  598 (652)
Q Consensus       564 ~~~~~~~id~~l~-~~~~~-~~~-~~~~l~~~~~~~~p  598 (652)
                      ++.+.+++||++. +++.. .++ .+..+...|...+|
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~  336 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDP  336 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCC
Confidence            9999999999997 66663 222 23444444544444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=365.60  Aligned_cols=204  Identities=29%  Similarity=0.528  Sum_probs=185.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ...+|...+.||+|.||.||+|+++.++.+||||.+.+.  .+...+.+..|+.+|+.++|||||++++++...+.+|||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            346788889999999999999999999999999999776  556677789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC------CCeEEeeeccc
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE------LNGKLGDFGLA  489 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~------~~~kL~DFGla  489 (652)
                      ||||.+|+|..|++.  ...+++...+.++.||+.||++||   +++||||||||+||||+..      -.+||+|||+|
T Consensus        88 MEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999954  447999999999999999999999   7999999999999999865      45899999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      +.+...  ......+|++-|||||++..++|+.|+|+||+|++||++++|+.||+....
T Consensus       163 R~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  163 RFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            987643  344567999999999999999999999999999999999999999986544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.1e-45  Score=352.27  Aligned_cols=274  Identities=25%  Similarity=0.343  Sum_probs=219.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hh-HHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QG-VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      +.|+.+.++|+|+||.||+++.+++|+.||||++..... .. .+-.++|+++|++++|+|+|.++.+|..+..++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            357888999999999999999999999999999965433 33 3456899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ||+. ++.+-|.+.+ ..++...+.+++.|++.|+.|+|   +++++||||||+|||++.++.+||||||.|+.+.. ..
T Consensus        82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG  155 (396)
T ss_pred             ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence            9987 4444443333 35888999999999999999999   79999999999999999999999999999998764 34


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      ...+..+.|.+|+|||.+.+ -.|+...||||+||++.||++|++.|.+...-++..++....+.+.         |+..
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~---------prhq  226 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI---------PRHQ  226 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC---------HHHH
Confidence            45667788999999999888 6799999999999999999999999999888888887776665542         2211


Q ss_pred             cCCCHHHHHHhhccCC-CCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          577 AEYDQSQVLMGELELP-DTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~-~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                      .-|...+.... +.+| ....-|-.+..+.....+.|++++++.+||++|++|+
T Consensus       227 ~iF~~N~~F~G-v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~  279 (396)
T KOG0593|consen  227 SIFSSNPFFHG-VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE  279 (396)
T ss_pred             HHhccCCceee-eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence            11211111111 1122 2223334455566777899999999999999999764

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-44  Score=375.46  Aligned_cols=246  Identities=27%  Similarity=0.481  Sum_probs=210.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..|...+.||+|||+.||.+++..+|+.||+|++.+.   .....+...+|++|.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999999889999999999774   2334567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |+|++++|.+++.  .+.++++.+++.+++||+.||.|||   +++|+|||||..|++|++++++||+|||||..+..+.
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999984  5667999999999999999999999   7999999999999999999999999999999887543


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      . ...+.+|||.|+|||++.....+..+||||+||++|-||.|++||+.....+....+.                   .
T Consensus       173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------------------~  232 (592)
T KOG0575|consen  173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------------------L  232 (592)
T ss_pred             c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-------------------h
Confidence            3 4455799999999999999999999999999999999999999998743322211111                   1


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYF  631 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~  631 (652)
                      .+|.                .|.     ....++.||+.+|+.-+|.+|||      |+||
T Consensus       233 ~~Y~----------------~P~-----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  233 NEYS----------------MPS-----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             cCcc----------------ccc-----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            1221                122     23468899999999999999994      6677

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7e-44  Score=355.23  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=210.2

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-eeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-DLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~  419 (652)
                      .+..+.||+|..|+||++.++.+++.+|+|.+... .....+++.+|++++++.+||+||.++|.|...+ ++.++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            34578899999999999999999999999999544 3445678999999999999999999999999998 599999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++|+|+.++..  .+.+++...-+|+.++++||.|||+  +++||||||||+|||++..|++||+|||.+..+...   .
T Consensus       161 DgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~  233 (364)
T KOG0581|consen  161 DGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I  233 (364)
T ss_pred             CCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence            99999999943  3569999999999999999999996  599999999999999999999999999999876543   4


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEY  579 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  579 (652)
                      ....+||..|||||.+.+..|+.++||||||++++|+++|+.|+...                             ...+
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-----------------------------~~~~  284 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-----------------------------NPPY  284 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-----------------------------CCCC
Confidence            45678999999999999999999999999999999999999999753                             1111


Q ss_pred             CHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          580 DQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       580 ~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                      ..--.++..+...++.+-|..    ...++++++++.++.-+|.+|+      .|+|+..
T Consensus       285 ~~~~~Ll~~Iv~~ppP~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  285 LDIFELLCAIVDEPPPRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             CCHHHHHHHHhcCCCCCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence            222233344444344333433    3457889999999999999998      5666653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-44  Score=362.32  Aligned_cols=255  Identities=24%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-------hHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-------GVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      .+.|.+.+.||+|+||.|-+|..+.+++.||||.+.+....       ......+|+++|++|+|||||++++++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45677889999999999999999999999999999764211       22345799999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeecc
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGL  488 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGl  488 (652)
                      .|||||||+||+|.+++-.  +..+.+..-.-+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999998844  445777788889999999999999   7999999999999999766   7799999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCC---CCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCC
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGK---SSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEG  565 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  565 (652)
                      |+....  ...+.+.+||+.|.|||++.++.   +..+.|+||+||+||-+|+|.+||.+...+..  +.+         
T Consensus       326 AK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~e---------  392 (475)
T KOG0615|consen  326 AKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKE---------  392 (475)
T ss_pred             hhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHH---------
Confidence            998763  34566789999999999998764   23478999999999999999999986432110  111         


Q ss_pred             ccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          566 RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       566 ~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                             ..+.+.|...               |.  ......++++||++.|+..||++|+      +|+|+.+.+
T Consensus       393 -------QI~~G~y~f~---------------p~--~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  393 -------QILKGRYAFG---------------PL--QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             -------HHhcCccccc---------------Ch--hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                   1112222211               11  1124467999999999999999999      689999754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5e-44  Score=356.24  Aligned_cols=205  Identities=27%  Similarity=0.417  Sum_probs=185.4

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ...++|++.+.||+|+||+||+++.+++++.+|+|++++..   ....+...+|..+|.+++||.||+++-.|++.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            34578999999999999999999999999999999998753   234567889999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      ||+||+.||.|..+|.  +...+++..+.-++.+|+.||.|||   +++||||||||+|||||.+|+++|+|||+|+...
T Consensus       102 lVld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999994  4556999999999999999999999   7999999999999999999999999999999543


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .. ...+...+||+.|||||++.+..++..+|+||+|+++|||++|.+||...+
T Consensus       177 ~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  177 KD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             cC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            32 334556899999999999999999999999999999999999999998643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-43  Score=363.15  Aligned_cols=278  Identities=28%  Similarity=0.370  Sum_probs=224.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  415 (652)
                      +.|+.+++||+|.||.||+|++..+|+.||+|+++-+.  .....-..+||.||++|.||||++|.+.....  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45777899999999999999999999999999997654  34456678999999999999999999998776  789999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      +|||+. +|.-++.. +.-.+++.++..+++|++.||+|+|   .++|+|||||.+|||||.+|.+||+|||||+++...
T Consensus       197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999977 88887743 3446999999999999999999999   799999999999999999999999999999998877


Q ss_pred             CCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      .....+..+-|..|+|||++.+. .|+...|+||.||||.||+.|++.|++..+-+++..+-..++...++.+. ..+=.
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP  350 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLP  350 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCC
Confidence            66667777889999999998875 69999999999999999999999999998888888888777776554322 11100


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCC-CCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPR-SSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~-~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      ...           +..+......+ ........+.+.+|+.+|+..+|++|.      .++||...
T Consensus       351 ~~~-----------~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  351 HAT-----------IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             ccc-----------ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            000           00111110000 011233456889999999999999996      45788443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-42  Score=329.92  Aligned_cols=276  Identities=25%  Similarity=0.363  Sum_probs=223.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-h-HHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-G-VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .+|...++||+|.||.||+|++..+++.||||+++..... + .....+|++.|+.++|+||+.++++|.+.+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4678889999999999999999999999999999765322 2 3457899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ||+. +|...+.++ ...++..++..++.++++||+|||   .+.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus        82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9976 898888554 457999999999999999999999   79999999999999999999999999999998865433


Q ss_pred             CceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       ..+..+-|..|+|||.+.+. .|+...|+||.||++.||+.|.+-|.+...-++...+-.+.+...++.+-++..   .
T Consensus       157 -~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~---l  232 (318)
T KOG0659|consen  157 -IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS---L  232 (318)
T ss_pred             -ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc---c
Confidence             33334779999999998875 589999999999999999999999998877777776666666655443322211   0


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                      .+|..         .......|.....+.+.+.+.||+.+|+.+||-+|+      .|+||..
T Consensus       233 pdY~~---------~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  233 PDYVK---------IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             ccHHH---------HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            11211         112222233335567778889999999999999999      5678886

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=356.15  Aligned_cols=201  Identities=37%  Similarity=0.598  Sum_probs=175.8

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHhcccCcCceeEEEeeeeccC-eeEEEEEec
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--GVREFVSEIATIGRLRHRNLVQLVGWCRRKG-DLLLVYDFM  419 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~  419 (652)
                      ...+.||+|+||+||+|.+.+. ..||||++......  ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3455699999999999999752 33999999765322  2568999999999999999999999999987 799999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce-EEecCCCCCceEeCCCC-CeEEeeeccceecccCCC
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV-VIHRDVKASNVLLDSEL-NGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~~~~~  497 (652)
                      ++|+|.+++++..+..+++..+++++.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            9999999998755678999999999999999999999   566 99999999999999997 99999999998755322 


Q ss_pred             CceeeccCCcCCCCCCCCC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPR--TGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~--~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      ...+...||..|||||++.  ...++.|+||||||+++|||+||+.||.....
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            2334468999999999999  66999999999999999999999999987554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-43  Score=335.04  Aligned_cols=206  Identities=27%  Similarity=0.435  Sum_probs=181.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEee-eeccCe-eEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGW-CRRKGD-LLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lV  415 (652)
                      .+|+++++||+|.||+||++.+..++..||.|.+.-.  +....+....|+.+|++|+|||||+++++ +.+.++ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4688899999999999999999999999999998643  34456778999999999999999999994 444455 8999


Q ss_pred             EEeccCCCcccccc--cCCccccchHHHhhhHHHHHHHHhhhccCccc-eEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          416 YDFMANGSLDSFLF--DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ-VVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       416 ~e~~~~gsL~~~l~--~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ||||..|+|...+.  ++.+..+++..+++++.|++.||..+|+-+.+ -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999884  35567799999999999999999999964433 3899999999999999999999999999988


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..... .....+|||.||+||.+...+|+.||||||+||++|||+.-++||.+.
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            76432 345578999999999999999999999999999999999999999875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=339.85  Aligned_cols=283  Identities=25%  Similarity=0.359  Sum_probs=230.2

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecC--cchhhHHHHHHHHHHhcccCcCceeEEEeeeec-----c
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR-----K  409 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  409 (652)
                      .....|...+.||+|+||.|+.+.+..+++.||||++..  ......++..+|+++|+.++|+||+.+.+.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            344566668899999999999999999999999999974  344566788999999999999999999998865     3


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      +.+|+|+|+|+ -+|...+..  +..|+......++.|+++||.|+|   +.+|+||||||+|+|++.+..+||+|||+|
T Consensus        99 ~DvYiV~elMe-tDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   99 NDVYLVFELME-TDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             ceeEEehhHHh-hHHHHHHHc--CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            57899999994 489998843  445999999999999999999999   699999999999999999999999999999


Q ss_pred             eecccCC-CCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          490 KLYEHGT-NPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       490 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      +...... ....+..+-|..|.|||.+.. ..|+...||||.||++.||++|++.|.+.+.-++..++-.+.+...++.+
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            9875432 223466788999999997654 67999999999999999999999999999888888877777666644333


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      ..+-.+..       ...++.  ++...+.|.....+.+.+.+.|||++|+.+||++|+|      |+|++.-
T Consensus       253 ~~i~s~~a-------r~yi~s--lp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  253 QKIRSEKA-------RPYIKS--LPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHhccHHH-------HHHHHh--CCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            32221111       111121  4566667777777889999999999999999999995      6677663

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=348.58  Aligned_cols=280  Identities=23%  Similarity=0.329  Sum_probs=233.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHhcccC-cCceeEEEeeeeccC-eeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLR-HRNLVQLVGWCRRKG-DLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  414 (652)
                      ..++|...++||.|.||.||+|+...+++.||||++++.-... .-.=++|++.|++|. ||||+++...+.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4568999999999999999999999999999999997653221 122368999999998 999999999998887 9999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |||||+. +|.+.+.++ +..+++..++.|+.||++||+|+|   ++|+.|||+||+|||+.....+||+|||+||... 
T Consensus        88 VfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-  161 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR-  161 (538)
T ss_pred             eHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc-
Confidence            9999965 999988666 778999999999999999999999   8999999999999999988899999999999664 


Q ss_pred             CCCCceeeccCCcCCCCCCCCC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPR-TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                       ..+..+..+.|.+|+|||++. .+.|+.+.|+||+||+++|+.+-++.|.+..+-+++..+..+++...+..       
T Consensus       162 -SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~-------  233 (538)
T KOG0661|consen  162 -SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS-------  233 (538)
T ss_pred             -cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc-------
Confidence             345677788999999999765 56799999999999999999999999999888888887777777664432       


Q ss_pred             ccccCCCHHHHHHhhccCCCCCC--CCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLR--GPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~--~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                           +.....+...+....++.  .|-....+.+.+++.+|+.+|+.-||++||+      |+||++.+.
T Consensus       234 -----~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  234 -----WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             -----chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                 222244444554444443  3444556678899999999999999999995      568887533

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=322.38  Aligned_cols=200  Identities=28%  Similarity=0.384  Sum_probs=183.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|+..+.||.|+||.|.+++.+.++..+|+|++++..-   .+.+...+|..+|+.+.||.++++.+.|.+.+.++||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            3568889999999999999999999999999999987643   3445678999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||.+||.|..+|++  .+++++..++.++.||+.||+|||   +.+|++|||||+|||||.+|.+||+|||.|+.... 
T Consensus       123 meyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             EeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            999999999999954  456999999999999999999999   79999999999999999999999999999997653 


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                         .+-+.+||+.|+|||.+....+...+|.|||||++|||+.|.+||....
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence               4677899999999999999999999999999999999999999998644

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=347.64  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=204.5

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCe
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  411 (652)
                      ....++|...+.||+|+|++|++|+...+++++|||++.+.-   ....+-...|-.+|.+| .||.|++|+..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            345578999999999999999999999999999999997652   22334567788899999 79999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      +|+|+||+++|+|.+++.+  .+.+++...+.++.+|+.||+|||   ..|||||||||+|||||.++++||+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999944  467999999999999999999999   79999999999999999999999999999998


Q ss_pred             cccCCCC----------c--eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHH
Q 038860          492 YEHGTNP----------A--TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVW  559 (652)
Q Consensus       492 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~  559 (652)
                      +......          .  ...++||..|.+||++..+..+..+|+|+|||+||+|+.|++||....+   ..      
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yl------  294 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YL------  294 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HH------
Confidence            7432111          1  1458999999999999999999999999999999999999999986321   11      


Q ss_pred             hhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCc
Q 038860          560 GKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       560 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~  628 (652)
                                           ..+.++ .+....++.         -.+.++||++|++..+|++|+++
T Consensus       295 ---------------------iFqkI~-~l~y~fp~~---------fp~~a~dLv~KLLv~dp~~Rlt~  332 (604)
T KOG0592|consen  295 ---------------------IFQKIQ-ALDYEFPEG---------FPEDARDLIKKLLVRDPSDRLTS  332 (604)
T ss_pred             ---------------------HHHHHH-HhcccCCCC---------CCHHHHHHHHHHHccCccccccH
Confidence                                 111110 111111111         12688999999999999999953

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=350.12  Aligned_cols=204  Identities=34%  Similarity=0.551  Sum_probs=180.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ..++..+.||+|-||.||.|.+.. ...||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            344567889999999999999976 457999999775 334567899999999999999999999999998999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      +.|+|.+||.......+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||||+....+....
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999999998766778999999999999999999999   7999999999999999999999999999999665554444


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRAL  548 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~  548 (652)
                      .....-+..|.|||.+..++++.|||||||||+||||+| |+.|+.....
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn  410 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN  410 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence            444445779999999999999999999999999999999 9999876543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-41  Score=328.31  Aligned_cols=285  Identities=23%  Similarity=0.271  Sum_probs=219.6

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-h-HHHHHHHHHHhcccCcCceeEEEeeeecc--CeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-G-VREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  413 (652)
                      ..+.|+..+.|++|.||.||+|++..+++.||+|+++..... + .-.-++|+.+|.+.+|||||.+-.+....  +.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            346788999999999999999999999999999999765321 1 12357899999999999999999887543  5799


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      ||||||+. +|...+..-+ .++...++..++.|+++|++|||   ...|+|||||++|+|+...|.+||+|||+||.+.
T Consensus       154 ~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            99999987 8888885433 57889999999999999999999   7889999999999999999999999999999887


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ... ...+..+-|..|+|||.+.+. .|+...|+||+||++.|++++++.|.+....++...+-...+...+..+-..-+
T Consensus       229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            643 345667789999999988875 589999999999999999999999999888777776666665554432211111


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      ....+.       +..-..+...-+...... ...+...|||++++..||.+|.+      |.||.+++.
T Consensus       308 lp~~k~-------~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  308 LPAVKK-------MTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             cchhhc-------cccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence            110000       000111111111111111 14578899999999999999995      679988543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.3e-41  Score=345.65  Aligned_cols=209  Identities=23%  Similarity=0.364  Sum_probs=184.1

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      .+...++|+.+..||+|+||.||+++-+++|+.+|+|++++..   ..+.+-...|-.+|....+|.||+++..|.+.+.
T Consensus       136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            3456789999999999999999999999999999999998763   3455668899999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      +||||||++||++..+|.  ....|++..+..++.+++.|+.-||   +.|+|||||||+|+|||..|++||+||||+.-
T Consensus       216 LYLiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             eEEEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence            999999999999999994  4557999999999999999999999   89999999999999999999999999999853


Q ss_pred             ccc---------------C-------CCC-----ce-------------------eeccCCcCCCCCCCCCCCCCCCccc
Q 038860          492 YEH---------------G-------TNP-----AT-------------------TRVVGTLGYLAPETPRTGKSSASSD  525 (652)
Q Consensus       492 ~~~---------------~-------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~s~~sD  525 (652)
                      +..               .       ...     ..                   ...+|||.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            311               0       000     00                   1247999999999999999999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCCC
Q 038860          526 VFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       526 v~SlGvvl~elltG~~p~~~~~~  548 (652)
                      +|||||++||||.|-+||....+
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp  393 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETP  393 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999987554

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6e-41  Score=346.30  Aligned_cols=248  Identities=28%  Similarity=0.462  Sum_probs=211.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|.+.+.||+|.||.||||+.+.+.+.||+|.+.+..  +...+.+.+|++|+++++||||+.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999999999999999997753  3456778999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+.+ +|..+|.  ....+++++++.++.++.+||.|||   +.+|.|||+||.|||++..+.+|++|||+|+....+. 
T Consensus        82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-  154 (808)
T ss_pred             hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence            9977 9999994  4567999999999999999999999   7999999999999999999999999999999776533 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ...+...||+-|||||...+++|+..+|+||+||++||+.+|++||.....   ..+++                     
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---~~Lv~---------------------  210 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---TQLVK---------------------  210 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---HHHHH---------------------
Confidence            345667899999999999999999999999999999999999999964211   11111                     


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                                 ..+.++.+.|.     ++...+.-+|+.++.-||.+|+      -|++|+..
T Consensus       211 -----------~I~~d~v~~p~-----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  211 -----------SILKDPVKPPS-----TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -----------HHhcCCCCCcc-----cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                       11112222222     4567899999999999999998      48888874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=342.83  Aligned_cols=247  Identities=25%  Similarity=0.404  Sum_probs=210.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ...|....+||+|..|.||.+....+++.||||++........+-+.+|+.+|+..+|+|||+++..|..++++|.||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            34677788999999999999999999999999999877666666789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      |++|+|.+.+   ....+++.++..|++++++||+|||   .++|+|||||.+|||++.++++||+|||.|..+..... 
T Consensus       352 m~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  352 MEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             cCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999988   3445999999999999999999999   79999999999999999999999999999998766543 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....+||+.|||||+.....|++|.||||||++++||+.|++||-...+-..+                          
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl--------------------------  478 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------------------------  478 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH--------------------------
Confidence            445578999999999999999999999999999999999999998642211110                          


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                                 .+-.....|.-....++.+.++|+|++|+..++++|.++.
T Consensus       479 -----------yLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~  518 (550)
T KOG0578|consen  479 -----------YLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAK  518 (550)
T ss_pred             -----------HHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHH
Confidence                       1111112233333345678999999999999999999643

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=330.98  Aligned_cols=203  Identities=32%  Similarity=0.504  Sum_probs=176.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC--eeEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG--DLLLVY  416 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~  416 (652)
                      ..++...+.||+|.||.||++...+++...|||..........+.+.+|+.+|.+++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345777899999999999999999889999999987764444677899999999999999999999855544  689999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEEeeeccceeccc-
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAKLYEH-  494 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~~~~~-  494 (652)
                      ||+++|+|.+++.+... .+++..+.++.+||++||+|||   +++|+||||||+|||++. ++.+||+|||+++.... 
T Consensus        96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999976555 7999999999999999999999   799999999999999999 79999999999987653 


Q ss_pred             -CCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 -GTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 -~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       ..........||+.|||||++..+ ....++|||||||++.||+||++||..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence             222334457899999999999864 344599999999999999999999976

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-40  Score=328.68  Aligned_cols=278  Identities=24%  Similarity=0.345  Sum_probs=220.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-----eeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-----DLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  413 (652)
                      +-.|+..+++|.|+||.||+|....+++.||||+.-.+.+..    .+|+.+|+++.|||||+++-+|....     ...
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            345777899999999999999999999999999986654322    35899999999999999999886432     346


Q ss_pred             EEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccce
Q 038860          414 LVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAK  490 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla~  490 (652)
                      |||||||. +|.+++..  ..+..++...+.-+..||++||.|||   ..+|+||||||.|+|+|.+ |.+||+|||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999987 99888853  23456788888889999999999999   7999999999999999977 999999999999


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      .+..+..  .....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..++..++-.+.+...++.+..
T Consensus       175 ~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  175 VLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            8876543  2344568999999998875 699999999999999999999999999888888888877777766544433


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCC-cccccchhHHHHHhhhccCCCCCCC------CccccccCcccc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSS-DGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYP  638 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~-~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~  638 (652)
                      +-     .++.       +...+.....|..+ ......+++.||+.+++..+|++|.      +|++|++.++..
T Consensus       253 mn-----~~y~-------~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  253 MN-----PNYT-------EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             cC-----cccc-------cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence            22     1221       11111222222211 3344567899999999999999999      779999987764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=336.26  Aligned_cols=252  Identities=26%  Similarity=0.456  Sum_probs=206.9

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc----ch-hhHHHHHHHHHHhcccC-cCceeEEEeeeeccC
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE----SK-QGVREFVSEIATIGRLR-HRNLVQLVGWCRRKG  410 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  410 (652)
                      ...++|...+.||+|.||+|++|....+++.||+|.+.+.    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999999999999999977653    11 22345668999999998 999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccc
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLA  489 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla  489 (652)
                      .+++||||+.+|+|.+++.+  ..++.+..+.++++|+++|++|||   .++|+||||||+|||++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999955  567899999999999999999999   7999999999999999999 99999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCC-CC-CccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGK-SS-ASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      .... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++....   .+..    ..     
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~----ki-----  235 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYR----KI-----  235 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHH----HH-----
Confidence            9764 2334556679999999999999977 75 7899999999999999999999862211   1100    00     


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                             ..+++          ..+....          .+.+.+|+.+|+..+|.+|+      .|+|+..
T Consensus       236 -------~~~~~----------~~p~~~~----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  236 -------RKGEF----------KIPSYLL----------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -------hcCCc----------cCCCCcC----------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                   00111          1111110          46889999999999999998      5788886

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-38  Score=327.33  Aligned_cols=202  Identities=27%  Similarity=0.441  Sum_probs=177.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .|+..+.||+|+||.||++.+..+++.||+|.+....   ......+.+|+.++.+++|+||+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4778899999999999999999889999999986542   2233467899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++|+|..++.......+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999988876544456899999999999999999999   7999999999999999999999999999998754322 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                       ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence             2234578999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.5e-39  Score=318.88  Aligned_cols=282  Identities=27%  Similarity=0.328  Sum_probs=217.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHhcccCcCc-eeEEEeeeeccC-----
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--GVREFVSEIATIGRLRHRN-LVQLVGWCRRKG-----  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  410 (652)
                      ...|...++||+|.||+||+|+...+|+.||+|+++-....  -.....+|+.++++++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34577788899999999999999999999999999765442  2345678999999999999 999999998877     


Q ss_pred             -eeEEEEEeccCCCcccccccCCc--cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          411 -DLLLVYDFMANGSLDSFLFDEPK--AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       411 -~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                       .+++|+||++. +|..++.....  ..++...+..++.||+.||+|||   +++|+||||||+|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             78999999965 99999865432  35777889999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCc
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGR  566 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  566 (652)
                      +|+.+.... ...+..++|..|+|||++.+. .|+...||||+||++.||+++++-|.+....++...+-...+...+..
T Consensus       166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            999665332 234556789999999999887 699999999999999999999999998776666555555555554432


Q ss_pred             cccccccccccCCCHHHHHHhhccCCCCC-CCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          567 VLEVIDPKLNAEYDQSQVLMGELELPDTL-RGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       567 ~~~~id~~l~~~~~~~~~~~~~l~~~~~~-~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                      .-....   ..+|+.        ..+.+. ..+.....+...+...||+.+|+..+|.+|+      +|.||+....
T Consensus       245 Wp~v~~---~~~~k~--------~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  245 WPGVSS---LPDYKA--------PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCccc---cccccc--------cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            222110   011211        111111 1111222233346899999999999999999      5677776533

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-39  Score=338.36  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=213.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .-|+..+.||.|+-|.|-+|++..+|+.+|||.+.+..   ......+.+|+.+|+.+.|||++++++.+.+..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45677889999999999999999999999999997652   223455788999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|.|.+++.+  ++++++.++.+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.+...+ 
T Consensus        92 Eyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-  165 (786)
T ss_pred             EecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence            99999999999954  567999999999999999999999   799999999999999999999999999999875443 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                       ..-.+.||.++|.|||++.+.+| +.++||||.||+||.||+|+.||++...   ..+...+.                
T Consensus       166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~----------------  225 (786)
T KOG0588|consen  166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQ----------------  225 (786)
T ss_pred             -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHH----------------
Confidence             34455699999999999999987 6789999999999999999999985321   11111110                


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccccCCCC
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYPSLST  642 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~~~~~  642 (652)
                      .+.|+          +      |     ......++|||.+|+..||.+|+      .|+|.....+.+....
T Consensus       226 ~G~f~----------M------P-----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~  277 (786)
T KOG0588|consen  226 RGVFE----------M------P-----SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKS  277 (786)
T ss_pred             cCccc----------C------C-----CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhh
Confidence            12221          1      1     13357899999999999999999      6889988777765533

>cd01951 lectin_L-type legume lectins

Probab=100.00  E-value=6e-38  Score=310.69  Aligned_cols=204  Identities=31%  Similarity=0.440  Sum_probs=171.5

Q ss_pred             CCCeEEecceEecc-CCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCC
Q 038860           34 SNNLTLQGIAKIEN-NGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSND  112 (652)
Q Consensus        34 ~~~~~~~g~a~~~~-~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~  112 (652)
                      ..++.++|+|.+.. ++.|+||++..+++|++||++||++|       ++|+|+|+|.|.... ..+||||||+|+|...
T Consensus        13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~-------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~   84 (223)
T cd01951          13 QSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPA   84 (223)
T ss_pred             hhhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc-------CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCC
Confidence            46899999999975 78999999999999999999999998       489999999999864 5689999999999875


Q ss_pred             CC-CCCC--ccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccc--eeecceecCCCCcccCCcC
Q 038860          113 LN-GLPS--QYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNA--SVEAAVYTDNSTKQDLSLK  187 (652)
Q Consensus       113 ~~-~~~g--~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~--~~~~~~~~~~~~~~~~~~~  187 (652)
                      .+ +.+|  ++||+       ...++.+||||||++|.+++||+.||||||+|+..+..  ..+..+..     .+....
T Consensus        85 ~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~-----~~~~~~  152 (223)
T cd01951          85 GALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSAS-----LPNGTG  152 (223)
T ss_pred             CccccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceee-----CCCccC
Confidence            44 4444  78887       45667899999999999888999999999999997642  11111110     122222


Q ss_pred             CCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccccccceeeccccc
Q 038860          188 GGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFK  258 (652)
Q Consensus       188 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~  258 (652)
                      +|+.++|||+|++.+++|+|++..... |..|.++..+||...++++||||||||||...+.|.|++|+|+
T Consensus       153 ~g~~~~v~I~Y~~~~~~L~v~l~~~~~-~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~  222 (223)
T cd01951         153 LGNEHTVRITYDPTTNTLTVYLDNGST-LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT  222 (223)
T ss_pred             CCCEEEEEEEEeCCCCEEEEEECCCCc-cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEec
Confidence            389999999999999999999997654 6678899999999999999999999999999999999999986

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=337.39  Aligned_cols=206  Identities=29%  Similarity=0.420  Sum_probs=184.3

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCe
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  411 (652)
                      ....++|...+.||+|.||+|+++..+.+++.+|||.+++.   .....+..+.|..|+... +||.+++++..|..+++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            34557899999999999999999999999999999999886   345667788888888777 59999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      +++||||+.||++..+.   ....+++..+.-++..++.||+|||   +++||+||||.+|||||.+|.+||+|||+++.
T Consensus       444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence            99999999999955554   3456999999999999999999999   79999999999999999999999999999995


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      ... ....+.+++||+.|||||++.+..|+...|.|||||+|||||.|+.||.+.++
T Consensus       518 ~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE  573 (694)
T KOG0694|consen  518 GMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE  573 (694)
T ss_pred             cCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            432 23467789999999999999999999999999999999999999999987554

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-38  Score=326.75  Aligned_cols=274  Identities=24%  Similarity=0.339  Sum_probs=205.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|+..+.||+|+||.||+|.+..++..||+|.++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            568999999999999999999998899999999875432 2334677899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++ +|.+++... ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus        85 ~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~  158 (288)
T cd07871          85 LDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K  158 (288)
T ss_pred             CCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence            975 888887433 335788999999999999999999   7999999999999999999999999999998653322 1


Q ss_pred             ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+....+........++.      
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  232 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT------  232 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc------
Confidence            2233468999999998765 568999999999999999999999998755443333222222222111111110      


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                         ..+.. .....+.....|.....+...+.+.||+++|+..+|.+|++++
T Consensus       233 ---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~  280 (288)
T cd07871         233 ---SNEEF-RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE  280 (288)
T ss_pred             ---cchhh-hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHH
Confidence               00000 1111122112222222334567889999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-38  Score=327.96  Aligned_cols=204  Identities=25%  Similarity=0.385  Sum_probs=177.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||.||++++..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999999889999999987542  2334567899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |++++.+..+..  ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            999877665442  2346889999999999999999999   79999999999999999999999999999987654333


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~  206 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE  206 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence            333446789999999999888899999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=319.18  Aligned_cols=206  Identities=28%  Similarity=0.389  Sum_probs=181.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..+.|++.+.||.|..++||+|+....++.||||++.-+. ....+.+.+|+..|+.++||||++.+..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            3478999999999999999999999999999999997653 334688999999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      .||.+|++.+.+...-...+++..+..|.+++++||.|||   .+|.||||||+.||||+.+|.+||+|||..-.+....
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999996655556999999999999999999999   7999999999999999999999999999766443222


Q ss_pred             CCce---eeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPAT---TRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~---~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .+..   ....||+.|||||++..  ..|+.|+||||||++..||.+|..||...
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~  235 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY  235 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence            2211   45689999999999544  46999999999999999999999999764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=321.60  Aligned_cols=197  Identities=33%  Similarity=0.528  Sum_probs=167.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcc--cCcCceeEEEeeeeccC----eeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR--LRHRNLVQLVGWCRRKG----DLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~  413 (652)
                      ...+..++||+|+||.||+|++.+  +.||||++....   ...|++|-+|.+.  ++|+||++++++-....    +++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccC--ceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            456678899999999999999975  899999997644   4457777777654  58999999999887665    899


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC------ccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG------YEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      ||+||.++|+|.+||   ....++|....+|+..+++||+|||++      ++++|+|||||++|||+..|++..|+|||
T Consensus       285 LVt~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999   456799999999999999999999984      46789999999999999999999999999


Q ss_pred             cceecccCCCC-ceeeccCCcCCCCCCCCCCCCC------CCccchHhHHHHHHHHHhCCCCCC
Q 038860          488 LAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKS------SASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       488 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~------s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      +|..+..+... .....+||.+|||||++.+..-      -.+.||||+|.|||||+++..-++
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~  425 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD  425 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            99988755432 2334789999999999877532      236899999999999999887664

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-39  Score=300.86  Aligned_cols=244  Identities=27%  Similarity=0.399  Sum_probs=207.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      +.++|++.+.||+|.||.||+|+.+.++-.||+|++.+..   .+-.+++.+|++|-+.|+||||+++++||.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3468999999999999999999999999999999997653   2234678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ++||.++|+|...|.......+++.....+++|+|.||.|+|   .++|+||||||+|+|++..+..||+|||-+.... 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999998777778999999999999999999999   7999999999999999999999999999988543 


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                        .......+||..|.+||+..+...+...|+|++|++.||++.|.+||+.....+...       .+            
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk-------rI------------  234 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK-------RI------------  234 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH-------HH------------
Confidence              234456799999999999999999999999999999999999999997643111100       00            


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS  627 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s  627 (652)
                                ....+      ..|     .....++.||+.+++.-+|.+|.+
T Consensus       235 ----------~k~~~------~~p-----~~is~~a~dlI~~ll~~~p~~r~~  266 (281)
T KOG0580|consen  235 ----------RKVDL------KFP-----STISGGAADLISRLLVKNPIERLA  266 (281)
T ss_pred             ----------HHccc------cCC-----cccChhHHHHHHHHhccCcccccc
Confidence                      00011      112     234578999999999999999985

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-38  Score=314.75  Aligned_cols=255  Identities=25%  Similarity=0.339  Sum_probs=211.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|+..+.||+|.-|+||++.+.+++..+|+|++.+..   +....+.+.|-+||+.++||.++.|++.+...+..|||
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            356788899999999999999999999999999998763   33455678899999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc-
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-  494 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~-  494 (652)
                      ||||+||+|...+++++...+++..++.++.+++-||+|||   -.|||.|||||+||||.++|++.|+||.|+..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999999999999999999999999999999999   79999999999999999999999999998743210 


Q ss_pred             --------------------------------C-C---------------------CCceeeccCCcCCCCCCCCCCCCC
Q 038860          495 --------------------------------G-T---------------------NPATTRVVGTLGYLAPETPRTGKS  520 (652)
Q Consensus       495 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  520 (652)
                                                      . .                     ...+..++||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011123589999999999999999


Q ss_pred             CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCC
Q 038860          521 SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRS  600 (652)
Q Consensus       521 s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~  600 (652)
                      +.++|+|+|||++||||.|..||.+....+...                             .++.+.+..+..      
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~-----------------------------NIv~~~l~Fp~~------  357 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR-----------------------------NIVGQPLKFPEE------  357 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH-----------------------------HHhcCCCcCCCC------
Confidence            999999999999999999999998865433221                             111111111111      


Q ss_pred             CcccccchhHHHHHhhhccCCCCCCCC----------ccccccC
Q 038860          601 SDGDKAAEGFDDLLNSLASSSFDKTTS----------CSYFENG  634 (652)
Q Consensus       601 ~~~~~~~~~~~dLl~~~~~~~~~~r~s----------~~~~~~~  634 (652)
                         +.....++||+++++.-||.+|+.          |++|+.+
T Consensus       358 ---~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  358 ---PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             ---CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence               134568899999999999999995          7777764

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=334.97  Aligned_cols=202  Identities=24%  Similarity=0.373  Sum_probs=176.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||++++..+++.||||++....   ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999999889999999997542   234456788999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999854  345899999999999999999999   7999999999999999999999999999987543211


Q ss_pred             CC-------------------------------------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhC
Q 038860          497 NP-------------------------------------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG  539 (652)
Q Consensus       497 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG  539 (652)
                      ..                                     .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01124699999999999988999999999999999999999


Q ss_pred             CCCCCCC
Q 038860          540 RRPIETR  546 (652)
Q Consensus       540 ~~p~~~~  546 (652)
                      +.||...
T Consensus       236 ~~Pf~~~  242 (364)
T cd05599         236 YPPFCSD  242 (364)
T ss_pred             CCCCCCC
Confidence            9999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-38  Score=332.30  Aligned_cols=281  Identities=22%  Similarity=0.331  Sum_probs=204.7

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----CeeE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----GDLL  413 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  413 (652)
                      +|++.+.||+|+||.||+|.+..++..||+|++...  .......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478899999999999999999988999999998643  223445788999999999999999999987543     3579


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||++ ++|.+++..  ...+++..+..++.||++||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 688888843  345899999999999999999999   7999999999999999999999999999998643


Q ss_pred             cCCC--CceeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          494 HGTN--PATTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       494 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      ....  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+....+....    +
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~  230 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP----E  230 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH----H
Confidence            2221  11234578999999998765  67899999999999999999999999765432222221111111110    0


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      .+. .+..  .........+..  ....|.....+...+.+.+++.+|+..+|++|++      |+||.....
T Consensus       231 ~~~-~i~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         231 TIS-RVRN--EKARRYLSSMRK--KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHH-Hhhh--hhHHHHHHhhcc--cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            000 0000  000111111111  1111112222334567899999999999999995      889988543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-38  Score=326.09  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=201.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999999889999999986532   234456889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            99999999999854  346889999999999999999999   799999999999999999999999999999865332 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ....+.    .            
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i~----~------------  212 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKIL----A------------  212 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----h------------
Confidence               223568999999999998889999999999999999999999997532211   011000    0            


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC-----------cccccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS-----------CSYFEN  633 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s-----------~~~~~~  633 (652)
                                ..+      ..|.     ...+.+.||+++|+..+|++|++           |.|+..
T Consensus       213 ----------~~~------~~~~-----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         213 ----------GKL------EFPR-----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             ----------CCc------CCCc-----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence                      000      0011     12357889999999999999996           888865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=314.57  Aligned_cols=202  Identities=27%  Similarity=0.481  Sum_probs=183.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..+|++.+.||+|.||+|-+|.....|+.||||.+++..   .+..-.+.+|++||+.|+||||++++.+|...+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            467889999999999999999998899999999998763   44455678999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||..+|.|.+|+.  ..+.|++.+.+.+++||.+|+.|+|   +.+++|||||.+|||||.++++||+|||++.++...
T Consensus       132 MEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  132 MEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999994  3456999999999999999999999   899999999999999999999999999999887643


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                        ...++++|.+-|.+||.+.+.+| .+..|-|||||+||.|+.|..||++.+
T Consensus       207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D  257 (668)
T KOG0611|consen  207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD  257 (668)
T ss_pred             --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence              34566899999999999999887 678999999999999999999998754

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.7e-38  Score=328.90  Aligned_cols=194  Identities=28%  Similarity=0.375  Sum_probs=171.4

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      +.||+|+||.||++++..+++.||+|+++...   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999889999999997642   234456788999999999999999999999999999999999999


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceee
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR  502 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  502 (652)
                      +|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~  154 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT  154 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence            99988853  346899999999999999999999   799999999999999999999999999998753221 122334


Q ss_pred             ccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       503 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence            5799999999999999999999999999999999999999965

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8e-38  Score=329.59  Aligned_cols=198  Identities=25%  Similarity=0.371  Sum_probs=177.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367899999999999999999999889999999997542   23446788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        97 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999999854  345888999999999999999999   799999999999999999999999999999865432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence                2235799999999999999999999999999999999999999965

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=316.33  Aligned_cols=248  Identities=28%  Similarity=0.447  Sum_probs=196.4

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--------------hhHHHHHHHHHHhcccCcCceeE
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--------------QGVREFVSEIATIGRLRHRNLVQ  401 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~  401 (652)
                      ....++|++.+.||+|.||.|-+|++..+++.||||++.+...              ...+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            4456899999999999999999999999999999999965421              11357889999999999999999


Q ss_pred             EEeeeecc--CeeEEEEEeccCCCcccccccCCccc-cchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC
Q 038860          402 LVGWCRRK--GDLLLVYDFMANGSLDSFLFDEPKAV-LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE  478 (652)
Q Consensus       402 l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~  478 (652)
                      |+.+..+.  +.+|||+|||..|.+...-   ...+ +++.+++++++++..||+|||   .++||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCC
Confidence            99998764  5799999999988876543   3333 999999999999999999999   7999999999999999999


Q ss_pred             CCeEEeeeccceecccCCC----CceeeccCCcCCCCCCCCCCCC----CCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 038860          479 LNGKLGDFGLAKLYEHGTN----PATTRVVGTLGYLAPETPRTGK----SSASSDVFAFGALLLEVACGRRPIETRALPE  550 (652)
Q Consensus       479 ~~~kL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~SlGvvl~elltG~~p~~~~~~~~  550 (652)
                      |++||+|||.+.....+..    ......+||+.|+|||++.++.    .+.+.||||+||+||.|+.|+.||-+...  
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--  324 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--  324 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence            9999999999986633321    1223468999999999887743    35678999999999999999999975321  


Q ss_pred             chhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC
Q 038860          551 ELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS  627 (652)
Q Consensus       551 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s  627 (652)
                       ..+-+.            ++.                    .+..-|..   +...+.++|||.+|+.-||++|++
T Consensus       325 -~~l~~K------------Ivn--------------------~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~  365 (576)
T KOG0585|consen  325 -LELFDK------------IVN--------------------DPLEFPEN---PEINEDLKDLIKRLLEKDPEQRIT  365 (576)
T ss_pred             -HHHHHH------------Hhc--------------------CcccCCCc---ccccHHHHHHHHHHhhcChhheee
Confidence             111110            111                    11111111   134578899999999999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.3e-38  Score=343.97  Aligned_cols=210  Identities=28%  Similarity=0.494  Sum_probs=182.7

Q ss_pred             hhhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccC
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKG  410 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  410 (652)
                      ..+.+.+..+.||+|.||+||+|+..+     ....||||.++..... ...+|++|++++..++|||||+++|.|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            345666778899999999999998753     3467999999887655 7789999999999999999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccC-----------C-ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC
Q 038860          411 DLLLVYDFMANGSLDSFLFDE-----------P-KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE  478 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~-----------~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~  478 (652)
                      ..++|+|||..|+|.+||...           . +.+|+..+.+.|+.|||.||+||-   ++.+|||||..+|+|+.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence            999999999999999999521           1 344899999999999999999999   7999999999999999999


Q ss_pred             CCeEEeeeccceecccCCCCce-eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCc
Q 038860          479 LNGKLGDFGLAKLYEHGTNPAT-TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALP  549 (652)
Q Consensus       479 ~~~kL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~  549 (652)
                      ..|||+||||+|.......... ....-..+||+||.+..+++|.+||||||||+|||+++ |+.||.+....
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            9999999999996544433332 23455789999999999999999999999999999999 99999876543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-37  Score=334.61  Aligned_cols=202  Identities=25%  Similarity=0.376  Sum_probs=175.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .|+..+.||+|+||.||+|+...+++.||+|.+....   ......+.+|+.++++++||||+++++.+.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999999999999999997542   2345678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC-
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT-  496 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~-  496 (652)
                      |+++|+|.+++.+.  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999988543  45888999999999999999999   7999999999999999999999999999975321000 


Q ss_pred             ---------------------------------------------CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHH
Q 038860          497 ---------------------------------------------NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGA  531 (652)
Q Consensus       497 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGv  531 (652)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00012347999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 038860          532 LLLEVACGRRPIETRA  547 (652)
Q Consensus       532 vl~elltG~~p~~~~~  547 (652)
                      ++|||++|+.||....
T Consensus       237 il~elltG~~Pf~~~~  252 (382)
T cd05625         237 ILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHhCCCCCCCCC
Confidence            9999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2e-37  Score=333.24  Aligned_cols=202  Identities=25%  Similarity=0.364  Sum_probs=175.8

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .|+..+.||+|+||+||+|++..+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999999999999999997542   3345678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++|+|.+++..  ...+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999854  345888999999999999999999   79999999999999999999999999999764311000


Q ss_pred             ----------------------------------------------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHH
Q 038860          498 ----------------------------------------------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGA  531 (652)
Q Consensus       498 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGv  531 (652)
                                                                    .......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0012357999999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 038860          532 LLLEVACGRRPIETRA  547 (652)
Q Consensus       532 vl~elltG~~p~~~~~  547 (652)
                      ++|||++|+.||....
T Consensus       237 il~elltG~~Pf~~~~  252 (381)
T cd05626         237 ILFEMLVGQPPFLAPT  252 (381)
T ss_pred             HHHHHHhCCCCCcCCC
Confidence            9999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=329.05  Aligned_cols=199  Identities=28%  Similarity=0.428  Sum_probs=178.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999999889999999997642   234567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++.++..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            99999999999843  346889999999999999999999   79999999999999999999999999999986533  


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  202 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST  202 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence              2334579999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-37  Score=332.18  Aligned_cols=195  Identities=23%  Similarity=0.273  Sum_probs=171.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ..+|++.+.||+|+||.||++.+..+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3679999999999999999999999999999997532      3467899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +. ++|..++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus       165 ~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            95 688887743  345889999999999999999999   689999999999999999999999999999754332222


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            33456799999999999999999999999999999999999988754

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.9e-37  Score=328.88  Aligned_cols=203  Identities=25%  Similarity=0.368  Sum_probs=177.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|+..+.||+|+||+||++....+++.||+|+++...   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999999889999999997542   233456788999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999854  346899999999999999999999   7999999999999999999999999999987543211


Q ss_pred             C----------------------------------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCC
Q 038860          497 N----------------------------------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP  542 (652)
Q Consensus       497 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p  542 (652)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001235799999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 038860          543 IETRA  547 (652)
Q Consensus       543 ~~~~~  547 (652)
                      |....
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            97643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-37  Score=328.96  Aligned_cols=285  Identities=23%  Similarity=0.278  Sum_probs=220.6

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-c-----CceeEEEeeeeccCeeEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-H-----RNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  414 (652)
                      +|.+.+.||+|.||+|-+|.+..+++.||||++++... -.++-..|+.+|..|+ |     -|+|+++++|..+++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            88999999999999999999999999999999987543 3455577999999986 3     489999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC--CCeEEeeeccceec
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE--LNGKLGDFGLAKLY  492 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~--~~~kL~DFGla~~~  492 (652)
                      |+|.+.. +|.+++..+.-..++...++.+++||+.||.+||   +.+|||+||||+||||.+.  ..+||+|||.++..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999954 9999998877778999999999999999999999   7999999999999999754  46999999999865


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc-----
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV-----  567 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-----  567 (652)
                      ....    ...+-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.+++..+..+.+......+     
T Consensus       342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            4322    2456688999999999999999999999999999999999999998888888877777765542211     


Q ss_pred             -cccccc-----ccccCCCH------HHHHHhhccCCCCCCCC-CCCc----cc-ccchhHHHHHhhhccCCCCCCC---
Q 038860          568 -LEVIDP-----KLNAEYDQ------SQVLMGELELPDTLRGP-RSSD----GD-KAAEGFDDLLNSLASSSFDKTT---  626 (652)
Q Consensus       568 -~~~id~-----~l~~~~~~------~~~~~~~l~~~~~~~~p-~~~~----~~-~~~~~~~dLl~~~~~~~~~~r~---  626 (652)
                       ....+.     +...+.+.      .+............+.| ..+.    .. .....+.|+|.+|+..||++|+   
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence             111222     11111110      01111000011222333 2111    11 3356789999999999999999   


Q ss_pred             ---CccccccC
Q 038860          627 ---SCSYFENG  634 (652)
Q Consensus       627 ---s~~~~~~~  634 (652)
                         .|+|+...
T Consensus       498 qal~Hpfl~~~  508 (586)
T KOG0667|consen  498 QALNHPFLTGT  508 (586)
T ss_pred             HHhcCcccccc
Confidence               68899854

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=329.88  Aligned_cols=203  Identities=26%  Similarity=0.398  Sum_probs=179.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999999889999999997542   234567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++...  ..+++..++.++.||+.||+|||   .++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999998543  56899999999999999999999   7999999999999999999999999999998654332


Q ss_pred             ----------------------------CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          497 ----------------------------NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       497 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                                                  ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                        112234579999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=321.62  Aligned_cols=192  Identities=28%  Similarity=0.360  Sum_probs=170.7

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ||+|+||.||++.+..+++.||+|.+...   .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999988999999998753   233456788999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeecc
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV  504 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  504 (652)
                      .+++..  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  154 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC  154 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence            999854  345899999999999999999999   7999999999999999999999999999998543222 2334457


Q ss_pred             CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       505 gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence            99999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.8e-37  Score=317.51  Aligned_cols=271  Identities=25%  Similarity=0.335  Sum_probs=196.8

Q ss_pred             cCccccccccccCceEEEEEEEcC-CCeEEEEEEecCcc--hhhHHHHHHHHHHhccc---CcCceeEEEeeee-----c
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHN-SKTEVAVKRISNES--KQGVREFVSEIATIGRL---RHRNLVQLVGWCR-----R  408 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  408 (652)
                      ++|++.+.||+|+||.||+|++.. ++..||+|.++...  ......+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368899999999999999999854 46889999986532  22234456677766655   6999999999885     2


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      ...+++||||++ ++|.+++.......+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 58988886555556899999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      ++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|++||......+...   .+......    
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~---~i~~~~~~----  227 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGL----  227 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHHhCC----
Confidence            9865433  23344578999999999988889999999999999999999999998654322221   11111100    


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                           ....++......... ........|.....+...+.+.+|+.+|+..+|++|+++.
T Consensus       228 -----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  282 (290)
T cd07862         228 -----PGEEDWPRDVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  282 (290)
T ss_pred             -----CChhhchhhhcccch-hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHH
Confidence                 000011110000000 0001111111112233456789999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.7e-37  Score=322.94  Aligned_cols=195  Identities=29%  Similarity=0.390  Sum_probs=171.1

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      +.||+|+||.||++.+..++..||+|.+....   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999889999999997642   234456788999999999999999999999999999999999999


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceee
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR  502 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  502 (652)
                      +|..++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~  154 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT  154 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence            99888843  346899999999999999999999   799999999999999999999999999998753221 122234


Q ss_pred             ccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       503 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  198 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence            57999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.9e-37  Score=322.82  Aligned_cols=202  Identities=30%  Similarity=0.398  Sum_probs=178.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||.||++++..++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999999899999999987653 3345678999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            9999999999854  3458899999999999999999994  346999999999999999999999999998765322  


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence             2234578999999999999999999999999999999999999997543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=330.37  Aligned_cols=203  Identities=23%  Similarity=0.342  Sum_probs=175.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||++....+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47889999999999999999999999999999986542   234567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999854  346888999999999999999999   7999999999999999999999999999996432100


Q ss_pred             C------------C----------------------------------ceeeccCCcCCCCCCCCCCCCCCCccchHhHH
Q 038860          497 N------------P----------------------------------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFG  530 (652)
Q Consensus       497 ~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlG  530 (652)
                      .            .                                  ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0            0                                  00124699999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 038860          531 ALLLEVACGRRPIETRA  547 (652)
Q Consensus       531 vvl~elltG~~p~~~~~  547 (652)
                      |++|||++|+.||....
T Consensus       236 vil~elltG~~Pf~~~~  252 (377)
T cd05629         236 AIMFECLIGWPPFCSEN  252 (377)
T ss_pred             hhhhhhhcCCCCCCCCC
Confidence            99999999999997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-37  Score=325.83  Aligned_cols=200  Identities=27%  Similarity=0.400  Sum_probs=176.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCC-eEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSK-TEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|++.+.||+|+||.||+|.+...+ ..||+|++....   ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3457999999999999999999876544 689999986532   234567889999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       108 lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999998543  45889999999999999999999   7999999999999999999999999999998654


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       183 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  231 (340)
T PTZ00426        183 T----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN  231 (340)
T ss_pred             C----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence            2    223457999999999999888999999999999999999999999753

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=299.11  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=209.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++.|++.+.||+|.|+.||++....+|+.+|+|.+...  ...+.+++.+|+.|.+.|+||||+++...+...+..|||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            456788899999999999999999999999999987532  334677889999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeeccceec
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGLAKLY  492 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGla~~~  492 (652)
                      +|+|.|++|..-+-  .+...++..+-..++||+++|.|+|   .++|||||+||+|+||.+.   .-+||+|||+|...
T Consensus        89 Fe~m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   89 FDLVTGGELFEDIV--AREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EecccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999876552  2356788888999999999999999   7999999999999999643   44899999999977


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      .  ....-....|||+|||||++...+++..+|||+.||+||-||.|.+||.+.+..   .+-+.               
T Consensus       164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~---------------  223 (355)
T KOG0033|consen  164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQ---------------  223 (355)
T ss_pred             C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHH---------------
Confidence            6  233445578999999999999999999999999999999999999999763321   11110               


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSY  637 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~  637 (652)
                       ...+.|+.                |.+. .+...+++++|+++|+..||.||+      .|+|..+-.-+
T Consensus       224 -I~~g~yd~----------------~~~~-w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~  276 (355)
T KOG0033|consen  224 -IKAGAYDY----------------PSPE-WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV  276 (355)
T ss_pred             -HhccccCC----------------CCcc-cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH
Confidence             01222321                1111 235678999999999999999999      57898774333

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-37  Score=327.04  Aligned_cols=203  Identities=26%  Similarity=0.344  Sum_probs=178.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||++....+++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999999889999999997642   234566889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999998543 246899999999999999999999   7999999999999999999999999999998765443


Q ss_pred             CCceeeccCCcCCCCCCCCC------CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPR------TGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ........||+.|+|||++.      ...++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            33334457999999999876      456789999999999999999999999753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-37  Score=319.40  Aligned_cols=202  Identities=25%  Similarity=0.373  Sum_probs=172.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999999998899999999875432 223457789999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |++ ++|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            996 5777777433 345888999999999999999999   7999999999999999999999999999997543222 


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            12233568999999998765 45788999999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.9e-37  Score=327.52  Aligned_cols=206  Identities=25%  Similarity=0.321  Sum_probs=178.0

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      ....++|++.+.||+|+||.||++++..+++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345678999999999999999999999889999999996532   22344578899999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++|+|.+++..   ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999998843   34788889999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCC----CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTG----KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ............||+.|+|||++.+.    .++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            44332233446799999999987653    47889999999999999999999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.1e-37  Score=323.31  Aligned_cols=195  Identities=29%  Similarity=0.390  Sum_probs=171.8

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      +.||+|+||.||++.+..+++.||+|++.+..   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999889999999997642   334567889999999999999999999999999999999999999


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceee
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR  502 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  502 (652)
                      +|..++..  ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~  154 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT  154 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence            99888843  346899999999999999999999   799999999999999999999999999998753222 122334


Q ss_pred             ccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       503 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence            57999999999999989999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=317.04  Aligned_cols=204  Identities=28%  Similarity=0.447  Sum_probs=184.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ...|+..++||+|.||.||+|.+..+++.||+|.+.-+ ....++++++|+.++..++++||.++++.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            34677789999999999999999999999999999765 34567889999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ||.+|++.+.|.  ....+++..+.-++++++.||.|||   .++.+|||||+.|||+..+|.+||+|||.+........
T Consensus        92 y~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999993  3445588888899999999999999   79999999999999999999999999999987765544


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .. ..++||+.|||||++....|+.|+||||||++.+||++|.+|+....+
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP  216 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP  216 (467)
T ss_pred             cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence            33 678999999999999988999999999999999999999999987655

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.9e-37  Score=318.75  Aligned_cols=280  Identities=24%  Similarity=0.353  Sum_probs=207.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            578999999999999999999998899999999875432 2334577899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++ +|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            975 888777443 335788999999999999999999   79999999999999999999999999999986433221 


Q ss_pred             ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....+.........+..     
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  234 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS-----  234 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc-----
Confidence            2223467899999998765 4688999999999999999999999987654444333333322221111100000     


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGV  635 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~  635 (652)
                          ... ......+.....+.....+...+.+.||+.+|+..+|++|++      |+|++...
T Consensus       235 ----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 ----NDE-FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             ----hhh-hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                000 001111111111111222344567899999999999999994      55887643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=335.15  Aligned_cols=216  Identities=31%  Similarity=0.563  Sum_probs=188.0

Q ss_pred             ccchhhhhhhhcC---------ccccccccccCceEEEEEEEcCCC---eEEEEEEecCcc-hhhHHHHHHHHHHhcccC
Q 038860          329 RYSYQELKQATNN---------FSAKQLLGHGGFGQVYKGTLHNSK---TEVAVKRISNES-KQGVREFVSEIATIGRLR  395 (652)
Q Consensus       329 ~~~~~el~~~~~~---------f~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~  395 (652)
                      .++|++-.++...         ..+.+.||.|.||.||+|.++..+   ..||||.++... ..+..+|+.|..||.++.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            3566665555443         367889999999999999997544   569999998764 456678999999999999


Q ss_pred             cCceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       396 h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      ||||++|.|+....+...+|.|||+||+|+.||+.+.. .+++.++.-++++|+.||.||-   +.++|||||.++|||+
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV  764 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV  764 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence            99999999999999999999999999999999976654 4999999999999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCCCceeeccC--CcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCC
Q 038860          476 DSELNGKLGDFGLAKLYEHGTNPATTRVVG--TLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRAL  548 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~  548 (652)
                      +.+..+|++|||++|.++.+.....+...|  ..+|.|||.+..++++.+|||||||+++||.++ |++||=+...
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence            999999999999999887766544444444  579999999999999999999999999999887 9999865443

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-36  Score=325.81  Aligned_cols=211  Identities=23%  Similarity=0.307  Sum_probs=182.6

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeee
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWC  406 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~  406 (652)
                      ..+.++....++|++.+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++
T Consensus        33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (371)
T cd05622          33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF  112 (371)
T ss_pred             hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            345566777799999999999999999999999999999999986532   22345578899999999999999999999


Q ss_pred             eccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       407 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      ...+..++||||+++|+|.+++..   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999999998843   34788889999999999999999   799999999999999999999999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCCCC----CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPRTG----KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      |+++..............||+.|+|||++...    .++.++|||||||++|||++|+.||...
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            99987654332233456799999999988654    3788999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.9e-37  Score=326.07  Aligned_cols=207  Identities=24%  Similarity=0.320  Sum_probs=179.1

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG  410 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  410 (652)
                      ++....++|++.+.||+|+||.||++.+..+++.||+|.+.+..   ....+.+.+|+.+++.++||||+++++++..++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34455678999999999999999999999889999999986532   223455788999999999999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++||||+++|+|.+++..   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|.
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            99999999999999998843   35788999999999999999999   7999999999999999999999999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCC----CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTG----KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..............||+.|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            7643322233456799999999988654    3788999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-36  Score=321.15  Aligned_cols=201  Identities=25%  Similarity=0.384  Sum_probs=173.3

Q ss_pred             CccccccccccCceEEEEEEEc---CCCeEEEEEEecCcc----hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCee
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES----KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  412 (652)
                      +|++.+.||+|+||.||+++..   .+++.||+|++.+..    ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999864   467899999986532    22345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++|+|.+++..  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            999999999999998854  345889999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            44333344456799999999998765 4788999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=312.82  Aligned_cols=201  Identities=27%  Similarity=0.448  Sum_probs=176.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      +|+..+.||+|+||.||++.+..+++.||+|.+.....   .....+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            47888999999999999999988899999999965422   223457789999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++|+|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886554556899999999999999999999   6899999999999999999999999999998654322 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       ......|+..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence             223347899999999999889999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.5e-37  Score=323.46  Aligned_cols=206  Identities=30%  Similarity=0.470  Sum_probs=171.7

Q ss_pred             hhcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc-
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK-  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  409 (652)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++.... ....+.+.+|+.++.++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4568999999999999999999752     235679999997543 23456789999999999 899999999988764 


Q ss_pred             CeeEEEEEeccCCCcccccccCC---------------------------------------------------------
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEP---------------------------------------------------------  432 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------  432 (652)
                      +.+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45899999999999998885321                                                         


Q ss_pred             ---ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcC
Q 038860          433 ---KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLG  508 (652)
Q Consensus       433 ---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~  508 (652)
                         ...+++..+.+++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134788889999999999999999   799999999999999999999999999999865332221 1223456788


Q ss_pred             CCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          509 YLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       509 y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      |+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~  280 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV  280 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.6e-37  Score=321.40  Aligned_cols=194  Identities=29%  Similarity=0.409  Sum_probs=170.2

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||++.+..+++.||+|.++...   ....+.+..|..++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999889999999997642   23445678899999888 699999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~  154 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCccc
Confidence            999888743  346899999999999999999999   79999999999999999999999999999874221 112334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            46799999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.5e-37  Score=328.84  Aligned_cols=203  Identities=23%  Similarity=0.358  Sum_probs=175.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||++++..+++.||+|.+....   ......+.+|+.++++++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999999999999999996542   223456789999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|..+....
T Consensus        81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999999854  345888999999999999999999   7999999999999999999999999999975321000


Q ss_pred             ------------------------------------------CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHH
Q 038860          497 ------------------------------------------NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLL  534 (652)
Q Consensus       497 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~  534 (652)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00012357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 038860          535 EVACGRRPIETRA  547 (652)
Q Consensus       535 elltG~~p~~~~~  547 (652)
                      ||++|+.||....
T Consensus       236 ell~G~~Pf~~~~  248 (376)
T cd05598         236 EMLVGQPPFLADT  248 (376)
T ss_pred             ehhhCCCCCCCCC
Confidence            9999999997644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=325.44  Aligned_cols=208  Identities=30%  Similarity=0.523  Sum_probs=178.1

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      .+.++.....+.+.+...||+|.||+||+|.+.+   .||||.+.-.  .....+.|.+|+.++++-||.||+-++|||.
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            3335555566677788999999999999999976   5999999754  4457789999999999999999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      ..+. .+|..+|+|-+|+.+++... ..++..+.+.|++||++|+.|||   .++|||||||..||+|.++++|||+|||
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence            8877 99999999999999997654 56999999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccC-CCCceeeccCCcCCCCCCCCCC---CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          488 LAKLYEHG-TNPATTRVVGTLGYLAPETPRT---GKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       488 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ++..-..- .........|...|||||++..   .+|++.+||||||+|+|||+||..||..
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi  595 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI  595 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence            98743221 1112233457889999998865   3689999999999999999999999983

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.7e-37  Score=323.22  Aligned_cols=196  Identities=29%  Similarity=0.384  Sum_probs=170.9

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      +.||+|+||.||++.+..+++.||+|.+....   ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999889999999997642   234456788999999999999999999999999999999999999


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceee
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR  502 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  502 (652)
                      +|..++..  ...+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT  155 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence            99888843  3468999999999999999999994  3799999999999999999999999999987533221 22234


Q ss_pred             ccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       503 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            57999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-36  Score=318.27  Aligned_cols=198  Identities=28%  Similarity=0.408  Sum_probs=170.8

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHH---hcccCcCceeEEEeeeeccCeeEEE
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIAT---IGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      |++.+.||+|+||.||+|.+..+++.||||++++..   ....+.+.+|+.+   +++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999999889999999997542   2233456666555   4567899999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|..++..   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999888743   45899999999999999999999   799999999999999999999999999998753221


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence             22234467999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.8e-37  Score=327.28  Aligned_cols=276  Identities=22%  Similarity=0.330  Sum_probs=205.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-----eeE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-----DLL  413 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  413 (652)
                      +|++.+.||+|+||.||++.+..+++.||+|++...  .....+++.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999888999999998653  2334567889999999999999999999998776     789


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|+||+. ++|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 578777743  346899999999999999999999   7999999999999999999999999999998765


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ...........+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.   .........++ .
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~g~~~~~~~-~  230 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT---DLLGTPSLEAM-R  230 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcCCCCHHHH-H
Confidence            4333333445689999999988764 47899999999999999999999998755433322222   22211111000 0


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCC----CcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRS----SDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~----~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      .    ..   +.....+ .......|..    .......+.+.||+.+|+..+|++|++      |+|++..
T Consensus       231 ~----~~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         231 S----AC---EGARAHI-LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             H----hh---HHHHHHH-HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            0    00   0001111 0111111110    111233568899999999999999994      6788763

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-36  Score=324.96  Aligned_cols=203  Identities=25%  Similarity=0.371  Sum_probs=177.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|+..+.||+|+||.||++....+++.||+|.+....   ......+.+|+.++..++|+||+++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999999889999999997532   234456788999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999854  345899999999999999999999   7999999999999999999999999999987542210


Q ss_pred             C----------------------------------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCC
Q 038860          497 N----------------------------------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP  542 (652)
Q Consensus       497 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p  542 (652)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  011235799999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 038860          543 IETRA  547 (652)
Q Consensus       543 ~~~~~  547 (652)
                      |....
T Consensus       236 f~~~~  240 (360)
T cd05627         236 FCSET  240 (360)
T ss_pred             CCCCC
Confidence            97643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.9e-36  Score=309.39  Aligned_cols=195  Identities=31%  Similarity=0.461  Sum_probs=170.9

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ||+|+||+||++.+..+++.||+|.+.....   ...+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999998899999999875422   2345678899999999999999999999999999999999999999


Q ss_pred             cccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceee
Q 038860          425 DSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR  502 (652)
Q Consensus       425 ~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  502 (652)
                      ..++..  .....+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            887743  23456899999999999999999999   79999999999999999999999999999986544322 2334


Q ss_pred             ccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       503 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            57899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-36  Score=316.46  Aligned_cols=200  Identities=28%  Similarity=0.403  Sum_probs=173.5

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCc-CceeEEEeeeeccCeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRH-RNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  416 (652)
                      +|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+..|..++..++| ++|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999999889999999997642   2345667889999999975 56888999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            99999999988843  345889999999999999999999   799999999999999999999999999998743221 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  204 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            12234467999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.8e-36  Score=319.25  Aligned_cols=194  Identities=29%  Similarity=0.410  Sum_probs=169.4

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||++.+..+++.||+|.+++.   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999998999999999764   223445677888888776 799999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~  154 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS  154 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence            999888743  346899999999999999999999   799999999999999999999999999998753221 12233


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            46799999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.3e-36  Score=316.55  Aligned_cols=200  Identities=28%  Similarity=0.391  Sum_probs=173.2

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      +|++.+.||+|+||.||+|++..+++.||+|.+.+..   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999999889999999997642   22334567788888777 5899999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            99999999988843  345889999999999999999999   7999999999999999999999999999997543211


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~  204 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  204 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence             2233457999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=316.31  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=213.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh---hHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ---GVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  413 (652)
                      ....|++.+.||+|.||.||+++...+|+.+|+|.+.+....   ......+|+.+|+++. ||||+++++.+......+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            456788889999999999999999999999999999776432   3467899999999998 999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC----CCeEEeeeccc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE----LNGKLGDFGLA  489 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~----~~~kL~DFGla  489 (652)
                      +|||++.||.|.+.+...  . +++..+..++.|++.++.|||   ..+|+||||||+|+|+...    +.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999655  2 999999999999999999999   7999999999999999643    47999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      .....  .......+||+.|+|||++....++..+||||+||++|.|++|.+||..........               .
T Consensus       187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------------~  249 (382)
T KOG0032|consen  187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------------A  249 (382)
T ss_pred             eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---------------H
Confidence            98765  446677899999999999999999999999999999999999999998754322211               0


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      +    +.+++                 .-.....+...+.+.|++++|+..+|.+|+      .|+|....
T Consensus       250 i----~~~~~-----------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  250 I----LRGDF-----------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             H----HcCCC-----------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            0    11111                 111112234468999999999999999999      68998764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.2e-36  Score=317.35  Aligned_cols=195  Identities=31%  Similarity=0.445  Sum_probs=169.9

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|++..+++.||+|++.+..   ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999997542   23445677888888876 699999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~  154 (320)
T cd05590          81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTS  154 (320)
T ss_pred             chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccc
Confidence            999988844  345899999999999999999999   799999999999999999999999999998753221 12234


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  199 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE  199 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            457999999999999889999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-36  Score=316.92  Aligned_cols=195  Identities=26%  Similarity=0.435  Sum_probs=168.5

Q ss_pred             ccccccCceEEEEEEEc---CCCeEEEEEEecCcc----hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          346 QLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES----KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +.||+|+||.||+++..   .+++.||+|.++...    ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999864   467889999997532    12334577899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++..  ...+.+..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  155 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T  155 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence            999999998843  345788889999999999999999   7999999999999999999999999999987543221 2


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~  203 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE  203 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence            233457999999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-36  Score=317.61  Aligned_cols=195  Identities=29%  Similarity=0.414  Sum_probs=170.0

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|++..+++.||+|++....   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999889999999997642   23445677888888866 799999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~  154 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTT  154 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC-Ccccc
Confidence            999988843  345889999999999999999999   799999999999999999999999999998754322 12233


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~  199 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD  199 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence            457999999999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.2e-36  Score=316.31  Aligned_cols=202  Identities=30%  Similarity=0.408  Sum_probs=177.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.++||+|+||.||++.+..++..+|+|.+.... ......+.+|++++++++||||++++++|...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999999889999999987653 3345678999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            9999999999854  3458889999999999999999994  357999999999999999999999999998755322  


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence             2233468999999999998889999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.4e-37  Score=336.66  Aligned_cols=283  Identities=21%  Similarity=0.273  Sum_probs=201.4

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC------cCceeEEEeeee
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR------HRNLVQLVGWCR  407 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~  407 (652)
                      ++...+++|++.++||+|+||.||+|.+..+++.||||+++.... ..+++..|+.++.+++      |.+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            344556889999999999999999999988899999999965322 2334556777766665      456889999887


Q ss_pred             cc-CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-------
Q 038860          408 RK-GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-------  479 (652)
Q Consensus       408 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-------  479 (652)
                      .. +..++|||++ +++|.+++.+  ...+++..+..++.||+.||.|||+  +.+|+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence            64 5789999988 6788888854  3468999999999999999999994  25999999999999998765       


Q ss_pred             ---------CeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 038860          480 ---------NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE  550 (652)
Q Consensus       480 ---------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~  550 (652)
                               .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                     49999999886422    22345689999999999999999999999999999999999999998765544


Q ss_pred             chhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCC---------CCcccccchhHHHHHhhhccCC
Q 038860          551 ELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPR---------SSDGDKAAEGFDDLLNSLASSS  621 (652)
Q Consensus       551 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~---------~~~~~~~~~~~~dLl~~~~~~~  621 (652)
                      ...++....+.+.........       ......+........+...|.         ........+.+.|||.+|+..|
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCG-------TEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhcc-------chhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            444444333322211100000       000000000000000000000         0000112356889999999999


Q ss_pred             CCCCCC------cccccc
Q 038860          622 FDKTTS------CSYFEN  633 (652)
Q Consensus       622 ~~~r~s------~~~~~~  633 (652)
                      |++|++      |+|+..
T Consensus       426 P~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        426 RQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             hhhCCCHHHHhcCccccc
Confidence            999996      889887

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=317.01  Aligned_cols=203  Identities=23%  Similarity=0.337  Sum_probs=176.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||+++...+++.||+|.+.+.   .....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4788999999999999999999988999999999653   2223456888999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++... ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999998432 345889999999999999999999   7999999999999999999999999999998655433


Q ss_pred             CCceeeccCCcCCCCCCCCCC-----CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ........||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            333334579999999998763     45788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.1e-36  Score=317.03  Aligned_cols=203  Identities=23%  Similarity=0.338  Sum_probs=175.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||++++..+++.+|+|.+.+..   ......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999999889999999986532   223345788999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++.+. ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999542 235889999999999999999999   7999999999999999999999999999998654333


Q ss_pred             CCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            33333457999999999875     346789999999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.6e-36  Score=315.93  Aligned_cols=195  Identities=27%  Similarity=0.381  Sum_probs=170.7

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||++....+++.||+|+++...   ....+.+.+|..++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999889999999997642   23455688899999888 699999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS  154 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence            999888743  346899999999999999999999   799999999999999999999999999998753221 12334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            467999999999999999999999999999999999999999643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.6e-36  Score=317.35  Aligned_cols=195  Identities=30%  Similarity=0.392  Sum_probs=167.4

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHH-HhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIA-TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||+||+|.+..+++.||+|++....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999889999999997542   223344555554 56788999999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS  154 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence            999988844  346889999999999999999999   799999999999999999999999999998753221 22334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  199 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence            467999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-36  Score=317.43  Aligned_cols=203  Identities=23%  Similarity=0.335  Sum_probs=176.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||++++..+++.||+|.+.+..   ......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999889999999986532   223445788999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999542 245889999999999999999999   7999999999999999999999999999998765433


Q ss_pred             CCceeeccCCcCCCCCCCCCC-----CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ........||+.|+|||++.+     +.++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            323334579999999998765     46788999999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-35  Score=304.83  Aligned_cols=193  Identities=31%  Similarity=0.481  Sum_probs=170.0

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ||+|+||.||++....+++.||+|.+....   ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999889999999986532   12234456799999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeecc
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV  504 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  504 (652)
                      .+++.......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            98886655556899999999999999999999   7999999999999999999999999999998654322  223456


Q ss_pred             CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       505 gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      |+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~  196 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            89999999999988899999999999999999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.7e-36  Score=315.14  Aligned_cols=195  Identities=29%  Similarity=0.429  Sum_probs=168.8

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|++..+++.||+|.++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997642   22345567788887754 899999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence            999988843  345889999999999999999999   7999999999999999999999999999987532221 2334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            567999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=316.18  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=194.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .+|+..+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999999889999999986543 23456789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|....      ..++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            9999987543      3456778899999999999999   79999999999999999999999999999987643221 


Q ss_pred             ceeeccCCcCCCCCCCCCC-----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+..                 
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-----------------  286 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC-----------------  286 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-----------------
Confidence            2234579999999998743     234568999999999999999999997322211111000                 


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                                    .+........|     ....+.+.+|+.+|+..+|++|+      .|+|+...
T Consensus       287 --------------~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        287 --------------AICMSQPPEAP-----ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             --------------HHhccCCCCCC-----CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                          00000000001     12345789999999999999999      67777664

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.3e-36  Score=313.36  Aligned_cols=195  Identities=28%  Similarity=0.438  Sum_probs=168.2

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|.+..+++.||+|.++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999997642   22344556677777654 799999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            999988843  345889999999999999999999   7999999999999999999999999999998643322 2334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            567999999999999989999999999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-35  Score=306.76  Aligned_cols=201  Identities=28%  Similarity=0.469  Sum_probs=176.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .|+..+.||+|+||.||++.+..+++.||+|.+....   ......+.+|+.++++++|++++++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999999999999999986542   2233457789999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999999886555556899999999999999999999   7999999999999999999999999999997654322 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence             222347899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.6e-36  Score=313.16  Aligned_cols=195  Identities=27%  Similarity=0.444  Sum_probs=168.8

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|.+..+++.||+|.++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999889999999997642   23345566788888764 899999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|.+++..  ...+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTC  154 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCcee
Confidence            999998843  345889999999999999999999   799999999999999999999999999998753221 12334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            467999999999999989999999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.7e-36  Score=328.93  Aligned_cols=203  Identities=22%  Similarity=0.322  Sum_probs=178.0

Q ss_pred             cCccccccccccCceEEEEEEEcCC-CeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNS-KTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ..|.+.+.||+|++|.||+|....+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3488999999999999999998776 788999987665555556788899999999999999999999999999999999


Q ss_pred             ccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      +++|+|.+++..  ....++++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988753  23446889999999999999999999   7999999999999999999999999999998765432


Q ss_pred             C-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          497 N-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       497 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2 123445799999999999999999999999999999999999999965

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=353.24  Aligned_cols=223  Identities=27%  Similarity=0.500  Sum_probs=182.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ...|...+.||+|+||.||+|++..++..||+|++.......    .+|++++++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            356778889999999999999998889999999986543221    3468889999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++|+|.+++.     .++|.++.+++.|+++||+|||+.++++|+||||||+||+++.++..++. ||.+.....    
T Consensus       765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            99999999993     38999999999999999999998777899999999999999999888875 666543321    


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                       .....||..|+|||++.+..++.++|||||||++|||++|+.||+... .....+.+|+...+........+|+.+..
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence             122367899999999999999999999999999999999999995432 23344666766655555555566666543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=305.72  Aligned_cols=205  Identities=31%  Similarity=0.521  Sum_probs=179.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .+...+.++||+|.||.|.++.... +..||||.++.... ...++|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            4556778999999999999999875 68999999988754 455899999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ||++|+|.+|+.......+......+|+.||++||+||.   +.++|||||.++|+|+|.++++||+|||++|-+..+..
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999997665455667778889999999999999   69999999999999999999999999999995544443


Q ss_pred             C-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHH--HhCCCCCCCCC
Q 038860          498 P-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV--ACGRRPIETRA  547 (652)
Q Consensus       498 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~el--ltG~~p~~~~~  547 (652)
                      . ...+.+-..+|||||.+..++++.++|||+||+++||+  ++.+.||....
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt  745 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT  745 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence            3 33445668899999999999999999999999999997  55888987543

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.6e-36  Score=312.64  Aligned_cols=195  Identities=30%  Similarity=0.435  Sum_probs=169.9

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||++.+..+++.||+|.+++..   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999997642   23445677888888887 699999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (318)
T cd05570          81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTS  154 (318)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccc
Confidence            999988843  346899999999999999999999   799999999999999999999999999998753221 12233


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence            457899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-35  Score=306.97  Aligned_cols=270  Identities=25%  Similarity=0.331  Sum_probs=196.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhccc---CcCceeEEEeeeec-----cC
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRL---RHRNLVQLVGWCRR-----KG  410 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  410 (652)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47889999999999999999999999999999865321  1223455677776665   69999999998864     24


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..+++|||+++ +|.+++.......+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999975 8888886555556899999999999999999999   7999999999999999999999999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ......  ......||..|+|||++.+..++.++|||||||++|||++|++||......+...   ..........    
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~~~----  227 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFDLIGLPP----  227 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH---HHHHHhCCCC----
Confidence            654322  2234568999999999988899999999999999999999999997643322211   1111110000    


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                       +..+..+...    . .-........+.....+...+.+.||+.+|+..+|++|+++.
T Consensus       228 -~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  280 (288)
T cd07863         228 -EDDWPRDVTL----P-RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF  280 (288)
T ss_pred             -hhhCcccccc----c-ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence             0000000000    0 000011111111222234456789999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.5e-36  Score=314.57  Aligned_cols=195  Identities=30%  Similarity=0.380  Sum_probs=167.8

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHH-HhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIA-TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||++.+..+++.||+|++....   .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999889999999997542   223345556655 46778999999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~  154 (325)
T cd05604          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT  154 (325)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence            999888843  346899999999999999999999   799999999999999999999999999998753221 22334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence            467999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.3e-36  Score=313.44  Aligned_cols=200  Identities=27%  Similarity=0.384  Sum_probs=172.7

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  416 (652)
                      +|+..+.||+|+||.||++.+..+++.||+|++....   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999999889999999997542   234456778888888885 677888999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++..  ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999998843  345899999999999999999999   7999999999999999999999999999987543221


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE  204 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence             1233456999999999999889999999999999999999999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-35  Score=308.64  Aligned_cols=201  Identities=30%  Similarity=0.390  Sum_probs=176.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.... .....++.+|++++++++||||+++++.|..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999999889999999987543 33446688999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++...  ..+++..+..++.|+++||.|||+  ..+++||||||+|||++.++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999998543  458899999999999999999994  368999999999999999999999999998754322   


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~  202 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD  202 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence            2234578999999999988889999999999999999999999996543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-35  Score=314.28  Aligned_cols=200  Identities=24%  Similarity=0.320  Sum_probs=171.5

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-----
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-----  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  410 (652)
                      ..++|++.+.||+|+||.||++.+..+++.||+|.+...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999999988999999999653  2334567889999999999999999999986443     


Q ss_pred             -eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          411 -DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       411 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                       ..++||||+++ +|...+.    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999975 5655552    24788889999999999999999   799999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            754322  22334578999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5e-36  Score=327.57  Aligned_cols=277  Identities=20%  Similarity=0.320  Sum_probs=198.5

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeecc--------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--------  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  409 (652)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++.....    ...+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            34679999999999999999999988899999998865322    234699999999999999999876432        


Q ss_pred             CeeEEEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeee
Q 038860          410 GDLLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDF  486 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DF  486 (652)
                      ..+++||||+++ +|.+++..  .....+++..++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 67666532  23456899999999999999999999   79999999999999999664 6999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCC
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEG  565 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  565 (652)
                      |+|+......  ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+....+..+.+....+
T Consensus       216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9998664322  2234578999999998765 468999999999999999999999998755433332222222111111


Q ss_pred             ccccccccccccCCCHHHHHHhhccCCCCCCCCCCC-cccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          566 RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSS-DGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       566 ~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~-~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      .+. .+.+.    +       ..+..+.....+... ......+.+.+|+.+|+..+|++|++      |+||+..++
T Consensus       294 ~~~-~~~~~----~-------~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        294 QLK-EMNPN----Y-------ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHH-Hhchh----h-------hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            000 01110    0       000011000000000 00123467899999999999999985      589887543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-36  Score=287.04  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=204.9

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--------hhhHHHHHHHHHHhccc-CcCceeEEEeeee
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--------KQGVREFVSEIATIGRL-RHRNLVQLVGWCR  407 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  407 (652)
                      ...+.|...+.||+|..+.|-++..+.++...|+|++....        ..-.+.-.+|+.||+++ .||+|+++.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            44567888999999999999999999999999999985421        11234567899999998 5999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      .....++|+|.|+.|.|.++|  ...-.+++...++|++|++.|++|||   .+.||||||||+|||+|++.++||+|||
T Consensus        94 s~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             CcchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence            999999999999999999999  44567999999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhh
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRT------GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGK  561 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  561 (652)
                      .|..+..+.  .....+||++|+|||.+..      ..|+...|+|+.||++|.||.|.+||-...   ++.+.    +.
T Consensus       169 Fa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlML----R~  239 (411)
T KOG0599|consen  169 FACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLML----RM  239 (411)
T ss_pred             eeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHH----HH
Confidence            999876543  4566899999999997653      347889999999999999999999985421   11111    11


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Cccccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFE  632 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~  632 (652)
                      ..            .+.|.-.                ++.| ........||+.+++..+|.+|+      .|+||.
T Consensus       240 Im------------eGkyqF~----------------speW-adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  240 IM------------EGKYQFR----------------SPEW-ADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             HH------------hcccccC----------------Ccch-hhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            11            1222110                1112 23356889999999999999999      578883

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.9e-35  Score=302.79  Aligned_cols=200  Identities=28%  Similarity=0.446  Sum_probs=176.2

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      |+..+.||+|+||+||++.+..+++.||+|.+....   ......+.+|+.++++++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999999889999999986542   22334578899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886555557999999999999999999999   7999999999999999999999999999997654322  


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ......|+..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            223457899999999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-35  Score=301.39  Aligned_cols=204  Identities=30%  Similarity=0.493  Sum_probs=173.4

Q ss_pred             hcCccccccccccCceEEEEEEEc---CCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|.+.   ..+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            457889999999999999999875   345789999997653 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +++++||||||+|||++.++.+|++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999998543 246899999999999999999999   79999999999999999999999999998765322


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ..........++..|+|||.+.+..++.++|||||||++||+++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~  212 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            21111222345678999999999999999999999999999875 99999653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.1e-35  Score=307.18  Aligned_cols=278  Identities=24%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57899999999999999999998889999999986543 22334677899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      ++ ++|.+++... ...+++..+..++.|+++||.|||   +.+++||||||+|||++.++.+||+|||++....... .
T Consensus        86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (301)
T cd07873          86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K  159 (301)
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence            97 5888887543 335889999999999999999999   7999999999999999999999999999997543322 1


Q ss_pred             ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......+++.|+|||.+.+ ..++.++|||||||++|||++|++||......+....+....+...+.....+++.    
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  235 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN----  235 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc----
Confidence            2223457889999998765 45788999999999999999999999765433222211111111111111111000    


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                          .  .......+...........+...+.+.||+.+|+..+|.+|++      |+||..
T Consensus       236 ----~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         236 ----E--EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             ----c--cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                0  0000111111000001122234567899999999999999994      666654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.4e-35  Score=300.50  Aligned_cols=249  Identities=29%  Similarity=0.448  Sum_probs=201.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .+|+..+.||+|++|.||+|.+...++.||+|.+.... ....++.+|++++++++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999998889999999987543 34567899999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.......+++..++.++.|+++||+|||   +++++||||||+||++++++.+||+|||+++.........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9999999986555566899999999999999999999   7999999999999999999999999999998765432222


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+   .    +....               
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~---------------  219 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLE---------------  219 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHH---------------
Confidence            222334678999999988899999999999999999998 999986532211   0    00000               


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                              .....    ..|     ....+.+.+++.+|+..+|++||+...+
T Consensus       220 --------~~~~~----~~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~l  255 (263)
T cd05052         220 --------KGYRM----ERP-----EGCPPKVYELMRACWQWNPSDRPSFAEI  255 (263)
T ss_pred             --------CCCCC----CCC-----CCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence                    00000    001     1123678999999999999999987664

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=312.78  Aligned_cols=275  Identities=24%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----  409 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  409 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999998889999999987542  23345678899999999999999999987543     


Q ss_pred             -CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          410 -GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       410 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                       ...++++|++ +++|.+++.   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence             3578999988 778888773   345899999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..   ......... ..
T Consensus       165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~-~~  236 (343)
T cd07878         165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL---KRIMEVVGT-PS  236 (343)
T ss_pred             ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHhCC-CC
Confidence            9865432    234568999999999876 56889999999999999999999999764332211   111111111 00


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCC---CcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRS---SDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~---~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      .+.+.. +...  ........+.     ..|..   .......+.+.||+.+|+..+|++|++      |+||...
T Consensus       237 ~~~~~~-~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         237 PEVLKK-ISSE--HARKYIQSLP-----HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHHHHh-cchh--hHHHHhhccc-----cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            011100 0000  0000111110     01111   011123456889999999999999995      5898764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=314.39  Aligned_cols=189  Identities=31%  Similarity=0.527  Sum_probs=168.5

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      ..++.||.|+.|.||+|++++  +.||||+++...       ..+|+-|++|+||||+.+.|+|.....+|||||||..|
T Consensus       127 sELeWlGSGaQGAVF~Grl~n--etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLHN--ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhccCcccceeeeeccC--ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            346889999999999999974  889999885432       24788899999999999999999999999999999999


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceee
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR  502 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  502 (652)
                      .|.+.|.  ...++.......|.++||.|+.|||   ...|||||||.-||||..+..+||+|||-++.....  .....
T Consensus       198 qL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS  270 (904)
T KOG4721|consen  198 QLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS  270 (904)
T ss_pred             cHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence            9999994  4456888899999999999999999   799999999999999999999999999998865432  23345


Q ss_pred             ccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       503 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ++||..|||||++.+.+.++|+|||||||||||||||.-||.+.+
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd  315 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD  315 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence            789999999999999999999999999999999999999998654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=318.08  Aligned_cols=202  Identities=33%  Similarity=0.492  Sum_probs=173.6

Q ss_pred             CccccccccccCceEEEEEEEcCCC----eEEEEEEecC---cchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSK----TEVAVKRISN---ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      +....++||+|+||.||+|.+...+    ..||||..+.   .......+|++|.++|++++|||||+++|++.....++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            3445589999999999999987532    2389999985   34677889999999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|||+|.||+|.++|.+... .++..++++++.+.|.||+|||   +++++||||..+|+|++.++.+||+|||+++.-.
T Consensus       238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999965543 6999999999999999999999   7999999999999999999999999999987543


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ... .......-..+|+|||.+..+.++.++|||||||++||+.+ |..||.+..
T Consensus       314 ~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~  367 (474)
T KOG0194|consen  314 QYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK  367 (474)
T ss_pred             cee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence            111 01111134679999999999999999999999999999999 899998754

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-35  Score=311.53  Aligned_cols=195  Identities=30%  Similarity=0.392  Sum_probs=166.2

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHH-HhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIA-TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||++++..+++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999889999999997542   122334444544 56778999999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|.+++..  ...+.+..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~  154 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS  154 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence            999998854  345778888899999999999999   799999999999999999999999999999753221 22334


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence            567999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-35  Score=310.40  Aligned_cols=195  Identities=30%  Similarity=0.393  Sum_probs=166.7

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHH-HhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIA-TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|++..+++.||+|++.+..   ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999997542   223344555554 57888999999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      ++|..++..  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS  154 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence            999888743  345888889999999999999999   799999999999999999999999999998753221 12234


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence            457999999999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.9e-35  Score=302.40  Aligned_cols=192  Identities=19%  Similarity=0.327  Sum_probs=165.7

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhh---HHHHHHHHHHhcccCcCceeEEEeeeec----cCeeEEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRNLVQLVGWCRR----KGDLLLVYD  417 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e  417 (652)
                      ...||+|++|.||+|.+.  ++.||||+++......   .+.+.+|+.+|++++||||+++++++.+    ....++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            367999999999999984  7899999997653322   5678899999999999999999999876    356899999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++|+|.+++...  ..+++....+++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||+++.....  
T Consensus       103 y~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--  176 (283)
T PHA02988        103 YCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--  176 (283)
T ss_pred             eCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence            99999999999543  468899999999999999999994  358889999999999999999999999999865322  


Q ss_pred             CceeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                        .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~  225 (283)
T PHA02988        177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL  225 (283)
T ss_pred             --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence              123468899999999876  67899999999999999999999999753

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-35  Score=320.90  Aligned_cols=195  Identities=25%  Similarity=0.298  Sum_probs=169.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ..+|.+.+.||+|+||.||++.+...++.||||....      ..+.+|+.++++++|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999999899999996432      2356899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC-
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-  497 (652)
                      +. ++|..++... ...+++.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       242 ~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 YR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            95 6888887443 236999999999999999999999   79999999999999999999999999999986543222 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      .......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            12234579999999999999999999999999999999999887653

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.3e-35  Score=314.23  Aligned_cols=200  Identities=23%  Similarity=0.311  Sum_probs=171.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  409 (652)
                      ..++|+..+.||+|+||.||++.+...++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999999888999999999754  233456788999999999999999999987543      


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      ...++||||+++ +|.+++.    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999965 6766662    24788899999999999999999   799999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +.....  .......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            865332  22234578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.5e-35  Score=306.95  Aligned_cols=197  Identities=24%  Similarity=0.379  Sum_probs=160.8

Q ss_pred             cccccccCceEEEEEEEcC--CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec--cCeeEEEEEecc
Q 038860          345 KQLLGHGGFGQVYKGTLHN--SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--KGDLLLVYDFMA  420 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~  420 (652)
                      .++||+|+||.||+|+...  +++.||+|.+.....  ...+.+|+.++++++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4679999999999999753  568899999865432  2456789999999999999999998854  456899999996


Q ss_pred             CCCcccccccC-------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe----CCCCCeEEeeeccc
Q 038860          421 NGSLDSFLFDE-------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL----DSELNGKLGDFGLA  489 (652)
Q Consensus       421 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl----~~~~~~kL~DFGla  489 (652)
                      + +|.+++...       ....+++..+..++.||+.||.|||   +++|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 777665321       2235889999999999999999999   7999999999999999    45678999999999


Q ss_pred             eecccCCC--CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          490 KLYEHGTN--PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       490 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87643322  12234678999999998876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-36  Score=312.76  Aligned_cols=195  Identities=28%  Similarity=0.396  Sum_probs=169.9

Q ss_pred             ccccccCceEEEEEEEc---CCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          346 QLLGHGGFGQVYKGTLH---NSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      +.||+|+||.||+++..   .+++.||+|++.....  .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998763   4678999999976432  234457789999999999999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~  155 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA  155 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence            9999998843  346899999999999999999999   7999999999999999999999999999998653321 233


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  201 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK  201 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence            4467999999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.9e-35  Score=305.63  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=195.5

Q ss_pred             hcCccccccccccCceEEEEEEEcC----------------CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN----------------SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQ  401 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  401 (652)
                      .++|++.++||+|+||.||++.+..                .+..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999998643                33479999987653 334567999999999999999999


Q ss_pred             EEeeeeccCeeEEEEEeccCCCcccccccCC-----------------ccccchHHHhhhHHHHHHHHhhhccCccceEE
Q 038860          402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI  464 (652)
Q Consensus       402 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv  464 (652)
                      +++++...+..++||||+++|+|.+++....                 ...+++..+++++.||+.||.|||   +.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999998874321                 134788899999999999999999   78999


Q ss_pred             ecCCCCCceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh--CCC
Q 038860          465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC--GRR  541 (652)
Q Consensus       465 HrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt--G~~  541 (652)
                      ||||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865432211 1223355789999999988899999999999999999987  556


Q ss_pred             CCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCC
Q 038860          542 PIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSS  621 (652)
Q Consensus       542 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~  621 (652)
                      ||......+   ....+...+..                       ... .....+|.     ...+.+.+|+.+|+..+
T Consensus       241 p~~~~~~~~---~~~~~~~~~~~-----------------------~~~-~~~~~~~~-----~~~~~~~~li~~cl~~~  288 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFFRD-----------------------QGR-QVYLFRPP-----PCPQGLYELMLQCWSRD  288 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHhhh-----------------------ccc-cccccCCC-----CCCHHHHHHHHHHccCC
Confidence            666432111   11111111100                       000 00000111     12357899999999999


Q ss_pred             CCCCCCcccc
Q 038860          622 FDKTTSCSYF  631 (652)
Q Consensus       622 ~~~r~s~~~~  631 (652)
                      |++||+....
T Consensus       289 p~~RPs~~~i  298 (304)
T cd05096         289 CRERPSFSDI  298 (304)
T ss_pred             chhCcCHHHH
Confidence            9999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-34  Score=297.61  Aligned_cols=194  Identities=29%  Similarity=0.430  Sum_probs=172.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|+..+.||+|++|.||+|.+..+++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999999888999999998654 334456789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|..+.      .+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.++|+|||++......   
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            9999987553      4678888999999999999999   799999999999999999999999999999865432   


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......|+..|+|||++.+..++.++|+||||+++|||++|+.||..
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            22335789999999999998999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-35  Score=325.65  Aligned_cols=209  Identities=26%  Similarity=0.348  Sum_probs=179.0

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-  410 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  410 (652)
                      +.....++|++.+.||+|+||.||++++..+++.||||++...  .......+.+|+.++..++|+|+++++..+.... 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            3445567999999999999999999999888999999998654  3345567889999999999999999988765432 


Q ss_pred             -------eeEEEEEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          411 -------DLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       411 -------~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                             .+++||||+++|+|.+++...  ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence                   368999999999999988542  2356899999999999999999999   7999999999999999999999


Q ss_pred             EEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          482 KLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       482 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999987643221 223346799999999999999999999999999999999999999975

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-36  Score=310.84  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe-eEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD-LLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~  416 (652)
                      ++|...+.+|+|+||.+++.+++..+..+++|.+.-.  .....+..++|+.++++++|||||.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5788899999999999999999988899999998654  23344567899999999999999999999998888 99999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      +||+||+|.+.+.+++..-++++.+..++.|++.|+.|||   +..|+|||||+.||++..+..+||+|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997777677999999999999999999999   7999999999999999999999999999999876543


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       .....++||+.||+||.+.+.+|..|+|||||||++|||++=+++|...+..   .++..+.+..        .+|.-.
T Consensus       161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~~--------~~Plp~  228 (426)
T KOG0589|consen  161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRGL--------YSPLPS  228 (426)
T ss_pred             -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhcc--------CCCCCc
Confidence             2445678999999999999999999999999999999999999999875432   2333222221        233222


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCC
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSS  601 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~  601 (652)
                      ..-.....++..+....+..||...
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~  253 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSAL  253 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHH
Confidence            2223333444555555666666653

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-35  Score=311.08  Aligned_cols=193  Identities=24%  Similarity=0.335  Sum_probs=167.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ...+|++.+.||+|+||.||+|....++..||+|......      ...|+.++++++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999999888999999854432      3468999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+. ++|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       138 ~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        138 HYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             ccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            995 5888887543 346899999999999999999999   789999999999999999999999999999753321  


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI  543 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~  543 (652)
                      .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            2233457899999999999999999999999999999999866554

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=334.25  Aligned_cols=208  Identities=32%  Similarity=0.540  Sum_probs=179.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCC-----eEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      ..+.+..+.||+|.||.||.|...+..     ..||||.+.+. +.+...+|++|..+|++++|||||+++|+|.+.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            445667788999999999999987533     34999999876 456678999999999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccC-----CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          413 LLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      ++++|||++|+|..||++.     ....|+...++.++.|||+|+.||+   +++.|||||.++|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999654     1456899999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCCcee-eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCc
Q 038860          488 LAKLYEHGTNPATT-RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALP  549 (652)
Q Consensus       488 la~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~  549 (652)
                      +|+.+......... +..-...|||||.+..+.++.|+|||||||+|||++| |..||......
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~  911 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF  911 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence            99954433332222 2244579999999999999999999999999999999 99999876543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.2e-35  Score=296.86  Aligned_cols=250  Identities=27%  Similarity=0.460  Sum_probs=200.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.++||+|++|.||+|...+ +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            4678999999999999999999764 5679999986543 2356789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            99999999997655567899999999999999999999   799999999999999999999999999999876543322


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......++..|+|||++....++.++|||||||++|||++ |+.||......+   ....+..                 
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~-----------------  219 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR-----------------  219 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc-----------------
Confidence            2233346778999999988889999999999999999998 999986532111   1111000                 


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccccc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFE  632 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~~  632 (652)
                                .      .+.|...   ...+.+.+++.+|+..+|++||+.+-+.
T Consensus       220 ----------~------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~  255 (261)
T cd05072         220 ----------G------YRMPRME---NCPDELYDIMKTCWKEKAEERPTFDYLQ  255 (261)
T ss_pred             ----------C------CCCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence                      0      0001111   2235788999999999999999887654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.9e-35  Score=313.75  Aligned_cols=278  Identities=21%  Similarity=0.270  Sum_probs=203.0

Q ss_pred             cCccccccccccCceEEEEEEEcC--CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHN--SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .+|++.+.||+|+||.||++...+  .+..||+|.+...     +...+|+.++++++||||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            468999999999999999997643  4578999988653     234579999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ++. ++|.+++  .....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.++|+|||+++.......
T Consensus       167 ~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        167 KYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            995 5888888  33456899999999999999999999   79999999999999999999999999999986543322


Q ss_pred             -CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 -PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+.......... . ..  .
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~-~-~~--~  316 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE-F-PQ--N  316 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc-c-CC--c
Confidence             22334679999999999999999999999999999999999999997755443333233333322211110 0 00  0


Q ss_pred             cCCCHHHHHHhhccCCC--CCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          577 AEYDQSQVLMGELELPD--TLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~--~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                      ......+ ....+....  ....|...........+.+++.+|+..+|++|+      .|+||..
T Consensus       317 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        317 GSTNLCK-HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             cchhHHH-HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence            0000011 111111100  001111111112345788999999999999999      5666654

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.5e-35  Score=313.39  Aligned_cols=206  Identities=30%  Similarity=0.444  Sum_probs=173.1

Q ss_pred             hhcCccccccccccCceEEEEEEE-----cCCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  410 (652)
                      ..++|++.+.||+|+||.||+|.+     .+++..||||+++... ....+.+.+|+.++..+ +||||++++++|...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345799999999999999999974     3456789999997543 33446788999999999 8999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCC----------------------------------------------------------
Q 038860          411 DLLLVYDFMANGSLDSFLFDEP----------------------------------------------------------  432 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  432 (652)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999988884321                                                          


Q ss_pred             ---------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          433 ---------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       433 ---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                                     ...+++..+++++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                           124788899999999999999999   79999999999999999999999999999986543322


Q ss_pred             Cc-eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          498 PA-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       498 ~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .. .....++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            11 122345678999999999999999999999999999998 88888653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.4e-35  Score=296.57  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++..++..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999999888999999999765545556788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++..  ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        88 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06646          88 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A  161 (267)
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence            999999998843  346889999999999999999999   7999999999999999999999999999998654322 1


Q ss_pred             ceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||......+..               ..+....+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---------------~~~~~~~~  226 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---------------FLMSKSNF  226 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---------------eeeecCCC
Confidence            223346889999999874   345788999999999999999999998643211100               00000000


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                          ..|.........+.+.+++++|+..+|++||+.+.
T Consensus       227 --------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  261 (267)
T cd06646         227 --------------------QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAER  261 (267)
T ss_pred             --------------------CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence                                00011011123468899999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.5e-35  Score=313.87  Aligned_cols=205  Identities=30%  Similarity=0.486  Sum_probs=172.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  410 (652)
                      ..++|++.+.||+|+||.||+|....     ++..||+|++.... ......+.+|+.+++.+ +|+||++++++|...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            34578999999999999999998643     33579999997543 33456688999999999 8999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCC----------------------------------------------------------
Q 038860          411 DLLLVYDFMANGSLDSFLFDEP----------------------------------------------------------  432 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  432 (652)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999998874321                                                          


Q ss_pred             ----------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc-ee
Q 038860          433 ----------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TT  501 (652)
Q Consensus       433 ----------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~  501 (652)
                                ...+++.++++++.||+.||.|||   +++|+||||||+|||+++++.+||+|||+++......... ..
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                      124788899999999999999999   7999999999999999999999999999998654332211 11


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      ...++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~  317 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG  317 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            2345678999999998899999999999999999997 9999965

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-35  Score=299.36  Aligned_cols=199  Identities=34%  Similarity=0.536  Sum_probs=176.1

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhH--HHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      |+..+.||+|+||+||++....+++.||+|.+........  ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6778999999999999999999999999999987644332  23456999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.  ....+++..+..++.|+++||.+||   +.+++|+||||+||+++.++.++|+|||.+... ......
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNEN  154 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSE
T ss_pred             cccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999995  3456899999999999999999999   689999999999999999999999999999864 222234


Q ss_pred             eeeccCCcCCCCCCCCC-CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPR-TGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .....++..|+|||.+. +...+.++||||+|+++|+|++|..||...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            44567899999999988 788999999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-34  Score=293.18  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|++|.||++....+++.|++|.+...  ......++.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477889999999999999999988999999998643  344567789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            99999999997654567899999999999999999999   79999999999999999999999999999987654322 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      ......|+..|+|||+..+..++.++|+||||+++|||++|+.||.....   .......    ..            +.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~------------~~  217 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKI----IR------------GV  217 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----Hc------------CC
Confidence            22334688999999999999999999999999999999999999975331   1111100    00            00


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                                       ..+...   ...+.+.+++.+|+..+|++||++.
T Consensus       218 -----------------~~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~  248 (256)
T cd08529         218 -----------------FPPVSQ---MYSQQLAQLIDQCLTKDYRQRPDTF  248 (256)
T ss_pred             -----------------CCCCcc---ccCHHHHHHHHHHccCCcccCcCHH
Confidence                             000010   2235789999999999999999754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=292.52  Aligned_cols=201  Identities=30%  Similarity=0.480  Sum_probs=175.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-----hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-----KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ++|+..+.||+|++|.||++....+++.||+|.+....     ....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999998889999999986432     2234578899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |+||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||||+||+++++++++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999998843  345888999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCCce--eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 GTNPAT--TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......  ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            222111  234678899999999998899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-35  Score=313.86  Aligned_cols=200  Identities=24%  Similarity=0.318  Sum_probs=171.6

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  409 (652)
                      ..++|+..+.||+|+||.||++.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999999888999999999754  233456778899999999999999999988543      


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            357999999965 6666652    34788999999999999999999   799999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +.....  .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            864332  22334578999999999999899999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-34  Score=297.95  Aligned_cols=202  Identities=29%  Similarity=0.447  Sum_probs=172.3

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|++.+.||+|++|.||+|.+..+++.||+|.++...  ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999998889999999986542  22346788899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCC-ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEP-KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ++ ++|.+++.... ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58888775432 356899999999999999999999   7999999999999999999999999999998654322 


Q ss_pred             CceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            122234678899999987654 57889999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-34  Score=298.81  Aligned_cols=249  Identities=25%  Similarity=0.433  Sum_probs=197.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCC-----eEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ++|++.+.||+|+||.||+|.....+     ..||+|.+.... .....++.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            46888999999999999999986544     679999987543 334567899999999999999999999999989999


Q ss_pred             EEEEeccCCCcccccccCCc--------------cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC
Q 038860          414 LVYDFMANGSLDSFLFDEPK--------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL  479 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~  479 (652)
                      ++|||+++++|.+++.....              ..+++..++.++.|++.||.|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999854321              45888999999999999999999   79999999999999999999


Q ss_pred             CeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHH
Q 038860          480 NGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDW  557 (652)
Q Consensus       480 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~  557 (652)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+   ....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999986533221 22333456889999999988899999999999999999998 999987533211   1110


Q ss_pred             HHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          558 VWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       558 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                          ...                           ..  ..+.+   ....+.+.+|+.+|+..+|++||+..-
T Consensus       239 ----i~~---------------------------~~--~~~~~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~  275 (283)
T cd05048         239 ----IRS---------------------------RQ--LLPCP---EDCPARVYALMIECWNEIPARRPRFKD  275 (283)
T ss_pred             ----HHc---------------------------CC--cCCCc---ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence                000                           00  00111   122467889999999999999998654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.9e-35  Score=330.27  Aligned_cols=203  Identities=24%  Similarity=0.366  Sum_probs=175.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.++||+|+||.||+|.+..+++.||+|++....   ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999999889999999997542   233467899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccC---------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          417 DFMANGSLDSFLFDE---------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       417 e~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      ||+++|+|.+++...         ....+++..+++++.||++||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988431         1234567788999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCC-----------------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          488 LAKLYEHGTN-----------------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       488 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      +++.......                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9986621110                 011234699999999999999999999999999999999999999975

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-34  Score=299.15  Aligned_cols=273  Identities=24%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|+..+.||+|++|.||+|.+..+++.||+|++....  ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999999889999999986542  2234567899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |++++.|..++..  ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            9999888877633  335899999999999999999999   79999999999999999999999999999987654321


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+....+......... ...+..++.  
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--  231 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTN--  231 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhcccc--
Confidence             2223457889999998765 45789999999999999999999999865443322221111111100 000000000  


Q ss_pred             cCCCHHHHHHhhccCCCCCC-CCCCCcccccchhHHHHHhhhccCCCCCCCCc
Q 038860          577 AEYDQSQVLMGELELPDTLR-GPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~-~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~  628 (652)
                       .+      ...+..+.... .|.....+...+.+.+|+.+|+..+|++||+.
T Consensus       232 -~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  277 (286)
T cd07847         232 -QF------FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC  277 (286)
T ss_pred             -cc------cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH
Confidence             00      00111111111 11111112335678899999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=266.26  Aligned_cols=269  Identities=25%  Similarity=0.348  Sum_probs=213.5

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .|...++||+|.||+||+|+..++++.||+|+++-+.  ..-....++|+.+++.++|+|||++++....++.+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4667889999999999999999999999999986543  22345678999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      |.. +|..|... -+..++.+..+.++.|+++||.++|   +..+.|||+||.|.|++.+|+.||+|||+++.+.-.- .
T Consensus        83 cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv-r  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R  156 (292)
T ss_pred             hhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence            954 78877633 3556899999999999999999999   6999999999999999999999999999999765422 2


Q ss_pred             ceeeccCCcCCCCCCCCCCCC-CCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      ..+..+-|..|.+|.++.+.+ |+...|+||.||++.|+.. |++.|.+.+..++...+-|+.+...++..-.+-.  | 
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~--l-  233 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK--L-  233 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc--C-
Confidence            334446799999999998865 7888999999999999987 7777888888888887778777776654322210  0 


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCC---CcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRS---SDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~---~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                      .+|.           +.+...+..   ...++....-+|||++++..+|..|++++
T Consensus       234 pdyk-----------~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae  278 (292)
T KOG0662|consen  234 PDYK-----------PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE  278 (292)
T ss_pred             CCCc-----------ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence            1111           111111222   22244556679999999999999999753

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-34  Score=293.46  Aligned_cols=201  Identities=30%  Similarity=0.495  Sum_probs=172.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|++.+.||+|+||.||++.... +..+|+|.+.... ....++.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            468888999999999999998865 5679999886442 23467889999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++|+|.+++.... ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||.++.........
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999885433 35889999999999999999999   7999999999999999999999999999988653322222


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            223345678999999988889999999999999999999 89998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9.5e-35  Score=301.59  Aligned_cols=281  Identities=24%  Similarity=0.308  Sum_probs=207.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-----hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-----GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      +|+..+.||+|++|.||+|.+..+++.||+|.+......     ....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477888999999999999999888999999999765322     334577899999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+ +++|.+++.... ..+++..++.++.||++||.|||   +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 889999985433 36899999999999999999999   799999999999999999999999999999876543


Q ss_pred             CCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      . .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+   ............         
T Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~---------  222 (298)
T cd07841         156 N-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTP---------  222 (298)
T ss_pred             C-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCC---------
Confidence            2 22233456788999998754 467889999999999999999988886543221   112221111100         


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccccC
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYPS  639 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~~  639 (652)
                      ....+..................+.........+.+.+++.+|+..+|++|+      .++||++.....+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence            0000000000000010001111111111223356789999999999999998      6889998766654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=301.23  Aligned_cols=204  Identities=28%  Similarity=0.391  Sum_probs=178.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|+..+.||+|++|.||++....+++.||+|.+.....   ...+.+..|++++++++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368889999999999999999998899999999976532   24567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++.......+++..+..++.|++.||+|||   ..+++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999986555567999999999999999999999   7999999999999999999999999999987553221


Q ss_pred             CC----------------------------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NP----------------------------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            10                            111246889999999999888999999999999999999999999754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=297.96  Aligned_cols=205  Identities=27%  Similarity=0.448  Sum_probs=185.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..+.|+.-++||+||||.||-++...+|+.+|.|++.+.   .+++...-++|-.+|.+++.+.||.+--.|+..+.+||
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            446788889999999999999999999999999998654   23344557889999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |+..|.||+|.-+|+...+..+++..++.++.+|+.||++||   ..+||.||+||+|||||+.|+++|+|+|||..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999998877778999999999999999999999   79999999999999999999999999999998765


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +.  .....+||.+|||||++.++.|+...|.|||||+||||+.|+.||....
T Consensus       340 g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  340 GK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             CC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            43  3333489999999999999999999999999999999999999997543

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=310.17  Aligned_cols=193  Identities=29%  Similarity=0.402  Sum_probs=163.9

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhccc---CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRL---RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      ||+|+||.||+|++..+++.||+|++.....   .....+..|..++.+.   +||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999998899999999965321   2233455677776655   699999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|..++..  ...+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~  154 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN  154 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence            999988843  446899999999999999999999   7999999999999999999999999999987543221 2233


Q ss_pred             eccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...||..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~  200 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE  200 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence            45799999999988764 4789999999999999999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-34  Score=295.84  Aligned_cols=205  Identities=29%  Similarity=0.451  Sum_probs=175.8

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeecc-----
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK-----  409 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----  409 (652)
                      +.+++.|+..+.||+|+||.||+|....+++.||+|.+.... .....+.+|+.++.++ +|+|++++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            346778999999999999999999999889999999986543 3345678899999998 699999999998753     


Q ss_pred             -CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          410 -GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       410 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                       ...+++|||+++++|.+++.......+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence             45899999999999999986544557899999999999999999999   68999999999999999999999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ++...... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            98654322 2233457899999999876     34578899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-34  Score=291.58  Aligned_cols=203  Identities=33%  Similarity=0.506  Sum_probs=175.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|++|.||+|.+.. ++.||+|.++... ...+++.+|+.++++++||||+++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            34678999999999999999999765 5789999987643 335678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++.......+++..+..++.|++.||.|||   +++++||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999996655456899999999999999999999   79999999999999999999999999999987653222


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      ........+..|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  207 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG  207 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence            22222233468999999998899999999999999999999 9999865

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.9e-34  Score=294.30  Aligned_cols=201  Identities=28%  Similarity=0.420  Sum_probs=176.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|+..+.||+|+||.||+|.+..+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            45788899999999999999999888999999998766555556788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++..  ...+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++....... .
T Consensus        88 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06645          88 CGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A  161 (267)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence            999999998843  346899999999999999999999   7899999999999999999999999999987654322 2


Q ss_pred             ceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......|+..|+|||++.   ...++.++|+|||||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence            233457899999999874   45688899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-34  Score=299.81  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=208.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|+..+.||+|++|.||++....+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            46899999999999999999999888999999999765555556788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.+   ..+++.++..++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++........ 
T Consensus        98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            999999998843   35788999999999999999999   79999999999999999999999999999986543322 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........               ...   ..+ 
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---------------~~~---~~~-  231 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---------------LIA---TNG-  231 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---------------eec---cCC-
Confidence            2233468899999999998889999999999999999999999996532211000               000   000 


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccccCCC
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYPSLS  641 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~~~~  641 (652)
                                        .|.........+.+.+++.+|+..+|++|+      .|+|++....+++..
T Consensus       232 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  282 (297)
T cd06656         232 ------------------TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLT  282 (297)
T ss_pred             ------------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccccC
Confidence                              000000012235678999999999999999      577888776666543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=294.74  Aligned_cols=194  Identities=30%  Similarity=0.488  Sum_probs=161.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcc--cCcCceeEEEeeeecc----Cee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR--LRHRNLVQLVGWCRRK----GDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~  412 (652)
                      ..+..+.+.||+|.||.||+|.++  |+.||||++....+   +.+.+|.+|.+.  |+|+||+.+++.-..+    .++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            456788899999999999999998  58899999976543   345566666655  5999999999876544    378


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC-----ccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG-----YEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      |||.+|.+.|||.+||.   ..+++....++++..+|.||++||.+     -++.|.|||||+.|||+.+++...|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEeeecccCCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            99999999999999994   35799999999999999999999963     36789999999999999999999999999


Q ss_pred             cceecccCCCC---ceeeccCCcCCCCCCCCCCCC------CCCccchHhHHHHHHHHHhCC
Q 038860          488 LAKLYEHGTNP---ATTRVVGTLGYLAPETPRTGK------SSASSDVFAFGALLLEVACGR  540 (652)
Q Consensus       488 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~SlGvvl~elltG~  540 (652)
                      ||.....+.+.   .....+||.+|||||++....      .-..+||||||.|+||++.+.
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc  423 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC  423 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence            99987665432   234568999999999887543      234689999999999997653

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-34  Score=297.33  Aligned_cols=274  Identities=23%  Similarity=0.305  Sum_probs=203.7

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|++.+.||+|++|.||+|.+..++..||+|++....  ......+.+|+.++++++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999998889999999987653  33456789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      + +++|.+++.... ..+++.+++.++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999885433 56899999999999999999999   799999999999999999999999999999876543322


Q ss_pred             ceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......|+..|+|||.+.+. .++.++||||+|++++||++|++||......   ....++.........  ...+.+..
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~  230 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNE--ETWPGLTS  230 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCCh--HHHhhccC
Confidence            33445789999999988654 4688999999999999999998888654322   222222222211100  00000000


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                      -.+     ...+..+.....+.....+...+.+.+|+++|+..+|++|+++.
T Consensus       231 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  277 (286)
T cd07832         231 LPD-----YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA  277 (286)
T ss_pred             cch-----hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHH
Confidence            000     00111111111111111123347889999999999999999653

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-34  Score=294.38  Aligned_cols=204  Identities=32%  Similarity=0.538  Sum_probs=180.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ...+|+..+.||+|++|.||+|.+.. +..+|+|.+.........++.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            45678899999999999999999987 88999999987766566788999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++.+.....+++.+++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999999997666667899999999999999999999   79999999999999999999999999999986543221


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence             2223346778999999988889999999999999999998 89998653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.7e-35  Score=299.46  Aligned_cols=274  Identities=26%  Similarity=0.330  Sum_probs=201.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|+..+.||+|++|.||+|.+.++++.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468889999999999999999988899999999865422  234568899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.++...  ...+++.+++.++.|+++||.|||   +.+++||||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            9999888877633  234899999999999999999999   6899999999999999999999999999998654432 


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      .......++..|+|||++.+ ..++.++||||||+++|||++|++||......+....+......+.         +...
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~  225 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI---------PRHQ  225 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc---------hhhH
Confidence            22333567899999998765 4578899999999999999999999975432221111111111110         0000


Q ss_pred             cCCCHHHHHHhhccCCCC-CCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          577 AEYDQSQVLMGELELPDT-LRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~-~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                      ..++..... ..+..+.. ...+.....+...+.+.+|+.+|+..+|++||+..
T Consensus       226 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  278 (286)
T cd07846         226 EIFQKNPLF-AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS  278 (286)
T ss_pred             HHhccchHh-hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHH
Confidence            000100000 00111110 01111111223457899999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2e-34  Score=296.09  Aligned_cols=251  Identities=25%  Similarity=0.442  Sum_probs=199.2

Q ss_pred             hcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      ..+|.+.+.||+|+||.||+|...+     .+..||+|.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568889999999999999998753     3578999999765444 457899999999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCC------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          413 LLVYDFMANGSLDSFLFDEP------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      ++||||+++++|.+++....            ...+++.++..++.|++.||.|||   +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999985421            245889999999999999999999   789999999999999999999


Q ss_pred             eEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHH
Q 038860          481 GKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWV  558 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~  558 (652)
                      +||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence            99999999986533221 11223346788999999999999999999999999999998 999986532211   11110


Q ss_pred             HhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          559 WGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       559 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                      .    .                           ......|.     .....+.+++.+|+..+|++|++..-+
T Consensus       238 ~----~---------------------------~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~ei  274 (280)
T cd05049         238 T----Q---------------------------GRLLQRPR-----TCPSEVYDIMLGCWKRDPQQRINIKDI  274 (280)
T ss_pred             H----c---------------------------CCcCCCCC-----CCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            0    0                           00000011     223578999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-34  Score=298.30  Aligned_cols=200  Identities=25%  Similarity=0.430  Sum_probs=178.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .+|+..+.||.|++|.||+|.+..+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            56899999999999999999998889999999997655555677889999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++..   ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........ .
T Consensus        99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  171 (296)
T cd06655          99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K  171 (296)
T ss_pred             CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence            99999998842   35899999999999999999999   79999999999999999999999999999886543322 2


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~  218 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            23346889999999999888999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=296.04  Aligned_cols=203  Identities=28%  Similarity=0.419  Sum_probs=178.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|++|.||++.+..++..||+|.+........+.+.+|++++++++|||++++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            45789999999999999999999888899999999876666677899999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++... ...+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++....... .
T Consensus        84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (280)
T cd06611          84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q  158 (280)
T ss_pred             cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence            9999999988543 245899999999999999999999   7999999999999999999999999999987553322 2


Q ss_pred             ceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ......|+..|+|||.+.     ...++.++|+||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            233456899999999864     345678999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7e-34  Score=292.71  Aligned_cols=199  Identities=28%  Similarity=0.438  Sum_probs=174.3

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      |++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            56788899999999999999988999999999776666677899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      ++|..++... ...+++..+..++.|+++||.|||   +.+++||||||+|||++.++.+||+|||++....... ....
T Consensus        87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (282)
T cd06643          87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  161 (282)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence            9998887542 346899999999999999999999   7999999999999999999999999999987643221 2223


Q ss_pred             eccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          502 RVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...++..|+|||++.     +..++.++|||||||++|||++|++||..
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  210 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE  210 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence            356899999999874     34578899999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=295.10  Aligned_cols=200  Identities=28%  Similarity=0.469  Sum_probs=180.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .-|.+.++||+|+||.||++.++.+|+.||||.+.-+  ...+++..|+.+|++...|++|+++|.|.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            3577889999999999999999999999999998654  34578899999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      .-|++.+.++- ++.+|.+.++..+++..++||+|||   ...-+|||||..||||+.+|.+||+|||.|-.+.. .-..
T Consensus       111 GAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAK  185 (502)
T ss_pred             CCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHh
Confidence            99999998854 4567999999999999999999999   78899999999999999999999999999976543 2234


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...+.||+.|||||++..-.|..++||||||++..||..|++||.+-
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI  232 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI  232 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence            45689999999999999999999999999999999999999999763

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.2e-34  Score=298.72  Aligned_cols=196  Identities=26%  Similarity=0.399  Sum_probs=160.2

Q ss_pred             ccccccCceEEEEEEEcC--CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec--cCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHN--SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--KGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  421 (652)
                      .+||+|+||.||+|...+  ++..||+|.+.....  ...+.+|+.++++++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999999754  457899999875432  2457789999999999999999998853  4578999999975


Q ss_pred             CCccccccc-------CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe----CCCCCeEEeeeccce
Q 038860          422 GSLDSFLFD-------EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL----DSELNGKLGDFGLAK  490 (652)
Q Consensus       422 gsL~~~l~~-------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl----~~~~~~kL~DFGla~  490 (652)
                       +|.+++..       .....+++..+..++.|++.||.|||   +++|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             77666531       12335889999999999999999999   7999999999999999    456789999999998


Q ss_pred             ecccCCCC--ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          491 LYEHGTNP--ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       491 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ........  ......||..|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76443221  2234578999999998876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.2e-34  Score=301.10  Aligned_cols=200  Identities=24%  Similarity=0.280  Sum_probs=168.5

Q ss_pred             cccccccc--CceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          344 AKQLLGHG--GFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       344 ~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      +.++||+|  +|++||++....+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999999999999999997542  233456778999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC--
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--  497 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~--  497 (652)
                      ++|+|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.++++||+.+........  
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999986544456899999999999999999999   79999999999999999999999999987543321110  


Q ss_pred             ----CceeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 ----PATTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                          .......++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                01122356778999999876  45889999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-34  Score=297.59  Aligned_cols=201  Identities=23%  Similarity=0.405  Sum_probs=178.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ..+|+..+.||+|++|.||+|.+..++..||+|.+........+.+.+|+.+++.++|+|++++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35889999999999999999999888999999999776555567788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++..   ..+++.++..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||++........ 
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654          99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             cCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            999999998842   35789999999999999999999   79999999999999999999999999999886543221 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~  219 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            223346889999999998888999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.8e-34  Score=293.98  Aligned_cols=201  Identities=28%  Similarity=0.434  Sum_probs=176.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      +.|++.+.||+|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++|+|++++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999999889999999998776667788999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|..++... ...+++..+..++.|++.+|.|||   +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus        92 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~  166 (292)
T cd06644          92 PGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR  166 (292)
T ss_pred             CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence            999998877433 345899999999999999999999   7999999999999999999999999999987543321 22


Q ss_pred             eeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  217 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence            23456889999999874     34568899999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.3e-34  Score=307.94  Aligned_cols=205  Identities=28%  Similarity=0.456  Sum_probs=173.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCC-----CeEEEEEEecCcch-hhHHHHHHHHHHhcccC-cCceeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNESK-QGVREFVSEIATIGRLR-HRNLVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  410 (652)
                      ..++|.+.++||+|+||.||+|.+...     +..||||++..... ...+.+.+|+++++++. ||||++++++|...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            356888999999999999999987432     34699999976433 34467899999999996 999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCC----------------------------------------------------------
Q 038860          411 DLLLVYDFMANGSLDSFLFDEP----------------------------------------------------------  432 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  432 (652)
                      ..+||||||++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998874321                                                          


Q ss_pred             ------------------------------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC
Q 038860          433 ------------------------------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD  476 (652)
Q Consensus       433 ------------------------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~  476 (652)
                                                          ...+++..+..++.|+++||.|||   +.+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                124778888999999999999999   79999999999999999


Q ss_pred             CCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          477 SELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       477 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      .++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            9999999999999865432221 2223456788999999998899999999999999999997 9999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.2e-34  Score=291.08  Aligned_cols=246  Identities=30%  Similarity=0.421  Sum_probs=194.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|++.+.||+|++|.||+|...+ +..+|+|.+.... ....++.+|+.++++++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            467888999999999999998765 4569999987543 23467899999999999999999999999888999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++..... .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          82 SNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999999854333 6899999999999999999999   7999999999999999999999999999988654332222


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||......+   ....+    ..            . 
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~------------~-  217 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV----SQ------------G-  217 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----hc------------C-
Confidence            222345678999999988889999999999999999998 999986432111   00000    00            0 


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                    .  +.+...   ...+.+.+++.+|+..+|++||+..-
T Consensus       218 --------------~--~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~  250 (256)
T cd05113         218 --------------L--RLYRPH---LASEKVYAIMYSCWHEKAEERPTFQQ  250 (256)
T ss_pred             --------------C--CCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHH
Confidence                          0  000010   12468899999999999999998753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.9e-34  Score=291.91  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=196.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|++.+.||+|++|.||+|.... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            568889999999999999998764 56799999876433 34568999999999999999999998854 5689999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.......+++.+++.++.|++.||.|||   +.+++||||||+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999999986655556899999999999999999999   7899999999999999999999999999998764433222


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....++..|+|||...+..++.++|+||||+++|||++ |+.||......   ...+..             .      
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~-------------~------  217 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQV-------------E------  217 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-------------H------
Confidence            223345678999999988889999999999999999999 89998653211   111100             0      


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFE  632 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~~  632 (652)
                              ...      +.|..   ......+.+++.+|+..+|++||+...+.
T Consensus       218 --------~~~------~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         218 --------RGY------RMPCP---QDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             --------cCC------CCCCC---CcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                    000      00111   12235789999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-34  Score=294.70  Aligned_cols=206  Identities=25%  Similarity=0.482  Sum_probs=173.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      .+++|+..+.||+|+||.||+|.+..     .+..||+|.+.... .....++.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999998652     34679999986542 2345678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCC--------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEE
Q 038860          412 LLLVYDFMANGSLDSFLFDEP--------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKL  483 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL  483 (652)
                      .++||||+++++|.+++....        ...+++..++.++.|++.||.|||   +.+++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999885421        234678889999999999999999   689999999999999999999999


Q ss_pred             eeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          484 GDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       484 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999998755332221 1122345778999999998899999999999999999999 78888653

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.1e-34  Score=289.78  Aligned_cols=201  Identities=25%  Similarity=0.406  Sum_probs=177.7

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      +|++.+.||+|+||.||++.+..++..+|+|.++.. .....+.+.+|+.++++++|+|++++++.+..++.++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            478889999999999999999988999999998643 3344567889999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.......+++..++.++.|++.||.|||   +++++|+||||+||++++++.++|+|||++....... ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence            9999999886555556889999999999999999999   7999999999999999999999999999998654322 22


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence            2345689999999999888899999999999999999999999965

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-34  Score=292.33  Aligned_cols=248  Identities=30%  Similarity=0.478  Sum_probs=196.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.++||+|+||.||+|.+.++ ..||+|+++.... ..+++.+|+.++++++||||+++++.+.. ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            45789999999999999999988764 4699999975332 34578899999999999999999998754 568999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++|+|.+++.......+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||.++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999999996554556899999999999999999999   799999999999999999999999999999876543322


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......++..|+|||+..+..++.++||||||+++|||++ |+.||......+   ...    ....             
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~----~~~~-------------  218 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD----QVER-------------  218 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH----HHhc-------------
Confidence            2233456778999999988899999999999999999999 888886532111   000    0000             


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                ..      ..|..   ....+.+.+++.+|+..+|++||+...+
T Consensus       219 ----------~~------~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~~  253 (262)
T cd05071         219 ----------GY------RMPCP---PECPESLHDLMCQCWRKEPEERPTFEYL  253 (262)
T ss_pred             ----------CC------CCCCc---cccCHHHHHHHHHHccCCcccCCCHHHH
Confidence                      00      00010   1224578899999999999999987654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.1e-34  Score=299.63  Aligned_cols=202  Identities=26%  Similarity=0.440  Sum_probs=171.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe----EEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT----EVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .+|+..+.||+|+||.||+|++..+++    .||+|.++... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            568999999999999999999765444    48999987543 34456789999999999999999999999865 5789


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ++||+++|+|.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            99999999999998643 335889999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCCce-eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTNPAT-TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~  215 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  215 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            332211 12234678999999999999999999999999999998 99998753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.5e-34  Score=295.23  Aligned_cols=205  Identities=29%  Similarity=0.509  Sum_probs=175.7

Q ss_pred             hcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|.+.+.||+|+||.||++.+.     .++..+|+|.+........+.+.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357889999999999999999863     345679999998766666778999999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccC-----------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeE
Q 038860          414 LVYDFMANGSLDSFLFDE-----------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK  482 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~k  482 (652)
                      +||||+++++|.+++...           ....+++.+++.++.|++.||+|||   +++++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            999999999999988532           1235899999999999999999999   79999999999999999999999


Q ss_pred             EeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          483 LGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       483 L~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      |+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999986533221 11223345778999999998899999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.3e-34  Score=289.38  Aligned_cols=249  Identities=28%  Similarity=0.462  Sum_probs=198.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.++||+|+||.||+|...+ ++.||+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            4678899999999999999998765 67899999875433 3467889999999999999999999874 4578999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99999999986655567899999999999999999999   799999999999999999999999999999876533222


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......++..|+|||++....++.++||||||+++|||++ |+.||......+   ....    .               
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~---------------  216 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQN----L---------------  216 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----H---------------
Confidence            2223346778999999998889999999999999999999 999997533111   0000    0               


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccccc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFE  632 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~~  632 (652)
                               ..   ..  +.|...   ...+.+.+++.+|+..+|++||+.+.+.
T Consensus       217 ---------~~---~~--~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~  254 (260)
T cd05067         217 ---------ER---GY--RMPRPD---NCPEELYELMRLCWKEKPEERPTFEYLR  254 (260)
T ss_pred             ---------Hc---CC--CCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence                     00   00  001111   1235789999999999999999877543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=283.80  Aligned_cols=203  Identities=28%  Similarity=0.380  Sum_probs=181.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|..+++||+|.||+|-+++-+.+++.+|+|++++..   +.....-+.|-++|+.-+||.+..+.-.|...+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            468999999999999999999999999999999998763   33444567888999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||..||.|.-+|.+  ...+++...+.+-..|..||.|||   +++||.||||.+|.|||++|++||+|||+|+.-- .
T Consensus       247 MeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K  320 (516)
T ss_pred             EEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc-c
Confidence            999999999998843  456888888999999999999999   6999999999999999999999999999998421 1


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ....+..++||+.|+|||++....|....|.|.+||++|||+||+.||...+
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence            2334567899999999999999999999999999999999999999998654

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=317.91  Aligned_cols=209  Identities=26%  Similarity=0.377  Sum_probs=176.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEee-eec------
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGW-CRR------  408 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------  408 (652)
                      ....++++.+.|.+|||+.||.|.+...+..+|+|++-..+....+...+|+.+|++|+ |+|||.+++. ...      
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            34556788999999999999999999877999999987778888889999999999997 9999999993 221      


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      .-+.+|.||||++|.|-+++..+....|++.++++|+.++++|+++||. ++.+|||||||-+||||+.+++.||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            1368999999999999999976555669999999999999999999995 467799999999999999999999999999


Q ss_pred             ceecccCCC-Cce-------eeccCCcCCCCCCCC---CCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          489 AKLYEHGTN-PAT-------TRVVGTLGYLAPETP---RTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       489 a~~~~~~~~-~~~-------~~~~gt~~y~aPE~~---~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      |.-.-.... ...       -...=|+.|+|||++   .+...++|+|||+|||+||-|+....||++.
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            874322111 000       011348999999975   4567899999999999999999999999864

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-34  Score=289.73  Aligned_cols=203  Identities=31%  Similarity=0.562  Sum_probs=174.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCC---CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|.+...   ...||+|.++... .....+|.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            35788999999999999999998643   4579999987653 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      +|||+++++|.+++.... ..+++.++++++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999985433 36899999999999999999999   79999999999999999999999999999997652


Q ss_pred             CCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          495 GTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       495 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~  211 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence            2211 1122345678999999998899999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-34  Score=294.72  Aligned_cols=202  Identities=28%  Similarity=0.388  Sum_probs=176.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||+||++....+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            357888999999999999999998889999999886543 3345778999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++..  ...+++..+..++.+++.||.|||+  ..+++||||||+||+++.++.++|+|||++......  
T Consensus        84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            9999999988843  3458999999999999999999995  368999999999999999999999999998754322  


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                       ......|+..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence             1223568999999999988889999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.5e-34  Score=294.88  Aligned_cols=204  Identities=26%  Similarity=0.378  Sum_probs=172.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++++|.+.+.||+|+||.||+|....++..||+|++...... ....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            457899999999999999999999888999999998654322 2345778999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+. ++|.+++... ...+++..+..++.|++.||.|||   ..+++||||||+|||++.++++||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 6777666433 245788889999999999999999   6899999999999999999999999999997543221


Q ss_pred             CCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      . ......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            1 12234578999999998764 57889999999999999999999997543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=295.16  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=212.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .-|...+.||+|.|..|-+|++.-+|+.||||++.+..-.  ....+.+|+..|+.++|||||++|.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4578889999999999999999999999999999876433  33467889999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-CCCCeEEeeeccceecccCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-SELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-~~~~~kL~DFGla~~~~~~~  496 (652)
                      +-.+|+|.+|+.+... .+.+....+++.||+.|+.|+|   +..+|||||||+||.+- +-|-+||.|||.+..+.++.
T Consensus        98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999976544 4899999999999999999999   79999999999999775 55889999999998766543


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCC-CccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSS-ASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                        ..+..+|...|-|||++.+..|+ ++.|||||||+||.|++|++||+.....+.+.+               +     
T Consensus       174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------I-----  231 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------I-----  231 (864)
T ss_pred             --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------h-----
Confidence              44567999999999999998875 567999999999999999999986543332221               1     


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccccCCC
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYPSLS  641 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~~~~  641 (652)
                                     +.|.-..|.     .+..+.+||+..|+.-+|.||-      +++|....-.-++|.
T Consensus       232 ---------------mDCKYtvPs-----hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~  283 (864)
T KOG4717|consen  232 ---------------MDCKYTVPS-----HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA  283 (864)
T ss_pred             ---------------hcccccCch-----hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence                           112212222     3457899999999999999997      788988865555553

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.2e-34  Score=295.98  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=198.3

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCC-----CeEEEEEEecCc-chhhHHHHHHHHHHhccc-CcCceeEEEeeeec
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNE-SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRR  408 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  408 (652)
                      ....++|+..+.||+|+||.||++.....     ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            44556789999999999999999987643     378999998764 234456788999999999 79999999999999


Q ss_pred             cCeeEEEEEeccCCCccccccc--------------CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceE
Q 038860          409 KGDLLLVYDFMANGSLDSFLFD--------------EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVL  474 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~--------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NIL  474 (652)
                      .+..+++|||+++|+|..++..              .....+++..++.++.|++.||.|||   +.+|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence            9999999999999999998853              22346899999999999999999999   799999999999999


Q ss_pred             eCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccch
Q 038860          475 LDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEEL  552 (652)
Q Consensus       475 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~  552 (652)
                      ++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+. 
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-  243 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-  243 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-
Confidence            99999999999999986643221 11222345678999999988899999999999999999998 9999865321110 


Q ss_pred             hHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       553 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                            .....                       .    ......|     ....+.+.+|+.+|+..+|++||++.-
T Consensus       244 ------~~~~~-----------------------~----~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e  283 (293)
T cd05053         244 ------FKLLK-----------------------E----GYRMEKP-----QNCTQELYHLMRDCWHEVPSQRPTFKQ  283 (293)
T ss_pred             ------HHHHH-----------------------c----CCcCCCC-----CCCCHHHHHHHHHHcccCcccCcCHHH
Confidence                  00000                       0    0000001     122457889999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-34  Score=290.49  Aligned_cols=199  Identities=29%  Similarity=0.449  Sum_probs=177.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+|++++++++......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999999889999999987553 34456788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++...   .+++..+..++.|++.||.|||   +++++||||+|+||++++++.++|+|||+++...... .
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~  153 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S  153 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence            9999999998432   6899999999999999999999   7999999999999999999999999999998765432 2


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~  200 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD  200 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            23345688899999999988899999999999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.5e-34  Score=298.37  Aligned_cols=203  Identities=30%  Similarity=0.509  Sum_probs=171.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCe--EEEEEEecCc-chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKT--EVAVKRISNE-SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|.+..++.  .+|+|.+... .....+++.+|+.++.++ +|+||+++++++...+.+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3578889999999999999999876554  4688887653 334556788999999999 89999999999999999999


Q ss_pred             EEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          415 VYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      |+||+++++|.+++....              ...+++.+++.++.|++.||+|||   +++++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999885422              235889999999999999999999   799999999999999999999


Q ss_pred             eEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          481 GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +||+|||+++.....  .......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            999999998643211  11122234678999999988889999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-34  Score=288.93  Aligned_cols=252  Identities=26%  Similarity=0.380  Sum_probs=203.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|+..+.||+|++|.||+|....+++.+++|.+........+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            67899999999999999999998888999999998766556788999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++... ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....... ..
T Consensus        83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  157 (262)
T cd06613          83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK  157 (262)
T ss_pred             CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence            999999988543 246899999999999999999999   7999999999999999999999999999988654322 12


Q ss_pred             eeeccCCcCCCCCCCCCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          500 TTRVVGTLGYLAPETPRTG---KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~---~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      .....++..|+|||.+.+.   .++.++|+||||+++|||++|+.||...........       ..             
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~-------------  217 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------IS-------------  217 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HH-------------
Confidence            2345688899999998776   789999999999999999999999975332111100       00             


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                               ...+      ..+...........+.+++.+|+..+|++|++.+.+
T Consensus       218 ---------~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  257 (262)
T cd06613         218 ---------KSNF------PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL  257 (262)
T ss_pred             ---------hccC------CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence                     0000      001111111223568899999999999999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=294.34  Aligned_cols=202  Identities=28%  Similarity=0.411  Sum_probs=171.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|+..+.||+|++|.||+|....+++.||+|.+...... ....+.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            6789999999999999999999888899999998654322 234567899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++ +|.+++.... ..+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++....... 
T Consensus        85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            975 8988885433 36889999999999999999999   79999999999999999999999999999875432211 


Q ss_pred             ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            1122356889999998765 458899999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=294.04  Aligned_cols=204  Identities=26%  Similarity=0.379  Sum_probs=176.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|+..+.||+|++|.||+|.+..+++.||+|.++..  .....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688999999999999999999988999999998653  23345678999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |++++.+..+...  ...+++.++..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            9998777655532  345899999999999999999999   78999999999999999999999999999987655433


Q ss_pred             CceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .......++..|+|||++.+. .++.++||||||+++|||++|++||.....
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  207 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD  207 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            233445788999999999888 789999999999999999999999976443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-33  Score=292.69  Aligned_cols=198  Identities=30%  Similarity=0.388  Sum_probs=176.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999999889999999986542   234567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999998543  46899999999999999999999   799999999999999999999999999999865443 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                         .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  201 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD  201 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence               23446899999999998888899999999999999999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.3e-34  Score=289.89  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=201.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .+|++.+.||+|++|.||++....++..+|||.+...   ......++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999999888999999988653   2334467889999999999999999999999999999999


Q ss_pred             EeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          417 DFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       417 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||+++++|.+++..  .....+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998853  23446899999999999999999999   79999999999999999999999999999886543


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      ... ......|+..|+|||.+.+..++.++|+||||+++|||++|..||........ ...                   
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-------------------  217 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC-------------------  217 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh-------------------
Confidence            221 22335688999999999888899999999999999999999999864321100 000                   


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                  ..+.....  .|..  .....+.+.+++.+|+..+|++||+..+.
T Consensus       218 ------------~~~~~~~~--~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  258 (267)
T cd08229         218 ------------KKIEQCDY--PPLP--SDHYSEELRQLVNMCINPDPEKRPDITYV  258 (267)
T ss_pred             ------------hhhhcCCC--CCCC--cccccHHHHHHHHHhcCCCcccCCCHHHH
Confidence                        00000000  0001  11234688999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.6e-34  Score=293.57  Aligned_cols=202  Identities=29%  Similarity=0.433  Sum_probs=173.6

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|++|.||+|++..+++.||+|.+....  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5888999999999999999998889999999986542  22335788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +. ++|.+++.......+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence            96 58888886655667899999999999999999999   7999999999999999999999999999987654322 1


Q ss_pred             ceeeccCCcCCCCCCCCCCCC-CCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||....
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            222335788999999876644 6889999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.7e-34  Score=294.88  Aligned_cols=204  Identities=29%  Similarity=0.519  Sum_probs=175.3

Q ss_pred             cCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .+|.+.+.||+|+||.||+|+...     ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            467888999999999999998642     356799999987766666789999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          415 VYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      ||||+++++|.+++....              ...+++..++.++.||+.||+|||   +++++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999985422              234889999999999999999999   799999999999999999999


Q ss_pred             eEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          481 GKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999975533221 11233456789999999998899999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-33  Score=286.38  Aligned_cols=243  Identities=27%  Similarity=0.425  Sum_probs=190.9

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      +.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999998889999999886543 34456789999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce-eec
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT-TRV  503 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~  503 (652)
                      .+++... ...+++.+++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||++........... ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9998543 345889999999999999999999   79999999999999999999999999999875443211111 111


Q ss_pred             cCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHH
Q 038860          504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQS  582 (652)
Q Consensus       504 ~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~  582 (652)
                      .++..|+|||.+.++.++.++||||||+++|||++ |..||........   .    ...                    
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~----~~~--------------------  209 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---R----EAI--------------------  209 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---H----HHH--------------------
Confidence            23457999999999899999999999999999998 8888864221100   0    000                    


Q ss_pred             HHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          583 QVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       583 ~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                         ......      +..   ....+.+.+++.+|+..+|++||+..-+
T Consensus       210 ---~~~~~~------~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~  246 (252)
T cd05084         210 ---EQGVRL------PCP---ELCPDAVYRLMERCWEYDPGQRPSFSTV  246 (252)
T ss_pred             ---HcCCCC------CCc---ccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence               000000      000   0123578899999999999999987643

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-33  Score=285.51  Aligned_cols=201  Identities=25%  Similarity=0.407  Sum_probs=179.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|+||.||.++...+++.+++|.+...  .....+++.+|+.++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999999999999988999999998654  344567789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++.++..++.|++.+|.|||   +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999996654567899999999999999999999   68999999999999999999999999999987644332 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence            22345689999999999888899999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-33  Score=287.71  Aligned_cols=247  Identities=27%  Similarity=0.439  Sum_probs=192.3

Q ss_pred             ccccccccccCceEEEEEEEcCC---CeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe-----
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD-----  411 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  411 (652)
                      |++.+.||+|+||.||+|.+..+   +..||+|+++..  .......+.+|+..++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999998643   478999998754  23445678999999999999999999998866554     


Q ss_pred             -eEEEEEeccCCCcccccccC----CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          412 -LLLVYDFMANGSLDSFLFDE----PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       412 -~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                       .++++||+++|+|..++...    ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999888432    2346899999999999999999999   799999999999999999999999999


Q ss_pred             ccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          487 GLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       487 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      |+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   ...+....    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~----  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRH----  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----
Confidence            999865433221 1222345678999999988899999999999999999999 88888653211   11111100    


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                                 ......|.     ...+.+.+++.+|+..+|++||+..-
T Consensus       231 ---------------------------~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~e  264 (273)
T cd05035         231 ---------------------------GNRLKQPE-----DCLDELYDLMYSCWRADPKDRPTFTK  264 (273)
T ss_pred             ---------------------------CCCCCCCc-----CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence                                       00000111     22457899999999999999998654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-33  Score=287.37  Aligned_cols=202  Identities=27%  Similarity=0.454  Sum_probs=175.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||+|....+++.||+|.+...   .......+.+|+.++++++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999999888999999987542   2334457889999999999999999999999999999999


Q ss_pred             EeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          417 DFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       417 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||+++++|.+++..  .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988743  22345888999999999999999999   79999999999999999999999999999987643


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            221 22234688899999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=310.55  Aligned_cols=203  Identities=32%  Similarity=0.459  Sum_probs=175.4

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC------eeEE
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG------DLLL  414 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  414 (652)
                      +...+.||+|+||.||+|+.+.+|+.||||.+.+.. ....+...+|+++|++++|+|||++.+.-....      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            455678999999999999999999999999998753 334556789999999999999999999865543      5789


Q ss_pred             EEEeccCCCcccccccC-CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC--CCCC--eEEeeeccc
Q 038860          415 VYDFMANGSLDSFLFDE-PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD--SELN--GKLGDFGLA  489 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~--~~~~--~kL~DFGla  489 (652)
                      |||||.+|+|...|.+. ....|++.+.+.+..++..||.|||   +.+|+||||||.||++-  .+++  -||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999999653 3346999999999999999999999   79999999999999994  3343  799999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      +-.+.+.  ....++||..|++||+... +.|+..+|.|||||++||++||..||.....+
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9776544  6677899999999999885 88999999999999999999999999764433

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8e-34  Score=295.51  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=198.2

Q ss_pred             hhcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  410 (652)
                      ..++|...+.||+|+||.||++.+.     ..+..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3467899999999999999999752     345679999987653 33446789999999999 7999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++||||+++|+|.+++.......+++.++..++.|++.||+|||   +++++|+||||+|||++.++.++|+|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999986544445899999999999999999999   7999999999999999999999999999998


Q ss_pred             ecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          491 LYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       491 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.  ....           
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~-----------  256 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKL-----------  256 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHH-----------
Confidence            65433221 1122345778999999999999999999999999999998 9999865322110  0000           


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                        ++              ...      +.+.   .....+.+.+++.+|+..+|++||+..-
T Consensus       257 --~~--------------~~~------~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~e  293 (302)
T cd05055         257 --IK--------------EGY------RMAQ---PEHAPAEIYDIMKTCWDADPLKRPTFKQ  293 (302)
T ss_pred             --HH--------------cCC------cCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence              00              000      0000   0122357899999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.8e-33  Score=287.38  Aligned_cols=207  Identities=30%  Similarity=0.492  Sum_probs=178.0

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      |++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34556777777889999999999999998888999999998776667778999999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCcccc--chHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEEeeeccce
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVL--NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAK  490 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~  490 (652)
                      +|+||+++++|.+++.... ..+  ++..+..++.|++.||.|||   ..+|+||||||+||+++. ++.++|+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999985432 234  78888999999999999999   799999999999999986 6789999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCCC--CCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTGK--SSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...... .......|+..|+|||++.+..  ++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         158 RLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             ecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence            654322 2223346889999999986643  78899999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-34  Score=295.21  Aligned_cols=200  Identities=36%  Similarity=0.612  Sum_probs=168.6

Q ss_pred             ccccccccCceEEEEEEEc----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          344 AKQLLGHGGFGQVYKGTLH----NSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ..+.||.|.||.||+|.+.    ..+..|+||.+.... ....++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999998    346789999996543 34578899999999999999999999999988889999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC-
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-  497 (652)
                      +++|+|.+++.......+++.++.+|+.||++||.|||   +.+++|+||+++||+++.++.+||+|||+++....... 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999997765667999999999999999999999   68999999999999999999999999999987632211 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .......+...|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            11122356789999999988889999999999999999999 78887653

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-34  Score=296.36  Aligned_cols=199  Identities=26%  Similarity=0.407  Sum_probs=169.2

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|++|.||+|.+..+++.||+|+++...  ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999999889999999986532  22235677899999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      ++ ++|.+++... ...+++..++.++.||++||.|||   +++++||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            97 4787776433 345899999999999999999999   79999999999999999999999999999986543221 


Q ss_pred             ceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......++..|+|||++.+. .++.++|||||||++|||++|..|+..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            22234678899999987664 478999999999999999999988643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.4e-34  Score=300.28  Aligned_cols=205  Identities=28%  Similarity=0.453  Sum_probs=171.3

Q ss_pred             hcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc-C
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK-G  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  410 (652)
                      .++|++.+.||+|+||.||+|.+.+     +++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3579999999999999999997543     34789999987543 23446688899999999 799999999988654 5


Q ss_pred             eeEEEEEeccCCCcccccccCC----------------------------------------------------------
Q 038860          411 DLLLVYDFMANGSLDSFLFDEP----------------------------------------------------------  432 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  432 (652)
                      .+++++||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999998874321                                                          


Q ss_pred             -ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCC
Q 038860          433 -KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYL  510 (652)
Q Consensus       433 -~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~  510 (652)
                       ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... ......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             126899999999999999999999   799999999999999999999999999999865433221 222345677899


Q ss_pred             CCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          511 APETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       511 aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      |||++.+..++.++|||||||++|||++ |+.||...
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~  279 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV  279 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999999999999999998 99998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-33  Score=291.62  Aligned_cols=203  Identities=27%  Similarity=0.499  Sum_probs=172.3

Q ss_pred             cCccccccccccCceEEEEEEEc----CCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLH----NSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ++|++.+.||+|+||.||+|...    ..+..||+|.+... ......++.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46788899999999999999853    34578999999754 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCC---------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC
Q 038860          415 VYDFMANGSLDSFLFDEP---------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL  479 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~  479 (652)
                      ||||+++++|.+++....               ...+++.+++.++.|++.||.|||   +++++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999884221               235788999999999999999999   79999999999999999999


Q ss_pred             CeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          480 NGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       480 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~  229 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG  229 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            999999999986533221 12233345778999999988889999999999999999998 9999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-33  Score=284.81  Aligned_cols=201  Identities=25%  Similarity=0.397  Sum_probs=175.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeec-cCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRR-KGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e  417 (652)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5888999999999999999998888999999986542  3445678899999999999999999998764 446899999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++.......+++.+++.++.|++.||++||   +.+++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999986655556899999999999999999999   7999999999999999999999999999998764322 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .......+++.|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            223345689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-33  Score=294.48  Aligned_cols=201  Identities=24%  Similarity=0.370  Sum_probs=174.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|+..+.||+|+||.||++....+++.|++|.+....   ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999999989999999987653   233457889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999999844  346899999999999999999999   7999999999999999999999999999987421100


Q ss_pred             --------------CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          497 --------------NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       497 --------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                                    ........|+..|+|||.+....++.++|+||||+++|||++|+.||.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~  218 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  218 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                          0011224578899999999888899999999999999999999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-33  Score=291.19  Aligned_cols=201  Identities=28%  Similarity=0.453  Sum_probs=173.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|++.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3678899999999999999999988999999988654 333456789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCC-ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEP-KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      +++++|..++.... ...+++..+..++.|++.||.|||+  +.+++||||||+||+++.++.+||+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            99999998885421 2368999999999999999999994  358999999999999999999999999998765322  


Q ss_pred             CceeeccCCcCCCCCCCCCCCC------CCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGK------SSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       ......++..|+|||.+.+..      ++.++|+|||||++|||++|+.||..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence             222346788999999886543      48899999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-33  Score=290.92  Aligned_cols=211  Identities=27%  Similarity=0.430  Sum_probs=180.0

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeec
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRR  408 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  408 (652)
                      .++.++....+.|++.+.||+|+||.||+|.+..+++.+|+|.+.... ....++..|+.++.++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466777778899999999999999999999998889999999986543 2345678899999998 69999999999853


Q ss_pred             ------cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeE
Q 038860          409 ------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK  482 (652)
Q Consensus       409 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~k  482 (652)
                            ....+++|||+++|+|.+++.......+++..+..++.|+++||.|||   +.+++||||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  457899999999999999886555556888999999999999999999   79999999999999999999999


Q ss_pred             EeeeccceecccCCCCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       483 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      |+|||++....... .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||..
T Consensus       162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~  228 (282)
T cd06636         162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence            99999987553221 1223356899999999875     34578899999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.6e-34  Score=288.89  Aligned_cols=200  Identities=32%  Similarity=0.433  Sum_probs=176.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|+..+.||+|++|.||++.+..+++.||+|.+.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999999889999999987653 34556789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCcc-ceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE-QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      +++++|.+++.... ..+++..+.+++.|++.||+|||   + .+++|+||||+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999985432 56889999999999999999999   6 8999999999999999999999999999876533221


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                         ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence               1156889999999998889999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-34  Score=287.95  Aligned_cols=251  Identities=30%  Similarity=0.485  Sum_probs=200.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|++|.||+|.+.+ +..||+|.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            35689999999999999999999865 5779999987543 334678999999999999999999999999889999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999997655567899999999999999999999   78999999999999999999999999999987653222


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      .......++..|+|||.+.+..++.++|+||||+++||+++ |+.||......   .........               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~---------------  220 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG---------------  220 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC---------------
Confidence            22223345678999999998889999999999999999998 99998653211   111110000               


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFE  632 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~~  632 (652)
                                  ...      |.+.   ...+.+.+++.+|+..+|++||+...+.
T Consensus       221 ------------~~~------~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         221 ------------YRM------PRPP---NCPEELYDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             ------------CCC------CCCC---CCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence                        000      1111   1135789999999999999999886543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=287.06  Aligned_cols=245  Identities=28%  Similarity=0.414  Sum_probs=193.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .+|++.+.||+|++|.||++.+.. +..+|+|.+..... ...++.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            357788999999999999998864 56799999865432 3356888999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          82 ANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999985433 36899999999999999999999   7999999999999999999999999999998654322222


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ....+                    
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~--------------------  214 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESV--------------------  214 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHH--------------------
Confidence            222234568999999998899999999999999999999 899986532111   00000                    


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                             ..    ......|.     ...+.+.+++.+|+..+|++|++..
T Consensus       215 -------~~----~~~~~~~~-----~~~~~~~~li~~cl~~~p~~Rpt~~  249 (256)
T cd05059         215 -------SA----GYRLYRPK-----LAPTEVYTIMYSCWHEKPEDRPAFK  249 (256)
T ss_pred             -------Hc----CCcCCCCC-----CCCHHHHHHHHHHhcCChhhCcCHH
Confidence                   00    00001111     2345789999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-33  Score=289.65  Aligned_cols=201  Identities=29%  Similarity=0.510  Sum_probs=167.3

Q ss_pred             ccccccccccCceEEEEEEEcCCCe--EEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc------Ce
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKT--EVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------GD  411 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  411 (652)
                      |.+.+.||+|+||.||+|.+...+.  .||+|.++..  .....+.+.+|+.++++++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999876554  6999988654  344567889999999999999999999987532      24


Q ss_pred             eEEEEEeccCCCccccccc----CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          412 LLLVYDFMANGSLDSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      .++++||+++|+|.+++..    .....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988732    22345899999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          488 LAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       488 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      +++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  217 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG  217 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99866432211 1122345778999999999999999999999999999999 8889865

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-34  Score=302.40  Aligned_cols=283  Identities=23%  Similarity=0.313  Sum_probs=207.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----Ce
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----GD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  411 (652)
                      .++|.+.+.||+|+||.||++.+..+++.||+|.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999999988999999998753  233445677899999999999999999988654     35


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++|+||+. ++|.+++..  ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999996 688888743  346899999999999999999999   79999999999999999999999999999986


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ..... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.......+..+.+..........
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            54322 22233467899999998765 46889999999999999999999999765433222222222222111111111


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSY  637 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~  637 (652)
                      .++..      ... ...+  +.....+.....+...+.+.+++.+|+..+|++|+      .|+||+..+..
T Consensus       237 ~~~~~------~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         237 RNEKA------RRY-IRSL--PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             Cchhh------hHH-HHhc--CcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            11110      000 1111  11111111111234567889999999999999999      68899875333

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-33  Score=286.75  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=201.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|++.+.||.|++|.||+|....++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999998888999999986542 33567889999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCc-cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEPK-AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      +++++|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999855322 56899999999999999999999   79999999999999999999999999999886654332


Q ss_pred             C---ceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          498 P---ATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       498 ~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      .   ......|+..|+|||++... .++.++|+|||||++|||++|+.||.......  ...+...              
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~--------------  221 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ--------------  221 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc--------------
Confidence            2   22334689999999998776 78999999999999999999999996532211  0101000              


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                         .               .....+.........+.+.+++.+|+..+|++||+..
T Consensus       222 ---~---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06610         222 ---N---------------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE  259 (267)
T ss_pred             ---C---------------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHH
Confidence               0               0000001110113346789999999999999999643

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=302.06  Aligned_cols=277  Identities=23%  Similarity=0.353  Sum_probs=201.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----Cee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----GDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  412 (652)
                      .++|++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999999889999999986532 33456688899999999999999999987544     357


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++|+||+++ +|..++.   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999965 7777663   345899999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCCCC--ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC---Cc
Q 038860          493 EHGTNP--ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE---GR  566 (652)
Q Consensus       493 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~  566 (652)
                      ......  ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ..........   +.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence            432211  1233568999999998654 5688999999999999999999999976433222   1122222211   11


Q ss_pred             cccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          567 VLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       567 ~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      +..+.+...      .+. ...  .+.....|.....+...+.+.+++.+|+..+|++|+      .|+|++..
T Consensus       234 ~~~~~~~~~------~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         234 LNCIISLRA------RNY-IKS--LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHhhchhh------hhH-Hhh--cCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            111111000      000 000  111111111111223356789999999999999999      56677764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-33  Score=290.59  Aligned_cols=211  Identities=25%  Similarity=0.366  Sum_probs=178.4

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeee-
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCR-  407 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  407 (652)
                      +.+..+..+.++|++.+.||+|+||.||++.+..+++.+|+|.+..... ...++.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            5566777889999999999999999999999998899999999865322 235678899999999 6999999999884 


Q ss_pred             ----ccCeeEEEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          408 ----RKGDLLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       408 ----~~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                          .++..++||||+++++|.+++..  .....+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                34568999999999999988742  23346889999999999999999999   7999999999999999999999


Q ss_pred             EEeeeccceecccCCCCceeeccCCcCCCCCCCCCC-----CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ||+|||+++...... .......|+..|+|||.+..     ..++.++|||||||++|||++|+.||..
T Consensus       164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence            999999998664322 12233468999999998753     4478899999999999999999999865

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-34  Score=324.42  Aligned_cols=211  Identities=24%  Similarity=0.399  Sum_probs=174.9

Q ss_pred             hhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec--
Q 038860          333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--  408 (652)
Q Consensus       333 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  408 (652)
                      .+.....++|++.+.||+|+||.||++.+..++..||+|.+...  .......+..|+.++++++||||+++++++..  
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            33445567899999999999999999999999999999998653  23345678999999999999999999998854  


Q ss_pred             cCeeEEEEEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCc----cceEEecCCCCCceEeCCC----
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGY----EQVVIHRDVKASNVLLDSE----  478 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~----~~~ivHrDlk~~NILl~~~----  478 (652)
                      ...++|||||+++|+|.++|...  ....+++..++.|+.||+.||.|||+..    .++|+||||||+||||+..    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            35689999999999999988542  2346999999999999999999999521    1469999999999999642    


Q ss_pred             -------------CCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCC
Q 038860          479 -------------LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPI  543 (652)
Q Consensus       479 -------------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~  543 (652)
                                   ..+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                         348999999998654322  2234579999999998854  45889999999999999999999999


Q ss_pred             CC
Q 038860          544 ET  545 (652)
Q Consensus       544 ~~  545 (652)
                      ..
T Consensus       244 ~~  245 (1021)
T PTZ00266        244 HK  245 (1021)
T ss_pred             Cc
Confidence            64

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8e-34  Score=294.73  Aligned_cols=202  Identities=30%  Similarity=0.508  Sum_probs=170.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe--EEEEEEecCc-chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT--EVAVKRISNE-SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999999876554  4788888753 334456789999999999 799999999999999999999


Q ss_pred             EEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          416 YDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                      +||+++++|.+++....              ...+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999985421              135889999999999999999999   7999999999999999999999


Q ss_pred             EEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ||+|||++.......  .......+..|+|||+.....++.++|||||||++|||++ |+.||...
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999986432111  1111233567999999988889999999999999999997 99999654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-33  Score=289.70  Aligned_cols=250  Identities=24%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCC-----CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            46788999999999999999998643     3789999987553 33456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCC--------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          413 LLVYDFMANGSLDSFLFDEP--------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      ++||||+++++|.+++....        ...+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999985422        234788999999999999999999   7999999999999999999999999


Q ss_pred             eeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhh
Q 038860          485 DFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKY  562 (652)
Q Consensus       485 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  562 (652)
                      |||+++....... .......++..|+|||.+.++.++.++|||||||++||+++ |+.||......+   ..+...   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~---  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI---  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh---
Confidence            9999986543221 12233456789999999988889999999999999999998 999986432211   111000   


Q ss_pred             cCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          563 GEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       563 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                       .                           ......|..     ..+.+.+++.+|+..+|++|++..-
T Consensus       236 -~---------------------------~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~  270 (277)
T cd05032         236 -D---------------------------GGHLDLPEN-----CPDKLLELMRMCWQYNPKMRPTFLE  270 (277)
T ss_pred             -c---------------------------CCCCCCCCC-----CCHHHHHHHHHHcCCChhhCCCHHH
Confidence             0                           000000111     1357889999999999999997653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-33  Score=286.57  Aligned_cols=247  Identities=29%  Similarity=0.466  Sum_probs=194.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|++.+.||+|++|.||++.+..+ ..+|+|.+.... ...+.+.+|+.++++++|+|++++++++.. +..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            4688899999999999999998764 469999886543 234568899999999999999999998754 5689999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            9999999997655556899999999999999999999   7899999999999999999999999999998664332222


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||......+   ...+...                  
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~------------------  218 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER------------------  218 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc------------------
Confidence            223346778999999988889999999999999999999 899987532111   1111000                  


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                               ....      |...   ...+.+.+++.+|+..+|++||+....
T Consensus       219 ---------~~~~------~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i  253 (260)
T cd05069         219 ---------GYRM------PCPQ---GCPESLHELMKLCWKKDPDERPTFEYI  253 (260)
T ss_pred             ---------CCCC------CCCc---ccCHHHHHHHHHHccCCcccCcCHHHH
Confidence                     0000      0000   123578999999999999999987654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-33  Score=286.19  Aligned_cols=199  Identities=29%  Similarity=0.465  Sum_probs=177.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|+..+.||+|++|.||+|....++..+++|.+.....  .+++.+|++++++++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            678999999999999999999988889999999976533  678999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++... ...+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++....... ..
T Consensus        81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~  155 (256)
T cd06612          81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AK  155 (256)
T ss_pred             CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-cc
Confidence            999999988432 356899999999999999999999   7899999999999999999999999999998664432 12


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~  201 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD  201 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2334588999999999888999999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-33  Score=290.25  Aligned_cols=251  Identities=26%  Similarity=0.434  Sum_probs=196.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      .+++|.+.+.||+|++|.||+|.+..     .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45779999999999999999999976     67889999987543 3344678999999999999999999999999889


Q ss_pred             eEEEEEeccCCCcccccccCC-----ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC---CeEE
Q 038860          412 LLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL---NGKL  483 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~---~~kL  483 (652)
                      .++||||+++++|.+++....     ...+++..+++++.||+.||+|||   +++++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999985432     235899999999999999999999   78999999999999998754   5999


Q ss_pred             eeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhh
Q 038860          484 GDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGK  561 (652)
Q Consensus       484 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  561 (652)
                      +|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+.+   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~---  234 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV---  234 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---
Confidence            999999865322111 1112234568999999998899999999999999999997 999987533211   11100   


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                ....                 .. ..|.     ...+.+.+++.+|+..+|++||+...
T Consensus       235 ----------~~~~-----------------~~-~~~~-----~~~~~~~~~i~~cl~~~p~~Rps~~~  270 (277)
T cd05036         235 ----------TGGG-----------------RL-DPPK-----GCPGPVYRIMTDCWQHTPEDRPNFAT  270 (277)
T ss_pred             ----------HcCC-----------------cC-CCCC-----CCCHHHHHHHHHHcCCCcccCcCHHH
Confidence                      0000                 00 0011     12357889999999999999998754

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-33  Score=290.06  Aligned_cols=249  Identities=26%  Similarity=0.438  Sum_probs=197.1

Q ss_pred             cCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .+|+..++||+|+||.||++...     .++..+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56788899999999999999753     2456899999887766667789999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCc-------------cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          415 VYDFMANGSLDSFLFDEPK-------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                      ++||+++++|.+++.....             ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999998854321             35889999999999999999999   7999999999999999999999


Q ss_pred             EEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 038860          482 KLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVW  559 (652)
Q Consensus       482 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  559 (652)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |++||......+.   ...  
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~--  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IEC--  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHH--
Confidence            9999999976533221 11122345678999999998999999999999999999998 9999864321110   000  


Q ss_pred             hhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          560 GKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       560 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                               ..    .......|.     ...+.+.+++.+|+..+|++|++..-
T Consensus       237 -------------------------~~----~~~~~~~~~-----~~~~~~~~li~~cl~~~P~~Rp~~~~  273 (280)
T cd05092         237 -------------------------IT----QGRELERPR-----TCPPEVYAIMQGCWQREPQQRMVIKD  273 (280)
T ss_pred             -------------------------HH----cCccCCCCC-----CCCHHHHHHHHHHccCChhhCCCHHH
Confidence                                     00    000001111     12357889999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=301.04  Aligned_cols=203  Identities=32%  Similarity=0.502  Sum_probs=184.3

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      +....++||-|.||.||.|.++.-...||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|..+..+|||.|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            445678999999999999999988889999999765 4567899999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +|+|.+||.+..+..++.-.++.++.||.+|++||.   .+.+|||||..+|+|+.++..+|++||||++++..+.....
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH  423 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH  423 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence            999999998888888888999999999999999999   89999999999999999999999999999999877665444


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ....-...|.|||.+....++.|+|||+|||+||||.| |..||.+-+
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid  471 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID  471 (1157)
T ss_pred             cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence            33444678999999999999999999999999999998 999998754

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-33  Score=286.42  Aligned_cols=200  Identities=28%  Similarity=0.472  Sum_probs=173.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc------hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES------KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      +|+..+.||+|++|.||++....+++.||+|.+....      ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999998889999999986432      1235678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceecc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLYE  493 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~  493 (652)
                      |+||+++++|.+++..  ...+++..+..++.|++.||.|||   +++++|+||||+||+++.++ .+||+|||.+....
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            9999999999999853  346889999999999999999999   79999999999999998775 59999999998664


Q ss_pred             cCCC---CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          494 HGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       494 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ....   .......|+..|+|||.+.+..++.++||||+|+++++|++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            3311   112234688999999999888899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.4e-33  Score=290.60  Aligned_cols=204  Identities=27%  Similarity=0.457  Sum_probs=173.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCC----------------eEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSK----------------TEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQ  401 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  401 (652)
                      ..+|++.+.||+|+||.||++.+...+                ..||+|.+.... ....+++.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467899999999999999999876432                568999987653 345678899999999999999999


Q ss_pred             EEeeeeccCeeEEEEEeccCCCcccccccCC---------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCc
Q 038860          402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEP---------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASN  472 (652)
Q Consensus       402 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~N  472 (652)
                      +++++..++..++++||+++++|.+++....         ...+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999985432         226899999999999999999999   7999999999999


Q ss_pred             eEeCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh--CCCCCCC
Q 038860          473 VLLDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC--GRRPIET  545 (652)
Q Consensus       473 ILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt--G~~p~~~  545 (652)
                      |+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++  |..||..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999986533221 12233456789999999988889999999999999999998  6677754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.2e-33  Score=285.06  Aligned_cols=201  Identities=29%  Similarity=0.449  Sum_probs=172.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-----chhhHHHHHHHHHHhcccCcCceeEEEeeeecc--Cee
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDL  412 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  412 (652)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+...     .....+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788999999999999999999988999999988532     123456788999999999999999999988663  467


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      +++|||+++++|.+++...  ..+++...++++.|++.||.|||   +++++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999988533  34788889999999999999999   799999999999999999999999999998865


Q ss_pred             ccCCC--CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          493 EHGTN--PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       493 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            32211  122334688999999999888899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-33  Score=299.24  Aligned_cols=297  Identities=27%  Similarity=0.363  Sum_probs=211.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhccc-CcCceeEEEeeeecc--Cee
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK--GDL  412 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  412 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++...  .......+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            356789999999999999999999888899999988543  233445677899999999 999999999998653  468


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||++ ++|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 5898887432   6889999999999999999999   799999999999999999999999999999866


Q ss_pred             ccCCC----CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          493 EHGTN----PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       493 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      .....    .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....+......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            44322    22334568999999998755 45788999999999999999999999764433222211111111110000


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC--ccccC
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG--VSYPS  639 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~--~~~~~  639 (652)
                      .     .+...  .....+..  .......+.....+.....+.+++.+|+..+|++|++      +.|++..  +....
T Consensus       238 ~-----~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         238 E-----SIKSP--FAATMLDS--LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             H-----HHHhh--hHHHhhhh--cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence            0     00000  00011111  1111112222222334578899999999999999995      6677664  33333


Q ss_pred             CCCCCceEEec
Q 038860          640 LSTSPITLVYG  650 (652)
Q Consensus       640 ~~~~~~~~~~~  650 (652)
                      ++.++++..++
T Consensus       309 ~~~~~~~~~~~  319 (337)
T cd07852         309 VLPYPITIPLD  319 (337)
T ss_pred             CCCCCccCCcc
Confidence            44455554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-33  Score=287.35  Aligned_cols=200  Identities=28%  Similarity=0.500  Sum_probs=173.2

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---------hhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---------QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      +|.+...||+|++|.||+|.+..+++.+|+|.+.....         ...+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            36677899999999999999988889999998865321         123568899999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++|+||+++++|.+++..  ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            9999999999999999843  345888999999999999999999   78999999999999999999999999999987


Q ss_pred             cccCCC-----CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          492 YEHGTN-----PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       492 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......     .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            653211     111234588999999999988899999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.7e-33  Score=289.74  Aligned_cols=212  Identities=29%  Similarity=0.390  Sum_probs=178.0

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeec
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRR  408 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  408 (652)
                      +.+.++..+.++|++.+.||+|+||.||++....+++.+|+|.+..... ...++.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            4456677788999999999999999999999988899999999865422 235677899999999 79999999999865


Q ss_pred             c-----CeeEEEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          409 K-----GDLLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       409 ~-----~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                      .     +..++|+||+++++|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999988743  23346899999999999999999999   7899999999999999999999


Q ss_pred             EEeeeccceecccCCCCceeeccCCcCCCCCCCCCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG-----KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ||+|||+++....... ......|+..|+|||.+...     .++.++|||||||++|||++|+.||...
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            9999999886543221 22234688999999987643     3688999999999999999999998653

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.8e-33  Score=284.31  Aligned_cols=202  Identities=26%  Similarity=0.441  Sum_probs=177.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|++|.||+|....+++.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5799999999999999999999988999999988642   2334567899999999999999999999999999999999


Q ss_pred             EeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          417 DFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       417 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||+++++|.+++..  .....+++.+++.++.+++.||.|||   +.+++||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999988853  23456899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ... ......++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            221 22334688999999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-33  Score=288.36  Aligned_cols=194  Identities=30%  Similarity=0.458  Sum_probs=170.2

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ||+|+||+||++....+++.||+|.+....   ......+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999998889999999986532   22344567899999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeecc
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV  504 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  504 (652)
                      .+++.......+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||.+.......  ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            99986655457899999999999999999999   7999999999999999999999999999988654322  223346


Q ss_pred             CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       505 gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ++..|+|||++.+..++.++||||||+++++|++|+.||...
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  197 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR  197 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence            788999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.2e-34  Score=293.95  Aligned_cols=198  Identities=27%  Similarity=0.414  Sum_probs=174.3

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      .|.....||+|+||.||++....++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            34445779999999999999988899999999876655566778999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +++|.+++..   ..+++..+..++.||+.||.|||   +++++||||||+||+++.++.++|+|||++....... ...
T Consensus       103 ~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  175 (292)
T cd06658         103 GGALTDIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR  175 (292)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence            9999998732   35889999999999999999999   6899999999999999999999999999987654322 222


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            335689999999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=307.45  Aligned_cols=198  Identities=33%  Similarity=0.552  Sum_probs=177.8

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCccc
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDS  426 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  426 (652)
                      .||+|.||+||-|++.++...+|||.+.....+..+-+..|+.+-++|+|+|||+++|.|.+++.+-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999999999999999999988777777778899999999999999999999999999999999999999999


Q ss_pred             ccccCCcccc--chHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEEeeeccceecccCCCCceeec
Q 038860          427 FLFDEPKAVL--NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAKLYEHGTNPATTRV  503 (652)
Q Consensus       427 ~l~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~  503 (652)
                      .|... -+++  ++...-.+.+||++||.|||   ++.|||||||-+|||++. .|.+||+|||-++++.. .++.+.++
T Consensus       662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF  736 (1226)
T ss_pred             HHHhc-cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence            98543 3445  77788889999999999999   799999999999999985 48899999999987653 56777888


Q ss_pred             cCCcCCCCCCCCCCCC--CCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          504 VGTLGYLAPETPRTGK--SSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       504 ~gt~~y~aPE~~~~~~--~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      .||..|||||++..++  |+..+|||||||++.||.||++||.+...+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp  784 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP  784 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence            9999999999998764  899999999999999999999999765543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-34  Score=299.93  Aligned_cols=245  Identities=25%  Similarity=0.415  Sum_probs=204.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      -...|.+...||+|.|+.|.+|++..++..||||.+++..-  .....+.+|+++|..++|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            45789999999999999999999999999999999987642  2334588999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+.+|.+.+|+..  ...+.+..+..++.|+.+|++|||   .+.|+|||||++||||+.+.++||+|||++..+..+
T Consensus       134 ~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence            999999999999954  344666888999999999999999   799999999999999999999999999999887643


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                        ......+|++.|.|||+..+..+ ++++|+||+|++||-|++|..||++....+                   .-++.
T Consensus       209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rv  267 (596)
T KOG0586|consen  209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRV  267 (596)
T ss_pred             --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchh
Confidence              34556799999999999988765 789999999999999999999998743211                   11222


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                      +.+.|.                .|..     +....++||++++..+|.+|.+++
T Consensus       268 l~gk~r----------------Ip~~-----ms~dce~lLrk~lvl~Pskr~~~d  301 (596)
T KOG0586|consen  268 LRGKYR----------------IPFY-----MSCDCEDLLRKFLVLNPSKRGPCD  301 (596)
T ss_pred             eeeeec----------------ccce-----eechhHHHHHHhhccCccccCCHH
Confidence            333321                1222     234778899999999999998654

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=291.33  Aligned_cols=257  Identities=23%  Similarity=0.349  Sum_probs=194.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCC--------------CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS--------------KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLV  403 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  403 (652)
                      .++|++.+.||+|+||.||++...+.              ...||+|.++... ......+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35789999999999999999987542              2358999997653 33456789999999999999999999


Q ss_pred             eeeeccCeeEEEEEeccCCCcccccccCC----------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCce
Q 038860          404 GWCRRKGDLLLVYDFMANGSLDSFLFDEP----------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNV  473 (652)
Q Consensus       404 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NI  473 (652)
                      +++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||   +.+++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999884321          124788999999999999999999   79999999999999


Q ss_pred             EeCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh--CCCCCCCCCCcc
Q 038860          474 LLDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC--GRRPIETRALPE  550 (652)
Q Consensus       474 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt--G~~p~~~~~~~~  550 (652)
                      ++++++.+||+|||++........ .......++..|+|||.+.++.++.++|||||||++|||++  |..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976533221 11222345778999999988899999999999999999988  566765432211


Q ss_pred             chhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          551 ELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       551 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                         .+......+..         .....              .... |     +...+.+.+++.+|+..+|++||+...
T Consensus       241 ---~~~~~~~~~~~---------~~~~~--------------~~~~-~-----~~~~~~l~~li~~~l~~~p~~RPs~~~  288 (295)
T cd05097         241 ---VIENTGEFFRN---------QGRQI--------------YLSQ-T-----PLCPSPVFKLMMRCWSRDIKDRPTFNK  288 (295)
T ss_pred             ---HHHHHHHhhhh---------ccccc--------------cCCC-C-----CCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence               11111111100         00000              0000 0     012357899999999999999998764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-33  Score=287.30  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=194.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCC---CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|.+.+.||+|+||.||+|.+.+.   ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            35688899999999999999987543   3569999987654 4456789999999999999999999998875 45789


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999998543 235899999999999999999999   79999999999999999999999999999986654


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      ..........++..|+|||.+....++.++||||||+++||+++ |+.||......+..   .+.    ..+        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~--------  224 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENG--------  224 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcC--------
Confidence            32222223345578999999988889999999999999999986 99999754321111   100    000        


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                         .....|     ....+.+.+++.+|+..+|++||++.-
T Consensus       225 -------------------~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~  257 (270)
T cd05056         225 -------------------ERLPMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTE  257 (270)
T ss_pred             -------------------CcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence                               000001     122357889999999999999998744

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=320.84  Aligned_cols=214  Identities=25%  Similarity=0.322  Sum_probs=189.5

Q ss_pred             CcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEE
Q 038860          327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLV  403 (652)
Q Consensus       327 ~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~  403 (652)
                      |.--...+++....+|.+++.||+|+||.|..++.+.+++.+|+|++.+..   .....-|..|-.+|..-..+=|++++
T Consensus        62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            333445677788899999999999999999999999999999999998742   23345688899999988899999999


Q ss_pred             eeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEE
Q 038860          404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKL  483 (652)
Q Consensus       404 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL  483 (652)
                      -.|.+..++|+|||||+||+|-..+.+-.  .+++..++.++..|.-||.-||   +.|+|||||||+|||||..|++||
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEee
Confidence            99999999999999999999999884433  6999999999999999999999   799999999999999999999999


Q ss_pred             eeeccceecccCCCCceeeccCCcCCCCCCCCC----C-CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR----T-GKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       484 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      +|||.|-.+..+..-.....+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||..
T Consensus       217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            999999888766555666779999999999765    2 5789999999999999999999999975

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-33  Score=284.08  Aligned_cols=197  Identities=36%  Similarity=0.572  Sum_probs=174.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|++|.||+|...  ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            357888999999999999999875  68899999977654 567899999999999999999999999988999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||.++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999996555457999999999999999999999   7999999999999999999999999999998653221  


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                        ....++..|+|||.+..+.++.++||||||+++||+++ |+.||..
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  202 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence              12345678999999988889999999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-33  Score=291.28  Aligned_cols=202  Identities=29%  Similarity=0.477  Sum_probs=171.4

Q ss_pred             cCccccccccccCceEEEEEEE----cCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec--cCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--KGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  413 (652)
                      ++|++.+.||+|+||.||++..    ..++..||+|.+........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788899999999999999984    34578899999987766677889999999999999999999998754  34689


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|+||+++++|.+++... ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999999998543 235899999999999999999999   7999999999999999999999999999998764


Q ss_pred             cCCCCce--eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          494 HGTNPAT--TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       494 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .......  ....++..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  213 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS  213 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence            4322111  112234569999999888899999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-33  Score=293.09  Aligned_cols=275  Identities=25%  Similarity=0.372  Sum_probs=199.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG------  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  410 (652)
                      .++|+..+.||+|+||.||+|....+++.||+|.+....  ......+.+|+.++++++||||++++++|...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999999889999999986432  222345678999999999999999999986543      


Q ss_pred             --eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          411 --DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       411 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                        ..++||||+.+ +|.+++... ...+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              45999999964 777776432 336899999999999999999999   68999999999999999999999999999


Q ss_pred             ceecccCCCC---ceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          489 AKLYEHGTNP---ATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       489 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      +.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+....+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9866432221   12234578899999987664 4788999999999999999999999865544433444433332222


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCC--CCCCCCcccccchhHHHHHhhhccCCCCCCCCc
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTL--RGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~--~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~  628 (652)
                      +....         ... ......+..+...  +.+.........+.+.|++.+|+..+|++|+++
T Consensus       246 ~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~  301 (310)
T cd07865         246 EVWPG---------VDK-LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA  301 (310)
T ss_pred             hhccc---------ccc-hhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence            11111         000 0001111111110  111111111234578899999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.9e-33  Score=283.30  Aligned_cols=201  Identities=29%  Similarity=0.465  Sum_probs=173.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-----chhhHHHHHHHHHHhcccCcCceeEEEeeeec--cCee
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--KGDL  412 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  412 (652)
                      .+|+..+.||+|+||.||+|.+..++..||+|.+...     .....+.+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788999999999999999999888999999988643     22345678899999999999999999998865  3568


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++++||+++++|.+++...  ..+++...+.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            8999999999999998543  35889999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCC--CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          493 EHGT--NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       493 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ....  ........++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence            3211  1122234688999999999988899999999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=289.64  Aligned_cols=202  Identities=30%  Similarity=0.449  Sum_probs=173.8

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeEEEEE
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLLLVYD  417 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  417 (652)
                      |++.+.||+|++|.||+|....+++.+|+|++....  ......+.+|+.++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999999889999999997653  33446788999999999999999999999888  88999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++ +|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8888875432 46899999999999999999999   68999999999999999999999999999987655433


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            23344467889999997765 4578999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-33  Score=288.00  Aligned_cols=261  Identities=28%  Similarity=0.377  Sum_probs=194.4

Q ss_pred             Cc-cccccccccCceEEEEEEE----cCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeecc--Cee
Q 038860          341 NF-SAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDL  412 (652)
Q Consensus       341 ~f-~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  412 (652)
                      +| +..+.||+|+||+||++..    ..++..||+|.+..... .....+.+|+.++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 7889999999999988653    34577899999976532 3456788999999999999999999988653  458


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      +++|||+++++|.+++..   ..+++.+++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999999999843   35899999999999999999999   799999999999999999999999999999866


Q ss_pred             ccCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          493 EHGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       493 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ......  ......++..|+|||.+....++.++||||||+++|||++|+.|+......-                 .++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----------------~~~  220 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-----------------EEM  220 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-----------------hhh
Confidence            433221  1122345667999999988889999999999999999999999986432110                 011


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                      ++..........  ....+...  ...|.+.   .....+.+++.+|+..+|++||+...+
T Consensus       221 ~~~~~~~~~~~~--~~~~~~~~--~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~i  274 (283)
T cd05080         221 IGPKQGQMTVVR--LIELLERG--MRLPCPK---NCPQEVYILMKNCWETEAKFRPTFRSL  274 (283)
T ss_pred             hcccccccchhh--hhhhhhcC--CCCCCCC---CCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            111110000000  00000000  0111111   223689999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4e-33  Score=282.56  Aligned_cols=201  Identities=24%  Similarity=0.424  Sum_probs=177.2

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|+||.+|++....+++.||+|++...  .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999999888999999998643  233456789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++.+++.++.|++.||.|||   +.+++|+||+|+|||++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999886554556889999999999999999999   79999999999999999999999999999986543221 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......|+..|+|||.+.+...+.++|+|||||+++||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence            22234688899999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.6e-33  Score=288.56  Aligned_cols=203  Identities=28%  Similarity=0.453  Sum_probs=173.2

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      +|+..+.||+|++|.||+|++..+++.||+|.+...... ....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            588899999999999999999988999999998765332 3456778999999999999999999999999999999999


Q ss_pred             cCCCcccccccCC-ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          420 ANGSLDSFLFDEP-KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       420 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      ++ +|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888775432 346899999999999999999999   68999999999999999999999999999975543221 


Q ss_pred             ceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      ......++..|++||++.+. .++.++||||||+++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  206 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN  206 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            12234578899999987654 578899999999999999999999986543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.4e-33  Score=290.42  Aligned_cols=202  Identities=24%  Similarity=0.348  Sum_probs=171.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  415 (652)
                      ++|+..+.||+|++|.||+|.+..+++.+|+|.++....  .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            578899999999999999999998899999999965432  2234567899999999999999999998877  889999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      +||+++ +|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999974 8888875433 36899999999999999999999   689999999999999999999999999999866543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      . .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus       160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2 122334578899999988654 46899999999999999999999997654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-33  Score=292.97  Aligned_cols=203  Identities=30%  Similarity=0.409  Sum_probs=170.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4689999999999999999999998899999999864422  2223466899999999999999999998654  56899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++ +|.+++... ...+++.+++.++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999964 788777443 356899999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~  213 (309)
T cd07845         161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS  213 (309)
T ss_pred             ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            321 2223345788999998865 457899999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=298.97  Aligned_cols=195  Identities=29%  Similarity=0.451  Sum_probs=175.9

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      .+.||+|.||+||-|+++.+|+.||||.+.+.  ...+..++.+|+.||++++||.||.+.-.|+..+.+++|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            57899999999999999999999999999765  3345577899999999999999999999999999999999999 56


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeeccceecccCCCCc
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGla~~~~~~~~~~  499 (652)
                      +..+.+.......|++.....++.||+.||.|||   .++|+|+||||+||||.+.   -++||+|||.||.+....  -
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F  722 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F  722 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence            8777777777888999999999999999999999   7999999999999999754   569999999999887543  3


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...++||+.|+|||++.++.|...-|+||.||++|--|+|..||.+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence            4457899999999999999999999999999999999999999975

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.8e-33  Score=285.61  Aligned_cols=202  Identities=28%  Similarity=0.453  Sum_probs=170.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe----EEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT----EVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .+|++.+.||+|+||.||+|.+..++.    .+++|.+.... .....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            467888999999999999999866554    47888876443 2345678889999999999999999998864 45788


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ++||+++|+|.+++... ...+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999543 346899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            322 12234557789999999998899999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.4e-33  Score=286.58  Aligned_cols=192  Identities=26%  Similarity=0.410  Sum_probs=160.2

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHh---cccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATI---GRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      .||+|+||.||++.+..+++.+|+|.+.....   .....+.+|..++   ...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999988899999998865421   1222334444333   33479999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +++|.+++..  ...+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.++|+|||++.......   .
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~  152 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence            9999988853  345899999999999999999999   7999999999999999999999999999987553321   2


Q ss_pred             eeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          501 TRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            23468999999998764 56889999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.4e-33  Score=284.70  Aligned_cols=198  Identities=27%  Similarity=0.422  Sum_probs=163.0

Q ss_pred             ccccccCceEEEEEEEcC--CCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          346 QLLGHGGFGQVYKGTLHN--SKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      +.||+|+||.||+|...+  ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998653  346799999876532 33457889999999999999999999999998999999999999


Q ss_pred             CcccccccCC---ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC-
Q 038860          423 SLDSFLFDEP---KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-  498 (652)
Q Consensus       423 sL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-  498 (652)
                      +|.+++....   ....++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999985422   234677788899999999999999   799999999999999999999999999998754322211 


Q ss_pred             ceeeccCCcCCCCCCCCCCC-------CCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTG-------KSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......++..|+|||++...       .++.++|+||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence            12234578899999987542       35789999999999999996 99999653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-33  Score=312.58  Aligned_cols=201  Identities=25%  Similarity=0.392  Sum_probs=160.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCe-EEEEE------------------EecCcchhhHHHHHHHHHHhcccCcCc
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKT-EVAVK------------------RISNESKQGVREFVSEIATIGRLRHRN  398 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~-~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n  398 (652)
                      ..++|++.+.||+|+||+||++..+.... ..+.|                  .+. ........+.+|+.++++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            35689999999999999999987653221 12222                  111 11223456889999999999999


Q ss_pred             eeEEEeeeeccCeeEEEEEeccCCCcccccccCC---ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP---KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       399 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      |+++++++...+..++|+|++. ++|.+++....   .......++..++.||+.||.|||   +++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999985 47777664321   122335667789999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCC
Q 038860          476 DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI  543 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~  543 (652)
                      +.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999876544333344567999999999999999999999999999999999988644

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-33  Score=291.41  Aligned_cols=206  Identities=29%  Similarity=0.431  Sum_probs=172.7

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC----
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG----  410 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  410 (652)
                      ...++|++.+.||+|++|.||+|.+..+++.||+|.++...  ......+.+|+.++++++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999999889999999996542  223356778999999999999999999987654    


Q ss_pred             ------eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          411 ------DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       411 ------~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                            ..++|+||+++ +|...+... ...+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999976 666666433 346899999999999999999999   7899999999999999999999999


Q ss_pred             eeccceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       485 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      |||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||....
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998765433222233456788999998765 457889999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.6e-33  Score=286.69  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      .|...+.||+|++|.||++....+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            45556799999999999999988889999999876555556678899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +++|.+++..   ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||.+....... ...
T Consensus       100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~  172 (285)
T cd06648         100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRR  172 (285)
T ss_pred             CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccc
Confidence            9999998844   45889999999999999999999   7999999999999999999999999999887554322 122


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYD  580 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  580 (652)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||......   .......                     
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~---------------------  228 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIR---------------------  228 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHH---------------------
Confidence            3356899999999998888999999999999999999999998642210   0000000                     


Q ss_pred             HHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          581 QSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       581 ~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                            ..  ..     |.........+.+.+++++|+..+|++|+      .|+|++..+.
T Consensus       229 ------~~--~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         229 ------DN--LP-----PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ------hc--CC-----CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                  00  00     01111112345789999999999999998      4566666443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.3e-33  Score=282.63  Aligned_cols=202  Identities=31%  Similarity=0.516  Sum_probs=174.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||++.+.. +..+|+|.+.... ...+.+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            4678999999999999999998754 5679999887543 345678899999999999999999999887 778999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            99999999997655567899999999999999999999   689999999999999999999999999999866443322


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......++..|+|||++..+.++.++|+|||||++||+++ |+.||...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence            2233345678999999988889999999999999999999 99998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.1e-33  Score=282.32  Aligned_cols=249  Identities=27%  Similarity=0.418  Sum_probs=199.7

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|++|.||+|....+++.|++|.+.....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            57888999999999999999988889999999876543  3667899999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++..  ...+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            999999999854  335789999999999999999999   799999999999999999999999999999876543322


Q ss_pred             cee---eccCCcCCCCCCCCCCCC---CCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          499 ATT---RVVGTLGYLAPETPRTGK---SSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       499 ~~~---~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ...   ...++..|+|||.+.+..   .+.++||||||+++||+++|+.||..........  ... .            
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~-~------------  220 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHV-G------------  220 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HHH-h------------
Confidence            211   356789999999988766   8899999999999999999999996532111000  000 0            


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                        .......|.   .....+.+.+++.+|+..+|++|++.+-
T Consensus       221 ------------------~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~  257 (264)
T cd06626         221 ------------------AGHKPPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASE  257 (264)
T ss_pred             ------------------cCCCCCCCc---ccccCHHHHHHHHHHccCCcccCCCHHH
Confidence                              000000111   1123467889999999999999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.5e-33  Score=284.27  Aligned_cols=244  Identities=26%  Similarity=0.378  Sum_probs=194.4

Q ss_pred             ccccccCceEEEEEEEcC-CC--eEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHN-SK--TEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|++|.||+|.+.. .+  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999864 23  3699999987765 567789999999999999999999999988 889999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC--c
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP--A  499 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~--~  499 (652)
                      ++|.+++.......+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999986544356899999999999999999999   799999999999999999999999999999876442221  1


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+   .......   .              
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~--------------  216 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---E--------------  216 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---c--------------
Confidence            122456789999999998899999999999999999998 999986432211   1111000   0              


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                   ......|.     .....+.+++.+|+..+|++||+...+
T Consensus       217 -------------~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         217 -------------GERLERPE-----ACPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             -------------CCcCCCCc-----cCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence                         00000010     123578899999999999999987654

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.5e-33  Score=282.65  Aligned_cols=240  Identities=27%  Similarity=0.405  Sum_probs=187.9

Q ss_pred             cccccCceEEEEEEEc--CCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          347 LLGHGGFGQVYKGTLH--NSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      .||+|+||.||+|.+.  .++..+|+|+++...  ....+++.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753  457889999986543  3345678999999999999999999998864 5678999999999


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc--e
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--T  500 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~--~  500 (652)
                      +|.+++..  ...+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.........  .
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            99999843  345889999999999999999999   7999999999999999999999999999998664433211  1


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEY  579 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  579 (652)
                      ....++..|+|||.+....++.++|+|||||++|||++ |+.||......   .....+             +.      
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i-------------~~------  213 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMI-------------ES------  213 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------HC------
Confidence            22234678999999988889999999999999999998 99999753211   111100             00      


Q ss_pred             CHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          580 DQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       580 ~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                              .      .+.+.+   ....+.+.|++.+|+..+|++||+.+..
T Consensus       214 --------~------~~~~~~---~~~~~~l~~li~~~~~~~p~~Rp~~~~i  248 (257)
T cd05116         214 --------G------ERMECP---QRCPPEMYDLMKLCWTYGVDERPGFAVV  248 (257)
T ss_pred             --------C------CCCCCC---CCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence                    0      000001   1234678999999999999999987654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-33  Score=292.96  Aligned_cols=197  Identities=27%  Similarity=0.418  Sum_probs=172.8

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      |+....||+|+||.||++.+..+++.||+|.+........+.+.+|+.++..++|||++++++.+..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            33455799999999999999888899999998765445556788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      ++|..++.   ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....... ....
T Consensus       103 ~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~  175 (297)
T cd06659         103 GALTDIVS---QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK  175 (297)
T ss_pred             CCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence            99998773   245889999999999999999999   7999999999999999999999999999987554322 2223


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  219 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS  219 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            45689999999999888899999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-33  Score=299.56  Aligned_cols=200  Identities=24%  Similarity=0.313  Sum_probs=171.5

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  409 (652)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|.+...  ......++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            347899999999999999999999988999999998653  233445678899999999999999999988643      


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      ...++||||+. ++|.+.+..    .+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999996 488777732    2888999999999999999999   789999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +......  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            8654322  2233467899999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=279.28  Aligned_cols=272  Identities=22%  Similarity=0.360  Sum_probs=206.9

Q ss_pred             hhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccC
Q 038860          332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKG  410 (652)
Q Consensus       332 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  410 (652)
                      ++++.+.|     .+.||+|+|+.|--++...++.++|||++.+.......+..+|++++...+ |+||++++.||.++.
T Consensus        75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            45555555     467999999999999999999999999999887777788999999999885 999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC---eEEeeec
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN---GKLGDFG  487 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~---~kL~DFG  487 (652)
                      .+|||||-|.||+|..++..  ...+++.++.++.++|+.||.|||   .++|.||||||+|||..+...   +||+||.
T Consensus       150 ~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             eEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999954  446899999999999999999999   899999999999999976544   8999999


Q ss_pred             cceecccC------CCCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHH
Q 038860          488 LAKLYEHG------TNPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVD  556 (652)
Q Consensus       488 la~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~  556 (652)
                      ++.-+...      ..+.....+|+..|||||+..     .-.|+.++|.|||||+||-||+|-+||.+....+-     
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-----  299 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-----  299 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-----
Confidence            87644221      122334568999999999643     23588899999999999999999999987654321     


Q ss_pred             HHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccc
Q 038860          557 WVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSY  630 (652)
Q Consensus       557 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~  630 (652)
                          -|..|...+.          ..+.+...+.--. -.-|...|. ...+++.||+++++..++-.|++      |+|
T Consensus       300 ----GWdrGe~Cr~----------CQ~~LFesIQEGk-YeFPdkdWa-hIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  300 ----GWDRGEVCRV----------CQNKLFESIQEGK-YEFPDKDWA-HISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             ----CccCCCccHH----------HHHHHHHHHhccC-CcCChhhhH-HhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence                1111111111          1111111111000 011333333 44678899999999988888874      567


Q ss_pred             cccC
Q 038860          631 FENG  634 (652)
Q Consensus       631 ~~~~  634 (652)
                      +...
T Consensus       364 ~~~~  367 (463)
T KOG0607|consen  364 VQRC  367 (463)
T ss_pred             cccc
Confidence            6654

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.8e-33  Score=285.10  Aligned_cols=198  Identities=28%  Similarity=0.428  Sum_probs=161.3

Q ss_pred             ccccccCceEEEEEEEcC--CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          346 QLLGHGGFGQVYKGTLHN--SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      +.||+|+||.||+|....  ....+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999997543  34578999876543 334567889999999999999999999999999999999999999


Q ss_pred             CcccccccCC---ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC-
Q 038860          423 SLDSFLFDEP---KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-  498 (652)
Q Consensus       423 sL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-  498 (652)
                      +|.+++....   ....++...+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999985532   233567888999999999999999   799999999999999999999999999998754322111 


Q ss_pred             ceeeccCCcCCCCCCCCC-------CCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPR-------TGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~-------~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......++..|+|||++.       ...++.++|||||||++|||++ |..||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            112334577899999764       3456889999999999999999 78888643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.1e-33  Score=281.57  Aligned_cols=201  Identities=25%  Similarity=0.445  Sum_probs=176.8

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|++|.||++....+++.+|+|.+...  .....+.+.+|+.++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478899999999999999999888999999998654  234457789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla~~~~~~~~  497 (652)
                      +++++|.+++.......+++..+.+++.|++.+|.|||   +++++||||||+||+++.+ +.+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999996655556899999999999999999999   7999999999999999865 458999999998764432 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       ......|+..|+|||.+.+...+.++||||||+++|+|++|+.||...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence             223356889999999999888999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-33  Score=284.27  Aligned_cols=200  Identities=29%  Similarity=0.470  Sum_probs=171.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch----------hhHHHHHHHHHHhcccCcCceeEEEeeeeccC
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK----------QGVREFVSEIATIGRLRHRNLVQLVGWCRRKG  410 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  410 (652)
                      +|...+.||+|++|.||+|....+++.||+|.++....          ...+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46778899999999999999988899999998853211          12346788999999999999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999998543  46899999999999999999999   6899999999999999999999999999998


Q ss_pred             ecccCCC-CceeeccCCcCCCCCCCCCCCC--CCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          491 LYEHGTN-PATTRVVGTLGYLAPETPRTGK--SSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       491 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ....... .......|+..|+|||.+....  ++.++|+||||+++||+++|..||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            6543221 1223356889999999887654  78999999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.5e-33  Score=287.94  Aligned_cols=201  Identities=24%  Similarity=0.416  Sum_probs=177.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|+..+.||+|+||.||++....++..||+|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            36889999999999999999998878889999998765555567789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.+   ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||++........ 
T Consensus        98 ~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            999999999843   35788999999999999999999   79999999999999999999999999999876543322 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ......|++.|+|||.+....++.++|+||||+++||+++|+.||...
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            223346889999999998888999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-32  Score=281.64  Aligned_cols=250  Identities=24%  Similarity=0.301  Sum_probs=192.7

Q ss_pred             hhhhhhhcCccccccc--cccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeecc
Q 038860          333 QELKQATNNFSAKQLL--GHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK  409 (652)
Q Consensus       333 ~el~~~~~~f~~~~~L--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  409 (652)
                      .+.....++|++.+.+  |+|+||.||++....++..+|+|.+........     |+.....+ +|||++++++.+...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444555677777776  999999999999998899999999865422211     22222222 699999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeecc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGL  488 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGl  488 (652)
                      +..++||||+++++|.+++...  ..+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            9999999999999999998543  37899999999999999999999   78999999999999999998 999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      ++.....     ....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ......+           
T Consensus       157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~-----------  219 (267)
T PHA03390        157 CKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESL-----------  219 (267)
T ss_pred             ceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHH-----------
Confidence            8865432     2235889999999999989999999999999999999999999743221 1110000           


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC-C------cccccc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT-S------CSYFEN  633 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~-s------~~~~~~  633 (652)
                                       ....  ......+     ....+.+.+++.+|+..+|++|+ +      |+||++
T Consensus       220 -----------------~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        220 -----------------LKRQ--QKKLPFI-----KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -----------------HHhh--cccCCcc-----cccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                             0000  0000000     12356889999999999999998 3      778754

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-33  Score=287.85  Aligned_cols=198  Identities=29%  Similarity=0.454  Sum_probs=174.3

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999998888999999987543 344567899999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.   ...+++..+..++.|++.|+.|||   +++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06642          85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence            9999999884   345889999999999999999999   7999999999999999999999999999998654322 12


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence            2234688999999999988899999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.4e-33  Score=286.85  Aligned_cols=203  Identities=30%  Similarity=0.475  Sum_probs=171.2

Q ss_pred             CccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      +|++.+.||+|+||.||+|....     ....+++|.+.... .....++.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999998753     23579999887653 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccC----------------------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCc
Q 038860          415 VYDFMANGSLDSFLFDE----------------------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASN  472 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~N  472 (652)
                      ++||+++++|.+++...                      ....+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            99999999999887431                      1235889999999999999999999   7999999999999


Q ss_pred             eEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          473 VLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       473 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999865332221 1223345778999999888889999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.5e-33  Score=289.34  Aligned_cols=279  Identities=22%  Similarity=0.298  Sum_probs=201.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|+..+.||+|++|.||+|.+..+++.||+|.+.....  ...+.+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            578899999999999999999988899999999865422  234568899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEEeeeccceecccCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~~~~~~~  496 (652)
                      |++ ++|.+++.......+++..+..++.||+.||+|||   +++++||||||+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 57877775444445688888999999999999999   789999999999999985 4679999999997654322


Q ss_pred             CCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                       .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+...   ......... .    ...+
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~-~----~~~~  228 (294)
T PLN00009        158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF---KIFRILGTP-N----EETW  228 (294)
T ss_pred             -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCC-C----hhhc
Confidence             12233457889999998766 457899999999999999999999997643322211   111111100 0    0000


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCC-CcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRS-SDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~-~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      .+..+.. ......  +.. ..+.. ...+...+.+.+++.+|+..+|++|+      .++|++++.
T Consensus       229 ~~~~~~~-~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        229 PGVTSLP-DYKSAF--PKW-PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             cccccch-hhhhhc--ccC-CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            0000000 000000  000 00000 11123456789999999999999999      667776653

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.5e-33  Score=283.12  Aligned_cols=203  Identities=30%  Similarity=0.565  Sum_probs=172.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCC---eEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSK---TEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|+..+.||+|++|.||+|.+..++   ..+|+|.++... ....+++.+|++++++++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999987544   379999987653 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++... ...+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999998543 346899999999999999999999   79999999999999999999999999999986643


Q ss_pred             CCCCcee--eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          495 GTNPATT--RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       495 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      .......  ....+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~  213 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD  213 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence            3222111  1223457999999988889999999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-33  Score=298.49  Aligned_cols=281  Identities=23%  Similarity=0.326  Sum_probs=205.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeec----cCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRR----KGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  412 (652)
                      ..+|++.+.||+|++|.||+|....+++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368899999999999999999999889999999987542  2345667889999999999999999998753    3468


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++|+||+. ++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999996 589888843  345899999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCCCC---ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          493 EHGTNP---ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       493 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      ......   ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....+...    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~----~  233 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS----E  233 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh----h
Confidence            432211   1234578999999998765 4688999999999999999999999976544332222221111111    1


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      +.++.....   ........  .+.....+.....+...+.+.+++.+|+..+|++|++      |+|++.-
T Consensus       234 ~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         234 EVLNRIGSD---RVRKYIQN--LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             Hhhhhhchh---hHHHHHhh--cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence            111111000   00001111  1111111111112334678999999999999999985      5888764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-33  Score=290.95  Aligned_cols=203  Identities=23%  Similarity=0.337  Sum_probs=169.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccC-cCceeEEEeeeeccCe-----
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGD-----  411 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  411 (652)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468899999999999999999998899999998865432  23456788999999995 6999999999877655     


Q ss_pred             eEEEEEeccCCCcccccccCC---ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEEeeec
Q 038860          412 LLLVYDFMANGSLDSFLFDEP---KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKLGDFG  487 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL~DFG  487 (652)
                      .++||||+++ +|.+++....   ...+++..++.++.||+.||.|||   +++++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8888875432   346899999999999999999999   799999999999999998 8899999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +++.+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||....
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~  216 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS  216 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9986543221 1223356889999998765 457899999999999999999999997643

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.2e-33  Score=279.25  Aligned_cols=196  Identities=33%  Similarity=0.533  Sum_probs=167.6

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ++||+|+||.||+|... ++..+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36999999999999875 478899999876543 3344688999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeecc
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV  504 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  504 (652)
                      .+++... ...+++..++.++.|++.+|.|||   +++++||||||+||+++.++.+||+|||++...............
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          80 LSFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            9988543 245889999999999999999999   799999999999999999999999999999765433222222234


Q ss_pred             CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       505 gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ++..|+|||++.+..++.++||||||+++||+++ |..||...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            4678999999998889999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.2e-33  Score=300.14  Aligned_cols=207  Identities=29%  Similarity=0.472  Sum_probs=173.2

Q ss_pred             hhhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcch-hhHHHHHHHHHHhcccC-cCceeEEEeeeecc
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESK-QGVREFVSEIATIGRLR-HRNLVQLVGWCRRK  409 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  409 (652)
                      ...++|.+.+.||+|+||.||+|++..     .+..||+|++..... ...+.+.+|+.++.++. ||||++++++|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            344578888999999999999998642     456899999976532 33457889999999997 99999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCC---------------------------------------------------------
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEP---------------------------------------------------------  432 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------  432 (652)
                      +..++|+||+++|+|.++++...                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999885421                                                         


Q ss_pred             ---------------------------------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCce
Q 038860          433 ---------------------------------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNV  473 (652)
Q Consensus       433 ---------------------------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NI  473 (652)
                                                             ...+++..++.++.|++.||.|||   +++++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceE
Confidence                                                   124677788999999999999999   79999999999999


Q ss_pred             EeCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          474 LLDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       474 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      |+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999986533221 11223457889999999998889999999999999999998 88898653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.8e-33  Score=280.65  Aligned_cols=202  Identities=28%  Similarity=0.468  Sum_probs=180.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|++.+.||+|++|.||++.+..+++.|++|++..... ...+.+.+|+.++.+++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            468889999999999999999998899999999876644 4567899999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCcc-ceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE-QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      +++++|.+++...  ..+++..++.++.|+++||.|||   + .+++||||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999543  56899999999999999999999   7 9999999999999999999999999999987654332


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      . .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            2 224568899999999999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.6e-33  Score=282.60  Aligned_cols=199  Identities=28%  Similarity=0.473  Sum_probs=171.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc------hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES------KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      +|+..+.||+|+||.||+|... +++.+|+|.+....      ......+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4778899999999999999875 57889999886432      2234568899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ++||+++++|.+++.+.  ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999998442  45889999999999999999999   78999999999999999999999999999875422


Q ss_pred             CC-----CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 GT-----NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ..     ........|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            11     1112335689999999999988899999999999999999999999965

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-33  Score=281.55  Aligned_cols=244  Identities=29%  Similarity=0.480  Sum_probs=197.2

Q ss_pred             ccccccCceEEEEEEEcCC---CeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|.....   +..|++|.+...... ..+.+.+|++++..++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999865   789999999876443 367889999999999999999999999999999999999999


Q ss_pred             CCcccccccCC-------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          422 GSLDSFLFDEP-------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       422 gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ++|.+++....       ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999986532       356899999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          495 GTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       495 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ... .......++..|+|||......++.++||||+|+++|||++ |+.||......   .+.+    ....        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~--------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE----YLRK--------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHc--------
Confidence            321 12233467889999999988889999999999999999999 69998764211   0000    0000        


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                         ..  +.+.+   ....+.+.+++.+|+..+|++||++..+
T Consensus       223 -------------------~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l  257 (262)
T cd00192         223 -------------------GY--RLPKP---EYCPDELYELMLSCWQLDPEDRPTFSEL  257 (262)
T ss_pred             -------------------CC--CCCCC---ccCChHHHHHHHHHccCCcccCcCHHHH
Confidence                               00  00001   1224678999999999999999987653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5e-33  Score=284.58  Aligned_cols=195  Identities=31%  Similarity=0.528  Sum_probs=164.5

Q ss_pred             ccccccCceEEEEEEEcCCCe--EEEEEEecCc-chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKT--EVAVKRISNE-SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|.+.+++.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999977664  4788988754 334556788999999999 799999999999999999999999999


Q ss_pred             CCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          422 GSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       422 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      |+|.+++....              ...+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999885422              234789999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      +++.....  ........+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  214 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  214 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            98632211  11112234567999999988889999999999999999997 9999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-35  Score=280.16  Aligned_cols=268  Identities=28%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-h-hhHHHHHHHHHHhcccCcCceeEEEeeeec--------c
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-K-QGVREFVSEIATIGRLRHRNLVQLVGWCRR--------K  409 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  409 (652)
                      +.|+...+||+|.||.||+|+..++++.||+|+.--+. + .-...-++|+.+|..++|+|++.++..|..        +
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666788999999999999999999999998764322 1 222345789999999999999999999854        2


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      ..+|||+.+|+. +|.-.|. +....++..++.++++++..||.|+|   ...|+|||+|+.|+|++.++.+||+|||++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc-CccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            358999999976 8877773 33456889999999999999999999   799999999999999999999999999999


Q ss_pred             eecccCCC---CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCC
Q 038860          490 KLYEHGTN---PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEG  565 (652)
Q Consensus       490 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  565 (652)
                      +.+....+   +..+..+-|..|++||.+.+ +.++++.|||+.||++.||.||.+-+++.....+..++...++.+..+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            87654332   33444566999999998776 569999999999999999999999999888777888888777766543


Q ss_pred             ccccccccccccCCCHHHHHHhhccCCCC----------CCCCCCCcccccchhHHHHHhhhccCCCCCCCC
Q 038860          566 RVLEVIDPKLNAEYDQSQVLMGELELPDT----------LRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS  627 (652)
Q Consensus       566 ~~~~~id~~l~~~~~~~~~~~~~l~~~~~----------~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s  627 (652)
                      -.-++..-.          +.+.+++++.          ...|..     ..+.+.||+++|+..||+||+.
T Consensus       252 vWP~~d~lp----------L~~sie~ePl~~~~~rkv~n~~kp~~-----kd~~a~dLle~ll~~DP~kR~~  308 (376)
T KOG0669|consen  252 VWPNVDNLP----------LYQSIELEPLPKGQKRKVKNRLKPYV-----KDDEALDLLEKLLKLDPTKRID  308 (376)
T ss_pred             cCCCcccch----------HHHhccCCCCCcchhhhhhhhccccc-----CChhHHHHHHHHhccCcccCcc
Confidence            322221111          1222221111          011222     1458899999999999999993

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-32  Score=280.57  Aligned_cols=193  Identities=30%  Similarity=0.393  Sum_probs=170.6

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ||+|++|.||++.+..+++.||+|.+....   ....+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999888999999987542   23446789999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeecc
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV  504 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  504 (652)
                      .+++.+.  ..+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            9999543  35889999999999999999999   7999999999999999999999999999998664432  223346


Q ss_pred             CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       505 gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      |+..|++||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            8899999999888889999999999999999999999997643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.8e-33  Score=280.22  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=197.5

Q ss_pred             ccccccccccCceEEEEEEEcCCC----eEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSK----TEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      |++.+.||+|+||.||++.....+    ..||+|.+...... ..+.+..|+.++..++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356788999999999999998755    88999999766443 5678999999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999986544333899999999999999999999   7899999999999999999999999999998765442


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                      ........++..|+|||.+.+..++.++||||+|++++||++ |+.||.....   ........    .           
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~----~-----------  219 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK----K-----------  219 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----c-----------
Confidence            222222347789999999988889999999999999999998 7888765211   11111000    0           


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                  .    .  ..+.+.   ...+.+.+++.+|+..+|++||+..-
T Consensus       220 ------------~----~--~~~~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~  253 (258)
T smart00219      220 ------------G----Y--RLPKPE---NCPPEIYKLMLQCWAEDPEDRPTFSE  253 (258)
T ss_pred             ------------C----C--CCCCCC---cCCHHHHHHHHHHCcCChhhCcCHHH
Confidence                        0    0  000111   13457889999999999999998653

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6e-33  Score=285.32  Aligned_cols=202  Identities=26%  Similarity=0.443  Sum_probs=170.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCe----EEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKT----EVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|+..+.||+|+||.||+|.+..+++    .||+|.+.... ....+++.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3578889999999999999999765554    48999987543 33456788999999999999999999999754 578


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +++||+++|+|.+++... ...+++..++.++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999998543 345899999999999999999999   7999999999999999999999999999998764


Q ss_pred             cCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          494 HGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       494 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      ..... ......++..|+|||...+..++.++|||||||++|||++ |..||..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            32211 1112234678999999988899999999999999999998 9999865

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=285.26  Aligned_cols=204  Identities=29%  Similarity=0.437  Sum_probs=174.6

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccC-----
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKG-----  410 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  410 (652)
                      ..+++|++.+.||+|++|.||+|.+..+++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            467899999999999999999999988889999999876543 346788999999999 6999999999996544     


Q ss_pred             -eeEEEEEeccCCCcccccccCC--ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          411 -DLLLVYDFMANGSLDSFLFDEP--KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       411 -~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                       .+++||||+++++|.+++....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999885432  457899999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCC-----CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ++....... .......|+..|+|||.+..     ..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            998654322 22233568999999998653     3467899999999999999999999964

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-33  Score=297.05  Aligned_cols=275  Identities=22%  Similarity=0.343  Sum_probs=199.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeecc------C
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------G  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  410 (652)
                      .++|...+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999998889999999986532  22345678999999999999999999998654      3


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++|+||+.. +|..++    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            46999999964 666554    235889999999999999999999   7899999999999999999999999999988


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhc--CCcc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYG--EGRV  567 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~  567 (652)
                      .....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........   ...+....  ...+
T Consensus       166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~  238 (342)
T cd07879         166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGPEF  238 (342)
T ss_pred             CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHH
Confidence            54321    223467889999998876 46889999999999999999999999864332211   11111111  0000


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      .+.++..     .. ......+  +...+.+.....+...+.+.+|+.+|+..+|++|++      |+||+....
T Consensus       239 ~~~~~~~-----~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         239 VQKLEDK-----AA-KSYIKSL--PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHhccc-----ch-HHHHhhc--CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000000     00 0000110  111111111112234567889999999999999995      899988644

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7e-33  Score=285.66  Aligned_cols=201  Identities=31%  Similarity=0.467  Sum_probs=170.5

Q ss_pred             cCccccccccccCceEEEEEEE----cCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc--Cee
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDL  412 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  412 (652)
                      ..|++.+.||+|+||.||++.+    ..++..||+|.++... ......+.+|+.++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3568889999999999999985    3457889999987553 33456789999999999999999999998775  568


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++++|.+++.+. ...+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            9999999999999998543 235899999999999999999999   799999999999999999999999999999866


Q ss_pred             ccCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          493 EHGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       493 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      ......  ......++..|+|||++.+..++.++||||||+++|||++++.|..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence            433221  1223456778999999988889999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.9e-34  Score=279.17  Aligned_cols=289  Identities=24%  Similarity=0.331  Sum_probs=204.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCC----eEEEEEEecCcchh-h-HHHHHHHHHHhcccCcCceeEEEeeeec-cCee
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSK----TEVAVKRISNESKQ-G-VREFVSEIATIGRLRHRNLVQLVGWCRR-KGDL  412 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  412 (652)
                      ..|+....||+|.||.||+|...+++    +.+|+|+++.+... + -....+|+.+++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888999999999999999765433    36899999765322 1 2345689999999999999999999877 7789


Q ss_pred             EEEEEeccCCCccccccc---CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC----CCeEEee
Q 038860          413 LLVYDFMANGSLDSFLFD---EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE----LNGKLGD  485 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~----~~~kL~D  485 (652)
                      +|++||.+. +|...++-   .....++...+..|+.||+.|+.|||   +.=|+||||||.|||+..+    |++||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 88877742   22346888999999999999999999   4669999999999999877    8999999


Q ss_pred             eccceecccCCCC--ceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCc------cchhHHH
Q 038860          486 FGLAKLYEHGTNP--ATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALP------EELVLVD  556 (652)
Q Consensus       486 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~------~~~~l~~  556 (652)
                      +|++|.+.....+  ....++-|..|+|||.+.+. .|+.+.||||.||++.||++-++.|.+.+..      -+...++
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999988654433  23456789999999998885 5899999999999999999999999765422      1222333


Q ss_pred             HHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCC--CC-CCcccccchhHHHHHhhhccCCCCCCCCc-----
Q 038860          557 WVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRG--PR-SSDGDKAAEGFDDLLNSLASSSFDKTTSC-----  628 (652)
Q Consensus       557 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~--p~-~~~~~~~~~~~~dLl~~~~~~~~~~r~s~-----  628 (652)
                      .+...+..-...+.  |.+ ..+..-+.++...........  +. ........+.+.+||.||+..||-||+++     
T Consensus       260 rIf~vLG~Pt~~~W--p~l-kk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDW--PDL-KKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHcCCCccccc--hhh-hhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            33333221111110  011 112222222222221111000  00 00011123458999999999999999964     


Q ss_pred             -cccccCc
Q 038860          629 -SYFENGV  635 (652)
Q Consensus       629 -~~~~~~~  635 (652)
                       .||.+..
T Consensus       337 h~yF~~d~  344 (438)
T KOG0666|consen  337 HPYFTEDP  344 (438)
T ss_pred             ccccccCC
Confidence             5776653

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.5e-33  Score=286.75  Aligned_cols=203  Identities=28%  Similarity=0.464  Sum_probs=171.1

Q ss_pred             cCccccccccccCceEEEEEEEcCC-----CeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .+|++.+.||+|+||.||+|.+..+     +..||+|+++..... ..+.+.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            3577889999999999999987542     478999999765433 3456889999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccC--------------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC
Q 038860          414 LVYDFMANGSLDSFLFDE--------------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL  479 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~  479 (652)
                      +++||+++++|.+++...              ....+++..+++++.|++.||.|||   +.+|+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999887421              1235888899999999999999999   79999999999999999999


Q ss_pred             CeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          480 NGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       480 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      .+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999886533221 11223356789999999988889999999999999999998 8888865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.2e-33  Score=280.94  Aligned_cols=241  Identities=26%  Similarity=0.416  Sum_probs=187.1

Q ss_pred             cccccCceEEEEEEEc--CCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCC
Q 038860          347 LLGHGGFGQVYKGTLH--NSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGS  423 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  423 (652)
                      .||+|+||.||+|.+.  +.+..||+|.+..... ...+++.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999875  3456799999976533 344678999999999999999999998864 57899999999999


Q ss_pred             cccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce--e
Q 038860          424 LDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--T  501 (652)
Q Consensus       424 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~--~  501 (652)
                      |.+++... ...+++..+++++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++..........  .
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99988543 346899999999999999999999   78999999999999999999999999999986543322111  1


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYD  580 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  580 (652)
                      ...++..|+|||.+....++.++|||||||++||+++ |+.||......+   ...    ....+               
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~---------------  214 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMS----FIEQG---------------  214 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHHCC---------------
Confidence            1233578999999988889999999999999999996 999987532111   000    00000               


Q ss_pred             HHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          581 QSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       581 ~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                              .      +.+.+   ....+.+.+++.+|+..+|++||+....
T Consensus       215 --------~------~~~~~---~~~~~~l~~li~~c~~~~~~~Rp~~~~i  248 (257)
T cd05115         215 --------K------RLDCP---AECPPEMYALMKDCWIYKWEDRPNFAKV  248 (257)
T ss_pred             --------C------CCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                    0      00000   1224678899999999999999976553

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.9e-33  Score=286.85  Aligned_cols=205  Identities=26%  Similarity=0.498  Sum_probs=171.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      ..++|++.+.||+|+||.||+|...+     .+..||+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45789999999999999999997652     34579999986543 2334568889999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCC--------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEE
Q 038860          412 LLLVYDFMANGSLDSFLFDEP--------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKL  483 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL  483 (652)
                      .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999985321        234567788899999999999999   799999999999999999999999


Q ss_pred             eeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          484 GDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       484 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      +|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~  224 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG  224 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999986533221 11222345678999999998899999999999999999998 7888865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.1e-33  Score=285.08  Aligned_cols=255  Identities=28%  Similarity=0.393  Sum_probs=193.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHH-hcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIAT-IGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||.||++.+..+++.||+|+++... .....++..|+.+ ++.++|||++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999999889999999987542 2233455566665 556689999999999999999999999


Q ss_pred             eccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccc-eEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          418 FMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ-VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       418 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |++ |+|.+++..  .....+++..++.++.|++.||+|||   ++ +++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 588777643  23356899999999999999999999   55 899999999999999999999999999986533


Q ss_pred             CCCCceeeccCCcCCCCCCCCCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ..  ......|+..|+|||.+.+    ..++.++|+|||||++|||++|+.||.......  .....             
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-------------  219 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQ-------------  219 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHH-------------
Confidence            21  2233468899999998765    446889999999999999999999986422110  00000             


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSY  637 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~  637 (652)
                                       .+. ......|..    ...+.+.+++.+|+..+|++|+      .|+|++.....
T Consensus       220 -----------------~~~-~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         220 -----------------VVE-EPSPQLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             -----------------HHh-cCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence                             000 000000111    1235788999999999999998      57777775433

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5e-33  Score=291.15  Aligned_cols=205  Identities=28%  Similarity=0.479  Sum_probs=171.5

Q ss_pred             hcCccccccccccCceEEEEEEEcC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK  409 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  409 (652)
                      ..+|.+.+.||+|+||.||++...+       ....+|+|.++... .....++.+|+.+++++ +||||++++++|...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3578889999999999999997632       34579999987543 34456788999999999 699999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      +..+++|||+++|+|.+++....              ...+++.++.+++.|++.||.|||   +.+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999985422              235889999999999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          476 DSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +.++.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |..||...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999986543221 11122234568999999988889999999999999999999 88888653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-32  Score=279.01  Aligned_cols=242  Identities=29%  Similarity=0.450  Sum_probs=190.0

Q ss_pred             ccccccCceEEEEEEEcCCC---eEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSK---TEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      ++||+|+||.||+|.+...+   ..+|+|.+..... ...+++.+|+.+++++.|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999876544   7899999976543 34567899999999999999999999876 4568999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce-
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT-  500 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~-  500 (652)
                      ++|.+++....  .+++..+..++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++.......... 
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999995433  6899999999999999999999   78999999999999999999999999999987644332211 


Q ss_pred             -eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          501 -TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       501 -~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ..+..++...    .            
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~----~------------  215 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESG----E------------  215 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcC----C------------
Confidence             11234568999999998899999999999999999998 9999865321   1111111000    0            


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFE  632 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~~  632 (652)
                                     ..  +..   ....+.+.|++.+|+..+|++||+...+.
T Consensus       216 ---------------~~--~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~~l~  249 (257)
T cd05060         216 ---------------RL--PRP---EECPQEIYSIMLSCWKYRPEDRPTFSELE  249 (257)
T ss_pred             ---------------cC--CCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence                           00  000   11235788999999999999999876543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.9e-33  Score=281.54  Aligned_cols=191  Identities=28%  Similarity=0.464  Sum_probs=161.2

Q ss_pred             ccccccCceEEEEEEEcC------------CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          346 QLLGHGGFGQVYKGTLHN------------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      +.||+|+||.||+|....            ....|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998642            22358999987765555667889999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC-------eEEeee
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN-------GKLGDF  486 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~-------~kL~DF  486 (652)
                      +||||+++++|..++... ...+++..+++++.||++||+|||   +++|+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999887543 345899999999999999999999   799999999999999987654       899999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCC-CCCCCCccchHhHHHHHHHHH-hCCCCCCC
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPR-TGKSSASSDVFAFGALLLEVA-CGRRPIET  545 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvvl~ell-tG~~p~~~  545 (652)
                      |++.....     .....++..|+|||++. +..++.++|||||||++|||+ +|+.|+..
T Consensus       157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (262)
T cd05077         157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD  212 (262)
T ss_pred             CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99875432     12345788999999886 466899999999999999998 58888764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.8e-33  Score=292.85  Aligned_cols=292  Identities=23%  Similarity=0.262  Sum_probs=205.0

Q ss_pred             cCccc-cccccccCceEEEEEEEcCCCeEEEEEEecCcchhh--------------HHHHHHHHHHhcccCcCceeEEEe
Q 038860          340 NNFSA-KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG--------------VREFVSEIATIGRLRHRNLVQLVG  404 (652)
Q Consensus       340 ~~f~~-~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  404 (652)
                      ++|.. .+.||+|+||.||+|.+..+++.||+|.+.......              ...+.+|+.++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45654 467999999999999998889999999986542211              124778999999999999999999


Q ss_pred             eeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       405 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      ++...+..++||||++ ++|.+++..  ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.++|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999997 589888843  345889999999999999999999   7999999999999999999999999


Q ss_pred             eeccceecccCC-------------CCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 038860          485 DFGLAKLYEHGT-------------NPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPE  550 (652)
Q Consensus       485 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~  550 (652)
                      |||++.......             ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998654110             1111223568899999998764 46889999999999999999999997654322


Q ss_pred             chhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC----
Q 038860          551 ELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT----  626 (652)
Q Consensus       551 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~----  626 (652)
                      .   ...+........         ...+............................+.+.+++.+|+..+|++|+    
T Consensus       242 ~---~~~i~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        242 Q---LGRIFELLGTPN---------EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             H---HHHHHHHhCCCc---------hhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            2   122222111100         000100000000000000000000011122356789999999999999998    


Q ss_pred             --CccccccCccccCCCCCCceEEe
Q 038860          627 --SCSYFENGVSYPSLSTSPITLVY  649 (652)
Q Consensus       627 --s~~~~~~~~~~~~~~~~~~~~~~  649 (652)
                        .|+||+.....=..+.-|..++.
T Consensus       310 ~l~~~~~~~~~~~~~~~~~~~~~~~  334 (335)
T PTZ00024        310 ALKHEYFKSDPLPCDPSQLPFNFLT  334 (335)
T ss_pred             HhcCcccCCCCCCCCcccCChhhhc
Confidence              67888764333233335555443

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.7e-33  Score=283.89  Aligned_cols=199  Identities=28%  Similarity=0.447  Sum_probs=175.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++++.+......++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999998888999999987543 34567789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++..   ..+++.++..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~  156 (277)
T cd06640          84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I  156 (277)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-c
Confidence            999999998843   35888999999999999999999   7999999999999999999999999999998664322 1


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence            22334678899999999888899999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.6e-33  Score=284.39  Aligned_cols=245  Identities=28%  Similarity=0.358  Sum_probs=200.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      +|++.+.||.|+||.||++.+..+++.||+|.+....   ....+.+.+|++++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999998889999999997542   2346788999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++...  ..+++..+..++.|+++||.|||   +++++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999998443  46899999999999999999999   7999999999999999999999999999988654332 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                       ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........    .+.....               
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~---------------  214 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQ---------------  214 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHh---------------
Confidence             22345688899999999888899999999999999999999999975432111    0000000               


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                                  .. .....|     ....+.+.+++.+|+..+|++|++..
T Consensus       215 ------------~~-~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~  248 (258)
T cd05578         215 ------------ET-ADVLYP-----ATWSTEAIDAINKLLERDPQKRLGDN  248 (258)
T ss_pred             ------------cc-ccccCc-----ccCcHHHHHHHHHHccCChhHcCCcc
Confidence                        00 000001     01236888999999999999999984

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.5e-33  Score=284.28  Aligned_cols=203  Identities=28%  Similarity=0.433  Sum_probs=173.5

Q ss_pred             cCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ++|+..+.||+|+||.||+|+...     ..+.|++|.+...... ...++.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            578889999999999999999753     3467999998765433 4578999999999999999999999999989999


Q ss_pred             EEEEeccCCCcccccccCC-------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          414 LVYDFMANGSLDSFLFDEP-------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      +||||+++|+|.+++....       ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999986433       125899999999999999999999   789999999999999999999999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      |+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            9987543322222233456778999999988889999999999999999999 7888854

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.1e-33  Score=283.93  Aligned_cols=203  Identities=32%  Similarity=0.552  Sum_probs=172.8

Q ss_pred             cCccccccccccCceEEEEEEEcCC---CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .+|++.+.||+|+||.||+|.+..+   +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            5688899999999999999987643   3479999987543 33456789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++.... ..+++.+++.++.|++.||.|||   +++++||||||+|||++.++.++|+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999985433 45899999999999999999999   799999999999999999999999999999876543


Q ss_pred             CCCcee--eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          496 TNPATT--RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       496 ~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......  ...++..|+|||++.+..++.++|+||||+++||+++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            222111  1223568999999998889999999999999999886 99998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-33  Score=295.20  Aligned_cols=282  Identities=25%  Similarity=0.336  Sum_probs=209.5

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-----eeE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-----DLL  413 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  413 (652)
                      +|++.+.||+|++|.||+|....+++.||+|++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788999999999999999998889999999987643  344567899999999999999999999988765     789


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      ++|||+++ +|.+++...  ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            99999974 888888433  37999999999999999999999   7999999999999999999999999999998765


Q ss_pred             cCCC--CceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          494 HGTN--PATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       494 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ....  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+....+......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-  233 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF-  233 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh-
Confidence            4331  123345678899999998887 789999999999999999999999987654332221111111111110000 


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSY  637 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~  637 (652)
                      .+      ..........  .......+.....+...+.+.+++.+|+..+|++|+      .|+||+.....
T Consensus       234 ~~------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         234 IT------SEKARNYLKS--LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             cc------ccchhhHHhh--cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            00      0000001111  111111111111223456889999999999999999      67899885443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-33  Score=281.05  Aligned_cols=199  Identities=30%  Similarity=0.478  Sum_probs=174.5

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-----hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-----KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      +|+..+.||+|++|.||+|....+++.|++|.+....     ....+.+.+|+.++++++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999998788999999986533     33557789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      +||+++++|.+++.+.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999998543  35889999999999999999999   799999999999999999999999999998865433


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCC-CCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .  ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||...
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            2  233456889999999887766 899999999999999999999998653

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-33  Score=291.44  Aligned_cols=204  Identities=25%  Similarity=0.397  Sum_probs=170.7

Q ss_pred             CccccccccccCceEEEEEEEcC--CCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHN--SKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLL  413 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  413 (652)
                      +|++.+.||+|++|.||+|....  .+..||+|.+....   ....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999987  78999999998743   33345678899999999999999999999888  7899


Q ss_pred             EEEEeccCCCccccccc---CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC----CCCeEEeee
Q 038860          414 LVYDFMANGSLDSFLFD---EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS----ELNGKLGDF  486 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~----~~~~kL~DF  486 (652)
                      +||||+++ +|.+++..   .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 66665532   12236889999999999999999999   799999999999999999    899999999


Q ss_pred             ccceecccCCC--CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          487 GLAKLYEHGTN--PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       487 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      |+++.......  .......++..|+|||.+.+ ..++.++|||||||+++||++|++||.....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            99986543322  12233567899999998766 4578999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-33  Score=291.38  Aligned_cols=204  Identities=29%  Similarity=0.491  Sum_probs=171.7

Q ss_pred             hcCccccccccccCceEEEEEEEcC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK  409 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  409 (652)
                      .++|.+.+.||+|+||.||++.+..       ....+|+|.+.... .....++.+|+.+++++ +||||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3578999999999999999998643       22469999997642 34456788999999999 799999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      +..++||||+++|+|.+++....              ...+++.++++++.|++.||+|||   +.+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999986432              235889999999999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          476 DSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      +.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            9999999999999876543211 11222234578999999988889999999999999999998 8888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=285.78  Aligned_cols=201  Identities=28%  Similarity=0.423  Sum_probs=172.0

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      |+..+.||+|++|.||+|.+..++..||+|++....  ......+.+|+.++++++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999998889999999987543  223456888999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      + ++|.+++.......+++..++.++.|+++||+|||   +++++||||+|+||+++.++.++|+|||+++....... .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence            5 68999886554456899999999999999999999   68999999999999999999999999999976543221 1


Q ss_pred             eeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .....++..|+|||++.+. .++.++|+||||+++|||++|+.||....
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  204 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS  204 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2223568899999987664 57889999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-32  Score=282.49  Aligned_cols=201  Identities=29%  Similarity=0.389  Sum_probs=174.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  416 (652)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+.... .....++.+|++++++++||||++++++|...  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999998889999999987543 24456789999999999999999999998653  4689999


Q ss_pred             EeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          417 DFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       417 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||+++++|.+++..  .....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887643  23455888999999999999999999   79999999999999999999999999999875432


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..   .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            21   12345788999999999889999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=279.43  Aligned_cols=201  Identities=29%  Similarity=0.458  Sum_probs=173.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-----chhhHHHHHHHHHHhcccCcCceeEEEeeeecc--Cee
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDL  412 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  412 (652)
                      .+|++.+.||+|++|.||+|.+..++..||+|.+...     .....+.+.+|++++++++|+||+++++++...  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5788999999999999999999888999999987532     223456788999999999999999999998664  468


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++++||+++++|.+++...  ..+++....+++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            8999999999999988532  34788999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCC--CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          493 EHGT--NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       493 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ....  ........|+..|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            3311  1122345689999999999988899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.6e-33  Score=281.76  Aligned_cols=190  Identities=29%  Similarity=0.518  Sum_probs=162.5

Q ss_pred             ccccccCceEEEEEEEcCCC----------eEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          346 QLLGHGGFGQVYKGTLHNSK----------TEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      +.||+|+||.||+|.+..++          ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999998755          35888887655433 6788999999999999999999999988 778999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-------CeEEeeecc
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-------NGKLGDFGL  488 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-------~~kL~DFGl  488 (652)
                      |||+++|+|.+++..... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999865432 6889999999999999999999   79999999999999999887       799999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCC--CCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTG--KSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +.....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+...
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            986433     2233567789999998876  78999999999999999999 57777553

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-32  Score=277.72  Aligned_cols=242  Identities=28%  Similarity=0.439  Sum_probs=192.1

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ++||+|++|.||++.+.+ ++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999987 899999998765433 556789999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce-eec
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT-TRV  503 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~  503 (652)
                      .+++... ...+++..+..++.+++.||.|||   +++++||||||+||+++.++.+||+|||+++.......... ...
T Consensus        80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9998543 235789999999999999999999   79999999999999999999999999999986542221111 112


Q ss_pred             cCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHH
Q 038860          504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQS  582 (652)
Q Consensus       504 ~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~  582 (652)
                      .++..|+|||.+.++.++.++|+||||+++|||++ |..||........   ....             ..         
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~~-------------~~---------  210 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RERI-------------ES---------  210 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHHH-------------hc---------
Confidence            34567999999988889999999999999999999 8888865322110   0000             00         


Q ss_pred             HHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          583 QVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       583 ~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                               ....  +.+   ......+.+++.+|+..+|++|+++..+
T Consensus       211 ---------~~~~--~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~el  245 (251)
T cd05041         211 ---------GYRM--PAP---QLCPEEIYRLMLQCWAYDPENRPSFSEI  245 (251)
T ss_pred             ---------CCCC--CCC---ccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence                     0000  000   1123578999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.8e-33  Score=286.75  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=195.7

Q ss_pred             hcCccccccccccCceEEEEEEEcC----------------CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN----------------SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQ  401 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  401 (652)
                      .++|++.+.||+|+||.||++...+                +...||+|.+.... .....++.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3578999999999999999986432                34569999997643 344567899999999999999999


Q ss_pred             EEeeeeccCeeEEEEEeccCCCcccccccCC---------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCc
Q 038860          402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEP---------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASN  472 (652)
Q Consensus       402 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~N  472 (652)
                      +++++...+..++||||+++++|.+++....         ...+++.+++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            9999999999999999999999999885422         124778899999999999999999   7899999999999


Q ss_pred             eEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh--CCCCCCCCCCc
Q 038860          473 VLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC--GRRPIETRALP  549 (652)
Q Consensus       473 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt--G~~p~~~~~~~  549 (652)
                      ||++.++.++|+|||+++........ ......++..|+|||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999865332211 1222345678999998888889999999999999999998  77787643221


Q ss_pred             cchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          550 EELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       550 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                      +.   +......+..         ..                 .....|...   ...+.+.+|+..|+..+|++||+..
T Consensus       241 ~~---~~~~~~~~~~---------~~-----------------~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~  288 (296)
T cd05095         241 QV---IENTGEFFRD---------QG-----------------RQVYLPKPA---LCPDSLYKLMLSCWRRNAKERPSFQ  288 (296)
T ss_pred             HH---HHHHHHHHhh---------cc-----------------ccccCCCCC---CCCHHHHHHHHHHcCCCcccCCCHH
Confidence            11   1100000000         00                 000001111   1235788999999999999999876


Q ss_pred             cc
Q 038860          630 YF  631 (652)
Q Consensus       630 ~~  631 (652)
                      .+
T Consensus       289 ~i  290 (296)
T cd05095         289 EI  290 (296)
T ss_pred             HH
Confidence            54

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=282.77  Aligned_cols=198  Identities=29%  Similarity=0.488  Sum_probs=173.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccC---cCceeEEEeeeeccCeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLR---HRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+... ......++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999999888999999998654 3344567889999999986   999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++..   ..+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            99999999998843   36899999999999999999999   7999999999999999999999999999998765433


Q ss_pred             CCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       .......|+..|+|||.+.++ .++.++|+|||||++|+|++|+.||..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  204 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD  204 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence             223345689999999987654 468899999999999999999999965

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=264.81  Aligned_cols=257  Identities=24%  Similarity=0.297  Sum_probs=200.1

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----Ce
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----GD  411 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  411 (652)
                      ...++|++.+.||+|||+.||+++...+++.+|+|++.-...++.+..++|++..++++|||++++++++..+     .+
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            4557899999999999999999998888999999999877777888899999999999999999999987544     35


Q ss_pred             eEEEEEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          412 LLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      .||+++|...|+|.+.+...  ....+++.+.++|+.++++||++||+. ..+++||||||.|||+.+++.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            89999999999999988542  344799999999999999999999942 234999999999999999999999999998


Q ss_pred             eecccCCCCc--------eeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHH
Q 038860          490 KLYEHGTNPA--------TTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWV  558 (652)
Q Consensus       490 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~  558 (652)
                      ....-.-...        -....-|..|+|||.+.   +...++++|||||||+||+|+.|..||+....          
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------  246 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------  246 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence            7543211111        11234688999999765   34578999999999999999999999974211          


Q ss_pred             HhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          559 WGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       559 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                          ..+.+.-++-   +..+                ..|+...   -.+...++++.|+..+|.+||+..-
T Consensus       247 ----~GgSlaLAv~---n~q~----------------s~P~~~~---yse~l~~lik~mlqvdP~qRP~i~~  292 (302)
T KOG2345|consen  247 ----QGGSLALAVQ---NAQI----------------SIPNSSR---YSEALHQLIKSMLQVDPNQRPTIPE  292 (302)
T ss_pred             ----cCCeEEEeee---cccc----------------ccCCCCC---ccHHHHHHHHHHhcCCcccCCCHHH
Confidence                1111111110   1111                1122211   2357789999999999999998654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.5e-33  Score=280.04  Aligned_cols=242  Identities=32%  Similarity=0.459  Sum_probs=192.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeee-ccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR-RKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~  418 (652)
                      ++|++.+.||+|++|.||++...  +..||+|.++...  ..+.+.+|+.++++++|+|++++++++. .++..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47888999999999999999875  5789999986543  3457889999999999999999999764 45678999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++.......+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999986655556899999999999999999999   7999999999999999999999999999988543322  


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                        ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+   +...+                 ..
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~-----------------~~  214 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV-----------------EK  214 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-----------------hc
Confidence              22344678999999988889999999999999999997 999986432110   11100                 00


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                      .+              ...     ..+...+.+.+++.+|+..+|++|++...+
T Consensus       215 ~~--------------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  249 (256)
T cd05082         215 GY--------------KMD-----APDGCPPVVYDVMKQCWHLDAATRPSFLQL  249 (256)
T ss_pred             CC--------------CCC-----CCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            00              000     001224578899999999999999987654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9e-33  Score=287.79  Aligned_cols=205  Identities=28%  Similarity=0.478  Sum_probs=172.9

Q ss_pred             hhcCccccccccccCceEEEEEEEc-------CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeec
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLH-------NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRR  408 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  408 (652)
                      ...+|.+.+.||+|+||.||+++..       ..+..||+|.+.... ....+++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567888999999999999999753       134579999987542 34557789999999999 89999999999999


Q ss_pred             cCeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceE
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVL  474 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NIL  474 (652)
                      ....++||||+++|+|.+++....              ...+++.+++.++.||++||.|||   +.+++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            999999999999999999985432              235788899999999999999999   799999999999999


Q ss_pred             eCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          475 LDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       475 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      ++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999866432221 1223345678999999988889999999999999999998 7888764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=282.03  Aligned_cols=202  Identities=27%  Similarity=0.451  Sum_probs=171.8

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe----EEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT----EVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .+|++.+.||+|+||.||+|.+..+++    .+|+|.+.... .....++.+|+.++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567888999999999999999865543    68999887654 3445678999999999999999999999987 78999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |+||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999986533 34899999999999999999999   69999999999999999999999999999987653


Q ss_pred             CCCCce-eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTNPAT-TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ...... ....++..|+|||.+....++.++|+||||+++||+++ |+.||...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  215 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI  215 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            322111 11223568999999988889999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-33  Score=284.67  Aligned_cols=190  Identities=26%  Similarity=0.448  Sum_probs=161.7

Q ss_pred             ccccccCceEEEEEEEcCCC-------eEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          346 QLLGHGGFGQVYKGTLHNSK-------TEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +.||+|+||.||+|.....+       ..|++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46999999999999886533       34899998766556667889999999999999999999999998899999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC--------eEEeeeccce
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN--------GKLGDFGLAK  490 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~--------~kL~DFGla~  490 (652)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.        ++++|||.+.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999986543 36899999999999999999999   799999999999999987765        6999999886


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCC-CCCC
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGR-RPIE  544 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~-~p~~  544 (652)
                      ....     .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~  207 (258)
T cd05078         157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS  207 (258)
T ss_pred             ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence            4432     223467889999999886 45799999999999999999985 5554

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-32  Score=292.40  Aligned_cols=283  Identities=22%  Similarity=0.300  Sum_probs=204.3

Q ss_pred             chhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeec
Q 038860          331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRR  408 (652)
Q Consensus       331 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  408 (652)
                      ...++...+++|.+.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34556678899999999999999999999998889999999997542  2334567889999999999999999998854


Q ss_pred             c------CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeE
Q 038860          409 K------GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK  482 (652)
Q Consensus       409 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~k  482 (652)
                      .      ...+++++++ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            3      3468888887 7788887732   35899999999999999999999   79999999999999999999999


Q ss_pred             EeeeccceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhh
Q 038860          483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGK  561 (652)
Q Consensus       483 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  561 (652)
                      |+|||+++....    ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..........   .....
T Consensus       161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~  233 (345)
T cd07877         161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRL  233 (345)
T ss_pred             Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHH
Confidence            999999885432    2233467899999998766 568889999999999999999999996543222111   11111


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                      ... ...+.. +.+...  ..+.....+.  .....+.........+.+.|++.+|+..+|++|+      .|+||..
T Consensus       234 ~~~-~~~~~~-~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         234 VGT-PGAELL-KKISSE--SARNYIQSLT--QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             hCC-CCHHHH-hhcccH--hHHHHHHHhc--ccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence            100 000000 001000  0111111111  1111111111123456789999999999999998      5677765

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.1e-33  Score=285.32  Aligned_cols=205  Identities=29%  Similarity=0.493  Sum_probs=173.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      ..++|+..+.||+|+||.||++.+..     ++..||+|.+.... ....+++.+|+.++++++||||+++++++..+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            35679999999999999999998753     56889999987653 3445678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCC--------------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCC
Q 038860          412 LLLVYDFMANGSLDSFLFDEP--------------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS  471 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~  471 (652)
                      .++++||+++|+|.+++....                    ...+++.+++.++.|++.||+|||   .++++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence            999999999999999985321                    234788899999999999999999   799999999999


Q ss_pred             ceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          472 NVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       472 NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      ||+++.++.++|+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999998865332211 1222344678999999988899999999999999999997 8888864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8e-33  Score=284.48  Aligned_cols=206  Identities=27%  Similarity=0.418  Sum_probs=174.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcC----CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeec-cCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN----SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRR-KGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  411 (652)
                      ..++|++.+.||+|+||.||+|.+..    .+..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45788999999999999999999875    35789999987543 3445678899999999999999999998776 467


Q ss_pred             eEEEEEeccCCCcccccccCCc------cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPK------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGD  485 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~D  485 (652)
                      .++++||+++++|.+++.....      ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999854321      46899999999999999999999   79999999999999999999999999


Q ss_pred             eccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          486 FGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       486 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence            9999865432211 1122345778999999988889999999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.6e-33  Score=285.07  Aligned_cols=200  Identities=35%  Similarity=0.464  Sum_probs=168.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5666788999999999999999889999999987543 234567889999999996 99999999999999999999999


Q ss_pred             ccCCCcccc---cccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          419 MANGSLDSF---LFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       419 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      ++. +|.++   +.......+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 55443   222334568999999999999999999995  458999999999999999999999999999765432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCC---CCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTG---KSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .  ......|+..|+|||.+.+.   .++.++|||||||++|||++|+.||..
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence            2  22234688999999998776   689999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=292.51  Aligned_cols=207  Identities=27%  Similarity=0.488  Sum_probs=181.3

Q ss_pred             cCccccccccccCceEEEEEEEcCC----CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNS----KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ......++||+|-||.||+|.+.+-    .-.||||..+.+. ....+.|+.|..+|++++||||++++|.|.+. ..|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            3445567899999999999998542    3459999998853 44567899999999999999999999999875 6899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |||.++.|.|..||..+ +..|+......++.||..||.|||   +.+.|||||..+|||+.+.-.+||+|||++|.++.
T Consensus       468 vmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            99999999999999654 446888999999999999999999   69999999999999999999999999999999887


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEE  551 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~  551 (652)
                      +.....+...-...|||||.+.-++++.++|||-|||++||++. |..||.+....+-
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV  601 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV  601 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence            77666666666889999999999999999999999999999987 9999998665543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-32  Score=284.50  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=198.6

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCC
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGS  423 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  423 (652)
                      ...+||+|+||.||++....+++.||+|.+..........+.+|+.++++++|+|++++++.+...+..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            34679999999999999988899999999876555556778999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeec
Q 038860          424 LDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV  503 (652)
Q Consensus       424 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  503 (652)
                      |.+++.   ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........ .....
T Consensus       104 L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~  176 (292)
T cd06657         104 LTDIVT---HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL  176 (292)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence            998873   235789999999999999999999   68999999999999999999999999999876543221 22335


Q ss_pred             cCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHH
Q 038860          504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQ  583 (652)
Q Consensus       504 ~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~  583 (652)
                      .|+..|+|||.+.+..++.++|+||+|+++|||++|+.||......+.   ....             ...+        
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~-------------~~~~--------  232 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMI-------------RDNL--------  232 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH-------------HhhC--------
Confidence            688999999999888899999999999999999999999865321111   0000             0000        


Q ss_pred             HHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          584 VLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       584 ~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                              +.     .........+.+.+++.+|+..+|++|+      .|+|+...-
T Consensus       233 --------~~-----~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         233 --------PP-----KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             --------Cc-----ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence                    00     0000112245678999999999999999      567777655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-32  Score=283.22  Aligned_cols=198  Identities=24%  Similarity=0.309  Sum_probs=166.1

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccC-cCceeEEEeeeecc--CeeEEEEE
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLR-HRNLVQLVGWCRRK--GDLLLVYD  417 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e  417 (652)
                      |++.+.||+|+||.||+|.+..+++.||+|+++.... .......+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            5678899999999999999988899999999876422 22234457888999885 99999999999887  88999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |++ ++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++. +.+||+|||+++...... 
T Consensus        81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-  153 (282)
T cd07831          81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-  153 (282)
T ss_pred             cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence            997 5887777443 246899999999999999999999   799999999999999999 999999999998654322 


Q ss_pred             CceeeccCCcCCCCCCCCC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPR-TGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                       ......++..|+|||.+. ++.++.++|||||||++|||++|+.||....
T Consensus       154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence             222346789999999764 4567889999999999999999999997644

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-32  Score=275.21  Aligned_cols=200  Identities=34%  Similarity=0.515  Sum_probs=179.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      .|+..+.||+|++|.||++.+..+++.+++|++........+.+.+|+.++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            47788999999999999999988889999999987665566789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +++|.+++.... ..+++..+..++.|++.||.|||   ..+++||||+|+||++++++.++|+|||.+........  .
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            999999885432 46899999999999999999999   79999999999999999999999999999987654332  3


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ....++..|+|||.+....++.++|+||||+++++|++|+.||...
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            4457889999999998888999999999999999999999998753

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-32  Score=282.85  Aligned_cols=191  Identities=27%  Similarity=0.412  Sum_probs=160.1

Q ss_pred             cccccCceEEEEEEEcC------------------------CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEE
Q 038860          347 LLGHGGFGQVYKGTLHN------------------------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQL  402 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  402 (652)
                      +||+|+||.||+|....                        ....|++|.+.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998532                        124589999976655556778899999999999999999


Q ss_pred             EeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC---
Q 038860          403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL---  479 (652)
Q Consensus       403 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~---  479 (652)
                      +++|......++||||+++|+|..++... ...+++..+..++.|+++||+|||   +++|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999888543 346889999999999999999999   79999999999999997643   


Q ss_pred             ----CeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHH-hCCCCCCCC
Q 038860          480 ----NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVA-CGRRPIETR  546 (652)
Q Consensus       480 ----~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~ell-tG~~p~~~~  546 (652)
                          .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                3799999988643221     22357788999998865 56899999999999999985 699998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.8e-33  Score=290.71  Aligned_cols=281  Identities=23%  Similarity=0.314  Sum_probs=204.7

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec-cC
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR-KG  410 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  410 (652)
                      ++...+++|+..+.||+|+||.||++.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3445778999999999999999999999988999999988643  22334667889999999999999999998865 56


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++++||+ +++|.+++.   ...+++..+..++.|+++||.|||   +++++||||||+||+++.++.++|+|||++.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999999 568888773   235788888899999999999999   7999999999999999999999999999987


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      ....    ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....+...++....
T Consensus       157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            5432    2223467889999998766 5689999999999999999999999976433222111111111111111101


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      ..+.    +  . ......+  ......|.....+...+.+.+++.+|+..+|++|+      .++|++..
T Consensus       233 ~~~~----~--~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         233 ICSE----N--T-LRFVQSL--PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             ccch----h--h-HHHHhhc--cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence            1110    0  0 0011111  11111222222234457899999999999999998      67777653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-32  Score=280.39  Aligned_cols=203  Identities=32%  Similarity=0.569  Sum_probs=172.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe---EEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT---EVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..|++.+.||+|+||.||+|.+..+++   .||+|.+... ......+|..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357888999999999999999876553   6999998765 344567899999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++... ...+++.+++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999988543 345899999999999999999999   799999999999999999999999999998765432


Q ss_pred             CCCc-ee-ecc--CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          496 TNPA-TT-RVV--GTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       496 ~~~~-~~-~~~--gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .... .. ...  .+..|+|||.+....++.++|||||||++||+++ |..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            2211 11 111  2457999999998899999999999999999886 99998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=283.58  Aligned_cols=285  Identities=22%  Similarity=0.296  Sum_probs=219.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC--cC----ceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR--HR----NLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~~~  411 (652)
                      .+++|.+..++|+|.||.|-.+.++.++..||||+++...+. .+.-+-|+++++++.  -|    -++++.+||...++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            478999999999999999999999998999999999765433 334567999999993  22    37888999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC--------------
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS--------------  477 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~--------------  477 (652)
                      .|+|+|.+ |.|+.+++..+.-.+++..+++.|+.|+++++++||   +.+++|-||||+|||+-+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 569999998877788999999999999999999999   799999999999999932              


Q ss_pred             ------CCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          478 ------ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       478 ------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                            +..+||+|||.|......    ....+.|..|+|||++.+-.++.++||||+||+|.|+.+|...|+..+..++
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                  235899999999864332    2556789999999999999999999999999999999999999998887788


Q ss_pred             hhHHHHHHhhhcCCccccc-----ccc-ccc--cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCC
Q 038860          552 LVLVDWVWGKYGEGRVLEV-----IDP-KLN--AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFD  623 (652)
Q Consensus       552 ~~l~~~~~~~~~~~~~~~~-----id~-~l~--~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~  623 (652)
                      +.+++.+.+.++...+...     ... +|.  ..+....  ++....+|....-.+...+.....+.|||++|+.+||.
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~--~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK--SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc--chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            8788877775543322221     000 110  0011110  11111222222222333344456788999999999999


Q ss_pred             CCC------Ccccccc
Q 038860          624 KTT------SCSYFEN  633 (652)
Q Consensus       624 ~r~------s~~~~~~  633 (652)
                      +|+      +|+||.-
T Consensus       396 ~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  396 RRITLREALSHPFFAR  411 (415)
T ss_pred             ccccHHHHhcCHHhhc
Confidence            999      4566653

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-32  Score=292.03  Aligned_cols=205  Identities=31%  Similarity=0.462  Sum_probs=169.3

Q ss_pred             hcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc-C
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK-G  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  410 (652)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||+++... ......+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            357899999999999999999853     356789999997643 33456788999999999 689999999988654 4


Q ss_pred             eeEEEEEeccCCCcccccccCC----------------------------------------------------------
Q 038860          411 DLLLVYDFMANGSLDSFLFDEP----------------------------------------------------------  432 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  432 (652)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999998875321                                                          


Q ss_pred             -------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC-Cceeecc
Q 038860          433 -------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-PATTRVV  504 (652)
Q Consensus       433 -------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~  504 (652)
                             ...+++.++.+++.|+++||+|||   +++|+||||||+|||++.++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124688889999999999999999   79999999999999999999999999999986532221 1122234


Q ss_pred             CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       505 gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            5678999999988899999999999999999997 99998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-32  Score=277.96  Aligned_cols=250  Identities=26%  Similarity=0.430  Sum_probs=199.0

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec--cCeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--KGDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  416 (652)
                      +|++.+.||.|+||.||++.+..++..||+|.+...  .....+.+.+|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999999888999999998653  33445678899999999999999999998754  45689999


Q ss_pred             EeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCc--cceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          417 DFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGY--EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       417 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ||+++++|.+++...  ....+++..++.++.|++.||.|||..+  +.+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542  2457899999999999999999999433  588999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ..... ......|+..|+|||.+.+..++.++|+||||+++++|++|+.||.....   ..+.+.+    ..+       
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~-------  225 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKI----KEG-------  225 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHH----hcC-------
Confidence            54332 12334689999999999988899999999999999999999999975431   1111100    000       


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                           .            .+   ..|     ......+.+++.+|+..+|++||+...
T Consensus       226 -----~------------~~---~~~-----~~~~~~~~~l~~~~l~~~p~~Rp~~~~  258 (265)
T cd08217         226 -----K------------FR---RIP-----YRYSSELNEVIKSMLNVDPDKRPSTEE  258 (265)
T ss_pred             -----C------------CC---CCc-----cccCHHHHHHHHHHccCCcccCCCHHH
Confidence                 0            00   001     112357899999999999999997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.5e-32  Score=277.94  Aligned_cols=201  Identities=30%  Similarity=0.491  Sum_probs=172.7

Q ss_pred             CccccccccccCceEEEEEEEcC-CCeEEEEEEecCc----------chhhHHHHHHHHHHhcc-cCcCceeEEEeeeec
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHN-SKTEVAVKRISNE----------SKQGVREFVSEIATIGR-LRHRNLVQLVGWCRR  408 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  408 (652)
                      +|++.+.||+|+||.||+|.+.. .++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999987 6788999987532          22344567889988865 699999999999999


Q ss_pred             cCeeEEEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          409 KGDLLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      .+..+++|||+++++|.+++..  .....+++..++.++.|++.||.|||+  ..+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743  234468999999999999999999994  478999999999999999999999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      |++.......  ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            9998754432  33445689999999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.5e-33  Score=283.19  Aligned_cols=244  Identities=28%  Similarity=0.466  Sum_probs=190.5

Q ss_pred             ccccccCceEEEEEEEcCCC------eEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          346 QLLGHGGFGQVYKGTLHNSK------TEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +.||+|+||.||+|+..+..      +.+|+|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999986433      679999886543 24456789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccC-----CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-----CeEEeeecc
Q 038860          419 MANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-----NGKLGDFGL  488 (652)
Q Consensus       419 ~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-----~~kL~DFGl  488 (652)
                      +++++|.+++...     ....+++.+++.++.|++.||.|||   +.+++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998542     2234789999999999999999999   68999999999999999877     899999999


Q ss_pred             ceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCc
Q 038860          489 AKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGR  566 (652)
Q Consensus       489 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  566 (652)
                      ++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||......   .....+        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~--------  226 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV--------  226 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH--------
Confidence            975533221 11122345788999999999999999999999999999998 99998643211   111100        


Q ss_pred             cccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          567 VLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       567 ~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                           +.                  ......|     ....+.+.+++.+|+..+|++||+...+
T Consensus       227 -----~~------------------~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i  263 (269)
T cd05044         227 -----TA------------------GGRLQKP-----ENCPDKIYQLMTNCWAQDPSERPTFDRI  263 (269)
T ss_pred             -----hc------------------CCccCCc-----ccchHHHHHHHHHHcCCCcccCCCHHHH
Confidence                 00                  0000001     1123577899999999999999987654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=277.84  Aligned_cols=191  Identities=27%  Similarity=0.369  Sum_probs=163.2

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHh-cccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATI-GRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|++|.||+|.+..+++.||+|.++....   .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            569999999999999988899999999875432   2233445555444 455899999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      ++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++....     ..
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~  151 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK  151 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence            999999843  345889999999999999999999   78999999999999999999999999999875432     22


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            346888999999998888899999999999999999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.3e-32  Score=276.94  Aligned_cols=200  Identities=31%  Similarity=0.522  Sum_probs=171.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .+|+..+.||+|+||.||++.+.. +..+|+|.+..... ...++.+|++++++++|||++++++++......++|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            467888999999999999998864 56899999865432 3456889999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          82 EHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999885432 35889999999999999999999   7899999999999999999999999999998654322212


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      .....++.+|+|||.+.++.++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            222345678999999988889999999999999999998 9999865

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.9e-32  Score=278.70  Aligned_cols=197  Identities=25%  Similarity=0.406  Sum_probs=159.3

Q ss_pred             ccccccCceEEEEEEEcCC--CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          346 QLLGHGGFGQVYKGTLHNS--KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      +.||+|+||.||+|.....  ...+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3599999999999976432  3456778776543 334578999999999999999999999999999999999999999


Q ss_pred             CcccccccCC--ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC-Cc
Q 038860          423 SLDSFLFDEP--KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-PA  499 (652)
Q Consensus       423 sL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~  499 (652)
                      +|.+++....  ....++..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999986432  234667778899999999999999   79999999999999999999999999999864322111 12


Q ss_pred             eeeccCCcCCCCCCCCCC-------CCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRT-------GKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  211 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH  211 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence            233567889999998753       245789999999999999997 5667754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-33  Score=283.83  Aligned_cols=272  Identities=25%  Similarity=0.343  Sum_probs=200.6

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      |+..+.||+|++|.||++....+++.+++|++.....  .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            5677889999999999999988899999999876533  24567888999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++ +|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||.+....... ..
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            75 8888775432 46899999999999999999999   7999999999999999999999999999998765433 12


Q ss_pred             eeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+...   .........      .+.....
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~------~~~~~~~  225 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGTP------DPEVWPK  225 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCC------chHhccc
Confidence            2334678899999998776 78999999999999999999999997654333222   111111110      0000000


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                      .... ........+.....+.....+...+.+.+++.+|+..+|++|++..
T Consensus       226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  275 (283)
T cd05118         226 FTSL-ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE  275 (283)
T ss_pred             chhh-hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHH
Confidence            0000 0000000111111111111223467899999999999999999643

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-32  Score=278.73  Aligned_cols=198  Identities=28%  Similarity=0.459  Sum_probs=174.0

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      -|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667889999999999999998888999999986543 344567889999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.   ...+++..+..++.|++.++.|||   +.+++|+||||+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06641          85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence            9999999884   345899999999999999999999   7999999999999999999999999999987654322 12


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....++..|+|||.+.+..++.++|+|||||++|||++|..||..
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  203 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE  203 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            2334688899999999888899999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-32  Score=285.05  Aligned_cols=198  Identities=31%  Similarity=0.466  Sum_probs=170.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..+.|+..+.||+|+||.||+|....+++.||+|.+....   ....+++.+|+++++.++|||+++++++|...+..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3456889999999999999999998889999999986432   2344678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |+||++ |+|.+++... ...+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        93 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          93 VMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             EHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            999997 5776666432 335899999999999999999999   79999999999999999999999999999876432


Q ss_pred             CCCCceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .     ....++..|+|||++.   .+.++.++||||||+++|||++|+.||..
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence            2     2346788999999874   45688999999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-32  Score=281.50  Aligned_cols=200  Identities=26%  Similarity=0.377  Sum_probs=170.9

Q ss_pred             CccccccccccCceEEEEEEEc---CCCeEEEEEEecCcch----hhHHHHHHHHHHhccc-CcCceeEEEeeeeccCee
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNESK----QGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  412 (652)
                      +|++.+.||+|+||.||++...   .++..||+|++.....    ...+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999874   3678999999875322    2345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++|+||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999999999999854  345888999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCC--CCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTG--KSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ............|+..|+|||.+...  .++.++||||||+++|+|++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            44333333345689999999998753  467899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.3e-32  Score=279.03  Aligned_cols=192  Identities=27%  Similarity=0.417  Sum_probs=160.8

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHH---HhcccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIA---TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      .||+|+||.||++.+..+++.||+|.+.....   .....+..|..   .++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999988899999999865421   11222334433   4444579999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......   .
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~  152 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence            9999988843  346999999999999999999999   7999999999999999999999999999987553321   2


Q ss_pred             eeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          501 TRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            234689999999998754 6899999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-32  Score=289.78  Aligned_cols=205  Identities=30%  Similarity=0.485  Sum_probs=171.9

Q ss_pred             hcCccccccccccCceEEEEEEEcC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK  409 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  409 (652)
                      ..+|++.+.||+|+||.||++.+..       .+..||+|.+.... ....+++.+|+.+++++ +||||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3468889999999999999998643       22468999887543 34467889999999999 799999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccC--------------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          410 GDLLLVYDFMANGSLDSFLFDE--------------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      +..++++||+++|+|.+++...              ....+++.+++.++.|++.||.|||   +++++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            9999999999999999998542              1235788999999999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          476 DSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999865432211 1222334568999999999999999999999999999998 88898654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-33  Score=297.25  Aligned_cols=202  Identities=26%  Similarity=0.454  Sum_probs=170.9

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecC--c--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC--eeEEEE
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--E--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG--DLLLVY  416 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~  416 (652)
                      +....||+|+|-+||+|.+..+|..||--.++.  .  .....+.|..|+.+|+.|+||||++++....+..  .+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            445679999999999999998898888433321  1  2344578999999999999999999999876544  588999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccceecccC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla~~~~~~  495 (652)
                      |.|..|+|..|+.+  ...++...+..|++||++||.|||+. .++|+|||||.+||+|+.+ |.|||+|+|||......
T Consensus       123 EL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999954  34578889999999999999999975 6899999999999999866 89999999999876543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                         ....++|||.|||||+.. ..|....||||||++++||+|+..||..-....+
T Consensus       200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ  251 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ  251 (632)
T ss_pred             ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH
Confidence               233479999999999877 7899999999999999999999999986554433

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-34  Score=295.35  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=205.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      +.+.++..||.|+||.||+|+.+.++...|-|.+...+....++|+-|++||....||+||++++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45677888999999999999999888888899998888888899999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      .||-++..+..- ...|.+.++.-+++|++.||.|||   ++.|||||||..|||+.-+|.++|+|||.+-.... ....
T Consensus       112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK  186 (1187)
T ss_pred             CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence            999988877543 457999999999999999999999   79999999999999999999999999998754322 1223


Q ss_pred             eeeccCCcCCCCCCCC-----CCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          500 TTRVVGTLGYLAPETP-----RTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~-----~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      ...++||+.|||||+.     ...+|+.++||||||++|.||..+.+|.....+..  .++.                  
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllK------------------  246 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLK------------------  246 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHH------------------
Confidence            4557999999999965     35689999999999999999999999976532211  0000                  


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                  ..-.-++.+..|...     ...+.|+|.+++.-+|+.|++      |+|+.+
T Consensus       247 ------------iaKSePPTLlqPS~W-----s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  247 ------------IAKSEPPTLLQPSHW-----SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             ------------HhhcCCCcccCcchh-----hhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence                        011112333334332     458999999999999999994      667654

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.8e-32  Score=281.38  Aligned_cols=204  Identities=29%  Similarity=0.448  Sum_probs=180.0

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ...++.|+..+.||+|++|.||+|.+..++..|++|.+..... ..+.+.+|++++++++|+|++++++.+...+..+++
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            3566789999999999999999999987889999999976544 566788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      +||+++++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999999995433 36999999999999999999999   799999999999999999999999999998755432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .. ......++..|++||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~  218 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR  218 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            21 22334578899999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.5e-33  Score=279.74  Aligned_cols=201  Identities=23%  Similarity=0.454  Sum_probs=175.6

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|+||.||++....++..+|+|.+....  ....+.+.+|+.++++++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999999889999999986542  23445678999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~~~~~  497 (652)
                      +++++|.+++.......+++..+..++.|+++||.|||   ..+++|+||||+||++++++ .+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence            99999999986655556899999999999999999999   78999999999999999885 46999999998664322 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .......|+..|+|||...+..++.++|+||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  204 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG  204 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            122334689999999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-32  Score=280.74  Aligned_cols=201  Identities=26%  Similarity=0.380  Sum_probs=171.7

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      |++.+.||+|++|.||+|....+++.|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5678899999999999999988889999999865432 22234567899999999 999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                       +|+|.+++.......+++.++..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||++.......  .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence             789988886554457899999999999999999999   7999999999999999999999999999998654322  2


Q ss_pred             eeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .....++..|+|||.+.. ..++.++|+||||++++||++|+.||.....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~  204 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE  204 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence            233468889999998754 5578999999999999999999999976543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-32  Score=275.82  Aligned_cols=196  Identities=31%  Similarity=0.487  Sum_probs=160.9

Q ss_pred             ccccccCceEEEEEEEcC---CCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeee-ccCeeEEEEEecc
Q 038860          346 QLLGHGGFGQVYKGTLHN---SKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCR-RKGDLLLVYDFMA  420 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~  420 (652)
                      +.||+|+||.||+|.+..   ....||+|++... .....+.+.+|+.+++.++|||++++++++. .++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   3467999998643 3345677889999999999999999999875 4556899999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC---
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN---  497 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~---  497 (652)
                      +++|.+++.... ..+++..+..++.|+++||.|||   +.+++||||||+|||++.++.+||+|||+++.......   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999985432 34677888899999999999999   78999999999999999999999999999985432211   


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhC-CCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG-RRPIET  545 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG-~~p~~~  545 (652)
                      .......++..|+|||.+.+..++.++|||||||++|||++| .+||..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            111233467789999999888899999999999999999995 555543

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-32  Score=279.26  Aligned_cols=200  Identities=30%  Similarity=0.458  Sum_probs=169.1

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhccc---CcCceeEEEeeeeccCe-----
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRL---RHRNLVQLVGWCRRKGD-----  411 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  411 (652)
                      |++.+.||+|++|.||+|++..+++.||+|++.....  .....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999988889999999974322  2234566787777665   59999999999987766     


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .+++|||+++ +|.+++.......+++..++.++.|+++||.|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999974 8888886544446899999999999999999999   78999999999999999999999999999987


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .....  ......++..|+|||.+.+..++.++|+|||||++|||++|++||....
T Consensus       157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            64432  2223457889999999998889999999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2e-32  Score=285.62  Aligned_cols=205  Identities=27%  Similarity=0.415  Sum_probs=169.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeecc-------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRK-------  409 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  409 (652)
                      .++|++.+.||+|++|.||+|.+..+++.+|+|++.....  .....+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999999998899999999865422  1234567899999999999999999987443       


Q ss_pred             -CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          410 -GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       410 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                       ..+++|+||+.+ +|...+... ...+++..+..++.|+++||.|||   +++++||||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999965 676666432 346999999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCCC----------ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          489 AKLYEHGTNP----------ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       489 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      ++........          ..+...+++.|+|||.+.+ ..++.++|||||||++|||++|++||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9865432211          1123467889999998765 4578999999999999999999999976544

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.98  E-value=2.7e-32  Score=276.36  Aligned_cols=195  Identities=33%  Similarity=0.555  Sum_probs=168.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|++.+.||+|+||.||++..  .++.||+|.++...  ....+.+|+.++++++|||++++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4688899999999999999975  46789999986543  235788999999999999999999998765 479999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++++|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999997655556899999999999999999999   799999999999999999999999999999864322    


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence            112234578999999988899999999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.3e-32  Score=288.53  Aligned_cols=280  Identities=21%  Similarity=0.288  Sum_probs=202.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC----
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG----  410 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  410 (652)
                      ...++|++.+.||+|+||.||++....++..||+|++...  .......+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3467899999999999999999999888999999998643  2233456889999999999999999999886543    


Q ss_pred             --eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          411 --DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       411 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                        ..++||||+ +++|.+++.   ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence              468999999 678888773   245899999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      ++.....    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||........   ..........  .
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~~~~~~~~--~  235 (343)
T cd07880         165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ---LMEIMKVTGT--P  235 (343)
T ss_pred             ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCC--C
Confidence            9865332    223467889999998776 4588899999999999999999999975432111   1111111000  0


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                      .......+....  .......+  +...+.......+...+.+.+++.+|+..+|++|+      .|+|++....
T Consensus       236 ~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         236 SKEFVQKLQSED--AKNYVKKL--PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             CHHHHHhhcchh--HHHHHHhc--cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            000111111100  01111111  11111001111123456788999999999999998      5678876433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=4.5e-32  Score=275.61  Aligned_cols=194  Identities=28%  Similarity=0.430  Sum_probs=170.3

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ||+|+||.||++++..+++.+++|.+.....   ...+.+.+|+.++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999976533   4556788999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC-------
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-------  497 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-------  497 (652)
                      .+++.+.  ..+++..+..++.|++.||+|||   +++++||||+|+||++++++.++|+|||++........       
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9998543  36899999999999999999999   79999999999999999999999999999886543321       


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .......++..|+|||.......+.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  204 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE  204 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            1223456788999999998888999999999999999999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=5.1e-32  Score=278.58  Aligned_cols=202  Identities=30%  Similarity=0.469  Sum_probs=172.4

Q ss_pred             cCccccccccccCceEEEEEEEcC----CCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeec--cCee
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHN----SKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRR--KGDL  412 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  412 (652)
                      ..|+..+.||+|+||.||++....    ++..||+|.+...... ..+++.+|++++++++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            457778999999999999998653    4788999999766443 56789999999999999999999999877  5578


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      +++|||+++++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            99999999999999995433 35899999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCCc--eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          493 EHGTNPA--TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       493 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            5322211  1122445679999999888999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-34  Score=320.55  Aligned_cols=206  Identities=29%  Similarity=0.448  Sum_probs=176.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .+-++....+||.|.||.||-|...++|+..|+|.+...  .....+...+|+.++..++|||+|+.+|+-.+++..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            344667778899999999999999999999999987543  233456678899999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      ||||++|+|.+.+..  ....++.....+..|++.|+.|||   +.+||||||||.||+|+.+|.+|++|||.|+.+...
T Consensus      1313 MEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            999999999999843  344677777889999999999999   799999999999999999999999999999987654


Q ss_pred             CC---CceeeccCCcCCCCCCCCCCCC---CCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          496 TN---PATTRVVGTLGYLAPETPRTGK---SSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       496 ~~---~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      ..   .......||+.|||||++.+..   ...++||||+|||++||+||++||...+.
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence            32   1223568999999999987643   56689999999999999999999976443

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=270.88  Aligned_cols=199  Identities=33%  Similarity=0.513  Sum_probs=177.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|++.+.||+|++|.||++.....++.|++|.+.....  .....+.+|++++++++|+|++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47788999999999999999988889999999977643  4567899999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            9999999988443  56899999999999999999999   79999999999999999999999999999987654332 


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ......++..|+|||...+..++.++||||+|+++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~  201 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD  201 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            12345688999999998888889999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=2e-32  Score=290.08  Aligned_cols=278  Identities=22%  Similarity=0.285  Sum_probs=200.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeecc---------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK---------  409 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  409 (652)
                      ..+|+..+.||+|+||.||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36899999999999999999999988999999999776656667788999999999999999999776543         


Q ss_pred             -----CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEE
Q 038860          410 -----GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKL  483 (652)
Q Consensus       410 -----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL  483 (652)
                           ...++|+||++ ++|.+++.   ...+++..++.++.||+.||.|||   +.+++||||||+||+++. ++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEE
Confidence                 35789999997 58887773   235889999999999999999999   799999999999999984 567899


Q ss_pred             eeeccceecccCCCC--ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHh
Q 038860          484 GDFGLAKLYEHGTNP--ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWG  560 (652)
Q Consensus       484 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~  560 (652)
                      +|||+++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....   ...
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---~~~  233 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL---ILE  233 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHH
Confidence            999999865322111  1123457889999997654 5678899999999999999999999976443222111   111


Q ss_pred             hhcCCccccccccccccCCCHHHHHHhhcc-CCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          561 KYGEGRVLEVIDPKLNAEYDQSQVLMGELE-LPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       561 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~-~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                      ....      .++.-....  .......+. .....+.|.....+.....+.+|+.+|+..+|++|+      .|+|++.
T Consensus       234 ~~~~------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         234 SVPV------VREEDRNEL--LNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             hcCC------CChHHhhhh--hhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            1100      000000000  000000000 111122222222234456789999999999999999      6788875


Q ss_pred             C
Q 038860          634 G  634 (652)
Q Consensus       634 ~  634 (652)
                      .
T Consensus       306 ~  306 (342)
T cd07854         306 Y  306 (342)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-33  Score=269.43  Aligned_cols=256  Identities=23%  Similarity=0.321  Sum_probs=200.6

Q ss_pred             hhcCcccc-ccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeec----cCe
Q 038860          338 ATNNFSAK-QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRR----KGD  411 (652)
Q Consensus       338 ~~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  411 (652)
                      .+++|++. ++||-|-.|.|..+..+.+++.+|+|++....+.     .+|++.--.. .|||||+++++|.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KA-----RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKA-----RREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHH-----HhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556553 6799999999999999999999999999765332     3566654444 69999999998854    456


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCeEEeeecc
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGL  488 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~kL~DFGl  488 (652)
                      +++|||.|+||.|...+.++....+++.++-.|++||..|+.|||   ..+|.||||||+|+|...   +..+||+|||.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            889999999999999998888888999999999999999999999   799999999999999964   45699999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      |+....  .......+-|+.|.|||++...+|+..+|+||+||++|-||+|-+||....-.                .+.
T Consensus       211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----------------ais  272 (400)
T KOG0604|consen  211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----------------AIS  272 (400)
T ss_pred             ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----------------cCC
Confidence            996432  23445567899999999999999999999999999999999999999653210                000


Q ss_pred             ccccccc-ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          569 EVIDPKL-NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       569 ~~id~~l-~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                      .-+..++ .+.|.                -|.+.| ..+++.+.|++++|+..+|.+|+      .|.|..-...
T Consensus       273 pgMk~rI~~gqy~----------------FP~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  273 PGMKRRIRTGQYE----------------FPEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             hhHHhHhhccCcc----------------CCChhH-hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            0011111 11221                133333 35678999999999999999998      6778665433

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=9.4e-33  Score=263.12  Aligned_cols=203  Identities=29%  Similarity=0.426  Sum_probs=172.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .++.+.+..||.|..|.|+++..+.++...|||...+. ++...++++..+.++.+-+ +|.||+.+|||..+...++.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            34556678899999999999999999999999998765 5566777888888776654 999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |.|. -+++..+.+ -..++++..+-++...+.+||.||-+  +.+|+|||+||+|||+|+.|++||+|||.+-++-.. 
T Consensus       171 elMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-  245 (391)
T KOG0983|consen  171 ELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-  245 (391)
T ss_pred             HHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence            9984 356665533 34568999999999999999999998  899999999999999999999999999998765432 


Q ss_pred             CCceeeccCCcCCCCCCCCCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRT---GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                       ...+...|-+.|||||.+.-   ..|+.++||||||++|+||.||+.||.+..
T Consensus       246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~  298 (391)
T KOG0983|consen  246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK  298 (391)
T ss_pred             -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence             34455689999999998754   468999999999999999999999998744

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=6.1e-32  Score=284.74  Aligned_cols=199  Identities=25%  Similarity=0.300  Sum_probs=165.7

Q ss_pred             cccccc--CceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHG--GFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      ..||+|  +||+||++.+..+++.||+|.+....  ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  89999999998889999999986532  33456788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc--
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--  499 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~--  499 (652)
                      ++|.+++.......+++..+..++.|++.||+|||   +.+++||||||+|||++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999886544456899999999999999999999   7999999999999999999999999998654332211111  


Q ss_pred             ----eeeccCCcCCCCCCCCCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          500 ----TTRVVGTLGYLAPETPRTG--KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       500 ----~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                          .....++..|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence                1112346679999998764  47899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=1.2e-31  Score=271.05  Aligned_cols=202  Identities=26%  Similarity=0.440  Sum_probs=178.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|+..+.||+|++|.||++.+..++..|++|++.....  ...+++.+|++++++++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            57888999999999999999998899999999976532  4566788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCC--ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFDEP--KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      +++++|.+++....  ...+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999886532  367999999999999999999999   6899999999999999999999999999998765432


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       .......|++.|+|||......++.++|+||+|+++++|++|+.||...
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence             2233357889999999998888999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=2.7e-32  Score=279.95  Aligned_cols=202  Identities=26%  Similarity=0.453  Sum_probs=177.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  415 (652)
                      ++|...+.||+|++|.||++....+++.||+|.+...   .....+.+.+|..++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4788899999999999999999888999999998753   2234467889999999998 99999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999998543  36999999999999999999999   799999999999999999999999999999865432


Q ss_pred             CC-------------------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TN-------------------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..                   .......++..|+|||......++.++|+||||++++++++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            21                   1223346789999999988888999999999999999999999999754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=6.2e-32  Score=285.20  Aligned_cols=276  Identities=24%  Similarity=0.319  Sum_probs=198.8

Q ss_pred             CccccccccccCceEEEEEEEcCC--CeEEEEEEecCc--chhhHHHHHHHHHHhccc-CcCceeEEEeeeecc----Ce
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNS--KTEVAVKRISNE--SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK----GD  411 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  411 (652)
                      +|++.+.||+|+||.||++.+...  +..||+|++...  .....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478889999999999999999877  889999998753  222345678899999999 599999999875432    45


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++++||+. ++|.+++..  ...+++..++.++.||+.||.|||   .++++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899986 588888843  346899999999999999999999   79999999999999999999999999999986


Q ss_pred             cccCCC---CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhc---C
Q 038860          492 YEHGTN---PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYG---E  564 (652)
Q Consensus       492 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~  564 (652)
                      ......   .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......+   ..........   +
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  231 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDE  231 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCH
Confidence            543221   11233578999999998765 468999999999999999999999997644322   2222222211   1


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      +.+..+.++       ........+  ......+.....+.....+.+++.+|+..+|++|++      ++|+..-
T Consensus       232 ~~~~~~~~~-------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         232 ETLSRIGSP-------KAQNYIRSL--PNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHHHhhhhh-------hHHHHHHhc--cccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            111111110       000111111  111111222222233568899999999999999995      6676543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=291.20  Aligned_cols=195  Identities=33%  Similarity=0.470  Sum_probs=171.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh---hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ---GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .|..++.||.|+||.||-+++..+.+.||||+..-..++   ...+++.|+..|.+++|||++.+.|+|......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            466678899999999999999999999999999765443   45689999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ||- |+-.+.+.-. +.++.+..+..|..+.+.||+|||   +.+.||||||..||||.+.|.|||+|||.|....+   
T Consensus       107 YCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            995 4777766332 446888999999999999999999   69999999999999999999999999999986543   


Q ss_pred             CceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                        ...++|||.|||||++.   .+.|+-|+||||||++..||.-+++|+-.
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn  227 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  227 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence              34578999999999764   57899999999999999999999999754

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=1.8e-31  Score=279.84  Aligned_cols=195  Identities=30%  Similarity=0.464  Sum_probs=168.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .|+..+.||+|+||.||++++..++..||+|.+....   ......+.+|+.++++++|||++++++++......++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4777889999999999999998889999999986432   2344578899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++ +|.+.+... ...+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++.....   
T Consensus       106 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         106 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            9974 777766432 345899999999999999999999   79999999999999999999999999999875432   


Q ss_pred             CceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                        .....|+..|+|||.+.   .+.++.++|||||||++|||++|+.||..
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  226 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  226 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence              22346888999999873   45688999999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.7e-32  Score=290.76  Aligned_cols=278  Identities=21%  Similarity=0.300  Sum_probs=202.6

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe---
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD---  411 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  411 (652)
                      ...++|+..+.||+|++|.||+|.+..+++.||+|++...  .....+.+.+|+.++++++|+|++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3467899999999999999999999988999999998653  23344667889999999999999999998766554   


Q ss_pred             ---eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          412 ---LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       412 ---~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                         .++|+||+ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999999 5699888843   45899999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      +......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..   ........ ...
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~-~~~  236 (343)
T cd07851         165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVG-TPD  236 (343)
T ss_pred             ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcC-CCC
Confidence            9865432    233467889999998765 46788999999999999999999999764332211   11111110 000


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      .+++ ..+.  .+.....+..+.  ...+...........+.+.|++.+|+..+|++||      .|+||+..
T Consensus       237 ~~~~-~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         237 EELL-QKIS--SESARNYIQSLP--QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             HHHH-hhcc--chhHHHHHHhcc--ccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence            0010 1111  011111111111  1111111111122356889999999999999998      56688763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=3.5e-31  Score=267.68  Aligned_cols=202  Identities=30%  Similarity=0.467  Sum_probs=178.6

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  416 (652)
                      +|+..+.||+|++|.||+|....++..|++|.+.....  ...+.+.+|+.++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47788999999999999999998899999999876542  4567889999999999999999999999988  8899999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++....  .+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999985433  7899999999999999999999   6999999999999999999999999999998765443


Q ss_pred             CC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          497 NP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       497 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .. ......++..|+|||.......+.++||||||+++++|++|+.||....
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            21 1234568899999999988889999999999999999999999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=4e-32  Score=279.08  Aligned_cols=200  Identities=28%  Similarity=0.433  Sum_probs=172.7

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      |+..+.||+|++|.||+|+...+++.||+|.+....  ....+.+..|+.++++++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999999889999999997653  333466788999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      + ++|.+++.... ..+++..++.++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++....... .
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            7 58999885432 46899999999999999999999   78999999999999999999999999999986543221 2


Q ss_pred             eeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          500 TTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            2234567889999988776 78999999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.2e-33  Score=276.29  Aligned_cols=204  Identities=27%  Similarity=0.392  Sum_probs=177.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..+|..+..||+|+||.|.+|..+++.+.+|||+++++.   ....+--+.|-++|... +-|.+++++.+|..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            357888999999999999999999999999999998762   23344455677777766 58899999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+.||+|-.++  ++-..+.+..+..++.+||-||-+||   +++|+.||||.+|||||.+|.+||+|||+++.---
T Consensus       428 VMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999998888  44556888899999999999999999   79999999999999999999999999999984221


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                       ....+.+.+||+.|+|||++...+|+..+|.|||||+||||+.|++||++.+.
T Consensus       503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence             12345568999999999999999999999999999999999999999998554

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=7.1e-32  Score=282.24  Aligned_cols=192  Identities=27%  Similarity=0.306  Sum_probs=161.0

Q ss_pred             CceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCcccccc
Q 038860          352 GFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF  429 (652)
Q Consensus       352 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~  429 (652)
                      ++|.||.++...+++.||+|++...  .....+.+.+|+.++++++|+||+++++++...+..+++|||+++++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            3445555555557899999998754  34456789999999999999999999999999999999999999999999986


Q ss_pred             cCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC------Cceeec
Q 038860          430 DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN------PATTRV  503 (652)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~~  503 (652)
                      ......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||.+........      ......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            554556889999999999999999999   79999999999999999999999999999875532211      112234


Q ss_pred             cCCcCCCCCCCCCCC--CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          504 VGTLGYLAPETPRTG--KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       504 ~gt~~y~aPE~~~~~--~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .++..|+|||.+...  .++.++|+|||||++|||++|+.||...
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            577899999988663  5788999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=1.3e-31  Score=274.12  Aligned_cols=201  Identities=30%  Similarity=0.494  Sum_probs=166.1

Q ss_pred             ccccccccccCceEEEEEEEcC---CCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC------
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG------  410 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  410 (652)
                      |++.+.||+|+||.||+|.+..   ++..||+|.+...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5677899999999999998643   4688999998754  2345667889999999999999999999886432      


Q ss_pred             eeEEEEEeccCCCcccccccC----CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          411 DLLLVYDFMANGSLDSFLFDE----PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      ..++++||+++|+|..++...    ....+++..+++++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998876422    2235788999999999999999999   689999999999999999999999999


Q ss_pred             ccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          487 GLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       487 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      |+++....... .......++..|++||.+....++.++||||||+++|||++ |++||..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~  218 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG  218 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence            99986543221 11222345678999999988889999999999999999999 8888864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1.1e-31  Score=277.12  Aligned_cols=200  Identities=27%  Similarity=0.397  Sum_probs=170.6

Q ss_pred             CccccccccccCceEEEEEEEc---CCCeEEEEEEecCcc----hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCee
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES----KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  412 (652)
                      +|++.+.||+|++|.||++...   ..++.||+|.+....    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999864   356789999987532    22345688999999999 599999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++++|.+++..  ...+++..+..++.|++++|.|||   ..+++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            999999999999998853  345889999999999999999999   799999999999999999999999999998865


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCC--CCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGK--SSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ............|+..|+|||.+.+..  .+.++||||||+++|||++|..||..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            443332333456899999999987665  78899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.6e-32  Score=280.74  Aligned_cols=202  Identities=26%  Similarity=0.403  Sum_probs=169.2

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecC--cchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  413 (652)
                      .....|+++++||+||.+.||++...+ ...+|+|++..  .+.+....|.+|+..|.+|+ |.+|+++++|-..++.+|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            445679999999999999999998865 46677776643  34556778999999999995 999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      |||||= ..+|..+|.........| .++.+.+||+.|+.++|   +.||||.||||.|+|+-+ |.+||+|||.|..+.
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ  510 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence            999986 459999996655444445 77889999999999999   799999999999999854 589999999999876


Q ss_pred             cCCCC-ceeeccCCcCCCCCCCCCCC-----------CCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          494 HGTNP-ATTRVVGTLGYLAPETPRTG-----------KSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       494 ~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .++.. .....+||..||+||.+...           +.++++||||+||+||+|+.|+.||..
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            65543 34567999999999965432           257899999999999999999999974

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=9.7e-32  Score=272.03  Aligned_cols=246  Identities=26%  Similarity=0.430  Sum_probs=200.0

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +|++.+.||+|++|.||++....+++.+++|.+....  .....++.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788999999999999999998889999999987542  33456788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      +++++|.+++.+.  ....+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988542  2356899999999999999999999   799999999999999999999999999999876543 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                        ......++..|++||.+.+..++.++|+||||+++|||++|+.||......+   +....    ..            
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~------------  215 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKV----QR------------  215 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hc------------
Confidence              2223468899999999998889999999999999999999999996533110   00000    00            


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                      ..+            +     +.+   ....+.+.+++.+|+..+|++||+..-+
T Consensus       216 ~~~------------~-----~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~  250 (256)
T cd08530         216 GKY------------P-----PIP---PIYSQDLQNFIRSMLQVKPKLRPNCDKI  250 (256)
T ss_pred             CCC------------C-----CCc---hhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            000            0     000   1234578999999999999999987543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=1.1e-31  Score=279.41  Aligned_cols=203  Identities=29%  Similarity=0.485  Sum_probs=170.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCe----EEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKT----EVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|+..+.||+|+||.||+|.+..++.    .||+|.+..... ....++.+|+.++++++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            3567888999999999999999876554    578998876532 3345788999999999999999999998754 467


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +++||+++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            999999999999998543 235889999999999999999999   7999999999999999999999999999998664


Q ss_pred             cCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          494 HGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       494 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            33221 1222345778999999998899999999999999999997 99998653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.3e-31  Score=276.07  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=168.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..++|++.+.||+|++|.||+|.+..+++.||||.++... .....++..|+.++.+.. ||||++++++|......+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            3467888999999999999999999889999999997543 234456677887777775 99999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++ +|.+++... ...+++..+..++.|++.||+|||+  ..+|+||||+|+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~-~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMST-CLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccCc-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            999854 666665332 3468999999999999999999994  358999999999999999999999999998765432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCC----CCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGK----SSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .  ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||..
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         169 K--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             C--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            2  122335788999999987554    78899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=4e-31  Score=274.13  Aligned_cols=202  Identities=19%  Similarity=0.262  Sum_probs=155.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCC---CeEEEEEEecCcchhh-----------HHHHHHHHHHhcccCcCceeEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-----------VREFVSEIATIGRLRHRNLVQLVG  404 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  404 (652)
                      .++|++.++||+|+||.||+|.+.++   +..+|+|.........           ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999998776   5667777643322111           011233445566778999999999


Q ss_pred             eeeccC----eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          405 WCRRKG----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       405 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      ++....    ..++++|++.. ++.+.+..  ....++..+..++.|++.||+|||   +++|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence            765543    34677777643 55554422  223567888999999999999999   789999999999999999999


Q ss_pred             eEEeeeccceecccCCC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          481 GKLGDFGLAKLYEHGTN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ++|+|||+|+.+.....      .......||+.|+|||...+..++.++|||||||++|||++|+.||...
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999987643211      1122346999999999999999999999999999999999999999865

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=286.18  Aligned_cols=203  Identities=29%  Similarity=0.424  Sum_probs=176.3

Q ss_pred             CccccccccccCceEEEEEEEcC---CCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..+..++||+|.||.|++|.+..   +...||||+++..... ...+|++|+.+|.+|+|+|+++|||...+ ....||+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            44556889999999999999864   2346999999876544 67899999999999999999999999987 6788999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |+++.|+|.+.|++..+..+-...+..++.|||.||.||.   .+++|||||..+|+||-....+||+||||.+.+..+.
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999998766677888899999999999999999   7999999999999999999999999999999876554


Q ss_pred             CCcee--eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          497 NPATT--RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       497 ~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      .....  ...-...|.|||.+..+.++.++|||+|||++|||+| |+.||.+..
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            33211  1123568999999999999999999999999999999 899998754

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=7.4e-31  Score=274.64  Aligned_cols=195  Identities=31%  Similarity=0.474  Sum_probs=167.2

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      |...+.||+|+||.||+|++..+++.|++|.+....   ....+.+.+|+.++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556778999999999999998889999999986532   23446788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +. ++|.+++... ...+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....     
T Consensus       103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----  172 (313)
T cd06633         103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----  172 (313)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence            96 5777766432 346899999999999999999999   7899999999999999999999999999986432     


Q ss_pred             ceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|..||...
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            222356889999999874   456888999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=3.1e-31  Score=276.88  Aligned_cols=197  Identities=33%  Similarity=0.484  Sum_probs=168.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .+.|+..+.||+|++|.||+|.+..+++.+|+|.+...   .....+++.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34577788999999999999999888899999998642   233456788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+. |+|.+++... ...+++.++..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            99996 5777766432 345889999999999999999999   789999999999999999999999999998765432


Q ss_pred             CCCceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                           ....|+..|+|||.+.   .+.++.++|||||||++|||++|+.||..
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  216 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence                 2346788999999864   35678899999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-33  Score=266.02  Aligned_cols=276  Identities=24%  Similarity=0.339  Sum_probs=208.2

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----CeeE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----GDLL  413 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  413 (652)
                      +.+..+-||.|+||.||...+..+|+.||+|++...-  -...+.+.+|+++|.-++|.|++..++...-.     .++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4455688999999999999999999999999987642  23457788999999999999999988876433     3678


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      ++.|.|.. +|.+.+-  ....++...+.-+.+||++||.|||   ..+|.||||||.|.|++++..+||+|||+|+..+
T Consensus       134 V~TELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence            99999965 8888883  4556888889999999999999999   7999999999999999999999999999999887


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      .+.....+..+-|..|+|||.+.+. .|+...||||.||++.||+.++-.|+...+-++..++-...+....+.+.-...
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            7776677777889999999999885 589999999999999999999999988777666666554444332211111100


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCC-CcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRS-SDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~-~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                            -....++..-...+... +-.. ........+..+++.+|+..+|++|++..
T Consensus       288 ------GAk~H~LR~~~k~Ps~~-vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~  338 (449)
T KOG0664|consen  288 ------GAKNHVLRAGLRAPDTQ-RLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVE  338 (449)
T ss_pred             ------hhHHHhhccCCCCCCcc-ceeeecCCcccchHHHHHHHHHhCCCCcccccHh
Confidence                  00111111111111111 0111 11112234678999999999999999643

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.5e-32  Score=281.71  Aligned_cols=216  Identities=24%  Similarity=0.398  Sum_probs=182.3

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ....-|..++.||-|+||.|.++...++...+|+|.+++.+   +.+..-..+|-.||.....+=||+|+-.|.+++.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            34567888999999999999999999999999999997753   334455778999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||+|++||++-.+|-  +...+++..++.++.++..|+++.|   +.|+|||||||+|||||.+|.+||.|||||.-+.
T Consensus       706 FVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999988884  3457889999999999999999999   8999999999999999999999999999984321


Q ss_pred             --cC-------CCC---c-----------------------------eeeccCCcCCCCCCCCCCCCCCCccchHhHHHH
Q 038860          494 --HG-------TNP---A-----------------------------TTRVVGTLGYLAPETPRTGKSSASSDVFAFGAL  532 (652)
Q Consensus       494 --~~-------~~~---~-----------------------------~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvv  532 (652)
                        ++       ...   .                             ....+||+.|+|||++....++.-+|.||.||+
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence              10       000   0                             012479999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcc-chhHHHH
Q 038860          533 LLEVACGRRPIETRALPE-ELVLVDW  557 (652)
Q Consensus       533 l~elltG~~p~~~~~~~~-~~~l~~~  557 (652)
                      ||||+.|+.||......+ +...+.|
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeeh
Confidence            999999999997665543 3334444

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-31  Score=266.32  Aligned_cols=193  Identities=30%  Similarity=0.402  Sum_probs=170.5

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      ||+|++|.||++....+++.+|+|.+.....   .....+..|+.++++++|+|++++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999988889999999876432   2456788999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeecc
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV  504 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  504 (652)
                      .+++...  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  154 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC  154 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence            9998543  35899999999999999999999   7999999999999999999999999999998764432 2234456


Q ss_pred             CCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       505 gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ++..|++||...+...+.++|+||||+++||+++|+.||...
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  196 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE  196 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            889999999998888899999999999999999999999653

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7.5e-31  Score=263.21  Aligned_cols=180  Identities=22%  Similarity=0.230  Sum_probs=155.3

Q ss_pred             cCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCccccccc
Q 038860          351 GGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD  430 (652)
Q Consensus       351 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  430 (652)
                      |.+|.||++.+..+++.+|+|++....     .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999997653     223455555556799999999999999999999999999999998854


Q ss_pred             CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCC
Q 038860          431 EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL  510 (652)
Q Consensus       431 ~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~  510 (652)
                      .  ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++|+|||.+......    .....++..|+
T Consensus        79 ~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~  149 (237)
T cd05576          79 F--LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC  149 (237)
T ss_pred             h--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence            3  35899999999999999999999   799999999999999999999999999987654332    12234577899


Q ss_pred             CCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       511 aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      |||...+..++.++|+||+|+++|||++|+.|+.
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            9999988889999999999999999999998764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-33  Score=262.96  Aligned_cols=200  Identities=32%  Similarity=0.396  Sum_probs=168.7

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .+.+..||.|.||+|+|-.++.+|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            3446789999999999999999999999999987644 4567788888765554 7999999999999999999999999


Q ss_pred             cCCCccccc---ccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          420 ANGSLDSFL---FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       420 ~~gsL~~~l---~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      . .||+.+-   +..++..+++..+-.|......||.||-+  +..|||||+||+||||+..|.+||||||.+-.+... 
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-  221 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-  221 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence            5 4766543   34456678999999999999999999998  789999999999999999999999999998755322 


Q ss_pred             CCceeeccCCcCCCCCCCCCCC--CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTG--KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       -..+.-.|-..|||||.+...  .|+.+|||||||++|+|+.||+.|+...
T Consensus       222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w  272 (361)
T KOG1006|consen  222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW  272 (361)
T ss_pred             -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence             233445788999999987643  4899999999999999999999999763

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.2e-30  Score=298.50  Aligned_cols=147  Identities=31%  Similarity=0.443  Sum_probs=132.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|.+.++||+|+||.||+|.+..+++.||||+++...   ......+..|+.++..++||||+++++++.....+++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367999999999999999999999889999999996542   23346788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      |||+++++|.+++..  ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999843  335888999999999999999999   6899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-32  Score=289.79  Aligned_cols=207  Identities=30%  Similarity=0.453  Sum_probs=176.4

Q ss_pred             ccccccccccCceEEEEEEEcCCC----eEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSK----TEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .+..++||+|+||+||+|.+.-.+    -+||+|++... ..+...++++|+.+|.+++|||+++++|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            455788999999999999886444    46999988665 3445678999999999999999999999998775 88999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      +||+.|+|.+|++.. +..+..+..+.|..|||+||.|||   +++++||||..+|||+.+-..+||.|||+|+....+.
T Consensus       777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999999653 446888899999999999999999   7999999999999999999999999999999887655


Q ss_pred             CCce-eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchh
Q 038860          497 NPAT-TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELV  553 (652)
Q Consensus       497 ~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  553 (652)
                      .... ....-.+.|||-|.+..++++.++|||||||++||++| |..|+++...++...
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d  911 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD  911 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH
Confidence            4322 22233578999999999999999999999999999999 999998765444333

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=257.58  Aligned_cols=202  Identities=27%  Similarity=0.408  Sum_probs=178.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|..++.||+|+|.+|.++++..+.+.+|+|+++++   ....+...+.|-.+.... +||.+|-++.+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            346899999999999999999999999999999999765   234455566777777666 6999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|.||+++|+|--++  +++..|+++.++.+...|.-||.|||   +++|+.||||.+|+|+|..|.+||.|+|+++.--
T Consensus       328 fvieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999998777  44556999999999999999999999   7999999999999999999999999999998422


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       .....+++++||+.|+|||.+.+..|....|.|+|||+++||+.|+.||+-
T Consensus       403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence             233456678999999999999999999999999999999999999999974

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=281.18  Aligned_cols=239  Identities=26%  Similarity=0.346  Sum_probs=194.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .+..|.....+|.|+|+.|-++.+..+++..++|++.+...    +-.+|+.++.+. +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            46788888899999999999999999999999999977622    234567666665 6999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe-CCCCCeEEeeeccceecccC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL-DSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl-~~~~~~kL~DFGla~~~~~~  495 (652)
                      |.+.++-|.+.+.....  .. .++..|+.+|+.|+.|||   .++++||||||+|||+ ++.++++|+|||.++.....
T Consensus       396 e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999888777644332  22 677789999999999999   7999999999999999 58899999999999865543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                          ....+-|..|.|||++....+++++|+||||++||+||+|+.||......                          
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------------------------  519 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------------------------  519 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------------------------
Confidence                23346689999999999999999999999999999999999999753221                          


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYF  631 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~  631 (652)
                             ..++..+..+..      .  ..+++.++|||+.|+..+|.+|+      .|+|+
T Consensus       520 -------~ei~~~i~~~~~------s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  520 -------IEIHTRIQMPKF------S--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------HHHHHhhcCCcc------c--cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                   111111111111      1  34578999999999999999999      46787

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=5.4e-31  Score=267.67  Aligned_cols=200  Identities=24%  Similarity=0.406  Sum_probs=168.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc-----chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      +|.+.+.||+|+||.||++.+...+..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            478889999999999999998876666666665432     122334567899999999999999999999999999999


Q ss_pred             EEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          416 YDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||+++++|.+++..  .....+++.+++.++.|+++||.|||   +.+++|+||||+||+++. +.+||+|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988753  23456899999999999999999999   799999999999999976 469999999998654


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ... .......|+..|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            322 222334678899999998888889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=243.02  Aligned_cols=203  Identities=31%  Similarity=0.412  Sum_probs=170.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      +.......||+|+||.|-+-++..+|...|+|++... ..+..++.+.|+.+..+- .+|.+|+++|...+++..++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            3445567799999999999999999999999999765 345567788888876655 79999999999999999999999


Q ss_pred             eccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          418 FMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       418 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      .|.- ||+.+-..  .....+++..+-+|+..+.+||.|||+  +..++|||+||+|||++.+|++|+||||.+-.+...
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            9954 88776532  345678999999999999999999998  889999999999999999999999999998765432


Q ss_pred             CCCceeeccCCcCCCCCCCCCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      -  ..+...|-..|||||.+..    ..|+-|+||||||+++.||.+++.||+...
T Consensus       203 i--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  203 I--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             h--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            1  2233468889999997654    368999999999999999999999997643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=8.5e-31  Score=292.84  Aligned_cols=201  Identities=30%  Similarity=0.479  Sum_probs=160.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeec--------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--------  408 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  408 (652)
                      -.++|+..+.||+||||.||+++.+-+|+.+|||++.-. +........+|+.++++|+|||||+++....+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            446889999999999999999999999999999999765 34455678899999999999999998753210        


Q ss_pred             --------------------------------------------------------------------------------
Q 038860          409 --------------------------------------------------------------------------------  408 (652)
Q Consensus       409 --------------------------------------------------------------------------------  408 (652)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------c--------CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhcc
Q 038860          409 -----------------------K--------GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE  457 (652)
Q Consensus       409 -----------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~  457 (652)
                                             +        -.+|+=||||+.-.|.+++.++.. .-.....++++++|++||.|+| 
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHHHHHH-
Confidence                                   0        124677888888666666643221 1145678899999999999999 


Q ss_pred             CccceEEecCCCCCceEeCCCCCeEEeeeccceecc----------------cC-CCCceeeccCCcCCCCCCCCCCC--
Q 038860          458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE----------------HG-TNPATTRVVGTLGYLAPETPRTG--  518 (652)
Q Consensus       458 ~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~----------------~~-~~~~~~~~~gt~~y~aPE~~~~~--  518 (652)
                        +++||||||||.||+|+++..|||+|||+|....                .+ .....+..+||.-|+|||++.+.  
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence              7999999999999999999999999999998621                00 11134567899999999988764  


Q ss_pred             -CCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          519 -KSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       519 -~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       +|+.|+|+||||||++||+.   ||..
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T  817 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGT  817 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCc
Confidence             49999999999999999984   4654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=5.2e-30  Score=279.43  Aligned_cols=204  Identities=24%  Similarity=0.378  Sum_probs=155.6

Q ss_pred             hhcCccccccccccCceEEEEEEEc----------------CCCeEEEEEEecCcchhhHHHH--------------HHH
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLH----------------NSKTEVAVKRISNESKQGVREF--------------VSE  387 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E  387 (652)
                      ..++|++.++||+|+||.||+|.+.                ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4679999999999999999999752                2346799999865433323333              346


Q ss_pred             HHHhcccCcCce-----eEEEeeeec--------cCeeEEEEEeccCCCcccccccCC----------------------
Q 038860          388 IATIGRLRHRNL-----VQLVGWCRR--------KGDLLLVYDFMANGSLDSFLFDEP----------------------  432 (652)
Q Consensus       388 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------  432 (652)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766654     677777753        356899999999999998885321                      


Q ss_pred             ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCC
Q 038860          433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP  512 (652)
Q Consensus       433 ~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aP  512 (652)
                      ...+++..++.++.|++.+|.|||   +.+|+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            123467788999999999999999   78999999999999999999999999999976544332222233458899999


Q ss_pred             CCCCCCCC----------------------CCccchHhHHHHHHHHHhCCC-CCC
Q 038860          513 ETPRTGKS----------------------SASSDVFAFGALLLEVACGRR-PIE  544 (652)
Q Consensus       513 E~~~~~~~----------------------s~~sDv~SlGvvl~elltG~~-p~~  544 (652)
                      |.+.....                      ..+.||||+||+++||++|.. |+.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            98754321                      234799999999999999875 664

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=4.1e-31  Score=245.99  Aligned_cols=279  Identities=21%  Similarity=0.300  Sum_probs=211.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeecc--CeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRK--GDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l  414 (652)
                      ..++|++.+++|+|.|+.||.|....+++.++||.+++..+   +.+.+|++||..|+ ||||+++++...+.  ..+.|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35789999999999999999999888889999999987543   45678999999997 99999999998765  45789


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccceecc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYE  493 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla~~~~  493 (652)
                      |+||+.+.+.....     +.++...+..++.++++||.|+|   +.||.|||+||.|+++|.. ..++|+|+|+|.++.
T Consensus       113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999887655443     45778888999999999999999   7999999999999999966 569999999999887


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCC-CCCCccchhHHHHHHhhhcCCc----c
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIE-TRALPEELVLVDWVWGKYGEGR----V  567 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~----~  567 (652)
                      .+....  ..+.+..|.-||.+.. ..++..-|+|||||++..|+..+.||- +.+..++...+..+.+.-.-..    .
T Consensus       185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            654332  3355778899998876 457788899999999999999999974 5556667666666554321100    0


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      .-.+||+..       .+++.-....+.+--.........+++.|||++++..|-.+|++      |+||...++
T Consensus       263 ~i~Ldp~~~-------~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~  330 (338)
T KOG0668|consen  263 QIDLDPQFE-------DILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE  330 (338)
T ss_pred             ccCCChhHh-------hHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence            011333321       22333333333332233333445689999999999999999995      678776543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.4e-30  Score=288.97  Aligned_cols=199  Identities=21%  Similarity=0.301  Sum_probs=145.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCC----CeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEee------ee
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNS----KTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW------CR  407 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  407 (652)
                      ..++|+..+.||+|+||.||+|++..+    +..||+|++......  +....|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567999999999999999999999888    889999998653221  111111  1111122222222111      34


Q ss_pred             ccCeeEEEEEeccCCCcccccccCCc------------------cccchHHHhhhHHHHHHHHhhhccCccceEEecCCC
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEPK------------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVK  469 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk  469 (652)
                      .....++||||+++++|.+++.....                  .......+..++.||+.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            56689999999999999888853321                  01123445679999999999999   7899999999


Q ss_pred             CCceEeCC-CCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCC----------------------CCCCccch
Q 038860          470 ASNVLLDS-ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG----------------------KSSASSDV  526 (652)
Q Consensus       470 ~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sDv  526 (652)
                      |+|||++. ++.+||+|||+|+..............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999987655444445567899999999954322                      23456799


Q ss_pred             HhHHHHHHHHHhCCCCC
Q 038860          527 FAFGALLLEVACGRRPI  543 (652)
Q Consensus       527 ~SlGvvl~elltG~~p~  543 (652)
                      |||||++|||+++..|.
T Consensus       363 wSlGviL~el~~~~~~~  379 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRS  379 (566)
T ss_pred             HHHHHHHHHHHhCcCCC
Confidence            99999999999977664

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-31  Score=264.83  Aligned_cols=207  Identities=28%  Similarity=0.421  Sum_probs=173.7

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chh-----hHHHHHHHHHHhcccCcCceeEEEeeeec-
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQ-----GVREFVSEIATIGRLRHRNLVQLVGWCRR-  408 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  408 (652)
                      ...++|-.+++||+|||+.||++.+....+.||+|+-.-.  -+.     ..+-..+|..|-+.|.||.||++++++.- 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            3446788899999999999999999888899999975322  111     22345689999999999999999999864 


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC---CCCCeEEee
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGD  485 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~---~~~~~kL~D  485 (652)
                      ...+|-|+|||+|.+|+-||  .....+++.+++.|+.||..||.||.+ .+.+|||-||||.||||-   ..|.+||.|
T Consensus       540 tdsFCTVLEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cccceeeeeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeee
Confidence            46789999999999999999  445578999999999999999999985 478999999999999994   448899999


Q ss_pred             eccceecccCCCC------ceeeccCCcCCCCCCCCCCC----CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          486 FGLAKLYEHGTNP------ATTRVVGTLGYLAPETPRTG----KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       486 FGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ||+++.++.+...      .+....||.+|++||++.-+    +.+.|.||||.||++|.++.|+.||...
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            9999988765443      24456899999999986544    4688999999999999999999999764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7e-30  Score=277.45  Aligned_cols=215  Identities=26%  Similarity=0.401  Sum_probs=185.3

Q ss_pred             ccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeee
Q 038860          329 RYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCR  407 (652)
Q Consensus       329 ~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  407 (652)
                      ...+..+...++-|++.+.||.|.+|.||+++...+++.+|+|+....... .++...|.++++.+ .|||++.++|++.
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            344556667788899999999999999999999999999999998765433 35667889999988 5999999999985


Q ss_pred             c-----cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeE
Q 038860          408 R-----KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK  482 (652)
Q Consensus       408 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~k  482 (652)
                      .     ++++|||||||.+|+..+.+..-....+.|+.+..|++.++.||.+||   ...++|||||-.||||+.++.+|
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEE
Confidence            4     468999999999999999987656778999999999999999999999   79999999999999999999999


Q ss_pred             EeeeccceecccCCCCceeeccCCcCCCCCCCCCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG-----KSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       483 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      |.|||++....... ......+||+.|||||++...     .|+.++|+||||++..||.-|.+|+.+..+
T Consensus       164 LvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             Eeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            99999998765533 344557899999999987643     367789999999999999999999976543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-31  Score=270.86  Aligned_cols=205  Identities=26%  Similarity=0.331  Sum_probs=181.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..+++....||-||||.|=+...+.....+|+|++++.   ...+.+....|-.+|...+.|.||+++..|.+.++.|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            34566778899999999999998775556889988764   334455677899999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      ||-|-||.|...|.+  +..++......++..+.+|++|||   .++||.|||||+|.|||.+|-+||.|||.|+.+..+
T Consensus       499 mEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  499 MEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999944  456888999999999999999999   799999999999999999999999999999987654


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE  550 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~  550 (652)
                        ..+-+++||+.|.|||++.++..+..+|.||||+++||||+|.+||...++..
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk  626 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK  626 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence              46677899999999999999999999999999999999999999999866543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=285.63  Aligned_cols=207  Identities=30%  Similarity=0.489  Sum_probs=175.5

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeee
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWC  406 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  406 (652)
                      +...++..+.+.||+|.||.|++|....       ....||||.++... ....+.+..|+++|+.+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3344555666799999999999998652       14679999998653 34667899999999999 599999999999


Q ss_pred             eccCeeEEEEEeccCCCcccccccCC------------c--cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCc
Q 038860          407 RRKGDLLLVYDFMANGSLDSFLFDEP------------K--AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASN  472 (652)
Q Consensus       407 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~N  472 (652)
                      .+++..++|.||++.|+|.++|+..+            .  ..++..+.+.++.|||.|++||+   +.+++||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence            99999999999999999999996544            0  23889999999999999999999   6999999999999


Q ss_pred             eEeCCCCCeEEeeeccceecccCCCCceeeccC--CcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          473 VLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG--TLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       473 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      ||+..+..+||+|||+|+...+..........|  ...|||||.+....++.|+|||||||+||||+| |..|+.+
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            999999999999999999665544433232232  456999999999999999999999999999999 8999976

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=251.04  Aligned_cols=283  Identities=20%  Similarity=0.235  Sum_probs=205.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc------C
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------G  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  410 (652)
                      ..+|.....+|.|.- .|..+.+.-.+++||+|+....  .....++-.+|..++..+.|+|+++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777788999988 7888888888899999988543  234456678999999999999999999998643      3


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      +.|+|||+|. ++|...+.    ..++-..+..|..|++.|++|||   ..+|+||||||+||++..++.+||.|||+|+
T Consensus        95 e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence            6799999995 58888874    34667788899999999999999   7999999999999999999999999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ....+  -..+..+.|..|.|||++.+-.+.+.+||||.||++.||++|+--|.+.+.-++...+....+...+.-..++
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            64432  3556678899999999999888999999999999999999999999876655554444444333322111111


Q ss_pred             ccc--ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccc
Q 038860          571 IDP--KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFE  632 (652)
Q Consensus       571 id~--~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~  632 (652)
                      ..-  ......++.+.....-..++..=++.....+....-++|||.+|+..+|++|+|      |+|++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            000  000000011110000011222221222222344567899999999999999994      66765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=5.3e-30  Score=262.98  Aligned_cols=301  Identities=20%  Similarity=0.227  Sum_probs=219.1

Q ss_pred             hhhhhhccCCcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC--
Q 038860          318 IEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR--  395 (652)
Q Consensus       318 ~~~~~~~~~~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--  395 (652)
                      ..+|.-..+=.++.+.|  ....+|.+....|+|-|++|.+|.+...+..||||++...... .+.=+.|+++|++|+  
T Consensus       412 ~DNWdDaEGYYrv~igE--~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~A  488 (752)
T KOG0670|consen  412 QDNWDDAEGYYRVRIGE--LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDA  488 (752)
T ss_pred             ccCcccccceEEEehhh--hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhcc
Confidence            34455444444444444  4557899999999999999999999988999999999875322 234467999999995  


Q ss_pred             ----cCceeEEEeeeeccCeeEEEEEeccCCCccccccc-CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCC
Q 038860          396 ----HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKA  470 (652)
Q Consensus       396 ----h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~  470 (652)
                          --|+++++..|...+++|||+|-+ ..+|.+.|.. ..+-.|....+..+++|++-||..|-   ..+|+|+||||
T Consensus       489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKP  564 (752)
T KOG0670|consen  489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKP  564 (752)
T ss_pred             CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCc
Confidence                457899999999999999999987 4588888854 23456888999999999999999999   79999999999


Q ss_pred             CceEeCCC-CCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          471 SNVLLDSE-LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       471 ~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      .|||+++. ..+||||||.|.......   .+...-+..|.|||++.+-+|+...|+||.||+||||.||+-.|.+....
T Consensus       565 DNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  565 DNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             cceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            99999976 568999999998665432   23334567899999999999999999999999999999999999998776


Q ss_pred             cchhHHHHHHhhhcCCccc--cccccccccCCC----H-----HHHHHhhccCCCC--------CCC-CCCCcccccchh
Q 038860          550 EELVLVDWVWGKYGEGRVL--EVIDPKLNAEYD----Q-----SQVLMGELELPDT--------LRG-PRSSDGDKAAEG  609 (652)
Q Consensus       550 ~~~~l~~~~~~~~~~~~~~--~~id~~l~~~~~----~-----~~~~~~~l~~~~~--------~~~-p~~~~~~~~~~~  609 (652)
                      ..+.+.-.+.+.++...+.  .++|.-...++.    .     +......+....+        ... -.+.+.+.....
T Consensus       642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~  721 (752)
T KOG0670|consen  642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ  721 (752)
T ss_pred             HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence            6665555555555432211  122221111110    0     0000000100000        011 123344566778


Q ss_pred             HHHHHhhhccCCCCCCCCc
Q 038860          610 FDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       610 ~~dLl~~~~~~~~~~r~s~  628 (652)
                      ++|||++|+..+|+||+++
T Consensus       722 ~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  722 LRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             HHHHHHHHhccChhhcCCH
Confidence            9999999999999999975

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=262.89  Aligned_cols=198  Identities=30%  Similarity=0.407  Sum_probs=171.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhH-----HHHHHHHHHhcccC---cCceeEEEeeee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGV-----REFVSEIATIGRLR---HRNLVQLVGWCR  407 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~-----~~~~~E~~~l~~l~---h~niv~l~~~~~  407 (652)
                      ..+|..++.+|+|+||.|++|.++.....|+||.+.+..-   ..+     -..-.|+.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3568899999999999999999999899999999976521   111     12457999999997   999999999999


Q ss_pred             ccCeeEEEEEec-cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          408 RKGDLLLVYDFM-ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       408 ~~~~~~lV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      +++.+||+||-. ++.+|.+++.  .+..+++.++.-|++|++.|+++||   +++|||||||-+||.++.+|-+||+||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeec
Confidence            999999999965 5567888884  4456999999999999999999999   799999999999999999999999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCC
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      |.|.....+   ....++||.+|.|||++.+.+| ...-|||++|++||.++..+.||.
T Consensus       715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999876543   3456789999999999999887 556799999999999999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=244.88  Aligned_cols=216  Identities=26%  Similarity=0.360  Sum_probs=179.2

Q ss_pred             hhhhhhhcCccccccccccCceEEEEEEEcCC-----CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeee
Q 038860          333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWC  406 (652)
Q Consensus       333 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~  406 (652)
                      +++.....+++...++-+|.||.||+|.+.+.     .+.|-+|.++... .-+...++.|.-.+..+.|||+.++.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            56666778899999999999999999976542     3457778776553 34567789999999999999999999998


Q ss_pred             ecc-CeeEEEEEeccCCCcccccc-----c-CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC
Q 038860          407 RRK-GDLLLVYDFMANGSLDSFLF-----D-EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL  479 (652)
Q Consensus       407 ~~~-~~~~lV~e~~~~gsL~~~l~-----~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~  479 (652)
                      .+. ...+.+|.++.-|+|..||.     + ...+.++..+...++.|++.|++|||   +.+|||.||..+|+++|+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            654 56789999999999999996     1 22456888889999999999999999   79999999999999999999


Q ss_pred             CeEEeeeccceecccCCCCc-eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccc
Q 038860          480 NGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEE  551 (652)
Q Consensus       480 ~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~  551 (652)
                      ++||+|=.++|.+-+..... .........||+||.+.+..++..+|||||||++|||+| |+.|+.+-++.+.
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm  507 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM  507 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence            99999999998654433222 222345678999999999999999999999999999999 9999987665443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-28  Score=249.73  Aligned_cols=133  Identities=26%  Similarity=0.366  Sum_probs=115.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC--------cCceeEEEeeeec--
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR--------HRNLVQLVGWCRR--  408 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~--  408 (652)
                      ..+|.+.++||-|.|++||++.+....+.||+|+.+... .-.+.-+.||++|++++        ..+||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            368999999999999999999999999999999986542 22345678999999884        2479999999975  


Q ss_pred             --cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          409 --KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       409 --~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                        +.++|||+|++ |.+|..++.....+.++...+.+|++||+.||.|||.  +.+|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence              45899999999 6689999977777789999999999999999999998  6699999999999999

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.5e-28  Score=242.81  Aligned_cols=187  Identities=32%  Similarity=0.493  Sum_probs=166.7

Q ss_pred             CceEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCccccccc
Q 038860          352 GFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD  430 (652)
Q Consensus       352 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  430 (652)
                      +||.||+|....+++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998888999999997765444 67899999999999999999999999999999999999999999999854


Q ss_pred             CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCC
Q 038860          431 EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL  510 (652)
Q Consensus       431 ~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~  510 (652)
                      ..  .+++..++.++.+++.++.|||   +.+++|+||+|+||+++.++.++|+|||.+.......  ......++..|+
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            33  2889999999999999999999   6899999999999999999999999999998765432  333456888999


Q ss_pred             CCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       511 aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      +||.......+.++||||||+++++|++|..||..
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999888889999999999999999999999865

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-29  Score=271.74  Aligned_cols=196  Identities=29%  Similarity=0.466  Sum_probs=161.4

Q ss_pred             CccccccccccCceE-EEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEe
Q 038860          341 NFSAKQLLGHGGFGQ-VYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      -|...+.+|.|..|+ ||+|...  ++.||||++-.+.   ..-..+|+..|+.- +||||+++++.-.++...|+..|.
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            355567899999986 8999996  5899999985542   33456899988877 599999999999999999999999


Q ss_pred             ccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---C--CCeEEeeecccee
Q 038860          419 MANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---E--LNGKLGDFGLAKL  491 (652)
Q Consensus       419 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~--~~~kL~DFGla~~  491 (652)
                      |.. +|.+++...  ......-...+.+..|+++||++||   ..+||||||||.||||+.   +  .+++|+|||+++.
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            965 999999652  1111111445778999999999999   699999999999999975   2  5699999999998


Q ss_pred             cccCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhC-CCCCCC
Q 038860          492 YEHGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG-RRPIET  545 (652)
Q Consensus       492 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG-~~p~~~  545 (652)
                      +..+...  ......||-+|+|||++.....+..+||||+||++|+.++| ..||..
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd  717 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD  717 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence            8765442  24557899999999999999989999999999999999995 999975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.1e-27  Score=236.83  Aligned_cols=200  Identities=31%  Similarity=0.480  Sum_probs=174.9

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEecc
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      |+..+.||+|++|.||++...++++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            56678899999999999999888899999999876544 66788999999999999999999999999899999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +++|.+++..... .+++..+..++.+++.++.+||   +.+++|+||+|.||+++.++.++|+|||.+...........
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999854322 1789999999999999999999   68999999999999999999999999999987654431123


Q ss_pred             eeccCCcCCCCCCCC-CCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          501 TRVVGTLGYLAPETP-RTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~-~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ....++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            345678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.9e-27  Score=240.66  Aligned_cols=201  Identities=26%  Similarity=0.443  Sum_probs=168.5

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcC---CCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccC
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKG  410 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  410 (652)
                      +....+.|...++||+|.|++||++.+..   ..+.||+|.+...+..  ....+|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            44456788999999999999999999877   6789999999776443  45789999999995 999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccc
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLA  489 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla  489 (652)
                      ...+|+||++.....++..     .++...+..++..++.||.++|   .+|||||||||+|+|.+.. ++-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhH
Confidence            9999999999988777763     3678889999999999999999   7999999999999999865 77899999999


Q ss_pred             eecccCC------C-------C------------------------------ceeeccCCcCCCCCCCCCCC-CCCCccc
Q 038860          490 KLYEHGT------N-------P------------------------------ATTRVVGTLGYLAPETPRTG-KSSASSD  525 (652)
Q Consensus       490 ~~~~~~~------~-------~------------------------------~~~~~~gt~~y~aPE~~~~~-~~s~~sD  525 (652)
                      ..++...      .       .                              ......||++|.|||++... ..++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7221100      0       0                              00124799999999988764 5799999


Q ss_pred             hHhHHHHHHHHHhCCCCCCC
Q 038860          526 VFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       526 v~SlGvvl~elltG~~p~~~  545 (652)
                      |||.||+++-+++++.||-.
T Consensus       261 iws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eeeccceeehhhcccccccc
Confidence            99999999999999999854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=5.6e-26  Score=221.09  Aligned_cols=184  Identities=36%  Similarity=0.597  Sum_probs=161.0

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCccc
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDS  426 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  426 (652)
                      ||+|.+|.||++....+++.+++|++...... ..+.+.+|+..+++++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999887899999999876443 35678899999999999999999999999899999999999999999


Q ss_pred             ccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEEeeeccceecccCCCCceeeccC
Q 038860          427 FLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAKLYEHGTNPATTRVVG  505 (652)
Q Consensus       427 ~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~g  505 (652)
                      ++.... ..+++..+..++.++++++.+||   +.+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            984332 35889999999999999999999   689999999999999999 89999999999986644321 2333567


Q ss_pred             CcCCCCCCCCCCC-CCCCccchHhHHHHHHHH
Q 038860          506 TLGYLAPETPRTG-KSSASSDVFAFGALLLEV  536 (652)
Q Consensus       506 t~~y~aPE~~~~~-~~s~~sDv~SlGvvl~el  536 (652)
                      ...|++||..... ..+.++|+|++|+++++|
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            8899999998877 788999999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-27  Score=249.58  Aligned_cols=203  Identities=29%  Similarity=0.423  Sum_probs=179.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|+..+.+|.|.||.|||+++..+++..|+|.++-......+-.++|+-+++.-+||||+.++|-+......+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            34689999999999999999999999999999999988777777778889999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ||.+|+|.+.-+  -..++++.++..+.+..++||+|||   .++-+|||||-.|||+++.+.+|++|||.+-.+... -
T Consensus        93 ycgggslQdiy~--~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-I  166 (829)
T ss_pred             ecCCCcccceee--ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh-h
Confidence            999999998774  3567999999999999999999999   799999999999999999999999999988765432 2


Q ss_pred             CceeeccCCcCCCCCCCC---CCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETP---RTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~---~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .......||+.|||||+.   ..+.|..++|||+.|+...|+---++|..+.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl  218 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL  218 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc
Confidence            234457899999999964   4567899999999999999998888886543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.9e-27  Score=221.94  Aligned_cols=202  Identities=23%  Similarity=0.362  Sum_probs=163.2

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEee-eeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGW-CRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~l  414 (652)
                      ...+.|.+.+.||+|.||.+-+++++.+++.+++|.+..... ..++|.+|..---.| .|.||+.-++. |...+.+.+
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            345679999999999999999999999999999999976543 457899998766566 49999987764 666778889


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-C-CCCeEEeeeccceec
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-S-ELNGKLGDFGLAKLY  492 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-~-~~~~kL~DFGla~~~  492 (652)
                      ++||+|.|+|.+-+.   ...+.+....+++.|+++|+.|+|   ++.+||||||.+|||+- . ..++||+|||+.+..
T Consensus       100 ~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999998873   345788888999999999999999   79999999999999993 3 357999999998753


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTG-----KSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      +..    ....--+..|.+||.....     ...+.+|+|.||++++.+|||+.||+.....
T Consensus       174 g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~  231 (378)
T KOG1345|consen  174 GTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM  231 (378)
T ss_pred             Cce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence            321    1122345678999965432     2477899999999999999999999854333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.4e-23  Score=219.84  Aligned_cols=168  Identities=20%  Similarity=0.209  Sum_probs=131.7

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcC-CCeEEEEEEecCc-----chhhHHHHHHHHHHhcccCcCceeEEEeeeecc
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHN-SKTEVAVKRISNE-----SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK  409 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  409 (652)
                      .....+|...+.||+|+||+||+|.+.. +++.||||++...     .....+.+.+|+++|++++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            4456789999999999999999998875 6778899987533     122356689999999999999998533222   


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCC-CCCceEeCCCCCeEEeeecc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDV-KASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDl-k~~NILl~~~~~~kL~DFGl  488 (652)
                      +..+|||||+++++|....   ...      ...++.|++++|.|||   +++|+|||| ||+|||++.++++||+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~~~---~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR---PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC---ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            4579999999999996321   111      1467889999999999   799999999 99999999999999999999


Q ss_pred             ceecccCCCC-------ceeeccCCcCCCCCCCCCCC
Q 038860          489 AKLYEHGTNP-------ATTRVVGTLGYLAPETPRTG  518 (652)
Q Consensus       489 a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  518 (652)
                      |+.+......       ..+...++..|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9976543211       11356788999999987654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-22  Score=212.27  Aligned_cols=204  Identities=24%  Similarity=0.312  Sum_probs=169.5

Q ss_pred             CccccccccccCceEEEEEEEcCCC-eEEEEEEecCcchhhHHHHHHHHHHhcccCc----CceeEEEeee-eccCeeEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSK-TEVAVKRISNESKQGVREFVSEIATIGRLRH----RNLVQLVGWC-RRKGDLLL  414 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  414 (652)
                      +|.+.++||+|+||.||++.+...+ ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999987754 6789998876543333367778888888863    6899999988 47778899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-----CCeEEeeeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-----LNGKLGDFGLA  489 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-----~~~kL~DFGla  489 (652)
                      ||+.+ |.+|.++........++..+.++|+.|++.+|++||   +.+++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 779999775555678999999999999999999999   7999999999999999865     46999999999


Q ss_pred             e--ecccCCC-----C-c-eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          490 K--LYEHGTN-----P-A-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       490 ~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      +  .+.....     . . .....||.+|.++....+...+++.|+||++.++.|++.|..||.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            9  4322111     1 1 2345699999999999999999999999999999999999999976543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=5e-23  Score=193.62  Aligned_cols=207  Identities=23%  Similarity=0.300  Sum_probs=172.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ...|++.++||+|+||.+|.|....+|+.||||.-+...+.  .++..|.++...|+ ...|..+..+..++..-.|||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            46899999999999999999999999999999998765433  35677888888887 4567777778888888899999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeeccceeccc
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGLAKLYEH  494 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGla~~~~~  494 (652)
                      .+ |.+|.+...-. ...++..+++-++-|++.-++|+|   .++.+||||||+|+|..-+   .++.|+|||+|+.+..
T Consensus        92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            98 67888766322 345888999999999999999999   7999999999999999744   5689999999997643


Q ss_pred             CCC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccch
Q 038860          495 GTN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL  552 (652)
Q Consensus       495 ~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~  552 (652)
                      ...      .......||.+|.+-....+...+.+.|+-|+|.+|.+...|..||++.......
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~  230 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK  230 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence            221      2334568999999988888888899999999999999999999999986554433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.87  E-value=1e-22  Score=238.73  Aligned_cols=147  Identities=20%  Similarity=0.271  Sum_probs=113.7

Q ss_pred             ccCc-CceeEEEeeee-------ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEE
Q 038860          393 RLRH-RNLVQLVGWCR-------RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI  464 (652)
Q Consensus       393 ~l~h-~niv~l~~~~~-------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv  464 (652)
                      .++| +||.+++++|.       +...+++++||+ +++|.+++... ...+++.+++.+++||++||.|||   +++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            3455 57888888872       234577888988 55999999543 356999999999999999999999   79999


Q ss_pred             ecCCCCCceEeCCC-------------------CCeEEeeeccceecccCCC---------------CceeeccCCcCCC
Q 038860          465 HRDVKASNVLLDSE-------------------LNGKLGDFGLAKLYEHGTN---------------PATTRVVGTLGYL  510 (652)
Q Consensus       465 HrDlk~~NILl~~~-------------------~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~  510 (652)
                      ||||||+||||+..                   +.+|++|||+++.......               .......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999653                   4566666666653211000               0011235889999


Q ss_pred             CCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       511 aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      |||++.+..++.++|||||||+||||++|.+|+.
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            9999999999999999999999999999988865

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=99.87  E-value=1.1e-20  Score=186.22  Aligned_cols=194  Identities=22%  Similarity=0.241  Sum_probs=135.3

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      .++.+.|+|.+. ++.|+||++..++.|++||+.|+++        .+|+|+|+|+|.... ..+||||||+++|...  
T Consensus        20 ~~w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~--------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~~--   87 (218)
T cd07308          20 GNWTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPA--------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEPG--   87 (218)
T ss_pred             CCeEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccC--------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCC--
Confidence            689999999997 8899999999999999999999998        379999999998753 5689999999999653  


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecC-Ccccccee-ecceecCCCCcccCCcCCCceE
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDIN-SMKSNASV-EAAVYTDNSTKQDLSLKGGKAI  192 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~n-s~~s~~~~-~~~~~~~~~~~~~~~~~~g~~~  192 (652)
                       ..|..+|.-+       ..+-+||||||+.|.   +...++|.+-+| +..+.... .........+..+.. ..+..+
T Consensus        88 -~~g~~~G~~~-------~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~~-~~~~~~  155 (218)
T cd07308          88 -SDGPLFGGPD-------KFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEKLELASCSLKFR-NSNAPT  155 (218)
T ss_pred             -CCCcccccCC-------CCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCccccccceeEecc-cCCCCe
Confidence             3455666522       345599999999985   333445554333 22221100 000000122211221 126789


Q ss_pred             EEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCc-ccccceEEEEecccccccccceeeccccc
Q 038860          193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSP-IFNEFMYVGFSASTGLLASSHNVLGWSFK  258 (652)
Q Consensus       193 ~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~-~l~~~~~vGfsastg~~~~~~~v~~w~f~  258 (652)
                      +++|.|+  .+.|.|.+.......  ..  .++++.. .+|+.+|+||||+||...+.|.|++|.+.
T Consensus       156 ~~~I~y~--~~~l~v~i~~~~~~~--~~--~c~~~~~~~l~~~~y~G~sA~tg~~~d~~dIls~~~~  216 (218)
T cd07308         156 TLRISYL--NNTLKVDITYSEGNN--WK--ECFTVEDVILPSQGYFGFSAQTGDLSDNHDILSVHTY  216 (218)
T ss_pred             EEEEEEE--CCEEEEEEeCCCCCC--cc--EEEEcCCcccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence            9999999  678999987532211  12  2333333 47889999999999999999999999764

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=5.9e-22  Score=194.50  Aligned_cols=203  Identities=23%  Similarity=0.306  Sum_probs=170.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      -+|++.++||+|.||.++.|+..-++++||||.-...++  .-++..|....+.| ..++|.+.+-+-..+.+-.||+|+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478999999999999999999888899999998755432  23455677777777 589999999888888888999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-----CCeEEeeeccceecc
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-----LNGKLGDFGLAKLYE  493 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-----~~~kL~DFGla~~~~  493 (652)
                      + |-+|++.. +-....++..++..+++|++.-++|+|   ++.+|.|||||+|+||...     ..+.|+|||+|+.+.
T Consensus       106 L-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 L-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             h-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            8 66887755 333556999999999999999999999   7999999999999999743     348999999999774


Q ss_pred             cCCC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          494 HGTN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       494 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      ....      .......||.+||+-....++..+.+.|+-|||-++++.|.|..||++...+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            3321      2234568999999999999999999999999999999999999999986543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=1.8e-20  Score=194.70  Aligned_cols=200  Identities=35%  Similarity=0.555  Sum_probs=169.7

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh---hHHHHHHHHHHhcccCcC-ceeEEEeeeeccCeeEEEEE
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ---GVREFVSEIATIGRLRHR-NLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e  417 (652)
                      |...+.||.|+||.||++.+.   ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            667888999999999999997   67899998765332   367899999999999988 79999999977777899999


Q ss_pred             eccCCCcccccccCCc-cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceecccC
Q 038860          418 FMANGSLDSFLFDEPK-AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLYEHG  495 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~~~  495 (652)
                      ++.++++.+++..... ..+.......++.|++.++.|+|   ..+++|||+||+||+++... .++++|||.++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999966633221 26888999999999999999999   78899999999999999998 7999999999865443


Q ss_pred             CCC-----ceeeccCCcCCCCCCCCCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNP-----ATTRVVGTLGYLAPETPRT---GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ...     ......|+..|+|||.+.+   .......|+||+|++++++++|..|+....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            322     2456789999999999887   578889999999999999999999976543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.84  E-value=4.1e-21  Score=183.17  Aligned_cols=106  Identities=24%  Similarity=0.198  Sum_probs=92.5

Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCcee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT  501 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  501 (652)
                      |+|.+++... ...+++.+++.++.|+++||.|||+   ++      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            6888888542 3469999999999999999999994   44      999999999999999  99998654322     


Q ss_pred             eccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       502 ~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       ..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence             2589999999999999999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.3e-20  Score=181.69  Aligned_cols=139  Identities=16%  Similarity=0.107  Sum_probs=107.5

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchh--h-------H-----------------HHHHHHHHHhcccCcCc
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--G-------V-----------------REFVSEIATIGRLRHRN  398 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n  398 (652)
                      .+.||+|++|.||+|.+. +|+.||||+++.....  .       .                 .....|++++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 6899999999754211  0       0                 12235999999998777


Q ss_pred             eeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhh-ccCccceEEecCCCCCceEeCC
Q 038860          399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL-HEGYEQVVIHRDVKASNVLLDS  477 (652)
Q Consensus       399 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivHrDlk~~NILl~~  477 (652)
                      +.....+..  ...+|||||++++++......  ...++.....+++.|++.+|.+| |   ..+|+||||||+|||++ 
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence            643332222  223899999998777654322  34688899999999999999999 6   68999999999999998 


Q ss_pred             CCCeEEeeeccceec
Q 038860          478 ELNGKLGDFGLAKLY  492 (652)
Q Consensus       478 ~~~~kL~DFGla~~~  492 (652)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.1e-20  Score=184.53  Aligned_cols=172  Identities=10%  Similarity=0.129  Sum_probs=132.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhH---HH------HHHHHHHhcccCcCceeEEEeeee
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV---RE------FVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      ...++|+..+.||.|+||.||+... + +..+|+|.+.+......   ..      +.+|+..+.+++|++|..+..++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~-~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-D-YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-C-CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3468999999999999999999766 3 56799999975432222   22      679999999999999999988855


Q ss_pred             cc--------CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC
Q 038860          408 RK--------GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL  479 (652)
Q Consensus       408 ~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~  479 (652)
                      ..        +..+|+|||++|.+|.++.      .++.    ....+++.+|..||   ..+++|||+||+||++++++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC
Confidence            32        3579999999999997764      1222    24568999999999   79999999999999999988


Q ss_pred             CeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHH
Q 038860          480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA  537 (652)
Q Consensus       480 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ell  537 (652)
                       ++|+|||.......+..  ..           .+.....+..++|+||||+++....
T Consensus       173 -i~liDfg~~~~~~e~~a--~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKA--KD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhh--HH-----------HHHHHhHhcccccccceeEeehHHH
Confidence             99999998875432111  00           0233444667899999999987653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=5.4e-21  Score=213.31  Aligned_cols=201  Identities=22%  Similarity=0.316  Sum_probs=163.2

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEec----Cc-ch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS----NE-SK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ...+.+|.|.+|.|+........+..+.|.+.    .. .. .....+..|+.+-..++|+|++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988888776555555555443    11 11 12223677888889999999998888887777766679


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++ +|..++.+.  ..+....+..+++|++.|+.|||   ..+|.|||+|++|+++..++.+||+|||.+..+....
T Consensus       401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 999988443  45888899999999999999999   7999999999999999999999999999998765443


Q ss_pred             C---CceeeccCCcCCCCCCCCCCCCCCCc-cchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          497 N---PATTRVVGTLGYLAPETPRTGKSSAS-SDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       497 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~-sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      .   ......+|...|+|||.+....|.+. .||||.|+++..|.+|+.||......
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence            3   34456789999999999999998776 69999999999999999999765443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=1.2e-19  Score=175.39  Aligned_cols=142  Identities=18%  Similarity=0.165  Sum_probs=110.4

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchh--------------------------hHHHHHHHHHHhcccCcCc
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--------------------------GVREFVSEIATIGRLRHRN  398 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n  398 (652)
                      ...||+|++|+||+|.+. +|+.||||+++.....                          ....+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 7899999998764210                          0122457899999999998


Q ss_pred             eeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC
Q 038860          399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE  478 (652)
Q Consensus       399 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~  478 (652)
                      +.....+...  ..+|||||++++++.....  ....++.....+++.|++.++.+||+  ..+|+||||||+|||++ +
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence            7544333322  2489999999886544321  22357788899999999999999993  29999999999999999 7


Q ss_pred             CCeEEeeeccceeccc
Q 038860          479 LNGKLGDFGLAKLYEH  494 (652)
Q Consensus       479 ~~~kL~DFGla~~~~~  494 (652)
                      +.++|+|||++....+
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.78  E-value=6.3e-20  Score=175.41  Aligned_cols=201  Identities=18%  Similarity=0.365  Sum_probs=158.9

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecC--cchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      .....+|.+...|..|+|++++  ..+++|++.-  .....-++|..|.-.|+-+.||||+.++|.|.....+.++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            3445678899999999999975  4466676643  23334467999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      +.|+|...|+.......+..++.+++.++++|++|||+. ++-|.---|.+..+++|++.+++|. .+-+++--     .
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf-----q  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF-----Q  342 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee-----e
Confidence            999999999998888899999999999999999999973 3444445689999999999888773 22222111     1


Q ss_pred             eeeccCCcCCCCCCCCCCCCC---CCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          500 TTRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~---s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                      .....-.+.||+||.+...+.   -..+|+|||++++|||.|++.||.+..+-+.
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec  397 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC  397 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence            111234689999999887664   3468999999999999999999987665443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=7.3e-19  Score=167.98  Aligned_cols=185  Identities=17%  Similarity=0.126  Sum_probs=137.8

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcchh----hHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEE
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ----GVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .+...|++|+||+||.+..  .+..++.+.+......    ....+.+|+++|++|. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4567899999999997766  4677887777654331    1235789999999995 5889999886    34699999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCC-CCCceEeCCCCCeEEeeeccceecccCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDV-KASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDl-k~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |++|.+|...+.   .      ....++.|++.+|.++|   .++|+|||| ||+|||++.++.++|+|||+|.......
T Consensus        79 yI~G~~L~~~~~---~------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         79 YLAGAAMYQRPP---R------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eecCccHHhhhh---h------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999988865431   1      11357789999999999   799999999 7999999999999999999998654322


Q ss_pred             CC----c--------eeeccCCcCCCCCCCCCCC-CCC-CccchHhHHHHHHHHHhCCCCCCC
Q 038860          497 NP----A--------TTRVVGTLGYLAPETPRTG-KSS-ASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       497 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ..    .        ......++.|++|+...-- ..+ ...+.++-|+-+|.++||+.|.-.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            10    0        1112357777887642221 222 457899999999999999988644

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=4.7e-20  Score=205.11  Aligned_cols=196  Identities=21%  Similarity=0.212  Sum_probs=151.4

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHH---HHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFV---SEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++...+.||++.|=+|.+|++.+ |. |+||++-+.. .-..+.|.   .|++ ...++|||.+++..+-...+..|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            67778899999999999999976 44 8899986543 22333343   4444 45558999999999888778889999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec--cc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EH  494 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~--~~  494 (652)
                      +|..+ +|.+.+  ..++.+...+.+.|+.|++.||..+|   +.+|+|||||.+|||+..-.-+.|+||..-+..  .+
T Consensus       101 qyvkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  101 QYVKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHHhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            99965 999988  34556888888999999999999999   899999999999999999999999999877632  22


Q ss_pred             CCCCcee----eccCCcCCCCCCCCCC----------CC-CCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          495 GTNPATT----RVVGTLGYLAPETPRT----------GK-SSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       495 ~~~~~~~----~~~gt~~y~aPE~~~~----------~~-~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      +.....+    +...-..|+|||....          .. .+++-||||+||++.||++ |++||..
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            2111111    1123347999995433          12 5788999999999999988 7888863

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=4.3e-19  Score=178.41  Aligned_cols=198  Identities=22%  Similarity=0.306  Sum_probs=134.1

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccC----------cCceeEEEeeee
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLR----------HRNLVQLVGWCR  407 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~  407 (652)
                      .+...+.||.|+++.||.+.+..+++++|+|.+...   .....+++.+|...+..+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            345678899999999999999999999999988533   3345677888876665542          222222222221


Q ss_pred             ---------cc---C-----eeEEEEEeccCCCcccccc---c--CCccccchHHHhhhHHHHHHHHhhhccCccceEEe
Q 038860          408 ---------RK---G-----DLLLVYDFMANGSLDSFLF---D--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH  465 (652)
Q Consensus       408 ---------~~---~-----~~~lV~e~~~~gsL~~~l~---~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH  465 (652)
                               ..   .     ..+++|+-+. ++|.+++.   .  .....+....++.+..|+++.+++||   ..|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     11   1     2367788774 48877652   1  12234556667788899999999999   799999


Q ss_pred             cCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCC--------CCCCCccchHhHHHHHHHHH
Q 038860          466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT--------GKSSASSDVFAFGALLLEVA  537 (652)
Q Consensus       466 rDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDv~SlGvvl~ell  537 (652)
                      +||||+|++++.+|.++|+||+........    ......+..|.+||....        -.++.+.|.|++|+++|.|.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999988754331    111345678999996533        24688999999999999999


Q ss_pred             hCCCCCCCC
Q 038860          538 CGRRPIETR  546 (652)
Q Consensus       538 tG~~p~~~~  546 (652)
                      ||+.||...
T Consensus       245 C~~lPf~~~  253 (288)
T PF14531_consen  245 CGRLPFGLS  253 (288)
T ss_dssp             HSS-STCCC
T ss_pred             HccCCCCCC
Confidence            999999754

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=2.3e-18  Score=167.62  Aligned_cols=137  Identities=16%  Similarity=0.199  Sum_probs=107.2

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-----CcCceeEEEeeeeccC---e-e
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-----RHRNLVQLVGWCRRKG---D-L  412 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~  412 (652)
                      +...+.||+|++|.||.  +..++.. +||++........+++.+|+.+++.+     .||||++++|++.++.   . +
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999996  5554444 69988765444567789999999999     5799999999998863   3 3


Q ss_pred             EEEEEe--ccCCCcccccccCCccccchHHHhhhHHHHHHHH-hhhccCccceEEecCCCCCceEeCCC----CCeEEee
Q 038860          413 LLVYDF--MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGL-LYLHEGYEQVVIHRDVKASNVLLDSE----LNGKLGD  485 (652)
Q Consensus       413 ~lV~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL-~~LH~~~~~~ivHrDlk~~NILl~~~----~~~kL~D  485 (652)
                      .+|+||  +++++|.+++.+.   .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++..    .+++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            478999  5679999999432   35544  35678888777 9999   7999999999999999743    4799999


Q ss_pred             eccc
Q 038860          486 FGLA  489 (652)
Q Consensus       486 FGla  489 (652)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5443

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=99.76  E-value=3.4e-17  Score=162.27  Aligned_cols=199  Identities=18%  Similarity=0.176  Sum_probs=129.8

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      +++.+.|+|.+. ++.|+||++.+++.|++||+.|+++        .+|+|+|+|+|.......+||||||+++....  
T Consensus        20 ~~w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~--------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~--   88 (248)
T cd06901          20 PLWDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYL--------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKERM--   88 (248)
T ss_pred             CCEEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccC--------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcCCC--
Confidence            689999999997 6799999999889999999999998        47999999999987666789999999998753  


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCC-CCCCCCce-eeecCCccccceeecceec-CCCCcccCCcCCCce
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEF-QDINDNHI-GIDINSMKSNASVEAAVYT-DNSTKQDLSLKGGKA  191 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~hv-gi~~ns~~s~~~~~~~~~~-~~~~~~~~~~~~g~~  191 (652)
                       ..|..+|-.+.-       .=+||-|||+.|..- .....+-| ++-.++........-+... .+.+..... ..+..
T Consensus        89 -~~G~~fG~~~~f-------~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~r-n~~~~  159 (248)
T cd06901          89 -QPGPVFGSKDNF-------HGLAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAGCSAPFR-NKDHD  159 (248)
T ss_pred             -ccCcccccCCCC-------ceEEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCceeeecc-CCCCC
Confidence             334445542211       227999999998531 01122223 2222232221111101000 123322221 34556


Q ss_pred             EEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCc-ccccceEEEEecccccccccceeecccccc
Q 038860          192 ILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSP-IFNEFMYVGFSASTGLLASSHNVLGWSFKI  259 (652)
Q Consensus       192 ~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~-~l~~~~~vGfsastg~~~~~~~v~~w~f~~  259 (652)
                      .+++|.|...  .+.|.+...+...    -..+++... .||...|+||||+||...+.|.+++-.+..
T Consensus       160 t~~rI~Y~~~--~l~v~vd~~~~~~----w~~Cf~~~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~~  222 (248)
T cd06901         160 TFVAIRYSKG--RLTVMTDIDGKNE----WKECFDVTGVRLPTGYYFGASAATGDLSDNHDIISMKLYE  222 (248)
T ss_pred             eEEEEEEECC--eEEEEEecCCCCc----eeeeEEeCCeecCCCCEEEEEecCCCCCCcEEEEEEEEec
Confidence            7899999964  4777666433211    112233322 278889999999999999999988766643

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.2e-18  Score=195.90  Aligned_cols=199  Identities=20%  Similarity=0.184  Sum_probs=158.3

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC---cCceeEEEeeeeccCe
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR---HRNLVQLVGWCRRKGD  411 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  411 (652)
                      .+.....|.+.+.||+|+||+||+|...+ ++.||+|.-++.+...   |.--.+++.||+   -+-|..+...+.-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            34445678899999999999999999988 9999999987765442   222233444444   2334444444445566


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-------CCCeEEe
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-------ELNGKLG  484 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-------~~~~kL~  484 (652)
                      -+||+||.+.|+|.+++.  ....++|.....++.|++..++.||   ..+|||+||||+|+||..       ..-++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            789999999999999994  5667999999999999999999999   799999999999999942       2458999


Q ss_pred             eeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCC
Q 038860          485 DFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP  542 (652)
Q Consensus       485 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p  542 (652)
                      |||.+..+.--.. ......++|-.+-.+|+..+++++.+.|.|.++.+++-||.|+.-
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9999875533222 234556889999999999999999999999999999999999854

>smart00090 RIO RIO-like kinase

Probab=99.73  E-value=1.5e-17  Score=165.90  Aligned_cols=143  Identities=17%  Similarity=0.189  Sum_probs=112.1

Q ss_pred             cCccccccccccCceEEEEEE-EcCCCeEEEEEEecCcchh------------------------hHHHHHHHHHHhccc
Q 038860          340 NNFSAKQLLGHGGFGQVYKGT-LHNSKTEVAVKRISNESKQ------------------------GVREFVSEIATIGRL  394 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  394 (652)
                      ..|++.+.||+|++|.||+|. +..+++.||+|.++.....                        ....+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998 5567899999998653210                        112356899999999


Q ss_pred             CcC--ceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce-EEecCCCCC
Q 038860          395 RHR--NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV-VIHRDVKAS  471 (652)
Q Consensus       395 ~h~--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivHrDlk~~  471 (652)
                      .+.  .+.+++++    ...++||||+++++|......  ...+...+...++.|++.++.+||   ..+ ++||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence            753  34455543    235899999999888776532  223556667889999999999999   788 999999999


Q ss_pred             ceEeCCCCCeEEeeeccceec
Q 038860          472 NVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       472 NILl~~~~~~kL~DFGla~~~  492 (652)
                      ||+++ +++++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=8.5e-19  Score=186.78  Aligned_cols=187  Identities=27%  Similarity=0.319  Sum_probs=153.4

Q ss_pred             cccccCceEEEEEEE---cCCCeEEEEEEecCcchhh--HHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEEecc
Q 038860          347 LLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQG--VREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      .+|+|.||.|+++.-   .+.+..+|+|.+.+.....  ......|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999987643   2346778888876542111  113455777888886 9999999999999999999999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCce
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +|.|...+..  ...........+...++-+++++|   +.+|+|||+|++||+++.+|.+++.|||+.+..-....   
T Consensus        81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            9999888843  334667777788889999999999   89999999999999999999999999999986533221   


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                        .+||..|||||++.  ......|.||||++.+||+||..||..
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence              18999999999988  567789999999999999999999986

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.71  E-value=1e-15  Score=149.87  Aligned_cols=198  Identities=19%  Similarity=0.218  Sum_probs=134.5

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      +++.+.|+|.+. ++.|+||++.+++.|.+|.+.|++. +       +|+.+|+|+|.... ..+||||||.++....  
T Consensus        22 ~~W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~-~-------~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~~--   89 (225)
T cd06902          22 PFWSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSF-E-------NWEVEVTFRVTGRG-RIGADGLAIWYTKERG--   89 (225)
T ss_pred             CceEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCC-C-------CEEEEEEEEEecCC-CCCCCEEEEEEECCCC--
Confidence            689999999996 7899999999999999999999984 2       79999999998653 3568999999998653  


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeec-CCccccceeeccee-cCCCCcccCCcCCCceE
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDI-NSMKSNASVEAAVY-TDNSTKQDLSLKGGKAI  192 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~-ns~~s~~~~~~~~~-~~~~~~~~~~~~~g~~~  192 (652)
                       ..|+.+|..+.-       .=+||.|||+.|.+  ..+.+.|.+-. ++........-+.. ..+.|..... +.+.+.
T Consensus        90 -~~G~~~G~~~~f-------~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~~~~r-n~~~p~  158 (225)
T cd06902          90 -EEGPVFGSSDKW-------NGVGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQNDGLTQALGSCLRDFR-NKPYPV  158 (225)
T ss_pred             -CCCCccCCCCcc-------cEEEEEEECCCCCC--CCCCcEEEEEECCCCeeccccCCCcccccceEEEecc-CCCCCe
Confidence             345556653322       22799999998853  23345563333 23222111111110 0122221111 335678


Q ss_pred             EEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcc-cccceEEEEecccccccccceeeccccc
Q 038860          193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPI-FNEFMYVGFSASTGLLASSHNVLGWSFK  258 (652)
Q Consensus       193 ~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~-l~~~~~vGfsastg~~~~~~~v~~w~f~  258 (652)
                      +++|.|..  ..|+|.+.... .+...-...++++..+ ||+..|+||||+||...+.|.|++|.+.
T Consensus       159 ~~rI~Y~~--~~l~V~~d~~~-~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~  222 (225)
T cd06902         159 RAKITYYQ--NVLTVSINNGF-TPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTF  222 (225)
T ss_pred             EEEEEEEC--CeEEEEEeCCc-CCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEe
Confidence            99999997  46888887422 2222223345555443 7888999999999999999999999875

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.1e-17  Score=166.04  Aligned_cols=144  Identities=24%  Similarity=0.352  Sum_probs=109.2

Q ss_pred             CcCceeEEEeeeec---------------------------cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHH
Q 038860          395 RHRNLVQLVGWCRR---------------------------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG  447 (652)
Q Consensus       395 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  447 (652)
                      +|||||++.++|.+                           ...+|+||.-.+. +|.+|+..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999987743                           2357899887754 899888432   3455666778999


Q ss_pred             HHHHHhhhccCccceEEecCCCCCceEeC--CC--CCeEEeeeccceeccc-CCC----CceeeccCCcCCCCCCCCCCC
Q 038860          448 VASGLLYLHEGYEQVVIHRDVKASNVLLD--SE--LNGKLGDFGLAKLYEH-GTN----PATTRVVGTLGYLAPETPRTG  518 (652)
Q Consensus       448 i~~aL~~LH~~~~~~ivHrDlk~~NILl~--~~--~~~kL~DFGla~~~~~-~~~----~~~~~~~gt~~y~aPE~~~~~  518 (652)
                      +++|+.|||   +++|.|||+|++|||+.  ++  -.+.|+|||+|--.+. +..    ...-...|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   89999999999999993  44  3478999998764322 111    111224577889999986543


Q ss_pred             C------CCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          519 K------SSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       519 ~------~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      +      -..|+|.|+.|.+.||+++...||..
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            2      25689999999999999999999975

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=8.6e-17  Score=180.17  Aligned_cols=140  Identities=18%  Similarity=0.273  Sum_probs=113.1

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEe-cCc-------chhhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-SNE-------SKQGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      ......|...+.||+|+||.||+|.+...  .+++|+. .+.       .....+.+.+|++++.+++|++++....++.
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            33345567789999999999999988653  3444432 111       1122356889999999999999998888887


Q ss_pred             ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      .....++||||+++++|.+++.          ....++.+++.+|.+||   +.+++||||||+|||+ .++.++|+|||
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence            7778899999999999988873          35678999999999999   7999999999999999 57799999999


Q ss_pred             ccee
Q 038860          488 LAKL  491 (652)
Q Consensus       488 la~~  491 (652)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9975

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=6.1e-17  Score=159.22  Aligned_cols=134  Identities=18%  Similarity=0.285  Sum_probs=111.7

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcch--------hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--------QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      +.||+|++|.||+|..  .+..|++|.......        .....+.+|+.++..++|+++.....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  356789997654221        122457889999999999998877777777778899999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      |++|++|.+++...     .+ .+..++.+++.+|.+||   ..+++|||++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999888332     12 78889999999999999   79999999999999999 78899999998874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.5e-16  Score=154.92  Aligned_cols=138  Identities=16%  Similarity=0.150  Sum_probs=108.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch----------------------hhHHHHHHHHHHhcccCcC
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK----------------------QGVREFVSEIATIGRLRHR  397 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~  397 (652)
                      ..|.+.+.||+|+||.||++... +++.||||++.....                      .....+..|..++..+.|+
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            34778899999999999999885 589999998754320                      0112356788889888877


Q ss_pred             --ceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          398 --NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       398 --niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                        .+++.++.    ...++||||+++++|......        .....++.+++.++.++|   ..+++||||||+||++
T Consensus        94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill  158 (198)
T cd05144          94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILV  158 (198)
T ss_pred             CCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEE
Confidence              44555543    345899999999998775421        334578899999999999   6999999999999999


Q ss_pred             CCCCCeEEeeeccceecc
Q 038860          476 DSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~  493 (652)
                      ++++.++|+|||++....
T Consensus       159 ~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCcEEEEECCccccCC
Confidence            999999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=1.5e-16  Score=154.92  Aligned_cols=130  Identities=18%  Similarity=0.296  Sum_probs=105.2

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCcc--------hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES--------KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .||+|++|.||+|...  +..|++|......        .....++.+|++++..++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            4899999999999853  5789999864321        11235678899999999988766555555566677999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      +++++|.+++.....         .++.+++.+|.+||   ..+++|||++|+||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887732211         78999999999999   79999999999999999 78999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.66  E-value=2.6e-16  Score=168.08  Aligned_cols=154  Identities=28%  Similarity=0.487  Sum_probs=127.3

Q ss_pred             hcccCcCceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCC
Q 038860          391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKA  470 (652)
Q Consensus       391 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~  470 (652)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.-...++++|+.||+|||+  +..-.|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            4578999999999999999999999999999999999965 34568999999999999999999996  44449999999


Q ss_pred             CceEeCCCCCeEEeeeccceecccCC-CCceeeccCCcCCCCCCCCCCCC-------CCCccchHhHHHHHHHHHhCCCC
Q 038860          471 SNVLLDSELNGKLGDFGLAKLYEHGT-NPATTRVVGTLGYLAPETPRTGK-------SSASSDVFAFGALLLEVACGRRP  542 (652)
Q Consensus       471 ~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~s~~sDv~SlGvvl~elltG~~p  542 (652)
                      .|+++|....+||.|||+........ ........-..-|.|||.+....       .+.+.|+||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987664211 11111122345799999887642       46779999999999999999999


Q ss_pred             CCCCC
Q 038860          543 IETRA  547 (652)
Q Consensus       543 ~~~~~  547 (652)
                      |+...
T Consensus       158 ~~~~~  162 (484)
T KOG1023|consen  158 FDLRN  162 (484)
T ss_pred             ccccc
Confidence            98643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=1.2e-16  Score=178.26  Aligned_cols=170  Identities=26%  Similarity=0.353  Sum_probs=123.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ..+|..+++|-.|+||.||..+++.+.+.+|+|.-++.      .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence            36888999999999999999999988899999543221      01110  22222333333                  


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC--
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT--  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~--  496 (652)
                         |+-...+..  ...++-        +++.+++|||   ..+|+|||+||+|.++..-|++|+.|||+.+..-...  
T Consensus       136 ---gDc~tllk~--~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKN--IGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhccc--CCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               222222311  112221        2378999999   7999999999999999999999999999987531110  


Q ss_pred             ------------CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 038860          497 ------------NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE  550 (652)
Q Consensus       497 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~  550 (652)
                                  ......++||+.|+|||++....|...+|+|++|+++||.+-|+.||.+...++
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee  265 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE  265 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence                        111234699999999999999999999999999999999999999998865443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.3e-15  Score=140.49  Aligned_cols=135  Identities=21%  Similarity=0.206  Sum_probs=114.7

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCc--CceeEEEeeeeccCeeEEEEEeccC
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.+.||+|.++.||++...+  ..+++|.......  ...+.+|+..+..++|  .+++++++++...+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            45779999999999999864  6799999866543  4568899999999976  5899999998888889999999998


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      +.+..+         +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777654         4566678899999999999964446899999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.61  E-value=9e-17  Score=168.35  Aligned_cols=123  Identities=28%  Similarity=0.460  Sum_probs=108.8

Q ss_pred             CeeEEEEEeccCCCccccccc-CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          410 GDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      ..+++.|++|...+|.+|+.+ ......++...+.+++|++.|+.|      ++.+|||+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            357899999999999999963 445568888999999999999999      6799999999999999999999999999


Q ss_pred             ceecccCC-----CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh
Q 038860          489 AKLYEHGT-----NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC  538 (652)
Q Consensus       489 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt  538 (652)
                      ........     ....+...||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            88766554     234566789999999999999999999999999999999987

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=3e-15  Score=144.27  Aligned_cols=138  Identities=18%  Similarity=0.197  Sum_probs=98.1

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchh--hHHH----------------------HHHHHHHhcccCcCc--
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--GVRE----------------------FVSEIATIGRLRHRN--  398 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--  398 (652)
                      .+.||+|+||+||+|.+. +++.||||++......  ....                      ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 6889999998654211  1111                      134555666654332  


Q ss_pred             eeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC
Q 038860          399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE  478 (652)
Q Consensus       399 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~  478 (652)
                      +.+.++.    ...++||||++++.+.........  .. .....++.+++.++.++|+  +.+|+||||||+||+++ +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-C
Confidence            4444443    245899999999654322211110  11 5677899999999999993  29999999999999999 8


Q ss_pred             CCeEEeeeccceecc
Q 038860          479 LNGKLGDFGLAKLYE  493 (652)
Q Consensus       479 ~~~kL~DFGla~~~~  493 (652)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.54  E-value=3.4e-13  Score=130.87  Aligned_cols=187  Identities=14%  Similarity=0.146  Sum_probs=124.0

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      .++.+.|+|.+. ++.|+||++ +++.|.+|-+.|+++-+       +|+.+|+|+|..+. ..+||||||.++..... 
T Consensus        21 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~~-------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~~~-   89 (215)
T cd06903          21 PNWQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLKD-------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDGNA-   89 (215)
T ss_pred             CCeEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCCC-------CEEEEEEEEecccC-CcCCCEEEEEEECCCcc-
Confidence            589999999997 789999999 99999999999999853       69999999998653 36899999999976532 


Q ss_pred             CCCC-ccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCCCcccCCcCCCceEE
Q 038860          115 GLPS-QYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAIL  193 (652)
Q Consensus       115 ~~~g-~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~  193 (652)
                       ..| ..+|-.+.-       .=+||.|||+.|.   .|  ...++..++-.............+.|.... .+.+.+.+
T Consensus        90 -~~g~~~fG~~~~f-------~Gl~I~~Dt~~n~---~p--~i~~~~NDGt~~yd~~~d~~~~~g~C~~~~-rn~~~p~~  155 (215)
T cd06903          90 -DVGTSSIYGPSKF-------DGLQLLIDNNGGS---GG--SLRGFLNDGSKDYKNEDVDSLAFGSCLFAY-QDSGVPST  155 (215)
T ss_pred             -cCCccccCCCCCC-------cEEEEEEECCCCC---Cc--eEEEEECCCCeeccccCCcccccceeeEec-cCCCCCEE
Confidence             111 233331111       1269999999873   11  122333233222211110000012232222 35667899


Q ss_pred             EEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcc-cc-cceEEEEecccccccccceeeccc
Q 038860          194 VWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPI-FN-EFMYVGFSASTGLLASSHNVLGWS  256 (652)
Q Consensus       194 ~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~-l~-~~~~vGfsastg~~~~~~~v~~w~  256 (652)
                      ++|.|......|+|.+...          .+++...+ || ...|+||||+||...+.|.|++-.
T Consensus       156 iri~Y~~~~~~l~v~vd~~----------~Cf~~~~v~lP~~~y~fGiSAaTg~~~d~hdIl~~~  210 (215)
T cd06903         156 IRLSYDALNSLFKVQVDNR----------LCFQTDKVQLPQGGYRFGITAANADNPESFEILKLK  210 (215)
T ss_pred             EEEEEECCCCEEEEEECCC----------EEEecCCeecCCCCCEEEEEEcCCCCCCcEEEEEEE
Confidence            9999998778899988631          12222222 56 567899999999999999987644

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=2.2e-14  Score=143.38  Aligned_cols=134  Identities=18%  Similarity=0.194  Sum_probs=103.7

Q ss_pred             cccc-ccCceEEEEEEEcCCCeEEEEEEecCcc-------------hhhHHHHHHHHHHhcccCcCce--eEEEeeeecc
Q 038860          346 QLLG-HGGFGQVYKGTLHNSKTEVAVKRISNES-------------KQGVREFVSEIATIGRLRHRNL--VQLVGWCRRK  409 (652)
Q Consensus       346 ~~LG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  409 (652)
                      ..|| .||.|+||.....  +..++||++....             ......+.+|+.++.+|+|+++  ++.+++...+
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4587 8999999999875  5779999885421             1223457889999999998875  6777765433


Q ss_pred             C----eeEEEEEeccC-CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          410 G----DLLLVYDFMAN-GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       410 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      .    ..++|+|++++ .+|.+++..   ..++..    .+.+++.+|.+||   +.+|+||||||+|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 688887733   234433    3578999999999   7999999999999999998899999


Q ss_pred             eecccee
Q 038860          485 DFGLAKL  491 (652)
Q Consensus       485 DFGla~~  491 (652)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=5.4e-15  Score=165.36  Aligned_cols=208  Identities=26%  Similarity=0.358  Sum_probs=166.1

Q ss_pred             hcCccccccccccCceEEEEEEEcC-CCeEEEEEEecCcc--hhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-SKTEVAVKRISNES--KQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  414 (652)
                      ...|...+.||+|.|+.|-...... ....+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4567778889999999998887643 34557777775543  223334445777777776 9999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceecc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLYE  493 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~  493 (652)
                      ..+|..++++.+-+........+....-.++.|+..++.|+|.  ..++.||||||+|.+++..+ ..+++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999888832222245666777899999999999995  58899999999999999999 99999999998776


Q ss_pred             c--CCCCceeeccC-CcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          494 H--GTNPATTRVVG-TLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       494 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .  +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.....
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            5  33334445678 9999999998884 457788999999999999999999976443

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=99.49  E-value=1.7e-12  Score=128.25  Aligned_cols=195  Identities=21%  Similarity=0.261  Sum_probs=119.9

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      .++.+.|+|.+. ++.|+||++.+++.|.+|.+.|++. +       +|+.+|+|+|........||||||.+.....  
T Consensus        22 ~~W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~-~-------~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~--   90 (229)
T PF03388_consen   22 PNWDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPF-D-------NWEIEFTFRISGQEKGLGGDGMAFWYTKDPG--   90 (229)
T ss_dssp             TTEEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEE-S-------EEEEEEEEEEESS-SSS-S-EEEEEEESSSS--
T ss_pred             CCEEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCc-c-------CEEEEEEEEEeccccCcCCCeEEEEEEcCcc--
Confidence            489999999997 8899999999999999999999998 3       7999999999987566789999999998653  


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCCC-CCCCCceeeecC-Cccccceeecceec-CCCCcccCCc-CCCc
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQ-DINDNHIGIDIN-SMKSNASVEAAVYT-DNSTKQDLSL-KGGK  190 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~hvgi~~n-s~~s~~~~~~~~~~-~~~~~~~~~~-~~g~  190 (652)
                       ..|..+|..+.       -.=+||=||||.|.+-. ......|.+-+| +-........+... .+.|.  ..+ +.+.
T Consensus        91 -~~G~~fG~~~~-------f~Gl~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~~~~~~~C~--~~~rn~~~  160 (229)
T PF03388_consen   91 -SDGPVFGGPDK-------FDGLGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGKDQSLGSCS--ADYRNSDV  160 (229)
T ss_dssp             -SSCSBTTB-SS--------EEEEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTTTT-SEEEE-----BTESS
T ss_pred             -ccccccCCCcc-------cceEEEEEEcccCCCcccccccceEEEEecCCCccccccccCcccccccce--eccCcCCC
Confidence             25556664222       12279999999986321 112344433332 21111111100000 01121  122 2456


Q ss_pred             eEEEEEEEcCCCCeEEEEEeeC---CCCCCCCeeeEEecCCcccccceEEEEecccccccccceeecc
Q 038860          191 AILVWVDYDSAENILNVTVSPN---SSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGW  255 (652)
Q Consensus       191 ~~~~~I~Y~~~~~~l~v~~~~~---~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w  255 (652)
                      ..+++|.|...  .+.|.+...   ....-..++.  ++ .-.||+..|+|+||+||...+.|.|++-
T Consensus       161 p~~~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~--~~-~v~LP~~~yfGvSA~Tg~~~d~hdi~s~  223 (229)
T PF03388_consen  161 PTRIRISYSKN--TLTVSIDSNYLKNQDDWELCFT--TD-GVDLPEGYYFGVSAATGELSDNHDILSV  223 (229)
T ss_dssp             EEEEEEEEETT--EEEEEEETSCCSECCTTEEEEE--ES-TEEGGSSBEEEEEEEESSSGGEEEEEEE
T ss_pred             CEEEEEEEECC--eEEEEEecccccCCcCCcEEEE--cC-CeecCCCCEEEEEecCCCCCCcEEEEEE
Confidence            77899999964  577777632   1111222222  21 1137888999999999999999988764

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=6e-13  Score=144.48  Aligned_cols=142  Identities=18%  Similarity=0.193  Sum_probs=99.5

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhH----------------------------------------HHH
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV----------------------------------------REF  384 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  384 (652)
                      .+.||.|++|+||+|++.+ |+.||||+.++......                                        -+|
T Consensus       122 ~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            3679999999999999874 78999999866421111                                        024


Q ss_pred             HHHHHHhcccC----cCceeEEEeee-eccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHH-HHhhhccC
Q 038860          385 VSEIATIGRLR----HRNLVQLVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS-GLLYLHEG  458 (652)
Q Consensus       385 ~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~-aL~~LH~~  458 (652)
                      .+|...+.+++    |.+-+.+-..+ ...+..+|||||++|++|.++...... ..   .+.+++.+++. .+..+|  
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH--
Confidence            45665555552    22223322222 223457999999999999887632111 11   23456666665 467788  


Q ss_pred             ccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       459 ~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                       ..+++|+|+||.||+++.+++++++|||++..+..
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             79999999999999999999999999999986643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=99.31  E-value=2.7e-11  Score=119.50  Aligned_cols=196  Identities=19%  Similarity=0.249  Sum_probs=135.4

Q ss_pred             CCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCC
Q 038860           34 SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL  113 (652)
Q Consensus        34 ~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~  113 (652)
                      ..++.+.|++.+. ..-|+||.+.+++.|.+|-..||...        +|...+.|++..+.....|||||+..+-....
T Consensus        71 ~~~W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s~--------~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~q  141 (351)
T KOG3839|consen   71 QPNWNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFSR--------DWEVLVHFKVHGQSKNLFGDGMAIWYTKERAQ  141 (351)
T ss_pred             ccCccccccEEEE-eeeeeccccccccccccccCCCcccc--------ceeEEEEEEEecCCCcccccceEEEeeccccc
Confidence            5789999999997 66799999999999999999999864        59999999999998899999999999987643


Q ss_pred             CCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCC--CCceeeecC-CccccceeecceecC-CCCcccCC-cCC
Q 038860          114 NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDIN--DNHIGIDIN-SMKSNASVEAAVYTD-NSTKQDLS-LKG  188 (652)
Q Consensus       114 ~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~hvgi~~n-s~~s~~~~~~~~~~~-~~~~~~~~-~~~  188 (652)
                         +|..+|-.++-       +.+||-.|||.|.+ +-+.  .+-|.+.+| +..|.--...+..+. .++...+. +..
T Consensus       142 ---~GPvFG~~dkF-------~GL~vfidtY~n~~-g~~~~v~P~isvmv~~gs~sYD~~~Dg~~tel~gc~a~~rn~~~  210 (351)
T KOG3839|consen  142 ---PGPVFGSKDKF-------TGLAVFIDTYGNHN-GPHEHVFPYISVMVNIGSLSYDHSKDGTHTELAGCTANFRNLPH  210 (351)
T ss_pred             ---CCCCCCCcccc-------eeEEEEEeccCCcC-CCcccceeeEEEEeccCCcccccCCCCCccccccceeeeccCCC
Confidence               66667764433       33899999999863 1111  122333322 222211111111111 22322222 112


Q ss_pred             CceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcc-cccceEEEEecccccccccceeecccc
Q 038860          189 GKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPI-FNEFMYVGFSASTGLLASSHNVLGWSF  257 (652)
Q Consensus       189 g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~-l~~~~~vGfsastg~~~~~~~v~~w~f  257 (652)
                        ...+-|.|+.  ++|++..+..+.    .....++++..+ +|.--|+|+||+||...+.|.+.+-.+
T Consensus       211 --dt~~~iry~~--~~l~~~~dl~~~----~~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl  272 (351)
T KOG3839|consen  211 --DTLVVIRYEK--KTLSISIDLEGP----NEWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKL  272 (351)
T ss_pred             --cceeEEEecC--CceEEEEecCCC----ceeeeeeeecceecccceEEeeeeccCccchhhHHHHhhh
Confidence              2456688987  677777775542    125556778776 888999999999999999999877665

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.29  E-value=9.6e-12  Score=136.67  Aligned_cols=145  Identities=16%  Similarity=0.175  Sum_probs=96.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhh----------------------------------H---
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG----------------------------------V---  381 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~---  381 (652)
                      ...|+. +.||+|++|+||+|+++++|+.||||+.++.....                                  .   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 78999999999999998879999999997642110                                  0   


Q ss_pred             ---HHHHHHHHHhcccC----cCceeEEEeeeec-cCeeEEEEEeccCCCcccccccCCc----cccchHHHhhhHHHHH
Q 038860          382 ---REFVSEIATIGRLR----HRNLVQLVGWCRR-KGDLLLVYDFMANGSLDSFLFDEPK----AVLNWEQRFKIIKGVA  449 (652)
Q Consensus       382 ---~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~i~  449 (652)
                         -+|.+|...+.+++    +.+.+.+=..+.+ ....+|||||++|+.+.++-.-...    ..+.......++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence               12445555555542    3333332222222 3457899999999999774211111    123333333333333 


Q ss_pred             HHHhhhccCccceEEecCCCCCceEeCCCC----CeEEeeeccceeccc
Q 038860          450 SGLLYLHEGYEQVVIHRDVKASNVLLDSEL----NGKLGDFGLAKLYEH  494 (652)
Q Consensus       450 ~aL~~LH~~~~~~ivHrDlk~~NILl~~~~----~~kL~DFGla~~~~~  494 (652)
                            +   ..+++|+|+||.||+++.++    +++++|||++..++.
T Consensus       277 ------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3   47899999999999999888    999999999987644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.4e-11  Score=116.40  Aligned_cols=130  Identities=18%  Similarity=0.115  Sum_probs=95.2

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCcee-EEEeeeeccCeeEEEEEeccCCC
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV-QLVGWCRRKGDLLLVYDFMANGS  423 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gs  423 (652)
                      .+.|+.|..+.||++...  +..+++|........ ...+..|+.++..+.+.+++ +++.+..  ...++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            456899999999999875  678999998655321 23457789999888655544 4554433  23579999999988


Q ss_pred             cccccccCCccccchHHHhhhHHHHHHHHhhhccCc--cceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          424 LDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY--EQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       424 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      +....          .....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            76531          111245678999999999421  22369999999999999 6689999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.22  E-value=8.9e-11  Score=112.45  Aligned_cols=140  Identities=19%  Similarity=0.133  Sum_probs=100.2

Q ss_pred             cccccccCceEEEEEEEcC------CCeEEEEEEecCcc----------------------hhhHHHH----HHHHHHhc
Q 038860          345 KQLLGHGGFGQVYKGTLHN------SKTEVAVKRISNES----------------------KQGVREF----VSEIATIG  392 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~  392 (652)
                      ...||.|.-+.||.|...+      .+..+|||..+...                      ....+.+    .+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998654      24789999774210                      0012223    38999999


Q ss_pred             ccCc--CceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhh-ccCccceEEecCCC
Q 038860          393 RLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL-HEGYEQVVIHRDVK  469 (652)
Q Consensus       393 ~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivHrDlk  469 (652)
                      ++..  -++.+++++    ..-+|||||+.+..+.....  ....++..+...+..+++.+|..| |   +.+++|+||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            8853  456667764    35689999997654422111  112344556677889999999998 7   7899999999


Q ss_pred             CCceEeCCCCCeEEeeeccceeccc
Q 038860          470 ASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       470 ~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      +.|||+++ +.+.|+|||.+....+
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCceeCCC
Confidence            99999974 6899999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=1.2e-11  Score=122.28  Aligned_cols=189  Identities=22%  Similarity=0.267  Sum_probs=131.7

Q ss_pred             HhcccCcCceeEEEeeeeccC-----eeEEEEEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccce
Q 038860          390 TIGRLRHRNLVQLVGWCRRKG-----DLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQV  462 (652)
Q Consensus       390 ~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~  462 (652)
                      .|-.+.|.||++++.|..+.+     +..++.|||..|+|..+|.+.  ....+......+|.-||+.||.|||+ |...
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            344557999999999876543     478899999999999999642  34467888889999999999999997 5899


Q ss_pred             EEecCCCCCceEeCCCCCeEEeeeccceeccc----CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh
Q 038860          463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEH----GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC  538 (652)
Q Consensus       463 ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt  538 (652)
                      |+|+++..+-|++..++-+|++- +.-.....    ........-.+-++|.+||+-..-..+..+|||+||+..+||.-
T Consensus       199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999998888742 11111100    01112223356789999999877788889999999999999988


Q ss_pred             CCCCCCCC-CCccchhHHHHHHhhhcCCccccccccccccCCC
Q 038860          539 GRRPIETR-ALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYD  580 (652)
Q Consensus       539 G~~p~~~~-~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  580 (652)
                      +.---... ..-+...-+..+.-....+...+.+.++++++..
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~  320 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPN  320 (458)
T ss_pred             heeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCC
Confidence            77542221 1111122222333334445555566666655543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.17  E-value=1.3e-10  Score=125.86  Aligned_cols=170  Identities=19%  Similarity=0.240  Sum_probs=128.5

Q ss_pred             EEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccc
Q 038860          358 KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLN  437 (652)
Q Consensus       358 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~  437 (652)
                      .|..+.++.+|.|+..+...........+-++.|+.+|||||++++......+.+|||+|-+.  .|..++..     +.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hH
Confidence            466666788899998877665444456677889999999999999999999999999999873  56666632     33


Q ss_pred             hHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCC
Q 038860          438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT  517 (652)
Q Consensus       438 ~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  517 (652)
                      .....-.+.||+.||.|||+  +.+++|++|...-|+++..|+.||++|.++........ ......--..|..|+.+..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence            45555678999999999997  78999999999999999999999999998875432211 1111111234556654332


Q ss_pred             CCCCCccchHhHHHHHHHHHhC
Q 038860          518 GKSSASSDVFAFGALLLEVACG  539 (652)
Q Consensus       518 ~~~s~~sDv~SlGvvl~elltG  539 (652)
                      ..  ...|.|-|||+++|++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  346999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=6e-10  Score=110.04  Aligned_cols=142  Identities=19%  Similarity=0.225  Sum_probs=110.3

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCc--CceeEEEeeeeccC---eeEEEEEec
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRH--RNLVQLVGWCRRKG---DLLLVYDFM  419 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lV~e~~  419 (652)
                      +.|+.|..+.+|++...+ ++.+++|....... .....+..|.++++.+++  .++.+++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998854 57899999765432 134567889999999975  34577788776642   568999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC-----------------------------------------
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG-----------------------------------------  458 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----------------------------------------  458 (652)
                      ++.++.+.+..   ..++..++..++.+++++|..||+.                                         
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99988876621   3467777888888888888888852                                         


Q ss_pred             ------------ccceEEecCCCCCceEeCC--CCCeEEeeecccee
Q 038860          459 ------------YEQVVIHRDVKASNVLLDS--ELNGKLGDFGLAKL  491 (652)
Q Consensus       459 ------------~~~~ivHrDlk~~NILl~~--~~~~kL~DFGla~~  491 (652)
                                  ....++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        1357899999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.09  E-value=7.8e-11  Score=126.42  Aligned_cols=200  Identities=25%  Similarity=0.333  Sum_probs=156.2

Q ss_pred             cCccccccccc--cCceEEEEEEE--cCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccC-cCceeEEEeeeeccCee
Q 038860          340 NNFSAKQLLGH--GGFGQVYKGTL--HNSKTEVAVKRISNESK--QGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       340 ~~f~~~~~LG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  412 (652)
                      ..|...+.+|.  |.+|.+|.+..  ..+...+|+|+-+....  .....=.+|+....+++ |+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            35666788999  99999999998  77788899998543221  22222245666666664 99999988888888899


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHH----HHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS----GLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFG  487 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~----aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFG  487 (652)
                      ++-.|++. .+|..+.+.. ...++...++....+..+    ||.++|   ...++|-|+||.||++..+ ...+++|||
T Consensus       194 fiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcc
Confidence            99999884 6888877542 223677778888888888    999999   6999999999999999999 889999999


Q ss_pred             cceecccCCCCc----eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          488 LAKLYEHGTNPA----TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       488 la~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      +...+....-..    .....|...|++||... +-++..+|+|++|.+.++..++..+...
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence            998876544211    12236788999999864 5578899999999999999998876644

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=99.07  E-value=5.2e-09  Score=104.94  Aligned_cols=194  Identities=20%  Similarity=0.277  Sum_probs=128.6

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      +-+.-.|||... .-.|+|+++-.++.|.+|-+.-+++-        .|..+-+|+|... ...++|||||.-+....  
T Consensus        54 PFW~~~GdAIas-~eqvRlaPSmrsrkGavWtka~~~fe--------~weVev~~rVtGr-GRiGAdGlaiWYt~~~G--  121 (497)
T KOG3838|consen   54 PFWSHHGDAIAS-SEQVRLAPSMRSRKGAVWTKASVPFE--------NWEVEVQFRVTGR-GRIGADGLAIWYTRGRG--  121 (497)
T ss_pred             ceeeecCccccc-ccceeeccccccccCceeecccCCcc--------cceEEEEEEeccc-ccccCCceEEEEecCCC--
Confidence            357789998874 66799999999999999888777763        4899999999876 56689999999876542  


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCC-ccccceeecce-ecCCCCcccCCcC-CCce
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINS-MKSNASVEAAV-YTDNSTKQDLSLK-GGKA  191 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns-~~s~~~~~~~~-~~~~~~~~~~~~~-~g~~  191 (652)
                       --|..+|-.+.=       .-+++-||.+.|.  +..|++-|.+-.|. -.+..-...+. .....|  -.+++ --.+
T Consensus       122 -~~GpVfGg~d~W-------nGigiffDSfdnD--~qknnP~Is~~lndGt~~ydh~~DGasQ~LssC--qrDFRNkPyP  189 (497)
T KOG3838|consen  122 -HVGPVFGGLDSW-------NGIGIFFDSFDND--GQKNNPAISVLLNDGTIPYDHPGDGASQGLSSC--QRDFRNKPYP  189 (497)
T ss_pred             -cccccccccccc-------cceEEEeeccccc--CCcCCccEEEEecCCcccccCCCccHHHHHHHh--hHHhccCCCC
Confidence             333444432211       1269999999986  44566667665442 22211111000 000111  12232 2357


Q ss_pred             EEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCc-ccccceEEEEecccccccccceeeccc
Q 038860          192 ILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSP-IFNEFMYVGFSASTGLLASSHNVLGWS  256 (652)
Q Consensus       192 ~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~-~l~~~~~vGfsastg~~~~~~~v~~w~  256 (652)
                      ..|+|+|-  .++|+|.+. ++..|..+ -..+++... .||...|+|.||+||....-|.|++..
T Consensus       190 vRarItY~--~nvLtv~in-nGmtp~d~-yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl  251 (497)
T KOG3838|consen  190 VRARITYY--GNVLTVMIN-NGMTPSDD-YEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSFL  251 (497)
T ss_pred             ceEEEEEe--ccEEEEEEc-CCCCCCCC-cceeEeccceeccCCCeeeeeecccccccccceeeeE
Confidence            89999998  567888886 34445544 333444433 478999999999999999999998754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=8.7e-10  Score=102.06  Aligned_cols=131  Identities=19%  Similarity=0.262  Sum_probs=100.4

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEec-Cc-------chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NE-------SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..+++|+-+.+|.+.+.+  ..+++|.-. +.       .+-..+...+|..++.+++--.|...+-+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            458899999999997753  446666432 21       11123457889999999876666655556666677789999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      |++|..|.+.+...         ...++..+-..+.-||   ..+|+|+||.++||++.... +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99998888888433         2457778888889999   79999999999999998774 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.03  E-value=1.2e-09  Score=100.44  Aligned_cols=143  Identities=20%  Similarity=0.248  Sum_probs=105.1

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEe-cCc-------chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-SNE-------SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ....|-+|+-+.|+++.+.  |+...||.- .+.       .+-..++..+|++.+.+++--.|.-..-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999999986  566667643 221       122345678899999988755554444445555556789


Q ss_pred             EEeccC-CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC---eEEeeecccee
Q 038860          416 YDFMAN-GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN---GKLGDFGLAKL  491 (652)
Q Consensus       416 ~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~---~kL~DFGla~~  491 (652)
                      |||+++ .++.+++...-......+....+++.|-+.+.-||   ...|+|+||..+||+|.+++.   +.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999976 46778775543333444444788999999999999   799999999999999976643   58999999763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.00  E-value=2.9e-10  Score=122.15  Aligned_cols=200  Identities=20%  Similarity=0.223  Sum_probs=148.5

Q ss_pred             hhhhcCccccccccccCceEEEEEEEc-CCCeEEEEEEecCcchhhHHH--HHHHHHHhccc-CcCceeEEEeeeeccCe
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVKRISNESKQGVRE--FVSEIATIGRL-RHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~  411 (652)
                      .....+|.....||.|.|+.|+....+ .++..+++|.+.+.......+  -..|+.+...+ .|.+++...........
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            344568889999999999999998766 567889999887653322221  13455555555 48888876665555556


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccce
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAK  490 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla~  490 (652)
                      .++--|||+++++...+  .....+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +..+++|||.+.
T Consensus       341 ~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             ccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            67889999999887665  33445778888999999999999999   7999999999999999886 888999999986


Q ss_pred             ecccCCCCceeeccCCcCC-CCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCC
Q 038860          491 LYEHGTNPATTRVVGTLGY-LAPETPRTGKSSASSDVFAFGALLLEVACGRRPI  543 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~  543 (652)
                      .+.-   ........+..| .+|+......+-.+.|+||||.-+.|.++|..--
T Consensus       416 ~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  416 RLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccce---ecccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            4221   111111223344 3666666778889999999999999999987543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.96  E-value=3.1e-10  Score=127.88  Aligned_cols=206  Identities=22%  Similarity=0.242  Sum_probs=148.4

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ...+++.+.+-+-+|.++.++.+.-..++...++|.....   .+...+....+-.+.-..++|-++...--+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            3456777888888999999998877666655555544322   1122223333333333334566665544445566789


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      |+++|..+++|..-|+...  +.+.+-....+..+..+++|||   ...+.|||++|.|.|...++..++.|||......
T Consensus       881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence            9999999999988885433  4565666677778899999999   5669999999999999999999999998432211


Q ss_pred             c---------------------CCC---------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCC
Q 038860          494 H---------------------GTN---------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI  543 (652)
Q Consensus       494 ~---------------------~~~---------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~  543 (652)
                      .                     ...         .......||+.|.+||.+.+......+|+|+.|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0                     000         0122357899999999999999999999999999999999999999


Q ss_pred             CCCC
Q 038860          544 ETRA  547 (652)
Q Consensus       544 ~~~~  547 (652)
                      ....
T Consensus      1036 na~t 1039 (1205)
T KOG0606|consen 1036 NAET 1039 (1205)
T ss_pred             CCcc
Confidence            7644

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.83  E-value=1.5e-08  Score=106.62  Aligned_cols=169  Identities=20%  Similarity=0.296  Sum_probs=130.1

Q ss_pred             ceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec----cCeeEEEEEeccC-CCcccc
Q 038860          353 FGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR----KGDLLLVYDFMAN-GSLDSF  427 (652)
Q Consensus       353 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~  427 (652)
                      -.+.|++...-+|..+++|+++....+....-..-++.++++.|+|+|++..++..    ...++|||+|.|+ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            45789999988899999999965544433333456788999999999999998863    3468999999986 356554


Q ss_pred             cccC-------------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          428 LFDE-------------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       428 l~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      -+..             .+...++..+|.++.|+..||.++|   +.|+.-+-|.+.+||++.+.+++|...|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321             2335788999999999999999999   68999899999999999999999988887766544


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP  542 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p  542 (652)
                      +..               |-+.   --.+-|.=.||.+++.|.||..-
T Consensus       446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            320               1111   12356899999999999999654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=3.2e-08  Score=94.55  Aligned_cols=126  Identities=20%  Similarity=0.234  Sum_probs=82.7

Q ss_pred             EEEEEEEcCCCeEEEEEEecCcc--------------------------hhhHHHHHHHHHHhcccCcC--ceeEEEeee
Q 038860          355 QVYKGTLHNSKTEVAVKRISNES--------------------------KQGVREFVSEIATIGRLRHR--NLVQLVGWC  406 (652)
Q Consensus       355 ~Vy~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~  406 (652)
                      .||.|...+ +..+|+|..+...                          ........+|.+.|.++...  ++.+++.+.
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            489998865 7899999874310                          00123467899999999755  566676543


Q ss_pred             eccCeeEEEEEecc--CCCcccccccCCccccchHHHhhhHHHHHHHHhh-hccCccceEEecCCCCCceEeCCCCCeEE
Q 038860          407 RRKGDLLLVYDFMA--NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY-LHEGYEQVVIHRDVKASNVLLDSELNGKL  483 (652)
Q Consensus       407 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~-LH~~~~~~ivHrDlk~~NILl~~~~~~kL  483 (652)
                          .-.|||||++  +..+....    ...++......++.+++..+.. +|   ..+|+|+||.+.|||++++ .+.|
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~----~~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLK----DVDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHH----HCGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             ----CCEEEEEecCCCccchhhHH----hccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence                3479999998  54454433    1112244556777888886555 56   7899999999999999988 9999


Q ss_pred             eeeccceecc
Q 038860          484 GDFGLAKLYE  493 (652)
Q Consensus       484 ~DFGla~~~~  493 (652)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999988543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=3.1e-08  Score=100.28  Aligned_cols=134  Identities=19%  Similarity=0.128  Sum_probs=95.7

Q ss_pred             CceEEEEEEEcCCCeEEEEEEecCcchh-hHH----------HHHHHHHHhcccCcCce--eEEEeeeec-----cCeeE
Q 038860          352 GFGQVYKGTLHNSKTEVAVKRISNESKQ-GVR----------EFVSEIATIGRLRHRNL--VQLVGWCRR-----KGDLL  413 (652)
Q Consensus       352 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~  413 (652)
                      ....|++....  |+.+.||+....... ..+          .+.+|...+.++...+|  ++++++...     ...-+
T Consensus        34 ~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            33446676653  578999987543311 111          36788888888854333  344555432     23568


Q ss_pred             EEEEeccCC-CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-------CCCeEEee
Q 038860          414 LVYDFMANG-SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-------ELNGKLGD  485 (652)
Q Consensus       414 lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-------~~~~kL~D  485 (652)
                      ||+|++++- +|.+++........+...+..++.+++..+.-||   ..||+|+|++++|||++.       +..+.|+|
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            999999875 7888874322234556677889999999999999   799999999999999975       46799999


Q ss_pred             eccce
Q 038860          486 FGLAK  490 (652)
Q Consensus       486 FGla~  490 (652)
                      |+.++
T Consensus       189 l~r~~  193 (268)
T PRK15123        189 LHRAQ  193 (268)
T ss_pred             CCccc
Confidence            99876

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=98.76  E-value=9.1e-07  Score=84.74  Aligned_cols=199  Identities=16%  Similarity=0.191  Sum_probs=113.5

Q ss_pred             CCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCC--CCCCCccccCCc
Q 038860           48 NGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL--NGLPSQYLGLLN  125 (652)
Q Consensus        48 ~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~--~~~~g~~lG~~~  125 (652)
                      +|.||||+...++.|.+.|.+++|--+.      -...+|.+-.-.. ...++||+||||+-....  ++..|+.||+.-
T Consensus        31 ~g~LRLT~~~~nqata~~~~~~FPs~~n------~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa~  103 (255)
T cd06900          31 NNRLRLTDASGNQATAVTLQRLFPSAGN------YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYAQ  103 (255)
T ss_pred             cCeEEeccCccCcceeEEEeeeeccCCC------eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCccccccc
Confidence            7889999999999999999999986321      3667777766544 556899999999954433  388999999986


Q ss_pred             cC-CCCCCcccEEEEEeecccCCCC-CCCCCCceeeecCCcc---ccc-eeecceecCCCCccc-CCc------CCCceE
Q 038860          126 ST-DIGNFSNHLFAVEFDTVQDFEF-QDINDNHIGIDINSMK---SNA-SVEAAVYTDNSTKQD-LSL------KGGKAI  192 (652)
Q Consensus       126 ~~-~~~~~~~~~vaVEFDt~~n~~~-~d~~~~hvgi~~ns~~---s~~-~~~~~~~~~~~~~~~-~~~------~~g~~~  192 (652)
                      .+ ....-....++|-||-|-|... .+....-.|---+++.   |.. +....|...+....+ ++.      .-+-++
T Consensus       104 ~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g~~gY~yl~gt~~~~~~id~~~~~~~~~~hrY  183 (255)
T cd06900         104 RNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSGYTGYKYITGTGVLPPGIDNNSTSTPAPGHRY  183 (255)
T ss_pred             ccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCCCcCceEecccCCCCcccccCCCCCCCCceEE
Confidence            54 2233456789999999888521 1211111122222221   100 011111111111111 111      122344


Q ss_pred             EEEEEEcC-CCCeEEEEEeeCCCCCCCCeeeEE---ecCC--cccccceEEEEecccccccccceeec
Q 038860          193 LVWVDYDS-AENILNVTVSPNSSKPKIPILSFR---VDLS--PIFNEFMYVGFSASTGLLASSHNVLG  254 (652)
Q Consensus       193 ~~~I~Y~~-~~~~l~v~~~~~~~~~~~p~ls~~---vdL~--~~l~~~~~vGfsastg~~~~~~~v~~  254 (652)
                      ++.|+=.. ....|+|.-+..+.....+ +...   ++..  .-.|+..+++|++|||.....|.|..
T Consensus       184 ~i~Ids~~~~~~~vsV~R~~~~gg~~~~-~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdn  250 (255)
T cd06900         184 RITIDSTNGDNAWLSVERDIGNGGAYFV-VILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDN  250 (255)
T ss_pred             EEEEecCCCCceEEEEEEEccCCceeEE-eecceeeccccCCCCCCccEEEEEEecCCCcccceeecc
Confidence            44444432 2334566655332211112 1112   2333  45799999999999999988888754

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>PRK09902 hypothetical protein; Provisional

Probab=98.52  E-value=6.5e-07  Score=86.13  Aligned_cols=138  Identities=20%  Similarity=0.196  Sum_probs=104.2

Q ss_pred             ccccCceEEEEEEEcCCCeEEEEEEecCcc------hhhHHHHHHHHHHhcccCcC--ceeEEEeeee-cc----CeeEE
Q 038860          348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES------KQGVREFVSEIATIGRLRHR--NLVQLVGWCR-RK----GDLLL  414 (652)
Q Consensus       348 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~l  414 (652)
                      -|+||-+.|++-...+  +.+-+|+.....      ..+...|.+|...|.+|...  .+.+.+ ++. ..    -.-+|
T Consensus        26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            5778999999987754  468899875321      23456799999999998533  345555 332 11    23689


Q ss_pred             EEEeccC-CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC--eEEeeecccee
Q 038860          415 VYDFMAN-GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN--GKLGDFGLAKL  491 (652)
Q Consensus       415 V~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~--~kL~DFGla~~  491 (652)
                      |+|-+++ -+|.+++......+.+...+..++.+++..+.-||   ..++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997754 47888875544445677888899999999999999   799999999999999986666  99999987763

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.48  E-value=6.7e-07  Score=88.00  Aligned_cols=137  Identities=16%  Similarity=0.156  Sum_probs=94.1

Q ss_pred             ccccccccccCceEEEEEEEcCCCeEEEEEEecCcc----------------------hhhHHHHHHHHHHhcccCcC--
Q 038860          342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES----------------------KQGVREFVSEIATIGRLRHR--  397 (652)
Q Consensus       342 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--  397 (652)
                      ..+...||-|.-+.||.|.+.. +.++|||.=+...                      .-......+|.+.|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3456789999999999999974 7899999532110                      01123456888999988655  


Q ss_pred             ceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC
Q 038860          398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS  477 (652)
Q Consensus       398 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~  477 (652)
                      .+.+.+++-    .-.+||||+++-.|...-.       +.+..-.++..|+.-+.-+-   ..||||+|+.+-||++++
T Consensus       172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         172 KVPKPIAWN----RHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCccccc----cceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence            677776654    3469999999866654331       12222223333333333322   378999999999999999


Q ss_pred             CCCeEEeeeccceecc
Q 038860          478 ELNGKLGDFGLAKLYE  493 (652)
Q Consensus       478 ~~~~kL~DFGla~~~~  493 (652)
                      +|.+.++||-.+....
T Consensus       238 dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         238 DGDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCCEEEEeCcccccCC
Confidence            9999999999876443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.45  E-value=1.7e-06  Score=89.27  Aligned_cols=192  Identities=18%  Similarity=0.250  Sum_probs=129.1

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeee------eccC-eeEEE
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWC------RRKG-DLLLV  415 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~-~~~lV  415 (652)
                      ..+-||+|+-+.+|-.---.   ..+-|++.........+.   +..|.+. .||-+-.-+.|=      .+++ .+-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhh---chhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            35679999999999643221   134577665433322222   2233333 465444323331      1222 36677


Q ss_pred             EEeccCCC-ccccc----ccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          416 YDFMANGS-LDSFL----FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       416 ~e~~~~gs-L~~~l----~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      |..+++.. +..++    .++.-....|.-.++.++.++.+.+-||   ..|.+-+|+.++|+|+++++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            87776642 22222    1223345789999999999999999999   7999999999999999999999999866444


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhC-CCCCCCC
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACG-RRPIETR  546 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG-~~p~~~~  546 (652)
                      ....  .......+|...|.+||.-.     +-..+...|.|.||++++++|.| +.||.+-
T Consensus       166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            3322  22344567899999999644     33457789999999999999886 9999753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.43  E-value=7.4e-07  Score=87.15  Aligned_cols=106  Identities=22%  Similarity=0.291  Sum_probs=82.1

Q ss_pred             HHHHHHHHHhcccCcCc--eeEEEeeeeccC----eeEEEEEeccCC-CcccccccCCccccchHHHhhhHHHHHHHHhh
Q 038860          382 REFVSEIATIGRLRHRN--LVQLVGWCRRKG----DLLLVYDFMANG-SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY  454 (652)
Q Consensus       382 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~  454 (652)
                      ....+|...+.+++...  .++.+++.....    ..+||+|++++. +|.+++.....  ++......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            45677888877775333  455666655432    458999999874 78888843222  5666788899999999999


Q ss_pred             hccCccceEEecCCCCCceEeCCCC---CeEEeeeccceec
Q 038860          455 LHEGYEQVVIHRDVKASNVLLDSEL---NGKLGDFGLAKLY  492 (652)
Q Consensus       455 LH~~~~~~ivHrDlk~~NILl~~~~---~~kL~DFGla~~~  492 (652)
                      ||   ..+|+|+|+++.|||++.+.   .+.|+||+.++..
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99   79999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=1.5e-06  Score=95.41  Aligned_cols=141  Identities=18%  Similarity=0.228  Sum_probs=91.1

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcchhhH------------------------------H----------HHH
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV------------------------------R----------EFV  385 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~  385 (652)
                      +-|+.++-|+||+|++++ |+.||||+.++.-....                              +          ++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568999999999999986 89999999865422110                              0          133


Q ss_pred             HHHHHhcccC-----cCceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHH-hhhccCc
Q 038860          386 SEIATIGRLR-----HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGL-LYLHEGY  459 (652)
Q Consensus       386 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL-~~LH~~~  459 (652)
                      +|...+.+++     .+++.-..=|..-.+...|+|||++|-.+.+...-+. ...+   +..++..++++. ..+-   
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~---  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLL---  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH---
Confidence            4444444442     3333222222223456689999999999988852222 2233   222333333321 1111   


Q ss_pred             cceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       460 ~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ..++.|+|..|.||+++.++++.+.|||+...++.
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            36899999999999999999999999999876654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.26  E-value=7.4e-06  Score=81.22  Aligned_cols=139  Identities=14%  Similarity=0.166  Sum_probs=84.3

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc--eeEEEeeeeccCeeEEEEEeccCC
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN--LVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      ...||+|..+.||+..    +..+++|......  ......+|.++++.+..-.  +.+.++++...+...+|||+++|.
T Consensus         6 ~~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         6 WTQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             heeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            3568999999999842    3457788876543  2234578999998886433  467778877777788999999986


Q ss_pred             C-ccccc---------------------ccCCccccchHHHh-hhHH----------HHHHH-Hhhhcc-CccceEEecC
Q 038860          423 S-LDSFL---------------------FDEPKAVLNWEQRF-KIIK----------GVASG-LLYLHE-GYEQVVIHRD  467 (652)
Q Consensus       423 s-L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------~i~~a-L~~LH~-~~~~~ivHrD  467 (652)
                      + +...+                     +.-........... ++..          .+... ..+|.. .....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 22111                     11000000100000 0000          00000 111110 1134679999


Q ss_pred             CCCCceEeCCCCCeEEeeeccce
Q 038860          468 VKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       468 lk~~NILl~~~~~~kL~DFGla~  490 (652)
                      +.|.||++++++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.18  E-value=1.8e-05  Score=76.59  Aligned_cols=137  Identities=12%  Similarity=0.172  Sum_probs=92.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHH---------HHHHHHHhcccCcC---ceeEEEee
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE---------FVSEIATIGRLRHR---NLVQLVGW  405 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~---niv~l~~~  405 (652)
                      ..++|...+.+-......|.+-...  +..+++|..+.......+.         ..+++..+.+++..   ....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3467888888887777777766654  5789999887654332222         23444444444322   22222222


Q ss_pred             ee-----ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          406 CR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       406 ~~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      ..     -....+|+|||++|..|.++..      ++.    .+...+.+++.-||   +.|+.|+|..|.|++++.+ .
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-c
Confidence            22     2235679999999988876541      222    24566778899999   7999999999999999965 5


Q ss_pred             eEEeeeccce
Q 038860          481 GKLGDFGLAK  490 (652)
Q Consensus       481 ~kL~DFGla~  490 (652)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.14  E-value=1.9e-05  Score=78.24  Aligned_cols=143  Identities=20%  Similarity=0.207  Sum_probs=84.5

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcC--ceeEEEeeeec---cCeeEEEEEec
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHR--NLVQLVGWCRR---KGDLLLVYDFM  419 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~e~~  419 (652)
                      .+.|+.|..+.||+....+  ..+++|.....  .....+.+|..+++.+...  .+.+++.++..   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4578999999999999876  47999998665  4456677888888888533  35667764432   33468999999


Q ss_pred             cCCCcccc----------------c---ccC--CccccchHH---------Hhhh------------HHHHHH-HHhhhc
Q 038860          420 ANGSLDSF----------------L---FDE--PKAVLNWEQ---------RFKI------------IKGVAS-GLLYLH  456 (652)
Q Consensus       420 ~~gsL~~~----------------l---~~~--~~~~l~~~~---------~~~i------------~~~i~~-aL~~LH  456 (652)
                      ++..+...                +   +..  ......+..         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            99877761                1   000  000000000         0000            111222 222332


Q ss_pred             c----CccceEEecCCCCCceEeC-CCCCeEEeeecccee
Q 038860          457 E----GYEQVVIHRDVKASNVLLD-SELNGKLGDFGLAKL  491 (652)
Q Consensus       457 ~----~~~~~ivHrDlk~~NILl~-~~~~~kL~DFGla~~  491 (652)
                      .    .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1    2357899999999999999 566678999998763

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.10  E-value=7.8e-07  Score=96.21  Aligned_cols=189  Identities=19%  Similarity=0.130  Sum_probs=135.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc-eeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN-LVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e  417 (652)
                      +.-+...+-+++|++++++|.+...+...+ .+.+...     .+..-++++|.+++||| .+..++-+..+...+++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            334445566899999999998876544333 6655433     23345788999999999 6666666777778899999


Q ss_pred             eccCC-CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          418 FMANG-SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       418 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ++..+ +-..-. ......+...+...+.+.-.+++++||+   ..-+|+|    ||+..+ ...|.+||+.+..+....
T Consensus       315 i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  315 ICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhcCCccccccC-ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc
Confidence            99877 221111 1122234444555566677788999994   4458888    777665 579999999887665432


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                        ......+|+.++|||+.....+..+.|+|++|+-..++.-|-+|-.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              3445679999999999999999999999999998888888877754

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.08  E-value=3.6e-05  Score=75.26  Aligned_cols=155  Identities=18%  Similarity=0.201  Sum_probs=99.9

Q ss_pred             ccchhhhhhhhcCcccccc---ccccCceEEEEEEEcCCCeEEEEEEecCcchhh-------------------H-----
Q 038860          329 RYSYQELKQATNNFSAKQL---LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-------------------V-----  381 (652)
Q Consensus       329 ~~~~~el~~~~~~f~~~~~---LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~-----  381 (652)
                      ..+++.+....++..+...   |..|..+.||+|... .+..+|+|+++......                   .     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3455666666666665555   556777789999874 37889999885431110                   0     


Q ss_pred             HHHHHHHHHhcccC--cCceeEEEeeeeccCeeEEEEEeccCCCcc-cccccCCccccchHHHhhhHHHHHHHHhhhccC
Q 038860          382 REFVSEIATIGRLR--HRNLVQLVGWCRRKGDLLLVYDFMANGSLD-SFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG  458 (652)
Q Consensus       382 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~  458 (652)
                      ....+|..-|.++.  +=.+.+.+++.    .-.|||||+....+- -.|   ....+...+...+..++++.+.-|-. 
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~-  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYK-  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHH-
Confidence            11345666676663  33444444443    237999999653111 111   11123333566677778888777763 


Q ss_pred             ccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       459 ~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                       ..++||+||..-|||+. ++.+.++|+|.|....+
T Consensus       185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence             48899999999999999 78999999999986553

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.01  E-value=3.8e-05  Score=77.14  Aligned_cols=138  Identities=14%  Similarity=0.172  Sum_probs=84.5

Q ss_pred             ccccCc-eEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEEeccCCCcc
Q 038860          348 LGHGGF-GQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGSLD  425 (652)
Q Consensus       348 LG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  425 (652)
                      |-.|.. ..||+....  +..+.+|+.....   ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444444 789998764  3578888876543   234567888888774 444667788777666789999999998776


Q ss_pred             ccc-------------------ccCCc--cccch--HHHhh-----------------------hHHHHHHHHhhhc-cC
Q 038860          426 SFL-------------------FDEPK--AVLNW--EQRFK-----------------------IIKGVASGLLYLH-EG  458 (652)
Q Consensus       426 ~~l-------------------~~~~~--~~l~~--~~~~~-----------------------i~~~i~~aL~~LH-~~  458 (652)
                      ...                   +..+.  .+...  .....                       ...++...|.... ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11000  00000  00000                       0111111111111 11


Q ss_pred             ccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       459 ~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ....++|+|+.|.|||++.+..+.|+||+.|.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            24679999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.01  E-value=1.8e-05  Score=86.60  Aligned_cols=142  Identities=15%  Similarity=0.181  Sum_probs=90.4

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhh-------------------------------------HHHHHHH
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-------------------------------------VREFVSE  387 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E  387 (652)
                      .+-||.-+.|+||+|+.++ |+.||||+.++.-+..                                     .-+|.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3579999999999999987 8999999876542211                                     0124455


Q ss_pred             HHHhccc----CcCc------eeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhcc
Q 038860          388 IATIGRL----RHRN------LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE  457 (652)
Q Consensus       388 ~~~l~~l----~h~n------iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~  457 (652)
                      .+...+.    .|-+      |.+++-.+  .....|+||||+|..+.+.-.-.. ..++...+   +..+.++...  .
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i---~~~l~~~~~~--q  316 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDI---LNKLVEAYLE--Q  316 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHH---HHHHHHHHHH--H
Confidence            5444333    3444      33333322  235689999999998877642221 22333333   3333332211  1


Q ss_pred             CccceEEecCCCCCceEeCC----CCCeEEeeeccceecccC
Q 038860          458 GYEQVVIHRDVKASNVLLDS----ELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       458 ~~~~~ivHrDlk~~NILl~~----~~~~kL~DFGla~~~~~~  495 (652)
                      -...|.+|+|-.|.||++++    ++++.+-|||+...+.+.
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            11367999999999999984    578999999998866543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.98  E-value=2.2e-05  Score=75.31  Aligned_cols=105  Identities=24%  Similarity=0.227  Sum_probs=83.0

Q ss_pred             HHHHHHhcccCc-CceeEEEeeeeccCeeEEEEEeccCCCccccccc-CCccccchHHHhhhHHHHHHHHhhhccCccce
Q 038860          385 VSEIATIGRLRH-RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV  462 (652)
Q Consensus       385 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~  462 (652)
                      ..|..+++.+++ +++++++|+|-+    ++|.||.+.+++...-.. ..-...+|..|.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888875 699999999943    578999987765421000 11124789999999999999999999765566


Q ss_pred             EEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       463 ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +.-+|++++|+-+++++++|++|...+...+
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            9999999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.93  E-value=9.4e-05  Score=87.45  Aligned_cols=81  Identities=12%  Similarity=0.258  Sum_probs=58.7

Q ss_pred             cccccccCceEEEEEEEcCCC--eEEEEEEecCcc-hhhHHHHHHHHHHhcccC-cCce--eEEEeeeecc---CeeEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSK--TEVAVKRISNES-KQGVREFVSEIATIGRLR-HRNL--VQLVGWCRRK---GDLLLV  415 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV  415 (652)
                      .+.++.|.+..+|+......+  ..+++|+..... ......+.+|.++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            566899999999998775432  467778765432 123356789999999995 6665  7888888764   467899


Q ss_pred             EEeccCCCcc
Q 038860          416 YDFMANGSLD  425 (652)
Q Consensus       416 ~e~~~~gsL~  425 (652)
                      |||+++..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999986543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.89  E-value=2.7e-06  Score=93.20  Aligned_cols=97  Identities=26%  Similarity=0.421  Sum_probs=76.5

Q ss_pred             HHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc--------eeeccCCcCCCCCCCCCC
Q 038860          446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--------TTRVVGTLGYLAPETPRT  517 (652)
Q Consensus       446 ~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~  517 (652)
                      .+++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+.+..........        ..-..-...|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345589999997  7899999999999999999999999999887544321111        111234568999999999


Q ss_pred             CCCCCccchHhHHHHHHHHHh-CCCCCC
Q 038860          518 GKSSASSDVFAFGALLLEVAC-GRRPIE  544 (652)
Q Consensus       518 ~~~s~~sDv~SlGvvl~ellt-G~~p~~  544 (652)
                      ...+.++|+||+|+++|-+.. |+.-+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~  211 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIA  211 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhh
Confidence            888999999999999999984 554443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.84  E-value=9.7e-05  Score=71.26  Aligned_cols=129  Identities=18%  Similarity=0.305  Sum_probs=88.1

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEecCcc----------------hhhHHHHHHHHHHhcccC------cCceeE
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES----------------KQGVREFVSEIATIGRLR------HRNLVQ  401 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~  401 (652)
                      ....||+|+.-.||.--.   .....||+.....                ....++..+|+.-...+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            356799999999997544   3457888887655                123455666666555554      889999


Q ss_pred             EEeeeeccCeeEEEEEeccCC------CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          402 LVGWCRRKGDLLLVYDFMANG------SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       402 l~~~~~~~~~~~lV~e~~~~g------sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      ++|+..++...-+|+|.+.+.      +|.+++..   ..++. ...+.+.+..+   ||-   +..|+.+|++|.||++
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~~f~~---~l~---~~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALDEFKR---YLL---DHHIVIRDLNPHNIVV  151 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHHHHHH---HHH---HcCCeecCCCcccEEE
Confidence            999999999999999987542      45566622   23444 44444444444   444   4669999999999999


Q ss_pred             CCC--C--CeEEee
Q 038860          476 DSE--L--NGKLGD  485 (652)
Q Consensus       476 ~~~--~--~~kL~D  485 (652)
                      ...  +  .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            643  2  466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.70  E-value=0.00024  Score=71.00  Aligned_cols=75  Identities=13%  Similarity=0.129  Sum_probs=46.7

Q ss_pred             ccccccCce-EEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcC---ceeEEEeeeecc---CeeEEEEEe
Q 038860          346 QLLGHGGFG-QVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHR---NLVQLVGWCRRK---GDLLLVYDF  418 (652)
Q Consensus       346 ~~LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~e~  418 (652)
                      +.|+.|+.. .||+..     ..+++|..+...  ....+.+|.+++..+...   .+.++++.....   +..+++|++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457767666 588751     246778765422  234678899888877532   344455444332   235889999


Q ss_pred             ccCCCcccc
Q 038860          419 MANGSLDSF  427 (652)
Q Consensus       419 ~~~gsL~~~  427 (652)
                      ++|.++.+.
T Consensus        76 i~G~~l~~~   84 (235)
T cd05155          76 LEGETATAA   84 (235)
T ss_pred             ecCCCCCcc
Confidence            999887543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.65  E-value=0.00042  Score=66.34  Aligned_cols=125  Identities=28%  Similarity=0.379  Sum_probs=89.9

Q ss_pred             cCccccccccccCc-eEEEEEEEcCCCeEEEEEEecCc---c--------h----------hhHHHHHHHHHHhcccC--
Q 038860          340 NNFSAKQLLGHGGF-GQVYKGTLHNSKTEVAVKRISNE---S--------K----------QGVREFVSEIATIGRLR--  395 (652)
Q Consensus       340 ~~f~~~~~LG~G~~-g~Vy~~~~~~~~~~vavK~~~~~---~--------~----------~~~~~~~~E~~~l~~l~--  395 (652)
                      .+++.++.||.|.- |.||+++..  |+.+|+|.+...   .        .          ....-|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67888999999999 999999986  579999994210   0        0          11235888999888885  


Q ss_pred             -cCce--eEEEeeeeccC------------------eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhh
Q 038860          396 -HRNL--VQLVGWCRRKG------------------DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY  454 (652)
Q Consensus       396 -h~ni--v~l~~~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~  454 (652)
                       +.++  ++++||..-..                  ...||.||.+...           .+.    .+-+.+|.+-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHH
Confidence             4466  99999973220                  1246777665422           122    2345667778888


Q ss_pred             hccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       455 LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      +|   ..+|+-+|+|+.|..     .-||+|||.+
T Consensus       180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            99   899999999999985     5799999964

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.60  E-value=0.00023  Score=66.04  Aligned_cols=129  Identities=16%  Similarity=0.189  Sum_probs=87.2

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeE-EEeeeeccCeeEEEEEeccC
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ-LVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +..+.|++|..|.||+|.+.+  ..+|+|+-+.++.  ...+..|.+++..+.-.++.+ ++.|-.    ..+.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC--ceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence            456779999999999999974  5899998776543  356888999999887666644 443332    2355999998


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCC-CCceEeCCCCCeEEeeecccee
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVK-ASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk-~~NILl~~~~~~kL~DFGla~~  491 (652)
                      -.|.+.-...     +-.    -+..+++.---|.   ..||-|+.|. |...+|-.+..+.|+||..|..
T Consensus        97 ~~L~~~~~~~-----~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG-----DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc-----cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8887655211     112    2233444433344   5778888876 4444444444999999998873

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.59  E-value=0.00036  Score=70.70  Aligned_cols=137  Identities=14%  Similarity=0.040  Sum_probs=78.0

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCce-eEEEeeeeccCeeEEEEEeccCCCcc
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL-VQLVGWCRRKGDLLLVYDFMANGSLD  425 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL~  425 (652)
                      .+..|-.+.+|+...  .+..+++|........-.-...+|..+++.+....+ .+++..+.    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            355677889998874  356788887654432211134678888888854333 34444432    36899999987765


Q ss_pred             ccc-----------------ccCC--ccccchHH-Hhhh------------HHHHHHHHhhh--ccCccceEEecCCCCC
Q 038860          426 SFL-----------------FDEP--KAVLNWEQ-RFKI------------IKGVASGLLYL--HEGYEQVVIHRDVKAS  471 (652)
Q Consensus       426 ~~l-----------------~~~~--~~~l~~~~-~~~i------------~~~i~~aL~~L--H~~~~~~ivHrDlk~~  471 (652)
                      ...                 +..+  ..+++... ...+            ..++...+...  .......++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            320                 1111  11111111 0111            11111111111  0112357999999999


Q ss_pred             ceEeCCCCCeEEeeeccce
Q 038860          472 NVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       472 NILl~~~~~~kL~DFGla~  490 (652)
                      ||++++++ +.|+||..|.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999876 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.56  E-value=0.00091  Score=69.25  Aligned_cols=78  Identities=10%  Similarity=0.014  Sum_probs=56.6

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCc---CceeEEEeeeec---cCeeEEEE
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH---RNLVQLVGWCRR---KGDLLLVY  416 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lV~  416 (652)
                      ...+.||.|..+.||+....+ + .+.+|..+...  ....+..|...++.|..   -.+.+++++|..   .+..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            345679999999999987644 3 46677754311  22467889999988853   367888888754   35689999


Q ss_pred             EeccCCCc
Q 038860          417 DFMANGSL  424 (652)
Q Consensus       417 e~~~~gsL  424 (652)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998766

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.54  E-value=0.0005  Score=68.52  Aligned_cols=140  Identities=18%  Similarity=0.192  Sum_probs=80.4

Q ss_pred             ccccccCceEEEEEEEcC-CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc-eeEEEeeeeccCeeEEEEEeccCCC
Q 038860          346 QLLGHGGFGQVYKGTLHN-SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN-LVQLVGWCRRKGDLLLVYDFMANGS  423 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~~~gs  423 (652)
                      +.|..|-...+|+....+ .+..+++|........ .-+..+|+.++..+...+ .+++++.+. .   .++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            457778888999987653 2467888977543222 122346888888885333 344544432 2   37999999977


Q ss_pred             ccccc-----------------ccCC-c--------ccc-chHHHhhhHH----------------------HHH---HH
Q 038860          424 LDSFL-----------------FDEP-K--------AVL-NWEQRFKIIK----------------------GVA---SG  451 (652)
Q Consensus       424 L~~~l-----------------~~~~-~--------~~l-~~~~~~~i~~----------------------~i~---~a  451 (652)
                      +....                 +... .        ... .+..+..+..                      .+.   ..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            64221                 1100 0        001 1112111111                      111   11


Q ss_pred             Hh-hhcc-CccceEEecCCCCCceEeCC-CCCeEEeeeccce
Q 038860          452 LL-YLHE-GYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAK  490 (652)
Q Consensus       452 L~-~LH~-~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~  490 (652)
                      |. .+.. .....++|+|+.+.|||++. +..+.|+||..|.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            11 1111 12468999999999999998 5789999999875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.37  E-value=0.0013  Score=70.24  Aligned_cols=77  Identities=10%  Similarity=0.072  Sum_probs=53.8

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcc-------hhhHHHHHHHHHHhcccC---cCceeEEEeeeeccCeeEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-------KQGVREFVSEIATIGRLR---HRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  414 (652)
                      .+.||.|.+..||+....+.++.|+||.-.+..       ....+.+..|.+.|..+.   ..++++++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            356899999999999997644689999854221       123455667777777763   345777777643  45789


Q ss_pred             EEEeccCCC
Q 038860          415 VYDFMANGS  423 (652)
Q Consensus       415 V~e~~~~gs  423 (652)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.29  E-value=0.00095  Score=69.09  Aligned_cols=141  Identities=18%  Similarity=0.131  Sum_probs=83.8

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc--eeEEEeee------eccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN--LVQLVGWC------RRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lV~  416 (652)
                      .+.|..|....+|+....+  ..+++|+....   ...+...|+.++..+.+..  +.+++...      ...+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS--GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC--CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            4567778888999986543  46888987652   2344566777777774332  44544421      2234568999


Q ss_pred             EeccCCCcccc----c----------cc------CC---ccccchHHHh----------hhHHHHHHHHhhhcc----Cc
Q 038860          417 DFMANGSLDSF----L----------FD------EP---KAVLNWEQRF----------KIIKGVASGLLYLHE----GY  459 (652)
Q Consensus       417 e~~~~gsL~~~----l----------~~------~~---~~~l~~~~~~----------~i~~~i~~aL~~LH~----~~  459 (652)
                      +|++|..+...    .          +.      ..   .....|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            99999776431    0          00      00   0011221110          011112233333331    12


Q ss_pred             cceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       460 ~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..+++|+|+.|.|||++++..+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            4679999999999999998777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.24  E-value=0.0013  Score=68.31  Aligned_cols=140  Identities=21%  Similarity=0.238  Sum_probs=82.1

Q ss_pred             ccccccCceEEEEEEEcC------CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc-eeEEEeeeeccCeeEEEEEe
Q 038860          346 QLLGHGGFGQVYKGTLHN------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN-LVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~  418 (652)
                      +.|..|-...+|+.....      .++.+++|....... ...+..+|.+++..+.... ..++++.+..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            445667777899887653      246788998765432 2234467888887775333 3455555542    358999


Q ss_pred             ccCCCccccc-----------------ccCCcc-------c--cchHHHhh--------------------------hHH
Q 038860          419 MANGSLDSFL-----------------FDEPKA-------V--LNWEQRFK--------------------------IIK  446 (652)
Q Consensus       419 ~~~gsL~~~l-----------------~~~~~~-------~--l~~~~~~~--------------------------i~~  446 (652)
                      ++|..+....                 +.....       .  .-|..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9987765321                 111000       0  00111111                          011


Q ss_pred             HHHHHHhhhc------cCccceEEecCCCCCceEeCCC----CCeEEeeeccce
Q 038860          447 GVASGLLYLH------EGYEQVVIHRDVKASNVLLDSE----LNGKLGDFGLAK  490 (652)
Q Consensus       447 ~i~~aL~~LH------~~~~~~ivHrDlk~~NILl~~~----~~~kL~DFGla~  490 (652)
                      .+...+..|-      ......++|+|+.+.|||++++    +.++++||..|.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            1222233332      1246789999999999999985    789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.20  E-value=0.0043  Score=64.99  Aligned_cols=141  Identities=16%  Similarity=0.150  Sum_probs=76.0

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc--eeEEEee------eeccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN--LVQLVGW------CRRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~  416 (652)
                      .+.|+.|....+|+....+ + .+++|+......   +....|..++..|...+  +.+.+..      ....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQ-G-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeCC-C-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            3456778888999987643 3 688898752222   23333455555543111  3333321      12245678999


Q ss_pred             EeccCCCcccc----c----------ccCC---------ccccch-HHHhh------------hHHH-HHHHHhhhcc--
Q 038860          417 DFMANGSLDSF----L----------FDEP---------KAVLNW-EQRFK------------IIKG-VASGLLYLHE--  457 (652)
Q Consensus       417 e~~~~gsL~~~----l----------~~~~---------~~~l~~-~~~~~------------i~~~-i~~aL~~LH~--  457 (652)
                      ||++|..+...    .          +...         ...+.| .....            .+.+ +...+..+..  
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            99998755321    0          1000         001111 11110            1111 1111222221  


Q ss_pred             --CccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          458 --GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       458 --~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                        ....++||+|+++.|||++.+...-|+||+.+.
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              135689999999999999976556899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.01  E-value=0.008  Score=62.60  Aligned_cols=142  Identities=19%  Similarity=0.133  Sum_probs=81.2

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc--eeEEEeee------eccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN--LVQLVGWC------RRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lV~  416 (652)
                      .+.++.|....+|+....+ + .+++|.......  ..+...|.+++..|....  +.+++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~-~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDV-G-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCC-C-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            4567777778999887542 3 577887754321  233445666666664222  34444322      1235678999


Q ss_pred             EeccCCCccccc--------------ccCCc----------cccchHHHh------------hhHHHHHHHHhhhcc---
Q 038860          417 DFMANGSLDSFL--------------FDEPK----------AVLNWEQRF------------KIIKGVASGLLYLHE---  457 (652)
Q Consensus       417 e~~~~gsL~~~l--------------~~~~~----------~~l~~~~~~------------~i~~~i~~aL~~LH~---  457 (652)
                      ||++|..+....              +....          ..-.|....            .....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999986653210              11000          001111110            001122334444432   


Q ss_pred             -CccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          458 -GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       458 -~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                       ....+++|+|+++.||+++.++...|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             235789999999999999988767899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.80  E-value=0.0072  Score=63.95  Aligned_cols=141  Identities=18%  Similarity=0.167  Sum_probs=81.9

Q ss_pred             ccccccCceEEEEEEEcC----CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCce-eEEEeeeeccCeeEEEEEecc
Q 038860          346 QLLGHGGFGQVYKGTLHN----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL-VQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~  420 (652)
                      ..|-.|-...+|+.....    .++.|++|.........+. -.+|..++..+...++ .++++.+..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345457777899987532    2367889988665433222 2568888888854444 3555655332    5899998


Q ss_pred             CCCccccc-----------------ccCC----ccccchHHHhhhHHHH-----------------HHHHhh----hcc-
Q 038860          421 NGSLDSFL-----------------FDEP----KAVLNWEQRFKIIKGV-----------------ASGLLY----LHE-  457 (652)
Q Consensus       421 ~gsL~~~l-----------------~~~~----~~~l~~~~~~~i~~~i-----------------~~aL~~----LH~-  457 (652)
                      +.+|...-                 |...    .....+.++.++..++                 ...+..    +.. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            87765220                 1111    1112233332332221                 111111    111 


Q ss_pred             CccceEEecCCCCCceEeCC-CCCeEEeeecccee
Q 038860          458 GYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAKL  491 (652)
Q Consensus       458 ~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~~  491 (652)
                      .....++|+|+++.|||+++ ++.+.++||..|..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22568999999999999986 46799999998763

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.65  E-value=0.018  Score=58.93  Aligned_cols=32  Identities=28%  Similarity=0.505  Sum_probs=26.4

Q ss_pred             cceEEecCCCCCceEeCCCCC-eEEeeecccee
Q 038860          460 EQVVIHRDVKASNVLLDSELN-GKLGDFGLAKL  491 (652)
Q Consensus       460 ~~~ivHrDlk~~NILl~~~~~-~kL~DFGla~~  491 (652)
                      ...++|+|+++.|||++++++ .-|+||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            346899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.51  E-value=0.026  Score=58.36  Aligned_cols=133  Identities=17%  Similarity=0.195  Sum_probs=82.9

Q ss_pred             cCceEEEEEEEcCCCeEEEEEEec-CcchhhHHHHHHHHHHhcccC--cCceeEEEeeeeccC--eeEEEEEeccCCCcc
Q 038860          351 GGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLR--HRNLVQLVGWCRRKG--DLLLVYDFMANGSLD  425 (652)
Q Consensus       351 G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~--~~~lV~e~~~~gsL~  425 (652)
                      |-.-.+|+....  ++.+++.+-. ...........+|..+|+.+.  ---+...++.|..+.  ..+.||+|++|..+.
T Consensus        36 G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~  113 (321)
T COG3173          36 GWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW  113 (321)
T ss_pred             CcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence            333345555443  5667777221 122334455667888887774  233455677776665  679999999986555


Q ss_pred             cccccCCccccchHHHhhhH-HHHHHHHhhhcc-----------------------------------------------
Q 038860          426 SFLFDEPKAVLNWEQRFKII-KGVASGLLYLHE-----------------------------------------------  457 (652)
Q Consensus       426 ~~l~~~~~~~l~~~~~~~i~-~~i~~aL~~LH~-----------------------------------------------  457 (652)
                      +.+.....   .    .+++ ..++..|.-||+                                               
T Consensus       114 ~~~~~~~~---~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W  186 (321)
T COG3173         114 SALPPESL---G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW  186 (321)
T ss_pred             CcCCcccc---h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence            44421111   1    1122 245555555552                                               


Q ss_pred             --------CccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          458 --------GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       458 --------~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                              .....++|+|+++.|++++....+-+.||+++..-
T Consensus       187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                    11467999999999999999988999999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.34  E-value=0.034  Score=57.04  Aligned_cols=75  Identities=19%  Similarity=0.337  Sum_probs=46.9

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc---CcCceeEEEeeeeccCeeEEEEEec
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL---RHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      +..+.++.|....+|+..  .+++.+.||.-...   ....|..|.+-|+.|   .--.+++++++....+..+||+||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345678889999999987  45678999987632   224566777777776   3456788898887777789999999


Q ss_pred             cCC
Q 038860          420 ANG  422 (652)
Q Consensus       420 ~~g  422 (652)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.02  E-value=0.03  Score=58.95  Aligned_cols=140  Identities=17%  Similarity=0.241  Sum_probs=79.1

Q ss_pred             cccccCceEEEEEEEcCC---CeEEEEEEecCcchhhHHHHHHHHHHhcccCcCce-eEEEeeeeccCeeEEEEEeccCC
Q 038860          347 LLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL-VQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      .|..|=...+|+....+.   +..|++|......... -+-.+|..+++.+...++ .++++++. .+   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            344466778898875432   2378899876543322 223568888888865444 45566553 22   589999877


Q ss_pred             Ccccc-------c----------ccCC----ccccchHHHhhhHHHH----------------------HHHHh----hh
Q 038860          423 SLDSF-------L----------FDEP----KAVLNWEQRFKIIKGV----------------------ASGLL----YL  455 (652)
Q Consensus       423 sL~~~-------l----------~~~~----~~~l~~~~~~~i~~~i----------------------~~aL~----~L  455 (652)
                      .|..-       +          +...    ..+--|..+.++..++                      ..-+.    .+
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            66321       1          1111    0011222222222221                      11111    11


Q ss_pred             cc-CccceEEecCCCCCceEeCC-CCCeEEeeecccee
Q 038860          456 HE-GYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAKL  491 (652)
Q Consensus       456 H~-~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~~  491 (652)
                      .+ ......+|.|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 12346899999999999975 47899999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.98  E-value=0.015  Score=56.86  Aligned_cols=32  Identities=31%  Similarity=0.432  Sum_probs=23.1

Q ss_pred             cceEEecCCCCCceEe-CCCCCeEEeeecccee
Q 038860          460 EQVVIHRDVKASNVLL-DSELNGKLGDFGLAKL  491 (652)
Q Consensus       460 ~~~ivHrDlk~~NILl-~~~~~~kL~DFGla~~  491 (652)
                      ...++|+|+.+.|||+ +.++.++|+||..|..
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            4679999999999999 7889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.94  E-value=0.008  Score=61.14  Aligned_cols=149  Identities=16%  Similarity=0.136  Sum_probs=95.2

Q ss_pred             cchhhhhhhhc---CccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---------h--------h-----hHHHH
Q 038860          330 YSYQELKQATN---NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---------K--------Q-----GVREF  384 (652)
Q Consensus       330 ~~~~el~~~~~---~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~--------~-----~~~~~  384 (652)
                      +.|..|+...+   -+...+.||-|.-+.||.+-+.. |++.++|.-+-..         +        .     ..-..
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            44444444333   45678899999999999999875 7788888421110         0        0     01123


Q ss_pred             HHHHHHhcccCc-C-ceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce
Q 038860          385 VSEIATIGRLRH-R-NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV  462 (652)
Q Consensus       385 ~~E~~~l~~l~h-~-niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~  462 (652)
                      .+|...|+.|.. . -+.+.++++    .-++|||++.+-.|...-+-.     +..++   ...+..-+.-|-   ..|
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~-----d~~~l---y~~lm~~Iv~la---~~G  222 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHVE-----DPPTL---YDDLMGLIVRLA---NHG  222 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeecC-----ChHHH---HHHHHHHHHHHH---HcC
Confidence            567777777742 2 234444443    457999999988887654222     22222   222222233344   589


Q ss_pred             EEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       463 ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      +||+|..-=||+++++..++++||-.+....+
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVSTSH  254 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhhccCC
Confidence            99999999999999999999999987765443

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.84  E-value=0.085  Score=56.46  Aligned_cols=73  Identities=11%  Similarity=0.107  Sum_probs=49.3

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcch-------hhHHHHHHHHHHhcccC---cCceeEEEeeeeccCeeEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-------QGVREFVSEIATIGRLR---HRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  414 (652)
                      .+.||.|....||+....  +..++||+-.....       ....+-..|...|+.+.   ..++.+++.++.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            567899999999998874  45699998752211       12223334555555543   3578889998884  4578


Q ss_pred             EEEeccC
Q 038860          415 VYDFMAN  421 (652)
Q Consensus       415 V~e~~~~  421 (652)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.83  E-value=0.062  Score=55.81  Aligned_cols=144  Identities=16%  Similarity=0.141  Sum_probs=93.6

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCc---------------------chhh-----HHHHHHHHHHhcccCc
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---------------------SKQG-----VREFVSEIATIGRLRH  396 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------------------~~~~-----~~~~~~E~~~l~~l~h  396 (652)
                      .+..+|..|.-+-||.+.-.+ |..+|||+++..                     ++..     .-....|+.-|.+|+.
T Consensus       147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            345678889999999998765 777999987431                     0000     1123467778888764


Q ss_pred             CceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC
Q 038860          397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD  476 (652)
Q Consensus       397 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~  476 (652)
                      ..|...--...  ..-.|||+|+....-..-.  -....++...+..+-.|++.-+.-|-+  ..++||.||.--|+|+-
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk--LKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPK--LKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH  299 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcc--cccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE
Confidence            44332111111  1347899999532111101  123346666777788888888888776  56799999999999885


Q ss_pred             CCCCeEEeeeccceeccc
Q 038860          477 SELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       477 ~~~~~kL~DFGla~~~~~  494 (652)
                      + |.+.|+|-+.+.-.++
T Consensus       300 d-G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  300 D-GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             C-CEEEEEEccccccCCC
Confidence            4 5899999998775443

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.79  E-value=0.091  Score=54.93  Aligned_cols=139  Identities=17%  Similarity=0.203  Sum_probs=79.5

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCce------eEEEe----eeeccCeeEEEE
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL------VQLVG----WCRRKGDLLLVY  416 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni------v~l~~----~~~~~~~~~lV~  416 (652)
                      .|.+ .-..+|+....+. . +++|..+..  ....+...|...+..|.-..+      ..+=|    .........-++
T Consensus        33 ~l~s-~eN~~f~~~~~~g-~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTEDG-R-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecCC-C-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3444 5567899888653 3 388988775  233445567777776632221      11111    111113678899


Q ss_pred             EeccCCCccc-cc--------------c----c----C--CccccchHH-------------HhhhHHHHHHHHhhhcc-
Q 038860          417 DFMANGSLDS-FL--------------F----D----E--PKAVLNWEQ-------------RFKIIKGVASGLLYLHE-  457 (652)
Q Consensus       417 e~~~~gsL~~-~l--------------~----~----~--~~~~l~~~~-------------~~~i~~~i~~aL~~LH~-  457 (652)
                      +|++|..+.. ..              +    +    .  ......|..             ......++...+..+.+ 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999988873 11              0    0    1  011233331             01122333344444433 


Q ss_pred             ---Cccce---EEecCCCCCceEeCCCCC-eEEeeeccce
Q 038860          458 ---GYEQV---VIHRDVKASNVLLDSELN-GKLGDFGLAK  490 (652)
Q Consensus       458 ---~~~~~---ivHrDlk~~NILl~~~~~-~kL~DFGla~  490 (652)
                         .....   +||+|+.|.||+++.+.. +.++||+-|.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               11223   999999999999999875 8999999876

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.70  E-value=0.05  Score=57.15  Aligned_cols=73  Identities=11%  Similarity=0.072  Sum_probs=45.9

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCcc-------hhhHHHHHHHHHHhcccC--cC-ceeEEEeeeeccCeeEEEE
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES-------KQGVREFVSEIATIGRLR--HR-NLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV~  416 (652)
                      .||.|....||++...+.++.|+||.-.+..       .-...+..-|...|+...  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            4799999999999986544689999764321       122334445666665542  34 34444433  344567899


Q ss_pred             EeccC
Q 038860          417 DFMAN  421 (652)
Q Consensus       417 e~~~~  421 (652)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=95.64  E-value=0.017  Score=67.72  Aligned_cols=156  Identities=19%  Similarity=0.189  Sum_probs=105.3

Q ss_pred             HHHHHHHHHHhcccCcCceeEEEeeeeccCee----EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhc
Q 038860          381 VREFVSEIATIGRLRHRNLVQLVGWCRRKGDL----LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH  456 (652)
Q Consensus       381 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH  456 (652)
                      +....-|...+.++.|+|++.++.|-.++...    .+..|++..-++...+.  ....++....+.+..++.+||.|+|
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHH
Confidence            34455677888899999999999987654332    33456777767766663  3446778888899999999999999


Q ss_pred             cCccceEEecCCCCC---ceEeCCCCCeEEe--eeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCC--ccchHhH
Q 038860          457 EGYEQVVIHRDVKAS---NVLLDSELNGKLG--DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA--SSDVFAF  529 (652)
Q Consensus       457 ~~~~~~ivHrDlk~~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDv~Sl  529 (652)
                      +   ....|.-+..+   +-..+.++.+.++  ||+..+.......  .....-+..+.+||......+..  ..|+|.+
T Consensus       304 ~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 S---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             H---hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHH
Confidence            4   44444333333   3333445556666  8887775543221  11223455678888777665544  4799999


Q ss_pred             HHHHHHHHhCCCCC
Q 038860          530 GALLLEVACGRRPI  543 (652)
Q Consensus       530 Gvvl~elltG~~p~  543 (652)
                      |..+..+..|..+-
T Consensus       379 gll~~~~~~~~~i~  392 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDIS  392 (1351)
T ss_pred             HHHHhhhhhcCccc
Confidence            99999999887664

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.53  E-value=0.035  Score=57.51  Aligned_cols=73  Identities=25%  Similarity=0.223  Sum_probs=58.5

Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      .+.|++|++. |++|...      ....|++...++.+.+..+.-+..  +-..-|||+...||||+ +|++.|+||-++
T Consensus       299 ~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         299 LYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             eEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence            3556777765 5555432      235688899999999988888876  67889999999999999 999999999999


Q ss_pred             eec
Q 038860          490 KLY  492 (652)
Q Consensus       490 ~~~  492 (652)
                      |.-
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            953

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	652
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-47
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-46
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-24
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-24
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-24
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-23
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-23
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-23
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-23
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-23
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-23
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-23
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-23
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-23
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-23
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-23
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-23
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-23
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-23
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-23
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-23
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-23
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-23
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-23
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-23
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-23
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-23
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-23
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-23
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-23
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-22
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-22
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-22
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-22
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-22
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-22
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-22
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-22
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-22
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-22
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-22
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-21
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-18
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-17
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		2e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-16
3usu_B	242	Crystal Structure Of Butea Monosperma Seed Lectin L		3e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-16
3usu_A	256	Crystal Structure Of Butea Monosperma Seed Lectin L		4e-16
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		4e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
1avb_A	226	Arcelin-1 From Phaseolus Vulgaris L Length = 226		1e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-15
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-14
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-14
1gz9_A	239	High-Resolution Crystal Structure Of Erythrina Cris		9e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-13
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-13
1ax0_A	239	Erythrina Corallodendron Lectin In Complex With N-A		4e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-13
3n35_A	242	Erythrina Corallodendron Lectin Mutant (Y106g) With		5e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-13
1uzy_A	242	Erythrina Crystagalli Lectin Length = 242		7e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-13
1fny_A	237	Legume Lectin Of The Bark Of Robinia Pseudoacacia.		7e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
1fyu_A	255	Crystal Structure Of Erythrina Corallodendron Lecti		8e-13
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		8e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
1fat_A	252	Phytohemagglutinin-L Length = 252		9e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-12
2sba_A	253	Soybean Agglutinin Complexed With 2,6-Pentasacchari		1e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
1bjq_A	253	The Dolichos Biflorus Seed Lectin In Complex With A		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
1sfy_A	239	Crystal Structure Of Recombinant Erythrina Corallod		1e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
1lte_A	239	Structure Of A Legume Lectin With An Ordered N-Link		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-12
1ioa_A	240	Arcelin-5, A Lectin-Like Defense Protein From Phase		3e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-12
1fay_A	238	Winged Bean Acidic Lectin Complexed With Methyl-Alp		4e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-11
1wbl_A	241	Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga		1e-11
1wbf_A	242	Winged Bean Lectin, Saccharide Free Form Length = 2		1e-11
2e7q_A	237	Crystal Structure Of Basic Winged Bean Lectin In Co		1e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		2e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-11
1dbn_A	239	Maackia Amurensis Leukoagglutinin (Lectin) With Sia		4e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
2bqp_A	234	The Structure Of The Pea Lectin-D-Glucopyranose Com		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-10
3soa_A	444	Full-Length Human Camkii Length = 444		3e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-10
1qnw_A	242	Lectin Ii From Ulex Europaeus Length = 242		3e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-10
1n47_A	233	Isolectin B4 From Vicia Villosa In Complex With The		5e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-09
2eig_A	234	Lotus Tetragonolobus Seed Lectin (Isoform) Length =		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
3zvx_A	261	Structure Of The Lectin From Platypodium Elegans In		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
1dhk_B	223	Structure Of Porcine Pancreatic Alpha-Amylase Lengt		1e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
1viw_B	205	Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Le		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
1gnz_A	257	Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
1hql_A	257	The Xenograft Antigen In Complex With The B4 Isolec		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
1n3o_A	252	Pterocarcpus Angolensis Lectin In Complex With Alph		4e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
1q8o_A	252	Pterocartpus Angolensis Lectin Pal In Complex With		4e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
1fx5_A	242	Crystal Structure Analysis Of Ulex Europaeus Lectin		5e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-07

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  209 bits (532), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 118/272 (43%), Positives = 172/272 (63%), Gaps = 7/272 (2%)
Query: 319 EDWELEVGP-QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES 377
           ED E+ +G  +R+S +EL+ A++NFS K +LG GGFG+VYKG L +  T VAVKR+  E 
Sbjct: 16  EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEER 74
Query: 378 KQGVR-EFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV- 435
            QG   +F +E+  I    HRNL++L G+C    + LLVY +MANGS+ S L + P++  
Sbjct: 75  XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 134
Query: 436 -LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH 494
            L+W +R +I  G A GL YLH+  +  +IHRDVKA+N+LLD E    +GDFGLAKL ++
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP--EEL 552
                   V GT+G++APE   TGKSS  +DVF +G +LLE+  G+R  +   L   +++
Sbjct: 195 KDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 254
Query: 553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQV 584
           +L+DWV G   E ++  ++D  L   Y   +V
Sbjct: 255 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 286

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (518), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 115/272 (42%), Positives = 169/272 (62%), Gaps = 7/272 (2%)
Query: 319 EDWELEVGP-QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES 377
           ED E+ +G  +R+S +EL+ A++NF  K +LG GGFG+VYKG L +    VAVKR+  E 
Sbjct: 8   EDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL-VAVKRLKEER 66
Query: 378 KQGVR-EFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV- 435
            QG   +F +E+  I    HRNL++L G+C    + LLVY +MANGS+ S L + P++  
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 436 -LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH 494
            L+W +R +I  G A GL YLH+  +  +IHRDVKA+N+LLD E    +GDFGLAKL ++
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP--EEL 552
                   V G +G++APE   TGKSS  +DVF +G +LLE+  G+R  +   L   +++
Sbjct: 187 KDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQV 584
           +L+DWV G   E ++  ++D  L   Y   +V
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  186 bits (471), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 107/251 (42%), Positives = 156/251 (62%), Gaps = 9/251 (3%)
Query: 329 RYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEI 388
           R    +L++ATNNF  K L+GHG FG+VYKG L +   +VA+KR + ES QG+ EF +EI
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESSQGIEEFETEI 86
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF--DEPKAVLNWEQRFKIIK 446
            T+   RH +LV L+G+C  + +++L+Y +M NG+L   L+  D P   ++WEQR +I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL-YEHGTNPATTRVVG 505
           G A GL YLH    + +IHRDVK+ N+LLD     K+ DFG++K   E G       V G
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV-LVDWVWGKYGE 564
           TLGY+ PE    G+ +  SDV++FG +L EV C R  I  ++LP E+V L +W    +  
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHNN 262
Query: 565 GRVLEVIDPKL 575
           G++ +++DP L
Sbjct: 263 GQLEQIVDPNL 273

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  184 bits (467), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/254 (42%), Positives = 157/254 (61%), Gaps = 15/254 (5%)
Query: 329 RYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEI 388
           R    +L++ATNNF  K L+GHG FG+VYKG L +   +VA+KR + ES QG+ EF +EI
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESSQGIEEFETEI 86
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF--DEPKAVLNWEQRFKIIK 446
            T+   RH +LV L+G+C  + +++L+Y +M NG+L   L+  D P   ++WEQR +I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR---- 502
           G A GL YLH    + +IHRDVK+ N+LLD     K+ DFG++K    GT    T     
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLXXV 200
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV-LVDWVWGK 561
           V GTLGY+ PE    G+ +  SDV++FG +L EV C R  I  ++LP E+V L +W    
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVES 259
Query: 562 YGEGRVLEVIDPKL 575
           +  G++ +++DP L
Sbjct: 260 HNNGQLEQIVDPNL 273

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 22/273 (8%)
Query: 319 EDWELEVGPQRY---SYQELKQATNNFSAKQL------LGHGGFGQVYKGTLHNSKTEVA 369
           E+  LEV   R+   S+ ELK  TNNF  + +      +G GGFG VYKG ++N  T VA
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 370 VKRISN----ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGS-L 424
           VK+++      +++  ++F  EI  + + +H NLV+L+G+     DL LVY +M NGS L
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D     +    L+W  R KI +G A+G+ +LHE +    IHRD+K++N+LLD     K+ 
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKIS 175
Query: 485 DFGLAKLYEH-GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           DFGLA+  E        +R+VGT  Y+APE  R G+ +  SD+++FG +LLE+  G   +
Sbjct: 176 DFGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 544 ETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN 576
           +    P +L+L      +  E  + + ID K+N
Sbjct: 235 DEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMN 266

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  159 bits (403), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 154/273 (56%), Gaps = 22/273 (8%)
Query: 319 EDWELEVGPQRY---SYQELKQATNNFSAKQL------LGHGGFGQVYKGTLHNSKTEVA 369
           E+  LEV   R+   S+ ELK  TNNF  + +      +G GGFG VYKG ++N  T VA
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 370 VKRISN----ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGS-L 424
           VK+++      +++  ++F  EI  + + +H NLV+L+G+     DL LVY +M NGS L
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D     +    L+W  R KI +G A+G+ +LHE +    IHRD+K++N+LLD     K+ 
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKIS 175
Query: 485 DFGLAKLYEH-GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           DFGLA+  E         R+VGT  Y+APE  R G+ +  SD+++FG +LLE+  G   +
Sbjct: 176 DFGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 544 ETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN 576
           +    P +L+L      +  E  + + ID K+N
Sbjct: 235 DEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMN 266

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  156 bits (395), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 96/259 (37%), Positives = 148/259 (57%), Gaps = 19/259 (7%)
Query: 330 YSYQELKQATNNFSAKQL------LGHGGFGQVYKGTLHNSKTEVAVKRISN----ESKQ 379
           +S+ ELK  TNNF  + +      +G GGFG VYKG ++N  T VAVK+++      +++
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 66
Query: 380 GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGS-LDSFLFDEPKAVLNW 438
             ++F  EI  + + +H NLV+L+G+     DL LVY +M NGS LD     +    L+W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTN 497
             R KI +G A+G+ +LHE +    IHRD+K++N+LLD     K+ DFGLA+  E     
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDW 557
               R+VGT  Y+APE  R G+ +  SD+++FG +LLE+  G   ++    P +L+L   
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIK 241
Query: 558 VWGKYGEGRVLEVIDPKLN 576
              +  E  + + ID K+N
Sbjct: 242 EEIEDEEKTIEDYIDKKMN 260

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 89/236 (37%), Positives = 135/236 (57%), Gaps = 18/236 (7%)
Query: 330 YSYQELKQATNNFSAKQL------LGHGGFGQVYKGTLHNSKTEVAVKRISN----ESKQ 379
           +S+ ELK  TNNF  + +       G GGFG VYKG ++N  T VAVK+++      +++
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 63
Query: 380 GVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNW 438
             ++F  EI    + +H NLV+L+G+     DL LVY +  NGSL D     +    L+W
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTN 497
             R KI +G A+G+ +LHE +    IHRD+K++N+LLD     K+ DFGLA+  E     
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
              +R+VGT  Y APE  R G+ +  SD+++FG +LLE+  G   ++    P+ L+
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 235

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 113/203 (55%), Gaps = 3/203 (1%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           + + K+ +G G FG V++   H S   V +    +   + V EF+ E+A + RLRH N+V
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-PKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             +G   +  +L +V ++++ GSL   L     +  L+  +R  +   VA G+ YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NR 156
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
              ++HR++K+ N+L+D +   K+ DFGL++L +  T  ++    GT  ++APE  R   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 520 SSASSDVFAFGALLLEVACGRRP 542
           S+  SDV++FG +L E+A  ++P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 3/203 (1%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           + + K+ +G G FG V++   H S   V +    +   + V EF+ E+A + RLRH N+V
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-PKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             +G   +  +L +V ++++ GSL   L     +  L+  +R  +   VA G+ YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NR 156
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
              ++HRD+K+ N+L+D +   K+ DFGL++L +      +    GT  ++APE  R   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDEP 215
Query: 520 SSASSDVFAFGALLLEVACGRRP 542
           S+  SDV++FG +L E+A  ++P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQP 238

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 4/213 (1%)
Query: 325 VGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF 384
           + P   +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           + E A +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
              ++S + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A     
Sbjct: 122 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 178
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
             + + APE+    K S  SDV+AFG LL E+A
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 4/213 (1%)
Query: 325 VGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF 384
           + P   +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           + E A +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
              ++S + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A     
Sbjct: 122 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
             + + APE+    K S  SDV+AFG LL E+A
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGLA++ E     A T   G +   + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 4/213 (1%)
Query: 325 VGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF 384
           + P   +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           + E A +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
              ++S + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A     
Sbjct: 122 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
             + + APE+    K S  SDV+AFG LL E+A
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 4/213 (1%)
Query: 325 VGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF 384
           + P   +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           + E A +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
              ++S + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A     
Sbjct: 122 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
             + + APE+    K S  SDV+AFG LL E+A
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 124 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 180
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 122/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL  +  A     Q   +++G+ASG+ Y
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G   + + +
Sbjct: 134 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 91
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 150
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 151 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 207 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 124 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 180
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIA 210

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 125 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 181
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 75
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 136 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 192
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEIA 219

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 43  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 101
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 160
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 161 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 125 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 125 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 120/212 (56%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL ++ E     A T   G +   + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 130/231 (56%), Gaps = 22/231 (9%)
Query: 330 YSYQELKQATNNFSAK---------QLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNE 376
           +++++  +A   F+ +         Q++G G FG+V  G L      +  VA+K + S  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           +++  R+F+SE + +G+  H N++ L G   +   ++++ +FM NGSLDSFL  +     
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQF 132
Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
              Q   +++G+A+G+ YL    +   +HRD+ A N+L++S L  K+ DFGL++  E  T
Sbjct: 133 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 189
Query: 497 -NPATTRVVG---TLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
            +P  T  +G    + + APE  +  K +++SDV+++G ++ EV + G RP
Sbjct: 190 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 4/213 (1%)
Query: 325 VGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF 384
           + P   +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 61
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           + E A +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  ++      +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
              ++S + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A     
Sbjct: 122 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
             + + APE+    K S  SDV+AFG LL E+A
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V + M NGSLDSFL  +  A     Q   +++G+ASG+ Y
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 134 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 122/212 (57%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V ++M NGSLDSFL  +  A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + G+    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 163 LSDMGF----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 120/212 (56%), Gaps = 15/212 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V + M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLA 511
           L + GY    +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +
Sbjct: 163 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 512 PETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           PE     K +++SDV+++G +L EV + G RP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 124/209 (59%), Gaps = 17/209 (8%)
Query: 345 KQLLGHGGFGQVYKGTLH---NSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLV 400
           ++++G G FG+V +G L      ++ VA+K +    +++  REF+SE + +G+  H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLF--DEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +L G       ++++ +FM NG+LDSFL   D    V+   Q   +++G+ASG+ YL   
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLA-- 133
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVG---TLGYLAPET 514
            E   +HRD+ A N+L++S L  K+ DFGL++ L E+ ++P  T  +G    + + APE 
Sbjct: 134 -EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 515 PRTGKSSASSDVFAFGALLLEV-ACGRRP 542
               K +++SD +++G ++ EV + G RP
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 124/209 (59%), Gaps = 17/209 (8%)
Query: 345 KQLLGHGGFGQVYKGTLH---NSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLV 400
           ++++G G FG+V +G L      ++ VA+K +    +++  REF+SE + +G+  H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLF--DEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +L G       ++++ +FM NG+LDSFL   D    V+   Q   +++G+ASG+ YL   
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLA-- 135
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVG---TLGYLAPET 514
            E   +HRD+ A N+L++S L  K+ DFGL++ L E+ ++P  T  +G    + + APE 
Sbjct: 136 -EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 515 PRTGKSSASSDVFAFGALLLEV-ACGRRP 542
               K +++SD +++G ++ EV + G RP
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 4/198 (2%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            + + K  LG G FG+VY+G        VAVK +  ++ + V EF+ E A +  ++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           VQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S + YL +  
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 127
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
            +  IHRD+ A N L+      K+ DFGL++L    T  A       + + APE+    K
Sbjct: 128 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 520 SSASSDVFAFGALLLEVA 537
            S  SDV+AFG LL E+A
Sbjct: 187 FSIKSDVWAFGVLLWEIA 204

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 308
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  +N      +   ++S
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHR++ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 369 AMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 425
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEIA 452

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 4/198 (2%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A +  ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           VQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S + YL +  
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 127
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
            +  IHRD+ A N L+      K+ DFGL++L    T  A       + + APE+    K
Sbjct: 128 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 520 SSASSDVFAFGALLLEVA 537
            S  SDV+AFG LL E+A
Sbjct: 187 FSIKSDVWAFGVLLWEIA 204

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 118/211 (55%), Gaps = 13/211 (6%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQGVREFVSEIATIGRL 394
            N S  +++G G FG+V  G L   SK E++V     ++    KQ  R+F+ E + +G+ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 103
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   +++V + M NGSLDSFL     A     Q   +++G+ASG+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKY 162
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLAP 512
           L    +   +HRD+ A N+L++S L  K+ DFGL+++ E     A T   G +   + +P
Sbjct: 163 LS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 513 ETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           E     K +++SDV+++G +L EV + G RP
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 126/230 (54%), Gaps = 22/230 (9%)
Query: 330 YSYQELKQATNNFSAK---------QLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNE 376
           ++Y+E  +A  +F+ +         +++G G  G+V  G L         VA+K + +  
Sbjct: 30  HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           +++  R+F+SE + +G+  H N+++L G   R    ++V ++M NGSLD+FL        
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQF 148
Query: 437 NWEQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
              Q   +++GV +G+ YL + GY    +HRD+ A NVL+DS L  K+ DFGL+++ E  
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 496 TNPATTRVVGTLG--YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
            + A T   G +   + APE       S++SDV++FG ++ EV A G RP
Sbjct: 205 PDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 12/208 (5%)
Query: 343 SAKQLLGHGGFGQVYKGTLHNS----KTEVAVKRISNESKQGVR-EFVSEIATIGRLRHR 397
           + ++++G G FG+VYKG L  S    +  VA+K +     +  R +F+ E   +G+  H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           N+++L G   +   ++++ ++M NG+LD FL  E     +  Q   +++G+A+G+ YL  
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLAPETP 515
                 +HRD+ A N+L++S L  K+ DFGL+++ E       T   G +   + APE  
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 516 RTGKSSASSDVFAFGALLLEVAC-GRRP 542
              K +++SDV++FG ++ EV   G RP
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 120/207 (57%), Gaps = 13/207 (6%)
Query: 345 KQLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           +Q++G G FG+V  G L      +  VA+K + S  +++  R+F+SE + +G+  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            L G   +   ++++ +FM NGSLDSFL  +        Q   +++G+A+G+ YL    +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLA---D 127
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT-NPATTRVVG---TLGYLAPETPR 516
              +HR + A N+L++S L  K+ DFGL++  E  T +P  T  +G    + + APE  +
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 517 TGKSSASSDVFAFGALLLEV-ACGRRP 542
             K +++SDV+++G ++ EV + G RP
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 126/230 (54%), Gaps = 22/230 (9%)
Query: 330 YSYQELKQATNNFSAK---------QLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNE 376
           ++Y+E  +A  +F+ +         +++G G  G+V  G L         VA+K + +  
Sbjct: 30  HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           +++  R+F+SE + +G+  H N+++L G   R    ++V ++M NGSLD+FL        
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQF 148
Query: 437 NWEQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
              Q   +++GV +G+ YL + GY    +HRD+ A NVL+DS L  K+ DFGL+++ E  
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 496 TNPATTRVVGTLG--YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
            + A T   G +   + APE       S++SDV++FG ++ EV A G RP
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 4/207 (1%)
Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A 
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 269
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YL +   +  IHR++ A N L+      K+ DFGL++L    T  A       + + 
Sbjct: 330 AMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 511 APETPRTGKSSASSDVFAFGALLLEVA 537
           APE+    K S  SDV+AFG LL E+A
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIA 413

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 127/228 (55%), Gaps = 20/228 (8%)
Query: 327 PQRYSYQELKQA-TNNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVK----RISNESKQG 380
           P R  +Q  K+   +    ++++G G FG+V  G L    K +VAV     ++    KQ 
Sbjct: 29  PNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR 88
Query: 381 VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNW 438
            R+F+ E + +G+  H N+V L G   R   +++V +FM NG+LD+FL   D    V+  
Sbjct: 89  -RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI-- 145
Query: 439 EQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN 497
            Q   +++G+A+G+ YL + GY    +HRD+ A N+L++S L  K+ DFGL+++ E    
Sbjct: 146 -QLVGMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 498 PATTRVVGTLG--YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
              T   G +   + APE  +  K +++SDV+++G ++ EV + G RP
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 4/198 (2%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ E A +  ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           VQL+G C R+    ++ +FM  G+L  +L +  +  ++      +   ++S + YL +  
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 127
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
            +  IHRD+ A N L+      K+ DFGL++L    T  A       + + APE+    K
Sbjct: 128 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNK 186
Query: 520 SSASSDVFAFGALLLEVA 537
            S  SDV+AFG LL E+A
Sbjct: 187 FSIKSDVWAFGVLLWEIA 204

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 127/231 (54%), Gaps = 24/231 (10%)
Query: 330 YSYQELKQATNNFSAK---------QLLGHGGFGQVYKGTLH---NSKTEVAVK--RISN 375
           ++Y++  QA + F+ +         +++G G FG+V  G L      +  VA+K  ++  
Sbjct: 3   HTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGY 62
Query: 376 ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV 435
             KQ  R+F+ E + +G+  H N++ L G   +   +++V ++M NGSLD+FL  +    
Sbjct: 63  TEKQR-RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQ 120
Query: 436 LNWEQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH 494
               Q   +++G+++G+ YL + GY    +HRD+ A N+L++S L  K+ DFGL+++ E 
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLED 176
Query: 495 GTNPATTRVVGTLG--YLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
               A T   G +   + APE     K +++SDV+++G ++ EV   G RP
Sbjct: 177 DPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV----SEIATIGRLRHR 397
            + ++++G GGFG+VY+        EVAVK   ++  + + + +     E      L+H 
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVASGLLY 454
           N++ L G C ++ +L LV +F   G L+  L  +   P  ++NW  +      +A G+ Y
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNY 120
Query: 455 LHEGYEQVVIHRDVKASNVLLDSEL-NG-------KLGDFGLAKLYEHGTNPATTRVVGT 506
           LH+     +IHRD+K+SN+L+  ++ NG       K+ DFGLA+ +   T        G 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGA 177
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             ++APE  R    S  SDV+++G LL E+  G  P
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 366 SFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 366 SFGILLTELTTKGRVP 381

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 126/235 (53%), Gaps = 32/235 (13%)
Query: 330 YSYQELKQATNNFSAK---------QLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNE 376
           +++++  QA   F+ +         +++G G FG+V  G L      +  VA+K + +  
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + +  R+F+SE + +G+  H N++ L G   +   ++++ ++M NGSLD+FL        
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN----- 124
Query: 437 NWEQRFKII------KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             + RF +I      +G+ SG+ YL    +   +HRD+ A N+L++S L  K+ DFG+++
Sbjct: 125 --DGRFTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 491 LYEHGTNPATTRVVGTLG--YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           + E     A T   G +   + APE     K +++SDV+++G ++ EV + G RP
Sbjct: 180 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 16  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 74  EE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 129
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 190 SFGILLTELTTKGRVP 205

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/201 (37%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG- 404
           Q +G G FG V  G    +K  VAVK I N++    + F++E + + +LRH NLVQL+G 
Sbjct: 199 QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
               KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL EG     +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 311
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTGKSSA 522
           HRD+ A NVL+  +   K+ DFGL K        ++T+  G L   + APE  R  K S 
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 523 SSDVFAFGALLLEV-ACGRRP 542
            SDV++FG LL E+ + GR P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/201 (37%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG- 404
           Q +G G FG V  G    +K  VAVK I N++    + F++E + + +LRH NLVQL+G 
Sbjct: 27  QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
               KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL EG     +
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 139
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTGKSSA 522
           HRD+ A NVL+  +   K+ DFGL K        ++T+  G L   + APE  R  K S 
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 523 SSDVFAFGALLLEV-ACGRRP 542
            SDV++FG LL E+ + GR P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 19  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 77  EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 132
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 193 SFGILLTELTTKGRVP 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/201 (37%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG- 404
           Q +G G FG V  G    +K  VAVK I N++    + F++E + + +LRH NLVQL+G 
Sbjct: 12  QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
               KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL EG     +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 124
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTGKSSA 522
           HRD+ A NVL+  +   K+ DFGL K        ++T+  G L   + APE  R  K S 
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 523 SSDVFAFGALLLEV-ACGRRP 542
            SDV++FG LL E+ + GR P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 17  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 75  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 130
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 191 SFGILLTELTTKGRVP 206

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 275 LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 333 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 449 SFGILLTELTTKGRVP 464

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 250 EE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 366 SFGILLTELTTKGRVP 381

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 15  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 73  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 128
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 189 SFGILLTELTTKGRVP 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           LG G FG+V+ GT  N  T VA+K +   N S +    F+ E   + +LRH  LVQL   
Sbjct: 193 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQLYAV 248
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +H
Sbjct: 249 VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 304
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD++A+N+L+   L  K+ DFGL +L E     A       + + APE    G+ +  SD
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 526 VFAFGALLLEVAC-GRRP 542
           V++FG LL E+   GR P
Sbjct: 365 VWSFGILLTELTTKGRVP 382

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + ++RH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/201 (37%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG- 404
           Q +G G FG V  G    +K  VAVK I N++    + F++E + + +LRH NLVQL+G 
Sbjct: 18  QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
               KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL EG     +
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 130
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTGKSSA 522
           HRD+ A NVL+  +   K+ DFGL K        ++T+  G L   + APE  R    S 
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 523 SSDVFAFGALLLEV-ACGRRP 542
            SDV++FG LL E+ + GR P
Sbjct: 185 KSDVWSFGILLWEIYSFGRVP 205

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           + A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ G L  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 23  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M  GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 81  EE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRD 136
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 197 SFGILLTELTTKGRVP 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M+ G L  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 139
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 200 SFGILLTELTTKGRVP 215

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL     
Sbjct: 23  LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 79
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M  GSL  FL  E    L   Q   +   +ASG+ Y+        +HRD
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRD 136
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 528 AFGALLLEVAC-GRRP 542
           +FG LL E+   GR P
Sbjct: 197 SFGILLTELTTKGRVP 212

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 117/211 (55%), Gaps = 23/211 (10%)
Query: 345 KQLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++++G G FG+V  G L      +  VA+K + +  + +  R+F+SE + +G+  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII------KGVASGLLY 454
            L G   +   ++++ ++M NGSLD+FL          + RF +I      +G+ SG+ Y
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKN-------DGRFTVIQLVGMLRGIGSGMKY 125
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG--YLAP 512
           L    +   +HRD+ A N+L++S L  K+ DFG++++ E     A T   G +   + AP
Sbjct: 126 LS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 513 ETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           E     K +++SDV+++G ++ EV + G RP
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 117/211 (55%), Gaps = 23/211 (10%)
Query: 345 KQLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++++G G FG+V  G L      +  VA+K + +  + +  R+F+SE + +G+  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII------KGVASGLLY 454
            L G   +   ++++ ++M NGSLD+FL          + RF +I      +G+ SG+ Y
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKN-------DGRFTVIQLVGMLRGIGSGMKY 131
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAP 512
           L    +   +HRD+ A N+L++S L  K+ DFG++++ E     A T   G   + + AP
Sbjct: 132 LS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 513 ETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           E     K +++SDV+++G ++ EV + G RP
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           Q +G G FG V+ G   N K +VA+K I  E      +F+ E   + +L H  LVQL G 
Sbjct: 11  QEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C  +  + LV++FM +G L  +L  + + +   E    +   V  G+ YL E     VIH
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 124
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N L+      K+ DFG+ +        ++T     + + +PE     + S+ SD
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 526 VFAFGALLLEV-ACGRRPIETRA 547
           V++FG L+ EV + G+ P E R+
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRS 207

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 4/198 (2%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            + + K  LG G +G+VY G        VAVK +  ++ + V EF+ E A +  ++H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 90
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           VQL+G C  +    +V ++M  G+L  +L +  +  +       +   ++S + YL +  
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK-- 148
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
            +  IHRD+ A N L+      K+ DFGL++L    T  A       + + APE+     
Sbjct: 149 -KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT 207
Query: 520 SSASSDVFAFGALLLEVA 537
            S  SDV+AFG LL E+A
Sbjct: 208 FSIKSDVWAFGVLLWEIA 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           Q +G G FG V+ G   N K +VA+K I  E      +F+ E   + +L H  LVQL G 
Sbjct: 13  QEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C  +  + LV++FM +G L  +L  + + +   E    +   V  G+ YL E     VIH
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 126
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N L+      K+ DFG+ +        ++T     + + +PE     + S+ SD
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 526 VFAFGALLLEV-ACGRRPIETRA 547
           V++FG L+ EV + G+ P E R+
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRS 209

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           Q +G G FG V+ G   N K +VA+K I  E      +F+ E   + +L H  LVQL G 
Sbjct: 16  QEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C  +  + LV++FM +G L  +L  + + +   E    +   V  G+ YL E     VIH
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 129
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N L+      K+ DFG+ +        ++T     + + +PE     + S+ SD
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 526 VFAFGALLLEV-ACGRRPIETRA 547
           V++FG L+ EV + G+ P E R+
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRS 212

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 10/209 (4%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +LG G +G VY G   +++  +A+K I     +  +    EIA    L+H+N+VQ +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGVASGLLYLHEGYEQVVIH 465
              G + +  + +  GSL + L  +   + + EQ      K +  GL YLH+     ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 466 RDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS--S 521
           RD+K  NVL+++  +G  K+ DFG +K    G NP T    GTL Y+APE    G     
Sbjct: 146 RDIKGDNVLINT-YSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 522 ASSDVFAFGALLLEVACGRRPIETRALPE 550
            ++D+++ G  ++E+A G+ P      P+
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQ 232

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 10/209 (4%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +LG G +G VY G   +++  +A+K I     +  +    EIA    L+H+N+VQ +G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGVASGLLYLHEGYEQVVIH 465
              G + +  + +  GSL + L  +   + + EQ      K +  GL YLH   +  ++H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 466 RDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS--S 521
           RD+K  NVL+++  +G  K+ DFG +K    G NP T    GTL Y+APE    G     
Sbjct: 132 RDIKGDNVLINT-YSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 522 ASSDVFAFGALLLEVACGRRPIETRALPE 550
            ++D+++ G  ++E+A G+ P      P+
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGEPQ 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 8/226 (3%)
Query: 327 PQRYSYQ-ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV 385
           PQ+  ++ E +         + LG G FG+V+ G  +N  T+VAVK +   S      F+
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFL 58
Query: 386 SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
           +E   + +L+H+ LV+L     ++  + ++ ++M NGSL  FL       L   +   + 
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 117
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG 505
             +A G+ ++ E   +  IHRD++A+N+L+   L+ K+ DFGLA+L E     A      
Sbjct: 118 AQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 174
Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPE 550
            + + APE    G  +  SDV++FG LL E+   GR P      PE
Sbjct: 175 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 220

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           Q +G G FG V+ G   N K +VA+K I  E      +F+ E   + +L H  LVQL G 
Sbjct: 33  QEIGSGQFGLVHLGYWLN-KDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C  +  + LV++FM +G L  +L  + + +   E    +   V  G+ YL E     VIH
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 146
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N L+      K+ DFG+ +        ++T     + + +PE     + S+ SD
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 526 VFAFGALLLEV-ACGRRPIETRA 547
           V++FG L+ EV + G+ P E R+
Sbjct: 207 VWSFGVLMWEVFSEGKIPYENRS 229

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 8/226 (3%)
Query: 327 PQRYSYQ-ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV 385
           PQ+  ++ E +         + LG G FG+V+ G  +N  T+VAVK +   S      F+
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFL 65
Query: 386 SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
           +E   + +L+H+ LV+L     ++  + ++ ++M NGSL  FL       L   +   + 
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 124
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG 505
             +A G+ ++ E   +  IHRD++A+N+L+   L+ K+ DFGLA+L E     A      
Sbjct: 125 AQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 181
Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPE 550
            + + APE    G  +  SDV++FG LL E+   GR P      PE
Sbjct: 182 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 227

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 27  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 140
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           Q +G G FG V+ G   N K +VA+K I  E      +F+ E   + +L H  LVQL G 
Sbjct: 13  QEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C  +  + LV++FM +G L  +L  + + +   E    +   V  G+ YL E     VIH
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---SVIH 126
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N L+      K+ DFG+ +        ++T     + + +PE     + S+ SD
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 526 VFAFGALLLEV-ACGRRPIETRA 547
           V++FG L+ EV + G+ P E R+
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRS 209

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 21  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE---FVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V+ G  +N  T+VAVK +    KQG      F++E   + +L+H+ LV+L  
Sbjct: 21  LGAGQFGEVWMG-YYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  I
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 525 DVFAFGALLLEVAC-GRRPIETRALPE 550
           DV++FG LL E+   GR P      PE
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 22  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 80  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 135
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 196 SFGILLTEIVTHGRIPYPGMTNPE 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 29  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 87  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 142
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 203 SFGILLTEIVTHGRIPYPGMTNPE 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 21  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE---FVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V+ G  +N  T+VAVK +    KQG      F++E   + +L+H+ LV+L  
Sbjct: 16  LGAGQFGEVWMG-YYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  I
Sbjct: 71  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 126
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  S
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 525 DVFAFGALLLEVAC-GRRPIETRALPE 550
           DV++FG LL E+   GR P      PE
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPE 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +NS T+VAVK +       V+ F+ E   +  L+H  LV+L     
Sbjct: 21  LGAGQFGEVWMGYYNNS-TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           R+  + ++ ++MA GSL  FL  +    +   +       +A G+ Y+     +  IHRD
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 135
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+NVL+   L  K+ DFGLA++ E     A       + + APE    G  +  SDV+
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 528 AFGALLLEVAC-GRRPIETR 546
           +FG LL E+   G+ P   R
Sbjct: 196 SFGILLYEIVTYGKIPYPGR 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 8/226 (3%)
Query: 327 PQRYSYQ-ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV 385
           PQ+  ++ E +         + LG G FG+V+ G  +N  T+VAVK +   S      F+
Sbjct: 4   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFL 61
Query: 386 SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
           +E   + +L+H+ LV+L     ++  + ++ ++M NGSL  FL       L   +   + 
Sbjct: 62  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 120
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG 505
             +A G+ ++ E   +  IHRD++A+N+L+   L+ K+ DFGLA+L E     A      
Sbjct: 121 AQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 177
Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPE 550
            + + APE    G  +  SDV++FG LL E+   GR P      PE
Sbjct: 178 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 223

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 27  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 140
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 31  LGAGQFGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 89  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 144
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 205 SFGILLTEIVTHGRIPYPGMTNPE 228

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 11/227 (4%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQG-VREFVSEIATIGR 393
           +   +F    LLG G F  VY+    ++  EVA+K I  ++  K G V+   +E+    +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L+H ++++L  +      + LV +   NG ++ +L +  K     E R   +  + +G+L
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGML 126
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           YLH      ++HRD+  SN+LL   +N K+ DFGLA   +       T + GT  Y++PE
Sbjct: 127 YLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL---VLVDW 557
                     SDV++ G +   +  GR P +T  +   L   VL D+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+  T +N  T+VAVK +   S   V  F++E   +  L+H  LV+L     
Sbjct: 23  LGAGQFGEVWMAT-YNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA-VV 79
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            K  + ++ +FMA GSL  FL  +  +     +       +A G+ ++ +   +  IHRD
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 136
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+ + L  K+ DFGLA++ E     A       + + APE    G  +  SDV+
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL+E+   GR P    + PE
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPE 220

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 7/203 (3%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           Q +G G FG V+ G   N K +VA+K I  E      +F+ E   + +L H  LVQL G 
Sbjct: 14  QEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C  +  + LV +FM +G L  +L  + + +   E    +   V  G+ YL E     VIH
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 127
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD+ A N L+      K+ DFG+ +        ++T     + + +PE     + S+ SD
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 526 VFAFGALLLEV-ACGRRPIETRA 547
           V++FG L+ EV + G+ P E R+
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRS 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG+G FG+V+ GT  N  T+VA+K +          F+ E   + +L+H  LVQL     
Sbjct: 17  LGNGQFGEVWMGTW-NGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +  + +V ++M  GSL  FL D     L       +   VA+G+ Y+        IHRD
Sbjct: 75  EE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 130
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++++N+L+ + L  K+ DFGLA+L E     A       + + APE    G+ +  SDV+
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 528 AFGALLLE-VACGRRP 542
           +FG LL E V  GR P
Sbjct: 191 SFGILLTELVTKGRVP 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+  T +N  T+VAVK +   S   V  F++E   +  L+H  LV+L     
Sbjct: 196 LGAGQFGEVWMAT-YNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA-VV 252
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            K  + ++ +FMA GSL  FL  +  +     +       +A G+ ++ +   +  IHRD
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+ + L  K+ DFGLA++ E     A       + + APE    G  +  SDV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL+E+   GR P    + PE
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPE 393

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 146/307 (47%), Gaps = 41/307 (13%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSE 387
           Q +K+  +N   K+ LG G FG+V+    +N      K  VAVK + + S    ++F  E
Sbjct: 8   QHIKR--HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHRE 65
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-PKAVLNWE------- 439
              +  L+H ++V+  G C     L++V+++M +G L+ FL    P AVL  E       
Sbjct: 66  AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTEL 125
Query: 440 ---QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHG 495
              Q   I + +A+G++YL     Q  +HRD+   N L+   L  K+GDFG+++ +Y   
Sbjct: 126 TQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
Query: 496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRPIETRALPEELVL 554
                   +  + ++ PE+    K +  SDV++ G +L E+   G++P    +  E +  
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242
Query: 555 VDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLL 614
           +        +GRVL+   P+   + +  ++++G  +    +R        K  +G   LL
Sbjct: 243 IT-------QGRVLQ--RPRTCPQ-EVYELMLGCWQREPHMR--------KNIKGIHTLL 284
Query: 615 NSLASSS 621
            +LA +S
Sbjct: 285 QNLAKAS 291

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+ G  +NS T+VAVK +       V+ F+ E   +  L+H  LV+L     
Sbjct: 20  LGAGQFGEVWMGYYNNS-TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ +FMA GSL  FL  +    +   +       +A G+ Y+     +  IHRD
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 134
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+NVL+   L  K+ DFGLA++ E     A       + + APE    G  +  S+V+
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 528 AFGALLLEVAC-GRRPIETR 546
           +FG LL E+   G+ P   R
Sbjct: 195 SFGILLYEIVTYGKIPYPGR 214

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE---FVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V+ G  +N  T+VAVK +    KQG      F++E   + +L+H+ LV+L  
Sbjct: 17  LGAGQFGEVWMG-YYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  I
Sbjct: 72  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 127
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HR+++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  S
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 525 DVFAFGALLLEVAC-GRRPIETRALPE 550
           DV++FG LL E+   GR P      PE
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPE 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 7/204 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G  G+V+ G  +N  T+VAVK +   S      F++E   + +L+H+ LV+L     
Sbjct: 21  LGAGQAGEVWMG-YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           ++A+N+L+   L+ K+ DFGLA+L E     A       + + APE    G  +  SDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 528 AFGALLLEVAC-GRRPIETRALPE 550
           +FG LL E+   GR P      PE
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 6   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 48
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L      ++
Sbjct: 49  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-----II 102
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 103 --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 157
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
           +    +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 158 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 116/236 (49%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 3   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 45
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L        
Sbjct: 46  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHII----- 99
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 100 --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 154
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
           +    +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 155 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 116/236 (49%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 1   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L        
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHII----- 97
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 98  --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
           +    +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 6   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 48
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L      ++
Sbjct: 49  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-----II 102
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 103 --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 157
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
           +    +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 158 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 28  DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 70
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L      ++
Sbjct: 71  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-----II 124
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 125 --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 179
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
           +    +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 180 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 112/224 (50%), Gaps = 31/224 (13%)
Query: 351 GGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWCRRK 409
           G FG V+K  L N    VAVK    + KQ  + E+  E+ ++  ++H N++Q +G   ++
Sbjct: 35  GRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIG-AEKR 89
Query: 410 G-----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE------- 457
           G     DL L+  F   GSL  FL      V++W +   I + +A GL YLHE       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYLAPETPR 516
           G++  + HRD+K+ NVLL + L   + DFGLA  +E G +   T   VGT  Y+APE   
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 517 TGKSSASS-----DVFAFGALLLEVA--C--GRRPIETRALPEE 551
              +         D++A G +L E+A  C     P++   LP E
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 29  DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 71
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L      ++
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-----II 125
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 126 --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 180
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
           +    +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 181 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 113/230 (49%), Gaps = 28/230 (12%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 5   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 47
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L    +   
Sbjct: 48  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKF 105
Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
             ++   I +  A G+ YLH    + +IHRD+K++N+ L  +   K+GDFGLA +    +
Sbjct: 106 EMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWS 162
Query: 497 NPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
                 ++ G++ ++APE  R   S   S  SDV+AFG +L E+  G+ P
Sbjct: 163 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 117/236 (49%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 1   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L      ++
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-----II 97
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 98  --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
                +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 153 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 223 SKFSVASDVWSFGVVLYEL 241

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 137
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 138 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 197 SKFSVASDVWSFGVVLYEL 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 192 SKFSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 130
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 131 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 190 SKFSVASDVWSFGVVLYEL 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 135
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 136 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 195 SKFSVASDVWSFGVVLYEL 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL  G 
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GT 131
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
           ++  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 132 KRY-IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 191 SKFSVASDVWSFGVVLYEL 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 136
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 137 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 196 SKFSVASDVWSFGVVLYEL 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 117/236 (49%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 21  DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 63
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L      ++
Sbjct: 64  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-----II 117
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 118 --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 172
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
                +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 173 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 138
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 139 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 198 SKFSVASDVWSFGVVLYEL 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 139
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 140 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 199 SKFSVASDVWSFGVVLYEL 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 192 SKFSVASDVWSFGVVLYEL 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 12/197 (6%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 404 GWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           G C   G  +L L+ +F+  GSL  +L  + K  ++  +  +    +  G+ YL  G ++
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKR 137
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGK 519
             IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+    K
Sbjct: 138 Y-IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 520 SSASSDVFAFGALLLEV 536
            S +SDV++FG +L E+
Sbjct: 197 FSVASDVWSFGVVLYEL 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 117/236 (49%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 29  DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 71
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L      ++
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-----II 125
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 126 --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 180
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
                +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 181 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 115/236 (48%), Gaps = 40/236 (16%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 1   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+      L +V  +    SL   L        
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHII----- 97
Query: 437 NWEQRFKIIKGV------ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
             E +F++IK +      A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA 
Sbjct: 98  --ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152
Query: 491 LYEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
           +    +      ++ G++ ++APE  R       S  SDV+AFG +L E+  G+ P
Sbjct: 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 11/209 (5%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           KQ    F   + LG G +G VYK     +   VA+K++  ES   ++E + EI+ + +  
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD 82
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
             ++V+  G   +  DL +V ++   GS+   +    K  L  ++   I++    GL YL
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYL 141
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR--VVGTLGYLAPE 513
           H   +   IHRD+KA N+LL++E + KL DFG+A      T+    R  V+GT  ++APE
Sbjct: 142 HFMRK---IHRDIKAGNILLNTEGHAKLADFGVAG---QLTDXMAKRNXVIGTPFWMAPE 195
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRP 542
             +    +  +D+++ G   +E+A G+ P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 150
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 151 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 210 SKFSVASDVWSFGVVLYEL 228

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 181 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           G        +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 150
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 151 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 210 SKFSVASDVWSFGVVLYEL 228

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 158 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           G        +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 28/230 (12%)
Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNE 376
           +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   ++  
Sbjct: 17  DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 59
Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+   K  L +V  +    SL   L    +   
Sbjct: 60  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKF 117
Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
             ++   I +  A G+ YLH    + +IHRD+K++N+ L  +   K+GDFGLA      +
Sbjct: 118 EMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 497 NPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
                 ++ G++ ++APE  R   S   S  SDV+AFG +L E+  G+ P
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +HRD
Sbjct: 74  KQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 129
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L++ +   K+ DFGL++   +  +   T  VG+   + +  PE     K S+ S
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           D++AFG L+ E+ + G+ P E
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYE 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +HRD
Sbjct: 70  KQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L++ +   K+ DFGL++   +  +   T  VG+   + +  PE     K S+ S
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           D++AFG L+ E+ + G+ P E
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYE 203

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +L H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L++ +   K+ DFGL++   +  +   T  VG+   + +  PE     K S+ S
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           D++AFG L+ E+ + G+ P E
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYE 208

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L++ +   K+ DFGL++   +  +   T  VG+   + +  PE     K S+ S
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           D++AFG L+ E+ + G+ P E
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYE 223

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L++ +   K+ DFGL++   +  +   T  VG+   + +  PE     K S+ S
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           D++AFG L+ E+ + G+ P E
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYE 223

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +L H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 324 EVGPQRYSYQELKQATNNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESK- 378
           EV P  +  + LK+  +       LG G FG+V    Y     N+  +VAVK +  ES  
Sbjct: 12  EVDPTHFEKRFLKRIRD-------LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG 64
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVL 436
             + +   EI  +  L H N+V+  G C   G   + L+ +F+ +GSL  +L  + K  +
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI 123
Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
           N +Q+ K    +  G+ YL  G  Q V HRD+ A NVL++SE   K+GDFGL K  E   
Sbjct: 124 NLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 497 NPATTR--VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              T +      + + APE     K   +SDV++FG  L E+
Sbjct: 181 EXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 192 SKFSVASDVWSFGVVLYEL 210

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +HRD
Sbjct: 81  KQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 136
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L++ +   K+ DFGL++   +  +   T  VG+   + +  PE     K S+ S
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           D++AFG L+ E+ + G+ P E
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYE 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV-REFVSEIATIGRLRH 396
           +++ F   + LG+G +  VYKG    +   VA+K +  +S++G     + EI+ +  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMAN---GSLDSFLF-DEPKAV-LNWEQRFKIIKGVASG 451
            N+V+L      +  L LV++FM N     +DS    + P+ + LN  + F+    +  G
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQG 120
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L + HE     ++HRD+K  N+L++     KLGDFGLA+ +    N  ++ VV TL Y A
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 512 PETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV 570
           P+     ++ S S D+++ G +L E+  G+         E+L L+  + G   E     V
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 571 ID-PKLNAEYDQ 581
              PK N    Q
Sbjct: 237 TKLPKYNPNIQQ 248

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G FG VYKG  H    +VAVK  ++ + + +  + F +E+A + + RH N++  +G+
Sbjct: 44  IGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              K +L +V  +    SL   L  + +      Q   I +  A G+ YLH    + +IH
Sbjct: 101 MT-KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA---KNIIH 155
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGT-NPATTRVVGTLGYLAPETPRTGKS---S 521
           RD+K++N+ L   L  K+GDFGLA +    + +    +  G++ ++APE  R   +   S
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 522 ASSDVFAFGALLLEVACGRRP 542
             SDV+++G +L E+  G  P
Sbjct: 216 FQSDVYSYGIVLYELMTGELP 236

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           K+ LG G FG+V+    +N      K  VAVK + + +    ++F  E   +  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
           V+  G C     L++V+++M +G L+ FL                + K  L   Q   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             +ASG++YL     Q  +HRD+   N L+ + L  K+GDFG+++ +Y           +
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
             + ++ PE+    K +  SDV++FG +L E+   G++P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L    + + +  +  +    +  G+ YL    
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI-DHIKLLQYTSQICKGMEYLGT-- 135
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHRD+   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 136 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 195 SKFSVASDVWSFGVVLYEL 213

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG G FG+V+    HN      K  VAVK +   S+   ++F  E   +  L+H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLF-------------DEPKAVLNWEQRFKIIKGVA 449
            G C     LL+V+++M +G L+ FL              D     L   Q   +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLG 508
           +G++YL   +    +HRD+   N L+   L  K+GDFG+++ +Y         R +  + 
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           ++ PE+    K +  SDV++FG +L E+   G++P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           K  LG G FG+V+    HN      K  VAVK +   S+   ++F  E   +  L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLF-------------DEPKAVLNWEQRFKIIK 446
           V+  G C     LL+V+++M +G L+ FL              D     L   Q   +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVG 505
            VA+G++YL   +    +HRD+   N L+   L  K+GDFG+++ +Y         R + 
Sbjct: 166 QVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
            + ++ PE+    K +  SDV++FG +L E+   G++P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG G FG+V+    HN      K  VAVK +   S+   ++F  E   +  L+H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLF-------------DEPKAVLNWEQRFKIIKGVA 449
            G C     LL+V+++M +G L+ FL              D     L   Q   +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLG 508
           +G++YL   +    +HRD+   N L+   L  K+GDFG+++ +Y         R +  + 
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           ++ PE+    K +  SDV++FG +L E+   G++P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 118/242 (48%), Gaps = 20/242 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD 94
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRPIETRALPEELV 553
                    +  + ++ PE    G  ++ +D ++FG LL E+ + G  P  +++  E L 
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 271
Query: 554 LV 555
            V
Sbjct: 272 FV 273

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/240 (32%), Positives = 113/240 (47%), Gaps = 23/240 (9%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNV 80
           F  FK L  NL LQG A +   G+L+LTN  S        +G+A YS+ +   +S    V
Sbjct: 8   FSKFKPLEPNLILQGDALVTVAGVLQLTNVDSNGVPEPSSLGRATYSAPINIWDSATGLV 67
Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+TSF   I          GLAF ++P          +LGL +S  +G+ +    AVE
Sbjct: 68  ASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSA-VGDTTYQTVAVE 126
Query: 141 FDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT ++  F             S+ S  +V+             SL  G+A  V + Y+S
Sbjct: 127 FDTYENTVFTDPPYTHIGFDVNSISSIKTVK------------WSLANGEAAKVLITYNS 174
Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSF 257
           A  +L  ++   SSK    IL+  VDLS +  E++ VGFSA+TG       +H+V  WSF
Sbjct: 175 AVKLLVASLVYPSSKTSF-ILADIVDLSSVLPEWVRVGFSAATGASKGYIETHDVFSWSF 233

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           ++LG G FGQ  K T   +   + +K +    ++  R F+ E+  +  L H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
             +   L  + +++  G+L   +     +   W QR    K +ASG+ YLH      +IH
Sbjct: 76  LYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLY-EHGTNPATTR------------VVGTLGYLAP 512
           RD+ + N L+    N  + DFGLA+L  +  T P   R            VVG   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL 552
           E           DVF+FG +L E+  GR   +   LP  +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTM 230

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 346 QLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           Q LG G FG V    Y     N+   VAVK++ + +++ +R+F  EI  +  L+H N+V+
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 402 LVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
             G C   G  +L L+ +++  GSL  +L  + K  ++  +  +    +  G+ YL    
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG--- 132
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRT 517
            +  IHR++   N+L+++E   K+GDFGL K+          +  G   + + APE+   
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 518 GKSSASSDVFAFGALLLEV 536
            K S +SDV++FG +L E+
Sbjct: 193 SKFSVASDVWSFGVVLYEL 211

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           +G G FG+V+ G L    T VAVK         ++ +F+ E   + +  H N+V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
            +K  + +V + +  G   +FL  E  A L  +   +++   A+G+ YL     +  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237
Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGYLAPETPRTGKSSASS 524
           D+ A N L+  +   K+ DFG+++    G   A+   R V  + + APE    G+ S+ S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV-PVKWTAPEALNYGRYSSES 296
Query: 525 DVFAFGALLLE 535
           DV++FG LL E
Sbjct: 297 DVWSFGILLWE 307

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 96
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 156
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 157 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 132 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           + A N L++ +   K+ DFGL++        ++      + +  PE     K S+ SD++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 528 AFGALLLEV-ACGRRPIE 544
           AFG L+ E+ + G+ P E
Sbjct: 191 AFGVLMWEIYSLGKMPYE 208

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQL 402
           LG G FG+V    Y     N+  +VAVK +  ES    + +   EI  +  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 403 VGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            G C   G   + L+ +F+ +GSL  +L  + K  +N +Q+ K    +  G+ YL  G  
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSR 133
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR--VVGTLGYLAPETPRTG 518
           Q V HRD+ A NVL++SE   K+GDFGL K  E      T +      + + APE     
Sbjct: 134 QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 519 KSSASSDVFAFGALLLEV 536
           K   +SDV++FG  L E+
Sbjct: 193 KFYIASDVWSFGVTLHEL 210

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 27  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 86
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 146
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 147 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 204 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           +G G FG+V+ G L    T VAVK         ++ +F+ E   + +  H N+V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
            +K  + +V + +  G   +FL  E  A L  +   +++   A+G+ YL     +  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237
Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGYLAPETPRTGKSSASS 524
           D+ A N L+  +   K+ DFG+++    G   A+   R V  + + APE    G+ S+ S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV-PVKWTAPEALNYGRYSSES 296
Query: 525 DVFAFGALLLE 535
           DV++FG LL E
Sbjct: 297 DVWSFGILLWE 307

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 28/233 (12%)
Query: 316 EVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RI 373
           +  +DWE+  G                +  Q +G G FG VYKG  H    +VAVK   +
Sbjct: 14  DAADDWEIPDG--------------QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNV 56
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
           +  + Q ++ F +E+  + + RH N++  +G+      L +V  +    SL   L    +
Sbjct: 57  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLH-ASE 114
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
                ++   I +  A G+ YLH    + +IHRD+K++N+ L  +   K+GDFGLA    
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 494 HGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
             +      ++ G++ ++APE  R   S   S  SDV+AFG +L E+  G+ P
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 331 SYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN-ESKQGVRE 383
           S  +LK+    N +  + LGHG FG+VY+G +       S  +VAVK +    S+Q   +
Sbjct: 47  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 106
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPK----AVLNW 438
           F+ E   I +  H+N+V+ +G   +     ++ + MA G L SFL +  P+    + L  
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 166
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEH 494
                + + +A G  YL E +    IHRD+ A N LL     G   K+GDFG+A+ +Y  
Sbjct: 167 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                    +  + ++ PE    G  ++ +D ++FG LL E+
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 348 LGHGGFGQVY--KGTLHNSKTEVAVKRI---SNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG GG   VY  + T+ N K  VA+K I     E ++ ++ F  E+    +L H+N+V +
Sbjct: 19  LGGGGMSTVYLAEDTILNIK--VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
           +          LV +++   +L  ++  E    L+ +        +  G+ + H+     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           ++HRD+K  N+L+DS    K+ DFG+AK     +   T  V+GT+ Y +PE  +   +  
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 523 SSDVFAFGALLLEVACGRRP 542
            +D+++ G +L E+  G  P
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP 211

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
                ++++G G FG V K        +VA+K+I +ES++  + F+ E+  + R+ H N+
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESER--KAFIVELRQLSRVNHPNI 64
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           V+L G C     + LV ++   GSL + L   EP                + G+ YLH  
Sbjct: 65  VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 459 YEQVVIHRDVKASNVLLDSELNG---KLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPET 514
             + +IHRD+K  N+LL +   G   K+ DFG A  +  H TN       G+  ++APE 
Sbjct: 123 QPKALIHRDLKPPNLLLVA--GGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEV 175
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPIE 544
                 S   DVF++G +L EV   R+P +
Sbjct: 176 FEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 23/207 (11%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+V+  T +N  T+VAVK +   S   V  F++E   +  L+H  LV+L     
Sbjct: 190 LGAGQFGEVWMAT-YNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA-VV 246
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            K  + ++ +FMA GSL  FL  +  +     +       +A G+ ++ +   +  IHRD
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 303
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           ++A+N+L+ + L  K+ DFGLA+             VG    + + APE    G  +  S
Sbjct: 304 LRAANILVSASLVCKIADFGLAR-------------VGAKFPIKWTAPEAINFGSFTIKS 350
Query: 525 DVFAFGALLLEVAC-GRRPIETRALPE 550
           DV++FG LL+E+   GR P    + PE
Sbjct: 351 DVWSFGILLMEIVTYGRIPYPGMSNPE 377

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG V  G     + +VAVK I  E      EF  E  T+ +L H  LV+  G C 
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
           ++  + +V ++++NG L ++L    K  L   Q  ++   V  G+ +L E ++   IHRD
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL-ESHQ--FIHRD 129
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPRTGKSSASS 524
           + A N L+D +L  K+ DFG+ +   +  +      VGT   + + APE     K S+ S
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 525 DVFAFGALLLEV-ACGRRPIE 544
           DV+AFG L+ EV + G+ P +
Sbjct: 187 DVWAFGILMWEVFSLGKMPYD 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
                ++++G G FG V K        +VA+K+I +ES++  + F+ E+  + R+ H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNI 63
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           V+L G C     + LV ++   GSL + L   EP                + G+ YLH  
Sbjct: 64  VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 459 YEQVVIHRDVKASNVLLDSELNG---KLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPET 514
             + +IHRD+K  N+LL +   G   K+ DFG A  +  H TN       G+  ++APE 
Sbjct: 122 QPKALIHRDLKPPNLLLVA--GGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEV 174
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPIE 544
                 S   DVF++G +L EV   R+P +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 148
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 108/228 (47%), Gaps = 28/228 (12%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           ++   G FG V+K  L N    VAVK    + KQ  +      +T G ++H NL+Q +  
Sbjct: 21  EIKARGRFGCVWKAQLMNDF--VAVKIFPLQDKQSWQSEREIFSTPG-MKHENLLQFIAA 77
Query: 406 CRR----KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE---- 457
            +R    + +L L+  F   GSL  +L      ++ W +   + + ++ GL YLHE    
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 458 ----GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYLAP 512
               G++  + HRD K+ NVLL S+L   L DFGLA  +E G  P  T   VGT  Y+AP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 513 ETPRTGKSSASS-----DVFAFGALLLEVACGRR----PIETRALPEE 551
           E      +         D++A G +L E+    +    P++   LP E
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFE 242

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVS-EIATIG 392
           K+    +  ++ LG G FG+V   T + ++ +VA+K IS +   K  +   V  EI+ + 
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGL 452
            LRH ++++L        D+++V ++ A G L  ++ ++ +   +  +RF   + +   +
Sbjct: 65  LLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRF--FQQIICAI 121
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            Y H      ++HRD+K  N+LLD  LN K+ DFGL+ +   G    T+   G+  Y AP
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAP 176
Query: 513 ETPRTGKSSASS--DVFAFGALLLEVACGRRPIETRALP 549
           E    GK  A    DV++ G +L  +  GR P +   +P
Sbjct: 177 EVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 118/247 (47%), Gaps = 22/247 (8%)
Query: 328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVS 386
           Q+    ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + 
Sbjct: 58  QKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 115
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFK 443
           E+  +       +V   G     G++ +  + M  GSLD  L      P+ +L      K
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----K 170
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTR 502
           +   V  GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N     
Sbjct: 171 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----S 224
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
            VGT  Y++PE  +    S  SD+++ G  L+E+A GR PI     P +   ++ ++G  
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP----PPDAKELELMFGCQ 280
Query: 563 GEGRVLE 569
            EG   E
Sbjct: 281 VEGDAAE 287

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-------SNESKQGVREFVSEIAT 390
           A N    ++ +G GGFG V+KG L   K+ VA+K +         E  +  +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  L H N+V+L G         +V +F+  G L   L D+   +  W  + +++  +A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIAL 133
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDS-----ELNGKLGDFGLAKLYEHGTNPATTRVVG 505
           G+ Y+ +     ++HRD+++ N+ L S      +  K+ DFGL++   H    + + ++G
Sbjct: 134 GIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLG 188
Query: 506 TLGYLAPETPRTGKSSAS--SDVFAFGALLLEVACGRRPIE 544
              ++APET    + S +  +D ++F  +L  +  G  P +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLR 395
           N+   + LG G FG+V       +  +VA+K I+ +       QG  E   EI+ +  LR
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H ++++L    + K ++++V ++  N   D ++    K      +RF   + + S + Y 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRF--FQQIISAVEYC 119
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H      ++HRD+K  N+LLD  LN K+ DFGL+ +   G    T+   G+  Y APE  
Sbjct: 120 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV- 173
Query: 516 RTGKSSASS--DVFAFGALLLEVACGRRPIETRALP 549
            +GK  A    DV++ G +L  + C R P +  ++P
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 209

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 323 LEVGPQRYSYQELKQ---ATNNFSAKQL------LGHGGFGQVYKGTLHNSKTEVAVKRI 373
           +++G +   +Q +KQ    T + + +        LG G FG+VYK     +    A K I
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
             +S++ + +++ EI  +    H N+V+L+     + +L ++ +F A G++D+ +  E +
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELE 129
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L   Q   + K     L YLH+     +IHRD+KA N+L   + + KL DFG++    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS---- 182
Query: 494 HGTNPATTR----VVGTLGYLAP-----ETPRTGKSSASSDVFAFGALLLEVA 537
              N  T +     +GT  ++AP     ET +       +DV++ G  L+E+A
Sbjct: 183 -AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYL- 168
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWEL 249

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 149
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRN 398
           FS  + +GHG FG VY      +   VA+K++S   KQ     ++ + E+  + +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            +Q  G   R+    LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET---P 515
               +IHRDVKA N+LL      KLGDFG A +      PA    VGT  ++APE     
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX-FVGTPYWMAPEVILAM 225
Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPI 543
             G+     DV++ G   +E+A  + P+
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 167
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 168 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWEL 248

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLR 395
           N+   + LG G FG+V       +  +VA+K I+ +       QG  E   EI+ +  LR
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H ++++L    + K ++++V ++  N   D ++    K      +RF   + + S + Y 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRF--FQQIISAVEYC 129
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H      ++HRD+K  N+LLD  LN K+ DFGL+ +   G    T+   G+  Y APE  
Sbjct: 130 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI 184
Query: 516 RTGKSSASS--DVFAFGALLLEVACGRRPIETRALP 549
            +GK  A    DV++ G +L  + C R P +  ++P
Sbjct: 185 -SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 219

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 109/204 (53%), Gaps = 18/204 (8%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G   +     ++T VAVK ++  +    R EF++E + +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN-------WEQRFKIIKGVASGLL 453
           L+G   +    L+V + MA+G L S+L    P+A  N        ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL+    +  +HRD+ A N ++  +   K+GDFG+ + +YE        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 513 ETPRTGKSSASSDVFAFGALLLEV 536
           E+ + G  + SSD+++FG +L E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLR 395
           N+   + LG G FG+V       +  +VA+K I+ +       QG  E   EI+ +  LR
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H ++++L    + K ++++V ++  N   D ++    K      +RF   + + S + Y 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRF--FQQIISAVEYC 128
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H      ++HRD+K  N+LLD  LN K+ DFGL+ +   G    T+   G+  Y APE  
Sbjct: 129 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI 183
Query: 516 RTGKSSASS--DVFAFGALLLEVACGRRPIETRALP 549
            +GK  A    DV++ G +L  + C R P +  ++P
Sbjct: 184 -SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 23/231 (9%)
Query: 323 LEVGPQRYSYQELKQ---ATNNFSAKQL------LGHGGFGQVYKGTLHNSKTEVAVKRI 373
           +++G +   +Q +KQ    T + + +        LG G FG+VYK     +    A K I
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
             +S++ + +++ EI  +    H N+V+L+     + +L ++ +F A G++D+ +  E +
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELE 129
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L   Q   + K     L YLH+     +IHRD+KA N+L   + + KL DFG++    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA--- 183
Query: 494 HGTNPATTR--VVGTLGYLAP-----ETPRTGKSSASSDVFAFGALLLEVA 537
             T     R   +GT  ++AP     ET +       +DV++ G  L+E+A
Sbjct: 184 KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 23/231 (9%)
Query: 323 LEVGPQRYSYQELKQ---ATNNFSAKQL------LGHGGFGQVYKGTLHNSKTEVAVKRI 373
           +++G +   +Q +KQ    T + + +        LG G FG+VYK     +    A K I
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
             +S++ + +++ EI  +    H N+V+L+     + +L ++ +F A G++D+ +  E +
Sbjct: 71  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELE 129
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L   Q   + K     L YLH+     +IHRD+KA N+L   + + KL DFG++    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA--- 183
Query: 494 HGTNPATTR--VVGTLGYLAP-----ETPRTGKSSASSDVFAFGALLLEVA 537
             T     R   +GT  ++AP     ET +       +DV++ G  L+E+A
Sbjct: 184 KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 149
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 144
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWEL 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRN 398
           FS  + +GHG FG VY      +   VA+K++S   KQ     ++ + E+  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            +Q  G   R+    LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 133
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET---P 515
               +IHRDVKA N+LL      KLGDFG A +      PA    VGT  ++APE     
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX-FVGTPYWMAPEVILAM 186
Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPI 543
             G+     DV++ G   +E+A  + P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 147
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWEL 228

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 148
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 146
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 147 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWEL 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLR 395
           N+   + LG G FG+V       +  +VA+K I+ +       QG  E   EI+ +  LR
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H ++++L    + K ++++V ++  N   D ++    K      +RF   + + S + Y 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRF--FQQIISAVEYC 123
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H      ++HRD+K  N+LLD  LN K+ DFGL+ +   G    T+   G+  Y APE  
Sbjct: 124 HR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV- 177
Query: 516 RTGKSSASS--DVFAFGALLLEVACGRRPIETRALP 549
            +GK  A    DV++ G +L  + C R P +  ++P
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 213

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ YL 
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYL- 141
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E
Sbjct: 142 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWEL 222

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ +L 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFL- 208
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+   +    +    L   ++A E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWEL 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ +L 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFL- 147
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+   +    +    L   ++A E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWEL 228

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLR 395
           Q    +  K+ LG GGFG V +    ++  +VA+K+   E     RE +  EI  + +L 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 396 HRNLV---------QLVGWCRRKGDL-LLVYDFMANGSLDSFL--FDEPKAVLNWEQRFK 443
           H N+V         Q +       DL LL  ++   G L  +L  F+    +     R  
Sbjct: 71  HPNVVSAREVPDGLQKLA----PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-T 125
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
           ++  ++S L YLHE     +IHRD+K  N++L      L  K+ D G AK  + G     
Sbjct: 126 LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LC 180
Query: 501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           T  VGTL YLAPE     K + + D ++FG L  E   G RP
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 109/205 (53%), Gaps = 18/205 (8%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G   +     ++T VAVK ++  +    R EF++E + +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN-------WEQRFKIIKGVASGLL 453
           L+G   +    L+V + MA+G L S+L    P+A  N        ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL+    +  +HRD+ A N ++  +   K+GDFG+ + +YE        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 513 ETPRTGKSSASSDVFAFGALLLEVA 537
           E+ + G  + SSD+++FG +L E+ 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ +L 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFL- 149
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+   +    +    L   ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLR 395
           Q    +  K+ LG GGFG V +    ++  +VA+K+   E     RE +  EI  + +L 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 396 HRNLV---------QLVGWCRRKGDL-LLVYDFMANGSLDSFL--FDEPKAVLNWEQRFK 443
           H N+V         Q +       DL LL  ++   G L  +L  F+    +     R  
Sbjct: 72  HPNVVSAREVPDGLQKLA----PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-T 126
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
           ++  ++S L YLHE     +IHRD+K  N++L      L  K+ D G AK  + G     
Sbjct: 127 LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LC 181
Query: 501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           T  VGTL YLAPE     K + + D ++FG L  E   G RP
Sbjct: 182 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 116/248 (46%), Gaps = 23/248 (9%)
Query: 19  SSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTN------DTSRKMGQAFYSSTLRF 72
           ++  D   F  FK    NL  QG A + ++G L+LT          + +G+A Y+S +  
Sbjct: 1   TTNTDSFTFSKFKPNQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPINI 60
Query: 73  KNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNF 132
            +S    V SF+TSF   I          GLAF ++P +      + +LGL +S  + N 
Sbjct: 61  WDSKTGVVASFATSFRFTIYAPNIATIADGLAFFLAPVSSPPKAGAGFLGLFDSA-VFNS 119
Query: 133 SNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAI 192
           S    AVEFDT ++  F             S+KS  +V          K DL+   G+A 
Sbjct: 120 SYQTVAVEFDTYENTVFLDPPDTHIGIDVNSIKSIKTV----------KWDLA--NGEAA 167
Query: 193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SS 249
            V + YDS+  +L   +   SSK    ILS  VDL  +  E++ +GFSA+TG  +    +
Sbjct: 168 KVLITYDSSAKLLVAALVYPSSKTSF-ILSDVVDLKSVLPEWVSIGFSAATGASSGYIET 226
Query: 250 HNVLGWSF 257
           H+V  WSF
Sbjct: 227 HDVFSWSF 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQL 402
           LG G FG+V    Y  T   +   VAVK +  ++    R  +  EI  +  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 403 VGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            G C   G   L LV +++  GSL  +L   P+  +   Q     + +  G+ YLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA--- 152
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG--TLGYLAPETPRTG 518
           Q  IHRD+ A NVLLD++   K+GDFGLAK    G      R  G   + + APE  +  
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 519 KSSASSDVFAFGALLLEV 536
           K   +SDV++FG  L E+
Sbjct: 213 KFYYASDVWSFGVTLYEL 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ +L 
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFL- 154
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+   +    +    L   ++A E
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWEL 235

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNS--KTEVAVKRISN-ESKQGVREFVSEIATIGRL-R 395
           N+   + ++G G FGQV K  +     + + A+KR+    SK   R+F  E+  + +L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQR 441
           H N++ L+G C  +G L L  ++  +G+L  FL               +   + L+ +Q 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT 501
                 VA G+ YL +   +  IHRD+ A N+L+      K+ DFGL++    G      
Sbjct: 135 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 187
Query: 502 RVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + +G L   ++A E+      + +SDV+++G LL E+
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ +L 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFL- 149
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+   +    +    L   ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ +L 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFL- 150
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPE 513
               +  +HRD+ A N +LD +   K+ DFGLA+ +Y+   +    +    L   ++A E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 514 TPRTGKSSASSDVFAFGALLLEV 536
           + +T K +  SDV++FG LL E+
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWEL 231

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNS--KTEVAVKRISN-ESKQGVREFVSEIATIGRL-R 395
           N+   + ++G G FGQV K  +     + + A+KR+    SK   R+F  E+  + +L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQR 441
           H N++ L+G C  +G L L  ++  +G+L  FL               +   + L+ +Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT 501
                 VA G+ YL +   +  IHRD+ A N+L+      K+ DFGL++    G      
Sbjct: 145 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 197
Query: 502 RVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + +G L   ++A E+      + +SDV+++G LL E+
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 118/247 (47%), Gaps = 22/247 (8%)
Query: 328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVS 386
           Q+    ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + 
Sbjct: 23  QKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFK 443
           E+  +       +V   G     G++ +  + M  GSLD  L      P+ +L      K
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----K 135
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTR 502
           +   V  GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N     
Sbjct: 136 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----S 189
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
            VGT  Y++PE  +    S  SD+++ G  L+E+A GR PI     P +   ++ ++G  
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP----PPDAKELELMFGCQ 245
Query: 563 GEGRVLE 569
            EG   E
Sbjct: 246 VEGDAAE 252

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 109/204 (53%), Gaps = 18/204 (8%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G   +     ++T VAVK ++  +    R EF++E + +      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN-------WEQRFKIIKGVASGLL 453
           L+G   +    L+V + MA+G L S+L    P+A  N        ++  ++   +A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL+    +  +HRD+ A N ++  +   K+GDFG+ + +YE        + +  + ++AP
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 513 ETPRTGKSSASSDVFAFGALLLEV 536
           E+ + G  + SSD+++FG +L E+
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 116/248 (46%), Gaps = 23/248 (9%)
Query: 19  SSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTN------DTSRKMGQAFYSSTLRF 72
           ++  D   F  FK    NL  QG A + ++G L+LT          + +G+A Y+S +  
Sbjct: 1   TTNTDSFTFSKFKPNQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPINI 60
Query: 73  KNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNF 132
            +S    V SF+TSF   I          GLAF ++P +      + +LGL +S  + N 
Sbjct: 61  WDSKTGVVASFATSFRFTIYAPNIATIADGLAFFLAPVSSPPKAGAGFLGLFDSA-VFNS 119
Query: 133 SNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAI 192
           S    AVEFDT ++  F             S+KS  +V          K DL+   G+A 
Sbjct: 120 SYQTVAVEFDTYENTVFLDPPDTHIGIDVNSIKSIKTV----------KWDLA--NGEAA 167
Query: 193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SS 249
            V + YDS+  +L   +   SSK    ILS  VDL  +  E++ +GFSA+TG  +    +
Sbjct: 168 KVLITYDSSAKLLVAALVYPSSKTSF-ILSDVVDLKSVLPEWVSIGFSAATGASSGYIET 226
Query: 250 HNVLGWSF 257
           H+V  WSF
Sbjct: 227 HDVFSWSF 234

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/240 (32%), Positives = 111/240 (46%), Gaps = 23/240 (9%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTN------DTSRKMGQAFYSSTLRFKNSLNSNV 80
           F  FK L  NL LQG A +   G+L+LTN           +G+A YS+ +   +S    V
Sbjct: 8   FSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLV 67
Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+TSF   I          GLAF ++P          +LGL +S   G+ +    AVE
Sbjct: 68  ASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGS-TYQTVAVE 126
Query: 141 FDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT ++  F             S+ S  +V+             SL  G+A  V + Y+S
Sbjct: 127 FDTYENTVFTDPPYTHIGFDVNSISSIKTVK------------WSLANGEAAKVLITYNS 174
Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSF 257
           A  +L  ++   SSK    IL+  VDLS +  E++ VGFSA+TG       +H+V  WSF
Sbjct: 175 AVKLLVASLVYPSSKTSF-ILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSF 233

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 22/241 (9%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + E+  + 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L      P+ +L      K+   V 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 114
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 115 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 168
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL 568
           Y++PE  +    S  SD+++ G  L+E+A GR PI     P +   ++ ++G   EG   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP----PPDAKELELMFGCQVEGDAA 224
Query: 569 E 569
           E
Sbjct: 225 E 225

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + E+  + 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L      P+ +L      K+   V 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 114
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 115 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 168
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           Y++PE  +    S  SD+++ G  L+E+A GR PI
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 18/221 (8%)
Query: 328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVS 386
           Q+    ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + 
Sbjct: 15  QKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 72
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFK 443
           E+  +       +V   G     G++ +  + M  GSLD  L      P+ +L      K
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----K 127
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTR 502
           +   V  GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N     
Sbjct: 128 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----S 181
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
            VGT  Y++PE  +    S  SD+++ G  L+E+A GR PI
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQL 402
           LG G FG+V    Y  T   +   VAVK +  +     R  +  EI  +  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 403 VGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            G C  +G+  L LV +++  GSL  +L   P+  +   Q     + +  G+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHS--- 135
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG--TLGYLAPETPRTG 518
           Q  IHR++ A NVLLD++   K+GDFGLAK    G      R  G   + + APE  +  
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 519 KSSASSDVFAFGALLLEV 536
           K   +SDV++FG  L E+
Sbjct: 196 KFYYASDVWSFGVTLYEL 213

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 22/241 (9%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + E+  + 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L      P+ +L      K+   V 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 114
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 115 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 168
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL 568
           Y++PE  +    S  SD+++ G  L+E+A GR PI     P +   ++ ++G   EG   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP----PPDAKELELMFGCQVEGDAA 224
Query: 569 E 569
           E
Sbjct: 225 E 225

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V  G    +  +VAVK ++ +  +    V +   EI  +   RH ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
                 D+ +V ++++ G L  ++    +  L+ ++  ++ + + SG+ Y H     +V+
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHR---HMVV 138
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K  NVLLD+ +N K+ DFGL+ +   G     +   G+  Y APE   +G+  A  
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPNYAAPEVI-SGRLYAGP 195
Query: 525 --DVFAFGALLLEVACGRRPIETRALP 549
             D+++ G +L  + CG  P +   +P
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVP 222

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQL 402
           LG G FG+V    Y  T   +   VAVK +  +     R  +  EI  +  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 403 VGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            G C  +G+  L LV +++  GSL  +L   P+  +   Q     + +  G+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA--- 135
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG--TLGYLAPETPRTG 518
           Q  IHR++ A NVLLD++   K+GDFGLAK    G      R  G   + + APE  +  
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 519 KSSASSDVFAFGALLLEV 536
           K   +SDV++FG  L E+
Sbjct: 196 KFYYASDVWSFGVTLYEL 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 113/230 (49%), Gaps = 21/230 (9%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + E+  + 
Sbjct: 5   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 62
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L      P+ +L      K+   V 
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 117
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 118 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN----EFVGTRS 171
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWV 558
           Y++PE  +    S  SD+++ G  L+E+A GR P    A+ E   L+D++
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFE---LLDYI 218

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVS 386
           Q+    ELK   ++F     LG G  G V K     S   +A K I  E K  +R + + 
Sbjct: 6   QKAKVGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFK 443
           E+  +       +V   G     G++ +  + M  GSLD  L +    P+ +L      K
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----K 118
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTR 502
           +   V  GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N     
Sbjct: 119 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----S 172
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
            VGT  Y+APE  +    S  SD+++ G  L+E+A GR PI
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 22/241 (9%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + E+  + 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L      P+ +L      K+   V 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 114
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 115 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 168
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL 568
           Y++PE  +    S  SD+++ G  L+E+A GR PI     P +   ++ ++G   EG   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP----PPDAKELELMFGCQVEGDAA 224
Query: 569 E 569
           E
Sbjct: 225 E 225

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 22/241 (9%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R + + E+  + 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVA 449
                 +V   G     G++ +  + M  GSLD  L      P+ +L      K+   V 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 114
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            GL YL E ++  ++HRDVK SN+L++S    KL DFG++ +L +   N      VGT  
Sbjct: 115 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 168
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL 568
           Y++PE  +    S  SD+++ G  L+E+A GR PI     P +   ++ ++G   EG   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP----PPDAKELELMFGCQVEGDAA 224
Query: 569 E 569
           E
Sbjct: 225 E 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQL 402
           LG G FG+V    Y  T   +   VAVK +       +R  +  EI  +  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 403 VGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            G C  +G+  + LV +++  GSL  +L   P+  +   Q     + +  G+ YLH    
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHA--- 129
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG--TLGYLAPETPRTG 518
           Q  IHR + A NVLLD++   K+GDFGLAK    G      R  G   + + APE  +  
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 519 KSSASSDVFAFGALLLEV 536
           K   +SDV++FG  L E+
Sbjct: 190 KFYYASDVWSFGVTLYEL 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQL 402
           LG G FG+V    Y  T   +   VAVK +       +R  +  EI  +  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 403 VGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            G C  +G+  + LV +++  GSL  +L   P+  +   Q     + +  G+ YLH    
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHA--- 130
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG--TLGYLAPETPRTG 518
           Q  IHR + A NVLLD++   K+GDFGLAK    G      R  G   + + APE  +  
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 519 KSSASSDVFAFGALLLEV 536
           K   +SDV++FG  L E+
Sbjct: 191 KFYYASDVWSFGVTLYEL 208

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 22/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-------SNESKQGVREFVSEIAT 390
           A N    ++ +G GGFG V+KG L   K+ VA+K +         E  +  +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  L H N+V+L G         +V +F+  G L   L D+   +  W  + +++  +A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIAL 133
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDS-----ELNGKLGDFGLAKLYEHGTNPATTRVVG 505
           G+ Y+ +     ++HRD+++ N+ L S      +  K+ DF L++   H    + + ++G
Sbjct: 134 GIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH----SVSGLLG 188
Query: 506 TLGYLAPETPRTGKSSAS--SDVFAFGALLLEVACGRRPIE 544
              ++APET    + S +  +D ++F  +L  +  G  P +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 22/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-------SNESKQGVREFVSEIAT 390
           A N    ++ +G GGFG V+KG L   K+ VA+K +         E  +  +EF  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           +  L H N+V+L G         +V +F+  G L   L D+   +  W  + +++  +A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIAL 133
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDS-----ELNGKLGDFGLAKLYEHGTNPATTRVVG 505
           G+ Y+ +     ++HRD+++ N+ L S      +  K+ DFG ++   H    + + ++G
Sbjct: 134 GIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH----SVSGLLG 188
Query: 506 TLGYLAPETPRTGKSSAS--SDVFAFGALLLEVACGRRPIE 544
              ++APET    + S +  +D ++F  +L  +  G  P +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLN------ 437
           F++E + +      ++V+L+G   +    L++ + M  G L S+L     A+ N      
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 438 --WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               +  ++   +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 114/223 (51%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-E 383
           Y   E + +    +  + LG G FG VY+G   +     ++T VAVK ++  +    R E
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN----- 437
           F++E + +      ++V+L+G   +    L+V + MA+G L S+L    P+A  N     
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 438 --WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
              ++  ++   +A G+ YL+    +  +HRD+ A N ++  +   K+GDFG+ + + E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + ++APE+ + G  + SSD+++FG +L E+ 
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 115/223 (51%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-E 383
           Y   E + +    +  + LG G FG VY+G   +     ++T VAVK ++  +    R E
Sbjct: 8   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN----- 437
           F++E + +      ++V+L+G   +    L+V + MA+G L S+L    P+A  N     
Sbjct: 68  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 438 --WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
              ++  ++   +A G+ YL+    +  +HR++ A N ++  +   K+GDFG+ + +YE 
Sbjct: 128 PTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 184
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + ++APE+ + G  + SSD+++FG +L E+ 
Sbjct: 185 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 115/223 (51%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-E 383
           Y   E + +    +  + LG G FG VY+G   +     ++T VAVK ++  +    R E
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN----- 437
           F++E + +      ++V+L+G   +    L+V + MA+G L S+L    P+A  N     
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 438 --WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
              ++  ++   +A G+ YL+    +  +HR++ A N ++  +   K+GDFG+ + +YE 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 183
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + ++APE+ + G  + SSD+++FG +L E+ 
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 24/231 (10%)
Query: 325 VGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNESK 378
           + P +  Y E  +   NN    + LG G FG+V + T       ++  +VAVK + + + 
Sbjct: 22  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 81
Query: 379 QGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
              +E  +SE+  +  L +H N+V L+G C   G +L++ ++   G L +FL  + +A L
Sbjct: 82  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 141
Query: 437 NWEQ--------RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL 488
           + E                VA G+ +L     +  IHRDV A NVLL +    K+GDFGL
Sbjct: 142 DKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGL 198
Query: 489 AKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           A+   + +N       R+   + ++APE+      +  SDV+++G LL E+
Sbjct: 199 ARDIMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 5   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLN------ 437
           F++E + +      ++V+L+G   +    L++ + M  G L S+L     A+ N      
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 438 --WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               +  ++   +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE 
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 181
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 27/231 (11%)
Query: 36  NLTLQGIAKIENNGILRLTN---DTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIV 92
           NL LQG A + + G L LTN   +    MG+AFYS+ ++  +    N+ SFST+F   I 
Sbjct: 15  NLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRIN 74
Query: 93  PEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQXX 152
            +      +GLAF + P      L  +YLGL N+T+    + H  AV FDTV +      
Sbjct: 75  AKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDA-HTVAVVFDTVSN------ 127
Query: 153 XXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPN 212
                     S++  A+ E+  +  N+         G+   V + YDS +N L V++   
Sbjct: 128 ---RIEIDVNSIRPIAT-ESCNFGHNN---------GEKAEVRITYDSPKNDLRVSLLYP 174
Query: 213 SSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFKIN 260
           SS+ K  + S  V L     +++ VGFSA++G       +HNVL WSF  N
Sbjct: 175 SSEEKCHV-SATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G   +     ++T VAVK ++  +    R EF++E + +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN-------WEQRFKIIKGVASGLL 453
           L+G   +    L+V + MA+G L S+L    P+A  N        ++  ++   +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL+    +  +HRD+ A N ++  +   K+GDFG+ + + E        + +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 513 ETPRTGKSSASSDVFAFGALLLEVA 537
           E+ + G  + SSD+++FG +L E+ 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNW 438
           F++E + +      ++V+L+G   +    L++ + M  G L S+L       E   VL  
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 134
Query: 439 EQRFKIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 29/226 (12%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           +L+G G FGQVY G  H    EVA++   I  +++  ++ F  E+    + RH N+V  +
Sbjct: 39  ELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C     L ++       +L S + D  K VL+  +  +I + +  G+ YLH    + +
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 464 IHRDVKASNVLLDSELNGK--LGDFGL---AKLYEHGTNPATTRVV-GTLGYLAPE---- 513
           +H+D+K+ NV  D   NGK  + DFGL   + + + G      R+  G L +LAPE    
Sbjct: 152 LHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 514 -TPRTGKS----SASSDVFAFGALLLEVACGRRPIETRALPEELVL 554
            +P T +     S  SDVFA G +  E+     P +T+  P E ++
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAII 252

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 120/246 (48%), Gaps = 28/246 (11%)
Query: 316 EVIEDWELE----VGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTL-----HNSK 365
           ++IE +E      + P +  Y E  +   NN    + LG G FG+V + T       ++ 
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 366 TEVAVKRISNESKQGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGS 423
            +VAVK + + +    +E  +SE+  +  L +H N+V L+G C   G +L++ ++   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 424 LDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE----------QVVIHRDVKASNV 473
           L +FL  + + VL  +  F I    AS    LH   +          +  IHRDV A NV
Sbjct: 137 LLNFLRRKSR-VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 474 LLDSELNGKLGDFGLAKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFG 530
           LL +    K+GDFGLA+   + +N       R+   + ++APE+      +  SDV+++G
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 531 ALLLEV 536
            LL E+
Sbjct: 254 ILLWEI 259

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 18/204 (8%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G   +     ++T VAVK ++  +    R EF++E + +      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN-------WEQRFKIIKGVASGLL 453
           L+G   +    L+V + MA+G L S+L    P+A  N        ++  ++   +A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAP 512
           YL+    +  +HRD+ A N ++  +   K+GDFG+ + + E        + +  + ++AP
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 513 ETPRTGKSSASSDVFAFGALLLEV 536
           E+ + G  + SSD+++FG +L E+
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLR- 395
           +NF   ++LG G FG+V    +  +    AVK +  +       V   ++E   +   R 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           H  L QL    +    L  V +F+  G L      S  FDE +A      RF   + + S
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA------RFYAAE-IIS 135
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGY 509
            L++LH+   + +I+RD+K  NVLLD E + KL DFG+ K  E   N  TT    GT  Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDY 190
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET 545
           +APE  +      + D +A G LL E+ CG  P E 
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V  G    +  +VAVK ++ +  +    V +   EI  +   RH ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
                 D  +V ++++ G L  ++    + V   E R ++ + + S + Y H     +V+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEAR-RLFQQILSAVDYCHR---HMVV 133
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K  NVLLD+ +N K+ DFGL+ +   G    T+   G+  Y APE   +G+  A  
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI-SGRLYAGP 190
Query: 525 --DVFAFGALLLEVACGRRPIETRALP 549
             D+++ G +L  + CG  P +   +P
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNW 438
           F++E + +      ++V+L+G   +    L++ + M  G L S+L       E   VL  
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 439 EQRFKIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNS--KTEVAVKRISN-ESKQGVREFVSEIATIGRL-R 395
           N+   + ++G G FGQV K  +     + + A+KR+    SK   R+F  E+  + +L  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQR 441
           H N++ L+G C  +G L L  ++  +G+L  FL               +   + L+ +Q 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT 501
                 VA G+ YL    ++  IHR++ A N+L+      K+ DFGL++    G      
Sbjct: 142 LHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK 194
Query: 502 RVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + +G L   ++A E+      + +SDV+++G LL E+
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNW 438
           F++E + +      ++V+L+G   +    L++ + M  G L S+L       E   VL  
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 439 EQRFKIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 76  LIG-VITENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---K 130
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 191 SASDVWMFGVCMWEI 205

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 24/205 (11%)
Query: 346 QLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----VASGLLYLH 456
           L+G C R +G  L+V  +M +G L +F+ +E           K + G    VA G+ +L 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFL- 150
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-----KLYEHGTNPATTRVVGTLGYLA 511
               +  +HRD+ A N +LD +   K+ DFGLA     K ++   N    ++   + ++A
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL--PVKWMA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEV 536
            E+ +T K +  SDV++FG LL E+
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWEL 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 24/231 (10%)
Query: 325 VGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNESK 378
           + P +  Y E  +   NN    + LG G FG+V + T       ++  +VAVK + + + 
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 379 QGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
              +E  +SE+  +  L +H N+V L+G C   G +L++ ++   G L +FL  + +A L
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 149
Query: 437 NWEQ--------RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL 488
           + E                VA G+ +L     +  IHRDV A NVLL +    K+GDFGL
Sbjct: 150 DKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGL 206
Query: 489 AKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           A+   + +N       R+   + ++APE+      +  SDV+++G LL E+
Sbjct: 207 ARDIMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNW 438
           F++E + +      ++V+L+G   +    L++ + M  G L S+L       E   VL  
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 439 EQRFKIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 185
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 37  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 96
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNW 438
           F++E + +      ++V+L+G   +    L++ + M  G L S+L       E   VL  
Sbjct: 97  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 156
Query: 439 EQRFKIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE 
Sbjct: 157 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 213
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 76  LIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 130
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 191 SASDVWMFGVCMWEI 205

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-EFVSE 387
           E + A    +  + LG G FG VY+G          +T VA+K ++  +    R EF++E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNWEQRF 442
            + +      ++V+L+G   +    L++ + M  G L S+L       E   VL      
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 443 KIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNP 498
           K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE     
Sbjct: 130 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
              + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 111/237 (46%), Gaps = 30/237 (12%)
Query: 316 EVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN 375
           E+++    +VGP+             ++  Q +G G +G V     H  KT VA+K+IS 
Sbjct: 32  EMVKGQPFDVGPR-------------YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISP 78
Query: 376 -ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-----DLLLVYDFMANGSLDSFLF 429
            E +   +  + EI  + R RH N++ +    R        D+ +V D M     D +  
Sbjct: 79  FEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET---DLYKL 135
Query: 430 DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA 489
            + + + N +     +  +  GL Y+H      V+HRD+K SN+L+++  + K+ DFGLA
Sbjct: 136 LKSQQLSN-DHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLA 191
Query: 490 KLY--EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPI 543
           ++   EH      T  V T  Y APE     K  + S D+++ G +L E+    RPI
Sbjct: 192 RIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPI 247

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 104 LIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 158
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 219 SASDVWMFGVCMWEI 233

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG--VREFVSEIATIGRLRHRNLVQLVG 404
           +LG G FG+V K     ++ E AVK I+  S +       + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
                    +V +    G L    FDE   +   +     +IIK V SG+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 463 VIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
           ++HRD+K  N+LL+S   + + K+ DFGL+  ++  T       +GT  Y+APE  R G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 520 SSASSDVFAFGALLLEVACGRRP 542
                DV++ G +L  +  G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 112/224 (50%), Gaps = 29/224 (12%)
Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNL 399
           ++LG G FG VYKG         K  VA+K I NE+   +   EF+ E   +  + H +L
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVASGLLY 454
           V+L+G C     + LV   M +G L  ++ +       + +LNW         +A G++Y
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMY 132
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAP 512
           L E   + ++HRD+ A NVL+ S  + K+ DFGLA+L E G         G +   ++A 
Sbjct: 133 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWMAL 188
Query: 513 ETPRTGKSSASSDVFAFGALLLEVAC-GRRP---IETRALPEEL 552
           E     K +  SDV+++G  + E+   G +P   I TR +P+ L
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 76  LIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 130
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 191 SASDVWMFGVCMWEI 205

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-EFVSE 387
           E + A    +  + LG G FG VY+G          +T VA+K ++  +    R EF++E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNWEQRF 442
            + +      ++V+L+G   +    L++ + M  G L S+L       E   VL      
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 443 KIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNP 498
           K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + +YE     
Sbjct: 126 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
              + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 73  LIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 188 SASDVWMFGVCMWEI 202

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS----NESKQGV-REFVSEI 388
           ++K     +     LG G F  VYK    N+   VA+K+I     +E+K G+ R  + EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
             +  L H N++ L+     K ++ LV+DFM    L+  + D    VL        +   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMT 121
Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
             GL YLH+ +   ++HRD+K +N+LLD     KL DFGLAK +    N A    V T  
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTRW 177
Query: 509 YLAPETPRTGKS-SASSDVFAFGALLLEV 536
           Y APE     +      D++A G +L E+
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 18/199 (9%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+VYK     +    A K I  +S++ + +++ EI  +    H  +V+L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
             G L ++ +F   G++D+ + +  +  L   Q   + + +   L +LH    + +IHRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLH---SKRIIHRD 134
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR----VVGTLGYLAP-----ETPRTG 518
           +KA NVL+  E + +L DFG++       N  T +     +GT  ++AP     ET +  
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 519 KSSASSDVFAFGALLLEVA 537
                +D+++ G  L+E+A
Sbjct: 190 PYDYKADIWSLGITLIEMA 208

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 18/199 (9%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G FG+VYK     +    A K I  +S++ + +++ EI  +    H  +V+L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
             G L ++ +F   G++D+ + +  +  L   Q   + + +   L +LH    + +IHRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLH---SKRIIHRD 142
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR----VVGTLGYLAP-----ETPRTG 518
           +KA NVL+  E + +L DFG++       N  T +     +GT  ++AP     ET +  
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 519 KSSASSDVFAFGALLLEVA 537
                +D+++ G  L+E+A
Sbjct: 198 PYDYKADIWSLGITLIEMA 216

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 78  LIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 132
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 193 SASDVWMFGVCMWEI 207

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 337 QATNNFSAKQLLGHGGFGQ--VYKGTLHNSK---TEVAVKRISNESKQGVREFVSEIATI 391
           Q+   +   Q +G G FG+  + K T    +    E+ + R+S++ ++  R    E+A +
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVL 77
Query: 392 GRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
             ++H N+VQ        G L +V D+   G L   + +  K VL  E   +I+      
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQED--QILDWFVQI 134
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
            L L   +++ ++HRD+K+ N+ L  +   +LGDFG+A++       A    +GT  YL+
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLS 193
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVL 554
           PE       +  SD++A G +L E+   +   E  ++ + LVL
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLVL 235

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 81  LIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 135
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 196 SASDVWMFGVCMWEI 210

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 34/249 (13%)
Query: 316 EVIEDWELE----VGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTL-----HNSK 365
           ++IE +E      + P +  Y E  +   NN    + LG G FG+V + T       ++ 
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 366 TEVAVKRISNESKQGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGS 423
            +VAVK + + +    +E  +SE+  +  L +H N+V L+G C   G +L++ ++   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 424 LDSFLFDEPKAVLNWEQRFKIIKG-------------VASGLLYLHEGYEQVVIHRDVKA 470
           L +FL  + + VL  +  F I                VA G+ +L     +  IHRDV A
Sbjct: 137 LLNFLRRKSR-VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAA 192
Query: 471 SNVLLDSELNGKLGDFGLAKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVF 527
            NVLL +    K+GDFGLA+   + +N       R+   + ++APE+      +  SDV+
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVW 250
Query: 528 AFGALLLEV 536
           ++G LL E+
Sbjct: 251 SYGILLWEI 259

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 79  LIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---K 133
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 194 SASDVWMFGVCMWEI 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNESKQGVR-EFVSEIATIGR 393
           NN    + +G G FG+V++        +   T VAVK +  E+   ++ +F  E A +  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAV----------------- 435
             + N+V+L+G C     + L++++MA G L+ FL    P  V                 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 436 ----LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK- 490
               L+  ++  I + VA+G+ YL    E+  +HRD+   N L+   +  K+ DFGL++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           +Y      A       + ++ PE+    + +  SDV+A+G +L E+
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRN 398
           +++  ++++G G    V        K +VA+KRI+ E  Q  + E + EI  + +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLF------DEPKAVLNWEQRFKIIKGVASGL 452
           +V        K +L LV   ++ GS+   +       +    VL+      I++ V  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV----VGTLG 508
            YLH+  +   IHRDVKA N+LL  + + ++ DFG++     G +    +V    VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 509 YLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           ++APE     +     +D+++FG   +E+A G  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G +   L     FDE +           I  +A
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT-------YITELA 123
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 177
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRN 398
           +++  ++++G G    V        K +VA+KRI+ E  Q  + E + EI  + +  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLF------DEPKAVLNWEQRFKIIKGVASGL 452
           +V        K +L LV   ++ GS+   +       +    VL+      I++ V  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV----VGTLG 508
            YLH+  +   IHRDVKA N+LL  + + ++ DFG++     G +    +V    VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 509 YLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           ++APE     +     +D+++FG   +E+A G  P
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY     NSK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 119 NALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET 545
           L PE           D+++ G L  E   G+ P E 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 11/215 (5%)
Query: 348 LGHGGFGQVYKGT--LHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG G FG V +G   +   + +VA+K +     K    E + E   + +L +  +V+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C+ +  L+LV +    G L  FL  + + +       +++  V+ G+ YL E   +  +
Sbjct: 78  VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPV-SNVAELLHQVSMGMKYLEE---KNFV 132
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGKSSA 522
           HRD+ A NVLL +    K+ DFGL+K      +  T R  G   L + APE     K S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 523 SSDVFAFGALLLE-VACGRRPIETRALPEELVLVD 556
            SDV+++G  + E ++ G++P +    PE +  ++
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNW 438
           F++E + +      ++V+L+G   +    L++ + M  G L S+L       E   VL  
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 439 EQRFKIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               K+I+    +A G+ YL+       +HRD+ A N  +  +   K+GDFG+ + +YE 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYET 178
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 456 LIG-VITENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---K 510
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ S    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 571 SASDVWMFGVCMWEI 585

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 112/224 (50%), Gaps = 29/224 (12%)
Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNL 399
           ++LG G FG VYKG         K  VA+K I NE+   +   EF+ E   +  + H +L
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVASGLLY 454
           V+L+G C     + LV   M +G L  ++ +       + +LNW         +A G++Y
Sbjct: 103 VRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMY 155
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAP 512
           L E   + ++HRD+ A NVL+ S  + K+ DFGLA+L E G         G +   ++A 
Sbjct: 156 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWMAL 211
Query: 513 ETPRTGKSSASSDVFAFGALLLEVAC-GRRP---IETRALPEEL 552
           E     K +  SDV+++G  + E+   G +P   I TR +P+ L
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRNLVQLVG 404
           LG G FG+V  G    +  +VAVK ++ +  +    V +   EI  +   RH ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
                 D  +V ++++ G L  ++    + V   E R ++ + + S + Y H     +V+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEAR-RLFQQILSAVDYCHR---HMVV 133
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K  NVLLD+ +N K+ DFGL+ +   G     +   G+  Y APE   +G+  A  
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPEVI-SGRLYAGP 190
Query: 525 --DVFAFGALLLEVACGRRPIETRALP 549
             D+++ G +L  + CG  P +   +P
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 76  LIG-VITENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---K 130
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ +    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 191 SASDVWMFGVCMWEI 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 117
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 118 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 171
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 348 LGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           LG   FG+VYKG L           VA+K + ++++  +RE F  E     RL+H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-FDEP-------------KAVLNWEQRFKIIKG 447
           L+G   +   L +++ + ++G L  FL    P             K+ L       ++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT 506
           +A+G+ YL   +   V+H+D+   NVL+  +LN K+ D GL + +Y           +  
Sbjct: 154 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + ++APE    GK S  SD++++G +L EV
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 175
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG--VREFVSEIATIGRLRHRNLVQLVG 404
           +LG G FG+V K     ++ E AVK I+  S +       + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
                    +V +    G L    FDE   +   +     +IIK V SG+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 463 VIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
           ++HRD+K  N+LL+S   + + K+ DFGL+  ++  T       +GT  Y+APE  R G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 520 SSASSDVFAFGALLLEVACGRRP 542
                DV++ G +L  +  G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG--VREFVSEIATIGRLRHRNLVQLVG 404
           +LG G FG+V K     ++ E AVK I+  S +       + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
                    +V +    G L    FDE   +   +     +IIK V SG+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 463 VIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
           ++HRD+K  N+LL+S   + + K+ DFGL+  ++  T       +GT  Y+APE  R G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 520 SSASSDVFAFGALLLEVACGRRP 542
                DV++ G +L  +  G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-E 383
           Y   E + A    +  + LG G FG VY+G          +T VA+K ++  +    R E
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNW 438
           F++E + +      ++V+L+G   +    L++ + M  G L S+L       E   VL  
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 439 EQRFKIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEH 494
               K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + + E 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
                  + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 122
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 123 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 176
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LRHRNLVQL 402
            LG GGF + ++ +  ++K EV   +I  +S   K   RE +S   +I R L H+++V  
Sbjct: 28  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            G+      + +V +     SL   L    KA+   E R+  ++ +  G  YLH      
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 141
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           VIHRD+K  N+ L+ +L  K+GDFGLA   E+      T + GT  Y+APE       S 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 200
Query: 523 SSDVFAFGALLLEVACGRRPIETRALPE 550
             DV++ G ++  +  G+ P ET  L E
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKE 228

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 123
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 177
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 119
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDY 173
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LRHRNLVQL 402
            LG GGF + ++ +  ++K EV   +I  +S   K   RE +S   +I R L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            G+      + +V +     SL   L    KA+   E R+  ++ +  G  YLH      
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 137
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           VIHRD+K  N+ L+ +L  K+GDFGLA   E+      T + GT  Y+APE       S 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 523 SSDVFAFGALLLEVACGRRPIETRALPE 550
             DV++ G ++  +  G+ P ET  L E
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVS-EIATIGRLRHRNLVQL 402
            LG GGF + ++ +  ++K EV   +I  +S   K   RE +S EI+    L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            G+      + +V +     SL   L    KA+   E R+  ++ +  G  YLH      
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 137
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           VIHRD+K  N+ L+ +L  K+GDFGLA   E+      T + GT  Y+APE       S 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 523 SSDVFAFGALLLEVACGRRPIETRALPE 550
             DV++ G ++  +  G+ P ET  L E
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELA 144
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 145 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 198
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 175
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELA 123
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 177
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 348 LGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           LG   FG+VYKG L           VA+K + ++++  +RE F  E     RL+H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-FDEP-------------KAVLNWEQRFKIIKG 447
           L+G   +   L +++ + ++G L  FL    P             K+ L       ++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGT 506
           +A+G+ YL   +   V+H+D+   NVL+  +LN K+ D GL + +Y           +  
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           + ++APE    GK S  SD++++G +L EV
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELA 135
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 136 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 189
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 230

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 123
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDY 177
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EF 384
           GP+   +++ +   + +  + +LG G F +V       ++  VA+K I+ E+ +G     
Sbjct: 7   GPR---WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRF 442
            +EIA + +++H N+V L       G L L+   ++ G L    FD    K         
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVL---LDSELNGKLGDFGLAKLYEHGTNPA 499
           ++I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+  +
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           T    GT GY+APE       S + D ++ G +   + CG  P
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 119/250 (47%), Gaps = 34/250 (13%)
Query: 316 EVIEDWELE----VGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTL-----HNSK 365
           ++IE +E      + P +  Y E  +   NN    + LG G FG+V + T       ++ 
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 366 TEVAVKRISNESKQGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGS 423
            +VAVK + + +    +E  +SE+  +  L +H N+V L+G C   G +L++ ++   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 424 LDSFLFDE--------------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVK 469
           L +FL  +              P+  L+          VA G+ +L     +  IHRDV 
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLAS---KNCIHRDVA 193
Query: 470 ASNVLLDSELNGKLGDFGLAKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDV 526
           A NVLL +    K+GDFGLA+   + +N       R+   + ++APE+      +  SDV
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDV 251
Query: 527 FAFGALLLEV 536
           +++G LL E+
Sbjct: 252 WSYGILLWEI 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 112/239 (46%), Gaps = 34/239 (14%)
Query: 325 VGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK----------RIS 374
           + P  Y  ++  +   ++   + LG G +G+V      N  +E A+K          R S
Sbjct: 21  INPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80
Query: 375 NESKQGVR---EFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DS 426
           +++K   +   E  +EI+ +  L H N+++L      K    LV +F   G L     + 
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR 140
Query: 427 FLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKL 483
             FDE  A         I+K + SG+ YLH+     ++HRD+K  N+LL+++   LN K+
Sbjct: 141 HKFDECDAA-------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190
Query: 484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            DFGL+  +    +      +GT  Y+APE  +  K +   DV++ G ++  + CG  P
Sbjct: 191 VDFGLSSFF--SKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 338 ATNNF---SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL 394
           A N+F   S  ++LG G FGQV+K     +  ++A K I     +   E  +EI+ + +L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H NL+QL      K D++LV +++  G L   + DE   +   +     +K +  G+ +
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-FMKQICEGIRH 202
Query: 455 LHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLYEHGTNPATTRVV--GTLGY 509
           +H+ Y   ++H D+K  N+L    D++   K+ DFGLA+ Y+    P     V  GT  +
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK----PREKLKVNFGTPEF 254
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           LAPE       S  +D+++ G +   +  G  P
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   N +   VRE F+ E  T+ +  H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G    +  + ++ +    G L SFL    K  L+          +++ L YL     +
Sbjct: 456 LIG-VITENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---K 510
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS 521
             +HRD+ A NVL+ +    KLGDFGL++  E  T    ++    + ++APE+    + +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 522 ASSDVFAFGALLLEV 536
           ++SDV+ FG  + E+
Sbjct: 571 SASDVWMFGVCMWEI 585

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 119
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSC---HAPSSRRTTLSGTLDY 173
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EF 384
           GP+   +++ +   + +  + +LG G F +V       ++  VA+K I+ E+ +G     
Sbjct: 7   GPR---WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRF 442
            +EIA + +++H N+V L       G L L+   ++ G L    FD    K         
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVL---LDSELNGKLGDFGLAKLYEHGTNPA 499
           ++I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+  +
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           T    GT GY+APE       S + D ++ G +   + CG  P
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 15/227 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISNESKQGVREFVS---EIA 389
           K   ++F   ++LG G FG+V+   K T  +S    A+K +  ++   VR+ V    E  
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMK-VLKKATLKVRDRVRTKMERD 82
Query: 390 TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGV 448
            +  + H  +V+L    + +G L L+ DF+  G L + L    K V+  E+  K  +  +
Sbjct: 83  ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAEL 139
Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
           A GL +LH      +I+RD+K  N+LLD E + KL DFGL+K        A +   GT+ 
Sbjct: 140 ALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVE 195
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
           Y+APE       S S+D +++G L+ E+  G  P + +   E + L+
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLR 395
           AT+ +     +G G +G VYK    +S   VA+K  R+ N  +      V E+A + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 396 ---HRNLVQLVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
              H N+V+L+  C      R+  + LV++ + +  L ++L   P   L  E    +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
              GL +LH      ++HRD+K  N+L+ S    KL DFGLA++Y +    A   VV TL
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALAPVVVTL 175
Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
            Y APE       +   D+++ G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPL 210

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 346 QLLGHGGFGQVYK------GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           ++LG GGFG+V+       G L+  K     +    +  QG    + E   + ++  R +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSL---------DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           V L      K DL LV   M  G +         D+  F EP+A+    Q       + S
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IVS 300
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           GL +LH+   + +I+RD+K  NVLLD + N ++ D GLA   + G    T    GT G++
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFM 356
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           APE     +   S D FA G  L E+   R P   R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 18/219 (8%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVR-EFVSE 387
           E + A    +  + LG G FG VY+G          +T VA+K ++  +    R EF++E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-----EPKAVLNWEQRF 442
            + +      ++V+L+G   +    L++ + M  G L S+L       E   VL      
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 443 KIIK---GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNP 498
           K+I+    +A G+ YL+       +HRD+ A N ++  +   K+GDFG+ + + E     
Sbjct: 124 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
              + +  + +++PE+ + G  +  SDV++FG +L E+A
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 346 QLLGHGGFGQVYK------GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           ++LG GGFG+V+       G L+  K     +    +  QG    + E   + ++  R +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSL---------DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           V L      K DL LV   M  G +         D+  F EP+A+    Q       + S
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IVS 300
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           GL +LH+   + +I+RD+K  NVLLD + N ++ D GLA   + G    T    GT G++
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFM 356
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           APE     +   S D FA G  L E+   R P   R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 346 QLLGHGGFGQVYK------GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           ++LG GGFG+V+       G L+  K     +    +  QG    + E   + ++  R +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSL---------DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           V L      K DL LV   M  G +         D+  F EP+A+    Q       + S
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IVS 300
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           GL +LH+   + +I+RD+K  NVLLD + N ++ D GLA   + G    T    GT G++
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFM 356
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           APE     +   S D FA G  L E+   R P   R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 346 QLLGHGGFGQVYK------GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           ++LG GGFG+V+       G L+  K     +    +  QG    + E   + ++  R +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSL---------DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           V L      K DL LV   M  G +         D+  F EP+A+    Q       + S
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-------IVS 300
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           GL +LH+   + +I+RD+K  NVLLD + N ++ D GLA   + G    T    GT G++
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFM 356
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           APE     +   S D FA G  L E+   R P   R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           F+    P+  L+ +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EF 384
           GP+   +++ +   + +  + +LG G F +V       ++  VA+K I+ E+ +G     
Sbjct: 7   GPR---WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSM 63
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRF 442
            +EIA + +++H N+V L       G L L+   ++ G L    FD    K         
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS 119
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVL---LDSELNGKLGDFGLAKLYEHGTNPA 499
           ++I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+  +
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           T    GT GY+APE       S + D ++ G +   + CG  P
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY       K  +A+K +  +   K GV  +   E+     L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 115
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL Y
Sbjct: 116 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDY 169
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLR 395
           AT+ +     +G G +G VYK    +S   VA+K  R+ N  +      V E+A + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 396 ---HRNLVQLVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
              H N+V+L+  C      R+  + LV++ + +  L ++L   P   L  E    +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
              GL +LH      ++HRD+K  N+L+ S    KL DFGLA++Y +    A   VV TL
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALDPVVVTL 175
Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
            Y APE       +   D+++ G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPL 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLR 395
           AT+ +     +G G +G VYK    +S   VA+K  R+ N    G    +S +  +  LR
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 396 ------HRNLVQLVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
                 H N+V+L+  C      R+  + LV++ + +  L ++L   P   L  E    +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
           ++    GL +LH      ++HRD+K  N+L+ S    KL DFGLA++Y +    A T VV
Sbjct: 126 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVV 180
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
            TL Y APE       +   D+++ G +  E+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 94/190 (49%), Gaps = 16/190 (8%)
Query: 384 FVSEIATIGRLRHRNLVQLVGWC--RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR 441
            VSE+  +  L+H N+V+       R    L +V ++   G L S +    K     ++ 
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 442 FKIIKGVASGLLYLHEGYEQ-----VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
           F +++ +    L L E + +      V+HRD+K +NV LD + N KLGDFGLA++  H T
Sbjct: 112 F-VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVD 556
           + A T  VGT  Y++PE       +  SD+++ G LL E+ C   P  T    +EL    
Sbjct: 171 SFAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL-CALMPPFTAFSQKELA--- 225
Query: 557 WVWGKYGEGR 566
              GK  EG+
Sbjct: 226 ---GKIREGK 232

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 11/215 (5%)
Query: 348 LGHGGFGQVYKGT--LHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           LG G FG V +G   +   + +VA+K +     K    E + E   + +L +  +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C+ +  L+LV +    G L  FL  + +  +      +++  V+ G+ YL E   +  +
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFV 458
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGKSSA 522
           HR++ A NVLL +    K+ DFGL+K      +  T R  G   L + APE     K S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 523 SSDVFAFGALLLE-VACGRRPIETRALPEELVLVD 556
            SDV+++G  + E ++ G++P +    PE +  ++
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G +   L     FDE +           I  +A
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT-------YITELA 123
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 124 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTLDY 177
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G FG+V+K     +  +VA+K++   NE +      + EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 406 CRRK--------GDLLLVYDFMAN---GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           CR K        G + LV+DF  +   G L + L    K  L+  +R  +++ + +GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 140
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV---VGTLGYLA 511
           +H      ++HRD+KA+NVL+  +   KL DFGLA+ +    N    R    V TL Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 512 PE 513
           PE
Sbjct: 198 PE 199

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLRHR 397
           NF  ++ +G G F +VY+         VA+K++        +   + + EI  + +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIKGVASGLLYL 455
           N+++         +L +V +    G L   +  F + K ++     +K    + S L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H    + V+HRD+K +NV + +    KLGD GL + +   T  A + +VGT  Y++PE  
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 208
Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
                +  SD+++ G LL E+A  + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 346 QLLGHGGFGQVYKGTLHN---SKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG V +G L     +  +VAVK  ++ N S++ + EF+SE A +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 401 QLVGWCRRKGDL-----LLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVAS 450
           +L+G C           +++  FM  G L ++L        PK +   +   K +  +A 
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI-PLQTLLKFMVDIAL 158
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT-LGY 509
           G+ YL     +  +HRD+ A N +L  ++   + DFGL+K    G      R+    + +
Sbjct: 159 GMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVA 537
           +A E+      ++ SDV+AFG  + E+A
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIA 243

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDY 175
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ +FG +    H  +   T + GTL Y
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTLDY 175
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LRHRNLVQL 402
            LG GGF + ++ +  ++K EV   +I  +S   K   RE +S   +I R L H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            G+      + +V +     SL   L    KA+   E R+  ++ +  G  YLH      
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 135
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           VIHRD+K  N+ L+ +L  K+GDFGLA   E+        + GT  Y+APE       S 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 523 SSDVFAFGALLLEVACGRRPIETRALPE 550
             DV++ G ++  +  G+ P ET  L E
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 32/227 (14%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRIS-NESKQGVREFVSEIATIGR 393
            N    + LG G FG+V K T  + K     T VAVK +  N S   +R+ +SE   + +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------------------FDEP 432
           + H ++++L G C + G LLL+ ++   GSL  FL                      D P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 433 -KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK- 490
            +  L           ++ G+ YL    E  ++HRD+ A N+L+      K+ DFGL++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           +YE  +    ++    + ++A E+      +  SDV++FG LL E+ 
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH-- 396
            ++F    +LG G FGQV K          A+K+I + +++ +   +SE+  +  L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 397 -----------RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---F 442
                      RN V+ +   ++K  L +  ++  NG+L   +  E    LN +QR   +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LN-QQRDEYW 119
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-------- 494
           ++ + +   L Y+H    Q +IHRD+K  N+ +D   N K+GDFGLAK            
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 495 -----GTNPATTRVVGTLGYLAPET-PRTGKSSASSDVFAFGALLLEV 536
                G++   T  +GT  Y+A E    TG  +   D+++ G +  E+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G FG+V+K     +  +VA+K++   NE +      + EI  +  L+H N+V L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 406 CRRK--------GDLLLVYDFMAN---GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           CR K        G + LV+DF  +   G L + L    K  L+  +R  +++ + +GL Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 139
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV---VGTLGYLA 511
           +H      ++HRD+KA+NVL+  +   KL DFGLA+ +    N    R    V TL Y  
Sbjct: 140 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 512 PE 513
           PE
Sbjct: 197 PE 198

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 120
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 121 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDY 174
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LRHRNLVQL 402
            LG GGF + ++ +  ++K EV   +I  +S   K   RE +S   +I R L H+++V  
Sbjct: 46  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            G+      + +V +     SL   L    KA+   E R+  ++ +  G  YLH      
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 159
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           VIHRD+K  N+ L+ +L  K+GDFGLA   E+        + GT  Y+APE       S 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 218
Query: 523 SSDVFAFGALLLEVACGRRPIETRALPE 550
             DV++ G ++  +  G+ P ET  L E
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLKE 246

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 119 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDY 172
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLR 395
           AT+ +     +G G +G VYK    +S   VA+K  R+ N  +      V E+A + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 396 ---HRNLVQLVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
              H N+V+L+  C      R+  + LV++ + +  L ++L   P   L  E    +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
              GL +LH      ++HRD+K  N+L+ S    KL DFGLA++Y +    A   VV TL
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALFPVVVTL 175
Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
            Y APE       +   D+++ G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPL 210

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 9/222 (4%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVS-EIATIGR 393
           +    +   + LG GGF + Y+ T  ++K   A K +      K   +E +S EIA    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L + ++V   G+      + +V +     SL   L    KAV   E R+  ++    G+ 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQ 156
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           YLH      VIHRD+K  N+ L+ +++ K+GDFGLA   E       T + GT  Y+APE
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPE 212
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                  S   D+++ G +L  +  G+ P ET  L E  + +
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRLRH 396
            +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
            N+++L G+      + L+ ++   G++   L     FDE +           I  +A+ 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL YL 
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTLDYLP 178
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           PE           D+++ G L  E   G  P E     E
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIG 392
           K   ++F   + LG G FG VY      +K  +A+K +  S   K+GV  +   EI    
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKG 447
            LRH N++++  +   +  + L+ +F   G L   L     FDE ++    E+       
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE------- 122
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +A  L Y HE   + VIHRD+K  N+L+  +   K+ DFG +    H  +     + GTL
Sbjct: 123 LADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTL 176
Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET 545
            YL PE           D++  G L  E   G  P ++
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 32/227 (14%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRIS-NESKQGVREFVSEIATIGR 393
            N    + LG G FG+V K T  + K     T VAVK +  N S   +R+ +SE   + +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------------------FDEP 432
           + H ++++L G C + G LLL+ ++   GSL  FL                      D P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 433 -KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK- 490
            +  L           ++ G+ YL    E  ++HRD+ A N+L+      K+ DFGL++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           +YE  +    ++    + ++A E+      +  SDV++FG LL E+ 
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LRHRNLVQL 402
            LG GGF + ++ +  ++K EV   +I  +S   K   RE +S   +I R L H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            G+      + +V +     SL   L    KA+   E R+  ++ +  G  YLH      
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 161
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           VIHRD+K  N+ L+ +L  K+GDFGLA   E+        + GT  Y+APE       S 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 523 SSDVFAFGALLLEVACGRRPIETRALPE 550
             DV++ G ++  +  G+ P ET  L E
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKE 248

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 120
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ +FG +    H  +   T + GTL Y
Sbjct: 121 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTLDY 174
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDY 175
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDY 175
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIG 392
           K   ++F   + LG G FG VY      +K  +A+K +  S   K+GV  +   EI    
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKG 447
            LRH N++++  +   +  + L+ +F   G L   L     FDE ++    E+       
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE------- 123
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +A  L Y HE   + VIHRD+K  N+L+  +   K+ DFG +    H  +     + GTL
Sbjct: 124 LADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTL 177
Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET 545
            YL PE           D++  G L  E   G  P ++
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G FG+V+K     +  +VA+K++   NE +      + EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 406 CRRK--------GDLLLVYDFMAN---GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           CR K        G + LV+DF  +   G L + L    K  L+  +R  +++ + +GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 140
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV---VGTLGYLA 511
           +H      ++HRD+KA+NVL+  +   KL DFGLA+ +    N    R    V TL Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 512 PE 513
           PE
Sbjct: 198 PE 199

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 32/227 (14%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRIS-NESKQGVREFVSEIATIGR 393
            N    + LG G FG+V K T  + K     T VAVK +  N S   +R+ +SE   + +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------------------FDEP 432
           + H ++++L G C + G LLL+ ++   GSL  FL                      D P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 433 -KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK- 490
            +  L           ++ G+ YL    E  ++HRD+ A N+L+      K+ DFGL++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           +YE  +    ++    + ++A E+      +  SDV++FG LL E+ 
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELA 119
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDTLCGTLDY 173
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+  ++ +G G F +V       +  EVAVK I     +   +++   E+  +  L H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L LV ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKF-RQIVSAVQYCHQK 133
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           Y   ++HRD+KA N+LLD ++N K+ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 134 Y---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQGK 188
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYKGTL-------HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +     
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRV 503
              VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H      TT  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG LL E+
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 115/244 (47%), Gaps = 37/244 (15%)
Query: 325 VGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNESK 378
           + P +  Y E  +   NN    + LG G FG+V + T       ++  +VAVK + + + 
Sbjct: 15  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 74
Query: 379 QGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
              +E  +SE+  +  L +H N+V L+G C   G +L++ ++   G L +FL  + +A+L
Sbjct: 75  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAML 134
Query: 437 N-------------------WEQR--FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL 475
                                E R        VA G+ +L     +  IHRDV A NVLL
Sbjct: 135 GPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL 191
Query: 476 DSELNGKLGDFGLAKLYEHGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGAL 532
            +    K+GDFGLA+   + +N       R+   + ++APE+      +  SDV+++G L
Sbjct: 192 TNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGIL 249
Query: 533 LLEV 536
           L E+
Sbjct: 250 LWEI 253

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRL 394
           A  +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
           RH N+++L G+      + L+ ++   G++   L     FDE +           I  +A
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT-------YITELA 144
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           + L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL Y
Sbjct: 145 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDY 198
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           L PE           D+++ G L  E   G+ P E     E
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 141/308 (45%), Gaps = 41/308 (13%)
Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGT-LHNSKTEVAVKRISNES-KQGVR-EFVSEIATI 391
           L +A   +     +G G +G+V+K   L N    VA+KR+  ++ ++G+    + E+A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 392 GRLR---HRNLVQLVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
             L    H N+V+L   C      R+  L LV++ + +  L ++L   P+  +  E    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
           ++  +  GL +LH      V+HRD+K  N+L+ S    KL DFGLA++Y      A T V
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSV 179
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYG 563
           V TL Y APE       +   D+++ G +  E+   R+P+  R   +    VD +     
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPL-FRGSSD----VDQL----- 228
Query: 564 EGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFD 623
            G++L+VI             L GE + P  +  PR +   K+A+  +  +  +     D
Sbjct: 229 -GKILDVIG------------LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 275
Query: 624 KTTSCSYF 631
               C  F
Sbjct: 276 LLLKCLTF 283

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I   E++  + +   EI  + +     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P   L+  Q   I++ +  GL YLH    
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS--- 142
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL      KL DFG+A      T       VGT  ++APE  +    
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 521 SASSDVFAFGALLLEVACGRRP 542
            + +D+++ G   +E+A G  P
Sbjct: 202 DSKADIWSLGITAIELARGEPP 223

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVR 382
           GP+   +++ +   + +  + +LG G F +V       ++  VA+K I+    E K+G  
Sbjct: 7   GPR---WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSM 63
Query: 383 EFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQ 440
           E  +EIA + +++H N+V L       G L L+   ++ G L    FD    K       
Sbjct: 64  E--NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERD 117
Query: 441 RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVL---LDSELNGKLGDFGLAKLYEHGTN 497
             ++I  V   + YLH+     ++HRD+K  N+L   LD +    + DFGL+K+ + G+ 
Sbjct: 118 ASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            +T    GT GY+APE       S + D ++ G +   + CG  P
Sbjct: 175 LSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 141/308 (45%), Gaps = 41/308 (13%)
Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGT-LHNSKTEVAVKRISNES-KQGVR-EFVSEIATI 391
           L +A   +     +G G +G+V+K   L N    VA+KR+  ++ ++G+    + E+A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 392 GRLR---HRNLVQLVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
             L    H N+V+L   C      R+  L LV++ + +  L ++L   P+  +  E    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
           ++  +  GL +LH      V+HRD+K  N+L+ S    KL DFGLA++Y      A T V
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSV 179
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYG 563
           V TL Y APE       +   D+++ G +  E+   R+P+  R   +    VD +     
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPL-FRGSSD----VDQL----- 228
Query: 564 EGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFD 623
            G++L+VI             L GE + P  +  PR +   K+A+  +  +  +     D
Sbjct: 229 -GKILDVIG------------LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 275
Query: 624 KTTSCSYF 631
               C  F
Sbjct: 276 LLLKCLTF 283

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLR 395
           ++ +  +++LG G FG+V       +  E AVK IS    + K      + E+  + +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVA 449
           H N+++L  +   KG   LV +    G L    FDE    +   +RF      +II+ V 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRFSEVDAARIIRQVL 136
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
           SG+ Y+H+     ++HRD+K  N+LL+S   + N ++ DFGL+  +E   +      +GT
Sbjct: 137 SGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGT 191
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE    G      DV++ G +L  +  G  P
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 18/200 (9%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYK      +  VA+KRI  +++ +G+    + EI+ +  L H N+V L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ----RFKIIKGVASGLLYLHEGYEQ 461
              +  L LV++FM    L   L DE K  L   Q     +++++GVA         ++ 
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVA-------HCHQH 138
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-TGKS 520
            ++HRD+K  N+L++S+   KL DFGLA+ +       T  VV TL Y AP+    + K 
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 521 SASSDVFAFGALLLEVACGR 540
           S S D+++ G +  E+  G+
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 18/200 (9%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYK      +  VA+KRI  +++ +G+    + EI+ +  L H N+V L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ----RFKIIKGVASGLLYLHEGYEQ 461
              +  L LV++FM    L   L DE K  L   Q     +++++GVA         ++ 
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVA-------HCHQH 138
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-TGKS 520
            ++HRD+K  N+L++S+   KL DFGLA+ +       T  VV TL Y AP+    + K 
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 521 SASSDVFAFGALLLEVACGR 540
           S S D+++ G +  E+  G+
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I   E++  + +   EI  + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P   L+  Q   I++ +  GL YLH    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS--- 137
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL      KL DFG+A      T       VGT  ++APE  +    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 521 SASSDVFAFGALLLEVACGRRP 542
            + +D+++ G   +E+A G  P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 141/308 (45%), Gaps = 41/308 (13%)
Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGT-LHNSKTEVAVKRISNES-KQGVR-EFVSEIATI 391
           L +A   +     +G G +G+V+K   L N    VA+KR+  ++ ++G+    + E+A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 392 GRLR---HRNLVQLVGWCR-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
             L    H N+V+L   C      R+  L LV++ + +  L ++L   P+  +  E    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
           ++  +  GL +LH      V+HRD+K  N+L+ S    KL DFGLA++Y      A T V
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSV 179
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYG 563
           V TL Y APE       +   D+++ G +  E+   R+P+  R   +    VD +     
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPL-FRGSSD----VDQL----- 228
Query: 564 EGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFD 623
            G++L+VI             L GE + P  +  PR +   K+A+  +  +  +     D
Sbjct: 229 -GKILDVIG------------LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 275
Query: 624 KTTSCSYF 631
               C  F
Sbjct: 276 LLLKCLTF 283

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 341 NFSAKQL-----LGHGGFGQVYKGTLHNSKTEVAVKRI-SNESKQGVREFVSEIATIGRL 394
           +F+A+ L     +G G +G V K     S   +AVKRI S   ++  ++ + ++  + R 
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 395 RHRN-LVQLVGWCRRKGDLLLVYDFMANGSLDSF---LFDEPKAVLNWEQRFKIIKGVAS 450
                +VQ  G   R+GD  +  + M+  S D F   ++     V+  E   KI      
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            L +L E  +  +IHRD+K SN+LLD   N KL DFG++   +   + A TR  G   Y+
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYM 192
Query: 511 APET--PRTGKS--SASSDVFAFGALLLEVACGRRP 542
           APE   P   +      SDV++ G  L E+A GR P
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I   E++  + +   EI  + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P   L+  Q   I++ +  GL YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS--- 122
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL      KL DFG+A      T       VGT  ++APE  +    
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 521 SASSDVFAFGALLLEVACGRRP 542
            + +D+++ G   +E+A G  P
Sbjct: 182 DSKADIWSLGITAIELARGEPP 203

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLR 395
           ++ +  +++LG G FG+V       +  E AVK IS    + K      + E+  + +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVA 449
           H N+++L  +   KG   LV +    G L    FDE    +   +RF      +II+ V 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRFSEVDAARIIRQVL 142
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
           SG+ Y+H+     ++HRD+K  N+LL+S   + N ++ DFGL+  +E   +      +GT
Sbjct: 143 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGT 197
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE    G      DV++ G +L  +  G  P
Sbjct: 198 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I   E++  + +   EI  + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P   L+  Q   I++ +  GL YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS--- 122
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL      KL DFG+A      T       VGT  ++APE  +    
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 521 SASSDVFAFGALLLEVACGRRP 542
            + +D+++ G   +E+A G  P
Sbjct: 182 DSKADIWSLGITAIELARGEPP 203

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 9/222 (4%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVS-EIATIGR 393
           +    +   + LG GGF + Y+ T  ++K   A K +      K   +E +S EIA    
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L + ++V   G+      + +V +     SL   L    KAV   E R+  ++    G+ 
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQ 140
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           YLH      VIHRD+K  N+ L+ +++ K+GDFGLA   E         + GT  Y+APE
Sbjct: 141 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKDLCGTPNYIAPE 196
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                  S   D+++ G +L  +  G+ P ET  L E  + +
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 238

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 93/190 (48%), Gaps = 16/190 (8%)
Query: 384 FVSEIATIGRLRHRNLVQLVGWC--RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR 441
            VSE+  +  L+H N+V+       R    L +V ++   G L S +    K     ++ 
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 442 FKIIKGVASGLLYLHEGYEQ-----VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
           F +++ +    L L E + +      V+HRD+K +NV LD + N KLGDFGLA++  H T
Sbjct: 112 F-VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVD 556
           + A    VGT  Y++PE       +  SD+++ G LL E+ C   P  T    +EL    
Sbjct: 171 SFAKA-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL-CALMPPFTAFSQKELA--- 225
Query: 557 WVWGKYGEGR 566
              GK  EG+
Sbjct: 226 ---GKIREGK 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 9/222 (4%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVS-EIATIGR 393
           +    +   + LG GGF + Y+ T  ++K   A K +      K   +E +S EIA    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L + ++V   G+      + +V +     SL   L    KAV   E R+  ++    G+ 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQ 156
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           YLH      VIHRD+K  N+ L+ +++ K+GDFGLA   E         + GT  Y+APE
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKXLCGTPNYIAPE 212
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                  S   D+++ G +L  +  G+ P ET  L E  + +
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 110/247 (44%), Gaps = 27/247 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKM------GQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG A I  +G+L+LT      M      G+  Y+  +   +S    V
Sbjct: 8   FSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTV 67
Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S    AV
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDN-SYQTLAV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  +  +             S++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSN-PWDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173
Query: 200 SAENILNVT-VSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGW 255
           +   IL+V  V P+S    I  ++  VD+  +  +++ VG S +TG     A +H+V  W
Sbjct: 174 APSKILHVVLVYPSSG--AIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSW 231
Query: 256 SFKINGP 262
           SF+ + P
Sbjct: 232 SFQASLP 238

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 9/222 (4%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVS-EIATIGR 393
           +    +   + LG GGF + Y+ T  ++K   A K +      K   +E +S EIA    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L + ++V   G+      + +V +     SL   L    KAV   E R+  ++    G+ 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQ 156
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           YLH      VIHRD+K  N+ L+ +++ K+GDFGLA   E         + GT  Y+APE
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKDLCGTPNYIAPE 212
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                  S   D+++ G +L  +  G+ P ET  L E  + +
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLR 395
           ++ +  +++LG G FG+V       +  E AVK IS    + K      + E+  + +L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVA 449
           H N+++L  +   KG   LV +    G L    FDE    +   +RF      +II+ V 
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRFSEVDAARIIRQVL 159
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
           SG+ Y+H+     ++HRD+K  N+LL+S   + N ++ DFGL+  +E   +      +GT
Sbjct: 160 SGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGT 214
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE    G      DV++ G +L  +  G  P
Sbjct: 215 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 122/261 (46%), Gaps = 27/261 (10%)
Query: 6   RIFSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTN------DTSR 59
           RI   LI L+   S+ L    F  F +   NL LQ  A + ++G LR+T        T+ 
Sbjct: 10  RIVLFLILLTKAASANLISFTFKKFNE--TNLILQRDATV-SSGKLRITKAAENGVPTAG 66
Query: 60  KMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQ 119
            +G+AFYS+ ++  ++    V S++TSF   +          GLAF + P          
Sbjct: 67  SLGRAFYSTPIQIWDNTTGTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPKDKGG 126
Query: 120 YLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNS 179
           +LGL +S +  + SN   AVEFDT     +              + S  S++       +
Sbjct: 127 FLGLFDSKNYAS-SNQTVAVEFDTF----YNGGWDPTERHIGIDVNSIKSIK-------T 174
Query: 180 TKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGF 239
           T  D +   G+   V + YDS+ N+L  ++   S K    I+S RVDL+ +  E++ VGF
Sbjct: 175 TSWDFA--NGENAEVLITYDSSTNLLVASLVHPSQKTSF-IVSERVDLTSVLPEWVSVGF 231
Query: 240 SASTGL---LASSHNVLGWSF 257
           SA+TGL      ++ VL WSF
Sbjct: 232 SATTGLSKGYVETNEVLSWSF 252

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVAVK I     +   +++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L LV ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKF-RQIVSAVQYCHQK 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           +   ++HRD+KA N+LLD+++N K+ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGK 187
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLR 395
           ++ +  +++LG G FG+V       +  E AVK IS    + K      + E+  + +L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVA 449
           H N+++L  +   KG   LV +    G L    FDE    +   +RF      +II+ V 
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRFSEVDAARIIRQVL 160
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
           SG+ Y+H+     ++HRD+K  N+LL+S   + N ++ DFGL+  +E   +      +GT
Sbjct: 161 SGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGT 215
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE    G      DV++ G +L  +  G  P
Sbjct: 216 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRL 394
           Q+   +    L+G G +G V K    ++   VA+K+   S++ K   +  + EI  + +L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-LFDEPKAVLNWEQRFKIIKGVASGLL 453
           RH NLV L+  C++K    LV++F+ +  LD   LF  P   L+++   K +  + +G+ 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNG-LDYQVVQKYLFQIINGIG 138
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV----VGTLGY 509
           + H      +IHRD+K  N+L+      KL DFG A+     T  A   V    V T  Y
Sbjct: 139 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYDDEVATRWY 190
Query: 510 LAPETPRTG-KSSASSDVFAFGALLLEVACG 539
            APE      K   + DV+A G L+ E+  G
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG G FG V    Y     N+   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 404 GWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           G     G  +L LV +++ +G L  FL    +A L+  +       +  G+ YL     +
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS---R 130
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGK 519
             +HRD+ A N+L++SE + K+ DFGLAKL     +    R  G   + + APE+     
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 520 SSASSDVFAFGALLLEV 536
            S  SDV++FG +L E+
Sbjct: 191 FSRQSDVWSFGVVLYEL 207

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVAVK I     +   +++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L LV ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKF-RQIVSAVQYCHQK 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           +   ++HRD+KA N+LLD+++N K+ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGK 187
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 92/182 (50%), Gaps = 24/182 (13%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G FG+V+K     +  +VA+K++   NE +      + EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 406 CRRKGD--------LLLVYDFMAN---GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           CR K          + LV+DF  +   G L + L    K  L+  +R  +++ + +GL Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 140
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV---VGTLGYLA 511
           +H      ++HRD+KA+NVL+  +   KL DFGLA+ +    N    R    V TL Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 512 PE 513
           PE
Sbjct: 198 PE 199

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 30/230 (13%)
Query: 333 QELKQATNN--------FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGV 381
           ++ KQ +NN        F+   +LG G FG+V       ++   A+K +  +       V
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDV 63
Query: 382 REFVSEIATIGRLRHRNLVQLVGWCRRKGD-LLLVYDFMANGSLDSFL-----FDEPKAV 435
              + E   +  L     +  +  C +  D L  V +++  G L   +     F EP+AV
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
               +       ++ GL +LH+   + +I+RD+K  NV+LDSE + K+ DFG+ K  EH 
Sbjct: 124 FYAAE-------ISIGLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHM 171
Query: 496 TNPATTR-VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
            +  TTR   GT  Y+APE         S D +A+G LL E+  G+ P +
Sbjct: 172 MDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I   E++  + +   EI  + +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P    +  Q   ++K +  GL YLH    
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHS--- 138
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL  + + KL DFG+A      T       VGT  ++APE  +    
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 521 SASSDVFAFGALLLEVACGRRP 542
            + +D+++ G   +E+A G  P
Sbjct: 198 DSKADIWSLGITAIELAKGEPP 219

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLV 400
           F+    +G G FG+VYKG  +++K  VA+K I   E++  + +   EI  + +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +  G   +   L ++ +++  GS    L   P   L       I++ +  GL YLH    
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHS--- 134
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +  IHRD+KA+NVLL  + + KL DFG+A      T       VGT  ++APE  +    
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 521 SASSDVFAFGALLLEVACGRRP 542
              +D+++ G   +E+A G  P
Sbjct: 194 DFKADIWSLGITAIELAKGEPP 215

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 10/216 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR-EFVSEIATIGRLRHRNLVQLVGWC 406
           LG G +  VYKG    +   VA+K I  E ++G     + E++ +  L+H N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR 466
             +  L LV++++ +  L  +L D+   ++N       +  +  GL Y H    Q V+HR
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHR 124
Query: 467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-- 524
           D+K  N+L++     KL DFGLA+     T      VV TL Y  P+    G +  S+  
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI-LLGSTDYSTQI 182
Query: 525 DVFAFGALLLEVACGRRPIETRALPEELVLVDWVWG 560
           D++  G +  E+A GR       + E+L  +  + G
Sbjct: 183 DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG 218

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 94/219 (42%), Gaps = 21/219 (9%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRLRH 396
            +F   + LG G FG VY      SK  +A+K +  +   K GV  +   E+     LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
            N+++L G+      + L+ ++   G++   L     FDE +           I  +A+ 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L Y H    + VIHRD+K  N+LL S    K+ DFG +    H  +     + GTL YL 
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRDTLCGTLDYLP 178
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           PE           D+++ G L  E   G  P E     E
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 13/226 (5%)
Query: 336 KQATNNFSAKQLLGHGGFGQVY--KGTLHNSKTEVAVKRISNESKQGVREFVS---EIAT 390
           K   + F   ++LG G FG+V+  K    +   ++   ++  ++   VR+ V    E   
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGVA 449
           +  + H  +V+L    + +G L L+ DF+  G L + L    K V+  E+  K  +  +A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA 136
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
             L +LH      +I+RD+K  N+LLD E + KL DFGL+K        A +   GT+ Y
Sbjct: 137 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEY 192
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
           +APE       + S+D ++FG L+ E+  G  P + +   E + ++
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 71  H-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 121
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 122 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL 394
           L+     F   +L+G+G +GQVYKG  H    ++A  ++ + +     E   EI  + + 
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKY 77
Query: 395 -RHRNLVQLVGWCRRKG------DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
             HRN+    G   +K        L LV +F   GS+   + +     L  E    I + 
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +  GL +LH+     VIHRD+K  NVLL      KL DFG++   +       T  +GT 
Sbjct: 138 ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTP 193
Query: 508 GYLAPETPRTGKSSAS-----SDVFAFGALLLEVACGRRPI 543
            ++APE     ++  +     SD+++ G   +E+A G  P+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV-SEIATIGRLRHRNLV 400
           F  K+ LG G F +V       +    AVK I  ++ +G    + +EIA + +++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEG 458
            L         L LV   ++ G L    FD    K     +    +I+ V   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLHR- 138
Query: 459 YEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
               ++HRD+K  N+L    D E    + DFGL+K+   G     +   GT GY+APE  
Sbjct: 139 --MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVL 194
Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
                S + D ++ G +   + CG  P
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           LG G +G+V       +  E A+K  R ++ S     + + E+A +  L H N+++L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
              K +  LV +    G L    FDE   +   N      IIK V SG+ YLH+     +
Sbjct: 105 FEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNI 157
Query: 464 IHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           +HRD+K  N+LL+S+      K+ DFGL+ ++E+         +GT  Y+APE  R  K 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPEVLRK-KY 214
Query: 521 SASSDVFAFGALLLEVACGRRP 542
               DV++ G +L  +  G  P
Sbjct: 215 DEKCDVWSIGVILFILLAGYPP 236

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH-- 396
            ++F    +LG G FGQV K          A+K+I + +++ +   +SE+  +  L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 397 -----------RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---F 442
                      RN V+ +   ++K  L +  ++  N +L   +  E    LN +QR   +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN---LN-QQRDEYW 119
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-------- 494
           ++ + +   L Y+H    Q +IHRD+K  N+ +D   N K+GDFGLAK            
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 495 -----GTNPATTRVVGTLGYLAPET-PRTGKSSASSDVFAFGALLLEV 536
                G++   T  +GT  Y+A E    TG  +   D+++ G +  E+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 144
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPI 227

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 13/226 (5%)
Query: 336 KQATNNFSAKQLLGHGGFGQVY--KGTLHNSKTEVAVKRISNESKQGVREFVS---EIAT 390
           K   + F   ++LG G FG+V+  K    +   ++   ++  ++   VR+ V    E   
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGVA 449
           +  + H  +V+L    + +G L L+ DF+  G L + L    K V+  E+  K  +  +A
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA 136
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
             L +LH      +I+RD+K  N+LLD E + KL DFGL+K        A +   GT+ Y
Sbjct: 137 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEY 192
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
           +APE       + S+D ++FG L+ E+  G  P + +   E + ++
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 13/226 (5%)
Query: 336 KQATNNFSAKQLLGHGGFGQVY--KGTLHNSKTEVAVKRISNESKQGVREFVS---EIAT 390
           K   + F   ++LG G FG+V+  K    +   ++   ++  ++   VR+ V    E   
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGVA 449
           +  + H  +V+L    + +G L L+ DF+  G L + L    K V+  E+  K  +  +A
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA 137
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
             L +LH      +I+RD+K  N+LLD E + KL DFGL+K        A +   GT+ Y
Sbjct: 138 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEY 193
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
           +APE       + S+D ++FG L+ E+  G  P + +   E + ++
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVAV+ I     +   +++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L LV ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKF-RQIVSAVQYCHQK 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           +   ++HRD+KA N+LLD+++N K+ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGK 187
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 146
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPI 229

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVAVK I     +   +++   E+  +  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLL 453
           +V+L      +  L LV ++ + G +  +L       E +A   + Q       + S + 
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ-------IVSAVQ 120
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           Y H+ +   ++HRD+KA N+LLD+++N K+ DFG +  +  G    T    G+  Y APE
Sbjct: 121 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPE 175
Query: 514 TPRTGKSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
             +  K      DV++ G +L  +  G  P + + L E
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 213

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--------SNESKQGVRE-FVSEIAT 390
            N+  K++LG G    V +     +  E AVK I        S E  Q +RE  + E+  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 391 IGRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA 449
           + ++  H N++QL           LV+D M  G L  +L +  K  L+ ++  KI++ + 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALL 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
             +  LH+     ++HRD+K  N+LLD ++N KL DFG +   + G       V GT  Y
Sbjct: 122 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSY 176
Query: 510 LAPET---------PRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           LAPE          P  GK     D+++ G ++  +  G  P   R
Sbjct: 177 LAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHR 219

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHN-SKT----EVAVKRISNESKQGVRE-FVSEIATIGRL 394
           N    ++LG G FG+V   T +  SKT    +VAVK +  ++    RE  +SE+  + +L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 395 -RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL------FDEPKA------------- 434
             H N+V L+G C   G + L++++   G L ++L      F E +              
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 435 --VLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
             VL +E        VA G+ +L     +  +HRD+ A NVL+      K+ DFGLA+  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 493 EHGTNPATT-RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              +N          + ++APE+   G  +  SDV+++G LL E+
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 99  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 152
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 212 GYTKSIDIWSVGCILAEML-SNRPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 144
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPI 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 89  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 142
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 202 GYTKSIDIWSVGCILAEML-SNRPI 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 144
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEM-LSNRPI 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 144
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPI 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 89  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 142
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 202 GYTKSIDIWSVGCILAEML-SNRPI 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 149
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 209 GYTKSIDIWSVGCILAEML-SNRPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 97  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 150
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 151 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 210 GYTKSIDIWSVGCILAEML-SNRPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 88  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 141
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 142 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 201 GYTKSIDIWSVGCILAEML-SNRPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 148
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 73  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 123
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 124 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLMET---DLYKLLKCQHLSN-DHICYFLYQILRGLKYIHSAN-- 148
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 24/227 (10%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSK--------TEVAVKRISNESKQGVREFVSE 387
           K+    +  K ++G G    V +  +H +          EV  +R+S E  + VRE    
Sbjct: 90  KEFYQKYDPKDVIGRG-VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 388 IATIGR--LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
              I R    H +++ L+        + LV+D M  G L  +L +  K  L+ ++   I+
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIM 206
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG 505
           + +   + +LH      ++HRD+K  N+LLD  +  +L DFG +   E G       + G
Sbjct: 207 RSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCG 261
Query: 506 TLGYLAPETPRTGKSSASS------DVFAFGALLLEVACGRRPIETR 546
           T GYLAPE  +              D++A G +L  +  G  P   R
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 111 RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 164
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 165 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 224 GYTKSIDIWSVGCILAEML-SNRPI 247

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIG 392
           K   N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   + 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
             RH  L  L    +    L  V ++   G L    F   +  +  E+R +     + S 
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 122
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYL 510
           L YLH    + V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YL
Sbjct: 123 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 177
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE         + D +  G ++ E+ CGR P 
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 144
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEM-LSNRPI 227

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--------SNESKQGVRE-FVSEIAT 390
            N+  K++LG G    V +     +  E AVK I        S E  Q +RE  + E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 391 IGRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA 449
           + ++  H N++QL           LV+D M  G L  +L +  K  L+ ++  KI++ + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALL 134
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
             +  LH+     ++HRD+K  N+LLD ++N KL DFG +   + G       V GT  Y
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSY 189
Query: 510 LAPET---------PRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           LAPE          P  GK     D+++ G ++  +  G  P   R
Sbjct: 190 LAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHR 232

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIG 392
           K   N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
             RH  L  L    +    L  V ++   G L    F   +  +  E+R +     + S 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYL 510
           L YLH    + V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YL
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE         + D +  G ++ E+ CGR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIG 392
           K   N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
             RH  L  L    +    L  V ++   G L    F   +  +  E+R +     + S 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYL 510
           L YLH    + V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YL
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE         + D +  G ++ E+ CGR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIG 392
           K   N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
             RH  L  L    +    L  V ++   G L    F   +  +  E+R +     + S 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYL 510
           L YLH    + V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YL
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE         + D +  G ++ E+ CGR P 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 337 QATN---NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR 393
           Q TN    F   ++LG G F +V+      +    A+K I            +EIA + +
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK 62
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           ++H N+V L           LV   ++ G L   + +  + V   +    +I+ V S + 
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVK 120
Query: 454 YLHEGYEQVVIHRDVKASNVL-LDSELNGKL--GDFGLAKLYEHGTNPATTRVVGTLGYL 510
           YLHE     ++HRD+K  N+L L  E N K+   DFGL+K+ ++G     +   GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYV 174
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE       S + D ++ G +   + CG  P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--------SNESKQGVRE-FVSEIAT 390
            N+  K++LG G    V +     +  E AVK I        S E  Q +RE  + E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 391 IGRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA 449
           + ++  H N++QL           LV+D M  G L  +L +  K  L+ ++  KI++ + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALL 134
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
             +  LH+     ++HRD+K  N+LLD ++N KL DFG +   + G    +  V GT  Y
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--VCGTPSY 189
Query: 510 LAPET---------PRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
           LAPE          P  GK     D+++ G ++  +  G  P   R
Sbjct: 190 LAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHR 232

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 38/222 (17%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQLVG 404
           + +G G +G+V++G  H     VAVK  S+  +Q   RE  +EI     LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGLWHGES--VAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIA 69
Query: 405 --WCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH---- 456
                R     L L+  +  +GSL  FL    +  L      ++    A GL +LH    
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFL---QRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 457 --EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT-------NPATTRVVGTL 507
             +G +  + HRD K+ NVL+ S L   + D GLA ++  G+       NP     VGT 
Sbjct: 127 GTQG-KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR----VGTK 181
Query: 508 GYLAPET----PRTG--KSSASSDVFAFGALLLEVACGRRPI 543
            Y+APE      RT   +S   +D++AFG +L E+A  RR I
Sbjct: 182 RYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTI 221

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLR 395
           ++ +  +++LG G FG+V       +  E AVK IS    + K      + E+  + +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVA 449
           H N+ +L  +   KG   LV +    G L    FDE    +   +RF      +II+ V 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IISRKRFSEVDAARIIRQVL 136
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
           SG+ Y H+     ++HRD+K  N+LL+S   + N ++ DFGL+  +E   +      +GT
Sbjct: 137 SGITYXHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKXKDKIGT 191
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE    G      DV++ G +L  +  G  P
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 148
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIG 392
           K   N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
             RH  L  L    +    L  V ++   G L    F   +  +  E+R +     + S 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYL 510
           L YLH    + V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YL
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE         + D +  G ++ E+ CGR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIG 392
           K   N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
             RH  L  L    +    L  V ++   G L    F   +  +  E+R +     + S 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYL 510
           L YLH    + V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YL
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE         + D +  G ++ E+ CGR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIG 392
           K   N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   + 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASG 451
             RH  L  L    +    L  V ++   G L    F   +  +  E+R +     + S 
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 120
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYL 510
           L YLH    + V++RD+K  N++LD + + K+ DFGL K  E  ++ AT +   GT  YL
Sbjct: 121 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 175
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE         + D +  G ++ E+ CGR P
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE---FVSEIATIGRLR 395
           ++ +   + LG G +G+V       +  E A+K I   S          + E+A + +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK------IIKGVA 449
           H N+++L  +   K +  LV +    G L    FDE    +   Q+F       I+K V 
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDE----IILRQKFSEVDAAVIMKQVL 131
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGT 506
           SG  YLH+     ++HRD+K  N+LL+S+      K+ DFGL+  +E G        +GT
Sbjct: 132 SGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGT 186
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE  R  K     DV++ G +L  + CG  P
Sbjct: 187 AYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 384 FVSEIATIGRLRHRNLVQLVGWC--RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR 441
            VSE+  +  L+H N+V+       R    L +V ++   G L S +    K     ++ 
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 442 FKIIKGVASGLLYLHEGYEQ-----VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
           F +++ +    L L E + +      V+HRD+K +NV LD + N KLGDFGLA++  H  
Sbjct: 112 F-VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE 170
Query: 497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVD 556
           + A    VGT  Y++PE       +  SD+++ G LL E+ C   P  T    +EL    
Sbjct: 171 DFA-KEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL-CALMPPFTAFSQKELA--- 225
Query: 557 WVWGKYGEGR 566
              GK  EG+
Sbjct: 226 ---GKIREGK 232

>pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKM------GQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG A I  +G+L+LT      M      G+  Y+  +   +     V
Sbjct: 8   FSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTV 67
Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S     V
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGIFNNSKQDN-SYQTLGV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  +  +             S++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSN-PWDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173
Query: 200 SAENILN-VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGW 255
           ++  IL+ V V P+S    I  ++  VD+  +  E++ VG S +TG     A +H+V  W
Sbjct: 174 ASSKILHAVLVYPSSG--AIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSW 231
Query: 256 SFKINGP 262
           SF+ + P
Sbjct: 232 SFQASLP 238

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGV-REFVSEIATIGRLRH 396
           ++F   + LG G FG VY      S   VA+K +  S   K+GV  +   EI     L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASG 451
            N+++L  +   +  + L+ ++   G L      S  FDE +          I++ +A  
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA-------TIMEELADA 135
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L+Y H    + VIHRD+K  N+LL  +   K+ DFG +    H  +     + GTL YL 
Sbjct: 136 LMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMCGTLDYLP 189
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIET 545
           PE       +   D++  G L  E+  G  P E+
Sbjct: 190 PEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG G FG V    Y     N+   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 404 GWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           G     G   L LV +++ +G L  FL    +A L+  +       +  G+ YL     +
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS---R 133
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGK 519
             +HRD+ A N+L++SE + K+ DFGLAKL     +    R  G   + + APE+     
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 520 SSASSDVFAFGALLLEV 536
            S  SDV++FG +L E+
Sbjct: 194 FSRQSDVWSFGVVLYEL 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSE--IATIGRLRHR 397
           +N    +L+G G +G VYKG+L   +  VAVK  S  ++Q    F++E  I  +  + H 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHD 67
Query: 398 NLVQ-LVGWCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGL 452
           N+ + +VG  R   D     LLV ++  NGSL  +L        +W    ++   V  GL
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGL 124
Query: 453 LYLH------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA------KLYEHG-TNPA 499
            YLH      + Y+  + HRD+ + NVL+ ++    + DFGL+      +L   G  + A
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 500 TTRVVGTLGYLAPET------PRTGKSSASS-DVFAFGALLLEV 536
               VGT+ Y+APE        R  +S+    D++A G +  E+
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 118
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y 
Sbjct: 119 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 171
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVAV+ I     +   +++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L LV ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKF-RQIVSAVQYCHQK 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           +   ++HRD+KA N+LLD+++N K+ DFG +  +  G         G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPELFQGK 187
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 110/247 (44%), Gaps = 27/247 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKM------GQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG + I  +G+L+LT      M      G+  Y+  +   +     V
Sbjct: 8   FSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTV 67
Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S     V
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGGGYLGIFNNSKQDN-SYQTLGV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  + ++             S++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSN-QWDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173
Query: 200 SAENILN-VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGW 255
           ++  IL+ V V P+S    I  ++  VD+  +  E++ VG S +TG     A +H+V  W
Sbjct: 174 ASSKILHAVLVYPSSG--AIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSW 231
Query: 256 SFKINGP 262
           SF+ + P
Sbjct: 232 SFQASLP 238

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV------LNWEQRFKIIKGVA 449
           H N+V+L+     +  L LV++F+   S+D   F +  A+      L     F++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
               + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y
Sbjct: 121 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 172
Query: 510 LAPETPRTGK-SSASSDVFAFGALLLEVACGR 540
            APE     K  S + D+++ G +  E+   R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVAVK I     +   +++   E+  +  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L LV ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKF-RQIVSAVQYCHQK 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           +   ++HRD+KA N+LLD+++N K+ DFG +  +  G         G   Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGK 187
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 327 PQRYSYQELKQAT-------------NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
           PQR S+++ + A              +NF     +G G  G V   T+ +S   VAVK++
Sbjct: 6   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM 62
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
               +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +     
Sbjct: 63  DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---H 119
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             +N EQ   +   V   L  LH    Q VIHRD+K+ ++LL  +   KL DFG      
Sbjct: 120 TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 176
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
               P    +VGT  ++APE           D+++ G +++E+  G  P
Sbjct: 177 KEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 117
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 148
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEM-LSNRPI 231

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREF-VSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 124
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 125 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 179
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G V      +S  +VAVK +    +Q      +E+  +   +H N+V++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L ++ +F+  G+L   +    +  LN EQ   + + V   L YLH    Q VIHRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRD 166
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           +K+ ++LL  +   KL DFG          P    +VGT  ++APE       +   D++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 528 AFGALLLEVACGRRP 542
           + G +++E+  G  P
Sbjct: 226 SLGIMVIEMVDGEPP 240

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 116
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 171
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLD----SFLFDEPKAVLNWEQRFKIIKGVASG 451
           H N+V+L+     +  L LV++F++    D    S L   P  ++     F++++G+A  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK-SYLFQLLQGLA-- 120
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y A
Sbjct: 121 --FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 512 PETPRTGK-SSASSDVFAFGALLLEVACGR 540
           PE     K  S + D+++ G +  E+   R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG G FG V    Y     N+   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 404 GWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           G     G   L LV +++ +G L  FL    +A L+  +       +  G+ YL     +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS---R 146
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGK 519
             +HRD+ A N+L++SE + K+ DFGLAKL     +    R  G   + + APE+     
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 520 SSASSDVFAFGALLLEV 536
            S  SDV++FG +L E+
Sbjct: 207 FSRQSDVWSFGVVLYEL 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 348 LGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           LG G FG V    Y     N+   VAVK++ +      R+F  EI  +  L    +V+  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 404 GWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           G     G   L LV +++ +G L  FL    +A L+  +       +  G+ YL     +
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS---R 134
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGK 519
             +HRD+ A N+L++SE + K+ DFGLAKL     +    R  G   + + APE+     
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 520 SSASSDVFAFGALLLEV 536
            S  SDV++FG +L E+
Sbjct: 195 FSRQSDVWSFGVVLYEL 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 117
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 117
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 116
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 171
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREF-VSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 124
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 125 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 179
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 327 PQRYSYQELKQAT-------------NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
           PQR S+++ + A              +NF     +G G  G V   T+ +S   VAVK++
Sbjct: 8   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM 64
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
               +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +     
Sbjct: 65  DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---H 121
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             +N EQ   +   V   L  LH    Q VIHRD+K+ ++LL  +   KL DFG      
Sbjct: 122 TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 178
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
               P    +VGT  ++APE           D+++ G +++E+  G  P
Sbjct: 179 KEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLD----SFLFDEPKAVLNWEQRFKIIKGVASG 451
           H N+V+L+     +  L LV++F++    D    S L   P  ++     F++++G+A  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK-SYLFQLLQGLA-- 119
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y A
Sbjct: 120 --FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 173
Query: 512 PETPRTGK-SSASSDVFAFGALLLEVACGR 540
           PE     K  S + D+++ G +  E+   R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV------LNWEQRFKIIKGVA 449
           H N+V+L+     +  L LV++F+   S+D   F +  A+      L     F++++G+A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
               + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y
Sbjct: 119 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 170
Query: 510 LAPETPRTGK-SSASSDVFAFGALLLEVACGR 540
            APE     K  S + D+++ G +  E+   R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLD----SFLFDEPKAVLNWEQRFKIIKGVASG 451
           H N+V+L+     +  L LV++F+     D    S L   P  ++     F++++G+A  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK-SYLFQLLQGLA-- 117
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y A
Sbjct: 118 --FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 171
Query: 512 PETPRTGK-SSASSDVFAFGALLLEVACGR 540
           PE     K  S + D+++ G +  E+   R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+++IS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 148
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G  G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 405 WCRRKGDL-LLVYDFMANGSL-DSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
             RR+G++  L  ++ + G L D    D    EP A     QRF     + +G++YLH G
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRF--FHQLMAGVVYLH-G 122
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 123 IG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 518 GKSSASS-DVFAFGALLLEVACGRRP 542
            +  A   DV++ G +L  +  G  P
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRH 396
           ++F   + +G G FG+V     +++K   A+K ++ +    +  VR    E+  +  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI-IKGVASGLLYL 455
             LV L    + + D+ +V D +  G L   L    + V   E+  K+ I  +   L YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYL 131
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
                Q +IHRD+K  N+LLD   +  + DF +A +    T    T + GT  Y+APE  
Sbjct: 132 QN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMF 186
Query: 516 RTGKSSASS---DVFAFGALLLEVACGRRPIETRA 547
            + K +  S   D ++ G    E+  GRRP   R+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG V+KG       + K  V +K I ++S +Q  +     +  IG L H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLYL 455
           +L+G C     L LV  ++  GSL   +        P+ +LNW  +      +A G+ YL
Sbjct: 97  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYL 149
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT-LGYLAPET 514
            E     ++HR++ A NVLL S    ++ DFG+A L              T + ++A E+
Sbjct: 150 EE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 515 PRTGKSSASSDVFAFGALLLEV 536
              GK +  SDV+++G  + E+
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWEL 228

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 121
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 122 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 176
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 108/247 (43%), Gaps = 27/247 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKM------GQAFYSSTLRFKNSLNSNV 80
           F  F+  +N+LTLQG A I  +G+L+LT      M      G+  Y+  +   +     V
Sbjct: 8   FSEFEPGNNDLTLQGAAIITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHIWDMTTGTV 67
Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S    AV
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDN-SYQTLAV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  +  +             S++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSN-PWDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173
Query: 200 SAENI-LNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGW 255
           ++  I L V V P+S    I  ++  VD+  +  E++ VG S +TG     A +H+V  W
Sbjct: 174 ASSKILLAVLVYPSSG--AIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSW 231
Query: 256 SFKINGP 262
           SF  + P
Sbjct: 232 SFHASLP 238

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           +F   +L+G GGFGQV+K           +KR+   +++  R    E+  + +L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 401 QLVG-W--------------CRRKGDLLLV-YDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
              G W               R K   L +  +F   G+L+ ++       L+     ++
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
            + +  G+ Y+H    + +I+RD+K SN+ L      K+GDFGL    ++  +    R  
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRXRSK 182
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           GTL Y++PE   +       D++A G +L E+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 117/248 (47%), Gaps = 31/248 (12%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTN-----DTSRKMGQAFYSSTLRFKNSLNSNVF 81
           FP F      L  QG A + + G+L+LTN      +S+ +G+A Y++  +  +S   NV 
Sbjct: 8   FPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVA 67
Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSN----DLNGLPSQYLGLLNSTDIGNFSNHLF 137
           SF TSF  +I    P     GLAF ++P +    DL G+    LG+       N SN + 
Sbjct: 68  SFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGM----LGIFKDGYF-NKSNQIV 122
Query: 138 AVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVD 197
           AVEFDT  + ++             ++ S  S++   +         +   G+   V++ 
Sbjct: 123 AVEFDTFSNGDWD----PKGRHLGINVNSIESIKTVPW---------NWTNGEVANVFIS 169
Query: 198 YDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLG 254
           Y+++   L  ++   S +    I+   VD+  +  E++  GFSA+TG+      +++VL 
Sbjct: 170 YEASTKSLTASLVYPSLETSF-IIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLS 228
Query: 255 WSFKINGP 262
           WSF+ N P
Sbjct: 229 WSFESNLP 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRV 503
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+ +        TT  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 7/195 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G V   T  ++  +VAVK++    +Q      +E+  +    H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +F+  G+L   +       +N EQ   +   V   L YLH    Q VIHRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHN---QGVIHRD 166
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           +K+ ++LL S+   KL DFG          P    +VGT  ++APE           D++
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 528 AFGALLLEVACGRRP 542
           + G +++E+  G  P
Sbjct: 226 SLGIMVIEMIDGEPP 240

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG V+KG       + K  V +K I ++S +Q  +     +  IG L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLYL 455
           +L+G C     L LV  ++  GSL   +        P+ +LNW  +      +A G+ YL
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYL 131
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT-LGYLAPET 514
            E     ++HR++ A NVLL S    ++ DFG+A L              T + ++A E+
Sbjct: 132 EE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 515 PRTGKSSASSDVFAFGALLLEV 536
              GK +  SDV+++G  + E+
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWEL 210

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRV 503
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+ +        TT  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + ++APE       +  SDV++FG L+ E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 37/218 (16%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y++ TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                   + ++APE       +  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKM------GQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG A I  +G+L+LT      M      G+  Y+  +   +     V
Sbjct: 8   FSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTV 67
Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S     V
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGIFNNSKQDN-SYQTLGV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  +  +             S++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSN-PWDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173
Query: 200 SAENILN-VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGW 255
           ++  IL+ V V P+S    I  ++  VD+  +  E++ VG S +TG     A +H+V  W
Sbjct: 174 ASSKILHAVLVYPSSG--AIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSW 231
Query: 256 SFKINGP 262
           SF+ + P
Sbjct: 232 SFQASLP 238

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 111/235 (47%), Gaps = 34/235 (14%)
Query: 36  NLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNVFSFSTSFAI 89
           NL LQ  A + ++G LRLTN           +G+AFYS+ ++  ++    V SF+TSF  
Sbjct: 15  NLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTF 74
Query: 90  VIVPEYPRLGG--HGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTV--Q 145
            I  + P   G   GLAF + P   +   P    G L   D  N + H  AVEFDT+  +
Sbjct: 75  NI--QVPNNAGPADGLAFALVP---VGSQPKDKGGFLGLFDGSNSNFHTVAVEFDTLYNK 129
Query: 146 DFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENIL 205
           D++              S+K+             T+ D     G+   V + YDS+ N+L
Sbjct: 130 DWDPTERHIGIDVNSIRSIKT-------------TRWDF--VNGENAEVLITYDSSTNLL 174
Query: 206 NVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSF 257
             ++   S K    I+S  VDL  +  E++ VGFSA+TG+      +++VL WSF
Sbjct: 175 VASLVYPSQKTSF-IVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN- 218
Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 219 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 111/235 (47%), Gaps = 34/235 (14%)
Query: 36  NLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNVFSFSTSFAI 89
           NL LQ  A + ++G LRLTN           +G+AFYS+ ++  ++    V SF+TSF  
Sbjct: 15  NLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTF 74
Query: 90  VIVPEYPRLGG--HGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTV--Q 145
            I  + P   G   GLAF + P   +   P    G L   D  N + H  AVEFDT+  +
Sbjct: 75  NI--QVPNNAGPADGLAFALVP---VGSQPKDKGGFLGLFDGSNSNFHTVAVEFDTLYNK 129
Query: 146 DFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENIL 205
           D++              S+K+             T+ D     G+   V + YDS+ N+L
Sbjct: 130 DWDPTERHIGIDVNSIRSIKT-------------TRWDF--VNGENAEVLITYDSSTNLL 174
Query: 206 NVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSF 257
             ++   S K    I+S  VDL  +  E++ VGFSA+TG+      +++VL WSF
Sbjct: 175 VASLVYPSQKTSF-IVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN- 218
Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 219 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           +F   +L+G GGFGQV+K           ++R+   +++  RE    +  + +L H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 401 QLVG-W---------------------------CRRKGDLLLV-YDFMANGSLDSFLFDE 431
              G W                            R K   L +  +F   G+L+ ++   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
               L+     ++ + +  G+ Y+H    + +IHRD+K SN+ L      K+GDFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
            ++  +   TR  GTL Y++PE   +       D++A G +L E+
Sbjct: 186 LKN--DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           N+V+L+     +  L LV++F+ +  L  F+       +        +  +  GL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
                V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y APE    
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 518 GK-SSASSDVFAFGALLLEVACGR 540
            K  S + D+++ G +  E+   R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 327 PQRYSYQELKQAT-------------NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
           PQR S+++ + A              +NF     +G G  G V   T+ +S   VAVK++
Sbjct: 51  PQRVSHEQFRAALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM 107
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
               +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +     
Sbjct: 108 DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---H 164
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             +N EQ   +   V   L  LH    Q VIHRD+K+ ++LL  +   KL DFG      
Sbjct: 165 TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
               P    +VGT  ++APE           D+++ G +++E+  G  P
Sbjct: 222 KEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE---FVSEIATIGRLR 395
           ++ +   + LG G +G+V       +  E A+K I   S          + E+A + +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK------IIKGVA 449
           H N+++L  +   K +  LV +    G L    FDE    +   Q+F       I+K V 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDE----IILRQKFSEVDAAVIMKQVL 114
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGT 506
           SG  YLH+     ++HRD+K  N+LL+S+      K+ DFGL+  +E G        +GT
Sbjct: 115 SGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGT 169
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE  R  K     DV++ G +L  + CG  P
Sbjct: 170 AYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 115/236 (48%), Gaps = 28/236 (11%)
Query: 36  NLTLQGIAKIENNGILRLT----NDTSR--KMGQAFYSSTLRFKNSLNSNVFSFSTSFAI 89
           N+ LQG A + ++G L+L     N T +   +G+A YS+ +   +    +V SF+ SF  
Sbjct: 17  NMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNF 76
Query: 90  VI-VPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFE 148
               P+  RL   GLAF ++P +      + YLGL N  + G   + + AVEFDT     
Sbjct: 77  TFYAPDTKRLAD-GLAFFLAPIDTKPQTHAGYLGLFNENESG---DQVVAVEFDT----- 127
Query: 149 FQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVT 208
           F+            ++ S  S++       +T  DL+    K   V + YD++ ++L  +
Sbjct: 128 FRNSWDPPNPHIGINVNSIRSIK-------TTSWDLA--NNKVAKVLITYDASTSLLVAS 178
Query: 209 VSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL--LASSHNVLGWSFKINGP 262
           +   S +    ILS  VDL     E++ +GFSA+TGL     SH+VL WSF  N P
Sbjct: 179 LVYPSQRTS-NILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNLP 233

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 398 NLVQLVGWCRRKGDLLLVYD--------FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA 449
           N+V+L+     +  L LV++        FM   +L        K+ L     F++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
               + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y
Sbjct: 117 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 168
Query: 510 LAPETPRTGK-SSASSDVFAFGALLLEVACGR 540
            APE     K  S + D+++ G +  E+   R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 115/243 (47%), Gaps = 26/243 (10%)
Query: 30  FKDL-SNNLTLQGIAKIENNGILRLTN------DTSRKMGQAFYSSTLRFKNSLNSNVFS 82
           FK+  S +  LQG A + ++G L+LT        T   +G+AFYSS ++  +     V S
Sbjct: 8   FKNFNSPSFILQGDATV-SSGKLQLTKVKENGIPTPSSLGRAFYSSPIQIYDKSTGAVAS 66
Query: 83  FSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFD 142
           ++TSF + I          G+AF + P          YLG+ +S D+ N S    AVEFD
Sbjct: 67  WATSFTVKISAPSKASFADGIAFALVPVGSEPRRNGGYLGVFDS-DVYNNSAQTVAVEFD 125
Query: 143 TVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAE 202
           T+ +  +             S+KS A+V               L  G+   + + Y++A 
Sbjct: 126 TLSNSGWD-PSMKHIGIDVNSIKSIATVS------------WDLANGENAEILITYNAAT 172
Query: 203 NILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFKI 259
           ++L  ++   S +    ILS RVD++    E++ VGFSA+TGL      +H+VL WSF  
Sbjct: 173 SLLVASLVHPSRRTSY-ILSERVDITNELPEYVSVGFSATTGLSEGYIETHDVLSWSFAS 231
Query: 260 NGP 262
             P
Sbjct: 232 KLP 234

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 8/210 (3%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ---GVREFVSEIATIGRLRH 396
           N F   ++LG GGFG+V    +  +    A K++  +  +   G    ++E   + ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           R +V L      K  L LV   M  G L   ++   +A     +       +  GL  LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
               + +++RD+K  N+LLD   + ++ D GLA     G        VGT+GY+APE  +
Sbjct: 304 R---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVK 358
Query: 517 TGKSSASSDVFAFGALLLEVACGRRPIETR 546
             + + S D +A G LL E+  G+ P + R
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 27/247 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKM------GQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG + I  +G+L+LT      M      G+  Y+  +   +     V
Sbjct: 8   FSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTV 67
Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S     V
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGIFNNSKQDN-SYQTLGV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  + ++             S++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSN-QWDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173
Query: 200 SAENILN-VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGW 255
           ++  +L+ V V P+S    I  ++  VD+  +  E++ VG S +TG     A +H+V  W
Sbjct: 174 ASSKLLHAVLVYPSSG--AIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSW 231
Query: 256 SFKINGP 262
           SF+ + P
Sbjct: 232 SFQASLP 238

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 148
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H         V T  Y APE     K
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 149
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H         V T  Y APE     K
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 209 GYTKSIDIWSVGCILAEML-SNRPI 232

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN- 218
Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 219 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G V+K     +   VA+KR+  ++  +GV    + EI  +  L+H+N+V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
                 L LV++F  +  L  + FD     L+ E     +  +  GL + H    + V+H
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK-SSASS 524
           RD+K  N+L++     KL DFGLA+ +       +  VV TL Y  P+     K  S S 
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 525 DVFAFGALLLEVACGRRPI 543
           D+++ G +  E+A   RP+
Sbjct: 184 DMWSAGCIFAELANAARPL 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L +F     L   P  ++     F++++G+A 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIK-SYLFQLLQGLA- 120
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 121 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 8/210 (3%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ---GVREFVSEIATIGRLRH 396
           N F   ++LG GGFG+V    +  +    A K++  +  +   G    ++E   + ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           R +V L      K  L LV   M  G L   ++   +A     +       +  GL  LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
               + +++RD+K  N+LLD   + ++ D GLA     G        VGT+GY+APE  +
Sbjct: 304 R---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVK 358
Query: 517 TGKSSASSDVFAFGALLLEVACGRRPIETR 546
             + + S D +A G LL E+  G+ P + R
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN- 210
Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 211 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN- 205
Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 206 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN- 264
Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 265 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 327 PQRYSYQELKQAT-------------NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
           PQR S+++ + A              +NF     +G G  G V   T+ +S   VAVK++
Sbjct: 128 PQRVSHEQFRAALQLVVDPGDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKM 184
Query: 374 SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
               +Q      +E+  +   +H N+V++        +L +V +F+  G+L   +     
Sbjct: 185 DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---H 241
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             +N EQ   +   V   L  LH    Q VIHRD+K+ ++LL  +   KL DFG      
Sbjct: 242 TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
               P    +VGT  ++APE           D+++ G +++E+  G  P
Sbjct: 299 KEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  +   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 146
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPI 229

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                   + ++APE       +  SDV++FG L+ E+
Sbjct: 209 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLV 400
           F  +  LG G    VY+     ++   A+K +     K+ VR   +EI  + RL H N++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHPNII 111
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +L        ++ LV + +  G L   + +  K   +       +K +   + YLHE   
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHE--- 166
Query: 461 QVVIHRDVKASNVLL-----DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
             ++HRD+K  N+L      D+ L  K+ DFGL+K+ EH     T  V GT GY APE  
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVLMKT--VCGTPGYCAPEIL 222
Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
           R        D+++ G +   + CG  P
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 117
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 117
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 118
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 119 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 120
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 121 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 119
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 120 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 117
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLV-G 404
           +G G F  VYKG    +  EVA   + +   +K   + F  E   +  L+H N+V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 405 W---CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIK---------GVASGL 452
           W    + K  ++LV +   +G+L ++L           +RFK+ K          +  GL
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYL-----------KRFKVXKIKVLRSWCRQILKGL 142
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
            +LH      +IHRD+K  N+ +       K+GD GLA L       A   V+GT  + A
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFXA 198
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           PE     K   S DV+AFG   LE A    P
Sbjct: 199 PEXYEE-KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 117
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNV 80
           F  F+    +L  QG A + +N  L+LT   S+       +G+A Y++ +R   S +S V
Sbjct: 8   FTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLV 66
Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL-NGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T+F   I             F  SP   + +G   + LGL  S++     N + +V
Sbjct: 67  ASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  + +              S++S A+          +K D   + GK     + Y+
Sbjct: 127 EFDTYPNTDIGDPNYRHIGIDVNSIRSKAA----------SKWDW--QNGKTATAHISYN 174
Query: 200 SAENILNVTVS-PNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFK 258
           SA   L+V  S PNSS     ++SF V+L+ +   ++ VGFSA+TG    ++N+L WSF+
Sbjct: 175 SASKRLSVVSSYPNSSPV---VVSFDVELNNVXPXWVRVGFSATTGQYTQTNNILAWSFR 231

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREF-VSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 121
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 122 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 174
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 119
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 120 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 116
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y AP
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 171
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 120
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 121 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  + R RH N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ LV   M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 111 RAPTIEQMKDVYLVTHLMGA---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 164
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 165 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 224 GYTKSIDIWSVGCILAEML-SNRPI 247

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 118
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 119 ---FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVAS 450
           H N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 119
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y 
Sbjct: 120 ---FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGR 540
           APE     K  S + D+++ G +  E+   R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 7/195 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G V   T+ +S   VAVK++    +Q      +E+  +   +H N+V++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +F+  G+L   +       +N EQ   +   V   L  LH    Q VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 141
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           +K+ ++LL  +   KL DFG          P    +VGT  ++APE           D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 528 AFGALLLEVACGRRP 542
           + G +++E+  G  P
Sbjct: 201 SLGIMVIEMVDGEPP 215

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++ ++ + G+L  +L           +D    P+  + ++     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLA+       Y+  TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                   + ++APE       +  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS---EIATIGRLR 395
           ++N+  K+ LG G F  V +     +  E A K I N  K   R+F     E     +L+
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQ 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLL 453
           H N+V+L    + +    LV+D +  G L    F++   +   +       I+ +   + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 119
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           Y H      ++HR++K  N+LL S+  G   KL DFGLA   E   + A     GT GYL
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  +    S   D++A G +L  +  G  P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 116
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y AP
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 171
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 27/247 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKM------GQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG + I  +G+L+LT      M      G+  Y+  +   +     V
Sbjct: 8   FSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWDMTTGTV 67
Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N +   N S     V
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGIFNQSKQDN-SYQTLGV 126
Query: 140 EFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  +  +             S++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSN-PWDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173
Query: 200 SAENILN-VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGW 255
           ++  +L+ V V P+S    I  ++  VD+  +  E++ VG S +TG     A +H+V  W
Sbjct: 174 ASSKLLHAVLVYPSSG--AIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSW 231
Query: 256 SFKINGP 262
           SF+ + P
Sbjct: 232 SFQASLP 238

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREF-VSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+ +I  +++ +GV    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 117
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREF-VSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+ +I  +++ +GV    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 116
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y AP
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 171
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 38/225 (16%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH---- 396
           +F    +LG G FGQV K          A+K+I + +++ +   +SE+  +  L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQYVV 65
Query: 397 ---------RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---FKI 444
                    RN V+     ++K  L +  ++  N +L   +  E    LN +QR   +++
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN---LN-QQRDEYWRL 121
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH---------- 494
            + +   L Y+H    Q +IHR++K  N+ +D   N K+GDFGLAK              
Sbjct: 122 FRQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 495 ---GTNPATTRVVGTLGYLAPET-PRTGKSSASSDVFAFGALLLE 535
              G++   T  +GT  Y+A E    TG  +   D ++ G +  E
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHR 397
            NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSF-----LFDEPKAVLNWEQRFKIIKGVASGL 452
           N+V+L+     +  L LV++F+ +  L  F     L   P  ++     F++++G+A   
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA--- 118
Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL Y AP
Sbjct: 119 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGR 540
           E     K  S + D+++ G +  E+   R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR-LR 395
           ++F   +++G G FG+V        +   AVK +  ++   K+  +  +SE   + + ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H  LV L    +    L  V D++  G L   L  E +  L    RF   + +AS L YL
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAE-IASALGYL 155
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL-YEHGTNPATTRVVGTLGYLAPET 514
           H      +++RD+K  N+LLDS+ +  L DFGL K   EH  N  T+   GT  YLAPE 
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEV 210
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPIETR 546
                   + D +  GA+L E+  G  P  +R
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 7/195 (3%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G V   T+ +S   VAVK++    +Q      +E+  +   +H N+V++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +F+  G+L   +       +N EQ   +   V   L  LH    Q VIHRD
Sbjct: 92  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 145
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
           +K+ ++LL  +   KL DFG          P    +VGT  ++APE           D++
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 528 AFGALLLEVACGRRP 542
           + G +++E+  G  P
Sbjct: 205 SLGIMVIEMVDGEPP 219

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVA+K I     +   +++   E+  +  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L L+ ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKF-RQIVSAVQYCHQ- 129
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
             + ++HRD+KA N+LLD+++N K+ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 130 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELFQGK 185
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 218

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS---EIATIGRLR 395
           ++N+  K+ LG G F  V +     +  E A K I N  K   R+F     E     +L+
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQ 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLL 453
           H N+V+L    + +    LV+D +  G L    F++   +   +       I+ +   + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 119
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           Y H      ++HR++K  N+LL S+  G   KL DFGLA   E   + A     GT GYL
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  +    S   D++A G +L  +  G  P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 110/240 (45%), Gaps = 33/240 (13%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLT----NDTSR--KMGQAFYSSTLRFKNSLNSNV 80
           FP F    + L LQG A I + G L+LT    N+  R   +G+AFYS  ++ K+S  +NV
Sbjct: 8   FPNFH-TDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS--NNV 64
Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+T+F  +I  +   +  +GLAF + P N       ++LG+ N T+    +    AV 
Sbjct: 65  ASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFN-TNNPEPNARTVAVV 123
Query: 141 FDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           F+T     F+             +  N               D     G+   V + YDS
Sbjct: 124 FNT-----FKNRIDFDKNFIKPYVNENC--------------DFHKYNGEKTDVQITYDS 164
Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSF 257
           + N L V +    S+ K  + S  V L    +E++ VGFS ++GL      +H+VL WSF
Sbjct: 165 SNNDLRVFLHFTVSQVKCSV-SATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSF 223

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 41/220 (18%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++  + + G+L  +L           +D    P+  + ++     
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN- 218
Query: 499 ATTRVVGTL--GYLAPETPRTGKSSASSDVFAFGALLLEV 536
                 G L   ++APE       +  SDV++FG L+ E+
Sbjct: 219 ------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS---EIATIGRLR 395
           ++N+  K+ LG G F  V +     +  E A K I N  K   R+F     E     +L+
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQ 62
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLL 453
           H N+V+L    + +    LV+D +  G L    F++   +   +       I+ +   + 
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 118
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           Y H      ++HR++K  N+LL S+  G   KL DFGLA   E   + A     GT GYL
Sbjct: 119 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 173
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  +    S   D++A G +L  +  G  P
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYK-GTLHNSK---TEVAVKRISNESKQGVREFVSEIATI 391
           K +  +F   + LG G FG+V+   + HN +    +V  K I    KQ V     E   +
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLML 60
Query: 392 GRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIK 446
             + H  ++++ G  +    + ++ D++  G L S L     F  P A     +      
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
            V   L YLH    + +I+RD+K  N+LLD   + K+ DFG AK         T  + GT
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYXLCGT 166
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             Y+APE   T   + S D ++FG L+ E+  G  P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 348 LGHGGFGQVYK----GTLHNSKTE---VAVKRISNE-SKQGVREFVSEIATIGRL-RHRN 398
           LG G FGQV      G   +   E   VAVK + ++ +++ + + VSE+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----------FD---EPKAVLNWEQRFKI 444
           ++ L+G C + G L ++  + + G+L  +L           +D    P+  + ++     
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK------LYEHGTNP 498
              +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA+       Y+  TN 
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
                   + ++APE       +  SDV++FG L+ E+
Sbjct: 220 RL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 21/231 (9%)
Query: 322 ELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SK 378
           E E+  +R S Q +K    +F   ++LG G FG+V+      +    A+K +  +     
Sbjct: 1   EPELNKERPSLQ-IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD 59
Query: 379 QGVREFVSEIATIG-RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEP 432
             V   + E   +     H  L  +    + K +L  V +++  G L   +     FD  
Sbjct: 60  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           +A     +       +  GL +LH    + +++RD+K  N+LLD + + K+ DFG+ K  
Sbjct: 120 RATFYAAE-------IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 169
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
             G +  T    GT  Y+APE     K + S D ++FG LL E+  G+ P 
Sbjct: 170 MLG-DAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREF-VSEIATIGRLR 395
           +  NF   + +G G +G VYK     +   VA+K+I  +++ +GV    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 396 HRNLVQLVGWCRRKGDLLLVYD--------FMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           H N+V+L+     +  L LV++        FM   +L        K+ L     F++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +A    + H      V+HRD+K  N+L+++E   KL DFGLA+ +          VV TL
Sbjct: 119 LA----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 508 GYLAPETPRTGK-SSASSDVFAFGALLLEVACGR 540
            Y APE     K  S + D+++ G +  E+   R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 108/244 (44%), Gaps = 33/244 (13%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           F  F++ S  L LQ  A I++NG+L LT  T       +  G+A Y+  ++  +S   NV
Sbjct: 7   FDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNV 66
Query: 81  FSFSTSFAIVIVPE--YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFA 138
            SF T F+  I     YP     GL F + P N   G     LG+    +     ++ FA
Sbjct: 67  ASFETRFSFNITQPYAYPE-PADGLTFFMVPPNSPQGEDGGNLGVFKPPE----GDNAFA 121
Query: 139 VEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDY 198
           VEFDT Q+                 +  N+ V       +S      L+ G    V + Y
Sbjct: 122 VEFDTFQN-------TWDPQVPHIGIDVNSIV-------SSKTLHFQLENGGVANVVIKY 167
Query: 199 DSAENILNVTVSPNSSKPKIPILSFRVDLSPIF--NEFMYVGFSASTGL---LASSHNVL 253
           DS   ILNV ++ +S    +  LS  VDL   F  +E++ VG SA+TG       +H ++
Sbjct: 168 DSPTKILNVVLAFHSVG-TVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEII 226
Query: 254 GWSF 257
            WSF
Sbjct: 227 SWSF 230

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLV 403
           ++ +G G FG+V++G       EVAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 47  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 102
Query: 404 G--------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
                    W +    L LV D+  +GSL  +L    +  +  E   K+    ASGL +L
Sbjct: 103 AADNKDNGTWTQ----LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHL 155
Query: 456 H------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGT 506
           H      +G +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT
Sbjct: 156 HMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 507 LGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             Y+APE        +  +S   +D++A G +  E+A
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 42/226 (18%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLR-HRNLVQLV 403
           LG G +G V+K     +   VAVK+I +    S    R F  EI  +  L  H N+V L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 404 GWCRRKGD--LLLVYDFMA---NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
              R   D  + LV+D+M    +  + + + +         Q  K+IK       YLH G
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK-------YLHSG 128
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY---------------EHGTN-----P 498
               ++HRD+K SN+LL++E + K+ DFGL++ +               E+  N     P
Sbjct: 129 G---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 499 ATTRVVGTLGYLAPETPR-TGKSSASSDVFAFGALLLEVACGRRPI 543
             T  V T  Y APE    + K +   D+++ G +L E+ CG +PI
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLV 403
           ++ +G G FG+V++G       EVAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 9   QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 64
Query: 404 G--------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
                    W +    L LV D+  +GSL  +L    +  +  E   K+    ASGL +L
Sbjct: 65  AADNKDNGTWTQ----LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHL 117
Query: 456 H------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGT 506
           H      +G +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT
Sbjct: 118 HMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176
Query: 507 LGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             Y+APE        +  +S   +D++A G +  E+A
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVGWC 406
           +G G +G V     + +K  VA+K+IS  E +   +  + EI  +   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 407 R-----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           R     +  D+ +V D M     D +   + + + N +     +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSAN-- 146
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGK 519
            V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE     K
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 520 S-SASSDVFAFGALLLEVACGRRPI 543
             + S D+++ G +L E+    RPI
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPI 229

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLV 403
           ++ +G G FG+V++G       EVAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 8   QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 63
Query: 404 G--------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
                    W +    L LV D+  +GSL  +L    +  +  E   K+    ASGL +L
Sbjct: 64  AADNKDNGTWTQ----LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHL 116
Query: 456 H------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGT 506
           H      +G +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT
Sbjct: 117 HMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 507 LGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             Y+APE        +  +S   +D++A G +  E+A
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS---EIATIGRLR 395
           ++N+  K+ LG G F  V +     +  E A K I N  K   R+F     E     +L+
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQ 86
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLL 453
           H N+V+L    + +    LV+D +  G L    F++   +   +       I+ +   + 
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 142
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           Y H      ++HR++K  N+LL S+  G   KL DFGLA   E   + A     GT GYL
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 197
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  +    S   D++A G +L  +  G  P
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 57/287 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--GVREF 384
           P+R  Y      +++F  K LLG G +G V   T   +   VA+K+I    K    +R  
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT- 56
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKG-----DLLLVYDFM-------------ANGSLDS 426
           + EI  +   +H N++ +    R        ++ ++ + M             ++  +  
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 427 FLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF 486
           F++   +AV       K++ G               VIHRD+K SN+L++S  + K+ DF
Sbjct: 117 FIYQTLRAV-------KVLHGSN-------------VIHRDLKPSNLLINSNCDLKVCDF 156
Query: 487 GLAKLYEH---------GTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEV 536
           GLA++ +          G     T  V T  Y APE   T  K S + DV++ G +L E+
Sbjct: 157 GLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 537 ACGRRPI-ETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQS 582
              RRPI   R    +L+L+  + G       L  I+     EY +S
Sbjct: 217 FL-RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 57/287 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--GVREF 384
           P+R  Y      +++F  K LLG G +G V   T   +   VA+K+I    K    +R  
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT- 56
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKG-----DLLLVYDFM-------------ANGSLDS 426
           + EI  +   +H N++ +    R        ++ ++ + M             ++  +  
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 427 FLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF 486
           F++   +AV       K++ G               VIHRD+K SN+L++S  + K+ DF
Sbjct: 117 FIYQTLRAV-------KVLHGSN-------------VIHRDLKPSNLLINSNCDLKVCDF 156
Query: 487 GLAKLYEH---------GTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEV 536
           GLA++ +          G     T  V T  Y APE   T  K S + DV++ G +L E+
Sbjct: 157 GLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 537 ACGRRPI-ETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQS 582
              RRPI   R    +L+L+  + G       L  I+     EY +S
Sbjct: 217 FL-RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLV 403
           ++ +G G FG+V++G       EVAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 14  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 69
Query: 404 G--------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
                    W +    L LV D+  +GSL  +L    +  +  E   K+    ASGL +L
Sbjct: 70  AADNKDNGTWTQ----LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHL 122
Query: 456 H------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGT 506
           H      +G +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT
Sbjct: 123 HMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181
Query: 507 LGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             Y+APE        +  +S   +D++A G +  E+A
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLV 403
           ++ +G G FG+V++G       EVAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 34  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 89
Query: 404 G--------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
                    W +    L LV D+  +GSL  +L    +  +  E   K+    ASGL +L
Sbjct: 90  AADNKDNGTWTQ----LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHL 142
Query: 456 H------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGT 506
           H      +G +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT
Sbjct: 143 HMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201
Query: 507 LGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             Y+APE        +  +S   +D++A G +  E+A
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVAVK I     +   +++   E+     L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L LV ++ + G +  +L    +     E R K  + + S + Y H+ 
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK-EKEARAKF-RQIVSAVQYCHQK 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
           +   ++HRD+KA N+LLD++ N K+ DFG +  +  G         G   Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGK 187
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLV 403
           ++ +G G FG+V++G       EVAVK  S+ E +   RE  +EI     LRH N++  +
Sbjct: 11  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 66
Query: 404 G--------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
                    W +    L LV D+  +GSL  +L    +  +  E   K+    ASGL +L
Sbjct: 67  AADNKDNGTWTQ----LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHL 119
Query: 456 H------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGT 506
           H      +G +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT
Sbjct: 120 HMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178
Query: 507 LGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             Y+APE        +  +S   +D++A G +  E+A
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 344 AKQL-----LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
           AKQ+     +G G +G+V+ G     K  V V   + E     RE  +EI     +RH N
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKV-FFTTEEASWFRE--TEIYQTVLMRHEN 92
Query: 399 LVQLVGWCRRKG-----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           ++  +     KG      L L+ D+  NGSL  +L       L+ +   K+     SGL 
Sbjct: 93  ILGFIA-ADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLC 148
Query: 454 YLHEGY-----EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN----PATTRVV 504
           +LH        +  + HRD+K+ N+L+       + D GLA  +   TN    P  TR V
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-V 207
Query: 505 GTLGYLAPETPRTG------KSSASSDVFAFGALLLEVA 537
           GT  Y+ PE           +S   +D+++FG +L EVA
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTE---VAVKRISNESKQGVRE-FVSEIATIGR 393
           A  +    ++LG G FG+VY+G   N K E   VAVK    +     +E F+SE   +  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L H ++V+L+G    +   +++ +    G L  +L +  K  L           +   + 
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMA 123
Query: 454 YLHEGYEQV-VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
           YL    E +  +HRD+   N+L+ S    KLGDFGL++  E       +     + +++P
Sbjct: 124 YL----ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 179
Query: 513 ETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           E+    + + +SDV+ F   + E+ + G++P
Sbjct: 180 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTE---VAVKRISNESKQGVRE-FVSEIATIGR 393
           A  +    ++LG G FG+VY+G   N K E   VAVK    +     +E F+SE   +  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L H ++V+L+G    +   +++ +    G L  +L +  K  L           +   + 
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMA 127
Query: 454 YLHEGYEQV-VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
           YL    E +  +HRD+   N+L+ S    KLGDFGL++  E       +     + +++P
Sbjct: 128 YL----ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183
Query: 513 ETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           E+    + + +SDV+ F   + E+ + G++P
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTE---VAVKRISNESKQGVRE-FVSEIATIGR 393
           A  +    ++LG G FG+VY+G   N K E   VAVK    +     +E F+SE   +  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L H ++V+L+G    +   +++ +    G L  +L +  K  L           +   + 
Sbjct: 82  LDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMA 139
Query: 454 YLHEGYEQV-VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
           YL    E +  +HRD+   N+L+ S    KLGDFGL++  E       +     + +++P
Sbjct: 140 YL----ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 195
Query: 513 ETPRTGKSSASSDVFAFGALLLEV-ACGRRP 542
           E+    + + +SDV+ F   + E+ + G++P
Sbjct: 196 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G V+K     +   VA+KR+  ++  +GV    + EI  +  L+H+N+V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
                 L LV++F  +  L  + FD     L+ E     +  +  GL + H    + V+H
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK-SSASS 524
           RD+K  N+L++     KL +FGLA+ +       +  VV TL Y  P+     K  S S 
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 525 DVFAFGALLLEVACGRRPI 543
           D+++ G +  E+A   RP+
Sbjct: 184 DMWSAGCIFAELANAGRPL 202

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N F   +LLG G FG+V       +    A+K +  E   +K  V   ++E   +   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASGLLYL 455
             L  L    +    L  V ++   G L    F   +  +  E R +     + S L YL
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYLAPET 514
           H   E+ V++RD+K  N++LD + + K+ DFGL K  E   + AT +   GT  YLAPE 
Sbjct: 127 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEV 182
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPI 543
                   + D +  G ++ E+ CGR P 
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N F   +LLG G FG+V       +    A+K +  E   +K  V   ++E   +   RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASGLLYL 455
             L  L    +    L  V ++   G L    F   +  +  E R +     + S L YL
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYLAPET 514
           H   E+ V++RD+K  N++LD + + K+ DFGL K  E   + AT +   GT  YLAPE 
Sbjct: 125 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEV 180
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPI 543
                   + D +  G ++ E+ CGR P 
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-R 395
            +F   +++G G + +V    L  +    A+K +  E     + +    +E     +   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H  LV L    + +  L  V +++  G L  F     + +     RF   + ++  L YL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAE-ISLALNYL 122
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP--ATTRVVGTLGYLAPE 513
           HE   + +I+RD+K  NVLLDSE + KL D+G+ K    G  P   T+   GT  Y+APE
Sbjct: 123 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 176
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
             R      S D +A G L+ E+  GR P +
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N F   +LLG G FG+V       +    A+K +  E   +K  V   ++E   +   RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASGLLYL 455
             L  L    +    L  V ++   G L    F   +  +  E R +     + S L YL
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYLAPET 514
           H   E+ V++RD+K  N++LD + + K+ DFGL K  E   + AT +   GT  YLAPE 
Sbjct: 126 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEV 181
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPI 543
                   + D +  G ++ E+ CGR P 
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-R 395
            +F   +++G G + +V    L  +    A+K +  E     + +    +E     +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H  LV L    + +  L  V +++  G L  F     + +     RF   + ++  L YL
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAE-ISLALNYL 126
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGYLAPE 513
           HE   + +I+RD+K  NVLLDSE + KL D+G+ K    G  P   T+   GT  Y+APE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 180
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
             R      S D +A G L+ E+  GR P +
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-R 395
            +F   +++G G + +V    L  +    A+K +  E     + +    +E     +   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H  LV L    + +  L  V +++  G L  F     + +     RF   + ++  L YL
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAE-ISLALNYL 137
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP--ATTRVVGTLGYLAPE 513
           HE   + +I+RD+K  NVLLDSE + KL D+G+ K    G  P   T+   GT  Y+APE
Sbjct: 138 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 191
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
             R      S D +A G L+ E+  GR P +
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 21/229 (9%)
Query: 324 EVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQG 380
           E+  +R S Q +K    +F   ++LG G FG+V+      +    A+K +  +       
Sbjct: 2   ELNKERPSLQ-IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60
Query: 381 VREFVSEIATIG-RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKA 434
           V   + E   +     H  L  +    + K +L  V +++  G L   +     FD  +A
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA 120
Query: 435 VLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH 494
                +       +  GL +LH    + +++RD+K  N+LLD + + K+ DFG+ K    
Sbjct: 121 TFYAAE-------IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           G +  T    GT  Y+APE     K + S D ++FG LL E+  G+ P 
Sbjct: 171 G-DAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 95  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 148
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 95  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 148
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNE--SKQGVREFVSEIATIGRL 394
             F+  ++LG G FG V +  L     S  +VAVK +  +  +   + EF+ E A +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 395 RHRNLVQLVG---WCRRKGDL---LLVYDFMANGSLDSFLF----DEPKAVLNWEQRFKI 444
            H ++ +LVG     R KG L   +++  FM +G L +FL      E    L  +   + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRV 503
           +  +A G+ YL     +  IHRD+ A N +L  ++   + DFGL+ K+Y           
Sbjct: 143 MVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              + +LA E+      +  SDV+AFG  + E+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYK   +N     A+K+I  E + +G+    + EI+ +  L+H N+V+L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              K  L+LV++ +        L D  +  L        +  + +G+ Y H+   + V+H
Sbjct: 69  IHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLH 123
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-TGKSSASS 524
           RD+K  N+L++ E   K+ DFGLA+ +       T  VV TL Y AP+    + K S + 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTI 182
Query: 525 DVFAFGALLLEVACG 539
           D+++ G +  E+  G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSE 387
           Q  K+   +F   ++LG G F  V       +  E A+K +  E +  ++E        E
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRE 58
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRF 442
              + RL H   V+L    +    L     +  NG L  ++     FDE         RF
Sbjct: 59  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RF 112
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TT 501
              + + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A   
Sbjct: 113 YTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             VGT  Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 169 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSE 387
           Q  K+   +F   ++LG G F  V       +  E A+K +  E +  ++E        E
Sbjct: 2   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRE 59
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRF 442
              + RL H   V+L    +    L     +  NG L  ++     FDE         RF
Sbjct: 60  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RF 113
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TT 501
              + + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A   
Sbjct: 114 YTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 169
Query: 502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             VGT  Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 170 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSE 387
           Q  K+   +F   ++LG G F  V       +  E A+K +  E +  ++E        E
Sbjct: 3   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRE 60
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRF 442
              + RL H   V+L    +    L     +  NG L  ++     FDE         RF
Sbjct: 61  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RF 114
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TT 501
              + + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A   
Sbjct: 115 YTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 170
Query: 502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             VGT  Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 171 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYK   +N     A+K+I  E + +G+    + EI+ +  L+H N+V+L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              K  L+LV++ + +  L   L D  +  L        +  + +G+ Y H+   + V+H
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLH 123
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-TGKSSASS 524
           RD+K  N+L++ E   K+ DFGLA+ +       T  VV TL Y AP+    + K S + 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTI 182
Query: 525 DVFAFGALLLEVACG 539
           D+++ G +  E+  G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 10/213 (4%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRN 398
           N+   + +G G F +V       +  EVA+K I     +   +++   E+  +  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L      +  L L+ ++ + G +  +L    + +   E R K  + + S + Y H+ 
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKF-RQIVSAVQYCHQ- 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
             + ++HRD+KA N+LLD+++N K+ DFG +  +  G         G   Y APE  +  
Sbjct: 133 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPELFQGK 188
Query: 519 KSSASS-DVFAFGALLLEVACGRRPIETRALPE 550
           K      DV++ G +L  +  G  P + + L E
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 108/252 (42%), Gaps = 36/252 (14%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTN-----DTSRKMGQAFYSSTLRFKNSLNSNVF 81
           F  F      L LQ  A+I +N +L LT       T    G+A Y+  ++  +S   NV 
Sbjct: 7   FNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA 66
Query: 82  SFSTSFAIVIVPEYPRL-GGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
           SF T F+  I   +PR     GL F I+P N   G    Y G+ N      F     AVE
Sbjct: 67  SFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPYPF----VAVE 122
Query: 141 FDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYT-DNSTKQDLSLKGGKAILVWVDYD 199
           FDT     F+             + S  S +   +T DN         GG A +V + YD
Sbjct: 123 FDT-----FRNTWDPQIPHIGIDVNSVISTKTVPFTLDN---------GGIANVV-IKYD 167
Query: 200 SAENILNVT-VSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG-------LLASSHN 251
           ++  IL+V  V P  S   I  ++  VDL  +  E + VGFSA+TG           +H+
Sbjct: 168 ASTKILHVVLVFP--SLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHD 225
Query: 252 VLGWSFKINGPA 263
           +L WSF  + P 
Sbjct: 226 ILSWSFSASLPG 237

>pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 108/252 (42%), Gaps = 36/252 (14%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTN-----DTSRKMGQAFYSSTLRFKNSLNSNVF 81
           F  F      L LQ  A+I +N +L LT       T    G+A Y+  ++  +S   NV 
Sbjct: 8   FNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA 67
Query: 82  SFSTSFAIVIVPEYPRL-GGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
           SF T F+  I   +PR     GL F I+P N   G    Y G+ N      F     AVE
Sbjct: 68  SFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPYPF----VAVE 123
Query: 141 FDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYT-DNSTKQDLSLKGGKAILVWVDYD 199
           FDT     F+             + S  S +   +T DN         GG A +V + YD
Sbjct: 124 FDT-----FRNTWDPQIPHIGIDVNSVISTKTVPFTLDN---------GGIANVV-IKYD 168
Query: 200 SAENILNVT-VSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG-------LLASSHN 251
           ++  IL+V  V P  S   I  ++  VDL  +  E + VGFSA+TG           +H+
Sbjct: 169 ASTKILHVVLVFP--SLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHD 226
Query: 252 VLGWSFKINGPA 263
           +L WSF  + P 
Sbjct: 227 ILSWSFSASLPG 238

>pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 108/252 (42%), Gaps = 36/252 (14%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTN-----DTSRKMGQAFYSSTLRFKNSLNSNVF 81
           F  F      L LQ  A+I +N +L LT       T    G+A Y+  ++  +S   NV 
Sbjct: 7   FNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA 66
Query: 82  SFSTSFAIVIVPEYPRL-GGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
           SF T F+  I   +PR     GL F I+P N   G    Y G+ N      F     AVE
Sbjct: 67  SFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSPYPF----VAVE 122
Query: 141 FDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYT-DNSTKQDLSLKGGKAILVWVDYD 199
           FDT     F+             + S  S +   +T DN         GG A +V + YD
Sbjct: 123 FDT-----FRNTWDPQIPHIGIDVNSVISTKTVPFTLDN---------GGIANVV-IKYD 167
Query: 200 SAENILNVT-VSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG-------LLASSHN 251
           ++  IL+V  V P  S   I  ++  VDL  +  E + VGFSA+TG           +H+
Sbjct: 168 ASTKILHVVLVFP--SLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHD 225
Query: 252 VLGWSFKINGPA 263
           +L WSF  + P 
Sbjct: 226 ILSWSFSASLPG 237

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N F   +LLG G FG+V       +    A+K +  E   +K  V   ++E   +   RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASGLLYL 455
             L  L    +    L  V ++   G L    F   +  +  E R +     + S L YL
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAPET 514
           H   E+ V++RD+K  N++LD + + K+ DFGL K  E   + AT +   GT  YLAPE 
Sbjct: 268 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEV 323
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPI 543
                   + D +  G ++ E+ CGR P 
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N F   +LLG G FG+V       +    A+K +  E   +K  V   ++E   +   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-VASGLLYL 455
             L  L    +    L  V ++   G L    F   +  +  E R +     + S L YL
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLGYLAPET 514
           H   E+ V++RD+K  N++LD + + K+ DFGL K  E   + AT +   GT  YLAPE 
Sbjct: 265 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEV 320
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPI 543
                   + D +  G ++ E+ CGR P 
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 93  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 146
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 207 SKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGV-REFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G VYK   +N     A+K+I  E + +G+    + EI+ +  L+H N+V+L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              K  L+LV++ +        L D  +  L        +  + +G+ Y H+   + V+H
Sbjct: 69  IHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLH 123
Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-TGKSSASS 524
           RD+K  N+L++ E   K+ DFGLA+ +       T  +V TL Y AP+    + K S + 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTI 182
Query: 525 DVFAFGALLLEVACG 539
           D+++ G +  E+  G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 79  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 132
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT--LGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N    +  G   + + APE     K S
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 26/243 (10%)
Query: 30  FKDL-SNNLTLQGIAKIENNGILRLTN------DTSRKMGQAFYSSTLRFKNSLNSNVFS 82
           FK+  S++  LQG A + ++  LRLT        T   +G+AFYSS ++  +     V S
Sbjct: 8   FKNFNSSSFILQGDATVSSSK-LRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVAS 66
Query: 83  FSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFD 142
           ++TSF   I          G+AF + P        S +LG+ +S D+ + S    AVEFD
Sbjct: 67  WATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDS-DVYDNSAQTVAVEFD 125
Query: 143 TVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAE 202
           T  + ++              + S  S+  A +          L  G+   + + Y++A 
Sbjct: 126 TFSNTDWD----PTSRHIGIDVNSIKSIRTASW---------GLANGQNAEILITYNAAT 172
Query: 203 NILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFKI 259
           ++L  ++   S +    I+S RVD++    E++ +GFSA+TGL      +H+VL WSF  
Sbjct: 173 SLLVASLVHPSRRTSY-IVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFAS 231
Query: 260 NGP 262
             P
Sbjct: 232 KLP 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 57/287 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ--GVREF 384
           P+R  Y      +++F  K LLG G +G V   T   +   VA+K+I    K    +R  
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT- 56
Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKG-----DLLLVYDFM-------------ANGSLDS 426
           + EI  +   +H N++ +    R        ++ ++ + M             ++  +  
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 427 FLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF 486
           F++   +AV       K++ G               VIHRD+K SN+L++S  + K+ DF
Sbjct: 117 FIYQTLRAV-------KVLHGSN-------------VIHRDLKPSNLLINSNCDLKVCDF 156
Query: 487 GLAKLYEH---------GTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEV 536
           GLA++ +          G        V T  Y APE   T  K S + DV++ G +L E+
Sbjct: 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 537 ACGRRPI-ETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQS 582
              RRPI   R    +L+L+  + G       L  I+     EY +S
Sbjct: 217 FL-RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 75  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 128
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 340 NNFSAKQLLGHGGFGQVY----KGTLHNSKTEVAVKRISNESKQ----GVREFVSEIATI 391
            +F   +++G G + +V     K T       V  K + N+ +        + V E A+ 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS- 110
Query: 392 GRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
               H  LV L    + +  L  V +++  G L  F     + +     RF   + ++  
Sbjct: 111 ---NHPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAE-ISLA 165
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGY 509
           L YLHE   + +I+RD+K  NVLLDSE + KL D+G+ K    G  P   T+   GT  Y
Sbjct: 166 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNY 219
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
           +APE  R      S D +A G L+ E+  GR P +
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 85  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 138
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIAT 390
           K+   +F   ++LG G F  V       +  E A+K +  E +  ++E        E   
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDV 60
Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKII 445
           + RL H   V+L    +    L     +  NG L  ++     FDE         RF   
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTA 114
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVV 504
           + + S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     V
Sbjct: 115 E-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           GT  Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 79  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 132
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 348 LGHGGFGQVYKGT---------LHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
           LG G F +++KG          LH  +TEV +K +    +     F    + + +L H++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLH--ETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           LV   G C    + +LV +F+  GSLD++L  + K  +N   + ++ K +A+ + +L E 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG---TNPATTRVVGTLGYLAPETP 515
               +IH +V A N+LL  E + K G+    KL + G   T      +   + ++ PE  
Sbjct: 133 ---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI 189
Query: 516 RTGKS-SASSDVFAFGALLLEVACG 539
              K+ + ++D ++FG  L E+  G
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 73  GICEAES-WMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 126
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 187 SKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCT------RFYTAE-IV 142
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 143 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +S SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 251

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 8/205 (3%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           +++   + LG G FG V++ T   +    A K +    +        EI T+  LRH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           V L        +++++Y+FM+ G L   + DE    ++ ++  + ++ V  GL ++HE  
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN 275
Query: 460 EQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
               +H D+K  N++  ++ +   KL DFGL    +   +   T   GT  + APE    
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 330
Query: 518 GKSSASSDVFAFGALLLEVACGRRP 542
                 +D+++ G L   +  G  P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL----R 395
            +F     LGHG +G+V+K          AVKR S    +G ++   ++A +G      +
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 396 HRNLVQL-VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           H   V+L   W   +G +L +   +   SL     +   A L   Q +  ++     L +
Sbjct: 116 HPCCVRLEQAW--EEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET 514
           LH    Q ++H DVK +N+ L      KLGDFGL  L E GT  A     G   Y+APE 
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPEL 227
Query: 515 PRTGKSSASSDVFAFGALLLEVAC 538
              G    ++DVF+ G  +LEVAC
Sbjct: 228 -LQGSYGTAADVFSLGLTILEVAC 250

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 8/205 (3%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           +++   + LG G FG V++ T   +    A K +    +        EI T+  LRH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           V L        +++++Y+FM+ G L   + DE    ++ ++  + ++ V  GL ++HE  
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN 169
Query: 460 EQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
               +H D+K  N++  ++ +   KL DFGL    +   +   T   GT  + APE    
Sbjct: 170 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 224
Query: 518 GKSSASSDVFAFGALLLEVACGRRP 542
                 +D+++ G L   +  G  P
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF--VSEIATIGRL-RHRNLVQLVG 404
           LG G F  V +     +  E A K I N  K   R+   +   A I RL +H N+V+L  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAK-IINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR--FKIIKGVASGLLYLHEGYEQV 462
               +G   L++D +  G L    F++  A   + +      I+ +   +L+ H+     
Sbjct: 89  SISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 463 VIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
           V+HRD+K  N+LL S+L G   KL DFGLA   E G   A     GT GYL+PE  R   
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 520 SSASSDVFAFGALLLEVACGRRP 542
                D++A G +L  +  G  P
Sbjct: 201 YGKPVDLWACGVILYILLVGYPP 223

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 15/206 (7%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           ++ +  +G G +G+V       ++   A K+I     + V  F  EI  +  L H N+++
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L        D+ LV +    G L   +    K V       +I+K V S + Y H   + 
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KL 142
Query: 462 VVIHRDVKASNVLL-----DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
            V HRD+K  N L      DS L  KL DFGLA  ++ G    T   VGT  Y++P+   
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPL--KLIDFGLAARFKPGKMMRTK--VGTPYYVSPQV-L 197
Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
            G      D ++ G ++  + CG  P
Sbjct: 198 EGLYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 15/206 (7%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           ++ +  +G G +G+V       ++   A K+I     + V  F  EI  +  L H N+++
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L        D+ LV +    G L   +    K V       +I+K V S + Y H   + 
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KL 125
Query: 462 VVIHRDVKASNVLL-----DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
            V HRD+K  N L      DS L  KL DFGLA  ++ G    T   VGT  Y++P+   
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPL--KLIDFGLAARFKPGKMMRTK--VGTPYYVSPQV-L 180
Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
            G      D ++ G ++  + CG  P
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +   +    RE  +SE+  +  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----- 447
           L  H N+V L+G C   G  L++ ++   G L +FL  +  + +  +    I++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 448 -----------VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
                      VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+   H  
Sbjct: 166 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR---HIK 219
Query: 497 NPATTRVVGT----LGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           N +   V G     + ++APE+      +  SDV+++G  L E+
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRL 394
           +    + +  + +G G +G+V++G+       VAVK  S+ + K   RE  +E+     L
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRE--TELYNTVML 59
Query: 395 RHRNLVQLVG--WCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           RH N++  +      R     L L+  +   GSL  +L       L+     +I+  +AS
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 116
Query: 451 GLLYLH------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATT 501
           GL +LH      +G +  + HRD+K+ N+L+       + D GLA ++   TN       
Sbjct: 117 GLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 502 RVVGTLGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             VGT  Y+APE            S    D++AFG +L EVA
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 117/249 (46%), Gaps = 29/249 (11%)
Query: 23  DELFFP--GFKDLSNNLTLQGIAKIENNGILRLT---NDTSRK--MGQAFYSSTLRFKNS 75
           DEL F    F     +L  QG A + + G+L+LT   N   +K  +G+A Y++ +R   +
Sbjct: 2   DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGN 61
Query: 76  LNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISP--SNDLNGLPSQYLGLLNSTDIGNFS 133
              +V SFSTSF  V+    P +   GLAF ++P  S   +G  S+YLGL N+++  + S
Sbjct: 62  TTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDS-S 120
Query: 134 NHLFAVEFDT--VQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLS-LKGGK 190
           N + AVEFDT     ++               ++S  +V+            ++ L   K
Sbjct: 121 NQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNK 180
Query: 191 AILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA--S 248
            ++  + Y S +   +V  S              VDL  I  E++ VGFSA+TG      
Sbjct: 181 TLIASLVYPSNQTTFSVAAS--------------VDLKEILPEWVRVGFSAATGYPTEVE 226
Query: 249 SHNVLGWSF 257
           +H+VL WSF
Sbjct: 227 THDVLSWSF 235

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +++A GSL   + +     ++  Q   + +     L +LH      VIHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 468 VKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           +K+ N+LL  + + KL DFG  A++    +  +T  +VGT  ++APE           D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 527 FAFGALLLEVACGRRP 542
           ++ G + +E+  G  P
Sbjct: 200 WSLGIMAIEMIEGEPP 215

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF--VSEIATIGRL-R 395
           T+++   + LG G F  V +        E A K I N  K   R+   +   A I RL +
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAK-IINTKKLSARDHQKLEREARICRLLK 88
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR--FKIIKGVASGLL 453
           H N+V+L      +G   LV+D +  G L    F++  A   + +      I  +   + 
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIHQILESVN 144
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           ++H+     ++HRD+K  N+LL S+  G   KL DFGLA +   G   A     GT GYL
Sbjct: 145 HIHQ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYL 200
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  R        D++A G +L  +  G  P
Sbjct: 201 SPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRL 394
           +   +  +  + +G G +G+V++G+       VAVK  S+ + K   RE  +E+     L
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRE--TELYNTVML 59
Query: 395 RHRNLVQLVG--WCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           RH N++  +      R     L L+  +   GSL  +L       L+     +I+  +AS
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 116
Query: 451 GLLYLH------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATT 501
           GL +LH      +G +  + HRD+K+ N+L+       + D GLA ++   TN       
Sbjct: 117 GLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 502 RVVGTLGYLAPET------PRTGKSSASSDVFAFGALLLEVA 537
             VGT  Y+APE            S    D++AFG +L EVA
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISN-ESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           + +G G +G+V++G+       VAVK  S+ + K   RE  +E+     LRH N++  + 
Sbjct: 43  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 98
Query: 405 --WCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH---- 456
                R     L L+  +   GSL  +L       L+     +I+  +ASGL +LH    
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 457 --EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGTLGYLA 511
             +G +  + HRD+K+ N+L+       + D GLA ++   TN         VGT  Y+A
Sbjct: 156 GTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 512 PET------PRTGKSSASSDVFAFGALLLEVA 537
           PE            S    D++AFG +L EVA
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 437 GICEAE-SWMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 490
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 551 SKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +          +   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY---LH 456
            L+G C + G  L+++ +F   G+L ++L  +    + ++  +K    +   + Y   + 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 457 EGYE----QVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLA 511
           +G E    +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+             L ++A
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 512 PETPRTGKSSASSDVFAFGALLLEV 536
           PET      +  SDV++FG LL E+
Sbjct: 215 PETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 86
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 139
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 140 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 248

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 94
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 147
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 148 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 86
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 139
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 140 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 248

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 348 LGHGGFGQVYKG--TLHNSKTEVAVKRISNESKQGV--REFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG   +      VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L  + + V + +   +++  V+ G+ YL E      
Sbjct: 438 GICEAE-SWMLVMEMAELGPLNKYL-QQNRHVKD-KNIIELVHQVSMGMKYLEES---NF 491
Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K      N   A T     + + APE     K S
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 522 ASSDVFAFGALLLEV-ACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 552 SKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF--VSEIATIGRL-R 395
           T+ +   + +G G F  V +     +  E A K I N  K   R+   +   A I RL +
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAK-IINTKKLSARDHQKLEREARICRLLK 61
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR--FKIIKGVASGLL 453
           H N+V+L      +G   LV+D +  G L    F++  A   + +      I+ +   +L
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVL 117
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           + H+     V+HRD+K  N+LL S+  G   KL DFGLA +   G   A     GT GYL
Sbjct: 118 HCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYL 173
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  R        D++A G +L  +  G  P
Sbjct: 174 SPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 348 LGHGGFGQVYKGT---------LHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
           LG G F +++KG          LH  +TEV +K +    +     F    + + +L H++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLH--ETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           LV   G C    + +LV +F+  GSLD++L  + K  +N   + ++ K +A  + +L E 
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAWAMHFLEEN 132
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG---TNPATTRVVGTLGYLAPETP 515
               +IH +V A N+LL  E + K G+    KL + G   T      +   + ++ PE  
Sbjct: 133 ---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI 189
Query: 516 RTGKS-SASSDVFAFGALLLEVACG 539
              K+ + ++D ++FG  L E+  G
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 142
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 143 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEGLIFAKIIKLEY 251

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 140
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV-VGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 249

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 71
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 124
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 125 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +          +   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF----------DEPKAVLNWEQRFKIIKGVA 449
            L+G C + G  L+++ +F   G+L ++L           D  K  L  E        VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLG 508
            G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+             L 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEV 536
           ++APET      +  SDV++FG LL E+
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 142
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 143 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 142
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 143 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF--RAGNEGLIFAKIIKLEY 251

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 14/213 (6%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR---EFVSEIATIGRLR 395
           ++ +   ++LG GG  +V+         +VAVK +  +  +       F  E      L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 396 HRNLVQL--VGWCRRKGDLL--LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           H  +V +   G        L  +V +++   +L   +  E    +  ++  ++I      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 128
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGY 509
           L + H+     +IHRDVK +N+L+ +    K+ DFG+A+      N    T  V+GT  Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           L+PE  R     A SDV++ G +L EV  G  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 20/228 (8%)
Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQG 380
           L +G QRY  +      N+      +G G  GQV+K     +   +AVK  R S   ++ 
Sbjct: 13  LTIGGQRYQAE-----INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67
Query: 381 VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
            R  +     +       +VQ  G      D+ +  + M  G+    L    +  +    
Sbjct: 68  KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERI 125
Query: 441 RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPA 499
             K+   +   L YL E +   VIHRDVK SN+LLD     KL DFG++ +L +   + A
Sbjct: 126 LGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKA 180
Query: 500 TTRVVGTLGYLAPET-----PRTGKSSASSDVFAFGALLLEVACGRRP 542
             R  G   Y+APE      P        +DV++ G  L+E+A G+ P
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 140
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 249

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 90
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 143
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 144 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 252

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 90
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 143
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 144 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 252

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 140
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 92
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 145
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 146 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 254

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 14/213 (6%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR---EFVSEIATIGRLR 395
           ++ +   ++LG GG  +V+         +VAVK +  +  +       F  E      L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 396 HRNLVQL--VGWCRRKGDLL--LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           H  +V +   G        L  +V +++   +L   +  E    +  ++  ++I      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 128
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGY 509
           L + H+     +IHRDVK +N+++ +    K+ DFG+A+      N    T  V+GT  Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           L+PE  R     A SDV++ G +L EV  G  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 142
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 143 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 251

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 38/234 (16%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------------------------ 375
           N ++ K  +G G +G V      N  T  A+K +S                         
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 376 --ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD--LLLVYDFMANGSLDSFLFDE 431
             + +  + +   EIA + +L H N+V+LV       +  L +V++ +  G +      +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
           P   L+ +Q     + +  G+ YLH    Q +IHRD+K SN+L+  + + K+ DFG++  
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 492 YEHGTNPATTRVVGTLGYLAPET---PRTGKSSASSDVFAFGALLLEVACGRRP 542
           ++ G++   +  VGT  ++APE+    R   S  + DV+A G  L     G+ P
Sbjct: 187 FK-GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F  V       +  E A+K +  E +  ++E        E   + RL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 89
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 142
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 143 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 336 KQATNNFSAKQLLGHGGFGQVY----KGTLHNSKTEVAVKRISNESKQGVREFVSEIATI 391
           +    +F+   +LG G FG+V     KGT      ++  K +  +        V +    
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 392 GRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIK 446
              +   L QL    +    L  V +++  G L   +     F EP AV    +      
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE------ 129
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVG 505
            +A GL +L     + +I+RD+K  NV+LDSE + K+ DFG+ K  E+  +  TT+   G
Sbjct: 130 -IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCG 183
Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
           T  Y+APE         S D +AFG LL E+  G+ P E
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 14/213 (6%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR---EFVSEIATIGRLR 395
           ++ +   ++LG GG  +V+         +VAVK +  +  +       F  E      L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 396 HRNLVQL--VGWCRRKGDLL--LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           H  +V +   G        L  +V +++   +L   +  E    +  ++  ++I      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 128
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGY 509
           L + H+     +IHRDVK +N+++ +    K+ DFG+A+      N    T  V+GT  Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           L+PE  R     A SDV++ G +L EV  G  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +++A GSL   + +     ++  Q   + +     L +LH      VIHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 468 VKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           +K+ N+LL  + + KL DFG  A++    +    + +VGT  ++APE           D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 527 FAFGALLLEVACGRRP 542
           ++ G + +E+  G  P
Sbjct: 200 WSLGIMAIEMIEGEPP 215

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +   +    RE  +SE+  +  
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----- 447
           L  H N+V L+G C   G  L++ ++   G L +FL  +  + +  +    I++      
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 448 -----------VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
                      VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+  ++ +
Sbjct: 159 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 497 N---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           N       R+   + ++APE+      +  SDV+++G  L E+
Sbjct: 216 NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +   +    RE  +SE+  +  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----- 447
           L  H N+V L+G C   G  L++ ++   G L +FL  +  + +  +    I++      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 448 -----------VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
                      VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+  ++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 497 N---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           N       R+   + ++APE+      +  SDV+++G  L E+
Sbjct: 200 NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +   +    RE  +SE+  +  
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----- 447
           L  H N+V L+G C   G  L++ ++   G L +FL  +  + +  +    I++      
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 448 -----------VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
                      VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+  ++ +
Sbjct: 161 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 497 N---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           N       R+   + ++APE+      +  SDV+++G  L E+
Sbjct: 218 NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +   +    RE  +SE+  +  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG----- 447
           L  H N+V L+G C   G  L++ ++   G L +FL  +  + +  +    I++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 448 -----------VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
                      VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+  ++ +
Sbjct: 166 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 497 N---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           N       R+   + ++APE+      +  SDV+++G  L E+
Sbjct: 223 NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +++A GSL   + +     ++  Q   + +     L +LH      VIHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR---VVGTLGYLAPETPRTGKSSASS 524
           +K+ N+LL  + + KL DFG          P  ++   +VGT  ++APE           
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 525 DVFAFGALLLEVACGRRP 542
           D+++ G + +E+  G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +++A GSL   + +     ++  Q   + +     L +LH      VIHRD
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 142
Query: 468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR---VVGTLGYLAPETPRTGKSSASS 524
           +K+ N+LL  + + KL DFG          P  ++   +VGT  ++APE           
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 525 DVFAFGALLLEVACGRRP 542
           D+++ G + +E+  G  P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFL---------FDEP----KAVLNWEQRFKIIK 446
            L+G C + G  L+++ +F   G+L ++L         +  P    K  L  E       
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR---V 503
            VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+  +   +P   R    
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDA 210
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
              L ++APET      +  SDV++FG LL E+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 342 FSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISN----ESKQGVREFVSEIATIGRL 394
           F   ++LG GG+G+V+   K T  N+    A+K +       + +      +E   +  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           +H  +V L+   +  G L L+ ++++ G L  F+  E + +   +     +  ++  L +
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRVVGTLGYLAPE 513
           LH+   + +I+RD+K  N++L+ + + KL DFGL K   H GT   T    GT+ Y+APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPE 191
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRP 542
                  + + D ++ GAL+ ++  G  P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+           
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
             L ++APET      +  SDV++FG LL E+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRH 396
           N+FS  +++G GGFG+VY     ++    A+K +  +    KQG         T+  L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNE 239
Query: 397 RNLVQLV--GWC----------RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           R ++ LV  G C               L  + D M  G L  +   +       + RF  
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYA 298
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
            + +  GL ++H  +   V++RD+K +N+LLD   + ++ D GLA  +      A+   V
Sbjct: 299 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 351
Query: 505 GTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           GT GY+APE  + G +  +S+D F+ G +L ++  G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRH 396
           N+FS  +++G GGFG+VY     ++    A+K +  +    KQG         T+  L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNE 239
Query: 397 RNLVQLV--GWC----------RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           R ++ LV  G C               L  + D M  G L  +   +       + RF  
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYA 298
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
            + +  GL ++H  +   V++RD+K +N+LLD   + ++ D GLA  +      A+   V
Sbjct: 299 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 351
Query: 505 GTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           GT GY+APE  + G +  +S+D F+ G +L ++  G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRH 396
           N+FS  +++G GGFG+VY     ++    A+K +  +    KQG         T+  L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNE 239
Query: 397 RNLVQLV--GWC----------RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           R ++ LV  G C               L  + D M  G L  +   +       + RF  
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYA 298
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
            + +  GL ++H  +   V++RD+K +N+LLD   + ++ D GLA  +      A+   V
Sbjct: 299 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 351
Query: 505 GTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           GT GY+APE  + G +  +S+D F+ G +L ++  G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRH 396
           N+FS  +++G GGFG+VY     ++    A+K +  +    KQG         T+  L  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNE 238
Query: 397 RNLVQLV--GWC----------RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           R ++ LV  G C               L  + D M  G L  +   +       + RF  
Sbjct: 239 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYA 297
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
            + +  GL ++H  +   V++RD+K +N+LLD   + ++ D GLA  +      A+   V
Sbjct: 298 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 350
Query: 505 GTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           GT GY+APE  + G +  +S+D F+ G +L ++  G  P
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 342 FSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISN----ESKQGVREFVSEIATIGRL 394
           F   ++LG GG+G+V+   K T  N+    A+K +       + +      +E   +  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           +H  +V L+   +  G L L+ ++++ G L  F+  E + +   +     +  ++  L +
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRVVGTLGYLAPE 513
           LH+   + +I+RD+K  N++L+ + + KL DFGL K   H GT   T    GT+ Y+APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPE 191
Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRP 542
                  + + D ++ GAL+ ++  G  P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +          +   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF------------DEPKAVLNWEQRFKIIKG 447
            L+G C + G  L+++ +F   G+L ++L             D  K  L  E        
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR---VV 504
           VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+  +   +P   R     
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDAR 211
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
             L ++APET      +  SDV++FG LL E+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 344 AKQLLGHGGFGQVYKGTL---HNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNL 399
           + +++G G FG VY G       ++ + A+K +S  ++ Q V  F+ E   +  L H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 400 VQLVG-WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           + L+G     +G   ++  +M +G L  F+   P+     +        VA G+ YL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY---EHGTNPATTRVVGTLGYLAPETP 515
            EQ  +HRD+ A N +LD     K+ DFGLA+     E+ +          + + A E+ 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 516 RTGKSSASSDVFAFGALLLEV 536
           +T + +  SDV++FG LL E+
Sbjct: 201 QTYRFTTKSDVWSFGVLLWEL 221

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+           
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
             L ++APET      +  SDV++FG LL E+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 14/213 (6%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR---EFVSEIATIGRLR 395
           ++ +   ++LG GG  +V+         +VAVK +  +  +       F  E      L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 396 HRNLVQL--VGWCRRKGDLL--LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           H  +V +   G        L  +V +++   +L   +  E    +  ++  ++I      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 128
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGY 509
           L + H+     +IHRDVK +N+++ +    K+ DFG+A+      N  T    V+GT  Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           L+PE  R     A SDV++ G +L EV  G  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
              +L +V +++A GSL   + +     ++  Q   + +     L +LH      VIHR+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRN 142
Query: 468 VKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDV 526
           +K+ N+LL  + + KL DFG  A++    +  +T  +VGT  ++APE           D+
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 527 FAFGALLLEVACGRRP 542
           ++ G + +E+  G  P
Sbjct: 201 WSLGIMAIEMIEGEPP 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG G +G V K     S   +AVKRI     S E K+ + +    + T+        V  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD---CPFTVTF 115
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASGLLYLH 456
            G   R+GD+ +  + M + SLD F     K V++  Q        KI   +   L +LH
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE--T 514
                 VIHRDVK SNVL+++    K+ DFG++         A T   G   Y+APE   
Sbjct: 171 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV--AKTIDAGCKPYMAPERIN 226
Query: 515 PRTGKS--SASSDVFAFGALLLEVACGRRPIETRALP 549
           P   +   S  SD+++ G  ++E+A  R P ++   P
Sbjct: 227 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 263

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVR-EFVSEIATIGRLRHRNLVQLVGW 405
           LG G +G+VYK     +   VA+KRI  E  ++GV    + E++ +  L+HRN+++L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
                 L L++++ A   L  ++   P   +   + F  +  + +G+ + H    +  +H
Sbjct: 102 IHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSF--LYQLINGVNFCH---SRRCLH 155
Query: 466 RDVKASNVLLD----SELNG-KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
           RD+K  N+LL     SE    K+GDFGLA+ +       T  ++ TL Y  PE     + 
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRH 214
Query: 521 -SASSDVFAFGALLLEV 536
            S S D+++   +  E+
Sbjct: 215 YSTSVDIWSIACIWAEM 231

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 14/213 (6%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR---EFVSEIATIGRLR 395
           ++ +   ++LG GG  +V+         +VAVK +  +  +       F  E      L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 396 HRNLVQL--VGWCRRKGDLL--LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           H  +V +   G        L  +V +++   +L   +  E    +  ++  ++I      
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 128
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGY 509
           L + H+     +IHRDVK +N+++ +    K+ DFG+A+      N  T    V+GT  Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           L+PE  R     A SDV++ G +L EV  G  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE----SK 378
           +++G +   +Q +    +++   + LG G F  V K     +  E A K I       S+
Sbjct: 11  VDLGTENLYFQSM--VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSR 68
Query: 379 QGV--REFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           +GV   E   E+  +  +RH N++ L      K D++L+ + ++ G L  FL +  K  L
Sbjct: 69  RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESL 126
Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNV-LLDSELNG---KLGDFGLAKLY 492
             ++  + +K +  G+ YLH    + + H D+K  N+ LLD  +     KL DFG+A   
Sbjct: 127 TEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 183
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E G       + GT  ++APE          +D+++ G +   +  G  P
Sbjct: 184 EAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+           
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
             L ++APET      +  SDV++FG LL E+
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-----FVSEIATIGRL 394
            +F   ++LG G F          +  E A+K +  E +  ++E        E   + RL
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVA 449
            H   V+L    +    L     +  NG L  ++     FDE         RF   + + 
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IV 140
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
           Y++PE      +  SSD++A G ++ ++  G  P   RA  E L+    +  +Y
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEY 249

>pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 51  LRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPS 110
           L LT      +G+A YSS +   +    NV +F TSF  VI          G  F I+P 
Sbjct: 31  LTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPV 90
Query: 111 NDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXXXXX-XXXXSMKSNAS 169
           +        YLG+ NS +    +    AVEFDT  +  +              S+KS   
Sbjct: 91  DTKPQTGGGYLGVFNSAEYDK-TTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKS--- 146
Query: 170 VEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVS-PNSS---KPKIPILSFRV 225
                       +   L+ G+   V + +++A N+L V+++ PN+S   +     LS  V
Sbjct: 147 ---------VNTKSWKLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVV 197
Query: 226 DLSPIFNEFMYVGFSASTGLLASSHNVLGWSF 257
            L  +  E++ +GFSA+TG   ++H VL WSF
Sbjct: 198 SLKDVVPEWVRIGFSATTGAEYAAHEVLSWSF 229

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR--- 502
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+  +   +P   R   
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGD 209
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
               L ++APET      +  SDV++FG LL E+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+           
Sbjct: 192 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
             L ++APET      +  SDV++FG LL E+
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE----SKQGV--REFVSEIATIGR 393
           +++   + LG G F  V K     +  E A K I       S++GV   E   E+  +  
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           +RH N++ L      K D++L+ + ++ G L  FL +  K  L  ++  + +K +  G+ 
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVH 129
Query: 454 YLHEGYEQVVIHRDVKASNV-LLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           YLH    + + H D+K  N+ LLD  +     KL DFG+A   E G       + GT  +
Sbjct: 130 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEF 184
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +APE          +D+++ G +   +  G  P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+           
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
             L ++APET      +  SDV++FG LL E+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+           
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
             L ++APET      +  SDV++FG LL E+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 14/213 (6%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR---EFVSEIATIGRLR 395
           ++ +   ++LG GG  +V+         +VAVK +  +  +       F  E      L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 396 HRNLVQL--VGWCRRKGDLL--LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           H  +V +   G        L  +V +++   +L   +  E    +  ++  ++I      
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 145
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT--TRVVGTLGY 509
           L + H+     +IHRDVK +N+++ +    K+ DFG+A+      N  T    V+GT  Y
Sbjct: 146 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           L+PE  R     A SDV++ G +L EV  G  P
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF--VSEIATIGRL-R 395
           T  +   + LG G F  V +     +  E A   I N  K   R+   +   A I RL +
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM-IINTKKLSARDHQKLEREARICRLLK 68
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR--FKIIKGVASGLL 453
           H N+V+L      +G   L++D +  G L    F++  A   + +      I+ +   +L
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVL 124
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           + H+     V+HR++K  N+LL S+L G   KL DFGLA   E G   A     GT GYL
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYL 180
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  R        D++A G +L  +  G  P
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 14/186 (7%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--------SKQGVREFVSEI 388
           + +  +S    LG G FG V+         EV VK I  E            + +   EI
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
           A + R+ H N+++++     +G   LV +   +G LD F F +    L+      I + +
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
            S + YL     + +IHRD+K  N+++  +   KL DFG A   E G    T    GT+ 
Sbjct: 140 VSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIE 194
Query: 509 YLAPET 514
           Y APE 
Sbjct: 195 YCAPEV 200

>pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 113/243 (46%), Gaps = 24/243 (9%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTN---DTSRKMGQAFYSSTLRFKNSLNSNVFSF 83
           F  F     N+  QG A +   G+L++T     T+  +G+A Y++ ++  +S+   V SF
Sbjct: 10  FDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASF 69
Query: 84  STSFAIVIVPEYPRLGGHGLAFTISPSNDL--NGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           +TSF+ V+  +    G  GLAF ++P+N    +G  +   GL +S+D  + SN + AVEF
Sbjct: 70  ATSFSFVVKADKSD-GVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKS-SNQIIAVEF 127
Query: 142 DTV--QDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           DT   + +               S+KS  +V+               + G+   V + Y 
Sbjct: 128 DTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK------------WDWRNGEVADVVITYR 175
Query: 200 SAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA--SSHNVLGWSF 257
           +    L V +S  S      I++  VDL  I  E++ VGFS   G  A   +H+VL W F
Sbjct: 176 APTKSLTVCLSYPSDGTS-NIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234
Query: 258 KIN 260
             N
Sbjct: 235 TSN 237

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR--- 502
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+  +   +P   R   
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGD 200
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
               L ++APET      +  SDV++FG LL E+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 348 LGHGGFGQVYKGT---LHNSKT--EVAVKRISNESKQGV-REFVSEIATIGRL-RHRNLV 400
           LG G FGQV +     +  + T   VAVK +   +     R  +SE+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 401 QLVGWCRRKG-DLLLVYDFMANGSLDSFLF--------------DEPKAVLNWEQRFKII 445
            L+G C + G  L+++ +F   G+L ++L               D  K  L  E      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR--- 502
             VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+  +   +P   R   
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGD 200
Query: 503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
               L ++APET      +  SDV++FG LL E+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE----SKQGV--REFVSEIATIGR 393
           +++   + LG G F  V K     +  E A K I       S++GV   E   E+  +  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           +RH N++ L      K D++L+ + ++ G L  FL +  K  L  ++  + +K +  G+ 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVH 122
Query: 454 YLHEGYEQVVIHRDVKASNV-LLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           YLH    + + H D+K  N+ LLD  +     KL DFG+A   E G       + GT  +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEF 177
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +APE          +D+++ G +   +  G  P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 341 NFSAKQLLGHGGFGQVY----KGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH 396
           +F+   +LG G FG+V     KGT      ++  K +  +        V +       + 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             L QL    +    L  V +++  G L   +     F EP AV    +       +A G
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-------IAIG 454
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGYL 510
           L +L     + +I+RD+K  NV+LDSE + K+ DFG+ K  E+  +  TT+   GT  Y+
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYI 509
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIE 544
           APE         S D +AFG LL E+  G+ P E
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 32/223 (14%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV-SEIATIGRLRHRNL 399
           +F   Q LG GGFG V++          A+KRI   +++  RE V  E+  + +L H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 400 VQLV-GWCRR-----------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR---FKI 444
           V+    W  +           K  L +        +L  ++    +  +   +R     I
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHI 123
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN------- 497
              +A  + +LH    + ++HRD+K SN+    +   K+GDFGL    +           
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 498 -PATTRVVGTLG---YLAPETPRTGKSSASSDVFAFGALLLEV 536
            PA  R  G +G   Y++PE       S   D+F+ G +L E+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 112/242 (46%), Gaps = 26/242 (10%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS-----RKMGQAFYSSTLRFKNSLNSNVF 81
           F  F    NNL LQ  A + + G L LT   +       +G+A Y++ +   +  N+ + 
Sbjct: 8   FTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD--NTTLA 65
Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           SF+TSF+ V+          GLAF ++P +        +LGL  +    + S    AVEF
Sbjct: 66  SFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLF-ADRAHDASYQTVAVEF 124
Query: 142 DTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSA 201
           DT  +                 + +N      + +  +T  D+ + G KA +V + Y ++
Sbjct: 125 DTYSN-------AWDPNYTHIGIDTN-----GIESKKTTPFDM-VYGEKANIV-ITYQAS 170
Query: 202 ENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFK 258
              L  ++    S+    + S RVDL  I  E++ VGFSA+TGL   +  +H+++ WSF 
Sbjct: 171 TKALAASLVFPVSQTSYAV-SARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFA 229
Query: 259 IN 260
           ++
Sbjct: 230 VS 231

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRL 394
           +  +N+  K L+G G +G VY     N+   VA+K+++   E     +  + EI  + RL
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 395 RHRNLVQL----VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK-IIKGVA 449
           +   +++L    +     K D L +   +A+  L   LF  P  +   EQ  K I+  + 
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKK-LFKTP--IFLTEQHVKTILYNLL 141
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
            G  ++HE     +IHRD+K +N LL+ + + K+ DFGLA+
Sbjct: 142 LGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 75  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 76  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 128
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 129 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 183
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 78  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 77  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 184
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 79  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 132 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 186
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 100 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 152
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 153 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 207
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 76  DNPHVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIA 128
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 129 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 183
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 72  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 124
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 125 EGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 179
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 99/225 (44%), Gaps = 43/225 (19%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LG G +G V K     S   +AVKRI     S E K+ + +    + T+        V  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD---CPFTVTF 71
Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASGLLYLH 456
            G   R+GD+ +  + M + SLD F     K V++  Q        KI   +   L +LH
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGL--------AKLYEHGTNPATTRVVGTLG 508
                 VIHRDVK SNVL+++    K+ DFG+        AK  + G  P          
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP---------- 174
Query: 509 YLAPE--TPRTGKS--SASSDVFAFGALLLEVACGRRPIETRALP 549
           Y+APE   P   +   S  SD+++ G  ++E+A  R P ++   P
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 69  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 121
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 176
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 402 LVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L G       + +V +    GSL D     +   +L    R+ +   VA G+ YL     
Sbjct: 80  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 133
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK----------LYEHGTNPATTRVVGTLGYL 510
           +  IHRD+ A N+LL +    K+GDFGL +          + EH   P          + 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--------FAWC 185
Query: 511 APETPRTGKSSASSDVFAFGALLLEV 536
           APE+ +T   S +SD + FG  L E+
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 77  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 184
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK-----RISNESKQGVREFVSEIATIGRLRHRNLV 400
           +++G G F  V +     +  + AVK     + ++       +   E +    L+H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF--KIIKGVASGLLYLHEG 458
           +L+      G L +V++FM    L   +     A   + +      ++ +   L Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 459 YEQVVIHRDVKASNVLLDSELNG---KLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPET 514
               +IHRDVK  NVLL S+ N    KLGDFG+A +L E G        VGT  ++APE 
Sbjct: 150 N---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEV 204
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
            +        DV+  G +L  +  G  P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 81  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 133
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 134 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 188
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 85  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 137
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 138 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 192
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 78  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 78  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 78  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 185
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 82  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 189
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 13/173 (7%)
Query: 326 GPQRYSYQELK--QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGV 381
           G +   +Q +K     +N+  K L+G G +G VY     N++  VA+K+++   E     
Sbjct: 10  GRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC 69
Query: 382 REFVSEIATIGRLRHRNLVQLVGWC----RRKGDLLLVYDFMANGSLDSFLFDEPKAVLN 437
           +  + EI  + RL+   +++L          K D L +   +A+  L   LF  P   L 
Sbjct: 70  KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTP-IFLT 127
Query: 438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
            E    I+  +  G  ++HE     +IHRD+K +N LL+ + + K+ DFGLA+
Sbjct: 128 EEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 402 LVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L G       + +V +    GSL D     +   +L    R+ +   VA G+ YL     
Sbjct: 76  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 129
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK----------LYEHGTNPATTRVVGTLGYL 510
           +  IHRD+ A N+LL +    K+GDFGL +          + EH   P          + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--------FAWC 181
Query: 511 APETPRTGKSSASSDVFAFGALLLEV 536
           APE+ +T   S +SD + FG  L E+
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 402 LVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L G       + +V +    GSL D     +   +L    R+ +   VA G+ YL     
Sbjct: 76  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 129
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK----------LYEHGTNPATTRVVGTLGYL 510
           +  IHRD+ A N+LL +    K+GDFGL +          + EH   P          + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP--------FAWC 181
Query: 511 APETPRTGKSSASSDVFAFGALLLEV 536
           APE+ +T   S +SD + FG  L E+
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW  +      +A
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 402 LVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L G       + +V +    GSL D     +   +L    R+ +   VA G+ YL     
Sbjct: 80  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 133
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK----------LYEHGTNPATTRVVGTLGYL 510
           +  IHRD+ A N+LL +    K+GDFGL +          + EH   P          + 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--------FAWC 185
Query: 511 APETPRTGKSSASSDVFAFGALLLEV 536
           APE+ +T   S +SD + FG  L E+
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 402 LVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L G       + +V +    GSL D     +   +L    R+ +   VA G+ YL     
Sbjct: 76  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 129
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK----------LYEHGTNPATTRVVGTLGYL 510
           +  IHRD+ A N+LL +    K+GDFGL +          + EH   P          + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--------FAWC 181
Query: 511 APETPRTGKSSASSDVFAFGALLLEV 536
           APE+ +T   S +SD + FG  L E+
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 402 LVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L G       + +V +    GSL D     +   +L    R+ +   VA G+ YL     
Sbjct: 86  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 139
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK----------LYEHGTNPATTRVVGTLGYL 510
           +  IHRD+ A N+LL +    K+GDFGL +          + EH   P          + 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--------FAWC 191
Query: 511 APETPRTGKSSASSDVFAFGALLLEV 536
           APE+ +T   S +SD + FG  L E+
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 348 LGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 402 LVGWCRRKGDLLLVYDFMANGSL-DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L G       + +V +    GSL D     +   +L    R+ +   VA G+ YL     
Sbjct: 86  LYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 139
Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLY----EHGTNPATTRVVGTLGYLAPETPR 516
           +  IHRD+ A N+LL +    K+GDFGL +      +H       +V     + APE+ +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV--PFAWCAPESLK 197
Query: 517 TGKSSASSDVFAFGALLLEV 536
           T   S +SD + FG  L E+
Sbjct: 198 TRTFSHASDTWMFGVTLWEM 217

>pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 107/234 (45%), Gaps = 24/234 (10%)
Query: 30  FKDLSNNLTLQGIAKIENNGILRLTND--TSRKMGQAFYSSTLRFKNSLNSNVFSFSTSF 87
           FKD   +L  QG AKI  +G L +  D   +R    A Y++ +   +S   NV SF TSF
Sbjct: 8   FKD-DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASFITSF 66
Query: 88  AIVI--VPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQ 145
           + ++  V  YP   G  + F ++P       P+   G L  TD  N  N   AVEFD+  
Sbjct: 67  SFIVSNVQRYPPTDG--VVFFLAPWG-TEIPPNSQGGYLGITDSSNSQNQFVAVEFDSHP 123
Query: 146 D-FEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENI 204
           + ++ +            S+ S  +V       N  +   SL+  KA ++   YDS   I
Sbjct: 124 NVWDPKSLRSSHIGIDVNSIMSLKAV-------NWNRVSGSLE--KATII---YDSDTKI 171
Query: 205 LNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSAST-GLLASSHNVLGWSF 257
           L V ++  + +  I  +S  +DL  +  E + VGFSA+T       H++  WSF
Sbjct: 172 LTVVMTHQNGQ--ITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSF 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKR-ISNESKQGVREF-VSEIATIGRLRHRNLVQLVGW 405
           +G G +G V+K    ++   VA+K+ + +E    +++  + EI  + +L+H NLV L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 406 CRRKGDLLLVYDFMAN---GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
            RRK  L LV+++  +     LD +    P+ ++       I       + + H+     
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-----SITWQTLQAVNFCHK---HN 122
Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSS- 521
            IHRDVK  N+L+      KL DFG A+L   G +      V T  Y +PE    G +  
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRSPEL-LVGDTQY 180
Query: 522 -ASSDVFAFGALLLEVACG 539
               DV+A G +  E+  G
Sbjct: 181 GPPVDVWAIGCVFAELLSG 199

>pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 28/243 (11%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNV 80
           F  F     NL  QG A    N IL+LT   S        +G+  +S+ +R      + V
Sbjct: 16  FINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRV 75
Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL--NGLPSQYLGLLN-STDIGNFSNHLF 137
            +  T F+  +          G+AF I+P +    +G     LGL N  T +   +N + 
Sbjct: 76  ANLQTQFSFFLSSPLSN-PADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVL 134
Query: 138 AVEFDT--VQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVW 195
           AVEFDT   Q+                S++S+  V                + GK + V 
Sbjct: 135 AVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVR------------WERREGKTLNVL 182
Query: 196 VDYDSAENILNVTVS-PNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLG 254
           V Y+ +   ++V  + P+  + +   LS  VDL+ I  E++ VGFSA++G    +HN+  
Sbjct: 183 VTYNPSTRTIDVVATYPDGQRYQ---LSHVVDLTTILPEWVRVGFSAASGEQFQTHNLES 239
Query: 255 WSF 257
           WSF
Sbjct: 240 WSF 242

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 323 LEVGPQRYSYQELKQATNNF--SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-Q 379
           +++G +   +Q ++   N +  ++K+L G G F  V +    ++  E A K +    + Q
Sbjct: 11  VDLGTENLYFQSMENFNNFYILTSKEL-GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 380 GVR-EFVSEIATIGRLRHR-NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLN 437
             R E + EIA +   +    ++ L        +++L+ ++ A G + S    E   +++
Sbjct: 70  DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL---NGKLGDFGLAKLYEH 494
                ++IK +  G+ YLH+     ++H D+K  N+LL S     + K+ DFG+++   H
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGAL 532
                   ++GT  YLAPE       + ++D++  G +
Sbjct: 187 ACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 346 QLLGHGGFGQVYKGTL----HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG VYKG       N K  VA+K +  N S +  +E + E   +  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-----PKAVLNWEQRFKIIKGVASGLLYL 455
           +L+G C     + LV   M  G L   + +       + +LNW  +      +A G+ YL
Sbjct: 83  RLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYL 135
Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY---EHGTNPATTRVVGTLGYLAP 512
            +     ++HRD+ A NVL+ S  + K+ DFGLA+L    E   +    +V   + ++A 
Sbjct: 136 EDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMAL 190
Query: 513 ETPRTGKSSASSDVFAFGALLLEVAC-GRRP---IETRALPEEL 552
           E+    + +  SDV+++G  + E+   G +P   I  R +P+ L
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 59
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ + M     D F F   +  L  E    
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQ-DLFDFITERGALQEELARS 118
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 119 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 170
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 171 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLV 400
           F  K+ LG G FG V+     +S  E  +K I+ +  Q  + +  +EI  +  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK--AVLNWEQRFKIIKGVASGLLYLHEG 458
           ++        ++ +V +    G L   +         L+     +++K + + L Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141
Query: 459 YEQVVIHRDVKASNVLL-DSELNG--KLGDFGLAKLY---EHGTNPATTRVVGTLGYLAP 512
             Q V+H+D+K  N+L  D+  +   K+ DFGLA+L+   EH TN A     GT  Y+AP
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-----GTALYMAP 195
Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           E  +    +   D+++ G ++  +  G  P    +L E
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 79  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFG AKL   G         G    
Sbjct: 132 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 186
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 77  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFG AKL   G         G    
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 184
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++L  G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 82  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 189
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 77  DNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFG AKL   G         G    
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 184
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 174
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK        AT  + GT  YLA
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGATWTLCGTPEYLA 227
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++L  G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 182
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF--VSEIATIGRL-R 395
           T+ +   + LG G F  V +     +  E A K I N  K   R+   +   A I RL +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK-IINTKKLSARDHQKLEREARICRLLK 61
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR--FKIIKGVASGLL 453
           H N+V+L      +G   LV+D +  G L    F++  A   + +      I+ +   + 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVN 117
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           + H      ++HRD+K  N+LL S+  G   KL DFGLA +   G   A     GT GYL
Sbjct: 118 HCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYL 173
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  R        D++A G +L  +  G  P
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFG AKL   G         G    
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 182
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+  +    S +  +E + E   +  +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 109 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 161
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 162 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 216
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQL----- 402
           LG GG G V+    ++    VA+K+I     Q V+  + EI  I RL H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 403 ---------VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
                    VG       + +V ++M     +     E   +L    R  + + +  GL 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL---EQGPLLEEHARLFMYQ-LLRGLK 134
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKL----YEHGTNPATTRVVGTLG 508
           Y+H      V+HRD+K +N+ +++E L  K+GDFGLA++    Y H  + +   V  T  
Sbjct: 135 YIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV--TKW 189
Query: 509 YLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
           Y +P    +  + + + D++A G +  E+  G+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++L  G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 82  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFGLAKL   G         G    
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVP 189
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF--VSEIATIGRL-R 395
           T+ +   + LG G F  V +     +  E A K I N  K   R+   +   A I RL +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK-IINTKKLSARDHQKLEREARICRLLK 61
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR--FKIIKGVASGLL 453
           H N+V+L      +G   LV+D +  G L    F++  A   + +      I+ +   + 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVN 117
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           + H      ++HRD+K  N+LL S+  G   KL DFGLA +   G   A     GT GYL
Sbjct: 118 HCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYL 173
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +PE  R        D++A G +L  +  G  P
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 82  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFG AKL   G         G    
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 189
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNE-SKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVA 449
            + ++ +L+G C     + L+   M  G L  ++ +       + +LNW         +A
Sbjct: 77  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG---T 506
            G+ YL +   + ++HRD+ A NVL+ +  + K+ DFG AKL   G         G    
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVP 184
Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           + ++A E+      +  SDV+++G  + E+   G +P
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 23/235 (9%)
Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN-- 375
           LEV  Q    +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  
Sbjct: 14  LEVLFQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 73
Query: 376 ESKQGVREFVSEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
           E   G R    E+  + ++      +++L+ W  R    +L+ +       D F F   +
Sbjct: 74  ELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITER 131
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAK 490
             L  E        V   + + H      V+HRD+K  N+L+D    EL  KL DFG   
Sbjct: 132 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGA 186
Query: 491 LYEHGTNPATTRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           L +   +   T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 187 LLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE----FVSEIAT 390
           L+    ++   +++G G FG+V +   H +  +V   ++ ++ +   R     F  E   
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 391 IGRLRHRNLVQLVGWCRRKGD--LLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIK 446
           +       +VQL  +C  + D  L +V ++M  G L + +  +D P+    W + +    
Sbjct: 129 MAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KWAKFY---- 179
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVG 505
             A  +L L   +   +IHRDVK  N+LLD   + KL DFG   K+ E G     T  VG
Sbjct: 180 -TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT-AVG 237
Query: 506 TLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRAL 548
           T  Y++PE  ++    G      D ++ G  L E+  G  P    +L
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 284

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQV--------------YKGTLHNSKTEVAVKRISNESK 378
           +E  +  N++   + L  G F ++              Y+ +L   K +      SN  K
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTK---SNNDK 80
Query: 379 QGVR----EFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKA 434
             ++    +F +E+  I  +++   +   G      ++ ++Y++M N S+    FDE   
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI--LKFDEYFF 138
Query: 435 VLNWE-------QRFK-IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF 486
           VL+         Q  K IIK V +   Y+H   E+ + HRDVK SN+L+D     KL DF
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDF 196
Query: 487 GLAKLYEHGTNPATTRVVGTLGYLAPE--TPRTGKSSASSDVFAFGALL 533
           G +   E+  +       GT  ++ PE  +  +  + A  D+++ G  L
Sbjct: 197 GES---EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE----FVSEI 388
           ++L+    ++   +++G G FG+V +   H S  +V   ++ ++ +   R     F  E 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIK 446
             +       +VQL    +    L +V ++M  G L + +  +D P+    W + +    
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFY---- 178
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVG 505
             A  +L L   +    IHRDVK  N+LLD   + KL DFG   K+ + G     T  VG
Sbjct: 179 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVG 236
Query: 506 TLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRAL 548
           T  Y++PE  ++    G      D ++ G  L E+  G  P    +L
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 283

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE----FVSEI 388
           ++L+    ++   +++G G FG+V +   H S  +V   ++ ++ +   R     F  E 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIK 446
             +       +VQL    +    L +V ++M  G L + +  +D P+    W + +    
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFY---- 173
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVG 505
             A  +L L   +    IHRDVK  N+LLD   + KL DFG   K+ + G     T  VG
Sbjct: 174 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVG 231
Query: 506 TLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRAL 548
           T  Y++PE  ++    G      D ++ G  L E+  G  P    +L
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE----FVSEI 388
           ++L+    ++   +++G G FG+V +   H S  +V   ++ ++ +   R     F  E 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIK 446
             +       +VQL    +    L +V ++M  G L + +  +D P+    W + +    
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFY---- 178
Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVG 505
             A  +L L   +    IHRDVK  N+LLD   + KL DFG   K+ + G     T  VG
Sbjct: 179 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVG 236
Query: 506 TLGYLAPETPRT----GKSSASSDVFAFGALLLEVACGRRPIETRAL 548
           T  Y++PE  ++    G      D ++ G  L E+  G  P    +L
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 283

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 60
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 119
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 120 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 171
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 22/235 (9%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHR 397
           + +   + +G+G +G V       +  +VA+K+I N  +     +  + E+  +   +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 398 NLVQLVGWCRRK---GDLLLVY---DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           N++ +    R     G+   VY   D M +         +P   L  E     +  +  G
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP---LTLEHVRYFLYQLLRG 170
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-----TTRVVGT 506
           L Y+H      VIHRD+K SN+L++     K+GDFG+A+     T+PA      T  V T
Sbjct: 171 LKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL--CTSPAEHQYFMTEYVAT 225
Query: 507 LGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWG 560
             Y APE   +  + + + D+++ G +  E+   R+    +    +L L+  V G
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 60
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 119
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 120 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 171
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 129/289 (44%), Gaps = 26/289 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G V       S  +VA+K++S   +S+   +    E+  +  ++H N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWE---QRFK-IIKGVASGLLYLHEGYEQ 461
                 L   YDF     +  F+  + + ++  E   ++ + ++  +  GL Y+H     
Sbjct: 110 FTPASSLRNFYDFYL---VMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA--- 163
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS- 520
            V+HRD+K  N+ ++ +   K+ DFGLA+   H     T  VV T  Y APE   +    
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPEVILSWMHY 219
Query: 521 SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYD 580
           + + D+++ G ++ E+  G+   + +   ++L  +  V G  G   V ++ D K    Y 
Sbjct: 220 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND-KAAKSYI 278
Query: 581 QSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS 629
           QS        LP T R   +    +A+    DLL  +     DK  + +
Sbjct: 279 QS--------LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 336 KQATNNFSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISN----ESKQGVREFVSEI 388
           K    NF   ++LG G +G+V+   K + H++    A+K +      +  +      +E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 389 ATIGRLRHRN-LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
             +  +R    LV L    + +  L L+ D++  G L + L    +     E   +I  G
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIYVG 166
Query: 448 -VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
            +   L +LH+     +I+RD+K  N+LLDS  +  L DFGL+K +            GT
Sbjct: 167 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 507 LGYLAPETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           + Y+AP+  R G S    + D ++ G L+ E+  G  P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1DHK|B Chain B, Structure Of Porcine Pancreatic Alpha-Amylase Length = 223

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 42/225 (18%)
Query: 36  NLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY 95
           NL LQG A + +NG L+L+ ++   M +AFYS+ ++ ++S   NV SF T+F + I    
Sbjct: 15  NLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHR 74
Query: 96  PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXX 155
                 GL F + P      +  +  G                VEFDT            
Sbjct: 75  QANSAVGLDFVLVP------VQPESKG------------DTVTVEFDT------------ 104
Query: 156 XXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSK 215
                     S  S++       S   D+    G+   V + Y+S+  + +V++S N S 
Sbjct: 105 --------FLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLS-NPST 155
Query: 216 PKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSF 257
            K   +S  V+L     +++ VGFSA++G       +H+VL WSF
Sbjct: 156 GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF 200

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 140
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 193
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + +G G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V ++M  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   K+ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 59
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 118
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 119 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 170
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 171 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 129/289 (44%), Gaps = 26/289 (8%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G V       S  +VA+K++S   +S+   +    E+  +  ++H N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNW---EQRFK-IIKGVASGLLYLHEGYEQ 461
                 L   YDF     +  F+  + + ++     E++ + ++  +  GL Y+H     
Sbjct: 92  FTPASSLRNFYDFYL---VMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA--- 145
Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS- 520
            V+HRD+K  N+ ++ +   K+ DFGLA+   H     T  VV T  Y APE   +    
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPEVILSWMHY 201
Query: 521 SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYD 580
           + + D+++ G ++ E+  G+   + +   ++L  +  V G  G   V ++ D K    Y 
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND-KAAKSYI 260
Query: 581 QSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS 629
           QS        LP T R   +    +A+    DLL  +     DK  + +
Sbjct: 261 QS--------LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + +G G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V ++M  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   K+ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 60
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 119
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 120 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 171
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|1VIW|B Chain B, Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Length = 205

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 42/225 (18%)
Query: 36  NLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY 95
           NL LQG A + +NG L+L+ ++   M +AFYS+ ++ ++S   NV SF T+F + I    
Sbjct: 15  NLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHR 74
Query: 96  PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQXXXXX 155
                 GL F + P      +  +  G                VEFDT            
Sbjct: 75  QANSAVGLDFVLVP------VQPESKG------------DTVTVEFDT------------ 104
Query: 156 XXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSK 215
                     S  S++       S   D+    G+   V + Y+S+  + +V++S N S 
Sbjct: 105 --------FLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLS-NPST 155
Query: 216 PKIPILSFRVDLSPIFNEFMYVGFSASTGLLASS---HNVLGWSF 257
            K   +S  V+L     +++ VGFSA++G    S   H+VL WSF
Sbjct: 156 GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF 200

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 74
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 133
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 134 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 185
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 88
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 147
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 148 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 199
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 88
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 147
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 148 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 199
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 87
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 146
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 147 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 198
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 88
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 147
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 148 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 199
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 88
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 147
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 148 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 199
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 87
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 146
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 147 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 198
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 74
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 133
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 134 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 185
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 22/235 (9%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHR 397
           + +   + +G+G +G V       +  +VA+K+I N  +     +  + E+  +   +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 398 NLVQLVGWCRRK---GDLLLVY---DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           N++ +    R     G+   VY   D M +         +P   L  E     +  +  G
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP---LTLEHVRYFLYQLLRG 171
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-----TTRVVGT 506
           L Y+H      VIHRD+K SN+L++     K+GDFG+A+     T+PA      T  V T
Sbjct: 172 LKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL--CTSPAEHQYFMTEYVAT 226
Query: 507 LGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWG 560
             Y APE   +  + + + D+++ G +  E+   R+    +    +L L+  V G
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 154
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 75
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 134
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 135 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 186
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 102
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 161
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 162 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 213
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 102
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 161
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 162 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 213
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 148
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 149 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 201
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 87
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 146
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 147 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 198
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLAGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 75
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 134
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 135 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 186
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 94
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 153
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 154 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 205
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 75
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 134
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 135 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 186
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 87
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 146
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 147 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 198
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIG 392
           +E++    +F   +++G G FG+V    + N++   A+K I N+ +   R      A   
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMK-ILNKWEMLKR------AETA 135
Query: 393 RLRHRNLVQLVGWCR----------RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF 442
             R    V + G C+           +  L LV D+   G L + L      +     RF
Sbjct: 136 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF 195
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATT 501
            I + V    L +   ++   +HRD+K  NVLLD   + +L DFG   K+ + GT  ++ 
Sbjct: 196 YIGEMV----LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV 251
Query: 502 RVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
             VGT  Y++PE  +      GK     D ++ G  + E+  G  P    +L E
Sbjct: 252 -AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 304

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFV 385
           +E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R   
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VP 107
Query: 386 SEIATIGRLRH--RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
            E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E    
Sbjct: 108 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARS 166
Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPAT 500
               V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   
Sbjct: 167 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVY 218
Query: 501 TRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
           T   GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLXGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 174
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEYLA 227
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIG 392
           +E++    +F   +++G G FG+V    + N++   A+K I N+ +   R      A   
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMK-ILNKWEMLKR------AETA 119
Query: 393 RLRHRNLVQLVGWCR----------RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF 442
             R    V + G C+           +  L LV D+   G L + L      +     RF
Sbjct: 120 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF 179
Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATT 501
            I       +L +   ++   +HRD+K  NVLLD   + +L DFG   K+ + GT  ++ 
Sbjct: 180 YI----GEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV 235
Query: 502 RVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
             VGT  Y++PE  +      GK     D ++ G  + E+  G  P    +L E
Sbjct: 236 -AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFVSEIATIG 392
           + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R    E+  + 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLK 62
Query: 393 RLR--HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           ++      +++L+ W  R    +L+ +       D F F   +  L  E        V  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
            + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   T   GT 
Sbjct: 122 AVRHCH---NXGVLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTR 173
Query: 508 GYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
            Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    ++E    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   K+ DFGLAK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFVSEIATIG 392
           + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R    E+  + 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLK 62
Query: 393 RLR--HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           ++      +++L+ W  R    +L+ +       D F F   +  L  E        V  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
            + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   T   GT 
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTR 173
Query: 508 GYLAPETPRTGKSSA-SSDVFAFGALLLEVACGRRPIE 544
            Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFVSEIATIG 392
           + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R    E+  + 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLK 62
Query: 393 RLR--HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           ++      +++L+ W  R    +L+ +       D F F   +  L  E        V  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
            + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   T   GT 
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYTDFDGTR 173
Query: 508 GYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
            Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 23/224 (10%)
Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISN--ESKQGVREFVS 386
           E +   + +    LLG GGFG VY G   +    VA+K     RIS+  E   G R    
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPM 59
Query: 387 EIATIGRLR--HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI 444
           E+  + ++      +++L+ W  R    +L+ +       D F F   +  L  E     
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSF 118
Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYEHGTNPATT 501
              V   + + H      V+HRD+K  N+L+D    EL  KL DFG   L +   +   T
Sbjct: 119 FWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL--KLIDFGSGALLK---DTVYT 170
Query: 502 RVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIE 544
              GT  Y  PE  R  +    S+ V++ G LL ++ CG  P E
Sbjct: 171 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 8/196 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 86  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 142
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 200
Query: 525 DVFAFGALLLEVACGR 540
           D+++ G ++ E+ C +
Sbjct: 201 DLWSVGCIMGEMVCHK 216

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           LG G F    K     S    AVK IS   +   ++ ++ +       H N+V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD 467
            +    LV + +  G L  F   + K   +  +   I++ + S + ++H+     V+HRD
Sbjct: 77  DQLHTFLVMELLNGGEL--FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRD 131
Query: 468 VKASNVLLDSE---LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           +K  N+L   E   L  K+ DFG A+L      P  T    TL Y APE         S 
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESC 190
Query: 525 DVFAFGALLLEVACGRRPIETR 546
           D+++ G +L  +  G+ P ++ 
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSH 212

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ ++A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 8/196 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 97  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 153
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 154 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 211
Query: 525 DVFAFGALLLEVACGR 540
           D+++ G ++ E+ C +
Sbjct: 212 DLWSVGCIMGEMVCHK 227

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 10/163 (6%)
Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNL 399
               +++L  GGF  VY+     S  E A+KR+ +  ++  R  + E+  + +L  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 400 VQLVGWC---RRKGDL----LLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASG 451
           VQ        + + D      L+   +  G L  FL   E +  L+ +   KI       
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH 494
           + ++H   +  +IHRD+K  N+LL ++   KL DFG A    H
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 340 NNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           + F   + LG G FG+V    +K T ++   ++  K+   + KQ +   ++E   +  + 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 92
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              LV+L    +   +L +V +++  G + S L     F EP A      RF   + V +
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT 146
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YL
Sbjct: 147 -FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYL 198
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE   +   + + D +A G L+ E+A G  P 
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 16/228 (7%)
Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE----FVSEI 388
           ++++    +F   +++G G FG+V    L N+    A+K I N+ +   R     F  E 
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREER 125
Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
             +     + +  L    +   +L LV D+   G L + L      +     RF +    
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL---- 181
Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG-LAKLYEHGTNPATTRVVGTL 507
           A  ++ +   ++   +HRD+K  N+L+D   + +L DFG   KL E GT  ++   VGT 
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTP 240
Query: 508 GYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
            Y++PE  +      G+     D ++ G  + E+  G  P    +L E
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    ++E    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   ++ DFGLAK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + +G G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   K+ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 8/175 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VAVK++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L       L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 112 DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
           DFGLA+     TN   T  V T  Y APE       +A+ D+++ G ++ E+  G
Sbjct: 169 DFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 346 QLLGHGGFGQVYKG-TLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLV 403
           +LLG G + +V    +L N K E AVK I  ++         E+ T+ + + ++N+++L+
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGK-EYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
            +        LV++ +  GS+ + +  + +   N  +  ++++ VA+ L +LH    + +
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREASRVVRDVAAALDFLH---TKGI 132
Query: 464 IHRDVKASNVLLDSELN---GKLGDFGLA---KLYEHG---TNPATTRVVGTLGYLAPET 514
            HRD+K  N+L +S       K+ DF L    KL       T P  T   G+  Y+APE 
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 515 PRTGKSSAS-----SDVFAFGALLLEVACGRRP 542
                  A+      D+++ G +L  +  G  P
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 144
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 203 LGVIMYILLCGYPP 216

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 29  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 74
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 122
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 123 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 182
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 183 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 340 NNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           + F   + LG G FG+V    +K T ++   ++  K+   + KQ +   ++E   +  + 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 92
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              LV+L    +   +L +V +++  G + S L     F EP A      RF   + V +
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT 146
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YL
Sbjct: 147 -FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYL 198
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE   +   + + D +A G L+ E+A G  P 
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVGWC 406
           +G G FG         S   VAVK I  E  + + E V  EI     LRH N+V+     
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 407 RRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
                L +V ++ + G L     ++  F E +A   ++Q       + SG+ Y H     
Sbjct: 84  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYCHA---M 133
Query: 462 VVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-PRTG 518
            V HRD+K  N LLD       K+ DFG +K     + P +T  VGT  Y+APE   +  
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 191
Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEE 551
                +DV++ G  L  +  G  P E    PEE
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFED---PEE 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 36  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 81
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 129
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 130 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 189
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 190 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 51  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 96
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 144
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 205 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 25  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 70
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 118
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 119 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 178
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 179 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 22  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 67
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 115
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 116 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 175
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 176 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 45  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 90
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 138
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 139 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 198
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 199 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 62
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 110
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 171 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 340 NNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           + F   + LG G FG+V    +K T ++   ++  K+   + KQ +   ++E   +  + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              LV+L    +   +L +V ++   G + S L     F EP A      RF   + V +
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT 154
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              YLH      +I+RD+K  N+++D +   K+ DFG AK         T  + GT  YL
Sbjct: 155 -FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYL 206
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 30  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 75
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 123
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 124 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 183
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 184 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 62
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV------------PETVYRVAR 110
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 171 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 29  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 74
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 122
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 123 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 182
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 183 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVGWC 406
           +G G FG         +K  VAVK I  E    + E V  EI     LRH N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 407 RRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
                L ++ ++ + G L     ++  F E +A   ++Q       + SG+ Y H     
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ-------LLSGVSYCHS---M 135
Query: 462 VVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-PRTG 518
            + HRD+K  N LLD       K+ DFG +K     + P +T  VGT  Y+APE   R  
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQE 193
Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEE 551
                +DV++ G  L  +  G  P E    PEE
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFED---PEE 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 18  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 63
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 111
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 112 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 171
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 172 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 340 NNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           + F   + LG G FG+V    +K T ++   ++  K+   + KQ +   ++E   +  + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              LV+L    +   +L +V +++  G + S L     F EP A      RF   + V +
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT 154
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YL
Sbjct: 155 -FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYL 206
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 62
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 110
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 171 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 146
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 151
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 209
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 210 LGVIMYILLCGYPP 223

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 190
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 249 LGVIMYILLCGYPP 262

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 152
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 210
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 211 LGVIMYILLCGYPP 224

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 340 NNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           + F   + LG G FG+V    +K T ++   ++  K+   + KQ +   ++E   +  + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              LV+L    +   +L +V +++  G + S L     F EP A      RF   + V +
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT 154
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YL
Sbjct: 155 -FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYL 206
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 21  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 66
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 114
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 115 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 174
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 175 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           P    +   + + D +A G L+ E+A G  P 
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 340 NNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           + F   + LG G FG+V    +K T ++   ++  K+   + KQ +   ++E   +  + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              LV+L    +   +L +V +++  G + S L     F EP A      RF   + V +
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT 154
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YL
Sbjct: 155 -FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYL 206
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 51  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 96
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 144
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 205 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 150
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 208
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 209 LGVIMYILLCGYPP 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 62
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 110
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 171 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 144
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 203 LGVIMYILLCGYPP 216

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 55  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 100
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 148
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 149 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 208
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 209 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN- 398
           + F   + LG G FG+V       +    A+K +    KQ V +      T+   R +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRIQQA 98
Query: 399 -----LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGV 448
                LV+L    +   +L +V ++   G + S L     F EP A      RF   + V
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIV 152
Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
            +   YLH      +I+RD+K  N+L+D +   K+ DFG AK         T  + GT  
Sbjct: 153 LT-FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPE 204
Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           YLAPE   +   + + D +A G L+ E+A G  P 
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 145
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 203
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 204 LGVIMYILLCGYPP 217

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 196
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 254
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 255 LGVIMYILLCGYPP 268

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KX 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 53  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 98
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 146
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 147 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 206
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 207 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 340 NNFSAKQLLGHGGFGQV----YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           + F   + LG G FG+V    +K T ++   ++  K+   + KQ +   ++E   +  + 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 120
Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
              LV+L    +   +L +V +++  G + S L     F EP A      RF   + V +
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT 174
Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
              YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YL
Sbjct: 175 -FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEYL 226
Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           APE   +   + + D +A G L+ E+A G  P 
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 139
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 140 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLA 192
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 160
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 218
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 219 LGVIMYILLCGYPP 232

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 96  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 141
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 189
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 190 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 249
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 250 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 23  WEV---PERY---------QNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 124
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 125 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-- 178
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 23  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 124
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 125 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 178
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 17  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 62  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 118
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 119 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 172
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 173 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I+K +   + YLH      + HRDVK  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 146
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D+++
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 529 FGALLLEVACGRRP 542
            G ++  + CG  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 23  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 124
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 125 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 178
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 25  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 126
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 127 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 181 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 30  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI 74
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 131
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 132 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 185
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KX 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK-----RISNESKQGVREFVSEIATIGRLRHRNLV 400
           +++G G F  V +     +  + AVK     + ++       +   E +    L+H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF--KIIKGVASGLLYLHEG 458
           +L+      G L +V++FM    L   +     A   + +      ++ +   L Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 459 YEQVVIHRDVKASNVLLDSELNG---KLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPET 514
               +IHRDVK   VLL S+ N    KLG FG+A +L E G        VGT  ++APE 
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEV 204
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
            +        DV+  G +L  +  G  P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 24  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 125
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 126 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 179
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           +G G FG         S   VAVK I    K        EI     LRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA-NVKREIINHRSLRHPNIVRFKEVIL 85
Query: 408 RKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
               L +V ++ + G L     ++  F E +A   ++Q       + SG+ Y H      
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYCHA---MQ 135
Query: 463 VIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-PRTGK 519
           V HRD+K  N LLD       K+ DFG +K     + P +T  VGT  Y+APE   +   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 193
Query: 520 SSASSDVFAFGALLLEVACGRRPIETRALPEE 551
               +DV++ G  L  +  G  P E    PEE
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFED---PEE 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 20  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 121
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 122 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 175
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 20  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 121
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 122 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 175
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 14  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 58
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 115
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 116 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 169
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 15  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 59
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 60  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 116
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 117 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 170
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 171 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 30  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 131
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 132 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 185
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 30  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 131
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 132 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 185
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 15  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 59
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 60  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 116
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 117 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 170
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 171 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 20  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 121
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 122 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 175
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 24  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 125
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 126 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 179
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 24  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 125
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 126 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 179
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 14  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 58
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +    
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV---K 114
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
            A L  +    +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 115 CAKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 169
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 23  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 124
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 125 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-- 178
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 154
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 16  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 60
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 61  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 117
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 118 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 171
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 172 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 154
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLA 207
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   K+ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK-----RISNESKQGVREFVSEIATIGRLRHRNLV 400
           +++G G F  V +     +  + AVK     + ++       +   E +    L+H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF--KIIKGVASGLLYLHEG 458
           +L+      G L +V++FM    L   +     A   + +      ++ +   L Y H+ 
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 151
Query: 459 YEQVVIHRDVKASNVLLDSELNG---KLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPET 514
               +IHRDVK   VLL S+ N    KLG FG+A +L E G        VGT  ++APE 
Sbjct: 152 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEV 206
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
            +        DV+  G +L  +  G  P
Sbjct: 207 VKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+      V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACGR 540
           D+++ G ++ E+ C +
Sbjct: 207 DIWSVGCIMGEMVCHK 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 29  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 130
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 131 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 184
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 154
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G V       S  ++AVK++S   +S    +    E+  +  ++H N++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 406 ------CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
                      D+ LV   M    L++ +  + + + +   +F +I  +  GL Y+H   
Sbjct: 119 FTPATSLEEFNDVYLVTHLMG-ADLNNIV--KCQKLTDDHVQF-LIYQILRGLKYIHSA- 173
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
              +IHRD+K SN+ ++ +   K+ DFGLA+     T+   T  V T  Y APE      
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 227
Query: 520 S-SASSDVFAFGALLLEVACGR 540
             + + D+++ G ++ E+  GR
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGR 249

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 14  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 58
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 115
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 116 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 169
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 38  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 82
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 139
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 140 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 193
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 41  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 142
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 143 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 196
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 197 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++  G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 101/231 (43%), Gaps = 31/231 (13%)
Query: 27  FPGF-KDLSNNLTLQGIAKIENNGILRL--TNDTSRKM----GQAFYSSTLRFKNSLNSN 79
           FP F  D+ +++  QG A     G L+L  TN     +    G+A YS  ++  ++   +
Sbjct: 9   FPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTES 67
Query: 80  VFSFSTSFAIVIVPEYPRLGGHG----LAFTISPSNDLNGLPSQYLGLLN-STDIGNFSN 134
           V SF T F   +     ++ G+G    LAF ++P +       +YLGL N ST      N
Sbjct: 68  VASFYTEFTFFL-----KITGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKN 122
Query: 135 HLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILV 194
            + AVEFDT  +  F             S+ S A+            +D  +  GK    
Sbjct: 123 QVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRW---------EDSDIFSGKIATA 173
Query: 195 WVDYDSAENILNVTVS-PNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG 244
            + YD +  IL V +S P+ S     ILS  VD+     E + VG SASTG
Sbjct: 174 RISYDGSAEILTVVLSYPDGSDY---ILSHSVDMRQNLPESVRVGISASTG 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 37  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 81
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 138
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 139 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 192
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   K+ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 37  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 81
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 138
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 139 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 192
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 38  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 139
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 140 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 193
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 101/231 (43%), Gaps = 31/231 (13%)
Query: 27  FPGF-KDLSNNLTLQGIAKIENNGILRL--TNDTSRKM----GQAFYSSTLRFKNSLNSN 79
           FP F  D+ +++  QG A     G L+L  TN     +    G+A YS  ++  ++   +
Sbjct: 9   FPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTES 67
Query: 80  VFSFSTSFAIVIVPEYPRLGGHG----LAFTISPSNDLNGLPSQYLGLLN-STDIGNFSN 134
           V SF T F   +     ++ G+G    LAF ++P +       +YLGL N ST      N
Sbjct: 68  VASFYTEFTFFL-----KITGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKN 122
Query: 135 HLFAVEFDTVQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAILV 194
            + AVEFDT  +  F             S+ S A+            +D  +  GK    
Sbjct: 123 QVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRW---------EDSDIFSGKIATA 173
Query: 195 WVDYDSAENILNVTVS-PNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG 244
            + YD +  IL V +S P+ S     ILS  VD+     E + VG SASTG
Sbjct: 174 RISYDGSAEILTVVLSYPDGSDY---ILSHSVDMRQNLPESVRVGISASTG 221

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 29  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 130
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 131 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-- 184
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 117/243 (48%), Gaps = 34/243 (13%)
Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQG 380
           +++G +   +Q +      +S  + +G GG  +V++  L+  K   A+K ++ E    Q 
Sbjct: 11  VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQT 69
Query: 381 VREFVSEIATIGRLRHRN--LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNW 438
           +  + +EIA + +L+  +  +++L  +      + +V +   N  L+S+L  + K++  W
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPW 127
Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL-DSELNGKLGDFGLAKLYEHGTN 497
           E++        + L  +H  ++  ++H D+K +N L+ D  L  KL DFG+A    +   
Sbjct: 128 ERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML--KLIDFGIA----NQMQ 177
Query: 498 PATTRV-----VGTLGYLAPETPRTGKSSASS-----------DVFAFGALLLEVACGRR 541
           P TT V     VGT+ Y+ PE  +   SS  +           DV++ G +L  +  G+ 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 542 PIE 544
           P +
Sbjct: 238 PFQ 240

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRL 394
           Q  + +  + L+G G +G V +      K  VA+K+I    E     +  + EIA + RL
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 395 RHRNLVQLVGWCRRKG----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK-IIKGVA 449
            H ++V+++     K     D L V   +A+      LF  P  V   E   K ++  + 
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK-LFRTP--VYLTELHIKTLLYNLL 166
Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN 497
            G+ Y+H      ++HRD+K +N L++ + + K+ DFGLA+  ++  N
Sbjct: 167 VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V +++A G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+L+D +   ++ DFG AK         T  + GT   LA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEALA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 321 WELEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN- 375
           + +EVG   ++    YQ LK           +G G  G V           VA+K++S  
Sbjct: 49  YSVEVGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 376 -ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSLDSFLFDEPK 433
            +++   +    E+  +  + H+N++ L+     +  L    D ++    +D+ L    +
Sbjct: 99  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+   
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 213
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
            GT+   T  V T  Y APE         + D+++ G ++ E+
Sbjct: 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 8/175 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VAVK++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L       L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 110 DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 166
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG 539
           DFGLA+     TN   T  V T  Y APE         + D+++ G ++ E+  G
Sbjct: 167 DFGLAR--TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 94/222 (42%), Gaps = 37/222 (16%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNL-VQLVGW 405
           LG G +G V K     S    AVKRI +  + Q  +  + ++    R       V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASGLLYLHEGY 459
             R+GD+ +  + + + SLD F     K V++  Q        KI   +   L +LH   
Sbjct: 102 LFREGDVWICXE-LXDTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGL--------AKLYEHGTNPATTRVVGTLGYLA 511
              VIHRDVK SNVL+++    K  DFG+        AK  + G  P          Y A
Sbjct: 157 S--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKP----------YXA 204
Query: 512 PE--TPRTGKS--SASSDVFAFGALLLEVACGRRPIETRALP 549
           PE   P   +   S  SD+++ G   +E+A  R P ++   P
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTP 246

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G +G V       +   VAVK++S   +S    +    E+  +  ++H N++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 406 ------CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
                      D+ LV   M    L++ +  + + + +   +F +I  +  GL Y+H   
Sbjct: 100 FTPARSLEEFNDVYLVTHLMG-ADLNNIV--KCQKLTDDHVQF-LIYQILRGLKYIHSA- 154
Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
              +IHRD+K SN+ ++ +   K+ DFGLA+     T+   T  V T  Y APE      
Sbjct: 155 --DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 208
Query: 520 S-SASSDVFAFGALLLEVACGR 540
             + + D+++ G ++ E+  GR
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGR 230

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 24  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 125
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 126 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-- 179
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ D+GLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 19/210 (9%)
Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS------EIATIGRL----RH 396
           LLG GGFG V+ G     + +VA+K I      G            E+A + ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
             +++L+ W   +   +LV +       D F +   K  L           V + + + H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQ-DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 457 EGYEQVVIHRDVKASNVLLDSELN-GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE-T 514
               + V+HRD+K  N+L+D      KL DFG   L     +   T   GT  Y  PE  
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFDGTRVYSPPEWI 210
Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRPIE 544
            R    +  + V++ G LL ++ CG  P E
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 20  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 121
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 122 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-- 175
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 321 WELEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN- 375
           + +EVG   ++    YQ LK           +G G  G V           VA+K++S  
Sbjct: 49  YSVEVGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 376 -ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSLDSFLFDEPK 433
            +++   +    E+  +  + H+N++ L+     +  L    D ++    +D+ L    +
Sbjct: 99  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+   
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 213
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
            GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+      V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACGR 540
           D+++ G ++ E+ C +
Sbjct: 207 DLWSVGCIMGEMVCHK 222

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 25  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 126
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 127 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T    T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACG 539
           D+++ G ++ E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 106 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 162
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 163 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 25  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 126
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 127 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T    T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 106 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 162
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 163 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 162 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 25  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 126
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 127 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T    T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 321 WELEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN- 375
           + +EVG   ++    YQ LK           +G G  G V           VA+K++S  
Sbjct: 12  YSVEVGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRP 61
Query: 376 -ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSLDSFLFDEPK 433
            +++   +    E+  +  + H+N++ L+     +  L    D ++    +D+ L    +
Sbjct: 62  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 121
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+   
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 176
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
            GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV+L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 153
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   ++ DFG AK         T  + GT  YLA
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLA 206
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACG 539
           D+++ G ++ E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 321 WELEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN- 375
           + +EVG   ++    YQ LK           +G G  G V           VA+K++S  
Sbjct: 11  YSVEVGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 376 -ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSLDSFLFDEPK 433
            +++   +    E+  +  + H+N++ L+     +  L    D ++    +D+ L    +
Sbjct: 61  FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ 120
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--T 175
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
            GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 169 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 113 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 169
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 170 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 93  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 149
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207
Query: 525 DVFAFGALLLEVACG 539
           D+++ G ++ E+  G
Sbjct: 208 DIWSVGCIMGEMIKG 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 321 WELEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN- 375
           + +EVG   ++    YQ LK           +G G  G V           VA+K++S  
Sbjct: 10  YSVEVGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRP 59
Query: 376 -ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSLDSFLFDEPK 433
            +++   +    E+  +  + H+N++ L+     +  L    D ++    +D+ L    +
Sbjct: 60  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 119
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+   
Sbjct: 120 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 174
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
            GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 175 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 321 WELEVGPQRYS----YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN- 375
           + +EVG   ++    YQ LK           +G G  G V           VA+K++S  
Sbjct: 11  YSVEVGDSTFTVLKRYQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 376 -ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSLDSFLFDEPK 433
            +++   +    E+  +  + H+N++ L+     +  L    D ++    +D+ L    +
Sbjct: 61  FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 120
Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 175
Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
            GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 169 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++     QG      
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNR 62
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 110
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 171 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 169 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             L +L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 154
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   K+ DFG AK         T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACG 539
           D+++ G ++ E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACG 539
           D+++ G ++ E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 41  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 142
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 143 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 196
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+      V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 197 --HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             L +L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQIVLT- 154
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   K+ DFG AK         T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+      V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 128/318 (40%), Gaps = 57/318 (17%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE------FVSE 387
           K   + +   + LG G  G+V       +  +VA++ IS    +    RE        +E
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           I  + +L H  ++++  +   + D  +V + M  G L    FD  K V N   +    K 
Sbjct: 205 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FD--KVVGNKRLKEATCKL 257
Query: 448 VASGLL----YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPAT 500
               +L    YLHE     +IHRD+K  NVLL S+      K+ DFG +K+   G     
Sbjct: 258 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 312
Query: 501 TRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPI-ETR---ALPEELV 553
             + GT  YLAPE   +  T   + + D ++ G +L     G  P  E R   +L +++ 
Sbjct: 313 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 372
Query: 554 -----LVDWVWGKYGEG-----RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDG 603
                 +  VW +  E      + L V+DPK                  + LR P   D 
Sbjct: 373 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK------------ARFTTEEALRHPWLQDE 420
Query: 604 DKAAEGFDDLLNSLASSS 621
           D     F DLL+    S+
Sbjct: 421 D-MKRKFQDLLSEENEST 437

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+      V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++     QG      
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNR 62
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P+ V    +
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PETVYRVAR 110
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 171 KQLVRG-EPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF---VSEIATIGRLRH 396
           + F   + LG G FG+V       +    A+K +  +    +++    ++E   +  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             L +L    +   +L +V ++   G + S L     F EP A      RF   + V + 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA------RFYAAQIVLT- 154
Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
             YLH      +I+RD+K  N+++D +   K+ DFG AK         T  + GT  YLA
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLA 207
Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           PE   +   + + D +A G L+ E+A G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 347 LLGHGGFGQVYK----GTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQL 402
           LLG G +G+V +     TL     ++  K+       G      EI  + RLRH+N++QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 403 VG--WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG------VASGLLY 454
           V   +   K  + +V ++   G +   L   P      E+RF + +       +  GL Y
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP------EKRFPVCQAHGYFCQLIDGLEY 124
Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPE 513
           LH    Q ++H+D+K  N+LL +    K+   G+A+ L+    +       G+  +  PE
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 514 TPRTGKSSASS---DVFAFGALLLEVACGRRPIE 544
               G  + S    D+++ G  L  +  G  P E
Sbjct: 182 I-ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 128/318 (40%), Gaps = 57/318 (17%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE------FVSE 387
           K   + +   + LG G  G+V       +  +VA+K IS    +    RE        +E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           I  + +L H  ++++  +   + D  +V + M  G L    FD  K V N   +    K 
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FD--KVVGNKRLKEATCKL 117
Query: 448 VASGLL----YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPAT 500
               +L    YLHE     +IHRD+K  NVLL S+      K+ DFG +K+   G     
Sbjct: 118 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 172
Query: 501 TRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPI-ETR---ALPEELV 553
             + GT  YLAPE   +  T   + + D ++ G +L     G  P  E R   +L +++ 
Sbjct: 173 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 232
Query: 554 -----LVDWVWGKYGEG-----RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDG 603
                 +  VW +  E      + L V+DPK                  + LR P   D 
Sbjct: 233 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK------------ARFTTEEALRHPWLQDE 280
Query: 604 DKAAEGFDDLLNSLASSS 621
           D     F DLL+    S+
Sbjct: 281 D-MKRKFQDLLSEENEST 297

>pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLT------NDTSRKMGQAFYSSTLRFKNSLNSNV 80
           FP F     NL  QG A+I+NN + +LT      N  +  +G+  +S+ +      +S V
Sbjct: 8   FPTFPSDQKNLIFQGDAQIKNNAV-QLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRV 66
Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLG-----LLNSTDIGNFSNH 135
            +F + F+  +       G  G+AF I+P +    +PS   G         T     +N 
Sbjct: 67  ANFQSQFSFSLKSPLSN-GADGIAFFIAPPD--TTIPSGSGGGLLGLFAPGTAQNTSANQ 123
Query: 136 LFAVEFDT--VQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAIL 193
           + AVEFDT   QD                S++S  +V+               + G+++ 
Sbjct: 124 VIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK------------WDRRDGQSLN 171
Query: 194 VWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVL 253
           V V ++ +   L+V V+  S   +  + S+ VD+  +  E++ VGFSA++G    +H + 
Sbjct: 172 VLVTFNPSTRNLDV-VATYSDGTRYEV-SYEVDVRSVLPEWVRVGFSAASGEQYQTHTLE 229
Query: 254 GWSF 257
            WSF
Sbjct: 230 SWSF 233

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 46/232 (19%)
Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++     QG      
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNR 62
Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
           E+  + +L H N+V+L  +    G+      L LV D++            P  V    +
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV------------PATVYRVAR 110
Query: 441 RFKIIKGVASGL---LYLHEGYEQV-------VIHRDVKASNVLLDSELNG-KLGDFGLA 489
            +   K     +   LY+++ +  +       + HRD+K  N+LLD +    KL DFG A
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS-DVFAFGALLLEVACGR 540
           K    G  P  + +     Y APE         SS DV++ G +L E+  G+
Sbjct: 171 KQLVRG-EPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 128/318 (40%), Gaps = 57/318 (17%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE------FVSE 387
           K   + +   + LG G  G+V       +  +VA+K IS    +    RE        +E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           I  + +L H  ++++  +   + D  +V + M  G L    FD  K V N   +    K 
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FD--KVVGNKRLKEATCKL 118
Query: 448 VASGLL----YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPAT 500
               +L    YLHE     +IHRD+K  NVLL S+      K+ DFG +K+   G     
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 173
Query: 501 TRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPI-ETR---ALPEELV 553
             + GT  YLAPE   +  T   + + D ++ G +L     G  P  E R   +L +++ 
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
Query: 554 -----LVDWVWGKYGEG-----RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDG 603
                 +  VW +  E      + L V+DPK                  + LR P   D 
Sbjct: 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK------------ARFTTEEALRHPWLQDE 281
Query: 604 DKAAEGFDDLLNSLASSS 621
           D     F DLL+    S+
Sbjct: 282 D-MKRKFQDLLSEENEST 298

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 128/318 (40%), Gaps = 57/318 (17%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE------FVSE 387
           K   + +   + LG G  G+V       +  +VA+K IS    +    RE        +E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           I  + +L H  ++++  +   + D  +V + M  G L    FD  K V N   +    K 
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FD--KVVGNKRLKEATCKL 118
Query: 448 VASGLL----YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPAT 500
               +L    YLHE     +IHRD+K  NVLL S+      K+ DFG +K+   G     
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 173
Query: 501 TRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPI-ETR---ALPEELV 553
             + GT  YLAPE   +  T   + + D ++ G +L     G  P  E R   +L +++ 
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
Query: 554 -----LVDWVWGKYGEG-----RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDG 603
                 +  VW +  E      + L V+DPK                  + LR P   D 
Sbjct: 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK------------ARFTTEEALRHPWLQDE 281
Query: 604 DKAAEGFDDLLNSLASSS 621
           D     F DLL+    S+
Sbjct: 282 D-MKRKFQDLLSEENEST 298

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 128/318 (40%), Gaps = 57/318 (17%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE------FVSE 387
           K   + +   + LG G  G+V       +  +VA+K IS    +    RE        +E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           I  + +L H  ++++  +   + D  +V + M  G L    FD  K V N   +    K 
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FD--KVVGNKRLKEATCKL 118
Query: 448 VASGLL----YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPAT 500
               +L    YLHE     +IHRD+K  NVLL S+      K+ DFG +K+   G     
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 173
Query: 501 TRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPI-ETR---ALPEELV 553
             + GT  YLAPE   +  T   + + D ++ G +L     G  P  E R   +L +++ 
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
Query: 554 -----LVDWVWGKYGEG-----RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDG 603
                 +  VW +  E      + L V+DPK                  + LR P   D 
Sbjct: 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK------------ARFTTEEALRHPWLQDE 281
Query: 604 DKAAEGFDDLLNSLASSS 621
           D     F DLL+    S+
Sbjct: 282 D-MKRKFQDLLSEENEST 298

>pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLT------NDTSRKMGQAFYSSTLRFKNSLNSNV 80
           FP F     NL  QG A+I+NN + +LT      N  +  +G+  +S+ +      +S V
Sbjct: 8   FPTFPSDQKNLIFQGDAQIKNNAV-QLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRV 66
Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLG-----LLNSTDIGNFSNH 135
            +F + F+  +       G  G+AF I+P +    +PS   G         T     +N 
Sbjct: 67  ANFQSQFSFSLKSPLSN-GADGIAFFIAPPD--TTIPSGSGGGLLGLFAPGTAQNTSANQ 123
Query: 136 LFAVEFDT--VQDFEFQXXXXXXXXXXXXSMKSNASVEAAVYTDNSTKQDLSLKGGKAIL 193
           + AVEFDT   QD                S++S  +V+               + G+++ 
Sbjct: 124 VIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK------------WDRRDGQSLN 171
Query: 194 VWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVL 253
           V V ++ +   L+V V+  S   +  + S+ VD+  +  E++ VGFSA++G    +H + 
Sbjct: 172 VLVTFNPSTRNLDV-VATYSDGTRYEV-SYEVDVRSVLPEWVRVGFSAASGEQYQTHTLE 229
Query: 254 GWSF 257
            WSF
Sbjct: 230 SWSF 233

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 337 QATNNFSAKQLLGHGGFGQVYKGTLHN-SKTEVAVKRISNESKQGVREFVSEIATIGRL- 394
           Q T+ +  K+ +G G +  V K  +H  +  E AVK I ++SK   R+   EI  + R  
Sbjct: 19  QFTDGYEVKEDIGVGSYS-VCKRCIHKATNMEFAVK-IIDKSK---RDPTEEIEILLRYG 73
Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSL-DSFLFD------EPKAVLNWEQRFKIIKG 447
           +H N++ L         + +V + M  G L D  L        E  AVL     F I K 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKT 128
Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPATTRV 503
           V     YLH    Q V+HRD+K SN+L   E       ++ DFG AK      N      
Sbjct: 129 VE----YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTP 180
Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA--LPEELV 553
             T  ++APE        A+ D+++ G LL  +  G  P        PEE++
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 20/222 (9%)
Query: 327 PQRYSY-QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV 385
           P  Y Y +E+  AT+       LG G FG+V++     +  + AVK++  E  +      
Sbjct: 64  PVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----A 114
Query: 386 SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
            E+     L    +V L G  R    + +  + +  GSL   + ++    L  ++    +
Sbjct: 115 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYL 172
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEH---GTNPATT 501
                GL YLH    + ++H DVKA NVLL S+  +  L DFG A   +    G +  T 
Sbjct: 173 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 502 RVV-GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             + GT  ++APE        A  DV++   ++L +  G  P
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 14  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 58
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 59  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 115
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 116 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 169
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+      V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 170 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KS 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGL +  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 346 QLLGHGGFGQV-YKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLV 403
           Q LG GGF  V     LH+     A+KRI    +Q  RE     A + RL  H N+++LV
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHF-YALKRILCHEQQD-REEAQREADMHRLFNHPNILRLV 92
Query: 404 GWCRR----KGDLLLVYDFMANGSLDSFL--FDEPKAVLNWEQRFKIIKGVASGLLYLH- 456
            +C R    K +  L+  F   G+L + +    +    L  +Q   ++ G+  GL  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFG---LAKLYEHGTNPATT-----RVVGTLG 508
           +GY     HRD+K +N+LL  E    L D G    A ++  G+  A T         T+ 
Sbjct: 153 KGYA----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 509 YLAPETPRTGKSSA---SSDVFAFGALLLEVACGRRPIE 544
           Y APE             +DV++ G +L  +  G  P +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 169 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 130/318 (40%), Gaps = 57/318 (17%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE------FVSE 387
           K   + +   + LG G  G+V       +  +VA+K IS    +    RE        +E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           I  + +L H  ++++  +   + D  +V + M  G L    FD  K V N   +    K 
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FD--KVVGNKRLKEATCKL 124
Query: 448 VASGLL----YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPAT 500
               +L    YLHE     +IHRD+K  NVLL S+      K+ DFG +K+   G     
Sbjct: 125 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 179
Query: 501 TRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPI-ETR---ALPEELV 553
             + GT  YLAPE   +  T   + + D ++ G +L     G  P  E R   +L +++ 
Sbjct: 180 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 239
Query: 554 -----LVDWVWGKYGEG-----RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDG 603
                 +  VW +  E      + L V+DPK     +++            LR P   D 
Sbjct: 240 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA------------LRHPWLQDE 287
Query: 604 DKAAEGFDDLLNSLASSS 621
           D     F DLL+    S+
Sbjct: 288 D-MKRKFQDLLSEENEST 304

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACG 539
           D+++ G ++ E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVGWC 406
           +G G FG         S   VAVK I  E  + + E V  EI     LRH N+V+     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 407 RRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
                L +V ++ + G L     ++  F E +A   ++Q       + SG+ Y H     
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYCHA---M 134
Query: 462 VVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-PRTG 518
            V HRD+K  N LLD       K+  FG +K     + P +T  VGT  Y+APE   +  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 192
Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEE 551
                +DV++ G  L  +  G  P E    PEE
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFED---PEE 222

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 38  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 139
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  
Sbjct: 140 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 193
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+      V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 194 --HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 368 VAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD-FMANGSL 424
           VA+K++S   +++   +    E+  +  + H+N++ L+     +  L    D ++    +
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
           D+ L    +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ 
Sbjct: 105 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 161
Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVA 537
           DFGLA+    GT+   T  V T  Y APE         + D+++ G ++ E+ 
Sbjct: 162 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVGWC 406
           +G G FG         +   VAVK I  E  + + E V  EI     LRH N+V+     
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 407 RRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
                L +V ++ + G L     ++  F E +A   ++Q       + SG+ Y H     
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ-------LISGVSYAHA---M 134
Query: 462 VVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-PRTG 518
            V HRD+K  N LLD       K+ DFG +K     + P +   VGT  Y+APE   +  
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGTPAYIAPEVLLKKE 192
Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEE 551
                +DV++ G  L  +  G  P E    PEE
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFED---PEE 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G  G V        +  VA+K++S   +++   +    E+  +  + H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 406 CRRKGDLLLVYD-FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +  L    D ++    +D+ L    +  L+ E+   ++  +  G+ +LH      +I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS 524
           HRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y APE         + 
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 525 DVFAFGALLLEVACG 539
           D+++ G ++ E+  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 103/246 (41%), Gaps = 25/246 (10%)
Query: 23  DELFFPGFKDLSNN---LTLQGIAKIENNGILRL----TNDTSRKMGQAFYSSTLRFKNS 75
           D+L F  FK+ S N   L+ QG A +   G+L+L     N      G A Y + +   N 
Sbjct: 2   DDLSFK-FKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60
Query: 76  LNSNVFSFSTSFAIVI-VPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSN 134
               + SF TSF+  +     P+    GL F ++P +        Y GL N T   + S 
Sbjct: 61  NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDS-SY 119
Query: 135 HLFAVEFDTV-QDFEFQXXXXXXXXXXXXSMKS-NASVEAAVYTDNSTKQDLSLKGGKAI 192
              AVEFDT+     F              +KS NA      Y  N+             
Sbjct: 120 QTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVAN---------- 169
Query: 193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL-LASSHN 251
            V + Y+++   L  +++  S +  I + S  VDL  I  E++ VGFS ST +   ++H 
Sbjct: 170 -VEIIYEASSKTLTASLTYPSDQTSISVTSI-VDLKEILPEWVSVGFSGSTYIGRQATHE 227
Query: 252 VLGWSF 257
           VL W F
Sbjct: 228 VLNWYF 233

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 34/224 (15%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRN- 398
           +S  + +G GG  +V++  L+  K   A+K ++ E    Q +  + +EIA + +L+  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 399 -LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
            +++L  +      + +V +   N  L+S+L  + K++  WE++        + L  +H 
Sbjct: 73  KIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERK----SYWKNMLEAVHT 126
Query: 458 GYEQVVIHRDVKASNVLL-DSELNGKLGDFGLAKLYEHGTNPATTRV-----VGTLGYLA 511
            ++  ++H D+K +N L+ D  L  KL DFG+A    +   P TT V     VGT+ Y+ 
Sbjct: 127 IHQHGIVHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMP 180
Query: 512 PETPRTGKSSASS-----------DVFAFGALLLEVACGRRPIE 544
           PE  +   SS  +           DV++ G +L  +  G+ P +
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 126/313 (40%), Gaps = 57/313 (18%)
Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE------FVSE 387
           K   + +   + LG G  G+V       +  +VA++ IS    +    RE        +E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 388 IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG 447
           I  + +L H  ++++  +   + D  +V + M  G L    FD  K V N   +    K 
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FD--KVVGNKRLKEATCKL 243
Query: 448 VASGLL----YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPAT 500
               +L    YLHE     +IHRD+K  NVLL S+      K+ DFG +K+   G     
Sbjct: 244 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLM 298
Query: 501 TRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPI-ETR---ALPEELV 553
             + GT  YLAPE   +  T   + + D ++ G +L     G  P  E R   +L +++ 
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
Query: 554 -----LVDWVWGKYGEG-----RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDG 603
                 +  VW +  E      + L V+DPK                  + LR P   D 
Sbjct: 359 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK------------ARFTTEEALRHPWLQDE 406
Query: 604 DKAAEGFDDLLNS 616
           D     F DLL+ 
Sbjct: 407 D-MKRKFQDLLSE 418

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 9/137 (6%)
Query: 409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDV 468
           K  LL++ + M  G L S + +         +  +I++ + + + +LH      + HRDV
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDV 135
Query: 469 KASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           K  N+L  S+      KL DFG AK     T  A      T  Y+APE     K   S D
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 192
Query: 526 VFAFGALLLEVACGRRP 542
           +++ G ++  + CG  P
Sbjct: 193 MWSLGVIMYILLCGFPP 209

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 9/137 (6%)
Query: 409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDV 468
           K  LL++ + M  G L S + +         +  +I++ + + + +LH      + HRDV
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDV 154
Query: 469 KASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           K  N+L  S+      KL DFG AK     T  A      T  Y+APE     K   S D
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 526 VFAFGALLLEVACGRRP 542
           +++ G ++  + CG  P
Sbjct: 212 MWSLGVIMYILLCGFPP 228

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 20/222 (9%)
Query: 327 PQRYSY-QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV 385
           P  Y Y +E+  AT+       LG G FG+V++     +  + AVK++  E  +      
Sbjct: 83  PVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----A 133
Query: 386 SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
            E+     L    +V L G  R    + +  + +  GSL   + ++    L  ++    +
Sbjct: 134 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYL 191
Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEH---GTNPATT 501
                GL YLH    + ++H DVKA NVLL S+  +  L DFG A   +    G +  T 
Sbjct: 192 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 502 RVV-GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             + GT  ++APE        A  DV++   ++L +  G  P
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 8/134 (5%)
Query: 412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS 471
           LL+V + +  G L S + D         +  +I K +   + YLH      + HRDVK  
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN---IAHRDVKPE 190
Query: 472 NVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFA 528
           N+L  S+      KL DFG AK  E  ++ + T    T  Y+APE     K   S D ++
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 529 FGALLLEVACGRRP 542
            G +   + CG  P
Sbjct: 249 LGVIXYILLCGYPP 262

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 25/226 (11%)
Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
           ++ +  K+ +G G + +  +     +  E AVK I ++SK+   E +  +   G+  H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI-DKSKRDPSEEIEILLRYGQ--HPN 82
Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSL-DSFL----FDEPKAVLNWEQRFKIIKGVASGLL 453
           ++ L         + LV + M  G L D  L    F E +A         ++  +   + 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-------VLHTIGKTVE 135
Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           YLH    Q V+HRD+K SN+L   E       ++ DFG AK      N        T  +
Sbjct: 136 YLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-AENGLLMTPCYTANF 191
Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET--RALPEELV 553
           +APE  +        D+++ G LL  +  G  P        PEE++
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 34/224 (15%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRN- 398
           +S  + +G GG  +V++  L+  K   A+K ++ E    Q +  + +EIA + +L+  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 399 -LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
            +++L  +      + +V +   N  L+S+L  + K++  WE++        + L  +H 
Sbjct: 70  KIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERK----SYWKNMLEAVHT 123
Query: 458 GYEQVVIHRDVKASNVLL-DSELNGKLGDFGLAKLYEHGTNPATTRV-----VGTLGYLA 511
            ++  ++H D+K +N L+ D  L  KL DFG+A    +   P TT V     VGT+ Y+ 
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMP 177
Query: 512 PETPRTGKSSASS-----------DVFAFGALLLEVACGRRPIE 544
           PE  +   SS  +           DV++ G +L  +  G+ P +
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 34/224 (15%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRN- 398
           +S  + +G GG  +V++  L+  K   A+K ++ E    Q +  + +EIA + +L+  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 399 -LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
            +++L  +      + +V +   N  L+S+L  + K++  WE++        + L  +H 
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERK----SYWKNMLEAVHT 170
Query: 458 GYEQVVIHRDVKASNVLL-DSELNGKLGDFGLAKLYEHGTNPATTRV-----VGTLGYLA 511
            ++  ++H D+K +N L+ D  L  KL DFG+A    +   P TT V     VGT+ Y+ 
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMP 224
Query: 512 PETPRTGKSSASS-----------DVFAFGALLLEVACGRRPIE 544
           PE  +   SS  +           DV++ G +L  +  G+ P +
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 321 WELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESK 378
           WE+   P+RY          N S    +G G +G V       +   VAVK++S   +S 
Sbjct: 18  WEV---PERY---------QNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGW------CRRKGDLLLVYDFMANGSLDSFLFDEP 432
              +    E+  +  ++H N++ L+             D+ LV   M    L++ +  + 
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV--KC 119
Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           + + +   +F +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DF LA+  
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLAR-- 173
Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGR 540
              T+   T  V T  Y APE        + + D+++ G ++ E+  GR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 27/186 (14%)
Query: 341 NFSAKQLLGHGGFGQ-VYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR---- 395
           +F  K +LGHG  G  VY+G   N   +VAVKRI  E       F      +  LR    
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNR--DVAVKRILPEC------FSFADREVQLLRESDE 76
Query: 396 HRNLVQLVGWCRRKG-DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           H N+++   +C  K      +   +   +L  ++  +  A L  E    +++   SGL +
Sbjct: 77  HPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAH 133
Query: 455 LHEGYEQVVIHRDVKASNVLL-----DSELNGKLGDFGLAKLYEHGTNPATTR--VVGTL 507
           LH      ++HRD+K  N+L+       ++   + DFGL K    G +  + R  V GT 
Sbjct: 134 LHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 508 GYLAPE 513
           G++APE
Sbjct: 191 GWIAPE 196

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 34/224 (15%)
Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRN- 398
           +S  + +G GG  +V++  L+  K   A+K ++ E    Q +  + +EIA + +L+  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 399 -LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
            +++L  +      + +V +   N  L+S+L  + K++  WE++        + L  +H 
Sbjct: 69  KIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERK----SYWKNMLEAVHT 122
Query: 458 GYEQVVIHRDVKASNVLL-DSELNGKLGDFGLAKLYEHGTNPATTRV-----VGTLGYLA 511
            ++  ++H D+K +N L+ D  L  KL DFG+A    +   P TT V     VGT+ Y+ 
Sbjct: 123 IHQHGIVHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMP 176
Query: 512 PETPRTGKSSASS-----------DVFAFGALLLEVACGRRPIE 544
           PE  +   SS  +           DV++ G +L  +  G+ P +
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	652
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-128
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-114
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-111
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-77
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	1e-66
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	2e-65
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	5e-65
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	2e-64
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	7e-63
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	1e-62
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	1e-61
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	2e-61
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	2e-61
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	2e-61
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	9e-61
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	1e-60
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	2e-60
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	5e-60
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-59
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	7e-59
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	1e-58
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	1e-57
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	2e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-56
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	6e-56
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	7e-56
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	6e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-54
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	1e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-51
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	5e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-48
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-43
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-38
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	1e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-34
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	4e-34
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	6e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-25
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-11
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	4e-11
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	8e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  379 bits (975), Expect = e-128
 Identities = 120/273 (43%), Positives = 173/273 (63%), Gaps = 7/273 (2%)

Query: 319 EDWELEVG-PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES 377
           ED E+ +G  +R+S +EL+ A++NFS K +LG GGFG+VYKG L +  T VAVKR+  E 
Sbjct: 8   EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEER 66

Query: 378 KQGV-REFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKA-- 434
            QG   +F +E+  I    HRNL++L G+C    + LLVY +MANGS+ S L + P++  
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126

Query: 435 VLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH 494
            L+W +R +I  G A GL YLH+  +  +IHRDVKA+N+LLD E    +GDFGLAKL ++
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE--L 552
                TT V GT+G++APE   TGKSS  +DVF +G +LLE+  G+R  +   L  +  +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVL 585
           +L+DWV G   E ++  ++D  L   Y   +V 
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVE 279

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  345 bits (887), Expect = e-114
 Identities = 104/265 (39%), Positives = 154/265 (58%), Gaps = 7/265 (2%)

Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK 378
             + +     R    +L++ATNNF  K L+GHG FG+VYKG L +   +VA+KR + ES 
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESS 76

Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF--DEPKAVL 436
           QG+ EF +EI T+   RH +LV L+G+C  + +++L+Y +M NG+L   L+  D P   +
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY-EHG 495
           +WEQR +I  G A GL YLH      +IHRDVK+ N+LLD     K+ DFG++K   E  
Sbjct: 137 SWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193

Query: 496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
               +T V GTLGY+ PE    G+ +  SDV++FG +L EV C R  I      E + L 
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

Query: 556 DWVWGKYGEGRVLEVIDPKLNAEYD 580
           +W    +  G++ +++DP L  +  
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIR 278

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  337 bits (866), Expect = e-111
 Identities = 103/283 (36%), Positives = 155/283 (54%), Gaps = 25/283 (8%)

Query: 319 EDWELEV---GPQRYSYQELKQATNNFSAKQ------LLGHGGFGQVYKGTLHNSKTEVA 369
           E+  LEV       +S+ ELK  TNNF  +        +G GGFG VYKG ++N  T VA
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58

Query: 370 VKRISN----ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLD 425
           VK+++      +++  ++F  EI  + + +H NLV+L+G+     DL LVY +M NGSL 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118

Query: 426 SFLFDEPK-AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
             L        L+W  R KI +G A+G+ +LH   E   IHRD+K++N+LLD     K+ 
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKIS 175

Query: 485 DFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
           DFGLA+  E       T+R+VGT  Y+APE    G+ +  SD+++FG +LLE+  G   +
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234

Query: 544 ETRALPEELVLVDWVWGKYGEGRVLE-VIDPKLNAEYDQSQVL 585
           +     E  +L+D       E + +E  ID K+N + D + V 
Sbjct: 235 DEH--REPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVE 274

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  247 bits (632), Expect = 9e-77
 Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 30/283 (10%)

Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
             + L   +      ++   G FG V+K  L N    VAVK    + KQ   +   E+ +
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 391 IGRLRHRNLVQLVGWCRR----KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIK 446
           +  ++H N++Q +G  +R      DL L+  F   GSL  FL       ++W +   I +
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128

Query: 447 GVASGLLYLHE-------GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA 499
            +A GL YLHE       G++  + HRD+K+ NVLL + L   + DFGLA  +E G +  
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 500 -TTRVVGTLGYLAPE-----TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
            T   VGT  Y+APE           +    D++A G +L E+A      +       L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 554 LVDWVWGKYGEGRVLEVI-----DPKLNAEYDQSQVL--MGEL 589
             + +        + EV+      P L   + +   +  + E 
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  218 bits (555), Expect = 1e-66
 Identities = 84/254 (33%), Positives = 117/254 (46%), Gaps = 23/254 (9%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRK------MGQAFYSSTLRFKNSLNSNV 80
           F  FK L  NL LQG A +   G+L+LTN           +G+A YS+ +   +S    V
Sbjct: 8   FSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLV 67

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+TSF   I          GLAF ++P          +LGL +S   G+ +    AVE
Sbjct: 68  ASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGS-TYQTVAVE 126

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT ++  F D    HIG D+NS+ S  +V              SL  G+A  V + Y+S
Sbjct: 127 FDTYENTVFTDPPYTHIGFDVNSISSIKTV------------KWSLANGEAAKVLITYNS 174

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSF 257
           A  +L  ++    S     IL+  VDLS +  E++ VGFSA+TG       +H+V  WSF
Sbjct: 175 AVKLLVASLVYP-SSKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSF 233

Query: 258 KINGPARALDLSSL 271
                      SS 
Sbjct: 234 ASKLAGXXTKDSSF 247

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  214 bits (545), Expect = 2e-65
 Identities = 72/245 (29%), Positives = 119/245 (48%), Gaps = 23/245 (9%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND-----TSRKMGQAFYSSTLRFKNSLNSNVF 81
           FP F      L  QG A + + G+L+LTN      +S+ +G+A Y++  +  +S   NV 
Sbjct: 8   FPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVA 67

Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           SF TSF  +I    P     GLAF ++P +         LG+       N SN + AVEF
Sbjct: 68  SFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGY-FNKSNQIVAVEF 126

Query: 142 DTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSA 201
           DT  + ++ D    H+GI++NS++S  +V              +   G+   V++ Y+++
Sbjct: 127 DTFSNGDW-DPKGRHLGINVNSIESIKTV------------PWNWTNGEVANVFISYEAS 173

Query: 202 ENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFK 258
              L  ++    S     I+   VD+  +  E++  GFSA+TG+      +++VL WSF+
Sbjct: 174 TKSLTASLVYP-SLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFE 232

Query: 259 INGPA 263
            N P 
Sbjct: 233 SNLPG 237

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  213 bits (544), Expect = 5e-65
 Identities = 73/259 (28%), Positives = 112/259 (43%), Gaps = 22/259 (8%)

Query: 27  FPGFK-DLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSN 79
           FP F  D+ +++  QG A     G L+L              G+A YS  ++  ++   +
Sbjct: 9   FPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTES 67

Query: 80  VFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFS-NHLFA 138
           V SF T F   +          GLAF ++P +       +YLGL N +     S N + A
Sbjct: 68  VASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVA 126

Query: 139 VEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDY 198
           VEFDT  +  F + +  HIGI++NS+ S A+            +D  +  GK     + Y
Sbjct: 127 VEFDTWTNPNFPEPSYRHIGINVNSIVSVAT---------KRWEDSDIFSGKIATARISY 177

Query: 199 DSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLAS-SHNVLGWSF 257
           D +  IL V +S         ILS  VD+     E + VG SASTG     +  +L W F
Sbjct: 178 DGSAEILTVVLSY--PDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRF 235

Query: 258 KINGPARALDLSSLPSLPG 276
             N  + ++  +  P +  
Sbjct: 236 SSNLQSTSVKAAMEPEITR 254

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  211 bits (539), Expect = 2e-64
 Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 17/233 (7%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS-RKMGQAFYSSTLRFKNSLNSNVFSFST 85
           F  F + +  +  QG   + +NG ++LTN      +G+  Y+  +R  +S   NV SF T
Sbjct: 8   FNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLT 67

Query: 86  SFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQ 145
           SF+  +          G+ F I+P +      S   G L  +D    + H   VEFDT  
Sbjct: 68  SFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSD-TKGAGHFVGVEFDTYS 126

Query: 146 DFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENIL 205
           + E+ D   +H+GID+NS+ S  +V              +   G  + V V YDS+   L
Sbjct: 127 NSEYNDPPTDHVGIDVNSVDSVKTV------------PWNSVSGAVVKVTVIYDSSTKTL 174

Query: 206 NVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASS-HNVLGWSF 257
           +V V+       I  ++  VDL     E +  GFSAS  L     H +  WSF
Sbjct: 175 SVAVTN--DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  207 bits (528), Expect = 7e-63
 Identities = 69/241 (28%), Positives = 108/241 (44%), Gaps = 20/241 (8%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND--TSRKMGQAFYSSTLRFKNSLNSNVFSFS 84
           +  FKD   +L  QG AKI  +G L +  D   +R    A Y++ +   +S   NV SF 
Sbjct: 5   YTRFKD-DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASFI 63

Query: 85  TSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTV 144
           TSF+ ++          G+ F ++P       P+   G L  TD  N  N   AVEFD+ 
Sbjct: 64  TSFSFIVSNVQRYPPTDGVVFFLAPWGT-EIPPNSQGGYLGITDSSNSQNQFVAVEFDSH 122

Query: 145 QD-FEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAEN 203
            + ++ + +  +HIGID+NS+ S  +V            + +   G      + YDS   
Sbjct: 123 PNVWDPKSLRSSHIGIDVNSIMSLKAV------------NWNRVSGSLEKATIIYDSDTK 170

Query: 204 ILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSAST-GLLASSHNVLGWSFKINGP 262
           IL V ++      +I  +S  +DL  +  E + VGFSA+T       H++  WSF     
Sbjct: 171 ILTVVMTHQ--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSFTSTLK 228

Query: 263 A 263
            
Sbjct: 229 E 229

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  206 bits (526), Expect = 1e-62
 Identities = 71/239 (29%), Positives = 107/239 (44%), Gaps = 19/239 (7%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTS 86
              F     NL  QG         L LT      +G+A YSS +   +    NV +F TS
Sbjct: 8   ITKFSPDQQNLIFQGDGYT-TKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTS 66

Query: 87  FAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQD 146
           F  VI          G  F I+P +        YLG+ NS +  + +    AVEFDT  +
Sbjct: 67  FTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAE-YDKTTQTVAVEFDTFYN 125

Query: 147 FEFQDIN-DNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENIL 205
             +   N D HIGID+NS+KS  +                L+ G+   V + +++A N+L
Sbjct: 126 AAWDPSNRDRHIGIDVNSIKSVNTK------------SWKLQNGEEANVVIAFNAATNVL 173

Query: 206 NVTVSPNSS----KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKIN 260
            V+++  ++    +     LS  V L  +  E++ +GFSA+TG   ++H VL WSF   
Sbjct: 174 TVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 232

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  204 bits (520), Expect = 1e-61
 Identities = 75/246 (30%), Positives = 114/246 (46%), Gaps = 25/246 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG A I  +G+L+LT             G+  Y+  +   +S    V
Sbjct: 8   FSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTV 67

Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S    AV
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDN-SYQTLAV 126

Query: 140 EFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  +  +      HIGID+NS++S  +            Q   L  G+   V + YD
Sbjct: 127 EFDTFSNP-WDPPQVPHIGIDVNSIRSIKT------------QPFQLDNGQVANVVIKYD 173

Query: 200 SAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWS 256
           +   IL+V +    S   I  ++  VD+  +  +++ VG S +TG     A +H+V  WS
Sbjct: 174 APSKILHVVLVYP-SSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWS 232

Query: 257 FKINGP 262
           F+ + P
Sbjct: 233 FQASLP 238

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  203 bits (518), Expect = 2e-61
 Identities = 78/250 (31%), Positives = 110/250 (44%), Gaps = 32/250 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND-----TSRKMGQAFYSSTLRFKNSLNSNVF 81
           F  F      L LQ  A+I +N +L LT       T    G+A Y+  ++  +S   NV 
Sbjct: 8   FNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA 67

Query: 82  SFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
           SF T F+  I   +PR     GL F I+P N   G    Y G+ N            AVE
Sbjct: 68  SFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLS----PYPFVAVE 123

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT ++    D    HIGID+NS+ S  +V              +L  G    V + YD+
Sbjct: 124 FDTFRNTW--DPQIPHIGIDVNSVISTKTV------------PFTLDNGGIANVVIKYDA 169

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG-------LLASSHNVL 253
           +  IL+V +    S   I  ++  VDL  +  E + VGFSA+TG           +H++L
Sbjct: 170 STKILHVVLVF-PSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDIL 228

Query: 254 GWSFKINGPA 263
            WSF  + P 
Sbjct: 229 SWSFSASLPG 238

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  204 bits (519), Expect = 2e-61
 Identities = 72/254 (28%), Positives = 117/254 (46%), Gaps = 26/254 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           +  F     N+ LQG A + ++G L+L             +G+A YS+ +   +    +V
Sbjct: 8   WNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSV 67

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+ SF         +    GLAF ++P +      + YLGL N        + + AVE
Sbjct: 68  ASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN---ESGDQVVAVE 124

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT ++    D  + HIGI++NS++S  +                L   K   V + YD+
Sbjct: 125 FDTFRNSW--DPPNPHIGINVNSIRSIKTT------------SWDLANNKVAKVLITYDA 170

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG--LLASSHNVLGWSFK 258
           + ++L  ++    S+    ILS  VDL     E++ +GFSA+TG  +   SH+VL WSF 
Sbjct: 171 STSLLVASLVY-PSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFA 229

Query: 259 INGPARALDLSSLP 272
            N P  + ++  L 
Sbjct: 230 SNLPHASSNIDPLD 243

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  204 bits (519), Expect = 2e-61
 Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 24/257 (9%)

Query: 12  IFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAF 65
           + L+   S+      F  F     NL  QG A    N IL+LT   S        +G+  
Sbjct: 1   MLLNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRIL 60

Query: 66  YSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL-NGLPSQYLGLL 124
           +S+ +R      + V +  T F+  +             F   P   + +G     LGL 
Sbjct: 61  HSAQVRLWEKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLF 120

Query: 125 NSTDIGNFS-NHLFAVEFDTV--QDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTK 181
           N     N S N + AVEFDT   Q+    D N  HIGID+NS++S+  V           
Sbjct: 121 NPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVV----------- 169

Query: 182 QDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSA 241
                + GK + V V Y+ +   ++V  +      +   LS  VDL+ I  E++ VGFSA
Sbjct: 170 -RWERREGKTLNVLVTYNPSTRTIDVVATYP--DGQRYQLSHVVDLTTILPEWVRVGFSA 226

Query: 242 STGLLASSHNVLGWSFK 258
           ++G    +HN+  WSF 
Sbjct: 227 ASGEQFQTHNLESWSFT 243

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  202 bits (514), Expect = 9e-61
 Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 19/239 (7%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLT----NDTSRKMGQAFYSSTLRFKNSLNSNVFS 82
           F  F     +L+ QG A +   G+L+L     N      G A Y + +   N     + S
Sbjct: 8   FKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELAS 67

Query: 83  FSTSFAIVIV-PEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           F TSF+  +     P+    GL F ++P +        Y GL N T   + S    AVEF
Sbjct: 68  FITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTK-CDSSYQTVAVEF 126

Query: 142 DTVQDF-EFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           DT+     F D    HIGID+N +KS  +             +          V + Y++
Sbjct: 127 DTIGSPVNFWDPGFPHIGIDVNCVKSINAERW----------NKRYGLNNVANVEIIYEA 176

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL-LASSHNVLGWSFK 258
           +   L  +++   S      ++  VDL  I  E++ VGFS ST +   ++H VL W F 
Sbjct: 177 SSKTLTASLTY-PSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFT 234

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  201 bits (513), Expect = 1e-60
 Identities = 73/248 (29%), Positives = 117/248 (47%), Gaps = 22/248 (8%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLT------NDTSRKMGQAFYSSTLRFKNSLNSNV 80
           F  F+    +L  QG A + +N  L+LT      N     +G+A Y++ +R   S +S V
Sbjct: 8   FTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLV 66

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNG-LPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T+F   I             F  SP   +      + LGL  S++     N + +V
Sbjct: 67  ASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSV 126

Query: 140 EFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  + +  D N  HIGID+NS++S A+                 + GK     + Y+
Sbjct: 127 EFDTYPNTDIGDPNYRHIGIDVNSIRSKAA------------SKWDWQNGKTATAHISYN 174

Query: 200 SAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKI 259
           SA   L+V  S  +S P   ++SF V+L+ +  +++ VGFSA+TG    ++N+L WSF+ 
Sbjct: 175 SASKRLSVVSSYPNSSP--VVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRS 232

Query: 260 NGPARALD 267
           +      +
Sbjct: 233 SLMGYQAN 240

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  201 bits (512), Expect = 2e-60
 Identities = 79/258 (30%), Positives = 123/258 (47%), Gaps = 32/258 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNV 80
           F  F     NL LQ  A + ++G LRLTN           +G+AFYS+ ++  ++    V
Sbjct: 8   FQRFN--ETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTV 65

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+TSF   I          GLAF + P          +LGL +     N + H  AVE
Sbjct: 66  ASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDG---SNSNFHTVAVE 122

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT+ + ++ D  + HIGID+NS++S  +                   G+   V + YDS
Sbjct: 123 FDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW------------DFVNGENAEVLITYDS 169

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSF 257
           + N+L  ++    S+    I+S  VDL  +  E++ VGFSA+TG+      +++VL WSF
Sbjct: 170 STNLLVASLVY-PSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

Query: 258 KIN----GPARALDLSSL 271
                    +  L+L++L
Sbjct: 229 ASKLSDETTSEGLNLANL 246

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  200 bits (510), Expect = 5e-60
 Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 31/258 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND------TSRKMGQAFYSSTLRFKNSLNSNV 80
           F  F   S++  LQG A + ++  LRLT        T   +G+AFYSS ++  +     V
Sbjct: 8   FKNFN--SSSFILQGDATVSSSK-LRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAV 64

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            S++TSF   I          G+AF + P        S +LG+ +S    N S    AVE
Sbjct: 65  ASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDN-SAQTVAVE 123

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT  + ++ D    HIGID+NS+KS  +                L  G+   + + Y++
Sbjct: 124 FDTFSNTDW-DPTSRHIGIDVNSIKSIRTA------------SWGLANGQNAEILITYNA 170

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSF 257
           A ++L  ++    S+    I+S RVD++    E++ +GFSA+TGL      +H+VL WSF
Sbjct: 171 ATSLLVASLVH-PSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229

Query: 258 KIN----GPARALDLSSL 271
                       LD++S 
Sbjct: 230 ASKLPDDSTTEPLDIASY 247

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  201 bits (512), Expect = 3e-59
 Identities = 61/256 (23%), Positives = 99/256 (38%), Gaps = 33/256 (12%)

Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT 390
           +  E     +N    +L+G G +G VYKG+L      VAVK  S  ++Q        I  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQNFINEK-NIYR 60

Query: 391 IGRLRHRNLVQLVGWCRRKGD-----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
           +  + H N+ + +    R         LLV ++  NGSL  +L        +W    ++ 
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLA 117

Query: 446 KGVASGLLYLHE------GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT--- 496
             V  GL YLH        Y+  + HRD+ + NVL+ ++    + DFGL+          
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 497 ----NPATTRVVGTLGYLAPE-------TPRTGKSSASSDVFAFGALLLEVACGRRPIET 545
               + A    VGT+ Y+APE             +    D++A G +  E+      +  
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 546 RALPEELVLV--DWVW 559
                E  +     V 
Sbjct: 238 GESVPEYQMAFQTEVG 253

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  200 bits (510), Expect = 4e-59
 Identities = 68/227 (29%), Positives = 122/227 (53%), Gaps = 21/227 (9%)

Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNE 376
           +D ++        + +L         K+ +G G FG V++   H   ++VAVK +   + 
Sbjct: 30  DDMDIP-------WCDLNI-------KEKIGAGSFGTVHRAEWHG--SDVAVKILMEQDF 73

Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAV 435
             + V EF+ E+A + RLRH N+V  +G   +  +L +V ++++ GSL   L     +  
Sbjct: 74  HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133

Query: 436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
           L+  +R  +   VA G+ YLH      ++HR++K+ N+L+D +   K+ DFGL++L +  
Sbjct: 134 LDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KAS 191

Query: 496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           T  ++    GT  ++APE  R   S+  SDV++FG +L E+A  ++P
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  196 bits (500), Expect = 7e-59
 Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 26/243 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS-----RKMGQAFYSSTLRFKNSLNSNVF 81
           F  F    NNL LQ  A + + G L LT   +       +G+A Y++ +   +  N+ + 
Sbjct: 8   FTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD--NTTLA 65

Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           SF+TSF+ V+          GLAF ++P +        +LGL       + S    AVEF
Sbjct: 66  SFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRA-HDASYQTVAVEF 124

Query: 142 DTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSA 201
           DT  +    D N  HIGID N ++S  +                +  G+   + + Y ++
Sbjct: 125 DTYSNAW--DPNYTHIGIDTNGIESKKTT------------PFDMVYGEKANIVITYQAS 170

Query: 202 ENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFK 258
              L  ++           +S RVDL  I  E++ VGFSA+TGL   +  +H+++ WSF 
Sbjct: 171 TKALAASLV-FPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFA 229

Query: 259 ING 261
           ++ 
Sbjct: 230 VSL 232

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  196 bits (499), Expect = 1e-58
 Identities = 80/249 (32%), Positives = 115/249 (46%), Gaps = 31/249 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           F  F++ S  L LQ  A I++NG+L LT  T       +  G+A Y+  ++  +S   NV
Sbjct: 7   FDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNV 66

Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y       GL F + P N   G     LG+    +  N     FAV
Sbjct: 67  ASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPPEGDNA----FAV 122

Query: 140 EFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT Q+    D    HIGID+NS+ S+ ++               L+ G    V + YD
Sbjct: 123 EFDTFQNTW--DPQVPHIGIDVNSIVSSKTL------------HFQLENGGVANVVIKYD 168

Query: 200 SAENILNVTVSPNSSKPKIPILSFRVDLSPIF--NEFMYVGFSASTGL---LASSHNVLG 254
           S   ILNV ++ + S   +  LS  VDL   F  +E++ VG SA+TG       +H ++ 
Sbjct: 169 SPTKILNVVLAFH-SVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIIS 227

Query: 255 WSFKINGPA 263
           WSF  +   
Sbjct: 228 WSFTSSLQE 236

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  193 bits (490), Expect = 1e-57
 Identities = 77/240 (32%), Positives = 111/240 (46%), Gaps = 29/240 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS---RKMGQAFYSSTLRFKNSLNSNVFSF 83
              F     NL LQG A + + G L LTN        MG+AFYS+ ++  +    N+ SF
Sbjct: 8   VETFN--KTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASF 65

Query: 84  STSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDT 143
           ST+F   I  +      +GLAF + P      L  +YLGL N+T+  +   H  AV FDT
Sbjct: 66  STNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTN-YDRDAHTVAVVFDT 124

Query: 144 VQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAEN 203
                      N I ID+NS++  A+       +N          G+   V + YDS +N
Sbjct: 125 ---------VSNRIEIDVNSIRPIATESCNFGHNN----------GEKAEVRITYDSPKN 165

Query: 204 ILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFKIN 260
            L V++    S  +   +S  V L     +++ VGFSA++G       +HNVL WSF  N
Sbjct: 166 DLRVSLLYP-SSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  193 bits (491), Expect = 2e-57
 Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 24/248 (9%)

Query: 26  FFPGFKDLSNNLTLQGIAKIENNGILRLT------NDTSRKMGQAFYSSTLRFKNSLNSN 79
           F+         +T  G A     G L+LT      N      GQA YS  +   +S    
Sbjct: 11  FWSYSLKNGTEITFLGDATR-IPGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGK 68

Query: 80  VFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFS-NHLFA 138
             SF TSF  ++   Y      GLAF ++P +        +LGL       + S N + A
Sbjct: 69  AASFYTSFTFLLKN-YGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVA 127

Query: 139 VEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDY 198
           VEFDT  + ++ D    HIGID+NS+ S A+            ++    G       + Y
Sbjct: 128 VEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRW---------ENDDAYGSSIATAHITY 178

Query: 199 DSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSF- 257
           D+   IL V +S      +  ILS  VDL+ +  + + +GFSA  G       +L W F 
Sbjct: 179 DARSKILTVLLSY--EHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHFF 235

Query: 258 -KINGPAR 264
             ++G  +
Sbjct: 236 STLDGTNK 243

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  193 bits (492), Expect = 1e-56
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 17/211 (8%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            ++LG G FGQ  K T   +   + +K +    ++  R F+ E+  +  L H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              +   L  + +++  G+L   +     +   W QR    K +ASG+ YLH      +I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-------------VVGTLGYLA 511
           HRD+ + N L+    N  + DFGLA+L                        VVG   ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           PE           DVF+FG +L E+      
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  189 bits (480), Expect = 6e-56
 Identities = 77/246 (31%), Positives = 120/246 (48%), Gaps = 24/246 (9%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDT---SRKMGQAFYSSTLRFKNSLNSNVFSF 83
           F  F     N+  QG A +   G+L++T  +   +  +G+A Y++ ++  +S+   V SF
Sbjct: 10  FDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASF 69

Query: 84  STSFAIVIVPEYPRLGGHGLAFTISPSNDL--NGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           +TSF+ V+  +    G  GLAF ++P+N    +G  +   GL +S+D    SN + AVEF
Sbjct: 70  ATSFSFVVKADKSD-GVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEF 127

Query: 142 DTVQDFEF--QDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           DT     +   D +  HIGID+NS+KS  +V                + G+   V + Y 
Sbjct: 128 DTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV------------KWDWRNGEVADVVITYR 175

Query: 200 SAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA--SSHNVLGWSF 257
           +    L V +S  S      I++  VDL  I  E++ VGFS   G  A   +H+VL W F
Sbjct: 176 APTKSLTVCLSYPSDGTS-NIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234

Query: 258 KINGPA 263
             N  A
Sbjct: 235 TSNLEA 240

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  188 bits (479), Expect = 7e-56
 Identities = 75/244 (30%), Positives = 115/244 (47%), Gaps = 27/244 (11%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND-----TSRKMGQAFYSSTLRFKNSLNSNVF 81
              F     +L  QG A + + G+L+LT           +G+A Y++ +R   +   +V 
Sbjct: 8   INNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVA 67

Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISP--SNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
           SFSTSF  V+    P +   GLAF ++P  S   +G  S+YLGL N+++  + SN + AV
Sbjct: 68  SFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAV 126

Query: 140 EFDTVQDFEFQ--DINDNHIGIDINSMKSNASVEAAVYTD-NSTKQDLSLKGGKAILVWV 196
           EFDT     +   D N  HIGID+N ++S  +V+        +      L   K ++  +
Sbjct: 127 EFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNKTLIASL 186

Query: 197 DYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA--SSHNVLG 254
            Y               S      ++  VDL  I  E++ VGFSA+TG      +H+VL 
Sbjct: 187 VYP--------------SNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLS 232

Query: 255 WSFK 258
           WSF 
Sbjct: 233 WSFT 236

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  186 bits (473), Expect = 6e-55
 Identities = 71/251 (28%), Positives = 113/251 (45%), Gaps = 33/251 (13%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           FP F    + L LQG A I + G L+LT   S        +G+AFYS  ++ K+S  +NV
Sbjct: 8   FPNFHT-DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS--NNV 64

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+T+F  +I  +   +  +GLAF + P N       ++LG+ N+ +    +    AV 
Sbjct: 65  ASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNN-PEPNARTVAVV 123

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           F+T +         N I  D N +K   +     +  N          G+   V + YDS
Sbjct: 124 FNTFK---------NRIDFDKNFIKPYVNENCDFHKYN----------GEKTDVQITYDS 164

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSF 257
           + N L V +           +S  V L    +E++ VGFS ++GL      +H+VL WSF
Sbjct: 165 SNNDLRVFLHFT-VSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSF 223

Query: 258 KINGPARALDL 268
                 +  ++
Sbjct: 224 SSKFRNKLSNI 234

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  186 bits (475), Expect = 1e-54
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRI----SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++++G GGFG+VY+        EVAVK        +  Q +     E      L+H N++
Sbjct: 12  EEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            L G C ++ +L LV +F   G L+  L  +    +  +        +A G+ YLH+   
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAI 126

Query: 461 QVVIHRDVKASNVLLDSELNG--------KLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
             +IHRD+K+SN+L+  ++          K+ DFGLA+ +   T        G   ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAP 183

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E  R    S  SDV+++G LL E+  G  P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  187 bits (477), Expect = 1e-54
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 12/200 (6%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           ++++G G FG V K        +VA+K+I +ES++  + F+ E+  + R+ H N+V+L G
Sbjct: 13  EEVVGRGAFGVVCKAKWRA--KDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
            C     + LV ++   GSL + L   EP                + G+ YLH    + +
Sbjct: 69  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 464 IHRDVKASNVLLDSELN-GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           IHRD+K  N+LL +     K+ DFG A   +       T   G+  ++APE       S 
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSE 182

Query: 523 SSDVFAFGALLLEVACGRRP 542
             DVF++G +L EV   R+P
Sbjct: 183 KCDVFSWGIILWEVITRRKP 202

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score =  182 bits (463), Expect = 1e-53
 Identities = 65/259 (25%), Positives = 104/259 (40%), Gaps = 54/259 (20%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTS 86
              F     NL LQG A + +NG L+L+ ++   M +AFYS+ ++ ++S   NV SF T+
Sbjct: 8   IDAFN--KTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTN 65

Query: 87  FAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQD 146
           F + I          GL F + P                             VEFDT   
Sbjct: 66  FTMNIRTHRQANSAVGLDFVLVPVQ------------------PESKGDTVTVEFDTFL- 106

Query: 147 FEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILN 206
                   + I ID+N+               S   D+    G+   V + Y+S+  + +
Sbjct: 107 --------SRISIDVNNNDI-----------KSVPWDVHDYDGQNAEVRITYNSSTKVFS 147

Query: 207 VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSFKINGPA 263
           V++S  S+  K   +S  V+L     +++ VGFSA++G       +H+VL WSF      
Sbjct: 148 VSLSNPST-GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFS----- 201

Query: 264 RALDLSSLPSLPGPKKKHH 282
                S   +L   K +  
Sbjct: 202 -----SKFINLKDQKSERS 215

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  182 bits (464), Expect = 6e-53
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 22/212 (10%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-------VREFVSEIATIGRLRHR 397
           ++ +G GGFG V+KG L   K+ VA+K +     +G        +EF  E+  +  L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           N+V+L G         +V +F+  G L   L D+    + W  + +++  +A G+ Y+  
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ- 139

Query: 458 GYEQVVIHRDVKASNVLLDS-----ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
                ++HRD+++ N+ L S      +  K+ DFGL++   H      + ++G   ++AP
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAP 195

Query: 513 E--TPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E         +  +D ++F  +L  +  G  P
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  180 bits (460), Expect = 3e-52
 Identities = 66/235 (28%), Positives = 113/235 (48%), Gaps = 28/235 (11%)

Query: 314 NAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI 373
           + +  +DWE+          ++          Q +G G FG VYKG  H    +VAVK +
Sbjct: 12  SRDAADDWEIP-------DGQITV-------GQRIGSGSFGTVYKGKWHG---DVAVKML 54

Query: 374 --SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE 431
             +  + Q ++ F +E+  + + RH N++  +G+      L +V  +    SL   L   
Sbjct: 55  NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHA- 112

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
            +     ++   I +  A G+ YLH    + +IHRD+K++N+ L  +   K+GDFGLA  
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169

Query: 492 YEHGTNPAT-TRVVGTLGYLAPETPRTGKS---SASSDVFAFGALLLEVACGRRP 542
               +      ++ G++ ++APE  R   S   S  SDV+AFG +L E+  G+ P
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  181 bits (460), Expect = 6e-52
 Identities = 62/248 (25%), Positives = 107/248 (43%), Gaps = 37/248 (14%)

Query: 310 KKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVA 369
           K  + +  +++W++        +++L+         +L+G G FGQVY G  H    EVA
Sbjct: 17  KASQTSIFLQEWDIP-------FEQLEI-------GELIGKGRFGQVYHGRWHG---EVA 59

Query: 370 VKRI--SNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF 427
           ++ I    +++  ++ F  E+    + RH N+V  +G C     L ++       +L S 
Sbjct: 60  IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119

Query: 428 LFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG 487
           + D  K VL+  +  +I + +  G+ YLH    + ++H+D+K+ NV  D      + DFG
Sbjct: 120 VRD-AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFG 174

Query: 488 LAKL----YEHGTNPATTRVVGTLGYLAPETPRTGKSSAS---------SDVFAFGALLL 534
           L  +                 G L +LAPE  R                SDVFA G +  
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234

Query: 535 EVACGRRP 542
           E+     P
Sbjct: 235 ELHAREWP 242

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  178 bits (454), Expect = 1e-51
 Identities = 40/202 (19%), Positives = 87/202 (43%), Gaps = 16/202 (7%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           L     G+++KG       ++ VK +     S +  R+F  E   +    H N++ ++G 
Sbjct: 18  LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 406 CRR--KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           C+        L+  +M  GSL + L +    V++  Q  K    +A G+ +LH   E ++
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLI 134

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA- 522
               + + +V++D ++  ++    +   ++      +   +    ++APE  +       
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTN 188

Query: 523 --SSDVFAFGALLLEVACGRRP 542
             S+D+++F  LL E+     P
Sbjct: 189 RRSADMWSFAVLLWELVTREVP 210

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score =  170 bits (433), Expect = 5e-50
 Identities = 56/188 (29%), Positives = 82/188 (43%), Gaps = 16/188 (8%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTS 86
              F     NL  QG         L LT      +G+A YSS +   +    NV +F TS
Sbjct: 8   ITKFSPDQQNLIFQGDGYT-TKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTS 66

Query: 87  FAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQD 146
           F  VI          G  F I+P +        YLG+ NS +  + +    AVEFDT  +
Sbjct: 67  FTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAE-YDKTTQTVAVEFDTFYN 125

Query: 147 FEFQDIN-DNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENIL 205
             +   N D HIGID+NS+KS  +                L+ G+   V + +++A N+L
Sbjct: 126 AAWDPSNRDRHIGIDVNSIKSVNTK------------SWKLQNGEEANVVIAFNAATNVL 173

Query: 206 NVTVS-PN 212
            V+++ PN
Sbjct: 174 TVSLTYPN 181

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  174 bits (442), Expect = 2e-49
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 33/234 (14%)

Query: 328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVS 386
           QR   +++          + +G G +G+V++G+       VAVK  S+  ++   RE   
Sbjct: 3   QRTVARDITL-------LECVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWFRET-- 51

Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRF 442
           E+     LRH N++  +            L L+  +   GSL  +L       L+     
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCL 108

Query: 443 KIIKGVASGLLYLHE-----GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN 497
           +I+  +ASGL +LH        +  + HRD+K+ N+L+       + D GLA ++   TN
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 498 P---ATTRVVGTLGYLAPE----TPRTGKSSAS--SDVFAFGALLLEVACGRRP 542
                    VGT  Y+APE    T +     +    D++AFG +L EVA     
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  170 bits (432), Expect = 8e-48
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 26/216 (12%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQLVG 404
           + +G G +G+V+ G       +VAVK      +    RE  +EI     +RH N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98

Query: 405 WCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE--- 457
              +       L L+ D+  NGSL  +L       L+ +   K+     SGL +LH    
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 458 --GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGTLGYLAP 512
               +  + HRD+K+ N+L+       + D GLA  +   TN         VGT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 513 E------TPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E           +S   +D+++FG +L EVA     
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  170 bits (432), Expect = 9e-48
 Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 27/245 (11%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQLVG 404
           + +G G FG+V++G       EVAVK  S+  ++   RE  +EI     LRH N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIA 103

Query: 405 WCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE--- 457
              +       L LV D+  +GSL  +L       +  E   K+    ASGL +LH    
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 160

Query: 458 --GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGTLGYLAP 512
               +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT  Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 513 E------TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGR 566
           E        +  +S   +D++A G +  E+A  R  I       +L   D V        
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 567 VLEVI 571
           + +V+
Sbjct: 280 MRKVV 284

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  168 bits (427), Expect = 1e-46
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 13/204 (6%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQLV 403
            + +G G FG+V+ G L    T VAVK            +F+ E   + +  H N+V+L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C +K  + +V + +  G   +FL  E    L  +   +++   A+G+ YL     +  
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE---SKCC 234

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY----LAPETPRTGK 519
           IHRD+ A N L+  +   K+ DFG+++    G         G         APE    G+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGR 291

Query: 520 SSASSDVFAFGALLLEVA-CGRRP 542
            S+ SDV++FG LL E    G  P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  162 bits (411), Expect = 2e-43
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 5/212 (2%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
             LG G +G+VY+G        VAVK +  E    V EF+ E A +  ++H NLVQL+G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
           C R+    ++ +FM  G+L  +L +  +  ++      +   ++S + YL    ++  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           R++ A N L+      K+ DFGL++L    T  A       + + APE+    K S  SD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 526 VFAFGALLLEVA-CGRRPIETRALPEELVLVD 556
           V+AFG LL E+A  G  P     L +   L++
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  154 bits (392), Expect = 1e-42
 Identities = 67/204 (32%), Positives = 100/204 (49%), Gaps = 15/204 (7%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           K  LG G +G+VY+G        VAVK +  E    V EF+ E A +  ++H NLVQL+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C R+    ++ +FM  G+L  +L +  +  ++      +   ++S + YL    ++  I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL-----APETPRTGK 519
           HRD+ A N L+      K+ DFGL++L    T  A                APE+    K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-----AKFPIKWTAPESLAYNK 188

Query: 520 SSASSDVFAFGALLLEVA-CGRRP 542
            S  SDV+AFG LL E+A  G  P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  151 bits (383), Expect = 5e-41
 Identities = 69/206 (33%), Positives = 114/206 (55%), Gaps = 13/206 (6%)

Query: 345 KQLLGHGGFGQVYKGTL---HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++++G G  G+V  G L         VA+K + +  +++  R+F+SE + +G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GY 459
           +L G   R    ++V ++M NGSLD+FL           Q   +++GV +G+ YL + GY
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGY 172

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL--APETPRT 517
               +HRD+ A NVL+DS L  K+ DFGL+++ E   + A T   G +     APE    
Sbjct: 173 ----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 518 GKSSASSDVFAFGALLLEVA-CGRRP 542
              S++SDV++FG ++ EV   G RP
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  152 bits (386), Expect = 3e-40
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 7/212 (3%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
             LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL   
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +H
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 526 VFAFGALLLEVA-CGRRPIETRALPEELVLVD 556
           V++FG LL E+   GR P       E L  V+
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (372), Expect = 4e-40
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 13/202 (6%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            + LG G FG V  G     + +VAVK I  E      EF  E  T+ +L H  LV+  G
Sbjct: 13  LKELGSGQFGVVKLGKW-KGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C ++  + +V ++++NG L ++L    K  L   Q  ++   V  G+ +L        I
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLE---SHQFI 126

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL---GYLAPETPRTGKSS 521
           HRD+ A N L+D +L  K+ DFG+ +             VGT     + APE     K S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 522 ASSDVFAFGALLLEVA-CGRRP 542
           + SDV+AFG L+ EV   G+ P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (377), Expect = 6e-40
 Identities = 53/230 (23%), Positives = 101/230 (43%), Gaps = 10/230 (4%)

Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQG 380
           +++G +   +Q +      +   Q +G G FG+           +  +K I  S  S + 
Sbjct: 11  VDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 381 VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQ 440
             E   E+A +  ++H N+VQ        G L +V D+   G L   +  +   +   +Q
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126

Query: 441 RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT 500
                  +   L ++H+   + ++HRD+K+ N+ L  +   +LGDFG+A++       A 
Sbjct: 127 ILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183

Query: 501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
              +GT  YL+PE       +  SD++A G +L E+   +   E  ++  
Sbjct: 184 A-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  150 bits (382), Expect = 7e-40
 Identities = 74/202 (36%), Positives = 104/202 (51%), Gaps = 17/202 (8%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            Q +G G FG V  G    +K  VAVK I N++    + F++E + + +LRH NLVQL+G
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253

Query: 405 WC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
                KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL        
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY--LAPETPRTGKSS 521
           +HRD+ A NVL+  +   K+ DFGL K        ++T+  G L     APE  R  K S
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 522 ASSDVFAFGALLLEVA-CGRRP 542
             SDV++FG LL E+   GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (370), Expect = 7e-40
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 13/216 (6%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            Q +G G FG V+ G    +K +VA+K I  E      +F+ E   + +L H  LVQL G
Sbjct: 13  VQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C  +  + LV +FM +G L  +L    + +   E    +   V  G+ YL    E  VI
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVI 126

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL---GYLAPETPRTGKSS 521
           HRD+ A N L+      K+ DFG+ +          T   GT     + +PE     + S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 522 ASSDVFAFGALLLEVA-CGRRPIETRALPEELVLVD 556
           + SDV++FG L+ EV   G+ P E R+  E +  + 
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  152 bits (385), Expect = 1e-39
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 7/212 (3%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
             LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  LVQL   
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
              +  + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+        +H
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSD 525
           RD++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+ +  SD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 526 VFAFGALLLEVA-CGRRPIETRALPEELVLVD 556
           V++FG LL E+   GR P       E L  V+
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  146 bits (370), Expect = 1e-39
 Identities = 74/202 (36%), Positives = 104/202 (51%), Gaps = 17/202 (8%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            Q +G G FG V  G    +K  VAVK I N++    + F++E + + +LRH NLVQL+G
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81

Query: 405 WC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
                KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 138

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY--LAPETPRTGKSS 521
           +HRD+ A NVL+  +   K+ DFGL K        ++T+  G L     APE  R  K S
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 522 ASSDVFAFGALLLEVA-CGRRP 542
             SDV++FG LL E+   GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  146 bits (370), Expect = 1e-39
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            + LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  LVQL G
Sbjct: 29  LKELGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
            C ++  + ++ ++MANG L ++L  E +     +Q  ++ K V   + YL     +  +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL-----APETPRTGK 519
           HRD+ A N L++ +   K+ DFGL++          T  VG+          PE     K
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSK--FPVRWSPPEVLMYSK 197

Query: 520 SSASSDVFAFGALLLEVA-CGRRP 542
            S+ SD++AFG L+ E+   G+ P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP 221

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (369), Expect = 1e-39
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 13/205 (6%)

Query: 345 KQLLGHGGFGQVYKGTL--HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
              LG G FG V +G       + +VA+K +     K    E + E   + +L +  +V+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYE 460
           L+G C+ +  L+LV +    G L  FL    +  +      +++  V+ G+ YL E  + 
Sbjct: 75  LIGVCQAEA-LMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 131

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTG 518
              +HRD+ A NVLL +    K+ DFGL+K      +  T R  G     + APE     
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 519 KSSASSDVFAFGALLLEVA-CGRRP 542
           K S+ SDV+++G  + E    G++P
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  145 bits (368), Expect = 2e-39
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 13/204 (6%)

Query: 346 QLLGHGGFGQVYKGTLHNSK--TEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQ 401
           + LG G FG V KG     K    VAVK + NE        E ++E   + +L +  +V+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           ++G C  +   +LV +    G L+ +L       +  +   +++  V+ G+ YL E  E 
Sbjct: 83  MIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL-E--ES 136

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTGK 519
             +HRD+ A NVLL ++   K+ DFGL+K      N    +  G     + APE     K
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196

Query: 520 SSASSDVFAFGALLLEVA-CGRRP 542
            S+ SDV++FG L+ E    G++P
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  146 bits (370), Expect = 4e-39
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 14/207 (6%)

Query: 345 KQLLGHGGFGQVYKGTLHNS----KTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNL 399
           ++++G G FG+VYKG L  S    +  VA+K + +  +++   +F+ E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-G 458
           ++L G   +   ++++ ++M NG+LD FL  E     +  Q   +++G+A+G+ YL    
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANMN 167

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY--LAPETPR 516
           Y    +HRD+ A N+L++S L  K+ DFGL+++ E       T   G +     APE   
Sbjct: 168 Y----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 517 TGKSSASSDVFAFGALLLEVA-CGRRP 542
             K +++SDV++FG ++ EV   G RP
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  147 bits (372), Expect = 5e-39
 Identities = 68/206 (33%), Positives = 116/206 (56%), Gaps = 13/206 (6%)

Query: 345 KQLLGHGGFGQVYKGTLHNS---KTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
            +++G G FG+V  G L      +  VA+K +    +++  R+F+ E + +G+  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GY 459
           +L G   +   +++V ++M NGSLDSFL  +  A     Q   +++G+ASG+ YL + GY
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL--APETPRT 517
               +HRD+ A N+L++S L  K+ DFGL ++ E     A T   G +     +PE    
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 518 GKSSASSDVFAFGALLLEVA-CGRRP 542
            K +++SDV+++G +L EV   G RP
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP 250

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  144 bits (365), Expect = 5e-39
 Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 11/201 (5%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            + LG G FG+V+ G   N  T+VAVK +  +       F++E   + +L+H+ LV+L  
Sbjct: 18  VERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVI 464
              ++  + ++ ++M NGSL  FL       L   +   +   +A G+ ++ E   +  I
Sbjct: 76  VVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131

Query: 465 HRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY--LAPETPRTGKSSA 522
           HRD++A+N+L+   L+ K+ DFGLA+L E      T R          APE    G  + 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 523 SSDVFAFGALLLEVA-CGRRP 542
            SDV++FG LL E+   GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (366), Expect = 6e-39
 Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 19/238 (7%)

Query: 345 KQLLGHGGFGQVYKGTLH----NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNL 399
            + LG G FG+V          N+  +VAVK +        + +   EI  +  L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 400 VQLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           V+  G C   G   + L+ +F+ +GSL  +L    K  +N +Q+ K    +  G+ YL  
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS 144

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETP 515
              +  +HRD+ A NVL++SE   K+GDFGL K  E      T +        + APE  
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 516 RTGKSSASSDVFAFGALLLEVA-CGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID 572
              K   +SDV++FG  L E+           AL  +++        +G+  V  +++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP-----THGQMTVTRLVN 254

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  144 bits (365), Expect = 7e-39
 Identities = 67/229 (29%), Positives = 114/229 (49%), Gaps = 15/229 (6%)

Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK 378
           E+ + E     Y Y+      +    + +LG G +G VY G   +++  +A+K I     
Sbjct: 6   EEGDCESDLLEYDYE-----YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNW 438
           +  +    EIA    L+H+N+VQ +G     G + +  + +  GSL + L  +   + + 
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 439 EQRFKII-KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHG 495
           EQ      K +  GL YLH   +  ++HRD+K  NVL+++  +G  K+ DFG +K    G
Sbjct: 121 EQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLA-G 175

Query: 496 TNPATTRVVGTLGYLAPETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
            NP T    GTL Y+APE    G      ++D+++ G  ++E+A G+ P
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  148 bits (375), Expect = 7e-39
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           + LG G FG+V+  T  N  T+VAVK +       V  F++E   +  L+H  LV+L   
Sbjct: 194 KKLGAGQFGEVWMATY-NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH 465
             ++  + ++ +FMA GSL  FL  +  +     +       +A G+ ++ +   +  IH
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307

Query: 466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY--LAPETPRTGKSSAS 523
           RD++A+N+L+ + L  K+ DFGLA++ E   N  T R          APE    G  +  
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 524 SDVFAFGALLLEVA-CGRRP 542
           SDV++FG LL+E+   GR P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  143 bits (364), Expect = 8e-39
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)

Query: 345 KQLLGHGGFGQVYKGTLH----NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
            Q LG G FG V          N+   VAVK++ + +++ +R+F  EI  +  L+H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 401 QLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +  G C   G   L L+ +++  GSL  +L    K  ++  +  +    +  G+ YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPR 516
             +  IHRD+   N+L+++E   K+GDFGL K+          +  G     + APE+  
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 517 TGKSSASSDVFAFGALLLEV 536
             K S +SDV++FG +L E+
Sbjct: 191 ESKFSVASDVWSFGVVLYEL 210

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  145 bits (367), Expect = 9e-39
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)

Query: 345 KQLLGHGGFGQVYKGTLH----NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
              LG G FG V          N+   VAVK++ +      R+F  EI  +  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 401 QLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +  G     G   L LV +++ +G L  FL    +A L+  +       +  G+ YL   
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPR 516
             +  +HRD+ A N+L++SE + K+ DFGLAKL     +    R  G     + APE+  
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 517 TGKSSASSDVFAFGALLLEVA-CGRRP 542
               S  SDV++FG +L E+     + 
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS 230

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  144 bits (365), Expect = 9e-39
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI---SNESKQGVREFVSEIATIGRLRH 396
            NF  ++ +G G F +VY+         VA+K++        +   + + EI  + +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------FDEPKAVLNWEQRFKIIKG 447
            N+++         +L +V +    G L   +           E   V  +         
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT-VWKY------FVQ 144

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           + S L ++H    + V+HRD+K +NV + +    KLGD GL + +   T  A + +VGT 
Sbjct: 145 LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTP 200

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            Y++PE       +  SD+++ G LL E+A  + P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  143 bits (362), Expect = 2e-38
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)

Query: 346 QLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL      K   AVK +        V +F++E   +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L+G C R +G  L+V  +M +G L +F+          +        VA G+ YL     
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLAS--- 146

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPETPRT 517
           +  +HRD+ A N +LD +   K+ DFGLA+ +Y+        +    L   ++A E+ +T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206

Query: 518 GKSSASSDVFAFGALLLEVAC-GRRP 542
            K +  SDV++FG LL E+   G  P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPP 232

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (364), Expect = 2e-38
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 33/223 (14%)

Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           K  LG G FG+V+    HN      K  VAVK +   S+   ++F  E   +  L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFL-------------FDEPKAVLNWEQRFKIIK 446
           V+  G C     LL+V+++M +G L+ FL              D     L   Q   +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVG 505
            VA+G++YL        +HRD+   N L+   L  K+GDFG+++ +Y         R VG
Sbjct: 166 QVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYR-VG 217

Query: 506 TLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
               L      PE+    K +  SDV++FG +L E+   G++P
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (363), Expect = 2e-38
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)

Query: 345 KQLLGHGGFGQVYKGTLH----NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
            Q LG G FG V          N+   VAVK++ + +++ +R+F  EI  +  L+H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 401 QLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +  G C   G   L L+ +++  GSL  +L    K  ++  +  +    +  G+ YL   
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG-- 162

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPR 516
             +  IHRD+   N+L+++E   K+GDFGL K+          +  G     + APE+  
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 517 TGKSSASSDVFAFGALLLEV 536
             K S +SDV++FG +L E+
Sbjct: 222 ESKFSVASDVWSFGVVLYEL 241

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  143 bits (362), Expect = 5e-38
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 346 QLLGHGGFGQVYKGTLH----NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
           ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GY 459
           +L+G C     + L+   M  G L  ++  E K  +  +        +A G+ YL +   
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLAPETPR 516
               +HRD+ A NVL+ +  + K+ DFGLAKL             G    + ++A E+  
Sbjct: 139 ----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192

Query: 517 TGKSSASSDVFAFGALLLEVA-CGRRP 542
               +  SDV+++G  + E+   G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  141 bits (359), Expect = 5e-38
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 34/224 (15%)

Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           K+ LG G FG+V+    +N      K  VAVK + + +    ++F  E   +  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKII 445
           V+  G C     L++V+++M +G L+ FL                + K  L   Q   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVV 504
             +ASG++YL     Q  +HRD+   N L+ + L  K+GDFG+++ +Y         R V
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYR-V 191

Query: 505 GTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
           G    L      PE+    K +  SDV++FG +L E+   G++P
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score =  135 bits (341), Expect = 1e-37
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 24/156 (15%)

Query: 134 NHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAIL 193
           +++ AVEFDT  + ++ D N  HIGID+NS++S  + +               + GK   
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW------------DWQNGKIAT 48

Query: 194 VWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVL 253
             + Y+S    L+VT     SKP    LS+ ++L  +  E++ VG SASTG     + V 
Sbjct: 49  AHISYNSVSKRLSVTSYYAGSKP--ATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVH 106

Query: 254 GWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGV 289
            WSF           SSL +    K+  +     GV
Sbjct: 107 SWSFT----------SSLWTNVAKKENENKYITRGV 132

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  141 bits (358), Expect = 1e-37
 Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 21/238 (8%)

Query: 345 KQLLGHGGFGQVYKGTLH----NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNL 399
            + LG G FG+V           +   VAVK + ++   Q    +  EI  +  L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 400 VQLVGWCRRKGD--LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           ++  G C   G   L LV +++  GSL  +L   P+  +   Q     + +  G+ YLH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETP 515
              Q  IHRD+ A NVLLD++   K+GDFGLAK    G      R  G     + APE  
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 516 RTGKSSASSDVFAFGALLLEVA-CGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID 572
           +  K   +SDV++FG  L E+               EL+ +       G+  VL + +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA-----QGQMTVLRLTE 262

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  140 bits (355), Expect = 2e-37
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 14/207 (6%)

Query: 345 KQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRN 398
            + LG G FG V +G           VAVK +  +     + + +F+ E+  +  L HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           L++L G       + +V +    GSL   L  + +         +    VA G+ YL   
Sbjct: 83  LIRLYGVVLTPP-MKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLES- 139

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY--LAPETPR 516
             +  IHRD+ A N+LL +    K+GDFGL +      +    +    + +   APE+ +
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 517 TGKSSASSDVFAFGALLLEVA-CGRRP 542
           T   S +SD + FG  L E+   G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  139 bits (353), Expect = 3e-37
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 348 LGHGGFGQVYKGTL---HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQLV 403
           +G G FG V++G      N    VA+K   +  S     +F+ E  T+ +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYEQV 462
           G       + ++ +    G L SFL    K  L+          +++ L YL    +   
Sbjct: 83  GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRF--- 137

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTGKS 520
            +HRD+ A NVL+ S    KLGDFGL++  E  T        G L   ++APE+    + 
Sbjct: 138 -VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRF 194

Query: 521 SASSDVFAFGALLLEVA-CGRRP 542
           +++SDV+ FG  + E+   G +P
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (358), Expect = 3e-37
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 13/206 (6%)

Query: 346 QLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
           +++G G FG VY GTL      K   AVK +        V +F++E   +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 402 LVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           L+G C R +G  L+V  +M +G L +F+          +        VA G+ +L     
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLAS--- 210

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPETPRT 517
           +  +HRD+ A N +LD +   K+ DFGLA+ +Y+   +    +    L   ++A E+ +T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270

Query: 518 GKSSASSDVFAFGALLLEVAC-GRRP 542
            K +  SDV++FG LL E+   G  P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPP 296

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  146 bits (369), Expect = 3e-37
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 13/205 (6%)

Query: 345 KQLLGHGGFGQVYKGTL--HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
              LG G FG V +G       + +VA+K +     K    E + E   + +L +  +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYE 460
           L+G C+ +  L+LV +    G L  FL    +  +      +++  V+ G+ YL E  + 
Sbjct: 401 LIGVCQAEA-LMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 457

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY--LAPETPRTG 518
              +HR++ A NVLL +    K+ DFGL+K      +  T R  G       APE     
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514

Query: 519 KSSASSDVFAFGALLLEVA-CGRRP 542
           K S+ SDV+++G  + E    G++P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 4e-37
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)

Query: 345 KQLLGHGGFGQVYKGTLH---NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
            +++G G FG VY G       ++ + A+K +      Q V  F+ E   +  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 401 QLVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
            L+G     +G   ++  +M +G L  F+   P+     +        VA G+ YL E  
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAE-- 142

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTL--GYLAPETPR 516
            Q  +HRD+ A N +LD     K+ DFGLA+ + +             L   + A E+ +
Sbjct: 143 -QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 517 TGKSSASSDVFAFGALLLEVA-CGRRP 542
           T + +  SDV++FG LL E+   G  P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  140 bits (354), Expect = 4e-37
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 29/219 (13%)

Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRN 398
            + LGHG FG+VY+G +       S  +VAVK +    S+Q   +F+ E   I +  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLL 453
           +V+ +G   +     ++ + MA G L SFL          + L       + + +A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEHGTNPATTRVVGTLGY 509
           YL    E   IHRD+ A N LL     G   K+GDFG+A+ +Y         R  G    
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYR-KGGCAM 206

Query: 510 L-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
           L      PE    G  ++ +D ++FG LL E+   G  P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (351), Expect = 6e-37
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 40/219 (18%)

Query: 348 LGHGGFGQVYKGTLHN-------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           LG G F +++KG            +TEV +K +    +     F    + + +L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
              G C    + +LV +F+  GSLD++L    K  +N   + ++ K +A+ + +L    E
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---E 131

Query: 461 QVVIHRDVKASNVLLDSELNG--------KLGDFGLAKLYEHGTNPATTRVVGTLGYL-- 510
             +IH +V A N+LL  E +         KL D G++              V     L  
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------------ITVLPKDILQE 179

Query: 511 -----APETPRTGKS-SASSDVFAFGALLLEVA-CGRRP 542
                 PE     K+ + ++D ++FG  L E+   G +P
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  138 bits (350), Expect = 6e-37
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 345 KQLLGHGGFGQVYKGTLHN---SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLV 400
            ++LG G FG+VY+G   N    K  VAVK    + +     +F+SE   +  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
           +L+G    +    ++ +    G L  +L +  K  L           +   + YL     
Sbjct: 77  KLIGIIEEE-PTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLES--- 131

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL---GYLAPETPRT 517
              +HRD+   N+L+ S    KLGDFGL++  E   +    +   T     +++PE+   
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINF 188

Query: 518 GKSSASSDVFAFGALLLEVA-CGRRP 542
            + + +SDV+ F   + E+   G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  138 bits (350), Expect = 6e-37
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 35/225 (15%)

Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRN 398
            + LG   FG+VYKG L           VA+K +          EF  E     RL+H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRFKI 444
           +V L+G   +   L +++ + ++G L  FL                  K+ L       +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRV 503
           +  +A+G+ YL       V+H+D+   NVL+  +LN K+ D GL  ++Y           
Sbjct: 134 VAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN- 189

Query: 504 VGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
                 L     APE    GK S  SD++++G +L EV   G +P
Sbjct: 190 ----SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (347), Expect = 1e-36
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 23/226 (10%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHR 397
            ++     +G G +G+  K    +    +  K +   + ++   +  VSE+  +  L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 398 NLVQLVGW--CRRKGDLLLVYDFMANGSLDSFL---------FDEPKAVLNWEQRFKIIK 446
           N+V+       R    L +V ++   G L S +          DE   VL        + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF-VLRV------MT 118

Query: 447 GVASGLLYLHE--GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
            +   L   H        V+HRD+K +NV LD + N KLGDFGLA++  H T+ A T  V
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FV 177

Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           GT  Y++PE       +  SD+++ G LL E+     P    +  E
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (348), Expect = 1e-36
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGRLRHRNLVQL 402
              +G G F  VYKG    +  EVA   +     +K   + F  E   +  L+H N+V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 403 VG----WCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLL 453
                   + K  ++LV + M +G+L ++L         K + +W       + +  GL 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI-KVLRSW------CRQILKGLQ 143

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           +LH      +IHRD+K  N+ +     G  K+GD GLA L           V+GT  ++A
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATL---KRASFAKAVIGTPEFMA 198

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           PE     K   S DV+AFG  +LE+A    P
Sbjct: 199 PEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  139 bits (352), Expect = 2e-36
 Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 29/216 (13%)

Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
           LGHG FG+VY+G +       S  +VAVK +    S+Q   +F+ E   I +  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
            +G   +     ++ + MA G L SFL          + L       + + +A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 457 EGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAK-LYEHGTNPATTRVVGTLGYL-- 510
              E   IHRD+ A N LL     G   K+GDFG+A+ +Y  G         G    L  
Sbjct: 199 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPV 250

Query: 511 ---APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
               PE    G  ++ +D ++FG LL E+   G  P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (349), Expect = 2e-36
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 345 KQLLGHGGFGQVYKGTLH----NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNL 399
            ++LG G FG V+KG       + K  V +K I     +Q  +     +  IG L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           V+L+G C     L LV  ++  GSL   +  + +  L  +        +A G+ YL E  
Sbjct: 78  VRLLGLCPGSS-LQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEE-- 133

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRT 517
              ++HR++ A NVLL S    ++ DFG+A L     +             ++A E+   
Sbjct: 134 -HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKWMALESIHF 191

Query: 518 GKSSASSDVFAFGALLLEVA-CGRRP 542
           GK +  SDV+++G  + E+   G  P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  137 bits (346), Expect = 4e-36
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 29/219 (13%)

Query: 345 KQLLGHGGFGQVYKGTLHN---SKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNL 399
            ++LG G FG V +G L     +  +VAVK  ++ N S++ + EF+SE A +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 400 VQLVGWC-----RRKGDLLLVYDFMANGSLDSFL----FDEPKAVLNWEQRFKIIKGVAS 450
           ++L+G C     +     +++  FM  G L ++L     +     +  +   K +  +A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGY 509
           G+ YL     +  +HRD+ A N +L  ++   + DFGL+K +Y            G +  
Sbjct: 159 GMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG-----DYYRQGRIAK 210

Query: 510 L-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
           +     A E+      ++ SDV+AFG  + E+A  G  P
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  137 bits (347), Expect = 4e-36
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 16/212 (7%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH----NSKTEVAVKRI-SNESKQGVREFVSEIATIGRL 394
             F   ++LG G FG VYKG         K  VA+K +    S +  +E + E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            + ++ +L+G C     + L+   M  G L  ++  E K  +  +        +A G+ Y
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT---LGYLA 511
           L +   + ++HRD+ A NVL+ +  + K+ DFGLAKL             G    + ++A
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMA 187

Query: 512 PETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
            E+      +  SDV+++G  + E+   G +P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (346), Expect = 6e-36
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 29/216 (13%)

Query: 348 LGHGGFGQVYKGTLHN-----SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
           LG G FG VY+G          +T VA+K +    S +   EF++E + +      ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL--------FDEPKAVLNWEQRFKIIKGVASGLL 453
           L+G   +    L++ + M  G L S+L         +   A  +  +  ++   +A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLGYL-- 510
           YL+       +HRD+ A N ++  +   K+GDFG+   +YE        R  G  G L  
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYR-KGGKGLLPV 204

Query: 511 ---APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
              +PE+ + G  +  SDV++FG +L E+A    +P
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  136 bits (345), Expect = 7e-36
 Identities = 66/243 (27%), Positives = 108/243 (44%), Gaps = 42/243 (17%)

Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHN--SKTEVAVKRI-SNESKQGVRE 383
           P    Y  L    N+   + ++G G FGQV K  +     + + A+KR+    SK   R+
Sbjct: 14  PDPTIYPVLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 71

Query: 384 FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-------------- 428
           F  E+  + +L  H N++ L+G C  +G L L  ++  +G+L  FL              
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131

Query: 429 FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL 488
            +   + L+ +Q       VA G+ YL    ++  IHRD+ A N+L+      K+ DFGL
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 188

Query: 489 AK---LYEHGTNPATTRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CG 539
           ++   +Y   T           G L     A E+      + +SDV+++G LL E+   G
Sbjct: 189 SRGQEVYVKKTM----------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 238

Query: 540 RRP 542
             P
Sbjct: 239 GTP 241

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  135 bits (341), Expect = 9e-36
 Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 25/219 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            +F   +L+G GGFGQV+K           +KR+   +++  RE    +  + +L H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66

Query: 400 VQLVG----------------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
           V   G                   +   L +  +F   G+L+ ++       L+     +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
           + + +  G+ Y+H    + +I+RD+K SN+ L      K+GDFGL    ++      +  
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181

Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            GTL Y++PE   +       D++A G +L E+      
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (340), Expect = 3e-35
 Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 28/235 (11%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV 400
           ++   Q LG GGF  V      +     A+KRI    +Q   E   E        H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 401 QLVGWCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVAS 450
           +LV +C R+        L+  F   G+    L++E + + +            ++ G+  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGT----LWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV------- 503
           GL  +H    +   HRD+K +N+LL  E    L D G           +   +       
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 504 -VGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVL 554
              T+ Y APE             +DV++ G +L  +  G  P +      + V 
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  134 bits (340), Expect = 3e-35
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 30/220 (13%)

Query: 345 KQLLGHGGFGQVYKGTLHN---SKTEVAVK--RISNESKQGVREFVSEIATIGRLRHRNL 399
            ++LG G FG V +  L     S  +VAVK  +    +   + EF+ E A +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 400 VQLVGWCRRKG------DLLLVYDFMANGSLDSFL----FDEPKAVLNWEQRFKIIKGVA 449
            +LVG   R          +++  FM +G L +FL      E    L  +   + +  +A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLG 508
            G+ YL     +  IHRD+ A N +L  ++   + DFGL+ K+Y                
Sbjct: 148 CGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA-----S 199

Query: 509 YL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
            L     A E+      +  SDV+AFG  + E+   G+ P
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  140 bits (354), Expect = 4e-35
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 346 QLLGHGGFGQVYKGTL---HNSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRNLVQ 401
           + +G G FG V++G      N    VA+K   +  S     +F+ E  T+ +  H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-GYE 460
           L+G       + ++ +    G L SFL    K  L+          +++ L YL    + 
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRF- 512

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL--GYLAPETPRTG 518
              +HRD+ A NVL+ S    KLGDFGL++  E  T        G L   ++APE+    
Sbjct: 513 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFR 567

Query: 519 KSSASSDVFAFGALLLEVA-CGRRP 542
           + +++SDV+ FG  + E+   G +P
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP 592

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (336), Expect = 8e-35
 Identities = 53/241 (21%), Positives = 104/241 (43%), Gaps = 38/241 (15%)

Query: 325 VGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVR 382
           +G +   +Q +      +S  + +G GG  +V++  L+  K   A+K ++      Q + 
Sbjct: 13  LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD 71

Query: 383 EFVSEIATIGRLRHRNL--VQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAV 435
            + +EIA + +L+  +   ++L  +      + +V +   N  L+S+L      D  +  
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 130

Query: 436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAK-LY 492
             W+        +   +  +H   +  ++H D+K +N L+    +G  KL DFG+A  + 
Sbjct: 131 SYWKN-------MLEAVHTIH---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQ 177

Query: 493 EHGTNPATTRVVGTLGYLAPE-----------TPRTGKSSASSDVFAFGALLLEVACGRR 541
              T+      VGT+ Y+ PE                K S  SDV++ G +L  +  G+ 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

Query: 542 P 542
           P
Sbjct: 238 P 238

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  132 bits (334), Expect = 8e-35
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 10/208 (4%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVRE-FVSEIATIGRLRHRNLVQLV 403
           LLG G F  VY+    ++  EVA+K I  ++  K G+ +   +E+    +L+H ++++L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
            +      + LV +   NG ++ +L +  K     E R   +  + +G+LYLH      +
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHS---HGI 133

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SA 522
           +HRD+  SN+LL   +N K+ DFGLA   +       T + GT  Y++PE   T  +   
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEI-ATRSAHGL 191

Query: 523 SSDVFAFGALLLEVACGRRPIETRALPE 550
            SDV++ G +   +  GR P +T  +  
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  132 bits (335), Expect = 9e-35
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 19/212 (8%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVRE-FVSEIATIGRLRHRNLVQLV 403
            LG GGF + ++ +  ++K   A K +      K   RE    EI+    L H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           G+      + +V +     SL           EP+A      R   ++ +  G  YLH  
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA------R-YYLRQIVLGCQYLHR- 133

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
               VIHRD+K  N+ L+ +L  K+GDFGLA   E+        + GT  Y+APE     
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 190

Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPE 550
             S   DV++ G ++  +  G+ P ET  L E
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (335), Expect = 1e-34
 Identities = 54/211 (25%), Positives = 83/211 (39%), Gaps = 23/211 (10%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRL-RHR 397
           +F     LGHG +G+V+K          AVKR        +     ++E+ +  ++ +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFL------FDEPKAVLNWEQRFKIIKGVASG 451
             V+L       G L L  +     SL            E +        +  ++     
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQV-------WGYLRDTLLA 169

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L +LH    Q ++H DVK +N+ L      KLGDFGL                G   Y+A
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMA 224

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           PE  +    +A +DVF+ G  +LEVAC    
Sbjct: 225 PELLQGSYGTA-ADVFSLGLTILEVACNMEL 254

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  133 bits (336), Expect = 1e-34
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 19/212 (8%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVRE-FVSEIATIGRLRHRNLVQLV 403
            LG GGF + ++ +  ++K   A K +      K   RE    EI+    L H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           G+      + +V +     SL           EP+A      R   ++ +  G  YLH  
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA------R-YYLRQIVLGCQYLHR- 159

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
               VIHRD+K  N+ L+ +L  K+GDFGLA   E+        + GT  Y+APE     
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 216

Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPE 550
             S   DV++ G ++  +  G+ P ET  L E
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score =  129 bits (324), Expect = 4e-34
 Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 14/162 (8%)

Query: 133 SNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAI 192
           ++ + AVE DT  + +  D +  HIGIDI S++S  +               +++ GK  
Sbjct: 1   ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKT------------AKWNMQNGKVG 48

Query: 193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNV 252
              + Y+S +  L+  VS          +S+ VDL  +  E++ VG SASTGL   ++ +
Sbjct: 49  TAHIIYNSVDKRLSAVVSY--PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTI 106

Query: 253 LGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASV 294
           L WSF     + +   ++       +       ++    A+ 
Sbjct: 107 LSWSFTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATT 148

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 76.8 bits (188), Expect = 6e-16
 Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 10/111 (9%)

Query: 26  FFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRK------MGQAFYSSTLRFKNSLNSN 79
            F  F     +L LQG A    +G L LT  +S        +G+A + + +    S ++ 
Sbjct: 129 MFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAV 187

Query: 80  VFSFSTSFAIVIVPEYPRLGGHGLAFTISP--SNDLNGLPSQYLGLLNSTD 128
           V SF  +F  +I          G+AF IS   S+  +G   + LGL    +
Sbjct: 188 VASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  137 bits (346), Expect = 4e-34
 Identities = 74/284 (26%), Positives = 107/284 (37%), Gaps = 33/284 (11%)

Query: 326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV 385
           G +  S     Q    +  K+ LG GGFG V +    ++  +VA+K+   E     RE  
Sbjct: 2   GGRSPSLP--TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW 59

Query: 386 -SEIATIGRLRHRNLVQLV------GWCRRKGDLLLVYDFMANGSLDSFLFD-EPKAVLN 437
             EI  + +L H N+V                  LL  ++   G L  +L   E    L 
Sbjct: 60  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119

Query: 438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEH 494
                 ++  ++S L YLH   E  +IHRD+K  N++L         K+ D G AK  + 
Sbjct: 120 EGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176

Query: 495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVL 554
           G        VGTL YLAPE     K + + D ++FG L  E   G RP      P +   
Sbjct: 177 GELCTE--FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW-- 232

Query: 555 VDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGP 598
                           +  K N        L G ++    L  P
Sbjct: 233 -------------HGKVREKSNEHIVVYDDLTGAVKFSSVLPTP 263

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  131 bits (332), Expect = 5e-34
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 29/221 (13%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR 393
           E ++  +  + +  +G G FG+V++     +  + AVK++  E  +     V E+     
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAG 106

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGV 448
           L    +V L G  R    + +  + +  GSL   +       E +A+         +   
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------YYLGQA 159

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTR--- 502
             GL YLH    + ++H DVKA NVLL S  +G    L DFG A   +      +     
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 503 -VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            + GT  ++APE        A  D+++   ++L +  G  P
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  131 bits (331), Expect = 9e-34
 Identities = 51/226 (22%), Positives = 98/226 (43%), Gaps = 38/226 (16%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGRLRHR 397
             +S  + +G GG  +V++  L+  K   A+K ++      Q +  + +EIA + +L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 398 NL--VQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
           +   ++L  +      + +V +   N  L+S+L      D  +    W+        +  
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-------MLE 119

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAK-LYEHGTNPATTRVVGTL 507
            +  +H   +  ++H D+K +N L+    +G  KL DFG+A  +    T+      VGT+
Sbjct: 120 AVHTIH---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 508 GYLAPE-----------TPRTGKSSASSDVFAFGALLLEVACGRRP 542
            Y+ PE                K S  SDV++ G +L  +  G+ P
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  131 bits (331), Expect = 2e-33
 Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 38/220 (17%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGRLRHRNL--VQ 401
           + +G GG  +V++  L+  K   A+K ++      Q +  + +EIA + +L+  +   ++
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLH 456
           L  +      + +V +   N  L+S+L      D  +    W+        +   +  +H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIH 172

Query: 457 EGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLY-EHGTNPATTRVVGTLGYLAPE 513
              +  ++H D+K +N L+    +G  KL DFG+A       T+      VG + Y+ PE
Sbjct: 173 ---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 514 -----------TPRTGKSSASSDVFAFGALLLEVACGRRP 542
                           K S  SDV++ G +L  +  G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  129 bits (326), Expect = 2e-33
 Identities = 67/238 (28%), Positives = 100/238 (42%), Gaps = 37/238 (15%)

Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHR 397
            + LG G FGQV +          +   VAVK +    +    R  +SE+  +  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 398 NLVQLVGWCRRKGD-LLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQRF 442
           N+V L+G C + G  L+++ +F   G+L ++L               D  K  L  E   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATT 501
                VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA  +Y+        
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----D 203

Query: 502 RVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRPIETRALPEELV 553
            V      L     APET      +  SDV++FG LL E+   G  P     + EE  
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  129 bits (327), Expect = 2e-33
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 37/227 (16%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-------NSKTEVAVKRI-SNESKQGVREFVSEIATI 391
           +  +  + LG G FGQV                  VAVK +  + +++ + + VSE+  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 392 GRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVL 436
             + +H+N++ L+G C + G L ++ ++ + G+L  +L                 P+  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHG 495
            ++        +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA  +    
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 496 TNPATTRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA 537
               TT      G L     APE       +  SDV++FG L+ E+ 
Sbjct: 212 YYKKTTN-----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  129 bits (327), Expect = 3e-33
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 43/233 (18%)

Query: 345 KQLLGHGGFGQVYKGTLHN-----SKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRN 398
            + +G G FG+V++            T VAVK +    S     +F  E A +    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL----------------------FDEPKAVL 436
           +V+L+G C     + L++++MA G L+ FL                             L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHG 495
           +  ++  I + VA+G+ YL    E+  +HRD+   N L+   +  K+ DFGL+  +Y   
Sbjct: 172 SCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 496 TNPATTRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
                         +      PE+    + +  SDV+A+G +L E+   G +P
Sbjct: 229 -----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  130 bits (329), Expect = 3e-33
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 38/228 (16%)

Query: 345 KQLLGHGGFGQVYKGTLH-------NSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-R 395
            + LG G FGQV             N  T+VAVK + S+ +++ + + +SE+  +  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQR 441
           H+N++ L+G C + G L ++ ++ + G+L  +L                 P+  L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPAT 500
                 VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA  ++       T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 501 TRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
           T      G L     APE       +  SDV++FG LL E+   G  P
Sbjct: 251 TN-----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (324), Expect = 4e-33
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 21/223 (9%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRL 394
             + + +    +LG G    V++G    +    A+K  +N S     +  + E   + +L
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 395 RHRNLVQL--VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF-KIIKGVASG 451
            H+N+V+L  +         +L+ +F   GSL + L +   A    E  F  +++ V  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 452 LLYLHEGYEQVVIHRDVKASNVLL----DSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           + +L    E  ++HR++K  N++     D +   KL DFG A+  E      +  + GT 
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTE 179

Query: 508 GYLAPE--------TPRTGKSSASSDVFAFGALLLEVACGRRP 542
            YL P+             K  A+ D+++ G      A G  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (324), Expect = 4e-33
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 38/244 (15%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRI-SNESKQGVREFVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +  +         +SE+  +  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL----------------FDEPKAVL 436
           L  H N+V L+G C   G  L++ ++   G L +FL                 ++ +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHG 495
           + E        VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA  +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 496 TNPATTRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRPIETRALP 549
                         L     APE+      +  SDV+++G  L E+   G  P     + 
Sbjct: 200 NYVVKGN-----ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 550 EELV 553
            +  
Sbjct: 255 SKFY 258

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (325), Expect = 4e-33
 Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 34/229 (14%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRI-SNESKQGVREFVSEIATIGR 393
           NN    + LG G FG+V + T       ++  +VAVK + S          +SE+  +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL------------FDEPKAVLNWEQ 440
           L +H N+V L+G C   G +L++ ++   G L +FL            F    +  +   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 441 RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPA 499
                  VA G+ +L     +  IHRDV A NVLL +    K+GDFGLA  +        
Sbjct: 166 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-- 220

Query: 500 TTRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
              +V     L     APE+      +  SDV+++G LL E+   G  P
Sbjct: 221 ---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (326), Expect = 6e-33
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 38/228 (16%)

Query: 345 KQLLGHGGFGQVYKGTLH-------NSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-R 395
            + LG G FGQV                  VAVK +  + +++ + + VSE+  +  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQR 441
           H+N++ L+G C + G L ++ ++ + G+L  +L                 P+  + ++  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPAT 500
                 +A G+ YL     Q  IHRD+ A NVL+      K+ DFGLA  +        T
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 501 TRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           T      G L     APE       +  SDV++FG L+ E+   G  P
Sbjct: 263 TN-----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (319), Expect = 8e-33
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 21/219 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFV-SEIATIGRLRH 396
            +F   + LG G FG VY      SK  +A+K +      K GV   +  E+     LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
            N+++L G+      + L+ ++   G++   L     FDE +           I  +A+ 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-------ATYITELANA 121

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L Y H    + VIHRD+K  N+LL S    K+ DFG +           T + GTL YL 
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLP 175

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           PE           D+++ G L  E   G+ P E     E
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  127 bits (321), Expect = 9e-33
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 43/233 (18%)

Query: 345 KQLLGHGGFGQVYKGTLH-----NSKTEVAVKRI-SNESKQGVREFVSEIATIGRLRHRN 398
            + LG G FG+V K T          T VAVK +  N S   +R+ +SE   + ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL----------------------FDEPKAVL 436
           +++L G C + G LLL+ ++   GSL  FL                          +  L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHG 495
                      ++ G+ YL E     ++HRD+ A N+L+      K+ DFGL+  +YE  
Sbjct: 148 TMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 496 TNPATTRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRP 542
           +    ++     G +     A E+      +  SDV++FG LL E+   G  P
Sbjct: 205 SYVKRSQ-----GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (319), Expect = 1e-32
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 21/217 (9%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRL-RHRNLVQLVGW 405
           LG G +G V K     S   +AVKRI        ++  + ++    R       V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASGLLYLHEGY 459
             R+GD+ +  + M + SLD F     K V++  Q        KI   +   L +LH   
Sbjct: 75  LFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE----TP 515
           +  VIHRDVK SNVL+++    K+ DFG++       + A     G   Y+APE      
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERINPEL 185

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL 552
                S  SD+++ G  ++E+A  R P ++   P + 
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  126 bits (319), Expect = 2e-32
 Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 38/241 (15%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
            ++F    +LG G FGQV K          A+K+I +  ++ +   +SE+  +  L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 399 LVQLVG-WCRR------------KGDLLLVYDFMANGSLDSFLFD---EPKAVLNWEQRF 442
           +V+    W  R            K  L +  ++  NG+L    +D           ++ +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT-- 500
           ++ + +   L Y+H    Q +IHRD+K  N+ +D   N K+GDFGLAK      +     
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 501 -----------TRVVGTLGYLAPE-TPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL 548
                      T  +GT  Y+A E    TG  +   D+++ G +  E+         R  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236

Query: 549 P 549
            
Sbjct: 237 I 237

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  126 bits (318), Expect = 6e-32
 Identities = 71/253 (28%), Positives = 105/253 (41%), Gaps = 22/253 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREF-VSEIATIGRLRHRNLVQLVGWC 406
           LG G  G V+K +   S   +A K I  E K  +R   + E+  +       +V   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 407 RRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
              G++ +  + M  GSLD  L       E   +L      K+   V  GL YL E  + 
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILG-----KVSIAVIKGLTYLRE--KH 151

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
            ++HRDVK SN+L++S    KL DFG++ +L     +      VGT  Y++PE  +    
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHY 207

Query: 521 SASSDVFAFGALLLEVACGRRPI--ETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE 578
           S  SD+++ G  L+E+A GR PI        E +                      LN  
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 579 YDQSQVLMGELEL 591
              S+  M   EL
Sbjct: 268 GMDSRPPMAIFEL 280

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  124 bits (313), Expect = 9e-32
 Identities = 51/240 (21%), Positives = 91/240 (37%), Gaps = 33/240 (13%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRN 398
            +F   Q LG GGFG V++          A+KRI     +    + + E+  + +L H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 399 LVQL---------VGWCRRKGDLLLVY---DFMANGSLDSFLFDEPKAVLNWEQRF--KI 444
           +V+              +     + +Y         +L  ++ +    +   E+     I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHI 123

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV- 503
              +A  + +LH    + ++HRD+K SN+    +   K+GDFGL    +      T    
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 504 ----------VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
                     VGT  Y++PE       S   D+F+ G +L E+     P  T+      +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  124 bits (314), Expect = 1e-31
 Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 22/231 (9%)

Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR 382
           L++ P+    Q       +      +G G +G V K     S   +AVKRI +   +  +
Sbjct: 9   LKISPE----QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64

Query: 383 E-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---FDEPKAVLN 437
           +  + ++  + R      +VQ  G   R+GD  +  + M+  S D F    +     V+ 
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIP 123

Query: 438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGT 496
            E   KI       L +L E     +IHRD+K SN+LLD   N KL DFG+  +L     
Sbjct: 124 EEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL----V 177

Query: 497 NP-ATTRVVGTLGYLAPE----TPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +  A TR  G   Y+APE    +         SDV++ G  L E+A GR P
Sbjct: 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (318), Expect = 1e-31
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 21/223 (9%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRL 394
             + + +    +LG G    V++G    +    A+K  +N S     +  + E   + +L
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 395 RHRNLVQL--VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF-KIIKGVASG 451
            H+N+V+L  +         +L+ +F   GSL + L +   A    E  F  +++ V  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 452 LLYLHEGYEQVVIHRDVKASNVLL----DSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           + +L    E  ++HR++K  N++     D +   KL DFG A+  E      +  + GT 
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTE 179

Query: 508 GYLAPE--------TPRTGKSSASSDVFAFGALLLEVACGRRP 542
            YL P+             K  A+ D+++ G      A G  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  124 bits (313), Expect = 2e-31
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 43/244 (17%)

Query: 345 KQLLGHGGFGQVYKGTLH-----NSKTEVAVKRI-SNESKQGVREFVSEIATIGRL-RHR 397
            ++LG G FG+V   T +         +VAVK +            +SE+  + +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------------------FDEPKAVL 436
           N+V L+G C   G + L++++   G L ++L                      +E   VL
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA-KLYEHG 495
            +E        VA G+ +L     +  +HRD+ A NVL+      K+ DFGLA  +    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 496 TNPATTRVVGTLGYL-----APETPRTGKSSASSDVFAFGALLLEVA-CGRRPIETRALP 549
                         L     APE+   G  +  SDV+++G LL E+   G  P     + 
Sbjct: 227 NYVVRGN-----ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281

Query: 550 EELV 553
               
Sbjct: 282 ANFY 285

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  123 bits (310), Expect = 2e-31
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 10/206 (4%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           +     LG G FG+VYK     +    A K I  +S++ + +++ EI  +    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+G     G L ++ +F   G++D+ +  E    L   Q   + + +   L +LH    +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SK 136

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE-----TPR 516
            +IHRD+KA NVL+  E + +L DFG++           +  +GT  ++APE     T +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
                  +D+++ G  L+E+A    P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  121 bits (305), Expect = 1e-30
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLV 400
           F+  + +G G FG+V+KG  + ++  VA+K I  E  +  + +   EI  + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFL----FDEPK-AVLNWEQRFKIIKGVASGLLYL 455
           +  G   +   L ++ +++  GS    L     DE + A         I++ +  GL YL
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--------ILREILKGLDYL 135

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H    +  IHRD+KA+NVLL      KL DFG+A           T  VGT  ++APE  
Sbjct: 136 HS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 191

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRP 542
           +     + +D+++ G   +E+A G  P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  119 bits (301), Expect = 3e-30
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 21/219 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFV-SEIATIGRLRH 396
           ++F   + LG G FG VY      +K  +A+K +      K+GV   +  EI     LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
            N++++  +   +  + L+ +F   G L   L     FDE ++          ++ +A  
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS-------ATFMEELADA 126

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L Y HE   + VIHRD+K  N+L+  +   K+ DFG +             + GTL YL 
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLP 180

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           PE           D++  G L  E   G  P ++ +  E
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  121 bits (305), Expect = 3e-30
 Identities = 29/245 (11%), Positives = 58/245 (23%), Gaps = 44/245 (17%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI---SNESKQGVREFVSEIAT 390
            L Q        + L  G    V+         + A+K     +  S+  +         
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 391 IGRLRHRNLVQLVGWCR--------------------------RKGDLLLVYDFMANGSL 424
             RL   +  +     R                             + LL+    +   L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL 174

Query: 425 DSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
           +            +          +   +      L     + ++H      N+ +  + 
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDG 231

Query: 480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE--TPRTGKSSASSDVFAFGALLLEVA 537
              LGD       + GT          + Y   E     T   + + + +  G  +  V 
Sbjct: 232 RLMLGDVSALW--KVGTRGPA--SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 538 CGRRP 542
           C   P
Sbjct: 288 CLFLP 292

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  120 bits (303), Expect = 3e-30
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 36/245 (14%)

Query: 323 LEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR 382
           +E+G  R               +++L  GGF  VY+     S  E A+KR+ +  ++  R
Sbjct: 23  VELGELRLR------------VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR 70

Query: 383 EFVSEIATIGRLR-HRNLVQLVGWC--------RRKGDLLLVYDFMANGSLDSFLFDEPK 433
             + E+  + +L  H N+VQ               + + LL+ +      ++     E +
Sbjct: 71  AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR 130

Query: 434 AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE 493
             L+ +   KI       + ++H   +  +IHRD+K  N+LL ++   KL DFG A    
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

Query: 494 HGTNPATTR-----------VVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACG 539
           H  + + +               T  Y  PE              D++A G +L  +   
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

Query: 540 RRPIE 544
           + P E
Sbjct: 250 QHPFE 254

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (302), Expect = 6e-30
 Identities = 48/241 (19%), Positives = 89/241 (36%), Gaps = 32/241 (13%)

Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
                 +E  +  N++   + L  G F ++            A+K+      +  R+F  
Sbjct: 18  YLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTK 75

Query: 387 -----------------EIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF 429
                            E+  I  +++   +   G      ++ ++Y++M N S+  F  
Sbjct: 76  SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135

Query: 430 DEPKAVLNWEQRF------KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKL 483
                  N+           IIK V +   Y+H   E+ + HRDVK SN+L+D     KL
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKL 193

Query: 484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPE--TPRTGKSSASSDVFAFGALLLEVACGRR 541
            DFG ++              GT  ++ PE  +  +  + A  D+++ G  L  +     
Sbjct: 194 SDFGESEYMVDKK---IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

Query: 542 P 542
           P
Sbjct: 251 P 251

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (306), Expect = 7e-30
 Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 20/213 (9%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNL 399
           +F  K +LGHG  G +    + +++ +VAVKRI  E          E+  +     H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFAD---REVQLLRESDEHPNV 80

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           ++     + +    +  +  A  +L  ++ ++        +   +++   SGL +LH   
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLH--- 135

Query: 460 EQVVIHRDVKASNVLL-----DSELNGKLGDFGLAKLYEHGTNPATTR--VVGTLGYLAP 512
              ++HRD+K  N+L+       ++   + DFGL K    G +  + R  V GT G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 513 E---TPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E          + + D+F+ G +   V      
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (298), Expect = 8e-30
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 9/202 (4%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
           ++  + +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
            +       +L +V +++A GSL   + +     ++  Q   + +     L +LH     
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SN 135

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
            VIHRD+K+ N+LL  + + KL DFG  A++    +  +T  +VGT  ++APE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 193

Query: 521 SASSDVFAFGALLLEVACGRRP 542
               D+++ G + +E+  G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  118 bits (298), Expect = 1e-29
 Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 18/228 (7%)

Query: 322 ELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV 381
            L +G QRY  +      N+      +G G  GQV+K     +   +AVK++     +  
Sbjct: 12  YLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE 66

Query: 382 RE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWE 439
            +  + ++  + +      +VQ  G      D+ +  + M     +          +   
Sbjct: 67  NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG-PIPER 124

Query: 440 QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA 499
              K+   +   L YL E  +  VIHRDVK SN+LLD     KL DFG++       + A
Sbjct: 125 ILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKA 180

Query: 500 TTRVVGTLGYLAPE-----TPRTGKSSASSDVFAFGALLLEVACGRRP 542
             R  G   Y+APE      P        +DV++ G  L+E+A G+ P
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (298), Expect = 2e-29
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 9/202 (4%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ 401
             +   +G G  G V      +S  +VAVK +    +Q      +E+  +   +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           +        +L ++ +F+  G+L   +       LN EQ   + + V   L YLH    Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH---AQ 160

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
            VIHRD+K+ ++LL  +   KL DFG  A++ +      +  +VGT  ++APE       
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLY 218

Query: 521 SASSDVFAFGALLLEVACGRRP 542
           +   D+++ G +++E+  G  P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (296), Expect = 2e-29
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 7/204 (3%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
              F   + LG G +G VYK     +   VA+K++  ES   ++E + EI+ + +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+  G   +  DL +V ++   GS+   +       L  ++   I++    GL YLH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF- 143

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
                IHRD+KA N+LL++E + KL DFG+A           T V+GT  ++APE  +  
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 200

Query: 519 KSSASSDVFAFGALLLEVACGRRP 542
             +  +D+++ G   +E+A G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (294), Expect = 3e-29
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 15/215 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRN 398
           +++  ++++G G    V        K +VA+KRI+ E  Q  + E + EI  + +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK------IIKGVASGL 452
           +V        K +L LV   ++ GS+   +        +            I++ V  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTR---VVGTLG 508
            YLH+      IHRDVKA N+LL  + + ++ DFG+ A L   G           VGT  
Sbjct: 135 EYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 509 YLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           ++APE     +     +D+++FG   +E+A G  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  118 bits (296), Expect = 6e-29
 Identities = 50/216 (23%), Positives = 79/216 (36%), Gaps = 15/216 (6%)

Query: 339 TNNFSAKQLLGHG--GFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGRL 394
              +    ++G G      V       +   V V+RI+    S + V     E+      
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+V          +L +V  FMA GS    +       +N      I++GV   L Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG-LAKLYEHGTNPAT-----TRVVGTLG 508
           +H       +HR VKAS++L+  +    L        +  HG             V  L 
Sbjct: 144 IHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 509 YLAPETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           +L+PE  +       A SD+++ G    E+A G  P
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (293), Expect = 2e-28
 Identities = 30/236 (12%), Positives = 61/236 (25%), Gaps = 44/236 (18%)

Query: 347 LLGHGGFGQVYKGTLHNSKTEVAVKRIS---NESKQGVREFVSEIATIGRLR-------- 395
           +LG        + T   +     V             +++   E+  +  LR        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 396 -----------------HRNLVQLVGWCRRKGDLLLVYDFM-ANGSLDSF---LFDEPKA 434
                             + ++++    R    L   + +     +L +F   L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 435 --VLNWEQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
              L    R ++   V   L  LH  G    ++H  ++  +++LD      L  F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 492 YEHGTNPATTRVVGTLGYLAPET-----PRTGKSSASSDVFAFGALLLEVACGRRP 542
                     R        A              + + D +  G  +  + C   P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  114 bits (287), Expect = 2e-28
 Identities = 44/236 (18%), Positives = 83/236 (35%), Gaps = 47/236 (19%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRL-R 395
           T  F   + +G G FG V+K          A+KR           +  + E+     L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---------FDEPKAVLNWEQRFKIIK 446
           H ++V+          +L+  ++   GSL   +         F E + + +       + 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE-LKDL------LL 122

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLD-------------------SELNGKLGDFG 487
            V  GL Y+H      ++H D+K SN+ +                    +++  K+GD G
Sbjct: 123 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
                   ++P      G   +LA E  +   +    +D+FA    ++  A     
Sbjct: 180 HVT---RISSPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (299), Expect = 3e-28
 Identities = 40/220 (18%), Positives = 77/220 (35%), Gaps = 39/220 (17%)

Query: 347 LLGHGGFGQVYKGTLHN-SKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRNLVQLVG 404
            + HGG G +Y     N +   V +K + +      +   ++E   +  + H ++VQ   
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ--- 143

Query: 405 WCRRKGDLLLVYDF----MANGSLDSF----------LFDEPKAVLNWEQRFKIIKGVAS 450
                     +++F      +G    +          L       L   +    +  +  
Sbjct: 144 ----------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILP 193

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            L YLH      +++ D+K  N++L  E   KL D G           +   + GT G+ 
Sbjct: 194 ALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQ 244

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
           APE  R    + ++D++  G  L  +         R +  
Sbjct: 245 APEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (289), Expect = 4e-28
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS---NESKQGVREFVSEIATIGRLRHRN 398
           FS  + +GHG FG VY      +   VA+K++S    +S +  ++ + E+  + +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            +Q  G   R+    LV ++    + D  L +  K  L   +   +  G   GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGL-AKLYEHGTNPATTRVVGTLGYLAPETPRT 517
               +IHRDVKA N+LL      KLGDFG  + +    +       VGT  ++APE    
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILA 224

Query: 518 GKSS---ASSDVFAFGALLLEVACGRRP 542
                     DV++ G   +E+A  + P
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP 252

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  114 bits (287), Expect = 6e-28
 Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 37/199 (18%)

Query: 333 QELKQATNNFSA----KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEI 388
           Q+L + +  F+     K+ +G G +    +     +  E AVK I ++SK+   E   EI
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTE---EI 66

Query: 389 ATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNW 438
             + R  +H N++ L         + +V + M  G     L D         E +A    
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE----LLDKILRQKFFSEREAS--- 119

Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEH 494
                ++  +   + YLH    Q V+HRD+K SN+L   E       ++ DFG AK    
Sbjct: 120 ----AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

Query: 495 GTNPATTRVVGTLGYLAPE 513
                 T    T  ++APE
Sbjct: 173 ENGLLMT-PCYTANFVAPE 190

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (286), Expect = 7e-28
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 17/221 (7%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR 393
            L+     F   +L+G+G +GQVYKG    +    A+K +         E   EI  + +
Sbjct: 18  ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKK 76

Query: 394 L-RHRNLVQLVG------WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIK 446
              HRN+    G             L LV +F   GS+   + +     L  E    I +
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
            +  GL +LH+     VIHRD+K  NVLL      KL DFG++   +       T  +GT
Sbjct: 137 EILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGT 192

Query: 507 LGYLAPETPRTGKSSASS-----DVFAFGALLLEVACGRRP 542
             ++APE     ++  ++     D+++ G   +E+A G  P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (283), Expect = 9e-28
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 8/200 (4%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQL 402
             LG GG   VY         +VA+K I       ++ ++ F  E+    +L H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
           +          LV +++   +L  ++  E    L+ +        +  G+ + H+     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
           ++HRD+K  N+L+DS    K+ DFG+AK     +   T  V+GT+ Y +PE  +   +  
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 523 SSDVFAFGALLLEVACGRRP 542
            +D+++ G +L E+  G  P
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP 211

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  112 bits (282), Expect = 1e-27
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 8/200 (4%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE-FVSEIATIGRLRHRNLVQL 402
           +L+G GG G VY+      +  VA+K +S    S    R     E  T GRL+  ++V +
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV 462
             +    G L +    +    L + L  +    L   +   I++ + S L   H      
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AG 154

Query: 463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSA 522
             HRDVK  N+L+ ++    L DFG+A              VGTL Y+APE      ++ 
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 523 SSDVFAFGALLLEVACGRRP 542
            +D++A   +L E   G  P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  112 bits (283), Expect = 3e-27
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 309 IKKIKNAEVIEDWELEVGPQRYSYQELKQATNN----FSAKQLLGHGGFGQVYKGTLHNS 364
           +K  + + +  D      P  +     KQ   N     S  ++LG G FGQV+K     +
Sbjct: 54  VKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT 113

Query: 365 KTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL 424
             ++A K I     +   E  +EI+ + +L H NL+QL      K D++LV +++  G L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173

Query: 425 ------DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE 478
                 +S+   E   +         +K +  G+ ++H   +  ++H D+K  N+L  + 
Sbjct: 174 FDRIIDESYNLTELDTI-------LFMKQICEGIRHMH---QMYILHLDLKPENILCVNR 223

Query: 479 LNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
                K+ DFGLA+ Y+           GT  +LAPE
Sbjct: 224 DAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPE 258

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  111 bits (279), Expect = 5e-27
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 35/213 (16%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLV 403
            + LG G F    K     S    AVK IS   +   ++   EI  +     H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLLY 454
                +    LV + +  G     LF+         E +A         I++ + S + +
Sbjct: 73  EVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEAS-------YIMRKLVSAVSH 121

Query: 455 LHEGYEQVVIHRDVKASNVLL-----DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           +H   +  V+HRD+K  N+L      + E+  K+ DFG A+L      P  T    TL Y
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKT-PCFTLHY 175

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            APE         S D+++ G +L  +  G+ P
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  112 bits (281), Expect = 6e-27
 Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 26/215 (12%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
            + +   + LG G FG V++     +      K I+           +EI+ + +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSL------DSFLFDEPKAVLNWEQRFKIIKGVASGL 452
           L+ L      K +++L+ +F++ G L      + +   E + +         ++    GL
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI-------NYMRQACEGL 162

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            ++H   E  ++H D+K  N++ +++     K+ DFGLA                T  + 
Sbjct: 163 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFA 217

Query: 511 APETPRTGKSSASSDVFAFGAL---LLEVACGRRP 542
           APE          +D++A G L   LL    G  P
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLL---SGLSP 249

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 9e-27
 Identities = 49/214 (22%), Positives = 95/214 (44%), Gaps = 20/214 (9%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHR 397
            + F  K+ LG G FG V+     +S  E  +K I+ + S+  + +  +EI  +  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASG 451
           N++++        ++ +V +    G     L +   +     +        +++K + + 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLG 508
           L Y H    Q V+H+D+K  N+L          K+ DFGLA+L++   +       GT  
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTAL 191

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y+APE  +    +   D+++ G ++  +  G  P
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  113 bits (285), Expect = 1e-26
 Identities = 57/250 (22%), Positives = 101/250 (40%), Gaps = 30/250 (12%)

Query: 308 IIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAK----QLLGHGGFGQVYKGTLHN 363
           I++         D  +    ++Y  Q ++   ++        + LG G FG V++ T   
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180

Query: 364 SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGS 423
           +    A K +    +        EI T+  LRH  LV L        +++++Y+FM+ G 
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240

Query: 424 L------DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS 477
           L      +     E +AV       + ++ V  GL ++H   E   +H D+K  N++  +
Sbjct: 241 LFEKVADEHNKMSEDEAV-------EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTT 290

Query: 478 ELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGAL--- 532
           + +   KL DFGL    +   +       GT  + APE          +D+++ G L   
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348

Query: 533 LLEVACGRRP 542
           LL    G  P
Sbjct: 349 LL---SGLSP 355

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (275), Expect = 1e-26
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 29/210 (13%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
            ++LG G F +V+      +    A+K I            +EIA + +++H N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLLYL 455
                    LV   ++ G     LFD         E  A         +I+ V S + YL
Sbjct: 74  IYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-------LVIQQVLSAVKYL 122

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
           H   E  ++HRD+K  N+L  +        + DFGL+K+ ++G     +   GT GY+AP
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAP 176

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E       S + D ++ G +   + CG  P
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  109 bits (274), Expect = 1e-26
 Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 36/192 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGR 393
           ++N+  K+ LG G F  V +     +  E A K I     S    Q +     E     +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKI 444
           L+H N+V+L    + +    LV+D +  G     LF+         E  A          
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-------HC 110

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATT 501
           I+ +   + Y H      ++HR++K  N+LL S+  G   KL DFGLA         A  
Sbjct: 111 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH 165

Query: 502 RVVGTLGYLAPE 513
              GT GYL+PE
Sbjct: 166 GFAGTPGYLSPE 177

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  108 bits (272), Expect = 3e-26
 Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 39/201 (19%)

Query: 336 KQATNNFSAK----QLLGHGGFGQVYKGTLHNSKTEVAVKRIS--------NESKQGVRE 383
             +T+ F       ++LG G    V +     +  E AVK I          E  Q +RE
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 384 FV-SEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EP 432
               E+  + ++  H N++QL           LV+D M  G L    FD         E 
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124

Query: 433 KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY 492
           +         KI++ +   +  LH+     ++HRD+K  N+LLD ++N KL DFG +   
Sbjct: 125 ETR-------KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 493 EHGTNPATTRVVGTLGYLAPE 513
           + G       V GT  YLAPE
Sbjct: 175 DPGEKLRE--VCGTPSYLAPE 193

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  108 bits (272), Expect = 3e-26
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 14/206 (6%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQL 402
           ++LG GG  +V+         +VAVK +  +          F  E      L H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 403 --VGWCRRKGDLL--LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
              G        L  +V +++   +L   +  E    +  ++  ++I      L + H+ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ- 134

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT--RVVGTLGYLAPETPR 516
               +IHRDVK +N+++ +    K+ DFG+A+      N  T    V+GT  YL+PE  R
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
                A SDV++ G +L EV  G  P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (273), Expect = 4e-26
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 15/179 (8%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV-----REFVSEIATIGRL 394
             +     LG G +  VYKG    +   VA+K I  E ++G      RE    ++ +  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           +H N+V L      +  L LV++++ +  L  +L D+   ++N       +  +  GL Y
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
            H      V+HRD+K  N+L++     KL DFGLA+     T      VV TL Y  P+
Sbjct: 116 CHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  110 bits (278), Expect = 4e-26
 Identities = 52/189 (27%), Positives = 78/189 (41%), Gaps = 29/189 (15%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRH 396
           T  +   + LG G F  V +     +  E A   I     S +  ++   E      L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKG 447
            N+V+L      +G   L++D +  G     LF+         E  A          I+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADAS-------HCIQQ 118

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVV 504
           +   +L+ H   +  V+HR++K  N+LL S+L G   KL DFGLA   E           
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FA 174

Query: 505 GTLGYLAPE 513
           GT GYL+PE
Sbjct: 175 GTPGYLSPE 183

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (269), Expect = 5e-26
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           +  +G G +G+V       ++   A K+I     + V  F  EI  +  L H N+++L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLLYL 455
                 D+ LV +    G     LF+         E  A        +I+K V S + Y 
Sbjct: 74  TFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-------RIMKDVLSAVAYC 122

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
           H   +  V HRD+K  N L  ++      KL DFGLA  ++ G    T   VGT  Y++P
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSP 177

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +    G      D ++ G ++  + CG  P
Sbjct: 178 QVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (272), Expect = 6e-26
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 28/215 (13%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-----NESKQGVREFVSEIATIGRLRHRNL 399
            +++G G F  V +     +  + AVK +      +       +   E +    L+H ++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KIIKGVASGLL 453
           V+L+      G L +V++FM        L  E     +    +        ++ +   L 
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           Y H   +  +IHRDVK   VLL S+ N    KLG FG+A         A  R VGT  ++
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFM 200

Query: 511 APETPRTGKSSASSDVFAFGAL---LLEVACGRRP 542
           APE  +        DV+  G +   LL    G  P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILL---SGCLP 232

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  107 bits (270), Expect = 6e-26
 Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 18/175 (10%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV-----REFVSEIATIGRLRHRNLVQL 402
           LG+G +  VYKG    +   VA+K +  +S++G      RE    I+ +  L+H N+V+L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVRL 68

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA----SGLLYLHEG 458
                 +  L LV++FM +  L  ++               ++K        GL + HE 
Sbjct: 69  YDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
               ++HRD+K  N+L++     KLGDFGLA+ +    N  ++ VV TL Y AP+
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPD 178

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  107 bits (270), Expect = 6e-26
 Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 33/188 (17%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLV 403
           + +LG G   +V       +  E AVK I  +          E+  + + + HRN+++L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLLY 454
            +   +    LV++ M  GS    +           E +A         +++ VAS L +
Sbjct: 78  EFFEEEDRFYLVFEKMRGGS----ILSHIHKRRHFNELEAS-------VVVQDVASALDF 126

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHG------TNPATTRVVG 505
           LH    + + HRD+K  N+L +        K+ DF L    +        + P      G
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 506 TLGYLAPE 513
           +  Y+APE
Sbjct: 184 SAEYMAPE 191

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (277), Expect = 7e-26
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)

Query: 322 ELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESK 378
            L   P  +        ++ +  +++LG G FG+V       +  E AVK IS    + K
Sbjct: 8   HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67

Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNW 438
                 + E+  + +L H N+++L  +   KG   LV +    G     LFDE  +    
Sbjct: 68  TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIIS---- 119

Query: 439 EQRF------KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLA 489
            +RF      +II+ V SG+ Y+H   +  ++HRD+K  N+LL+S+      ++ DFGL+
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             +E          +GT  Y+APE    G      DV++ G +L  +  G  P
Sbjct: 177 THFEAS--KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  108 bits (272), Expect = 7e-26
 Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 36/192 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-----SNESKQGVREFVSEIATIGR 393
           ++N+  K+ LG G F  V +     +  E A K I     S    Q +     E     +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 84

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKI 444
           L+H N+V+L    + +    LV+D +  G     LF+         E  A          
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-------HC 133

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATT 501
           I+ +   + Y H      ++HR++K  N+LL S+  G   KL DFGLA         A  
Sbjct: 134 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH 188

Query: 502 RVVGTLGYLAPE 513
              GT GYL+PE
Sbjct: 189 GFAGTPGYLSPE 200

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (277), Expect = 8e-26
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 25/234 (10%)

Query: 320 DWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNES 377
             +L+  P  +   +    +  +   + LG G +G+V       +  E A+K I  ++ S
Sbjct: 17  QGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS 76

Query: 378 KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLN 437
                + + E+A +  L H N+++L  +   K +  LV +    G     LFDE      
Sbjct: 77  TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIH--- 129

Query: 438 WEQRF------KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGL 488
              +F       IIK V SG+ YLH   +  ++HRD+K  N+LL+S+      K+ DFGL
Sbjct: 130 -RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185

Query: 489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           + ++E+         +GT  Y+APE  R  K     DV++ G +L  +  G  P
Sbjct: 186 SAVFENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  107 bits (270), Expect = 8e-26
 Identities = 48/220 (21%), Positives = 94/220 (42%), Gaps = 31/220 (14%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NESKQGVREFVSEIATIGR 393
           K+    +   + LG G FG V++    +SK     K +      +  V++   EI+ +  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNI 57

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSL------DSFLFDEPKAVLNWEQRFKIIKG 447
            RHRN++ L        +L+++++F++   +       +F  +E + V         +  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQ 110

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVG 505
           V   L +LH      + H D++  N++  +  +   K+ +FG A+  + G N     +  
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFT 165

Query: 506 TLGYLAPETPRTGKSSASSDVFAFGAL---LLEVACGRRP 542
              Y APE  +    S ++D+++ G L   LL    G  P
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLL---SGINP 202

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  106 bits (267), Expect = 9e-26
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 31/230 (13%)

Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREF 384
             R +          ++   +LG G FG+V K     ++ E AVK I  ++   +     
Sbjct: 9   SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68

Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAV 435
           + E+  + +L H N+++L           +V +    G     LFD         E  A 
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA 124

Query: 436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLY 492
                  +IIK V SG+ Y+H   +  ++HRD+K  N+LL+S+      K+ DFGL+  +
Sbjct: 125 -------RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +  T       +GT  Y+APE  R G      DV++ G +L  +  G  P
Sbjct: 175 QQNTKMKD--RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  109 bits (273), Expect = 1e-25
 Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 38/233 (16%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRN 398
           N   ++++LG+G  G V        +  VAVKR+           + EI  +     H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRML---IDFCDIALMEIKLLTESDDHPN 70

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLL 453
           +++          L +  +   N +L   +      DE   +        +++ +ASG+ 
Sbjct: 71  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG-------------KLGDFGLAKLYEHGTNPAT 500
           +LH      +IHRD+K  N+L+ +                  + DFGL K  + G +   
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 501 TR---VVGTLGYLAPE-------TPRTGKSSASSDVFAFGALLLEVAC-GRRP 542
           T      GT G+ APE            + + S D+F+ G +   +   G+ P
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (269), Expect = 1e-25
 Identities = 66/252 (26%), Positives = 101/252 (40%), Gaps = 56/252 (22%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-NESKQGVREFVSEIATIGRLRHRNLVQLV 403
           +  LG G    VY+     ++   A+K +     K+ VR   +EI  + RL H N+++L 
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHPNIIKLK 114

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLLY 454
                  ++ LV + +  G     LFD         E  A          +K +   + Y
Sbjct: 115 EIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAA-------DAVKQILEAVAY 163

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           LH   E  ++HRD+K  N+L  +       K+ DFGL+K+ EH        V GT GY A
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCA 218

Query: 512 PETPRTGKSSASSDVFAFGA---LLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL 568
           PE  R        D+++ G    +LL   CG  P                + + G+  + 
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILL---CGFEP---------------FYDERGDQFMF 260

Query: 569 EVIDPKLNAEYD 580
             I   LN EY 
Sbjct: 261 RRI---LNCEYY 269

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (269), Expect = 2e-25
 Identities = 58/244 (23%), Positives = 94/244 (38%), Gaps = 48/244 (19%)

Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI-------SNESKQ 379
            +   +   K+    +  K ++G G    V +     +  E AVK +       S E  +
Sbjct: 81  DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE 140

Query: 380 GVREFV-SEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD------- 430
            VRE    E   + ++  H +++ L+        + LV+D M  G L    FD       
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVA 196

Query: 431 --EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL 488
             E +          I++ +   + +LH      ++HRD+K  N+LLD  +  +L DFG 
Sbjct: 197 LSEKETR-------SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGF 246

Query: 489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASS------DVFAFG----ALLLEVAC 538
           +   E G       + GT GYLAPE  +              D++A G     LL     
Sbjct: 247 SCHLEPG-EKLRE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL----A 300

Query: 539 GRRP 542
           G  P
Sbjct: 301 GSPP 304

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score =   99 bits (249), Expect = 3e-25
 Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 8/108 (7%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNV 80
           F  F     +L  QG A    N +L++T   S         G+  YS+ LR     ++ +
Sbjct: 8   FTKFDPNQEDLIFQGHATS-TNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVL 65

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTD 128
            SF T     I   Y      GLAF I+P + +      +LGL  + +
Sbjct: 66  TSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYHGGFLGLFPNAN 113

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (265), Expect = 4e-25
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 17/212 (8%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVS------EIATIG 392
            +S    LG G FG V+         EV VK I  E   +    E         EIA + 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGL 452
           R+ H N+++++     +G   LV +   +G LD F F +    L+      I + + S +
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            YL     + +IHRD+K  N+++  +   KL DFG A   E G    T    GT+ Y AP
Sbjct: 144 GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAP 198

Query: 513 ETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           E    G        ++++ G  L  +     P
Sbjct: 199 EV-LMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (266), Expect = 5e-25
 Identities = 34/254 (13%), Positives = 67/254 (26%), Gaps = 53/254 (20%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIAT 390
           EL +         +LG        + T   +     V       +     +++   E+  
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 391 IGRLR-------------------------HRNLVQLVGWCRRKG--DLLLVYDFMA--N 421
           +  LR                          + ++++    R         +Y  M    
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 422 GSLDSFLFDEPKA--VLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
            +    L         L    R ++   V   L  LH      ++H  ++  +++LD   
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 243

Query: 480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET-----------PRTGKSSASSDVFA 528
              L  F                   + G+  PE             R    + S D +A
Sbjct: 244 GVFLTGFEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 529 FGALLLEVACGRRP 542
            G ++  + C   P
Sbjct: 299 LGLVIYWIWCADLP 312

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (263), Expect = 6e-25
 Identities = 46/190 (24%), Positives = 78/190 (41%), Gaps = 27/190 (14%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS------NESKQGVREFVSEIATIG 392
            + +   + LG G F  V K    ++  E A K I       +       E   E++ + 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKG 447
           ++ H N++ L      + D++L+ + ++ G L           E +A          IK 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQ 123

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPATTRV 503
           +  G+ YLH    + + H D+K  N++L  +       KL DFGLA   E G       +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178

Query: 504 VGTLGYLAPE 513
            GT  ++APE
Sbjct: 179 FGTPEFVAPE 188

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (270), Expect = 6e-25
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 42/246 (17%)

Query: 322 ELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS------- 374
            + + P  Y  ++  +   ++   + LG G +G+V      N  +E A+K I        
Sbjct: 18  GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77

Query: 375 ------NESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL 428
                    ++   E  +EI+ +  L H N+++L      K    LV +F   G     L
Sbjct: 78  RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----L 133

Query: 429 FD---------EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
           F+         E  A         I+K + SG+ YLH   +  ++HRD+K  N+LL+++ 
Sbjct: 134 FEQIINRHKFDECDAA-------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKN 183

Query: 480 NG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           +    K+ DFGL+  +           +GT  Y+APE  +  K +   DV++ G ++  +
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240

Query: 537 ACGRRP 542
            CG  P
Sbjct: 241 LCGYPP 246

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  105 bits (264), Expect = 6e-25
 Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 42/238 (17%)

Query: 327 PQRYSYQELKQATNNFSA-----KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV 381
                +Q  +      +      KQ+LG G  G+V +     +  + A+K + +  K   
Sbjct: 11  GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--A 68

Query: 382 REFVSEIATIGRL-RHRNLVQLVGWC----RRKGDLLLVYDFMANGSL-------DSFLF 429
           R+   E+    +     ++V ++         K  LL++ + M  G L           F
Sbjct: 69  RQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125

Query: 430 DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL-----DSELNGKLG 484
            E +A        +I++ + + + +LH      + HRDVK  N+L      D+ L  KL 
Sbjct: 126 TEREAA-------EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL--KLT 173

Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           DFG AK          T    T  Y+APE     K   S D+++ G ++  + CG  P
Sbjct: 174 DFGFAKETTQN--ALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (264), Expect = 7e-25
 Identities = 38/230 (16%), Positives = 73/230 (31%), Gaps = 25/230 (10%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGT-----LHNSKTEVAVKRISNESKQGVREFVSEI 388
           E +  +       LLG G F QVY+ T        +K +  +K     +          +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL---FDEPKAVLNWEQRFKII 445
             +        ++       +   +LV +  + G+L + +    + P+ V+         
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLL-----------DSELNGKLGDFGLAK-LYE 493
             +   +  +H   +  +IH D+K  N +L           D      L D G +  +  
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
                  T    T G+   E   + K  +   D F   A +  +  G   
Sbjct: 236 FPKGTIFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  108 bits (272), Expect = 9e-25
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSE---IATIGR 393
           N+FS  +++G GGFG+VY     ++    A+K +  +    KQG    ++E   ++ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGV 448
                +V +         L  + D M  G L   L     F E         RF   + +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM------RFYAAE-I 301

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
             GL ++H    + V++RD+K +N+LLD   + ++ D GLA  +           VGT G
Sbjct: 302 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHG 355

Query: 509 YLAPETPRTGKS-SASSDVFAFGALLLEVACGRRP 542
           Y+APE  + G +  +S+D F+ G +L ++  G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  107 bits (269), Expect = 9e-25
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 24/227 (10%)

Query: 329 RYSYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREF 384
           ++ + E +    + F   ++LG GGFG+V+   +  +    A K+++ +    ++G +  
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232

Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL---------DSFLFDEPKAV 435
           + E   + ++  R +V L      K DL LV   M  G +         D+  F EP+A 
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA- 291

Query: 436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
                 F   + + SGL +LH+   + +I+RD+K  NVLLD + N ++ D GLA   + G
Sbjct: 292 -----IFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342

Query: 496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
                    GT G++APE     +   S D FA G  L E+   R P
Sbjct: 343 QTKTKGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (263), Expect = 1e-24
 Identities = 46/190 (24%), Positives = 78/190 (41%), Gaps = 27/190 (14%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS------NESKQGVREFVSEIATIG 392
            + +   + LG G F  V K    ++  E A K I       +       E   E++ + 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKG 447
           ++ H N++ L      + D++L+ + ++ G L           E +A          IK 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQ 123

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPATTRV 503
           +  G+ YLH    + + H D+K  N++L  +       KL DFGLA   E G       +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178

Query: 504 VGTLGYLAPE 513
            GT  ++APE
Sbjct: 179 FGTPEFVAPE 188

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  104 bits (262), Expect = 1e-24
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 16/180 (8%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGR 393
             +    L+G G +G V K    ++   VA+K+       + V     RE    I  + +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE----IKLLKQ 80

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           LRH NLV L+  C++K    LV++F+ + ++   L +     L+++   K +  + +G+ 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIG 138

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           + H      +IHRD+K  N+L+      KL DFG A+            V  T  Y APE
Sbjct: 139 FCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  107 bits (269), Expect = 1e-24
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 23/224 (10%)

Query: 330 YSYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFV 385
           + + E +  T N F   ++LG GGFG+V    +  +    A K++  +    ++G    +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232

Query: 386 SEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNW 438
           +E   + ++  R +V L      K  L LV   M  G L           F E +A    
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA---- 288

Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP 498
              F   + +  GL  LH    + +++RD+K  N+LLD   + ++ D GLA     G   
Sbjct: 289 --VFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT 341

Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
              R VGT+GY+APE  +  + + S D +A G LL E+  G+ P
Sbjct: 342 IKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (260), Expect = 1e-24
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 21/213 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES----KQGVREFVSEIATIGRLR 395
            +F   ++LG G F  V       +  E A+K +         + V     E   + RL 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLD 88

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
           H   V+L    +    L     +  NG L  ++     FDE         RF   + + S
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAE-IVS 141

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR-VVGTLGY 509
            L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+    +  A     VGT  Y
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           ++PE      +  SSD++A G ++ ++  G  P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 2e-24
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 24/208 (11%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFD--EPKAVLN-WEQRFK---IIKGVASGLLYLHEG 458
             R      L  ++ + G L    FD  EP   +   + +     ++ GV     YLH  
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG- 123

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA---TTRVVGTLGYLAPET- 514
               + HRD+K  N+LLD   N K+ DFGLA ++ +             GTL Y+APE  
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELL 179

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
            R    +   DV++ G +L  +  G  P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (264), Expect = 2e-24
 Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 52/270 (19%)

Query: 308 IIKKIKNAEVIEDWELEVGPQR---YSYQELKQATNNFSAKQL---------LGHGGFGQ 355
           ++ K K   +  + E+ +   R   + + +L     +   K L         LG G  G+
Sbjct: 91  LVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150

Query: 356 VYKGTLHNSKTEVAVKRIS--------NESKQGVREFVSEIATIGRLRHRNLVQLVGWCR 407
           V       +  +VA++ IS                   +EI  + +L H  ++++  +  
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210

Query: 408 RKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            + D  +V + M  G     LFD         E                +   + YLH  
Sbjct: 211 AE-DYYIVLELMEGGE----LFDKVVGNKRLKEATCK-------LYFYQMLLAVQYLH-- 256

Query: 459 YEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE-- 513
            E  +IHRD+K  NVLL S+      K+ DFG +K+    +   T  + GT  YLAPE  
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVL 313

Query: 514 -TPRTGKSSASSDVFAFGALLLEVACGRRP 542
            +  T   + + D ++ G +L     G  P
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  104 bits (261), Expect = 2e-24
 Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 30/185 (16%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGRLRHRNLVQ 401
           +G G FG+V+K     +  +VA+K++  E+ K+G      RE    I  +  L+H N+V 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 80

Query: 402 LVG--------WCRRKGDLLLVYDFMANGSLD-SFLFDEPKAVLNWEQRFKIIKGVASGL 452
           L+         + R KG + LV+DF      D + L           +  ++++ + +GL
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY----EHGTNPATTRVVGTLG 508
            Y+H      ++HRD+KA+NVL+  +   KL DFGLA+ +        N  T RVV TL 
Sbjct: 138 YYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLW 193

Query: 509 YLAPE 513
           Y  PE
Sbjct: 194 YRPPE 198

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  104 bits (262), Expect = 2e-24
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 38/216 (17%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLV 403
            Q+LG G  G+V +     ++ + A+K + +  K   R    E+    R  +  ++V++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARR---EVELHWRASQCPHIVRIV 121

Query: 404 GWC----RRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNWEQRFKIIKGVASGL 452
                    +  LL+V + +  G L           F E +A        +I+K +   +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGEAI 174

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGY 509
            YLH      + HRDVK  N+L  S+      KL DFG AK      N  TT    T  Y
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTT-PCYTPYY 229

Query: 510 LAPETPRTGKSSASSDVFAFGAL---LLEVACGRRP 542
           +APE     K   S D+++ G +   LL   CG  P
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILL---CGYPP 262

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  103 bits (258), Expect = 2e-24
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 16/180 (8%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGR 393
             +     +G G +G V+K    ++   VA+K+         +     RE    I  + +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE----IRMLKQ 58

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L+H NLV L+   RRK  L LV+++  + ++   L D  +  +       I       + 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVN 116

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           + H+      IHRDVK  N+L+      KL DFG A+L    ++     V  T  Y +PE
Sbjct: 117 FCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (265), Expect = 2e-24
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRH 396
              ++   +LG G FG+V K     ++ E AVK I  ++   +     + E+  + +L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKG 447
            N+++L           +V +    G     LFD         E  A        +IIK 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-------RIIKQ 129

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVV 504
           V SG+ Y+H   +  ++HRD+K  N+LL+S+      K+ DFGL+  ++  T       +
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI 184

Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           GT  Y+APE  R G      DV++ G +L  +  G  P
Sbjct: 185 GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  102 bits (257), Expect = 3e-24
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGRLRHRNLVQ 401
           +G G +G V+K     +   VA+KR+  +   +GV     RE    I  +  L+H+N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNIVR 65

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L         L LV++F  +  L  +  D     L+ E     +  +  GL + H     
Sbjct: 66  LHDVLHSDKKLTLVFEFC-DQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS- 520
            V+HRD+K  N+L++     KL +FGLA+ +       +  VV TL Y  P+     K  
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 179

Query: 521 SASSDVFAFGALLLEVACGRRPI 543
           S S D+++ G +  E+A   RP+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  101 bits (255), Expect = 4e-24
 Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 35/194 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI------SNESKQGVREFVSEIATIG 392
            +++   + LG G F  V K     +  E A K I      S+       E   E+  + 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFK 443
            +RH N++ L      K D++L+ + ++ G     LFD         E +A        +
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEAT-------Q 112

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPA 499
            +K +  G+ YLH    + + H D+K  N++L  +       KL DFG+A   E G    
Sbjct: 113 FLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169

Query: 500 TTRVVGTLGYLAPE 513
              + GT  ++APE
Sbjct: 170 N--IFGTPEFVAPE 181

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 4e-24
 Identities = 61/190 (32%), Positives = 89/190 (46%), Gaps = 21/190 (11%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI----SNESKQGV-----REF 384
           ++K     +     LG G F  VYK    N+   VA+K+I     +E+K G+     RE 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE- 62

Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLD-SFLFDEPKAVLNWEQRFK 443
              I  +  L H N++ L+     K ++ LV+DFM     D   +  +   VL       
Sbjct: 63  ---IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKA 116

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
            +     GL YLH+ +   ++HRD+K +N+LLD     KL DFGLAK +       T +V
Sbjct: 117 YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 173

Query: 504 VGTLGYLAPE 513
           V T  Y APE
Sbjct: 174 V-TRWYRAPE 182

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 4e-24
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 35/194 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI------SNESKQGVREFVSEIATIG 392
            + +   + LG G F  V K    ++  + A K I      S+       +   E++ + 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFK 443
            ++H N++ L      K D++L+ + +A G     LFD         E +A        +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEAT-------E 118

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPA 499
            +K + +G+ YLH      + H D+K  N++L          K+ DFGLA   + G    
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--E 173

Query: 500 TTRVVGTLGYLAPE 513
              + GT  ++APE
Sbjct: 174 FKNIFGTPEFVAPE 187

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  101 bits (255), Expect = 6e-24
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 15/172 (8%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGRLRHRNLVQ 401
           +G G +G VYK     +   VA+K+I  ++  +GV     RE    I+ +  L H N+V+
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNIVK 66

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+     +  L LV++F+ +  L  F+       +        +  +  GL + H     
Sbjct: 67  LLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---H 122

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
            V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV TL Y APE
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (256), Expect = 6e-24
 Identities = 50/254 (19%), Positives = 89/254 (35%), Gaps = 53/254 (20%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS-----NESKQGVREFVSEIATIGR 393
              +  K  +G G +G V     + ++   A+K ++       + + V    +E+  + +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSL----------------------------- 424
           L H N+ +L      +  + LV +    G L                             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 425 ---DSFLFDEPKAVLNWEQRF------KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL 475
              ++          + +          I++ + S L YLH    Q + HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 476 DSELNG--KLGDFGLAKLY---EHGTNPATTRVVGTLGYLAPE--TPRTGKSSASSDVFA 528
            +  +   KL DFGL+K +    +G     T   GT  ++APE             D ++
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 529 FGALLLEVACGRRP 542
            G LL  +  G  P
Sbjct: 262 AGVLLHLLLMGAVP 275

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (255), Expect = 7e-24
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 24/208 (11%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           Q LG G +G+V       ++  VAVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 405 WCRRKGDLLLVYDFMANGSLDSFLFD--EPKAVLN-WEQRFK---IIKGVASGLLYLHEG 458
             R      L  ++ + G L    FD  EP   +   + +     ++ GV     YLH  
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG- 123

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA---TTRVVGTLGYLAPET- 514
               + HRD+K  N+LLD   N K+ DFGLA ++ +             GTL Y+APE  
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELL 179

Query: 515 PRTGKSSASSDVFAFGALLLEVACGRRP 542
            R    +   DV++ G +L  +  G  P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (252), Expect = 1e-23
 Identities = 48/195 (24%), Positives = 76/195 (38%), Gaps = 37/195 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS--------NESKQGVREFVSEIAT 390
            + +   + LG G  G+V       +  +VA+K IS                   +EI  
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQR 441
           + +L H  ++++  +   + D  +V + M  G     LFD         E          
Sbjct: 69  LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE----LFDKVVGNKRLKEATCK------ 117

Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHGTNP 498
                 +   + YLH   E  +IHRD+K  NVLL S   +   K+ DFG +K+    +  
Sbjct: 118 -LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-- 171

Query: 499 ATTRVVGTLGYLAPE 513
               + GT  YLAPE
Sbjct: 172 LMRTLCGTPTYLAPE 186

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (252), Expect = 2e-23
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 21/209 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS------EIATIGRLRHR-- 397
            LLG GGFG VY G   +    VA+K +  +      E  +      E+  + ++     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYL 455
            +++L+ W  R    +L+ +       D  LFD    +  L  E        V   + + 
Sbjct: 109 GVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHC 165

Query: 456 HEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET 514
           H      V+HRD+K  N+L+D      KL DFG   L +      T    GT  Y  PE 
Sbjct: 166 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTD-FDGTRVYSPPEW 219

Query: 515 PRTGK-SSASSDVFAFGALLLEVACGRRP 542
            R  +    S+ V++ G LL ++ CG  P
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  100 bits (251), Expect = 3e-23
 Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 36/241 (14%)

Query: 326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK-----RISNESKQG 380
           G    S  + +    N+   + +G G F +V       +  EVA+K     +++  S Q 
Sbjct: 1   GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK 60

Query: 381 VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD---------E 431
           +     E+  +  L H N+V+L      +  L L+ ++ + G +    FD         E
Sbjct: 61  LF---REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKE 113

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
            +A   + Q   I+  V     Y H+   + ++HRD+KA N+LLD+++N K+ DFG +  
Sbjct: 114 KEARSKFRQ---IVSAVQ----YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNE 163

Query: 492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSA--SSDVFAFGALLLEVACGRRPIETRALP 549
           +  G         G   Y APE  + GK       DV++ G +L  +  G  P + + L 
Sbjct: 164 FTVGGKLDAF--CGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220

Query: 550 E 550
           E
Sbjct: 221 E 221

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 17/172 (9%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGRLRHRNLVQ 401
           +G G +G VYK    +    VA+KRI  ++  +G+     RE    I+ +  L H N+V 
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHHPNIVS 83

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L+     +  L LV++FM    L   L DE K  L   Q    +  +  G+ + H+    
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCHQHR-- 139

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
            ++HRD+K  N+L++S+   KL DFGLA+ +       T  VV TL Y AP+
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 56/211 (26%), Positives = 86/211 (40%), Gaps = 23/211 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS------EIATIGRLR---- 395
            LLG GGFG V+ G     + +VA+K I      G            E+A + ++     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLL 453
           H  +++L+ W   +   +LV +       D  LFD    K  L           V + + 
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQ-D--LFDYITEKGPLGEGPSRCFFGQVVAAIQ 153

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
           + H    + V+HRD+K  N+L+D      KL DFG   L  H          GT  Y  P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF--DGTRVYSPP 207

Query: 513 ETPRTGK-SSASSDVFAFGALLLEVACGRRP 542
           E     +  +  + V++ G LL ++ CG  P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 98.7 bits (247), Expect = 5e-23
 Identities = 52/172 (30%), Positives = 85/172 (49%), Gaps = 17/172 (9%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGRLRHRNLVQ 401
           +G G +G VYK   +N     A+K+I  E   +G+     RE    I+ +  L+H N+V+
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKHSNIVK 64

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L      K  L+LV++ + +  L   L D  +  L        +  + +G+ Y H+    
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120

Query: 462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
            V+HRD+K  N+L++ E   K+ DFGLA+ +       T  +V TL Y AP+
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 23/211 (10%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS----EIATIGRLRHRNLVQ 401
            LLG G +G+V +     +    AVK +  +  + +    +    EI  + RLRH+N++Q
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 402 L--VGWCRRKGDLLLVYDFMANGSLDSFLFDE-PKAVLN-WEQRFK---IIKGVASGLLY 454
           L  V +   K  + +V ++   G  +  + D  P+      +       +I G+     Y
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV-GTLGYLAPE 513
           LH    Q ++H+D+K  N+LL +    K+   G+A+         T R   G+  +  PE
Sbjct: 125 LHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 514 TPRTGK--SSASSDVFAFGALLLEVACGRRP 542
                   S    D+++ G  L  +  G  P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 40/243 (16%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS------------- 386
           N ++ K  +G G +G V      N  T  A+K +S +       F               
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 387 -------------EIATIGRLRHRNLVQL--VGWCRRKGDLLLVYDFMANGSLDSFLFDE 431
                        EIA + +L H N+V+L  V     +  L +V++ +  G +     + 
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEV 128

Query: 432 PKA-VLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK 490
           P    L+ +Q     + +  G+ YLH    Q +IHRD+K SN+L+  + + K+ DFG++ 
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 491 LYEHGTNPATTRVVGTLGYLAPETPRTGK---SSASSDVFAFGALLLEVACGRRPIETRA 547
            ++      +   VGT  ++APE+    +   S  + DV+A G  L     G+ P     
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

Query: 548 LPE 550
           +  
Sbjct: 245 IMC 247

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 99.7 bits (249), Expect = 1e-22
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 23/218 (10%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           ++F   + +G G FG+V     +++K   A+K ++ +    +  VR    E+  +  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASG 451
             LV L    + + D+ +V D +  G L   L     F E         +  I + +   
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV------KLFICE-LVMA 127

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L YL     Q +IHRD+K  N+LLD   +  + DF +A +    T   T  + GT  Y+A
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMA 182

Query: 512 PE--TPRTGKS-SASSDVFAFGALLLEVACGRRPIETR 546
           PE  + R G   S + D ++ G    E+  GRRP   R
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 25/182 (13%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHR-NLVQ 401
            + LG G F  V +    ++  E A K +      +    E + EIA +   +    ++ 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 402 LVGWCRRKGDLLLVYDFMANGSL-------DSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
           L        +++L+ ++ A G +        + +  E   +       ++IK +  G+ Y
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-------RLIKQILEGVYY 146

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           LH   +  ++H D+K  N+LL S       K+ DFG+++   H        ++GT  YLA
Sbjct: 147 LH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLA 201

Query: 512 PE 513
           PE
Sbjct: 202 PE 203

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 22/177 (12%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGV-----REFVSEIATIGRLRHRNLVQ 401
           LG G +G+VYK     +   VA+KRI  E  ++GV     RE    ++ +  L+HRN+++
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQHRNIIE 97

Query: 402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
           L         L L++++  N  L  ++  +    ++       +  + +G+ + H     
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHSRR-- 152

Query: 462 VVIHRDVKASNVLLDSELNG-----KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
             +HRD+K  N+LL           K+GDFGLA+ +       T  ++ TL Y  PE
Sbjct: 153 -CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 31/219 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVS-EIATIGRLRHRNLVQL 402
             LG G FG+V  G    +  +VAVK ++ +      V   +  EI  +   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLL 453
                   D  +V ++++ G L    FD         E +A   ++Q   I+  V     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQ---ILSAVD---- 125

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           Y H     +V+HRD+K  NVLLD+ +N K+ DFGL+ +   G    T+   G+  Y APE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 180

Query: 514 TPRTGK--SSASSDVFAFGALLLEVACGRRPIETRALPE 550
               G+  +    D+++ G +L  + CG  P +   +P 
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 57/191 (29%), Positives = 89/191 (46%), Gaps = 19/191 (9%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVS----EIAT 390
             AT+ +     +G G +G VYK    +S   VA+K +   +   G          E+A 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 391 IGRLR---HRNLVQLV-----GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF 442
           + RL    H N+V+L+         R+  + LV++ +    L ++L   P   L  E   
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 443 KIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR 502
            +++    GL +LH      ++HRD+K  N+L+ S    KL DFGLA++Y +     T  
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALTPV 179

Query: 503 VVGTLGYLAPE 513
           VV TL Y APE
Sbjct: 180 VV-TLWYRAPE 189

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 95.6 bits (238), Expect = 3e-21
 Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 25/184 (13%)

Query: 348 LGHGGFGQVYKGTLHNSKT--EVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLV 403
           +G G +G VYK    + K   + A+K+I     S    RE    IA +  L+H N++ L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 404 GWCRRKGD--LLLVYDFMAN------GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
                  D  + L++D+  +          +   ++    L       ++  +  G+ YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNG----KLGDFGLAKLYEHGTNPAT--TRVVGTLGY 509
           H  +   V+HRD+K +N+L+  E       K+ D G A+L+     P      VV T  Y
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 510 LAPE 513
            APE
Sbjct: 202 RAPE 205

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.7 bits (236), Expect = 4e-21
 Identities = 63/217 (29%), Positives = 90/217 (41%), Gaps = 29/217 (13%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS-EIATIGRLRHRNLVQLVG 404
           + +G G FG         +K  VAVK I  E    + E V  EI     LRH N+V+   
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 405 WCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFK---IIKGVASGLLYLH 456
                  L ++ ++ + G L   +     F E +A      RF    ++ GV+    Y H
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA------RFFFQQLLSGVS----YCH 133

Query: 457 EGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPET 514
                 + HRD+K  N LLD       K+ DFG +K     + P +T  VGT  Y+APE 
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 188

Query: 515 -PRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
             R       +DV++ G  L  +  G  P E    P 
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 95.6 bits (238), Expect = 5e-21
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 31/219 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVS-EIATIGRLRHRNLVQL 402
             LG G FG+V  G    +  +VAVK ++ +      V   +  EI  +   RH ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLL 453
                   D+ +V ++++ G L    FD         E ++   ++Q   I+ GV     
Sbjct: 82  YQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQ---ILSGVD---- 130

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           Y H     +V+HRD+K  NVLLD+ +N K+ DFGL+ +   G    T+   G+  Y APE
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 185

Query: 514 TPRTGK--SSASSDVFAFGALLLEVACGRRPIETRALPE 550
               G+  +    D+++ G +L  + CG  P +   +P 
Sbjct: 186 VIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.8 bits (236), Expect = 6e-21
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 37/211 (17%)

Query: 316 EVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN 375
            V    +    PQ  SY + K           +G+G FG VY+  L +S   VA+K++  
Sbjct: 40  VVATPGQGPDRPQEVSYTDTKV----------IGNGSFGVVYQAKLCDSGELVAIKKVLQ 89

Query: 376 ESKQGVREFVSEIATIGRLRHRNLVQL------VGWCRRKGDLLLVYDFMANGSLDSFLF 429
           + +   R    E+  + +L H N+V+L       G  + +  L LV D++        ++
Sbjct: 90  DKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVY 140

Query: 430 DEPKAVLNWEQRFKI--IKG----VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG-K 482
              +     +Q   +  +K     +   L Y+H      + HRD+K  N+LLD +    K
Sbjct: 141 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLK 197

Query: 483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           L DFG AK    G  P  + +  +  Y APE
Sbjct: 198 LCDFGSAKQLVRG-EPNVSYIC-SRYYRAPE 226

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.5 bits (233), Expect = 7e-21
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 32/219 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVS-EIATIGRLRHRNLVQL 402
           + LG G FG+V   T + ++ +VA+K IS +   K  +   V  EI+ +  LRH ++++L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 403 VGWCRRKGDLLLVYDFMANGSLDSFLFD---------EPKAVLNWEQRFKIIKGVASGLL 453
                   D+++V ++ A G L    FD         E +    ++Q   II  +     
Sbjct: 75  YDVITTPTDIVMVIEY-AGGEL----FDYIVEKKRMTEDEGRRFFQQ---IICAIE---- 122

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           Y H      ++HRD+K  N+LLD  LN K+ DFGL+ +   G    T+   G+  Y APE
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177

Query: 514 TPRTGK--SSASSDVFAFGALLLEVACGRRPIETRALPE 550
               GK  +    DV++ G +L  +  GR P +   +P 
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 59/190 (31%), Positives = 96/190 (50%), Gaps = 19/190 (10%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGT-LHNSKTEVAVKRISNES-KQGV-----REFVSEI 388
            +A   +     +G G +G+V+K   L N    VA+KR+  ++ ++G+     RE V+ +
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVL 65

Query: 389 ATIGRLRHRNLVQL-----VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK 443
             +    H N+V+L     V    R+  L LV++ + +  L ++L   P+  +  E    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124

Query: 444 IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV 503
           ++  +  GL +LH      V+HRD+K  N+L+ S    KL DFGLA++Y      A T V
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSV 179

Query: 504 VGTLGYLAPE 513
           V TL Y APE
Sbjct: 180 VVTLWYRAPE 189

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.1 bits (234), Expect = 1e-20
 Identities = 50/245 (20%), Positives = 97/245 (39%), Gaps = 24/245 (9%)

Query: 312 IKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK 371
           ++  + I ++     P     ++++    +F   +++G G FG+V    L N+    A+K
Sbjct: 46  LRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMK 105

Query: 372 RISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL 428
            ++      +     F  E   +     + +  L    +   +L LV D+   G L + L
Sbjct: 106 ILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165

Query: 429 ------FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK 482
                   E  A      RF + + +   +  +H+      +HRD+K  N+L+D   + +
Sbjct: 166 SKFEDRLPEEMA------RFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIR 215

Query: 483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPE-----TPRTGKSSASSDVFAFGALLLEVA 537
           L DFG            ++  VGT  Y++PE         G+     D ++ G  + E+ 
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

Query: 538 CGRRP 542
            G  P
Sbjct: 276 YGETP 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 55/242 (22%), Positives = 93/242 (38%), Gaps = 21/242 (8%)

Query: 312 IKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVK 371
           ++  + I+++           ++L+    ++   +++G G FG+V      +++   A+K
Sbjct: 41  LRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100

Query: 372 RISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL 428
            +S      +     F  E   +       +VQL    +    L +V ++M  G L + +
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160

Query: 429 ----FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
                 E  A      RF   + V   L  +H       IHRDVK  N+LLD   + KL 
Sbjct: 161 SNYDVPEKWA------RFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLA 210

Query: 485 DFGLAKLYEHGTNPATTRVVGTLGYLAPE----TPRTGKSSASSDVFAFGALLLEVACGR 540
           DFG                VGT  Y++PE        G      D ++ G  L E+  G 
Sbjct: 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

Query: 541 RP 542
            P
Sbjct: 271 TP 272

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 25/225 (11%)

Query: 328 QRYSYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES----KQGVR 382
           +++       A  + F   + LG G FG+V       S    A+K +  +     KQ + 
Sbjct: 28  KKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IE 86

Query: 383 EFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLN 437
             ++E   +  +    LV+L    +   +L +V +++A G + S L     F EP A   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--- 143

Query: 438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN 497
              RF     +     YLH      +I+RD+K  N+L+D +   ++ DFG AK  +  T 
Sbjct: 144 ---RF-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196

Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
             T  + GT   LAPE   +   + + D +A G L+ E+A G  P
Sbjct: 197 --T--LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 49/272 (18%), Positives = 88/272 (32%), Gaps = 51/272 (18%)

Query: 292 ASVVLAICILSLAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHG 351
             V  A   +     Y IK+I+                      ++      A   L H 
Sbjct: 20  GVVFEAKNKVD-DCNYAIKRIR--------------LPNRELAREKVMREVKALAKLEHP 64

Query: 352 GFGQVYKGTLHNSKTEVAVKR-----------ISNESKQGVREFVSEIATIGRLRHRNLV 400
           G  + +   L     +   +                S   +     +I  +     +N V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYL 455
             +     K  L +        +L  ++      ++ +  +       I   +A  + +L
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL----HIFIQIAEAVEFL 180

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPAT-----------TRVV 504
           H    + ++HRD+K SN+    +   K+GDFGL    +      T           T  V
Sbjct: 181 HS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237

Query: 505 GTLGYLAPETPRTGKS-SASSDVFAFGALLLE 535
           GT  Y++PE    G + S   D+F+ G +L E
Sbjct: 238 GTKLYMSPEQ-IHGNNYSHKVDIFSLGLILFE 268

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 19/63 (30%), Positives = 32/63 (50%), Gaps = 1/63 (1%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFV-SEIATIGRLRHRN 398
            +F   Q +G GGFG V++          A+KRI   +++  RE V  E+  + +L H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 399 LVQ 401
           +V+
Sbjct: 66  IVR 68

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 30/217 (13%), Positives = 62/217 (28%), Gaps = 46/217 (21%)

Query: 346 QLLGHGGFGQVYKGT---LHNSKTEVAVKRI---SNESKQGVREFVSEIATIGRLRHRNL 399
              G     Q ++     L     +VA+  +          ++E +S    + R+    +
Sbjct: 37  IFHGGVPPLQFWQALDTALDR---QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE-G 458
            +++     +   L+V +++  GSL       P          + ++ +A+     H  G
Sbjct: 94  ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRAG 149

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
               V       S V +  +        G   L                  +    P+  
Sbjct: 150 ----VALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDANPQ-- 182

Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                 D+   GA L  +   R P+    +   L   
Sbjct: 183 -----DDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 28/194 (14%)

Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIG 392
           +  +Q    ++  +++G+G FG V++  L  S  EVA+K++  + +   RE    +  + 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRE----LQIMR 87

Query: 393 RLRHRNLVQL------VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF--KI 444
            ++H N+V L       G  + +  L LV +++        ++   +     +Q     +
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLL 142

Query: 445 IKG----VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTNPA 499
           IK     +   L Y+H      + HRD+K  N+LLD      KL DFG AK+   G  P 
Sbjct: 143 IKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPN 198

Query: 500 TTRVVGTLGYLAPE 513
            + +  +  Y APE
Sbjct: 199 VSYIC-SRYYRAPE 211

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.8 bits (223), Expect = 3e-19
 Identities = 54/250 (21%), Positives = 95/250 (38%), Gaps = 29/250 (11%)

Query: 309 IKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEV 368
           + + K       W   +  +    +E++   ++F   +++G G F +V    +  +    
Sbjct: 33  LAQDKYVADFLQWAEPIVVRL---KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVY 89

Query: 369 AVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLD 425
           A+K ++      +  V  F  E   +     R + QL    + +  L LV ++   G L 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149

Query: 426 SFL------FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
           + L           A      RF + + +   +  +H       +HRD+K  N+LLD   
Sbjct: 150 TLLSKFGERIPAEMA------RFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCG 199

Query: 480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE-------TPRTGKSSASSDVFAFGAL 532
           + +L DFG            +   VGT  YL+PE        P TG      D +A G  
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259

Query: 533 LLEVACGRRP 542
             E+  G+ P
Sbjct: 260 AYEMFYGQTP 269

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N F   +LLG G FG+V       +    A+K +  E   +K  V   ++E   +   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASG 451
             L  L    +    L  V ++   G L        +F E +A      RF   + + S 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------RFYGAE-IVSA 260

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV-GTLGYL 510
           L YLH   E+ V++RD+K  N++LD + + K+ DFGL K  E   + AT +   GT  YL
Sbjct: 261 LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYL 316

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE         + D +  G ++ E+ CGR P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 25/193 (12%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           ++  + F  +++ G G FG V  G   ++   VA+K++  + +   RE +  +  +  L 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77

Query: 396 HRNLVQLVGWCRRKGD-------LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI--IK 446
           H N+VQL  +    G+       L +V +++        L    +     +       IK
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIK 132

Query: 447 G----VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPAT 500
                +   +  LH      V HRD+K  NVL++   +G  KL DFG AK       P  
Sbjct: 133 VFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPS-EPNV 189

Query: 501 TRVVGTLGYLAPE 513
             +  +  Y APE
Sbjct: 190 AYIC-SRYYRAPE 201

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.0 bits (214), Expect = 1e-18
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES----KQGVREFVSEIATIGRLR 395
            +F   + LG G FG+V+     ++    A+K +  E     KQ V     E   +  + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL-----FDEPKAVLNWEQRFKIIKGVAS 450
           H  ++++ G  +    + ++ D++  G L S L     F  P A      +F   + V  
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA------KFYAAE-VCL 117

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            L YLH    + +I+RD+K  N+LLD   + K+ DFG AK     T   T  + GT  Y+
Sbjct: 118 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--T--LCGTPDYI 170

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE   T   + S D ++FG L+ E+  G  P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.8 bits (217), Expect = 3e-18
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 26/215 (12%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSE---IATIGR 393
            +F+   +LG G FG+V       +    AVK +  +       V   + E   +A  G+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGV 448
                L QL    +    L  V +++  G L         F EP A       F     +
Sbjct: 401 --PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA------VF-YAAEI 451

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV-GTL 507
           A GL +L     + +I+RD+K  NV+LDSE + K+ DFG+ K  E+  +  TT+   GT 
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTP 506

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            Y+APE         S D +AFG LL E+  G+ P
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.1 bits (213), Expect = 6e-18
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 30/232 (12%)

Query: 327 PQRYSYQELKQA---TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ES 377
            Q YS +           +   + +G G  G V           VA+K++S        +
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 105

Query: 378 KQGVREFVSEIATIGRLRHRNLVQLV------GWCRRKGDLLLVYDFMANGSLDSFLFDE 431
           K+  RE    +  +  + H+N++ L+             D+ LV + M     D+ L   
Sbjct: 106 KRAYRE----LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQV 156

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
            +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+ 
Sbjct: 157 IQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213

Query: 492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
              GT+   T  V T  Y APE         + D+++ G ++ E+    + +
Sbjct: 214 A--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKIL 262

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 33/183 (18%)

Query: 326 GPQRYSYQELKQATNN---FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR 382
           GP   S  ++K+           Q+LG G  G+V +     ++ + A+K + +  K   R
Sbjct: 1   GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--AR 58

Query: 383 EFVSEIATIGRL-RHRNLVQLVGWC----RRKGDLLLVYDFMANGSL-------DSFLFD 430
               E+    R  +  ++V++V         +  LL+V + +  G L           F 
Sbjct: 59  R---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115

Query: 431 EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG---KLGDFG 487
           E +A        +I+K +   + YLH      + HRDVK  N+L  S+      KL DFG
Sbjct: 116 EREAS-------EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165

Query: 488 LAK 490
            AK
Sbjct: 166 FAK 168

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 19/211 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   +   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVASG 451
             L  L    +    L  V ++   G L        +F E +A      RF   + + S 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA------RFYGAE-IVSA 117

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L YLH    + V++RD+K  N++LD + + K+ DFGL K          T   GT  YLA
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 173

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           PE         + D +  G ++ E+ CGR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 340 NNFSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGR 393
           + F   ++LG G FG+V+   K +  +++   A+K +   +   +  V     E   +  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVE 82

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGV 448
           + H  +V+L    + +G L L+ DF+  G L        +F E         +F + + +
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV------KFYLAE-L 135

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
           A  L +LH      +I+RD+K  N+LLD E + KL DFGL+K        A +   GT+ 
Sbjct: 136 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVE 191

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y+APE       + S+D ++FG L+ E+  G  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 82.6 bits (205), Expect = 3e-17
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 340 NNFSAKQLLGHGGFGQVY---KGTLHNSKTEVAVKRISNESKQGVREFVSEIA-TIG--- 392
             F   ++LG GG+G+V+   K T  N+    A+K +    K  +     + A T     
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK---KAMIVRNAKDTAHTKAERN 73

Query: 393 ---RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKI 444
               ++H  +V L+   +  G L L+ ++++ G L        +F E  A       F +
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA------CFYL 127

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVV 504
            + ++  L +LH+   + +I+RD+K  N++L+ + + KL DFGL K   H      T   
Sbjct: 128 AE-ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FC 182

Query: 505 GTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           GT+ Y+APE       + + D ++ GAL+ ++  G  P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 31/202 (15%)

Query: 327 PQRYSYQELKQA---TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ES 377
              Y     K A      + +   +G G +G V       S  +VA+K++S        +
Sbjct: 8   KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA 67

Query: 378 KQGVREFVSEIATIGRLRHRNLVQLV------GWCRRKGDLLLVYDFMANGSLDSFLFDE 431
           K+  RE    +  +  ++H N++ L+         R   D  LV  FM      + L   
Sbjct: 68  KRAYRE----LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKI 118

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
                + E+   ++  +  GL Y+H      V+HRD+K  N+ ++ +   K+ DFGLA+ 
Sbjct: 119 MGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR- 174

Query: 492 YEHGTNPATTRVVGTLGYLAPE 513
                +   T  V T  Y APE
Sbjct: 175 ---HADAEMTGYVVTRWYRAPE 193

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 81.6 bits (202), Expect = 8e-17
 Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 27/245 (11%)

Query: 314 NAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVY---KGTLHNSKTEVAV 370
             E +   + E+     +    K    NF   ++LG G +G+V+   K + H++    A+
Sbjct: 28  GGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 87

Query: 371 K-----RISNESKQGVREFVSEIATIGRLRHRN-LVQLVGWCRRKGDLLLVYDFMANGSL 424
           K      I  ++K       +E   +  +R    LV L    + +  L L+ D++  G L
Sbjct: 88  KVLKKATIVQKAKT-TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 146

Query: 425 DSFL-----FDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
            + L     F E +       +  + + +   L +LH+     +I+RD+K  N+LLDS  
Sbjct: 147 FTHLSQRERFTEHEV------QIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNG 196

Query: 480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS--SASSDVFAFGALLLEVA 537
           +  L DFGL+K +            GT+ Y+AP+  R G S    + D ++ G L+ E+ 
Sbjct: 197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256

Query: 538 CGRRP 542
            G  P
Sbjct: 257 TGASP 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 26/215 (12%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGV--REFVSEIAT-----IG 392
            +F   ++LG G FG+V+      +    A+K +    K  V   + V            
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK---KDVVLMDDDVECTMVEKRVLSL 73

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKG 447
              H  L  +    + K +L  V +++  G L         FD  +A       F     
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA------TF-YAAE 126

Query: 448 VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTL 507
           +  GL +LH    + +++RD+K  N+LLD + + K+ DFG+ K    G     T   GT 
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTP 182

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            Y+APE     K + S D ++FG LL E+  G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 51/232 (21%), Positives = 97/232 (41%), Gaps = 30/232 (12%)

Query: 327 PQRYSYQELKQA---TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ES 377
              YS +           +   + +G G  G V        +  VA+K++S        +
Sbjct: 9   NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68

Query: 378 KQGVREFVSEIATIGRLRHRNLVQLV------GWCRRKGDLLLVYDFMANGSLDSFLFDE 431
           K+  R    E+  +  + H+N++ L+             D+ +V + M     D+ L   
Sbjct: 69  KRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQV 119

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
            +  L+ E+   ++  +  G+ +LH      +IHRD+K SN+++ S+   K+ DFGLA+ 
Sbjct: 120 IQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176

Query: 492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI 543
               T+   T  V T  Y APE         + D+++ G ++ E+      +
Sbjct: 177 AG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVL 225

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIAT----IGRLR 395
           ++F   +++G G FG+V        +   AVK +  ++    +E    ++     +  ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGVAS 450
           H  LV L    +    L  V D++  G L         F EP+A      RF   + +AS
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA------RFYAAE-IAS 150

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            L YLH      +++RD+K  N+LLDS+ +  L DFGL K      +  +T   GT  YL
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYL 206

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE         + D +  GA+L E+  G  P
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 62/214 (28%), Positives = 90/214 (42%), Gaps = 24/214 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSE---IATIGR 393
            +F+   +LG G FG+V       +    AVK +  +       V   + E   +A  G+
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGV 448
                L QL    +    L  V +++  G L         F EP A       F     +
Sbjct: 80  --PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA------VF-YAAEI 130

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
           A GL +L     + +I+RD+K  NV+LDSE + K+ DFG+ K          T   GT  
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 186

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y+APE         S D +AFG LL E+  G+ P
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 45/246 (18%), Positives = 82/246 (33%), Gaps = 51/246 (20%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
           +  +S  + LG G FG V +     S    A+K++  + +   RE    +  +  L H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61

Query: 399 LVQL---VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------------- 442
           +++L         +           N                                  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 443 ----KIIKGVAS-------------------GLLYLHEGYEQVVIHRDVKASNVLLDSEL 479
               K++K                        + ++H      + HRD+K  N+L++S+ 
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178

Query: 480 NG-KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVA 537
           N  KL DFG AK       P+   +  +  Y APE        + S D+++ G +  E+ 
Sbjct: 179 NTLKLCDFGSAKKLIPS-EPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGEL- 235

Query: 538 CGRRPI 543
              +P+
Sbjct: 236 ILGKPL 241

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSE---IATIGR 393
           +NF   ++LG G FG+V    +  +    AVK +  +       V   ++E   ++    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGV 448
             H  L QL    +    L  V +F+  G L      S  FDE +A      RF     +
Sbjct: 83  --HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA------RF-YAAEI 133

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
            S L++LH+   + +I+RD+K  NVLLD E + KL DFG+ K          T   GT  
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPD 189

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y+APE  +      + D +A G LL E+ CG  P
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 24/214 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSE---IATIGR 393
            +F   +++G G + +V    L  +    A+K +  E     + +    +E         
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLFDEPKAVLNWEQRFKIIKGV 448
             H  LV L    + +  L  V +++  G L           E  A      RF   + +
Sbjct: 69  --HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA------RFYSAE-I 119

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
           +  L YLHE   + +I+RD+K  NVLLDSE + KL D+G+ K      +  +T   GT  
Sbjct: 120 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPN 175

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y+APE  R      S D +A G L+ E+  GR P
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 25/233 (10%)

Query: 322 ELEVGPQRYSYQELKQAT-NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---S 377
           E E    R S +        +F   +++G G + +V    L  +    A++ +  E    
Sbjct: 33  EKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND 92

Query: 378 KQGVREFVSE---IATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSL-----DSFLF 429
            + +    +E           H  LV L    + +  L  V +++  G L          
Sbjct: 93  DEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL 150

Query: 430 DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA 489
            E  A      RF   + ++  L YLHE   + +I+RD+K  NVLLDSE + KL D+G+ 
Sbjct: 151 PEEHA------RFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

Query: 490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           K      +  +T   GT  Y+APE  R      S D +A G L+ E+  GR P
Sbjct: 201 KEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 40/206 (19%), Positives = 80/206 (38%), Gaps = 41/206 (19%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE------SKQGVREFVSEIATIG 392
            + +  + L+G G +G V +      K  VA+K+I          K+ +R    EIA + 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILN 107

Query: 393 RLRHRNLVQLV-----GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK---- 443
           RL H ++V+++         +  +L +V +       DS      K +            
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDF----KKLFRTPVYLTELHI 158

Query: 444 ------IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN 497
                 ++     G+ Y+H      ++HRD+K +N L++ + + K+ DFGLA+  ++  N
Sbjct: 159 KTLLYNLLV----GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

Query: 498 PATTRVVGTLGYLAPETPRTGKSSAS 523
             +   +                +  
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLK 237

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 44/211 (20%)

Query: 327 PQRYSYQELKQA---TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-----ESK 378
                     Q       ++    +G G +G V     + +K  VA+K+IS        +
Sbjct: 11  AAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ 70

Query: 379 QGVREFVSEIATIGRLRHRNLVQLV-----GWCRRKGDLLLVYDFMANGSLDSFLFDEPK 433
           + +RE    I  + R RH N++ +          +  D+ +V D M     ++ L     
Sbjct: 71  RTLRE----IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDL----Y 117

Query: 434 AVLNW----EQRFK-----IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG 484
            +L                I++G    L Y+H      V+HRD+K SN+LL++  + K+ 
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC 170

Query: 485 DFGLAKLY--EHGTNPATTRVVGTLGYLAPE 513
           DFGLA++   +H      T  V T  Y APE
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 48/226 (21%), Positives = 94/226 (41%), Gaps = 21/226 (9%)

Query: 326 GPQRYSYQELKQA---TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVR 382
             + + Y+         +++   + LG G + +V++     +  +V VK +    K+   
Sbjct: 19  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--- 75

Query: 383 EFVSEIATIGRLR-HRNLVQL--VGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWE 439
           +   EI  +  LR   N++ L  +          LV++ + N           + + +++
Sbjct: 76  KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYD 131

Query: 440 QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTNP 498
            RF  +  +   L Y H      ++HRDVK  NV++D E    +L D+GLA+ Y H    
Sbjct: 132 IRF-YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQE 186

Query: 499 ATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPI 543
              RV  +  +  PE     +    S D+++ G +L  +   + P 
Sbjct: 187 YNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 30/202 (14%)

Query: 327 PQRYSYQELKQA---TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ES 377
              Y  +  K A      +   Q +G G +G V       +  +VA+K++         +
Sbjct: 9   SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 68

Query: 378 KQGVREFVSEIATIGRLRHRNLVQLV------GWCRRKGDLLLVYDFMANGSLDSFLFDE 431
           K+  RE    +  +  +RH N++ L+             D  LV  FM    L   +  E
Sbjct: 69  KRAYRE----LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE 123

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
               L  ++   ++  +  GL Y+H      +IHRD+K  N+ ++ +   K+ DFGLA+ 
Sbjct: 124 K---LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR- 176

Query: 492 YEHGTNPATTRVVGTLGYLAPE 513
                +   T  V T  Y APE
Sbjct: 177 ---QADSEMTGYVVTRWYRAPE 195

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 42/197 (21%), Positives = 68/197 (34%), Gaps = 36/197 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN--ESKQGVREFVS---------E 387
            + ++ ++ +  G +G V  G + +    VA+KR+ N     + V              E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 388 IATIGRLRHRNLVQLV-----GWCRRKGDLLLVYDFMAN------GSLDSFLFDEPKAVL 436
           I  +    H N++ L              L LV + M              +  +     
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF 139

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
            +            GL  LHE     V+HRD+   N+LL    +  + DF LA+  E   
Sbjct: 140 MY-HILL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTA 186

Query: 497 NPATTRVVGTLGYLAPE 513
           +   T  V    Y APE
Sbjct: 187 DANKTHYVTHRWYRAPE 203

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.1 bits (181), Expect = 2e-14
 Identities = 38/203 (18%), Positives = 58/203 (28%), Gaps = 48/203 (23%)

Query: 338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--------SNESKQGVREFVSEIA 389
            T      + +G G FG+V++       T VA+K I        +   ++   E + EI 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 390 TIGRL---------RHRNLVQLVGWCRRKGD----LLLVYDFM------ANGSLDSF--- 427
               L         R    + L      +G     LL  +D        AN   D F   
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 428 --------------LFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNV 473
                         L      + +      I+  + + L            HRD+   NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 474 LLDSELNGKLGDFGLAKLYEHGT 496
           LL      KL      K     +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPS 216

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 44/202 (21%), Positives = 80/202 (39%), Gaps = 41/202 (20%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ESKQGVREFVSEIATIG 392
            +N+  K L+G G +G VY     N++  VA+K+++       + K+ +R    EI  + 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILN 80

Query: 393 RLRHRNLVQLVGWCRRKG-----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFK---- 443
           RL+   +++L             +L +V +       DS L    K +            
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDL----KKLFKTPIFLTEEHI 131

Query: 444 ------IIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN 497
                 ++     G  ++HE     +IHRD+K +N LL+ + + K+ DFGLA+      +
Sbjct: 132 KTILYNLLL----GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 498 PATTRVVGTLGYLAPETPRTGK 519
                 +       P      K
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKK 206

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 50/205 (24%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
            + +   + LG GG G V+    ++    VA+K+I     Q V+  + EI  I RL H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 399 LVQL--------------VGWCRRKGDLLLVYDFM--------ANGSLDS-----FLFDE 431
           +V++              VG       + +V ++M          G L       F++  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY-- 127

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAK 490
                   Q  +       GL Y+H      V+HRD+K +N+ +++E L  K+GDFGLA+
Sbjct: 128 --------QLLR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 491 LY--EHGTNPATTRVVGTLGYLAPE 513
           +    +      +  + T  Y +P 
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPR 194

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 30/202 (14%)

Query: 327 PQRYSYQELKQA---TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ES 377
           P  Y  +  K        +     +G G +G V       +   VAVK++S        +
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 378 KQGVREFVSEIATIGRLRHRNLVQLV------GWCRRKGDLLLVYDFMANGSLDSFLFDE 431
           K+  RE    +  +  ++H N++ L+             D+ LV   M    L++ +  +
Sbjct: 73  KRTYRE----LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ 127

Query: 432 PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL 491
               L  +    +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+ 
Sbjct: 128 K---LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR- 180

Query: 492 YEHGTNPATTRVVGTLGYLAPE 513
               T    T  V T  Y APE
Sbjct: 181 ---HTADEMTGYVATRWYRAPE 199

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 60/239 (25%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN-----ESKQGVREFVSEIATIGR 393
           +++F  K LLG G +G V   T   +   VA+K+I        + + +RE    I  +  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKH 65

Query: 394 LRHRNLVQLV-----GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
            +H N++ +             ++ ++ + M      + L              ++I   
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLH-------------RVISTQ 107

Query: 449 A--------------SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE- 493
                            +  LH      VIHRD+K SN+L++S  + K+ DFGLA++ + 
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

Query: 494 --------HGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPI 543
                    G        V T  Y APE   T    S + DV++ G +L E+   RRPI
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPI 222

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260

 Score = 70.6 bits (172), Expect = 1e-13
 Identities = 37/224 (16%), Positives = 73/224 (32%), Gaps = 23/224 (10%)

Query: 34  SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVP 93
                  G A    + I R+      + G  +  +   F+N        +       +  
Sbjct: 48  VPFWAHAGNAIPSADQI-RIAPSLKSQRGSVWTKTKAAFEN--------WEVEVTFRVTG 98

Query: 94  EYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDIN 153
              R+G  GLA   + +  L+G       +  S D+ N       + FD+  +   ++  
Sbjct: 99  R-GRIGADGLAIWYTENQGLDG------PVFGSADMWNG----VGIFFDSFDNDGKKNNP 147

Query: 154 DNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNS 213
              +  +   +  +   + A     S ++D   K      V       +  L V ++   
Sbjct: 148 AIVVVGNNGQINYDHQNDGATQALASCQRDFRNKP---YPVRAKITYYQKTLTVMINNGF 204

Query: 214 SKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSF 257
           +  K          + +     + G SA+TG LA  H+VL +  
Sbjct: 205 TPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 248

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 45/203 (22%), Positives = 81/203 (39%), Gaps = 48/203 (23%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN------ESKQGVREFVSEIATIG 392
              +   + LG G +G V+K     +   VAVK+I +      ++++  RE    I  + 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILT 63

Query: 393 RLR-HRNLVQLVGWCRRKG--DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKG-- 447
            L  H N+V L+   R     D+ LV+D+M     ++ L               +I+   
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLH-------------AVIRANI 105

Query: 448 ------------VASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
                       +   + YLH G    ++HRD+K SN+LL++E + K+ DFGL++ + + 
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162

Query: 496 TNPATTRVVGTLGYLAPETPRTG 518
                   +              
Sbjct: 163 RRVTNNIPLSINENTENFDDDQP 185

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 44/187 (23%), Positives = 71/187 (37%), Gaps = 6/187 (3%)

Query: 359 GTLHNS-KTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD 417
           G L    +++              R+    +  I     R L  +           +   
Sbjct: 112 GNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

Query: 418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS 477
            +++   +    D  K  L  E        VA G+ +L     +  IHRD+ A N+LL  
Sbjct: 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 228

Query: 478 ELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV 536
           +   K+ DFGLA+ +Y+             L ++APET      +  SDV++FG LL E+
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

Query: 537 AC-GRRP 542
              G  P
Sbjct: 289 FSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 26/106 (24%), Positives = 48/106 (45%), Gaps = 8/106 (7%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQG-VREFVSEIATIGR 393
           +     + LG G FGQV +          +   VAVK +   +     R  +SE+  +  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 394 L-RHRNLVQLVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLN 437
           +  H N+V L+G C +  G L+++ +F   G+L ++L  +    + 
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253

 Score = 63.0 bits (152), Expect = 4e-11
 Identities = 32/237 (13%), Positives = 66/237 (27%), Gaps = 28/237 (11%)

Query: 26  FFPGFKDLSN----NLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVF 81
               ++ + +        QG   + +  + RLT D   K G  +       K+       
Sbjct: 12  LIKPYQGVGSSSMPLWDFQGSTILTSQYV-RLTPDERSKEGSIWNHQPCFLKD------- 63

Query: 82  SFSTSFAIVIV-PEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            +       +       L G G+A   +              +  S D  +      A+ 
Sbjct: 64  -WEMHVHFKVHGTGKKNLHGDGIALWYTRD------RLVPGPVFGSKDNFHG----LAIF 112

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
            DT  + E  +    +I + +N+   +                   +  +    ++    
Sbjct: 113 LDTYPNDETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRN-RDHDTFLAVRY 171

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSF 257
           +   L V             +       P      Y G SA TG L+ +H+++    
Sbjct: 172 SRGRLTVMTDLEDKNEWKNCIDITGVRLP---TGYYFGASAGTGDLSDNHDIISMKL 225

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 56.8 bits (137), Expect = 8e-11
 Identities = 17/39 (43%), Positives = 24/39 (61%)

Query: 219 PILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSF 257
             LS  V L  +  E++ +GFSA+TG   ++H VL WSF
Sbjct: 4   YTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSF 42

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 63.7 bits (154), Expect = 1e-10
 Identities = 80/536 (14%), Positives = 141/536 (26%), Gaps = 178/536 (33%)

Query: 127 TDIGNFSNH----LFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQ 182
            + G         L   E   V +F+ +D+ D        S+ S   ++  + + ++   
Sbjct: 9   FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDM-----PKSILSKEEIDHIIMSKDAVSG 63

Query: 183 DLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSAS 242
            L        L W      E ++   V     +     L     +SPI  E      S  
Sbjct: 64  TL-------RLFWTLLSKQEEMVQKFVE-EVLRINYKFL-----MSPIKTE--QRQPSMM 108

Query: 243 TGLLASSHNVLGWSFKINGPARALDLSSLPSLPGPKKKHHTGAIVGVSIASVVLAICILS 302
           T +     + L ++          D          + + +                    
Sbjct: 109 TRMYIEQRDRL-YN----------DNQVFAKYNVSRLQPYL------------------- 138

Query: 303 LAIIYIIKKIKNAEVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHG--GFGQVYKGT 360
                   K++ A       L          EL+ A N      +L  G  G G      
Sbjct: 139 --------KLRQA-------L---------LELRPAKN------VLIDGVLGSG------ 162

Query: 361 LHNSKTEVAVKRISNESKQGVREFVSEI--ATIGRLRHRNLVQLVGWCRRKGDLL----- 413
               KT VA+    +   Q   +F  +I    +              C     +L     
Sbjct: 163 ----KTWVALDVCLSYKVQCKMDF--KIFWLNLKN------------CNSPETVLEMLQK 204

Query: 414 LVYDFMANGSLDSFLFDEPKAVLNWEQ----RFKIIKGVASGLLYLHEGYEQVVIHRDVK 469
           L+Y    N +  S      K  ++  Q    R    K   + LL L           +V+
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL----------LNVQ 254

Query: 470 ASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAF 529
            +             +     L        TTR      +L+  T         S     
Sbjct: 255 NAKAW-------NAFNLSCKIL-------LTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300

Query: 530 G---ALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLM 586
               +LLL+          + LP E++                  +P+  +       ++
Sbjct: 301 DEVKSLLLKYL----DCRPQDLPREVLT----------------TNPRRLS-------II 333

Query: 587 GEL--ELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKT-TSCSYFENGVSYPS 639
            E   +   T    +  + DK     +  LN L  + + K     S F      P+
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 5e-08
 Identities = 57/365 (15%), Positives = 116/365 (31%), Gaps = 81/365 (22%)

Query: 322 ELEVGPQRYSYQELKQA-----TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE 376
           + E G  +Y Y+++         +NF  K +        + K  L  SK E+    I   
Sbjct: 8   DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQ------DMPKSIL--SKEEI--DHIIMS 57

Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV-YDFMANG--------SLDSF 427
                      +      +   +VQ     +   ++L + Y F+ +         S+ + 
Sbjct: 58  KDAVSGTLR--LFWTLLSKQEEMVQ-----KFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110

Query: 428 LFDEPKAVL-NWEQ--------RFKIIKGVASGLLYL-HEGYEQVVIH------RDVKAS 471
           ++ E +  L N  Q        R +    +   LL L       V+I       +   A 
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN--VLIDGVLGSGKTWVAL 168

Query: 472 NVLLDSELNGKLGDFGL--AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAF 529
           +V L  ++  K+ DF +    L    +      ++  L Y       +    +S+     
Sbjct: 169 DVCLSYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227

Query: 530 GALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGEL 589
            ++  E+   RR ++++     L+++  V       +     +          ++L+   
Sbjct: 228 HSIQAEL---RRLLKSKPYENCLLVLLNVQNA----KAWNAFNL-------SCKILL--- 270

Query: 590 ELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFEN--GVSYPSL-----ST 642
               T R  + +D   AA      L+   S +       S            L     +T
Sbjct: 271 ----TTRFKQVTDFLSAATTTHISLDHH-SMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325

Query: 643 SPITL 647
           +P  L
Sbjct: 326 NPRRL 330

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 4e-06
 Identities = 78/583 (13%), Positives = 154/583 (26%), Gaps = 187/583 (32%)

Query: 24  ELFFPGF-KDLS----NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNS 78
            +F   F  +       ++    ++K E + I+   +  S  +       TL  K     
Sbjct: 23  SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL---RLFWTLLSKQ--EE 77

Query: 79  NVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFA 138
            V  F      V+   Y  L          PS        Q   L N        N +FA
Sbjct: 78  MVQKF---VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND-------NQVFA 127

Query: 139 ---V----EFDTVQD--FEFQDINDNHIGIDINSM----KSNASVEAAVYTDNSTKQDLS 185
              V     +  ++    E +        + I+ +    K+   V   V      +  + 
Sbjct: 128 KYNVSRLQPYLKLRQALLELRP----AKNVLIDGVLGSGKT--WVALDVCLSYKVQCKMD 181

Query: 186 LKGGKAILVWVD---YDSAENI------LNVTVSPN-------SSKPKIPILSFRVDLSP 229
            K     + W++    +S E +      L   + PN       SS  K+ I S + +L  
Sbjct: 182 FK-----IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 230 IFNEFMYVGFSASTGLLASSHNVLG--WSFKINGPARALDLSSLPSLPGPKKKHHTGAIV 287
           +     Y        LL     VL    + K      A +LS                  
Sbjct: 237 LLKSKPYE-----NCLL-----VLLNVQNAKA---WNAFNLS------------------ 265

Query: 288 GVSIASVVLAICILSLAIIYIIKKI----KNAEVIEDWELEVGPQRYSYQELKQATNNFS 343
                      C           KI    +  +V +     +     ++  L   +   +
Sbjct: 266 -----------C-----------KILLTTRFKQVTDF----LSAATTTHISLDHHSMTLT 299

Query: 344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-------VREFVSE-IATIGRLR 395
             ++             L     +   + +  E           + E + + +AT    +
Sbjct: 300 PDEVKS-----------LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSF-LFDE----PKAVLN--WEQ-------- 440
           H N  +L        ++L   ++      D   +F      P  +L+  W          
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKM--FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406

Query: 441 -------RFKIIKGVASGLLYLHEGYEQVVIHRDVKAS--NVLLDS-ELNGKLGDFGLAK 490
                     + K      + +   Y ++ +  + + +    ++D   +        L  
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466

Query: 491 L------YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVF 527
                  Y H            +G+         + +    VF
Sbjct: 467 PYLDQYFYSH------------IGHHLKNIEHPERMTLFRMVF 497

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 38/182 (20%), Positives = 67/182 (36%), Gaps = 41/182 (22%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNESKQGVREF-----VSEIA 389
             +     +G GGFG +Y   +++S          VK   +++     E       ++  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 390 TIGRLRHRNLVQLVG-----WCRRKGDLLLVYDFMA----NGSLDSFLFDE------PKA 434
            I +      ++ +G                Y FM        L   +++        K 
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRFSRKT 153

Query: 435 VLNW-EQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGK--LGDFGLAK 490
           VL    +   I++       Y+HE  Y    +H D+KASN+LL+ +   +  L D+GLA 
Sbjct: 154 VLQLSLRILDILE-------YIHEHEY----VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Query: 491 LY 492
            Y
Sbjct: 203 RY 204

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR---------- 395
           + LG G F  V+      + T VA+K +  + K        EI  + R+           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 396 -HRNLVQLVGWCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
              ++++L+     KG     +++V++ +   +L + +       +      +I K +  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSE------LNGKLGDFGLA-KLYEHGTNPATTRV 503
           GL Y+H      +IH D+K  NVL++        +  K+ D G A    EH TN   TR 
Sbjct: 143 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200

Query: 504 VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR 540
                Y +PE          +D+++   L+ E+  G 
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 40/176 (22%), Positives = 62/176 (35%), Gaps = 32/176 (18%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREF-----VSEIATI 391
           N +   + +G GGFG +Y     N   + A   +  E +       E      V++   I
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 392 GRLRHRNLVQLVG-----WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIK 446
            +   R  +  +G                Y FM    L   L      +      FK   
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK----ISGQNGTFKK-S 151

Query: 447 GVA-------SGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGK--LGDFGLAKLY 492
            V          L Y+HE  Y    +H D+KA+N+LL  +   +  L D+GL+  Y
Sbjct: 152 TVLQLGIRMLDVLEYIHENEY----VHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 39/214 (18%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHR----- 397
           +++G G FGQV K   H     VA+K + NE +   Q       EI  +  LR +     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNT 158

Query: 398 -NLVQLVGWCRRKGDLLLV--------YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
            N++ ++     +  + +         Y+ +       F     +         K    +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR---------KFAHSI 209

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGT 506
              L  LH   +  +IH D+K  N+LL  +     K+ DFG +  YEH         + +
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YEHQR---VYTYIQS 262

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGR 540
             Y APE     +     D+++ G +L E+  G 
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 36/178 (20%), Positives = 64/178 (35%), Gaps = 33/178 (18%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKT--------EVAVK------RISNESKQGVREF- 384
             +  K        G +Y+    ++ T        + ++K      R+ NE     R   
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 385 ---VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMA----NGSLDSFLFDEPKAVLN 437
              V++   +       +   +G+   +      Y F+       SL S L   PK VL+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPKHVLS 157

Query: 438 WEQRFKIIKGVASGLLYLHE-GYEQVVIHRDVKASNVLLDSELNGK--LGDFGLAKLY 492
                ++   +   L +LHE  Y    +H +V A N+ +D E   +  L  +G A  Y
Sbjct: 158 ERSVLQVACRLLDALEFLHENEY----VHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 42/169 (24%), Positives = 64/169 (37%), Gaps = 33/169 (19%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            NF   + +G G FG++  G    +   VA+K    +S+        E     +L   + 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66

Query: 400 VQLVGWCRRKGDLLLVYDFMA----NGSLDSFLFDE------PKAVLNW-EQRFKIIKGV 448
           +  V +    G     Y+ M       SL+  LFD        K VL    Q    ++  
Sbjct: 67  IPQVYYFGPCGK----YNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRME-- 119

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK-----LGDFGLAKLY 492
                Y+H    + +I+RDVK  N L+    N       + DF LAK Y
Sbjct: 120 -----YVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           N +   + +G G FG +Y GT   +  EVA+K    ++K        E      ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66

Query: 400 VQLVGWCRRKGDLLLVYDFMA----NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           +  + WC  +GD    Y+ M       SL+  LF+      + +    +   + S + Y+
Sbjct: 67  IPTIRWCGAEGD----YNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGK---LGDFGLAKLY 492
           H    +  IHRDVK  N L+     G    + DFGLAK Y
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 17/160 (10%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           N F   + +G G FG++Y GT   +  EVA+K  + ++K     +  E      L+    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64

Query: 400 VQLVGWCRRKGDLLLVYDFMA----NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           +  V W   +GD    Y+ +       SL+  LF+     L+ +    +   + + + ++
Sbjct: 65  IPNVRWFGVEGD----YNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGK---LGDFGLAKLY 492
           H    +  +HRD+K  N L+          + DFGLAK Y
Sbjct: 120 H---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.8 bits (129), Expect = 9e-08
 Identities = 51/271 (18%), Positives = 90/271 (33%), Gaps = 71/271 (26%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR--- 395
              +   + LG G F  V+       K  VA+K +   ++      + EI  +  +R   
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 396 -----HRNLVQLVGWCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIK 446
                   +VQL+   +  G     + +V++ + +  L  ++       L      KII+
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---------------------------- 478
            V  GL YLH   +  +IH D+K  N+LL                               
Sbjct: 154 QVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 479 ---------------------LNGKLGDFGLA-KLYEHGTNPATTRVVGTLGYLAPETPR 516
                                L  K+ D G A  +++H T    TR      Y + E   
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266

Query: 517 TGKSSASSDVFAFGALLLEVACGRRPIETRA 547
               +  +D+++   +  E+A G    E  +
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYLFEPHS 297

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 34/169 (20%), Positives = 66/169 (39%), Gaps = 33/169 (19%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            ++   + +G G FG +++GT   +  +VA+K     S     +   E  T   L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67

Query: 400 VQLVGWCRRKGDLLLVYDFMA----NGSLDSFLFDE------PKAVLNW-EQRFKIIKGV 448
           +  V +  ++G     ++ +       SL+  L D        K V    +Q    ++  
Sbjct: 68  IPNVYYFGQEGL----HNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQ-- 120

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK-----LGDFGLAKLY 492
                 +HE   + +++RD+K  N L+    +       + DFG+ K Y
Sbjct: 121 -----SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 13/209 (6%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVRE--FVSEIATIGR 393
            + +    L+G G FGQV K      +  VA+K I N+     Q   E   +  +     
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
                +V L      +  L LV++ ++  +L   L +     ++     K  + + + LL
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           +L    E  +IH D+K  N+LL +      K+ DFG +            + + +  Y +
Sbjct: 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR---IYQYIQSRFYRS 226

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGR 540
           PE         + D+++ G +L+E+  G 
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 32/153 (20%), Positives = 56/153 (36%), Gaps = 28/153 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLR 395
            N F   + +G G FG+V      ++K   AVK + N  K           E   + +++
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQ 89

Query: 396 HR-----NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRF------KI 444
           +      N+V+  G       + L+++      L   L++      N    F        
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITR--NNYNGFHIEDIKLY 142

Query: 445 IKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS 477
              +   L YL    +  + H D+K  N+LLD 
Sbjct: 143 CIEILKALNYLR---KMSLTHTDLKPENILLDD 172

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 30/179 (16%), Positives = 61/179 (34%), Gaps = 34/179 (18%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGT-LHNSKTEVAVKRISNESK---QGVREFVSEIATIGRL 394
              +     LG G FG+V +       K++VA+K I N  K           EI  + ++
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKI 73

Query: 395 RHR------NLVQLVGWCRRKGDLLLV--------YDFMANGSLDSFLFDEPKAVLNWEQ 440
           + +        V +  W    G + +         ++F+   +   +     +       
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR------- 126

Query: 441 RFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA 499
              +   +   L +LH   E  + H D+K  N+L  +     L +   +   +   N +
Sbjct: 127 --HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 37/170 (21%), Positives = 63/170 (37%), Gaps = 30/170 (17%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTE-VAVKRISNESK---QGVREFVSEIATIGRLRHR---- 397
             LG G FG+V +   H +    VAVK + N  +          SEI  +  L       
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNS 75

Query: 398 --NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKI--IKGVA---- 449
               VQ++ W    G + +V++      L    +D  K   N    F++  I+ +A    
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKE--NGFLPFRLDHIRKMAYQIC 128

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA 499
             + +LH      + H D+K  N+L       +  +  + +      NP 
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	652
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	100.0
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.97
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	99.76
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	99.54
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	99.21
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.85
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.36
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.35
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.94
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.74
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.6
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.34
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.24
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.23
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.99
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.74
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.74
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.74
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.27
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.88
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.25
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.49
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	87.51
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	85.19
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.95

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=1.1e-61  Score=482.14  Aligned_cols=226  Identities=35%  Similarity=0.529  Sum_probs=206.0

Q ss_pred             CCCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCCC------ceEEEEeCCceeeccCCCCceeeeEEEEEEEEe
Q 038860           19 SSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIV   92 (652)
Q Consensus        19 ~~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~~------~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~   92 (652)
                      .+...+|+|++|+.  .||+|+|+|.+. +|.|+||+...+      ++|||+|++||+|||+++|+++||+|+|+|.|.
T Consensus        23 sa~~~sF~f~~F~~--~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsTsFsF~I~   99 (281)
T 3ujo_A           23 SANLISFTFKKFNE--TNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVASWATSFTFNLQ   99 (281)
T ss_dssp             -CEEEEEEESSCCS--TTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSSCCBEEEEEEEEEECC
T ss_pred             cCCcceEEcCCCCc--cCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCCCCceeEEEEEEEEEe
Confidence            34678999999984  799999999997 999999998765      899999999999999999999999999999999


Q ss_pred             cCCCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeec
Q 038860           93 PEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEA  172 (652)
Q Consensus        93 ~~~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~  172 (652)
                      +++...+||||||||+|....|+++||||||+|.+++ ++.+|+|||||||++|.+| ||++|||||||||+.|..+++|
T Consensus       100 ~~~~~~~gdGlAF~laP~~~~p~~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~-Dp~~nHVGIDvNSi~S~~t~~~  177 (281)
T 3ujo_A          100 APNAASPADGLAFALVPVGSQPKDKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIKSIKTTSW  177 (281)
T ss_dssp             CSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSS-CCSSSEEEEEESSSCCSCEEEC
T ss_pred             cCCCCCCCCceEEEEecCCCCCCCCcceeeeccccCC-CccCcEEEEEEeccccccC-CCCCCeEEEEcCCCCccccccc
Confidence            8877889999999999988667788999999998876 7789999999999999887 9999999999999999988865


Q ss_pred             ceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc---cccc
Q 038860          173 AVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASS  249 (652)
Q Consensus       173 ~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~---~~~~  249 (652)
                                  ++.+|+.++|||+||+.+++|+|++++.+. |..|+++..+||+++|||+|||||||+||.   ..|.
T Consensus       178 ------------~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~-~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~~~~~~e~  244 (281)
T 3ujo_A          178 ------------DFANGENAEVLITYDSSTNLLVASLVHPSQ-KTSFIVSERVDLTSVLPEWVSVGFSATTGLSKGYVET  244 (281)
T ss_dssp             ------------CCCSSCCEEEEEEECTTTCEEEEEEECTTT-CCCEEEEEECCSTTTSCSEEEEEEEEEECSSTTSCCC
T ss_pred             ------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCCceEEEEechHHhccCcEEEEEEeecCCCCcccce
Confidence                        366899999999999999999999998664 557899999999999999999999999996   5899


Q ss_pred             ceeecccccccCC
Q 038860          250 HNVLGWSFKINGP  262 (652)
Q Consensus       250 ~~v~~w~f~~~~~  262 (652)
                      |.|++|+|++...
T Consensus       245 H~IlsWSFss~l~  257 (281)
T 3ujo_A          245 NEVLSWSFASKLS  257 (281)
T ss_dssp             CEEEEEEEEEEEC
T ss_pred             eEEEEEEEEEEcC
Confidence            9999999987643

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=1.3e-61  Score=476.80  Aligned_cols=227  Identities=36%  Similarity=0.486  Sum_probs=208.5

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCCC------ceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSR------KMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~~------~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|.+++.||+|+|+|.+.++|.|+||+...+      ++|||+|++||+||++++|+++||+|+|+|.|.++
T Consensus         2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~   81 (251)
T 3ipv_A            2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAP   81 (251)
T ss_dssp             EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeCC
Confidence            357899999987678999999999977999999998765      89999999999999999999999999999999998


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      +...+||||||||+|....|+..||||||+|.+++ +..+|+|||||||++|.+|+||++|||||||||+.|..+++|  
T Consensus        82 ~~~~~gdGlAF~lap~~~~~~~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~~--  158 (251)
T 3ipv_A           82 NIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKW--  158 (251)
T ss_dssp             STTSCCEEEEEEEEETTCCCCCCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCceEEEEecCCCCCCCCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCccccccee--
Confidence            77889999999999988666678999999998776 778999999999999988889999999999999999988764  


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccce
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHN  251 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~  251 (652)
                                ++.+|+.++|||+||+.+++|+|++++.+. |..|+|+..|||+.+||++|||||||+||..   .|.|.
T Consensus       159 ----------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e~h~  227 (251)
T 3ipv_A          159 ----------SLANGEAAKVLITYNSAVKLLVASLVYPSS-KTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHD  227 (251)
T ss_dssp             ----------CCCTTCEEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCE
T ss_pred             ----------EecCCCEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCcEEEEEEEecCCCccccceeE
Confidence                      477999999999999999999999997654 5678999999999999999999999999998   89999


Q ss_pred             eecccccccC
Q 038860          252 VLGWSFKING  261 (652)
Q Consensus       252 v~~w~f~~~~  261 (652)
                      |++|+|++..
T Consensus       228 IlsWsF~s~l  237 (251)
T 3ipv_A          228 VFSWSFASKL  237 (251)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEEEEEC
Confidence            9999998753

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=6.3e-61  Score=473.12  Aligned_cols=230  Identities=32%  Similarity=0.455  Sum_probs=207.0

Q ss_pred             ccCCCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEE
Q 038860           17 PVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIV   90 (652)
Q Consensus        17 ~~~~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~   90 (652)
                      +..+...+|+|++|.+++.||+|+|+|.+.++|.|+||+...      +++|||+|++||+||++++|+++||+|+|+|.
T Consensus         6 ~~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F~   85 (261)
T 3zyr_A            6 ANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSFF   85 (261)
T ss_dssp             --CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEEE
T ss_pred             cCcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEEE
Confidence            345567899999998767899999999997799999999765      68999999999999999999999999999999


Q ss_pred             EecCCCCCCcCcEEEEEccCCCC-C-CCCCccccCCccCCCCC-CcccEEEEEeecc---cCCCCCCCCCCceeeecCCc
Q 038860           91 IVPEYPRLGGHGLAFTISPSNDL-N-GLPSQYLGLLNSTDIGN-FSNHLFAVEFDTV---QDFEFQDINDNHIGIDINSM  164 (652)
Q Consensus        91 i~~~~~~~~gdGlaF~l~p~~~~-~-~~~g~~lG~~~~~~~~~-~~~~~vaVEFDt~---~n~~~~d~~~~hvgi~~ns~  164 (652)
                      |.++ ...+||||||||+|.... | +++|+||||+|.+++++ ..||+|||||||+   +|.+| ||++|||||||||+
T Consensus        86 I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNsi  163 (261)
T 3zyr_A           86 LSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNSI  163 (261)
T ss_dssp             EECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESSS
T ss_pred             EecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCCC
Confidence            9987 677899999999998753 5 78999999999887744 5789999999999   99887 99999999999999


Q ss_pred             cccceeecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccc
Q 038860          165 KSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG  244 (652)
Q Consensus       165 ~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg  244 (652)
                      .|..+++|            ++.+|+.++|||+||+.+++|+|++++.+.  ..|+|+..+||+++||++|||||||+||
T Consensus       164 ~S~~s~~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~v~VGFSAsTG  229 (261)
T 3zyr_A          164 RSSKVVRW------------ERREGKTLNVLVTYNPSTRTIDVVATYPDG--QRYQLSHVVDLTTILPEWVRVGFSAASG  229 (261)
T ss_dssp             SCSEEEEC------------CCCTTCCEEEEEEEETTTTEEEEEEECTTC--CEEEEEEECCGGGTSCSEEEEEEEEEES
T ss_pred             Cccccccc------------cccCCceEEEEEEEcCCCCEEEEEEEcCCC--CCeEEEEEechHHhCcCcEEEEEEecCC
Confidence            99988865            456899999999999999999999997654  3789999999999999999999999999


Q ss_pred             cccccceeecccccccCC
Q 038860          245 LLASSHNVLGWSFKINGP  262 (652)
Q Consensus       245 ~~~~~~~v~~w~f~~~~~  262 (652)
                      ...|.|.|++|+|++...
T Consensus       230 ~~~e~h~IlsWsF~s~l~  247 (261)
T 3zyr_A          230 EQFQTHNLESWSFTSTLL  247 (261)
T ss_dssp             SSCCEEEEEEEEEEEEEC
T ss_pred             CccceEEEEEEEEEEEcC
Confidence            999999999999987643

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=1.2e-59  Score=461.39  Aligned_cols=224  Identities=32%  Similarity=0.474  Sum_probs=203.4

Q ss_pred             ceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-----CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCC
Q 038860           22 LDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-----SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYP   96 (652)
Q Consensus        22 ~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~   96 (652)
                      ..+|+|++|.+++.+|+|+|+|.+.++|.|+||++.     .++.|||+|++||+||++.+|+++||+|+|+|.|.+++.
T Consensus         3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~~   82 (237)
T 1fny_A            3 SLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPNP   82 (237)
T ss_dssp             EEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSST
T ss_pred             ceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCCC
Confidence            468999999976689999999999878999999876     679999999999999999999999999999999998877


Q ss_pred             CCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceec
Q 038860           97 RLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYT  176 (652)
Q Consensus        97 ~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~  176 (652)
                      ..+||||||||+|....|+++|+||||+|.++ ++..+|+|||||||++|.+ +||++||||||+||+.|..++++    
T Consensus        83 ~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~-~Dp~~nHVGIdvNsi~S~~~~~~----  156 (237)
T 1fny_A           83 ATTADGLAFFLAPVDTQPLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIESIKTVPW----  156 (237)
T ss_dssp             TSCCEEEEEEEEETTCCCCCCGGGTTTCC----CCTTSCCEEEEEECSCCTT-TCCSSSEEEEEESSSSCSEEEEC----
T ss_pred             CCCCCCEEEEeccCCCCCCCCCCcccccccCC-CCccccEEEEEeecccCcc-cCCCCCceEEecCCccccccccc----
Confidence            78899999999998766788999999999765 4779999999999999988 59999999999999999988764    


Q ss_pred             CCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccceee
Q 038860          177 DNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHNVL  253 (652)
Q Consensus       177 ~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~v~  253 (652)
                              ++.+|+.++|||+||+.+++|+|++++.+. |..|+|+..+||+.+||++|||||||+||..   .+.|.|+
T Consensus       157 --------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~Il  227 (237)
T 1fny_A          157 --------NWTNGEVANVFISYEASTKSLTASLVYPSL-ETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVL  227 (237)
T ss_dssp             --------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEE
T ss_pred             --------cccCCCEEEEEEEEeCCCcEEEEEEecCCC-CCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccceeEEE
Confidence                    477899999999999999999999997654 5678999999999999999999999999999   9999999


Q ss_pred             ccccccc
Q 038860          254 GWSFKIN  260 (652)
Q Consensus       254 ~w~f~~~  260 (652)
                      +|+|++.
T Consensus       228 sWsF~s~  234 (237)
T 1fny_A          228 SWSFESN  234 (237)
T ss_dssp             EEEEEEE
T ss_pred             EEEEEEe
Confidence            9999864

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=3e-59  Score=464.10  Aligned_cols=242  Identities=30%  Similarity=0.424  Sum_probs=205.9

Q ss_pred             CceeEEcCCCC-CCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEec
Q 038860           21 QLDELFFPGFK-DLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVP   93 (652)
Q Consensus        21 ~~~~f~~~~F~-~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~   93 (652)
                      ...+|+|++|. +++.+|+|+|+|.+. +|.|+||++.      .++.|||||++||+||++.+|+++||+|+|+|+|.+
T Consensus         3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~~   81 (257)
T 1hql_A            3 DSVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKI   81 (257)
T ss_dssp             -CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEE
T ss_pred             cceEEEcCCCCCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEec
Confidence            45689999998 445799999999998 9999999875      578999999999999999999999999999999998


Q ss_pred             CCCCCCcCcEEEEEccCCCCCCCCCccccCCccCC-CCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeec
Q 038860           94 EYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTD-IGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEA  172 (652)
Q Consensus        94 ~~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~-~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~  172 (652)
                      + ...+||||||||+|....++++|+||||+|.++ +++..+|+|||||||++|.+|+||++||||||+|++.|..++++
T Consensus        82 ~-~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~~~  160 (257)
T 1hql_A           82 T-GNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRW  160 (257)
T ss_dssp             C-SSCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEEC
T ss_pred             C-CCCCCCcEEEEEecCCCCCCCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccceecc
Confidence            7 677899999999998766688999999999776 36788999999999999999889999999999999999988876


Q ss_pred             ceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccc-cccccce
Q 038860          173 AVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG-LLASSHN  251 (652)
Q Consensus       173 ~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg-~~~~~~~  251 (652)
                      .         -.+|.+|+.++|||+||+.+++|+|++++.+.  ..|+|+..+||+.+||++|||||||+|| ...+.|.
T Consensus       161 ~---------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~~H~  229 (257)
T 1hql_A          161 E---------DSDIFSGKIATARISYDGSAEILTVVLSYPDG--SDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVY  229 (257)
T ss_dssp             C---------HHHHTSCSCEEEEEEEETTTTEEEEEEEETTT--EEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEE
T ss_pred             C---------cccccCCceEEEEEEEeCCCCEEEEEEecCCC--CceeeEEeechHHhcCCceEEEEEeccCCCccceeE
Confidence            2         11356799999999999999999999998654  4689999999999999999999999999 8999999


Q ss_pred             eecccccccCCCCCCCCCCCCCCC
Q 038860          252 VLGWSFKINGPARALDLSSLPSLP  275 (652)
Q Consensus       252 v~~w~f~~~~~~~~~~~s~~p~~p  275 (652)
                      |++|+|++..+.+..+.+.+|.+|
T Consensus       230 IlsWsF~s~~~~~~~~~~~~p~~~  253 (257)
T 1hql_A          230 ILSWRFSSNLQSTSVKAAMEPEIT  253 (257)
T ss_dssp             EEEEEEEEEC--------------
T ss_pred             EEEEEeEecCCCCCcccccCCCCC
Confidence            999999998887777777777766

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=2.2e-59  Score=460.69  Aligned_cols=225  Identities=33%  Similarity=0.507  Sum_probs=204.9

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-----CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-----SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY   95 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~   95 (652)
                      ...+|+|++|..++.+|+|+|+|.+.++|.|+||++.     .++.|||+|++||+||++.+|+++||+|+|+|.|.+++
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~   81 (239)
T 1dbn_A            2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAPN   81 (239)
T ss_dssp             CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence            4578999999966689999999999878999999876     67999999999999999999999999999999999887


Q ss_pred             CCCCcCcEEEEEccCCC-CC-CCCCccccCCccCCCCCCcccEEEEEeecccC---CCCCCCCCCceeeecCCcccccee
Q 038860           96 PRLGGHGLAFTISPSND-LN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQD---FEFQDINDNHIGIDINSMKSNASV  170 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~-~~-~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n---~~~~d~~~~hvgi~~ns~~s~~~~  170 (652)
                      ...+||||||||+|... .| +++|+||||+|.++ ++..+|+|||||||++|   .+ +||++||||||+||+.|..++
T Consensus        82 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~~~~  159 (239)
T 1dbn_A           82 PDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESIKTV  159 (239)
T ss_dssp             TTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCccccceE
Confidence            77889999999999875 45 78999999999765 46789999999999999   77 599999999999999999887


Q ss_pred             ecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc--cc
Q 038860          171 EAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL--AS  248 (652)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~--~~  248 (652)
                      ++            +|.+|+.++|||+||+.+++|+|++++.+. |..|+|+..+||+.+||++|||||||+||..  .+
T Consensus       160 ~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~  226 (239)
T 1dbn_A          160 QW------------DWINGGVAFATITYLAPNKTLIASLVYPSN-QTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVE  226 (239)
T ss_dssp             EC------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCC
T ss_pred             cc------------cccCCCEEEEEEEEeCCCcEEEEEEccCCC-CCcceEEEEechHHhCCccEEEEEEeccCCCccce
Confidence            64            477999999999999999999999998654 5578999999999999999999999999999  99


Q ss_pred             cceeeccccccc
Q 038860          249 SHNVLGWSFKIN  260 (652)
Q Consensus       249 ~~~v~~w~f~~~  260 (652)
                      .|.|++|+|++.
T Consensus       227 ~h~IlsWsF~s~  238 (239)
T 1dbn_A          227 THDVLSWSFTST  238 (239)
T ss_dssp             CCEEEEEEEEEE
T ss_pred             eeEEEEEEeEec
Confidence            999999999863

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=5.9e-59  Score=457.88  Aligned_cols=226  Identities=29%  Similarity=0.406  Sum_probs=206.4

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC---CCceEE-EEeCCceeeccCCCCceeeeEEEEEEEEecC-C
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT---SRKMGQ-AFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE-Y   95 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~---~~~~G~-~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~   95 (652)
                      ...+|+|++|..++.+|+|+|+|.+.++|.|+||++.   .++.|| |+|++||+||++.+|+++||+|+|+|.|.++ +
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~   81 (242)
T 1fx5_A            2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN   81 (242)
T ss_dssp             CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence            4578999999966689999999999878999999886   689999 9999999999999999999999999999987 5


Q ss_pred             CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCC-CCCCCCceeeecCCccccceeecce
Q 038860           96 PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEF-QDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      ...+||||||||+|....++++|+||||+|.++ ++..+|+|||||||++|.++ +||++||||||+|++.|..++++  
T Consensus        82 ~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~~--  158 (242)
T 1fx5_A           82 PKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW--  158 (242)
T ss_dssp             GGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCcEEEEEecCCCCCCCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceecc--
Confidence            677899999999998766788999999999765 47799999999999999987 79999999999999999988764  


Q ss_pred             ecCCCCcccCCcCCC--ceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccc--ccccccc
Q 038860          175 YTDNSTKQDLSLKGG--KAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSAST--GLLASSH  250 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g--~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsast--g~~~~~~  250 (652)
                                ++.+|  +.++|||+||+.+++|+|++++.+. |..|+|+..+||+.+||++|||||||+|  |.. +.|
T Consensus       159 ----------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h  226 (242)
T 1fx5_A          159 ----------NKRYGLNNVANVEIIYEASSKTLTASLTYPSD-QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ-ATH  226 (242)
T ss_dssp             ----------CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-EEE
T ss_pred             ----------cccCCCceeEEEEEEEeCCCCEEEEEEecCCC-CccceeeEEechHHhCCccEEEEEEecccCCCc-cee
Confidence                      47789  9999999999999999999998654 5578999999999999999999999999  999 999


Q ss_pred             eeecccccccC
Q 038860          251 NVLGWSFKING  261 (652)
Q Consensus       251 ~v~~w~f~~~~  261 (652)
                      .|++|+|++..
T Consensus       227 ~IlsWsF~s~l  237 (242)
T 1fx5_A          227 EVLNWYFTSTF  237 (242)
T ss_dssp             EEEEEEEEEES
T ss_pred             EEEEEEeEeec
Confidence            99999998764

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=8.6e-59  Score=453.80  Aligned_cols=222  Identities=29%  Similarity=0.425  Sum_probs=203.4

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCC-CCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTND-TSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLG   99 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~   99 (652)
                      ...+|+|++|++++.+|+|+|+|.+.++|.|+||++ ..+++|||+|++||+||++++|+++||+|+|+|.|.+++...+
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~~~~   81 (232)
T 1v6i_A            2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYDP   81 (232)
T ss_dssp             EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSBC
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCCCCC
Confidence            356899999996668999999999987899999998 8889999999999999999999999999999999998877788


Q ss_pred             cCcEEEEEccCC-CCC-CC-CCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceec
Q 038860          100 GHGLAFTISPSN-DLN-GL-PSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYT  176 (652)
Q Consensus       100 gdGlaF~l~p~~-~~~-~~-~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~  176 (652)
                      ||||||||+|.. ..| ++ +|+||||+|.    ++.+|+|||||||++|.+++||++||||||+|++.|..++++    
T Consensus        82 gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~----  153 (232)
T 1v6i_A           82 ADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW----  153 (232)
T ss_dssp             CCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC----
T ss_pred             CCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc----
Confidence            999999999987 345 67 8999999986    568999999999999999899999999999999999988764    


Q ss_pred             CCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc--ccccceeec
Q 038860          177 DNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL--LASSHNVLG  254 (652)
Q Consensus       177 ~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~--~~~~~~v~~  254 (652)
                              ++.+|+.++|||+||+.+++|+|++++ + +|..|+|+..+||+.+||++|||||| +||.  ..+.|.|++
T Consensus       154 --------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~Ils  222 (232)
T 1v6i_A          154 --------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D-NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRS  222 (232)
T ss_dssp             --------CCCTTCEEEEEEEEETTTTEEEEEEEC-T-TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEE
T ss_pred             --------cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEE
Confidence                    477999999999999999999999998 4 46789999999999999999999999 9999  689999999


Q ss_pred             ccccccC
Q 038860          255 WSFKING  261 (652)
Q Consensus       255 w~f~~~~  261 (652)
                      |+|++..
T Consensus       223 WsF~s~l  229 (232)
T 1v6i_A          223 WSFTSTL  229 (232)
T ss_dssp             EEEEEEE
T ss_pred             EEEEeec
Confidence            9998753

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=1e-58  Score=455.86  Aligned_cols=224  Identities=32%  Similarity=0.499  Sum_probs=203.7

Q ss_pred             ceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC
Q 038860           22 LDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY   95 (652)
Q Consensus        22 ~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~   95 (652)
                      ..+|+|++|.+++.+|+|+|+|.+.++|.|+||++.      .++.|||+|++||+||++.+|+++||+|+|+|.|.++.
T Consensus         3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~   82 (239)
T 1gzc_A            3 TISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQPY   82 (239)
T ss_dssp             EEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCCC
T ss_pred             eEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence            468999999976689999999999878999999876      57899999999999999999999999999999999876


Q ss_pred             -CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           96 -PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        96 -~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                       ...+||||||||+|....|+++|+||||+|.++ +++.+|+|||||||++|. |.||++||||||+||+.|..+++|  
T Consensus        83 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~~~--  158 (239)
T 1gzc_A           83 TRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQPF--  158 (239)
T ss_dssp             SSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCcEEEEEecCCCCCCCCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCCCeEEEecCCccccccccc--
Confidence             677899999999998766788999999999765 477899999999999998 777999999999999999888764  


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc---ccccce
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHN  251 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~---~~~~~~  251 (652)
                                +|.+|+.++|||+||+.+++|+|++++.+. |..|+|+..+||+.+||++|||||||+||.   ..+.|.
T Consensus       159 ----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~  227 (239)
T 1gzc_A          159 ----------QLDNGQVANVVIKYDAPSKILHVVLVYPSS-GAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHD  227 (239)
T ss_dssp             ----------CCCTTCEEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCE
T ss_pred             ----------cccCCCEEEEEEEEeCCCcEEEEEEecCCC-CccceEEEEechHHhCCCceEEEEEeccCCCccccceEE
Confidence                      477999999999999999999999997654 567899999999999999999999999997   489999


Q ss_pred             eeccccccc
Q 038860          252 VLGWSFKIN  260 (652)
Q Consensus       252 v~~w~f~~~  260 (652)
                      |++|+|++.
T Consensus       228 IlsWsF~s~  236 (239)
T 1gzc_A          228 VYSWSFQAS  236 (239)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEEeEEe
Confidence            999999865

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=7.7e-58  Score=452.34  Aligned_cols=223  Identities=32%  Similarity=0.472  Sum_probs=203.9

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|.+++.+|+|+|+|.+.++|.|+||++.      .++.|||+|++||+||++.+|+++||+|+|+|.|.++
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~   81 (253)
T 1sbf_A            2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP   81 (253)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECS
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeCC
Confidence            3568999999966689999999999878999999876      5789999999999999999999999999999999988


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      +...+||||||||+|....|+++|+||||+|.+   ++.+|+|||||||++|.  +||++||||||+|++.|..++++  
T Consensus        82 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~~--  154 (253)
T 1sbf_A           82 DTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTSW--  154 (253)
T ss_dssp             STTSCCEEEEEEEEETTCCCCCCGGGTTTCCTT---SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCcEEEEEecCCCCCCCCCCccccccCC---CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceecc--
Confidence            777889999999999876678899999999876   56899999999999998  69999999999999999888764  


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc--ccccee
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL--ASSHNV  252 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~--~~~~~v  252 (652)
                                ++.+|+.++|||+||+.+++|+|++++.+. |..|+++..+||+.+||++|||||||+||..  .+.|.|
T Consensus       155 ----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~H~I  223 (253)
T 1sbf_A          155 ----------DLANNKVAKVLITYDASTSLLVASLVYPSQ-RTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDV  223 (253)
T ss_dssp             ----------CCCTTCCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCEEEE
T ss_pred             ----------cccCCCeeEEEEEEeCCCcEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCccceeeEE
Confidence                      477899999999999999999999997654 5678999999999999999999999999999  999999


Q ss_pred             ecccccccC
Q 038860          253 LGWSFKING  261 (652)
Q Consensus       253 ~~w~f~~~~  261 (652)
                      ++|+|++..
T Consensus       224 lsWsF~s~l  232 (253)
T 1sbf_A          224 LSWSFASNL  232 (253)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEeEeec
Confidence            999998764

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=8.6e-58  Score=449.59  Aligned_cols=225  Identities=34%  Similarity=0.523  Sum_probs=205.0

Q ss_pred             CCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC---CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCC
Q 038860           20 SQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT---SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYP   96 (652)
Q Consensus        20 ~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~---~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~   96 (652)
                      +...+|+|++|..++.+|+|+|+|.+.++|.|+||++.   .++.|||+|++||+||++.+|+++||+|+|+|.|.++ .
T Consensus         3 ~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~-~   81 (242)
T 1qnw_A            3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD-K   81 (242)
T ss_dssp             CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-S
T ss_pred             ccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC-C
Confidence            45679999999966689999999999878999999986   7899999999999999999999999999999999987 7


Q ss_pred             CCCcCcEEEEEccCCC-CC-CCCCccccCCccCCCCCCcccEEEEEeecc----cCCCCCCCCCCceeeecCCcccccee
Q 038860           97 RLGGHGLAFTISPSND-LN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTV----QDFEFQDINDNHIGIDINSMKSNASV  170 (652)
Q Consensus        97 ~~~gdGlaF~l~p~~~-~~-~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~----~n~~~~d~~~~hvgi~~ns~~s~~~~  170 (652)
                      ..+||||||||+|... .| +++|+||||+|.++ +++.+|+|||||||+    +|.  +||++||||||+|++.|..++
T Consensus        82 ~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~~~~  158 (242)
T 1qnw_A           82 SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSIKTV  158 (242)
T ss_dssp             SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC--CCCCCCcEEEecCCcccccee
Confidence            7789999999999874 45 78999999999765 477899999999999    997  699999999999999998887


Q ss_pred             ecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc--cc
Q 038860          171 EAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL--AS  248 (652)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~--~~  248 (652)
                      +|            ++.+|+.++|||+||+.+++|+|++++.+. |..|+|+..+||+.+||++|||||||+||..  .+
T Consensus       159 ~~------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~  225 (242)
T 1qnw_A          159 KW------------DWRNGEVADVVITYRAPTKSLTVCLSYPSD-GTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFE  225 (242)
T ss_dssp             EC------------CCCTTCCEEEEEEEEGGGTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCB
T ss_pred             cc------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC-CcceeEEEeechHHhcCCceEEEEEeccCCCccce
Confidence            64            477899999999999999999999997654 6678999999999999999999999999999  99


Q ss_pred             cceeecccccccC
Q 038860          249 SHNVLGWSFKING  261 (652)
Q Consensus       249 ~~~v~~w~f~~~~  261 (652)
                      .|.|++|+|++..
T Consensus       226 ~h~IlsWsF~s~l  238 (242)
T 1qnw_A          226 THDVLSWYFTSNL  238 (242)
T ss_dssp             CCEEEEEEEEEEC
T ss_pred             EEEEEEEEeEeec
Confidence            9999999998753

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=2.8e-57  Score=447.08  Aligned_cols=225  Identities=32%  Similarity=0.477  Sum_probs=202.8

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|..+..+|+|+|+|.+.++|.|+||++..      ++.|||||++||+||++ +|+++||+|+|+|+|.++
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g~~~sFst~F~F~I~~~   80 (240)
T 2fmd_A            2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLVASFETTFTFSISQG   80 (240)
T ss_dssp             CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TCSEEEEEEEEEEECCBS
T ss_pred             cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CCCcCcEEEEEEEEEecC
Confidence            45789999999666899999999998789999999876      79999999999999999 999999999999999987


Q ss_pred             CCCCCcCcEEEEEccCCCCC-C-CCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeec
Q 038860           95 YPRLGGHGLAFTISPSNDLN-G-LPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEA  172 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~-~-~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~  172 (652)
                       ...+||||||||+|....| + ++|++|||++.+++++..+++|||||||++|.+++||++||||||+|++.|..+.++
T Consensus        81 -~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~~  159 (240)
T 2fmd_A           81 -SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW  159 (240)
T ss_dssp             -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC
T ss_pred             -CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeEE
Confidence             7778999999999988656 3 899999999988777789999999999999998889999999999999999888764


Q ss_pred             ceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccccccccee
Q 038860          173 AVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNV  252 (652)
Q Consensus       173 ~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v  252 (652)
                                  ++.+|+.++|||+||+.+++|+|++++.+.  ..|+++..+||+.+||++|||||||+||...+.|.|
T Consensus       160 ------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~I  225 (240)
T 2fmd_A          160 ------------DWQNGKTATAHISYNSASKRLSVVSSYPNS--SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNI  225 (240)
T ss_dssp             ------------CCCSSCEEEEEEEEETTTTEEEEEEECTTS--CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCEE
T ss_pred             ------------EeeCCCEEEEEEEEeCCCCEEEEEEecCCC--CceEEEEEechHHhCCCceEEEEEeccCCccccEEE
Confidence                        467899999999999999999999997654  578999999999999999999999999999999999


Q ss_pred             ecccccccC
Q 038860          253 LGWSFKING  261 (652)
Q Consensus       253 ~~w~f~~~~  261 (652)
                      ++|+|++..
T Consensus       226 lsWsF~s~~  234 (240)
T 2fmd_A          226 LAWSFRSSL  234 (240)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEeEecC
Confidence            999998753

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=1.9e-57  Score=444.26  Aligned_cols=218  Identities=31%  Similarity=0.456  Sum_probs=199.9

Q ss_pred             eeEEcCCCCCCCCCeEEecceEeccCCcEEecCC--CCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCc
Q 038860           23 DELFFPGFKDLSNNLTLQGIAKIENNGILRLTND--TSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGG  100 (652)
Q Consensus        23 ~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~--~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g  100 (652)
                      ++|+|++|. +..+|+|+|+|.+.++|.|+||++  ..++.|||+|++||+||++.+|+++||+|+|+|.|.++....+|
T Consensus         1 ~sF~f~~F~-~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~~g   79 (234)
T 2eig_A            1 VSFNYTRFK-DDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYPPT   79 (234)
T ss_dssp             CEEEESSCC-SSSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSCCC
T ss_pred             CeEEcCCCC-CCCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCCCC
Confidence            379999998 347999999999987899999998  77899999999999999999999999999999999998777899


Q ss_pred             CcEEEEEccCCC-CC-CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCC---CceeeecCCccccceeeccee
Q 038860          101 HGLAFTISPSND-LN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDIND---NHIGIDINSMKSNASVEAAVY  175 (652)
Q Consensus       101 dGlaF~l~p~~~-~~-~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~hvgi~~ns~~s~~~~~~~~~  175 (652)
                      |||||||+|... .| +++|+||||+|.+   ++.+|+|||||||++|.  +||++   ||||||+||+.|..++++   
T Consensus        80 dGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~~---  151 (234)
T 2eig_A           80 DGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVNW---  151 (234)
T ss_dssp             CEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEEC---
T ss_pred             CcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceecc---
Confidence            999999999874 45 7899999999875   56899999999999998  69999   999999999999888764   


Q ss_pred             cCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccc--ccccccceee
Q 038860          176 TDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSAST--GLLASSHNVL  253 (652)
Q Consensus       176 ~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsast--g~~~~~~~v~  253 (652)
                               ++.+|+.++|||+||+.+++|+|++++ + +|..|+|+..+||+.+||++|||||||+|  |.. +.|.|+
T Consensus       152 ---------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~Il  219 (234)
T 2eig_A          152 ---------NRVSGSLEKATIIYDSDTKILTVVMTH-Q-NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDIY  219 (234)
T ss_dssp             ---------CCCTTCCEEEEEEEETTTTEEEEEEEE-T-TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEEE
T ss_pred             ---------cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEEE
Confidence                     477899999999999999999999998 5 46679999999999999999999999999  999 999999


Q ss_pred             cccccccC
Q 038860          254 GWSFKING  261 (652)
Q Consensus       254 ~w~f~~~~  261 (652)
                      +|+|++..
T Consensus       220 sWsF~s~l  227 (234)
T 2eig_A          220 SWSFTSTL  227 (234)
T ss_dssp             EEEEEEEC
T ss_pred             EEEEEecC
Confidence            99998764

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=1.7e-57  Score=450.38  Aligned_cols=223  Identities=32%  Similarity=0.504  Sum_probs=203.7

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|..  .+|+|+|+|.+. +|.|+||++.      .++.|||||++||+||++.+|+++||+|+|+|.|.++
T Consensus         2 ~~~~F~f~~F~~--~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~   78 (253)
T 1g7y_A            2 DIQSFSFKNFNS--SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAP   78 (253)
T ss_dssp             EEEEEEESSCCS--SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             cceEEEcCCCCc--CCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecC
Confidence            356899999985  799999999998 9999999876      5799999999999999999999999999999999987


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      ....+||||||||+|....|+++|+||||+|.+++ +..+|+|||||||++|.+ +||++||||||+||+.|..++++  
T Consensus        79 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~-~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t~~~--  154 (253)
T 1g7y_A           79 NKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTASW--  154 (253)
T ss_dssp             SGGGCCCEEEEEEEETTCCCCCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCcEEEEEecCCCCCCCCCCcccccccCCC-CccCceEEEEecceeccC-cCCCCCcEeeccCCccccceecc--
Confidence            66778999999999987667889999999997754 679999999999999988 69999999999999999888764  


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccce
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHN  251 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~  251 (652)
                                ++.+|+.++|||+||+.+++|+|++++.+. |..|+++..+||+.+||++|||||||+||..   .+.|.
T Consensus       155 ----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~  223 (253)
T 1g7y_A          155 ----------GLANGQNAEILITYNAATSLLVASLVHPSR-RTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHD  223 (253)
T ss_dssp             ----------CCCTTSEEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCE
T ss_pred             ----------ccCCCCeEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeCcCCCCcccceeE
Confidence                      477899999999999999999999997654 5678999999999999999999999999999   99999


Q ss_pred             eecccccccC
Q 038860          252 VLGWSFKING  261 (652)
Q Consensus       252 v~~w~f~~~~  261 (652)
                      |++|+|++..
T Consensus       224 IlsWsF~s~l  233 (253)
T 1g7y_A          224 VLSWSFASKL  233 (253)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEEEeeC
Confidence            9999998764

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=2.6e-57  Score=447.02  Aligned_cols=223  Identities=29%  Similarity=0.385  Sum_probs=202.4

Q ss_pred             CceeEEcCCC----CCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEE
Q 038860           21 QLDELFFPGF----KDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIV   90 (652)
Q Consensus        21 ~~~~f~~~~F----~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~   90 (652)
                      ...+|+|++|    .+++.+|+|+|+|.+. +|.|+||++.      .++.|||+|++||+||+ .+|+++||+|+|+|+
T Consensus         2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F~   79 (243)
T 1gsl_A            2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTFL   79 (243)
T ss_dssp             CCCEEEESCCCCTTCCTTSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEEE
T ss_pred             cceEEEcCCCccccCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEEE
Confidence            3568999999    6445799999999998 9999999876      57999999999999999 999999999999999


Q ss_pred             EecCCCCCCcCcEEEEEccCCCCCCCCCccccCCccCCC-CCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccce
Q 038860           91 IVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDI-GNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNAS  169 (652)
Q Consensus        91 i~~~~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~-~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~  169 (652)
                      |.++ ...+||||||||+|....++++|+||||++.+++ +++.+|+|||||||++|.+|+||++||||||+|++.|..+
T Consensus        80 I~~~-~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~~~  158 (243)
T 1gsl_A           80 LKNY-GAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT  158 (243)
T ss_dssp             EEES-SSSCBCEEEEEEEETTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred             EecC-CCCCCCCEEEEEecCCCCCCCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCccccce
Confidence            9987 6778999999999987667889999999998764 7788999999999999999889999999999999999888


Q ss_pred             eecceecCCCCcccCCcCC---CceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc
Q 038860          170 VEAAVYTDNSTKQDLSLKG---GKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL  246 (652)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~---g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~  246 (652)
                      .++            ++.+   |+.++|||+||+.+++|+|++++.+.  ..|+|+..+||+.+||++|||||||+|| .
T Consensus       159 ~~~------------~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~~vGFSAsTG-~  223 (243)
T 1gsl_A          159 TRW------------ENDDAYGSSIATAHITYDARSKILTVLLSYEHG--RDYILSHVVDLAKVLPQKVRIGFSAGVG-Y  223 (243)
T ss_dssp             EEC------------CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS--CEEEEEEECCHHHHSCSEEEEEEEEEEC-B
T ss_pred             eee------------EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC--CceeEEEEechHHhCCCceEEEEEeccC-C
Confidence            765            3556   99999999999999999999998654  4689999999999999999999999999 9


Q ss_pred             cccceeecccccccC
Q 038860          247 ASSHNVLGWSFKING  261 (652)
Q Consensus       247 ~~~~~v~~w~f~~~~  261 (652)
                      .+.|.|++|+|++..
T Consensus       224 ~~~h~IlsWsF~s~l  238 (243)
T 1gsl_A          224 DEVTYILSWHFFSTL  238 (243)
T ss_dssp             SEEEEEEEEEEEEEC
T ss_pred             cceeEEEEEEEEeec
Confidence            999999999998764

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=3.3e-57  Score=445.44  Aligned_cols=221  Identities=33%  Similarity=0.460  Sum_probs=201.6

Q ss_pred             ceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-----CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC-C
Q 038860           22 LDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-----SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE-Y   95 (652)
Q Consensus        22 ~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~   95 (652)
                      ..+|+|++|..++.+|+|+|+|.+.++|.|+||++.     .++.|||+|++||+||++.+|+++||+|+|+|+|.++ +
T Consensus         3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~   82 (242)
T 1wbf_A            3 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPFP   82 (242)
T ss_dssp             EEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSCC
T ss_pred             ceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCCCC
Confidence            468999999966689999999999878999999876     6799999999999999999999999999999999987 6


Q ss_pred             CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeeccee
Q 038860           96 PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVY  175 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~  175 (652)
                      ...+||||||||+|....++++|+||||+|.+    +.+|+|||||||++|.  +||++||||||+|++.|..+.++   
T Consensus        83 ~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~~---  153 (242)
T 1wbf_A           83 RPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVPF---  153 (242)
T ss_dssp             SSCCCEEEEEEEECSSCCCCCCGGGTTTCCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC---
T ss_pred             CCCCCCcEEEEEecCCCCCCCCCCccccccCC----CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceeee---
Confidence            67789999999999876678899999999865    5789999999999998  69999999999999999888764   


Q ss_pred             cCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccc----ccc---cc
Q 038860          176 TDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSAST----GLL---AS  248 (652)
Q Consensus       176 ~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsast----g~~---~~  248 (652)
                               ++.+|+.++|||+||+.+++|+|++++.+. |..|+|+..+||+.+||++|||||||+|    |..   .+
T Consensus       154 ---------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~~~~~  223 (242)
T 1wbf_A          154 ---------TLDNGGIANVVIKYDASTKILHVVLVFPSL-GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATE  223 (242)
T ss_dssp             ---------CCCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCC
T ss_pred             ---------EecCCCEEEEEEEEeCCCCEEEEEEccCCC-CCcceEEEEechHHhcCCceEEEEEEeecCcCCccccccc
Confidence                     477999999999999999999999998654 5578999999999999999999999999    888   89


Q ss_pred             cceeecccccccC
Q 038860          249 SHNVLGWSFKING  261 (652)
Q Consensus       249 ~~~v~~w~f~~~~  261 (652)
                      .|.|++|+|++..
T Consensus       224 ~h~IlsWsF~s~l  236 (242)
T 1wbf_A          224 THDILSWSFSASL  236 (242)
T ss_dssp             CCEEEEEEEEEEC
T ss_pred             eEEEEEEEeEecC
Confidence            9999999998764

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=5.5e-57  Score=442.44  Aligned_cols=222  Identities=31%  Similarity=0.485  Sum_probs=201.3

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-----CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-----SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY   95 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~   95 (652)
                      ...+|+|++|.+++.+|+|+|+|.+.++|.|+||++.     .++.|||+|++||+||++.+  ++||+|+|+|+|.+++
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~--~~sFsT~F~F~I~~~~   79 (233)
T 1n47_A            2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT--LASFTTSFSFVMAAPA   79 (233)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC--BCEEEEEEEEECCCSS
T ss_pred             cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC--cCCEEEEEEEEEeCCC
Confidence            3568999999976689999999999878999999877     47999999999999999877  9999999999999887


Q ss_pred             CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeeccee
Q 038860           96 PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVY  175 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~  175 (652)
                      ...+||||||||+|....|+++|+||||+|.++ ++..+|+|||||||++|.  +||++||||||+||+.|..++++   
T Consensus        80 ~~~~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~~~---  153 (233)
T 1n47_A           80 AAAVADGLAFFLAPPDTQPQARGGFLGLFADRA-HDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTPF---  153 (233)
T ss_dssp             TTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEEC---
T ss_pred             CCCCCCcEEEEEecCCCCCCCCCCcccccccCC-CCccCceEEEEeccccCC--CCCCCCcEEEccCCccccccccc---
Confidence            778899999999998766778899999999774 478899999999999998  69999999999999999888764   


Q ss_pred             cCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---ccccee
Q 038860          176 TDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHNV  252 (652)
Q Consensus       176 ~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~v  252 (652)
                               ++.+|+.++|||+||+.+++|+|++++.+. +..|+|+..+||+.+||++|||||||+||..   .+.|.|
T Consensus       154 ---------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h~I  223 (233)
T 1n47_A          154 ---------DMVYGEKANIVITYQASTKALAASLVFPVS-QTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDI  223 (233)
T ss_dssp             ---------CCCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEE
T ss_pred             ---------cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCccccceeEE
Confidence                     477899999999999999999999997654 3478999999999999999999999999999   999999


Q ss_pred             eccccccc
Q 038860          253 LGWSFKIN  260 (652)
Q Consensus       253 ~~w~f~~~  260 (652)
                      ++|+|++.
T Consensus       224 lsWsF~s~  231 (233)
T 1n47_A          224 VSWSFAVS  231 (233)
T ss_dssp             EEEEEEEE
T ss_pred             EEEEEEee
Confidence            99999864

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=6.8e-57  Score=443.13  Aligned_cols=225  Identities=32%  Similarity=0.460  Sum_probs=204.5

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCc
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGG  100 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g  100 (652)
                      ...+|+|++|..+..+|+|+|+|. .++|.|+||++.+++.|||||++||+||++.+|+++||+|+|+|+|.++....+|
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~~g   80 (234)
T 2bqp_A            2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVA   80 (234)
T ss_dssp             EEEEEEESSBCTTCTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCC
T ss_pred             cceEEEcCCCCCCCCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCCCC
Confidence            356899999996668999999999 5699999999999999999999999999999999999999999999988777899


Q ss_pred             CcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCC--CCceeeecCCccccceeecceecCC
Q 038860          101 HGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDIN--DNHIGIDINSMKSNASVEAAVYTDN  178 (652)
Q Consensus       101 dGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~hvgi~~ns~~s~~~~~~~~~~~~  178 (652)
                      |||||||+|....|+++|++|||+|.++ ++..+++|||||||++|.+ +||+  +||||||+|++.|..+.++      
T Consensus        81 dGlAF~l~p~~~~p~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~~------  152 (234)
T 2bqp_A           81 DGFTFFIAPVDTKPQTGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW------  152 (234)
T ss_dssp             CEEEEEEEETTCCCCCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC------
T ss_pred             CcEEEEEecCCCCCCCCCCccccccccC-CCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccceEee------
Confidence            9999999998766678899999999775 4788999999999999988 5999  9999999999999888764      


Q ss_pred             CCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCC----CCCCCeeeEEecCCcccccceEEEEecccccccccceeec
Q 038860          179 STKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSS----KPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLG  254 (652)
Q Consensus       179 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~----~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~  254 (652)
                            ++.+|+.++|||+||+.+++|+|++++.+.    +|..|+++..+||+.+||++|||||||+||...+.|.|++
T Consensus       153 ------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~Ils  226 (234)
T 2bqp_A          153 ------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLS  226 (234)
T ss_dssp             ------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEE
T ss_pred             ------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEEEE
Confidence                  467899999999999999999999987654    3567899999999999999999999999999999999999


Q ss_pred             cccccc
Q 038860          255 WSFKIN  260 (652)
Q Consensus       255 w~f~~~  260 (652)
                      |+|++.
T Consensus       227 WsF~s~  232 (234)
T 2bqp_A          227 WSFHSE  232 (234)
T ss_dssp             EEEEEE
T ss_pred             EEEEee
Confidence            999864

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=2.3e-57  Score=449.23  Aligned_cols=222  Identities=34%  Similarity=0.492  Sum_probs=203.0

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|..  .+|+|+|+|.+.++|.|+||++.      .++.|||||++||+||++.+|+++||+|+|+|.|.++
T Consensus         2 ~~~~F~f~~F~~--~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~   79 (252)
T 1fat_A            2 NDIYFNFQRFNE--TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVP   79 (252)
T ss_dssp             CCEEEEESSCCG--GGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCCC
T ss_pred             cceEEEcCCCCc--CCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeCC
Confidence            457899999985  79999999999878999999876      5789999999999999999999999999999999988


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      +...+||||||||+|....|+++|+||||+|.+   ++.+|+|||||||++|.+ +||++||||||+|++.|..++++  
T Consensus        80 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~~~~--  153 (252)
T 1fat_A           80 NNAGPADGLAFALVPVGSQPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTRW--  153 (252)
T ss_dssp             SSCBCCEEEEEEEEETTCCCCCSGGGTTTCCSS---CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCcEEEEEccCCCCCCCCCccccccccC---CccCcEEEEEeecccCCC-CCCCCCeEEEecCCccccceecc--
Confidence            777789999999999876678899999999876   568999999999999988 69999999999999999888764  


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccce
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHN  251 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~  251 (652)
                                ++.+|+.++|||+||+.+++|+|++++.+. |..|+++..+||+.+||++|||||||+||..   .+.|.
T Consensus       154 ----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~  222 (252)
T 1fat_A          154 ----------DFVNGENAEVLITYDSSTNLLVASLVYPSQ-KTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETND  222 (252)
T ss_dssp             ----------CCCTTCEEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCE
T ss_pred             ----------cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCCcccceEE
Confidence                      477899999999999999999999997654 5578999999999999999999999999999   99999


Q ss_pred             eecccccccC
Q 038860          252 VLGWSFKING  261 (652)
Q Consensus       252 v~~w~f~~~~  261 (652)
                      |++|+|++..
T Consensus       223 IlsWsF~s~l  232 (252)
T 1fat_A          223 VLSWSFASKL  232 (252)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEEEeeC
Confidence            9999998764

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=6.9e-57  Score=443.18  Aligned_cols=221  Identities=35%  Similarity=0.505  Sum_probs=201.6

Q ss_pred             ceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC-
Q 038860           22 LDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE-   94 (652)
Q Consensus        22 ~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-   94 (652)
                      ..+|+|++|..++.+|+|+|+|.+.++|.|+||++.      .++.|||||++||+||++.+|+++||+|+|+|+|.++ 
T Consensus         2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~~   81 (238)
T 1f9k_A            2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY   81 (238)
T ss_dssp             EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred             CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecCC
Confidence            468999999966689999999999878999999876      5799999999999999999999999999999999987 


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      ....+||||||||+|....|+++|+||||+|.+   ++ +|+|||||||++|.  +||++||||||+|++.|..++++  
T Consensus        82 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~~~--  153 (238)
T 1f9k_A           82 AYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLHF--  153 (238)
T ss_dssp             SSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSS---CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCcEEEEEccCCCCCCCCCCcccccccC---CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceEee--
Confidence            677789999999999876678889999999876   45 99999999999998  69999999999999999887764  


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCccccc--ceEEEEecccccc---ccc
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNE--FMYVGFSASTGLL---ASS  249 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~--~~~vGfsastg~~---~~~  249 (652)
                                ++.+|+.++|||+||+.+++|+|++++.+. |..|+++..+||+.+||+  +|||||||+||..   .+.
T Consensus       154 ----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~~~~  222 (238)
T 1f9k_A          154 ----------QLENGGVANVVIKYDSPTKILNVVLAFHSV-GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVET  222 (238)
T ss_dssp             ----------CCCTTCCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCE
T ss_pred             ----------cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCceeEEEEechHHhCCCCceEEEEEEeCcCCCCcccce
Confidence                      477999999999999999999999998654 557899999999999999  9999999999999   999


Q ss_pred             ceeecccccccC
Q 038860          250 HNVLGWSFKING  261 (652)
Q Consensus       250 ~~v~~w~f~~~~  261 (652)
                      |.|++|+|++..
T Consensus       223 h~IlsWsF~s~~  234 (238)
T 1f9k_A          223 HEIISWSFTSSL  234 (238)
T ss_dssp             EEEEEEEEEEEC
T ss_pred             EEEEEeEeEeec
Confidence            999999998753

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=2.3e-56  Score=435.43  Aligned_cols=217  Identities=36%  Similarity=0.511  Sum_probs=197.5

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCC---CCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTND---TSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPR   97 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~---~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~   97 (652)
                      ...+|+|++|+.  .||+|+|+|.+.++|.|+||++   ..++.|||+|++||+||++.+|+++||+|+|+|.|.+++..
T Consensus         2 ~~~~F~f~~F~~--~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~~   79 (226)
T 1avb_A            2 NDASFNVETFNK--TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIE   79 (226)
T ss_dssp             EEEEEEESSCCG--GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTT
T ss_pred             cceEEEcCCCCc--cCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCCC
Confidence            346899999985  7999999999977999999998   77899999999999999999999999999999999998777


Q ss_pred             CCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecC
Q 038860           98 LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTD  177 (652)
Q Consensus        98 ~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~  177 (652)
                      .+||||||||+|....|+++|+||||+|.++ ++..+|+|||||||+         +||||||+|++.|..++++     
T Consensus        80 ~~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~-----  144 (226)
T 1avb_A           80 NSAYGLAFALVPVGSRPKLKGRYLGLFNTTN-YDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESC-----  144 (226)
T ss_dssp             SCCEEEEEEEEETTCCCCCCGGGTTTCSCSS-CCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC-----
T ss_pred             CCCCcEEEEEecCCCCCCCCCCcccccccCC-CCCcccEEEEEecCc---------CCccceeecCcccCccccC-----
Confidence            8999999999998766678899999999764 477899999999998         5999999999999998876     


Q ss_pred             CCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccceeec
Q 038860          178 NSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHNVLG  254 (652)
Q Consensus       178 ~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~v~~  254 (652)
                           +..+.+|+.++|||+||+.+++|+|++++.+. +..|+++..+||+.+||++|||||||+||..   .+.|.|++
T Consensus       145 -----~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~Ils  218 (226)
T 1avb_A          145 -----NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSS-EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLS  218 (226)
T ss_dssp             -----CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEE
T ss_pred             -----CccccCCCeEEEEEEEeCCCcEEEEEEeecCC-CccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEEE
Confidence                 45677999999999999999999999998654 3378999999999999999999999999999   99999999


Q ss_pred             cccccc
Q 038860          255 WSFKIN  260 (652)
Q Consensus       255 w~f~~~  260 (652)
                      |+|++.
T Consensus       219 WsF~s~  224 (226)
T 1avb_A          219 WSFSSN  224 (226)
T ss_dssp             EEEEEE
T ss_pred             EEEEee
Confidence            999863

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=5.2e-55  Score=429.28  Aligned_cols=216  Identities=33%  Similarity=0.505  Sum_probs=195.2

Q ss_pred             CceeEEcCCCCCCCCC-eEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEec
Q 038860           21 QLDELFFPGFKDLSNN-LTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVP   93 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~-~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~   93 (652)
                      ...+|+|++|..  .| |+|+|+|.+.++|.|+||++..      ++.|||+|++||+||++.  +++||+|+|+|.|.+
T Consensus         2 ~~~~F~f~~F~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~--~vaSFsT~F~F~I~~   77 (240)
T 1ioa_A            2 TETSFNFPNFHT--DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN--NVASFNTNFTFIIRA   77 (240)
T ss_dssp             CCCEEEESSCCT--TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS--CBEEEEEEEEEECCB
T ss_pred             cceEEEcCCCCC--CCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC--ccccEEEEEEEEEeC
Confidence            356899999985  68 9999999998799999998876      789999999999999986  899999999999998


Q ss_pred             CCCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecc
Q 038860           94 EYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAA  173 (652)
Q Consensus        94 ~~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~  173 (652)
                      ++...+||||||||+|....|+++|+||||+|.++ +++.+|+|||||||+         +||||||+|++.|..+++| 
T Consensus        78 ~~~~~~gdGlAF~l~p~~~~p~~~g~~LGL~n~~~-~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~-  146 (240)
T 1ioa_A           78 KNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNN-PEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNENC-  146 (240)
T ss_dssp             SCTTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSS-CCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCCcEEEEEecCCCCCCCCCCcccccccCC-CCCcCcEEEEEecCc---------CCceeeeeCCccccccccC-
Confidence            87778999999999998766678899999999764 477899999999998         5999999999999998876 


Q ss_pred             eecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccc
Q 038860          174 VYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSH  250 (652)
Q Consensus       174 ~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~  250 (652)
                               +..+.+|+.++|||+||+.+++|+|++++.+. +..|+++..+||+.+||++|||||||+||..   .+.|
T Consensus       147 ---------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H  216 (240)
T 1ioa_A          147 ---------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVS-QVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETH  216 (240)
T ss_dssp             ---------CHHHHCSSCEEEEEEEETTTTEEEEEEEETTT-CCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCC
T ss_pred             ---------CccccCCCEEEEEEEEeCCCcEEEEEEecCCC-CccceeEEEechHHhCCCceEEEEEeccCCCCccccee
Confidence                     34567899999999999999999999998654 4478999999999999999999999999999   9999


Q ss_pred             eeecccccccC
Q 038860          251 NVLGWSFKING  261 (652)
Q Consensus       251 ~v~~w~f~~~~  261 (652)
                      .|++|+|++..
T Consensus       217 ~IlsWsF~s~~  227 (240)
T 1ioa_A          217 DVLSWSFSSKF  227 (240)
T ss_dssp             EEEEEEEEEEE
T ss_pred             EEEEEEEEeeC
Confidence            99999998764

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=100.00  E-value=1.9e-51  Score=398.40  Aligned_cols=201  Identities=31%  Similarity=0.468  Sum_probs=176.1

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCc
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGG  100 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g  100 (652)
                      ...+|+|++|..  .||+|+|+|.+.++|.|+||++..++.|||+|++||++|++.+|+++||+|+|+|.|.+++...+|
T Consensus         2 ~~~~F~f~~F~~--~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~g   79 (223)
T 1dhk_B            2 TETSFIIDAFNK--TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSA   79 (223)
T ss_dssp             CCCEEEESSCCG--GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CC
T ss_pred             cceEEEcCCCCc--CCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCCC
Confidence            356899999985  799999999998799999999988999999999999999999999999999999999988777889


Q ss_pred             CcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCCC
Q 038860          101 HGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNST  180 (652)
Q Consensus       101 dGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~~  180 (652)
                      |||||||+|....|+                  +++|||||||+         +||||||+|++ |..++++        
T Consensus        80 dGlAF~l~p~~~~p~------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~--------  123 (223)
T 1dhk_B           80 VGLDFVLVPVQPESK------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPW--------  123 (223)
T ss_dssp             SEEEEEEEEC------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEEC--------
T ss_pred             CceEEEEecCCCCCC------------------ccEEEEEecCC---------CCcccccCCcc-ccccccC--------
Confidence            999999999764321                  34899999998         59999999999 9888875        


Q ss_pred             cccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccceeecccc
Q 038860          181 KQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHNVLGWSF  257 (652)
Q Consensus       181 ~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~v~~w~f  257 (652)
                        +..+.+|+.++|||+||+.+++|+|++++.+. +..|+++..+||+.+||++|||||||+||..   .+.|.|++|+|
T Consensus       124 --~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF  200 (223)
T 1dhk_B          124 --DVHDYDGQNAEVRITYNSSTKVFSVSLSNPST-GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF  200 (223)
T ss_dssp             --CGGGTTTSCEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEE
T ss_pred             --CccccCCCEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEE
Confidence              45677999999999999999999999997654 3478999999999999999999999999999   99999999999


Q ss_pred             cccCC
Q 038860          258 KINGP  262 (652)
Q Consensus       258 ~~~~~  262 (652)
                      ++..+
T Consensus       201 ~s~~~  205 (223)
T 1dhk_B          201 SSKFI  205 (223)
T ss_dssp             EEEC-
T ss_pred             Eeccc
Confidence            97643

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=100.00  E-value=2.8e-49  Score=370.18  Aligned_cols=177  Identities=31%  Similarity=0.438  Sum_probs=161.6

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCc
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGG  100 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g  100 (652)
                      ...+|+|++|..++.+|+|+|+|. .++|.|+||+...+++|||+|++||+||++.+|+++||+|+|+|.|.++....+|
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~~g   80 (181)
T 2ltn_A            2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVA   80 (181)
T ss_dssp             EEEEEEESSCCSSCTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCC
T ss_pred             cceEEEcCCCCCCCCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCCCC
Confidence            356899999996668999999999 6789999999988999999999999999999999999999999999988777889


Q ss_pred             CcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCC--CCceeeecCCccccceeecceecCC
Q 038860          101 HGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDIN--DNHIGIDINSMKSNASVEAAVYTDN  178 (652)
Q Consensus       101 dGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~hvgi~~ns~~s~~~~~~~~~~~~  178 (652)
                      |||||||+|....|+++|+||||+|.++ ++..+|+|||||||++|.+ +||+  +|||||||||+.|..+++|      
T Consensus        81 dGlAF~l~p~~~~p~~~g~~LGL~n~~~-~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~------  152 (181)
T 2ltn_A           81 DGFTFFIAPVDTKPQTGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW------  152 (181)
T ss_dssp             CEEEEEEEETTCCCCCCGGGTTTCSCSS-CCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC------
T ss_pred             CceEEEEecCCCCCCCCCccccccccCC-CCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceecc------
Confidence            9999999998765678899999999774 4778999999999999988 6999  9999999999999988865      


Q ss_pred             CCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeC
Q 038860          179 STKQDLSLKGGKAILVWVDYDSAENILNVTVSPN  212 (652)
Q Consensus       179 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~  212 (652)
                            ++.+|+.++|||+||+.+++|+|++++.
T Consensus       153 ------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~  180 (181)
T 2ltn_A          153 ------KLQNGEEANVVIAFNAATNVLTVSLTYP  180 (181)
T ss_dssp             ------CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred             ------ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence                  3679999999999999999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.9e-50  Score=419.31  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=211.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ..|+..++||+|+||+||+|++..+++.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999999999999999997665555567889999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++|+|.+++..   ..+++.++..++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+.+.... ..
T Consensus       154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~  226 (346)
T 4fih_A          154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR  226 (346)
T ss_dssp             TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred             CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence            99999998843   45999999999999999999999   7999999999999999999999999999999765432 23


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEY  579 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  579 (652)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....   .....+...                  
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~------------------  285 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN------------------  285 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS------------------
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcC------------------
Confidence            45578999999999999999999999999999999999999999753221   111111000                  


Q ss_pred             CHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          580 DQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       580 ~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                                      ..|.........+.+.||+.+|+..||++|+      .|+||...
T Consensus       286 ----------------~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          286 ----------------LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             ----------------SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----------------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence                            0011111223457899999999999999999      57898764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.7e-50  Score=413.37  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=209.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999997542   334577899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|.+++..  ...+++.++..++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999953  456999999999999999999999   7999999999999999999999999999999875433


Q ss_pred             -CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 -NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 -~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                       .......+||+.|||||++.+..++.++||||+||++|||++|+.||.....   ..+...+.                
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~----------------  247 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKII----------------  247 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----------------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----------------
Confidence             2345567899999999999999999999999999999999999999975321   11111110                


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------------ccccccC
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------------CSYFENG  634 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------------~~~~~~~  634 (652)
                      ..++          ..      |.     ...+.++||+.+|+..||++|++            |+||++.
T Consensus       248 ~~~~----------~~------p~-----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          248 KLEY----------DF------PE-----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HTCC----------CC------CT-----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             cCCC----------CC------Cc-----ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            0000          00      11     23467899999999999999995            5688763

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-50  Score=420.37  Aligned_cols=204  Identities=24%  Similarity=0.410  Sum_probs=178.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  .....+.+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999999999999999999754  3345678999999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|.+++.......+++.+++.|+.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999997666667899999999999999999999   7999999999999999999999999999998654321


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence             1234568999999999999999999999999999999999999999764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.3e-49  Score=420.68  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=211.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .+.|+..+.||+|+||.||+|++..+++.||||++........+.+.+|+.+|++++|||||+++++|.+.+.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            35799999999999999999999999999999999766555556788999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      |++|+|.+++..   ..+++.++..++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+.+.... .
T Consensus       230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~  302 (423)
T 4fie_A          230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P  302 (423)
T ss_dssp             CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred             CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence            999999998843   45999999999999999999999   7999999999999999999999999999999765432 3


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....   .....+..                  
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~------------------  361 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD------------------  361 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH------------------
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHc------------------
Confidence            345678999999999999999999999999999999999999999753221   11111100                  


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                               .  .     .|.........+.+.|||.+|+..||++|+      .|+||...
T Consensus       362 ---------~--~-----~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          362 ---------N--L-----PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ---------S--C-----CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ---------C--C-----CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                     0  0     011111123457899999999999999999      57898763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.6e-49  Score=409.99  Aligned_cols=200  Identities=25%  Similarity=0.329  Sum_probs=175.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .+.|+..++||+|+||.||+|++..+++.||||+++....     ..+|+.++++++|||||++++++.+++.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4568889999999999999999999999999999976432     24699999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceecccCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~~~~~  497 (652)
                      |++|+|.+++..  ...+++.++..++.||+.||+|||   +++|+||||||+||||+.++ ++||+|||+|+....+..
T Consensus       132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            999999999953  346999999999999999999999   79999999999999999987 699999999997654322


Q ss_pred             C----ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          498 P----ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       498 ~----~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .    .....+||+.|||||++.+..++.++|||||||++|||++|+.||.....
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~  261 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR  261 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence            1    12335799999999999999999999999999999999999999976543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-49  Score=409.96  Aligned_cols=205  Identities=29%  Similarity=0.521  Sum_probs=180.2

Q ss_pred             hcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|.+.+.||+|+||+||+|++.+     ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            3578889999999999999998753     47889999998877777789999999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccC-----------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeE
Q 038860          414 LVYDFMANGSLDSFLFDE-----------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK  482 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~k  482 (652)
                      ||||||++|+|.++|...           ....++|.++++|+.||++||+|||   +++|+||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999643           2356999999999999999999999   69999999999999999999999


Q ss_pred             EeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          483 LGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       483 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      |+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~  234 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  234 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999865443222 2223568999999999999999999999999999999999 99999764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.6e-49  Score=409.24  Aligned_cols=205  Identities=30%  Similarity=0.513  Sum_probs=174.8

Q ss_pred             hcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|.+.++||+|+||+||+|++.+     +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+.++
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3567888999999999999998753     57889999998877777789999999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCC-------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          414 LVYDFMANGSLDSFLFDEP-------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      ||||||++|+|.+++....             ..+++|.++++|+.||++||+|||   +++|+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            9999999999999986432             246999999999999999999999   699999999999999999999


Q ss_pred             eEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          481 GKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~  264 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL  264 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence            99999999987644322 23345689999999999999999999999999999999999 99999764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-48  Score=396.86  Aligned_cols=245  Identities=27%  Similarity=0.430  Sum_probs=196.5

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec----cCeeEEEE
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR----KGDLLLVY  416 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  416 (652)
                      +..+.||+|+||.||+|.+..++..||+|++...  .....+.|.+|+.++++++|||||+++++|..    ++.++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            6677899999999999999999999999999654  33455779999999999999999999999864    35689999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce--EEecCCCCCceEeCC-CCCeEEeeeccceecc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV--VIHRDVKASNVLLDS-ELNGKLGDFGLAKLYE  493 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDlk~~NILl~~-~~~~kL~DFGla~~~~  493 (652)
                      |||++|+|.+++.+  ...+++..+..++.||+.||+|||   +++  |+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999954  456999999999999999999999   566  999999999999984 7899999999998543


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      .   ......+||+.|||||++.+ .++.++|||||||++|||+||+.||.+......  +..    ....+        
T Consensus       184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~----~i~~~--------  245 (290)
T 3fpq_A          184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----RVTSG--------  245 (290)
T ss_dssp             T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----HHTTT--------
T ss_pred             C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH----HHHcC--------
Confidence            2   24456789999999998864 699999999999999999999999975332111  111    11000        


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                            ..|. .......+.+.||+.+|+..+|++|+|      |+||++
T Consensus       246 ----------------------~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          246 ----------------------VKPA-SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------------CCCG-GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------------CCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                                  0000 001122457899999999999999994      677764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.4e-49  Score=406.07  Aligned_cols=249  Identities=26%  Similarity=0.348  Sum_probs=198.4

Q ss_pred             cCccccccccccCceEEEEEEEc---CCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ++|++.+.||+|+||+||+|+..   .+++.||||++++..  ......+.+|+.+|++++|||||++++++.+.+.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999874   457899999997642  2233467889999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |||||++|+|.+++.+  ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            9999999999999954  446999999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      .. ......+||+.|||||++.+..++.++|||||||++|||+||+.||.+....+   +...+..              
T Consensus       179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~--------------  240 (304)
T 3ubd_A          179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMILK--------------  240 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH--------------
T ss_pred             CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHHc--------------
Confidence            22 23345689999999999999999999999999999999999999997643211   1111100              


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC-----------ccccccC
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS-----------CSYFENG  634 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s-----------~~~~~~~  634 (652)
                        .          ..      ..|.     ...+.+.||+.+|+..||++|++           |+||++.
T Consensus       241 --~----------~~------~~p~-----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          241 --A----------KL------GMPQ-----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             --C----------CC------CCCT-----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             --C----------CC------CCCC-----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence              0          00      0111     23468899999999999999997           6788764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=399.74  Aligned_cols=202  Identities=30%  Similarity=0.527  Sum_probs=170.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..+++++.++||+|+||+||+|++.+   .||||+++..  .....++|.+|+.++++++|||||+++|+|.+ +.++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            34677889999999999999998753   5999998643  34556789999999999999999999999865 568999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      ||||++|+|.++|... ...++|.++++|+.||++||+|||   +++||||||||+||||++++.+||+|||+|+.....
T Consensus       110 mEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            9999999999999654 346999999999999999999999   689999999999999999999999999999876543


Q ss_pred             C-CCceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 T-NPATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      . .......+||+.|||||++.   .++++.++|||||||+||||+||+.||.+..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~  241 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN  241 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence            2 22345568999999999875   3468999999999999999999999997643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-48  Score=401.86  Aligned_cols=204  Identities=29%  Similarity=0.468  Sum_probs=177.1

Q ss_pred             cCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .+++..+.||+|+||+||+|.+.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45667889999999999999874     356889999997653 334578999999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC
Q 038860          414 LVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL  479 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~  479 (652)
                      ||||||++|+|.++|....              ...++|.++++|+.||++||+|||   +++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999995422              346999999999999999999999   69999999999999999999


Q ss_pred             CeEEeeeccceecccCC-CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          480 NGKLGDFGLAKLYEHGT-NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       480 ~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .+||+|||+|+...... ........||+.|||||++.++.++.++|||||||++|||+| |+.||.+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            99999999998764432 233445689999999999999999999999999999999998 89999764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-48  Score=394.06  Aligned_cols=246  Identities=24%  Similarity=0.424  Sum_probs=190.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999997542   233567899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+ +|+|.+++..  ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++++||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 6799998854  346999999999999999999999   7999999999999999999999999999998654322


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                        .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.....   ..+...+..               
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~---------------  226 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISN---------------  226 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---------------
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHc---------------
Confidence              3345689999999999988876 5799999999999999999999975321   111111000               


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                       +.+          .      .|.     ...+.+.||+.+|+..+|++|+|      |+||+.
T Consensus       227 -~~~----------~------~p~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          227 -GVY----------T------LPK-----FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -TCC----------C------CCT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -CCC----------C------CCC-----CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence             000          0      011     23468899999999999999994      668764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-47  Score=404.23  Aligned_cols=282  Identities=21%  Similarity=0.301  Sum_probs=213.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeec------cC
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRR------KG  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  410 (652)
                      .++|++.+.||+|+||.||+|++..+|+.||||+++...  ....+.+.+|+.+|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999999999999999997542  3445678899999999999999999998753      36


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      .+|||||||+ |+|.+++..  ...+++.++..+++||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            7899999996 689998854  456999999999999999999999   7999999999999999999999999999998


Q ss_pred             ecccCC---CCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCc
Q 038860          491 LYEHGT---NPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGR  566 (652)
Q Consensus       491 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  566 (652)
                      .+....   .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+....+....+......
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            764321   2234557899999999987775 568999999999999999999999987654444443333322221111


Q ss_pred             cccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          567 VLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       567 ~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      ... +     ...... .....  .+.....|.....+...+.+.|||.+|+..||++|+      .|+||...+
T Consensus       287 ~~~-~-----~~~~~~-~~~~~--~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          287 IQA-V-----GAERVR-AYIQS--LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             TC-----------CHH-HHHHS--SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhh-h-----hhhhhh-hhhhc--CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            000 0     000000 01111  122222222222334567899999999999999999      578998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-46  Score=389.02  Aligned_cols=201  Identities=29%  Similarity=0.413  Sum_probs=165.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC----eeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG----DLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV  415 (652)
                      ++|.+.+.||+|+||+||+|++.  |+.||||+++..... ...+..|+..+.+++|||||+++++|.+.+    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            45778899999999999999984  789999999764332 223446777778899999999999998654    57999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCc-----cceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY-----EQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ||||++|+|.+++..   ..++|..+.+++.|+++||+|||+.+     .++|+||||||+||||+.++++||+|||+|+
T Consensus        80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999953   45899999999999999999999531     3499999999999999999999999999999


Q ss_pred             ecccCCCC---ceeeccCCcCCCCCCCCCCC------CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          491 LYEHGTNP---ATTRVVGTLGYLAPETPRTG------KSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       491 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ........   .....+||+.|||||++.+.      .++.++|||||||++|||+||++|+...
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~  221 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence            77554321   22346899999999988754      3677999999999999999999988653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.9e-46  Score=392.36  Aligned_cols=204  Identities=23%  Similarity=0.363  Sum_probs=173.6

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEc---CCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeecc
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK  409 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  409 (652)
                      .+....++|++.+.||+|+||+||+|+++   .+++.||+|++.+..  ...++.+|+++|+.+ +||||+++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            34455678999999999999999999875   357889999987653  235678899999998 699999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeecc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGL  488 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGl  488 (652)
                      +.+|+|||||++|+|.+++.     .+++.++..++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            99999999999999999882     4899999999999999999999   7999999999999999877 7999999999


Q ss_pred             ceecccCCC---------------------------CceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCC
Q 038860          489 AKLYEHGTN---------------------------PATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGR  540 (652)
Q Consensus       489 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~  540 (652)
                      |+.......                           ...+..+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            986543211                           112345799999999998775 5899999999999999999999


Q ss_pred             CCCCCCC
Q 038860          541 RPIETRA  547 (652)
Q Consensus       541 ~p~~~~~  547 (652)
                      .||....
T Consensus       245 ~Pf~~~~  251 (361)
T 4f9c_A          245 YPFYKAS  251 (361)
T ss_dssp             SSSSCCS
T ss_pred             CCCCCCC
Confidence            9996533

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-46  Score=394.59  Aligned_cols=211  Identities=29%  Similarity=0.436  Sum_probs=181.8

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCC-----CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCc-CceeEEEeee
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNES-KQGVREFVSEIATIGRLRH-RNLVQLVGWC  406 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~  406 (652)
                      +.+...++|++.+.||+|+||+||+|.+...     ++.||||++.... ....++|.+|+++|.+++| ||||+++|+|
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            3445568899999999999999999998653     3689999997654 3445789999999999965 8999999999


Q ss_pred             ecc-CeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCC
Q 038860          407 RRK-GDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKAS  471 (652)
Q Consensus       407 ~~~-~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~  471 (652)
                      .+. +.++||||||++|+|.++|....              ...+++.+++.++.||++||+|||   +++||||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcc
Confidence            764 56899999999999999996432              245899999999999999999999   799999999999


Q ss_pred             ceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          472 NVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       472 NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      |||+++++.+||+|||+|+....+... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999976544332 2345679999999999999999999999999999999998 999997644

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-46  Score=385.05  Aligned_cols=199  Identities=25%  Similarity=0.431  Sum_probs=162.7

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC--------
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG--------  410 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  410 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999999999999999997543 334567899999999999999999999986543        


Q ss_pred             ----eeEEEEEeccCCCcccccccCCc-cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEee
Q 038860          411 ----DLLLVYDFMANGSLDSFLFDEPK-AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGD  485 (652)
Q Consensus       411 ----~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~D  485 (652)
                          .+|+|||||++|+|.+++..... ...++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                37999999999999999965332 33566778899999999999999   79999999999999999999999999


Q ss_pred             eccceecccCCCC-----------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          486 FGLAKLYEHGTNP-----------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       486 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      ||+|+........           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            9999976543221           1234579999999999999999999999999999999996   764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.6e-44  Score=399.24  Aligned_cols=201  Identities=26%  Similarity=0.407  Sum_probs=175.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhH---HHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGV---REFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .++|++.+.||+|+||.||+|++..+++.||||++.+..   ....   .....++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            468999999999999999999999999999999996532   1122   2233456777888999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      |||||||+||+|.++|..  ...+++..+..++.||+.||+|||   +++||||||||+||||+.+|.+||+|||+|+..
T Consensus       268 ylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999999953  456999999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ...   .....+||+.|||||++.. ..|+.++|||||||++|||++|++||....
T Consensus       343 ~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          343 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             SSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             CCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            543   2345689999999999865 579999999999999999999999997643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-43  Score=395.92  Aligned_cols=254  Identities=22%  Similarity=0.349  Sum_probs=211.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+|+.++||||+++++++.+.+.++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36899999999999999999999999999999999876666667889999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC--CCeEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE--LNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~--~~~kL~DFGla~~~~~~~  496 (652)
                      |++|+|.+++... ...+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+... 
T Consensus       236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            9999999988543 346999999999999999999999   7999999999999999854  88999999999977543 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       ......+||+.|||||++.+..++.++||||+||++|||++|+.||.+....+.   ...+..                
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i~~----------------  370 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKS----------------  370 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHT----------------
T ss_pred             -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHh----------------
Confidence             344556899999999999999999999999999999999999999976432111   111100                


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      ..+.                 +.........+.+.||+.+|+..||++|++      |+|+...
T Consensus       371 ~~~~-----------------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          371 CDWN-----------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             TCCC-----------------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CCCC-----------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            0000                 000111234568899999999999999995      6798764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.4e-42  Score=357.41  Aligned_cols=276  Identities=38%  Similarity=0.660  Sum_probs=227.3

Q ss_pred             cccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       328 ~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      .++.+.++...+++|+..+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            45667778889999999999999999999999975 47899999998776667788999999999999999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCC--ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEee
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEP--KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGD  485 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~D  485 (652)
                      ..+..++||||+++|+|.+++....  ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999996543  235899999999999999999999   69999999999999999999999999


Q ss_pred             eccceecccCC-CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          486 FGLAKLYEHGT-NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       486 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      ||+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......|.......
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            99998654322 22234456899999999998889999999999999999999999999876666656666666555555


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                      +.+...+++.+.....                       +...+.+.+++.+|+..+|++||+..-
T Consensus       263 ~~~~~~~~~~~~~~~~-----------------------~~~~~~l~~li~~~l~~dP~~Rps~~e  305 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIR-----------------------PESLRKFGDTAVKCLALSSEDRPSMGD  305 (321)
T ss_dssp             TCCCSSSSSSCTTCSC-----------------------HHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccHHHhcChhhccccC-----------------------HHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            5554555443322211                       233457788888999999999987653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-42  Score=375.49  Aligned_cols=216  Identities=21%  Similarity=0.313  Sum_probs=189.1

Q ss_pred             cccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEe
Q 038860          328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVG  404 (652)
Q Consensus       328 ~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~  404 (652)
                      ..+.+++++...++|++.++||+|+||+||+|++..+++.||+|++.+...   .....+.+|..++..++||||+++++
T Consensus        62 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             ccchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            345667788889999999999999999999999999999999999975322   12234788999999999999999999


Q ss_pred             eeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       405 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      +|.+.+..++|||||++|+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEc
Confidence            999999999999999999999999542 346999999999999999999999   7999999999999999999999999


Q ss_pred             eeccceecccCCCCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       485 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      |||+|+.............+||+.|+|||++.     .+.++.++|||||||++|||++|+.||....
T Consensus       218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            99999876544333344568999999999886     5678999999999999999999999997643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.2e-41  Score=347.23  Aligned_cols=255  Identities=22%  Similarity=0.367  Sum_probs=210.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            34689999999999999999999988899999999976665566778999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++|+|.+++..   ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus        98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999843   35899999999999999999999   69999999999999999999999999999987654332


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....   ....                
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~----------------  231 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATN----------------  231 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHH----------------
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhC----------------
Confidence             33456799999999999999999999999999999999999999975432111100   0000                


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                                        ..|.........+.+.+|+.+|+..+|++|++      |+|++....
T Consensus       232 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          232 ------------------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             ------------------CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ------------------CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence                              00000111233467899999999999999995      688876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.6e-41  Score=352.78  Aligned_cols=253  Identities=45%  Similarity=0.770  Sum_probs=209.8

Q ss_pred             CcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHhcccCcCceeEEEee
Q 038860          327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-GVREFVSEIATIGRLRHRNLVQLVGW  405 (652)
Q Consensus       327 ~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  405 (652)
                      ..++++.++....++|+..+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            467899999999999999999999999999999865 4789999999765322 23368899999999999999999999


Q ss_pred             eeccCeeEEEEEeccCCCcccccccCC--ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEE
Q 038860          406 CRRKGDLLLVYDFMANGSLDSFLFDEP--KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKL  483 (652)
Q Consensus       406 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL  483 (652)
                      +...+..++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999996543  345999999999999999999999533339999999999999999999999


Q ss_pred             eeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC--CCccchhHHHHHHhh
Q 038860          484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR--ALPEELVLVDWVWGK  561 (652)
Q Consensus       484 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~--~~~~~~~l~~~~~~~  561 (652)
                      +|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||...  .........+|+...
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999999977655544555567999999999998888999999999999999999999999632  122344556677666


Q ss_pred             hcCCccccccccccccCCC
Q 038860          562 YGEGRVLEVIDPKLNAEYD  580 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~  580 (652)
                      .....+...++..+...+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~  274 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYK  274 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCC
T ss_pred             hhchhhhhhcChhhccccC
Confidence            6666666666665554443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.5e-40  Score=344.06  Aligned_cols=264  Identities=22%  Similarity=0.340  Sum_probs=214.7

Q ss_pred             CcccchhhhhhhhcC----------ccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCc
Q 038860          327 PQRYSYQELKQATNN----------FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH  396 (652)
Q Consensus       327 ~~~~~~~el~~~~~~----------f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  396 (652)
                      +..+++++++.+++.          |+..+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            345777777777654          7778899999999999999998899999999987666667789999999999999


Q ss_pred             CceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC
Q 038860          397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD  476 (652)
Q Consensus       397 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~  476 (652)
                      |||+++++++...+..++||||+++++|.+++..   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence            9999999999999999999999999999998843   45899999999999999999999   69999999999999999


Q ss_pred             CCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHH
Q 038860          477 SELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVD  556 (652)
Q Consensus       477 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~  556 (652)
                      .++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......   ....
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~  251 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMK  251 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH
T ss_pred             CCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence            99999999999998765432 2234567999999999999999999999999999999999999999753211   1111


Q ss_pred             HHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccc
Q 038860          557 WVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSY  630 (652)
Q Consensus       557 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~  630 (652)
                      .+...                                  ..|.........+.+.+|+.+|+..+|++|++      |+|
T Consensus       252 ~~~~~----------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          252 RLRDS----------------------------------PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             HHHHS----------------------------------SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHhcC----------------------------------CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            10000                                  00111111233467899999999999999994      567


Q ss_pred             cccC
Q 038860          631 FENG  634 (652)
Q Consensus       631 ~~~~  634 (652)
                      +...
T Consensus       298 ~~~~  301 (321)
T 2c30_A          298 LLQT  301 (321)
T ss_dssp             GGGC
T ss_pred             hccC
Confidence            7653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-40  Score=348.46  Aligned_cols=252  Identities=24%  Similarity=0.410  Sum_probs=208.2

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            3457899999999999999999999888999999999754  33456678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++..  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999999854  345899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCC-CccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSS-ASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      .  ......+||+.|+|||.+.+..+. .++|||||||++|||++|+.||.+....+   +...+.              
T Consensus       167 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~--------------  227 (328)
T 3fe3_A          167 G--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVL--------------  227 (328)
T ss_dssp             S--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH--------------
T ss_pred             C--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH--------------
Confidence            3  234456899999999999887765 78999999999999999999997643111   111000              


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                                  ....      ..|.     ...+.+.+|+.+|+..+|++|+      .|+|+....
T Consensus       228 ------------~~~~------~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          228 ------------RGKY------RIPF-----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             ------------HCCC------CCCT-----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             ------------hCCC------CCCC-----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                        0000      1111     1346789999999999999999      578887643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.7e-40  Score=346.77  Aligned_cols=202  Identities=29%  Similarity=0.394  Sum_probs=180.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+++...+++.||+|++++.   .......+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            46899999999999999999999989999999999764   233456788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++|+|..++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999998843  346899999999999999999999   799999999999999999999999999999854322


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence             22344568999999999999999999999999999999999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-41  Score=360.84  Aligned_cols=217  Identities=23%  Similarity=0.308  Sum_probs=188.8

Q ss_pred             CcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEE
Q 038860          327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLV  403 (652)
Q Consensus       327 ~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~  403 (652)
                      +..+++++.....++|++.+.||+|+||.||++++..+++.||+|++.+..   ....+.+.+|..++.+++||||++++
T Consensus        48 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            344667777888899999999999999999999999899999999997532   22234578899999999999999999


Q ss_pred             eeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEE
Q 038860          404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKL  483 (652)
Q Consensus       404 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL  483 (652)
                      +++.+.+..|+||||+++|+|.+++.+. ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||
T Consensus       128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          128 FAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEE
Confidence            9999999999999999999999999543 236899999999999999999999   799999999999999999999999


Q ss_pred             eeeccceecccCCCCceeeccCCcCCCCCCCCC-------CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-------TGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       484 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +|||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||....
T Consensus       204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  274 (412)
T 2vd5_A          204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS  274 (412)
T ss_dssp             CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence            999999876544332334468999999999886       4568999999999999999999999997643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-40  Score=356.51  Aligned_cols=203  Identities=28%  Similarity=0.395  Sum_probs=178.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|++.+.||+|+||.||++++..+++.||+|++++..   ....+.+.+|..++.++ +||||+++++++...+.++
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3468999999999999999999999999999999997652   22334578899999887 8999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|..++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       130 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999998854  346999999999999999999999   7999999999999999999999999999998532


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      . ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       205 ~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          205 R-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             C-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             c-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            2 223345578999999999999999999999999999999999999999753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8e-40  Score=340.59  Aligned_cols=281  Identities=25%  Similarity=0.310  Sum_probs=209.9

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...++|++.+.||+|+||.||+|.+.. ++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            455789999999999999999999965 8899999997543  2234678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++ +|.+++... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        97 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            9999975 787777543 345899999999999999999999   79999999999999999999999999999987653


Q ss_pred             CCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      .. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....+..........   
T Consensus       172 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---  247 (311)
T 3niz_A          172 PV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV---  247 (311)
T ss_dssp             CC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG---
T ss_pred             Cc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh---
Confidence            32 23344578999999998876 56899999999999999999999999876655443333222222211111100   


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                            ..... ............+.....+...+.+.||+.+|+..+|++|++      |+||++.
T Consensus       248 ------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          248 ------QELPL-WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             ------TTSHH-HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             ------hccch-hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                  00000 011111111122222222334568899999999999999995      7788764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.2e-40  Score=349.18  Aligned_cols=251  Identities=26%  Similarity=0.371  Sum_probs=205.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999996542   23456788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++|+|..++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999854  446999999999999999999999   799999999999999999999999999999876533


Q ss_pred             CCCceeeccCCcCCCCCCCCCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRT---GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                        .......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+.......           
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------  235 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-----------  235 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----------
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----------
Confidence              23455689999999999864   45899999999999999999999999754332222111111000           


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC-------cccccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS-------CSYFEN  633 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s-------~~~~~~  633 (652)
                                           ....|.     ...+.+.+|+.+|+..+|++|++       |+||++
T Consensus       236 ---------------------~~~~p~-----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          236 ---------------------VVTYPS-----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             ---------------------CCCCCT-----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             ---------------------ccCCCC-----cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence                                 000011     12357889999999999999987       578765

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=352.17  Aligned_cols=203  Identities=29%  Similarity=0.432  Sum_probs=175.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++++.   .....+.+.+|..++..+ +||||+++++++...+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            357899999999999999999999999999999999764   233456688999999988 6999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|..++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       101 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999854  346999999999999999999999   7999999999999999999999999999998533


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence            22 22344568999999999998888999999999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-39  Score=335.35  Aligned_cols=275  Identities=24%  Similarity=0.321  Sum_probs=205.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999999999999999997543  3345678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++ +|.+++.. ....+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence            9976 55555533 2356999999999999999999999   6899999999999999999999999999998764322 


Q ss_pred             CceeeccCCcCCCCCCCCCCCC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhc---CCcccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYG---EGRVLEVIDP  573 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~id~  573 (652)
                      .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+......  ......+.....   ........+ 
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~-  232 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTK-  232 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGG-
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcc-
Confidence            2334457899999999987765 799999999999999999988886433221  122222222221   111100000 


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                       + .++.       .. .............+...+.+.+|+.+|+..+|++|++      |+||++
T Consensus       233 -~-~~~~-------~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  288 (292)
T 3o0g_A          233 -L-PDYK-------PY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             -S-TTCC-------CC-CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             -c-cccc-------cc-ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence             0 0000       00 0000011111222345678899999999999999994      678775

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-40  Score=359.34  Aligned_cols=211  Identities=23%  Similarity=0.306  Sum_probs=184.2

Q ss_pred             chhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       331 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      .+.+++...++|++.+.||+|+||.||+|++..+++.||+|++.+...   ...+.+.+|+.+++.++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            345667778899999999999999999999999999999999965321   22334788999999999999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      +.+..++||||+++|+|.+++..   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccc
Confidence            99999999999999999998843   35899999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCC----CCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGK----SSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +|+.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||....
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  277 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  277 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence            99876543322334568999999999887655    7889999999999999999999997643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-40  Score=340.92  Aligned_cols=199  Identities=27%  Similarity=0.379  Sum_probs=179.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+++...+++.||+|++.+..   ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999999899999999997642   23456788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++|+|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.... 
T Consensus        85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            999999999999954  345899999999999999999999   79999999999999999999999999999986543 


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence               233467999999999999999999999999999999999999999753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.2e-40  Score=345.42  Aligned_cols=202  Identities=28%  Similarity=0.399  Sum_probs=179.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||++++..+++.||+|++.+.   .....+.+.+|..++.++ +||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            36799999999999999999999999999999999764   233456788999999988 89999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999999853  346899999999999999999999   79999999999999999999999999999985432


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      . .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       163 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  213 (345)
T 3a8x_A          163 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  213 (345)
T ss_dssp             T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred             C-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence            2 22344568999999999999999999999999999999999999999653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-39  Score=344.81  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=207.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh------hHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ------GVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      ..+.|++.+.||+|+||.||++.+..+++.||+|.+......      ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            456899999999999999999999999999999999764321      35678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC----CeEEeeec
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL----NGKLGDFG  487 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~----~~kL~DFG  487 (652)
                      .++||||+++|+|.+++..  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999943  446999999999999999999999   79999999999999998876    79999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+   ....+..    +  
T Consensus       165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i~~----~--  233 (361)
T 2yab_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANITA----V--  233 (361)
T ss_dssp             SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHT----T--
T ss_pred             CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----c--
Confidence            998765432  2344679999999999999999999999999999999999999997632211   1111100    0  


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                              ...++..                   ......+.+.+|+.+|+..+|++|+      .|+|+..
T Consensus       234 --------~~~~~~~-------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          234 --------SYDFDEE-------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             --------CCCCCHH-------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             --------CCCCCch-------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence                    0001100                   0112346789999999999999999      5788874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-39  Score=348.07  Aligned_cols=208  Identities=23%  Similarity=0.276  Sum_probs=182.2

Q ss_pred             hhcCcccccccccc--CceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHG--GFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|++.+.||+|  +||.||+|++..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45789999999999  99999999999899999999997543  344567889999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|||||++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999997655567999999999999999999999   7999999999999999999999999999987543


Q ss_pred             cCC------CCceeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          494 HGT------NPATTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       494 ~~~------~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      ...      ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  242 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA  242 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            211      111223478999999999887  5789999999999999999999999976543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=335.53  Aligned_cols=204  Identities=27%  Similarity=0.459  Sum_probs=182.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46789999999999999999999999999999999877777778899999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999543 346899999999999999999999   799999999999999999999999999999876433221


Q ss_pred             c-------------eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          499 A-------------TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       499 ~-------------~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            1             11457999999999999999999999999999999999999998653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=339.05  Aligned_cols=275  Identities=21%  Similarity=0.285  Sum_probs=208.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC--eeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG--DLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999999989999999997643 334567889999999999999999999987655  78999


Q ss_pred             EEeccCCCcccccccCCc-cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe----CCCCCeEEeeeccce
Q 038860          416 YDFMANGSLDSFLFDEPK-AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL----DSELNGKLGDFGLAK  490 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl----~~~~~~kL~DFGla~  490 (652)
                      |||+++++|.+++..... ..+++.+++.++.|++.||+|||   +++|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999965332 33899999999999999999999   7999999999999999    778889999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCC--------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc-hhHHHHHHhh
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPR--------TGKSSASSDVFAFGALLLEVACGRRPIETRALPEE-LVLVDWVWGK  561 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~  561 (652)
                      ......  ......||+.|+|||++.        +..++.++|||||||++|||++|+.||........ ...+..+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            765432  333457999999999865        56789999999999999999999999975443222 2222222222


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                      .........-+ .....++          . .....+.........+.+.+|+.+|+..+|++|+++.-
T Consensus       243 ~p~~~~~~~~~-~~~~~~~----------~-~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (319)
T 4euu_A          243 KPSGAISGVQK-AENGPID----------W-SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (319)
T ss_dssp             CCTTCCEEEEC-STTCCEE----------E-ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCcccchhhhc-ccCCccc----------c-CccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence            22221111111 0000000          0 00111122223345678899999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-39  Score=343.68  Aligned_cols=199  Identities=25%  Similarity=0.323  Sum_probs=179.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||++++..+++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999999899999999996542   23456788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++|+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999954  345899999999999999999999   799999999999999999999999999999876432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                          ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  241 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence                33457999999999999999999999999999999999999999753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-39  Score=350.17  Aligned_cols=207  Identities=28%  Similarity=0.455  Sum_probs=168.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccC-cCceeEEEeeeecc--Cee
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRK--GDL  412 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~  412 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++.++. ||||+++++++...  ...
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            457899999999999999999999999999999998653  3445567889999999997 99999999999754  378


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++|||||+ ++|..++..   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999997 588888843   46899999999999999999999   699999999999999999999999999999875


Q ss_pred             ccCC--------------------CCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          493 EHGT--------------------NPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       493 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                      ....                    ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            3311                    112344589999999998876 6789999999999999999999999987554333

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-39  Score=356.07  Aligned_cols=285  Identities=19%  Similarity=0.263  Sum_probs=194.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec-----cCe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR-----KGD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  411 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999999989999999999653  33456788999999999999999999999843     357


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .|+||||+ +++|.+++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 4689888843  346999999999999999999999   68999999999999999999999999999987


Q ss_pred             cccCCC--------------------------CceeeccCCcCCCCCCCC-CCCCCCCccchHhHHHHHHHHHh------
Q 038860          492 YEHGTN--------------------------PATTRVVGTLGYLAPETP-RTGKSSASSDVFAFGALLLEVAC------  538 (652)
Q Consensus       492 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~SlGvvl~ellt------  538 (652)
                      ......                          ...+..+||+.|+|||++ ....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            643221                          123445789999999975 56679999999999999999999      


Q ss_pred             -----CCCCCCCCCCcc-----------------chhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCC
Q 038860          539 -----GRRPIETRALPE-----------------ELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLR  596 (652)
Q Consensus       539 -----G~~p~~~~~~~~-----------------~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~  596 (652)
                           |+++|.+.....                 .......+........ .+.+     ..........-.-..+....
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~-~~~~-----~~~~~~~~~~~~~~~~~~~~  359 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS-EEDI-----EALEKEDAKRYIRIFPKREG  359 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC-HHHH-----HTSSCHHHHHHHTTSCCCCC
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC-HHHH-----hhcCCHHHHHHHHhcCCCCC
Confidence                 566665432100                 0011111111111000 0000     00000000000011122222


Q ss_pred             CCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          597 GPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       597 ~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      .+.....+...+.+.|||.+|+..+|++|+      .|+||+...
T Consensus       360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            222233345578899999999999999999      578998863

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-39  Score=346.57  Aligned_cols=214  Identities=25%  Similarity=0.295  Sum_probs=188.9

Q ss_pred             CcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-----cCceeE
Q 038860          327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-----HRNLVQ  401 (652)
Q Consensus       327 ~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  401 (652)
                      ...+++++.....++|++.++||+|+||.||+|++..+++.||||++... ....+.+..|+.++++++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            45677788888889999999999999999999999988999999999753 334456778999998886     999999


Q ss_pred             EEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC----
Q 038860          402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS----  477 (652)
Q Consensus       402 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~----  477 (652)
                      +++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 899999997665566999999999999999999999   799999999999999975    


Q ss_pred             ---------------------CCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHH
Q 038860          478 ---------------------ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEV  536 (652)
Q Consensus       478 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~el  536 (652)
                                           ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 788999999999864432    2345789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCc
Q 038860          537 ACGRRPIETRALP  549 (652)
Q Consensus       537 ltG~~p~~~~~~~  549 (652)
                      ++|+.||......
T Consensus       253 l~g~~pf~~~~~~  265 (360)
T 3llt_A          253 YTGSLLFRTHEHM  265 (360)
T ss_dssp             HHSSCSCCCSSHH
T ss_pred             HHCCCCCCCCcHH
Confidence            9999999865433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-39  Score=343.84  Aligned_cols=203  Identities=28%  Similarity=0.381  Sum_probs=179.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.+..   ....+.+..|..++..+ +||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999999889999999997642   23456788999999988 7999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999853  345899999999999999999999   7999999999999999999999999999998543


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          173 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             CT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence            22 22344568999999999999999999999999999999999999999753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.9e-40  Score=339.48  Aligned_cols=278  Identities=26%  Similarity=0.331  Sum_probs=205.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-----hhHHHHHHHHHHhcccC---cCceeEEEeeeecc
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-----QGVREFVSEIATIGRLR---HRNLVQLVGWCRRK  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  409 (652)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....     .....+.+|+.++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            46789999999999999999999988899999999864321     11235567777777664   99999999999765


Q ss_pred             C-----eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          410 G-----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       410 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      .     ..++||||++ ++|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5799999997 59999997666566999999999999999999999   6899999999999999999999999


Q ss_pred             eeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       485 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      |||+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....+...+
T Consensus       163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99999865432  2334568999999999999999999999999999999999999999765433322222211111111


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      .....        .....     .-..+....++.....+...+.+.+|+.+|+..+|++|+      .|+|+...
T Consensus       241 ~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          241 DDWPR--------DVSLP-----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TTSCS--------SCSSC-----GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhccc--------hhhcc-----ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            11100        00000     000111111111222234567899999999999999999      57787764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.8e-40  Score=344.87  Aligned_cols=205  Identities=26%  Similarity=0.428  Sum_probs=180.1

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCe
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  411 (652)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++++..   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999999999999999997642   23456678899999887 89999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++||||+++|+|.+++..  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999843  346899999999999999999999   69999999999999999999999999999985


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence            43222 2345568999999999999999999999999999999999999999753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.3e-39  Score=331.94  Aligned_cols=276  Identities=24%  Similarity=0.340  Sum_probs=201.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5789999999999999999998 5688999999965432  234678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++ +|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            9975 888887543 346899999999999999999999   7999999999999999999999999999998654322 


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....+............   .
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE---L  231 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG---S
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc---c
Confidence            22334578999999998876 4589999999999999999999999976443222221111111111100000000   0


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                      ..++.        ........|.........+.+.+|+.+|+..+|++|++      |+||++
T Consensus       232 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          232 PKYDP--------NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TTCCT--------TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccc--------ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            00000        00001111111222344678899999999999999995      677764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-39  Score=338.63  Aligned_cols=204  Identities=26%  Similarity=0.414  Sum_probs=177.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999999998899999999865432 234568899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC-
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT-  496 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~-  496 (652)
                      |+++|+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999999943  345999999999999999999999   7999999999999999999999999999998764322 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  212 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            222345679999999999877765 778999999999999999999997643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.2e-39  Score=336.10  Aligned_cols=278  Identities=27%  Similarity=0.381  Sum_probs=195.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            4689999999999999999999998899999999975432 234678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccC----CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          418 FMANGSLDSFLFDE----PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       418 ~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      |++ |+|.+++...    ....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5998888432    2245899999999999999999999   7999999999999999999999999999998764


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....+...+..... +.
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~  237 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS-VT  237 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG-GG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh-hh
Confidence            3322 2334578999999998876 4689999999999999999999999986543332222221111111111000 00


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCC-------CcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRS-------SDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~-------~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      . + ..+.          .....+.+..       .......+.+.||+.+|+..+|++|++      |+||.+.
T Consensus       238 ~-~-~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          238 K-L-PKYN----------PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             G-C-TTCC----------TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             h-h-hhcc----------cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence            0 0 0000          0000000000       001123468899999999999999994      7898874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.3e-40  Score=337.30  Aligned_cols=203  Identities=24%  Similarity=0.461  Sum_probs=175.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46899999999999999999999988999999998543   334457889999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++..  ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            999999999999843  346899999999999999999999   799999999999999999999999999999876544


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  215 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE  215 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            333445567999999999999999999999999999999999999999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=337.53  Aligned_cols=283  Identities=22%  Similarity=0.256  Sum_probs=206.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999999889999999986543  2345678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           83 YCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             CCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence            9999999888743  345899999999999999999999   7999999999999999999999999999998765322 


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...............-.... 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY-  235 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG-
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc-
Confidence            22334578999999998876 5689999999999999999999999987554333332222111110000000000000 


Q ss_pred             cCCCHHHHHHhhccCCCCC-CCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcccc
Q 038860          577 AEYDQSQVLMGELELPDTL-RGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYP  638 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~-~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~  638 (652)
                               ......+... ..+.....+...+.+.+|+.+|+..+|++|+      .|+||++.....
T Consensus       236 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          236 ---------FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             ---------GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ---------cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence                     0000011110 0011111133456789999999999999999      588998865544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-39  Score=345.48  Aligned_cols=279  Identities=23%  Similarity=0.323  Sum_probs=206.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-----
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-----  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  410 (652)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            357899999999999999999999999999999999653  3334567899999999999999999999987653     


Q ss_pred             -eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          411 -DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       411 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                       .+++||||+ +++|.+++..   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence             469999999 7899998843   45899999999999999999999   799999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +....    ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+....+....    
T Consensus       176 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~----  247 (367)
T 1cm8_A          176 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA----  247 (367)
T ss_dssp             EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH----
T ss_pred             ccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH----
Confidence            87543    2344578999999998876 67999999999999999999999999875433332222222211111    


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      +.+ +.+.  .......+..+  +...+.+.....+...+.+.||+.+|+..+|++|++      |+||+...+
T Consensus       248 ~~~-~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          248 EFV-QRLQ--SDEAKNYMKGL--PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHH-HTCS--CHHHHHHHHHS--CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHH-HHhh--hHHHHHHHHhC--CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            000 0110  01111122222  222222222333455678999999999999999995      789987543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=331.47  Aligned_cols=245  Identities=26%  Similarity=0.413  Sum_probs=194.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--------------------------hhHHHHHHHHHHhc
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--------------------------QGVREFVSEIATIG  392 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  392 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4689999999999999999999999999999999865421                          12356889999999


Q ss_pred             ccCcCceeEEEeeeec--cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCC
Q 038860          393 RLRHRNLVQLVGWCRR--KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKA  470 (652)
Q Consensus       393 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~  470 (652)
                      +++||||+++++++..  .+..++||||+++++|.+++.   ...+++..++.++.||+.||+|||   +++|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            9999999999999986  567899999999999998763   346999999999999999999999   68999999999


Q ss_pred             CceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCC---CCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          471 SNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK---SSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       471 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +|||++.++.+||+|||+++...... .......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999998765432 2334467999999999987765   3778999999999999999999997532


Q ss_pred             CccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC
Q 038860          548 LPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS  627 (652)
Q Consensus       548 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s  627 (652)
                      .   ..+...+.                          ...+..      |.   .+...+.+.+|+.+|+..+|++|++
T Consensus       245 ~---~~~~~~~~--------------------------~~~~~~------~~---~~~~~~~l~~li~~~l~~dp~~R~s  286 (298)
T 2zv2_A          245 I---MCLHSKIK--------------------------SQALEF------PD---QPDIAEDLKDLITRMLDKNPESRIV  286 (298)
T ss_dssp             H---HHHHHHHH--------------------------HCCCCC------CS---SSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred             H---HHHHHHHh--------------------------cccCCC------CC---ccccCHHHHHHHHHHhhcChhhCCC
Confidence            1   01000000                          000000      11   1123468899999999999999996


Q ss_pred             c
Q 038860          628 C  628 (652)
Q Consensus       628 ~  628 (652)
                      +
T Consensus       287 ~  287 (298)
T 2zv2_A          287 V  287 (298)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-39  Score=339.21  Aligned_cols=267  Identities=26%  Similarity=0.374  Sum_probs=201.5

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC----
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG----  410 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  410 (652)
                      +....++|++.+.||+|+||.||+|++.  ++.||||++..... ....+..|+.++++++||||+++++++....    
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            3445578999999999999999999886  68999999976543 3345667999999999999999999998754    


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccc----------eEEecCCCCCceEeCCCCC
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ----------VVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~----------~ivHrDlk~~NILl~~~~~  480 (652)
                      .+++||||+++|+|.+++..   ..+++..++.++.|++.||+|||   +.          +|+||||||+|||++.++.
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             eEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            47999999999999999943   35899999999999999999999   56          9999999999999999999


Q ss_pred             eEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhH
Q 038860          481 GKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTG-----KSSASSDVFAFGALLLEVACGRRPIETRALPEELVL  554 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l  554 (652)
                      +||+|||+++........ ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||...........
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            999999999876543322 23345799999999988763     456688999999999999999999986544332221


Q ss_pred             HHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCC---cccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          555 VDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSS---DGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       555 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~---~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                      ....                 .......+.......   ...+|...   ......+.+.+|+.+|+..+|++||++.-
T Consensus       250 ~~~~-----------------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          250 EEEI-----------------GQHPSLEDMQEVVVH---KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             HHHH-----------------CSSCCHHHHHHHHTT---SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhh-----------------ccCCchhhhhhhhhc---ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence            1110                 111111111111111   11111111   11123356899999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.6e-39  Score=358.11  Aligned_cols=206  Identities=28%  Similarity=0.458  Sum_probs=184.3

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ...++|+..+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            34578999999999999999999999899999999996542   234566889999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999997655556999999999999999999999   6999999999999999999999999999998765


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            332  3344689999999999999899999999999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=338.94  Aligned_cols=254  Identities=18%  Similarity=0.283  Sum_probs=207.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            3578999999999999999999999999999999997543 344668899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC--CCCeEEeeeccceecccC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS--ELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~--~~~~kL~DFGla~~~~~~  495 (652)
                      |+++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.  ++.+||+|||+++.....
T Consensus        82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999999998543 346899999999999999999999   799999999999999987  789999999999876543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .....+....            .
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~------------~  220 (321)
T 1tki_A          158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAE------------Y  220 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTC------------C
T ss_pred             --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCC------------C
Confidence              2345567999999999999888999999999999999999999999763321   1111111000            0


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                        .+..                   ...+...+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       221 --~~~~-------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          221 --TFDE-------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             --CCCH-------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             --CCCh-------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence              0000                   001123467889999999999999995      6788764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=341.87  Aligned_cols=254  Identities=19%  Similarity=0.272  Sum_probs=207.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46899999999999999999999999999999999876555667889999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC--CCCeEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS--ELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~--~~~~kL~DFGla~~~~~~~  496 (652)
                      +++|+|.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus       130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-  204 (387)
T 1kob_A          130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  204 (387)
T ss_dssp             CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence            9999999988543 346899999999999999999999   799999999999999974  477999999999876543 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .....+...               
T Consensus       205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~---------------  265 (387)
T 1kob_A          205 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRC---------------  265 (387)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHC---------------
T ss_pred             -cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC---------------
Confidence             2334457999999999999999999999999999999999999999763211   111111000               


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                                 ....+       ........+.+.+|+.+|+..+|++|+      .|+|+...
T Consensus       266 -----------~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          266 -----------DWEFD-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             -----------CCCCC-------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------CCCCC-------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                       00000       001112346789999999999999999      46788764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=337.99  Aligned_cols=254  Identities=22%  Similarity=0.345  Sum_probs=206.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK------QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+.....      ...+.+.+|+.++++++||||+++++++...+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34579999999999999999999998999999999865432      135678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC----CeEEeeec
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL----NGKLGDFG  487 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~----~~kL~DFG  487 (652)
                      .++||||+++++|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++    .+||+|||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999999943  356999999999999999999999   79999999999999999887    79999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+...      
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~------  232 (326)
T 2y0a_A          164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVSAV------  232 (326)
T ss_dssp             TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHT------
T ss_pred             CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHhc------
Confidence            998765332  23345799999999999989999999999999999999999999975322111   1100000      


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                          .    ..+..                   .......+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       233 ----~----~~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          233 ----N----YEFED-------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             ----C----CCCCH-------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             ----C----CCcCc-------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                0    00000                   000122457889999999999999994      7788653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-39  Score=339.95  Aligned_cols=262  Identities=23%  Similarity=0.299  Sum_probs=204.1

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-----chhhHHHHHHHHHHhcccCcCceeEEEeeeecc
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-----SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK  409 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  409 (652)
                      +....++|++.+.||+|+||.||+|.+..+++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            455678899999999999999999999999999999998654     234557899999999999999999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccC--------------------------------------CccccchHHHhhhHHHHHHH
Q 038860          410 GDLLLVYDFMANGSLDSFLFDE--------------------------------------PKAVLNWEQRFKIIKGVASG  451 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~i~~a  451 (652)
                      +..++||||+++|+|.+++...                                      ....+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999988410                                      12235677888999999999


Q ss_pred             HhhhccCccceEEecCCCCCceEeCCCC--CeEEeeeccceecccCCC---CceeeccCCcCCCCCCCCCC--CCCCCcc
Q 038860          452 LLYLHEGYEQVVIHRDVKASNVLLDSEL--NGKLGDFGLAKLYEHGTN---PATTRVVGTLGYLAPETPRT--GKSSASS  524 (652)
Q Consensus       452 L~~LH~~~~~~ivHrDlk~~NILl~~~~--~~kL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~~s  524 (652)
                      |+|||   +++|+||||||+|||++.++  .+||+|||+++.+.....   .......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   68999999999999998776  899999999987644222   12345679999999998865  6789999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCccc
Q 038860          525 DVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGD  604 (652)
Q Consensus       525 Dv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~  604 (652)
                      |||||||++|||++|+.||......+.   ...+..                          .....      +. ....
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~--------------------------~~~~~------~~-~~~~  301 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADT---ISQVLN--------------------------KKLCF------EN-PNYN  301 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH--------------------------CCCCT------TS-GGGG
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHh--------------------------ccccc------CC-cccc
Confidence            999999999999999999975432111   111000                          00000      00 0111


Q ss_pred             ccchhHHHHHhhhccCCCCCCCC------ccccccCc
Q 038860          605 KAAEGFDDLLNSLASSSFDKTTS------CSYFENGV  635 (652)
Q Consensus       605 ~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~  635 (652)
                      ...+.+.+|+.+|+..+|++|++      |+|+++..
T Consensus       302 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             GSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            23468899999999999999996      67877643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.3e-39  Score=335.48  Aligned_cols=255  Identities=23%  Similarity=0.306  Sum_probs=181.7

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEEeccCCC
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGS  423 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs  423 (652)
                      .+.||+|+||.||+|.+..+++.||||++...   ....+.+|+.++++++ ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            37899999999999999999999999999654   3356778999999997 9999999999999999999999999999


Q ss_pred             cccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC---CeEEeeeccceecccCCCCce
Q 038860          424 LDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL---NGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       424 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~---~~kL~DFGla~~~~~~~~~~~  500 (652)
                      |.+++..  ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++   .+||+|||+++...... ...
T Consensus        93 L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~  166 (325)
T 3kn6_A           93 LFERIKK--KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL  166 (325)
T ss_dssp             HHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence            9999954  346999999999999999999999   79999999999999997665   79999999998654432 233


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYD  580 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  580 (652)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................+            .+ 
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~------------~~-  233 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG------------DF-  233 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT------------CC-
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC------------CC-
Confidence            44578999999999999999999999999999999999999997643211100000111111000            00 


Q ss_pred             HHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCccc
Q 038860          581 QSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVSY  637 (652)
Q Consensus       581 ~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~~  637 (652)
                                      .+.........+.+.+|+.+|+..+|++|++      |+|+.+....
T Consensus       234 ----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          234 ----------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             ----------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             ----------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence                            0000111234568999999999999999995      6788775443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8e-39  Score=348.44  Aligned_cols=201  Identities=25%  Similarity=0.390  Sum_probs=170.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----C
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----G  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  410 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            357899999999999999999999999999999999764  334557889999999999999999999999766     5


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..|+||||++ ++|.+++..  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            7899999996 599998843  346999999999999999999999   6899999999999999999999999999999


Q ss_pred             ecccCCC---------------------CceeeccCCcCCCCCCCC-CCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          491 LYEHGTN---------------------PATTRVVGTLGYLAPETP-RTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       491 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      .......                     ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            7654321                     123556899999999975 56679999999999999999998655543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-39  Score=344.17  Aligned_cols=279  Identities=23%  Similarity=0.312  Sum_probs=195.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  409 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            347899999999999999999999999999999999653  334556788999999999999999999998654      


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      ...++|+|++ +++|.+++..   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            5679999999 6899998843   46999999999999999999999   799999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +....    ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+....+....    
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~----  251 (367)
T 2fst_X          180 RHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA----  251 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH----
T ss_pred             ccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH----
Confidence            86542    2344679999999998876 67899999999999999999999999875543333322222222111    


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                      +.+.. +..  .........+.  .....+.....+...+.+.|||.+|+..+|++|+      .|+||+...+
T Consensus       252 ~~~~~-~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          252 ELLKK-ISS--ESARNYIQSLT--QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHTT-CCC--HHHHHHHHTSC--CCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHH-hhh--HHHHHHHhccC--CCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            11110 000  01111122221  1111111112234467899999999999999999      5789987533

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=340.89  Aligned_cols=280  Identities=25%  Similarity=0.344  Sum_probs=204.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999999889999999997543322 12456799999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      ++ |+|.+++... ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K  155 (324)
T ss_dssp             CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence            97 5888888543 346899999999999999999999   7999999999999999999999999999998654322 2


Q ss_pred             ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....+...........+     
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-----  230 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS-----  230 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-----
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc-----
Confidence            2334578999999998876 5689999999999999999999999987554433333322222222211111111     


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                         ..+  ......+...........+...+.+.||+.+|+..+|++|+      .|+||....
T Consensus       231 ---~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          231 ---NEE--FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             ---CHH--HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ---chh--hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence               000  11111111111111111223457889999999999999999      578998853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.8e-39  Score=341.89  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=206.2

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456899999999999999999999989999999999654  33455678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeecccee
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGLAKL  491 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGla~~  491 (652)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.+   +.+||+|||+++.
T Consensus       106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999998854  346899999999999999999999   7999999999999999865   4599999999986


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI  571 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  571 (652)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+...+..           
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~-----------  244 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKA-----------  244 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-----------
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh-----------
Confidence            65322  23446799999999999998999999999999999999999999975321   111111100           


Q ss_pred             ccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          572 DPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       572 d~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                     ...      ..|.. ......+.+.+|+.+|+..+|++|++      |+|+..
T Consensus       245 ---------------~~~------~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          245 ---------------GAY------DYPSP-EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             ---------------TCC------CCCTT-GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             ---------------CCC------CCCcc-cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                           000      00111 11233568899999999999999995      677764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-39  Score=332.73  Aligned_cols=198  Identities=28%  Similarity=0.354  Sum_probs=167.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|+..++||+|+||+||+|.+..+++.||||++....  .....++..|+..+.++ +||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            68999999999999999999999889999999986532  23344556666666665 8999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+ +++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence            999 67998888543 346999999999999999999999   689999999999999999999999999999876432 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       .......||+.|+|||++.+ .++.++|||||||++|||++|..|+..
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence             23344579999999998875 789999999999999999999777643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.2e-39  Score=352.60  Aligned_cols=204  Identities=23%  Similarity=0.315  Sum_probs=171.6

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  409 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            357899999999999999999999999999999999764  334567788999999999999999999998654      


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      ...++||||+++ +|.+.+.    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            457999999976 4655552    24889999999999999999999   689999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                      +.....  ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+....++
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~  271 (464)
T 3ttj_A          212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ  271 (464)
T ss_dssp             -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            866432  234456899999999999999999999999999999999999999987554333

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.2e-39  Score=332.68  Aligned_cols=211  Identities=31%  Similarity=0.538  Sum_probs=172.0

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      .+..++....++|++.+.||+|+||.||+|++.  ++.||+|++....  ....+++.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            344445556789999999999999999999874  6889999987653  345578999999999999999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCC-ccccchHHHhhhHHHHHHHHhhhccCccce--EEecCCCCCceEeCCCCCeEEe
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEP-KAVLNWEQRFKIIKGVASGLLYLHEGYEQV--VIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      ..+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +++  |+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence            9999999999999999999996533 234899999999999999999999   688  9999999999999999999999


Q ss_pred             eeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       485 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      |||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       182 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~  242 (309)
T 3p86_A          182 DFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL  242 (309)
T ss_dssp             CCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             CCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999998644322 2234467999999999999999999999999999999999999999754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.2e-39  Score=337.17  Aligned_cols=247  Identities=23%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999899999999996542   12235688999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+ +|+|.+++..  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        88 ~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             ECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999 6799888844  346899999999999999999999   799999999999999999999999999999865433


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      .  .....+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......+.                ...+.  
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~--  221 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVN--  221 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCC--
T ss_pred             c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHH--
Confidence            2  2334579999999999988775 7899999999999999999999975322110                00000  


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                       .                .....|.     ...+.+.+|+.+|+..+|++|+      .|+||..
T Consensus       222 -~----------------~~~~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          222 -S----------------CVYVMPD-----FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -S----------------SCCCCCT-----TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -c----------------CCCCCcc-----cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence             0                0001111     2346889999999999999999      5788876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-38  Score=353.14  Aligned_cols=206  Identities=29%  Similarity=0.448  Sum_probs=183.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++.+..   ......+.+|+.++++++||||+++++++...+.+++
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            3478999999999999999999999899999999997542   2345678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCC--ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          415 VYDFMANGSLDSFLFDEP--KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ||||+++|+|.+++....  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            999999999999886533  456999999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       340 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          340 KAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CTTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             cCCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            5432 22344589999999999999999999999999999999999999997643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.5e-39  Score=348.89  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=205.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4568999999999999999999999999999999997543  34456789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC---CCCCeEEeeeccceec
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLY  492 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~---~~~~~kL~DFGla~~~  492 (652)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||   +++|+||||||+|||++   .++.+||+|||+++..
T Consensus        89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999988543  45899999999999999999999   79999999999999998   4578999999999866


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+...+..            
T Consensus       164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~------------  227 (444)
T 3soa_A          164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKA------------  227 (444)
T ss_dssp             CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH------------
T ss_pred             cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHh------------
Confidence            5432 233456899999999999999999999999999999999999999965321   111111000            


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                                    .....      |.. ......+.+.+|+.+|+..+|++|+      .|+|+...
T Consensus       228 --------------~~~~~------~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          228 --------------GAYDF------PSP-EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             --------------TCCCC------CTT-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             --------------CCCCC------Ccc-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                          00000      011 1123356899999999999999999      56788764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-39  Score=355.03  Aligned_cols=204  Identities=28%  Similarity=0.388  Sum_probs=170.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...   .......+.+|+.++++++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346799999999999999999999999999999999754   23344667899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||+|||+  .++|+||||||+|||++.++.+||+|||+|+....
T Consensus       226 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999998844  3468999999999999999999993  28999999999999999999999999999985432


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      . ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       302 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          302 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            2 22334568999999999999999999999999999999999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.2e-39  Score=341.88  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=199.3

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccCC
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANG  422 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  422 (652)
                      ...+.||+|+||.||+|.+..+++.||+|++........+++.+|+.++++++||||+++++++...+..++||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33678999999999999999889999999998776666778999999999999999999999999999999999999999


Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe--CCCCCeEEeeeccceecccCCCCce
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL--DSELNGKLGDFGLAKLYEHGTNPAT  500 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl--~~~~~~kL~DFGla~~~~~~~~~~~  500 (652)
                      +|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++......  ..
T Consensus       172 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~  245 (373)
T 2x4f_A          172 ELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL  245 (373)
T ss_dssp             EEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence            999888543 346899999999999999999999   7999999999999999  567889999999999765432  23


Q ss_pred             eeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCC
Q 038860          501 TRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYD  580 (652)
Q Consensus       501 ~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  580 (652)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ....+...                .+ 
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~----------------~~-  305 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNNILAC----------------RW-  305 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHT----------------CC-
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhc----------------cC-
Confidence            34579999999999998899999999999999999999999997643211   11111000                00 


Q ss_pred             HHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          581 QSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       581 ~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                               .       +.........+.+.+|+.+|+..+|++|++      |+||++.
T Consensus       306 ---------~-------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          306 ---------D-------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             ---------C-------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             ---------C-------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence                     0       000111233568899999999999999995      6787764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.3e-39  Score=342.45  Aligned_cols=202  Identities=29%  Similarity=0.393  Sum_probs=170.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHH-hcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIAT-IGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||++++..+++.||+|++.+..   ....+.+.+|..+ ++.++||||+++++++...+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999999999999999997653   2234556777776 577899999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999854  346889999999999999999999   79999999999999999999999999999986432


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      . .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  242 (373)
T 2r5t_A          192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  242 (373)
T ss_dssp             C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            2 22345568999999999999999999999999999999999999999753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7e-39  Score=339.30  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=204.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-----hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-----QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....     ...+.+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4579999999999999999999999999999999864321     13567899999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC---eEEeeecc
Q 038860          414 LVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN---GKLGDFGL  488 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~---~kL~DFGl  488 (652)
                      +||||+++++|.+++...  ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887542  2335899999999999999999999   799999999999999987654   99999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....    ..+...+..        
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~--------  246 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIK--------  246 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHH--------
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHc--------
Confidence            98765432 22344579999999999999999999999999999999999999997521    111111000        


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                              ..+..                 .........+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       247 --------~~~~~-----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          247 --------GKYKM-----------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             --------TCCCC-----------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             --------CCCCC-----------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                    00000                 00000123468899999999999999994      7788764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-38  Score=340.02  Aligned_cols=206  Identities=28%  Similarity=0.474  Sum_probs=179.0

Q ss_pred             hhcCccccccccccCceEEEEEEEc-------CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeec
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLH-------NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRR  408 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  408 (652)
                      ..++|++.+.||+|+||.||+|.+.       .++..||||+++... ....+++.+|+.+++++ +||||++++++|..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3468999999999999999999874       245679999997653 34567899999999999 89999999999999


Q ss_pred             cCeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceE
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVL  474 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NIL  474 (652)
                      .+..++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +++|+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence            999999999999999999986432              235889999999999999999999   799999999999999


Q ss_pred             eCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          475 LDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       475 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999987654322 22334567889999999999999999999999999999999 99999764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.1e-39  Score=335.43  Aligned_cols=202  Identities=25%  Similarity=0.404  Sum_probs=168.5

Q ss_pred             hcCccccccccccCceEEEEEEEc---CCCeEEEEEEecCcc----hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES----KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      .++|++.+.||+|+||.||+++..   .+++.||+|++.+..    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            468999999999999999999985   578999999997642    2234567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++||||+++++|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999999843  345889999999999999999999   68999999999999999999999999999985


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  224 (327)
T 3a62_A          171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE  224 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence            43221 2234457999999999999989999999999999999999999999753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.2e-38  Score=329.22  Aligned_cols=281  Identities=20%  Similarity=0.243  Sum_probs=207.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeec--cCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRR--KGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   .+.+.+|+.++++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            468999999999999999999999889999999997543   356889999999997 9999999999987  6678999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceeccc
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLYEH  494 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~~  494 (652)
                      |||+++++|.+++.     .+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999998872     3888999999999999999999   79999999999999999776 899999999987654


Q ss_pred             CCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      ..  ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ..............+.+.++.
T Consensus       184 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHH
T ss_pred             CC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHH
Confidence            33  2334578999999999877 678999999999999999999999996433221  111111122211111111111


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      .-................................+.+.+|+.+|+..+|++|++      |+||...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            100000111111111111111111111222335678999999999999999995      7788764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.1e-39  Score=335.33  Aligned_cols=279  Identities=22%  Similarity=0.292  Sum_probs=198.5

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            34456789999999999999999999999999999999975532  2345678999999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-----CCCCeEEeeec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-----SELNGKLGDFG  487 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-----~~~~~kL~DFG  487 (652)
                      ++||||+++ +|.+++...  ..+++..++.++.||+.||.|||   +++|+||||||+|||++     .++.+||+|||
T Consensus       109 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            999999974 999988543  35899999999999999999999   68999999999999994     45569999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCc
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGR  566 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  566 (652)
                      +++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....+......
T Consensus       183 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          183 LARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            998764322 233445789999999998774 489999999999999999999999976543322222111111111110


Q ss_pred             ccccc-ccccccCCCHHHHHHhhccCCCCCCCCCC---CcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          567 VLEVI-DPKLNAEYDQSQVLMGELELPDTLRGPRS---SDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       567 ~~~~i-d~~l~~~~~~~~~~~~~l~~~~~~~~p~~---~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      ..... .+.+..              ..+......   .......+.+.+|+.+|+..+|++|+      .|+||+..
T Consensus       262 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          262 WPGVTALPDWKQ--------------SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             STTGGGSTTCCT--------------TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhh--------------hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            00000 000000              000000000   00112356889999999999999999      47788764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-38  Score=325.19  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=206.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            34679999999999999999999999899999999987666667789999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---CCCCCeEEeeeccceeccc
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---~~~~~~kL~DFGla~~~~~  494 (652)
                      |+++++|.+++..  ...+++..++.++.|++.||.|||   +++|+||||||+|||+   +.++.+||+|||++.....
T Consensus        87 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999998854  345899999999999999999999   7999999999999999   7889999999999987654


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      ..  ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+   .......    +.        
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~----~~--------  223 (277)
T 3f3z_A          162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKIRE----GT--------  223 (277)
T ss_dssp             TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH----CC--------
T ss_pred             cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh----CC--------
Confidence            32  33445799999999987654 8999999999999999999999997633211   1110000    00        


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                        ..+..                   .......+.+.+|+.+|+..+|++|++      |+||+..
T Consensus       224 --~~~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          224 --FTFPE-------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             --CCCCH-------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             --CCCCc-------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence              00000                   000123468899999999999999995      6788763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=336.89  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=191.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            45578999999999999999999999889999999997653  3356788999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCeEEeeeccceecc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYE  493 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~kL~DFGla~~~~  493 (652)
                      ||+++++|.+++..  ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       128 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          128 ELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999999854  345899999999999999999999   689999999999999975   7899999999998654


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .+...+.    .         
T Consensus       203 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~----~---------  265 (349)
T 2w4o_A          203 HQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRIL----N---------  265 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHH----T---------
T ss_pred             cc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHH----h---------
Confidence            32  22344679999999999999999999999999999999999999997533211  0111000    0         


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                         ..+              ....|   ......+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       266 ---~~~--------------~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          266 ---CEY--------------YFISP---WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             ---TCC--------------CCCTT---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             ---CCC--------------ccCCc---hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence               000              00001   11233568899999999999999996      6787764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=336.52  Aligned_cols=282  Identities=26%  Similarity=0.320  Sum_probs=202.6

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-----hHHHHHHHHHHhcccCcCceeEEEeeeeccC
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-----GVREFVSEIATIGRLRHRNLVQLVGWCRRKG  410 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  410 (652)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++......     ..+.+.+|+.++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            34457899999999999999999999988999999999754221     1246789999999999999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++||||+++ +|..++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999986 888887543 346889999999999999999999   7999999999999999999999999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      ...... .......||+.|+|||.+.+. .++.++|||||||++|||++|.+||......+.   ...+...........
T Consensus       161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTT
T ss_pred             eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhh
Confidence            764322 233446789999999988664 588999999999999999999999976533222   122222211100000


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                           +.....    ....+........|.........+.+.+|+.+|+..+|++|+      .|+||.+.+
T Consensus       237 -----~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          237 -----WPDMCS----LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             -----SSSTTS----STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             -----hhhhcc----CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                 000000    000000011111111111123457899999999999999999      578998743

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.4e-39  Score=326.81  Aligned_cols=256  Identities=27%  Similarity=0.414  Sum_probs=205.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4578999999999999999999999999999999986542   2234678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++..  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999998843  345899999999999999999999   79999999999999999999999999999865432


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..   ..+                
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~----------------  219 (279)
T 3fdn_A          162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---KRI----------------  219 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH----------------
T ss_pred             c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH---HHH----------------
Confidence            2   234457899999999999999999999999999999999999999753211110   000                


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccccCCC
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYPSLS  641 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~~~~  641 (652)
                                  ......    .|     ....+.+.+|+.+|+..+|++|+      .|+|+.....-++..
T Consensus       220 ------------~~~~~~----~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~  271 (279)
T 3fdn_A          220 ------------SRVEFT----FP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC  271 (279)
T ss_dssp             ------------HHTCCC----CC-----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCCCC
T ss_pred             ------------HhCCCC----CC-----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCcccc
Confidence                        000000    01     11246789999999999999999      578888865555443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-38  Score=330.45  Aligned_cols=264  Identities=21%  Similarity=0.344  Sum_probs=209.3

Q ss_pred             ccchhhhhhhhcCcccc-ccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccC-cCceeEEEe
Q 038860          329 RYSYQELKQATNNFSAK-QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLR-HRNLVQLVG  404 (652)
Q Consensus       329 ~~~~~el~~~~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~  404 (652)
                      ...++......+.|.+. +.||+|+||.||+|.+..+++.||+|++.....  ....++.+|+.++.+++ ||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            45556666777788887 889999999999999998899999999976432  33567899999999995 799999999


Q ss_pred             eeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCe
Q 038860          405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNG  481 (652)
Q Consensus       405 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~  481 (652)
                      ++...+..++||||+++|+|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||++.   ++.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcE
Confidence            9999999999999999999999997665677999999999999999999999   799999999999999998   7899


Q ss_pred             EEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhh
Q 038860          482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGK  561 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  561 (652)
                      ||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...   .+.  
T Consensus       174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~--  246 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL---NIS--  246 (327)
T ss_dssp             EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH--
T ss_pred             EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HHH--
Confidence            999999998765332  2334579999999999999999999999999999999999999997633211100   000  


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                                                ......     .........+.+.+|+.+|+..+|++||      .|+|++.
T Consensus       247 --------------------------~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          247 --------------------------QVNVDY-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             --------------------------HTCCCC-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             --------------------------hccccc-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence                                      000000     0001112346789999999999999999      4678765

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.2e-38  Score=343.27  Aligned_cols=204  Identities=21%  Similarity=0.302  Sum_probs=177.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc------CcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL------RHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~  411 (652)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++.... ...+++.+|+.+++.+      .|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3467999999999999999999999999999999997643 3345677788888776      57799999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC--eEEeeeccc
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN--GKLGDFGLA  489 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~--~kL~DFGla  489 (652)
                      .++||||+. ++|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 69999887665566999999999999999999999   689999999999999999887  999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE  550 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~  550 (652)
                      +....    ......||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus       250 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          250 CYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             EETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             eecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            76432    2334578999999999999999999999999999999999999998754433

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-38  Score=336.55  Aligned_cols=282  Identities=24%  Similarity=0.311  Sum_probs=212.7

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----C
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----G  410 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  410 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            34568999999999999999999999899999999997543 33457789999999999999999999998654     4


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++||||++ |+|.+++..   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            6899999997 589888843   45899999999999999999999   7999999999999999999999999999998


Q ss_pred             ecccCCC--CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          491 LYEHGTN--PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       491 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      .......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....+......+
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            7653322  12244589999999997654 55899999999999999999999999876544443332222222111111


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      ..        ..... ........+.....|.....+...+.+.+|+.+|+..+|++|+      .|+|++..
T Consensus       257 ~~--------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          257 NC--------IINLK-ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HT--------CCCHH-HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HH--------hhhhh-HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            11        01111 0111111222222222222334567899999999999999999      47898874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=332.92  Aligned_cols=204  Identities=33%  Similarity=0.549  Sum_probs=175.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCC---CeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|.+..+   +..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            46789999999999999999999744   445999999765 34456789999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999998543 346999999999999999999999   79999999999999999999999999999997654


Q ss_pred             CCCCc--eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTNPA--TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .....  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  258 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM  258 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence            33222  223356788999999988889999999999999999999 99999653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.9e-38  Score=324.02  Aligned_cols=274  Identities=35%  Similarity=0.577  Sum_probs=213.3

Q ss_pred             CcccchhhhhhhhcCcccc------ccccccCceEEEEEEEcCCCeEEEEEEecCc----chhhHHHHHHHHHHhcccCc
Q 038860          327 PQRYSYQELKQATNNFSAK------QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE----SKQGVREFVSEIATIGRLRH  396 (652)
Q Consensus       327 ~~~~~~~el~~~~~~f~~~------~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  396 (652)
                      ...|++.++..++++|...      +.||+|+||.||+|..  .++.||+|++...    .....+.+.+|+.++++++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            4678999999999999887      8999999999999987  3688999998653    23345778999999999999


Q ss_pred             CceeEEEeeeeccCeeEEEEEeccCCCcccccccC-CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDE-PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       397 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      |||+++++++...+..++||||+++++|.+++... ....+++..++.++.|++.||.|||   +++|+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998543 2346899999999999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhH
Q 038860          476 DSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVL  554 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l  554 (652)
                      +.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            99999999999999876543222 2234579999999998764 578999999999999999999999986543332221


Q ss_pred             HHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          555 VDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       555 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                      +...... ....+.+.+++.+.                        .......+.+.+++.+|+..+|++||+...+
T Consensus       246 ~~~~~~~-~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l  297 (307)
T 2nru_A          246 IKEEIED-EEKTIEDYIDKKMN------------------------DADSTSVEAMYSVASQCLHEKKNKRPDIKKV  297 (307)
T ss_dssp             HHHHHHT-TSCCHHHHSCSSCS------------------------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHhhh-hhhhhhhhcccccc------------------------ccchHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence            1110000 01111111111110                        0111234578889999999999999986543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.7e-39  Score=335.46  Aligned_cols=204  Identities=25%  Similarity=0.422  Sum_probs=171.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe---
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD---  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  411 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999999998889999999997642   3345678999999999999999999999876543   


Q ss_pred             -eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          412 -LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       412 -~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                       .++||||+++++|.+++..  ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             4999999999999999853  346899999999999999999999   7999999999999999999999999999998


Q ss_pred             ecccCCC--CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          491 LYEHGTN--PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       491 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  222 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD  222 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            6644322  2233457999999999999999999999999999999999999999764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.1e-39  Score=329.03  Aligned_cols=210  Identities=31%  Similarity=0.503  Sum_probs=186.9

Q ss_pred             hhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       333 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      ++.....++|++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            344456788999999999999999999999889999999997643 3457789999999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++++|.+++.......+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            99999999999999997666667999999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5444333344567889999999988899999999999999999999 99999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.4e-38  Score=331.44  Aligned_cols=202  Identities=23%  Similarity=0.388  Sum_probs=171.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-------  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  410 (652)
                      .++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999999889999999997543 335577999999999999999999999985543       


Q ss_pred             --------------------------------------------------eeEEEEEeccCCCcccccccCC-ccccchH
Q 038860          411 --------------------------------------------------DLLLVYDFMANGSLDSFLFDEP-KAVLNWE  439 (652)
Q Consensus       411 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~  439 (652)
                                                                        ..++||||+++++|.+++.... ....++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3799999999999999996532 3345667


Q ss_pred             HHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC-----------CceeeccCCcC
Q 038860          440 QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-----------PATTRVVGTLG  508 (652)
Q Consensus       440 ~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~  508 (652)
                      .++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   79999999999999999999999999999997654321           12233579999


Q ss_pred             CCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCC
Q 038860          509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRPI  543 (652)
Q Consensus       509 y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~  543 (652)
                      |+|||.+.+..++.++|||||||++|||++|..|+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            99999999999999999999999999999987664

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.6e-39  Score=330.23  Aligned_cols=266  Identities=24%  Similarity=0.397  Sum_probs=200.8

Q ss_pred             hcCccccccccccCceEEEEEE----EcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeecc--Cee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGT----LHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  412 (652)
                      .++|++.+.||+|+||.||+|+    ...+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            4689999999999999999998    4557899999999887777778899999999999999999999998654  568


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999999554 335899999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCC--CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          493 EHGTN--PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       493 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      .....  .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....    ...    ........   
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~----~~~~~~~~---  233 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFM----RMIGNDKQ---  233 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHH----HHHCTTCC---
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHH----hhhcCccc---
Confidence            54322  122334577889999999989999999999999999999999999864210    000    11111000   


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                            ... ........+....  +.|.+.   ...+.+.+|+.+|+..+|++||+...+
T Consensus       234 ------~~~-~~~~~~~~~~~~~--~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~el  282 (295)
T 3ugc_A          234 ------GQM-IVFHLIELLKNNG--RLPRPD---GCPDEIYMIMTECWNNNVNQRPSFRDL  282 (295)
T ss_dssp             ------THH-HHHHHHHHHHTTC--CCCCCT---TCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ------cch-hHHHHHHHHhccC--cCCCCc---CcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                  000 0001111111111  111111   234689999999999999999987643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.2e-39  Score=354.19  Aligned_cols=207  Identities=31%  Similarity=0.502  Sum_probs=182.9

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ....+|++.+.||+|+||.||+|.+..++..||||.++... ...++|.+|+.+|++++||||++++++|...+..++||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            34567899999999999999999999888999999997653 34578999999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999997655567999999999999999999999   7999999999999999999999999999999765432


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ........++..|+|||++....++.++|||||||++|||++ |+.||....
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence            222233456789999999988889999999999999999999 999997643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-37  Score=319.13  Aligned_cols=258  Identities=24%  Similarity=0.355  Sum_probs=207.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            457899999999999999999999998999999999654  334557788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC---eEEeeeccceec
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN---GKLGDFGLAKLY  492 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~---~kL~DFGla~~~  492 (652)
                      |||+++++|.+++..  ...+++..+..++.|++.||.|||   +++|+||||||+||+++.++.   +||+|||++...
T Consensus        84 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999999888844  345899999999999999999999   799999999999999987655   999999999866


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......   .....+..            
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~------------  221 (284)
T 3kk8_A          159 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKA------------  221 (284)
T ss_dssp             CSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH------------
T ss_pred             ccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHh------------
Confidence            4322  233467999999999999999999999999999999999999999653211   11110000            


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYP  638 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~  638 (652)
                                    ....      .|... .....+.+.+|+.+|+..+|++|+      .|+|+.+...-.
T Consensus       222 --------------~~~~------~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          222 --------------GAYD------YPSPE-WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             --------------TCCC------CCTTT-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             --------------cccc------CCchh-hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence                          0000      01110 112346789999999999999999      477887754433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.2e-38  Score=335.47  Aligned_cols=254  Identities=22%  Similarity=0.295  Sum_probs=193.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            45789999999999999999999998999999999976432 23567899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC--eEEeeeccceecccC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN--GKLGDFGLAKLYEHG  495 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~--~kL~DFGla~~~~~~  495 (652)
                      |+++|+|.+++..  ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.  +||+|||+++.....
T Consensus        97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999998843  345899999999999999999999   799999999999999987765  999999999743322


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCc-cchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSAS-SDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                        .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||............  ....             
T Consensus       172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~-------------  234 (361)
T 3uc3_A          172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRI-------------  234 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHH-------------
T ss_pred             --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHH-------------
Confidence              22344579999999999888777665 89999999999999999999764332221110  0000             


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                                    +...  ...|..   ....+.+.+|+.+|+..+|++|+      .|+||..
T Consensus       235 --------------~~~~--~~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          235 --------------LSVK--YSIPDD---IRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             --------------HTTC--CCCCTT---SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             --------------hcCC--CCCCCc---CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence                          0000  000111   12346889999999999999999      5778854

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.9e-39  Score=335.98  Aligned_cols=274  Identities=27%  Similarity=0.378  Sum_probs=203.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3468999999999999999999999989999999986543  33456688999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          103 FEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            999999988887633  345899999999999999999999   799999999999999999999999999999865432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      . .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+....+..            
T Consensus       178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  244 (331)
T 4aaa_A          178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL------------  244 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC------------
T ss_pred             c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC------------
Confidence            2 223345789999999988775 68999999999999999999999997654322222111111100            


Q ss_pred             cccCCCHHHHHHh------hccCCC-CCCCCCCCcccccchhHHHHHhhhccCCCCCCCCc------ccccc
Q 038860          575 LNAEYDQSQVLMG------ELELPD-TLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC------SYFEN  633 (652)
Q Consensus       575 l~~~~~~~~~~~~------~l~~~~-~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~------~~~~~  633 (652)
                          .........      ....+. ....|.....+...+.+.+|+.+|+..+|++||++      +||+.
T Consensus       245 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          245 ----IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             ----CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ----ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                000000000      000111 11111111223446789999999999999999964      56654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.5e-38  Score=334.95  Aligned_cols=282  Identities=24%  Similarity=0.357  Sum_probs=207.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeec--------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRR--------  408 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  408 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....  .....+.+|+.++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4689999999999999999999998899999999865432  234567899999999999999999999876        


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      .+..++||||+++ +|.+.+... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            4468999999975 777666433 345899999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCC---CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          489 AKLYEHGTN---PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       489 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      ++.......   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            987653221   22344578999999998876 45899999999999999999999999875544433333333322222


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCc--ccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSD--GDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~--~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      ......-+..+          ...+.......+.....  .....+.+.+|+.+|+..+|++|+      .|+||...+
T Consensus       251 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          251 EVWPNVDNYEL----------YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTSTTGGGCGG----------GTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hhccccccchh----------hcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            11111100000          01111111111000000  001135688999999999999999      578887643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5e-38  Score=359.62  Aligned_cols=203  Identities=28%  Similarity=0.383  Sum_probs=180.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|++.+.||+|+||.||+|++..+++.||||++++.   .....+.+..|..++..+ +||+|+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            457899999999999999999999999999999999754   223456678899999988 7999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      |||||+++|+|..++..  ...+++..++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+...
T Consensus       419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999954  346999999999999999999999   7999999999999999999999999999998643


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       494 ~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          494 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             CT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            32 22345578999999999999999999999999999999999999999764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-38  Score=333.05  Aligned_cols=253  Identities=20%  Similarity=0.304  Sum_probs=200.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++......    ..+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            456799999999999999999999999999999999765332    34688888888 7999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC----CCeEEeeeccceec
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE----LNGKLGDFGLAKLY  492 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~----~~~kL~DFGla~~~  492 (652)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||   +++|+||||||+|||+.++    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999998854  345899999999999999999999   7999999999999998543    34999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+...+.    .        
T Consensus       171 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~--------  237 (342)
T 2qr7_A          171 RAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----S--------  237 (342)
T ss_dssp             BCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----H--------
T ss_pred             cCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----c--------
Confidence            5432 23345678999999999888788999999999999999999999997543222111111110    0        


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                          +.+          ..      +. .......+.+.+|+.+|+..+|++|++      |+|+..
T Consensus       238 ----~~~----------~~------~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          238 ----GKF----------SL------SG-GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             ----CCC----------CC------CS-TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             ----CCc----------cc------Cc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence                000          00      00 001133568899999999999999995      567754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.7e-38  Score=319.33  Aligned_cols=250  Identities=25%  Similarity=0.457  Sum_probs=182.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            4679999999999999999999988899999999965422   2346789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999998543 346899999999999999999999   789999999999999999999999999999876432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..                   ....
T Consensus       166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------------~~~~  225 (278)
T 3cok_A          166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------------------NKVV  225 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------------CC
T ss_pred             CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------------------HHHh
Confidence            21 223457899999999999989999999999999999999999999753321110                   0000


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                      ..++                ..|.     ...+.+.+|+.+|+..+|++|+      .|+|+..
T Consensus       226 ~~~~----------------~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          226 LADY----------------EMPS-----FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             SSCC----------------CCCT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             hccc----------------CCcc-----ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence            0000                0111     2345789999999999999999      4566654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-38  Score=337.78  Aligned_cols=215  Identities=29%  Similarity=0.440  Sum_probs=182.3

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEE-----cCCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEE
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQL  402 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  402 (652)
                      +...+.....++|++.+.||+|+||.||+|.+     ..+++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455666788999999999999999999994     4456899999997653 34456799999999999 79999999


Q ss_pred             EeeeeccC-eeEEEEEeccCCCcccccccCCc------------------------------------------------
Q 038860          403 VGWCRRKG-DLLLVYDFMANGSLDSFLFDEPK------------------------------------------------  433 (652)
Q Consensus       403 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------  433 (652)
                      ++++...+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988755 48999999999999999865322                                                


Q ss_pred             ----------------cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          434 ----------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       434 ----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                                      ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            12899999999999999999999   69999999999999999999999999999986644322


Q ss_pred             C-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          498 P-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       498 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      . ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  300 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  300 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence            2 2344578999999999998999999999999999999998 999997644

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-37  Score=332.85  Aligned_cols=212  Identities=22%  Similarity=0.292  Sum_probs=181.0

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cC-----ceeEEE
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HR-----NLVQLV  403 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~  403 (652)
                      +.........++|++.+.||+|+||.||+|.+..+++.||||++.... ...+++..|+.+++.++ |+     ++++++
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            344455566789999999999999999999999889999999997543 33466778888888775 44     499999


Q ss_pred             eeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC--CCCCe
Q 038860          404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD--SELNG  481 (652)
Q Consensus       404 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~--~~~~~  481 (652)
                      +++...+..++||||++ ++|.+++.......+++..++.++.|++.||.|||+. +.+|+||||||+|||++  .++.+
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            99999999999999996 5999999765555699999999999999999999942 47899999999999995  46789


Q ss_pred             EEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      ||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999876432    2345789999999999999999999999999999999999999986543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-37  Score=334.85  Aligned_cols=254  Identities=23%  Similarity=0.324  Sum_probs=191.8

Q ss_pred             hcCcccc-ccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeec----cCee
Q 038860          339 TNNFSAK-QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRR----KGDL  412 (652)
Q Consensus       339 ~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  412 (652)
                      .++|.+. +.||+|+||.||++.+..+++.||||++...     ..+.+|+.++.++ +||||+++++++..    .+.+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567776 6899999999999999999999999999643     3456788877544 89999999998865    5678


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCeEEeeeccc
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLA  489 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~kL~DFGla  489 (652)
                      ++||||+++|+|.+++.......+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999997655567999999999999999999999   699999999999999997   788999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      +.....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........                
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------------  273 (400)
T 1nxk_A          212 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------------  273 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC----------------
T ss_pred             cccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH----------------
Confidence            865432  23345678999999999999999999999999999999999999997643211100                


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                          .     ............      |... .....+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       274 ----~-----~~~~i~~~~~~~------~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          274 ----G-----MKTRIRMGQYEF------PNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ----S-----HHHHHHHTCCCC------CTTT-TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ----H-----HHHHHHcCcccC------CCcc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                0     000000111111      1111 1133567899999999999999995      6777653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.5e-38  Score=342.92  Aligned_cols=248  Identities=25%  Similarity=0.468  Sum_probs=204.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....   .....+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4689999999999999999999998899999999975422   2356788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++|+|.+++..  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           95 MEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999999954  446999999999999999999999   799999999999999999999999999999876543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      .  .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......   +...+.    .+         
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~----~~---------  231 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKIC----DG---------  231 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHHH----TT---------
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHHh----cC---------
Confidence            2  3344579999999999888765 689999999999999999999997643211   111110    00         


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                         .+                ..|.     ...+.+.+|+.+|+..+|++|++      |+||..
T Consensus       232 ---~~----------------~~p~-----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          232 ---IF----------------YTPQ-----YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ---CC----------------CCCT-----TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ---Cc----------------CCCc-----cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence               00                0011     12457899999999999999994      778865

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6e-38  Score=327.84  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=205.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh------hHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ------GVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+......      ..+++.+|+.++++++||||+++++++...+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            346799999999999999999999988999999999754321      35678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC----CeEEeeec
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL----NGKLGDFG  487 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~----~~kL~DFG  487 (652)
                      .++||||+++++|.+++..  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999954  346899999999999999999999   69999999999999999887    79999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      +++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+   ....+..    .  
T Consensus       165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~----~--  233 (321)
T 2a2a_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANITS----V--  233 (321)
T ss_dssp             TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHT----T--
T ss_pred             cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh----c--
Confidence            998765432  2334579999999999999999999999999999999999999997532211   1110000    0  


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                              ...+...                   ......+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       234 --------~~~~~~~-------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          234 --------SYDFDEE-------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             --------CCCCCHH-------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             --------ccccChh-------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence                    0000000                   00123457899999999999999995      6777653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.1e-38  Score=334.67  Aligned_cols=277  Identities=24%  Similarity=0.346  Sum_probs=204.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee---
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL---  412 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  412 (652)
                      ..++|...+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            347899999999999999999999999999999999764  333457788999999999999999999999877654   


Q ss_pred             ---EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          413 ---LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       413 ---~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                         ++||||++ ++|.+++    ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       120 ~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence               99999997 5888777    234899999999999999999999   689999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +....    ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....+....    
T Consensus       192 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~----  263 (371)
T 4exu_A          192 RHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT----  263 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH----
T ss_pred             ccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH----
Confidence            86543    2334578999999998877 67899999999999999999999999865433222211111111110    


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      +.++ .+..  .........+.  ...........+...+.+.+|+.+|+..+|++|+      .|+||+...
T Consensus       264 ~~~~-~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          264 EFVQ-KLND--KAAKSYIQSLP--QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHT-TCSC--HHHHHHHHHSC--CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHH-Hhhh--hhhhhhhhccC--CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            1100 0000  01111112211  1111111111233467899999999999999999      578998743

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-38  Score=321.60  Aligned_cols=203  Identities=31%  Similarity=0.460  Sum_probs=177.6

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            45789999999999999999998875 67899999976432 34678999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           84 YISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             ccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999999998543 345899999999999999999999   79999999999999999999999999999987654432


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY  209 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence            23333456778999999988889999999999999999999 99999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.2e-38  Score=339.47  Aligned_cols=254  Identities=22%  Similarity=0.322  Sum_probs=192.5

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--------hhhHHHHHHHHHHhcccCcCceeEEEeeeec
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--------KQGVREFVSEIATIGRLRHRNLVQLVGWCRR  408 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  408 (652)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++....        ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34578999999999999999999999999999999986542        1122357899999999999999999999854


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEee
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGD  485 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~D  485 (652)
                       +..++||||+++|+|.+++..  ...+++..++.++.|++.||+|||   +++|+||||||+|||++.+   ..+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence             458999999999999998854  346899999999999999999999   6899999999999999754   4599999


Q ss_pred             eccceecccCCCCceeeccCCcCCCCCCCCCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhh
Q 038860          486 FGLAKLYEHGTNPATTRVVGTLGYLAPETPRT---GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY  562 (652)
Q Consensus       486 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  562 (652)
                      ||+++.....  .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.........  ...+..  
T Consensus       286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~~--  359 (419)
T 3i6u_A          286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS--  359 (419)
T ss_dssp             SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHHT--
T ss_pred             cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHhc--
Confidence            9999875432  23345679999999999863   56788999999999999999999999754322211  111100  


Q ss_pred             cCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          563 GEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       563 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                    ..+.                 ..+.......+.+.+|+.+|+..+|++|++      |+|+.+
T Consensus       360 --------------~~~~-----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          360 --------------GKYN-----------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             --------------TCCC-----------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             --------------CCCC-----------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence                          0000                 000001123467899999999999999994      678765

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5e-38  Score=322.72  Aligned_cols=202  Identities=25%  Similarity=0.395  Sum_probs=173.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|.+.+.||+|+||.||++.+..++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467999999999999999999999889999999997653 3345788999999999999999999999999999999999


Q ss_pred             eccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---CCCCCeEEeeeccceec
Q 038860          418 FMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLY  492 (652)
Q Consensus       418 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---~~~~~~kL~DFGla~~~  492 (652)
                      |+++|+|.+++...  ....+++..++.++.|++.||+|||   +++|+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988542  2356999999999999999999999   7999999999999999   45578999999999865


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ....  ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~  228 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT  228 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence            4432  234457999999999875 56889999999999999999999999763

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=341.00  Aligned_cols=275  Identities=21%  Similarity=0.289  Sum_probs=205.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC--eeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG--DLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999999989999999997643 234567889999999999999999999988654  78999


Q ss_pred             EEeccCCCcccccccCCc-cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe----CCCCCeEEeeeccce
Q 038860          416 YDFMANGSLDSFLFDEPK-AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL----DSELNGKLGDFGLAK  490 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl----~~~~~~kL~DFGla~  490 (652)
                      |||+++|+|.+++..... ..+++..++.++.||+.||+|||   +++|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965332 23899999999999999999999   7999999999999999    777889999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCC--------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc-chhHHHHHHhh
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRT--------GKSSASSDVFAFGALLLEVACGRRPIETRALPE-ELVLVDWVWGK  561 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~  561 (652)
                      ......  ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||....... ....+..+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            764332  2334579999999998764        457789999999999999999999997543322 22222222222


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                      .....+... .....+.++          ... ...+.........+.+.+++.+|+..+|++|+++.-
T Consensus       243 ~p~~~~~~~-~~~~~~~~~----------~~~-~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (396)
T 4eut_A          243 KPSGAISGV-QKAENGPID----------WSG-DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (396)
T ss_dssp             CCTTCCEEE-ECSTTCCEE----------EES-SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCcccchhh-eeccCCCcc----------cCc-cCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence            221111111 000000000          000 011112222344567889999999999999998764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-38  Score=330.31  Aligned_cols=269  Identities=21%  Similarity=0.308  Sum_probs=199.7

Q ss_pred             hcCcccc-ccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEE
Q 038860          339 TNNFSAK-QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       339 ~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .+.|++. +.||+|+||.||+|.+..+++.||||++........+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678874 7899999999999999888999999999776555667889999999885 7999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC---eEEeeeccceecc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN---GKLGDFGLAKLYE  493 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~---~kL~DFGla~~~~  493 (652)
                      ||+++++|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.   +||+|||+++...
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           91 EKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999954  346899999999999999999999   689999999999999998766   9999999998654


Q ss_pred             cCCC------CceeeccCCcCCCCCCCCCC-----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhh
Q 038860          494 HGTN------PATTRVVGTLGYLAPETPRT-----GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY  562 (652)
Q Consensus       494 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  562 (652)
                      ....      .......||+.|+|||.+..     ..++.++|||||||++|||++|+.||......+.....       
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-------  238 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR-------  238 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---------
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc-------
Confidence            2211      12233569999999998865     45789999999999999999999999865433211000       


Q ss_pred             cCCccccccccccccCCC-HHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          563 GEGRVLEVIDPKLNAEYD-QSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       563 ~~~~~~~~id~~l~~~~~-~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                        .           .... ....+...+... ....|.. ......+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       239 --~-----------~~~~~~~~~~~~~i~~~-~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          239 --G-----------EACPACQNMLFESIQEG-KYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             ---------------CCHHHHHHHHHHHHHC-CCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             --c-----------ccchhHHHHHHHHHhcc-CcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence              0           0000 001111111000 0001110 01123568899999999999999995      6788764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-37  Score=321.57  Aligned_cols=206  Identities=20%  Similarity=0.275  Sum_probs=179.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.....  .+.+.+|+.+++++ +|+|++++++++......++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            34689999999999999999999988899999999865432  24577899999999 7999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC-----eEEeeecccee
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN-----GKLGDFGLAKL  491 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~-----~kL~DFGla~~  491 (652)
                      ||+ +++|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.     +||+|||+++.
T Consensus        86 e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999 99999999543 335899999999999999999999   799999999999999987766     99999999997


Q ss_pred             cccCCCC------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 038860          492 YEHGTNP------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE  550 (652)
Q Consensus       492 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~  550 (652)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  225 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT  225 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc
Confidence            6543321      2345679999999999999999999999999999999999999998755433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8e-38  Score=323.17  Aligned_cols=257  Identities=24%  Similarity=0.325  Sum_probs=190.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcc--cCcCceeEEEeeeec----cCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR--LRHRNLVQLVGWCRR----KGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~  411 (652)
                      ..++|++.+.||+|+||.||+|++  +++.||||++....   ...+..|.+++..  ++||||+++++++..    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            357899999999999999999988  47899999996543   3344556666555  799999999998654    346


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCc-----cceEEecCCCCCceEeCCCCCeEEeee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY-----EQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      .++||||+++|+|.+++.   ...+++..+++++.|++.||+|||+..     +++|+||||||+|||++.++.+||+||
T Consensus        81 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            899999999999999993   346999999999999999999999322     489999999999999999999999999


Q ss_pred             ccceecccCCCCc---eeeccCCcCCCCCCCCCCC------CCCCccchHhHHHHHHHHHhC----------CCCCCCCC
Q 038860          487 GLAKLYEHGTNPA---TTRVVGTLGYLAPETPRTG------KSSASSDVFAFGALLLEVACG----------RRPIETRA  547 (652)
Q Consensus       487 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDv~SlGvvl~elltG----------~~p~~~~~  547 (652)
                      |+++.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998765433221   2234799999999998776      445789999999999999999          66664322


Q ss_pred             CccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC
Q 038860          548 LPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS  627 (652)
Q Consensus       548 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s  627 (652)
                      ..+..                            .................|.........+.+.+|+.+|+..+|++||+
T Consensus       238 ~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  289 (301)
T 3q4u_A          238 PNDPS----------------------------FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT  289 (301)
T ss_dssp             CSSCC----------------------------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred             CCCcc----------------------------hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence            21110                            00000000000111111111112234567899999999999999998


Q ss_pred             ccc
Q 038860          628 CSY  630 (652)
Q Consensus       628 ~~~  630 (652)
                      +..
T Consensus       290 ~~~  292 (301)
T 3q4u_A          290 ALR  292 (301)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=334.37  Aligned_cols=207  Identities=19%  Similarity=0.196  Sum_probs=176.4

Q ss_pred             hhhhhhhcCccccccccccCceEEEEEE-----EcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC---cCceeEEEe
Q 038860          333 QELKQATNNFSAKQLLGHGGFGQVYKGT-----LHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR---HRNLVQLVG  404 (652)
Q Consensus       333 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~  404 (652)
                      .++....++|++.+.||+|+||.||+|.     ...+++.||+|++.....   .++..|+.++.+++   |+||+++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            4455667889999999999999999994     556788999999976543   34566666666665   999999999


Q ss_pred             eeeccCeeEEEEEeccCCCcccccccC---CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC----
Q 038860          405 WCRRKGDLLLVYDFMANGSLDSFLFDE---PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS----  477 (652)
Q Consensus       405 ~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~----  477 (652)
                      ++...+..++||||+++|+|.+++...   ....+++..++.++.||+.||+|||   +++|+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccC
Confidence            999999999999999999999999532   3456999999999999999999999   799999999999999998    


Q ss_pred             -------CCCeEEeeeccceecccCC-CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          478 -------ELNGKLGDFGLAKLYEHGT-NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       478 -------~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                             ++.+||+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                   8999999999998654322 2234556899999999999999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.9e-38  Score=329.29  Aligned_cols=284  Identities=21%  Similarity=0.282  Sum_probs=210.8

Q ss_pred             hhcCccccccccccCceEEEEEEE-cCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc------eeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTL-HNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN------LVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~  410 (652)
                      ..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|++      ++++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            346899999999999999999998 5578999999997643 34567889999999987665      999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-------------
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-------------  477 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-------------  477 (652)
                      ..++||||+ +++|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 889999997665557899999999999999999999   799999999999999987             


Q ss_pred             ------CCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          478 ------ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       478 ------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                            ++.+||+|||+++....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  66899999999986443    22345789999999999998999999999999999999999999987554333


Q ss_pred             hhHHHHHHhhhcCCccc--------cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCC
Q 038860          552 LVLVDWVWGKYGEGRVL--------EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFD  623 (652)
Q Consensus       552 ~~l~~~~~~~~~~~~~~--------~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~  623 (652)
                      ...+.............        ..-...+............. ..+..   ..........+.+.+|+.+|+..+|+
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA-CKPLK---EFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH-CCCGG---GGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhc-Ccchh---hhcccchhhHHHHHHHHHHHhCcCcc
Confidence            33333222211110000        00000111111111111111 11111   11111223456789999999999999


Q ss_pred             CCC------CccccccC
Q 038860          624 KTT------SCSYFENG  634 (652)
Q Consensus       624 ~r~------s~~~~~~~  634 (652)
                      +|+      .|+||+..
T Consensus       319 ~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          319 KRITLREALKHPFFDLL  335 (339)
T ss_dssp             TSCCHHHHTTSGGGGGG
T ss_pred             cccCHHHHhcCHHHHHH
Confidence            999      46777654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.1e-38  Score=327.76  Aligned_cols=206  Identities=22%  Similarity=0.251  Sum_probs=180.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+.....  .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            4689999999999999999999988899999999865432  23578899999999 89999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC-----eEEeeeccceec
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN-----GKLGDFGLAKLY  492 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~-----~kL~DFGla~~~  492 (652)
                      |+ +++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 99999998543 346999999999999999999999   689999999999999998887     999999999976


Q ss_pred             ccCCCC------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          493 EHGTNP------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       493 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                      ......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~  225 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL  225 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence            443221      12456899999999999999999999999999999999999999987654443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.9e-37  Score=314.84  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=204.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999999889999999996543 3345778999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC-
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT-  496 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~-  496 (652)
                      |+++++|.+++..  ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++....... 
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999943  346899999999999999999999   7999999999999999999999999999998664322 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                      ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+...               
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~---------------  224 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK---------------  224 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT---------------
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc---------------
Confidence            122344578999999999887665 7789999999999999999999976433211 11111000               


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                       ..    .........+.+.+|+.+|+..+|++|++      |+||+.
T Consensus       225 -----------------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (276)
T 2yex_A          225 -----------------KT----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (276)
T ss_dssp             -----------------CT----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -----------------cc----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence                             00    00001123467889999999999999995      466654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-38  Score=322.49  Aligned_cols=202  Identities=32%  Similarity=0.525  Sum_probs=176.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|.+.+ ++.||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            4678999999999999999999875 67899999976532 346789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           87 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            9999999998543 346899999999999999999999   799999999999999999999999999999865432222


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~  211 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  211 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            2333457788999999988899999999999999999999 99999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=327.91  Aligned_cols=277  Identities=24%  Similarity=0.345  Sum_probs=205.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe-----
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD-----  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  411 (652)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46899999999999999999999999999999999764  23345678999999999999999999999987654     


Q ss_pred             -eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          412 -LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       412 -~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                       .++||||++ ++|.+++.    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999997 58888872    24899999999999999999999   6999999999999999999999999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      ....    ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....+..... ..+
T Consensus       175 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~  249 (353)
T 3coi_A          175 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE-FVQ  249 (353)
T ss_dssp             C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH-HHT
T ss_pred             CCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH-HHH
Confidence            6432    2334578999999998876 678999999999999999999999998754322222111111111100 000


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                          .+...  ........+  +...+.+.....+...+.+.+|+.+|+..+|++|+      .|+||.....
T Consensus       250 ----~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          250 ----KLNDK--AAKSYIQSL--PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             ----TCSCH--HHHHHHHTS--CBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             ----HHhhH--HHHHHHHhC--cCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                01000  011111221  11112222222334567899999999999999999      5789987543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.1e-38  Score=332.49  Aligned_cols=283  Identities=24%  Similarity=0.309  Sum_probs=208.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----Ce
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----GD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  411 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4578999999999999999999999889999999997543 33456788999999999999999999988654     67


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++||||++ ++|.+++..   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            899999997 589888843   46899999999999999999999   69999999999999999999999999999987


Q ss_pred             cccCCCC---------ceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhh
Q 038860          492 YEHGTNP---------ATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGK  561 (652)
Q Consensus       492 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  561 (652)
                      .......         ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            6432211         1223578999999997654 67899999999999999999999999875433332222222221


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      .........+.      ..........+.  .....+.....+...+.+.+|+.+|+..+|++|+      .|+|+....
T Consensus       242 ~~~~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          242 PHSDNDLRCIE------SPRAREYIKSLP--MYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCSTTTTTTCC------CHHHHHHHHTSC--CCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             Cchhccccccc------cchhhHHhhccc--CCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            11111111100      001111111211  1111111112234467889999999999999999      678988753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-37  Score=323.19  Aligned_cols=254  Identities=24%  Similarity=0.394  Sum_probs=203.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            34679999999999999999999998899999999987655555678899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---CCCCCeEEeeeccceeccc
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---~~~~~~kL~DFGla~~~~~  494 (652)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999998843  345899999999999999999999   6899999999999999   7788999999999975432


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......   .+...+..    +         
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~----~---------  222 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKE----G---------  222 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----C---------
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHc----C---------
Confidence            1   233457999999999999999999999999999999999999999753211   11111100    0         


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGV  635 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~  635 (652)
                                   ....+    .|.   .....+.+.+++.+|+..+|++|++      |+|++...
T Consensus       223 -------------~~~~~----~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          223 -------------YYEFE----SPF---WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             -------------CCCCC----TTT---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             -------------CCCCC----ccc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                         00000    000   1123468899999999999999995      57887643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=331.65  Aligned_cols=201  Identities=26%  Similarity=0.406  Sum_probs=177.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--------hhHHHHHHHHHHhcccCcCceeEEEeeeecc
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--------QGVREFVSEIATIGRLRHRNLVQLVGWCRRK  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  409 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45689999999999999999999999999999999976421        1234577899999999999999999999999


Q ss_pred             CeeEEEEEeccCC-CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          410 GDLLLVYDFMANG-SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       410 ~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      +..++||||+.+| +|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999777 99988844  345999999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCC
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ++......  ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus       177 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          177 AAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             CEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            98765432  3344679999999999888776 7899999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.1e-38  Score=333.09  Aligned_cols=202  Identities=30%  Similarity=0.414  Sum_probs=178.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            46899999999999999999999988999999999765 33445678999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999999954  3458999999999999999999993  238999999999999999999999999999755332  


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             2234578999999999999999999999999999999999999997643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-38  Score=332.49  Aligned_cols=256  Identities=26%  Similarity=0.426  Sum_probs=203.4

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      .+....++|++.+.||+|+||.||+|.+..     +++.||+|.++... ....+.+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344566889999999999999999999873     45889999997653 344577999999999999999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCC----------------------ccccchHHHhhhHHHHHHHHhhhccCccceEEe
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEP----------------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIH  465 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH  465 (652)
                      ..+..++||||+++|+|.+++....                      ...+++.+++.++.||++||.|||   +++|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence            9999999999999999999985432                      256899999999999999999999   799999


Q ss_pred             cCCCCCceEeCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCC
Q 038860          466 RDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPI  543 (652)
Q Consensus       466 rDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~  543 (652)
                      |||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999986543221 22334568899999999988889999999999999999999 99999


Q ss_pred             CCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCC
Q 038860          544 ETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFD  623 (652)
Q Consensus       544 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~  623 (652)
                      ......+   ....    ...+..                           ...|     ....+.+.+|+.+|+..+|+
T Consensus       278 ~~~~~~~---~~~~----~~~~~~---------------------------~~~~-----~~~~~~l~~li~~~l~~~p~  318 (343)
T 1luf_A          278 YGMAHEE---VIYY----VRDGNI---------------------------LACP-----ENCPLELYNLMRLCWSKLPA  318 (343)
T ss_dssp             TTSCHHH---HHHH----HHTTCC---------------------------CCCC-----TTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCChHH---HHHH----HhCCCc---------------------------CCCC-----CCCCHHHHHHHHHHcccCcc
Confidence            7532111   1110    000000                           0001     12235788999999999999


Q ss_pred             CCCCcccc
Q 038860          624 KTTSCSYF  631 (652)
Q Consensus       624 ~r~s~~~~  631 (652)
                      +||+...+
T Consensus       319 ~Rps~~~~  326 (343)
T 1luf_A          319 DRPSFCSI  326 (343)
T ss_dssp             GSCCHHHH
T ss_pred             cCCCHHHH
Confidence            99987654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.9e-38  Score=330.30  Aligned_cols=213  Identities=26%  Similarity=0.459  Sum_probs=164.2

Q ss_pred             hhhhhhhhcCccccccccccCceEEEEEEEcCCCe---EEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeee
Q 038860          332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKT---EVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWC  406 (652)
Q Consensus       332 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  406 (652)
                      ++++....++|++.+.||+|+||.||+|.+..++.   .||+|.+...  .....+++.+|+.++++++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34455567899999999999999999999876554   7999999765  344567899999999999999999999999


Q ss_pred             eccCee------EEEEEeccCCCcccccccCC----ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC
Q 038860          407 RRKGDL------LLVYDFMANGSLDSFLFDEP----KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD  476 (652)
Q Consensus       407 ~~~~~~------~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~  476 (652)
                      ......      ++||||+++|+|.+++....    ...+++..++.++.|++.||.|||   +++|+||||||+|||++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLA  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEc
Confidence            876654      99999999999999985321    225899999999999999999999   69999999999999999


Q ss_pred             CCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          477 SELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       477 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      .++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            999999999999986644322 22234467889999999999999999999999999999999 999997643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-37  Score=322.83  Aligned_cols=202  Identities=26%  Similarity=0.372  Sum_probs=168.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999999889999999997653   23346789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++..  ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999853  346899999999999999999999   799999999999999999999999999999876544


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .........|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence            33334456799999999999999999999999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-38  Score=338.19  Aligned_cols=278  Identities=20%  Similarity=0.284  Sum_probs=201.3

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec-------
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR-------  408 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  408 (652)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++......    ..+|+.+++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999999999999999998654322    2369999999999999999999843       


Q ss_pred             -------------------------------cCeeEEEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhh
Q 038860          409 -------------------------------KGDLLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYL  455 (652)
Q Consensus       409 -------------------------------~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~L  455 (652)
                                                     ....++||||++ |+|.+.+..  .....+++..+..++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999998 587777643  3345799999999999999999999


Q ss_pred             ccCccceEEecCCCCCceEeC-CCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHH
Q 038860          456 HEGYEQVVIHRDVKASNVLLD-SELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALL  533 (652)
Q Consensus       456 H~~~~~~ivHrDlk~~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl  533 (652)
                      |   +.+|+||||||+|||++ .++.+||+|||+++......  ......||+.|+|||.+.+. .++.++||||+||++
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            9   79999999999999998 67899999999998764432  23345789999999988765 489999999999999


Q ss_pred             HHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCC-CcccccchhHHH
Q 038860          534 LEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRS-SDGDKAAEGFDD  612 (652)
Q Consensus       534 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~-~~~~~~~~~~~d  612 (652)
                      |||++|+.||......+....+....+......+.. +++    .+.       ....+.....+.. .......+.+.|
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~-~~~----~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIR-MNP----HYT-------EVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH-HCT----TC---------CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH-hCc----ccc-------cccCCccCcccHHhhCCCCCCHHHHH
Confidence            999999999987543333222211111111100000 000    010       0111111110000 001123467899


Q ss_pred             HHhhhccCCCCCCCC------ccccccCc
Q 038860          613 LLNSLASSSFDKTTS------CSYFENGV  635 (652)
Q Consensus       613 Ll~~~~~~~~~~r~s------~~~~~~~~  635 (652)
                      |+.+|+..+|++|++      |+||+..+
T Consensus       301 li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             HHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence            999999999999995      89998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=336.58  Aligned_cols=205  Identities=30%  Similarity=0.498  Sum_probs=176.3

Q ss_pred             hcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999953     45778999999754 344556789999999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCC-----ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC---CeEEe
Q 038860          413 LLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL---NGKLG  484 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~---~~kL~  484 (652)
                      ++||||+++|+|.+++....     ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999995432     245899999999999999999999   79999999999999999554   59999


Q ss_pred             eeccceecccC-CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          485 DFGLAKLYEHG-TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       485 DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      |||+++..... .........||+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~  290 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  290 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999865332 2233344678999999999988999999999999999999998 99999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-38  Score=337.44  Aligned_cols=289  Identities=20%  Similarity=0.264  Sum_probs=204.4

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-----------hhHHHHHHHHHHhcccCcCc
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-----------QGVREFVSEIATIGRLRHRN  398 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n  398 (652)
                      ....++....++|++.+.||+|+||.||+|.+.. ++.||||++.....           ...+.+.+|+.++++++|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            3456778889999999999999999999999876 89999999854321           22477899999999999999


Q ss_pred             eeEEEeeeec-----cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCce
Q 038860          399 LVQLVGWCRR-----KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNV  473 (652)
Q Consensus       399 iv~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NI  473 (652)
                      |+++++++..     ....++||||++ |+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI  165 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence            9999999843     346899999997 5888877543 346899999999999999999999   68999999999999


Q ss_pred             EeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccch
Q 038860          474 LLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEEL  552 (652)
Q Consensus       474 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~  552 (652)
                      |++.++.+||+|||+++.....  .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999854332  23344578999999998876 67899999999999999999999999865432222


Q ss_pred             hHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC-----
Q 038860          553 VLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS-----  627 (652)
Q Consensus       553 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s-----  627 (652)
                         ..+..........+...    ............. .......+.....+...+.+.+|+.+|+..+|++|++     
T Consensus       244 ---~~i~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          244 ---NKIVEVVGTPKIEDVVM----FSSPSARDYLRNS-LSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             ---HHHHHHHCCCCHHHHHH----TSCHHHHHHTTTC-CCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ---HHHHHHcCCCChHHhhh----ccchhhhHHHHhh-cccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence               22222221111110000    0000000001010 0011111111112234567999999999999999996     


Q ss_pred             -ccccccC
Q 038860          628 -CSYFENG  634 (652)
Q Consensus       628 -~~~~~~~  634 (652)
                       |+||+..
T Consensus       316 ~hp~f~~~  323 (362)
T 3pg1_A          316 RHPYFESL  323 (362)
T ss_dssp             TSGGGTTT
T ss_pred             cCchhhhc
Confidence             8899875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-38  Score=339.08  Aligned_cols=206  Identities=29%  Similarity=0.481  Sum_probs=177.8

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||.+.... ....++|.+|+.++++++||||++++++|...+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34568899999999999999999999889999999997653 33445788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       191 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999999999542 345899999999999999999999   799999999999999999999999999999864332


Q ss_pred             CCCc-eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          496 TNPA-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       496 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .... .....++..|+|||.+.++.++.++|||||||++|||++ |+.||...
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~  319 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL  319 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            1111 111235678999999988889999999999999999998 99999753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.8e-37  Score=331.78  Aligned_cols=202  Identities=23%  Similarity=0.303  Sum_probs=175.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC--------cCceeEEEeeee---
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR--------HRNLVQLVGWCR---  407 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  407 (652)
                      .++|++.++||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999999999999999999754 334567889999999986        788999999987   


Q ss_pred             -ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccc-eEEecCCCCCceEeCCCC------
Q 038860          408 -RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ-VVIHRDVKASNVLLDSEL------  479 (652)
Q Consensus       408 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDlk~~NILl~~~~------  479 (652)
                       .....++||||+ +++|.+++.......+++..++.++.||+.||.|||   ++ +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             566899999999 567777775555567999999999999999999999   57 999999999999999775      


Q ss_pred             -------------------------------------------CeEEeeeccceecccCCCCceeeccCCcCCCCCCCCC
Q 038860          480 -------------------------------------------NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR  516 (652)
Q Consensus       480 -------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  516 (652)
                                                                 .+||+|||+++.....    .....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       7999999999876432    23457899999999999


Q ss_pred             CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          517 TGKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       517 ~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      +..++.++|||||||++|||++|+.||......
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  299 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGE  299 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence            999999999999999999999999999765443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-37  Score=319.03  Aligned_cols=203  Identities=26%  Similarity=0.431  Sum_probs=180.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|.+...   .....+.+.+|+.++++++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            346799999999999999999999998999999998654   23455678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++..  ...+++.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           93 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999998843  346899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       168 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          168 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             TT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Cc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            22 2234457899999999999888999999999999999999999999753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.8e-38  Score=325.28  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=202.9

Q ss_pred             hhhhcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK  409 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  409 (652)
                      ....++|.+.+.||+|+||.||+|.+.     .++..||+|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            344678999999999999999999983     345889999997643 44567899999999999999999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCCc----------------------cccchHHHhhhHHHHHHHHhhhccCccceEEecC
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPK----------------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD  467 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrD  467 (652)
                      +..++||||+++++|.+++.....                      ..+++..++.++.||+.||.|||   +++|+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccc
Confidence            999999999999999999864322                      34899999999999999999999   69999999


Q ss_pred             CCCCceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       468 lk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      |||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876443221 2233467889999999988889999999999999999999 9999975


Q ss_pred             CCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCC
Q 038860          546 RALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKT  625 (652)
Q Consensus       546 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r  625 (652)
                      ......   ...+...                               .....|     ....+.+.+|+.+|+..+|++|
T Consensus       256 ~~~~~~---~~~~~~~-------------------------------~~~~~~-----~~~~~~~~~li~~~l~~dp~~R  296 (314)
T 2ivs_A          256 IPPERL---FNLLKTG-------------------------------HRMERP-----DNCSEEMYRLMLQCWKQEPDKR  296 (314)
T ss_dssp             CCGGGH---HHHHHTT-------------------------------CCCCCC-----TTCCHHHHHHHHHHTCSSGGGS
T ss_pred             CCHHHH---HHHhhcC-------------------------------CcCCCC-----ccCCHHHHHHHHHHccCChhhC
Confidence            432111   1100000                               000001     1234678899999999999999


Q ss_pred             CCcccc
Q 038860          626 TSCSYF  631 (652)
Q Consensus       626 ~s~~~~  631 (652)
                      |+...+
T Consensus       297 ps~~~l  302 (314)
T 2ivs_A          297 PVFADI  302 (314)
T ss_dssp             CCHHHH
T ss_pred             cCHHHH
Confidence            887543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-38  Score=347.11  Aligned_cols=255  Identities=27%  Similarity=0.457  Sum_probs=202.7

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      +.....++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.++++++||||+++++++. .+..+
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            344556789999999999999999999865 6789999997653 34678999999999999999999999987 56789


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999999996554456889999999999999999999   6899999999999999999999999999998654


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ...........++..|+|||++..+.++.++|||||||++|||++ |+.||......+   ....+..            
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~------------  400 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER------------  400 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHH------------
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc------------
Confidence            321112223456789999999988899999999999999999999 999997532211   1111000            


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccccc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFEN  633 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~~~  633 (652)
                                     ..      +.|.+.   ...+.+.+|+.+|+..+|++||+...+..
T Consensus       401 ---------------~~------~~~~~~---~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          401 ---------------GY------RMPRPE---NCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ---------------TC------CCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CC------CCCCCC---CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                           00      001111   12357888999999999999988665433

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.8e-37  Score=316.12  Aligned_cols=247  Identities=25%  Similarity=0.472  Sum_probs=196.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh-------hHHHHHHHHHHhcccCcCceeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ-------GVREFVSEIATIGRLRHRNLVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  410 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......       ..+.+.+|+.++++++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            357899999999999999999999988999999998654221       1167899999999999999999999997665


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce--EEecCCCCCceEeCCCCC-----eEE
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV--VIHRDVKASNVLLDSELN-----GKL  483 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDlk~~NILl~~~~~-----~kL  483 (652)
                        ++||||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++.     +||
T Consensus        97 --~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             --eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence              7999999999998888543 346999999999999999999999   678  999999999999988776     999


Q ss_pred             eeeccceecccCCCCceeeccCCcCCCCCCCCC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhh
Q 038860          484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR--TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGK  561 (652)
Q Consensus       484 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  561 (652)
                      +|||+++....    ......||+.|+|||.+.  ...++.++|||||||++|||++|+.||........ .........
T Consensus       171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~  245 (287)
T 4f0f_A          171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREE  245 (287)
T ss_dssp             CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHHS
T ss_pred             CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhcc
Confidence            99999974332    344567999999999984  45578899999999999999999999975433221 111111000


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                      .                              .....|     ....+.+.+|+.+|+..+|++||+...
T Consensus       246 ~------------------------------~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~  279 (287)
T 4f0f_A          246 G------------------------------LRPTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY  279 (287)
T ss_dssp             C------------------------------CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             C------------------------------CCCCCC-----cccCHHHHHHHHHHhcCChhhCcCHHH
Confidence            0                              000000     122467899999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6e-38  Score=334.82  Aligned_cols=204  Identities=33%  Similarity=0.576  Sum_probs=166.1

Q ss_pred             hcCccccccccccCceEEEEEEEc---CCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|++.   ..+..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            468999999999999999999886   45678999999765 33456789999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999543 346899999999999999999999   68999999999999999999999999999987654


Q ss_pred             CCCCc--eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTNPA--TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .....  .....++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~  254 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM  254 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            32221  222345788999999998999999999999999999998 99999754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.3e-38  Score=340.62  Aligned_cols=276  Identities=24%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeecc------Cee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------GDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  412 (652)
                      ..+|+..+.||+|+||.||+|++..+++.||||++.....    ...+|++++++++||||++++++|...      ..+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3468899999999999999999998899999999865432    234699999999999999999998542      236


Q ss_pred             EEEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccc
Q 038860          413 LLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLA  489 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla  489 (652)
                      ++||||+++ +|.+.+..  .....+++..++.++.||++||+|||   +++|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999976 66555532  23456999999999999999999999   7999999999999999965 56899999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+....+....+.+.
T Consensus       205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9764432  23345789999999988764 78999999999999999999999998754333222221111111111110


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCC-cccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSS-DGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~-~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      + +++..    .       ....+.....|... ..+...+.+.||+.+|+..+|++|++      |+||+..++
T Consensus       283 ~-~~~~~----~-------~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          283 E-MNPNY----T-------EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             H-HCSCC----C-------CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             h-hChhh----h-------hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            0 11110    0       00111111111100 01233568999999999999999995      789987543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-38  Score=332.56  Aligned_cols=205  Identities=24%  Similarity=0.366  Sum_probs=175.5

Q ss_pred             hhcCccccccccccCceEEEEEEEc---CCCeEEEEEEecCcc----hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES----KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  409 (652)
                      ..++|++.+.||+|+||.||+++..   .+++.||||+++...    ....+.+.+|+.+++++ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3468999999999999999999984   468999999987532    12334567899999999 699999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      +..++||||+++++|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999999954  346899999999999999999999   689999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +..............||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence            8764433333445689999999999875  347889999999999999999999997543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-38  Score=322.84  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=188.6

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcC---CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      ....++|++.+.||+|+||.||+|.+..   .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            3445789999999999999999999864   34679999987643 344567899999999999999999999985 457


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence            89999999999999998543 346899999999999999999999   69999999999999999999999999999987


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ...+..    +     
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~----~-----  233 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIEN----G-----  233 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHT----T-----
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHc----C-----
Confidence            65443333444567889999999988889999999999999999997 9999976432211   111000    0     


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                              .+.|..   ....+.+.+++.+|+..+|++||+...
T Consensus       234 ------------------------~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~  266 (281)
T 1mp8_A          234 ------------------------ERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTE  266 (281)
T ss_dssp             ------------------------CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------------------------CCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHH
Confidence                                    000001   123467889999999999999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-37  Score=330.00  Aligned_cols=205  Identities=26%  Similarity=0.447  Sum_probs=178.5

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--------hhhHHHHHHHHHHhccc-CcCceeEEEee
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--------KQGVREFVSEIATIGRL-RHRNLVQLVGW  405 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~  405 (652)
                      .....++|++.+.||+|+||.||+|.+..+++.||||++....        ....+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999998889999999986542        11245678999999999 79999999999


Q ss_pred             eeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEee
Q 038860          406 CRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGD  485 (652)
Q Consensus       406 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~D  485 (652)
                      +...+..++||||+++++|.+++..  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999853  346899999999999999999999   68999999999999999999999999


Q ss_pred             eccceecccCCCCceeeccCCcCCCCCCCCC------CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          486 FGLAKLYEHGTNPATTRVVGTLGYLAPETPR------TGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       486 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ||++.......  ......||+.|+|||++.      ...++.++|||||||++|||++|+.||...
T Consensus       244 fG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          244 FGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            99998765432  334567999999999875      335788999999999999999999999753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.6e-38  Score=321.63  Aligned_cols=206  Identities=29%  Similarity=0.468  Sum_probs=176.0

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .....++|++.+.||+|+||.||++.+.. +..||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            34456789999999999999999998874 77899999976532 34678999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++... ...+++.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999543 345999999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            22222233456788999999998889999999999999999998 99999754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-37  Score=344.93  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=199.8

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...++|++.+.||+|+||.||+|.+..++..||+|++....  ......+.+|+.++++++||||++++++|...+..++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567999999999999999999999889999999997643  2335678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeecccee
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGLAKL  491 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGla~~  491 (652)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++..   +.+||+|||+++.
T Consensus       114 v~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          114 VMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999888843  345899999999999999999999   7999999999999999764   4599999999987


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI  571 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  571 (652)
                      .....  ......||+.|+|||++. +.++.++||||+||++|||++|+.||......+   +...+..           
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~-----------  251 (494)
T 3lij_A          189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVEK-----------  251 (494)
T ss_dssp             CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH-----------
T ss_pred             CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh-----------
Confidence            65432  334467999999999876 568999999999999999999999997643211   1111100           


Q ss_pred             ccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          572 DPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       572 d~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                                     .....      +. .......+.+.+|+.+|+..+|++|+      .|+|+..
T Consensus       252 ---------------~~~~~------~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          252 ---------------GKYTF------DS-PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             ---------------TCCCC------CS-GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             ---------------CCCCC------Cc-hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence                           00000      00 00113356889999999999999999      5778876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-37  Score=327.37  Aligned_cols=210  Identities=29%  Similarity=0.466  Sum_probs=178.4

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeee
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCR  407 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  407 (652)
                      .....++|++.+.||+|+||.||+|.+.     .++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445678999999999999999999973     356789999997643 33456789999999999 8999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCCc---------------------cccchHHHhhhHHHHHHHHhhhccCccceEEec
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEPK---------------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHR  466 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHr  466 (652)
                      ..+..++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||   +++|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence            99999999999999999999965332                     34899999999999999999999   7999999


Q ss_pred             CCCCCceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 038860          467 DVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIE  544 (652)
Q Consensus       467 Dlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~  544 (652)
                      ||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876544322 2233567889999999988899999999999999999998 999997


Q ss_pred             CCC
Q 038860          545 TRA  547 (652)
Q Consensus       545 ~~~  547 (652)
                      ...
T Consensus       277 ~~~  279 (344)
T 1rjb_A          277 GIP  279 (344)
T ss_dssp             TCC
T ss_pred             cCC
Confidence            643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-37  Score=325.88  Aligned_cols=202  Identities=26%  Similarity=0.432  Sum_probs=180.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|.+.+.||+|+||.||++.+..+++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46789999999999999999999999999999998654   234556789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++..  ...+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999999998843  346899999999999999999999   689999999999999999999999999999876533


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence            2 2234457999999999998888999999999999999999999999753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-37  Score=327.60  Aligned_cols=198  Identities=33%  Similarity=0.479  Sum_probs=173.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .+.|+..+.||+|+||.||+|.+..+++.||||++...   .....+++.+|+.++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588899999999999999999888999999999654   233456789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||++ |+|.+++... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.... 
T Consensus       133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            99997 5887777432 346899999999999999999999   68999999999999999999999999999986542 


Q ss_pred             CCCceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                          .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||...
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  256 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  256 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                23457999999999873   567899999999999999999999999753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-37  Score=320.41  Aligned_cols=205  Identities=26%  Similarity=0.408  Sum_probs=166.7

Q ss_pred             ccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcc--cCcCceeEEEeee
Q 038860          329 RYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR--LRHRNLVQLVGWC  406 (652)
Q Consensus       329 ~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~  406 (652)
                      ...........++|++.+.||+|+||.||+|++.  ++.||||++.....   ..+..|.+++..  ++||||+++++++
T Consensus        26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             CCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            3344444556689999999999999999999885  78999999865432   334445555544  4899999999999


Q ss_pred             ecc----CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccc--------eEEecCCCCCceE
Q 038860          407 RRK----GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ--------VVIHRDVKASNVL  474 (652)
Q Consensus       407 ~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~--------~ivHrDlk~~NIL  474 (652)
                      ...    ...++||||+++|+|.+++..   ..+++..++.++.|++.||.|||   ..        +|+||||||+|||
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nil  174 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNIL  174 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEE
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEE
Confidence            876    689999999999999999943   35899999999999999999999   45        9999999999999


Q ss_pred             eCCCCCeEEeeeccceecccCCCCc---eeeccCCcCCCCCCCCCCCCCCCc------cchHhHHHHHHHHHhCCCCCC
Q 038860          475 LDSELNGKLGDFGLAKLYEHGTNPA---TTRVVGTLGYLAPETPRTGKSSAS------SDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       475 l~~~~~~kL~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------sDv~SlGvvl~elltG~~p~~  544 (652)
                      ++.++.+||+|||+++.........   .....||+.|+|||++.+...+.+      +|||||||++|||++|..|+.
T Consensus       175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            9999999999999998664432221   224579999999999888776665      999999999999999965553

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.7e-37  Score=322.35  Aligned_cols=269  Identities=18%  Similarity=0.269  Sum_probs=206.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhh-----------------HHHHHHHHHHhcccCcCcee
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-----------------VREFVSEIATIGRLRHRNLV  400 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv  400 (652)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|++.......                 .+.+.+|+.++++++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            357899999999999999999999  68999999986542211                 27789999999999999999


Q ss_pred             EEEeeeeccCeeEEEEEeccCCCcccc------cccCCccccchHHHhhhHHHHHHHHhhhccCcc-ceEEecCCCCCce
Q 038860          401 QLVGWCRRKGDLLLVYDFMANGSLDSF------LFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE-QVVIHRDVKASNV  473 (652)
Q Consensus       401 ~l~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivHrDlk~~NI  473 (652)
                      ++++++...+..++||||+++++|.++      +.......+++..++.++.|++.||.|||   + ++|+||||||+||
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI  183 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence            999999999999999999999999999      65444677999999999999999999999   6 9999999999999


Q ss_pred             EeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCC-CCCC-ccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          474 LLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG-KSSA-SSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       474 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                      |++.++.+||+|||++......   ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||....... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred             EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence            9999999999999999876432   33456799999999999887 5666 9999999999999999999998654321 


Q ss_pred             hhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC-----
Q 038860          552 LVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT-----  626 (652)
Q Consensus       552 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~-----  626 (652)
                       .....+    ..+... .  +.-...+           .......+.........+.+.+|+.+|+..+|++|+     
T Consensus       260 -~~~~~i----~~~~~~-~--~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~  320 (348)
T 2pml_X          260 -ELFNNI----RTKNIE-Y--PLDRNHF-----------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA  320 (348)
T ss_dssp             -HHHHHH----TSCCCC-C--CCSSSSS-----------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             -HHHHHH----hccCcC-C--ccchhhh-----------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence             111111    111100 0  0000000           000000011111134457899999999999999999     


Q ss_pred             -CccccccC
Q 038860          627 -SCSYFENG  634 (652)
Q Consensus       627 -s~~~~~~~  634 (652)
                       .|+||...
T Consensus       321 l~hp~f~~~  329 (348)
T 2pml_X          321 LKHEWLADT  329 (348)
T ss_dssp             HTSGGGTTC
T ss_pred             hcCccccCC
Confidence             56787764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.6e-38  Score=327.59  Aligned_cols=204  Identities=25%  Similarity=0.438  Sum_probs=168.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeE----EEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTE----VAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|+..+.||+|+||.||+|.+..+++.    ||+|.+.... ....+++.+|+.++++++||||++++++|.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            36799999999999999999998766654    5888875442 345578999999999999999999999998764 78


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|+||+++|+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999998653 346899999999999999999999   6899999999999999999999999999998765


Q ss_pred             cCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          494 HGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       494 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ..... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  224 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence            43322 2334467889999999999999999999999999999999 999997643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.4e-38  Score=326.97  Aligned_cols=205  Identities=28%  Similarity=0.461  Sum_probs=173.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeE----EEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTE----VAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|++.+.||+|+||.||+|.+..+++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            36789999999999999999999876665    7888775432 233356778999999999999999999986 45689


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999998543 356999999999999999999999   6899999999999999999999999999998765


Q ss_pred             cCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCC
Q 038860          494 HGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRAL  548 (652)
Q Consensus       494 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~  548 (652)
                      .... .......||..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  223 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL  223 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence            4332 23345578889999999998999999999999999999999 9999986543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.4e-37  Score=323.42  Aligned_cols=281  Identities=25%  Similarity=0.326  Sum_probs=207.2

Q ss_pred             hhhhcCccccccccccCceEEEEEEEc-CCCeEEEEEEecCcch--hhHHHHHHHHHHhccc---CcCceeEEEeeee--
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLH-NSKTEVAVKRISNESK--QGVREFVSEIATIGRL---RHRNLVQLVGWCR--  407 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--  407 (652)
                      ..+.++|++.+.||+|+||.||+|.+. .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.  
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            345688999999999999999999995 6689999999865322  1123456677777666   8999999999987  


Q ss_pred             ---ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          408 ---RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       408 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                         .....++||||++ |+|.+++.......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence               5667899999997 69999986655556999999999999999999999   7999999999999999999999999


Q ss_pred             eeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       485 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      |||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.   ...+......
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~  237 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGL  237 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCC
Confidence            999998654321  23345789999999999999999999999999999999999999986443222   2222221111


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCc
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGV  635 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~  635 (652)
                      ....     .+.......     ..........+.........+.+.+|+.+|+..+|++|++      |+||....
T Consensus       238 ~~~~-----~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          238 PGEE-----DWPRDVALP-----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             CCGG-----GSCTTCSSC-----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCcc-----cCccccccc-----hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            0000     000000000     0000011111111222344578899999999999999995      68988753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=324.92  Aligned_cols=266  Identities=25%  Similarity=0.383  Sum_probs=203.0

Q ss_pred             cccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeee
Q 038860          328 QRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWC  406 (652)
Q Consensus       328 ~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  406 (652)
                      ..+++.++....++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            345566777788999999999999999999999988899999999865432 346788999999999 799999999999


Q ss_pred             ec------cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          407 RR------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       407 ~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      ..      .+..++||||+++++|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence            76      467899999999999999997655567999999999999999999999   689999999999999999999


Q ss_pred             eEEeeeccceecccCCCCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHH
Q 038860          481 GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV  555 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~  555 (652)
                      +||+|||++....... .......||+.|+|||.+.     +..++.++|||||||++|||++|+.||........   .
T Consensus       168 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~  243 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---L  243 (326)
T ss_dssp             EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H
T ss_pred             EEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H
Confidence            9999999998654322 1233457899999999876     56789999999999999999999999965321110   0


Q ss_pred             HHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cc
Q 038860          556 DWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CS  629 (652)
Q Consensus       556 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~  629 (652)
                      .....                              ...    |.. ......+.+.+|+.+|+..+|++|++      |+
T Consensus       244 ~~~~~------------------------------~~~----~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          244 FLIPR------------------------------NPA----PRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             HHHHH------------------------------SCC----CCC-SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             HHhhc------------------------------Ccc----ccC-CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence            00000                              000    000 01123468899999999999999995      66


Q ss_pred             ccccCcc
Q 038860          630 YFENGVS  636 (652)
Q Consensus       630 ~~~~~~~  636 (652)
                      |+.....
T Consensus       289 ~~~~~~~  295 (326)
T 2x7f_A          289 FIRDQPN  295 (326)
T ss_dssp             HHHCCTT
T ss_pred             HHhhCcc
Confidence            7766543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.6e-37  Score=318.07  Aligned_cols=200  Identities=26%  Similarity=0.423  Sum_probs=175.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK------QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....      ...+.+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            578999999999999999999998899999999865421      13577899999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC----CeEEeeeccc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL----NGKLGDFGLA  489 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~----~~kL~DFGla  489 (652)
                      +||||+++++|.+++..  ...+++..++.++.|++.||.|||   +++++||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999843  346899999999999999999999   79999999999999998876    7999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  214 (283)
T 3bhy_A          160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE  214 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence            8764322  233457899999999999899999999999999999999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-36  Score=313.28  Aligned_cols=198  Identities=30%  Similarity=0.472  Sum_probs=172.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec----cCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR----KGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  413 (652)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4578888999999999999999999999999998754  34456778999999999999999999998865    35689


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce--EEecCCCCCceEeC-CCCCeEEeeeccce
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV--VIHRDVKASNVLLD-SELNGKLGDFGLAK  490 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDlk~~NILl~-~~~~~kL~DFGla~  490 (652)
                      +||||+++++|.+++..  ...+++..++.++.|++.||.|||   +.+  |+||||||+|||++ .++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999943  346899999999999999999999   677  99999999999998 78999999999997


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ....   .......||+.|+|||.+. +.++.++||||||+++|||++|+.||...
T Consensus       181 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          181 LKRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             GCCT---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccc---cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence            5432   2334567999999999876 45899999999999999999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=327.21  Aligned_cols=278  Identities=22%  Similarity=0.296  Sum_probs=198.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeee-----------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR-----------  407 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  407 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999999889999999998776677788999999999999999999999873           


Q ss_pred             ---ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-CCCCeEE
Q 038860          408 ---RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-SELNGKL  483 (652)
Q Consensus       408 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-~~~~~kL  483 (652)
                         ..+..++||||++ |+|.+++.   ...+++..++.++.|++.||+|||   +++|+||||||+|||++ .++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence               3467899999997 69999884   345899999999999999999999   79999999999999997 5679999


Q ss_pred             eeeccceecccCCC--CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHh
Q 038860          484 GDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWG  560 (652)
Q Consensus       484 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~  560 (652)
                      +|||+++.......  .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   ...+..
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~  239 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILE  239 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence            99999987643211  12334567999999998765 6789999999999999999999999986442221   111211


Q ss_pred             hhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          561 KYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       561 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                      ......  ....+.+......  .....+.   ....|.....+...+.+.+|+.+|+..+|++|+      .|+|++.
T Consensus       240 ~~~~~~--~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          240 SIPVVH--EEDRQELLSVIPV--YIRNDMT---EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             HSCCCC--HHHHHHHHTTSCH--HHHHHTT---SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             hcCCCc--hhhhhhhhhcCcc--ccccccc---CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            111000  0000000000000  0001110   011111111223457899999999999999999      4667764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-37  Score=317.57  Aligned_cols=205  Identities=31%  Similarity=0.515  Sum_probs=177.0

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ....++|++.+.||+|+||.||+|.+.+ +..||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++|
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   85 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence            3445789999999999999999999864 6789999997643 235678999999999999999999999874 468999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999996544446999999999999999999999   799999999999999999999999999999876543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence            3222233457889999999988889999999999999999999 99999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.5e-38  Score=342.73  Aligned_cols=206  Identities=32%  Similarity=0.516  Sum_probs=173.2

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .....++|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            34456789999999999999999999976 5679999997653 235679999999999999999999999976 67899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            999999999999996544456899999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ..........++..|+|||.+..+.++.++|||||||++|||++ |+.||...
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  385 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  385 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence            33333334567889999999988899999999999999999999 99999753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.6e-37  Score=336.24  Aligned_cols=199  Identities=34%  Similarity=0.507  Sum_probs=174.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-eeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-DLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~  416 (652)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||+++...  ..+.|.+|+.++++++||||+++++++...+ ..++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            4567889999999999999999986  5799999997654  4467999999999999999999999987665 789999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999997655555899999999999999999999   799999999999999999999999999999854321 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                         .....++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  391 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  391 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence               122357889999999999999999999999999999998 999997643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.9e-37  Score=326.33  Aligned_cols=284  Identities=19%  Similarity=0.262  Sum_probs=210.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCC-eEEEEEEecCcchhhHHHHHHHHHHhcccCcCc------eeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSK-TEVAVKRISNESKQGVREFVSEIATIGRLRHRN------LVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~  410 (652)
                      ..++|++.+.||+|+||.||+|.+..++ +.||+|+++... ...+.+.+|+.++++++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3578999999999999999999997665 789999997643 34467888999999998776      999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---------------
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---------------  475 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---------------  475 (652)
                      ..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence            999999999 667777776555557999999999999999999999   7999999999999999               


Q ss_pred             ----CCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 038860          476 ----DSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEE  551 (652)
Q Consensus       476 ----~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~  551 (652)
                          +.++.+||+|||+++....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                5678999999999986433    22345799999999999999999999999999999999999999986554333


Q ss_pred             hhHHHHHHhhhcCCcccc------ccc--cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCC
Q 038860          552 LVLVDWVWGKYGEGRVLE------VID--PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFD  623 (652)
Q Consensus       552 ~~l~~~~~~~~~~~~~~~------~id--~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~  623 (652)
                      ...+....+.........      ..+  ..+......... ......+..   +.........+.+.+|+.+|+..+|+
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRY-VKENCKPLK---SYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHH-HHHHCCCGG---GGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcc-ccccCCccc---ccccccchhHHHHHHHHHHHhcCChh
Confidence            333333222211110000      000  011111111111 111111111   11112223356788999999999999


Q ss_pred             CCC------CccccccC
Q 038860          624 KTT------SCSYFENG  634 (652)
Q Consensus       624 ~r~------s~~~~~~~  634 (652)
                      +|+      .|+||...
T Consensus       324 ~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGL  340 (355)
T ss_dssp             TSCCHHHHTTSGGGGGC
T ss_pred             hCcCHHHHhcChhhcCC
Confidence            999      67898875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.9e-37  Score=318.69  Aligned_cols=201  Identities=28%  Similarity=0.451  Sum_probs=180.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            457899999999999999999998889999999997543 3456789999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++..   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus       101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  173 (303)
T ss_dssp             CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred             eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence            9999999999843   46899999999999999999999   6899999999999999999999999999998765432 


Q ss_pred             CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence            2234457899999999999999999999999999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-37  Score=322.22  Aligned_cols=265  Identities=25%  Similarity=0.391  Sum_probs=184.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999998888999999986543 33456788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccc------CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          416 YDFMANGSLDSFLFD------EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      |||+++++|.+++..      .....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999998853      12456899999999999999999999   689999999999999999999999999999


Q ss_pred             eecccCCC----CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          490 KLYEHGTN----PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       490 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      ........    .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+...   ......  
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~--  243 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQND--  243 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHTSS--
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhccC--
Confidence            76543211    12234579999999998865 568999999999999999999999997643222111   000000  


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                             .+.+....                  +.........+.+.+|+.+|+..+|++||      .|+||...
T Consensus       244 -------~~~~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          244 -------PPSLETGV------------------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             -------CCCTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             -------CCcccccc------------------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence                   00000000                  00011112346789999999999999999      45666553

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-37  Score=330.75  Aligned_cols=199  Identities=23%  Similarity=0.312  Sum_probs=166.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG------  410 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  410 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999999988999999999753  3344567889999999999999999999997654      


Q ss_pred             eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          411 DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ..++||||+++ +|.+++.    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            78999999975 7877773    34889999999999999999999   6999999999999999999999999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            65432  22344679999999999999999999999999999999999999998643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-37  Score=344.50  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=205.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4568999999999999999999999899999999986542   3456778999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---CCCCCeEEeeecccee
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKL  491 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---~~~~~~kL~DFGla~~  491 (652)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||+   +.++.+||+|||+++.
T Consensus       104 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999998854  345899999999999999999999   6999999999999999   4678899999999986


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI  571 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  571 (652)
                      ....  .......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+   ....+..           
T Consensus       179 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~-----------  241 (484)
T 3nyv_A          179 FEAS--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEK-----------  241 (484)
T ss_dssp             BCCC--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH-----------
T ss_pred             cccc--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHc-----------
Confidence            6433  23345679999999998865 68999999999999999999999997643211   1111100           


Q ss_pred             ccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          572 DPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       572 d~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                           +.+          .       +.........+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       242 -----~~~----------~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          242 -----GKY----------T-------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             -----CCC----------C-------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             -----CCC----------C-------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence                 000          0       000011234568899999999999999995      7888763

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.3e-37  Score=311.69  Aligned_cols=197  Identities=20%  Similarity=0.367  Sum_probs=172.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeecc--CeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|++.  ++.||+|++...  .....+.+.+|+.++++++||||+++++++...  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            467999999999999999999985  688999999764  334557799999999999999999999999877  78899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce--EEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV--VIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ||||+++|+|.+++.......+++..++.++.|++.||.|||   +++  ++||||||+|||++.++.++|+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999997665557999999999999999999999   678  999999999999999999999999987643


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCC---ccchHhHHHHHHHHHhCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSA---SSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..      ....||+.|+|||.+.+...+.   ++||||||+++|||++|+.||...
T Consensus       164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  214 (271)
T 3kmu_A          164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL  214 (271)
T ss_dssp             SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred             cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            22      2346899999999988765544   799999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-36  Score=314.56  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=204.1

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---------hhhHHHHHHHHHHhcccC-cCceeEEEeee
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---------KQGVREFVSEIATIGRLR-HRNLVQLVGWC  406 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  406 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....         ....+.+.+|+.++++++ ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999999899999999986542         123456889999999996 99999999999


Q ss_pred             eccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       407 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      ...+..++||||+++++|.+++..  ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999999853  346899999999999999999999   799999999999999999999999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCC------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHh
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPR------TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWG  560 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~  560 (652)
                      |++.......  ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||......   .....+..
T Consensus       169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~  243 (298)
T 1phk_A          169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRMIMS  243 (298)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred             cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHHHHhc
Confidence            9998765432  334457899999999874      456889999999999999999999999653211   11110000


Q ss_pred             hhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          561 KYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       561 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                                                ....      .+.+ ......+.+.+|+.+|+..+|++|+      .|+||...
T Consensus       244 --------------------------~~~~------~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          244 --------------------------GNYQ------FGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             --------------------------TCCC------CCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             --------------------------CCcc------cCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence                                      0000      0000 1113346789999999999999999      45777653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4e-37  Score=327.41  Aligned_cols=255  Identities=19%  Similarity=0.239  Sum_probs=190.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCC-----CeEEEEEEecCcchhhH-----------HHHHHHHHHhcccCcCceeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNS-----KTEVAVKRISNESKQGV-----------REFVSEIATIGRLRHRNLVQ  401 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  401 (652)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456899999999999999999998764     47899999876542211           12445667788889999999


Q ss_pred             EEeeeecc----CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-
Q 038860          402 LVGWCRRK----GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-  476 (652)
Q Consensus       402 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-  476 (652)
                      +++++...    ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            99998765    4589999999 99999998543 356999999999999999999999   68999999999999999 


Q ss_pred             -CCCCeEEeeeccceecccCCCC------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          477 -SELNGKLGDFGLAKLYEHGTNP------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       477 -~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                       .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999876433211      123456999999999999999999999999999999999999999864332


Q ss_pred             cchhHHHHHHhhhcCCcccccccccccc-C-CCHHHHHHhhccCCCCCCCCCC
Q 038860          550 EELVLVDWVWGKYGEGRVLEVIDPKLNA-E-YDQSQVLMGELELPDTLRGPRS  600 (652)
Q Consensus       550 ~~~~l~~~~~~~~~~~~~~~~id~~l~~-~-~~~~~~~~~~l~~~~~~~~p~~  600 (652)
                      ..  ......... ...+.+++++++.. . ......++..+...++..||..
T Consensus       268 ~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~  317 (364)
T 3op5_A          268 PK--YVRDSKIRY-RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLY  317 (364)
T ss_dssp             HH--HHHHHHHHH-HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             HH--HHHHHHHHh-hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCH
Confidence            22  122221111 12334445555421 2 2233344444445555566654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.7e-37  Score=342.06  Aligned_cols=254  Identities=24%  Similarity=0.429  Sum_probs=202.9

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-------------hhHHHHHHHHHHhcccCcCceeEEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-------------QGVREFVSEIATIGRLRHRNLVQLV  403 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~  403 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.....             ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            456789999999999999999999999999999999875421             2346789999999999999999999


Q ss_pred             eeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC---C
Q 038860          404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL---N  480 (652)
Q Consensus       404 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~---~  480 (652)
                      +++.+.+..++||||+++|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++   .
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999998844  346999999999999999999999   69999999999999998775   6


Q ss_pred             eEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHh
Q 038860          481 GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWG  560 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~  560 (652)
                      +||+|||+++......  ......||+.|+|||++. +.++.++||||+||++|+|++|+.||......+   +...+..
T Consensus       188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~  261 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIKKVEK  261 (504)
T ss_dssp             EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHc
Confidence            9999999998765432  334457999999999876 468999999999999999999999997643211   1111100


Q ss_pred             hhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          561 KYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       561 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                          +.        .  .+...                   ......+.+.+|+.+|+..+|++|++      |+|+...
T Consensus       262 ----~~--------~--~~~~~-------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          262 ----GK--------Y--YFDFN-------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             ----CC--------C--CCCHH-------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             ----CC--------C--CCCcc-------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence                00        0  00000                   00123468899999999999999995      6788764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.6e-37  Score=316.68  Aligned_cols=199  Identities=21%  Similarity=0.311  Sum_probs=172.5

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...  ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            356899999999999999999999988999999999764  234456788999999999 89999999999999999999


Q ss_pred             EEEeccCCCcccccccCC--ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC--------------
Q 038860          415 VYDFMANGSLDSFLFDEP--KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE--------------  478 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~--------------  478 (652)
                      ||||+++++|.+++....  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999995432  256899999999999999999999   7999999999999999844              


Q ss_pred             -----CCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          479 -----LNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       479 -----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                           ..+||+|||++.......     ...||+.|+|||.+.+. .++.++|||||||++|||++|.+|+.
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                 479999999998764322     23589999999998766 56689999999999999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-37  Score=341.46  Aligned_cols=254  Identities=23%  Similarity=0.393  Sum_probs=203.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  ......+.+|+.++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4568999999999999999999999889999999986532  23456789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC---CCCCeEEeeeccceec
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLY  492 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~---~~~~~kL~DFGla~~~  492 (652)
                      |||+++|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999999988844  346899999999999999999999   79999999999999995   4567999999999866


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      ...  .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+   ....+..            
T Consensus       175 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~------------  236 (486)
T 3mwu_A          175 QQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVET------------  236 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH------------
T ss_pred             CCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh------------
Confidence            433  23344579999999999875 58999999999999999999999997643211   1111100            


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCc
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGV  635 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~  635 (652)
                          +.+          ..       .........+.+.+|+.+|+..+|++|++      |+|+....
T Consensus       237 ----~~~----------~~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          237 ----GKY----------AF-------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ----TCC----------CS-------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ----CCC----------CC-------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                000          00       00011233568899999999999999995      67887643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=338.30  Aligned_cols=202  Identities=24%  Similarity=0.377  Sum_probs=155.2

Q ss_pred             cCccc-cccccccCceEEEEEEEc--CCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeee--ccCeeEE
Q 038860          340 NNFSA-KQLLGHGGFGQVYKGTLH--NSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR--RKGDLLL  414 (652)
Q Consensus       340 ~~f~~-~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  414 (652)
                      +.|++ .++||+|+||.||+|.+.  .+++.||+|++.....  ...+.+|+.++++++||||+++++++.  .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34655 457999999999999976  4578899999976432  246788999999999999999999994  4678999


Q ss_pred             EEEeccCCCcccccccC-------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe----CCCCCeEE
Q 038860          415 VYDFMANGSLDSFLFDE-------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL----DSELNGKL  483 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl----~~~~~~kL  483 (652)
                      ||||+++ +|.+++...       ....+++..++.++.||+.||.|||   +++|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999964 777776421       1234899999999999999999999   6999999999999999    67789999


Q ss_pred             eeeccceecccCCC--CceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          484 GDFGLAKLYEHGTN--PATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       484 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      +|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999987653222  223456899999999988774 58999999999999999999999997644

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.3e-37  Score=320.02  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=199.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            45689999999999999999999998899999999987766667889999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+++++|.+++... ...+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++....... 
T Consensus        97 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999999988542 345899999999999999999999   6899999999999999999999999999976432211 


Q ss_pred             CceeeccCCcCCCCCCCC-----CCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccc
Q 038860          498 PATTRVVGTLGYLAPETP-----RTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVID  572 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  572 (652)
                      .......||+.|+|||.+     ....++.++||||||+++|||++|+.||......+   ........           
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~-----------  237 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKS-----------  237 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS-----------
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHhcc-----------
Confidence            112234689999999987     46778999999999999999999999997533111   00000000           


Q ss_pred             cccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          573 PKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       573 ~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                                          .   .|.........+.+.+|+.+|+..+|++||+      |+|+...
T Consensus       238 --------------------~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          238 --------------------D---PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             --------------------C---CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             --------------------C---CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence                                0   0000111123457899999999999999996      6777654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-37  Score=325.83  Aligned_cols=265  Identities=25%  Similarity=0.340  Sum_probs=204.8

Q ss_pred             hcCccccccccccCceEEEEEEE----cCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeee--ccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR--RKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  412 (652)
                      .++|++.+.||+|+||.||++++    ..+++.||+|++........+.+.+|+.++++++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36899999999999999999994    5678999999998877777788999999999999999999999886  45678


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++++|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999999999999998543 235899999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          493 EHGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       493 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ......  ......||..|+|||.+.+..++.++||||||+++|||++|+.||......        ......       
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--------~~~~~~-------  242 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE--------FLRMMG-------  242 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--------HHHHCC-------
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch--------hhhhcc-------
Confidence            543321  123346788899999998888999999999999999999999998652110        000000       


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                          ..............+........|     ....+.+.+|+.+|+..+|++||+...+
T Consensus       243 ----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~el  294 (327)
T 3lxl_A          243 ----CERDVPALSRLLELLEEGQRLPAP-----PACPAEVHELMKLCWAPSPQDRPSFSAL  294 (327)
T ss_dssp             --------CCHHHHHHHHHHTTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----cccccccHHHHHHHhhcccCCCCC-----CcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence                011111112222222111111111     1234678899999999999999987554

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.3e-37  Score=315.49  Aligned_cols=254  Identities=26%  Similarity=0.412  Sum_probs=198.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|.....||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34556678999999999999999889999999998766666678999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCC-ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeEEeeeccceecccCCC
Q 038860          420 ANGSLDSFLFDEP-KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       420 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~kL~DFGla~~~~~~~~  497 (652)
                      ++++|.+++.... ...+++..+..++.|++.||.|||   +++|+||||||+|||++. ++.+||+|||+++..... .
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-N  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-C
Confidence            9999999986532 335678889999999999999999   689999999999999987 899999999999875432 2


Q ss_pred             CceeeccCCcCCCCCCCCCCCC--CCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGK--SSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                      .......||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.......... ..  .                
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~--~----------------  238 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FK--V----------------  238 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HH--H----------------
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hh--h----------------
Confidence            2233457899999999987643  7889999999999999999999996432211100 00  0                


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                                 .....  ....|     ....+.+.+|+.+|+..+|++||+      |+|+...
T Consensus       239 -----------~~~~~--~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          239 -----------GMFKV--HPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             -----------HHHCC--CCCCC-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             -----------ccccc--ccccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence                       00000  00001     123468899999999999999995      5777654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-37  Score=328.96  Aligned_cols=207  Identities=29%  Similarity=0.474  Sum_probs=179.5

Q ss_pred             hhcCccccccccccCceEEEEEEEcC-------CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeec
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRR  408 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  408 (652)
                      ..++|.+.+.||+|+||.||+|.+..       .+..||+|++.... ....+++.+|+++++++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            45689999999999999999999753       33679999997653 34557899999999999 89999999999999


Q ss_pred             cCeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceE
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVL  474 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NIL  474 (652)
                      .+..++||||+++|+|.+++....              ...+++..++.++.||+.||+|||   +++|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            999999999999999999986432              245899999999999999999999   689999999999999


Q ss_pred             eCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          475 LDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       475 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999986654322 22334567889999999999999999999999999999999 999997643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.4e-37  Score=313.60  Aligned_cols=244  Identities=28%  Similarity=0.447  Sum_probs=185.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch----hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK----QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|+..+.||+|+||.||+|.+.  ++.||+|++.....    ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3468999999999999999999985  68899999875432    23567889999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce---EEecCCCCCceEeCC--------CCCeE
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV---VIHRDVKASNVLLDS--------ELNGK  482 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~---ivHrDlk~~NILl~~--------~~~~k  482 (652)
                      +||||+++++|.+++.   ...+++..++.++.|++.||.|||   +++   |+||||||+|||++.        ++.+|
T Consensus        83 lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceE
Confidence            9999999999999983   346899999999999999999999   566   999999999999986        67899


Q ss_pred             EeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhh
Q 038860          483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY  562 (652)
Q Consensus       483 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  562 (652)
                      |+|||+++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   ...   ...
T Consensus       157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~  227 (271)
T 3dtc_A          157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAY---GVA  227 (271)
T ss_dssp             ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH---HHH
T ss_pred             EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---hhh
Confidence            99999998654322   224578999999999988889999999999999999999999997532111   000   000


Q ss_pred             cCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          563 GEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       563 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                      .                       ...      ..+.+   ....+.+.+++.+|+..+|++||++..
T Consensus       228 ~-----------------------~~~------~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e  263 (271)
T 3dtc_A          228 M-----------------------NKL------ALPIP---STCPEPFAKLMEDCWNPDPHSRPSFTN  263 (271)
T ss_dssp             T-----------------------SCC------CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             c-----------------------CCC------CCCCC---cccCHHHHHHHHHHhcCCcccCcCHHH
Confidence            0                       000      00011   122467899999999999999998754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-37  Score=319.88  Aligned_cols=196  Identities=26%  Similarity=0.433  Sum_probs=173.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCC-------eEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSK-------TEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      .++|++.+.||+|+||.||+|.+..++       ..||+|.+........+.+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467899999999999999999987655       5799999987776777889999999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC--------eEE
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN--------GKL  483 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~--------~kL  483 (652)
                      .++||||+++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999543 334899999999999999999999   799999999999999998877        999


Q ss_pred             eeeccceecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCC
Q 038860          484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPI  543 (652)
Q Consensus       484 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~  543 (652)
                      +|||++....     ......||+.|+|||.+.+ ..++.++||||||+++|||++|..|+
T Consensus       163 ~Dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          163 SDPGISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             CCCCSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ccCccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            9999986432     2234568999999999887 67899999999999999999965544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-37  Score=332.51  Aligned_cols=258  Identities=10%  Similarity=0.052  Sum_probs=184.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhccc--CcCceeEEE-------ee
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRL--RHRNLVQLV-------GW  405 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~  405 (652)
                      ....|+..+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.+  +||||++++       ++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            3456999999999999999999999889999999998753   23455677885544444  699988865       33


Q ss_pred             eecc-----------------CeeEEEEEeccCCCcccccccCCccccchHHH------hhhHHHHHHHHhhhccCccce
Q 038860          406 CRRK-----------------GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQR------FKIIKGVASGLLYLHEGYEQV  462 (652)
Q Consensus       406 ~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~i~~aL~~LH~~~~~~  462 (652)
                      +...                 ...++||||++ |+|.+++... ...+++..+      +.++.||+.||+|||   +++
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKG  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence            3222                 34799999998 8999999653 223566666      788899999999999   799


Q ss_pred             EEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCC
Q 038860          463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGR  540 (652)
Q Consensus       463 ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~  540 (652)
                      |+||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++|||||||++|||++|+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999986532    2224567899999999987  67999999999999999999999


Q ss_pred             CCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccC
Q 038860          541 RPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASS  620 (652)
Q Consensus       541 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~  620 (652)
                      .||..........        +      .  .....               ......+.........+.+.+|+.+|+..
T Consensus       291 ~Pf~~~~~~~~~~--------~------~--~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~  339 (371)
T 3q60_A          291 LPFGLVTPGIKGS--------W------K--RPSLR---------------VPGTDSLAFGSCTPLPDFVKTLIGRFLNF  339 (371)
T ss_dssp             CSTTBCCTTCTTC--------C------C--BCCTT---------------SCCCCSCCCTTSSCCCHHHHHHHHHHTCS
T ss_pred             CCCCCcCcccccc--------h------h--hhhhh---------------hccccccchhhccCCCHHHHHHHHHHcCC
Confidence            9997643221000        0      0  00000               00000011111123457899999999999


Q ss_pred             CCCCCCC------ccccccCc
Q 038860          621 SFDKTTS------CSYFENGV  635 (652)
Q Consensus       621 ~~~~r~s------~~~~~~~~  635 (652)
                      +|++|++      |+||++..
T Consensus       340 dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          340 DRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             STTTCCCHHHHTTSHHHHHHH
T ss_pred             ChhhCCCHHHHhcCHHHHHHH
Confidence            9999994      57777643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-37  Score=334.20  Aligned_cols=274  Identities=21%  Similarity=0.298  Sum_probs=198.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC------ee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG------DL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  412 (652)
                      ..+|++.+.||+|+||.||+|++..+++ ||+|++......    ..+|+.+++.++||||+++++++...+      ..
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3579999999999999999999987555 888887654322    236999999999999999999996543      37


Q ss_pred             EEEEEeccCCCcccccc-cCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-CCCCeEEeeeccce
Q 038860          413 LLVYDFMANGSLDSFLF-DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-SELNGKLGDFGLAK  490 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-~~~~~kL~DFGla~  490 (652)
                      ++||||++++.+..... ......+++..++.++.||+.||+|||   +++|+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            89999998744333221 123456899999999999999999999   79999999999999999 78999999999998


Q ss_pred             ecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          491 LYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       491 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      ......  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+....+....+......+ .
T Consensus       191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~-~  267 (394)
T 4e7w_A          191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI-K  267 (394)
T ss_dssp             ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH-H
T ss_pred             cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH-H
Confidence            764432  23345789999999988765 5899999999999999999999999875433332222221111111000 0


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCC---CcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRS---SDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~---~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      .+++.             ......+...+..   .......+.+.||+.+|+..+|++|++      |+||+..+.
T Consensus       268 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          268 TMNPN-------------YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHCGG-------------GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhChh-------------hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            01110             0111111111111   011224578999999999999999995      899987644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.6e-37  Score=314.48  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=203.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999999889999999996542   22346788999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999998543  45899999999999999999999   799999999999999999999999999999765432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                         ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+   ....+.            ..  
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~------------~~--  227 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THRRIV------------NV--  227 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH------------TT--
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHHHHh------------cc--
Confidence               2334578999999999999999999999999999999999999997532111   000000            00  


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                  ..      ..|     ....+.+.+++.+|+..+|++|++      |+|+..
T Consensus       228 ------------~~------~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          228 ------------DL------KFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             ------------CC------CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ------------cc------CCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence                        00      001     123467899999999999999995      567776

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.4e-37  Score=321.41  Aligned_cols=209  Identities=29%  Similarity=0.442  Sum_probs=180.7

Q ss_pred             hhhhcCccccccccccCceEEEEEEE-----cCCCeEEEEEEecCcch-hhHHHHHHHHHHhccc-CcCceeEEEeeeec
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTL-----HNSKTEVAVKRISNESK-QGVREFVSEIATIGRL-RHRNLVQLVGWCRR  408 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  408 (652)
                      ....++|++.+.||+|+||.||+|.+     ..+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34457899999999999999999985     34678899999976533 3457789999999999 89999999999999


Q ss_pred             cCeeEEEEEeccCCCcccccccCCc----------------cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCc
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPK----------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASN  472 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~N  472 (652)
                      .+..++||||+++|+|.+++.....                ..+++..++.++.|++.||.|||   +++|+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccce
Confidence            9999999999999999999864332                24899999999999999999999   6999999999999


Q ss_pred             eEeCCCCCeEEeeeccceecccCCCCc-eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          473 VLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       473 ILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ||++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999999999999999998765443221 223457889999999988899999999999999999999 999997643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=326.40  Aligned_cols=201  Identities=25%  Similarity=0.407  Sum_probs=167.5

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCc--CceeEEEeeeeccCee
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRH--RNLVQLVGWCRRKGDL  412 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~  412 (652)
                      ...++|++.+.||+|+||.||++.+. +++.||||++...  .....+.+.+|+.++.+++|  +||+++++++...+..
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            34567999999999999999999985 4889999998654  34455788999999999976  9999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||| +.+++|.+++..  ...+++.++..++.||+.||.|||   +++|+||||||+|||++ ++.+||+|||+++..
T Consensus        85 ~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            99999 457899999954  346899999999999999999999   68999999999999997 578999999999876


Q ss_pred             ccCCCC-ceeeccCCcCCCCCCCCCC-----------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          493 EHGTNP-ATTRVVGTLGYLAPETPRT-----------GKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       493 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            543322 2345679999999998754           6788999999999999999999999964

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=324.50  Aligned_cols=269  Identities=22%  Similarity=0.337  Sum_probs=187.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeee-----ccCee
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR-----RKGDL  412 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~  412 (652)
                      ..++|++.+.||+|+||.||+|+.  +++.||||++....... .....|+..+..++||||+++++.+.     .....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            457899999999999999999987  47899999997543322 11234444455689999999998543     23467


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccc---------eEEecCCCCCceEeCCCCCeEE
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ---------VVIHRDVKASNVLLDSELNGKL  483 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~---------~ivHrDlk~~NILl~~~~~~kL  483 (652)
                      ++||||+++|+|.+++..   ...++..++.++.||+.||.|||   +.         +|+||||||+|||++.++.+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            899999999999999943   34588999999999999999999   56         9999999999999999999999


Q ss_pred             eeeccceecccCCC-------CceeeccCCcCCCCCCCCCC-------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          484 GDFGLAKLYEHGTN-------PATTRVVGTLGYLAPETPRT-------GKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       484 ~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      +|||+++.......       .......||+.|+|||++.+       ..++.++|||||||++|||++|..|+......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987653221       12234579999999998876       34567899999999999999998776543221


Q ss_pred             cchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCC-CCcccccchhHHHHHhhhccCCCCCCCCc
Q 038860          550 EELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPR-SSDGDKAAEGFDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       550 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~-~~~~~~~~~~~~dLl~~~~~~~~~~r~s~  628 (652)
                      ....               ..+...........+..............|. ........+.+.+|+.+|+..+|++||++
T Consensus       242 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          242 PEYQ---------------MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             CCCC---------------CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hHHH---------------HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence            1100               0000001111111111111100011111111 11112344578999999999999999986


Q ss_pred             cc
Q 038860          629 SY  630 (652)
Q Consensus       629 ~~  630 (652)
                      .-
T Consensus       307 ~e  308 (336)
T 3g2f_A          307 QX  308 (336)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-37  Score=325.59  Aligned_cols=211  Identities=29%  Similarity=0.464  Sum_probs=181.5

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCe-----EEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeee
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKT-----EVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWC  406 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  406 (652)
                      +.....++|++.+.||+|+||.||+|.+..++.     .||+|.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            455667899999999999999999999876553     79999997653 34556789999999999 899999999999


Q ss_pred             eccCeeEEEEEeccCCCcccccccCC------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceE
Q 038860          407 RRKGDLLLVYDFMANGSLDSFLFDEP------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVL  474 (652)
Q Consensus       407 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NIL  474 (652)
                      ...+..++||||+++|+|.+++....            ...+++..++.++.|++.||.|||   +++|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence            99999999999999999999985422            235799999999999999999999   689999999999999


Q ss_pred             eCCCCCeEEeeeccceecccCCCCc-eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          475 LDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       475 l~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            9999999999999998765433221 233467889999999988899999999999999999998 999997643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.1e-38  Score=339.07  Aligned_cols=245  Identities=15%  Similarity=0.163  Sum_probs=189.8

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHH---HHhcccCcCceeEEE-------
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEI---ATIGRLRHRNLVQLV-------  403 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------  403 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+   .++++++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3457899999999999999999999888999999999743   334567889999   555666899999998       


Q ss_pred             eeeeccC-----------------eeEEEEEeccCCCcccccccCC-----ccccchHHHhhhHHHHHHHHhhhccCccc
Q 038860          404 GWCRRKG-----------------DLLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVASGLLYLHEGYEQ  461 (652)
Q Consensus       404 ~~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~  461 (652)
                      +++...+                 ..++||||+ +|+|.+++....     ...+++..++.++.||+.||+|||   ++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~  225 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY  225 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hC
Confidence            5554443                 278999999 679999985421     234556889999999999999999   68


Q ss_pred             eEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCC-----------CCCCccchHhHH
Q 038860          462 VVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG-----------KSSASSDVFAFG  530 (652)
Q Consensus       462 ~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDv~SlG  530 (652)
                      +|+||||||+|||++.++.+||+|||+++...    .......| +.|+|||++.+.           .++.++||||||
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999998532    23445577 999999998877           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhH
Q 038860          531 ALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGF  610 (652)
Q Consensus       531 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~  610 (652)
                      |++|||++|+.||......+..                +.+.+    ..                        ....+.+
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~----------------~~~~~----~~------------------------~~~~~~~  336 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGS----------------EWIFR----SC------------------------KNIPQPV  336 (377)
T ss_dssp             HHHHHHHHSSCCC------CCS----------------GGGGS----SC------------------------CCCCHHH
T ss_pred             HHHHHHHHCCCCCcccccccch----------------hhhhh----hc------------------------cCCCHHH
Confidence            9999999999999653221100                00000    00                        1224688


Q ss_pred             HHHHhhhccCCCCCCCC------ccccccC
Q 038860          611 DDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       611 ~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                      .+|+.+|+..+|++|++      |+||+..
T Consensus       337 ~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          337 RALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            99999999999999995      4666653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=315.34  Aligned_cols=204  Identities=25%  Similarity=0.391  Sum_probs=173.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc----hhhHHHHHHHHHHhcccCcCceeEEEeee--eccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES----KQGVREFVSEIATIGRLRHRNLVQLVGWC--RRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~  412 (652)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+....    ....+.+.+|+.++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999999889999999997643    23457789999999999999999999998  445678


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||++++ |.+++.......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 777775555567999999999999999999999   789999999999999999999999999999876


Q ss_pred             ccCCC-CceeeccCCcCCCCCCCCCCCC--CCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          493 EHGTN-PATTRVVGTLGYLAPETPRTGK--SSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       493 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ..... .......||+.|+|||.+.+..  .+.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD  216 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            43222 2234457899999999887644  377999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-37  Score=324.51  Aligned_cols=214  Identities=25%  Similarity=0.473  Sum_probs=182.8

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEE
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLV  403 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  403 (652)
                      +...+.....++|++.+.||+|+||.||+|.+.     .+++.||+|.+.... ......+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444566677889999999999999999999876     346789999997653 33456789999999999999999999


Q ss_pred             eeeeccCeeEEEEEeccCCCcccccccCC--------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          404 GWCRRKGDLLLVYDFMANGSLDSFLFDEP--------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       404 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      +++.+.+..++||||+++|+|.+++....        ...+++..++.++.|++.||.|||   +++|+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999985422        135789999999999999999999   6899999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          476 DSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            9999999999999986543221 12223456889999999988899999999999999999999 89998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.4e-37  Score=328.22  Aligned_cols=289  Identities=22%  Similarity=0.281  Sum_probs=196.3

Q ss_pred             hhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe-
Q 038860          333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD-  411 (652)
Q Consensus       333 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  411 (652)
                      .+.....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+..+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3455667899999999999999999999998899999999865432 22345678888889999999999999865433 


Q ss_pred             ------eEEEEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-CCCeE
Q 038860          412 ------LLLVYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-ELNGK  482 (652)
Q Consensus       412 ------~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-~~~~k  482 (652)
                            .++||||+++ +|...+..  .....+++..+..++.|++.||.|||. ++++|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999986 55444321  234568899999999999999999993 1489999999999999996 89999


Q ss_pred             EeeeccceecccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhh
Q 038860          483 LGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGK  561 (652)
Q Consensus       483 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  561 (652)
                      |+|||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....+.
T Consensus       173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            99999998765432  23345789999999988665 4899999999999999999999999875433222211111111


Q ss_pred             hcCCccccccccccccCCCHHHHHHhhccCCCCCCCCC----CCcccccchhHHHHHhhhccCCCCCCCC------cccc
Q 038860          562 YGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPR----SSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYF  631 (652)
Q Consensus       562 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~----~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~  631 (652)
                      ... .....+++.... .+          .......|.    ........+.+.+|+.+|+..+|++|++      |+||
T Consensus       251 ~~~-~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          251 PSR-EVLRKLNPSHTD-VD----------LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             CCH-HHHHHHCTTCCC-GG----------GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             CCH-HHHHhcccchhh-cc----------ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            100 011111111000 00          000000000    0111123568999999999999999994      7899


Q ss_pred             ccCcccc
Q 038860          632 ENGVSYP  638 (652)
Q Consensus       632 ~~~~~~~  638 (652)
                      .......
T Consensus       319 ~~~~~~~  325 (360)
T 3e3p_A          319 DELHDPA  325 (360)
T ss_dssp             GGGGCTT
T ss_pred             cccCCcc
Confidence            8864433

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.3e-37  Score=314.19  Aligned_cols=253  Identities=26%  Similarity=0.347  Sum_probs=186.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.++...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4578999999999999999999999889999999997652  22233445555668888999999999999999999999


Q ss_pred             EEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccc-eEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          416 YDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ-VVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      |||++ |+|.+++..  .....+++..++.++.|++.||.|||   ++ +|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 488777743  23457999999999999999999999   56 9999999999999999999999999999866


Q ss_pred             ccCCCCceeeccCCcCCCCCCCC----CCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETP----RTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      ....  ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........  .....          
T Consensus       161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~----------  226 (290)
T 3fme_A          161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQV----------  226 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHHHH----------
T ss_pred             cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--HHHHH----------
Confidence            4432  22334799999999985    566789999999999999999999999975322111  00000          


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                          +..... ..|.    ....+.+.+|+.+|+..+|++||+      |+||..
T Consensus       227 --------------------~~~~~~-~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          227 --------------------VEEPSP-QLPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             --------------------HHSCCC-CCCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             --------------------hccCCC-Cccc----ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence                                000000 0011    123467899999999999999994      567655

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=323.63  Aligned_cols=201  Identities=22%  Similarity=0.293  Sum_probs=167.5

Q ss_pred             hcCccccccccccCceEEEEEEEcC---CCeEEEEEEecCcchh-----------hHHHHHHHHHHhcccCcCceeEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNESKQ-----------GVREFVSEIATIGRLRHRNLVQLVG  404 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  404 (652)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|+.......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4689999999999999999999976   6788999998765321           1134678888999999999999999


Q ss_pred             eeec----cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-
Q 038860          405 WCRR----KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-  479 (652)
Q Consensus       405 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-  479 (652)
                      ++..    ....++||||+ +++|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            9987    67899999999 99999999543  37999999999999999999999   68999999999999999887 


Q ss_pred             -CeEEeeeccceecccCCC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          480 -NGKLGDFGLAKLYEHGTN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       480 -~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                       .+||+|||+++.+.....      .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence             999999999987643221      112445799999999999998999999999999999999999999965

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=316.60  Aligned_cols=203  Identities=29%  Similarity=0.467  Sum_probs=174.2

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....  ..+++.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999999889999999997643  3467889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++.. ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999999843 2346899999999999999999999   7999999999999999999999999999998765432


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                       .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  228 (314)
T 3com_A          180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI  228 (314)
T ss_dssp             -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             2233457899999999999889999999999999999999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.2e-37  Score=328.01  Aligned_cols=199  Identities=25%  Similarity=0.406  Sum_probs=167.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccC--cCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLR--HRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  414 (652)
                      ..+|++.+.||+|+||.||++.+.. ++.||||++...  .....+.+.+|+.++++++  ||||+++++++...+..++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            3569999999999999999999876 889999998654  3445678999999999996  5999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||| +.+++|.+++...  ..+++..+..++.||+.||.|||   +++|+||||||+|||++ ++.+||+|||+++....
T Consensus       134 v~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             EEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            999 5688999998543  36888999999999999999999   79999999999999996 57899999999987654


Q ss_pred             CCCC-ceeeccCCcCCCCCCCCCC-----------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 GTNP-ATTRVVGTLGYLAPETPRT-----------GKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||..
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence            3221 2345679999999998754           4688899999999999999999999965

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.5e-37  Score=321.82  Aligned_cols=209  Identities=27%  Similarity=0.408  Sum_probs=164.1

Q ss_pred             hhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeee----
Q 038860          333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCR----  407 (652)
Q Consensus       333 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~----  407 (652)
                      +.+.....+|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++.++. ||||+++++++.    
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            344455678999999999999999999999889999999997766666778999999999996 999999999983    


Q ss_pred             ----ccCeeEEEEEeccCCCccccccc-CCccccchHHHhhhHHHHHHHHhhhccCccce--EEecCCCCCceEeCCCCC
Q 038860          408 ----RKGDLLLVYDFMANGSLDSFLFD-EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV--VIHRDVKASNVLLDSELN  480 (652)
Q Consensus       408 ----~~~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDlk~~NILl~~~~~  480 (652)
                          .....++||||++ |+|.+++.. .....+++..++.++.||+.||.|||   ..+  |+||||||+|||++.++.
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSC
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCC
Confidence                3446899999996 699888854 23446999999999999999999999   677  999999999999999999


Q ss_pred             eEEeeeccceecccCCCC-----------ceeeccCCcCCCCCCCC---CCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          481 GKLGDFGLAKLYEHGTNP-----------ATTRVVGTLGYLAPETP---RTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      +||+|||+++........           ......||+.|+|||.+   .+..++.++|||||||++|||++|+.||..
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            999999999876543221           11234689999999998   566788999999999999999999999964

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.5e-37  Score=316.61  Aligned_cols=205  Identities=26%  Similarity=0.432  Sum_probs=173.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEcC---CCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      ...++|++.+.||+|+||.||+|.+..   .+..||+|.+... .....+.+.+|+.++++++||||+++++++.++ ..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            345789999999999999999998754   3456999999765 334567899999999999999999999998754 57


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        88 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            8999999999999998543 345899999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence            5443333344567889999999988889999999999999999998 99999753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.9e-37  Score=314.01  Aligned_cols=205  Identities=23%  Similarity=0.335  Sum_probs=171.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeee-eccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWC-RRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~  416 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......  .++.+|+.+++.++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999999888999999987554322  3577899999999988877766665 5667789999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---CCCCCeEEeeeccceecc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---~~~~~~kL~DFGla~~~~  493 (652)
                      ||+ +++|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 89999998532 345899999999999999999999   7999999999999999   788999999999999765


Q ss_pred             cCCC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          494 HGTN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       494 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      ....      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  221 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence            4432      1233567999999999999999999999999999999999999999865443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=316.24  Aligned_cols=198  Identities=29%  Similarity=0.484  Sum_probs=165.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|.+...  ...+.+.+|+.++++++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            357889999999999999999885  588999999754  345678999999999999999999999874  47999999


Q ss_pred             ccCCCcccccccCCc-cccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC-eEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFDEPK-AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN-GKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~-~kL~DFGla~~~~~~~  496 (652)
                      +++|+|.+++..... ..+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999965432 34788999999999999999999533389999999999999998876 799999999755322 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                         .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence               23346899999999999999999999999999999999999999754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=327.62  Aligned_cols=200  Identities=21%  Similarity=0.268  Sum_probs=172.2

Q ss_pred             hcCccccccccccCceEEEEEEEcC--------CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeE---------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN--------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQ---------  401 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  401 (652)
                      .++|++.+.||+|+||.||+|.+..        .++.||+|.+...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999986        3789999998754     35778999999999999987         


Q ss_pred             ------EEeeeec-cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceE
Q 038860          402 ------LVGWCRR-KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVL  474 (652)
Q Consensus       402 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NIL  474 (652)
                            +++++.. .+..++||||+ +++|.+++.......+++..++.++.||+.||.|||   +++|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  5666665 67889999999 999999997654567999999999999999999999   689999999999999


Q ss_pred             eCCCC--CeEEeeeccceecccCCC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          475 LDSEL--NGKLGDFGLAKLYEHGTN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       475 l~~~~--~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ++.++  .+||+|||+++.......      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  899999999987643221      1123457999999999999999999999999999999999999999865


Q ss_pred             C
Q 038860          547 A  547 (652)
Q Consensus       547 ~  547 (652)
                      .
T Consensus       272 ~  272 (352)
T 2jii_A          272 L  272 (352)
T ss_dssp             T
T ss_pred             C
Confidence            4

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.5e-37  Score=319.04  Aligned_cols=258  Identities=23%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeee----ccCe
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCR----RKGD  411 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~  411 (652)
                      ....++|++.+.||+|+||.||++.+..+++.||+|++........+.+.+|+.++++++||||+++++++.    ....
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            345578999999999999999999998889999999997766667788999999999999999999999986    3457


Q ss_pred             eEEEEEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          412 LLLVYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      .++||||+++|+|.+++...  ....+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            89999999999999988542  3456999999999999999999999   689999999999999999999999999998


Q ss_pred             eecccCCCC--------ceeeccCCcCCCCCCCCCCCC---CCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHH
Q 038860          490 KLYEHGTNP--------ATTRVVGTLGYLAPETPRTGK---SSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWV  558 (652)
Q Consensus       490 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~  558 (652)
                      .........        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||........       
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------  254 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-------  254 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-------
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-------
Confidence            764321111        012345799999999987654   68899999999999999999999853110000       


Q ss_pred             HhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccccc
Q 038860          559 WGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYFEN  633 (652)
Q Consensus       559 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~~~  633 (652)
                                           ...........      .|..   ....+.+.+|+.+|+..+|++||+...+-.
T Consensus       255 ---------------------~~~~~~~~~~~------~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  299 (317)
T 2buj_A          255 ---------------------SVALAVQNQLS------IPQS---PRHSSALWQLLNSMMTVDPHQRPHIPLLLS  299 (317)
T ss_dssp             ---------------------CHHHHHHCC--------CCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------hhhHHhhccCC------CCcc---ccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                                 00001111000      0111   122467889999999999999998765443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.9e-37  Score=316.41  Aligned_cols=264  Identities=27%  Similarity=0.372  Sum_probs=200.1

Q ss_pred             hcCccccccccccCceEEEEEE----EcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc--Ce
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGT----LHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  411 (652)
                      .+.|++.+.||+|+||.||+|.    ...+++.||+|++.... ....+.+.+|+.++++++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3568899999999999999999    45678999999997543 33457789999999999999999999999876  66


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++||||+++++|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            89999999999999998543 345899999999999999999999   79999999999999999999999999999987


Q ss_pred             cccCCC--CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          492 YEHGTN--PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       492 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      ......  .......||..|+|||.+.+..++.++||||||+++|||++|+.|+....     ....   ...       
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~---~~~-------  240 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFL---KMI-------  240 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHH---HHH-------
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHh---hcc-------
Confidence            654332  12234568889999999988889999999999999999999999865311     1000   000       


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                        .+.. .... .......+......  +.+   ....+.+.+|+.+|+..+|++|+++..
T Consensus       241 --~~~~-~~~~-~~~~~~~~~~~~~~--~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~  292 (302)
T 4e5w_A          241 --GPTH-GQMT-VTRLVNTLKEGKRL--PCP---PNCPDEVYQLMRKCWEFQPSNRTSFQN  292 (302)
T ss_dssp             --CSCC-GGGH-HHHHHHHHHTTCCC--CCC---TTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             --CCcc-cccC-HHHHHHHHhccCCC--CCC---CCCCHHHHHHHHHHcCCCCCCCCCHHH
Confidence              0000 1111 11111111111111  111   123468999999999999999998764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-36  Score=312.67  Aligned_cols=204  Identities=23%  Similarity=0.336  Sum_probs=174.6

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeee-eccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWC-RRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~  416 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......  +++.+|+.++++++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999999888999999998654332  4578899999999988876666655 5567789999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---CCCCCeEEeeeccceecc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---~~~~~~kL~DFGla~~~~  493 (652)
                      ||+ +++|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            999 89999998532 346999999999999999999999   7999999999999999   478899999999998765


Q ss_pred             cCCCC------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          494 HGTNP------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       494 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                      .....      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  220 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  220 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence            54321      23456799999999999999999999999999999999999999986543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-36  Score=316.56  Aligned_cols=202  Identities=25%  Similarity=0.377  Sum_probs=171.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--------hhHHHHHHHHHHhcccCcCceeEEEeeeecc
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--------QGVREFVSEIATIGRLRHRNLVQLVGWCRRK  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  409 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+.....        .....+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            34679999999999999999999999999999999865421        2234588999999999999999999998765


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC---eEEeee
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN---GKLGDF  486 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~---~kL~DF  486 (652)
                      . .++||||+++++|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            4 8999999999999998853  446899999999999999999999   799999999999999987654   999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCC---CCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETP---RTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      |+++.....  .......||+.|+|||++   ....++.++|||||||++|||++|+.||....
T Consensus       162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            999875432  122345799999999986   35678999999999999999999999997643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-37  Score=313.59  Aligned_cols=202  Identities=32%  Similarity=0.514  Sum_probs=176.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+++.+|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4678999999999999999999874 67899999976533 346789999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++++|.+++... ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++........
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            9999999998543 345899999999999999999999   799999999999999999999999999999865332111


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  209 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence            2233457889999999988889999999999999999999 89999753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.6e-37  Score=322.30  Aligned_cols=207  Identities=28%  Similarity=0.471  Sum_probs=177.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEc-------CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeee
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLH-------NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCR  407 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  407 (652)
                      ...++|++.+.||+|+||.||+|.+.       .++..||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34578999999999999999999975       346789999997653 34567789999999999 8999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCce
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNV  473 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NI  473 (652)
                      ..+..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||   +++|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence            9999999999999999999996533              234899999999999999999999   79999999999999


Q ss_pred             EeCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          474 LLDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       474 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      |++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            999999999999999987654321 12233457889999999988889999999999999999999 99999754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-36  Score=314.73  Aligned_cols=205  Identities=26%  Similarity=0.436  Sum_probs=167.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            346799999999999999999999888999999999753   34456778999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccc--CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          415 VYDFMANGSLDSFLFD--EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ||||+++++|.+++..  .....+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999998853  23456899999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            4322 2233457899999999999999999999999999999999999999753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-37  Score=314.26  Aligned_cols=205  Identities=29%  Similarity=0.490  Sum_probs=174.8

Q ss_pred             hhcCccccc-cccccCceEEEEEEEc--CCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQ-LLGHGGFGQVYKGTLH--NSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ..++|.+.+ .||+|+||.||+|.+.  .++..||+|.+.... ....+++.+|+.++++++||||+++++++ ..+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            345677776 8999999999999864  457889999998753 44567899999999999999999999999 456789


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++++|.+++... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            999999999999998543 346899999999999999999999   7999999999999999999999999999998765


Q ss_pred             cCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          494 HGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       494 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      .....  ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  218 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  218 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            43221  1223456889999999988889999999999999999998 999997643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-36  Score=310.31  Aligned_cols=201  Identities=26%  Similarity=0.485  Sum_probs=169.6

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3468999999999999999999999889999999996542   2335678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++..  ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++.....
T Consensus        89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           89 VMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999999854  345899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCC
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ..  ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            22  2234578999999999887765 6899999999999999999999975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.4e-37  Score=315.60  Aligned_cols=252  Identities=27%  Similarity=0.465  Sum_probs=186.3

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...++|++.+.||+|+||.||+|++..   .||+|++...  .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l   96 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   96 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence            345789999999999999999998753   5999998654  3445678999999999999999999999664 456899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999988543 346899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CC-CCceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          495 GT-NPATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       495 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      .. ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||......+.  +...+....    .   
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~----~---  243 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGS----L---  243 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTS----C---
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcccc----c---
Confidence            22 22334457999999999876   56788899999999999999999999976433211  111110000    0   


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                          .+..     ........+.+.+|+.+|+..+|++||+...
T Consensus       244 --------------------~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  278 (289)
T 3og7_A          244 --------------------SPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPR  278 (289)
T ss_dssp             --------------------CCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --------------------Ccch-----hhccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence                                0000     0011123467889999999999999998654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.4e-37  Score=314.99  Aligned_cols=204  Identities=26%  Similarity=0.437  Sum_probs=174.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeee--ccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCR--RKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+...  .....+.+.+|+.++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46899999999999999999999988999999999754  3345567899999999999999999999874  4568999


Q ss_pred             EEEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCccce-----EEecCCCCCceEeCCCCCeEEeeec
Q 038860          415 VYDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGYEQV-----VIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-----ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      ||||+++++|.+++...  ....+++..++.++.|++.||.|||   +.+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998542  2345899999999999999999999   577     9999999999999999999999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      +++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence            998654321 1123457899999999998888999999999999999999999999754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.5e-37  Score=318.12  Aligned_cols=215  Identities=29%  Similarity=0.440  Sum_probs=182.1

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEE
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQL  402 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  402 (652)
                      +...+.....++|++.+.||+|+||.||+|.+.     .+++.||+|++.... ....+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            344555666789999999999999999999853     456889999997653 33456789999999999 79999999


Q ss_pred             EeeeeccC-eeEEEEEeccCCCcccccccCCc--------------cccchHHHhhhHHHHHHHHhhhccCccceEEecC
Q 038860          403 VGWCRRKG-DLLLVYDFMANGSLDSFLFDEPK--------------AVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD  467 (652)
Q Consensus       403 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrD  467 (652)
                      ++++...+ ..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||   +++|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99987754 58999999999999999965432              22889999999999999999999   68999999


Q ss_pred             CCCCceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          468 VKASNVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       468 lk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      |||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876543322 2234567899999999988899999999999999999998 9999976


Q ss_pred             CC
Q 038860          546 RA  547 (652)
Q Consensus       546 ~~  547 (652)
                      ..
T Consensus       254 ~~  255 (316)
T 2xir_A          254 VK  255 (316)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.3e-37  Score=319.56  Aligned_cols=203  Identities=30%  Similarity=0.507  Sum_probs=172.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEE--EEEEecCc-chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEV--AVKRISNE-SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|.+..++..+  |+|.+... .....+.+.+|+.+++++ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999998877755  99998754 233456789999999999 89999999999999999999


Q ss_pred             EEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC
Q 038860          415 VYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN  480 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~  480 (652)
                      ||||+++++|.+++....              ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999996532              246899999999999999999999   799999999999999999999


Q ss_pred             eEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          481 GKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +||+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  245 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  245 (327)
T ss_dssp             EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence            999999999743321  12233457889999999988889999999999999999998 99999754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.6e-37  Score=313.36  Aligned_cols=198  Identities=26%  Similarity=0.461  Sum_probs=175.1

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec---------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR---------  408 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  408 (652)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++.....    .+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            34679999999999999999999998899999999976542    45689999999999999999998854         


Q ss_pred             -------cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          409 -------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       409 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                             ....++||||+++++|.+++.......+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   455899999999999999997655567999999999999999999999   6899999999999999999999


Q ss_pred             EEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      ||+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus       162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            999999998765432  2334579999999999998899999999999999999999998864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-36  Score=322.32  Aligned_cols=200  Identities=23%  Similarity=0.349  Sum_probs=172.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-----------cCceeEEEeeee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-----------HRNLVQLVGWCR  407 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  407 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999999998889999999997543 34466788999998886           899999999987


Q ss_pred             ccC----eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccc-eEEecCCCCCceEeC------
Q 038860          408 RKG----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ-VVIHRDVKASNVLLD------  476 (652)
Q Consensus       408 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDlk~~NILl~------  476 (652)
                      ..+    ..++||||+ +++|.+++.......+++..++.++.||+.||+|||   ++ +|+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 889999997655566999999999999999999999   67 999999999999994      


Q ss_pred             CCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          477 SELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       477 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      ..+.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            4457999999999876432    233478999999999999999999999999999999999999997644

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.5e-37  Score=320.96  Aligned_cols=204  Identities=25%  Similarity=0.435  Sum_probs=168.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeE----EEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTE----VAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|++.+.||+|+||.||+|.+..+++.    ||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            46899999999999999999998776654    577777543 3345678999999999999999999999998764 78


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|+||+++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999998653 345899999999999999999999   7999999999999999999999999999998764


Q ss_pred             cCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          494 HGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       494 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      .... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  224 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            3322 22233457889999999999999999999999999999999 999997644

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-36  Score=315.33  Aligned_cols=212  Identities=27%  Similarity=0.472  Sum_probs=169.8

Q ss_pred             hhhhhhhhcCccccccccccCceEEEEEEEcC---CCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeee
Q 038860          332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWC  406 (652)
Q Consensus       332 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  406 (652)
                      +.++....++|.+.+.||+|+||.||+|.+..   ++..||+|.+...  .....+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34455567889999999999999999998764   4568999998754  344557799999999999999999999999


Q ss_pred             eccC-----eeEEEEEeccCCCccccccc----CCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC
Q 038860          407 RRKG-----DLLLVYDFMANGSLDSFLFD----EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS  477 (652)
Q Consensus       407 ~~~~-----~~~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~  477 (652)
                      ...+     ..++||||+++++|.+++..    .....+++..++.++.|++.||.|||   +++|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcC
Confidence            7754     35999999999999998842    23456999999999999999999999   799999999999999999


Q ss_pred             CCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          478 ELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       478 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            99999999999986644322 22334467889999999999999999999999999999999 88998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-36  Score=317.68  Aligned_cols=204  Identities=30%  Similarity=0.567  Sum_probs=169.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCC----CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS----KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .++|+..+.||+|+||.||+|.+..+    +..||+|.+.... ......+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            45788889999999999999998654    3469999997653 344567899999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++++|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       123 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999998543 346899999999999999999999   6899999999999999999999999999998765


Q ss_pred             cCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          494 HGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       494 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      .....  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  254 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL  254 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence            43221  1223356789999999988899999999999999999999 99999653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.5e-37  Score=345.43  Aligned_cols=208  Identities=32%  Similarity=0.512  Sum_probs=178.5

Q ss_pred             hhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       333 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .......++|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            3344556789999999999999999999976 5679999997653 235679999999999999999999999976 678


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++|+|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            99999999999999996544456899999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ............++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~  468 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  468 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4321111223456789999999988899999999999999999999 99999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-36  Score=313.57  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=196.4

Q ss_pred             hhhhhhcCccccc-cccccCceEEEEEEE--cCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeec
Q 038860          334 ELKQATNNFSAKQ-LLGHGGFGQVYKGTL--HNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRR  408 (652)
Q Consensus       334 el~~~~~~f~~~~-~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  408 (652)
                      ++....++|.+.+ .||+|+||.||+|.+  ..+++.||||++....  ....+++.+|+.++++++||||+++++++ .
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            3444557888888 999999999999965  4557889999997653  23457799999999999999999999999 5


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      .+..++||||+++++|.+++..  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence            5678999999999999999954  345899999999999999999999   68999999999999999999999999999


Q ss_pred             ceecccCCCCc--eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCC
Q 038860          489 AKLYEHGTNPA--TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEG  565 (652)
Q Consensus       489 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  565 (652)
                      ++.........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+   ....    ...+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~  236 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAM----LEKG  236 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTT
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC
Confidence            98765433211  222356789999999988888999999999999999999 999997633211   1110    0000


Q ss_pred             ccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          566 RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       566 ~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                                 .....|     ....+.+.+++.+|+..+|++||+...+
T Consensus       237 ---------------------------~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l  270 (291)
T 1xbb_A          237 ---------------------------ERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAV  270 (291)
T ss_dssp             ---------------------------CCCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ---------------------------CCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                                       000001     1234678899999999999999986543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.9e-36  Score=315.10  Aligned_cols=203  Identities=29%  Similarity=0.437  Sum_probs=169.2

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcc--cCcCceeEEEeeee
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGR--LRHRNLVQLVGWCR  407 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  407 (652)
                      ..........++|++.+.||+|+||.||+|++.  ++.||||++....   .+.+.+|.+++..  ++||||+++++++.
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            333344455678999999999999999999984  7899999996543   3567778888877  78999999999998


Q ss_pred             ccC----eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCc-----cceEEecCCCCCceEeCCC
Q 038860          408 RKG----DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY-----EQVVIHRDVKASNVLLDSE  478 (652)
Q Consensus       408 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivHrDlk~~NILl~~~  478 (652)
                      ...    ..++||||+++|+|.+++..   ..+++..++.++.|++.||.|||...     +.+|+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence            775    78999999999999999943   35899999999999999999999321     4899999999999999999


Q ss_pred             CCeEEeeeccceecccCCCC---ceeeccCCcCCCCCCCCCCCC------CCCccchHhHHHHHHHHHhCC
Q 038860          479 LNGKLGDFGLAKLYEHGTNP---ATTRVVGTLGYLAPETPRTGK------SSASSDVFAFGALLLEVACGR  540 (652)
Q Consensus       479 ~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~SlGvvl~elltG~  540 (652)
                      +.+||+|||+++........   ......||+.|+|||.+.+..      ++.++|||||||++|||++|.
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~  254 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC  254 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence            99999999999876544321   123457999999999887653      336899999999999999993

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.8e-36  Score=328.96  Aligned_cols=208  Identities=22%  Similarity=0.308  Sum_probs=176.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCc-CceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH-RNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.++||+|+||.||+|.+..+++.||||++......  .++..|+++++.++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999999888999999988654322  347789999999976 566666667777788999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe---CCCCCeEEeeeccceeccc
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL---DSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl---~~~~~~kL~DFGla~~~~~  494 (652)
                      |+ +++|.+++... ...+++..++.|+.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 89999998532 346999999999999999999999   7999999999999999   5789999999999997654


Q ss_pred             CCCC------ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchh
Q 038860          495 GTNP------ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV  553 (652)
Q Consensus       495 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~  553 (652)
                      ....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~  223 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ  223 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence            3321      2235689999999999999999999999999999999999999998765544433

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.5e-36  Score=315.80  Aligned_cols=259  Identities=21%  Similarity=0.307  Sum_probs=177.0

Q ss_pred             hhcCccccc-cccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec----cCee
Q 038860          338 ATNNFSAKQ-LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR----KGDL  412 (652)
Q Consensus       338 ~~~~f~~~~-~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  412 (652)
                      ..++|.+.+ .||+|+||.||+|.+..+++.||+|++...... .++   ....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-RQE---VDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH-HHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH-HHH---HHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            457888855 699999999999999988999999999764221 122   2233556689999999999876    4568


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeeccc
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGLA  489 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGla  489 (652)
                      ++||||+++|+|.+++.......+++.+++.++.|++.||.|||   +++|+||||||+|||++.+   +.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999997665567999999999999999999999   7899999999999999864   55999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      +.....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........                
T Consensus       179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------------  239 (336)
T 3fhr_A          179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------------  239 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------------
Confidence            865432   2334578999999999988889999999999999999999999996532211000                


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcccc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVSYP  638 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~~~  638 (652)
                          ......     ......      .|... .....+.+.+|+.+|+..+|++|++      |+|+......+
T Consensus       240 ----~~~~~~-----~~~~~~------~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          240 ----GMKRRI-----RLGQYG------FPNPE-WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             --------------------C------CCTTT-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             ----hHHHhh-----hccccc------cCchh-hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence                000000     000000      01111 1134568899999999999999994      56887754433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-36  Score=317.19  Aligned_cols=206  Identities=30%  Similarity=0.497  Sum_probs=171.8

Q ss_pred             hhcCccccccccccCceEEEEEE-----EcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGT-----LHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD  411 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  411 (652)
                      ..++|++.+.||+|+||.||+|.     ...++..||||.+... ......++.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            45789999999999999999998     4456788999999754 34455678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCcccccccCC-----ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCeEE
Q 038860          412 LLLVYDFMANGSLDSFLFDEP-----KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKL  483 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~kL  483 (652)
                      .++||||+++++|.+++....     ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999996432     245899999999999999999999   799999999999999984   456999


Q ss_pred             eeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          484 GDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       484 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  249 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  249 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence            99999986543322 22334578999999999988899999999999999999998 99999753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=340.99  Aligned_cols=205  Identities=28%  Similarity=0.478  Sum_probs=170.4

Q ss_pred             hhcCccccc-cccccCceEEEEEEEc--CCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          338 ATNNFSAKQ-LLGHGGFGQVYKGTLH--NSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       338 ~~~~f~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ..+++.+.+ .||+|+||.||+|.+.  .++..||||+++... ....+++.+|+.+|++++||||++++++|.. +..+
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            344555555 7999999999999876  346779999997653 3456789999999999999999999999976 5689


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       412 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999999999543 446999999999999999999999   6999999999999999999999999999998764


Q ss_pred             cCCCCc--eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          494 HGTNPA--TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       494 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ......  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  544 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  544 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            332211  222345789999999998999999999999999999998 999997643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-36  Score=308.43  Aligned_cols=200  Identities=28%  Similarity=0.401  Sum_probs=170.1

Q ss_pred             CccccccccccCceEEEEEEEcCCC---eEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee-EEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSK---TEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL-LLV  415 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV  415 (652)
                      .|+..++||+|+||.||+|.+..++   ..||+|.+.... ....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5666799999999999999975543   379999997643 34567899999999999999999999999876655 999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+.+|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999553 456899999999999999999999   689999999999999999999999999999865332


Q ss_pred             C---CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          496 T---NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       496 ~---~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      .   ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~  229 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY  229 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence            1   122334567899999999999999999999999999999999665543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=318.19  Aligned_cols=266  Identities=25%  Similarity=0.399  Sum_probs=202.4

Q ss_pred             hcCccccccccccCceEEEEEEE----cCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC--ee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG--DL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  412 (652)
                      .++|++.+.||+|+||.||++.+    ..+++.||+|++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45789999999999999999984    4578999999998876677788999999999999999999999987654  78


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999999543 245899999999999999999999   799999999999999999999999999999876


Q ss_pred             ccCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          493 EHGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       493 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....        .............+.
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--------~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--------AEFMRMIGNDKQGQM  267 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--------HHHHHHHCTTCCTHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--------HHHHHhhccccchhh
Confidence            543321  1223457788999999988889999999999999999999999986421        000011110000000


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                ....+...+....  +.|.+   ....+.+.+|+.+|+..+|++||+...+
T Consensus       268 ----------~~~~~~~~~~~~~--~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~el  313 (326)
T 2w1i_A          268 ----------IVFHLIELLKNNG--RLPRP---DGCPDEIYMIMTECWNNNVNQRPSFRDL  313 (326)
T ss_dssp             ----------HHHHHHHHHHTTC--CCCCC---TTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ----------hHHHHHHHhhcCC--CCCCC---CcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence                      0001111111111  11111   1234688999999999999999987543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-36  Score=317.73  Aligned_cols=200  Identities=30%  Similarity=0.445  Sum_probs=171.8

Q ss_pred             cCc-cccccccccCceEEEEEEE----cCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc--Ce
Q 038860          340 NNF-SAKQLLGHGGFGQVYKGTL----HNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK--GD  411 (652)
Q Consensus       340 ~~f-~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  411 (652)
                      ++| ++.+.||+|+||.||++.+    ..+++.||||++.... ....+.+.+|+.++++++||||+++++++...  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            445 8999999999999988865    3467899999997653 34567799999999999999999999999874  57


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++||||+++|+|.+++..   ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            8999999999999999943   34899999999999999999999   79999999999999999999999999999997


Q ss_pred             cccCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          492 YEHGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       492 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .......  ......||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            6543321  22334678899999999888899999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-36  Score=321.13  Aligned_cols=204  Identities=30%  Similarity=0.471  Sum_probs=163.1

Q ss_pred             cCccccccccccCceEEEEEEEcCC---CeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeec-cCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR-KGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  414 (652)
                      ..|+..+.||+|+||.||+|.+...   +..||+|.+... .....+++.+|+.++++++||||++++++|.. .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            3567788999999999999987532   346899998754 33456789999999999999999999998754 567899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++... ...+++..++.++.||++||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999999543 345889999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCC---CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          495 GTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       495 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ...   .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||....
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~  301 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  301 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence            221   12234467889999999999999999999999999999999 677776543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.2e-36  Score=309.32  Aligned_cols=204  Identities=30%  Similarity=0.475  Sum_probs=169.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCC---CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeee-ccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCR-RKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~  413 (652)
                      ..+|++.+.||+|+||.||+|.+..+   ...||+|.+.... ....+.+.+|+.++++++||||++++++|. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            45788899999999999999997542   3468999987643 345577999999999999999999999864 456789


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999999543 345889999999999999999999   7999999999999999999999999999998654


Q ss_pred             cCCC---CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          494 HGTN---PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       494 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ....   .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence            3221   22334567889999999988899999999999999999999 55566543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-36  Score=310.18  Aligned_cols=244  Identities=31%  Similarity=0.454  Sum_probs=189.7

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeecc-CeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-GDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~  416 (652)
                      ..++|++.+.||+|+||.||++.+.  ++.||+|.+....  ..+.+.+|+.++++++||||+++++++... +..++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            4578999999999999999999875  6899999997643  456789999999999999999999997554 5789999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+++++|.+++.......+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..... 
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            9999999999996554445899999999999999999999   799999999999999999999999999999854432 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+   ....    ...+          
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~----~~~~----------  230 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKG----------  230 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTT----------
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcC----------
Confidence               223357889999999988899999999999999999998 999997543211   1110    0000          


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                       .....|     ....+.+.+++.+|+..+|++||+..-+
T Consensus       231 -----------------~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l  264 (278)
T 1byg_A          231 -----------------YKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQL  264 (278)
T ss_dssp             -----------------CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -----------------CCCCCc-----ccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence                             000000     1224678899999999999999986543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-35  Score=310.05  Aligned_cols=202  Identities=31%  Similarity=0.407  Sum_probs=153.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHH-HhcccCcCceeEEEeeeeccCeeEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIA-TIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++.... .....++..|+. +++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3578999999999999999999999889999999997653 333455666666 77888999999999999999999999


Q ss_pred             EEeccCCCccccccc---CCccccchHHHhhhHHHHHHHHhhhccCccc-eEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          416 YDFMANGSLDSFLFD---EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ-VVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      |||+++ +|.+++..   .....+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999975 77776632   23456899999999999999999999   56 999999999999999999999999999986


Q ss_pred             cccCCCCceeeccCCcCCCCCCCC----CCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETP----RTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....  ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            54322  22334799999999998    456789999999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-35  Score=306.46  Aligned_cols=196  Identities=27%  Similarity=0.473  Sum_probs=164.2

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec---------
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR---------  408 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  408 (652)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346799999999999999999999888999999999653 3455778999999999999999999998754         


Q ss_pred             ----cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          409 ----KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       409 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                          .+..++||||+++++|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence                45789999999999999999643 345788999999999999999999   6899999999999999999999999


Q ss_pred             eeccceecccCC-------------CCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHh
Q 038860          485 DFGLAKLYEHGT-------------NPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVAC  538 (652)
Q Consensus       485 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~ellt  538 (652)
                      |||+++......             ........||+.|+|||.+.+. .++.++|||||||++|||++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            999998654321             1122345789999999998764 68999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.5e-36  Score=335.56  Aligned_cols=276  Identities=26%  Similarity=0.368  Sum_probs=204.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeec------cCe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR------KGD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  411 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999888999999998764 34456779999999999999999999999765      667


Q ss_pred             eEEEEEeccCCCcccccccCC-ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCC---eEEeeec
Q 038860          412 LLLVYDFMANGSLDSFLFDEP-KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELN---GKLGDFG  487 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~---~kL~DFG  487 (652)
                      .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999996532 336899999999999999999999   699999999999999997765   9999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      +++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     ..|..........
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence            998765432  234467999999999999999999999999999999999999999753211     1111111100111


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCc------cccccCc
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC------SYFENGV  635 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~------~~~~~~~  635 (652)
                      .......+.+..          ........|. .......+.+.+|+.+|+..+|++|+++      +||++..
T Consensus       243 ~~~~~~~l~g~~----------~~~~~lp~p~-~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          243 HIVVYDDLTGAV----------KFSSVLPTPN-HLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             -CCSCCCCSSSC----------CCCSSSCCSC-CCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhhhhhhcccc----------ccccccCCch-hhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            111111111111          1111111121 1223456789999999999999999977      6777643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3e-36  Score=342.65  Aligned_cols=241  Identities=28%  Similarity=0.412  Sum_probs=188.2

Q ss_pred             ccccccCceEEEEEEEc--CCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLH--NSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      +.||+|+||.||+|.+.  ..++.||||+++...  ....+++.+|+.++++++||||++++++|.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999664  456889999997653  2346789999999999999999999999965 468899999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC--Cc
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN--PA  499 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~--~~  499 (652)
                      |+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus       454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            999999943  346899999999999999999999   79999999999999999999999999999987654332  22


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   ....    ...+             
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~----i~~~-------------  588 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAM----LEKG-------------  588 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTT-------------
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC-------------
Confidence            333457889999999999999999999999999999998 999997643211   1110    0000             


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                .      +.+.+   ....+.+.+|+.+|+..+|++||+...+
T Consensus       589 ----------~------~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l  622 (635)
T 4fl3_A          589 ----------E------RMGCP---AGCPREMYDLMNLCWTYDVENRPGFAAV  622 (635)
T ss_dssp             ----------C------CCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ----------C------CCCCC---CCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence                      0      00001   1223678899999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8e-36  Score=306.45  Aligned_cols=202  Identities=28%  Similarity=0.475  Sum_probs=176.0

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44578999999999999999999998889999999986543  2345778999999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC---CCeEEeeecccee
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE---LNGKLGDFGLAKL  491 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~---~~~kL~DFGla~~  491 (652)
                      |+||+++++|.+++..  ...+++..++.++.||+.||.|||   +++++||||||+||+++.+   +.+||+|||++..
T Consensus        99 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           99 VGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999999988854  345899999999999999999999   7899999999999999764   4699999999986


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      .....  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (287)
T 2wei_A          174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK  225 (287)
T ss_dssp             BCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence            54332  2234468999999998765 4899999999999999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-35  Score=307.54  Aligned_cols=212  Identities=25%  Similarity=0.406  Sum_probs=171.7

Q ss_pred             CCcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccC--cCceeE
Q 038860          326 GPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLR--HRNLVQ  401 (652)
Q Consensus       326 ~~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~  401 (652)
                      ....+.++.+....++|++.+.||+|+||.||++.+.. ++.||+|.+...  .....+.+.+|+.++.+++  |+||++
T Consensus        14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             ------CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            44566677777778899999999999999999999865 788999998653  3445678899999999997  599999


Q ss_pred             EEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          402 LVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       402 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                      +++++...+..++||| +.+++|.+++...  ..+++..++.++.|++.||.|||   +++|+||||||+|||+++ +.+
T Consensus        93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~  165 (313)
T 3cek_A           93 LYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GML  165 (313)
T ss_dssp             EEEEEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEE
T ss_pred             EEEEeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeE
Confidence            9999999999999999 5678999998543  46899999999999999999999   789999999999999965 799


Q ss_pred             EEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCC-----------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          482 KLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRT-----------GKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ||+|||+++........ ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||..
T Consensus       166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            99999999876443221 2234578999999998765           4678899999999999999999999965

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-35  Score=305.45  Aligned_cols=203  Identities=29%  Similarity=0.420  Sum_probs=164.7

Q ss_pred             hcCccccccccccCceEEEEEEEcC-CC--eEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-SK--TEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .++|++.+.||+|+||.||+|.+.. ++  ..||+|+++..   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4689999999999999999998643 22  36999998754   2345678999999999999999999999998765 8


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ++|+||+++++|.+++... ...+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            8999999999999998543 345899999999999999999999   689999999999999999999999999999876


Q ss_pred             ccCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          493 EHGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       493 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ......  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  228 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL  228 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence            543221  1223467889999999988888999999999999999999 99999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5e-35  Score=304.61  Aligned_cols=202  Identities=27%  Similarity=0.376  Sum_probs=153.3

Q ss_pred             hhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...++|+..+.||+|+||.||+|.+..+++.||||++.....  ...+.+.++..+++.++||||+++++++...+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            345789999999999999999999998899999999976432  223344455567788899999999999999999999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccc-eEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ-VVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      ||||+ ++.+. .+.......+++..++.++.|++.||.|||   .+ +|+||||||+|||++.++.+||+|||++....
T Consensus       102 v~e~~-~~~~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          102 AMELM-GTCAE-KLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EECCC-SEEHH-HHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEecc-CCcHH-HHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            99999 43444 343333456899999999999999999999   54 99999999999999999999999999997654


Q ss_pred             cCCCCceeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          494 HGTNPATTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ...  ......||+.|+|||.+.     ...++.++||||||+++|||++|+.||..
T Consensus       177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            322  233457899999999884     45688999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=308.51  Aligned_cols=245  Identities=24%  Similarity=0.381  Sum_probs=190.2

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh------hHHHHHHHHHHhccc----CcCceeEEEee
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ------GVREFVSEIATIGRL----RHRNLVQLVGW  405 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~  405 (652)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999999888999999999764321      223456789988888    89999999999


Q ss_pred             eeccCeeEEEEEe-ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-CCCCeEE
Q 038860          406 CRRKGDLLLVYDF-MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-SELNGKL  483 (652)
Q Consensus       406 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-~~~~~kL  483 (652)
                      +...+..++|+|| +++++|.+++..  ...+++..++.++.||+.||.|||   +.+|+||||||+||+++ .++.+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            9999999999999 789999999954  345899999999999999999999   79999999999999999 7899999


Q ss_pred             eeeccceecccCCCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhh
Q 038860          484 GDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY  562 (652)
Q Consensus       484 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  562 (652)
                      +|||+++.....   ......||..|+|||++.+..+ +.++||||||+++|||++|+.||....     .    .    
T Consensus       182 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~----~----  245 (312)
T 2iwi_A          182 IDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E----I----  245 (312)
T ss_dssp             CCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H----H----
T ss_pred             EEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H----H----
Confidence            999999876542   2334568999999998876665 458999999999999999999996410     0    0    


Q ss_pred             cCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          563 GEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       563 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                                            ......      .|     ....+.+.+++.+|+..+|++|++      |+|+...
T Consensus       246 ----------------------~~~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          246 ----------------------LEAELH------FP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             ----------------------HHTCCC------CC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             ----------------------hhhccC------Cc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence                                  000000      01     123457889999999999999995      5688774

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-35  Score=310.09  Aligned_cols=245  Identities=23%  Similarity=0.390  Sum_probs=198.8

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchh------hHHHHHHHHHHhcccC--cCceeEEEeeee
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQ------GVREFVSEIATIGRLR--HRNLVQLVGWCR  407 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~  407 (652)
                      ....++|++.+.||+|+||.||+|.+..+++.||||.+......      ..+.+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567899999999999999999999988999999999654321      2245667999999996  599999999999


Q ss_pred             ccCeeEEEEEeccC-CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC-CCCCeEEee
Q 038860          408 RKGDLLLVYDFMAN-GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD-SELNGKLGD  485 (652)
Q Consensus       408 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~-~~~~~kL~D  485 (652)
                      ..+..++|+|++.+ ++|.+++..  ...+++..++.++.|++.||+|||   +++|+||||||+|||++ .++.+||+|
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            99999999999976 899998844  346899999999999999999999   79999999999999999 778999999


Q ss_pred             eccceecccCCCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          486 FGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       486 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      ||+++.....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....        ...      
T Consensus       194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~------  256 (320)
T 3a99_A          194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EII------  256 (320)
T ss_dssp             CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH------
T ss_pred             Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhh------
Confidence            9999876532   2334579999999998877665 678999999999999999999996420        000      


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                             .              .....           .....+.+.+|+.+|+..+|++||+      ++|+.+.
T Consensus       257 -------~--------------~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          257 -------R--------------GQVFF-----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             -------H--------------CCCCC-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             -------c--------------ccccc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence                   0              00000           0122467899999999999999995      5587764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-35  Score=337.52  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=196.4

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcC---CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeecc
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHN---SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK  409 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  409 (652)
                      +.....++|++.+.||+|+||.||+|.+..   .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            334455788999999999999999999864   34679999987643 3445679999999999999999999999854 


Q ss_pred             CeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                      +..++||||+++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            5689999999999999999543 345899999999999999999999   689999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +..............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+   ....+..    +   
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~----~---  608 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN----G---  608 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHH----T---
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc----C---
Confidence            8765443333444567889999999988899999999999999999997 999997643211   1111000    0   


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                                .+.|.+   ....+.+.+|+.+|+..+|++||+...
T Consensus       609 --------------------------~~~~~~---~~~~~~l~~li~~~l~~dP~~RPs~~e  641 (656)
T 2j0j_A          609 --------------------------ERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTE  641 (656)
T ss_dssp             --------------------------CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --------------------------CCCCCC---ccccHHHHHHHHHHcCCChhHCcCHHH
Confidence                                      000011   122457889999999999999998654

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=100.00  E-value=3.5e-34  Score=286.03  Aligned_cols=198  Identities=18%  Similarity=0.188  Sum_probs=151.4

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCC-CCCcCcEEEEEccCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYP-RLGGHGLAFTISPSNDL  113 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~-~~~gdGlaF~l~p~~~~  113 (652)
                      .++.++|+|.+. +|.|+||++.+++.||+||+.|+++        +||+|+|+|+|.++.. ..+||||||+|+|... 
T Consensus        25 ~~~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~--------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~-   94 (253)
T 2dur_A           25 PLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFL--------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRL-   94 (253)
T ss_dssp             CSEEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCC--------SSEEEEEEEEEECCCCTTCCCCEEEEEEESCCS-
T ss_pred             CCEEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCcc--------CcEEEEEEEEEecCCCCCcCCCcEEEEEECCCC-
Confidence            699999999995 9999999999999999999999997        4899999999998765 5789999999999764 


Q ss_pred             CCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCC----CCcccCCc-CC
Q 038860          114 NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDN----STKQDLSL-KG  188 (652)
Q Consensus       114 ~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~----~~~~~~~~-~~  188 (652)
                        ..|++||+.+       .++.|||||||++|.++  ++  |++++|+++.+..+..+....++    ...-...+ +.
T Consensus        95 --~~G~~lG~~~-------~~~gvAVefDT~~n~~~--~~--~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~~n~  161 (253)
T 2dur_A           95 --VPGPVFGSKD-------NFHGLAIFLDTYPNDET--TE--RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNR  161 (253)
T ss_dssp             --CEETBTEECS-------SCEEEEEEEECSCCCTT--CC--SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCCBTC
T ss_pred             --CCCcccCcCC-------CCCEEEEEEECCCCCCC--CC--CCCcEEEEEecCCceeeeccCCCcccccccccHhhccC
Confidence              3578999632       35779999999999743  32  67777777666554432100011    00012234 45


Q ss_pred             CceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccccccceeeccccccc
Q 038860          189 GKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKIN  260 (652)
Q Consensus       189 g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~~~  260 (652)
                      |+.++|||+|++.  +|+|.+++.+..+..+++  .++ ...||+++||||||+||...+.|.|++|+|..-
T Consensus       162 g~~~~v~I~Y~~~--~L~V~l~~~~~~~~~~~~--~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl  228 (253)
T 2dur_A          162 DHDTFLAVRYSRG--RLTVMTDLEDKNEWKNCI--DIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL  228 (253)
T ss_dssp             SSCEEEEEEEETT--EEEEEEECSSSSCCEEEE--EEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred             CCCeEEEEEEECC--EEEEEEeCCCCCCceEEE--EeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence            8899999999965  899999975543333433  344 345899999999999999999999999999753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=309.13  Aligned_cols=209  Identities=31%  Similarity=0.457  Sum_probs=171.6

Q ss_pred             cchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          330 YSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      ...++.....++|++.+.||+|+||.||+|.+.+   .||+|.+....  ....+.+.+|+.++++++||||+++++++.
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM   99 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            3345555667899999999999999999999864   49999986542  223355778999999999999999999999


Q ss_pred             ccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          408 RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       408 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      ..+..++||||+++++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||
T Consensus       100 ~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          100 SPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             CSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             cCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecC
Confidence            999999999999999999999543 346899999999999999999999   68999999999999998 6799999999


Q ss_pred             cceecccCC----CCceeeccCCcCCCCCCCCCC---------CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          488 LAKLYEHGT----NPATTRVVGTLGYLAPETPRT---------GKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       488 la~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      +++......    ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            987643211    122233468999999998764         45788999999999999999999999753

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-34  Score=333.06  Aligned_cols=193  Identities=22%  Similarity=0.343  Sum_probs=167.8

Q ss_pred             hcCccccccccccCceEEEEEEEcC-CCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCe-----
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHN-SKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGD-----  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  411 (652)
                      .++|++.+.||+|+||.||+|.+.. +++.||||++... .......+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4789999999999999999999975 6899999998654 33455678999999999999999999999987665     


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .||||||+++++|.+++..    .+++.+++.++.||+.||.|||   +++|+||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999988732    6999999999999999999999   6999999999999999986 899999999987


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      ....     ....||+.|+|||++.++. +.++|||||||++|||++|.+|+..
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            6432     3457999999999887654 8899999999999999999988864

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=100.00  E-value=1.9e-34  Score=253.77  Aligned_cols=114  Identities=35%  Similarity=0.520  Sum_probs=105.4

Q ss_pred             ccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCC
Q 038860          134 NHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNS  213 (652)
Q Consensus       134 ~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~  213 (652)
                      ||+|||||||++|.+++||++||||||+||+.|.+++++            ++.+|+.++|||+||+.+++|+|++++.+
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~------------~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~   68 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW------------DWQNGKIATAHISYNSVSKRLSVTSYYAG   68 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------------CCCTTSCEEEEEEEETTTTEEEEEEECSS
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee------------EEcCCCEEEEEEEEeCCCcEEEEEEccCC
Confidence            588999999999999889999999999999999988864            36799999999999999999999999765


Q ss_pred             CCCCCCeeeEEecCCcccccceEEEEecccccccccceeecccccccC
Q 038860          214 SKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKING  261 (652)
Q Consensus       214 ~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~~~~  261 (652)
                      .+  .|+|+..+||+++||++|||||||+||...+.|.|++|+|++..
T Consensus        69 ~~--~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l  114 (133)
T 1qmo_E           69 SK--PATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL  114 (133)
T ss_dssp             SC--CEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred             Cc--cceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence            43  78999999999999999999999999999999999999998763

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-34  Score=313.92  Aligned_cols=199  Identities=24%  Similarity=0.362  Sum_probs=155.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      +.|...+.||+|+||+||.+.. .+++.||||++....   .+.+.+|+.++.++ +||||+++++++...+..++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            3445578899999999987544 458999999986542   34577899999887 899999999999999999999999


Q ss_pred             ccCCCcccccccCCcc-----ccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-------------CC
Q 038860          419 MANGSLDSFLFDEPKA-----VLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-------------LN  480 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~-----~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-------------~~  480 (652)
                      ++ |+|.+++......     ..++..++.++.||+.||+|||   +++|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 6999998543221     1234456789999999999999   6999999999999999754             47


Q ss_pred             eEEeeeccceecccCCCC---ceeeccCCcCCCCCCCCCC-------CCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          481 GKLGDFGLAKLYEHGTNP---ATTRVVGTLGYLAPETPRT-------GKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       481 ~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      +||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||...
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            999999999976543321   1234579999999998865       668999999999999999999 99999653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=314.91  Aligned_cols=202  Identities=24%  Similarity=0.391  Sum_probs=159.4

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeE
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  413 (652)
                      +.....+|+..+.||+|+||+||.... .+++.||||++......   .+.+|+.+++++ +||||+++++++.+.+..+
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            344556799999999999999654333 35789999999764322   245799999999 7999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-----CCCeEEeeecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-----ELNGKLGDFGL  488 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-----~~~~kL~DFGl  488 (652)
                      +||||++ |+|.+++.... ..+.+..++.++.||+.||.|||   +++|+||||||+|||++.     ...+||+|||+
T Consensus        95 lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            9999996 59999986543 23555667889999999999999   699999999999999953     24588999999


Q ss_pred             ceecccCCC--CceeeccCCcCCCCCCCCC---CCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 038860          489 AKLYEHGTN--PATTRVVGTLGYLAPETPR---TGKSSASSDVFAFGALLLEVAC-GRRPIET  545 (652)
Q Consensus       489 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~SlGvvl~ellt-G~~p~~~  545 (652)
                      ++.......  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||..
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            987654321  2334467999999999987   4567889999999999999999 9999864

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=100.00  E-value=1.2e-33  Score=282.78  Aligned_cols=191  Identities=17%  Similarity=0.193  Sum_probs=150.2

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      .++.++|+|.+ .+|.|+||++.+++.||+||+.|+++        ++|+|+|+|+|..++ ..+||||||+|+|...  
T Consensus        49 ~~w~~~G~a~i-~~~~IrLT~~~~~~~G~~w~~~p~~~--------~sF~t~F~F~I~~~~-~~~gdGlAF~l~~~~~--  116 (260)
T 1gv9_A           49 PFWAHAGNAIP-SADQIRIAPSLKSQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTENQG--  116 (260)
T ss_dssp             TTEEEEETCEE-CSSCEEEECSSTTCEEEEEESSCBCC--------SSEEEEEEEEEECSS-SCCCCEEEEEEESSCC--
T ss_pred             CCeEEcccEEe-eCCEEEeCCCCCCCEEEEEECCCccc--------cCEEEEEEEEEecCC-CCCCCeEEEEEecCCC--
Confidence            69999999999 48999999999999999999999964        689999999999764 4689999999999754  


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCCC-CC------CCCceeeecCC-ccccceeecceecCCCCcccCCc
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQ-DI------NDNHIGIDINS-MKSNASVEAAVYTDNSTKQDLSL  186 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~hvgi~~ns-~~s~~~~~~~~~~~~~~~~~~~~  186 (652)
                       .+|++||+.       ..++.|||||||+.|.++. +|      +++|+|||+|+ +.|.....+          ...+
T Consensus       117 -~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~~~~c----------~~~~  178 (260)
T 1gv9_A          117 -LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASC----------QRDF  178 (260)
T ss_dssp             -CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCSEEE----------CCCC
T ss_pred             -CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccceeecc----------Chhh
Confidence             367888983       2456799999999997431 22      46788888775 544433332          1223


Q ss_pred             -CCCceEEEEEEEcCCCCeEEEEEeeCCCCCC--CCeeeEEecCCcccccceEEEEecccccccccceeecccccc
Q 038860          187 -KGGKAILVWVDYDSAENILNVTVSPNSSKPK--IPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKI  259 (652)
Q Consensus       187 -~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~--~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~~  259 (652)
                       ++|..++|||+|++.  +|+|.+.+.. ++.  ...++..+| ...||+++||||||+||...+.|.|++|+|..
T Consensus       179 ~n~g~~~~~~I~Y~~~--~L~V~l~~~~-~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~~e~hdIlsw~~~~  250 (260)
T 1gv9_A          179 RNKPYPVRAKITYYQK--TLTVMINNGF-TPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFLTFQ  250 (260)
T ss_dssp             BSCSSCEEEEEEEETT--EEEEEEECSS-CCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEEEEE
T ss_pred             ccCCCcEEEEEEEECC--EEEEEEeecc-CCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCCcceEEEEEEEEEE
Confidence             358899999999986  8999998642 222  235777888 67799999999999999999999999999964

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.9e-35  Score=314.95  Aligned_cols=202  Identities=16%  Similarity=0.201  Sum_probs=159.3

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHhcccCc-Ccee-----------
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK---QGVREFVSEIATIGRLRH-RNLV-----------  400 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv-----------  400 (652)
                      ...+..|...+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.+++.++| +|..           
T Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred             CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence            3445568888999999999999999998999999999874322   235678999999999976 2211           


Q ss_pred             ----E------EEeeeec-----cCeeEEEEEeccCCCcccccc-----cCCccccchHHHhhhHHHHHHHHhhhccCcc
Q 038860          401 ----Q------LVGWCRR-----KGDLLLVYDFMANGSLDSFLF-----DEPKAVLNWEQRFKIIKGVASGLLYLHEGYE  460 (652)
Q Consensus       401 ----~------l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~  460 (652)
                          .      +..++..     ....+++|+++ +++|.+++.     ......+++..++.++.||++||+|||   +
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~  229 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---H  229 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence                1      1111111     12356777765 679998883     233556899999999999999999999   7


Q ss_pred             ceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCC----------CCCCCCCccchHhHH
Q 038860          461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP----------RTGKSSASSDVFAFG  530 (652)
Q Consensus       461 ~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDv~SlG  530 (652)
                      ++|+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++||||||
T Consensus       230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             CCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence            99999999999999999999999999999865432    344577 999999988          556688899999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 038860          531 ALLLEVACGRRPIETR  546 (652)
Q Consensus       531 vvl~elltG~~p~~~~  546 (652)
                      |++|||++|+.||...
T Consensus       305 vil~elltg~~Pf~~~  320 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDD  320 (413)
T ss_dssp             HHHHHHHHSSCCCCTT
T ss_pred             HHHHHHHHCCCCCCCc
Confidence            9999999999999753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-33  Score=292.31  Aligned_cols=240  Identities=21%  Similarity=0.305  Sum_probs=184.0

Q ss_pred             hhcCcccc-ccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHh-cccCcCceeEEEeeeec----cCe
Q 038860          338 ATNNFSAK-QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATI-GRLRHRNLVQLVGWCRR----KGD  411 (652)
Q Consensus       338 ~~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~  411 (652)
                      ..++|.+. +.||+|+||.||++.+..+++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            34677777 7899999999999999988999999999653     3456788887 55589999999999876    678


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCeEEeeecc
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGL  488 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~kL~DFGl  488 (652)
                      .++||||+++|+|.+++.......+++..++.++.|++.||.|||   +++|+||||||+|||++.   ++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            899999999999999997665567999999999999999999999   799999999999999998   78899999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +....                       +..++.++|||||||++|||++|+.||........           .. .+.
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~-~~~  211 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SP-GMK  211 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------C-CSC
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hH-HHH
Confidence            87532                       23467799999999999999999999965322110           00 000


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccccCC
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSYPSL  640 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~~~~  640 (652)
                      .   ......+                ..|.. ......+.+.+|+.+|+..+|++|+      .|+|+......+.+
T Consensus       212 ~---~~~~~~~----------------~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~  269 (299)
T 3m2w_A          212 T---RIRMGQY----------------EFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  269 (299)
T ss_dssp             C---SSCTTCC----------------SSCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred             H---HHhhccc----------------cCCch-hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence            0   0000000                00000 0012356899999999999999999      57788775544433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.8e-35  Score=307.17  Aligned_cols=192  Identities=20%  Similarity=0.218  Sum_probs=159.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--------hhhHHHHHHHHHHhcccC---------cCceeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--------KQGVREFVSEIATIGRLR---------HRNLVQ  401 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~  401 (652)
                      .++|++.+.||+|+||.||+|++  +++.||||++....        ....+.+.+|+.++++++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46789999999999999999998  47999999997542        223467888999888886         666666


Q ss_pred             EEee-----------------eec-------------cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHH
Q 038860          402 LVGW-----------------CRR-------------KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG  451 (652)
Q Consensus       402 l~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~a  451 (652)
                      +.+.                 +..             .+..++||||+++|++.+.+.+   ..+++..++.++.||+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            6654                 332             6789999999999987766632   458999999999999999


Q ss_pred             HhhhccCccceEEecCCCCCceEeCCCC--------------------CeEEeeeccceecccCCCCceeeccCCcCCCC
Q 038860          452 LLYLHEGYEQVVIHRDVKASNVLLDSEL--------------------NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA  511 (652)
Q Consensus       452 L~~LH~~~~~~ivHrDlk~~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~a  511 (652)
                      |+|||+  +++|+||||||+|||++.++                    .+||+|||+|+.....      ...||+.|+|
T Consensus       174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred             HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence            999993  38999999999999999887                    8999999999976532      3479999999


Q ss_pred             CCCCCCCCCCCccchHhHHHH-HHHHHhCCCCCC
Q 038860          512 PETPRTGKSSASSDVFAFGAL-LLEVACGRRPIE  544 (652)
Q Consensus       512 PE~~~~~~~s~~sDv~SlGvv-l~elltG~~p~~  544 (652)
                      ||++.+.. +.++||||++++ .+++++|..||.
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            99988766 889999998777 777888998884

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-33  Score=290.27  Aligned_cols=174  Identities=14%  Similarity=0.143  Sum_probs=153.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999999889999999997653   33457899999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||+++++|.+++...    ....++.+++.|++.||+|||   +++|+||||||+|||++.++.+||+++|        
T Consensus       110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            9999999999998432    344568889999999999999   7999999999999999999999997433        


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                                   |++|       ++.++|||||||++|||++|+.||....
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                         3333       6889999999999999999999998643

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.97  E-value=1e-30  Score=255.26  Aligned_cols=116  Identities=33%  Similarity=0.529  Sum_probs=106.8

Q ss_pred             cccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeC
Q 038860          133 SNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPN  212 (652)
Q Consensus       133 ~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~  212 (652)
                      .||+|||||||++|.+|+||++|||||||||+.|.++++|            ++.+|+.++|||+||+.+++|+|++++.
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~   68 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW------------NMQNGKVGTAHIIYNSVDKRLSAVVSYP   68 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC------------CCCTTCEEEEEEEEETTTTEEEEEEECT
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc------------cccCCCEEEEEEEEeCCCCEEEEEEecC
Confidence            3789999999999999899999999999999999988865            3679999999999999999999999876


Q ss_pred             CCCCCCCeeeEEecCCcccccceEEEEecccccccccceeecccccccCC
Q 038860          213 SSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGP  262 (652)
Q Consensus       213 ~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~~~~~  262 (652)
                      +.  ..|+|+..+||+++|+++|||||||+||...+.|+|++|+|++..+
T Consensus        69 ~~--~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~  116 (237)
T 1nls_A           69 NA--DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK  116 (237)
T ss_dssp             TS--CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred             CC--CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEeccc
Confidence            54  5789999999999999999999999999999999999999987643

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.96  E-value=2.6e-29  Score=216.04  Aligned_cols=105  Identities=29%  Similarity=0.430  Sum_probs=94.8

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|..+..||+|+|+|.+.+ |.|+||+...      +++|||+|++||+|||+ +|+++||+|+|+|.|.++
T Consensus         2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg~vaSFsT~F~F~I~~~   79 (113)
T 1qmo_A            2 QSLSFSFTKFDPNQEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVLTSFDTIINFEISTP   79 (113)
T ss_dssp             EEEEEEESSCCSSCTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEEEECS
T ss_pred             cceEEEcCCCCCCCCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CCCEEeeEEEEEEEEecC
Confidence            356899999997668999999999985 9999998765      68999999999999999 999999999999999988


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccC
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNST  127 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~  127 (652)
                      ....+||||||||+|....|+++|+||||+|.+
T Consensus        80 ~~~~~gdGlAF~lap~~~~p~s~g~~LGL~n~~  112 (113)
T 1qmo_A           80 YTSRIADGLAFFIAPPDSVISYHGGFLGLFPNA  112 (113)
T ss_dssp             SSSCCCCEEEEEEECTTCCCCCCGGGTTTCSSC
T ss_pred             CCCCCCCeEEEEecCCCCCCCCCccccccccCC
Confidence            777899999999999876567899999999865

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=7.8e-30  Score=285.80  Aligned_cols=186  Identities=16%  Similarity=0.074  Sum_probs=131.8

Q ss_pred             cccccCceEEEEEEEcCCCeEEEEEEecCc----------chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEE
Q 038860          347 LLGHGGFGQVYKGTLHNSKTEVAVKRISNE----------SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       347 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ..+.|+.|.+..++....|+.+|+|.+...          .....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            356677777766665556788999999653          123456799999999999 699999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      |||++|++|.+++...  .+++..   +|+.||+.||+|||   +++||||||||+||||++++++||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999999543  345543   58999999999999   799999999999999999999999999999876543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP  542 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p  542 (652)
                      . ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 C-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             C-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2 23445689999999999875 466789999999998877655444

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.93  E-value=5.9e-25  Score=218.59  Aligned_cols=185  Identities=17%  Similarity=0.214  Sum_probs=143.4

Q ss_pred             CCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCC
Q 038860           34 SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL  113 (652)
Q Consensus        34 ~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~  113 (652)
                      ..++.++|+|.+. ++.|+||++ .++.|++|.+.|+++.       ++|+|+|+|+|..+. ..+||||||+++|....
T Consensus        30 i~~w~~~G~a~v~-~~~IrLTp~-~~s~G~iW~~~p~~~~-------~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~~~   99 (256)
T 2a6y_A           30 PNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK-------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNI   99 (256)
T ss_dssp             CTTEEEEETCEEE-TBEEECCCS-TTCEEEEEESSCEEES-------SCEEEEEEEEEESCC-SCCSCEEEEEEEECSSS
T ss_pred             cCCeEEccceEEe-CCEEEECCC-CCceEEEeeCCCCccc-------CCEEEEEEEEEecCC-CCCCCeEEEEEeCCCCc
Confidence            4699999999994 999999998 6789999888888753       489999999998764 33799999999997642


Q ss_pred             CCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCC------CCceeeecCCccccceeecceecCCCCcccCCc-
Q 038860          114 NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDIN------DNHIGIDINSMKSNASVEAAVYTDNSTKQDLSL-  186 (652)
Q Consensus       114 ~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~-  186 (652)
                      + ..|+.+|..+       ..+-+||||||+.|.   .|.      +.|+++|.+++.+.....+.          ..+ 
T Consensus       100 ~-~~g~~~G~~~-------~f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~----------~~~r  158 (256)
T 2a6y_A          100 P-RDKQLYNGPV-------NYDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASCL----------MGYQ  158 (256)
T ss_dssp             C-CCCTBTTBCT-------TCEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEEE----------CCCT
T ss_pred             c-cCCcccCcCC-------CCCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceecce----------eecc
Confidence            2 5678888853       223489999999873   333      57888887764444333321          122 


Q ss_pred             CCCceEEEEEEEc-CCCCeEEEEEeeCCCCCCCCeeeEEecCCcc-cccce-EEEEecccc---cccccceeecccccc
Q 038860          187 KGGKAILVWVDYD-SAENILNVTVSPNSSKPKIPILSFRVDLSPI-FNEFM-YVGFSASTG---LLASSHNVLGWSFKI  259 (652)
Q Consensus       187 ~~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~-l~~~~-~vGfsastg---~~~~~~~v~~w~f~~  259 (652)
                      ++|...++||.|+ +..+.|+|.+.+          ..++++..+ ||+++ ||||||+||   ...+.|.|++|+|..
T Consensus       159 n~~~~~~v~I~Y~~~~~~~L~V~i~~----------~~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~  227 (256)
T 2a6y_A          159 DSSVPSTIRVTYDLEDDNLLKVQVDN----------KVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFN  227 (256)
T ss_dssp             TCSSCEEEEEEEEGGGTSEEEEEETT----------EEEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEE
T ss_pred             cCCCcEEEEEEEecCCCcEEEEEEcC----------EEEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEe
Confidence            4788999999999 878899999974          124455555 88997 699999999   888999999999986

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.8e-26  Score=257.00  Aligned_cols=185  Identities=16%  Similarity=0.157  Sum_probs=145.4

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcc--------hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--------KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      ...+.||+|+||.||+|...  +..+++|+.....        ....+.+.+|++++++++||||+++..++...+..+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            34678999999999999543  5788999864321        1124568999999999999999966666667778899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++++|.+++..          +..++.|+++||+|||   +++|+||||||+|||++.  ++||+|||+++....
T Consensus       417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            9999999999999843          5689999999999999   799999999999999999  999999999997644


Q ss_pred             CCCCc------eeeccCCcCCCCCCCCCC--CCCCCccchHhHHHHHHHHHhCCCCCC
Q 038860          495 GTNPA------TTRVVGTLGYLAPETPRT--GKSSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       495 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                      .....      .....||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            22111      235689999999999876  567888999999999999888887764

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.92  E-value=4.8e-25  Score=215.13  Aligned_cols=105  Identities=28%  Similarity=0.429  Sum_probs=93.7

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|.|++|.+.+.||+|+|+|.+.++|.|+||++..      +++|||+|++||+||++ +++++||+|+|+|.|.++
T Consensus       124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~~vaSFsT~F~F~I~~~  202 (237)
T 1nls_A          124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKSP  202 (237)
T ss_dssp             EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCCS
T ss_pred             ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CCCEeeeEEEEEEEEecC
Confidence            44689999999877899999999998799999998763      68999999999999997 889999999999999986


Q ss_pred             CCCCCcCcEEEEEccCC-CCC-CCCCccccCCccC
Q 038860           95 YPRLGGHGLAFTISPSN-DLN-GLPSQYLGLLNST  127 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~-~~~-~~~g~~lG~~~~~  127 (652)
                       ...+||||||||+|.. ..| +++||||||+|.+
T Consensus       203 -~~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~  236 (237)
T 1nls_A          203 -DSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             -CCCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence             4468999999999987 456 8999999999875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=2.1e-23  Score=213.15  Aligned_cols=150  Identities=15%  Similarity=0.095  Sum_probs=119.4

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch------------------hhHHHHHHHHHHhcccCc
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK------------------QGVREFVSEIATIGRLRH  396 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h  396 (652)
                      +......|++.+.||+|+||.||+|.+ .+++.||+|.++....                  .....+.+|+.++++++ 
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            334445666779999999999999999 7789999999965321                  13456899999999998 


Q ss_pred             CceeEEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC
Q 038860          397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD  476 (652)
Q Consensus       397 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~  476 (652)
                       | +++.+++.. +..++||||+++++|.+ +..        .....++.|++.||.|||   +.+|+||||||+|||++
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence             4 556665433 56799999999999988 411        234469999999999999   79999999999999999


Q ss_pred             CCCCeEEeeeccceecccCCCCceeeccCCcCCCCCCCCC
Q 038860          477 SELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR  516 (652)
Q Consensus       477 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  516 (652)
                       ++.+||+|||+|+.              +..++|||++.
T Consensus       228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence             99999999999973              33567888653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=4.5e-19  Score=178.76  Aligned_cols=139  Identities=17%  Similarity=0.119  Sum_probs=107.2

Q ss_pred             CccccccccccCceEEEEEEEcCCCeE--EEEEEecCcch------------------------hhHHHHHHHHHHhccc
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTE--VAVKRISNESK------------------------QGVREFVSEIATIGRL  394 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l  394 (652)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++....                        .....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999999666888  99998754311                        1123678999999999


Q ss_pred             CcCce--eEEEeeeeccCeeEEEEEeccC-C----CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecC
Q 038860          395 RHRNL--VQLVGWCRRKGDLLLVYDFMAN-G----SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRD  467 (652)
Q Consensus       395 ~h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrD  467 (652)
                      +|+++  +.++.+    +..+|||||+.+ |    +|.++..     ..++..+..++.|++.+|.|||.  ..+|+|||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-----ELKELDVEGIFNDVVENVKRLYQ--EAELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-----GGGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-----ccChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence            88764  344432    356899999942 4    4444331     13356778899999999999993  38999999


Q ss_pred             CCCCceEeCCCCCeEEeeeccceec
Q 038860          468 VKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       468 lk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999864

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=99.76  E-value=1.1e-17  Score=162.53  Aligned_cols=190  Identities=18%  Similarity=0.194  Sum_probs=128.2

Q ss_pred             CCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCC
Q 038860           34 SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL  113 (652)
Q Consensus        34 ~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~  113 (652)
                      .+++.+.|+|.+. ++.|+||++ .++.|.+|.+.|+++.+       +|+++|+|+|..+. ..+||||||++++....
T Consensus        23 ~~~W~~~G~a~i~-~~~IrLTp~-~~~~G~iWs~~p~~~~~-------~weie~~Fri~g~~-~~~gdGlA~W~t~~~~~   92 (222)
T 2a6z_A           23 PNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYS-GQTDGGISFWFVQDSNI   92 (222)
T ss_dssp             CTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS-------CEEEEEEEEEESCC-SCCSCEEEEEEEECSSS
T ss_pred             cCCcEEcccEEEc-CCEEEECCC-CCCeEEEEeCCCCCCCC-------CEEEEEEEEEeCCC-CCCCCEEEEEEECCCcc
Confidence            3699999999996 889999999 57789999999998754       79999999998653 34799999999987541


Q ss_pred             CCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCC-ccccceeecceecCCCCcccCCcCCCceE
Q 038860          114 NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINS-MKSNASVEAAVYTDNSTKQDLSLKGGKAI  192 (652)
Q Consensus       114 ~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns-~~s~~~~~~~~~~~~~~~~~~~~~~g~~~  192 (652)
                       ...|..+|..+.-       .=+||+|||+.|.      .++|.+.+|. -.+...........++|.... .+.+...
T Consensus        93 -~~~g~~~G~~~~f-------~GL~I~~Dt~~n~------~p~i~~~~ndG~~~yd~~~~~~~~~~~C~~~~-rn~~~~~  157 (222)
T 2a6z_A           93 -PRDKQLYNGPVNY-------DGLQLLVDNNGPL------GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGY-QDSSVPS  157 (222)
T ss_dssp             -CCCCTBTTBCTTC-------EEEEEEEESCSTT------SSEEEEEEEESSSCCCGGGHHHHCSEEEECCC-TTEEEEE
T ss_pred             -cCCCcccCCCCCC-------CEEEEEEECCCCC------CceEEEEECCCCeeeccCCCccccccccceec-cCCCCcE
Confidence             1344555552221       2269999998872      3556554432 111110000000012221121 1457789


Q ss_pred             EEEEEEc-CCCCeEEEEEeeCCCCCCCCeee-EEecCCcccccc-eEEEEecccc---cccccceeeccccc
Q 038860          193 LVWVDYD-SAENILNVTVSPNSSKPKIPILS-FRVDLSPIFNEF-MYVGFSASTG---LLASSHNVLGWSFK  258 (652)
Q Consensus       193 ~~~I~Y~-~~~~~l~v~~~~~~~~~~~p~ls-~~vdL~~~l~~~-~~vGfsastg---~~~~~~~v~~w~f~  258 (652)
                      +++|.|+ ...+.|+|.+..      ..++. ..|+    ||+. .|+||||+||   ...+.|.|++|++.
T Consensus       158 ~~rI~Y~~~~~~~l~v~id~------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~  219 (222)
T 2a6z_A          158 TIRVTYDLEDDNLLKVQVDN------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF  219 (222)
T ss_dssp             EEEEEEEGGGTSEEEEEETT------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred             EEEEEEEcCCCcEEEEEEcC------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence            9999998 667789998864      11221 1233    5666 4799999999   88889999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=8.1e-17  Score=169.15  Aligned_cols=138  Identities=13%  Similarity=0.113  Sum_probs=99.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--------------hhHHH--------HHHHHHHhcccCcCc
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--------------QGVRE--------FVSEIATIGRLRHRN  398 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~n  398 (652)
                      -|++.+.||+|++|.||+|.+.. |+.||||+++....              .....        ..+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            48999999999999999999864 88999998753210              00111        234556666664443


Q ss_pred             ee--EEEeeeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC
Q 038860          399 LV--QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD  476 (652)
Q Consensus       399 iv--~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~  476 (652)
                      +.  ..+++    ...+|||||+++++|..+...        .....++.|++.+|.+||   +.+||||||||.|||++
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence            32  22221    224799999999888765421        233568899999999999   68999999999999998


Q ss_pred             CCC----------CeEEeeeccceeccc
Q 038860          477 SEL----------NGKLGDFGLAKLYEH  494 (652)
Q Consensus       477 ~~~----------~~kL~DFGla~~~~~  494 (652)
                      +++          .+.|+||+.+....+
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             CCCCcccccccccceEEEEeCCcccCCC
Confidence            776          389999999876443

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=99.54  E-value=1.3e-13  Score=133.28  Aligned_cols=186  Identities=13%  Similarity=0.104  Sum_probs=122.0

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      +++.+.|+|.+. ++.|+||++ +++.|.+|-+.|+.+-+       +|+.+|+|+|...... +||||||.++..+.. 
T Consensus        27 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~~~-------~weiev~Fri~G~~~~-~gdGlA~Wyt~~~~~-   95 (226)
T 2a6v_A           27 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIKD-------AMTIEWTFRSFGFRGS-TKGGLAFWLKQGNEG-   95 (226)
T ss_dssp             TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCSS-------CEEEEEEEEEESCCSC-CSCEEEEEEECSCCC-
T ss_pred             CCcEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCCCC-------CeEEEEEEEEecCCCC-CCCEEEEEEECCCCC-
Confidence            689999999997 778999999 99999999999998622       6999999999876433 799999999976531 


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCce-eeecCCccccceeecceecCCCCcccCCcCCCceEE
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHI-GIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAIL  193 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hv-gi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~  193 (652)
                       ..|..+|-...      .-.=+||.|||+.|.      ...| ++-.++-.+.....  ....++|..+. .+.+...+
T Consensus        96 -~~g~vfGg~~d------~f~GlgI~~Dt~~n~------~p~i~~~~NDGt~~yd~~~--~~~~g~C~~~~-rn~~~~t~  159 (226)
T 2a6v_A           96 -DSTELFGGSSK------KFNGLMILLRLDDKL------GESVTAYLNDGTKDLDIES--SPYFASCLFQY-QDSMVPST  159 (226)
T ss_dssp             -CCCTBTTTBCS------SCEEEEEEEEEETTT------EEEEEEEEEESSSCCCTTT--SCCSEEEECCC-SSCSSCEE
T ss_pred             -CCcccccccCC------CccEEEEEEECCCCC------CceEEEEECCCCcccCCCC--CcccceEeEec-cCCCCCEE
Confidence             23333321010      112279999999762      1223 22222322211110  01112232221 24567889


Q ss_pred             EEEEEc-CCCCeEEEEEeeCCCCCCCCeeeEEecCCc-ccccce--EEEEecccccccccceeecccc
Q 038860          194 VWVDYD-SAENILNVTVSPNSSKPKIPILSFRVDLSP-IFNEFM--YVGFSASTGLLASSHNVLGWSF  257 (652)
Q Consensus       194 ~~I~Y~-~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~-~l~~~~--~vGfsastg~~~~~~~v~~w~f  257 (652)
                      ++|.|. ...+.|+|.+..      ..+    +.... .||...  |+||||+||...+.|.|++..+
T Consensus       160 ~ri~Y~~~~~~~l~v~id~------~~C----f~~~~v~LP~g~~~yfGiSAaTg~~~D~hdils~~~  217 (226)
T 2a6v_A          160 LRLTYNPLDNHLLKLQMDN------RVC----FQTRKVKFMGSSPFRIGTSAINDASKESFEILKMKL  217 (226)
T ss_dssp             EEEEEEGGGTSEEEEEETT------EEE----EEESCCCGGGTSCBEEEEEEECCTTCCEEEEEEEEE
T ss_pred             EEEEEEccCCCEEEEEEcC------Cee----EEECCeecCCCCccEEEEEEcCCCCcccEEEEEEEE
Confidence            999996 456789998863      112    22222 256555  9999999999999999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=3.9e-12  Score=127.91  Aligned_cols=147  Identities=16%  Similarity=0.076  Sum_probs=114.5

Q ss_pred             hhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEE
Q 038860          336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       336 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  414 (652)
                      .....+|+....++.|+.+.||+....  +..+++|............+.+|+.+++.+. +..+.++++++...+..++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            344567888889999999999999754  5789999987532222345788999998884 6778899999988889999


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC------------------------------------
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG------------------------------------  458 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------  458 (652)
                      ||||++|.+|.+.+.       +......++.+++++|..||+.                                    
T Consensus        88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999988876541       1223346788999999999961                                    


Q ss_pred             --------------------ccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          459 --------------------YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       459 --------------------~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                                          ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                016699999999999998765567999998753

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=99.21  E-value=2.2e-12  Score=93.26  Aligned_cols=45  Identities=38%  Similarity=0.538  Sum_probs=41.6

Q ss_pred             CCeeeEEecCCcccccceEEEEecccccccccceeecccccccCC
Q 038860          218 IPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKINGP  262 (652)
Q Consensus       218 ~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~~~~~  262 (652)
                      .|+++..+||+++||++|||||||+||...+.|+|++|+|++..+
T Consensus         3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~~   47 (52)
T 2ltn_B            3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELS   47 (52)
T ss_dssp             EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred             eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeecc
Confidence            478999999999999999999999999999999999999987643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=7.4e-11  Score=117.96  Aligned_cols=143  Identities=15%  Similarity=0.105  Sum_probs=102.6

Q ss_pred             hhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc--eeEEEeeeeccCee
Q 038860          335 LKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN--LVQLVGWCRRKGDL  412 (652)
Q Consensus       335 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~  412 (652)
                      +.....++......+.|..+.||+.... ++..+++|......   ...+.+|+.+++.+.+.+  +.+++++....+..
T Consensus        15 l~~~~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           15 WVERLFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             GTTTTTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             HHHhcCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            3444456665555456667999999754 46779999986542   235678999998886544  55688888887889


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCc---------------------------------
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY---------------------------------  459 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---------------------------------  459 (652)
                      ++||||++|.+|.  ...     .   ....++.++++.|..||+..                                 
T Consensus        91 ~~v~e~i~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEEECCSSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEEecCCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            9999999998884  211     1   11256677777777777521                                 


Q ss_pred             ----------------------cceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          460 ----------------------EQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       460 ----------------------~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                                            ...++|+|++|.|||++.+..+.|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  23499999999999998776677999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.01  E-value=9.3e-10  Score=115.86  Aligned_cols=142  Identities=12%  Similarity=0.171  Sum_probs=107.0

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEec--Ccc-hhhHHHHHHHHHHhcccC--cCceeEEEeeeecc---CeeEEE
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS--NES-KQGVREFVSEIATIGRLR--HRNLVQLVGWCRRK---GDLLLV  415 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV  415 (652)
                      ..+.|+.|.++.||+....+  ..+++|+..  ... ......+.+|..+++.+.  +..+++++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            35678999999999988753  578888876  332 122346778999999886  45678899988776   458999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCc------------------------------------
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY------------------------------------  459 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------  459 (652)
                      |||++|..+.+..    ...++..++..++.++++.|..||+..                                    
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999998875432    123677888899999999999999620                                    


Q ss_pred             -------------------cceEEecCCCCCceEeCCCCC--eEEeeecccee
Q 038860          460 -------------------EQVVIHRDVKASNVLLDSELN--GKLGDFGLAKL  491 (652)
Q Consensus       460 -------------------~~~ivHrDlk~~NILl~~~~~--~kL~DFGla~~  491 (652)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               267999999999999997753  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.85  E-value=4.4e-10  Score=115.55  Aligned_cols=184  Identities=16%  Similarity=0.176  Sum_probs=120.4

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCc--eeEEEeeeeccC---eeEEEEEe
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRN--LVQLVGWCRRKG---DLLLVYDF  418 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~  418 (652)
                      .+.++.|....||+..     ..+++|.....  .....+.+|..+++.+. +..  +.+++......+   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863     45889986543  33467888999998873 332  445555544333   34889999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC----------------------------------------
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG----------------------------------------  458 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~----------------------------------------  458 (652)
                      ++|.+|....    ...++..++..++.+++..|..||+.                                        
T Consensus        98 i~G~~l~~~~----~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLL----LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHH----HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCccc----cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998886533    12356667777788888888777741                                        


Q ss_pred             ---------------ccceEEecCCCCCceEeCC--CCCeEEeeeccceecccCCCCceeeccCCcCC---CCCCCCCC-
Q 038860          459 ---------------YEQVVIHRDVKASNVLLDS--ELNGKLGDFGLAKLYEHGTNPATTRVVGTLGY---LAPETPRT-  517 (652)
Q Consensus       459 ---------------~~~~ivHrDlk~~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  517 (652)
                                     ....++|+|++|.||++++  ...+.|+||+.+...+....     ......+   ..|+.... 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHH
Confidence                           1246899999999999998  45678999999875432110     0000011   11110000 


Q ss_pred             ----CC---------CCCccchHhHHHHHHHHHhCCCCCC
Q 038860          518 ----GK---------SSASSDVFAFGALLLEVACGRRPIE  544 (652)
Q Consensus       518 ----~~---------~s~~sDv~SlGvvl~elltG~~p~~  544 (652)
                          +.         .....+.|+++.++|++.+|+.++.
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                00         0112589999999999999988763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=1.4e-06  Score=87.36  Aligned_cols=136  Identities=18%  Similarity=0.151  Sum_probs=95.6

Q ss_pred             cccccCce-EEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEEeccCCCc
Q 038860          347 LLGHGGFG-QVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGSL  424 (652)
Q Consensus       347 ~LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL  424 (652)
                      .+..|..| .||+......+..+++|+-...   ...++.+|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445555 6999887766778999987544   3446778998888774 33477888999888899999999998776


Q ss_pred             ccccccCCccccchHHHhhhHHHHHHHHhhhccC----------------------------------------------
Q 038860          425 DSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG----------------------------------------------  458 (652)
Q Consensus       425 ~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~----------------------------------------------  458 (652)
                      .+....      .......+..+++..|..||+.                                              
T Consensus       108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            554311      1122233445555555555520                                              


Q ss_pred             ---------ccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          459 ---------YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       459 ---------~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                               ....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     123589999999999999877677999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.36  E-value=1.6e-06  Score=88.84  Aligned_cols=136  Identities=21%  Similarity=0.178  Sum_probs=92.0

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcC---ceeEEEeeee-ccCeeEEEEEecc
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHR---NLVQLVGWCR-RKGDLLLVYDFMA  420 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~  420 (652)
                      .+.++.|....||+.     +..+++|....  ......+.+|..+|+.+.+.   .+.+.+.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456788888899987     35688888533  23346788999999998642   3566777664 4556789999999


Q ss_pred             CCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC------------------------------------------
Q 038860          421 NGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG------------------------------------------  458 (652)
Q Consensus       421 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------------  458 (652)
                      |.+|.....    ..++..++..++.++++.|..||+.                                          
T Consensus        97 G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           97 GQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             SEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             CeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            988765321    1123333444444444444444421                                          


Q ss_pred             ---------------ccceEEecCCCCCceEeCC---CCC-eEEeeecccee
Q 038860          459 ---------------YEQVVIHRDVKASNVLLDS---ELN-GKLGDFGLAKL  491 (652)
Q Consensus       459 ---------------~~~~ivHrDlk~~NILl~~---~~~-~kL~DFGla~~  491 (652)
                                     ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           1346899999999999987   455 48999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=3.8e-06  Score=87.90  Aligned_cols=82  Identities=6%  Similarity=-0.004  Sum_probs=57.1

Q ss_pred             cccc-cccCceEEEEEEEc---C---CCeEEEEEEecCcc---hhhHHHHHHHHHHhcccC-c--CceeEEEeeeecc--
Q 038860          345 KQLL-GHGGFGQVYKGTLH---N---SKTEVAVKRISNES---KQGVREFVSEIATIGRLR-H--RNLVQLVGWCRRK--  409 (652)
Q Consensus       345 ~~~L-G~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  409 (652)
                      .+.| +.|....+|+....   +   .+..+++|......   ......+.+|..+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999998764   1   14678899875533   101234677888888884 3  3567788887665  


Q ss_pred             -CeeEEEEEeccCCCccc
Q 038860          410 -GDLLLVYDFMANGSLDS  426 (652)
Q Consensus       410 -~~~~lV~e~~~~gsL~~  426 (652)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999987765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.94  E-value=9.4e-06  Score=86.31  Aligned_cols=76  Identities=12%  Similarity=0.040  Sum_probs=49.1

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcch-------hhHHHHHHHHHHhcccCc--C-ceeEEEeeeeccCeeEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-------QGVREFVSEIATIGRLRH--R-NLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  414 (652)
                      .+.||.|..+.||++.....+..+++|.......       .....+..|.++++.+..  + .+.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            4678999999999997665567899998654321       122345678888887742  3 344566543  345689


Q ss_pred             EEEeccCC
Q 038860          415 VYDFMANG  422 (652)
Q Consensus       415 V~e~~~~g  422 (652)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.74  E-value=0.00019  Score=74.09  Aligned_cols=140  Identities=16%  Similarity=0.188  Sum_probs=79.5

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcC--ceeEEEee------eeccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHR--NLVQLVGW------CRRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lV~  416 (652)
                      .+.|+.|..+.||+....+  ..+++|+.....    .++..|..++..|...  .+.+++..      ....+..+++|
T Consensus        37 ~~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDS--GAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EEECC----CEEEEEEETT--EEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeeccccccCcEEEEEeCC--CCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            3456667789999987743  458999987632    2233455555555311  23344431      12356789999


Q ss_pred             EeccCCCccc-----------c---ccc--C----Cc------cccchHHH-----------------------------
Q 038860          417 DFMANGSLDS-----------F---LFD--E----PK------AVLNWEQR-----------------------------  441 (652)
Q Consensus       417 e~~~~gsL~~-----------~---l~~--~----~~------~~l~~~~~-----------------------------  441 (652)
                      ||++|..+..           .   ++.  .    +.      ..-.|...                             
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            9999876541           0   110  0    00      00122110                             


Q ss_pred             --hhhHHHHHHHHhhhcc----------CccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          442 --FKIIKGVASGLLYLHE----------GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       442 --~~i~~~i~~aL~~LH~----------~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                        ..+..++..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              0111223345566652          125789999999999999888889999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.60  E-value=0.00033  Score=71.63  Aligned_cols=138  Identities=14%  Similarity=0.121  Sum_probs=91.7

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC---cCceeEEEeeeeccCeeEEEEEecc
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR---HRNLVQLVGWCRRKGDLLLVYDFMA  420 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~  420 (652)
                      ..+.|+.|....+|+....  +..+++|+....   ....+..|...|+.|.   ...+++++.++...+..++||||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3567899999999998763  567889987643   2456788998888884   3568888988887888999999999


Q ss_pred             CCCcccc-----------cccCCc-c-------------------ccchHHHh---hhH----------------HHHHH
Q 038860          421 NGSLDSF-----------LFDEPK-A-------------------VLNWEQRF---KII----------------KGVAS  450 (652)
Q Consensus       421 ~gsL~~~-----------l~~~~~-~-------------------~l~~~~~~---~i~----------------~~i~~  450 (652)
                      +..+..-           |+.... .                   .-+|....   ++.                ..+..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            9876321           111100 0                   11343221   111                11221


Q ss_pred             HH-hhhc-cCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          451 GL-LYLH-EGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       451 aL-~~LH-~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                      .+ ..|. ......++|+|+.+.|++++.++ +.|+|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22 2332 12257899999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.34  E-value=0.0006  Score=68.74  Aligned_cols=79  Identities=20%  Similarity=0.270  Sum_probs=56.0

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-c--CceeEEEeeeeccCeeEEEEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-H--RNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .....+.+|.|..+.||+....+ |+.|.+|+...........|..|...|+.|. .  -.+.+++++.    .-++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            34456779999999999999865 7889999876554333345778988888774 2  2345555543    3478999


Q ss_pred             eccCCCc
Q 038860          418 FMANGSL  424 (652)
Q Consensus       418 ~~~~gsL  424 (652)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.24  E-value=0.00071  Score=72.50  Aligned_cols=75  Identities=16%  Similarity=0.182  Sum_probs=50.8

Q ss_pred             cccccccCceEEEEEEEcC-------CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCce-eEEEeeeeccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL-VQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  416 (652)
                      .+.|+.|-...+|+....+       .+..+++|+......  ...+.+|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4567888889999998753       246788998854211  1345578888888853333 567776543    2899


Q ss_pred             EeccCCCcc
Q 038860          417 DFMANGSLD  425 (652)
Q Consensus       417 e~~~~gsL~  425 (652)
                      ||++|.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999875554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.23  E-value=0.00071  Score=72.25  Aligned_cols=32  Identities=19%  Similarity=0.262  Sum_probs=28.6

Q ss_pred             cceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       460 ~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      ...++|+|+++.|||++.++ ++|+||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            68899999999999998876 999999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.23  E-value=0.00082  Score=68.79  Aligned_cols=143  Identities=13%  Similarity=0.100  Sum_probs=79.0

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc--eeEEEeee------eccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN--LVQLVGWC------RRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lV~  416 (652)
                      .+.|+.|....+|+....+ + .+++|......  ...++..|..++..+....  +.+++...      ...+..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3457778889999988754 3 68899887531  1123456777777664222  23333221      1235678999


Q ss_pred             EeccCCCcccc--------------ccc------CCc----cccchHHHh--------h----hHHHHHHHHhhhcc---
Q 038860          417 DFMANGSLDSF--------------LFD------EPK----AVLNWEQRF--------K----IIKGVASGLLYLHE---  457 (652)
Q Consensus       417 e~~~~gsL~~~--------------l~~------~~~----~~l~~~~~~--------~----i~~~i~~aL~~LH~---  457 (652)
                      +|++|..+...              ++.      ...    ....|....        .    +...+...+..++.   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            99998765321              010      000    001122210        0    01113333444432   


Q ss_pred             -CccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          458 -GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       458 -~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                       ....+++|+|+++.|||++.+..+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             2246899999999999999875568999998763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.07  E-value=0.0017  Score=69.98  Aligned_cols=76  Identities=12%  Similarity=0.087  Sum_probs=48.9

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCce-eEEEeeeeccCeeEEEEEeccCCC
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL-VQLVGWCRRKGDLLLVYDFMANGS  423 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gs  423 (652)
                      .+.|+.|-...+|+....+.+..+++|+......... +-.+|..++..|...++ .++++.+..    .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            4568888889999998765457888998754322111 12468888888864444 567777632    25999999866


Q ss_pred             cc
Q 038860          424 LD  425 (652)
Q Consensus       424 L~  425 (652)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.04  E-value=0.0017  Score=68.11  Aligned_cols=141  Identities=20%  Similarity=0.174  Sum_probs=83.4

Q ss_pred             ccccccCceEEEEEEEcC-------CCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEEE
Q 038860          346 QLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      +.|..|-...+|+.....       .+..+++|+.... ........+|..+++.+. +.-..++++.+.++    +|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            457778888899988742       3467889986432 223455668999988884 32235677766542    8999


Q ss_pred             eccCCCccccc-----------------ccC----Ccccc-chHHHhhhHHHHHH-------------------HHhhhc
Q 038860          418 FMANGSLDSFL-----------------FDE----PKAVL-NWEQRFKIIKGVAS-------------------GLLYLH  456 (652)
Q Consensus       418 ~~~~gsL~~~l-----------------~~~----~~~~l-~~~~~~~i~~~i~~-------------------aL~~LH  456 (652)
                      |++|..|..--                 +..    .+.+. -|.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            99987664211                 110    01111 23444444443322                   122221


Q ss_pred             ----c-CccceEEecCCCCCceEeCCC----CCeEEeeecccee
Q 038860          457 ----E-GYEQVVIHRDVKASNVLLDSE----LNGKLGDFGLAKL  491 (652)
Q Consensus       457 ----~-~~~~~ivHrDlk~~NILl~~~----~~~kL~DFGla~~  491 (652)
                          . .....++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 225689999999999999876    7899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.99  E-value=0.0012  Score=66.90  Aligned_cols=72  Identities=6%  Similarity=0.041  Sum_probs=44.6

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCce-eEEEeeeeccCeeEEEEEec-cCC
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL-VQLVGWCRRKGDLLLVYDFM-ANG  422 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~g  422 (652)
                      .+.|+.|....+|+.      ..+++|+........ ....+|..+++.+....+ .++++.+.+  .-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence            677889999999998      348888876542211 122457777776642222 456655433  346899999 665


Q ss_pred             Ccc
Q 038860          423 SLD  425 (652)
Q Consensus       423 sL~  425 (652)
                      +|.
T Consensus        94 ~l~   96 (301)
T 3dxq_A           94 TMS   96 (301)
T ss_dssp             ECC
T ss_pred             cCC
Confidence            553

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.74  E-value=0.0031  Score=65.90  Aligned_cols=75  Identities=13%  Similarity=0.131  Sum_probs=44.6

Q ss_pred             cccccccCceEEEEEEEcC--------CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc-eeEEEeeeeccCeeEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHN--------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN-LVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV  415 (652)
                      .+.|+.|....+|+....+        .+..+++|+....... ..+...|..+++.+...+ ..++++...    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            3557788888999998753        1257888887553222 112356788887775333 345665442    2689


Q ss_pred             EEeccCCCc
Q 038860          416 YDFMANGSL  424 (652)
Q Consensus       416 ~e~~~~gsL  424 (652)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988655

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.74  E-value=0.0058  Score=62.48  Aligned_cols=141  Identities=14%  Similarity=0.186  Sum_probs=79.6

Q ss_pred             ccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc--eeEEEee-----eeccCeeEEEEEe
Q 038860          346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN--LVQLVGW-----CRRKGDLLLVYDF  418 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~e~  418 (652)
                      ..++ |....||+....+ |+.+++|...... .....+..|..++..+....  +++++..     ....+..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDED-RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTT-CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCC-CCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 7888999876543 5679999986431 12345566777777774222  3444443     1224456889999


Q ss_pred             ccCCCcccc----c----------cc----C---CccccchHHH----------------------hhhHHHHHHHHhhh
Q 038860          419 MANGSLDSF----L----------FD----E---PKAVLNWEQR----------------------FKIIKGVASGLLYL  455 (652)
Q Consensus       419 ~~~gsL~~~----l----------~~----~---~~~~l~~~~~----------------------~~i~~~i~~aL~~L  455 (652)
                      ++|..+...    +          +.    .   .....++...                      ...+..++..+.-+
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            988655320    0          10    0   0011121110                      01111222222211


Q ss_pred             c-cCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          456 H-EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       456 H-~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      - ......++|+|+++.|||++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 11257799999999999999 4 899999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.74  E-value=0.0037  Score=64.26  Aligned_cols=32  Identities=41%  Similarity=0.461  Sum_probs=28.3

Q ss_pred             cceEEecCCCCCceEeCCC----CCeEEeeecccee
Q 038860          460 EQVVIHRDVKASNVLLDSE----LNGKLGDFGLAKL  491 (652)
Q Consensus       460 ~~~ivHrDlk~~NILl~~~----~~~kL~DFGla~~  491 (652)
                      ...++|+|+.+.|||++.+    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            5789999999999999874    6789999998874

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.27  E-value=0.018  Score=59.44  Aligned_cols=32  Identities=31%  Similarity=0.381  Sum_probs=28.7

Q ss_pred             cceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       460 ~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46899999999999999888899999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.25  E-value=0.075  Score=56.40  Aligned_cols=141  Identities=12%  Similarity=0.140  Sum_probs=83.0

Q ss_pred             cccccccCceEEEEEEEcCC-------CeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNS-------KTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .+.+..|-...+|+......       +..+++|+....... .-+..+|..+++.+. +.-..++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            34567788889999987521       467888887543221 112346788887774 222345555432    26899


Q ss_pred             EeccCCCcccc-c----------------ccC-----------CccccchHHHhhhHHHHH-------------------
Q 038860          417 DFMANGSLDSF-L----------------FDE-----------PKAVLNWEQRFKIIKGVA-------------------  449 (652)
Q Consensus       417 e~~~~gsL~~~-l----------------~~~-----------~~~~l~~~~~~~i~~~i~-------------------  449 (652)
                      ||++|..|..- +                +..           ...+.-|.++.++..++-                   
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998765321 0                000           111112344333333221                   


Q ss_pred             HHHhhhc---------------------cCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          450 SGLLYLH---------------------EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       450 ~aL~~LH---------------------~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      ..+..|.                     ......++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            1222221                     112467999999999999 7778899999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.49  E-value=0.29  Score=51.41  Aligned_cols=31  Identities=29%  Similarity=0.384  Sum_probs=25.9

Q ss_pred             ceEEecCCCCCceEe------CCCCCeEEeeecccee
Q 038860          461 QVVIHRDVKASNVLL------DSELNGKLGDFGLAKL  491 (652)
Q Consensus       461 ~~ivHrDlk~~NILl------~~~~~~kL~DFGla~~  491 (652)
                      ..++|+|+.+.|||+      +++..++++||..|..
T Consensus       244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            457899999999999      3456799999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=87.51  E-value=0.4  Score=45.48  Aligned_cols=102  Identities=14%  Similarity=0.050  Sum_probs=63.4

Q ss_pred             CcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCceee
Q 038860          423 SLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTR  502 (652)
Q Consensus       423 sL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  502 (652)
                      +|.+.|.. ...+++++++|.++.|.+.+|.-+-.  ...-..+=+-|..|+|..+|.+.+.+ ..+.            
T Consensus        34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            67777743 35679999999999999999877610  01101222346899999999887753 1110            


Q ss_pred             ccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCC
Q 038860          503 VVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRP  542 (652)
Q Consensus       503 ~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p  542 (652)
                       .....+.|||... ...+.+.=|||||+++|..+-=..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             1122456888763 3456778899999999999874433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=85.19  E-value=0.25  Score=33.63  Aligned_cols=7  Identities=14%  Similarity=0.487  Sum_probs=2.9

Q ss_pred             EEEeehh
Q 038860          286 IVGVSIA  292 (652)
Q Consensus       286 ~i~~~v~  292 (652)
                      +++.+++
T Consensus        14 Ia~~vVG   20 (44)
T 2jwa_A           14 IISAVVG   20 (44)
T ss_dssp             HHHHHHH
T ss_pred             hHHHHHH
Confidence            3344444

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.95  E-value=0.1  Score=56.06  Aligned_cols=62  Identities=6%  Similarity=0.090  Sum_probs=18.2

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEE------EEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeee
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAV------KRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCR  407 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  407 (652)
                      ...+.||   ||.||+|.+.....+||+      |.....  ..+....|.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3455676   999999999765568898      766543  2334457888999999999999999888654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	652
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	2e-66
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	4e-64
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	1e-63
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	3e-63
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	1e-62
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	1e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-62
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	3e-62
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-61
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	4e-61
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	4e-61
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	4e-61
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-60
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	9e-60
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	2e-59
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	2e-59
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	6e-59
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	6e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-57
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	1e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-56
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	4e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-55
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	7e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-49
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	6e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-40
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	7e-40
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	4e-24
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-32
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	3e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20
d2a6va1	218	b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake	1e-10
d2a6za1	221	b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake	4e-09

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  216 bits (550), Expect = 2e-66
 Identities = 74/246 (30%), Positives = 113/246 (45%), Gaps = 25/246 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           F  F+  ++NLTLQG A I  +G+L+LT             G+  Y+  +   +S    V
Sbjct: 8   FSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTV 67

Query: 81  FSFSTSFAIVIVPEYPR-LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y R L   GL F + P+         YLG+ N++   N S    AV
Sbjct: 68  ASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDN-SYQTLAV 126

Query: 140 EFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT  +  +      HIGID+NS++S  +                L  G+   V + YD
Sbjct: 127 EFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQ------------PFQLDNGQVANVVIKYD 173

Query: 200 SAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWS 256
           +   IL+V +    S   I  ++  VD+  +  +++ VG S +TG     A +H+V  WS
Sbjct: 174 APSKILHVVLVY-PSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWS 232

Query: 257 FKINGP 262
           F+ + P
Sbjct: 233 FQASLP 238

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  209 bits (533), Expect = 4e-64
 Identities = 72/243 (29%), Positives = 106/243 (43%), Gaps = 22/243 (9%)

Query: 27  FPGFK-DLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSN 79
           FP F  D+ +++  QG A     G L+L              G+A YS  ++  ++   +
Sbjct: 6   FPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTES 64

Query: 80  VFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFS-NHLFA 138
           V SF T F   +          GLAF ++P +       +YLGL N +     S N + A
Sbjct: 65  VASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVA 123

Query: 139 VEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDY 198
           VEFDT  +  F + +  HIGI++NS+ S A+            +D  +  GK     + Y
Sbjct: 124 VEFDTWTNPNFPEPSYRHIGINVNSIVSVATK---------RWEDSDIFSGKIATARISY 174

Query: 199 DSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLAS-SHNVLGWSF 257
           D +  IL V +S         ILS  VD+     E + VG SASTG     +  +L W F
Sbjct: 175 DGSAEILTVVLSY--PDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRF 232

Query: 258 KIN 260
             N
Sbjct: 233 SSN 235

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  208 bits (531), Expect = 1e-63
 Identities = 68/241 (28%), Positives = 107/241 (44%), Gaps = 20/241 (8%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND---TSRKMGQAFYSSTLRFKNSLNSNVFSF 83
           F  F     N+  QG A +   G+L++T     T+  +G+A Y++ ++  +S+   V SF
Sbjct: 8   FDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASF 67

Query: 84  STSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDT 143
           +TSF+ V+  +          F    ++ +    S  +  L S+     SN + AVEFDT
Sbjct: 68  ATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDT 127

Query: 144 VQDFEFQ--DINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSA 201
                +   D +  HIGID+NS+KS                    + G+   V + Y + 
Sbjct: 128 YFGKAYNPWDPDFKHIGIDVNSIKSI------------KTVKWDWRNGEVADVVITYRAP 175

Query: 202 ENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA--SSHNVLGWSFKI 259
              L V +S   S     I++  VDL  I  E++ VGFS   G  A   +H+VL W F  
Sbjct: 176 TKSLTVCLSY-PSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTS 234

Query: 260 N 260
           N
Sbjct: 235 N 235

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  208 bits (529), Expect = 3e-63
 Identities = 71/253 (28%), Positives = 116/253 (45%), Gaps = 26/253 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRK------MGQAFYSSTLRFKNSLNSNV 80
           +  F     N+ LQG A + ++G L+L             +G+A YS+ +   +    +V
Sbjct: 8   WNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSV 67

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+ SF         +    GLAF ++P    +  P  + G L   +     + + AVE
Sbjct: 68  ASFAASFNFTFYAPDTKRLADGLAFFLAPI---DTKPQTHAGYLGLFNENESGDQVVAVE 124

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT ++    D  + HIGI++NS++S  +                L   K   V + YD+
Sbjct: 125 FDTFRNSW--DPPNPHIGINVNSIRSIKTT------------SWDLANNKVAKVLITYDA 170

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL--ASSHNVLGWSFK 258
           + ++L  ++    S+    ILS  VDL     E++ +GFSA+TGL     SH+VL WSF 
Sbjct: 171 STSLLVASLV-YPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFA 229

Query: 259 INGPARALDLSSL 271
            N P  + ++  L
Sbjct: 230 SNLPHASSNIDPL 242

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  205 bits (523), Expect = 1e-62
 Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 19/238 (7%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND----TSRKMGQAFYSSTLRFKNSLNSNVFS 82
           F  F     +L+ QG A +   G+L+L            G A Y + +   N     + S
Sbjct: 8   FKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELAS 67

Query: 83  FSTSFAI-VIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           F TSF+  +     P+    GL F ++P +        Y GL N T   + S    AVEF
Sbjct: 68  FITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTK-CDSSYQTVAVEF 126

Query: 142 DTVQ-DFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           DT+     F D    HIGID+N +KS           N+ + +          V + Y++
Sbjct: 127 DTIGSPVNFWDPGFPHIGIDVNCVKSI----------NAERWNKRYGLNNVANVEIIYEA 176

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL-LASSHNVLGWSF 257
           +   L  +++   S      ++  VDL  I  E++ VGFS ST +   ++H VL W F
Sbjct: 177 SSKTLTASLTYP-SDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYF 233

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  205 bits (522), Expect = 1e-62
 Identities = 64/233 (27%), Positives = 98/233 (42%), Gaps = 17/233 (7%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS-RKMGQAFYSSTLRFKNSLNSNVFSFST 85
           F  F + +  +  QG   + +NG ++LTN      +G+  Y+  +R  +S   NV SF T
Sbjct: 8   FNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLT 67

Query: 86  SFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQ 145
           SF+  +          G+ F I+P +          G          + H   VEFDT  
Sbjct: 68  SFSFEMKDIKDYDPADGIIFFIAPEDTQIP-AGSIGGGTLGVSDTKGAGHFVGVEFDTYS 126

Query: 146 DFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENIL 205
           + E+ D   +H+GID+NS+ S                  +   G  + V V YDS+   L
Sbjct: 127 NSEYNDPPTDHVGIDVNSVDSV------------KTVPWNSVSGAVVKVTVIYDSSTKTL 174

Query: 206 NVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASS-HNVLGWSF 257
           +V V+ +     I  ++  VDL     E +  GFSAS  L     H +  WSF
Sbjct: 175 SVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 2e-62
 Identities = 81/289 (28%), Positives = 122/289 (42%), Gaps = 14/289 (4%)

Query: 334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIG 392
           ELK   ++F     LG G  G V+K +   S   +A K I  E K  +R   + E+  + 
Sbjct: 2   ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59

Query: 393 RLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGL 452
                 +V   G     G++ +  + M  GSLD  L    +  +  +   K+   V  GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGL 117

Query: 453 LYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            YL E  +  ++HRDVK SN+L++S    KL DFG++              VGT  Y++P
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSP 172

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPE-ELVLVDWVWGKYGEGRVLEVI 571
           E  +    S  SD+++ G  L+E+A GR PI      E EL+    V G   E       
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 572 DPKLNAEYD-QSQVLMGELELPDTLRG--PRSSDGDKAAEGFDDLLNSL 617
             +  + Y   S+  M   EL D +    P        +  F D +N  
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  204 bits (520), Expect = 3e-62
 Identities = 78/243 (32%), Positives = 112/243 (46%), Gaps = 31/243 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           F  F++ S  L LQ  A I++NG+L LT  T       +  G+A Y+  ++  +S   NV
Sbjct: 7   FDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNV 66

Query: 81  FSFSTSFAIVIVPEYPRL-GGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAV 139
            SF T F+  I   Y       GL F + P N     P    G           ++ FAV
Sbjct: 67  ASFETRFSFNITQPYAYPEPADGLTFFMVPPN----SPQGEDGGNLGVFKPPEGDNAFAV 122

Query: 140 EFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYD 199
           EFDT Q+    D    HIGID+NS+ S+ ++               L+ G    V + YD
Sbjct: 123 EFDTFQNTW--DPQVPHIGIDVNSIVSSKTL------------HFQLENGGVANVVIKYD 168

Query: 200 SAENILNVTVSPNSSKPKIPILSFRVDLSPIF--NEFMYVGFSASTGL---LASSHNVLG 254
           S   ILNV ++ + S   +  LS  VDL   F  +E++ VG SA+TG       +H ++ 
Sbjct: 169 SPTKILNVVLAFH-SVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIIS 227

Query: 255 WSF 257
           WSF
Sbjct: 228 WSF 230

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-61
 Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 28/243 (11%)

Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNE 376
           +DWE+                   +  Q +G G FG VYKG  H    +VAVK +  +  
Sbjct: 1   DDWEIP--------------DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43

Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           + Q ++ F +E+  + + RH N++  +G+      L +V  +    SL   L        
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-F 101

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
              +   I +  A G+ YLH    + +IHRD+K++N+ L  +L  K+GDFGLA +    +
Sbjct: 102 EMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158

Query: 497 NPA-TTRVVGTLGYLAPE---TPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL 552
                 ++ G++ ++APE          S  SDV+AFG +L E+  G+ P       +++
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

Query: 553 VLV 555
           + +
Sbjct: 219 IFM 221

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  201 bits (513), Expect = 4e-61
 Identities = 77/249 (30%), Positives = 109/249 (43%), Gaps = 32/249 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND-----TSRKMGQAFYSSTLRFKNSLNSNVF 81
           F  F      L LQ  A+I +N +L LT       T    G+A Y+  ++  +S   NV 
Sbjct: 7   FNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVA 66

Query: 82  SFSTSFAIVIVPEYPRLGG-HGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
           SF T F+  I   +PR     GL F I+P N   G    Y G+ N            AVE
Sbjct: 67  SFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSP----YPFVAVE 122

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT ++    D    HIGID+NS+ S            +     +L  G    V + YD+
Sbjct: 123 FDTFRNTW--DPQIPHIGIDVNSVIS------------TKTVPFTLDNGGIANVVIKYDA 168

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL-------LASSHNVL 253
           +  IL+V +    S   I  ++  VDL  +  E + VGFSA+TG           +H++L
Sbjct: 169 STKILHVVLVF-PSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDIL 227

Query: 254 GWSFKINGP 262
            WSF  + P
Sbjct: 228 SWSFSASLP 236

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  202 bits (514), Expect = 4e-61
 Identities = 78/258 (30%), Positives = 123/258 (47%), Gaps = 31/258 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND------TSRKMGQAFYSSTLRFKNSLNSNV 80
           F  F   S++  LQG A + ++  LRLT        T   +G+AFYSS ++  +     V
Sbjct: 8   FKNFN--SSSFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAV 64

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            S++TSF   I          G+AF + P        S +LG+ +S    N S    AVE
Sbjct: 65  ASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDN-SAQTVAVE 123

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT  + ++ D    HIGID+NS+KS  +                L  G+   + + Y++
Sbjct: 124 FDTFSNTDW-DPTSRHIGIDVNSIKSIRTA------------SWGLANGQNAEILITYNA 170

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSF 257
           A ++L  ++  + S+    I+S RVD++    E++ +GFSA+TGL      +H+VL WSF
Sbjct: 171 ATSLLVASLV-HPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229

Query: 258 KIN----GPARALDLSSL 271
                       LD++S 
Sbjct: 230 ASKLPDDSTTEPLDIASY 247

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  201 bits (511), Expect = 4e-61
 Identities = 73/240 (30%), Positives = 106/240 (44%), Gaps = 29/240 (12%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS---RKMGQAFYSSTLRFKNSLNSNVFSF 83
              F     NL LQG A + + G L LTN        MG+AFYS+ ++  +    N+ SF
Sbjct: 8   VETFN--KTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASF 65

Query: 84  STSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDT 143
           ST+F   I  +      +GLAF + P      L  +YLGL N+T            + D 
Sbjct: 66  STNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTT----------NYDRDA 115

Query: 144 VQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAEN 203
                  D   N I ID+NS++  A+       +N          G+   V + YDS +N
Sbjct: 116 HTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNN----------GEKAEVRITYDSPKN 165

Query: 204 ILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHNVLGWSFKIN 260
            L V++    S  +   +S  V L     +++ VGFSA++G       +HNVL WSF  N
Sbjct: 166 DLRVSLLYP-SSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  199 bits (508), Expect = 2e-60
 Identities = 76/240 (31%), Positives = 117/240 (48%), Gaps = 28/240 (11%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRK------MGQAFYSSTLRFKNSLNSNV 80
           F  F     NL LQ  A + ++G LRLTN           +G+AFYS+ ++  ++    V
Sbjct: 8   FQRFN--ETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTV 65

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+TSF   I          GLAF + P          +LGL + +   N + H  AVE
Sbjct: 66  ASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGS---NSNFHTVAVE 122

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           FDT+ + ++ D  + HIGID+NS++S  +                   G+   V + YDS
Sbjct: 123 FDTLYNKDW-DPTERHIGIDVNSIRSIKT------------TRWDFVNGENAEVLITYDS 169

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSF 257
           + N+L  ++    S+    I+S  VDL  +  E++ VGFSA+TG+      +++VL WSF
Sbjct: 170 STNLLVASLVY-PSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 3e-60
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 20/235 (8%)

Query: 319 EDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK 378
           ++WE+     R + + +++          LG G FG+V+ G  +N  T+VAVK +  +  
Sbjct: 6   DEWEVP----RETLKLVER----------LGAGQFGEVWMGY-YNGHTKVAVKSL-KQGS 49

Query: 379 QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNW 438
                F++E   + +L+H+ LV+L      +  + ++ ++M NGSL  FL       L  
Sbjct: 50  MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTI 108

Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP 498
            +   +   +A G+ ++ E   +  IHRD++A+N+L+   L+ K+ DFGLA+L E     
Sbjct: 109 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165

Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
           A       + + APE    G  +  SDV++FG LL E+    R         E++
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  198 bits (504), Expect = 9e-60
 Identities = 67/239 (28%), Positives = 98/239 (41%), Gaps = 22/239 (9%)

Query: 26  FFPGFKDLSNNLTLQGIAKIENNGILRLTND------TSRKMGQAFYSSTLRFKNSLNSN 79
           F+         +T  G A     G L+LT             GQA YS  +   +S    
Sbjct: 11  FWSYSLKNGTEITFLGDATR-IPGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGK 68

Query: 80  VFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFS-NHLFA 138
             SF TSF   ++  Y      GLAF ++P +        +LGL       + S N + A
Sbjct: 69  AASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVA 127

Query: 139 VEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDY 198
           VEFDT  + ++ D    HIGID+NS+ S A+            ++    G       + Y
Sbjct: 128 VEFDTWINKDWNDPPYPHIGIDVNSIVSVATT---------RWENDDAYGSSIATAHITY 178

Query: 199 DSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSF 257
           D+   IL V +S      +  ILS  VDL+ +  + + +GFSA  G       +L W F
Sbjct: 179 DARSKILTVLLSY--EHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHF 234

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  197 bits (501), Expect = 2e-59
 Identities = 70/244 (28%), Positives = 117/244 (47%), Gaps = 23/244 (9%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND-----TSRKMGQAFYSSTLRFKNSLNSNVF 81
           FP F      L  QG A + + G+L+LTN      +S+ +G+A Y++  +  +S   NV 
Sbjct: 8   FPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVA 67

Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           SF TSF  +I    P     GLAF ++P +         LG+         SN + AVEF
Sbjct: 68  SFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNK-SNQIVAVEF 126

Query: 142 DTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSA 201
           DT  + ++ D    H+GI++NS++S  +               +   G+   V++ Y+++
Sbjct: 127 DTFSNGDW-DPKGRHLGINVNSIESIKT------------VPWNWTNGEVANVFISYEAS 173

Query: 202 ENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFK 258
              L  ++    S     I+   VD+  +  E++  GFSA+TG+      +++VL WSF+
Sbjct: 174 TKSLTASLVYP-SLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFE 232

Query: 259 INGP 262
            N P
Sbjct: 233 SNLP 236

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  196 bits (500), Expect = 2e-59
 Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 26/242 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS-----RKMGQAFYSSTLRFKNSLNSNVF 81
           F  F    NNL LQ  A + + G L LT   +       +G+A Y++ +   ++  + + 
Sbjct: 8   FTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN--TTLA 65

Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEF 141
           SF+TSF+ V+          GLAF ++P +        +LGL       + S    AVEF
Sbjct: 66  SFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRA-HDASYQTVAVEF 124

Query: 142 DTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSA 201
           DT  +    D N  HIGID N ++S  +                +  G+   + + Y ++
Sbjct: 125 DTYSNAW--DPNYTHIGIDTNGIESKKT------------TPFDMVYGEKANIVITYQAS 170

Query: 202 ENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLGWSFK 258
              L  ++           +S RVDL  I  E++ VGFSA+TGL   +  +H+++ WSF 
Sbjct: 171 TKALAASLVFP-VSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFA 229

Query: 259 IN 260
           ++
Sbjct: 230 VS 231

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (489), Expect = 6e-57
 Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 4/227 (1%)

Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           P   +Y + +    + + K  LG G +G+VY+G        VAVK +  ++ + V EF+ 
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62

Query: 387 EIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIK 446
           E A +  ++H NLVQL+G C R+    ++ +FM  G+L  +L +  +  ++      +  
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 447 GVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGT 506
            ++S + YL +   +  IHRD+ A N L+      K+ DFGL++L    T  A       
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
           + + APE+    K S  SDV+AFG LL E+A             ++ 
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  189 bits (481), Expect = 1e-56
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 25/242 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND------TSRKMGQAFYSSTLRFKNSLNSNV 80
           FP F     NL  QG A+I+NN  ++LT         +  +G+  +S+ +      +S V
Sbjct: 8   FPTFPSDQKNLIFQGDAQIKNNA-VQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRV 66

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL-NGLPSQYLGLLNSTDIGN-FSNHLFA 138
            +F + F+  +             F   P   + +G     LGL       N  +N + A
Sbjct: 67  ANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIA 126

Query: 139 VEFDTVQDFEFQDI--NDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWV 196
           VEFDT    +      N  HIGID+NS++S                    + G+++ V V
Sbjct: 127 VEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVK------------TVKWDRRDGQSLNVLV 174

Query: 197 DYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWS 256
            ++ +   L+V  +   S      +S+ VD+  +  E++ VGFSA++G    +H +  WS
Sbjct: 175 TFNPSTRNLDVVATY--SDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWS 232

Query: 257 FK 258
           F 
Sbjct: 233 FT 234

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 2e-56
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 13/219 (5%)

Query: 332 YQELKQATN---NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEI 388
           Y+ + +  N    +     LG G FG+VYK     +    A K I  +S++ + +++ EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
             +    H N+V+L+     + +L ++ +F A G++D+ + +  +  L   Q   + K  
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLG 508
              L YLH   +  +IHRD+KA N+L   + + KL DFG++           +  +GT  
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPY 175

Query: 509 YLAPE-----TPRTGKSSASSDVFAFGALLLEVACGRRP 542
           ++APE     T +       +DV++ G  L+E+A    P
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 3e-56
 Identities = 67/245 (27%), Positives = 130/245 (53%), Gaps = 22/245 (8%)

Query: 330 YSYQELKQATNNFSAK---------QLLGHGGFGQVYKGTLHNS---KTEVAVKRI-SNE 376
           +++++  +A   F+ +         Q++G G FG+V  G L      +  VA+K + S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 377 SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVL 436
           +++  R+F+SE + +G+  H N++ L G   +   ++++ +FM NGSLDSFL        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
              Q   +++G+A+G+ YL    +   +HRD+ A N+L++S L  K+ DFGL++  E  T
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 497 NPATTR----VVGTLGYLAPETPRTGKSSASSDVFAFGALLLE-VACGRRPIETRALPEE 551
           +  T          + + APE  +  K +++SDV+++G ++ E ++ G RP       + 
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 552 LVLVD 556
           +  ++
Sbjct: 243 INAIE 247

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  188 bits (478), Expect = 4e-56
 Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 25/243 (10%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTND-----TSRKMGQAFYSSTLRFKNSLNSNVF 81
              F     +L  QG A + + G+L+LT           +G+A Y++ +R   +   +V 
Sbjct: 8   INNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVA 67

Query: 82  SFSTSFAIVIVPEYPRLGGHGLAFTISPSN-DLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
           SFSTSF  V+    P +   GLAF ++P +  +          L +    + SN + AVE
Sbjct: 68  SFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVE 127

Query: 141 FDTVQDFEFQ--DINDNHIGIDINSMKSNASVEAAVYTDNSTKQD-LSLKGGKAILVWVD 197
           FDT     +   D N  HIGID+N ++S  +V+               L   K ++  + 
Sbjct: 128 FDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNKTLIASLV 187

Query: 198 YDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL--ASSHNVLGW 255
           Y               S      ++  VDL  I  E++ VGFSA+TG      +H+VL W
Sbjct: 188 YP--------------SNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSW 233

Query: 256 SFK 258
           SF 
Sbjct: 234 SFT 236

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 6e-56
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 6/214 (2%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            +   +  LG G FG+V+ GT  N  T VA+K +          F+ E   + +LRH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           VQL         + +V ++M+ GSL  FL  E    L   Q   +   +ASG+ Y+    
Sbjct: 75  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
               +HRD++A+N+L+   L  K+ DFGLA+L E     A       + + APE    G+
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 520 SSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
            +  SDV++FG LL E+    R      +  E++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-55
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 7/218 (3%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
            + +  + LG G FG V  G     + +VA+K I  E      EF+ E   +  L H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           VQL G C ++  + ++ ++MANG L ++L +        +Q  ++ K V   + YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLES-- 118

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
            +  +HRD+ A N L++ +   K+ DFGL++        ++      + +  PE     K
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 520 SSASSDVFAFGALLLEV-ACGRRPIETRALPEELVLVD 556
            S+ SD++AFG L+ E+ + G+ P E     E    + 
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  184 bits (468), Expect = 7e-55
 Identities = 69/240 (28%), Positives = 108/240 (45%), Gaps = 33/240 (13%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNV 80
           FP F    + L LQG A I + G L+LT   S        +G+AFYS  ++ K+S  +NV
Sbjct: 8   FPNFHT-DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS--NNV 64

Query: 81  FSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVE 140
            SF+T+F  +I  +   +  +GLAF + P N       ++LG+ N+ +    +    AV 
Sbjct: 65  ASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNN-PEPNARTVAVV 123

Query: 141 FDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDS 200
           F+T ++    D + N I   +N                          G+   V + YDS
Sbjct: 124 FNTFKN--RIDFDKNFIKPYVNENCDF-----------------HKYNGEKTDVQITYDS 164

Query: 201 AENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA---SSHNVLGWSF 257
           + N L V +           +S  V L    +E++ VGFS ++GL      +H+VL WSF
Sbjct: 165 SNNDLRVFLHFT-VSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSF 223

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-54
 Identities = 70/215 (32%), Positives = 103/215 (47%), Gaps = 12/215 (5%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
                 Q +G G FG V  G       +VAVK I N++    + F++E + + +LRH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62

Query: 400 VQLVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           VQL+G     KG L +V ++MA GSL  +L    ++VL  +   K    V   + YL   
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
                +HRD+ A NVL+  +   K+ DFGL K      +         + + APE  R  
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175

Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
           K S  SDV++FG LL E+    R    R   +++V
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-54
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 6/214 (2%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           +  +  Q +G G FG V+ G   N K +VA+K I  E      +F+ E   + +L H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           VQL G C  +  + LV++FM +G L  +L  +   +   E    +   V  G+       
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGM---AYLE 118

Query: 460 EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGK 519
           E  VIHRD+ A N L+      K+ DFG+ +        ++T     + + +PE     +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 520 SSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
            S+ SDV++FG L+ EV    +         E+V
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-54
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 9/210 (4%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRN 398
           ++     +G G +G+  K    +    +  K +   + ++   +  VSE+  +  L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 399 LVQLVGWC--RRKGDLLLVYDFMANGSLDSFLFDEPKA--VLNWEQRFKIIKGVASGLLY 454
           +V+       R    L +V ++   G L S +    K    L+ E   +++  +   L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 455 LHE--GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAP 512
            H        V+HRD+K +NV LD + N KLGDFGLA++  H T+ A    VGT  Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           E       +  SD+++ G LL E+     P
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPP 213

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 5e-54
 Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 28/269 (10%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVG 404
           ++ +G G FG+V++G       EVAVK  S+  ++      +EI     LRH N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 405 WCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY- 459
              +       L LV D+  +GSL  +L       +  E   K+    ASGL +LH    
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 460 ----EQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGTLGYLAP 512
               +  + HRD+K+ N+L+       + D GLA  ++  T+    A    VGT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 513 E------TPRTGKSSASSDVFAFGALLLEVACGRRPI----ETRALPEELVLVDWVWGKY 562
           E        +  +S   +D++A G +  E+A          + +    +LV  D    + 
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 563 GEGRVLEVIDPKLNAEYDQSQVLMGELEL 591
            +    + + P +   +   + L    ++
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKI 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 5e-54
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 11/219 (5%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN---ESKQGVREFVSEIATIGRLRH 396
            +F   + LG G FG VY      SK  +A+K +     E      +   E+     LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
            N+++L G+      + L+ ++   G++   L    K   + ++    I  +A+ L Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
               + VIHRD+K  N+LL S    K+ DFG +    H  +   T + GTL YL PE   
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIE 177

Query: 517 TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                   D+++ G L  E   G+ P E     E    +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (469), Expect = 7e-54
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 16/220 (7%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG---VREFVSEIATIGRLRHRN 398
           FS  + +GHG FG VY      +   VA+K++S   KQ     ++ + E+  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
            +Q  G   R+    LV ++    + D     +    L   +   +  G   GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH-- 132

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE---TP 515
               +IHRDVKA N+LL      KLGDFG A +            VGT  ++APE     
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAM 186

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
             G+     DV++ G   +E+A  + P+        L  +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 3e-53
 Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 7/217 (3%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN 398
              ++  + +G G  G VY      +  EVA+++++ + +      ++EI  +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V  +       +L +V +++A GSL   + +      +  Q   + +     L +LH  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLH-- 133

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
               VIHRD+K+ N+LL  + + KL DFG         +  +T +VGT  ++APE     
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 191

Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                 D+++ G + +E+  G  P         L L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-52
 Identities = 61/231 (26%), Positives = 113/231 (48%), Gaps = 12/231 (5%)

Query: 333 QELKQATNNFSAKQL-LGHGGFGQVYKGTLH--NSKTEVAVKRISNESKQG-VREFVSEI 388
           ++L    +N     + LG G FG V +G       + +VA+K +   +++    E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 389 ATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGV 448
             + +L +  +V+L+G C+ +  L+LV +    G L  FL  + +  +      +++  V
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118

Query: 449 ASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGT 506
           + G+ YL E   +  +HRD+ A NVLL +    K+ DFGL+K    +     A +     
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 507 LGYLAPETPRTGKSSASSDVFAFGALLLEV-ACGRRPIETRALPEELVLVD 556
           L + APE     K S+ SDV+++G  + E  + G++P +    PE +  ++
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-52
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 14/213 (6%)

Query: 348 LGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           +G G F  VYKG    +  EVA   + +   +K   + F  E   +  L+H N+V+    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 406 C----RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQ 461
                + K  ++LV + M +G+L ++L       +  +      + +  GL +LH     
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RTP 133

Query: 462 VVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
            +IHRD+K  N+ +       K+GD GLA L           V+GT  ++APE     K 
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEM-YEEKY 189

Query: 521 SASSDVFAFGALLLEVACGRRPIETRALPEELV 553
             S DV+AFG  +LE+A    P        ++ 
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (461), Expect = 3e-52
 Identities = 55/241 (22%), Positives = 103/241 (42%), Gaps = 13/241 (5%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           +++   + LG G FG V++ T   +    A K +    +        EI T+  LRH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           V L        +++++Y+FM+ G L   + DE    ++ ++  + ++ V  GL ++H   
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH--- 141

Query: 460 EQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
           E   +H D+K  N++  ++ +   KL DFGL    +   +   T   GT  + APE    
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 199

Query: 518 GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA 577
                 +D+++ G L   +  G  P       E L  V     K  +  + +     ++ 
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGISE 254

Query: 578 E 578
           +
Sbjct: 255 D 255

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 6e-52
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 8/219 (3%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIATIGRLRHRN 398
            ++   Q LG G +G+V       ++  VAVK +  +      E    EI     L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+  G  R      L  ++ + G L   +  +    +      +    + +G++YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH-- 120

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRT 517
               + HRD+K  N+LLD   N K+ DFGLA ++ +        ++ GTL Y+APE  + 
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 518 GK-SSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
            +  +   DV++ G +L  +  G  P +  +   +    
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-51
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 13/202 (6%)

Query: 348 LGHGGFGQVYKGTLHNSKT--EVAVKRISNESKQG--VREFVSEIATIGRLRHRNLVQLV 403
           LG G FG V KG     K    VAVK + NE+       E ++E   + +L +  +V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 404 GWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVV 463
           G C  +   +LV +    G L+ +L       +  +   +++  V+ G+ YL E      
Sbjct: 75  GICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE---SNF 128

Query: 464 IHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPETPRTGKSS 521
           +HRD+ A NVLL ++   K+ DFGL+K    +     A T     + + APE     K S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 522 ASSDVFAFGALLLE-VACGRRP 542
           + SDV++FG L+ E  + G++P
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP 210

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (447), Expect = 7e-51
 Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 32/252 (12%)

Query: 331 SYQELKQATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQGVR-EF 384
               L+   NN    + +G G FG+V++            T VAVK +  E+   ++ +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 385 VSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD-------------- 430
             E A +    + N+V+L+G C     + L++++MA G L+ FL                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 431 --------EPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK 482
                        L+  ++  I + VA+G+ YL E      +HRD+   N L+   +  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 483 LGDFGLAK-LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRR 541
           + DFGL++ +Y      A       + ++ PE+    + +  SDV+A+G +L E+     
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 542 PIETRALPEELV 553
                   EE++
Sbjct: 241 QPYYGMAHEEVI 252

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-50
 Identities = 65/261 (24%), Positives = 109/261 (41%), Gaps = 34/261 (13%)

Query: 323 LEVGPQRYSYQELKQ-ATNNFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRISNE 376
             V  + Y Y    +    N    ++LG G FG+V   T +         +VAVK +  +
Sbjct: 19  FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 78

Query: 377 SKQGVRE-FVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF----- 429
           +    RE  +SE+  + +L  H N+V L+G C   G + L++++   G L ++L      
Sbjct: 79  ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138

Query: 430 ----------------DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNV 473
                           +E   VL +E        VA G+ +L     +  +HRD+ A NV
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 195

Query: 474 LLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGAL 532
           L+      K+ DFGLA+ +               + ++APE+   G  +  SDV+++G L
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255

Query: 533 LLE-VACGRRPIETRALPEEL 552
           L E  + G  P     +    
Sbjct: 256 LWEIFSLGVNPYPGIPVDANF 276

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-50
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 23/232 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNS--KTEVAVKRISNE-SKQGVREFVSEIATIGRL-R 395
           N+   + ++G G FGQV K  +     + + A+KR+    SK   R+F  E+  + +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL--------------FDEPKAVLNWEQR 441
           H N++ L+G C  +G L L  ++  +G+L  FL               +   + L+ +Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 442 FKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATT 501
                 VA G+ YL +   +  IHRD+ A N+L+      K+ DFGL++  E       T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 502 RVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
                + ++A E+      + +SDV+++G LL E+              EL 
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-49
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 28/247 (11%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNESKQGVRE-FVSEIATIGR 393
           N  S  + LG G FG+V + T +     ++   VAVK +   +    RE  +SE+  +  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 394 L-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFL----------------FDEPKAVL 436
           L  H N+V L+G C   G  L++ ++   G L +FL                 ++ +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHG 495
           + E        VA G+ +L     +  IHRD+ A N+LL      K+ DFGLA+ +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
                      + ++APE+      +  SDV+++G  L E+           +P +    
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVDSKFY 258

Query: 556 DWVWGKY 562
             +   +
Sbjct: 259 KMIKEGF 265

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-49
 Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 9/214 (4%)

Query: 333 QELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIA 389
           Q  K+   +F   ++LG G F  V       +  E A+K +       +  V     E  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 390 TIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA 449
            + RL H   V+L    +    L     +  NG L  ++        +          + 
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIV 118

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH-GTNPATTRVVGTLG 508
           S L YLH    + +IHRD+K  N+LL+ +++ ++ DFG AK+             VGT  
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 509 YLAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           Y++PE      +  SSD++A G ++ ++  G  P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-49
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 23/238 (9%)

Query: 320 DWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSK---TEVAVKRISNE 376
           D+E++   +R                  +G G FG V++G   + +     VA+K   N 
Sbjct: 1   DYEIQ--RERIELGRC------------IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC 46

Query: 377 SKQGVRE-FVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV 435
           +   VRE F+ E  T+ +  H ++V+L+G    +  + ++ +    G L SFL     + 
Sbjct: 47  TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS- 104

Query: 436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG 495
           L+          +++ L YL     +  +HRD+ A NVL+ S    KLGDFGL++  E  
Sbjct: 105 LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

Query: 496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
           T    ++    + ++APE+    + +++SDV+ FG  + E+              +++
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 3e-49
 Identities = 61/221 (27%), Positives = 114/221 (51%), Gaps = 11/221 (4%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNS----KTEVAVKRISNESKQGVR-EFVSEIATIGRL 394
           +  + ++++G G FG+VYKG L  S    +  VA+K +     +  R +F+ E   +G+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 395 RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLY 454
            H N+++L G   +   ++++ ++M NG+LD F   E     +  Q   +++G+A+G+ Y
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 455 LHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRV--VGTLGYLAP 512
           L        +HRD+ A N+L++S L  K+ DFGL+++ E       T       + + AP
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
           E     K +++SDV++FG ++ EV              E++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  167 bits (425), Expect = 6e-49
 Identities = 63/234 (26%), Positives = 97/234 (41%), Gaps = 44/234 (18%)

Query: 27  FPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTS 86
              F     NL LQG A + +NG L+L+ ++   M +AFYS+ ++ ++S   NV SF T+
Sbjct: 8   IDAFN--KTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTN 65

Query: 87  FAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQD 146
           F + I          GL F + P                             VEFDT   
Sbjct: 66  FTMNIRTHRQANSAVGLDFVLVPVQ------------------PESKGDTVTVEFDTFLS 107

Query: 147 FEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILN 206
               D+N+N I                     S   D+    G+   V + Y+S+  + +
Sbjct: 108 RISIDVNNNDI--------------------KSVPWDVHDYDGQNAEVRITYNSSTKVFS 147

Query: 207 VTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASS---HNVLGWSF 257
           V++S   S  K   +S  V+L     +++ VGFSA++G    S   H+VL WSF
Sbjct: 148 VSLSNP-STGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF 200

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-49
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 14/221 (6%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNESKQG-VREFVSEIATIGRLRH 396
           +F   +++G G FG VY GTL ++   K   AVK ++  +  G V +F++E   +    H
Sbjct: 30  HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 397 RNLVQLVGWC-RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
            N++ L+G C R +G  L+V  +M +G L +F+ +E       +        VA G+ +L
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL 146

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG---TNPATTRVVGTLGYLAP 512
                +  +HRD+ A N +LD +   K+ DFGLA+        +    T     + ++A 
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 513 ETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
           E+ +T K +  SDV++FG LL E+     P        ++ 
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  171 bits (435), Expect = 2e-48
 Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 14/265 (5%)

Query: 316 EVIEDWELEVGPQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISN 375
           +  ED   +  PQ    ++     + +   + LG G FG V++     +      K I+ 
Sbjct: 6   KFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64

Query: 376 ESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAV 435
                     +EI+ + +L H  L+ L      K +++L+ +F++ G L   +  E    
Sbjct: 65  PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK- 123

Query: 436 LNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYE 493
           ++  +    ++    GL ++H   E  ++H D+K  N++ +++     K+ DFGLA    
Sbjct: 124 MSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

Query: 494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
                       T  + APE          +D++A G L   +  G  P       E L 
Sbjct: 181 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238

Query: 554 LVDWVWGKYGEGRVLEVIDPKLNAE 578
            V     K  +    E     ++ E
Sbjct: 239 NV-----KRCDWEFDEDAFSSVSPE 258

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (419), Expect = 7e-47
 Identities = 48/212 (22%), Positives = 94/212 (44%), Gaps = 5/212 (2%)

Query: 332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE-FVSEIAT 390
           +++ +   + +  + +LG G F +V       ++  VA+K I+ ++ +G      +EIA 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 391 IGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
           + +++H N+V L       G L L+   ++ G L   + ++           ++I  V  
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLD 118

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            + YLH+        +        LD +    + DFGL+K+ + G+    +   GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYV 176

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           APE       S + D ++ G +   + CG  P
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 4e-46
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 14/226 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNE---SKQGVREFVSEIATIGR 393
            +    + LG G FG V +G           VAVK +  +     + + +F+ E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           L HRNL++L G       + +V +    GSL   L              +    VA G+ 
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMG 125

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP--ATTRVVGTLGYLA 511
           YL     +  IHRD+ A N+LL +    K+GDFGL +      +             + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 512 PETPRTGKSSASSDVFAFGALLLE-VACGRRPIETRALPEELVLVD 556
           PE+ +T   S +SD + FG  L E    G+ P       + L  +D
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-45
 Identities = 61/267 (22%), Positives = 121/267 (45%), Gaps = 30/267 (11%)

Query: 327 PQRYSYQELKQA------TNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISN 375
           P+ +S  ++             +  + LG G FG VY+G          +T VA+K ++ 
Sbjct: 1   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60

Query: 376 E-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLF----- 429
             S +   EF++E + +      ++V+L+G   +    L++ + M  G L S+L      
Sbjct: 61  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120

Query: 430 ---DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF 486
              +   A  +  +  ++   +A G+ YL+       +HRD+ A N ++  +   K+GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 177

Query: 487 GLAK-LYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET 545
           G+ + +YE        + +  + +++PE+ + G  +  SDV++FG +L E+A        
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--- 234

Query: 546 RALPEELVLVDWVWGKYGEGRVLEVID 572
              P + +  + V     EG +L+  D
Sbjct: 235 ---PYQGLSNEQVLRFVMEGGLLDKPD 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  163 bits (413), Expect = 2e-45
 Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 15/230 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLR- 395
           N+FS  +++G GGFG+VY     ++    A+K +  +    KQG    ++E   +  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 396 --HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
                +V +         L  + D M  G L   L        +          +  GL 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLE 121

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           ++H    + V++RD+K +N+LLD   + ++ D GLA  +           VGT GY+APE
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPE 175

Query: 514 TPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY 562
             + G +  +S+D F+ G +L ++  G  P       ++  +        
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-45
 Identities = 44/209 (21%), Positives = 89/209 (42%), Gaps = 9/209 (4%)

Query: 336 KQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR 395
           K+    +   + LG G FG V++    +SK     K +  +          EI+ +   R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           HRN++ L        +L+++++F++   +   + +     LN  +    +  V   L +L
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFL 118

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNG--KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPE 513
           H      + H D++  N++  +  +   K+ +FG A+  + G N           Y APE
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPE 173

Query: 514 TPRTGKSSASSDVFAFGALLLEVACGRRP 542
             +    S ++D+++ G L+  +  G  P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  159 bits (403), Expect = 6e-45
 Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 14/223 (6%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLR 395
           ++ +   ++LG GG  +V+         +VAVK +  +          F  E      L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 396 HRNLVQLVGWCRRKGD----LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           H  +V +      +        +V +++   +L   +  E    +  ++  ++I      
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--TTRVVGTLGY 509
           L + H+     +IHRDVK +N+++ +    K+ DFG+A+      N    T  V+GT  Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL 552
           L+PE  R     A SDV++ G +L EV  G  P    +     
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 11/218 (5%)

Query: 342 FSAKQLLGHGGFGQVYKGTLHNSKTE----VAVKRISNE-SKQGVREFVSEIATIGRLRH 396
           F   ++LG G FG VYKG       +    VA+K +    S +  +E + E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
            ++ +L+G C     + L+   M  G L  ++ +    +   +        +A G+ YL 
Sbjct: 71  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGTNPATTRVVGTLGYLAPETP 515
           +   + ++HRD+ A NVL+ +  + K+ DFGLAK L               + ++A E+ 
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELV 553
                +  SDV+++G  + E+              E+ 
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  158 bits (401), Expect = 1e-44
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 23/218 (10%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRIS---------NESKQGVREFVSEIATI 391
           N+  K++LG G    V +     +  E AVK I           E ++     + E+  +
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 392 GRLR-HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVAS 450
            ++  H N++QL           LV+D M  G L  +L ++    L+ ++  KI++ +  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLE 121

Query: 451 GLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
            +  LH   +  ++HRD+K  N+LLD ++N KL DFG +   + G       V GT  YL
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 176

Query: 511 APETPRTG------KSSASSDVFAFGALLLEVACGRRP 542
           APE                 D+++ G ++  +  G  P
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-44
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 10/215 (4%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGR-LR 395
            +F   ++LG G FG+V+      +    A+K +  +       V   + E   +     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
           H  L  +    + K +L  V +++  G L   +    K   +  +       +  GL +L
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETP 515
           H    + +++RD+K  N+LLD + + K+ DFG+ K    G     T   GT  Y+APE  
Sbjct: 120 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEIL 175

Query: 516 RTGKSSASSDVFAFGALLLEVACGRRPIETRALPE 550
              K + S D ++FG LL E+  G+ P   +   E
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-44
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 33/257 (12%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLH-------NSKTEVAVKRISNE-SKQGVREFVSEIATI 391
           +     + LG G FGQV             N  T+VAVK + ++ +++ + + +SE+  +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 392 GRL-RHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFD--------------EPKAVL 436
             + +H+N++ L+G C + G L ++ ++ + G+L  +L                 P+  L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 437 NWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT 496
           + +        VA G+ YL     +  IHRD+ A NVL+  +   K+ DFGLA+   H  
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 497 NPATTRV-VGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLV 555
               T      + ++APE       +  SDV++FG LL E+            P   V V
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGVPV 243

Query: 556 DWVWGKYGEGRVLEVID 572
           + ++    EG  ++   
Sbjct: 244 EELFKLLKEGHRMDKPS 260

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 5e-44
 Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 17/284 (5%)

Query: 339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-VREFVSEIATIGRLRHR 397
              ++    +G G +G V     + +K  VA+K+IS    Q   +  + EI  + R RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKA-VLNWEQRFKIIKGVASGLLYLH 456
           N++ +    R      +   ++    + + L+   K   L+ +     +  +  GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY--EHGTNPATTRVVGTLGYLAPET 514
                 V+HRD+K SN+LL++  + K+ DFGLA++   +H      T  V T  Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 515 PRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP 573
                  + S D+++ G +L E+   R     +   ++L  +  + G   +  +  +I+ 
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSL 617
           K              L LP   + P +     A     DLL+ +
Sbjct: 244 KAR---------NYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-43
 Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 17/279 (6%)

Query: 341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHRN 398
           NF   + +G G +G VYK     +   VA+K+I    E++      + EI+ +  L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +V+L+     +  L LV++F+ +  L  F+       +        +  +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120

Query: 459 YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTG 518
               V+HRD+K  N+L+++E   KL DFGLA+ +       T  VV              
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 519 KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE 578
             S + D+++ G +  E+   R      +  ++L  +    G            P     
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-----------TPDEVVW 227

Query: 579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSL 617
              + +   +   P   R   S       E    LL+ +
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 31/256 (12%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESKQG-VREFVSEIATIGR 393
           +     + LG G FGQV +          +   VAVK +   +     R  +SE+  +  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 394 -LRHRNLVQLVGWCRRKGD-LLLVYDFMANGSLDSFLF--------------DEPKAVLN 437
              H N+V L+G C + G  L+++ +F   G+L ++L               D  K  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK-LYEHGT 496
            E        VA G+ +L     +  IHRD+ A N+LL  +   K+ DFGLA+ +Y+   
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVD 556
                     L ++APET      +  SDV++FG LL E+               + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDE 244

Query: 557 WVWGKYGEGRVLEVID 572
               +  EG  +   D
Sbjct: 245 EFCRRLKEGTRMRAPD 260

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 6e-42
 Identities = 71/278 (25%), Positives = 109/278 (39%), Gaps = 24/278 (8%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-----VREFVSEIATIGRLRHRNLV 400
             LG G F  VYK    N+   VA+K+I    +        R  + EI  +  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 401 QLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYE 460
            L+     K ++ LV+DFM        +  +   VL        +     GL YLH+   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--- 118

Query: 461 QVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS 520
             ++HRD+K +N+LLD     KL DFGLAK +    N A T  V T  Y APE     + 
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARM 177

Query: 521 -SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEY 579
                D++A G +L E+      +   +  ++L             R+ E +      ++
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT------------RIFETLGTPTEEQW 225

Query: 580 DQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSL 617
                L   +        P       A +   DL+  L
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 263

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-41
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 28/266 (10%)

Query: 327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVS 386
           PQ  SY + K          ++G+G FG VY+  L +S   VA+K++  + +   R    
Sbjct: 17  PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---- 62

Query: 387 EIATIGRLRHRNLVQLVGWCRRKGD------LLLVYDFMANGSLDSFL-FDEPKAVLNWE 439
           E+  + +L H N+V+L  +    G+      L LV D++          +   K  L   
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122

Query: 440 QRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEHGTNP 498
                +  +   L Y+H      + HRD+K  N+LLD +    KL DFG AK    G   
Sbjct: 123 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

Query: 499 ATTRVVGTLGYLAP-ETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDW 557
            +   + +  Y AP         ++S DV++ G +L E+  G+      +  ++LV +  
Sbjct: 180 VSY--ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

Query: 558 VWGKYGEGRVLEVIDPKLNAEYDQSQ 583
           V G     ++ E+       ++ Q +
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIK 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (379), Expect = 3e-41
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 12/206 (5%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
            +F   + LG G FG+V+     ++    A+K +  E     + V     E   +  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
             ++++ G  +    + ++ D++  G L S L    +              V   L YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLH 121

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
               + +I+RD+K  N+LLD   + K+ DFG AK         T  + GT  Y+APE   
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVS 174

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
           T   + S D ++FG L+ E+  G  P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 1e-40
 Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 19/239 (7%)

Query: 338 ATNNFSAKQLLGHGGFGQVYKGT-LHNSKTEVAVKRISNES------KQGVREFVSEIAT 390
           A   +     +G G +G+V+K   L N    VA+KR+  ++         +RE V+ +  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRH 63

Query: 391 IGRLRHRNLVQLVGWC-----RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKII 445
           +    H N+V+L   C      R+  L LV++ +       +L   P+  +  E    ++
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMM 122

Query: 446 KGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVG 505
             +  GL +LH      V+HRD+K  N+L+ S    KL DFGLA++Y        T VV 
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV 177

Query: 506 TLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE 564
           TL Y APE       +   D+++ G +  E+   +      +  ++L  +  V G  GE
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 19/280 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHR 397
             +   + +G G +G VYK   +N     A+K+I    E +      + EI+ +  L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           N+V+L      K  L+LV++ +           E    L        +  + +G+ Y H+
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD 118

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
              + V+HRD+K  N+L++ E   K+ DFGLA+ +       T  +V            +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 518 GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA 577
            K S + D+++ G +  E+  G       +  ++L+ +  + G            P    
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG-----------TPNSKN 224

Query: 578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSL 617
             + +++   +         P  S      E   DLL+ +
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-40
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 18/206 (8%)

Query: 345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLV 403
            Q+LG G  G+V +     ++ + A+K + +  K        E+    R  +  ++V++V
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 404 GWCR----RKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
                    +  LL+V + +  G L S + D         +  +I+K +   + YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128

Query: 460 EQVVIHRDVKASNVLLDSELNG---KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
              + HRDVK  N+L  S+      KL DFG AK      +  T     T  Y+APE   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
             K   S D+++ G ++  + CG  P
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (368), Expect = 6e-40
 Identities = 53/231 (22%), Positives = 90/231 (38%), Gaps = 15/231 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNL 399
           N +   + +G G FG +Y GT   +  EVA+K    ++K    +   E      ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 400 VQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGY 459
           +  + WC  +GD  ++   +   SL+  LF+      + +    +   + S + Y+H   
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 460 EQVVIHRDVKASNVLLDSELNGKL---GDFGLAKLYEHGTN------PATTRVVGTLGYL 510
               IHRDVK  N L+     G L    DFGLAK Y                + GT  Y 
Sbjct: 124 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 511 APETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGK 561
           +  T    + S   D+ + G +L+    G  P +      +    + +  K
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score =  143 bits (363), Expect = 7e-40
 Identities = 38/125 (30%), Positives = 62/125 (49%), Gaps = 14/125 (11%)

Query: 133 SNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAI 192
           ++ + AVE DT  + +  D +  HIGIDI S++S  +               +++ GK  
Sbjct: 1   ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTA------------KWNMQNGKVG 48

Query: 193 LVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNV 252
              + Y+S +  L+  VS          +S+ VDL  +  E++ VG SASTGL   ++ +
Sbjct: 49  TAHIIYNSVDKRLSAVVSY--PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTI 106

Query: 253 LGWSF 257
           L WSF
Sbjct: 107 LSWSF 111

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 99.2 bits (247), Expect = 4e-24
 Identities = 31/129 (24%), Positives = 53/129 (41%), Gaps = 10/129 (7%)

Query: 8   FSALIFLSIPVSSQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKM 61
           F++ +  +    +      F  F     +L LQG A    +G L LT  +S        +
Sbjct: 111 FTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSV 170

Query: 62  GQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISP--SNDLNGLPSQ 119
           G+A + + +    S ++ V SF  +F  +I          G+AF IS   S+  +G   +
Sbjct: 171 GRALFYAPVHIWES-SAVVASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGR 228

Query: 120 YLGLLNSTD 128
            LGL    +
Sbjct: 229 LLGLFPDAN 237

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-39
 Identities = 59/206 (28%), Positives = 87/206 (42%), Gaps = 9/206 (4%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           N+F   +LLG G FG+V       +    A+K +  E   +K  V   V+E   +   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
             L  L    +    L  V ++   G L   L  E       E+       + S L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH 122

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
               + V++RD+K  N++LD + + K+ DFGL K              GT  YLAPE   
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLE 178

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
                 + D +  G ++ E+ CGR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 65/292 (22%), Positives = 123/292 (42%), Gaps = 27/292 (9%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHR 397
           + +     +G G FG+V+K     +  +VA+K++   NE +      + EI  +  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 398 NLVQLVGWC--------RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVA 449
           N+V L+  C        R KG + LV+DF  +           K      +  ++++ + 
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLL 127

Query: 450 SGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP---ATTRVVGT 506
           +GL   +  +   ++HRD+KA+NVL+  +   KL DFGLA+ +    N      T  V T
Sbjct: 128 NGL---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 507 LGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEG 565
           L Y  PE     +      D++  G ++ E+      ++      +L L+  + G     
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 566 RVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSL 617
               V + +L  + +  +    + ++ D L+               DL++ L
Sbjct: 245 VWPNVDNYELYEKLELVK--GQKRKVKDRLKAYVRD------PYALDLIDKL 288

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-39
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI------SNESKQGVREFVSEIATIGR 393
           + +   + LG G F  V K    ++  + A K I      S+       +   E++ +  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 394 LRHRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLL 453
           ++H N++ L      K D++L+ + +A G L  FL ++    L  E+  + +K + +G+ 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVY 127

Query: 454 YLHEGYEQVVIHRDVKASNVLLDSE----LNGKLGDFGLAKLYEHGTNPATTRVVGTLGY 509
           YLH      + H D+K  N++L          K+ DFGLA   + G       + GT  +
Sbjct: 128 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEF 182

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
           +APE          +D+++ G +   +  G  P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (360), Expect = 8e-39
 Identities = 43/231 (18%), Positives = 86/231 (37%), Gaps = 19/231 (8%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN- 398
            ++   + +G G FG +++GT   +  +VA+K     S     +   E  T   L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG 458
           +  +  + +     +LV D +  G     L D      + +      K + + +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 118

Query: 459 YEQVVIHRDVKASNVLLDSELNG-----KLGDFGLAKLY------EHGTNPATTRVVGTL 507
            E+ +++RD+K  N L+    +       + DFG+ K Y      +H        + GT 
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 508 GYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWV 558
            Y++  T    + S   D+ A G + +    G  P +           + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 3e-38
 Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 17/213 (7%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVRE------FVSEIATIGR 393
           + +    LLG GGFG VY G   +    VA+K +  +      E         E+  + +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 394 LR--HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           +      +++L+ W  R    +L+ +             E  A L  E        V   
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEA 122

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNG-KLGDFGLAKLYEHGTNPATTRVVGTLGYL 510
           + + H      V+HRD+K  N+L+D      KL DFG   L +   +   T   GT  Y 
Sbjct: 123 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYS 176

Query: 511 APETPRTGK-SSASSDVFAFGALLLEVACGRRP 542
            PE  R  +    S+ V++ G LL ++ CG  P
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-38
 Identities = 55/259 (21%), Positives = 103/259 (39%), Gaps = 8/259 (3%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRI--SNESKQGVREFVSEIATIGRLRHR 397
             +   + +G G +G V+K     +   VA+KR+   ++ +      + EI  +  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 398 NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE 457
           N+V+L         L LV++F          FD     L+ E     +  +  GL + H 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 458 GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRT 517
              + V+HRD+K  N+L++     KL +FGLA+ +       +  VV             
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 518 GKSSASSDVFAFGALLLEVACGRRPIET-RALPEELVLVDWVWGKYGEGRVLEVIDPKLN 576
              S S D+++ G +  E+A   RP+     + ++L  +  + G   E +   +      
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 577 AEYDQSQVLMGELELPDTL 595
             Y         + +   L
Sbjct: 237 KPYPMYPATTSLVNVVPKL 255

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 8e-38
 Identities = 58/300 (19%), Positives = 114/300 (38%), Gaps = 31/300 (10%)

Query: 330 YSYQELKQATNNFSAK----QLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE 383
           +  QE+ +      A     Q +G G +G V       +  +VA+K++     S+   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRKG------DLLLVYDFMANGSLDSFLFDEPKAVLN 437
              E+  +  +RH N++ L+             D  LV  FM  G+    L    K  L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LG 119

Query: 438 WEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN 497
            ++   ++  +  GL Y+H      +IHRD+K  N+ ++ +   K+ DFGLA+      +
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADS 173

Query: 498 PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDW 557
             T  VV              + + + D+++ G ++ E+  G+   +     ++L  +  
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233

Query: 558 VWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSL 617
           V G             +        +       LP+  +   +S    A+    +LL  +
Sbjct: 234 VTGTP---------PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (346), Expect = 3e-36
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 12/206 (5%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE---SKQGVREFVSEIATIGRLRH 396
           + F   + LG G FG+V       S    A+K +  +     + +   ++E   +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 397 RNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLH 456
             LV+L    +   +L +V +++A G + S L    +   +          +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158

Query: 457 EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPR 516
                 +I+RD+K  N+L+D +   ++ DFG AK  +      T  + GT   LAPE   
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIIL 211

Query: 517 TGKSSASSDVFAFGALLLEVACGRRP 542
           +   + + D +A G L+ E+A G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-34
 Identities = 58/288 (20%), Positives = 112/288 (38%), Gaps = 20/288 (6%)

Query: 340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHR 397
             +   + +G G  G V           VA+K++S    ++   +    E+  +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 398 NLVQLVGWCRRKG------DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
           N++ L+     +       D+ LV + M          +        E+   ++  +  G
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCG 131

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           + +LH      +IHRD+K SN+++ S+   K+ DFGLA+    GT+   T  V T  Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 186

Query: 512 PETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI 571
           PE         + D+++ G ++ E+   +     R   ++   V    G      + ++ 
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 572 DPKLNAEYDQSQVLMGELE--LPDTLRGPRSSDGDKAAEGFDDLLNSL 617
               N   ++ +          PD+L    S      A    DLL+ +
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  130 bits (327), Expect = 4e-34
 Identities = 61/313 (19%), Positives = 115/313 (36%), Gaps = 25/313 (7%)

Query: 314 NAEVIEDWELEVGPQRYSYQELKQATNN---FSAKQLLGHGGFGQVYKGTLHNSKTEVAV 370
            A V  D       + + Y+       N   +   + LG G + +V++     +  +V V
Sbjct: 6   RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65

Query: 371 KRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGD--LLLVYDFMANGSLDSF 427
           K +    K+   +   EI  +  LR   N++ L    +        LV++ + N      
Sbjct: 66  KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122

Query: 428 LFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDF 486
                   L        +  +   L Y H      ++HRDVK  NV++D E    +L D+
Sbjct: 123 Y-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW 174

Query: 487 GLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPI-E 544
           GLA+ Y  G        V +  +  PE     +    S D+++ G +L  +   + P   
Sbjct: 175 GLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232

Query: 545 TRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGD 604
                ++LV +  V G       ++  + +L+  ++    ++G        R   S +  
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND---ILGRHSRKRWERFVHSENQH 289

Query: 605 KAAEGFDDLLNSL 617
             +    D L+ L
Sbjct: 290 LVSPEALDFLDKL 302

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-33
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 15/213 (7%)

Query: 340 NNFSAKQLLGHGGFGQVYKG---TLHNSKTEVAVKRIS----NESKQGVREFVSEIATIG 392
            NF   ++LG G +G+V+     + H++    A+K +      +  +      +E   + 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 393 RLRHR-NLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASG 451
            +R    LV L    + +  L L+ D++  G L + L    +      +    +  +   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLA 141

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPATTRVVGTLGYLA 511
           L +LH+     +I+RD+K  N+LLDS  +  L DFGL+K +            GT+ Y+A
Sbjct: 142 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 512 PETPRTGKS--SASSDVFAFGALLLEVACGRRP 542
           P+  R G S    + D ++ G L+ E+  G  P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 6e-32
 Identities = 55/279 (19%), Positives = 110/279 (39%), Gaps = 21/279 (7%)

Query: 330 YSYQELKQA----TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVRE 383
           +  QEL +        +     +G G +G V       +   VAVK++S    S    + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 384 FVSEIATIGRLRHRNLVQLVGWCRRK-----GDLLLVYDFMANGSLDSFLFDEPKAVLNW 438
              E+  +  ++H N++ L+            + + +   +    L++ +  +    L  
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTD 120

Query: 439 EQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP 498
           +    +I  +  GL Y+H      +IHRD+K SN+ ++ +   K+ DFGLA+  +     
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---E 174

Query: 499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWV 558
            T  V                 + + D+++ G ++ E+  GR         ++L L+  +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

Query: 559 WGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRG 597
            G  G   +L+ I  +    Y QS   M ++   +   G
Sbjct: 235 VGTPGA-ELLKKISSESARNYIQSLTQMPKMNFANVFIG 272

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (269), Expect = 3e-27
 Identities = 37/226 (16%), Positives = 70/226 (30%), Gaps = 23/226 (10%)

Query: 32  DLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVI 91
                    G A    + I R+      + G  +  +   F+N        +       +
Sbjct: 21  GTVPFWAHAGNAIPSADQI-RIAPSLKSQRGSVWTKTKAAFEN--------WEVEVTFRV 71

Query: 92  VPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQD 151
                R+G  GLA   + +  L+G      G  +         +   + FD+  +     
Sbjct: 72  TGRG-RIGADGLAIWYTENQGLDG---PVFGSADM-------WNGVGIFFDSFDNDG--K 118

Query: 152 INDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSP 211
            N+  I +  N+ + N   +    T  +          K   V       +  L V ++ 
Sbjct: 119 KNNPAIVVVGNNGQINYDHQNDGAT-QALASCQRDFRNKPYPVRAKITYYQKTLTVMINN 177

Query: 212 NSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSF 257
             +  K          + +     + G SA+TG LA  H+VL +  
Sbjct: 178 GFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 1e-25
 Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 19/213 (8%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGW 405
           + LG G F  V+      + T VA+K +  + K        EI  + R+   +  +    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 406 CRRKG-DLLLVYDFMANGSLDSFLFDE-------------PKAVLNWEQRFKIIKGVASG 451
                  LL  ++      +   +  E                 +      +I K +  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 452 LLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLAKLYEHG-TNPATTRVVGTLGY 509
           L Y+H      +IH D+K  NVL++       L    +A L      +   T  + T  Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 510 LAPETPRTGKSSASSDVFAFGALLLEVACGRRP 542
            +PE          +D+++   L+ E+  G   
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.1 bits (215), Expect = 2e-20
 Identities = 29/159 (18%), Positives = 55/159 (34%), Gaps = 20/159 (12%)

Query: 346 QLLGHGGFGQVYKGTLHNSKTEVAVK--RISNESKQGVR--------EFVSEIATIGRLR 395
           +L+G G    V+         E  VK  ++ + S + V+         F        R  
Sbjct: 6   KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 396 HRNLVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYL 455
            R L +L G    K     VY +  N  L   +  +    +  E   +++  +   +   
Sbjct: 65  FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 456 HEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH 494
           +    + ++H D+   NVL+  E    + DF  +     
Sbjct: 120 Y---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 31/243 (12%), Positives = 69/243 (28%), Gaps = 42/243 (17%)

Query: 20  SQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSN 79
           S  + L     +   +  TL    K+E      LT   + K G  +       K+++   
Sbjct: 7   SLPNLLEVTDQQKELSQWTLGDKVKLEEGRF-VLTPGKNTK-GSLWLKPEYSIKDAMTIE 64

Query: 80  VFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHL--F 137
               S  F              GLAF +   N+ +           +   G  S      
Sbjct: 65  WTFRSFGFR--------GSTKGGLAFWLKQGNEGDS----------TELFGGSSKKFNGL 106

Query: 138 AVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNS--TKQDLSLKGGKAILVW 195
            +             +D   G  + +  ++ + +  + +     +             + 
Sbjct: 107 MILLRL---------DDKL-GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLR 156

Query: 196 VDYDSAEN-ILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLG 254
           + Y+  +N +L + +       ++   + +V      +    +G SA       S  +L 
Sbjct: 157 LTYNPLDNHLLKLQM-----DNRVCFQTRKVKFMG--SSPFRIGTSAINDASKESFEILK 209

Query: 255 WSF 257
              
Sbjct: 210 MKL 212

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 33/225 (14%), Positives = 63/225 (28%), Gaps = 33/225 (14%)

Query: 30  FKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAI 89
            + + NN      A +E   I  LT++ + K G  +       K+S     F+   +F  
Sbjct: 18  TRKVPNNWQTGEQASLEEGRI-VLTSNQNSK-GSLWLKQGFDLKDS-----FTMEWTFRS 70

Query: 90  VIVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEF 149
           V    Y      G++F     +++      Y G +N             +  D       
Sbjct: 71  V---GYSGQTDGGISFWFVQDSNIPRDKQLYNGPVNYDG--------LQLLVDNNGPLGP 119

Query: 150 QDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAEN-ILNVT 208
                 + G              A                    + V YD  ++ +L V 
Sbjct: 120 TLRGQLNDGQKPVDKTKIYDQSFASCLMGY------QDSSVPSTIRVTYDLEDDNLLKVQ 173

Query: 209 VSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVL 253
           V           + F+       +    +G +A  G + ++    
Sbjct: 174 VDNK--------VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESF 210

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	652
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	100.0
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	100.0
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	100.0
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	100.0
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	100.0
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	100.0
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.95
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.94
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	99.84
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	99.8
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.92
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.47
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.53
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.46
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.17

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=1.4e-54  Score=425.31  Aligned_cols=226  Identities=31%  Similarity=0.423  Sum_probs=200.5

Q ss_pred             ceeEEcCCCCCC-CCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           22 LDELFFPGFKDL-SNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        22 ~~~f~~~~F~~~-~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      +++|+|++|.+. .++|+|+|+|.+. +|.|+||+..      ..++|||+|++||+||+..+|+++||+|+|+|.|.+.
T Consensus         1 ~~sF~f~~F~~~~~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~   79 (236)
T d1hqla_           1 SVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT   79 (236)
T ss_dssp             CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred             CEEEEeCCCCCCCcCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCC
Confidence            368999999764 4689999999985 8999999854      3578999999999999999999999999999999875


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCC-CCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecc
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIG-NFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAA  173 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~-~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~  173 (652)
                       ...+||||||||+|....++..|++||+++..+.+ ...+++|||||||++|.+++||++||||||+|++.|..+.++.
T Consensus        80 -~~~~gDGlAFvl~p~~~~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~~~  158 (236)
T d1hqla_          80 -GNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWE  158 (236)
T ss_dssp             -SSCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEECC
T ss_pred             -CCCCCceEEEEEeCCCCCCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccccc
Confidence             55689999999999876668899999999877654 4578999999999999999999999999999999998877653


Q ss_pred             eecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc-ccccee
Q 038860          174 VYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL-ASSHNV  252 (652)
Q Consensus       174 ~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~-~~~~~v  252 (652)
                               ..++.+|+.++|||+||+.+++|+|+|++.+  +..|++++.|||+.+|+++||||||||||.. .+.|.|
T Consensus       159 ---------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I  227 (236)
T d1hqla_         159 ---------DSDIFSGKIATARISYDGSAEILTVVLSYPD--GSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYI  227 (236)
T ss_dssp             ---------HHHHTSCSCEEEEEEEETTTTEEEEEEEETT--TEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEE
T ss_pred             ---------cccccCCCEEEEEEEEeCCCcEEEEEEecCC--CCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEE
Confidence                     4578899999999999999999999998753  5678899999999999999999999999975 577999


Q ss_pred             eccccccc
Q 038860          253 LGWSFKIN  260 (652)
Q Consensus       253 ~~w~f~~~  260 (652)
                      ++|+|++.
T Consensus       228 ~sWsF~s~  235 (236)
T d1hqla_         228 LSWRFSSN  235 (236)
T ss_dssp             EEEEEEEE
T ss_pred             EEeEeEec
Confidence            99999864

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=1.2e-53  Score=420.09  Aligned_cols=226  Identities=29%  Similarity=0.394  Sum_probs=199.3

Q ss_pred             CceeEEcCCCCC----CCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEE
Q 038860           21 QLDELFFPGFKD----LSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIV   90 (652)
Q Consensus        21 ~~~~f~~~~F~~----~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~   90 (652)
                      ..++|+|++|.+    +..||+|+|+|.+. +|.|+||+..      .+++|||+|++||+||++ +++++||+|+|+|.
T Consensus         2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~~~asFsT~F~f~   79 (243)
T d1leda_           2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGKAASFYTSFTFL   79 (243)
T ss_dssp             CCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TSCBCEEEEEEEEE
T ss_pred             CceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CCcEeeEEEEEEEE
Confidence            467999999974    35789999999996 8999999654      358999999999999995 79999999999998


Q ss_pred             EecCCCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCC-CcccEEEEEeecccCCCCCCCCCCceeeecCCccccce
Q 038860           91 IVPEYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGN-FSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNAS  169 (652)
Q Consensus        91 i~~~~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~-~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~  169 (652)
                      |.+. ...+||||||||+|....++..|++||+++..+.++ ..+++|||||||++|.+++||++||||||+|++.|..+
T Consensus        80 i~~~-~~~~gdGlAF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~~  158 (243)
T d1leda_          80 LKNY-GAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT  158 (243)
T ss_dssp             EEES-SSSCBCEEEEEEEETTCCCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred             cCCC-CCCCCCceEEEEcCCCCCCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCcccccc
Confidence            8775 456899999999998765678899999998776544 57899999999999999999999999999999999888


Q ss_pred             eecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccccccc
Q 038860          170 VEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASS  249 (652)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~  249 (652)
                      .++.         ..++.+|+.++|||+||+.+++|+|++++.  ++..|++++.|||+.+|+++||||||||||. .+.
T Consensus       159 ~~~~---------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~--~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~~~  226 (243)
T d1leda_         159 TRWE---------NDDAYGSSIATAHITYDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-DEV  226 (243)
T ss_dssp             EECC---------HHHHTSCCEEEEEEEEETTTTEEEEEEEET--TSCEEEEEEECCHHHHSCSEEEEEEEEEECB-SEE
T ss_pred             cccc---------cCCcccCceeEEEEEEECCCCEEEEEEeeC--CCCCceEEEecCHHHhcCCcEEEEEEcccCC-cce
Confidence            7763         346789999999999999999999999875  4667899999999999999999999999995 589


Q ss_pred             ceeecccccccC
Q 038860          250 HNVLGWSFKING  261 (652)
Q Consensus       250 ~~v~~w~f~~~~  261 (652)
                      |.|++|+|++..
T Consensus       227 h~I~sWsF~s~l  238 (243)
T d1leda_         227 TYILSWHFFSTL  238 (243)
T ss_dssp             EEEEEEEEEEEC
T ss_pred             eeEEEEEEEeeC
Confidence            999999998653

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=9.2e-53  Score=415.09  Aligned_cols=228  Identities=29%  Similarity=0.401  Sum_probs=201.6

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC----CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC-C
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS----RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE-Y   95 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~----~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~   95 (652)
                      ..++|+|++|+++++||+|+|+|.+.++|.|+||+...    ++.|||+|++||+||++.+++++||+|+|+|.|... +
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~~~   81 (240)
T d1fx5a_           2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN   81 (240)
T ss_dssp             CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred             CceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCCCC
Confidence            45789999999877899999999988899999998653    478999999999999999999999999999999765 3


Q ss_pred             CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCC-CCCCCCCCceeeecCCccccceeecce
Q 038860           96 PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDF-EFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~-~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      ...+||||||||+|.....+.+|++||+++.++ ++..+++|||||||++|. +++||++||||||+|++.+..+.++  
T Consensus        82 ~~~ggdG~AFvl~p~~~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~~--  158 (240)
T d1fx5a_          82 PKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW--  158 (240)
T ss_dssp             GGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCcEEEEECCCCCCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCccccccccc--
Confidence            456889999999997654588999999998765 456789999999999984 7789999999999999998877765  


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc-ccccceee
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL-LASSHNVL  253 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~-~~~~~~v~  253 (652)
                              +..+.+|+.++|||+||+.+++|.|++++.+ +|..|+++..|||+.+|+++||||||||||. ..+.|.|+
T Consensus       159 --------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~  229 (240)
T d1fx5a_         159 --------NKRYGLNNVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVL  229 (240)
T ss_dssp             --------CCCCSGGGCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEE
T ss_pred             --------ccccCCCCeEEEEEEEcCCCCEEEEEEecCC-CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEE
Confidence                    4567789999999999999999999998655 5778899999999999999999999999996 56889999


Q ss_pred             ccccccc
Q 038860          254 GWSFKIN  260 (652)
Q Consensus       254 ~w~f~~~  260 (652)
                      +|+|++.
T Consensus       230 sWsFsst  236 (240)
T d1fx5a_         230 NWYFTST  236 (240)
T ss_dssp             EEEEEEE
T ss_pred             EEEeEEe
Confidence            9999864

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=2.9e-52  Score=411.30  Aligned_cols=226  Identities=32%  Similarity=0.507  Sum_probs=200.7

Q ss_pred             ceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC
Q 038860           22 LDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY   95 (652)
Q Consensus        22 ~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~   95 (652)
                      +++|+|++|+.+++||+|+|+|.+.++|.||||+..+      +++|||+|++||+||++.+++++||+|+|+|.|....
T Consensus         3 ~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~~~   82 (239)
T d1gzca_           3 TISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQPY   82 (239)
T ss_dssp             EEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCCC
T ss_pred             eEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEecCC
Confidence            5789999999877899999999998899999998754      4789999999999999999999999999999997653


Q ss_pred             -CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           96 -PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        96 -~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                       ...+||||||+|+|....++..+++||+++..+. ...++.|||||||++|. ++||+++|||||+|++.|..+.+   
T Consensus        83 ~~~~g~dG~aF~l~p~~~~~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n~-~~d~~~~HvgI~vn~~~s~~t~~---  157 (239)
T d1gzca_          83 TRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQP---  157 (239)
T ss_dssp             SSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEE---
T ss_pred             CCCCCCCeEEEEECCCCCCCCCCcccccccccCCC-CCccceEEEEEEccccC-CCCCCCCEEEEEECCccccccCC---
Confidence             4568899999999988766788999999876654 45778899999999994 78999999999999999987765   


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc---ccccce
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHN  251 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~---~~~~~~  251 (652)
                               .++++|+.++|||+||+.+++|+|++++.. +|..|.++..+||+++|+++|||||||+||.   ..|.|.
T Consensus       158 ---------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~  227 (239)
T d1gzca_         158 ---------FQLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHD  227 (239)
T ss_dssp             ---------CCCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCE
T ss_pred             ---------ccccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeE
Confidence                     367899999999999999999999998644 6888999999999999999999999999994   568899


Q ss_pred             eecccccccCC
Q 038860          252 VLGWSFKINGP  262 (652)
Q Consensus       252 v~~w~f~~~~~  262 (652)
                      |++|+|++..|
T Consensus       228 V~sWsF~s~lp  238 (239)
T d1gzca_         228 VYSWSFQASLP  238 (239)
T ss_dssp             EEEEEEEEEEC
T ss_pred             EEEEEeEeeCC
Confidence            99999998644

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=1.1e-51  Score=406.93  Aligned_cols=225  Identities=34%  Similarity=0.546  Sum_probs=198.8

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC---CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT---SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPR   97 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~---~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~   97 (652)
                      .+++|+|++|.++++||+|+|+|.+.++|.|+||+..   .+++|||+|++||+||++.+++++||+|+|+|.|.++ ..
T Consensus         2 ~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~-~~   80 (237)
T d1qnwa_           2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD-KS   80 (237)
T ss_dssp             CSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-SS
T ss_pred             CcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecC-CC
Confidence            4678999999987889999999999888999999864   4589999999999999999999999999999999775 45


Q ss_pred             CCcCcEEEEEccCCC-CC-CCCCccccCCccCCCCCCcccEEEEEeecccCCCCC--CCCCCceeeecCCccccceeecc
Q 038860           98 LGGHGLAFTISPSND-LN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQ--DINDNHIGIDINSMKSNASVEAA  173 (652)
Q Consensus        98 ~~gdGlaF~l~p~~~-~~-~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~hvgi~~ns~~s~~~~~~~  173 (652)
                      .+||||||||+|... .+ ++.++++|+.+..+ +.+.+++|||||||++|.+++  ||++||||||+|++.|..+++  
T Consensus        81 ~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~-~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~~--  157 (237)
T d1qnwa_          81 DGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK--  157 (237)
T ss_dssp             CCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEE--
T ss_pred             CCcceeEEEEeCCCCCCCCCCccccccccCCCC-CCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCcccccc--
Confidence            589999999999874 34 77888889887553 467899999999999997654  689999999999999877664  


Q ss_pred             eecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccccc--ccce
Q 038860          174 VYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA--SSHN  251 (652)
Q Consensus       174 ~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~--~~~~  251 (652)
                                .++.+|+.++|||+||+.+++|+|++++.+ +|..|+|+..|||+.+|+++||||||||||...  |.|+
T Consensus       158 ----------~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~  226 (237)
T d1qnwa_         158 ----------WDWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHD  226 (237)
T ss_dssp             ----------CCCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCE
T ss_pred             ----------cccCCCcEEEEEEEEcCCCcEEEEEEecCC-CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeE
Confidence                      357789999999999999999999998654 688899999999999999999999999999864  7899


Q ss_pred             eeccccccc
Q 038860          252 VLGWSFKIN  260 (652)
Q Consensus       252 v~~w~f~~~  260 (652)
                      |++|+|++.
T Consensus       227 I~sWsF~s~  235 (237)
T d1qnwa_         227 VLSWYFTSN  235 (237)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEeEeEEe
Confidence            999999864

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=1e-51  Score=406.42  Aligned_cols=222  Identities=34%  Similarity=0.486  Sum_probs=196.7

Q ss_pred             ceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-----CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC-
Q 038860           22 LDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-----SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY-   95 (652)
Q Consensus        22 ~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~-   95 (652)
                      +++|+|++|..++++|+|+|+|.+..+|.|+||+..     .+++|||+|++||+||++.+++++||+|+|+|.|.... 
T Consensus         2 t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~~   81 (237)
T d2d3sa1           2 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPFP   81 (237)
T ss_dssp             EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSCC
T ss_pred             eEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCCC
Confidence            578999999877789999999999878899999854     46899999999999999999999999999999997653 


Q ss_pred             CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeeccee
Q 038860           96 PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVY  175 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~  175 (652)
                      ...+||||||+|+|....++..|++||+++..    ..+++|||||||++|.  +||++||||||+|++.|..+.+    
T Consensus        82 ~~~g~dGlaFvl~p~~~~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~~~----  151 (237)
T d2d3sa1          82 RPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP----  151 (237)
T ss_dssp             SSCCCEEEEEEEECSSCCCCBCGGGTTTBCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE----
T ss_pred             CCCCCCeEEEEeCCCCccCCccccccccccCC----CcCceEEEEEEeecCC--CCCCCCcEEEEcCCCccccccc----
Confidence            44678999999999876668899999998753    3578899999999997  6999999999999999876654    


Q ss_pred             cCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc-------ccc
Q 038860          176 TDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL-------LAS  248 (652)
Q Consensus       176 ~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~-------~~~  248 (652)
                              ..+.+|+.++|||+||+.+++|+|++++.+ +|..|+++..+||+.+|+++||||||||||.       +.|
T Consensus       152 --------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e  222 (237)
T d2d3sa1         152 --------FTLDNGGIANVVIKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATE  222 (237)
T ss_dssp             --------CCCCTTCEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCC
T ss_pred             --------eeecCCCEEEEEEEEECCCCEEEEEEEcCC-CCcccceeeEechHHhCCCcEEEEEEeECCCCccCccccce
Confidence                    467899999999999999999999999765 4777889999999999999999999999994       568


Q ss_pred             cceeecccccccCC
Q 038860          249 SHNVLGWSFKINGP  262 (652)
Q Consensus       249 ~~~v~~w~f~~~~~  262 (652)
                      .|.|++|+|++..|
T Consensus       223 ~h~I~sWsFss~lp  236 (237)
T d2d3sa1         223 THDILSWSFSASLP  236 (237)
T ss_dssp             CCEEEEEEEEEECC
T ss_pred             eeEEEEeEeEeeCC
Confidence            99999999987643

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=100.00  E-value=2.1e-51  Score=408.13  Aligned_cols=228  Identities=32%  Similarity=0.478  Sum_probs=195.8

Q ss_pred             CCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEec
Q 038860           20 SQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVP   93 (652)
Q Consensus        20 ~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~   93 (652)
                      +.+++|+|++|++++.||+|+|+|.+.++|.|+||++.      ..++|||+|++||+||++.++++++|+|+|+|.|..
T Consensus         1 a~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~   80 (251)
T d1g9fa_           1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA   80 (251)
T ss_dssp             CEEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEEC
T ss_pred             CceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEec
Confidence            34689999999987789999999999889999999864      347899999999999999999999999999999998


Q ss_pred             CCCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecc
Q 038860           94 EYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAA  173 (652)
Q Consensus        94 ~~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~  173 (652)
                      .....+||||||+|+|....++..+|+||+++..   ...++.|||||||++|.  +||+++|||||+|++.|..+..  
T Consensus        81 ~~~~~~gDGlAFvl~p~~~~~~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~~~~--  153 (251)
T d1g9fa_          81 PDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS--  153 (251)
T ss_dssp             SCC--CCEEEEEEEEETTCCCCCCGGGTTTCCTT---SCCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSEEEE--
T ss_pred             CCCCCCCCceEEEEecCCCCCCCccCccCccccc---CCCcceEEEEEecccCC--CCCCCCcEeEEecCcccccccc--
Confidence            8888899999999999887668888999998764   44678899999999997  6999999999999999876664  


Q ss_pred             eecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccccc--ccce
Q 038860          174 VYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLA--SSHN  251 (652)
Q Consensus       174 ~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~--~~~~  251 (652)
                                .++.+|+.++|||+||+.+++|+|+++... +|..|+++..+||+.+|+++||||||||||...  |.|.
T Consensus       154 ----------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~h~  222 (251)
T d1g9fa_         154 ----------WDLANNKVAKVLITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHD  222 (251)
T ss_dssp             ----------CCCCTTCCEEEEEEEETTTTEEEEEEEEGG-GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCCEEE
T ss_pred             ----------eEecCCCEEEEEEEEECCccEEEEEEecCC-CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCceeE
Confidence                      467899999999999999999999998543 678899999999999999999999999999865  7899


Q ss_pred             eecccccccCCCCC
Q 038860          252 VLGWSFKINGPARA  265 (652)
Q Consensus       252 v~~w~f~~~~~~~~  265 (652)
                      |++|+|++..+++.
T Consensus       223 I~sWsF~s~~~~~~  236 (251)
T d1g9fa_         223 VLSWSFASNLPHAS  236 (251)
T ss_dssp             EEEEEEEEEECC--
T ss_pred             EEEeEeECCCCCCC
Confidence            99999998765443

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=100.00  E-value=4.6e-50  Score=394.16  Aligned_cols=220  Identities=36%  Similarity=0.546  Sum_probs=193.4

Q ss_pred             ceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC
Q 038860           22 LDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY   95 (652)
Q Consensus        22 ~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~   95 (652)
                      ..+|+|++|+.+++||+|+|+|.+.++|.|+||+...      +++|||+|++||+||++.+++++||+|+|+|.|.+..
T Consensus         2 ~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~~   81 (234)
T d1f9ka_           2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY   81 (234)
T ss_dssp             EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred             ceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECCC
Confidence            4789999998777899999999998889999998743      4789999999999999999999999999999998653


Q ss_pred             -CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           96 -PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        96 -~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                       ...+||||||+|+|....++..|+++|+++..    ..++.|||||||++|.  +||++||||||+|++.|..+.+   
T Consensus        82 ~~~~g~dG~aF~i~p~~~~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~~---  152 (234)
T d1f9ka_          82 AYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP----EGDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH---  152 (234)
T ss_dssp             SSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSS----CCSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE---
T ss_pred             CCCCccceEEEEECCCCCCcccccccccccCCC----CccceEEEEEeccccC--CCCCCCcEeEecCCcccccccc---
Confidence             34678999999999876567889999987653    3567899999999997  7999999999999998876654   


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccc--cceEEEEeccccc---cccc
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFN--EFMYVGFSASTGL---LASS  249 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~--~~~~vGfsastg~---~~~~  249 (652)
                               +++.+|+.++|||+||+.+++|+|++++.. ++..|.|+..|||+.+|+  ++|||||||+||.   ..|.
T Consensus       153 ---------~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~  222 (234)
T d1f9ka_         153 ---------FQLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVET  222 (234)
T ss_dssp             ---------CCCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCE
T ss_pred             ---------ccccCCCEEEEEEEEcCCCcEEEEEEEeCC-CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceee
Confidence                     468899999999999999999999999765 466788999999999997  6799999999995   4678


Q ss_pred             ceeeccccccc
Q 038860          250 HNVLGWSFKIN  260 (652)
Q Consensus       250 ~~v~~w~f~~~  260 (652)
                      |.|++|+|++.
T Consensus       223 h~I~sWsF~s~  233 (234)
T d1f9ka_         223 HEIISWSFTSS  233 (234)
T ss_dssp             EEEEEEEEEEE
T ss_pred             eEEEEEEeEEe
Confidence            99999999863

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.4e-49  Score=390.92  Aligned_cols=221  Identities=34%  Similarity=0.519  Sum_probs=197.1

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ..++|+|++|+.  +||+|+|||.+.++|.||||+...      .++|||+|++||+||++.+++++||+|+|+|.|...
T Consensus         2 ~~~sF~f~~F~~--~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~~   79 (233)
T d1g8wa_           2 NDIYFNFQRFNE--TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVP   79 (233)
T ss_dssp             EEEEEEESSCCG--GGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCCC
T ss_pred             CceEEECCCCCc--CcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEecC
Confidence            468999999987  789999999998899999997543      479999999999999999999999999999999988


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      +...+||||||+|+|.+..++..|++||+++..   +..++.|||||||++|.++ ||+++||||++|++.+..+.+   
T Consensus        80 ~~~~~gDGlAF~l~~~~~~~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s~~~~~---  152 (233)
T d1g8wa_          80 NNAGPADGLAFALVPVGSQPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTR---  152 (233)
T ss_dssp             SSCBCCEEEEEEEEETTCCCCCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEE---
T ss_pred             CCCCCCCeEEEEEecCCCCCCcccccCCccccC---CCcccEEEEEeecccCCCC-CCCCCeEEEECCCcceeeecc---
Confidence            777889999999999887678899999998754   3467889999999999875 999999999999998876664   


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc---ccccce
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHN  251 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~---~~~~~~  251 (652)
                               .++.+|+.++|||+||+.+++|.|++.+.+ +|..|+++..+||+.+||++|||||||+||.   ..|.|.
T Consensus       153 ---------~~~~~g~~~~~~I~yd~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~  222 (233)
T d1g8wa_         153 ---------WDFVNGENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETND  222 (233)
T ss_dssp             ---------CCCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCE
T ss_pred             ---------ccccCCcEEEEEEEEeCCCcEEEEEEEeCC-CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeE
Confidence                     357789999999999999999999998755 5778899999999999999999999999995   456799


Q ss_pred             eeccccccc
Q 038860          252 VLGWSFKIN  260 (652)
Q Consensus       252 v~~w~f~~~  260 (652)
                      |++|+|++.
T Consensus       223 I~sWsFss~  231 (233)
T d1g8wa_         223 VLSWSFASK  231 (233)
T ss_dssp             EEEEEEEEE
T ss_pred             EEEEEEEEE
Confidence            999999863

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=100.00  E-value=1.9e-49  Score=395.52  Aligned_cols=223  Identities=32%  Similarity=0.517  Sum_probs=198.2

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|++  ++|+|+|||.+. ++.|+||++..      .++|||+|++||+||++.+++++||+|+|+|+|.+.
T Consensus         2 ~~~sF~f~~F~~--~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~   78 (253)
T d1g7ya_           2 DIQSFSFKNFNS--SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAP   78 (253)
T ss_dssp             EEEEEEESSCCS--SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             cccEEecCCCCc--ccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecC
Confidence            357899999987  799999999996 88899998643      478999999999999999999999999999999887


Q ss_pred             CCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecce
Q 038860           95 YPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAV  174 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~  174 (652)
                      ....+||||||+|+|.+..++..++++|+++..+. ...++.+||||||++|.++ ||+++|||||+|++.|..+.+   
T Consensus        79 ~~~~ggDGlAF~l~~~~~~~~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s~~~~~---  153 (253)
T d1g7ya_          79 NKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTAS---  153 (253)
T ss_dssp             SGGGCCCEEEEEEEETTCCCCCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEE---
T ss_pred             CCCCCCCceEEEEeCCCCCCCCCcccccccccCCC-CCcCceEEEEEeceecCCC-CCCCCcEEEeeCCcccccccC---
Confidence            77778999999999988767888999999986554 4567889999999999875 999999999999999877764   


Q ss_pred             ecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccc---cccccce
Q 038860          175 YTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG---LLASSHN  251 (652)
Q Consensus       175 ~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg---~~~~~~~  251 (652)
                               ..+.+|+.++|||+||+.+++|+|+++... +|..|+++..+||+.+||++|||||||+||   ...+.|.
T Consensus       154 ---------~~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~  223 (253)
T d1g7ya_         154 ---------WGLANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHD  223 (253)
T ss_dssp             ---------CCCCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCE
T ss_pred             ---------CCccCCCEEEEEEEEeCCcEEEEEEEecCC-CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccE
Confidence                     357899999999999999999999998643 688889999999999999999999999999   4678999


Q ss_pred             eecccccccC
Q 038860          252 VLGWSFKING  261 (652)
Q Consensus       252 v~~w~f~~~~  261 (652)
                      |++|+|++..
T Consensus       224 IlsWsF~s~l  233 (253)
T d1g7ya_         224 VLSWSFASKL  233 (253)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEeEEeC
Confidence            9999998753

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=100.00  E-value=3.7e-49  Score=391.07  Aligned_cols=227  Identities=33%  Similarity=0.526  Sum_probs=199.9

Q ss_pred             CCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-----CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           20 SQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-----SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        20 ~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      +.+++|+|++|.+++.||+|+|+|.+.++|.||||++.     .+++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus         1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~   80 (239)
T d1dbna_           1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP   80 (239)
T ss_dssp             CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence            35689999999887789999999999888999999763     4578999999999999999999999999999999988


Q ss_pred             CCCCCcCcEEEEEccCCC-CC-CCCCccccCCccCCCCCCcccEEEEEeecccCCCCC--CCCCCceeeecCCcccccee
Q 038860           95 YPRLGGHGLAFTISPSND-LN-GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQ--DINDNHIGIDINSMKSNASV  170 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~-~~-~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~hvgi~~ns~~s~~~~  170 (652)
                      ....+||||||+|+|... .+ ++.|++||+++..+ ++..++.+||||||++|.+++  ||+.+|||||+|++.|....
T Consensus        81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~~  159 (239)
T d1dbna_          81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV  159 (239)
T ss_dssp             STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccccc
Confidence            778899999999999774 33 78899999998664 456789999999999997654  78999999999999987766


Q ss_pred             ecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc--cc
Q 038860          171 EAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL--AS  248 (652)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~--~~  248 (652)
                      +.            .+.+|+.+.|||+|++.++.|.|++.+.. +|..|.++..+||+.+|+++||||||||||..  .|
T Consensus       160 ~~------------~~~~g~~~~~~i~y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~  226 (239)
T d1dbna_         160 QW------------DWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVE  226 (239)
T ss_dssp             EC------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCC
T ss_pred             cc------------eEeCCceeEEEEEEcCCCCEEEEEEEecC-CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcc
Confidence            54            45679999999999999999999998654 57778899999999999999999999999975  46


Q ss_pred             cceeeccccccc
Q 038860          249 SHNVLGWSFKIN  260 (652)
Q Consensus       249 ~~~v~~w~f~~~  260 (652)
                      .|+|++|+|++.
T Consensus       227 ~H~I~sWsFss~  238 (239)
T d1dbna_         227 THDVLSWSFTST  238 (239)
T ss_dssp             CCEEEEEEEEEE
T ss_pred             eeEEEEEEeEEe
Confidence            799999999863

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=100.00  E-value=5.5e-49  Score=387.23  Aligned_cols=226  Identities=29%  Similarity=0.381  Sum_probs=193.9

Q ss_pred             CCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCC
Q 038860           20 SQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRL   98 (652)
Q Consensus        20 ~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~   98 (652)
                      +++++|+|++|++.+.+|.|+|||.+.++|.||||++. .+++|||+|++||+||++.++++++|+|+|+|.|.+.....
T Consensus         1 a~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~~~   80 (232)
T d1v6ia_           1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYD   80 (232)
T ss_dssp             CEEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSB
T ss_pred             CccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCCCC
Confidence            35689999999987788999999999888999999864 48999999999999999999999999999999999988888


Q ss_pred             CcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCC
Q 038860           99 GGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDN  178 (652)
Q Consensus        99 ~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~  178 (652)
                      +||||||+|+|.....+..++ .|+....+..+..++.|||||||++|.+.+||+++|||||+|++.+.....       
T Consensus        81 ~gDG~AF~l~~~~~~~~~~~~-~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~-------  152 (232)
T d1v6ia_          81 PADGIIFFIAPEDTQIPAGSI-GGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP-------  152 (232)
T ss_dssp             CCCEEEEEEEETTCCCCTTCC-CGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE-------
T ss_pred             CCCeEEEEEECCCCCCCCCcc-CCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCcccccccc-------
Confidence            999999999998754322222 222222223356789999999999999889999999999999998876553       


Q ss_pred             CCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc-cccceeecccc
Q 038860          179 STKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL-ASSHNVLGWSF  257 (652)
Q Consensus       179 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~-~~~~~v~~w~f  257 (652)
                           .++.+|+.++|||+||+.+++|.|+++..  ++..|.++..+||+.+||++|||||||+||.. .+.|.|++|+|
T Consensus       153 -----~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~--~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWsF  225 (232)
T d1v6ia_         153 -----WNSVSGAVVKVTVIYDSSTKTLSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF  225 (232)
T ss_dssp             -----CCCCTTCEEEEEEEEETTTTEEEEEEECT--TSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEEE
T ss_pred             -----cccCCCCEEEEEEEEeCCceEEEEEEecC--CCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeEe
Confidence                 45789999999999999999999999854  45677899999999999999999999999975 58899999999


Q ss_pred             ccc
Q 038860          258 KIN  260 (652)
Q Consensus       258 ~~~  260 (652)
                      ++.
T Consensus       226 ss~  228 (232)
T d1v6ia_         226 TST  228 (232)
T ss_dssp             EEE
T ss_pred             EEe
Confidence            864

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=100.00  E-value=3.7e-49  Score=390.80  Aligned_cols=227  Identities=32%  Similarity=0.479  Sum_probs=200.8

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC-----CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT-----SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY   95 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~   95 (652)
                      .+++|+|++|.+++++++|+|||.+.++|.||||++.     .+++|||+|++||+||++.+++++||+|+|+|.|....
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~~   81 (237)
T d1fnya_           2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN   81 (237)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred             ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecCC
Confidence            3579999999987889999999999888999999863     46899999999999999999999999999999999887


Q ss_pred             CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeeccee
Q 038860           96 PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVY  175 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~  175 (652)
                      ...+||||||+|+|.+..++..|+++|+++..+ .+..++.+||||||++|.++ ||+++||||++|++.|..+.+    
T Consensus        82 ~~~~gDG~AF~l~~~~~~~~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~~----  155 (237)
T d1fnya_          82 PATTADGLAFFLAPVDTQPLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVP----  155 (237)
T ss_dssp             TTSCCEEEEEEEEETTCCCCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEE----
T ss_pred             CCCCCCeeEEEEcCCCCCcccccCcccccCCCC-ccCccceEEEEeccccccCC-CCCCceEEEecCCCccccccc----
Confidence            888999999999998876688889999987543 35678899999999999875 999999999999999876664    


Q ss_pred             cCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccc---ccccccee
Q 038860          176 TDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG---LLASSHNV  252 (652)
Q Consensus       176 ~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg---~~~~~~~v  252 (652)
                              .++.+|+.++|||+||+..++|.|++.+.+ ++..|+++..+||+.++|++|||||||+||   ...|.|.|
T Consensus       156 --------~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I  226 (237)
T d1fnya_         156 --------WNWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDV  226 (237)
T ss_dssp             --------CCCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEE
T ss_pred             --------ccccCCcEEEEEEEEeCCccEEEEEEEeCC-CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEE
Confidence                    356789999999999999999999998765 567788999999999999999999999999   45678999


Q ss_pred             ecccccccCC
Q 038860          253 LGWSFKINGP  262 (652)
Q Consensus       253 ~~w~f~~~~~  262 (652)
                      ++|+|+++.|
T Consensus       227 ~sWsF~s~lp  236 (237)
T d1fnya_         227 LSWSFESNLP  236 (237)
T ss_dssp             EEEEEEEEEC
T ss_pred             EEeEeEEeCC
Confidence            9999998644

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=100.00  E-value=1.2e-48  Score=384.96  Aligned_cols=222  Identities=30%  Similarity=0.487  Sum_probs=196.9

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC-----CceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS-----RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEY   95 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~-----~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~   95 (652)
                      .+++|+|++|+++.++|+|+|+|.+.++|.||||++..     +++|||||++||+||+.  ..++||+|+|+|.|.+..
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~--~~~~sF~t~f~f~i~~~~   79 (233)
T d1n47a_           2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN--TTLASFTTSFSFVMAAPA   79 (233)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCS--SCBCEEEEEEEEECCCSS
T ss_pred             CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCC--CeeeeEEEEEEEEEeCCC
Confidence            35799999998877899999999998889999998653     58999999999999985  368999999999999887


Q ss_pred             CCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeeccee
Q 038860           96 PRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVY  175 (652)
Q Consensus        96 ~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~  175 (652)
                      ...+||||||+|+|.+..++..|++||+++..+. +..++.|||||||++|.  +||++||||||+|++.|..+.+    
T Consensus        80 ~~~~gDGlAF~l~~~~~~~~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~~----  152 (233)
T d1n47a_          80 AAAVADGLAFFLAPPDTQPQARGGFLGLFADRAH-DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP----  152 (233)
T ss_dssp             TTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEE----
T ss_pred             CCCCCCceEEEECCCCCCCCCCCCccccccccCC-CCcCceEEEEEEeeecC--CCCCCCceeEccCCcccccccc----
Confidence            8889999999999988766888999999976554 46778899999999997  6999999999999999876664    


Q ss_pred             cCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccc---ccccccee
Q 038860          176 TDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG---LLASSHNV  252 (652)
Q Consensus       176 ~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg---~~~~~~~v  252 (652)
                              ..+.+|+.++|||+||+.+++|.|++.... +|..|.++..+||+.+||++|||||||+||   ...+.|.|
T Consensus       153 --------~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I  223 (233)
T d1n47a_         153 --------FDMVYGEKANIVITYQASTKALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDI  223 (233)
T ss_dssp             --------CCCCTTSCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEE
T ss_pred             --------ceecCCCEEEEEEEEcCCCeEEEEEEEeCC-CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEE
Confidence                    467889999999999999999999998654 577889999999999999999999999999   45688999


Q ss_pred             eccccccc
Q 038860          253 LGWSFKIN  260 (652)
Q Consensus       253 ~~w~f~~~  260 (652)
                      ++|+|+++
T Consensus       224 ~sWsFss~  231 (233)
T d1n47a_         224 VSWSFAVS  231 (233)
T ss_dssp             EEEEEEEE
T ss_pred             EEEEeEEE
Confidence            99999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-49  Score=396.41  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=204.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+++.+|++++++++||||+++++++.+.+..+||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999999999999999997653 2334578999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC-
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT-  496 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~-  496 (652)
                      |+++|+|.+++..  ...+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        84 y~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999999953  456999999999999999999999   7999999999999999999999999999999765433 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... .... .               
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~~-~---------------  221 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWK-E---------------  221 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHHH-T---------------
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHHh-c---------------
Confidence            223455689999999999988775 578999999999999999999997643222111 0000 0               


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                                          ..+.........+.+.||+.+|+..+|++|+      .|+||+.
T Consensus       222 --------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         222 --------------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             --------------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             --------------------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                                0000011123356889999999999999999      4677753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=400.17  Aligned_cols=251  Identities=22%  Similarity=0.365  Sum_probs=210.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|++.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999999999999999997665556678999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++|+|.+++.+   ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++++||+|||+|+...... ..
T Consensus       100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK  172 (293)
T ss_dssp             TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred             CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence            99999988743   35999999999999999999999   7999999999999999999999999999999765433 23


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccCC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEY  579 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  579 (652)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..   ......                  
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~------------------  231 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLIATN------------------  231 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHH------------------
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH---HHHHhC------------------
Confidence            44568999999999999999999999999999999999999999753321111   100000                  


Q ss_pred             CHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          580 DQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       580 ~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                                      ..|.........+.+.+|+.+|+..+|++|+|      |+||+..
T Consensus       232 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         232 ----------------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             ----------------CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----------------CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                            00111111234578999999999999999995      7898753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=407.67  Aligned_cols=204  Identities=29%  Similarity=0.404  Sum_probs=181.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++... ....+++.+|+.+|++++||||++++++|.+.+.+++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4578999999999999999999999999999999997653 334567899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|.+++.+  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++++||+|||+|+..... 
T Consensus        84 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            99999999999954  3469999999999999999999994  348999999999999999999999999999876432 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRAL  548 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~  548 (652)
                        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence              22346899999999999999999999999999999999999999986543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=389.22  Aligned_cols=241  Identities=27%  Similarity=0.406  Sum_probs=202.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||+||+|++..+++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999999999999999986542   234567899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|.+++..  ...+++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  158 (263)
T ss_dssp             ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred             eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC--
Confidence            99999999999853  346999999999999999999999   79999999999999999999999999999986543  


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +...+.    .            
T Consensus       159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~----~------------  218 (263)
T d2j4za1         159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRIS----R------------  218 (263)
T ss_dssp             -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH----T------------
T ss_pred             -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHHH----c------------
Confidence             23445689999999999999999999999999999999999999997533211   111100    0            


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~  628 (652)
                      .++                ..|.     ...+.+.+|+.+|+..+|++|+|+
T Consensus       219 ~~~----------------~~p~-----~~s~~~~~li~~~L~~dp~~R~t~  249 (263)
T d2j4za1         219 VEF----------------TFPD-----FVTEGARDLISRLLKHNPSQRPML  249 (263)
T ss_dssp             TCC----------------CCCT-----TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCC----------------CCCc-----cCCHHHHHHHHHHccCCHhHCcCH
Confidence            000                0011     234688999999999999999954

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=393.30  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      +.|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|+++|++++||||+++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999999999999999998776666778999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++|+|.+++.+. ...+++.++..++.||++||.|||   +++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus        92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~  166 (288)
T d2jfla1          92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  166 (288)
T ss_dssp             TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence            999999987543 346999999999999999999999   7999999999999999999999999999998653321 12


Q ss_pred             eeeccCCcCCCCCCCCC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccc
Q 038860          500 TTRVVGTLGYLAPETPR-----TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPK  574 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  574 (652)
                      .....||+.|+|||++.     +..++.++|||||||++|||++|+.||.+....+..   ..+..              
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~~i~~--------------  229 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---LKIAK--------------  229 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHH--------------
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH---HHHHc--------------
Confidence            23467999999999873     456899999999999999999999999764322211   10000              


Q ss_pred             cccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          575 LNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       575 l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                        .                  ..|.........+.+.||+.+|+..+|++|+|      |+|+..
T Consensus       230 --~------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         230 --S------------------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             --S------------------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             --C------------------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence              0                  00111111234578999999999999999994      567654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-48  Score=394.96  Aligned_cols=262  Identities=27%  Similarity=0.412  Sum_probs=213.6

Q ss_pred             CcccchhhhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeee
Q 038860          327 PQRYSYQELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWC  406 (652)
Q Consensus       327 ~~~~~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  406 (652)
                      |+.-.|++.+...++|++.+.||+|+||+||+|.+..+++.||||+++... ...++|.+|+.+|++++||||++++++|
T Consensus         4 p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_           4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             TTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            344445555556678999999999999999999999889999999997653 3457799999999999999999999999


Q ss_pred             eccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeee
Q 038860          407 RRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDF  486 (652)
Q Consensus       407 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DF  486 (652)
                      .+++..++|||||++|+|.+++.......+++..++.++.||++||+|||   +++|+||||||+||||+.++.+||+||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccc
Confidence            99999999999999999999997766778999999999999999999999   699999999999999999999999999


Q ss_pred             ccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCc
Q 038860          487 GLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGR  566 (652)
Q Consensus       487 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  566 (652)
                      |+|+..............|++.|+|||++.++.++.++|||||||++|||++|..|+........  +.+.+        
T Consensus       160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i--------  229 (287)
T d1opja_         160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL--------  229 (287)
T ss_dssp             CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH--------
T ss_pred             cceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH--------
Confidence            99987655443344445689999999999999999999999999999999997777643222111  11110        


Q ss_pred             cccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          567 VLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       567 ~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                           ..              .    .....|     ....+.+.+|+.+|+..+|++|||++-
T Consensus       230 -----~~--------------~----~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~e  265 (287)
T d1opja_         230 -----EK--------------D----YRMERP-----EGCPEKVYELMRACWQWNPSDRPSFAE  265 (287)
T ss_dssp             -----HT--------------T----CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----hc--------------C----CCCCCC-----ccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence                 00              0    000011     123467899999999999999998654

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=100.00  E-value=4.6e-46  Score=369.39  Aligned_cols=224  Identities=29%  Similarity=0.481  Sum_probs=195.3

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      .+.+|+|++|++++++|+|+|+|.+. ++.|+||++.      ..++|||+|++||+||++.++++++|+|+|+|+|..+
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~   80 (241)
T d1ukga_           2 DSLSFGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSP   80 (241)
T ss_dssp             CEEEEEESSCCSCCSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECS
T ss_pred             ccEEEEeCCCCCCCCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecC
Confidence            35789999998877899999999997 7899999864      3588999999999999999999999999999999875


Q ss_pred             CCCCCcCcEEEEEccCCC-CC-CCCCccccCCccCC-CCCCcccEEEEEeecccCCCCC--CCCCCceeeecCCccccce
Q 038860           95 YPRLGGHGLAFTISPSND-LN-GLPSQYLGLLNSTD-IGNFSNHLFAVEFDTVQDFEFQ--DINDNHIGIDINSMKSNAS  169 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~~-~~-~~~g~~lG~~~~~~-~~~~~~~~vaVEFDt~~n~~~~--d~~~~hvgi~~ns~~s~~~  169 (652)
                       ...+|||||||++|... .+ +.+|+++|+++... .+...++.|||||||+.|.+.+  ||+++|||||+|++.|...
T Consensus        81 -~~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~  159 (241)
T d1ukga_          81 -LSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKT  159 (241)
T ss_dssp             -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEE
T ss_pred             -CCCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCcccccc
Confidence             44579999999998763 34 67788888887554 4457889999999999986544  5889999999999998766


Q ss_pred             eecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccccccc
Q 038860          170 VEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASS  249 (652)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~  249 (652)
                      .+            .++.+|+.++|||+||+.+++|+|+++..  ++..|.++..+||+.+++++|||||||+||...+.
T Consensus       160 ~~------------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~  225 (241)
T d1ukga_         160 VK------------WDRRDGQSLNVLVTFNPSTRNLDVVATYS--DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQT  225 (241)
T ss_dssp             EE------------CCCCTTCCEEEEEEEETTTTEEEEEEEET--TCCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCE
T ss_pred             cc------------cccCCCcEEEEEEEEeCCCcEEEEEEccC--CCCceEEEEEEehHHhCCCcEEEEEEEecCCCCce
Confidence            54            45788999999999999999999999875  46678899999999999999999999999999999


Q ss_pred             ceeeccccccc
Q 038860          250 HNVLGWSFKIN  260 (652)
Q Consensus       250 ~~v~~w~f~~~  260 (652)
                      |.|++|+|++.
T Consensus       226 H~IlsWsFss~  236 (241)
T d1ukga_         226 HTLESWSFTST  236 (241)
T ss_dssp             EEEEEEEEEEE
T ss_pred             eEEEEeEEEEE
Confidence            99999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=390.63  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=200.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999997542   234567899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|.+++..  ...+++..++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        88 Ey~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            99999999998843  456999999999999999999999   7999999999999999999999999999999775433


Q ss_pred             C-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          497 N-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       497 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+...+.                
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~----------------  223 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKII----------------  223 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----------------
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHHHHH----------------
Confidence            2 234456899999999999999999999999999999999999999975321   11111000                


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~  628 (652)
                      ..++                ..|.     ...+.+.||+++|+..+|++|+|+
T Consensus       224 ~~~~----------------~~p~-----~~s~~~~~li~~~L~~dP~~R~t~  255 (288)
T d1uu3a_         224 KLEY----------------DFPE-----KFFPKARDLVEKLLVLDATKRLGC  255 (288)
T ss_dssp             TTCC----------------CCCT-----TCCHHHHHHHHTTSCSSGGGSTTS
T ss_pred             cCCC----------------CCCc-----cCCHHHHHHHHHHccCCHhHCcCH
Confidence            0000                0111     234678999999999999999964

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=386.69  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=190.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec--cCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--KGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV  415 (652)
                      ++|++.+.||+|+||+||+|++..+++.||+|.+...  .....+.+.+|++++++++||||+++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999999999999999999764  33455678999999999999999999999864  4568999


Q ss_pred             EEeccCCCcccccccC--CccccchHHHhhhHHHHHHHHhhhccCc--cceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          416 YDFMANGSLDSFLFDE--PKAVLNWEQRFKIIKGVASGLLYLHEGY--EQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      ||||++|+|.+++...  ....+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998542  3456999999999999999999999411  13499999999999999999999999999997


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI  571 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  571 (652)
                      ..... .......||+.|||||++.+..++.++|||||||++|||++|+.||......   .+...+.    ++      
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~----~~------  229 (269)
T d2java1         164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR----EG------  229 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH----HT------
T ss_pred             cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHH----cC------
Confidence            65432 2334568999999999999999999999999999999999999999753211   1111100    00      


Q ss_pred             ccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          572 DPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       572 d~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                            .               ....|     ....+.+.+|+.+|+..+|++|||++
T Consensus       230 ------~---------------~~~~~-----~~~s~~l~~li~~~L~~dp~~Rps~~  261 (269)
T d2java1         230 ------K---------------FRRIP-----YRYSDELNEIITRMLNLKDYHRPSVE  261 (269)
T ss_dssp             ------C---------------CCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ------C---------------CCCCC-----cccCHHHHHHHHHHcCCChhHCcCHH
Confidence                  0               00001     12346889999999999999999754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-47  Score=390.57  Aligned_cols=254  Identities=24%  Similarity=0.412  Sum_probs=191.8

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..+.|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|++++||||+++++++.+++.+||||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45679999999999999999999999999999999976532 23456889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC---CCCCeEEeeeccceecc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD---SELNGKLGDFGLAKLYE  493 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~---~~~~~kL~DFGla~~~~  493 (652)
                      |||++|+|.+++..  ...+++.++..++.||+.||+|||   +++|+||||||+|||+.   +++.+||+|||+|+...
T Consensus        87 E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          87 QLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             eccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999954  456999999999999999999999   79999999999999995   57899999999998664


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      ...  .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+....   .+...+..             
T Consensus       162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~-------------  223 (307)
T d1a06a_         162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILK-------------  223 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHT-------------
T ss_pred             CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhc-------------
Confidence            332  334467999999999999999999999999999999999999999753211   11111100             


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                         ..+              ....|   ..+...+.+.||+.+|+..+|++|+|      |+|+...
T Consensus       224 ---~~~--------------~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         224 ---AEY--------------EFDSP---YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ---TCC--------------CCCTT---TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ---cCC--------------CCCCc---cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence               000              00001   11234568999999999999999995      6688764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3e-46  Score=391.45  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=210.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+|++++||||+++++++.+.+.+++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999999999999999999877666677899999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC--CCCeEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS--ELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~--~~~~kL~DFGla~~~~~~~  496 (652)
                      |++|+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.  ++.+||+|||+|+..... 
T Consensus       105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            9999999988543 346999999999999999999999   799999999999999964  578999999999976543 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       .......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+   ....+...               
T Consensus       180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~---------------  240 (350)
T d1koaa2         180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKSC---------------  240 (350)
T ss_dssp             -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT---------------
T ss_pred             -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHhC---------------
Confidence             34455689999999999999999999999999999999999999997543211   11111000               


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                       .+                 .+.........+.+.||+.+|+..||++|+      .|+|+...
T Consensus       241 -~~-----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         241 -DW-----------------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             -CC-----------------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             -CC-----------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence             00                 000111123356889999999999999999      56788764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=376.07  Aligned_cols=240  Identities=27%  Similarity=0.420  Sum_probs=192.7

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec----cCeeEEEE
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR----KGDLLLVY  416 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  416 (652)
                      +..+.||+|+||+||+|.+..+++.||+|++...  .....+.+.+|+++|++++||||+++++++..    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5667899999999999999999999999998654  33455679999999999999999999999864    35689999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccce--EEecCCCCCceEeC-CCCCeEEeeeccceecc
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQV--VIHRDVKASNVLLD-SELNGKLGDFGLAKLYE  493 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDlk~~NILl~-~~~~~kL~DFGla~~~~  493 (652)
                      ||+++|+|.+++.+  ...+++..++.++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999943  346899999999999999999999   566  99999999999996 57899999999998543


Q ss_pred             cCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          494 HGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       494 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      .   .......||+.|||||++.+ .++.++|||||||++|||++|+.||........  +..    ....+.     . 
T Consensus       167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~----~i~~~~-----~-  230 (270)
T d1t4ha_         167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----RVTSGV-----K-  230 (270)
T ss_dssp             T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----HHTTTC-----C-
T ss_pred             C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH----HHHcCC-----C-
Confidence            2   23456789999999998865 599999999999999999999999975332111  111    110000     0 


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSC  628 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~  628 (652)
                                              |. .......+.+.+|+.+|+..+|++|+|+
T Consensus       231 ------------------------~~-~~~~~~~~~~~~li~~~l~~dp~~R~s~  260 (270)
T d1t4ha_         231 ------------------------PA-SFDKVAIPEVKEIIEGCIRQNKDERYSI  260 (270)
T ss_dssp             ------------------------CG-GGGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ------------------------Cc-ccCccCCHHHHHHHHHHccCCHhHCcCH
Confidence                                    00 0011234578999999999999999964

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=390.43  Aligned_cols=203  Identities=29%  Similarity=0.385  Sum_probs=182.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      .++|++.+.||+|+||.||+|++..+++.||||++++..   ....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            467999999999999999999999999999999997642   33457789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      ||||++|+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999998843  456899999999999999999999   799999999999999999999999999999865432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      . ......+||+.|+|||++.+..++.++||||+||++|||++|++||....
T Consensus       159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence            2 23445789999999999999999999999999999999999999997643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.8e-46  Score=388.16  Aligned_cols=254  Identities=19%  Similarity=0.268  Sum_probs=210.5

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++.......+.+.+|+.+|++++||||+++++++.+++.++|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999999989999999999876656667889999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeC--CCCCeEEeeeccceecccCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLD--SELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~--~~~~~kL~DFGla~~~~~~~  496 (652)
                      |++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+||||+  .++.+||+|||+|+..... 
T Consensus       108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            9999998877433 346999999999999999999999   79999999999999998  5689999999999977543 


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+   ....+..                
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~----------------  242 (352)
T d1koba_         183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKR----------------  242 (352)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH----------------
T ss_pred             -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----------------
Confidence             34455689999999999999999999999999999999999999997643211   1111100                


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccC
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENG  634 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~  634 (652)
                                ...  .     +.........+.+.||+.+|+..+|++|++      |+|++..
T Consensus       243 ----------~~~--~-----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         243 ----------CDW--E-----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ----------CCC--C-----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----------CCC--C-----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                      000  0     000111234568899999999999999995      7798763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-46  Score=385.86  Aligned_cols=203  Identities=32%  Similarity=0.558  Sum_probs=165.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe---EEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT---EVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ++|++.++||+|+||+||+|.+..+++   .||||++... .....++|.+|+.+|++++|||||+++|+|...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456778899999999999999875543   6999998764 444567899999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      ||||++|+|.+++... ...+++.++++++.||++||.|||   +++|+||||||+||||+.++.+||+|||+|+.....
T Consensus       106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9999999999988543 346999999999999999999999   699999999999999999999999999999876543


Q ss_pred             CCCc----eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCC
Q 038860          496 TNPA----TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETR  546 (652)
Q Consensus       496 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~  546 (652)
                      ....    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.+.
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~  237 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  237 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence            3221    223467999999999999999999999999999999998 89999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=381.60  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=200.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||.||+|.+++ +..||||+++... ...++|.+|+.++++++||||++++|++.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            4678899999999999999999864 6889999997643 345679999999999999999999998865 567999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++|+|.+++.......+++.++++|+.||++||.|||   +++|+||||||+||||+.++.+||+|||+|+........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999999886665667999999999999999999999   699999999999999999999999999999987654433


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+.......  .+...+..                  
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~i~~------------------  225 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLER------------------  225 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT------------------
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh------------------
Confidence            4445678999999999998999999999999999999999766554322111  11111100                  


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                   ..  +.+.+   ....+.+.+|+.+|+..+|++|||.+-
T Consensus       226 -------------~~--~~~~p---~~~~~~l~~li~~cl~~~P~~Rpt~~e  259 (272)
T d1qpca_         226 -------------GY--RMVRP---DNCPEELYQLMRLCWKERPEDRPTFDY  259 (272)
T ss_dssp             -------------TC--CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -------------cC--CCCCc---ccChHHHHHHHHHHcCCCHhHCcCHHH
Confidence                         00  00111   123457889999999999999998654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.4e-46  Score=382.96  Aligned_cols=198  Identities=27%  Similarity=0.383  Sum_probs=179.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||++++..   ....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999999999999999997542   234577899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|..++..  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        84 E~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--  156 (316)
T d1fota_          84 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  156 (316)
T ss_dssp             CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eecCCccccccccc--cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence            99999999988843  445788899999999999999999   79999999999999999999999999999987643  


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                        .....+||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus       157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  204 (316)
T d1fota_         157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  204 (316)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence              234568999999999999999999999999999999999999999763

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-46  Score=384.72  Aligned_cols=246  Identities=27%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ..|+..+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999999999999999997543   334567999999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|..++..  ...+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        95 E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            99999999766633  356999999999999999999999   79999999999999999999999999999986533  


Q ss_pred             CCceeeccCCcCCCCCCCCCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          497 NPATTRVVGTLGYLAPETPRT---GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                         .....||+.|||||++.+   +.++.++|||||||++|||++|+.||.+....+.   ...+..             
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---~~~i~~-------------  228 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQ-------------  228 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH-------------
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHh-------------
Confidence               234579999999998753   4689999999999999999999999975322111   000000             


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                                       ..    .|... .....+.+.+|+.+|+..+|++|+|      |+|+..
T Consensus       229 -----------------~~----~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         229 -----------------NE----SPALQ-SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             -----------------SC----CCCCS-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             -----------------CC----CCCCC-CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                             00    00000 0123468899999999999999995      567754

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=100.00  E-value=1.5e-45  Score=362.31  Aligned_cols=217  Identities=31%  Similarity=0.486  Sum_probs=188.2

Q ss_pred             CCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCC------CceEEEEeCCceeeccCCCCceeeeEEEEEEEEec
Q 038860           20 SQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTS------RKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVP   93 (652)
Q Consensus        20 ~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~   93 (652)
                      ++.++|+|++|++ +.+|+|+|||.+.++|.|+||++.+      .++|||+|++||+||+  +++++||+|+|+|.|.+
T Consensus         1 a~~~sF~f~~F~~-~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~--~~~~~sFst~F~f~i~~   77 (228)
T d1ioaa_           1 ATETSFNFPNFHT-DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD--SNNVASFNTNFTFIIRA   77 (228)
T ss_dssp             CCCCEEEESSCCT-TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC--SSCBEEEEEEEEEECCB
T ss_pred             CccceEEcCCCCC-CCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC--CCceeeEEEEEEEEEec
Confidence            3567899999986 3579999999998889999998754      4689999999999998  57899999999999999


Q ss_pred             CCCCCCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecc
Q 038860           94 EYPRLGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAA  173 (652)
Q Consensus        94 ~~~~~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~  173 (652)
                      .+...+||||||+|+|.+..++..|++||+++..+ ++..++.|||||||+.|.  .|++.+|+++++++..        
T Consensus        78 ~~~~~~gDGlAF~l~~~~~~~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~--------  146 (228)
T d1ioaa_          78 KNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENC--------  146 (228)
T ss_dssp             SCTTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEEC--------
T ss_pred             CCCCCCCCEEEEEEeCCCCCCCCCccccccccccC-CCCcceeEEEEecCcccc--ccCCCCccceeccccc--------
Confidence            88888999999999998876788899999998654 356788999999999986  5888888888876532        


Q ss_pred             eecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccc---cccccc
Q 038860          174 VYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTG---LLASSH  250 (652)
Q Consensus       174 ~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg---~~~~~~  250 (652)
                               +..+.+|+.++|||+||+.+++|+|++++.. +|..|.++..+||+.+||++|||||||+||   ...|.|
T Consensus       147 ---------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h  216 (228)
T d1ioaa_         147 ---------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETH  216 (228)
T ss_dssp             ---------CHHHHCSSCEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCC
T ss_pred             ---------ccccccCcEEEEEEEEcCCCCEEEEEEEeCC-CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEE
Confidence                     2346689999999999999999999999754 678899999999999999999999999999   455789


Q ss_pred             eeeccccccc
Q 038860          251 NVLGWSFKIN  260 (652)
Q Consensus       251 ~v~~w~f~~~  260 (652)
                      .|++|+|++.
T Consensus       217 ~I~sWsFss~  226 (228)
T d1ioaa_         217 DVLSWSFSSK  226 (228)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEEeEEe
Confidence            9999999863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=379.62  Aligned_cols=201  Identities=31%  Similarity=0.545  Sum_probs=169.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      .++|++.+.||+|+||+||+|+..+   .||||+++..  .....+.|.+|+.++++++||||+++++++.+ +.+++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            4678899999999999999998643   5999998654  34567889999999999999999999998865 5689999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      |||++|+|.+++... ...+++..++.++.||++||+|||   +++|+||||||+||||+.++.+||+|||+|+......
T Consensus        83 Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          83 QWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             ECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             ecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            999999999999643 346999999999999999999999   6899999999999999999999999999998765432


Q ss_pred             C-CceeeccCCcCCCCCCCCCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          497 N-PATTRVVGTLGYLAPETPRT---GKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       497 ~-~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      . .......||+.|||||++.+   ..++.++|||||||++|||+||+.||.+..
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~  213 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  213 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence            2 23445689999999998764   357899999999999999999999997643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-46  Score=376.30  Aligned_cols=201  Identities=31%  Similarity=0.509  Sum_probs=166.1

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|+..+.||+|+||+||+|.+.+ ++.||||+++... ...++|.+|++++++++||||++++|+|...+..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3578899999999999999999875 6789999997643 3446799999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++|+|.+++... ...+++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             cCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            9999999988543 356899999999999999999999   799999999999999999999999999999877554444


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhC-CCCCCC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACG-RRPIET  545 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG-~~p~~~  545 (652)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+..
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~  205 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  205 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence            44456799999999999999999999999999999999995 555443

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.1e-45  Score=363.06  Aligned_cols=217  Identities=33%  Similarity=0.456  Sum_probs=194.2

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCC---CCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTND---TSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPR   97 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~---~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~   97 (652)
                      .+++|+|++|++  +||+|+|||.+.++|.||||+.   .++++|||+|++||+||++.+++++||+|+|+|.|.+....
T Consensus         2 ~~~sf~f~~F~~--~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~~~   79 (226)
T d1avba_           2 NDASFNVETFNK--TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIE   79 (226)
T ss_dssp             EEEEEEESSCCG--GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTT
T ss_pred             CceEEECCCCCc--cceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCCCC
Confidence            568999999987  7999999999988889999974   45689999999999999999999999999999999998888


Q ss_pred             CCcCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecC
Q 038860           98 LGGHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTD  177 (652)
Q Consensus        98 ~~gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~  177 (652)
                      .+||||||+|+|....++..|+++|+++.          ++|||||+.|...+|+..||||||+|+..+..+.+.     
T Consensus        80 ~~gDG~aF~i~~~~~~~g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~-----  144 (226)
T d1avba_          80 NSAYGLAFALVPVGSRPKLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESC-----  144 (226)
T ss_dssp             SCCEEEEEEEEETTCCCCCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEEC-----
T ss_pred             CCCceEEEEEccCCCCCCCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCcccccccc-----
Confidence            89999999999988766888899999764          379999999976679999999999999998777765     


Q ss_pred             CCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEeccccc---ccccceeec
Q 038860          178 NSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGL---LASSHNVLG  254 (652)
Q Consensus       178 ~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~---~~~~~~v~~  254 (652)
                           ...+.+|+.+.|||+||+.+++|+|++++.+ ++..|.++..+||+.+||++|||||||+||.   ..|.|+|++
T Consensus       145 -----~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~Ils  218 (226)
T d1avba_         145 -----NFGHNNGEKAEVRITYDSPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLS  218 (226)
T ss_dssp             -----CSGGGTTCEEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEE
T ss_pred             -----ccccCCCeEEEEEEEEcCCCcEEEEEEEeCC-CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEE
Confidence                 4467899999999999999999999999765 5778889999999999999999999999995   456799999


Q ss_pred             cccccc
Q 038860          255 WSFKIN  260 (652)
Q Consensus       255 w~f~~~  260 (652)
                      |+|+++
T Consensus       219 WsF~s~  224 (226)
T d1avba_         219 WSFSSN  224 (226)
T ss_dssp             EEEEEE
T ss_pred             EEeEEe
Confidence            999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=380.02  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=205.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc------hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES------KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .++|++.+.||+|+||+||+|++..+++.||||++++..      ....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999999999999999986532      12357799999999999999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC----CeEEeeecc
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL----NGKLGDFGL  488 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~----~~kL~DFGl  488 (652)
                      +||||||++|+|.+++..  ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence            999999999999999854  346999999999999999999999   79999999999999998776    499999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      |+......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+   ....+..    ..  
T Consensus       164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~----~~--  232 (293)
T d1jksa_         164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVSA----VN--  232 (293)
T ss_dssp             CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHT----TC--
T ss_pred             hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHHHh----cC--
Confidence            98765432  3344579999999999999999999999999999999999999997643211   1111100    00  


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                              ..+.                   ....+...+.+.||+.+|+..+|++|+|      |+|++.
T Consensus       233 --------~~~~-------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         233 --------YEFE-------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             --------CCCC-------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             --------CCCC-------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                    0000                   0001123467899999999999999994      678875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=380.26  Aligned_cols=275  Identities=26%  Similarity=0.284  Sum_probs=204.1

Q ss_pred             ccccccccCceEEEEEEEcCCCeEEEEEEecCcchhh-----HHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          344 AKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQG-----VREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       344 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .+++||+|+||+||+|++..+++.||||+++......     .+.+.+|+.++++++||||+++++++..++.+++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999999999999999996543221     24688999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      ++++++..+.  .....+++..+..+++||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...... .
T Consensus        82 ~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~  155 (299)
T d1ua2a_          82 METDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-R  155 (299)
T ss_dssp             CSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-C
T ss_pred             hcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc-c
Confidence            9988776665  33456899999999999999999999   7999999999999999999999999999998655432 2


Q ss_pred             ceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      .....+||+.|+|||++... .++.++|||||||++|||++|++||......+....+....+........+....    
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~----  231 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL----  231 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS----
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc----
Confidence            33345799999999987654 5799999999999999999999999865443333322222222111111000000    


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                              ............|.........+.+.||+.+|+..||++|+      .|+||++.+.
T Consensus       232 --------~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         232 --------PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             --------TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             --------chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence                    00000011111111112234467899999999999999999      5789987544

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-45  Score=386.26  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=200.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHH---HHHHHHhcccCcCceeEEEeeeeccCee
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREF---VSEIATIGRLRHRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  412 (652)
                      .++|++.+.||+|+||.||+|++..+++.||||++.+..   ......+   ..|+.+++.++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999999999999999986432   1122233   3457778888999999999999999999


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceec
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLY  492 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~  492 (652)
                      |+|||||++|+|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999999954  456889999999999999999999   799999999999999999999999999999976


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI  571 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  571 (652)
                      ...   ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+...+..               
T Consensus       158 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---------------  219 (364)
T d1omwa3         158 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---------------  219 (364)
T ss_dssp             SSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---------------
T ss_pred             CCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------
Confidence            543   2344579999999999865 568999999999999999999999997644332211110               


Q ss_pred             ccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC-----------cccccc
Q 038860          572 DPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS-----------CSYFEN  633 (652)
Q Consensus       572 d~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s-----------~~~~~~  633 (652)
                                     ..  .......|     ....+.+.||+.+|+..+|++|++           |+||++
T Consensus       220 ---------------~~--~~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         220 ---------------MT--LTMAVELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             ---------------HS--SSCCCCCC-----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             ---------------hc--ccCCCCCC-----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence                           00  00000111     123467889999999999999986           778765

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=368.03  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=203.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFM  419 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  419 (652)
                      ++|+..+.||+|+||.||+|+++ +++.||||+++.... ..++|.+|+.++++++||||++++|+|.+.+.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            68899999999999999999986 578999999976543 3468999999999999999999999999999999999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA  499 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  499 (652)
                      ++|+|..++... ...+++..+++++.|+++||.|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus        82 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999987543 346889999999999999999999   6999999999999999999999999999998766554444


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+   +...+.    +              
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~----~--------------  216 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA----Q--------------  216 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH----T--------------
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHH----h--------------
Confidence            555679999999999999999999999999999999998 899997643211   111100    0              


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCS  629 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~  629 (652)
                                   ..  +.+.+.   ...+.+.+|+.+|+..+|++|||.+
T Consensus       217 -------------~~--~~~~p~---~~~~~l~~li~~cl~~dP~~RPt~~  249 (258)
T d1k2pa_         217 -------------GL--RLYRPH---LASEKVYTIMYSCWHEKADERPTFK  249 (258)
T ss_dssp             -------------TC--CCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             -------------CC--CCCCcc---cccHHHHHHHHHHccCCHhHCcCHH
Confidence                         00  001111   2235789999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-45  Score=384.33  Aligned_cols=198  Identities=25%  Similarity=0.328  Sum_probs=180.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  416 (652)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+..   ....+.+.+|+.+|+.++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            58999999999999999999999999999999996532   234567899999999999999999999999999999999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGT  496 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~  496 (652)
                      ||+.+|+|..++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+....  
T Consensus       121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence            99999999999854  346999999999999999999999   79999999999999999999999999999997653  


Q ss_pred             CCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          497 NPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       497 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  241 (350)
T d1rdqe_         194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence              233467999999999999999999999999999999999999999753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=374.26  Aligned_cols=204  Identities=29%  Similarity=0.502  Sum_probs=174.9

Q ss_pred             hcCcccccc-ccccCceEEEEEEEcC--CCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQL-LGHGGFGQVYKGTLHN--SKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~-LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|.+.+. ||+|+||.||+|.+..  ++..||||+++... ....++|.+|+++|++++||||++++|+|.. +.++|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            456777774 9999999999998753  45679999997653 4456789999999999999999999999865 46899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      |||||++|+|.+++... +..+++.++++++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999987443 346999999999999999999999   69999999999999999999999999999997654


Q ss_pred             CCC--CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          495 GTN--PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       495 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      ...  .......||+.|+|||++.++.++.++|||||||++|||+| |+.||....
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence            332  22234568999999999998999999999999999999998 999997643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=380.24  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=200.0

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCC-----eEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeeccC
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSK-----TEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKG  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  410 (652)
                      ..++|++.+.||+|+||+||+|++...+     ..||+|.+.... ......+.+|+.++.++ +|||||+++++|.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            3468999999999999999999987543     369999986543 33446789999999998 8999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccCC---------------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCC
Q 038860          411 DLLLVYDFMANGSLDSFLFDEP---------------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVK  469 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk  469 (652)
                      ..++|||||++|+|.+++....                     ...+++..++.++.||++||+|||   +++|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            9999999999999999996432                     235899999999999999999999   6999999999


Q ss_pred             CCceEeCCCCCeEEeeeccceecccCCCCc-eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          470 ASNVLLDSELNGKLGDFGLAKLYEHGTNPA-TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       470 ~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      |+|||++.++.+||+|||+|+......... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998765543322 234578999999999999999999999999999999998 899997644


Q ss_pred             CccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC
Q 038860          548 LPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS  627 (652)
Q Consensus       548 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s  627 (652)
                      ..+..  ...+...                 +                +.+.+   ....+.+.+|+.+|+..+|++|||
T Consensus       272 ~~~~~--~~~~~~~-----------------~----------------~~~~p---~~~~~~l~~li~~cl~~dP~~RPt  313 (325)
T d1rjba_         272 VDANF--YKLIQNG-----------------F----------------KMDQP---FYATEEIYIIMQSCWAFDSRKRPS  313 (325)
T ss_dssp             CSHHH--HHHHHTT-----------------C----------------CCCCC---TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHH--HHHHhcC-----------------C----------------CCCCC---CcCCHHHHHHHHHHcCCChhHCcC
Confidence            32211  1111000                 0                00111   123467899999999999999998


Q ss_pred             cc
Q 038860          628 CS  629 (652)
Q Consensus       628 ~~  629 (652)
                      .+
T Consensus       314 ~~  315 (325)
T d1rjba_         314 FP  315 (325)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-44  Score=367.66  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=204.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---------hhhHHHHHHHHHHhcccC-cCceeEEEeeeec
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---------KQGVREFVSEIATIGRLR-HRNLVQLVGWCRR  408 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  408 (652)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...         ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999999899999999986542         112346889999999997 9999999999999


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      ++..|||||||++|+|.+++..  ...+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999954  456999999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCCCceeeccCCcCCCCCCCCC------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhh
Q 038860          489 AKLYEHGTNPATTRVVGTLGYLAPETPR------TGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKY  562 (652)
Q Consensus       489 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  562 (652)
                      ++......  ......||+.|+|||.+.      ...++.++||||+||++|||++|+.||.+....+   ....+..  
T Consensus       157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~~i~~--  229 (277)
T d1phka_         157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIMS--  229 (277)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH--
T ss_pred             eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHHHHHh--
Confidence            99775432  334568999999999764      3457889999999999999999999997643111   1110000  


Q ss_pred             cCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------Ccccccc
Q 038860          563 GEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFEN  633 (652)
Q Consensus       563 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~  633 (652)
                                    +.+                . +.....+...+.+.||+.+|+..+|++|+      .|+|++.
T Consensus       230 --------------~~~----------------~-~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         230 --------------GNY----------------Q-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             --------------TCC----------------C-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             --------------CCC----------------C-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                          000                0 01111224557899999999999999999      4567653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=374.65  Aligned_cols=281  Identities=25%  Similarity=0.321  Sum_probs=207.9

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK--QGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....  ...+++.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            589999999999999999999999999999999965432  235678999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+.+ ++..++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9965 5555554445567999999999999999999999   7999999999999999999999999999998764332 


Q ss_pred             CceeeccCCcCCCCCCCCCCCC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      .......||+.|+|||.+.... ++.++||||+||++|||++|+.||.+....+....+........+.....     ..
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~  231 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG-----VT  231 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT-----GG
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc-----cc
Confidence            2333457999999999866655 58899999999999999999999986543222221111111111111000     00


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                      ...+      .....+.....+.....+...+.+.||+++|+..+|++|+|      |+||++.+.
T Consensus       232 ~~~~------~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         232 SMPD------YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GSTT------CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccc------cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            0000      00001111111112222344578999999999999999995      569987644

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=369.69  Aligned_cols=240  Identities=27%  Similarity=0.390  Sum_probs=189.7

Q ss_pred             ccccccCceEEEEEEEcC--CCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEeccC
Q 038860          346 QLLGHGGFGQVYKGTLHN--SKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDFMAN  421 (652)
Q Consensus       346 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  421 (652)
                      ++||+|+||+||+|.+..  +++.||||+++...  ....++|.+|+.+|++++||||++++++|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998754  45789999996542  3345689999999999999999999999965 467899999999


Q ss_pred             CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCCc--
Q 038860          422 GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNPA--  499 (652)
Q Consensus       422 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~~--  499 (652)
                      |+|.+++..  ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.........  
T Consensus        92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            999999853  346999999999999999999999   6899999999999999999999999999999765433222  


Q ss_pred             eeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          500 TTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       500 ~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....   .+...+.    .+             
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~----~~-------------  226 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLE----KG-------------  226 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----TT-------------
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHH----cC-------------
Confidence            234578999999999999999999999999999999998 89999764321   1111110    00             


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                      .+.|.+   ....+.+.+|+.+|+..+|++||+.+-
T Consensus       227 ----------------~~~~~p---~~~~~~~~~li~~cl~~dp~~RPs~~~  259 (277)
T d1xbba_         227 ----------------ERMGCP---AGCPREMYDLMNLCWTYDVENRPGFAA  259 (277)
T ss_dssp             ----------------CCCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ----------------CCCCCC---cccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence                            000111   122467889999999999999998643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=371.62  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=193.9

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEEe
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  418 (652)
                      .++|++.+.||+|+||+||+|++.++ +.||||+++... ...+.|.+|+.++++++|||||+++++|.+ +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            35799999999999999999999764 679999997543 345779999999999999999999999865 568999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++|+|..++.......++|.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+........
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            99999999987666667999999999999999999999   689999999999999999999999999999877554444


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccccC
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAE  578 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  578 (652)
                      ......||+.|+|||++.++.++.++|||||||++|||++|..|+.......+  ...++...                 
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~~-----------------  230 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG-----------------  230 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT-----------------
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc-----------------
Confidence            44556799999999999999999999999999999999997766654322111  11111100                 


Q ss_pred             CCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCcccc
Q 038860          579 YDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSYF  631 (652)
Q Consensus       579 ~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~~  631 (652)
                                      .+.|..   ....+.+.+|+.+|+..+|++||+++-.
T Consensus       231 ----------------~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i  264 (285)
T d1fmka3         231 ----------------YRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYL  264 (285)
T ss_dssp             ----------------CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----------------CCCCCC---cccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence                            001111   1224578899999999999999976543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-44  Score=373.72  Aligned_cols=256  Identities=22%  Similarity=0.290  Sum_probs=201.8

Q ss_pred             hcCccccc-cccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhccc-CcCceeEEEeeeec----cCee
Q 038860          339 TNNFSAKQ-LLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRL-RHRNLVQLVGWCRR----KGDL  412 (652)
Q Consensus       339 ~~~f~~~~-~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  412 (652)
                      .++|++.+ .||+|+||+||+|++..+++.||||+++..     ..+.+|+.++.++ +||||+++++++.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898875 599999999999999999999999999653     3466799887665 79999999999865    4678


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCeEEeeeccc
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLA  489 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~kL~DFGla  489 (652)
                      |+|||||++|+|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997655567999999999999999999999   799999999999999986   457999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+........   .....        
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~--------  228 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTR--------  228 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------C--------
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHH--------
Confidence            8765432  3345689999999999999999999999999999999999999997643221111   00000        


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccccCcc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFENGVS  636 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~~~~  636 (652)
                          .....+                ..|.. ......+.+.||+.+|+..+|++|++      |+|+.....
T Consensus       229 ----i~~~~~----------------~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         229 ----IRMGQY----------------EFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             ----CCSCSS----------------SCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             ----HhcCCC----------------CCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence                000000                01111 11234578999999999999999995      568865433

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=375.06  Aligned_cols=201  Identities=26%  Similarity=0.439  Sum_probs=178.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhc-ccCcCceeEEEeeeeccCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIG-RLRHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||++++..   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999999999999999997542   234456777777765 67999999999999999999999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccC
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~  495 (652)
                      ||||++|+|.+++..  ...+++.+++.++.||+.||+|||   +++|+||||||+|||+++++++||+|||+|+.....
T Consensus        82 mEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            999999999999953  446899999999999999999999   699999999999999999999999999999865443


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~  206 (320)
T d1xjda_         157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  206 (320)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence            2 3344568999999999999999999999999999999999999999764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=366.30  Aligned_cols=203  Identities=29%  Similarity=0.525  Sum_probs=167.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCCC----eEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSK----TEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      .+.|+..++||+|+||.||+|.++.++    ..||||++.... .....+|.+|+.++++++|||||+++|+|.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            356888999999999999999987543    479999997643 344567999999999999999999999999999999


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +|||||.+++|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+++...
T Consensus        86 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          86 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999998877543 346999999999999999999999   7999999999999999999999999999998765


Q ss_pred             cCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          494 HGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       494 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .....  ......||+.|+|||++.++.++.++|||||||++|||++|..|+..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence            43322  23345689999999999999999999999999999999997666544

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.9e-44  Score=365.26  Aligned_cols=203  Identities=25%  Similarity=0.416  Sum_probs=171.4

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC----e
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES---KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG----D  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  411 (652)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|+.++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999999999999999997542   334567999999999999999999999987653    4


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .|+||||+++++|.+++..  ...+++.+++.++.||++||+|||   +++|+||||||+|||++.++..+|+|||.++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            7999999999999988843  446999999999999999999999   79999999999999999999999999999886


Q ss_pred             cccCCC--CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 038860          492 YEHGTN--PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETR  546 (652)
Q Consensus       492 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~  546 (652)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  217 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD  217 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence            543322  2344568999999999999999999999999999999999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=370.90  Aligned_cols=253  Identities=19%  Similarity=0.301  Sum_probs=206.4

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ..++|++.+.||+|+||+||+|.+..+++.||||.++..... ...+.+|+++|++++||||+++++++.+.+.+|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            346899999999999999999999999999999999765433 3568899999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC--CCeEEeeeccceecccC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE--LNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~--~~~kL~DFGla~~~~~~  495 (652)
                      ||++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.+  ..+||+|||+++.....
T Consensus        82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999999998543 336899999999999999999999   7999999999999999854  57999999999876432


Q ss_pred             CCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKL  575 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  575 (652)
                        .......||+.|+|||...+..++.++||||+||++|||++|+.||......+   ....+..               
T Consensus       158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~~---------------  217 (321)
T d1tkia_         158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMN---------------  217 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHH---------------
T ss_pred             --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---------------
Confidence              33455689999999999999999999999999999999999999997643211   1111100               


Q ss_pred             ccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          576 NAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       576 ~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                       ..+.          .       .....+...+.+.||+++|+..+|++|++      |+|+..
T Consensus       218 -~~~~----------~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         218 -AEYT----------F-------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -TCCC----------C-------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -CCCC----------C-------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence             0000          0       00001123467899999999999999997      778865

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-43  Score=361.51  Aligned_cols=275  Identities=23%  Similarity=0.316  Sum_probs=204.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||+||+|++. +++.||||++....  ....+.+.+|+.+|++++||||+++++++...+..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 57899999996643  2335678999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      |+.++.+..+.  .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||.|....... 
T Consensus        81 ~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          81 HLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            99887766665  33456999999999999999999999   6999999999999999999999999999998764432 


Q ss_pred             CceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                      .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+....+.................   .
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~  231 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE---L  231 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG---S
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh---h
Confidence            23344578999999998765 4578999999999999999999999986543332222221111111111100000   0


Q ss_pred             cCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------ccccc
Q 038860          577 AEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFE  632 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~  632 (652)
                      ..+        ..........|.........+.+.||+++|+..||++|+|      |+||+
T Consensus       232 ~~~--------~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         232 PKY--------DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             TTC--------CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             hhc--------ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            000        0111222222333333445678999999999999999995      46765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=363.50  Aligned_cols=248  Identities=24%  Similarity=0.376  Sum_probs=188.6

Q ss_pred             hcCccccccccccCceEEEEEEEcCC---CeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .++|++.+.||+|+||.||+|.+..+   +..||||.++... ....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            46799999999999999999998643   4579999987643 3345679999999999999999999999964 67899


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ||||+++|+|.+++... ...+++..++.++.||++||.|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999887543 446899999999999999999999   79999999999999999999999999999997765


Q ss_pred             CCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccc
Q 038860          495 GTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       495 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      ..........||+.|+|||++.+..++.++|||||||++|||++ |++||......+   +...+..    +        
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~----~--------  225 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN----G--------  225 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT----T--------
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----C--------
Confidence            55445566778999999999999999999999999999999998 899987643221   1111110    0        


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                           .+.|.+   +...+.+.+|+.+|+..+|++|||++-
T Consensus       226 ---------------------~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~e  258 (273)
T d1mp8a_         226 ---------------------ERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTE  258 (273)
T ss_dssp             ---------------------CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ---------------------CCCCCC---CCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence                                 000111   123467899999999999999998753

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.3e-42  Score=335.19  Aligned_cols=199  Identities=31%  Similarity=0.484  Sum_probs=167.2

Q ss_pred             CCceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCC
Q 038860           20 SQLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLG   99 (652)
Q Consensus        20 ~~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~   99 (652)
                      +.+++|+|++|++  +||+|+|||.+.++|.||||++.++++|||+|++||+||++.+++++||+|+|+|+|.+.+...+
T Consensus         1 a~~~sF~~~~F~~--~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~~   78 (204)
T d1dhkb_           1 ATETSFIIDAFNK--TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANS   78 (204)
T ss_dssp             CCCCEEEESSCCG--GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---C
T ss_pred             CccceEECCCCCc--cCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCCC
Confidence            3567899999976  79999999999888999999999999999999999999999999999999999999999877788


Q ss_pred             cCcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCC
Q 038860          100 GHGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNS  179 (652)
Q Consensus       100 gdGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~  179 (652)
                      ||||||+++|...                  ...++.+||||||+.         ||+++|+++...... ..       
T Consensus        79 gdGlaf~~~~~~~------------------~~~~~~~~vefDt~~---------n~~~~d~~~~~~~~~-~~-------  123 (204)
T d1dhkb_          79 AVGLDFVLVPVQP------------------ESKGDTVTVEFDTFL---------SRISIDVNNNDIKSV-PW-------  123 (204)
T ss_dssp             CSEEEEEEEEC------------------------CCEEEEEETTT---------TEEEEEETTEEEEEE-EC-------
T ss_pred             CceEEEEecCCCC------------------CCCCcEeeEeeEccc---------ccccCcccccccccc-cc-------
Confidence            9999999999642                  234567999999986         467777776543221 11       


Q ss_pred             CcccCCcCCCceEEEEEEEcCCCCeEEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccc---cccceeeccc
Q 038860          180 TKQDLSLKGGKAILVWVDYDSAENILNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLL---ASSHNVLGWS  256 (652)
Q Consensus       180 ~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~---~~~~~v~~w~  256 (652)
                         +..+.+|+.++|||+||+..++|+|+++..+ +|..|.++..+||+.+||++|||||||+||..   .|.|.|++|+
T Consensus       124 ---~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWs  199 (204)
T d1dhkb_         124 ---DVHDYDGQNAEVRITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWS  199 (204)
T ss_dssp             ---CGGGTTTSCEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEE
T ss_pred             ---ccEecCCCEEEEEEEEcCCCEEEEEEEecCC-CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEE
Confidence               4567889999999999999999999999765 46678899999999999999999999999964   4679999999


Q ss_pred             ccc
Q 038860          257 FKI  259 (652)
Q Consensus       257 f~~  259 (652)
                      |++
T Consensus       200 Fss  202 (204)
T d1dhkb_         200 FSS  202 (204)
T ss_dssp             EEE
T ss_pred             EEe
Confidence            985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-44  Score=366.92  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=203.6

Q ss_pred             hhhhhhhhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcch-hhHHHHHHHHHHhcccCcCceeEEEee
Q 038860          332 YQELKQATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNESK-QGVREFVSEIATIGRLRHRNLVQLVGW  405 (652)
Q Consensus       332 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  405 (652)
                      +.+++..+++|++.+.||+|+||+||+|++.+     +++.||||+++.... ...++|.+|+.++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            44566677899999999999999999999763     457899999976543 345679999999999999999999999


Q ss_pred             eeccCeeEEEEEeccCCCcccccccCC----------------------ccccchHHHhhhHHHHHHHHhhhccCccceE
Q 038860          406 CRRKGDLLLVYDFMANGSLDSFLFDEP----------------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVV  463 (652)
Q Consensus       406 ~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~i  463 (652)
                      |...+..+++|||+++|+|.+++....                      ...+++..++.++.|++.||+|||   +++|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence            999999999999999999999885321                      234899999999999999999999   7999


Q ss_pred             EecCCCCCceEeCCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCC-C
Q 038860          464 IHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR-R  541 (652)
Q Consensus       464 vHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~-~  541 (652)
                      +||||||+|||++.++.+||+|||+|+....... ...+...||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999986643322 2334567899999999999999999999999999999999986 5


Q ss_pred             CCCCCCCccchhHHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCC
Q 038860          542 PIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSS  621 (652)
Q Consensus       542 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~  621 (652)
                      ||......+   +...+.    ++.                             +.+.+   ....+.+.+|+.+|+..+
T Consensus       242 p~~~~~~~e---~~~~v~----~~~-----------------------------~~~~p---~~~~~~~~~li~~cl~~~  282 (301)
T d1lufa_         242 PYYGMAHEE---VIYYVR----DGN-----------------------------ILACP---ENCPLELYNLMRLCWSKL  282 (301)
T ss_dssp             TTTTSCHHH---HHHHHH----TTC-----------------------------CCCCC---TTCCHHHHHHHHHHTCSS
T ss_pred             CCCCCCHHH---HHHHHH----cCC-----------------------------CCCCC---ccchHHHHHHHHHHcCCC
Confidence            665432211   111110    000                             00111   122357889999999999


Q ss_pred             CCCCCCccc
Q 038860          622 FDKTTSCSY  630 (652)
Q Consensus       622 ~~~r~s~~~  630 (652)
                      |++||+...
T Consensus       283 P~~RPt~~e  291 (301)
T d1lufa_         283 PADRPSFCS  291 (301)
T ss_dssp             GGGSCCHHH
T ss_pred             hhHCcCHHH
Confidence            999998654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=364.34  Aligned_cols=278  Identities=25%  Similarity=0.308  Sum_probs=204.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCC-CeEEEEEEecCcch--hhHHHHHHHHHHhccc---CcCceeEEEeeeec----
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNS-KTEVAVKRISNESK--QGVREFVSEIATIGRL---RHRNLVQLVGWCRR----  408 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  408 (652)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++....  .....+.+|+.+++.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999998654 67899999865422  1223456677777665   79999999999853    


Q ss_pred             -cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeec
Q 038860          409 -KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFG  487 (652)
Q Consensus       409 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFG  487 (652)
                       ....+++|||++++.+.... ......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             35689999999887665433 234556899999999999999999999   7999999999999999999999999999


Q ss_pred             cceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcc
Q 038860          488 LAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRV  567 (652)
Q Consensus       488 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  567 (652)
                      +++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+....+.......
T Consensus       162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            98865432  2334568999999999999999999999999999999999999999875443333322222222111111


Q ss_pred             ccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          568 LEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       568 ~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      .....  +          ... ........|.........+.+.||+.+|+..||++|+      .|+||++..
T Consensus       240 ~~~~~--~----------~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         240 PRDVA--L----------PRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CTTCS--S----------CGG-GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccc--c----------hhh-hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            00000  0          000 0111111222222334567899999999999999999      578887754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-44  Score=357.47  Aligned_cols=241  Identities=31%  Similarity=0.438  Sum_probs=189.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeec-cCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRR-KGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~  418 (652)
                      ++|++.+.||+|+||.||+|.++  ++.||||+++...  ..++|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            56788899999999999999985  6789999997643  34679999999999999999999999865 4668999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP  498 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~  498 (652)
                      +++|+|.+++.......++|..+++++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999997655567999999999999999999999   69999999999999999999999999999986543    


Q ss_pred             ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCcccccccccccc
Q 038860          499 ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLNA  577 (652)
Q Consensus       499 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  577 (652)
                      ......+|..|+|||++.++.++.++|||||||++|||+| |++||......+   +..++..                 
T Consensus       156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~-----------------  215 (262)
T d1byga_         156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK-----------------  215 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT-----------------
T ss_pred             CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc-----------------
Confidence            2233468999999999999999999999999999999998 677776532211   1111100                 


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          578 EYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       578 ~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                      ..+.|.+   ....+.+.+|+.+|+..+|++|||+..
T Consensus       216 ----------------~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~  249 (262)
T d1byga_         216 ----------------GYKMDAP---DGCPPAVYEVMKNCWHLDAAMRPSFLQ  249 (262)
T ss_dssp             ----------------TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----------------CCCCCCC---ccCCHHHHHHHHHHcccCHhHCcCHHH
Confidence                            0000111   122367889999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=365.49  Aligned_cols=203  Identities=26%  Similarity=0.441  Sum_probs=170.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe----EEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT----EVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  414 (652)
                      .+|++.+.||+|+||+||+|.+..+++    .||+|+++.. .....++|.+|+.++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999876664    5899988654 344567899999999999999999999999875 5678


Q ss_pred             EEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceeccc
Q 038860          415 VYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEH  494 (652)
Q Consensus       415 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~  494 (652)
                      ++||+.+|+|.+++... ...+++..+++++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999887543 456999999999999999999999   68999999999999999999999999999997654


Q ss_pred             CCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 038860          495 GTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRA  547 (652)
Q Consensus       495 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~  547 (652)
                      .... ......||+.|+|||++.++.++.++|||||||++|||+| |++||....
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~  218 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  218 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence            4332 2334578999999999999999999999999999999998 888987644

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=364.51  Aligned_cols=284  Identities=23%  Similarity=0.281  Sum_probs=208.0

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHhcccCcCceeEEEeeeeccC----eeE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES-KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG----DLL  413 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  413 (652)
                      +.+|++.++||+|+||+||+|++..+++.||||++.... ....+.+++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            467999999999999999999999899999999997643 344567899999999999999999999986543    234


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      ++++|+.+|+|.+++..   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            55566779999999843   35999999999999999999999   7999999999999999999999999999998764


Q ss_pred             cCC--CCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          494 HGT--NPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       494 ~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ...  .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.................   
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  237 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL---  237 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH---
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh---
Confidence            322  122345679999999998854 56788999999999999999999999765433322222222111111000   


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVSY  637 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~~  637 (652)
                            ...............+.....|.....+...+.+.||+.+|+..||++|+      .|+|++.....
T Consensus       238 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         238 ------NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             ------HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             ------hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                  00000111111122222223333333344567899999999999999998      67888865443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=365.39  Aligned_cols=277  Identities=23%  Similarity=0.325  Sum_probs=202.9

Q ss_pred             hhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC-----
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG-----  410 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  410 (652)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..  .....+.+.+|+.+|++++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            357899999999999999999999999999999999754  3344567899999999999999999999997654     


Q ss_pred             -eeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccc
Q 038860          411 -DLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLA  489 (652)
Q Consensus       411 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla  489 (652)
                       .+++||||+ +.+|..+..   ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence             579999999 556766652   346999999999999999999999   799999999999999999999999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +....    ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..............    
T Consensus       169 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  240 (346)
T d1cm8a_         169 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA----  240 (346)
T ss_dssp             EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH----
T ss_pred             eccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH----
Confidence            87543    2345679999999998766 45789999999999999999999999875433322222222111110    


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      +.... .  ...........  .+...+.+.........+.+.|||++|+..+|++|+      .|+||+..
T Consensus       241 ~~~~~-~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         241 EFVQR-L--QSDEAKNYMKG--LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHT-C--SCHHHHHHHHH--SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHhh-h--cchhhhhhhcc--CCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            00000 0  01111111111  112222222222234567899999999999999999      67899874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=355.98  Aligned_cols=200  Identities=30%  Similarity=0.398  Sum_probs=164.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeeccC----eeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG----DLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV  415 (652)
                      .+|...+.||+|+||.||+|++.  ++.||||+++..... ......|+..+.+++||||++++++|.+.+    .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            35778889999999999999974  689999999654322 222345666667889999999999997654    58999


Q ss_pred             EEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC-----ccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          416 YDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG-----YEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      ||||++|+|.+++.+   ..++|.++++++.|++.||+|||+.     .+++|+||||||+||||+.++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999954   3589999999999999999999963     24799999999999999999999999999999


Q ss_pred             ecccCCC---CceeeccCCcCCCCCCCCCCCC------CCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          491 LYEHGTN---PATTRVVGTLGYLAPETPRTGK------SSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       491 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                      .......   .......||+.|+|||++.+..      ++.++|||||||++|||+||..|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            7754432   1234568999999999876543      57789999999999999999988864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-43  Score=363.04  Aligned_cols=281  Identities=24%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec--------
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR--------  408 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  408 (652)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  .....+++.+|+.+|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999999989999999998654  23345678899999999999999999998855        


Q ss_pred             cCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecc
Q 038860          409 KGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGL  488 (652)
Q Consensus       409 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGl  488 (652)
                      .+..++||||++++.+..+.  .....+++..++.+++|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence            34689999999887766554  33456888999999999999999999   79999999999999999999999999999


Q ss_pred             ceecccCCC---CceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcC
Q 038860          489 AKLYEHGTN---PATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGE  564 (652)
Q Consensus       489 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  564 (652)
                      ++.......   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+....+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987653221   222335799999999988765 6899999999999999999999999865443333333333333322


Q ss_pred             CccccccccccccCCCHHHHHHhhccCCCCCCCCCC--CcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          565 GRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRS--SDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       565 ~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~--~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                      ..........+..          .+........+..  .......+.+.|||.+|+..||++|+      .|+||.+.
T Consensus       244 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYE----------KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-----------------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhh----------hhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            2111111111100          0000000000000  00012246788999999999999999      67898863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-43  Score=358.82  Aligned_cols=207  Identities=29%  Similarity=0.437  Sum_probs=166.3

Q ss_pred             hhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCceeEEEeeeecc-
Q 038860          338 ATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRNLVQLVGWCRRK-  409 (652)
Q Consensus       338 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  409 (652)
                      ..++|++.+.||+|+||.||+|.+..     +++.||||+++... ....+.+.+|..++.++ +|+||+++++++... 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            34679999999999999999999754     34689999997543 34456788888888887 689999999998664 


Q ss_pred             CeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      +.+++|||||++|+|.+++....              ...+++.+++.++.||++||+|||   +++|+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeE
Confidence            56899999999999999985432              235899999999999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCC-CCCCCCC
Q 038860          476 DSELNGKLGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR-RPIETRA  547 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~-~p~~~~~  547 (652)
                      +.++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||++|. +||....
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999987654332 2334567999999999999999999999999999999999974 5676543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=356.71  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=188.8

Q ss_pred             cCccccccccccCceEEEEEEEcCC---CeEEEEEEecCc---chhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNE---SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLL  413 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  413 (652)
                      ++|++.+.||+|+||.||+|++...   ...||||++.+.   .....++|.+|+.+|++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5789999999999999999987532   347999998754   33455789999999999999999999999976 4678


Q ss_pred             EEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecc
Q 038860          414 LVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYE  493 (652)
Q Consensus       414 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~  493 (652)
                      +||||+++|+|.+++... ...+++..+++++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999999999999887543 346999999999999999999999   6999999999999999999999999999999765


Q ss_pred             cCCCC--ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          494 HGTNP--ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       494 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      .....  ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+....+   ...++...         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~~~---------  230 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKE---------  230 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTS---------
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHHhC---------
Confidence            43322  2233567889999999999999999999999999999998 899997533211   11111100         


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                                             ..+.|.+.   ...+.+.+|+.+|+..+|++|||.+-
T Consensus       231 -----------------------~~~~~~~~---~~~~~l~~li~~cl~~dp~~RPt~~e  264 (273)
T d1u46a_         231 -----------------------GERLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVA  264 (273)
T ss_dssp             -----------------------CCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----------------------CCCCCCcc---cccHHHHHHHHHHcCCChhHCcCHHH
Confidence                                   00111111   22367899999999999999998643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-43  Score=355.99  Aligned_cols=241  Identities=23%  Similarity=0.383  Sum_probs=195.6

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHhcccC--cCceeEEEeeeeccCe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK------QGVREFVSEIATIGRLR--HRNLVQLVGWCRRKGD  411 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  411 (652)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....      ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999999999999999999865321      12234678999999996  8999999999999999


Q ss_pred             eEEEEEeccC-CCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCC-CCeEEeeeccc
Q 038860          412 LLLVYDFMAN-GSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSE-LNGKLGDFGLA  489 (652)
Q Consensus       412 ~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~-~~~kL~DFGla  489 (652)
                      .++||||+.+ +++.+++.  ....+++.+++.++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 46666663  3456999999999999999999999   7999999999999999854 78999999999


Q ss_pred             eecccCCCCceeeccCCcCCCCCCCCCCCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccc
Q 038860          490 KLYEHGTNPATTRVVGTLGYLAPETPRTGKS-SASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVL  568 (652)
Q Consensus       490 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  568 (652)
                      +.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||....         .+          
T Consensus       159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i----------  216 (273)
T d1xwsa_         159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EI----------  216 (273)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH----------
T ss_pred             eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HH----------
Confidence            865432   3345689999999999887665 567899999999999999999996421         00          


Q ss_pred             cccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccC
Q 038860          569 EVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENG  634 (652)
Q Consensus       569 ~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~  634 (652)
                                      ....+..+           ....+.+.||+.+|+..+|++|+      .|+|+++.
T Consensus       217 ----------------~~~~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         217 ----------------IRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             ----------------HHCCCCCS-----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ----------------hhcccCCC-----------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                            00000000           12346889999999999999999      46788764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=358.26  Aligned_cols=201  Identities=30%  Similarity=0.507  Sum_probs=171.3

Q ss_pred             cCccccccccccCceEEEEEEEcCCCe--EEEEEEecCc-chhhHHHHHHHHHHhccc-CcCceeEEEeeeeccCeeEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKT--EVAVKRISNE-SKQGVREFVSEIATIGRL-RHRNLVQLVGWCRRKGDLLLV  415 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  415 (652)
                      ++|++.+.||+|+||.||+|++.+++.  .||||+++.. .....++|.+|+++|+++ +||||++++++|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999999987765  4788888654 334566799999999999 799999999999999999999


Q ss_pred             EEeccCCCcccccccC--------------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCe
Q 038860          416 YDFMANGSLDSFLFDE--------------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNG  481 (652)
Q Consensus       416 ~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~  481 (652)
                      |||+++|+|.++++..              ....+++.++++++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999998643              2356999999999999999999999   7999999999999999999999


Q ss_pred             EEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCC-CCCC
Q 038860          482 KLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRR-PIET  545 (652)
Q Consensus       482 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~-p~~~  545 (652)
                      ||+|||+|+......  ......||..|+|||.+.++.++.++|||||||++|||++|.. ||..
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence            999999998654322  2234568999999999999999999999999999999999765 5654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.1e-42  Score=355.92  Aligned_cols=280  Identities=21%  Similarity=0.284  Sum_probs=203.5

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeec--cCeeEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRR--KGDLLLVY  416 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~  416 (652)
                      ++|++.++||+|+||+||+|++..+++.||||+++...   .+++.+|+.+|++++ ||||+++++++..  ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999999999999999999997643   356788999999995 9999999999874  45689999


Q ss_pred             EeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceecccC
Q 038860          417 DFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLYEHG  495 (652)
Q Consensus       417 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~~~~  495 (652)
                      |||++++|..+.     ..+++..++.+++||+.||.|||   +++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999998765     35899999999999999999999   79999999999999998665 5999999999876543


Q ss_pred             CCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccc-hhHHHHHHhhhcCCcccccccc
Q 038860          496 TNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEE-LVLVDWVWGKYGEGRVLEVIDP  573 (652)
Q Consensus       496 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~id~  573 (652)
                      .  ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ...+....+...........+.
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            2  33455789999999987765 479999999999999999999999976443221 1111111110000000000000


Q ss_pred             ccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          574 KLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       574 ~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      .....+.   ..............+.........+.+.|||++|+..+|++|+      .|+||.++.
T Consensus       262 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         262 ELDPRFN---DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCCGGGG---GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             ccCcccc---hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            0000000   0000000111111122222234567899999999999999998      677887653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=362.09  Aligned_cols=275  Identities=24%  Similarity=0.305  Sum_probs=199.9

Q ss_pred             CccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCceeEEEeeeecc------CeeEE
Q 038860          341 NFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLVQLVGWCRRK------GDLLL  414 (652)
Q Consensus       341 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  414 (652)
                      +|+..++||+|+||+||+|++..+++.||||++......    ..+|+.+|++++||||++++++|...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            577889999999999999999999999999999765322    24699999999999999999998543      34789


Q ss_pred             EEEeccCCCcccccc-cCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC-CeEEeeeccceec
Q 038860          415 VYDFMANGSLDSFLF-DEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL-NGKLGDFGLAKLY  492 (652)
Q Consensus       415 V~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~-~~kL~DFGla~~~  492 (652)
                      |||||+++.+..... ......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998754333322 134557999999999999999999999   79999999999999999775 8999999999876


Q ss_pred             ccCCCCceeeccCCcCCCCCCCCCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccc
Q 038860          493 EHGTNPATTRVVGTLGYLAPETPRT-GKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI  571 (652)
Q Consensus       493 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  571 (652)
                      ....  ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+....+......+.+..
T Consensus       174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            5433  2334579999999998765 568999999999999999999999997654333222222111111110000000


Q ss_pred             ccccccCCCHHHHHHhhccCCCCCCCCC-CCcccccchhHHHHHhhhccCCCCCCC------CccccccCcc
Q 038860          572 DPKLNAEYDQSQVLMGELELPDTLRGPR-SSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGVS  636 (652)
Q Consensus       572 d~~l~~~~~~~~~~~~~l~~~~~~~~p~-~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~~  636 (652)
                       +.           ......+.....|. ....+...+.+.|||.+|+..||++|+      .|+||++..+
T Consensus       252 -~~-----------~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         252 -PN-----------YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             -C--------------CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             -cc-----------hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence             00           00001111111111 111223457899999999999999999      5889987544

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=346.08  Aligned_cols=277  Identities=23%  Similarity=0.312  Sum_probs=208.1

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeeccCeeEEEEE
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  417 (652)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+++.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999999999999999986542  3456788999999999999999999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCC
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTN  497 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~  497 (652)
                      ++.+++|..++.  ....+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+.......
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999988887764  3456889999999999999999999   79999999999999999999999999999997654332


Q ss_pred             CceeeccCCcCCCCCCCCCCCC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccccccccc
Q 038860          498 PATTRVVGTLGYLAPETPRTGK-SSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVIDPKLN  576 (652)
Q Consensus       498 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  576 (652)
                       ......++..|+|||.+.... ++.++||||+||++|||++|+.||.......+  ....+........         .
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~---------~  224 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPT---------E  224 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCC---------T
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCC---------h
Confidence             233346788999999877655 68999999999999999999999754332221  1122222111100         0


Q ss_pred             cCCCHHHHHHhhccCC-CCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC------cccccc
Q 038860          577 AEYDQSQVLMGELELP-DTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS------CSYFEN  633 (652)
Q Consensus       577 ~~~~~~~~~~~~l~~~-~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s------~~~~~~  633 (652)
                      ..+............+ ...............+.+.|||.+|+..||.+|+|      |+||++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            0000000000000000 01111112222345678999999999999999995      568875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-42  Score=354.34  Aligned_cols=216  Identities=29%  Similarity=0.451  Sum_probs=181.4

Q ss_pred             Ccccchhh-hhhhhcCccccccccccCceEEEEEEEc-----CCCeEEEEEEecCcc-hhhHHHHHHHHHHhccc-CcCc
Q 038860          327 PQRYSYQE-LKQATNNFSAKQLLGHGGFGQVYKGTLH-----NSKTEVAVKRISNES-KQGVREFVSEIATIGRL-RHRN  398 (652)
Q Consensus       327 ~~~~~~~e-l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~n  398 (652)
                      |..+++.. .+...++|++.+.||+|+||.||+|++.     .+++.||||+++... .....+|.+|+.+++++ +|||
T Consensus         9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hpn   88 (311)
T d1t46a_           9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN   88 (311)
T ss_dssp             TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCC
Confidence            44444433 2234578999999999999999999874     356789999997653 34456799999999999 6999


Q ss_pred             eeEEEeeeeccCeeEEEEEeccCCCcccccccCC----------------ccccchHHHhhhHHHHHHHHhhhccCccce
Q 038860          399 LVQLVGWCRRKGDLLLVYDFMANGSLDSFLFDEP----------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQV  462 (652)
Q Consensus       399 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~  462 (652)
                      |++++++|.+.+..++|||||++|+|.+++....                ...+++..+++++.||++||+|||   +++
T Consensus        89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~  165 (311)
T d1t46a_          89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKN  165 (311)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            9999999999999999999999999999985432                236899999999999999999999   799


Q ss_pred             EEecCCCCCceEeCCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CC
Q 038860          463 VIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GR  540 (652)
Q Consensus       463 ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~  540 (652)
                      ++||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |+
T Consensus       166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~  245 (311)
T d1t46a_         166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS  245 (311)
T ss_dssp             CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence            999999999999999999999999999976544332 2334688999999999999999999999999999999999 55


Q ss_pred             CCCCC
Q 038860          541 RPIET  545 (652)
Q Consensus       541 ~p~~~  545 (652)
                      +|+..
T Consensus       246 p~~~~  250 (311)
T d1t46a_         246 SPYPG  250 (311)
T ss_dssp             CSSTT
T ss_pred             CCCCC
Confidence            55544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-42  Score=352.05  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=196.3

Q ss_pred             hcCccccccccccCceEEEEEEEcCCC-------eEEEEEEecCcch-hhHHHHHHHHHHhccc-CcCceeEEEeeeecc
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSK-------TEVAVKRISNESK-QGVREFVSEIATIGRL-RHRNLVQLVGWCRRK  409 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  409 (652)
                      .++|++.+.||+|+||.||+|+....+       ..||||+++.... ....++.+|...+.++ +||||++++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            468889999999999999999876543       4799999976543 4557889999999888 799999999999999


Q ss_pred             CeeEEEEEeccCCCcccccccCC--------------ccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEe
Q 038860          410 GDLLLVYDFMANGSLDSFLFDEP--------------KAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLL  475 (652)
Q Consensus       410 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl  475 (652)
                      +..++||||+++|+|.+++....              ...+++.++++++.||+.||+|||   +++|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999995432              245899999999999999999999   7999999999999999


Q ss_pred             CCCCCeEEeeeccceecccCCCC-ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccchh
Q 038860          476 DSELNGKLGDFGLAKLYEHGTNP-ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVAC-GRRPIETRALPEELV  553 (652)
Q Consensus       476 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~ellt-G~~p~~~~~~~~~~~  553 (652)
                      +.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |++||......   .
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence            99999999999999977554332 3344678999999999999999999999999999999998 78888653321   1


Q ss_pred             HHHHHHhhhcCCccccccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCCccc
Q 038860          554 LVDWVWGKYGEGRVLEVIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTSCSY  630 (652)
Q Consensus       554 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s~~~  630 (652)
                      +    +.....+.                             +.+.+.   ...+.+.+|+.+|+..+|++|||+.-
T Consensus       246 ~----~~~i~~~~-----------------------------~~~~p~---~~~~~l~~li~~cl~~dP~~Rps~~e  286 (299)
T d1fgka_         246 L----FKLLKEGH-----------------------------RMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQ  286 (299)
T ss_dssp             H----HHHHHTTC-----------------------------CCCCCS---SCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             H----HHHHHcCC-----------------------------CCCCCc---cchHHHHHHHHHHccCCHhHCcCHHH
Confidence            1    11110000                             000111   22357889999999999999998653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=356.14  Aligned_cols=206  Identities=26%  Similarity=0.470  Sum_probs=176.9

Q ss_pred             hhhcCccccccccccCceEEEEEEEcC-----CCeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeeccC
Q 038860          337 QATNNFSAKQLLGHGGFGQVYKGTLHN-----SKTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRRKG  410 (652)
Q Consensus       337 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  410 (652)
                      ...++|++.+.||+|+||+||+|.+..     .++.||||+++.. .......|.+|+.++++++||||++++++|...+
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            334688899999999999999998853     3578999999764 3345567999999999999999999999999999


Q ss_pred             eeEEEEEeccCCCcccccccC--------CccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeE
Q 038860          411 DLLLVYDFMANGSLDSFLFDE--------PKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGK  482 (652)
Q Consensus       411 ~~~lV~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~k  482 (652)
                      ..++|||||++|+|.+++...        ....+++..+.+++.|+++||.|||   +++|+||||||+|||++.++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence            999999999999999988532        1234789999999999999999999   68999999999999999999999


Q ss_pred             EeeeccceecccCCC-CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCC-CCCCC
Q 038860          483 LGDFGLAKLYEHGTN-PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGR-RPIET  545 (652)
Q Consensus       483 L~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~-~p~~~  545 (652)
                      |+|||+|+....... .......||+.|+|||.+.++.++.++||||||+++|||+||. +||..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~  238 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  238 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence            999999987644322 2233457899999999999999999999999999999999985 66654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=350.19  Aligned_cols=197  Identities=31%  Similarity=0.486  Sum_probs=170.0

Q ss_pred             cccccccCceEEEEEEEcCC---CeEEEEEEecCc-chhhHHHHHHHHHHhcccCcCceeEEEeeeec-cCeeEEEEEec
Q 038860          345 KQLLGHGGFGQVYKGTLHNS---KTEVAVKRISNE-SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR-KGDLLLVYDFM  419 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  419 (652)
                      .++||+|+||+||+|.+..+   ...||||+++.. .....++|.+|+++|++++||||++++|+|.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999998653   346999999754 45566889999999999999999999999865 56899999999


Q ss_pred             cCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeeccceecccCCCC-
Q 038860          420 ANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKLYEHGTNP-  498 (652)
Q Consensus       420 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~~~~~~~~-  498 (652)
                      ++|+|.+++... ...+++..+++++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            999999988543 445788899999999999999999   799999999999999999999999999999976543222 


Q ss_pred             --ceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 038860          499 --ATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIET  545 (652)
Q Consensus       499 --~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~  545 (652)
                        ......||+.|+|||.+.++.++.++||||||+++|||+||+.||..
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence              22345789999999999999999999999999999999998888764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=351.87  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=202.0

Q ss_pred             cCccccccccccCceEEEEEEEc---CCCeEEEEEEecCcc----hhhHHHHHHHHHHhcccCc-CceeEEEeeeeccCe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLH---NSKTEVAVKRISNES----KQGVREFVSEIATIGRLRH-RNLVQLVGWCRRKGD  411 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  411 (652)
                      ++|++.+.||+|+||+||+|++.   .+++.||||.+++..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999873   468899999986532    2234567889999999976 899999999999999


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .+++|||+.+|+|.+++..  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999854  345778899999999999999999   79999999999999999999999999999987


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTG--KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLE  569 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (652)
                      .............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+....+...           
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-----------  247 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-----------  247 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-----------
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-----------
Confidence            654444444556899999999988654  4688999999999999999999999865443322211100           


Q ss_pred             ccccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCCC-----------cccccc
Q 038860          570 VIDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTTS-----------CSYFEN  633 (652)
Q Consensus       570 ~id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~s-----------~~~~~~  633 (652)
                                        ....  ....|.     ...+.+.+|+.+|+..+|++|+|           |+||+.
T Consensus       248 ------------------~~~~--~~~~~~-----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         248 ------------------ILKS--EPPYPQ-----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             ------------------HHHC--CCCCCT-----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ------------------cccC--CCCCcc-----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence                              0000  000111     23468999999999999999985           578766

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-41  Score=353.37  Aligned_cols=278  Identities=21%  Similarity=0.248  Sum_probs=202.7

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHhcccCcCceeEEEeeeecc-----Ce
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNES--KQGVREFVSEIATIGRLRHRNLVQLVGWCRRK-----GD  411 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  411 (652)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...  ....+++.+|+.+|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999999999999999997643  34456789999999999999999999998643     34


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      .++++||+.+|+|.+++..   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            5667788889999999843   35999999999999999999999   79999999999999999999999999999975


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTG-KSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEV  570 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (652)
                      ...    ......||+.|+|||...+. .++.++|||||||++|||++|+.||.+.+.......   +...... .    
T Consensus       171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~-~----  238 (348)
T d2gfsa1         171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGT-P----  238 (348)
T ss_dssp             CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCC-C----
T ss_pred             cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCC-C----
Confidence            432    33445789999999986665 568899999999999999999999986543222222   2121111 0    


Q ss_pred             cccccccCCCHHHHHHhhccCCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          571 IDPKLNAEYDQSQVLMGELELPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       571 id~~l~~~~~~~~~~~~~l~~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                       ...+......................+.........+.+.|||.+|+..||++|+      .|+||....
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         239 -GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             -CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             -ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence             0011111111111111111111111111111234567899999999999999999      478998643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.5e-40  Score=337.54  Aligned_cols=207  Identities=20%  Similarity=0.268  Sum_probs=176.8

Q ss_pred             hcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCc-CceeEEEeeeeccCeeEEEEE
Q 038860          339 TNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRH-RNLVQLVGWCRRKGDLLLVYD  417 (652)
Q Consensus       339 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  417 (652)
                      .++|++.+.||+|+||+||+|++..+++.||||.+.....  ...+.+|+++++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            3689999999999999999999999999999999865432  2346678888888864 899999999999999999999


Q ss_pred             eccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC-----CCCeEEeeeccceec
Q 038860          418 FMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS-----ELNGKLGDFGLAKLY  492 (652)
Q Consensus       418 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~-----~~~~kL~DFGla~~~  492 (652)
                      |+ +++|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+|+..
T Consensus        82 ~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            99 67998887543 346899999999999999999999   799999999999999974     567999999999976


Q ss_pred             ccCCC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccch
Q 038860          493 EHGTN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEEL  552 (652)
Q Consensus       493 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~  552 (652)
                      .....      .......||+.|||||.+.+..++.++|||||||++|||++|+.||.........
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~  222 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK  222 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH
Confidence            54322      1234468999999999999999999999999999999999999999876554443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-40  Score=346.74  Aligned_cols=278  Identities=21%  Similarity=0.263  Sum_probs=195.4

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCc--chhhHHHHHHHHHHhcccCcCceeEEEeeeec------cCe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNE--SKQGVREFVSEIATIGRLRHRNLVQLVGWCRR------KGD  411 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  411 (652)
                      ++|++.++||+|+||+||+|++..+++.||||++...  .....+++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999999999999999999754  33445678999999999999999999999864      367


Q ss_pred             eEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          412 LLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       412 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      +|+|||||.++.+. .+    ...+++..++.+++||+.||.|||   +++|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~-~~----~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VI----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHH-HH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHHH-hh----hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            89999999765444 44    235889999999999999999999   79999999999999999999999999999886


Q ss_pred             cccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccchhHHHHHHhhhcCCcccccc
Q 038860          492 YEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALPEELVLVDWVWGKYGEGRVLEVI  571 (652)
Q Consensus       492 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  571 (652)
                      ....  .......||+.|+|||++.+..++.++||||+||+++||++|+.||.........   ..+...... ...+.+
T Consensus       169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~---~~i~~~~~~-~~~~~~  242 (355)
T d2b1pa1         169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW---NKVIEQLGT-PCPEFM  242 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCC-CCHHHH
T ss_pred             cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH---HHHHHhccC-CCHHHH
Confidence            5432  2344567999999999999999999999999999999999999999765322221   111111110 000000


Q ss_pred             ccccccCCCHHHHHHhhcc----------CCCCCCCCCCCcccccchhHHHHHhhhccCCCCCCC------CccccccCc
Q 038860          572 DPKLNAEYDQSQVLMGELE----------LPDTLRGPRSSDGDKAAEGFDDLLNSLASSSFDKTT------SCSYFENGV  635 (652)
Q Consensus       572 d~~l~~~~~~~~~~~~~l~----------~~~~~~~p~~~~~~~~~~~~~dLl~~~~~~~~~~r~------s~~~~~~~~  635 (652)
                      ..    .............          .+...............+.+.||+++|+..+|++|+      .|+||.+..
T Consensus       243 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         243 KK----LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             TT----SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HH----hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            00    0000000000000          000111111111223456789999999999999998      589998744

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-39  Score=334.83  Aligned_cols=203  Identities=22%  Similarity=0.282  Sum_probs=168.2

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCcee-EEEeeeeccCeeEEEEEe
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV-QLVGWCRRKGDLLLVYDF  418 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~  418 (652)
                      ++|++.+.||+|+||.||+|++..+++.||||.+......  .++..|+++++.++|+|++ .+..++...+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999999989999999998764322  3577899999999877655 455556777888999999


Q ss_pred             ccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCC---CCCeEEeeeccceecccC
Q 038860          419 MANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDS---ELNGKLGDFGLAKLYEHG  495 (652)
Q Consensus       419 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~---~~~~kL~DFGla~~~~~~  495 (652)
                      + +++|...+.. ....+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..+||+|||+|+.+...
T Consensus        85 ~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             c-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9 4566665533 3446899999999999999999999   799999999999999864   457999999999987543


Q ss_pred             CC------CceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 038860          496 TN------PATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRALP  549 (652)
Q Consensus       496 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~~~  549 (652)
                      ..      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~  219 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  219 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence            22      1234568999999999999999999999999999999999999999865443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-35  Score=312.64  Aligned_cols=201  Identities=22%  Similarity=0.289  Sum_probs=162.0

Q ss_pred             cCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-----------cCceeEEEeeeec
Q 038860          340 NNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-----------HRNLVQLVGWCRR  408 (652)
Q Consensus       340 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  408 (652)
                      .+|++.++||+|+||+||+|++..+++.||||+++.... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            359999999999999999999999999999999976532 3456778888888775           5789999988865


Q ss_pred             c--CeeEEEEEeccCCCcc-cccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCC------
Q 038860          409 K--GDLLLVYDFMANGSLD-SFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSEL------  479 (652)
Q Consensus       409 ~--~~~~lV~e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~------  479 (652)
                      .  ...+++++++..+... ..........+++..+..++.||++||+|||+  ..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence            4  4566777776554432 22233445678899999999999999999995  48999999999999998664      


Q ss_pred             CeEEeeeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 038860          480 NGKLGDFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALLLEVACGRRPIETRA  547 (652)
Q Consensus       480 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl~elltG~~p~~~~~  547 (652)
                      .++++|||.+.....    ......||+.|+|||.+....++.++||||+||+++||++|+.||....
T Consensus       170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            399999999986543    2234579999999999999999999999999999999999999997543

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.95  E-value=2.7e-28  Score=235.50  Aligned_cols=115  Identities=33%  Similarity=0.541  Sum_probs=105.4

Q ss_pred             cccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCCCcccCCcCCCceEEEEEEEcCCCCeEEEEEeeC
Q 038860          133 SNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNSTKQDLSLKGGKAILVWVDYDSAENILNVTVSPN  212 (652)
Q Consensus       133 ~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~  212 (652)
                      .|++|||||||++|.+++||++||||||+|++.|..+.+            +++.+|+.++|||+||+.+++|+|+++..
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~------------~~l~~G~~~~v~I~Yd~~~~~L~V~~~~~   68 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK------------WNMQNGKVGTAHIIYNSVDKRLSAVVSYP   68 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE------------CCCCTTCEEEEEEEEETTTTEEEEEEECT
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceec------------ccccCCCEEEEEEEEecCCcEEEEEEecC
Confidence            378999999999999889999999999999999877664            46889999999999999999999999854


Q ss_pred             CCCCCCCeeeEEecCCcccccceEEEEecccccccccceeecccccccC
Q 038860          213 SSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFKING  261 (652)
Q Consensus       213 ~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~~~~  261 (652)
                        ++..|++++.+||+.+|+++||||||||||...+.|.|++|+|++..
T Consensus        69 --~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~  115 (237)
T d1nlsa_          69 --NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL  115 (237)
T ss_dssp             --TSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred             --CCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence              46778999999999999999999999999999999999999998754

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=4.3e-26  Score=223.46  Aligned_cols=198  Identities=18%  Similarity=0.192  Sum_probs=136.6

Q ss_pred             CCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCCC
Q 038860           35 NNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDLN  114 (652)
Q Consensus        35 ~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~~  114 (652)
                      .++.++|+|.+. ++.|+||++.++++|++||++|+++-        +|+|+|+|.+... ...+||||||+|+|+.   
T Consensus        24 ~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~~--------~F~~~f~f~~~~~-~~~ggdG~aF~i~~~~---   90 (228)
T d1gv9a_          24 PFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE--------NWEVEVTFRVTGR-GRIGADGLAIWYTENQ---   90 (228)
T ss_dssp             TTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCCS--------SEEEEEEEEEECS-SSCCCCEEEEEEESSC---
T ss_pred             cceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCcccc--------CcEEEEEEeccCC-CCCCCCEEEEEEecCC---
Confidence            467999999986 78899999999999999999999983        6999999999864 4468999999999975   


Q ss_pred             CCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccc-cceeecceec-CCCCcccCCcCCCceE
Q 038860          115 GLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKS-NASVEAAVYT-DNSTKQDLSLKGGKAI  192 (652)
Q Consensus       115 ~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s-~~~~~~~~~~-~~~~~~~~~~~~g~~~  192 (652)
                      +..|+.+|..       ...+-+||||||+.|.  ++++.+|+.++.|.... ....+..... ...+.... ...+..+
T Consensus        91 ~~~g~~~G~~-------~~~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  160 (228)
T d1gv9a_          91 GLDGPVFGSA-------DMWNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDF-RNKPYPV  160 (228)
T ss_dssp             CCEEEETTEC-------SCCEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHHCSEEECCCC-BSCSSCE
T ss_pred             CCCCCccCcC-------CCCceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCccccccceeeee-cCCceEE
Confidence            3455666652       2335589999999997  57888888887764331 1111100000 01111111 1234456


Q ss_pred             EEEEEEcCCCCeEEEEEeeCCCCCCCC-eeeEEecCCcccccceEEEEecccccccccceeeccccc
Q 038860          193 LVWVDYDSAENILNVTVSPNSSKPKIP-ILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFK  258 (652)
Q Consensus       193 ~~~I~Y~~~~~~l~v~~~~~~~~~~~p-~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~  258 (652)
                      ++|++|+  .+.|+|++.........+ .....++ ...+|+++||||||+||...+.|.|++|.+.
T Consensus       161 ~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~~  224 (228)
T d1gv9a_         161 RAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFLTF  224 (228)
T ss_dssp             EEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEEEE
T ss_pred             EEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCeEEEEEEEEE
Confidence            6666666  678999998665533333 3333333 5568999999999999999999999998764

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.91  E-value=4e-25  Score=213.11  Aligned_cols=106  Identities=26%  Similarity=0.420  Sum_probs=93.7

Q ss_pred             CceeEEcCCCCCCCCCeEEecceEeccCCcEEecCCC------CCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecC
Q 038860           21 QLDELFFPGFKDLSNNLTLQGIAKIENNGILRLTNDT------SRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPE   94 (652)
Q Consensus        21 ~~~~f~~~~F~~~~~~~~~~g~a~~~~~~~i~Lt~~~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~   94 (652)
                      ...+|+|++|.+++.||+|+|+|.+.++|.||||+..      ..++|||+|++||+|||+ +++++||+|+|+|.|.+.
T Consensus       124 n~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~~~~SFsT~F~F~I~~~  202 (237)
T d1nlsa_         124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKSP  202 (237)
T ss_dssp             EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCCS
T ss_pred             ccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CCcEeeEEEEEEEEEecC
Confidence            5689999999988899999999999889999999754      457999999999999995 899999999999999886


Q ss_pred             CCCCCcCcEEEEEccCC-CCC-CCCCccccCCccCC
Q 038860           95 YPRLGGHGLAFTISPSN-DLN-GLPSQYLGLLNSTD  128 (652)
Q Consensus        95 ~~~~~gdGlaF~l~p~~-~~~-~~~g~~lG~~~~~~  128 (652)
                      . ..+||||||||+|.. ..| ++.|+||||+|.+|
T Consensus       203 ~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n  237 (237)
T d1nlsa_         203 D-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN  237 (237)
T ss_dssp             S-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred             C-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence            4 568999999999975 445 89999999998763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.3e-22  Score=192.83  Aligned_cols=169  Identities=13%  Similarity=0.125  Sum_probs=119.5

Q ss_pred             cccccccccCceEEEEEEEcCCCeEEEEEEecCcch------------------hhHHHHHHHHHHhcccCcCceeEEEe
Q 038860          343 SAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK------------------QGVREFVSEIATIGRLRHRNLVQLVG  404 (652)
Q Consensus       343 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  404 (652)
                      .+.++||+|+||.||+|.+. +|+.||||+++....                  ........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45788999999999999986 488999998753210                  11234567888999999999998876


Q ss_pred             eeeccCeeEEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccCccceEEecCCCCCceEeCCCCCeEEe
Q 038860          405 WCRRKGDLLLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEGYEQVVIHRDVKASNVLLDSELNGKLG  484 (652)
Q Consensus       405 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDlk~~NILl~~~~~~kL~  484 (652)
                      +..    .+++|||+++..+..         ++......++.|++.+|+|||   +++|+||||||+|||++++ .++|+
T Consensus        82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            532    379999998755433         344556689999999999999   7999999999999999965 59999


Q ss_pred             eeccceecccCCCCceeeccCCcCCCCCCCCCCCCCCCccchHhHHHHH
Q 038860          485 DFGLAKLYEHGTNPATTRVVGTLGYLAPETPRTGKSSASSDVFAFGALL  533 (652)
Q Consensus       485 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~SlGvvl  533 (652)
                      |||+|+...+......  ...+...+ .| ...+.|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~~~--l~rd~~~~-~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREI--LERDVRNI-IT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHH--HHHHHHHH-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHH--HHHHHHHH-HH-HHcCCCCCcccHHHHHHHH
Confidence            9999986543221000  00000000 00 0135578889999976544

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.84  E-value=2e-20  Score=180.92  Aligned_cols=199  Identities=14%  Similarity=0.157  Sum_probs=129.6

Q ss_pred             eEEcCCCCC---CCCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCc
Q 038860           24 ELFFPGFKD---LSNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGG  100 (652)
Q Consensus        24 ~f~~~~F~~---~~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g  100 (652)
                      .|+++.+-.   -..++.+.|+|.+. +|.|+||++ .++.|.+|+++|+++++       +|+++|+|+|... ...+|
T Consensus         9 ~~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~-------~f~~~~~F~i~g~-~~~gg   78 (221)
T d2a6za1           9 DYSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD-------SFTMEWTFRSVGY-SGQTD   78 (221)
T ss_dssp             GGCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS-------CEEEEEEEEEESC-CSCCS
T ss_pred             cccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccCC-------CeEEEEEEEEeCC-CCCCC
Confidence            467766532   24689999999997 889999987 57889999999999986       6999999999864 34579


Q ss_pred             CcEEEEEccCCCCCCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCccccceeecceecCCCC
Q 038860          101 HGLAFTISPSNDLNGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMKSNASVEAAVYTDNST  180 (652)
Q Consensus       101 dGlaF~l~p~~~~~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~s~~~~~~~~~~~~~~  180 (652)
                      |||||++++.... +..|+++|..+       ...-+||||||+.|.    ....|+.++.++......... ......+
T Consensus        79 dG~af~~~~~~~~-~~~g~~~G~~~-------~~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~-~~~~~~~  145 (221)
T d2a6za1          79 GGISFWFVQDSNI-PRDKQLYNGPV-------NYDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIY-DQSFASC  145 (221)
T ss_dssp             CEEEEEEEECSSS-CCCCTBTTBCT-------TCEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGHH-HHCSEEE
T ss_pred             CcEEEEEEcCCCc-cccccccccCC-------CCceEEEEEECCCCC----CCceEEEecCCCccccccCCc-cccccee
Confidence            9999999976532 34555566522       234489999999873    122333444333221111100 0000111


Q ss_pred             cccCC-cCCCceEEEEEEEcCCCCe-EEEEEeeCCCCCCCCeeeEEecCCcccccceEEEEecccccccccceeecc
Q 038860          181 KQDLS-LKGGKAILVWVDYDSAENI-LNVTVSPNSSKPKIPILSFRVDLSPIFNEFMYVGFSASTGLLASSHNVLGW  255 (652)
Q Consensus       181 ~~~~~-~~~g~~~~~~I~Y~~~~~~-l~v~~~~~~~~~~~p~ls~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w  255 (652)
                        ... ..++...+++|.|++.++. |.|.+...        +...++--.+.++++|+||||+||...+.|.+..+
T Consensus       146 --~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~--------~c~~~~~v~lp~~~~~fG~SA~TG~~~~~hd~~~i  212 (221)
T d2a6za1         146 --LMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK--------VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEI  212 (221)
T ss_dssp             --ECCCTTEEEEEEEEEEEEGGGTSEEEEEETTE--------EEEEESCCCCCSSEEEEEEEEECCSGGGCCCEEEE
T ss_pred             --eecccCCCCCEEEEEEEecCccceEEEEecCc--------EeEEECCeecCCCCEEEEEEEccCCccCCCceEEE
Confidence              222 3467778999999876554 67877521        11122222223577899999999998888775444

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.80  E-value=3.1e-19  Score=171.75  Aligned_cols=190  Identities=14%  Similarity=0.111  Sum_probs=127.1

Q ss_pred             CCCeEEecceEeccCCcEEecCCCCCceEEEEeCCceeeccCCCCceeeeEEEEEEEEecCCCCCCcCcEEEEEccCCCC
Q 038860           34 SNNLTLQGIAKIENNGILRLTNDTSRKMGQAFYSSTLRFKNSLNSNVFSFSTSFAIVIVPEYPRLGGHGLAFTISPSNDL  113 (652)
Q Consensus        34 ~~~~~~~g~a~~~~~~~i~Lt~~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~p~~~~  113 (652)
                      -.++.+.|+|.+. +|.|+||++ .++.|++|++.|+++++       +|+++|+|+|... ...+||||||++++....
T Consensus        21 ~~~W~~~G~~~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~-------~f~i~~~F~i~g~-~~~~~dG~afw~~~~~~~   90 (218)
T d2a6va1          21 LSQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIKD-------AMTIEWTFRSFGF-RGSTKGGLAFWLKQGNEG   90 (218)
T ss_dssp             TTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCSS-------CEEEEEEEEEESC-CSCCSCEEEEEEECSCCC
T ss_pred             cCccEECCCEEEE-CCEEEECCC-CCCeeEEEeCCcccccc-------cceEEEEEEEeCC-CCCCCCcEEEEEEcCCcc
Confidence            3689999999997 899999998 46789999999999987       6999999999865 345799999999986532


Q ss_pred             CCCCCccccCCccCCCCCCcccEEEEEeecccCCCCCCCCCCceeeecCCcc-ccceeecceecCCCCcccCCcCCCceE
Q 038860          114 NGLPSQYLGLLNSTDIGNFSNHLFAVEFDTVQDFEFQDINDNHIGIDINSMK-SNASVEAAVYTDNSTKQDLSLKGGKAI  192 (652)
Q Consensus       114 ~~~~g~~lG~~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~hvgi~~ns~~-s~~~~~~~~~~~~~~~~~~~~~~g~~~  192 (652)
                      .+ .++..|..+.-       .=+||||||+.|.      .+||.+.+|.=. .....+-  ...+.+.. -...++...
T Consensus        91 ~~-~~~~~G~~~~f-------~GlaV~fDt~~n~------~~~i~~~~ndGs~~~~~~~d--~~~g~c~~-~~~~~~~~~  153 (218)
T d2a6va1          91 DS-TELFGGSSKKF-------NGLMILLRLDDKL------GESVTAYLNDGTKDLDIESS--PYFASCLF-QYQDSMVPS  153 (218)
T ss_dssp             CC-CTBTTTBCSSC-------EEEEEEEEEETTT------EEEEEEEEEESSSCCCTTTS--CCSEEEEC-CCSSCSSCE
T ss_pred             cC-CCcccccCCCc-------ceEEEEEECCCCC------CCeEEEEeCCCCccccccCC--cccceEEe-cccCCCCcE
Confidence            22 12222221111       1279999999874      367777554211 0000000  00011111 113567789


Q ss_pred             EEEEEEcCCCCe-EEEEEeeCCCCCCCCeee-EEecCCcccccceEEEEecccccccccceeeccccc
Q 038860          193 LVWVDYDSAENI-LNVTVSPNSSKPKIPILS-FRVDLSPIFNEFMYVGFSASTGLLASSHNVLGWSFK  258 (652)
Q Consensus       193 ~~~I~Y~~~~~~-l~v~~~~~~~~~~~p~ls-~~vdL~~~l~~~~~vGfsastg~~~~~~~v~~w~f~  258 (652)
                      +++|.|+..... ++|.+..      +.++. ..|+|  ..++++|+||||+||...+.|.|.+|++.
T Consensus       154 ~~~i~Y~~~~~~~l~v~id~------~~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~  213 (218)
T d2a6va1         154 TLRLTYNPLDNHLLKLQMDN------RVCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLY  213 (218)
T ss_dssp             EEEEEEEGGGTSEEEEEETT------EEEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred             EEEEEEECcccceEEEEeCC------cEEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEE
Confidence            999999875543 6776652      11221 22333  24577999999999999999999999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=1.7e-07  Score=91.19  Aligned_cols=149  Identities=18%  Similarity=0.097  Sum_probs=99.5

Q ss_pred             hhhhhhcCccccccccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC-cCceeEEEeeeeccCee
Q 038860          334 ELKQATNNFSAKQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR-HRNLVQLVGWCRRKGDL  412 (652)
Q Consensus       334 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  412 (652)
                      +++.....|+..+..+.+..+.||+...  .+..+.+|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            4555566777766655555678998764  35667889887654444445677888877664 33467788888888889


Q ss_pred             EEEEEeccCCCcccccccCCccccchHHHhhhHHHHHHHHhhhccC----------------------------------
Q 038860          413 LLVYDFMANGSLDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHEG----------------------------------  458 (652)
Q Consensus       413 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~----------------------------------  458 (652)
                      ++||+++++.++.+....       ......++.++++.+..||+.                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998776543311       111222334444444444420                                  


Q ss_pred             ----------------------ccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          459 ----------------------YEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       459 ----------------------~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                                            ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  024589999999999999876667999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.92  E-value=2.8e-05  Score=74.52  Aligned_cols=131  Identities=18%  Similarity=0.136  Sum_probs=84.1

Q ss_pred             cccccC-ceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccC--cCceeEEEeeeeccCeeEEEEEeccCCC
Q 038860          347 LLGHGG-FGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLR--HRNLVQLVGWCRRKGDLLLVYDFMANGS  423 (652)
Q Consensus       347 ~LG~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gs  423 (652)
                      .+..|. -+.||+....+ +..+++|........   .+..|...++.+.  .-.+.+++.++.+.+..++||++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            344444 36789988754 666888987655433   3556777777664  3335678888888888999999999877


Q ss_pred             cccccccCCccccchHHHhhhHHHHHHHHhhhcc----------------------------------------------
Q 038860          424 LDSFLFDEPKAVLNWEQRFKIIKGVASGLLYLHE----------------------------------------------  457 (652)
Q Consensus       424 L~~~l~~~~~~~l~~~~~~~i~~~i~~aL~~LH~----------------------------------------------  457 (652)
                      +.+....       .   ...+.+++..|.-||+                                              
T Consensus        93 ~~~~~~~-------~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          93 LLSSHLA-------P---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTTSCCC-------H---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccccc-------H---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            6543200       0   0111122222222221                                              


Q ss_pred             ---------CccceEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          458 ---------GYEQVVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       458 ---------~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                               .....++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                     1134589999999999999876678999998763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.47  E-value=0.0001  Score=75.64  Aligned_cols=77  Identities=12%  Similarity=0.040  Sum_probs=48.2

Q ss_pred             cccccccCceEEEEEEEcCCCeEEEEEEecCcch-------hhHHHHHHHHHHhcccC---cCceeEEEeeeeccCeeEE
Q 038860          345 KQLLGHGGFGQVYKGTLHNSKTEVAVKRISNESK-------QGVREFVSEIATIGRLR---HRNLVQLVGWCRRKGDLLL  414 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  414 (652)
                      .+.||.|....||+.....+++.+++|......+       ....+...|.+.|+.+.   ...+++++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            3458999999999999877778899997643211       11223445777776552   24466666654  345578


Q ss_pred             EEEeccCCC
Q 038860          415 VYDFMANGS  423 (652)
Q Consensus       415 V~e~~~~gs  423 (652)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.53  E-value=0.0034  Score=63.82  Aligned_cols=75  Identities=15%  Similarity=0.144  Sum_probs=49.6

Q ss_pred             cccccccCceEEEEEEEcC-------CCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCc-eeEEEeeeeccCeeEEEE
Q 038860          345 KQLLGHGGFGQVYKGTLHN-------SKTEVAVKRISNESKQGVREFVSEIATIGRLRHRN-LVQLVGWCRRKGDLLLVY  416 (652)
Q Consensus       345 ~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  416 (652)
                      .+.|+.|-.-.+|+.....       ..+.|.+++.... . ......+|..+++.+.-.+ ..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3567888888999998753       2345667666532 2 2234557888888885334 4577777754    5799


Q ss_pred             EeccCCCcc
Q 038860          417 DFMANGSLD  425 (652)
Q Consensus       417 e~~~~gsL~  425 (652)
                      ||+++..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999876554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.46  E-value=0.0036  Score=61.78  Aligned_cols=135  Identities=14%  Similarity=0.139  Sum_probs=77.0

Q ss_pred             ceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCcee--EEEe-----eeeccCeeEEEEEeccCCCcc
Q 038860          353 FGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV--QLVG-----WCRRKGDLLLVYDFMANGSLD  425 (652)
Q Consensus       353 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~-----~~~~~~~~~lV~e~~~~gsL~  425 (652)
                      --.||+....+ |..+++|..+... ...+++..|...+..|....+.  ..+.     .+...+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~d-g~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDED-RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTT-CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCC-CCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            45899998864 7889999987642 2345567788887777433221  1111     223455678899999875443


Q ss_pred             ccc--------------c----c---CCccccch-------------------HH---HhhhHHHHHHHHhh-hccCccc
Q 038860          426 SFL--------------F----D---EPKAVLNW-------------------EQ---RFKIIKGVASGLLY-LHEGYEQ  461 (652)
Q Consensus       426 ~~l--------------~----~---~~~~~l~~-------------------~~---~~~i~~~i~~aL~~-LH~~~~~  461 (652)
                      ..-              +    .   .....+++                   ..   ....+.++...+.- +.+....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            210              0    0   00011111                   11   11222223332222 1223357


Q ss_pred             eEEecCCCCCceEeCCCCCeEEeeecccee
Q 038860          462 VVIHRDVKASNVLLDSELNGKLGDFGLAKL  491 (652)
Q Consensus       462 ~ivHrDlk~~NILl~~~~~~kL~DFGla~~  491 (652)
                      ++||+|+.+.|||++++  ..++||+-|..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            89999999999999754  46899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.17  E-value=0.0098  Score=58.03  Aligned_cols=157  Identities=15%  Similarity=0.083  Sum_probs=82.5

Q ss_pred             cchhhhhhhhcCcccccc-----ccccCceEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHhcccCcCcee--EE
Q 038860          330 YSYQELKQATNNFSAKQL-----LGHGGFGQVYKGTLHNSKTEVAVKRISNESKQGVREFVSEIATIGRLRHRNLV--QL  402 (652)
Q Consensus       330 ~~~~el~~~~~~f~~~~~-----LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l  402 (652)
                      .+-+|+.....+|.+.+.     |..|---+.|+.+..+  ..+++|+......  .+++..|++++..|...++.  ..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccc
Confidence            345666666677765333     4466668889988754  3488998865322  23344566666666433221  11


Q ss_pred             Ee------eeeccCeeEEEEEeccCCCcccccc----------------------cCCccc-----------------cc
Q 038860          403 VG------WCRRKGDLLLVYDFMANGSLDSFLF----------------------DEPKAV-----------------LN  437 (652)
Q Consensus       403 ~~------~~~~~~~~~lV~e~~~~gsL~~~l~----------------------~~~~~~-----------------l~  437 (652)
                      +.      +....+....++.++.+......-.                      ......                 ..
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11      1112345566777776644432110                      000000                 00


Q ss_pred             hHHHhhhHHHHHHHHhhhc-cCccceEEecCCCCCceEeCCCCCeEEeeeccce
Q 038860          438 WEQRFKIIKGVASGLLYLH-EGYEQVVIHRDVKASNVLLDSELNGKLGDFGLAK  490 (652)
Q Consensus       438 ~~~~~~i~~~i~~aL~~LH-~~~~~~ivHrDlk~~NILl~~~~~~kL~DFGla~  490 (652)
                      .......+..+...+.-.+ .....++||+|+.+.||+++.+...-|+||+.|.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111112222222222222 1346899999999999999988777899999876